PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Armstrong, AJ; Gupta, S; Healy, P; Kemeny, G; Leith, B; Zalutsky, MR; Spritzer, C; Davies, C; Rothwell, C; Ware, K; Somarelli, JA; Wood, K; Ribar, T; Giannakakou, P; Zhang, JR; Gerber, D; Anand, M; Foo, WC; Halabi, S; Gregory, SG; George, DJ				Armstrong, Andrew J.; Gupta, Santosh; Healy, Patrick; Kemeny, Gabor; Leith, Beth; Zalutsky, Michael R.; Spritzer, Charles; Davies, Catrin; Rothwell, Colin; Ware, Kathryn; Somarelli, Jason A.; Wood, Kris; Ribar, Thomas; Giannakakou, Paraskevi; Zhang, Jiaren; Gerber, Drew; Anand, Monika; Foo, Wen-Chi; Halabi, Susan; Gregory, Simon G.; George, Daniel J.			Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; EPITHELIAL PLASTICITY; ALKALINE-PHOSPHATASE; DOUBLE-BLIND; DNA-REPAIR; SURVIVAL; PHASE-3; GROWTH; TRANSITION; EXPRESSION	Background Radium-223 is a targeted alpha-particle therapy that improves survival in men with metastatic castration resistant prostate cancer (mCRPC), particularly in men with elevated serum levels of bone alkaline phosphatase (B-ALP). We hypothesized that osteomimicry, a form of epithelial plasticity leading to an osteoblastic phenotype, may contribute to intralesional deposition of radium-223 and subsequent irradiation of the tumor microenvironment. Methods We conducted a pharmacodynamic study (NCT02204943) of radium-223 in men with bone mCRPC. Prior to and three and six months after radium-223 treatment initiation, we collected CTCs and metastatic biopsies for phenotypic characterization and CTC genomic analysis. The primary objective was to describe the impact of radium-223 on the prevalence of CTC B-ALP over time. We measured radium-223 decay products in tumor and surrounding normal bone during treatment. We validated genomic findings in a separate independent study of men with bone metastatic mCRPC (n = 45) and publicly accessible data of metastatic CRPC tissues. Results We enrolled 20 men with symptomatic bone predominant mCRPC and treated with radium-223. We observed greater radium-223 radioactivity levels in metastatic bone tumor containing biopsies compared with adjacent normal bone. We found evidence of persistent Cellsearch CTCs and B-ALP (+) CTCs in the majority of men over time during radium-223 therapy despite serum B-ALP normalization. We identified genomic gains in osteoblast mimicry genes including gains of ALPL, osteopontin, SPARC, OB-cadherin and loss of RUNX2, and validated genomic alterations or increased expression at the DNA and RNA level in an independent cohort of 45 men with bone-metastatic CRPC and in 150 metastatic biopsies from men with mCRPC. Conclusions Osteomimicry may contribute in part to the uptake of radium-223 within bone metastases and may thereby enhance the therapeutic benefit of this bone targeting radiotherapy.	[Armstrong, Andrew J.; Gupta, Santosh; Kemeny, Gabor; Leith, Beth; Davies, Catrin; Rothwell, Colin; Ware, Kathryn; Somarelli, Jason A.; Gerber, Drew; Anand, Monika; George, Daniel J.] Duke Univ, Dept Med, Duke Canc Inst, Div Med Oncol, Durham, NC 27708 USA; [Armstrong, Andrew J.; Wood, Kris; Ribar, Thomas] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Armstrong, Andrew J.; Gupta, Santosh; Healy, Patrick; Kemeny, Gabor; Zalutsky, Michael R.; Spritzer, Charles; Davies, Catrin; Rothwell, Colin; Ware, Kathryn; Somarelli, Jason A.; Anand, Monika; Halabi, Susan; Gregory, Simon G.; George, Daniel J.] Duke Canc Inst, Duke Prostate & Urol Canc Ctr, Durham, NC 27710 USA; [Gupta, Santosh; Gregory, Simon G.] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA; [Healy, Patrick; Halabi, Susan] Duke Univ, Dept Biostat, Durham, NC USA; [Zalutsky, Michael R.; Spritzer, Charles] Duke Univ, Dept Radiol, Durham, NC 27710 USA; [Giannakakou, Paraskevi; Zhang, Jiaren] Weill Cornell Med Coll, New York, NY USA; [Foo, Wen-Chi] Duke Univ, Duke Dept Pathol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Cornell University; Duke University	Armstrong, AJ (corresponding author), Duke Univ, Dept Med, Duke Canc Inst, Div Med Oncol, Durham, NC 27708 USA.; Armstrong, AJ (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Armstrong, AJ (corresponding author), Duke Canc Inst, Duke Prostate & Urol Canc Ctr, Durham, NC 27710 USA.	andrew.armstrong@duke.edu	Halabi, Susan/AFL-7973-2022; Halabi, Susan/AAG-7938-2022	Halabi, Susan/0000-0003-4135-2777; Halabi, Susan/0000-0003-4135-2777; Gregory, Simon/0000-0002-7805-1743; Armstrong, Andrew/0000-0001-7012-1754; zalutsky, michael/0000-0002-5456-0324	Prostate Cancer Foundation; Department of Defense Prostate Cancer Clinical Trials Consortium (DOD PCCTC); Movember; Bayer	Prostate Cancer Foundation; Department of Defense Prostate Cancer Clinical Trials Consortium (DOD PCCTC); Movember; Bayer(Bayer AG)	Funded as an investigator initiated study to Duke University by Bayer. For the PROPHECY study, we acknowledge funding from the Prostate Cancer Foundation and Movember and support from the Department of Defense Prostate Cancer Clinical Trials Consortium (DOD PCCTC).	Abida W, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00029; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Armstrong AJ, 2011, MOLCANCER RES; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Bitting RL, 2014, CANCER METAST REV, V33, P441, DOI 10.1007/s10555-013-9483-z; Cho HJ, 2014, CANCER DISCOV, V4, P318, DOI 10.1158/2159-8290.CD-13-0346; Chu GCY, 2014, ENDOCR-RELAT CANCER, V21, P311, DOI 10.1530/ERC-13-0548; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Flux GD, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160748; Gonzalez A, 2017, PROSTATE, V77, P321, DOI 10.1002/pros.23270; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Gupta S, 2017, CLIN CANCER RES, V23, P1346, DOI 10.1158/1078-0432.CCR-16-1211; Haider M, 2016, CLIN EXP METASTAS, V33, P239, DOI 10.1007/s10585-015-9773-7; Heller G, 2018, J CLIN ONCOL, V36, P572, DOI 10.1200/JCO.2017.75.2998; Hoskin P, 2014, LANCET ONCOL, V15, P1397, DOI 10.1016/S1470-2045(14)70474-7; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Knerr K, 2004, INT J CANCER, V111, P152, DOI 10.1002/ijc.20223; Koeneman KS, 1999, PROSTATE, V39, P246; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-55; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lopez-Riquelme N, 2013, APMIS, V121, P1139, DOI 10.1111/apm.12061; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Perez-Lopez R, 2016, RADIOLOGY, V280, P151, DOI 10.1148/radiol.2015150799; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rao SR, 2017, BRIT J CANCER, V116, P227, DOI 10.1038/bjc.2016.402; Reyes EE, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0313-z; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Ruscetti M, 2015, CANCER RES, V75, P2749, DOI 10.1158/0008-5472.CAN-14-3476; Sailer V, 2018, CANCER-AM CANCER SOC, V124, P1008, DOI 10.1002/cncr.31173; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Sartor O, 2017, ANN ONCOL, V28, P1090, DOI 10.1093/annonc/mdx044; Sartor O, 2014, LANCET ONCOL, V15, P738, DOI 10.1016/S1470-2045(14)70183-4; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2015, J CLIN ONCOL, V33, P1348, DOI 10.1200/JCO.2014.55.3487; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Sieh S, 2014, BONE, V63, P121, DOI 10.1016/j.bone.2014.02.001; Spritzer CE, 2013, RADIOLOGY, V269, P816, DOI 10.1148/radiol.13121782; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; Ware KE, 2016, ONCOTARGET, V7, P50520, DOI 10.18632/oncotarget.10476; Zou M, 2017, CANCER DISCOV, V7, P736, DOI 10.1158/2159-8290.CD-16-1174	49	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216934	10.1371/journal.pone.0216934	http://dx.doi.org/10.1371/journal.pone.0216934			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136607	gold, Green Published			2022-12-27	WOS:000469224300012
J	Singh, D; Thakur, S; Thayil, SM; Kesavan, AK				Singh, Drishtant; Thakur, Sharad; Thayil, Seema Madhumal; Kesavan, Anup Kumar			Characterization of a cold-active, detergent-stable metallopeptidase purified from Bacillus sp. S1DI 10 using Response Surface Methodology	PLOS ONE			English	Article							THERMOSTABLE ALKALINE PROTEASE; SERINE-PROTEASE; NATTOKINASE PRODUCTION; PURIFICATION; CLONING; OPTIMIZATION; ENZYMES; PHYLOGENIES; BACTERIA	The colder regions of Earth are inhabited by cold-adapted microorganisms designated as psychrophiles that are known to produce cold-active enzymes, such as peptidases, chaperones, lipases, cellulases, and phosphatases. These types of enzymes are a major part of the market of industrial enzymes. Bacteria isolated from water samples collected from the Chamba region in the Himalayas were screened for peptidase production using skim milk agar plates. Among the peptidase-producing bacteria isolated, 20% of the isolates exhibited fast growth and maximum zones of clearance, and thus, were used for further studies. The 16S rDNA sequence analysis of isolate S1DI 10 identified it as a Bacillus sp. The peptidase was cloned in pET28a vector and expressed in Escherichia coli BL21(DE3) and the His-tagged recombinant protein was purified using Ni-NTA column. The purified peptidase of SIDI 10 was found to be an alkaline, cold-active peptidase with optimal enzyme activity at 10 degrees C and pH 8. An approach of one variable at a time was used to further study the effect of various metal ions, organic solvents and detergents on the peptidase enzyme. The peptidase activity was enhanced in the presence of Fe2+ and Mn2+ ( metal ions), hexane ( organic solvent), SDS-sodium dodecyl sulfate ( anionic detergent) and Tween 80 ( nonionic detergent). Response surface methodology ( RSM) was used to determine the cumulative effect of these five variables. A 2(5) full factorial central composite design was applied for the five independent variables to determine the optimal combinations of these constituents at the maximum peptidase activity.	[Singh, Drishtant; Thakur, Sharad; Thayil, Seema Madhumal; Kesavan, Anup Kumar] Guru Nanak Dev Univ, Dept Mol Biol & Biochem, Mol Microbiol Lab, Amritsar, Punjab, India	Guru Nanak Dev University	Kesavan, AK (corresponding author), Guru Nanak Dev Univ, Dept Mol Biol & Biochem, Mol Microbiol Lab, Amritsar, Punjab, India.	akesav@gmail.com	, Drishtant Singh/CAI-1626-2022; Kesavan, Anup Kumar/AAF-1468-2019	, Drishtant Singh/0000-0003-0179-2057; 	UPE (University with the Potential for Excellence) by UGC, India	UPE (University with the Potential for Excellence) by UGC, India	We are grateful to the UPE (University with the Potential for Excellence) by UGC, India for providing the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghel VS, 2005, ENZYME MICROB TECH, V36, P654, DOI 10.1016/j.enzmictec.2004.09.005; Catara G, 2003, EXTREMOPHILES, V7, P391, DOI 10.1007/s00792-003-0337-4; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Deepak V, 2008, BIORESOURCE TECHNOL, V99, P8170, DOI 10.1016/j.biortech.2008.03.018; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Elbanna K, 2015, EXTREMOPHILES, V19, P763, DOI 10.1007/s00792-015-0752-3; Feller G, 1996, FEMS MICROBIOL REV, V18, P189, DOI 10.1016/0168-6445(96)00011-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gerze A, 2005, APPL BIOCHEM BIOTECH, V121, P335, DOI 10.1385/ABAB:121:1-3:0335; Godfrey T, 1996, IND ENZYMOLOGY, V2nd; Haddar A, 2009, BIORESOURCE TECHNOL, V100, P3366, DOI 10.1016/j.biortech.2009.01.061; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Huston AL, 2000, ENVIRON MICROBIOL, V2, P383, DOI 10.1046/j.1462-2920.2000.00118.x; Jang HJ, 2002, EXTREMOPHILES, V6, P233, DOI 10.1007/s00792-001-0248-1; Joshi GK, 2007, BRAZ J MICROBIOL, V38, P773, DOI 10.1590/S1517-83822007000400034; Kaur S, 2001, WORLD J MICROB BIOT, V17, P125, DOI 10.1023/A:1016637528648; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Kulakova L, 1999, APPL ENVIRON MICROB, V65, P611; Kumar CG, 2002, LETT APPL MICROBIOL, V34, P13, DOI [10.1046/j.1472-765x.2002.01044.x, 10.1046/j.1472-765X.2002.01044.x]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu JG, 2005, PROCESS BIOCHEM, V40, P2757, DOI 10.1016/j.procbio.2004.12.025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANACHINI PL, 1988, APPL MICROBIOL BIOT, V28, P409, DOI 10.1007/BF00268205; Margesin R., 2008, PSYCHROPHILES BIODIV, P211, DOI [10.1002/0471263397.env150, DOI 10.1002/0471263397.ENV150]; MORIHARA K, 1974, ADV ENZYMOL RAMB, V41, P179; Morita Y, 1998, APPL MICROBIOL BIOT, V50, P669, DOI 10.1007/s002530051349; Mukherjee AK, 2011, NEW BIOTECHNOL, V28, P182, DOI 10.1016/j.nbt.2010.11.003; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; Okuda M, 2008, EXTREMOPHILES, V4, P229; RAHMAN RNZA, 1994, APPL MICROBIOL BIOT, V40, P822, DOI 10.1007/s002530050074; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Porro C, 2003, EXTREMOPHILES, V7, P221, DOI 10.1007/s00792-003-0316-9; Secades P, 2003, FEMS MICROBIOL LETT, V226, P273, DOI 10.1016/S0378-1097(03)00599-8; Singh S, 2014, 3 BIOTECH, V4, P411, DOI 10.1007/s13205-013-0169-6; Son ES, 2003, J MICROBIOL, V41, P58; Sookkheo B, 2000, PROTEIN EXPRES PURIF, V20, P142, DOI 10.1006/prep.2000.1282; Sung JH, 2010, APPL BIOCHEM BIOTECH, V162, P900, DOI 10.1007/s12010-009-8830-6; Swathi M.N, 2011, INT J PHARM RES DEV, V3, P216; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Toyokawa Y, 2010, APPL MICROBIOL BIOT, V86, P1867, DOI 10.1007/s00253-009-2434-5; TSUCHIDA O, 1986, CURR MICROBIOL, V14, P7, DOI 10.1007/BF01568094; Valicente F. H., 2008, Revista Brasileira de Milho e Sorgo, V7, P195; Wang QF, 2005, BIOTECHNOL LETT, V27, P1195, DOI 10.1007/s10529-005-0016-x; Wang QF, 2008, BIOCHEM ENG J, V38, P362, DOI 10.1016/j.bej.2007.07.025	48	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216990	10.1371/journal.pone.0216990	http://dx.doi.org/10.1371/journal.pone.0216990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120932	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700045
J	van Beusekom, I; Bakhshi-Raiez, F; de Keizer, NF; van der Schaaf, M; Termorshuizen, F; Dongelmans, DA				van Beusekom, Ilse; Bakhshi-Raiez, Ferishta; de Keizer, Nicolette F.; van der Schaaf, Marike; Termorshuizen, Fabian; Dongelmans, Dave A.			Dutch ICU survivors have more consultations with general practitioners before and after ICU admission compared to a matched control group from the general population	PLOS ONE			English	Article							CARE; RISK	Background General Practitioners (GPs) play a key role in the healthcare trajectory of patients. If the patient experiences problems that are typically non-life-threatening, such as the symptoms of post-intensive-care syndrome, the GP will be the first healthcare professional they consult. The primary aim of this study is to gain insight in the frequency of GP consultations during the year before hospital admission and the year after discharge for ICU survivors and a matched control group from the general population. The secondary aim of this study is to gain insight into differences between subgroups of the ICU population with respect to the frequency of GP consultations. Methods We conducted a retrospective cohort study, combining a national health insurance claims database and a national quality registry for ICUs. Clinical data of patients admitted to an ICU in 2013 were enriched with claims data from the years 2012, 2013 and 2014. Poisson regression was used to assess the differences in frequency of GP consultations between the ICU population and the control group. Results ICU patients have more consultations with GPs during the year before and after admission than individuals in the control group. In the last four weeks before admission, ICU patients have 3.58 (CI 3.37; 3.80) times more GP consultations than the control group, and during the first four weeks after discharge they have 4.98 (CI 4.74; 5.23) times more GP consultations. In the year after hospital discharge ICU survivors have an increased GP consultation rate compared to the year before their hospital admission. Conclusions Close to hospital admission and shortly after hospital discharge, the frequency of GP consultations substantially increases in the population of ICU survivors. Even a year after hospital discharge, ICU survivors have increased GP consultation rates. Therefore, GPs should be well informed about the problems ICU patients suffer after discharge, in order to provide suitable follow-up care.	[van Beusekom, Ilse; Bakhshi-Raiez, Ferishta; de Keizer, Nicolette F.; Termorshuizen, Fabian] Univ Amsterdam, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Dept Med Informat, Amsterdam, Netherlands; [van Beusekom, Ilse; Bakhshi-Raiez, Ferishta; de Keizer, Nicolette F.; Termorshuizen, Fabian; Dongelmans, Dave A.] Natl Intens Care Evaluat NICE Fdn, Amsterdam, Netherlands; [van der Schaaf, Marike] Univ Amsterdam, Amsterdam UMC, Dept Rehabil, Amsterdam Movement Sci, Amsterdam, Netherlands; [van der Schaaf, Marike] Amsterdam Univ Appl Sci, Fac Hlth, Ctr Appl Res, Amsterdam, Netherlands; [Dongelmans, Dave A.] Univ Amsterdam, Amsterdam UMC, Dept Intens Care Med, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	van Beusekom, I (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Dept Med Informat, Amsterdam, Netherlands.; van Beusekom, I (corresponding author), Natl Intens Care Evaluat NICE Fdn, Amsterdam, Netherlands.	i.vanbeusekom@amc.uva.nl	Dongelmans, Dave/AAA-8974-2019	Dongelmans, Dave/0000-0001-8477-6671	National Intensive Care Evaluation (NICE) foundation	National Intensive Care Evaluation (NICE) foundation	The National Intensive Care Evaluation (NICE) foundation pays the department of Medical Informatics for processing, checking and maintaining the Dutch quality registry. Drs. van Beusekom, Dr. Bakhshi-Raiez, Professor de Keizer and Dr. Termorshuizen are employees of the department of medical informatics and work for the NICE registry. Professor de Keizer and Dr. Dongelmans are members of the NICE board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard AS, 2014, INTENSIVE CRIT CARE, V30, P2; Connolly B, 2012, CRIT CARE, V16, DOI [10.1186/CC11219, 10.1186/cc11219]; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Jeitziner MM, 2015, J CLIN NURS, V24, P9; Knol F.A, 1998, HOOG NAAR LAAG LAAG; Lamers LM, 1999, MED CARE, V37, P824, DOI 10.1097/00005650-199908000-00012; Lamers LM, 2004, HEALTH POLICY, V68, P113, DOI 10.1016/j.healthpol.2003.09.001; Lone NI, 2016, AM J RESP CRIT CARE, V194, P198, DOI 10.1164/rccm.201511-2234OC; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Pandharipande PP, 2013, NEW ENGL J MED, V369, P14; Parker AM, 2015, CRIT CARE MED, V43, P5; Roos LL, 1991, METHOD INFORM MED, V30, P2; Schellevis FG, 1994, BR J GEN PRACT, V44, P383; Stevens RD, 2007, INTENS CARE MED, V33, P11, DOI [10.1007/s00134-006-0431-z, DOI 10.1007/S00134-006-0431-Z]; van Beusekom I, 2017, J CRIT CARE, V44; van Beusekom I, 2019, CRIT CARE MED, V47, P324, DOI 10.1097/CCM.0000000000003576; van Beusekom I, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021249; van der Schaaf M, 2009, J REHABIL MED, V41, P5; van der Schaaf M, 2009, J REHABIL MED, V41, P13; van der Schaaf M, 2012, CRIT CARE MED, V40, P2742, DOI 10.1097/CCM.0b013e31825ae849; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Williams TA, 2010, ANAESTH INTENSIVE CA, V38, P4; Zimmerman JE, 2006, CRIT CARE MED, V34, P5	25	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217225	10.1371/journal.pone.0217225	http://dx.doi.org/10.1371/journal.pone.0217225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120959	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700072
J	Finnegan, A; Langhaug, L; Schenk, K; Puffer, ES; Rusakaniko, S; Choi, Y; Mahaso, S; Green, EP				Finnegan, Amy; Langhaug, Lisa; Schenk, Katie; Puffer, Eve S.; Rusakaniko, Simbarashe; Choi, Yujung; Mahaso, Simbarashe; Green, Eric P.			The prevalence and process of pediatric HIV disclosure: A population-based prospective cohort study in Zimbabwe	PLOS ONE			English	Article							INFECTED CHILDREN; DIAGNOSIS; ADOLESCENTS; AGE; ADJUSTMENT; PATTERNS; IMPACT	Introduction The objective of this study was to estimate the prevalence of pediatric HIV disclosure in rural Zimbabwe and track the process of disclosure over time. Methods We recruited a population-based sample of 372 caregivers of HIV-positive children ages 9 to 15 to participate in a survey about disclosure. Using data from this cross-sectional sample, we then identified a prospective cohort of 123 caregivers who said their HIV-positive child did not know his or her HIV status, and we followed this non-disclosed cohort of caregivers through two additional waves of data collection over the next 12 months. At each wave, we inquired about the timing and process of disclosure and psychosocial factors related to HIV disclosure. Results The overall prevalence of disclosure in the cross-sectional sample was 66.9% (95% CI 62.0 to 71.5%). Only 26.9% of children knew how they were infected and that they can transmit the virus to others (i.e. "full disclosure"). Older children were more likely to know their status. Among the non-disclosed caregivers at baseline, nearly 60% of these children learned their HIV status over the course of the 12-month study period, but only 17.1% learned how they were infected and that they can transmit the virus to others. Most caregivers were satisfied with their child's disclosure experience. Caregivers who had not disclosed their child's HIV status to the child worried that disclosure would lead to stigma in the community, provoke questions from their child they would not be able to answer, or cause the child to reject the caregiver in anger. Conclusions This study suggests that rates of pediatric HIV disclosure may be larger than typically reported, but also reinforces the idea that most children do not know key details about their illness, such as how they were infected and that they can infect others.	[Finnegan, Amy; Puffer, Eve S.; Choi, Yujung; Green, Eric P.] Duke Global Hlth Inst, Durham, NC 27710 USA; [Langhaug, Lisa] REPSSI, Harare, Zimbabwe; [Schenk, Katie] George Mason Univ, Coll Hlth & Human Serv, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Rusakaniko, Simbarashe] Univ Zimbabwe, Fac Med, Dept Community Med, Harare, Zimbabwe; [Puffer, Eve S.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Mahaso, Simbarashe] Batanai HIV&AIDS Serv Org, Masvingo Cbd, Zimbabwe	Duke University; George Mason University; University of Zimbabwe; Duke University	Green, EP (corresponding author), Duke Global Hlth Inst, Durham, NC 27710 USA.	eric.green@duke.edu	Finnegan, Amy/AAI-9533-2020	Finnegan, Amy/0000-0003-4940-6581	Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R21HD076695-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R21HD076695-03; EG, KS, https://www.nichd.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderomilehin O, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00166; Ajzen I., 1985, ACTION CONTROL, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2013, OPEN DATA KIT 2 0 EX; Atwiine B, 2015, AIDS CARE, V27, P424, DOI 10.1080/09540121.2014.978735; Bachanas PJ, 2001, J PEDIATR PSYCHOL, V26, P331, DOI 10.1093/jpepsy/26.6.331; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Binagwaho A, 2013, RWANDA MED J, V69, P143, DOI [10.1093/jpids/pit024, DOI 10.1093/JPIDS/PIT024]; Britto C, 2016, J DEV BEHAV PEDIATR, V37, P496, DOI 10.1097/DBP.0000000000000303; Brown BJ, 2011, AIDS CARE, V23, P1053, DOI 10.1080/09540121.2011.554523; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Chaudoir SR, 2011, SOC SCI MED, V72, P1618, DOI 10.1016/j.socscimed.2011.03.028; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; FunckBrentano I, 1997, ARCH PEDIAT ADOL MED, V151, P978, DOI 10.1001/archpedi.1997.02170470012002; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Green E., READINESS DISCLOSE P; Instone S L, 2000, J Pediatr Health Care, V14, P235, DOI 10.1067/mph.2000.107338; Kiragu K, 2008, YOU BUILD IT WILL TH; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Krauss BJ, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00181; Lester P, 2002, JAIDS-J ACQ IMM DEF, V31, P309, DOI 10.1097/00126334-200211010-00006; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Nehring W M, 2000, J Soc Pediatr Nurs, V5, P5, DOI 10.1111/j.1744-6155.2000.tb00081.x; Nichols J, 2017, AIDS BEHAV, V21, P59, DOI 10.1007/s10461-016-1481-z; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Suryavanshi N, 2012, CHALLENGES DISCLOSUR; Tasker M., 1992, SECRECY DISCLOSURE C; Turissini ML, 2013, J PEDIATR INFECT DIS, V2, P136, DOI 10.1093/jpids/pit024; UNAIDS, 2021, FACT SHEET WORLD AID; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wiener LS, 2006, J ADOLESCENT HEALTH, V38, P307, DOI 10.1016/j.jadohealth.2005.03.024; Wiener LS, 1996, PEDIATR AIDS HIV INF, V7, P310; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization and others, 2014, OP GUID HIV TEST COU; Zimbabwe National Statistics Agency and ICF International, 2016, ZIMB DEM HLTH SURV 2; ZNSA, 2012, ZIMB POP CENS 2012	42	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215659	10.1371/journal.pone.0215659	http://dx.doi.org/10.1371/journal.pone.0215659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116741	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400008
J	Vera, EJ; Chew, YV; Nicholson, L; Burns, H; Anderson, P; Chen, HT; Williams, L; Keung, K; Zanjani, NT; Dervish, S; Patrick, E; Wang, XM; Yi, SN; Hawthorne, W; Alexander, S; OConnell, PJ; Hu, M				Vera, Elvira Jimenez; Chew, Yi Vee; Nicholson, Leigh; Burns, Heather; Anderson, Patricia; Chen, Hsiao-Ting; Williams, Lindy; Keung, Karen; Zanjani, Negar Talaei; Dervish, Suat; Patrick, Ellis; Wang, Xin Maggie; Yi, Shounan; Hawthorne, Wayne; Alexander, Stephen; OConnell, Philip J.; Hu, Min			Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; MISMATCHED RENAL-TRANSPLANTATION; REGULATORY T-CELLS; NK CELLS; B-CELLS; EXPRESSION; TOLERANCE; PHENOTYPE; ANTIBODY; SUBSETS	Understanding the immunological phenotype of transplant recipients is important to improve outcomes and develop new therapies. Immunophenotyping of whole peripheral blood (WPB) by flow cytometry is a rapid method to obtain large amounts of data relating to the outcomes of different transplant treatments with limited patient impact. Healthy individuals and patients with type 1 diabetes (T1D) enrolled in islet transplantation were recruited and WPB was collected. 46 fluorochrome-conjugated mouse-anti-human antibodies were used (43 of 46 antibodies were titrated). BD cytometer setup and tracking beads were used to characterize and adjust for cytometer performance. Antibody cocktails were pre-mixed < 60 minutes before staining. Multicolour panels were designed based on fluorochrome brightness, antigen density, co-expression, and fluorochrome spillover into non-primary detectors in each panel on a 5 laser flow cytometer. WPB sample staining used 50-300 mu l WPB for each panel and was performed within 2 hours of blood sample collection. Samples were acquired on a BD-LSRFortessa. The operating procedures, including specimen collection, antibody cocktails, staining protocol, flow-cytometer setup and data analysis, were standardized. The staining index of 43 antibodies and the spillover spreading matrix for each panel was calculated. The final concentrations for the 46 antibodies used was determined for staining of WPB samples. Absolute cell-count and 7 leukocyte profiling panels consisting of subsets and/or status of granulocytes, monocytes, dendritic, B, NK, and T cells including regulatory T cells (Tregs) and NKT were designed and established on a 5 laser BD-LSR Fortessa. 13 T1D patients, including 4 islet transplant recipients and 8 healthy controls, were evaluated. The ability to reproducibly measure immune subsets and immune-profiles of islet transplant patients up to 18 months post transplantation has been established as a tool to measure immune cell reconstitution after transplantation.	[Vera, Elvira Jimenez; Chew, Yi Vee; Nicholson, Leigh; Burns, Heather; Anderson, Patricia; Chen, Hsiao-Ting; Williams, Lindy; Keung, Karen; Zanjani, Negar Talaei; Yi, Shounan; Hawthorne, Wayne; OConnell, Philip J.; Hu, Min] Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia; [Dervish, Suat; Wang, Xin Maggie] Westmead Inst Med Res, Flow Cytometry Core Facil, Sydney, NSW, Australia; [Patrick, Ellis] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Patrick, Ellis; OConnell, Philip J.; Hu, Min] Univ Sydney, Fac Med & Hlth, Westmead Clin Sch, Sydney, NSW, Australia; [Alexander, Stephen] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Sydney	Hu, M (corresponding author), Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia.; Hu, M (corresponding author), Univ Sydney, Fac Med & Hlth, Westmead Clin Sch, Sydney, NSW, Australia.	min.hu@sydney.edu.au	Patrick, Ellis/B-1763-2013; O'Connell, Philip John/AFK-9353-2022	Patrick, Ellis/0000-0002-5253-4747; O'Connell, Philip John/0000-0002-2036-283X	National Health and Medical Research Council of Australia (NHMRC) [APP1013185]; DVC University of Sydney Research Fellowship [IRMA178768]; NMHRC [APP1125456]; Juvenile Diabetes Research Foundation/Australian Research Council; National Health and Medical Research Council of Australia [APP10373210]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); DVC University of Sydney Research Fellowship; NMHRC; Juvenile Diabetes Research Foundation/Australian Research Council; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	M. Hu was awarded an Early Career Fellowship from the National Health and Medical Research Council of Australia (NHMRC) (APP1013185), DVC University of Sydney Research Fellowship (IRMA178768). P.J. O'Connell was a recipient of a Senior Practitioner Fellowship from the NMHRC (APP1125456). The work was supported by funding from the Juvenile Diabetes Research Foundation/Australian Research Council and the National Health and Medical Research Council of Australia (APP10373210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, AUSTR NZ DIALYSIS TR; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Bernstein HB, 2006, J IMMUNOL, V177, P3669, DOI 10.4049/jimmunol.177.6.3669; Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Boiocchi L, 2013, BLOOD, V122, P296, DOI 10.1182/blood-2013-05-500413; Braza F, 2015, J AM SOC NEPHROL, V26, P1795, DOI 10.1681/ASN.2014050480; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Couzi L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00003; Foley B, 2011, BLOOD, V118, P2784, DOI 10.1182/blood-2011-04-347070; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Furebring M, 2002, CRIT CARE, V6, P363, DOI 10.1186/cc1524; Gerlach UA, 2013, TRANSPLANTATION, V95, P1512, DOI 10.1097/TP.0b013e318290de18; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Golubovskaya V, 2016, CANCERS, V8, DOI 10.3390/cancers8030036; Hackstein H, 2005, AM J TRANSPLANT, V5, P2945, DOI 10.1111/j.1600-6143.2005.01101.x; Hadad U, 2014, IMMUNOL RES, V58, P259, DOI 10.1007/s12026-014-8493-4; Hasan M, 2015, CLIN IMMUNOL, V157, P261, DOI 10.1016/j.clim.2014.12.008; Hu M, 2013, AM J TRANSPLANT, V13, P2819, DOI 10.1111/ajt.12445; Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Karahan GE, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00686; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kawai T, 2013, NEW ENGL J MED, V368, P1850, DOI 10.1056/NEJMc1213779; Kim KW, 2012, EXP MOL MED, V44, P465, DOI 10.3858/emm.2012.44.8.053; Krasselt M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4321; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LENKEI R, 1995, CLIN IMMUNOL IMMUNOP, V77, P131, DOI 10.1006/clin.1995.1136; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P13, DOI 10.1016/j.jaci.2007.11.030; Li XC, 2013, CURR OPIN ORGAN TRAN, V18, P387, DOI 10.1097/MOT.0b013e3283626130; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mack DG, 2009, J IMMUNOL, V182, P7317, DOI 10.4049/jimmunol.0804305; Mackay CR, 2014, J CLIN INVEST, V124, P3682, DOI 10.1172/JCI77837; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Marino J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00582; Martinez-Llordella M, 2008, J CLIN INVEST, V118, P2845, DOI 10.1172/JCI35342; Matteucci E, 2011, J CLIN IMMUNOL, V31, P977, DOI 10.1007/s10875-011-9573-z; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Nguyen R, 2013, CYTOM PART A, V83A, P306, DOI 10.1002/cyto.a.22251; Oberbarnscheidt MH, 2011, SEMIN IMMUNOL, V23, P264, DOI 10.1016/j.smim.2011.06.006; Olson WC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-26; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Parkes MD, 2017, TRANSPLANTATION, V101, pE102, DOI 10.1097/TP.0000000000001586; Pilat N, 2010, AM J TRANSPLANT, V10, P10; Pinzon-Charry A, 2005, NEOPLASIA, V7, P1112, DOI 10.1593/neo.05442; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Rogers NJ, 2001, AM J TRANSPLANT, V1, P97, DOI 10.1034/j.1600-6143.2001.001002097.x; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sallusto F, 2000, CURR TOP MICROBIOL, V251, P167; Sconocchia G, 2005, LEUKEMIA, V19, P69, DOI 10.1038/sj.leu.2403550; Scozzi D, 2017, AM J TRANSPLANT, V17, P328, DOI 10.1111/ajt.13940; Solari MG, 2008, TRANSPLANTATION, V85, P1513, DOI 10.1097/TP.0b013e318173a768; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Streitz M, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-17; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Telford WG, 2009, CYTOM PART A, V75A, P1031, DOI 10.1002/cyto.a.20790; Thorarinsdottir K, 2016, CLIN EXP IMMUNOL, V185, P252, DOI 10.1111/cei.12795; van den Bosch TPP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00153; van Gurp E, 2008, AM J TRANSPLANT, V8, P1711, DOI 10.1111/j.1600-6143.2008.02307.x; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wang Z, 2012, AM J TRANSPLANT, V12, P1398, DOI 10.1111/j.1600-6143.2012.04060.x; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhuang Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12623	70	10	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217163	10.1371/journal.pone.0217163	http://dx.doi.org/10.1371/journal.pone.0217163			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116766	Green Published, gold			2022-12-27	WOS:000468607400048
J	Vlieghe, K; Picker, M				Vlieghe, Kelly; Picker, Mike			Do high soil temperatures on Namibian fairy circle discs explain the absence of vegetation?	PLOS ONE			English	Article							DESERT; ORIGIN; COMPETITION; KAOKOLAND; PATCHES; STORAGE; STRESS; SEEDS	Evenly-dispersed enigmatic bare discs known as 'fairy circles' occur within grasslands of the pro-Namib Desert. In spite of their conspicuous appearance, their nature and origin is still debated. The possible inhibitory effects of high surface and sub-surface soil temperatures on grass germination and seedling development on fairy circles have not yet been investigated. We measured maximum, mean daily (24 hour) and mean daytime (sunrise to sunset) temperatures of fairy circles and matrices in the NamibRand Nature Reserve (southwest Namibia). Optimum germination and growing temperatures, and thermal maxima of Stipagrostis ciliata, a grass commonly associated with fairy circle grasslands, were determined experimentally in growth trials. Seeds and seedlings were exposed to temperatures of 35 degrees C, 37 degrees C, 41 degrees C, 44 degrees C and 47 degrees C for 10 days. The optimum growth temperature range of S. ciliata seedlings was determined to be 35 C to 37 degrees C, with depressed growth above 47 degrees C. Seed germination was also depressed at 47 degrees C, and optimal germination occurred between 35 degrees C to 37 degrees C. Circle soils were consistently 2 degrees C cooler than matrix soils at both surface and 15 cm depths, and though the soil surface achieved daily temperatures of 45 degrees C and 47 degrees C for the circle and matrix respectively, mean daily temperatures at 15 cm depth were 36 degrees C and 38 degrees C respectively, coinciding with the optimum germination and growing temperature of S. ciliata. Circle soil temperature is thus unlikely to limit S. ciliata germination and seedling growth and contribute to the maintenance of a bare disc, as both thermal conditions and the presence of higher soil moisture on circles provide a more favourable growing environment than the matrix.	[Vlieghe, Kelly; Picker, Mike] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa	University of Cape Town	Vlieghe, K (corresponding author), Univ Cape Town, Dept Biol Sci, Cape Town, South Africa.	kelly.vlieghe@alumni.uct.ac.za			National Research Foundation [SFH1207183413]; University Research Committee (University of Cape Town) scholarship; National Research Foundation Incentive funding grant [85506]	National Research Foundation; University Research Committee (University of Cape Town) scholarship; National Research Foundation Incentive funding grant	This work was funded by the following grants: K. E. P. Vlieghe was supported by a National Research Foundation free-standing bursary (SFH1207183413), and by a University Research Committee (University of Cape Town) scholarship. M. D. Picker was supported by a National Research Foundation Incentive funding grant (85506). NRF website: https://www.nrf.ac.za/	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Al-Kayssi AW, 1990, J AGR ENG RES, V45, P241, DOI 10.1016/S0021-8634(05)80076-9; Albrecht CF, 2001, S AFR J SCI, V97, P23; Bahrani M. J., 2006, Journal of New Seeds, V8, P83, DOI 10.1300/J153v08n01_07; Barbier N, 2008, ECOLOGY, V89, P1521, DOI 10.1890/07-0365.1; Becker T, 2000, BASIC APPL ECOL, V1, P149, DOI 10.1078/1439-1791-00021; Bewley JD, 2013, SEEDS PHYSL DEV GERM; Blott SJ, 2012, SEDIMENTOLOGY, V59, P2071, DOI 10.1111/j.1365-3091.2012.01335.x; Breshears DD, 1998, INT J PLANT SCI, V159, P1010, DOI 10.1086/314083; CHEIKH N, 1994, PLANT PHYSIOL, V106, P45, DOI 10.1104/pp.106.1.45; Cramer MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070876; Daws MI, 2007, S AFR J BOT, V73, P262, DOI 10.1016/j.sajb.2006.12.004; EICKER A, 1982, S AFR J BOT, V1, P69, DOI 10.1016/S0022-4618(16)30180-2; Fakhfakh LM, 2018, J ARID LAND, V10, P304, DOI 10.1007/s40333-018-0050-x; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; Frenette-Dussault C, 2012, J VEG SCI, V23, P208, DOI 10.1111/j.1654-1103.2011.01350.x; Gardner C.M., 1999, SOIL PHYS CONSTRAINT; Getzin S, 2015, ECOGRAPHY, V38, P1, DOI 10.1111/ecog.00911; Giess W., 1970, DINTERIA, V4, P1; Hachfeld B., 2000, Dinteria, P113; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Juergens N, 2015, ECOL ENTOMOL, V40, P661, DOI 10.1111/een.12266; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Kumar S, 2011, ACTA PHYSIOL PLANT, V33, P2091, DOI 10.1007/s11738-011-0748-2; Lakshmi V, 2003, HYDROL PROCESS, V17, P3041, DOI 10.1002/hyp.1275; Lee K. E., 1971, TERMITES AND SOILS; Liu HL, 2013, ARID LAND RES MANAG, V27, P65, DOI 10.1080/15324982.2012.719569; Ludwig JA, 1999, CATENA, V37, P257, DOI 10.1016/S0341-8162(98)00067-8; Meron E, 2012, ECOL MODEL, V234, P70, DOI 10.1016/j.ecolmodel.2011.05.035; Meyer JJM, 2015, S AFR J BOT, V98, P10, DOI 10.1016/j.sajb.2015.01.019; Moll E.J., 1994, P 13 PLENARY M AETFA, P1203; Muller M.A.N., 2007, GRASSES OF NAMIBIA; Munson S.M., 2014, G WRIGHT FORUM, V31, P137; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Picker MD, 2012, ECOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-2311.2011.01332.x; Roberts EH, PLANTS TEMPERATURE; Russell EH, 1973, SOIL CONDITIONS PLAN, V10; Tarnita CE, 2017, NATURE, V541, P398, DOI 10.1038/nature20801; Theron GK, 1979, J S AFRICAN BIOL SOC, V98, P10; Tschinkel WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038056; Uys V.M., 2002, GUIDE TERMITE GENERA; Van Rheede van Oudtshoorn K., 1999, DISPERSAL BIOL DESER, DOI 10.1007/978-3-662-03561-0; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3; Vlieghe K, 2015, ECOL ENTOMOL, V40, P42, DOI 10.1111/een.12157; Whitaker C, 2004, S AFR J BOT, V70, P622, DOI 10.1016/S0254-6299(15)30201-5; Zhang HZ, 2015, ECOL COMPLEX, V22, P32, DOI 10.1016/j.ecocom.2015.02.001; 2011, J ARID ENVIRON, V75, P446, DOI DOI 10.1016/J	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217153	10.1371/journal.pone.0217153	http://dx.doi.org/10.1371/journal.pone.0217153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107927	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200032
J	Choi, H; Chung, H; Muntaner, C				Choi, Hongjo; Chung, Haejoo; Muntaner, Carles			Social selection in historical time: The case of tuberculosis in South Korea after the East Asian financial crisis	PLOS ONE			English	Article							INTRA-GENERATIONAL MOBILITY; RECENT ECONOMIC-CRISIS; HEALTH SELECTION; SOCIOECONOMIC-STATUS; PAID EMPLOYMENT; PUBLIC-HEALTH; MENTAL-HEALTH; ILL HEALTH; MORTALITY; IMPACT	The perspectives of social selection and causation have long been debated. Social selection theory is as "social" as social causation theory, since all diseases are social and no biological process occurs outside society. To identify the social selection pathway and historical juncture affected by socioeconomic and political changes, we investigated the reciprocal impact of suffering from tuberculosis (TB) on the current socioeconomic position (SEP), stratified by childhood SEP. We also examined the extent to which the social consequences of ill health changed since the East Asian economic downturn. Data were collected for 2007-2012 from the Korea National Health and Nutritional Examination Survey. To identify associations between TB history and current household income (HHI), we constructed an ordinal logistic regression model adjusted for covariates, including age, gender, educational attainment, and job status. We adopted a recursive regression model to examine trend changes in this association from 1980-2012 to 2003-2012. Of 28,136 participants, 936 had experienced TB. In the first ordinal logistic regression, the TB group was more likely to have lower HHI than the non-TB group. The odds ratios (ORs) increased from 1.30 (1980-2012) to 1.86 (2003-2012) for the TB group, increasing their probability of having low HHI. Among the low childhood SEP group, the TB group's probability of having low HHI was 1.35 (95% confidence interval [CI]: 1.16-1.57) during 1980-2012, which increased to 2.01 (95% CI: 1.37-2.95) during 2003-2012. For the high childhood SEP group, the TB group's OR range fluctuated, similar to that for the non-TB group. The results support the social selection pathway from TB history to adverse impact on current SEP. Our study identified downward social mobility due to TB history among the low childhood SEP group. Moreover, negative social consequences deteriorated since the East Asian economic crisis.	[Choi, Hongjo] Korean Natl TB Assoc, Dept Res & Dev, Korean Inst TB, Cheongju, South Korea; [Chung, Haejoo] Korea Univ, Grad Sch, Dept Publ Hlth Sci, BK21 PLUS Program Embodiment Hlth Soc Interact, Seoul, South Korea; [Chung, Haejoo] Korea Univ, Coll Hlth Sci, Sch Hlth Policy & Management, Seoul, South Korea; [Muntaner, Carles] Univ Toronto, Bloomberg Fac Nursing, Toronto, ON, Canada; [Muntaner, Carles] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Korea University; Korea University; University of Toronto; University of Toronto	Chung, H (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth Sci, BK21 PLUS Program Embodiment Hlth Soc Interact, Seoul, South Korea.; Chung, H (corresponding author), Korea Univ, Coll Hlth Sci, Sch Hlth Policy & Management, Seoul, South Korea.	hpolicy@korea.ac.kr		Choi, Hongjo/0000-0001-8853-7061; Chung, Haejoo/0000-0002-2661-4161	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [2016S1A3A2923475]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1488]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (2016S1A3A2923475) received by H. Chung, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1488) received by H. Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A., 1988, TRANSCENDING GEN LIN; Akresh IR, 2008, AM J PUBLIC HEALTH, V98, P2058, DOI 10.2105/AJPH.2006.100974; Anderson LR, 2018, SOC SCI MED, V197, P153, DOI 10.1016/j.socscimed.2017.11.026; Biggs B, 2010, SOC SCI MED, V71, P266, DOI 10.1016/j.socscimed.2010.04.002; Burton M., 1983, CRIT SOC POLICY, V7, P54; Cardano M, 2004, SOC SCI MED, V58, P1563, DOI 10.1016/S0277-9536(03)00354-X; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Cheong, 2001, ASIAN ECON J, V15, P39, DOI 10.1111/1467-8381.00122; Cin C.B., 2013, INT J ADV SCI TECHNO, V53, P95; Claussen B, 2005, SOC SCI MED, V61, P2513, DOI 10.1016/j.socscimed.2005.04.045; de Camargo KR, 2011, GLOB PUBLIC HEALTH, V6, P102, DOI 10.1080/17441692.2010.514617; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; Eaton WW, 2001, J HEALTH SOC BEHAV, V42, P277, DOI 10.2307/3090215; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; GLADSTONE DE, 1985, SOC POLICY ADMIN, V19, P101, DOI 10.1111/j.1467-9515.1985.tb00225.x; Ha SK, 2001, J CONTEMP ASIA, V31, P196, DOI 10.1080/00472330180000121; Haas SA, 2006, J HEALTH SOC BEHAV, V47, P339, DOI 10.1177/002214650604700403; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; ILLSLEY R, 1955, BRIT MED J, V2, P1520, DOI 10.1136/bmj.2.4955.1520; ISAAC LW, 1989, AM SOCIOL REV, V54, P873, DOI 10.2307/2095713; Jung JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141230; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Khang YH, 2004, J EPIDEMIOL COMMUN H, V58, P308, DOI 10.1136/jech.2003.012989; Kim HJ, 2004, ANN EPIDEMIOL, V14, P442, DOI 10.1016/j.annepidem.2003.09.018; Kim HJ, 2003, B WORLD HEALTH ORGAN, V81, P567; Kim IH, 2008, AM J IND MED, V51, P748, DOI 10.1002/ajim.20626; Kim JH, 2015, EMERG INFECT DIS, V21, P1913, DOI 10.3201/eid2111.141894; Kim SS, 2013, AM J IND MED, V56, P1245, DOI 10.1002/ajim.22201; Kim Y, 2011, HEALTH POLICY, V100, P239, DOI 10.1016/j.healthpol.2010.08.008; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Laurence YV, 2015, PHARMACOECONOMICS, V33, P939, DOI 10.1007/s40273-015-0279-6; Lew WJ, 1999, TUBERC RESP DIS, V46, P301; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Macintyre K, 2017, INT J TUBERC LUNG D, V21, pS87, DOI 10.5588/ijtld.17.0151; Manor O, 2003, SOC SCI MED, V57, P2217, DOI 10.1016/S0277-9536(03)00097-2; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; MCKEOWN T, 1975, POP STUD-J DEMOG, V29, P391, DOI 10.2307/2173935; Mulatu MS, 2002, J HEALTH SOC BEHAV, V43, P22, DOI 10.2307/3090243; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Schuring M, 2007, J EPIDEMIOL COMMUN H, V61, P597, DOI 10.1136/jech.2006.047456; Stubbs T, 2018, CRIT PUBLIC HEALTH, V28, P132, DOI 10.1080/09581596.2017.1340589; Stuckler D, 2008, PLOS MED, V5, P1079, DOI 10.1371/journal.pmed.0050143; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; van den Berg T, 2010, OCCUP ENVIRON MED, V67, P845, DOI 10.1136/oem.2009.051730; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; WEST P, 1991, SOC SCI MED, V32, P373, DOI 10.1016/0277-9536(91)90338-D; Winston CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-206; World Health Organization, 2014, GLOB STRAT TARG TUB; Yang BM, 2001, HEALTH POLICY PLANN, V16, P372, DOI 10.1093/heapol/16.4.372; 김희진, 2012, [The Korean Journal of Medicine, 대한내과학회지], V82, P257; 2009, SOC SCI MED, V68, P2240, DOI DOI 10.1016/J.SOCSCIMED.2009.03.041	54	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217055	10.1371/journal.pone.0217055	http://dx.doi.org/10.1371/journal.pone.0217055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY3MG	31095637	Green Published, gold, Green Submitted			2022-12-27	WOS:000468030100072
J	Demilew, YM; Firew, BS				Demilew, Yeshalem Mulugeta; Firew, Belet Sewasew			Factors associated with noncommunicable disease among adults in Mecha district, Ethiopia: A case control study	PLOS ONE			English	Article							RISK-FACTORS; HYPERTENSION; PREVALENCE; OBESITY; BURDEN	Background In Ethiopia, the incidence and prevalence of noncommunicable diseases are rising. Within the country, the magnitude of these diseases varies from region to region. However, information about factors associated with noncommunicable disease is limited in the study area. Therefore, the objective of this study was to identify factors associated with noncommunicable disease among adults in Mecha district. Methods Community-based case-control study was carried out among 728 cases and 2907 controls from February1-August 30/ 2017. The study participants were chosen using a multi-stage sampling technique. Data were collected using structured questionnaire. Fasting blood glucose level was measured in the morning after 8hours of fasting. Statistical Package for Social Science (SPSS) version 20 software was used to enter and analyze data. Crude and adjusted Odds ratios were done for each explanatory variable at 95% confidence level. Results The likelihood of developing noncommunicable disease was higher among participants who drank alcohol [AOR = 1.72, 95% CI: (1.3, 2.1)] and coffee [AOR = 4.54, 95% CI: (3.4, 5.9)], did not take vegetables [AOR = 2. 30, 95% CI: (1.6, 3.1)] and fruits [AOR = 2.04, 95% CI: (1.4, 2.9)], took packed oil [AOR = 2.35, 95% CI: (1.7, 3.1)], overweight or obesity [AOR = 2.23, 95% CI: (1.3, 3.8)] and physically inactive [AOR = 1.71, 95% CI: (1.2, 2.4)]. Conclusion Of those assessed, the main factors associated with noncommunicable disease were drinking alcohol and coffee, not taking vegetables and fruits, taking packed oil, being overweight and physically inactive. Thus, the finding suggests changing the dietary habit of the community to increase consumption of fruits and vegetables, use of unsaturated fat for cooking, to avoid consumption of alcohol and to decrease taking coffee, to do physical activity and weight reduction.	[Demilew, Yeshalem Mulugeta] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Firew, Belet Sewasew] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Med, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Demilew, YM (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.	yeshalem_mulugeta@yahoo.com		Conklin, Annalijn/0000-0002-6532-8790	Bahir Dar University	Bahir Dar University	The authors are grateful to Bahir Dar University for its financial support for materials to do fasting blood glucose level and fee for the principal investigator during field work, laboratory professionals, supervisors and data clerk. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	Abebe SM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015496; Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agaba EI, 2017, CARDIOVASC J AFR, V28, P377, DOI 10.5830/CVJA-2017-021; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Alzeidan R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165036; [Anonymous], 2003, DIET NUTR PREV CHRON; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; Ethiopian Public Health Association, 2012, EM PUBL HLTH PROBL E; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105536; Giday A, 2010, ETHIOP J HEALTH DEV, V24, P145; Giday TK, 2014, INT J PHARM BIOL SCI, V7; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; IDF W, 2006, DEF DIAGN DIAB MELL; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Keller A, 2012, LANCET, V380, pS316; Longo-Mbenza B, 2008, EUR J CARDIOV PREV R, V15, P503, DOI 10.1097/HJR.0b013e3282f21640; Machado LMM, 2011, INT J ENV RES PUB HE, V8, P3216, DOI 10.3390/ijerph8083216; Maire Bernard, 2002, Sante, V12, P45; Mandil AM, 2016, SAUDI MED J, V37, P1243, DOI 10.15537/smj.2016.11.16268; Melaku YA, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0447-x; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Molla M., 2015, SCI J PUBLIC HLTH, V3, P514; Murad MA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/616145; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Navarro AM, 2017, CLIN NUTR, Vxxx, P1; Negi PC, 2016, INDIAN HEART J, V168, P165; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Pan B, 2014, CHINA PREVENTING CHR, V11; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Phaswana-Mafuya N, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.19880; Prevett M, 2012, ETHIOP J HEALTH SCI, V22, P1; Rahimi K, 2015, CIRC RES, V116, P925, DOI 10.1161/CIRCRESAHA.116.304723; Saeed KMI, 2013, CENTRAL ASIAN J GLOB, V2; Siegel KR, 2014, BRIT MED BULL, V111, P31, DOI 10.1093/bmb/ldu018; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Tomas B, 2015, EUROPEAN J PREVENTIV, V3, P124; Wakabayashi M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2662-9; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; Wandera SO, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27923; WHO, 2021, WHO STEPWISE APPR SU; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2013, GLOB ACT PLAN PREV C	49	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216446	10.1371/journal.pone.0216446	http://dx.doi.org/10.1371/journal.pone.0216446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141502	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000011
J	Li, F; Vanwezer, N; Boivin, N; Gao, X; Ott, F; Petraglia, M; Roberts, P				Li, Feng; Vanwezer, Nils; Boivin, Nicole; Gao, Xing; Ott, Florian; Petraglia, Michael; Roberts, Patrick			Heading north: Late Pleistocene environments and human dispersals in central and eastern Asia	PLOS ONE			English	Article							HIGH LAKE LEVELS; HOMO-SAPIENS; SOUTHERN DISPERSAL; HUMAN COLONIZATION; TIBETAN PLATEAU; QAIDAM BASIN; STONE-AGE; CHINA; CHRONOLOGY; POPULATIONS	The adaptability of our species, as revealed by the geographic routes and palaeoenvironmental contexts of human dispersal beyond Africa, is a prominent topic in archaeology and palaeoanthropology. Northern and Central Asia have largely been neglected as it has been assumed that the deserts and mountain ranges of these regions acted as 'barriers', forcing human populations to arc north into temperate and arctic Siberia. Here, we test this proposition by constructing Least Cost Path models of human dispersal under glacial and interstadial conditions between prominent archaeological sites in Central and East Asia. Incorporating information from palaeoclimatic, palaeolake, and archaeological data, we demonstrate that regions such as the Gobi Desert and the Altai Mountain chains could have periodically acted as corridors and routes for human dispersals and framing biological interactions between hominin populations. Review of the archaeological datasets in these regions indicates the necessity of wide-scale archaeological survey and excavations in many poorly documented parts of Eurasia. We argue that such work is likely to highlight the 'northern routes' of human dispersal as variable, yet crucial, foci for understanding the extreme adaptive plasticity characteristic of the emergence of Homo sapiens as a global species, as well as the cultural and biological hybridization of the diverse hominin species present in Asia during the Late Pleistocene.	[Li, Feng; Gao, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Li, Feng; Gao, Xing] CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China; [Vanwezer, Nils; Boivin, Nicole; Ott, Florian; Petraglia, Michael; Roberts, Patrick] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Gao, Xing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Petraglia, Michael] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; [Roberts, Patrick] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Queensland	Li, F (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.; Li, F (corresponding author), CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China.; Vanwezer, N; Petraglia, M; Roberts, P (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany.; Petraglia, M (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA.; Roberts, P (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.	lifeng@ivpp.ac.cn; vanwezer@shh.mpg.de; petraglia@shh.mpg.de; roberts@shh.mpg.de	Petraglia, Michael/ABA-9748-2021	BOIVIN, NICOLE/0000-0002-7783-4199; Petraglia, Michael/0000-0003-2522-5727; Roberts, Patrick/0000-0002-4403-7548; Vanwezer, Nils/0000-0002-2330-0204; Ott, Florian/0000-0001-7319-7180	Max-Planck-Gesellschaft (DE); Strategic Priority Research Program of Chinese Academy of Sciences [XDB26000000]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2017102]	Max-Planck-Gesellschaft (DE); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of the Chinese Academy of Sciences	This study was funded by Max-Planck-Gesellschaft (DE) to Nicole Boivin, Strategic Priority Research Program of Chinese Academy of Sciences grant XDB26000000 to Feng Li, and Youth Innovation Promotion Association of the Chinese Academy of Sciences grant 2017102 to Feng Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; [Anonymous], 2012, HUMAN ADAPTATION ASI; Bae CJ, 2017, SCIENCE, V358, DOI 10.1126/science.aai9067; Bae CJ, 2014, QUATERN INT, V354, P169, DOI 10.1016/j.quaint.2014.06.051; Beeton TA, 2014, J BIOGEOGR, V41, P95, DOI 10.1111/jbi.12183; Bell T., 1999, MAP ARCHAEOLOGY SPAT, P85; Blinkhorn J, 2013, QUATERNARY SCI REV, V77, P233, DOI 10.1016/j.quascirev.2013.06.012; Blomdin R, 2016, QUATERNARY SCI REV, V153, P78, DOI 10.1016/j.quascirev.2016.07.029; Blomdin R, 2018, QUAT GEOCHRONOL, V47, P54, DOI 10.1016/j.quageo.2018.05.008; Bohorquez P, 2016, INT GEOL REV, V58, P1795, DOI 10.1080/00206814.2015.1046956; Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Bolus M., 2011, CHARACTERISTIC FEATU, P3; Brantingham PJ, 2006, WORLD ARCHAEOL, V38, P387, DOI 10.1080/00438240600813301; Brantingham PJ, 2001, CURR ANTHROPOL, V42, P735, DOI 10.1086/323817; Brantingham PJ, 1999, ASTRIDE MOVIUS LINE; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Buzhilova A, 2017, CURR ANTHROPOL, V58, pS491, DOI 10.1086/694232; Chen FH, 2008, CHINESE SCI BULL, V53, P1725, DOI 10.1007/s11434-008-0227-3; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Conard NJ, 2010, P NATL ACAD SCI USA, V107, P7621, DOI 10.1073/pnas.1001458107; Dennell R, 2017, CURR ANTHROPOL, V58, pS383, DOI 10.1086/694174; Derevianko AP, 2012, ARCHAEOL ETHNOL ANTH, V40, P2, DOI 10.1016/j.aeae.2013.04.002; Derevianko A.P., 2010, PALEOLIT ORKHONA; Derevianko A.P., 2000, ARCHAEOLOGY ETHNOLOG, V1, P23; Derevianko AP, 2001, ARCHAEOLOGY ETHNOLOG, V1, P25, DOI [DOI 10.1016/J.AEAE.2015.11.004, 10.1016/j.aeae.2015.11.004]; Derevianko AP., 2007, ARCHAEOL ETHNOL ANTH, V29, P16, DOI [10.1134/S1563011007010021, DOI 10.1134/S1563011007010021]; Deviese T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08018-8; Douka K, 2019, NATURE, V565, P640, DOI 10.1038/s41586-018-0870-z; Drake NA, 2013, QUATERN INT, V300, P48, DOI 10.1016/j.quaint.2012.12.018; Dunbar R, 2003, SCIENCE, V302, P1160, DOI 10.1126/science.1092116; Edilis A, 2018, NEW ARCHAEOLOGICAL D, P29; Ehlers J, 2011, DEV QUATER SCI, V15, P1; Esri, 2013, WORLD MAJ RIV; Esri, 2013, CART WORLD WAT BOD; Fan AC, 2012, QUAT GEOCHRONOL, V10, P143, DOI 10.1016/j.quageo.2012.01.007; Field JS, 2007, J ANTHROPOL ARCHAEOL, V26, P88, DOI 10.1016/j.jaa.2006.06.001; Field JS, 2005, J WORLD PREHIST, V19, P1, DOI 10.1007/s10963-005-9000-6; Fitzsimmons KE, 2017, J HUM EVOL, V113, P107, DOI 10.1016/j.jhevol.2017.07.006; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gladyshev SA, 2012, QUATERN INT, V281, P36, DOI 10.1016/j.quaint.2012.01.032; Glantz M, 2018, QUATERN INT, V466, P82, DOI 10.1016/j.quaint.2016.06.037; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T., 2015, EMERGENCE DIVERSITY, P437; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Grove M, 2015, QUATERN INT, V369, P17, DOI 10.1016/j.quaint.2014.08.019; Han WX, 2014, QUATERNARY RES, V82, P66, DOI 10.1016/j.yqres.2014.02.004; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill K, 2010, EVOL ANTHROPOL, V18, P187, DOI [10.1002/evan.20224, DOI 10.1002/EVAN.20224]; Hill KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102806; Jacobs Z, 2019, NATURE, V565, P594, DOI 10.1038/s41586-018-0843-2; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Kaifu Y., 2015, EMERGENCE DIVERSITY; Kealy S, 2018, J HUM EVOL, V125, P59, DOI 10.1016/j.jhevol.2018.10.003; Kendal J, 2011, PHILOS T R SOC B, V366, P785, DOI 10.1098/rstb.2010.0306; Khatsenovich AM, 2017, QUATERN INT, V442, P78, DOI 10.1016/j.quaint.2016.10.013; Kondo Y, 2018, REPLACE NEANDERTHAL, P199, DOI 10.1007/978-981-10-6826-3_13; Koppes M, 2008, QUATERNARY SCI REV, V27, P846, DOI 10.1016/j.quascirev.2008.01.009; Krivoshapkin AI, 2010, RADIOCARBON, V52, P549, DOI 10.1017/S0033822200045586; Krivoshapkin Andrei I., 2007, B INDO PACIFIC ASS, V26, P5; Kuhle M, 2011, DEV QUATER SCI, V15, P943, DOI 10.1016/B978-0-444-53447-7.00068-4; Kuzmin YV, 1998, J WORLD PREHIST, V12, P1, DOI 10.1023/A:1022431307503; Lai ZP, 2014, J PALEOLIMNOL, V51, P197, DOI 10.1007/s10933-013-9710-1; Lan YH, 2018, GEOSCI FRONT, V9, P223, DOI 10.1016/j.gsf.2017.03.003; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Lehmkuhl F, 2016, ANN GLACIOL, V57, P169, DOI 10.3189/2016AoG71A030; Lehmkuhl F, 2011, DEV QUATER SCI, V15, P967, DOI 10.1016/B978-0-444-53447-7.00069-6; Li F, 2018, J CHEM RES, P170, DOI [10.3184/174751918X15222671415597, 10.1016/j.jhevol.2018.02.011]; Li F, 2016, SCI CHINA EARTH SCI, V59, P1540, DOI 10.1007/s11430-016-5305-9; Li F, 2014, J ANTHROPOL RES, V70, P35, DOI 10.3998/jar.0521004.0070.103; Li XZ, 2013, J GEOPHYS RES-ATMOS, V118, P7481, DOI 10.1002/jgrd.50611; Li ZL, 2016, CLIM RES, V69, P193, DOI 10.3354/cr01405; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Long H, 2015, SCI CHINA EARTH SCI, V58, P183, DOI 10.1007/s11430-014-4993-2; Ma ZB, 2004, QUATERN INT, V121, P89, DOI 10.1016/j.quaint.2004.01.025; Madsen DB, 2001, ANTIQUITY, V75, P706, DOI 10.1017/S0003598X00089213; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Michel V, 2016, J HUM EVOL, V101, P101, DOI 10.1016/j.jhevol.2016.07.008; Parton A, 2015, QUATERN INT, V382, P82, DOI 10.1016/j.quaint.2015.01.005; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Prokopenko AA, 2001, QUATERNARY RES, V55, P123, DOI 10.1006/qres.2000.2212; Rabett RJ, 2018, NAT ECOL EVOL, V2, P212, DOI 10.1038/s41559-017-0436-8; Ranov VA, 2012, ARCHAEOL ETHNOL ANTH, V40, P2, DOI 10.1016/j.aeae.2012.08.002; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Roberts P, 2018, NAT HUM BEHAV, V2, P542, DOI 10.1038/s41562-018-0394-4; Roberts P, 2016, EVOL ANTHROPOL, V25, P306, DOI 10.1002/evan.21508; Roberts P, 2015, WORLD ARCHAEOL, V47, P718, DOI 10.1080/00438243.2015.1073119; Rybin EP, 2014, QUATERN INT, V347, P39, DOI 10.1016/j.quaint.2014.04.031; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Slon V, 2018, NATURE, V561, P113, DOI 10.1038/s41586-018-0455-x; Stewart BA, 2016, VERTEBR PALEOBIOL PA, P247, DOI 10.1007/978-94-017-7520-5_14; Stewart BA, 2012, QUATERN INT, V270, P40, DOI 10.1016/j.quaint.2011.11.028; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tostevin G., 2000, NEANDERTHALS MODERN, P90; Vasiliev SG, 2009, ARCHAEOL ETHNOL ANTH, V37, P13, DOI 10.1016/j.aeae.2010.02.005; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; Wang NA, 2011, CHINESE SCI BULL, V56, P1799, DOI 10.1007/s11434-011-4498-8; Wang YF, 1995, CHINESE SCI BULL, V40, P725; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; Wunnemann B, 2007, DEV QUATER SCI, V9, P11, DOI 10.1016/S1571-0866(07)09003-3; Yang XP, 2011, QUATERNARY SCI REV, V30, P3219, DOI 10.1016/j.quascirev.2011.08.009; Yang XP, 2010, QUATERNARY RES, V73, P1, DOI 10.1016/j.yqres.2009.10.011; Yu G, 2007, PALAEOGEOGR PALAEOCL, V250, P167, DOI 10.1016/j.palaeo.2007.03.010; Zhang S.S., 1960, PALEOVERTEBRATA PALE, V2, P129; Zhang S-S, 1959, PALEOVERTEBRATA PALE, V1, P31; Zhang XL, 2018, SCIENCE, V362, P1049, DOI 10.1126/science.aat8824; Zhao JD, 2013, QUATERN INT, V311, P44, DOI 10.1016/j.quaint.2013.07.047; ZHENG HH, 1989, GEOCHIMICA, V4, P343; Zheng MP, 1996, SALINE LAKE RESOURCE	113	26	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216433	10.1371/journal.pone.0216433	http://dx.doi.org/10.1371/journal.pone.0216433			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141504	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000009
J	Puchades, MA; Csucs, G; Ledergerber, D; Leergaard, TB; Bjaalie, JG				Puchades, Maja A.; Csucs, Gergely; Ledergerber, Debora; Leergaard, Trygve B.; Bjaalie, Jan G.			Spatial registration of serial microscopic brain images to three-dimensional reference atlases with the QuickNII tool	PLOS ONE			English	Article							WAXHOLM SPACE ATLAS; MOUSE-BRAIN; CONNECTOME; MAPS	Modern high throughput brain wide profiling techniques for cells and their morphology, connectivity, and other properties, make the use of reference atlases with 3D coordinate frameworks essential. However, anatomical location of observations made in microscopic sectional images from rodent brains is typically determined by comparison with 2D anatomical reference atlases. A major challenge in this regard is that microscopic sections often are cut with orientations deviating from the standard planes used in the reference atlases, resulting in inaccuracies and a need for tedious correction steps. Overall, efficient tools for registration of large series of section images to reference atlases are currently not widely available. Here we present QuickNII, a stand-alone software tool for semi-automated affine spatial registration of sectional image data to a 3D reference atlas coordinate framework. A key feature in the tool is the capability to generate user defined cut planes through the reference atlas, matching the orientation of the cut plane of the sectional image data. The reference atlas is transformed to match anatomical landmarks in the corresponding experimental images. In this way, the spatial relationship between experimental image and atlas is defined, without introducing distortions in the original experimental images. Following anchoring of a limited number of sections containing key landmarks, transformations are propagated across the entire series of sectional images to reduce the amount of manual steps required. By having coordinates assigned to the experimental images, further analysis of the distribution of features extracted from the images is greatly facilitated.	[Puchades, Maja A.; Csucs, Gergely; Leergaard, Trygve B.; Bjaalie, Jan G.] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Neural Syst Lab, Oslo, Norway; [Ledergerber, Debora] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NTNU, Trondheim, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU)	Bjaalie, JG (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Neural Syst Lab, Oslo, Norway.	j.g.bjaalie@medisin.uio.no	Bjaalie, Jan G. G./AAW-6445-2021; Puchades, Maja/D-5835-2013	Bjaalie, Jan G. G./0000-0001-7899-906X; Puchades, Maja/0000-0002-4536-8197; Leergaard, Trygve B./0000-0001-5965-8470; Csucs, Gergely/0000-0002-2093-6274	European Union's Horizon 2020 Research and Innovation Programme [720270, 785907]; Research Council of Norway [269774]	European Union's Horizon 2020 Research and Innovation Programme; Research Council of Norway(Research Council of Norway)	This work was supported by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 720270 (HBP SGA1) and Grant Agreement No. 785907 (HBP SGA2), with additional support from The Research Council of Norway, Grant Agreement No. 269774 (INCF National Node) to JGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Bjerke IE, 2018, EUR PSYCHIAT, V50, P70, DOI 10.1016/j.eurpsy.2018.02.004; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Campagnola L, 2014, J NEUROSCI, V34, P2214, DOI 10.1523/JNEUROSCI.4669-13.2014; Dempsey B, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00009; Furth D, 2018, NAT NEUROSCI, V21, P139, DOI 10.1038/s41593-017-0027-7; Ju T, 2006, J NEUROSCI METH, V156, P84, DOI 10.1016/j.jneumeth.2006.02.020; Kim Y, 2017, CELL, V171, P456, DOI 10.1016/j.cell.2017.09.020; Kjonigsen LJ, 2015, NEUROIMAGE, V108, P441, DOI 10.1016/j.neuroimage.2014.12.080; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Majka P, 2013, NEUROINFORMATICS, V11, P507, DOI 10.1007/s12021-013-9199-9; Niedworok CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11879; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Schubert N, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00051; Shiffman S, 2018, J NEUROSCI METH, V308, P219, DOI 10.1016/j.jneumeth.2018.08.005; Tiesinga P, 2015, CURR OPIN NEUROBIOL, V32, P107, DOI 10.1016/j.conb.2015.02.003; Vandenberghe ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep20958; Zakiewicz IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137571; Zakiewicz IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022669	21	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216796	10.1371/journal.pone.0216796	http://dx.doi.org/10.1371/journal.pone.0216796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141518	Green Published, gold			2022-12-27	WOS:000469323000024
J	Ram, H; Kaur, A; Gandass, N; Singh, S; Deshmukh, R; Sonah, H; Sharma, TR				Ram, Hasthi; Kaur, Amandeep; Gandass, Nishu; Singh, Shweta; Deshmukh, Rupesh; Sonah, Humira; Sharma, Tilak Raj			Molecular characterization and expression dynamics of MTP genes under various spatio-temporal stages and metal stress conditions in rice	PLOS ONE			English	Article							HEAVY-METALS; METABOLISM; TOLERANCE; DATABASE	Metal Tolerance Proteins (MTPs) are the class of membrane proteins involved in the transport of metals, mainly Zn, Mn, Fe, Cd, Co and Ni, and confer metal tolerance in plants. In the present study, a comprehensive molecular analysis of rice MTP genes was performed to understand the evolution, distribution and expression dynamics of MTP genes. Exploration of the whole genome re-sequencing information available for three thousand rice genotypes highlighted the evolution and allelic diversity of MTP genes. Based on the presence of nonsynonymous single nucleotide polymorphism (SNP), MTP1, MTP6, MTP8 and MTP9 were found to be the most conserved genes. Furthermore, results showed localization of MTP1, MTP8.1 and MTP9, and MTP11, respectively with QTLs/m- QTLs for Zn and Cd accumulation, making these genes promising candidates to understand the QTL regulation. Expression profiling of the entire set of 10 MTP genes revealed root and shoot specific expressions of MTP9 and MTP8.1, respectively, under all tested vegetative stages. Expression of seedspecific MTPs increased as seed maturation progressed, which revealed their potential role in transporting metals during seed filling. Upon exposure to harmful heavy metals, expression of most MTP genes decreased in root and increased in shoot, suggests that different mechanisms are being employed by MTPs in different tissues. Contrastingly, only a few MTPs were found to be responsive to Fe and/or Zn starvation conditions. The extensive analysis of MTPs presented here will be helpful in identifying candidate MTP genes for crop biofortification and bioremediation purposes.	[Ram, Hasthi; Kaur, Amandeep; Gandass, Nishu; Singh, Shweta; Deshmukh, Rupesh; Sonah, Humira; Sharma, Tilak Raj] NABI, Dept Agribiotechnol, Sas Nagar Mohali, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Sharma, TR (corresponding author), NABI, Dept Agribiotechnol, Sas Nagar Mohali, Punjab, India.	hrmundel84@gmail.com; trsharma@nabi.res.in	Deshmukh, Rupesh Kailasrao/C-6479-2012	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; Ram, Dr Hasthi/0000-0003-0893-3895; Sonah, Humira/0000-0003-4796-6120; Singh, Shweta/0000-0003-4408-5766	DST-INSPIRE Faculty grant from Department of Science and Technology, Govt. of India [DST/INSPIRE/04/2016/001118]; National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Govt. of India	DST-INSPIRE Faculty grant from Department of Science and Technology, Govt. of India; National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Govt. of India	This research was funded by DST-INSPIRE Faculty grant from Department of Science and Technology, Govt. of India (http://www.dst.gov.in/), awarded to HR with grant no. DST/INSPIRE/04/2016/001118, and core grant from National Agri-Food Biotechnology Institute (NABI) (https://nabi.res.in/), Department of Biotechnology (DBT), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Barker K, 2015, HART STUD PRIV LAW, P3; Bashir K, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00015, 10.3389/fpls.2013.00090]; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Borrill P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00053; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Deshmukh RK, 2016, J PLANT BIOCHEM BIOT, V25, P142, DOI 10.1007/s13562-015-0319-5; Deshmukh RK, 2015, PLANT J, V83, P489, DOI 10.1111/tpj.12904; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Esposito S, 2012, INT J PHYTOREMEDIAT, V14, P443, DOI 10.1080/15226514.2011.620904; dos Santos LMG, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20170202; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; John Wiley & Sons Ltd, 2001, ENCY LIFE SCI, P287; Li WF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00040; Liu JK, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00345; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackill DJ, 2018, RICE, V11, DOI 10.1186/s12284-018-0208-3; Menguer PK, 2013, J EXP BOT, V64, P2871, DOI 10.1093/jxb/ert136; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Reeves RD, 2018, NEW PHYTOL, V218, P407, DOI 10.1111/nph.14907; Takemoto Y, 2017, PLANT CELL PHYSIOL, V58, P1573, DOI 10.1093/pcp/pcx082; TULCHINSKY TH, 2010, PUBLIC HLTH REV, V32, P243; Ueno D, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.170, 10.1038/nplants.2015.170]; Xia L, 2017, J GENET GENOMICS, V44, P235, DOI 10.1016/j.jgg.2017.05.003; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9; Zhang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174987	31	19	19	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217360	10.1371/journal.pone.0217360	http://dx.doi.org/10.1371/journal.pone.0217360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136613	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300029
J	Traitanon, O; Mathew, JM; Shetty, A; Bontha, SV; Maluf, DG; El Kassis, Y; Park, SH; Han, J; Ansari, MJ; Leventhal, JR; Mas, V; Gallon, L				Traitanon, Opas; Mathew, James M.; Shetty, Aneesha; Bontha, Sai Vineela; Maluf, Daniel G.; El Kassis, Yvonne; Park, Sook H.; Han, Jing; Ansari, M. Javeed; Leventhal, Joseph R.; Mas, Valeria; Gallon, Lorenzo			Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil	PLOS ONE			English	Article							REGULATORY T-CELLS; RENAL-TRANSPLANTATION; ALLOGRAFT FUNCTION; CYCLOSPORINE; CALCINEURIN; CONVERSION; INHIBITOR; IMMUNOSUPPRESSION; METAANALYSIS; SIROLIMUS	Calcineurin inhibitors (CNI), the cornerstone of immunosuppression after transplantation are implicated in nephrotoxicity and allograft dysfunction. We hypothesized that combined low doses of CNI and Everolimus (EVR) may result in better graft outcomes and greater tolerogenic milieu. Forty adult renal transplant recipients were prospectively randomized to (steroid free) low dose Tacrolimus (TAC) and EVR or standard dose TAC and Mycophenolate (MMF) after Alemtuzumab induction. Baseline characteristics were statistically similar. EVR levels were maintained at 3-8 ng/ml. TAC levels were 4.5 +/- 1.9 and 6.4 +/- 1.5 ng/ml in the TAC+EVR and TAC+MMF group respectively. Follow up was 14 +/- 4 and 17 +/- 5 months respectively and included protocol kidney biopsies at 3 and 12 months post-transplantation. Rejection-rate was lower in the TAC+EVR group. However patient and overall graft survival, eGFR and incidence of adverse events were similar. TAC+EVR induced expansion of CD4(+)CD25(hi)Foxp3(+) regulatory T cells as early as 3 months and expansion of IFN-gamma(+)CD4(+)CD25(hi)Foxp3(+) regulatory T cells at 12 months post-transplant. Gene expression profile showed a trend toward decreased inflammation, angiogenesis and connective tissue growth in the TAC+EVR Group. Thus, greater tolerogenic mechanisms were found to be operating in patients with low dose TAC+EVR and this might be responsible for the lower rejection-rate than in patients on standard dose TAC+MMF. However, further studies with longer follow up and evaluating impact on T regulatory cells are warranted.	[Traitanon, Opas; Shetty, Aneesha; El Kassis, Yvonne; Park, Sook H.; Ansari, M. Javeed; Gallon, Lorenzo] Northwestern Univ, Dept Med Nephrol, Chicago, IL 60611 USA; [Traitanon, Opas] Thammasart Univ Hosp, Dept Med Nephrol, Pathum Thani, Thailand; [Mathew, James M.; Leventhal, Joseph R.] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA; [Mathew, James M.; Han, Jing; Ansari, M. Javeed; Leventhal, Joseph R.; Gallon, Lorenzo] Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Mathew, James M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Bontha, Sai Vineela; Maluf, Daniel G.; Mas, Valeria] Methodist Univ Transplant Inst, Memphis, TN USA; [Bontha, Sai Vineela; Maluf, Daniel G.; Mas, Valeria] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA	Northwestern University; Thammasat University; Northwestern University; Northwestern University; Northwestern University; University of Tennessee System; University of Tennessee Health Science Center	Gallon, L (corresponding author), Northwestern Univ, Dept Med Nephrol, Chicago, IL 60611 USA.; Mathew, JM (corresponding author), Northwestern Univ, Dept Surg, Chicago, IL 60611 USA.; Mathew, JM; Gallon, L (corresponding author), Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA.; Mathew, JM (corresponding author), Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA.	James-mathew@northwestern.edu; L-gallon@northwestern.edu		Mathew, James/0000-0002-5667-750X; bontha, sai vineela/0000-0001-8914-1966	Novartis [Agmt 4/16/12]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK108738] Funding Source: NIH RePORTER	Novartis(Novartis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by Novartis through an investigator initiated grant to LG (Agmt 4/16/12). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the funders approved the publication of the results.	Bemelman FJ, 2017, AM J TRANSPLANT, V17, P1020, DOI 10.1111/ajt.14048; Bodziak KA, 2009, TRANSPL INT, V22, P519, DOI 10.1111/j.1432-2277.2008.00800.x; Bohra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048063; Chhabra D, 2013, AM J TRANSPLANT, V13, P2902, DOI 10.1111/ajt.12437; Chhabra D, 2012, CLIN J AM SOC NEPHRO, V7, P504, DOI 10.2215/CJN.06940711; Daniel V, 2008, TRANSPL INT, V21, P646, DOI 10.1111/j.1432-2277.2008.00662.x; Daniel V, 2014, INT REV IMMUNOL, V33, P195, DOI 10.3109/08830185.2013.845181; De Serres SA, 2012, J AM SOC NEPHROL, V23, P174, DOI 10.1681/ASN.2011040360; Dumur CI, 2004, CLIN CHEM, V50, P1994, DOI 10.1373/clinchem.2004.033225; Gallon L, 2015, TRANSPLANTATION, V99, P1774, DOI 10.1097/TP.0000000000000717; Gallon L, 2015, KIDNEY INT, V87, P828, DOI 10.1038/ki.2014.350; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Klawitter J, 2015, EXPERT OPIN DRUG SAF, V14, P1055, DOI 10.1517/14740338.2015.1040388; Knoll GA, 1999, BRIT MED J, V318, P1104, DOI 10.1136/bmj.318.7191.1104; Levitsky J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156535; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Mas VR, 2004, LIVER TRANSPLANT, V10, P607, DOI 10.1002/lt.20118; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Mulay AV, 2005, AM J TRANSPLANT, V5, P1748, DOI 10.1111/j.1600-6143.2005.00931.x; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Pascual J, 2018, J AM SOC NEPHROL, V29, P1979, DOI 10.1681/ASN.2018010009; Racusen Lorraine C, 2004, Am J Transplant, V4, P1562, DOI 10.1111/j.1600-6143.2004.00585.x; Salvadori M, 2009, TRANSPLANTATION, V88, P1194, DOI 10.1097/TP.0b013e3181bb43ec; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Shetty A, 2016, AM J TRANSPLANT, V16, P218; Shing CM, 2012, TRANSPL INT, V25, P337, DOI 10.1111/j.1432-2277.2011.01420.x; Team RDC, 2005, R LANG ENV STAT COMP; Traitanon O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129658; van de Berg PJEJ, 2012, IMMUNOLOGY, V136, P198, DOI 10.1111/j.1365-2567.2012.03570.x; Vitiello D, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.24; Webster AC, 2005, BMJ-BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216300	10.1371/journal.pone.0216300	http://dx.doi.org/10.1371/journal.pone.0216300			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136582	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300005
J	Ab Rahim, L; Kudiri, KM; Bahattacharjee, S				Ab Rahim, Lukman; Kudiri, Krishna Mohan; Bahattacharjee, Shiladitya			Framework for parallelisation on big data	PLOS ONE			English	Article								The parallelisation of big data is emerging as an important framework for large-scale parallel data applications such as seismic data processing. The field of seismic data is so large or complex that traditional data processing software is incapable of dealing with it. For example, the implementation of parallel processing in seismic applications to improve the processing speed is complex in nature. To overcome this issue, a simple technique which that helps provide parallel processing for big data applications such as seismic algorithms is needed. In our framework, we used the Apache Hadoop with its MapReduce function. All experiments were conducted on the RedHat CentOS platform. Finally, we studied the bottlenecks and improved the overall performance of the system for seismic algorithms (stochastic inversion).	[Ab Rahim, Lukman; Kudiri, Krishna Mohan; Bahattacharjee, Shiladitya] Univ Teknol PETRONAS, High Performance Cloud Comp Ctr, Seri Iskandar, Perak, Malaysia	Universiti Teknologi Petronas	Ab Rahim, L (corresponding author), Univ Teknol PETRONAS, High Performance Cloud Comp Ctr, Seri Iskandar, Perak, Malaysia.	lukmanrahim@utp.edu.my	Kudiri, Krishna Mohan/H-3935-2013	Kudiri, Krishna Mohan/0000-0002-4951-0680	Hitachi Asia Malaysia Sdn. Bhd.	Hitachi Asia Malaysia Sdn. Bhd.	This work was supported by the Hitachi Asia Malaysia Sdn. Bhd. to HPCCC, UTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addair TG, 2014, COMPUT GEOSCI-UK, V66, P145, DOI 10.1016/j.cageo.2014.01.014; Azzedin F, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON COLLABORATION TECHNOLOGIES AND SYSTEMS (CTS), P155; Baaziz A, 2013, INT J INNOV, V1, P19, DOI 10.5585/iji.v1i1.4; Brule M, 2013, TAPPING POWER BIG DA, P1; Chen Z, 2017, 3 INT C COMP INT COM, P1; Dwornik M, 2012, LECT NOTES COMPUT SC, V7204, P353, DOI 10.1007/978-3-642-31500-8_36; Hems A, 2013, DRILLING NEW BUSINES, P1; Hollingsworth J, 2013, ORACLE OIL GAS IND B, P1; Krauzowicz L, 2012, COMM COM INF SC, V291, P440, DOI 10.1007/978-3-642-31217-5_46; Ma ZH, 2017, 2017 2ND IEEE INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND BIG DATA ANALYSIS (ICCCBDA 2017), P180, DOI 10.1109/ICCCBDA.2017.7951907; Nicholson R, 2012, IDC ENERGY INSIGHTS, P1; Xin W, 2013, INT C SYST ENG MOD, P812; Yan XS, 2018, COMPUT GEOSCI-UK, V110, P81, DOI 10.1016/j.cageo.2017.10.002; [No title captured]	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0214044	10.1371/journal.pone.0214044	http://dx.doi.org/10.1371/journal.pone.0214044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120878	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700003
J	Alonso, CH; Tanner, JJ; Wiggins, ME; Sinha, P; Parvataneni, HK; Ding, MZ; Seubert, CN; Rice, MJ; Garvan, CW; Price, CC				Alonso, Carlos Hernaiz; Tanner, Jared J.; Wiggins, Margaret E.; Sinha, Preeti; Parvataneni, Hari K.; Ding, Mingzhou; Seubert, Christoph N.; Rice, Mark J.; Garvan, Cynthia W.; Price, Catherine C.			Proof of principle: Preoperative cognitive reserve and brain integrity predicts intra-individual variability in processed EEG (Bispectral Index Monitor) during general anesthesia	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; ALZHEIMERS-DISEASE; VENTRICULAR VOLUME; OLDER-ADULTS; MILD; DEMENTIA; IMPAIRMENT; DECLINE; ELECTROENCEPHALOGRAM; WHITE	Background Preoperative cognitive reserve and brain integrity may explain commonly observed intraoperative fluctuations seen on a standard anesthesia depth monitor used ubiquitously in operating rooms throughout the nation. Neurophysiological variability indicates compromised regulation and organization of neural networks. Based on theories of neuronal integrity changes that accompany aging, we assessed the relative contribution of: 1) premorbid cognitive reserve, 2) current brain integrity (gray and white matter markers of neurodegenerative disease), and 3) current cognition (specifically domains of processing speed/working memory, episodic memory, and motor function) on intraoperative neurophysiological variability as measured from a common intraoperative tool, the Bispectral Index Monitor (BIS). Methods This sub-study included participants from a parent study of non-demented older adults electing unilateral Total Knee Arthroplasty (TKA) with the same surgeon and anesthesia protocol, who also completed a preoperative neuropsychological assessment and preoperative 3T brain magnetic resonance imaging scan. Left frontal two-channel derived EEG via the BIS was acquired preoperatively (un-medicated and awake) and continuously intraoperatively with time from tourniquet up to tourniquet down. Data analyses used correlation and regression modeling. Results Fifty-four participants met inclusion criteria for the sub-study. The mean (SD) age was 69.5 (7.4) years, 54% were male, 89% were white, and the mean (SD) American Society of Anesthesiologists score was 2.76 (0.47). We confirmed that brain integrity positively and significantly associated with each of the cognitive domains of interest. EEG intra-individual variability (squared deviation from the mean BIS value between tourniquet up and down) was significantly correlated with cognitive reserve (r = -. 40, p =.003), brain integrity (r = -. 37, p =.007), and a domain of processing speed/working memory (termed cognitive efficiency; r = -. 31, p =.021). Hierarchical regression models that sequentially included age, propofol bolus dose, cognitive reserve, brain integrity, and cognitive efficiency found that intraoperative propofol bolus dose (p =.001), premorbid cognitive reserve (p =.008), and current brain integrity (p =.004) explained a significant portion of intraoperative intra-individual variability from the BIS monitor. Conclusions Older adults with higher premorbid reserve and less brain disease were more stable intraoperatively on a depth of anesthesia monitor. Researchers need to replicate findings within larger cohorts and other surgery types.	[Alonso, Carlos Hernaiz; Tanner, Jared J.; Wiggins, Margaret E.; Sinha, Preeti; Price, Catherine C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Parvataneni, Hari K.] Univ Florida, Coll Med, Dept Orthoped Surg, Gainesville, FL USA; [Ding, Mingzhou] Univ Florida, Herbert Wertheim Coll Engn, Dept Biomed Engn, Gainesville, FL USA; [Seubert, Christoph N.; Garvan, Cynthia W.; Price, Catherine C.] Univ Florida, Dept Anesthesiol, Gainesville, FL 32611 USA; [Rice, Mark J.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Price, Catherine C.] Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Price, Catherine C.] Dept Anesthesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Vanderbilt University	Price, CC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.; Price, CC (corresponding author), Univ Florida, Dept Anesthesiol, Gainesville, FL 32611 USA.; Price, CC (corresponding author), Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.; Price, CC (corresponding author), Dept Anesthesiol, Gainesville, FL 32611 USA.	cep23@phhp.ufl.edu	Sinha, Preeti/AAW-1072-2021	Price, Catherine/0000-0001-5994-0644	National Institute of Nursing Research of the National Institutes of Health [R01NR014181]; National Institutes of Health's Clinical and Translational Science Awards program [UL1TR001427, KL2TR001429, TL1TR001428]; 1Florida Alzheimer's Disease Research Center - National Institute on Aging [P50AG047266]; Fogerty International Center of the National Institutes of Health [D43TW009120]; National Institute of Neurological Disorders and Stroke [R01NS082386]; National Science Foundation [IIS1404494]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, KL2TR001429, TL1TR001428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047266] Funding Source: NIH RePORTER	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health's Clinical and Translational Science Awards program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 1Florida Alzheimer's Disease Research Center - National Institute on Aging; Fogerty International Center of the National Institutes of Health; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by National Institute of Nursing Research of the National Institutes of Health under award number R01NR014181 (to CHA, JJT, HKP, MZ, MJR, CWG, CP), the National Institutes of Health's Clinical and Translational Science Awards program funded by UL1TR001427, KL2TR001429, TL1TR001428, the 1Florida Alzheimer's Disease Research Center supported by the National Institute on Aging under award number P50AG047266 (to CWG), and Fogerty International Center of the National Institutes of Health under award number D43TW009120 (to PS). Additional grant support provided by National Institute of Neurological Disorders and Stroke under award R01NS082386 (to CCP) and the National Science Foundation IIS1404494 (to CCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amini S, 2019, ANESTHESIA ANALGESIA; Andersson M, 2008, DEMENT GERIATR COGN, V26, P284, DOI 10.1159/000160962; BARRETT PT, 1994, PERS INDIV DIFFER, V16, P3, DOI 10.1016/0191-8869(94)90107-4; Carmichael OT, 2007, NEUROBIOL AGING, V28, P389, DOI 10.1016/j.neurobiolaging.2006.01.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook SE, 2009, J GERIATR PSYCH NEUR, V22, P103, DOI 10.1177/0891988708328214; Crowley SJ, 2018, J INT NEUROPSYCH SOC, V24, P206, DOI 10.1017/S1355617717000868; Culley DJ, 2016, ANESTH ANALG, V123, P186, DOI 10.1213/ANE.0000000000001277; Desikan S, 2018, P NATL ACAD SCI USA, V115, pE2644, DOI 10.1073/pnas.1716531115; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Donix M, 2013, PSYCHIAT RES-NEUROIM, V214, P212, DOI 10.1016/j.pscychresns.2013.09.006; Duarte Leonardo Teixeira Domingues, 2009, Rev. Bras. Anestesiol., V59, P99, DOI 10.1590/S0034-70942009000100013; Femminella GD, 2014, J ALZHEIMERS DIS, V42, P369, DOI 10.3233/JAD-140513; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Giattino CM, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00024; HACHINSKI VC, 1986, CAN J NEUROL SCI, V13, P533; Hasan KM, 2016, J NEUROIMAGING, V26, P278, DOI 10.1111/jon.12297; Haynes BI, 2017, J INT NEUROPSYCH SOC, V23, P431, DOI 10.1017/S1355617717000236; Huang HQ, 2018, J ALZHEIMERS DIS, V62, P319, DOI 10.3233/JAD-170496; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Kertai MD, 2012, ANESTH ANALG, V114, P533, DOI 10.1213/ANE.0b013e31823ee030; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Libon DJ, 2004, CLIN NEUROPSYCHOL, V18, P83, DOI 10.1080/13854040490507181; Luck T, 2017, AM J GERIAT PSYCHIAT, V25, P328, DOI 10.1016/j.jagp.2016.07.001; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; Mathews DM, 2012, ANESTH ANALG, V114, P759, DOI 10.1213/ANE.0b013e3182455ac2; MELLA N, 2013, THESCIENTIFICWORLDJO, DOI DOI 10.1155/2013/350623; Michielse S, 2010, NEUROIMAGE, V52, P1190, DOI 10.1016/j.neuroimage.2010.05.019; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Moretti DV, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0162-x; Moretti DV, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00031; Moy G, 2011, NEUROSCIENCE, V186, P88, DOI 10.1016/j.neuroscience.2011.04.028; Nakatsuka I, 2002, J CLIN ANESTH, V14, P196, DOI 10.1016/S0952-8180(01)00384-1; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Price CC, 2015, J ALZHEIMERS DIS, V48, P833, DOI 10.3233/JAD-150407; Price CC, 2014, ANESTHESIOLOGY, V120, P601, DOI 10.1097/ALN.0000000000000080; Price CC, 2012, NEUROLOGY, V79, P734, DOI 10.1212/WNL.0b013e3182661ef6; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Rossini PM, 2008, CLIN NEUROPHYSIOL, V119, P1534, DOI 10.1016/j.clinph.2008.03.026; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Satz P., 1993, NEUROPSYCHOLOGY, V7, P22; Shin KS, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.31; Stern Y, 2018, ALZHEIMERS DEMENTI S; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Vemuri P, 2011, BRAIN, V134, P1479, DOI 10.1093/brain/awr049; Williams SN., 2015, HOSPITALIZATION TOTA; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216209	10.1371/journal.pone.0216209	http://dx.doi.org/10.1371/journal.pone.0216209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120896	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700009
J	Ahmed, Z; Saada, M; Jones, AM; Al-Hamid, AM				Ahmed, Zamzam; Saada, Mohammad; Jones, Alan M.; Al-Hamid, Abdullah M.			Medical errors: Healthcare professionals' perspective at a tertiary hospital in Kuwait	PLOS ONE			English	Article								Medical errors are of economic importance and can contribute to serious adverse events for patients. Medical errors refer to preventable events resulting from healthcare interactions, whether these events harm the patient or not. In Kuwait, there is a paucity literature detailing the causes, forms, and risks of medical errors in their state-funded healthcare facilities. This study aimed to explore medical errors, their causes and preventive strategies in a Kuwait tertiary hospital based on the perceptions and experience of a cross-section of healthcare professionals using a questionnaire with 27 open (n = 10) and closed (n = 17) questions. The recruited healthcare professionals in this study included pharmacists, nurses, physicians, dentists, radiographers, hospital administrators, surgeons, nutritionists, and physiotherapists. The collected data were analysed quantitatively using descriptive statistics. A total of 203 participants filled and completed the survey questionnaire. The frequency of medical errors in Kuwait was found to be high at 60.3% ranging from incidences of prolonged hospital stays (32.9%), adverse events and life-threatening complications (32.3%), and fatalities (20.9%). The common medical errors result from incomplete instructions, incorrect dosage, and incorrect route of administration, diagnosis errors, and labelling errors. The perceived causes of these medical errors include high workload, lack of support systems, stress, medical negligence, inadequate training, miscommunication, poor collaboration, and non-adherence to safety guidelines among the healthcare professionals.	[Ahmed, Zamzam; Saada, Mohammad; Al-Hamid, Abdullah M.] Univ Hertfordshire, Sch Pharm, Hatfield, Herts, England; [Jones, Alan M.; Al-Hamid, Abdullah M.] Univ Birmingham, Sch Pharm, Edgbaston, England	University of Hertfordshire; University of Birmingham	Al-Hamid, AM (corresponding author), Univ Hertfordshire, Sch Pharm, Hatfield, Herts, England.; Al-Hamid, AM (corresponding author), Univ Birmingham, Sch Pharm, Edgbaston, England.	A.M.AlHamid@bham.ac.uk	Jones, Alan M/F-3086-2015	Jones, Alan M/0000-0002-3897-5626; Saada, Mohammad/0000-0002-0062-9779				Abduldaeem HMK., 2016, IJPP, V24, P4; Ali H, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2960-x; Alkhaja K, 2015, INT J CLIN PHARM TH, V43, P294; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; Brownlie K, 2014, INT J CLIN PHARM-NET, V36, P303, DOI 10.1007/s11096-013-9875-8; Buck M. L., 2008, PEDIAT PHARM, V14, P1; Cottney A., 2014, BMJ QUAL IMPROVE REP, V3; Delbanco T, 2007, NEW ENGL J MED, V357, P1682, DOI 10.1056/NEJMp078104; Fahimi F, 2010, IRAN J PHARM RES, V9, P297; Ghobashi MM, 2014, EPIDEMIOL BIOSTAT PU, V11, DOI 10.2427/9101; Grasso BC, 2003, PSYCHIAT SERV, V54, P677, DOI 10.1176/appi.ps.54.5.677; Grober ED, 2005, CAN J SURG, V48, P39; Harding L, 2014, J NURS EDUC, V47, P43; Hassan Zailinawati Abu, 2006, Malays Fam Physician, V1, P70; Jones JH, 2010, J NURS CARE QUAL, V25, P240, DOI 10.1097/NCQ.0b013e3181d5b948; Kim IS, 2013, ASIAN NURS RES, V7, P26, DOI 10.1016/j.anr.2013.01.001; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Larson MG, 2006, CIRCULATION, V114, P76, DOI 10.1161/CIRCULATIONAHA.105.584474; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Lisby M, 2010, INT J QUAL HEALTH C, V22, P507, DOI 10.1093/intqhc/mzq059; Mousavi M, 2012, INT J CLIN PHARM-NET, V34, P374, DOI 10.1007/s11096-012-9620-8; Mrayyan Majd T, 2007, J Nurs Manag, V15, P659, DOI 10.1111/j.1365-2834.2007.00724.x; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Reid-Searl K, 2008, J CLIN NURS, V17, P2750, DOI 10.1111/j.1365-2702.2008.02486.x; Santos Jânia Oliveira, 2007, Acta paul. enferm., V20, P483, DOI 10.1590/S0103-21002007000400016; Schneider P, 2012, TXB CLIN PHARM PRACT, P424; Scott H, 2016, INT J PHARM PRACT, V3, P8; Stubbs J, 2006, J PSYCHOPHARMACOL, V20, P553, DOI 10.1177/0269881106059808; Tang FI, 2007, J CLIN NURS, V16, P447, DOI 10.1111/j.1365-2702.2005.01540.x; Van Harten WH, 2009, HEALTHCARE MANAGEMEN, P1; World Health Organisation (WHO), 2018, DAT STAT EUR MED ERR	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217023	10.1371/journal.pone.0217023	http://dx.doi.org/10.1371/journal.pone.0217023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116773	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400037
J	Hosny, KM; Kassem, MA; Foaud, MM				Hosny, Khalid M.; Kassem, Mohamed A.; Foaud, Mohamed M.			Classification of skin lesions using transfer learning and augmentation with Alex-net	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; METHODOLOGICAL APPROACH; MELANOMA; DIAGNOSIS; CANCER; SYSTEM	Skin cancer is one of most deadly diseases in humans. According to the high similarity between melanoma and nevus lesions, physicians take much more time to investigate these lesions. The automated classification of skin lesions will save effort, time and human life. The purpose of this paper is to present an automatic skin lesions classification system with higher classification rate using the theory of transfer learning and the pre-trained deep neural network. The transfer learning has been applied to the Alex-net in different ways, including fine-tuning the weights of the architecture, replacing the classification layer with a softmax layer that works with two or three kinds of skin lesions, and augmenting dataset by fixed and random rotation angles. The new softmax layer has the ability to classify the segmented color image lesions into melanoma and nevus or into melanoma, seborrheic keratosis, and nevus. The three well-known datasets, MED-NODE, Derm (IS & Quest) and ISIC, are used in testing and verifying the proposed method. The proposed DCNN weights have been fine-tuned using the training and testing dataset from ISIC in addition to 10-fold cross validation for MED-NODE and DermIS-DermQuest. The accuracy, sensitivity, specificity, and precision measures are used to evaluate the performance of the proposed method and the existing methods. For the datasets, MED-NODE, Derm (IS & Quest) and ISIC, the proposed method has achieved accuracy percentages of 96.86%, 97.70%, and 95.91% respectively. The performance of the proposed method has outperformed the performance of the existing classification methods of skin cancer.	[Hosny, Khalid M.] Zagazig Univ, Fac Comp & Informat, Dept Informat Technol, Zagazig, Egypt; [Kassem, Mohamed A.] Modern Acad, Dept Informat Syst, Cairo, Egypt; [Foaud, Mohamed M.] Zagazig Univ, Dept Elect & Commun, Fac Engn, Zagazig, Egypt	Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA); Egyptian Knowledge Bank (EKB); Zagazig University	Hosny, KM (corresponding author), Zagazig Univ, Fac Comp & Informat, Dept Informat Technol, Zagazig, Egypt.	k_hosny@yahoo.com	kassem, mohamed/AAF-3990-2019; Hosny, Khalid M./B-1404-2008	kassem, mohamed/0000-0002-5150-5004; Hosny, Khalid M./0000-0001-8065-8977				Almarashi Jamal Q. M., 2016, 2016 IEEE International Conference on Plasma Science (ICOPS), DOI 10.1109/PLASMA.2016.7534125; Amelard R, 2012, IEEE ENG MED BIO, P4458, DOI 10.1109/EMBC.2012.6346956; American Cancer Society, 2018, CANC FACTS FIG 2018; [Anonymous], STANF CS CLASS NOT; [Anonymous], 2012, DERMTOLOGY INFORM SY; Apalla Z, 2017, DERMATOLOGY THER, V7, pS5, DOI 10.1007/s13555-016-0165-y; Athi Narayan S, MATLAB CENTRAL PROGR; Ballerini Lucia, 2013, COLOR MED IMAGE ANAL, P63; Barata C, 2019, IEEE J BIOMED HEALTH, V23, P1096, DOI 10.1109/JBHI.2018.2845939; BINDER M, 1995, ARCH DERMATOL, V131, P286, DOI 10.1001/archderm.131.3.286; Celebi ME, 2007, COMPUT MED IMAG GRAP, V31, P362, DOI 10.1016/j.compmedimag.2007.01.003; Codella N., 2015, LECT NOTES COMPUTER, V9352, P118, DOI DOI 10.1007/978-3-319-24888-2; Codella NCF, 2017, IBM J RES DEV, V61, DOI 10.1147/JRD.2017.2708299; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Giotis I, 2015, EXPERT SYST APPL, V42, P6578, DOI 10.1016/j.eswa.2015.04.034; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Gutman D., 2016, SKIN LESION ANAL MEL; Jafari MH, 2016, IEEE ENG MED BIO, P1357, DOI 10.1109/EMBC.2016.7590959; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Karabulut E., 2016, INT C INT COMP COMP, V2, P26; Kostopoulos SA, 2017, INT J MED INFORM, V105, P1, DOI 10.1016/j.ijmedinf.2017.05.016; Krizhevsky A., P 25 INT C NEUR INF, P1097; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Mishra N. K., 2016, OVERVIEW MELANOMA DE; Nasr-Esfahani E, 2016, IEEE ENG MED BIO, P1373, DOI 10.1109/EMBC.2016.7590963; Pathan S, 2018, BIOMED SIGNAL PROCES, V44, P25, DOI 10.1016/j.bspc.2018.03.017; Perez F, 2018, LECT NOTES COMPUT SC, V11041, P303, DOI 10.1007/978-3-030-01201-4_33; Premaladha J, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0460-2; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Schaefer G, 2014, MEMET COMPUT, V6, P233, DOI 10.1007/s12293-014-0144-8; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Srinivas S, 2016, FRONT ROBOT AI, V2, DOI 10.3389/frobt.2015.00036; Stojanovic M, 2014, VOJNOSANIT PREGL, V71, P1062, DOI 10.2298/VSP1411062S; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tommasi T, 2006, LECT NOTES COMPUT SC, V4241, P1; Pham TC, 2018, LECT NOTES ARTIF INT, V10752, P573, DOI 10.1007/978-3-319-75420-8_54; Wenpeng Y., CORR; Yang X., NOVEL MULTITASK DEEP; Yu LQ, 2017, IEEE T MED IMAGING, V36, P994, DOI 10.1109/TMI.2016.2642839	42	104	105	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217293	10.1371/journal.pone.0217293	http://dx.doi.org/10.1371/journal.pone.0217293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112591	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000048
J	Lim, CG; Poh, XWW; Fung, SSD; Guan, C; Bautista, D; Cheung, YB; Zhang, HH; Yeo, SN; Krishnan, R; Lee, TS				Lim, Choon Guan; Poh, Xue Wei Wendy; Fung, Shuen Sheng Daniel; Guan, Cuntai; Bautista, Dianne; Cheung, Yin Bun; Zhang, Haihong; Yeo, Si Ning; Krishnan, Ranga; Lee, Tih Shih			A randomized controlled trial of a brain-computer interface based attention training program for ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; CHILDREN; METAANALYSIS; ADOLESCENTS; MTA	Objective The use of brain-computer interface in neurofeedback therapy for attention deficit hyperactivity disorder (ADHD) is a relatively new approach. We conducted a randomized controlled trial (RCT) to determine whether an 8-week brain computer interface (BCI)-based attention training program improved inattentive symptoms in children with ADHD compared to a waitlist-control group, and the effects of a subsequent 12-week lower-intensity training. Study design We randomized 172 children aged 6-12 attending an outpatient child psychiatry clinic diagnosed with inattentive or combined subtypes of ADHD and not receiving concurrent pharmacotherapy or behavioral intervention to either the intervention or waitlist-control group. Intervention involved 3 sessions of BCI-based training for 8 weeks, followed by 3 training sessions per month over the subsequent 12 weeks. The waitlist-control group received similar 20-week intervention after a wait-time of 8 weeks. Results The participants' mean age was 8.6 years (SD = 1.51), with 147 males (85.5%) and 25 females (14.5%). Modified intention to treat analyzes conducted on 163 participants with at least one follow-up rating showed that at 8 weeks, clinician-rated inattentive symptoms on the ADHD-Rating Scale (ADHD-RS) was reduced by 3.5 (SD 3.97) in the intervention group compared to 1.9 (SD 4.42) in the waitlist-control group (between-group difference of 1.6; 95% CI 0.3 to 2.9 p = 0.0177). At the end of the full 20-week treatment, the mean reduction (pre-post BCI) of the pooled group was 3.2 (95% CI 2.4 to 4.1). Conclusion The results suggest that the BCI-based attention training program can improve ADHD symptoms after a minimum of 24 sessions and maintenance training may sustain this improvement. This intervention may be an option for treating milder cases or as an adjunctive treatment.	[Lim, Choon Guan; Poh, Xue Wei Wendy; Fung, Shuen Sheng Daniel] Inst Mental Hlth, Dept Child & Adolescent Psychiat, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore; [Bautista, Dianne; Cheung, Yin Bun] Singapore Clin Res Inst, Dept Biostat, Singapore, Singapore; [Bautista, Dianne; Cheung, Yin Bun] Duke Natl Univ Singapore Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Cheung, Yin Bun] Univ Tampere, Ctr Child Hlth Res, Tampere, Finland; [Cheung, Yin Bun] Tampere Univ Hosp, Tampere, Finland; [Zhang, Haihong] ASTAR, Inst Infocomm Res, Neural & Biomed Technol Dept, Singapore, Singapore; [Yeo, Si Ning; Krishnan, Ranga; Lee, Tih Shih] Duke Natl Univ Singapore Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore Clinical Research Institute; Tampere University; Tampere University; Tampere University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Lim, CG (corresponding author), Inst Mental Hlth, Dept Child & Adolescent Psychiat, Singapore, Singapore.	choon_guan_lim@imh.com.sg	Guan, Cuntai/G-7835-2016	Guan, Cuntai/0000-0002-0872-3276; Lim, Choon Guan/0000-0001-5296-6745	National Medical Research Council of Singapore [CIRG11nov087]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This study was supported by a grant from National Medical Research Council of Singapore (URL: http://www.nmrc.gov.sg/).Grant Number CIRG11nov087 was awarded to TSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE, DOI DOI 10.1037/0893-3200.21.4.726; Angelakis E, 2007, ACTA NEUROCHIR SUPPL, V97, P555; Arns M, 2017, ENCEPHALE, V43, P135, DOI 10.1016/j.encep.2016.11.003; Baumeister S, 2019, ADHD-ATTEND DEFICIT, V11, P31, DOI 10.1007/s12402-018-0269-6; Baumeister S, 2018, NEUROSCIENCE, V378, P89, DOI 10.1016/j.neuroscience.2016.09.025; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Carelli L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1695290; Chan E, 2016, JAMA-J AM MED ASSOC, V315, P1997, DOI 10.1001/jama.2016.5453; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dalsgaard Soren, 2013, Crim Behav Ment Health, V23, P86, DOI 10.1002/cbm.1860; DuPaul GJ, 2016, PSYCHOL ASSESSMENT, V28, P214, DOI 10.1037/pas0000166; Evans SW, 2018, J CLIN CHILD ADOLESC, V47, P157, DOI 10.1080/15374416.2017.1390757; Fairclough DL, 2002, DESIGN ANAL QUALITY; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fung DSS, 2014, SINGAP MED J, V55, P411, DOI 10.11622/smedj.2014098; Goode AP, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0094; Health EDCDMo, 2014, SING BURD DIS STUD 2; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Jiang Y, 2017, FRONT AGING NEUROSCI, V9, P9; March J, 2007, ANN M AM AC CHILD AD; McDermott AF, 2020, J ATTEN DISORD, V24, P1443, DOI 10.1177/1087054715623044; Mohr-Jensen C, 2016, CLIN PSYCHOL REV, V48, P32, DOI 10.1016/j.cpr.2016.05.002; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Pakdaman F, 2018, NEUROL SCI, V39, P2071, DOI 10.1007/s10072-018-3539-3; Parker J, 2013, PSYCHOL RES BEHAV MA, V6, P87, DOI 10.2147/PRBM.S49114; Phua HP, 2009, SINGAP MED J, V50, P468; Sciberras E, 2014, PEDIATRICS, V133, P801, DOI 10.1542/peds.2013-3686; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Sterman MB, 1996, BIOFEEDBACK SELF-REG, V21, P3, DOI 10.1007/BF02214147; Xia Weiping, 2015, Shanghai Arch Psychiatry, V27, P356, DOI 10.11919/j.issn.1002-0829.215115; Zuberer A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00135	32	23	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216225	10.1371/journal.pone.0216225	http://dx.doi.org/10.1371/journal.pone.0216225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112554	gold, Green Submitted, Green Published			2022-12-27	WOS:000468451000011
J	Chlebus, G; Meine, H; Thoduka, S; Abolmaali, N; van Ginneken, B; Hahn, HK; Schenk, A				Chlebus, Grzegorz; Meine, Hans; Thoduka, Smita; Abolmaali, Nasreddin; van Ginneken, Bram; Hahn, Horst Karl; Schenk, Andrea			Reducing inter-observer variability and interaction time of MR liver volumetry by combining automatic CNN-based liver segmentation and manual corrections	PLOS ONE			English	Article							MODEL; CT	Purpose To compare manual corrections of liver masks produced by a fully automatic segmentation method based on convolutional neural networks (CNN) with manual routine segmentations in MR images in terms of inter-observer variability and interaction time. Methods For testing, patient's precise reference segmentations that fulfill the quality requirements for liver surgery were manually created. One radiologist and two radiology residents were asked to provide manual routine segmentations. We used our automatic segmentation method Liver-Net to produce liver masks for the test cases and asked a radiologist assistant and one further resident to correct the automatic results. All observers were asked to measure their interaction time. Both manual routine and corrected segmentations were compared with the reference annotations. Results The manual routine segmentations achieved a mean Dice index of 0.95 and a mean relative error (RVE) of 4.7%. The quality of liver masks produced by the Liver-Net was on average 0.95 Dice and 4.5% RVE. Liver masks resulting from manual corrections of automatically generated segmentations compared to routine results led to a significantly lower inter-observer variability (mean per case absolute RVE difference across observers 0.69%) when compared to manual routine ones (2.75%). The mean interaction time was 2 min for manual corrections and 10 min for manual routine segmentations. Conclusions The quality of automatic liver segmentations is on par with those from manual routines. Using automatic liver masks in the clinical workflow could lead to a reduction of segmentation time and a more consistent liver volume estimation across different observers.	[Chlebus, Grzegorz; Meine, Hans; van Ginneken, Bram; Hahn, Horst Karl; Schenk, Andrea] Fraunhofer Inst Digital Med MEVIS, Bremen, Germany; [Chlebus, Grzegorz; van Ginneken, Bram] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Diagnost Image Anal Grp, Med Ctr, Nijmegen, Netherlands; [Meine, Hans] Univ Bremen, Med Image Comp Grp, Bremen, Germany; [Thoduka, Smita; Abolmaali, Nasreddin] Stadt Klinikum Dresden, Dept Radiol, Dresden, Germany; [Hahn, Horst Karl] Jacobs Univ, Bremen, Germany	Radboud University Nijmegen; University of Bremen; Technische Universitat Dresden; Municipal Hospital Dresden; Jacobs University	Chlebus, G (corresponding author), Fraunhofer Inst Digital Med MEVIS, Bremen, Germany.; Chlebus, G (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Diagnost Image Anal Grp, Med Ctr, Nijmegen, Netherlands.	grzegorz.chlebus@mevis.fraunhofer.de	Meine, Hans/AAX-7040-2020; Abolmaali, Nasreddin/AFL-7713-2022; Abolmaali, Nasreddin/AAG-7655-2022; van Ginneken, Bram/A-3728-2012; Schenk, Andrea/AAF-1323-2021; Chlebus, Grzegorz/B-6845-2018	Meine, Hans/0000-0002-7557-5007; van Ginneken, Bram/0000-0003-2028-8972; Schenk, Andrea/0000-0003-1806-8380; Chlebus, Grzegorz/0000-0001-6994-696X	Fraunhofer-Gesellschaft	Fraunhofer-Gesellschaft	The work was funded by the Fraunhofer-Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Christiane Engel, Andrea Koller, Sergio Mercogliano and Claudia Bohme for providing feedback and manual segmentations and Susanne Diekmann for the help in the error analysis. The work was funded by the Fraunhofer-Gesellschaft. The Titan Xp used for this research was donated by the NVIDIA Corporation.	Bereciartua A, 2015, BIOMED SIGNAL PROCES, V20, P71, DOI 10.1016/j.bspc.2015.04.005; Bilic Patrick, 2019, CORR; Chlebus G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33860-7; Christ P.F., 2017, CORR; Drozdzal M, 2016, LECT NOTES COMPUT SC, V10008, P179, DOI 10.1007/978-3-319-46976-8_19; Frid-Adar M, 2018, NEUROCOMPUTING, V321, P321, DOI 10.1016/j.neucom.2018.09.013; Gotra A, 2017, ABDOM RADIOL, V42, P478, DOI 10.1007/s00261-016-0912-7; He BC, 2016, MED PHYS, V43, P2421, DOI 10.1118/1.4946817; Huynh HT, 2017, INT J COMPUT ASS RAD, V12, P235, DOI 10.1007/s11548-016-1498-9; Kennedy A, 2012, AM J CLIN ONCOL-CANC, V35, P91, DOI 10.1097/COC.0b013e3181f47583; Li XM, 2018, IEEE T MED IMAGING, V37, P2663, DOI 10.1109/TMI.2018.2845918; Milletari F., 2017, LNCS, P161, DOI [10.1007/978-3-319-66182-7_19, DOI 10.1007/978-3-319-66182-7_19]; Nakayama Y, 2006, RADIOLOGY, V240, P743, DOI 10.1148/radiol.2403050850; Portney, 2019, FDN CLIN RES APPL PR; Prasoon A, 2013, LECT NOTES COMPUT SC, V8150, P246, DOI 10.1007/978-3-642-40763-5_31; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sandrasegaran K, 1999, ABDOM IMAGING, V24, P61, DOI 10.1007/s002619900441; SCHENK A, LECT NOTES COMPUT SC, V1935, P186; Shi CF, 2017, MED IMAGE ANAL, V38, P30, DOI 10.1016/j.media.2017.02.008; Le TN, 2015, BIO-MED MATER ENG, V26, pS1361, DOI 10.3233/BME-151434; Weiler F, 2015, P CURAC 2015, P139; Yuan Y., 2017, CORR	22	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217228	10.1371/journal.pone.0217228	http://dx.doi.org/10.1371/journal.pone.0217228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107915	gold, Green Submitted, Green Published			2022-12-27	WOS:000468285200037
J	Fukao, K; Ando, Y; Noshi, T; Kitano, M; Noda, T; Kawai, M; Yoshida, R; Sato, A; Shishido, T; Naito, A				Fukao, Keita; Ando, Yoshinori; Noshi, Takeshi; Kitano, Mitsutaka; Noda, Takahiro; Kawai, Makoto; Yoshida, Ryu; Sato, Akihiko; Shishido, Takao; Naito, Akira			Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models	PLOS ONE			English	Article							OSELTAMIVIR; EFFICACY; INFECTION; NEURAMINIDASE; SAFETY; H5N1	Baloxavir marboxil (BXM) is an orally available small molecule inhibitor of cap-dependent endonuclease (CEN), an essential enzyme in the initiation of mRNA synthesis of influenza viruses. In the present study, we evaluated the efficacy of BXM against influenza virus infection in mouse models. Single-day oral administration of BXM completely prevented mortality due to infection with influenza A and B virus in mice. Moreover, 5-day repeated administration of BXM was more effective for reducing mortality and body weight loss in mice infected with influenza A virus than oseltamivir phosphate (OSP), even when the treatment was delayed up to 96 hours post infection (p.i.). Notably, administration of BXM, starting at 72 hours p.i. led to significant decrease in virus titers of >2-log(10) reduction compared to the vehicle control within 24 hours after administration. Virus reduction in the lung was significantly greater than that observed with OSP. In addition, profound and sustained reduction of virus titer was observed in the immunocompromised mouse model without emergence of variants possessing treatment-emergent amino acid substitutions in the target protein. In our immunocompetent and immunocompromised mouse models, delayed treatment with BXM resulted in rapid and potent reduction in infectious virus titer and prevention of signs of influenza infection, suggesting that BXM could extend the therapeutic window for patients with influenza virus infection regardless of the host immune status.	[Fukao, Keita; Ando, Yoshinori; Noshi, Takeshi; Kitano, Mitsutaka; Kawai, Makoto; Yoshida, Ryu; Sato, Akihiko; Shishido, Takao; Naito, Akira] Shionogi & Co Ltd, Osaka, Japan; [Noda, Takahiro] Shionogi Techno Advance Res Co Ltd, Osaka, Japan	Shionogi & Company Limited; Shionogi & Company Limited	Shishido, T (corresponding author), Shionogi & Co Ltd, Osaka, Japan.	takao.shishido@shionogi.co.jp			Shionogi and Co., Ltd (Osaka, Japan)	Shionogi and Co., Ltd (Osaka, Japan)	This study was sponsored by Shionogi and Co., Ltd (Osaka, Japan), manufacturer/licensee of baloxavir marboxil. The sponsor provided support in the form of salaries for authors [KF, YA, TN, MK, TN, MK, RY, AS, TS and AN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfelali M, 2016, HUM VACC IMMUNOTHER, V12, P709, DOI 10.1080/21645515.2015.1085144; Baz M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110610; Bosaeed M, 2018, HUM VACC IMMUNOTHER, V14, P1311, DOI 10.1080/21645515.2018.1445446; Byrn RA, 2015, ANTIMICROB AGENTS CH, V59, P1574, DOI 10.1128/AAC.04623-14; Ceravolo A, 2013, J Prev Med Hyg, V54, P1; Doll MK, 2017, J ANTIMICROB CHEMOTH, V72, P2990, DOI 10.1093/jac/dkx271; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Fukao K, 2019, J ANTIMICROB CHEMOTH, V74, P654, DOI 10.1093/jac/dky462; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Ison MG, 2006, J INFECT DIS, V193, P765, DOI 10.1086/500464; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Ison MG, 2018, IDWEEK, DOI [10.1093/ofid/ofy229.2190, DOI 10.1093/OFID/OFY229.2190]; Kawai M, 2016, Int. PCT Pub. NO., Patent No. [WO 201617 5224A1, 2016175224, WO2016/175224A1]; Kiso M, 2018, J INFECT DIS, V217, P887, DOI 10.1093/infdis/jix606; Kitano M, 2013, ANTIMICROB AGENTS CH, V57, P2286, DOI 10.1128/AAC.02324-12; Koshimichi H, 2018, CLIN DRUG INVEST, V38, P1189, DOI 10.1007/s40261-018-0710-9; Koszalka P, 2017, INFLUENZA OTHER RESP, V11, P240, DOI 10.1111/irv.12446; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; MASTINO A, 1991, J CHEMOTHERAPY, V3, P156; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Noshi T, 2017, 27 ECCMID, P1973; Noshi T, 2018, ANTIVIR RES, V160, P109, DOI 10.1016/j.antiviral.2018.10.008; Omoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27890-4; Pflug A, 2017, VIRUS RES, V234, P103, DOI 10.1016/j.virusres.2017.01.013; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Shang H, 2013, VIRUS INFECT, V368, P2277; Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06; Taniguchi K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39683-4; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; van der Vries E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003343; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008; 2018, ANTIVIR RES, V157, P38, DOI DOI 10.1016/J.ANTIVIRAL.2018.07.001	35	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217307	10.1371/journal.pone.0217307	http://dx.doi.org/10.1371/journal.pone.0217307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107922	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200045
J	Wilke, ABB; Vasquez, C; Petrie, W; Beier, JC				Wilke, Andre B. B.; Vasquez, Chalmers; Petrie, William; Beier, John C.			Tire shops in Miami-Dade County, Florida are important producers of vector mosquitoes	PLOS ONE			English	Article							ZIKA VIRUS; AEDES-ALBOPICTUS; DENGUE; TRANSMISSION; AEGYPTI; URBANIZATION; EPIDEMIOLOGY; DIVERSITY; DIPTERA; TRADE	Human mobility in urban environments is a central part of urbanization and has determined the layout of how cities are projected, built and renovated. One of the most problematic issues of urbanization is how to properly dispose of used tires, considering the worldwide annual production of approximately 1.4 billion units every year. Despite the efforts to properly dispose of used tires, they still represent a major problem for public health, notably serving as potential breeding sites for vector mosquitoes. Miami-Dade County, Florida has been suffering from arbovirus outbreaks for decades, including dengue, West Nile and yellow fever viruses. The objective of this study was to survey tire shops inserted in the urban matrix across Miami-Dade County for the presence of vector mosquitoes. This study used a cross-sectional design to survey the production of vector mosquitoes at 12 tires shops. Mosquitoes were found in all but one of the tires shops surveyed. We collected a total of 1,110 mosquitoes comprising 528 adults and 582 immatures. Aedes aegypti and Culex quinquefasciatus were abundantly found in both their immature and adult forms, constituting 99.99% of the mosquito samples collected. Aedes aegypti was the most abundant species recorded displaying the highest values in the Shannon and Simpson indices. The findings of this study demonstrate that vector mosquitoes, primarily Ae. aegypti, are being produced in tires shops in Miami indicating these habitats are highly favorable breeding environments for the production of vector mosquitoes and emphasizing the need to address how the abundance and presence of mosquitoes may vary seasonally in these environments.	[Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of Miami	Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	axb1737@med.miami.edu	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	CDC [1U01CK000510-03]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	JCB - This research was supported by CDC (https://www.cdc.gov/) grant 1U01CK000510-03: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P489; Aydin H, 2012, FUEL, V102, P605, DOI 10.1016/j.fuel.2012.06.067; Azael Che-Mendoza, 2011, OPERATIONAL GUIDE AS, P1; BEIER JC, 1983, J MED ENTOMOL, V20, P76, DOI 10.1093/jmedent/20.1.76; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992; Buehler R, 2011, J TRANSP GEOGR, V19, P644, DOI 10.1016/j.jtrangeo.2010.07.005; Buzas MA, 1998, J FORAMIN RES, V28, P233; Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005; Colwell R. K., 2009, PRINCETON GUIDE ECOL, V663, P257, DOI DOI 10.1515/9781400833023.257; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Darsie Jr RF, 2000, TECHNICAL B FLORIDA; Dinh ETN, 2018, J AM MOSQUITO CONTR, V34, P47, DOI 10.2987/17-6689.1; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Gill J, 2000, EMERG INFECT DIS, V6, P30; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1; Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0; Ilkilic C, 2011, FUEL PROCESS TECHNOL, V92, P1129, DOI 10.1016/j.fuproc.2011.01.009; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Li Y., 2018, INT J ORG INNOV, V11, P1, DOI DOI 10.1186/S13068-018-1048-5; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665; Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Musso D, 2018, LANCET INFECT DIS, V3099, P1, DOI [10.1016/S1473-3099(18)30269-X, DOI 10.1016/S1473-3099(18)30269-X]; Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919; PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O; Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855; POND WL, 1966, AM J TROP MED HYG, V15, P205, DOI 10.4269/ajtmh.1966.15.205; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991; Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; Satterthwaite D, 2008, ENVIRON URBAN, V20, P539, DOI 10.1177/0956247808096127; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sienkiewicz M, 2012, WASTE MANAGE, V32, P1742, DOI 10.1016/j.wasman.2012.05.010; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Straif SC, 1996, J MED ENTOMOL, V33, P608, DOI 10.1093/jmedent/33.4.608; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; UN Deparment of Social and Economic Affairs, 2014, WORLD URB PROSP; Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2; Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688; Wilke ABB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209625; Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9; Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003; Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156; Yang HS, 2004, BIORESOURCE TECHNOL, V95, P61, DOI 10.1016/j.biortech.2004.02.002; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2; Yilmaz A, 2009, WASTE MANAGE, V29, P1541, DOI 10.1016/j.wasman.2008.11.002	62	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217177	10.1371/journal.pone.0217177	http://dx.doi.org/10.1371/journal.pone.0217177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107881	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200034
J	Ao, ZJ; Wang, LJ; Mendoza, EJ; Cheng, KD; Zhu, WJ; Cohen, EA; Fowke, K; Qiu, XG; Kobinger, G; Yao, XJ				Ao, Zhujun; Wang, Lijun; Mendoza, Emelissa J.; Cheng, Keding; Zhu, Wenjun; Cohen, Eric A.; Fowke, Keith; Qiu, Xiangguo; Kobinger, Gary; Yao, Xiaojian			Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses	PLOS ONE			English	Article							DOUBLE-BLIND; VACCINE; PROTEINS; DIFFERENTIATION; REPLICATION; RESISTANCE; INFECTION; VIRIONS; INNATE; MODEL	The development of an effective vaccine against HIV infection remains a global priority. Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which aims at optimizing the HIV-specific immune response using primed DCs to promote and enhance both the cellular and humoral arms of immunity. Since the Ebola virus envelope glycoprotein (EboGP) has strong DC-targeting ability, we investigated whether EboGP is able to direct HIV particles towards DCs efficiently and promote potent HIV-specific immune responses. Our results indicate that the incorporation of EboGP into non-replicating virus-like particles (VLPs) enhances their ability to target human monocyte-derived dendritic cells (MDDCs) and monocyte-derived macrophages (MDMs). Also, a mucin-like domain deleted EboGP (EboGP Delta M) can further enhanced the MDDCs and MDMs-targeting ability. Furthermore, we investigated the effect of EboGP on HIV immunogenicity in mice, and the results revealed a significantly stronger HIV-specific humoral immune response when immunized with EboGP-pseudotyped HIV VLPs compared with those immunized with HIV VLPs. Splenocytes harvested from mice immunized with EboGP-pseudotyped HIV VLPs secreted increased levels of macrophage inflammatory proteins-1 alpha (MIP-1 alpha) and IL-4 upon stimulation with HIV Env and/or Gag peptides compared with those harvested from mice immunized with HIV VLPs. Collectively, this study provides evidence for the first time that the incorporation of EboGP in HIV VLPs can facilitate DC and macrophage targeting and induce more potent immune responses against HIV.	[Ao, Zhujun; Wang, Lijun; Yao, Xiaojian] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Lab Mol Human Retrovirol, Winnipeg, MB, Canada; [Ao, Zhujun; Fowke, Keith; Qiu, Xiangguo; Yao, Xiaojian] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Med Microbiol, Winnipeg, MB, Canada; [Wang, Lijun] Zunyi Med Coll, Dept Histol & Embryol, Zunyi, Guizhou, Peoples R China; [Mendoza, Emelissa J.; Cheng, Keding; Zhu, Wenjun; Qiu, Xiangguo] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada; [Cohen, Eric A.] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Kobinger, Gary] Univ Laval, CHUL, Ctr Rech Infectiol, Quebec City, PQ, Canada	University of Manitoba; University of Manitoba; Zunyi Medical University; Public Health Agency of Canada; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Laval University	Yao, XJ (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Lab Mol Human Retrovirol, Winnipeg, MB, Canada.; Yao, XJ (corresponding author), Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Med Microbiol, Winnipeg, MB, Canada.; Kobinger, G (corresponding author), Univ Laval, CHUL, Ctr Rech Infectiol, Quebec City, PQ, Canada.	Gary.Kobinger@crchudequebec.ulaval.ca; xiao-jian.yao@umanitoba.ca		Yao, Xiaojian/0000-0002-5022-1309	Manitoba Research Chair Grant; Canadian Institute of Health Research (CIHR)/MHRC RPP grant [RPA-132176]; CIHR-IAVI Grant [OVV-152411]; Public Health Agency of Canada	Manitoba Research Chair Grant; Canadian Institute of Health Research (CIHR)/MHRC RPP grant; CIHR-IAVI Grant; Public Health Agency of Canada	This work was supported by Manitoba Research Chair Grant to XJY, Canadian Institute of Health Research (CIHR)/MHRC RPP grant (#RPA-132176) to XJY, and CIHR-IAVI Grant (#OVV-152411) to GK and also partially supported by Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0637-9; Ao ZJ, 2016, J VIROL METHODS, V228, P95, DOI 10.1016/j.jviromet.2015.11.019; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025; Coelho AVC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121985; Choi E, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0317-2; Citterio S, 1999, METHODS, V19, P142, DOI 10.1006/meth.1999.0839; Cohn L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00255; D'Souza M Patricia, 2004, Curr HIV/AIDS Rep, V1, P18, DOI 10.1007/s11904-004-0003-1; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Engelmayer J, 2001, J VIROL, V75, P2142, DOI 10.1128/JVI.75.5.2142-2153.2001; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fuchs JD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv082; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Gandhi RT, 2016, JAIDS-J ACQ IMM DEF, V71, P246, DOI 10.1097/QAI.0000000000000852; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Martinez O, 2007, VIROLOGY, V364, P342, DOI 10.1016/j.virol.2007.03.020; Martinez O, 2013, J VIROL, V87, P3801, DOI 10.1128/JVI.02695-12; Martinez O, 2012, ANTIVIR RES, V93, P416, DOI 10.1016/j.antiviral.2012.01.011; Medina MF, 2003, MOL THER, V8, P777, DOI 10.1016/S1525-0016(03)00266-1; Mohan GS, 2015, J VIROL, V89, P1205, DOI 10.1128/JVI.01810-14; Pankrac J, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0177-4; Passmore JS, 2001, IMMUNOLOGY, V102, P146, DOI 10.1046/j.1365-2567.2001.01164.x; Pena J, 2012, VIRAL IMMUNOL, V25, P37, DOI 10.1089/vim.2011.0044; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ritchie AJ, 2003, INFECT IMMUN, V71, P4421, DOI 10.1128/IAI.71.8.4421-4431.2003; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Song RJ, 2007, MOL THER, V15, P1007, DOI 10.1038/mt.sj.6300129; Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581; Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; Walker WE, 2015, J VIROL, V89, P5502, DOI 10.1128/JVI.00118-15; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zhang X, 2016, ANTIVIR RES, V127, P20, DOI 10.1016/j.antiviral.2016.01.001; 2015, SCIENCE, V349, P739, DOI DOI 10.1126/SCIENCE.AAB3920; 1995, SCIENCE, V270, P1811	47	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216949	10.1371/journal.pone.0216949	http://dx.doi.org/10.1371/journal.pone.0216949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100082	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600023
J	Belmonte, FR; Dedousis, N; Sipula, I; Desai, NA; Singhi, AD; Chu, YX; Zhang, YZ; Bannwarth, S; Paquis-Flucklinger, V; Harrington, L; Shiva, S; Jurczak, MJ; O'Doherty, RM; Kaufman, BA				Belmonte, Frances R.; Dedousis, Nikolaos; Sipula, Ian; Desai, Nikita A.; Singhi, Aatur D.; Chu, Yanxia; Zhang, Yingze; Bannwarth, Sylvie; Paquis-Flucklinger, Veronique; Harrington, Lea; Shiva, Sruti; Jurczak, Michael J.; O'Doherty, Robert M.; Kaufman, Brett A.			Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PPAR-GAMMA; ADIPOSE-TISSUE; FATTY LIVER; OBESITY; GENE; INACTIVATION; CONTRIBUTES	Petite Integration Factor 1 (PIF1) is a multifunctional helicase present in nuclei and mitochondria. PIF1 knock out (KO) mice exhibit accelerated weight gain and decreased wheel running on a normal chow diet. In the current study, we investigated whether Pif1 ablation alters whole body metabolism in response to weight gain. PIF1 KO and wild type (WT) C57BL/6J mice were fed a Western diet (WD) rich in fat and carbohydrates before evaluation of their metabolic phenotype. Compared with weight gain-resistant WT female mice, WD-fed PIF1 KO females, but not males, showed accelerated adipose deposition, decreased locomotor activity, and reduced whole-body energy expenditure without increased dietary intake. Surprisingly, PIF1 KO females did not show obesity-induced alterations in fasting blood glucose and glucose clearance. WD-fed PIF1 KO females developed mild hepatic steatosis and associated changes in liver gene expression that were absent in weight-matched, WD-fed female controls, linking hepatic steatosis to Pif1 ablation rather than increased body weight. WD-fed PIF1 KO females also showed decreased expression of inflammation-associated genes in adipose tissue. Collectively, these data separated weight gain from inflammation and impaired glucose homeostasis. They also support a role for Pif1 in weight gain resistance and liver metabolic dysregulation during nutrient stress.	[Belmonte, Frances R.; Desai, Nikita A.; Shiva, Sruti; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondria Med, Pittsburgh, PA 15260 USA; [Belmonte, Frances R.; Desai, Nikita A.; Shiva, Sruti; Kaufman, Brett A.] Vasc Med Inst, Pittsburgh, PA 15260 USA; [Dedousis, Nikolaos; Sipula, Ian; Jurczak, Michael J.; O'Doherty, Robert M.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Biomed Sci Tower, Pittsburgh, PA USA; [Singhi, Aatur D.] Univ Pittsburgh, Dept Pathol, Scaife Hall, Pittsburgh, PA USA; [Singhi, Aatur D.] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Scaife Hall, Pittsburgh, PA USA; [Chu, Yanxia; Zhang, Yingze] UPMC Montefiore Hosp, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA USA; [Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Univ Cote dAzur, CHU Nice, INSERM, CNRS,IRCAN, Nice, France; [Harrington, Lea] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montreal	Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondria Med, Pittsburgh, PA 15260 USA.; Kaufman, BA (corresponding author), Vasc Med Inst, Pittsburgh, PA 15260 USA.	bkauf@pitt.edu		Zhang, YIngze/0000-0001-8042-6105; Belmonte, Frances/0000-0002-3402-8744	NIGMS [R01GM110424]; NIDDK [T32DK007052, R01DK102839]; Center for Metabolism and Mitochondrial Medicine (C3M); Stimulating Pittsburgh Research in Geroscience (SPRIG) Award; Pittsburgh Liver Research Center (PLRC); C3M; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052, R01DK102839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110424] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Metabolism and Mitochondrial Medicine (C3M); Stimulating Pittsburgh Research in Geroscience (SPRIG) Award; Pittsburgh Liver Research Center (PLRC); C3M; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BAK was supported by NIGMS (R01GM110424). RMO was supported by NIDDK (R01DK102839) and the Center for Metabolism and Mitochondrial Medicine (C3M) funding. FB was supported by NIDDK (T32DK007052) and the animal costs were supported by NIGMS and Stimulating Pittsburgh Research in Geroscience (SPRIG) Award. ND was supported by C3M. ADS was supported by Pittsburgh Liver Research Center (PLRC).	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; [Anonymous], 2010, ASSESSMENT FEEDING B; Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llewellyn CH, 2013, INT J OBESITY, V37, P1506, DOI 10.1038/ijo.2013.30; Mangahas JL, 2001, MOL BIOL CELL, V12, P4078, DOI 10.1091/mbc.12.12.4078; Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schuldt A, 2011, NAT REV MOL CELL BIO, V12, DOI 10.1038/nrm3142; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Twig G, 2014, DIABETES CARE, V37, P2989, DOI 10.2337/dc14-0869; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Vega LR, 2007, PLOS GENET, V3, P1065, DOI 10.1371/journal.pgen.0030105; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0203101	10.1371/journal.pone.0203101	http://dx.doi.org/10.1371/journal.pone.0203101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136580	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300001
J	Czech, L; Stamatakis, A				Czech, Lucas; Stamatakis, Alexandros			Scalable methods for analyzing and visualizing phylogenetic placement of metagenomic samples	PLOS ONE			English	Article							COMPOSITIONAL DATA; DIVERSITY; SEQUENCE; IDENTIFICATION; COMMUNITIES; ANNOTATION; SEARCH; READS; SILVA; VIEW	Background The exponential decrease in molecular sequencing cost generates unprecedented amounts of data. Hence, scalable methods to analyze these data are required. Phylogenetic (or Evolutionary) Placement methods identify the evolutionary provenance of anonymous sequences with respect to a given reference phylogeny. This increasingly popular method is deployed for scrutinizing metagenomic samples from environments such as water, soil, or the human gut. Novel methods Here, we present novel and, more importantly, highly scalable methods for analyzing phylogenetic placements of metagenomic samples. More specifically, we introduce methods for (a) visualizing differences between samples and their correlation with associated meta-data on the reference phylogeny, (b) clustering similar samples using a variant of the k-means method, and (c) finding phylogenetic factors using an adaptation of the Phylofactorization method. These methods enable to interpret metagenomic data in a phylogenetic context, to find patterns in the data, and to identify branches of the phylogeny that are driving these patterns. Results To demonstrate the scalability and utility of our methods, as well as to provide exemplary interpretations of our methods, we applied them to 3 publicly available datasets comprising 9782 samples with a total of approximately 168 million sequences. The results indicate that new biological insights can be attained via our methods.	[Czech, Lucas; Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Computat Mol Evolut Grp, Heidelberg, Germany; [Stamatakis, Alexandros] Karlsruhe Inst Technol, Inst Theoret Informat, Karlsruhe, Germany	Heidelberg Institute for Theoretical Studies; Helmholtz Association; Karlsruhe Institute of Technology	Czech, L; Stamatakis, A (corresponding author), Heidelberg Inst Theoret Studies, Computat Mol Evolut Grp, Heidelberg, Germany.; Stamatakis, A (corresponding author), Karlsruhe Inst Technol, Inst Theoret Informat, Karlsruhe, Germany.	lucas.czech@h-its.org; alexandros.stamatakis@h-its.org	Stamatakis, Alexandros/B-8740-2009; Czech, Lucas/AAF-8722-2021	Stamatakis, Alexandros/0000-0003-0353-0691; Czech, Lucas/0000-0002-1340-9644	Klaus Tschira Stiftung gGmbH	Klaus Tschira Stiftung gGmbH	This work was financially supported by the Klaus Tschira Stiftung gGmbH (https://www.klaus-tschira-stiftung.de) in Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2018, INTRO CATEGORICAL DA; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Arthur D., 2006, Proceedings of the Twenty-Second Annual Symposium on Computational Geometry (SCG'06), P144, DOI 10.1145/1137856.1137880; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Barbera P, 2018, SYSTEMATIC BIOL; Berger SA, 2011, BIOINFORMATICS, V27, P2068, DOI 10.1093/bioinformatics/btr320; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bischof H, 1999, PATTERN ANAL APPL, V2, P59, DOI 10.1007/s100440050015; Bottou L., 1995, Advances in Neural Information Processing Systems 7, P585; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Czech L, 2018, BIOINFORMATICS; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Dunthorn M, 2014, MOL BIOL EVOL, V31, P993, DOI 10.1093/molbev/msu055; Dupont AOC, 2016, ENVIRON MICROBIOL, V18, P2010, DOI 10.1111/1462-2920.13220; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards David J, 2013, Microb Inform Exp, V3, P2, DOI 10.1186/2042-5783-3-2; Egozcue JJ, 2005, MATH GEOL, V37, P795, DOI 10.1007/s11004-005-7381-9; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Everitt B.S., 2010, CAMBRIDGE DICT STAT, DOI DOI 10.1017/CBO9780511779633; Giner CR, 2016, APPL ENVIRON MICROB, V82, P4757, DOI 10.1128/AEM.00560-16; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gloor GB, 2016, AUST J STAT, V45, P73, DOI 10.17713/ajs.v45i4.122; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; GOOD IJ, 1956, J ROY STAT SOC B, V18, P113; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grant S.G, 2017, J MOL CANC, P1; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; Hamerly G, 2004, ADV NEUR IN, V16, P281; Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jackson DA, 1997, ECOLOGY, V78, P929; Egozcue JJ, 2016, AUST J STAT, V45, P25, DOI 10.17713/ajs.v45i4.126; Kanungo T., 2003, 18 ANN S COMP GEOM S, V28, P89; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kozlov AM, 2016, NUCLEIC ACIDS RES, V44, P5022, DOI 10.1093/nar/gkw396; Kriegel HP, 2011, WIRES DATA MIN KNOWL, V1, P231, DOI 10.1002/widm.30; Krzanowski W.J., 1994, MULTIVARIATE ANAL; Lamp D, 2012, ACHIEVING REAL-TIME IN DISTRIBUTED COMPUTING: FROM GRIDS TO CLOUDS, P200, DOI 10.4018/978-1-60960-827-9.ch011; Legendre P., 1998, NUMERICAL ECOLOGY DE, V20; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Levina E, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P251, DOI 10.1109/ICCV.2001.937632; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Logares R, 2012, J MICROBIOL METH, V91, P106, DOI 10.1016/j.mimet.2012.07.017; Lovell D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004075; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mahe F., 2014, PEERJ, V2014, P1, DOI [10.7717/peerj.593, DOI 10.7717/PEERJ.593]; Mahe F, 2017, NAT ECOL EVOL, V1, DOI [10.1038/s41559-017-00911, 10.1038/s41559-017-0091]; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; MALLOWS CL, 1972, ANN MATH STAT, V43, P508, DOI 10.1214/aoms/1177692631; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Matsen F. A., 2011, PLOS ONE, V8, P1; Matsen FA, 2011, EDGE PRINCIPAL COMPO; Matsen FA, 2015, SYST BIOL, V64, pE26, DOI 10.1093/sysbio/syu053; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Mignardi M, 2014, GENOME MED, V6, DOI 10.1186/gm548; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00162-16; Nguyen NP, 2014, BIOINFORMATICS, V30, P3548, DOI 10.1093/bioinformatics/btu721; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Pawlowsky-Glahn V., 2015, MODELLING ANAL COMPO, DOI DOI 10.1002/9781119003144; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Potapova M., 2011, PATTERNS DIATOM DIST; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RACHEV ST, 1985, THEOR PROBAB APPL+, V29, P647, DOI 10.1137/1129093; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shah N, 2018, BIOINFORMATICS; Silverman JD, 2017, ELIFE, V6, DOI 10.7554/eLife.21887; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thorndike RL., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tsilimigras MCB, 2016, ANN EPIDEMIOL, V26, P330, DOI 10.1016/j.annepidem.2016.03.002; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Washburne AD, 2018, BIORXIV; Washburne AD, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1353; Washburne AD, 2017, PEERJ, V5, DOI 10.7717/peerj.2969; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	110	44	45	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217050	10.1371/journal.pone.0217050	http://dx.doi.org/10.1371/journal.pone.0217050			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136592	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300014
J	Tavares, TD; de Oliveira, BR; Silva, VD; da Silva, RP; dos Santos, AF; Okida, ES				Tavares, Tiago de Oliveira; de Oliveira, Bruno Rocca; Silva, Vantuir de Albuquerque; da Silva, Rouverson Pereira; dos Santos, Adao Felipe; Okida, Estela Silva			The times, movements and operational efficiency of mechanized coffee harvesting in sloped areas	PLOS ONE			English	Article								Coffee farms have been adopting the microterraces system, a technique that reduces the effect of the slope by moving the soil between the crop lines. In this way, all the mechanized operations can be carried out normally, except for harvesting, due to the work limitation of the harvesters, who work in areas with a maximum slope of 20%. One option is to use unilateral harvesters, which crop one side at a time; however, there has been no research on these microterrace machines to evaluate their performance and to compare it with those of the other harvesting methods in those regions. This study aimed to compare the mechanized harvest performance in the microterraces with the manual and semimechanized harvesting methods. The study was carried out in an agricultural area of the municipality of Ouro Fino / MG, Brazil, in a crop production site where the microterraces were built six years before the experiment. The treatments were assigned to a split-block design with seven repetitions and consisted of mechanized harvest-unilateral harvester with bag storage; manual harvest-regionally experienced workers; and semimechanized harvest-with portable breakers. Through an analysis of the times and movements, the operational efficiency and operational and effective field capabilities were measured. The adoption of microterraces allows the efficient mechanization of areas previously impossible to mechanize. The unilateral harvester is a potential tool for the partial replacement of manual labor in the harvest, performing a service equivalent to that of 23.68 manual workers and 10.55 manual workers in the semimechanized system.	[Tavares, Tiago de Oliveira; de Oliveira, Bruno Rocca; Silva, Vantuir de Albuquerque; da Silva, Rouverson Pereira; dos Santos, Adao Felipe; Okida, Estela Silva] Sao Paulo State Univ, Lab Agr Machinery & Mechanizat, Dept Agr Engn, Jaboticabal, SP, Brazil	Universidade Estadual Paulista	de Oliveira, BR (corresponding author), Sao Paulo State Univ, Lab Agr Machinery & Mechanizat, Dept Agr Engn, Jaboticabal, SP, Brazil.	brunorocca1@outlook.com	dos Santos, Adão Felipe/P-7312-2019; da Silva, Rouverson Pereira/ABG-7394-2021; de Oliveira, Bruno Rocca/V-7521-2019	dos Santos, Adão Felipe/0000-0003-3405-5360; da Silva, Rouverson Pereira/0000-0001-8852-2548; de Oliveira, Bruno Rocca/0000-0002-1364-4548; Santos, Felipe/0000-0001-7264-3396				[Anonymous], 2008, THESIS; [Anonymous], 1996, MAQUINAS AGRICOLAS E; Arnaez J, 2015, CATENA, V128, P122, DOI 10.1016/j.catena.2015.01.021; ASABE, 2011, AGR MACH MAN DAT; Cirillo EJ, 2007, REV CIENTIFICA ELETR, V6; CONAB-Companhia Nacional De Abastecimento, 2018, CANA DEACUCAR, V5, P1; Cunha J. P. B., 2016, Coffee Science, V11, P87; Oliveira Ezequiel de, 2007, Cienc. Rural, V37, P1466, DOI 10.1590/S0103-84782007000500041; Embrapa Solos, 2013, SISTEMA BRASILEIRO C; Japiassu L. B., 2010, Coffee Science, V5, P28; Madeira PBF, 2014, 40 C BRAS PESQ CAF S; MATIELLO J. B., 2010, CULTURA CAFE BRASIL; Matiello JB, 2007, 33 C BRAS PESQ CAF L; MIALHE L. G., 1974, MANUAL MECANIZACAO A; Molin J. P., 2002, Engenharia Agricola, V22, P83; Nuintin AA, 2014, CUSTOS AGRONEGOCIO, V10; Paula M, 2013, ENGENHARIA AMBIENTAL, V10, P90; Pedro FC, 2010, MONOGRAFIA ESPECIALI; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Santinato F, 2015, CIENC RURAL, V45, P1809, DOI 10.1590/0103-8478cr20140801; Silva F. M., 2003, Engenharia Agricola, V23, P309; Silva FM, 2000, 26 C BRAS PESQ CAF M, P345; Silva FM, 2013, S PESQ CAF BRAS; Silva RP, 2008, CIENCIA RURAL, P1286; Sousa Filho GR, 2013, AVALIACAO COLHEITA M; Tarolli P, 2015, LAND DEGRAD DEV, V26, P92, DOI 10.1002/ldr.2311; Tarolli P, 2014, ANTHROPOCENE, V6, P10, DOI 10.1016/j.ancene.2014.03.002; Zonta MV, 2016, THESIS, P2016	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217286	10.1371/journal.pone.0217286	http://dx.doi.org/10.1371/journal.pone.0217286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136595	Green Submitted, gold, Green Published			2022-12-27	WOS:000469224300024
J	Garside, K; Henderson, R; Makarenko, I; Masoller, C				Garside, Kathryn; Henderson, Robin; Makarenko, Irina; Masoller, Cristina			Topological data analysis of high resolution diabetic retinopathy images	PLOS ONE			English	Article								Diabetic retinopathy is a complication of diabetes that produces changes in the blood vessel structure in the retina, which can cause severe vision problems and even blindness. In this paper, we demonstrate that by identifying topological features in very high resolution retinal images, we can construct a classifier that discriminates between healthy patients and those with diabetic retinopathy using summary statistics of these features. Topological data analysis identifies the features as connected components and holes in the images and describes the extent to which they persist across the image. These features are encoded in persistence diagrams, summaries of which can be used to discrimate between diabetic and healthy patients. The method has the potential to be an effective automated screening tool, with high sensitivity and specificity.	[Garside, Kathryn; Henderson, Robin; Makarenko, Irina] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne, Tyne & Wear, England; [Masoller, Cristina] Univ Politecn Cataluna, Dept Phys, Barcelona, Spain	Newcastle University - UK; Universitat Politecnica de Catalunya	Garside, K (corresponding author), Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne, Tyne & Wear, England.	K.A.Garside2@newcastle.ac.uk	Masoller, Cristina/M-3696-2014	Masoller, Cristina/0000-0003-0768-2019; Garside, Kathryn/0000-0001-5727-0405	Spanish MINECO [FIS2015-66503, FIS2015-66503-C3-2-P]; program ICREA ACADEMIA of Generalitat de Catalunya	Spanish MINECO(Spanish Government); program ICREA ACADEMIA of Generalitat de Catalunya	C.M. is supported in part by the Spanish MINECO (FIS2015-66503 and FIS2015-66503-C3-2-P) and the program ICREA ACADEMIA of Generalitat de Catalunya. K.G, R.H and I.M received no specific funding for this work.	Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Antal B, 2014, KNOWL-BASED SYST, V60, P20, DOI 10.1016/j.knosys.2013.12.023; Biscio C, 2016, ACCUMULATED PERSISTE, P1; Bubenik P, 2015, J MACH LEARN RES, V16, P77; Budai A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/154860; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Henderson R, 2017, STAT TOPOLOGY RANDOM, P1; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Kirkizlar E, 2013, OPHTHALMOLOGY, V120, P2604, DOI 10.1016/j.ophtha.2013.06.029; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075699; Niemeijer M, 2010, IEEE T MED IMAGING, V29, P185, DOI 10.1109/TMI.2009.2033909; Phan ADT, 2014, DIABETES CARE, V37, pE252, DOI 10.2337/dc14-0929; Sandhu HS, 2018, INVEST OPHTH VIS SCI, V59, P3155, DOI 10.1167/iovs.17-23677; Solomon SD, 2017, DIABETES CARE, V40, P412, DOI 10.2337/dc16-2641; Soomro TA, 2017, PATTERN ANAL APPL, V20, P927, DOI 10.1007/s10044-017-0630-y; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Takahashi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179790	20	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217413	10.1371/journal.pone.0217413	http://dx.doi.org/10.1371/journal.pone.0217413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125372	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700038
J	de Miguel-Diez, J; Hernandez-Vazquez, J; Lopez-De-Andres, A; Alvaro-Meca, A; Hernandez-Barrera, V; Jimenez-Garcia, R				de Miguel-Diez, Javier; Hernandez-Vazquez, Julio; Lopez-de-Andres, Ana; Alvaro-Meca, Alejandro; Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo			Analysis of environmental risk factors for chronic obstructive pulmonary disease exacerbation: A case-crossover study (2004-2013)	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; URBAN AIR-POLLUTION; SHORT-TERM EXPOSURE; HOSPITAL ADMISSIONS; PARTICULATE MATTER; ASTHMATIC-PATIENTS; NITROGEN-DIOXIDE; DAILY MORTALITY; TIME-SERIES; COPD	Purpose We aim to assess if air pollution levels and climatological factors are associated with hospital admissions for exacerbation of chronic obstructive pulmonary disease (COPD) in Spain from 2004 to 2013. Methods We conducted a retrospective study. Information on pollution level and climatological factors were obtained from the Spanish Meteorological Agency and hospitalizations from the Spanish hospital discharge database. A case-crossover design was used to identify factors associated with hospitalizations and in hospital mortality. Postal codes were used to assign climatic and pollutant factors to each patient. Results We detected 162,338 hospital admissions for COPD exacerbation. When seasonal effects were evaluated we observed that hospital admissions and mortality were more frequent in autumn and winter. In addition, we found significant associations of temperature, humidity, ozone (O-3), carbon monoxide (CO), particulate matter up to 10 mu m in size (PM10) and nitrogen dioxide (NO2) with hospital admissions. Lower temperatures at admission with COPD exacerbation versus 1, 1.5, 2 and 3 weeks prior to hospital admission for COPD exacerbation, were associated with a higher probability of dying in the hospital. Other environmental factors that were related to in-hospital mortality were NO2, O-3, PM10 and CO. Conclusions Epidemiology of hospital admissions by COPD exacerbation was negatively affected by colder climatological factors (seasonality and absolute temperature) and short-term exposure to major air pollution (NO2, O-3, CO and PM10).	[de Miguel-Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Pneumol, Madrid, Spain; [Hernandez-Vazquez, Julio] Hosp Univ Infanta Leonor, Dept Pneumol, Madrid, Spain; [Lopez-de-Andres, Ana; Alvaro-Meca, Alejandro; Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo] Univ Rey Juan Carlos, Dept Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; Hospital Universitario Infanta Leonor; Universidad Rey Juan Carlos	Lopez-De-Andres, A (corresponding author), Univ Rey Juan Carlos, Dept Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain.	ana.lopez@urjc.es	Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; de Miguel-Diez, Javier/0000-0003-4543-573X; Hernandez-Vazquez, Julio/0000-0001-9029-3510; Alvaro-Meca, Alejandro/0000-0003-1315-4386; Hernandez-Barrera, Valentin/0000-0001-5790-1959	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) [PI16/00564]; Menarini [HUIL-15/07]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III); Menarini(Menarini Group)	This study forms part of research funded by the FIS	Aga E, 2003, EUR RESPIR J, V21, p28S, DOI 10.1183/09031936.03.00402803; Almagro P, 2015, INT J CHRONIC OBSTR, V10, P899, DOI 10.2147/COPD.S75710; Alvaro-Meca A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165944; Anderson HR, 1997, EUR RESPIR J, V10, P1064, DOI 10.1183/09031936.97.10051064; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Bayram H, 2001, J ALLERGY CLIN IMMUN, V107, P287, DOI 10.1067/mai.2001.111141; Bloemsma LD, 2016, ENVIRON RES, V151, P458, DOI 10.1016/j.envres.2016.08.018; Budinger GRS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018525; Choi J, 2018, INT J CHRONIC OBSTR, V13, P1053, DOI 10.2147/COPD.S156617; DEVALIA JL, 1994, LANCET, V344, P1668, DOI 10.1016/S0140-6736(94)90458-8; DeVries R, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0179-z; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Donaldson GC, 2014, INT J CHRONIC OBSTR, V9, P1101, DOI 10.2147/COPD.S54475; Foster WM, 2000, J APPL PHYSIOL, V89, P1804, DOI 10.1152/jappl.2000.89.5.1804; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hansel NN, 2016, COPD, V13, P372, DOI 10.3109/15412555.2015.1089846; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Jaakkola JJK, 2003, EUR RESPIR J, V21, p81S, DOI 10.1183/09031936.03.00402703; Kakinoki Y, 1998, ACTA OTO-LARYNGOL, P221; Kelsall JE, 1997, AM J EPIDEMIOL, V146, P750; Ko FWS, 2012, RESPIROLOGY, V17, P395, DOI 10.1111/j.1440-1843.2011.02112.x; Krachunov Iliya I, 2017, Folia Med (Plovdiv), V59, P423, DOI 10.1515/folmed-2017-0053; Li JH, 2016, INT J CHRONIC OBSTR, V11, P3079, DOI 10.2147/COPD.S122282; Li MH, 2016, CHEST, V149, P447, DOI 10.1378/chest.15-0513; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MACNEE W, CHEST S2, V117, pS39, DOI DOI 10.1378/CHEST.117.5_SUPPL_2.390S; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Neuberger M, 2013, INT J ENV RES PUB HE, V10, P4728, DOI 10.3390/ijerph10104728; Oh SM, 2011, MUTAT RES-GEN TOX EN, V723, P142, DOI 10.1016/j.mrgentox.2011.04.003; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Qiu H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030492; R Core Team, 2011, R LANG ENV STAT COMP; Rue H., 2014, INLA FUNCTIONS WHICH; Santus P, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-95; Sauerzapf V, 2009, J EPIDEMIOL COMMUN H, V63, P324, DOI 10.1136/jech.2008.077024; Sooryanarain H, 2015, ANNU REV ANIM BIOSCI, V3, P347, DOI 10.1146/annurev-animal-022114-111017; Soriano J.B., 2010, EUR RESPIR J, V36, P758; Sunyer J, 2001, INT J EPIDEMIOL, V30, P1138, DOI 10.1093/ije/30.5.1138; Wong Chit-Ming, 2010, Res Rep Health Eff Inst, P283; Wordley J, 1997, OCCUP ENVIRON MED, V54, P108, DOI 10.1136/oem.54.2.108; Xu ZY, 2000, ARCH ENVIRON HEALTH, V55, P115, DOI 10.1080/00039890009603397; Yang QY, 2005, ENVIRON RES, V99, P99, DOI 10.1016/j.envres.2004.09.014; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961	45	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217143	10.1371/journal.pone.0217143	http://dx.doi.org/10.1371/journal.pone.0217143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120946	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700061
J	Eyler, L; Hubbard, A; Juillard, C				Eyler, Lauren; Hubbard, Alan; Juillard, Catherine			Optimization and validation of the EconomicClusters model for facilitating global health disparities research: Examples from Cameroon and Ghana	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SOCIOECONOMIC-STATUS; HOUSEHOLD WEALTH; INEQUALITIES; MORTALITY; POSITION; CHILDREN; INDEXES; TRAUMA; EQUITY	Health disparities research in low-and middle-income countries (LMICs) is hampered by the difficulty of measuring economic status in low-resource settings. We previously developed the EconomicClusters k-medoids clustering-based algorithm for defining population-specific economic models based on few Demographic and Health Surveys (DHS) assets. The algorithm previously defined a twenty-group economic model for Cameroon. The aims of this study are to optimize the functionality of our EconomicClusters algorithm and app based on collaborator feedback from early use of this twenty-group economic model, to test the validity of the model as a metric of economic status, and to assess the utility of the model in another LMIC context. We condense the twenty Cameroonian economic groups into fewer, ordinally-ranked, groups using agglomerative hierarchical clustering based on mean cluster child height-for-age Z-score (HAZ), women's literacy score, and proportion of children who are deceased. We develop an EconomicClusters model for Ghana consisting of five economic groups and rank these groups based on the same three variables. The proportion of variance in women's literacy score accounted for by the EconomicClusters model was 5-12% less than the proportion of variance accounted for by the DHS Wealth Index model. The proportion of the variance in child HAZ and proportion of children who are deceased accounted for by the EconomicClusters model was similar to (0.4-2.5% less than) the proportion of variance accounted for by the DHS Wealth Index model. The EconomicClusters model requires asking only five questions, as opposed to greater than twenty Wealth Index questions. The EconomicClusters algorithm and app could facilitate health disparities research in any country with DHS data by generating ordinally-ranked, population-specific economic models that perform nearly as well as the Wealth Index in evaluating variability in health and social outcomes based on wealth status but that are more feasible to assess in time-constrained settings.	[Eyler, Lauren] Univ Calif San Francisco, Dept Surg, Ctr Global Surg Studies, San Francisco, CA 94143 USA; [Hubbard, Alan] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Juillard, Catherine] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Juillard, C (corresponding author), Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.	CJuillard@mednet.ucla.edu		Hubbard, Alan/0000-0002-3769-0127; Dang, Lauren Eyler/0000-0002-2967-0855				[Anonymous], R LANG ENV STAT COMP; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Chakraborty NM, 2016, GLOB HEALTH-SCI PRAC, V4, P141, DOI 10.9745/GHSP-D-15-00384; Ergo A, 2016, GLOB HEALTH-SCI PRAC, V4, P155, DOI 10.9745/GHSP-D-15-00385; Eyler L., 2016, ECONOMICCLUSTERS; Eyler L, 2016, INT J MED INFORM, V94, P49, DOI 10.1016/j.ijmedinf.2016.05.004; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Finch BK, 2011, ECON HUM BIOL, V9, P272, DOI 10.1016/j.ehb.2011.02.005; Fox J., 2019, R COMPANION APPL REG, V.; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Grusky DB, 2008, MANY DIMENSIONS OF POVERTY, P20; Hennig C, 2013, J R STAT SOC C-APPL, V62, P309, DOI 10.1111/j.1467-9876.2012.01066.x; Houweling TAJ, 2010, BRIT MED BULL, V93, P7, DOI 10.1093/bmb/ldp048; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; Kacker S, 2016, INJURY, V47, P658, DOI 10.1016/j.injury.2015.12.011; Kaufman L., 2009, FINDING GROUPS DATA; Krishna A, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26523; Lartey ST, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0074-9; Lumley, 2021, ANAL COMPLEX SURVEY; Maechler M, 2017, CLUSTER CLUSTER ANAL; Minujin A, 2003, J HUM DEV, V4, P397, DOI DOI 10.1080/1464988032000125764; Patel AB, 2007, INDIAN J PEDIATR, V74, P349, DOI 10.1007/s12098-007-0058-2; Pitchforth E, 2007, HEALTH POLICY PLANN, V22, P311, DOI 10.1093/heapol/czm022; Rasanathan K., 2011, P WORLD C SOC DET HL; RStudio Team, 2016, RSTUDIO INT DEV R; Rutstein S. O., 2004, DHS COMP REPORTS; Rutstein S.O, 2014, DHS METHODOLOGICAL R; Rutstein SO, 2008, DHS WEALTH INDEX APP; Signorell A., 2020, DESCTOOLS TOOLS DESC; Strauss ME, 2009, ANNU REV CLIN PSYCHO, V5, P1, DOI 10.1146/annurev.clinpsy.032408.153639; Studer M, 2013, WEIGHTEDCLUSTER LIB, DOI [10.12682/lives.2296-1658.2013.24, DOI 10.12682/LIVES.2296-1658.2013.24]; Tajik P, 2014, INT J PREVENTIVE MED, V5, P46; United Nations, 2020, GOAL 10 RED IN COUNT; United Nations Committee for Development Policy, 2009, IMPL MILL DEV GOALS; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilunda C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-27; Zere Eyob, 2003, Int J Equity Health, V2, P7, DOI 10.1186/1475-9276-2-7	41	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217197	10.1371/journal.pone.0217197	http://dx.doi.org/10.1371/journal.pone.0217197			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120921	gold, Green Submitted, Green Published			2022-12-27	WOS:000468775700116
J	Peng, L; Guo, H; Ma, PL; Sun, YQ; Dennison, L; Aplan, PD; Hess, JL; Friedman, AD				Peng, Lei; Guo, Hong; Ma, Peilin; Sun, Yuqing; Dennison, Lauren; Aplan, Peter D.; Hess, Jay L.; Friedman, Alan D.			HoxA9 binds and represses the Cebpa+8 kb enhancer	PLOS ONE			English	Article							C/EBP-ALPHA; MYELODYSPLASTIC SYNDROME; DIFFERENTIAL EXPRESSION; MYELOID PROGENITORS; TRANSCRIPTION; COFACTORS; PROMOTER; GENES; CELLS; MICE	C/EBP alpha plays a key role in specifying myeloid lineage development. HoxA9 is expressed in myeloid progenitors, with its level diminishing during myeloid maturation, and HOXA9 is over-expressed in a majority of acute myeloid leukemia cases, including those expressing NUP98-HOXD13. The objective of this study was to determine whether HoxA9 directly represses Cebpa gene expression. We find 4-fold increased HoxA9 and 5-fold reduced Cebpa in marrow common myeloid and LSK progenitors from Vav-NUP98-HOXD13 transgenic mice. Conversely, HoxA9 decreases 5-fold while Cebpa increases during granulocytic differentiation of 32Dcl3 myeloid cells. Activation of exogenous HoxA9-ER in 32Dcl3 cells reduces Cebpa mRNA even in the presence of cycloheximide, suggesting direct repression. Cebpa transcription in murine myeloid cells is regulated by a hematopoietic-specific +37 kb enhancer and by a more widely active +8 kb enhancer. ChIP-Seq analysis of primary myeloid progenitor cells expressing exogenous HoxA9 or HoxA9-ER demonstrates that HoxA9 localizes to both the +8 kb and +37 kb Cebpa enhancers. Gel shift analysis demonstrates HoxA9 binding to three consensus sites in the +8 kb enhancer, but no affinity for the single near-consensus site present in the +37 kb enhancer. Activity of a Cebpa +8 kb enhancer/promoter-luciferase reporter in 32Dcl3 or MOLM14 myeloid cells is increased similar to 2-fold by mutation of its three HOXA9-binding sites, suggesting that endogenous HoxA9 represses +8 kb Cebpa enhancer activity. In contrast, mutation of five C/EBP alpha-binding sites in the +8 kb enhancer reduces activity 3-fold. Finally, expression of a +37 kb enhancer/promoter-hCD4 transgene reporter is reduced similar to 2-fold in marrow common myeloid progenitors when the Vav-NUP98-HOXD13 transgene is introduced. Overall, these data support the conclusion that HoxA9 represses Cebpa expression, at least in part via inhibition of its +8 kb enhancer, potentially allowing normal myeloid progenitors to maintain immaturity and contributing to the pathogenesis of acute myeloid leukemia associated with increased HOXA9.	[Peng, Lei; Guo, Hong; Dennison, Lauren; Friedman, Alan D.] Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21218 USA; [Ma, Peilin; Sun, Yuqing; Hess, Jay L.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guo, Hong] Lishui Univ, Coll Med & Hlth, Dept Med, Lishui, Peoples R China	Johns Hopkins University; Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Lishui University	Friedman, AD (corresponding author), Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21218 USA.	afriedm2@jhmi.edu		Friedman, Alan/0000-0002-5615-7061	National Institutes of Health [R01 HL130034, P30 CA006973]; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [ZIABC010982, P30CA006973] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants R01 HL130034 to ADF and P30 CA006973, (www.nih.gov) and the Giant Food Children's Cancer Research Fund (www.giantfood.com).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeff M, 2008, LEUKEMIA, V22, P2041, DOI 10.1038/leu.2008.198; [Anonymous], 2018, BLOOD, V131, P1081, DOI [10.1182/blood-2017-07-795757, DOI 10.1182/BLOOD-2017-07-795757]; Avellino R, 2016, BLOOD, V127, P2991, DOI 10.1182/blood-2016-01-695759; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Choi CW, 2008, HAEMATOL-HEMATOL J, V93, P1394, DOI 10.3324/haematol.13042; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Chung YJ, 2008, P NATL ACAD SCI USA, V105, P14088, DOI 10.1073/pnas.0804507105; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Fujino T, 2001, EXP HEMATOL, V29, P856, DOI 10.1016/S0301-472X(01)00655-5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo H, 2018, J IMMUNOL, V201, P1692, DOI 10.4049/jimmunol.1800244; Guo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150809; Guo H, 2014, J LEUKOCYTE BIOL, V96, P419, DOI 10.1189/jlb.2AB0314-145R; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kummalue T, 2003, J LEUKOCYTE BIOL, V74, P464, DOI 10.1189/jlb.1202622; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SCOTT LM, 1992, BLOOD, V80, P1725; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Sun Y, 2018, CANCER CELL, V34, P1, DOI [10.1016/j.ccell.2018.06.010, DOI 10.1016/J.CCELL.2018.06.010]; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zhong XX, 2018, BLOOD ADV, V2, P3137, DOI 10.1182/bloodadvances.2018025866	35	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217604	10.1371/journal.pone.0217604	http://dx.doi.org/10.1371/journal.pone.0217604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120998	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700114
J	Suzuki, A; Puri, S; Leland, P; Puri, A; Moudgil, T; Fox, BA; Puri, RK; Joshi, BH				Suzuki, Akiko; Puri, Sachin; Leland, Pamela; Puri, Ankit; Moudgil, Tarsem; Fox, Bernard A.; Puri, Raj K.; Joshi, Bharat H.			Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer	PLOS ONE			English	Article							PYRUVATE-KINASE M2; GENE-TRANSCRIPTION; UP-REGULATION; RECEPTOR; ISOFORM; PROTEIN; EXPRESSION; CHAIN; OVEREXPRESSION; ACTIVATION	Pyruvate kinase M2 (PKM2) is an alternatively spliced variant, which mediates the conversion of glucose to lactate in cancer cells under normoxic conditions, known as the Warburg effect. Previously, we demonstrated that PKM2 is one of 97 genes that are overexpressed in non-small-cell lung cancer (NSCLC) cell lines. Herein, we demonstrate a novel role of subcellular PKM2 expression as a biomarker of therapeutic response after targeting this gene by shRNA or small molecule inhibitor (SMI) of PKM2 enzyme activity in vitro and in vivo. We examined two established lung cancer cell lines, nine patients derived NSCLC and three normal lung fibroblast cell lines for PKM2 mRNA, protein and enzyme activity by RT-qPCR, immunocytochemistry (ICC), and Western blot analysis. All eleven NSCLC cell lines showed upregulated PKM2 enzymatic activity and protein expression mainly in their cytoplasm. Targeting PKM2 by shRNA or SMI, NSCLC cells showed significantly reduced mRNA, enzyme activity, cell viability, and colony formation, which also downregulated cytosolic PKM2 and upregulated nuclear enzyme activities. Normal lung fibroblast cell lines did not express PKM2, which served as negative controls. PKM2 targeting by SMI slowed tumor growth while gene-silencing significantly reduced growth of human NSCLC xenografts. Tumor sections from responding mice showed >70% reduction in cytoplasmic PKM2 with low or undetectable nuclear staining by immunohistochemistry (IHC). In sharp contrast, non-responding tumors showed a >38% increase in PKM2 nuclear staining with low or undetectable cytoplasmic staining. In conclusion, these results confirmed PKM2 as a target for cancer therapy and an unique function of subcellular PKM2, which may characterize therapeutic response to anti-PKM2 therapy in NSCLC.	[Suzuki, Akiko; Leland, Pamela; Puri, Ankit; Puri, Raj K.; Joshi, Bharat H.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Puri, Sachin; Moudgil, Tarsem; Fox, Bernard A.] Providence Canc Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Mol & Tumor Immunol, Portland, OR USA; [Fox, Bernard A.] OHSU, Dept Mol Microbiol & Immunol, Portland, OR USA	US Food & Drug Administration (FDA); Oregon Health & Science University	Joshi, BH (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	bharat.joshi@fda.hhs.gov						Azoitei N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0490-2; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gines A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123830; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Hamabe A, 2014, P NATL ACAD SCI USA, V111, P15526, DOI 10.1073/pnas.1407717111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Joshi BH, 2000, CANCER RES, V60, P1168; Joshi BH, 2008, CANCER RES, V68, P9311, DOI 10.1158/0008-5472.CAN-08-2810; Joshi BH, 2015, DISCOV MED, V20, P273; Joshi BH, 2014, CANCER MED-US, V3, P1615, DOI 10.1002/cam4.330; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Li J, 2014, CLIN TRANSL ONCOL, V16, P200, DOI 10.1007/s12094-013-1063-8; Li Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep16082; Li YH, 2018, GENE, V668, P48, DOI 10.1016/j.gene.2018.05.038; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Lu W, 2016, SCI REP-UK, V6, DOI 10.1038/srep26351; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Ortega JF, 2016, ONCOTARGET, V7, P24339, DOI 10.18632/oncotarget.8248; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Puri S, 2012, 27 ANN M SOC IMM CAN; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xia L, 2016, J BIOL CHEM, V291, P26138, DOI 10.1074/jbc.M116.737056; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yang YC, 2016, ONCOGENE, V35, P3387, DOI 10.1038/onc.2015.397; Yang YC, 2018, CANCER LETT, V421, P28, DOI 10.1016/j.canlet.2018.01.075; Zhou HP, 2016, ONCOTARGET, V7, P23947, DOI 10.18632/oncotarget.8114	43	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217131	10.1371/journal.pone.0217131	http://dx.doi.org/10.1371/journal.pone.0217131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120964	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700058
J	Timofeev, V; Bahtejeva, I; Mironova, R; Titareva, G; Lev, I; Christiany, D; Borzilov, A; Bogun, A; Vergnaud, G				Timofeev, Vitalii; Bahtejeva, Irina; Mironova, Raisa; Titareva, Galina; Lev, Igor; Christiany, David; Borzilov, Alexander; Bogun, Alexander; Vergnaud, Gilles			Insights from Bacillus anthracis strains isolated from permafrost in the tundra zone of Russia	PLOS ONE			English	Article							INJECTIONAL ANTHRAX; MICROBIAL ECOLOGY; HEROIN USERS; OUTBREAK; DISEASE; SOIL	This article describes Bacillus anthracis strains isolated during an outbreak of anthrax on the Yamal Peninsula in the summer of 2016 and independently in Yakutia in 2015. A common feature of these strains is their conservation in permafrost, from which they were extracted either due to the thawing of permafrost (Yamal strains) or as the result of paleontological excavations (Yakut strains). All strains isolated on the Yamal share an identical genotype belonging to lineage B.Br.001/002, pointing to a common source of infection in a territory over 250 km in length. In contrast, during the excavations in Yakutia, three genetically different strains were recovered from a single pit. One strain belongs to B.Br.001/002, and whole genome sequence analysis showed that it is most closely related to the Yamal strains in spite of the remoteness of Yamal from Yakutia. The two other strains contribute to two different branches of A.Br.008/011, one of the remarkable polytomies described so far in the B. anthracis species. The geographic distribution of the strains belonging to A.Br.008/011 is suggesting that the polytomy emerged in the thirteenth century, in combination with the constitution of a unified Mongol empire extending from China to Eastern Europe. We propose an evolutionary model for B. anthracis recent evolution in which the B lineage spread throughout Eurasia and was subsequently replaced by the A lineage except in some geographically isolated areas.	[Timofeev, Vitalii; Bahtejeva, Irina; Mironova, Raisa; Titareva, Galina; Lev, Igor; Borzilov, Alexander; Bogun, Alexander] FBIS, SRCAMB, Obolensk, Russia; [Christiany, David; Vergnaud, Gilles] Univ Paris Sud, Univ Paris Saclay, CNRS, CEA,I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Timofeev, V (corresponding author), FBIS, SRCAMB, Obolensk, Russia.; Vergnaud, G (corresponding author), Univ Paris Sud, Univ Paris Saclay, CNRS, CEA,I2BC, Gif Sur Yvette, France.	timofeev_vitalii@mail.ru; gilles.vergnaud@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Borzilov, Alexander/AAI-8583-2020; Bogun, Alexander/U-2441-2017; Bakhteeva, Irina/AAA-7780-2022; Timofeev, Vitalii/V-2376-2019; Vergnaud, Gilles/AAC-1162-2020	Vergnaud, Gilles/0000-0003-0913-194X; Bogun, Alexander/0000-0001-5454-2495; Bakhteeva, Irina/0000-0002-6897-3613; Vergnaud, Gilles/0000-0003-0913-194X; Timofeev, Vitalii/0000-0002-9501-1380	Sectoral Scientific Program: Problem-oriented research in the epidemiological surveillance of infectious and parasitic diseases (2016-2020), of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor); French Agence Nationale de la Recherche [ANR-14-ASMA-0002-02]	Sectoral Scientific Program: Problem-oriented research in the epidemiological surveillance of infectious and parasitic diseases (2016-2020), of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor); French Agence Nationale de la Recherche(French National Research Agency (ANR))	The work of TV, BI, MR, TG, LI, BogA, and BorA is supported by the Sectoral Scientific Program: Problem-oriented research in the epidemiological surveillance of infectious and parasitic diseases (2016-2020), of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) (http://www.rospotrebnadzor.ru/). The work of Vg and CD is supported by the French Agence Nationale de la Recherche grant ANR-14-ASMA-0002-02 "Microtype". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MM, 2013, THAI J VET MED, V43, P449; Antwerpen MH, 2017, MBIO, V8, DOI [10.1128/mbio.00440-17, 10.1128/mBio.00440-17]; Aring;ogren J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089112; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Blouin Y., 2014, NEW SCENARIO EARLY E; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Blouin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052841; Braun P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135346; Buntgen U, 2016, SCI REP-UK, V6, DOI 10.1038/srep25606; Chakraborty A, 2012, AM J TROP MED HYG, V86, P703, DOI 10.4269/ajtmh.2012.11-0234; Chambers J, 1988, DEVILS HORSEMEN MONG; Cherkasskiy BL, 1999, J APPL MICROBIOL, V87, P192, DOI 10.1046/j.1365-2672.1999.00868.x; Cherkasskiy BL, 2003, PUTESHESTVIE EPIDEMI; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; DASH JG, 1995, REP PROG PHYS, V58, P115, DOI 10.1088/0034-4885/58/1/003; DRAGON DC, 1995, CAN VET J, V36, P295; Elvander M, 2017, TRANSBOUND EMERG DIS, V64, P892, DOI 10.1111/tbed.12456; Fowler R. A., 2011, Journal of Bioterrorism and Biodefense, V2, P107; GATES CC, 1995, CAN J VET RES, V59, P256; Girault G., 2015, THESIS; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Govorunova VA, 2012, PROBLEMY OSOBO OPASN, V2, P82; Griffin DW, 2009, APPL GEOCHEM, V24, P1464, DOI 10.1016/j.apgeochem.2009.04.016; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Jung KH, 2012, J VET SCI, V13, P385, DOI 10.4142/jvs.2012.13.4.385; Keim P, 2015, EBIOMEDICINE, V2, P1613, DOI 10.1016/j.ebiom.2015.10.004; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kospokevich V, 1984, B COMMISSION STUDYIN, V53, P139; Kracalik I, 2017, VACCINE, V35, P6283, DOI 10.1016/j.vaccine.2017.09.081; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111; Lembo T, 2011, EMERG INFECT DIS, V17, P387, DOI 10.3201/eid1703.101290; Lienemann T, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1250-4; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Maksimovic Z, 2017, REV SCI TECH OIE, V36, P959, DOI 10.20506/rst.36.3.2727; Okello A, 2015, HEALTH POLICY PLANN, V30, P804, DOI 10.1093/heapol/czu059; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Okutani A, 2011, JPN J INFECT DIS, V64, P345; Peculi A, 2015, J BIOTERROR BIODEF, V6, DOI [10.4172/2157-2526, DOI 10.4172/2157-2526]; Popova A., 2017, OPYT LIKVIDATSII VSP; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Revich BA, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8482; Sahl JW, 2016, MBIO, V7, DOI [10.1128/mBio.01501-16, 10.1128/mbio.01501-16]; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Saunders J.J, 2001, HIST MONGOL CONQUEST; Savinych AV, 2017, VESTNIK VOYSK RKHB Z, V1, P18; Smith KL, 1999, J APPL MICROBIOL, V87, P204, DOI 10.1046/j.1365-2672.1999.00871.x; Spencer RC, 2003, J CLIN PATHOL, V56, P182, DOI 10.1136/jcp.56.3.182; Stahli M, 1999, WATER RESOUR RES, V35, P95, DOI 10.1029/1998WR900045; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Turner WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27311; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Venkateswaran K, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00021-17; Vergnaud G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146216; WHO, 2008, ANTHRAX HUMANS ANIMA; Williams PJ, 1991, FROZEN EARTH FUNDAME	64	24	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0209140	10.1371/journal.pone.0209140	http://dx.doi.org/10.1371/journal.pone.0209140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116737	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400003
J	Alhabib, KF; Kinsara, AJ; Alghamdi, S; Al-Murayeh, M; Hussein, GA; AlSaif, S; Khalaf, H; Alfaleh, H; Hersi, A; Kashour, T; Al-saleh, A; Ali, M; Ullah, A; Mhish, H; Abdo, AN; Almutairi, F; Arafah, MR; AlKutshan, R; Aldosari, M; AlSabatien, BY; Alrazzaz, M; Maria, AM; Aref, AH; Selim, MM; Morsy, AM; AlTohari, FA; Alrifai, AA; Awaad, AA; El-Sayed, H; Mansour, S; Atwa, AA; Abdelkader, S; Altamimi, N; Saleh, E; Alhaidari, W; ElShihawy, EA; Busaleh, AH; Abdalmoutaleb, M; Fawzy, EM; Mokhtar, Z; Saleh, AM; Ahmad, MA; Almasswary, A; Alshehri, M; Abohatab, KM; AlGarni, T; Butt, M; Altaj, I; Abdullah, F; Alhosni, Y; Osman, HB; Bugti, N; Aziz, AA; Alarabi, A; AlHarbi, IA				Alhabib, Khalid F.; Kinsara, Abdulhalim J.; Alghamdi, Saleh; Al-Murayeh, Mushabab; Hussein, Gamal Abdin; AlSaif, Shukri; Khalaf, Hassan; Alfaleh, Hussam; Hersi, Ahmad; Kashour, Tarek; Al-saleh, Ayman; Ali, Mohammad; Ullah, Anhar; Mhish, Hassan; Abdo, Abdulrahman Nouri; Almutairi, Fawaz; Arafah, Mohammed R.; AlKutshan, Raed; Aldosari, Mubarak; AlSabatien, Basel Y.; Alrazzaz, Mohammad; Maria, Adel M.; Aref, Aziza H.; Selim, Muhammed M.; Morsy, Ayman M.; AlTohari, Fathi A.; Alrifai, Ammar A.; Awaad, Awatif A.; El-Sayed, Hassan; Mansour, Sherief; Atwa, Ashraf A.; Abdelkader, Salah; Altamimi, Naif; Saleh, Elnatheer; Alhaidari, Wael; ElShihawy, El Husseini A.; Busaleh, Ali H.; Abdalmoutaleb, Mohammed; Fawzy, Essam M.; Mokhtar, Zaki; Saleh, Adil M.; Ahmad, Mohammed A.; Almasswary, Adel; Alshehri, Mohammed; Abohatab, Khalid M.; AlGarni, Turki; Butt, Modaser; Altaj, Ibrahim; Abdullah, Farhan; Alhosni, Yahya; Osman, Hadia B.; Bugti, Najeebullah; Aziz, Atif A.; Alarabi, Abdulrahman; AlHarbi, Ibrahim A.			The first survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program)	PLOS ONE			English	Article							ST-SEGMENT-ELEVATION; BASE-LINE CHARACTERISTICS; ACUTE CORONARY SYNDROMES; MANAGEMENT-PRACTICES; GENDER-DIFFERENCES; FRENCH REGISTRY; ESC; ASSOCIATION; GUIDELINES; THERAPY	Background Prior acute coronary syndrome (ACS) registries in Saudi Arabia might not have accurately described the true demographics and cardiac care of patients with ACS. We aimed to evaluate the clinical characteristics, management, and outcomes of a representative sample of patients with acute myocardial infarction (AMI) in Saudi Arabia. Methods We conducted a 1-month snap-shot, prospective, multi-center registry study in 50 hospitals from various health care sectors in Saudi Arabia. We followed patients for 1 month and 1 year after hospital discharge. Patients with AMI included those with or without ST-segment elevation (STEMI or NSTEMI, respectively). This program survey will be repeated every 5 years. Results Between May 2015 and January 2017, we enrolled 2233 patients with ACS (mean age was 56 [standard deviation = 13] years; 55.6% were Saudi citizens, 85.7% were men, and 65.9% had STEMI). Coronary artery disease risk factors were high; 52.7% had diabetes mellitus and 51.2% had hypertension. Emergency Medical Services (EMS) was utilized in only 5.2% of cases. Revascularization for patients with STEMI included thrombolytic therapy (29%), primary percutaneous coronary intervention (PCI); (42.5%), neither (29%), or a pharmacoinvasive approach (3%). Non-Saudis with STEMI were less likely to undergo primary PCI compared to Saudis (35.8% vs. 48.7%; respectively, p < 0.001), and women were less likely than men to achieve a door-to-balloon time of <90 min (42% vs. 65%; respectively, p = 0.003). Around half of the patients with NSTEMI did not undergo a coronary angiogram. All-cause mortality rates were 4%, 5.8%, and 8.1%, in-hospital, at 1 month, and at 1 year, respectively. These rates were significantly higher in women than in men. Conclusions There is an urgent need for primary prevention programs, improving the EMS infrastructure and utilization, and establishing organized ACS network programs. AMI care needs further improvement, particularly for women and non-Saudis.	[Alhabib, Khalid F.; Alfaleh, Hussam; Hersi, Ahmad; Kashour, Tarek; Al-saleh, Ayman; Ullah, Anhar] King Saud Univ, Dept Cardiac Sci, Coll Med, King Fahad Cardiac Ctr, Riyadh, Saudi Arabia; [Kinsara, Abdulhalim J.] King Saud bin Abdulaziz Univ Hlth Sci, Minist Natl Guard Hlth Affair, Dept Cardiol, COM WR King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Alghamdi, Saleh] Madinah Cardiac Ctr, Madinah, Saudi Arabia; [Al-Murayeh, Mushabab; Alshehri, Mohammed] Armed Forces Hosp Southern Reg, Khamis Mushayt, Saudi Arabia; [Hussein, Gamal Abdin] King Salman North West Armed Forces Hosp, Tabuk, Saudi Arabia; [AlSaif, Shukri] Saud AlBabtain Cardiac Ctr, Dammam, Saudi Arabia; [Khalaf, Hassan] Prince Sultan Cardiac Ctr, Buraydah, Saudi Arabia; [Khalaf, Hassan] Hail Cardiac Ctr, Hail, Saudi Arabia; [Ali, Mohammad] Saudi Heart Assoc, Riyadh, Saudi Arabia; [Mhish, Hassan] King Fahd Med City, King Salman Heart Ctr, Riyadh, Saudi Arabia; [Abdo, Abdulrahman Nouri] Obeid Specialized Hosp, Riyadh, Saudi Arabia; [Almutairi, Fawaz] Secur Forces Hosp, Riyadh, Saudi Arabia; [Arafah, Mohammed R.] Dallah Hosp, Riyadh, Saudi Arabia; [AlKutshan, Raed] Aljazeera Hosp, Riyadh, Saudi Arabia; [Aldosari, Mubarak] King Saud Med City Riyadh Med Complex, Riyadh, Saudi Arabia; [AlSabatien, Basel Y.] Alwatani Natl Care Hosp, Riyadh, Saudi Arabia; [Alrazzaz, Mohammad] AlFalah Hosp, Riyadh, Saudi Arabia; [Maria, Adel M.] King Salman Hosp, Riyadh, Saudi Arabia; [Aref, Aziza H.] Imam Abdulrahman Faisal Hosp, Riyadh, Saudi Arabia; [Selim, Muhammed M.] King Fahad Gen Hosp Jeddah, Jeddah, Saudi Arabia; [Morsy, Ayman M.] AlNoor Specialist Hosp, Mecca, Saudi Arabia; [AlTohari, Fathi A.] Secur Forces Hosp, Mecca, Saudi Arabia; [Alrifai, Ammar A.] King Abdulaziz Hosp & Oncol Ctr, Jeddah, Saudi Arabia; [Awaad, Awatif A.] Althager Gen Hosp, Jeddah, Saudi Arabia; [El-Sayed, Hassan] King Abdulaziz Specialist Hosp, Altaif, Saudi Arabia; [Mansour, Sherief] AlZahra Hosp, Madinah, Saudi Arabia; [Atwa, Ashraf A.] Al Dar Hosp, Madinah, Saudi Arabia; [Abdelkader, Salah] AlMiqat Hosp, Madinah, Saudi Arabia; [Altamimi, Naif] King Fahad Hosp, Madinah, Saudi Arabia; [Saleh, Elnatheer] Ohud Hosp, Madinah, Saudi Arabia; [Alhaidari, Wael] Alansar Hosp, Madinah, Saudi Arabia; [ElShihawy, El Husseini A.] Prince Sultan Cardiac Ctr, Alhofuf Alhasa, Saudi Arabia; [Busaleh, Ali H.] Al Qateef Cent Hosp, Al Qateef, Saudi Arabia; [Abdalmoutaleb, Mohammed] Mohammad Dossary Hosp, Al Khobar, Saudi Arabia; [Fawzy, Essam M.] King Khalid Gen Hosp, Hafar Albatin, Saudi Arabia; [Mokhtar, Zaki] King Saud Hosp, Unizah, Saudi Arabia; [Saleh, Adil M.] Dr Sulaiman Alhabib Hosp, Buraydah, Saudi Arabia; [Ahmad, Mohammed A.] Alrass Gen Hosp, Arrass, Saudi Arabia; [Almasswary, Adel] Aseer Cent Hosp, Abha, Saudi Arabia; [Abohatab, Khalid M.] AlNamas Gen Hosp, Alnamas, Saudi Arabia; [AlGarni, Turki] Khamis Mushayt Gen Hosp, Khamis Mushayt, Saudi Arabia; [Butt, Modaser] King Khalid Civilian Hosp, Tabuk, Saudi Arabia; [Altaj, Ibrahim] Prince Abdulla bin Abdulaziz bin Musaed Cardiac C, Arar Cardiac Ctr, Ar Ar, Saudi Arabia; [Abdullah, Farhan] Prince Abdulaziz Bin Musaid Hosp, Ar Ar, Saudi Arabia; [Alhosni, Yahya] King Khalid Hosp, Prince Sultan Cardiac Ctr, Najran, Saudi Arabia; [Osman, Hadia B.] Prince Meteb Ibn Abdulaziz Hosp, Sakaka, Saudi Arabia; [Bugti, Najeebullah] King Abdullaziz Specialist Hosp, Sakaka, Saudi Arabia; [Aziz, Atif A.] Dumat AlJandal Hosp, Dumat Aljandal, Saudi Arabia; [Alarabi, Abdulrahman] King Fahad Cent Hosp, Albaha, Saudi Arabia; [AlHarbi, Ibrahim A.] King Fahad Cent Hosp, Jizan, Saudi Arabia	King Saud University; King Saud Bin Abdulaziz University for Health Sciences; Prince Sultan Cardiac Center; King Fahad Medical City; Security Forces Hospital - Saudi Arabia; King Saud Medical City; King Saud Bin Abdulaziz University for Health Sciences; Imam Abdulrahman Al Faisal Hospital - Dammam; Security Forces Hospital - Saudi Arabia; Jordan University of Science & Technology; King Abdullah University Hospital; Prince Sultan Cardiac Center; Assir Central Hospital; King Khalid Hospital; Prince Sultan Cardiac Center	Alhabib, KF (corresponding author), King Saud Univ, Dept Cardiac Sci, Coll Med, King Fahad Cardiac Ctr, Riyadh, Saudi Arabia.	khalidalhabib13@hotmail.com	Ullah, Anhar/CAJ-2116-2022; GARNI, TURKI AL/ABI-4669-2020; AlSaif, Shukri/GZM-0822-2022; Kinsara, Abdulhalim/AAL-1207-2020; Hersi, Ahmad/ABC-9266-2020	GARNI, TURKI AL/0000-0003-1041-9174; Kinsara, Abdulhalim/0000-0002-6414-8720; Alhabib, Khalid/0000-0002-6692-3874; Ullah, Anhar/0000-0001-6768-2112; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, College of Medicine,/0000-0001-9073-534X	AstraZeneca (KSA); Algorithm pharmaceutical company; Saudi Heart Association; Emergency Department Support Program; Ministry of Health; College of Medicine Research Center at King Khalid University Hospital, King Saud University	AstraZeneca (KSA)(AstraZeneca); Algorithm pharmaceutical company; Saudi Heart Association; Emergency Department Support Program; Ministry of Health; College of Medicine Research Center at King Khalid University Hospital, King Saud University	This research was funded by AstraZeneca (KSA), Algorithm pharmaceutical company, Saudi Heart Association, Emergency Department Support Program, Ministry of Health, and the College of Medicine Research Center at King Khalid University Hospital, King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The STARS Program was managed under the auspices of the Saudi Heart Association. We would like to thank the study investigators and data collectors for their dedication and collaboration (see the list of Co-investigators and data collectors, Appendix), and Mohammad Ali for coordinating the study. Prof. Khalid F AlHabib (Principal Investigator) had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	AlFaleh HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124012; AlHabib KF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147385; AlHabib KF, 2011, J SAUDI HEART ASSOC, V23, P233, DOI 10.1016/j.jsha.2011.05.004; AlHabib KF, 2012, ANN SAUDI MED, V32, P9, DOI 10.5144/0256-4947.2012.9; Belle L, 2017, ARCH CARDIOVASC DIS, V110, P366, DOI 10.1016/j.acvd.2017.05.001; Chieffo Alaide, 2012, EuroIntervention, V8 Suppl P, pP27, DOI 10.4244/EIJV8SPA6; Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765; Hersi A, 2013, ANN SAUDI MED, V33, P339, DOI 10.5144/0256-4947.2013.339; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kristensen SD, 2014, EUR HEART J, V35, P1957, DOI 10.1093/eurheartj/eht529; Leurent G, 2014, ARCH CARDIOVASC DIS, V107, P291, DOI 10.1016/j.acvd.2014.04.005; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Schiele F, 2011, AM J CARDIOL, V108, P789, DOI 10.1016/j.amjcard.2011.04.031; Shavadia J, 2013, CAN J CARDIOL, V29, P951, DOI 10.1016/j.cjca.2012.10.018; Shehab A, 2019, CURR VASC PHARMACOL, V17, P388, DOI 10.2174/1570161116666180315104820; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Storey RF, 2011, EUR HEART J, V32, P2945, DOI 10.1093/eurheartj/ehr231; Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1093/eurheartj/ehy462, 10.1016/j.rec.2018.11.011, 10.1016/j.jacc.2018.08.1038]; Valgimigli M, 2018, LANCET, V392, P835, DOI 10.1016/S0140-6736(18)31714-8; Zaman MJ, 2014, EUR HEART J, V35, P1551, DOI 10.1093/eurheartj/ehu039; 2011, LANCET, V377, P1409, DOI DOI 10.1016/S0140-6736(11)60404-2; 2014, CIRCULATION, V129, P1629, DOI DOI 10.1161/CIRCULATIONAHA.113.005874	25	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216551	10.1371/journal.pone.0216551	http://dx.doi.org/10.1371/journal.pone.0216551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112586	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000016
J	Gutsol, AA; Blanco, P; Samokhina, SI; Afanasiev, SA; Kennedy, CRJ; Popov, SV; Burns, KD				Gutsol, Alex A.; Blanco, Paula; Samokhina, Svetlana I.; Afanasiev, Sergey A.; Kennedy, Chris R. J.; Popov, Sergey V.; Burns, Kevin D.			A novel method for comparison of arterial remodeling in hypertension: Quantification of arterial trees and recognition of remodeling patterns on histological sections	PLOS ONE			English	Article							REGIONAL BLOOD FLOWS; RESISTANCE ARTERIES; ANGIOTENSIN-II; VASCULAR CHANGES; MORPHOMETRIC EVIDENCE; CEREBRAL ARTERIOLES; PULMONARY-ARTERIES; MEDIAL HYPERTROPHY; RENAL-HYPERTENSION; STRUCTURAL-CHANGES	Remodeling of spatially heterogeneous arterial trees is routinely quantified on tissue sections by averaging linear dimensions, with lack of comparison between different organs and models. The impact of experimental models or hypertension treatment modalities on organ-specific vascular remodeling remains undefined. A wide variety of arterial remodeling types has been demonstrated for hypertensive models, which include differences across organs. The purpose of this study was to reassess methods for measurement of arterial remodeling and to establish a morphometric algorithm for standard and comparable quantification of vascular remodeling in hypertension in different vascular beds. We performed a novel and comprehensive morphometric analysis of terminal arteries in the brain, heart, lung, liver, kidney, spleen, stomach, intestine, skin, skeletal muscle, and adrenal glands of control and Goldblatt hypertensive rats on routinely processed tissue sections. Mean dimensions were highly variable but grouping them into sequential 5 mu m intervals permitted creation of reliable linear regression equations and complex profiles. Averaged arterial dimensions demonstrated seven remodeling patterns that were distinct from conventional inward-outward and hypertrophic-eutrophic definitions. Numerical modeling predicted at least nineteen variants of arterial spatial conformations. Recognition of remodeling variants was not possible using averaged dimensions, their ratios, or the remodeling and growth indices. To distinguish remodeling patterns, a three-dimensional modeling was established and tested. The proposed algorithm permits quantitative analysis of arterial remodeling in different organs and may be applicable for comparative studies between animal hypertensive models and human hypertension. Arterial wall tapering is the most important factor to consider in arterial morphometry, while perfusion fixation with vessel relaxation is not necessary. Terminal arteries in organs undergo the same remodeling pattern in Goldblatt rats, except for organs with hemodynamics affected by the arterial clip. The existing remodeling nomenclature should be replaced by a numerical classification applicable to any type of arterial remodeling.	[Gutsol, Alex A.; Kennedy, Chris R. J.; Burns, Kevin D.] Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [Blanco, Paula] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Samokhina, Svetlana I.] Tomsk State Univ, Tomsk, Russia; [Afanasiev, Sergey A.; Popov, Sergey V.] Cardiol Res Inst, Tomsk, Russia; [Burns, Kevin D.] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Tomsk State University; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; University of Ottawa	Gutsol, AA (corresponding author), Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada.	agutsol@uottawa.ca	Popov, Sergey/F-1751-2014; Gutsol, Alex/ABC-3028-2020; Samokhina, Svetlana I./G-8308-2014; Samokhina, Svetlana/AAI-9029-2020	Popov, Sergey/0000-0002-9050-4493; Gutsol, Alex/0000-0002-6251-1338				Anderson WP, 2007, J HYPERTENS, V25, P649, DOI 10.1097/HJH.0b013e3280112cf6; ASHEN MD, 1994, CLIN EXP HYPERTENS, V16, P261, DOI 10.3109/10641969409072216; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Baumbach GL, 2002, CIRC RES, V91, P931, DOI 10.1161/01.RES.0000041408.64867.1D; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; BERRY CL, 1982, J PATHOL, V136, P85, DOI 10.1002/path.1711360203; BOEGEHOLD MA, 1991, AM J PHYSIOL, V261, pR934, DOI 10.1152/ajpregu.1991.261.4.R934; Boswell CA, 2014, MOL PHARMACEUT, V11, P1591, DOI 10.1021/mp400748t; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Brekke JF, 2002, AM J PHYSIOL-HEART C, V283, pH2210, DOI 10.1152/ajpheart.00633.2002; Briones AM, 2006, AM J PHYSIOL-HEART C, V291, pH193, DOI 10.1152/ajpheart.00802.2005; Bund SJ, 2003, J VASC RES, V40, P547, DOI 10.1159/000075678; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; CHAROCOPOS F, 1984, J PHYSIOLOGY PARIS, V79, P162; CHOBANIAN AV, 1984, EXP MOL PATHOL, V41, P153, DOI 10.1016/0014-4800(84)90015-7; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; Davis J.C., 2002, STAT DATA ANAL GEOLO; De Ciuceis C, 2005, ARTERIOSCL THROM VAS, V25, P2106, DOI 10.1161/01.ATV.0000181743.28028.57; Denton KM, 2000, AM J PHYSIOL-REG I, V279, pR629, DOI 10.1152/ajpregu.2000.279.2.R629; Favreau F, 2010, KIDNEY INT, V78, P1110, DOI 10.1038/ki.2010.142; FURUYAMA M, 1962, TOHOKU J EXP MED, V76, P388, DOI 10.1620/tjem.76.388; Gabeler Edward E E, 2002, BMC Cardiovasc Disord, V2, P16, DOI 10.1186/1471-2261-2-16; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; GREENBLATT EP, 1993, J CARDIOVASC PHARM, V21, P235, DOI 10.1097/00005344-199302000-00008; Gutierrez J, 2014, ATHEROSCLEROSIS, V235, P371, DOI 10.1016/j.atherosclerosis.2014.05.925; GUTSOL AA, 1988, KARDIOLOGIYA, V28, P48; HANSTEDE JG, 1986, ACTA MORPHOL NEER SC, V24, P281; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; Heagerty AM, 2010, J CELL MOL MED, V14, P1037, DOI 10.1111/j.1582-4934.2010.01080.x; HELMCHEN U, 1984, J CARDIOVASC PHARM, V6, pS696, DOI 10.1097/00005344-198406004-00017; Herrington W, 2016, CIRC RES, V118, P535, DOI 10.1161/CIRCRESAHA.115.307611; Hill GS, 2006, KIDNEY INT, V69, P823, DOI 10.1038/sj.ki.5000163; HISLOP A, 1978, J ANAT, V125, P71; Imhof E., 2007, CARTOGRAPHIC RELIEF; Jing L, 2011, INT J MOL SCI, V12, P8333, DOI 10.3390/ijms12128333; Kernohan JW, 1929, ARCH INTERN MED, V44, P395, DOI 10.1001/archinte.1929.00140030094010; KETT MM, 1995, HYPERTENSION, V25, P335, DOI 10.1161/01.HYP.25.3.335; Kinuno H, 2005, CLIN EXP PHARMACOL P, V32, P173, DOI 10.1111/j.1440-1681.2005.04167.x; Korshunov VA, 2007, HYPERTENSION, V50, P1057, DOI 10.1161/HYPERTENSIONAHA.107.096289; KUWAHIRA I, 1993, J APPL PHYSIOL, V74, P211, DOI 10.1152/jappl.1993.74.1.211; Laurent S, 2015, CIRC RES, V116, P1007, DOI 10.1161/CIRCRESAHA.116.303596; LEE RMKW, 1983, BLOOD VESSELS, V20, P245; LEE RMKW, 1985, CAN J PHYSIOL PHARM, V63, P392, DOI 10.1139/y85-070; Lee RMKW, 2017, HYPERTENS RES, V40, P311, DOI 10.1038/hr.2016.145; LIARD JF, 1986, J HYPERTENS, V4, P399, DOI 10.1097/00004872-198608000-00002; LIMAS C, 1980, AM J PATHOL, V98, P357; LIU DT, 1994, J HYPERTENS, V12, P145; LIU J, 1988, CIRC RES, V62, P1001, DOI 10.1161/01.RES.62.5.1001; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P1713, DOI 10.1093/ndt/17.10.1713; Lu L, 2003, AM J PHYSIOL-HEART C, V285, pH1370, DOI 10.1152/ajpheart.00260.2003; MACLEAN MR, 1990, BRIT J PHARMACOL, V99, P340, DOI 10.1111/j.1476-5381.1990.tb14705.x; Casare FAM, 2016, AM J PHYSIOL-RENAL, V310, pF1295, DOI 10.1152/ajprenal.00471.2015; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Montaudon M, 2009, EUR RADIOL, V19, P1328, DOI 10.1007/s00330-008-1284-3; Mulvany MJ, 1996, HYPERTENSION, V28, P505; New DI, 2004, KIDNEY INT, V65, P1818, DOI 10.1111/j.1523-1755.2004.00591.x; Nordborg C, 1983, J Hypertens, V1, P333, DOI 10.1097/00004872-198312000-00002; NORDBORG C, 1980, STROKE, V11, P266, DOI 10.1161/01.STR.11.3.266; Novikov YV, 2006, B EXP BIOL MED+, V141, P479, DOI 10.1007/s10517-006-0204-2; Ohara M, 2015, CLIN EXP PHARMACOL P, V42, P687, DOI 10.1111/1440-1681.12411; OWENS GK, 1988, HYPERTENSION, V11, P198, DOI 10.1161/01.HYP.11.2.198; Polichnowski AJ, 2009, HYPERTENSION, V54, P1269, DOI 10.1161/HYPERTENSIONAHA.109.139287; Rizzoni D, 2000, J HYPERTENS, V18, P885, DOI 10.1097/00004872-200018070-00010; Rizzoni D, 2012, INTERN EMERG MED, V7, P205, DOI 10.1007/s11739-011-0548-0; Sakaeda T, 1998, J DRUG TARGET, V6, P261, DOI 10.3109/10611869808996834; Schiffrin EL, 1997, J HYPERTENS, V15, P571, DOI 10.1097/00004872-199715060-00002; Schiffrin EL, 2004, AM J HYPERTENS, V17, P1192, DOI 10.1016/j.amjhyper.2004.05.023; Schoen FJ, 2012, PATHOLOGIC BASIS DIS, V7th, P511; SHORT DS, 1959, J PATHOL BACTERIOL, V78, P321, DOI 10.1002/path.1700780202; Shweta A, 2005, J HYPERTENS, V23, P851, DOI 10.1097/01.hjh.0000163155.29740.d2; Simon G, 2003, CLIN EXP PHARMACOL P, V30, P476, DOI 10.1046/j.1440-1681.2003.03856.x; Skogstrand T, 2013, J HYPERTENS, V31, P152, DOI 10.1097/HJH.0b013e32835a5d4e; SMEDA JS, 1988, CIRC RES, V63, P518, DOI 10.1161/01.RES.63.3.518; Swokowski EW, 2012, ALGEBRA TRIGONOMETRY; Tapia E, 2003, KIDNEY INT, V63, P994, DOI 10.1046/j.1523-1755.2003.00811.x; TERANISHI Y, 1988, JPN J PHYSIOL, V38, P47, DOI 10.2170/jjphysiol.38.47; Tsamis A, 2007, AM J PHYSIOL-HEART C, V293, pH3130, DOI 10.1152/ajpheart.00684.2007; van Heijst A, 2004, VIRCHOWS ARCH, V445, P36, DOI 10.1007/s00428-004-1044-y; VANBOOM M, 1980, CLIN EXP PHARMACOL P, V7, P627; WEIBEL ER, 1980, STEREOLOGICAL METHOD, V2; WHITWORTH JA, 1990, J HYPERTENS, V8, P27, DOI 10.1097/00004872-199001000-00006; Yamaki S, 1997, TOHOKU J EXP MED, V182, P83, DOI 10.1620/tjem.182.83; Zar JH., 2010, BIOSTAT ANAL, V5th; Zeng JS, 1998, CHINESE MED J-PEKING, V111, P741; 2004, J VASC RES, V41, P277, DOI DOI 10.1159/000078826; ARTERIOSCLER THROMB, V20, P2057; 2005, KIDNEY INT, V67, P237, DOI DOI 10.1111/J.1523-1755.2005.00074.X; 2011, VIRCHOWS ARCH, V459, P99, DOI DOI 10.1007/S00428-011-1100-3	89	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216734	10.1371/journal.pone.0216734	http://dx.doi.org/10.1371/journal.pone.0216734			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112562	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000019
J	Martinez, JE; Zuberogoitia, I; Escarabajal, JM; Gomez, GJ; Calvo, JF; Margalida, A				Martinez, Jose E.; Zuberogoitia, Inigo; Escarabajal, Jose M.; Gomez, Gines J.; Calvo, Jose F.; Margalida, Antoni			Copulatory behaviour in the Bonelli's Eagle: Assessing the paternity assurance hypothesis	PLOS ONE			English	Article							TERRITORIAL INTRUSIONS; SPERM COMPETITION; FREQUENT COPULATIONS; COURTSHIP; PATTERNS; RESPONSES; DENSITY; HABITAT; MODELS; MILVUS	We examined copulatory behaviour in the Bonelli's Eagle (Aquila fasciata) at nesting sites in the eastern zone of the Baetic Cordillera, southern Spain, between 2010 and 2012. We observed the copulatory behaviour of 15 pairs during the pre-laying period. Bonelli's Eagles commenced sexual activity ca. 69 days before egg-laying. Ninety-six percent of mounting attempts were successful. Bonelli's Eagle pairs averaged 99.8 copulation attempts per clutch, with an average copulation frequency of 0.86 copulation attempts per day. Pairs displayed a daily bimodal pattern of copulation activity, with copulations occurring most frequently in the evening. We used our data to test three predictions with regard to the paternity assurance hypothesis. Prediction 1, that within-pair copulations increase with local breeding density, was rejected because our models showed no evidence for it. Prediction 2, that within-pair copulations increase during the female fertile period, was marginally supported. Finally, Prediction 3, that mate attendance increases during the female fertile period, was also rejected because mate-guarding did not increase as the fertile period approached. However, mate-guarding was positively correlated with within-pair copulation frequency. Moderate copulation rates compared to other raptors and the absence of mate-guarding suggest that, in the study area, Bonelli's Eagles exhibit only partially adaptive behaviour to assure their paternity. A possible explanation could be related to the low number of extra-pair encounters observed (opportunities for which appear to be rare), although the gradual increase in within-pair copulations during the female fertile period is consistent with the sperm competition hypothesis. The results are discussed based on the signalling hypothesis, which proposes that raptors signal territory ownership to conspecifics, and possibly to other raptor species, by copulating frequently and conspicuously in the defended nesting area.	[Martinez, Jose E.; Escarabajal, Jose M.; Gomez, Gines J.] Bonellis Eagle Study & Conservat Grp, Murcia, Spain; [Martinez, Jose E.; Calvo, Jose F.] Univ Murcia, Dept Ecol & Hidrol, Campus Espinardo, Murcia, Spain; [Zuberogoitia, Inigo] Estudios Medioambientales Icarus SL, Bilbao, Bizkaia, Spain; [Margalida, Antoni] UCLM, CSIC, JCCM, Inst Game & Wildlife Res,IREC, Ciudad Real, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Bern	Martinez, JE (corresponding author), Bonellis Eagle Study & Conservat Grp, Murcia, Spain.; Martinez, JE (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Campus Espinardo, Murcia, Spain.	ecoljemt@um.es	Margalida, Antoni/AAG-5337-2020; Calvo, José Francisco/C-7076-2009; Margalida, Antoni/A-2723-2011	Calvo, José Francisco/0000-0002-3813-4333; Martinez, Jose Enrique/0000-0002-1200-5795; Margalida, Antoni/0000-0002-0576-3993				[Anonymous], 1998, SPERM COMPETITION SE; [Anonymous], 1992, SPERM COMP BIRDS; [Anonymous], 1987, COP BEH BIRDS BEH, V101, P101; Arroyo BE, 1999, CONDOR, V101, P340, DOI 10.2307/1369997; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertran J, 1999, CONDOR, V101, P164, DOI 10.2307/1370459; Bertran J, ANN CEEM, V3; Bertran J, 2016, PEERJ, V4, DOI 10.7717/peerj.1749; BirdLife International, 2016, AQ FASC, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22696076A89510184.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22696076A89510184.EN]; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bosch R, 2010, IBIS, V152, P105, DOI 10.1111/j.1474-919X.2009.00985.x; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Carrete M, 2002, BIODIVERS CONSERV, V11, P975, DOI 10.1023/A:1015856924451; CHEYLAN G, 1972, Alauda, V40, P214; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Crowe SA, 2009, ANIM BEHAV, V77, P183, DOI 10.1016/j.anbehav.2008.09.024; Martinez JE, 2014, ORNIS FENNICA, V91, P67; Ferrero JJ, 2003, J RAPTOR RES, V37, P1; Forsman D, 2016, HELM FIELD GUIDE, P1; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hoi Herbert, 2013, PLoS One, V8, pe62541, DOI 10.1371/journal.pone.0062541; HUNTER FM, 1992, ANIM BEHAV, V44, P149, DOI 10.1016/S0003-3472(05)80764-X; KOGA K, 1994, BIRD STUDY, V41, P29, DOI 10.1080/00063659409477194; Komdeur J, 1999, P ROY SOC B-BIOL SCI, V266, P2075, DOI 10.1098/rspb.1999.0890; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2103, DOI 10.1098/rspb.2001.1750; Lens L, 1997, BEHAV ECOL, V8, P87, DOI 10.1093/beheco/8.1.87; Margalida A, 2007, BIRD STUDY, V54, P112, DOI 10.1080/00063650709461462; Margalida A, 2010, J ETHOL, V28, P179, DOI 10.1007/s10164-009-0169-5; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V33, P261, DOI 10.1007/BF02027123; Mougeot F, 2006, ANIM BEHAV, V71, P101, DOI 10.1016/j.anbehav.2005.03.036; Mougeot F, 2004, ANIM BEHAV, V67, P1067, DOI 10.1016/j.anbehav.2003.10.011; Mougeot F, 2000, ANIM BEHAV, V59, P633, DOI 10.1006/anbe.1999.1373; Mougeot F, 2002, ANIM BEHAV, V64, P759, DOI 10.1006/anbe.2002.1968; Mougeot F, 2001, BEHAV ECOL, V12, P1, DOI 10.1093/beheco/12.1.1; Moulton LL, 2013, J FIELD ORNITHOL, V84, P160, DOI 10.1111/jofo.12014; NEGRO JJ, 1992, ANIM BEHAV, V43, P921, DOI 10.1016/0003-3472(92)90005-T; Negro JJ, 2001, ANIM BEHAV, V62, P803, DOI 10.1006/anbe.2001.1811; Parellada X., 1984, RAPINYAIRES MEDITERR, VII, P70; Parker G.A., 1984, P1; PETRIE M, 1993, BEHAVIOUR, V127, P265, DOI 10.1163/156853993X00056; R Development Core Team, 2009, R LANG ENV STAT COMP; Sanz A, 2005, ARDEOLA, V52, P347; SIMMONS R, 1990, ANIM BEHAV, V40, P1151, DOI 10.1016/S0003-3472(05)80181-2; Tella JL, 1996, THESIS; TORTOSA FS, 1992, BEHAVIOUR, V121, P288, DOI 10.1163/156853992X00408; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Villarroel M, 1998, ANIM BEHAV, V56, P289, DOI 10.1006/anbe.1998.0788; Wojczulanis-Jakubas K, 2014, BEHAV ECOL SOCIOBIOL, V68, P1521, DOI 10.1007/s00265-014-1761-4; Xirouchakis SM, 2007, ETHOL ECOL EVOL, V19, P1; CONDOR, V102, P349; 2016, J ORNITHOL, V157, P981, DOI DOI 10.1007/S10336-016-1357-Z; 1996, ANIMAL BEHAV, V51, P945; 1994, BIRD STUDY, V41, P37; 2013, J ORNITHOL, V154, P63, DOI DOI 10.1007/S10336-012-0871-X; 1987, ANIMAL BEHAV, V35, P755; 2016, J ORNITHOL, V157, P971, DOI DOI 10.1007/S10336-016-1347-1; 2002, ANIM BEHAV, V64, P77, DOI DOI 10.1006/ANBE.2002.3035	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217175	10.1371/journal.pone.0217175	http://dx.doi.org/10.1371/journal.pone.0217175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112564	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000040
J	Ton, HT; Yang, L; Xie, ZC				Ton, Hoai T.; Yang, Lei; Xie, Zhongcong			Sevoflurane increases locomotion activity in mice	PLOS ONE			English	Article							MASK INDUCTION; HYPERACTIVITY; SEIZURES; ANESTHESIA; ACTIVATION; EMERGENCE	Clinical observations show emergence of agitation and hyperactivity during the anesthesia induction and/or recovery period post-anesthesia. However, an animal model to illustrate this clinical phenomenon has not yet been established. We therefore set out to investigate whether sevoflurane, a commonly used anesthetic, could alter locomotion in mice during the anesthesia induction and recovery period post-anesthesia. The activity of the mice was recorded 5 minutes before, during (for 30 minutes), and 40 minutes after the administration of the anesthetic sevoflurane [1-, 1.5- and 2-fold minimum alveolar concentration] at 37 degrees C. The total walking distance and velocity of movement were measured and quantified as the indexes of locomotion. We found that the anesthetic sevoflurane increased the locomotion of the mice during the induction period of the anesthesia. During the recovery phase after anesthesia, the mice exhibited increased locomotion for a short period of time (about 5 minutes) and then displayed a sharp decrease in mobility for up to 60 minutes following the end of anesthesia administration. The anesthetic sevoflurane did not significantly alter the food intake and body weight of the mice. Furthermore, we found that Alzheimer's disease transgenic mice exhibited a greater degree of sevoflurane-induced hyperactivity than the wild-type mice did. Our results showed that inhalation of the anesthetic sevoflurane induced an acute hyperactivity in mice, particularly among Alzheimer's disease transgenic mice. These findings from the pilot studies have established an animal model to promote further studies into postoperative emergence agitation, hyperactivity and the underlying mechanisms into these conditions.	[Ton, Hoai T.; Yang, Lei; Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA 02129 USA; [Ton, Hoai T.; Yang, Lei; Xie, Zhongcong] Harvard Med Sch, Charlestown, MA 02129 USA; [Ton, Hoai T.] Vinh Univ, Dept Biol, Vinh City, Nghe An, Vietnam; [Yang, Lei] Shanghai Jiao Tong Univ, Ruijing Hosp, Dept Anesthesia, Shanghai, Peoples R China	Harvard University; Massachusetts General Hospital; Vinh University; Shanghai Jiao Tong University	Xie, ZC (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA 02129 USA.; Xie, ZC (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	zxie@mgh.harvard.edu			National Institutes of Health, Bethesda, MD [R01GM088801, R01HD 086977]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by R01GM088801 and R01HD 086977 from the National Institutes of Health, Bethesda, MD (to Z.X.).	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051; Busche MA, 2015, BIOESSAYS, V37, P624, DOI 10.1002/bies.201500004; Dahmani S, 2010, BRIT J ANAESTH, V104, P216, DOI 10.1093/bja/aep376; de Haan W, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005707; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Esmaeili MH, 2018, BRAIN RES BULL, V137, P265, DOI 10.1016/j.brainresbull.2018.01.001; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Julliac B, 2013, Ann Fr Anesth Reanim, V32, pe143, DOI 10.1016/j.annfar.2013.07.812; Liang P, 2017, BRIT J ANAESTH, V119, P1047, DOI 10.1093/bja/aex043; Mohanram A, 2007, CAN J ANAESTH, V54, P657, DOI 10.1007/BF03022961; Pilge S, 2013, ANESTHESIOLOGY, V119, P447, DOI 10.1097/ALN.0b013e31827335b9; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Ton HT, 2017, P NATL ACAD SCI USA, V114, P3762, DOI 10.1073/pnas.1618144114; Vakkuri A, 2001, ACTA ANAESTH SCAND, V45, P805, DOI 10.1034/j.1399-6576.2001.045007805.x; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009; 2010, ANESTHESIOLOGY, V112, P1404, DOI DOI 10.1097/ALN.0B013E3181D94DE1; 2015, NEUROBIOL AGING, V36, P1, DOI DOI 10.1016/J.NEUROBIOLAGING.2014.08.014	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0206649	10.1371/journal.pone.0206649	http://dx.doi.org/10.1371/journal.pone.0206649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112538	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000001
J	Biagiotti, S; Bianchi, M; Rossi, L; Chessa, L; Magnani, M				Biagiotti, Sara; Bianchi, Marzia; Rossi, Luigia; Chessa, Luciana; Magnani, Mauro			Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38	PLOS ONE			English	Article							OXIDATIVE STRESS; NEUROLOGICAL SYMPTOMS; FUNCTIONAL-CHARACTERIZATION; GENE-PRODUCT; REDOX STATE; KINASE; ATM; DEGRADATION; PROTEIN; BETAMETHASONE	Oxidative stress has been shown to play a crucial role in the pathophysiology of the disease Ataxia Telangiectasia. We have recently demonstrated that Dexamethasone treatment is able to counteract the oxidative state by promoting nuclear factor erythroid 2-related factor 2 (NRF2) nuclear accumulation. However, substantial gaps remain in our knowledge of the underlying molecular mechanism(s) according to which Dexamethasone acts as an NRF2 inducer. Herein we investigate the possible effects of the drug on the main NRF2 activation pathways by initially focusing on key kinases known to differently affect NRF2 activation. Neither AKT nor ERK1/2, known to be NRF2-activating kinases, were found to be activated upon Dexamethasone treatment, thus excluding their involvement in the transcription factor nuclear shift. Likewise, GSK3 inactivating kinase was not inhibited, thus ruling out its role in NRF2 activation. On the other hand, p38 MAPK, another NRF2-inhibitory kinase, was indeed switched-off in Ataxia Telangiectasia cells by Dexamethasone-mediated induction of DUSP1 phosphatase, and therefore it appeared that it might account for NRF2 triggering. However, this mechanism was excluded by the use of a selective p38 inhibitor, which failed to cause a significant NRF2 nuclear shift and target gene induction. Finally, dexamethasone effects on the classical oxidative pathway orchestrated by KEAP1 were addressed. Dexamethasone was found to decrease the expression of the inhibitor KEAP1 at both mRNA and protein levels and to induce the shift from the reduced to the oxidized form of KEAP1, thus favouring NRF2 translocation into the nucleus. Furthermore, preliminary data revealed very low levels of the negative regulator Fyn in Ataxia Telangiectasia cells, which might account for the prolonged NRF2-activated gene expression.	[Biagiotti, Sara; Bianchi, Marzia; Rossi, Luigia; Magnani, Mauro] Univ Urbino, Dept Biomol Sci, Urbino, Italy; [Chessa, Luciana] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy	University of Urbino; Sapienza University Rome	Biagiotti, S (corresponding author), Univ Urbino, Dept Biomol Sci, Urbino, Italy.	sara.biagiotti@uniurb.it	Magnani, Mauro/A-1919-2008; Biagiotti, Sara/E-5043-2016	Biagiotti, Sara/0000-0001-9554-7858; Magnani, Mauro/0000-0001-6456-6626; Bianchi, Marzia/0000-0001-9352-7319				Ambrose M, 2013, BLOOD, V121, P4036, DOI 10.1182/blood-2012-09-456897; Anuranjani, 2014, REDOX BIOL, V2, P832, DOI 10.1016/j.redox.2014.02.008; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Biagiotti S, 2016, FEBS J, V283, P3962, DOI 10.1111/febs.13901; Biagiotti S, 2014, MOL CELL BIOCHEM, V392, P13, DOI 10.1007/s11010-014-2013-7; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; BODER E, 1958, PEDIATRICS, V21, P526; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Broccoletti T, 2011, EUR J NEUROL, V18, P564, DOI 10.1111/j.1468-1331.2010.03203.x; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chessa L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-5; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; COOKE M P, 1989, New Biologist, V1, P66; Cuadrado A, 2015, FREE RADICAL BIO MED, V88, P147, DOI 10.1016/j.freeradbiomed.2015.04.029; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Esteras N, 2016, BIOL CHEM, V397, P383, DOI 10.1515/hsz-2015-0295; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Gatti RA, 2009, EUR J NEUROL, V16, P653, DOI 10.1111/j.1468-1331.2009.02597.x; Giardino G, 2013, EUR J NEUROL, V20, P740, DOI 10.1111/ene.12024; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamsler A, 2001, CANCER RES, V61, P1849; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Leuzzi V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000098; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Menotta M, 2017, MOL CELL BIOCHEM, V12, P126, DOI DOI 10.1186/S13023-017-0669-2; Menotta M, 2018, MOL CELL BIOCHEM, V438, P153, DOI 10.1007/s11010-017-3122-x; Menotta M, 2017, CELL BIOCHEM BIOPHYS, V75, P95, DOI 10.1007/s12013-016-0775-0; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Palma Linda, 2011, BMC Pharmacology, V11, P8, DOI 10.1186/1471-2210-11-8; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Quarantelli M, 2013, EUR J PAEDIATR NEURO, V17, P135, DOI 10.1016/j.ejpn.2012.06.002; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; Russo I, 2009, EUR J NEUROL, V16, P755, DOI 10.1111/j.1468-1331.2009.02600.x; Saito R, 2016, MOL CELL BIOL, V36, P271, DOI 10.1128/MCB.00868-15; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Weil R, 1999, J VIROL, V73, P3709, DOI 10.1128/JVI.73.5.3709-3717.1999; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; 2008, HEPATOLOGY, V48, P1292, DOI DOI 10.1002/HEP.22472; 2002, DNA REPAIR, V1, P3, DOI DOI 10.1016/S1568-7864(01)00007-6	58	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216668	10.1371/journal.pone.0216668	http://dx.doi.org/10.1371/journal.pone.0216668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107893	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200014
J	Pires, MM; Schochat, E				Pires, Mayra Monteiro; Schochat, Eliane			The effectiveness of an auditory temporal training program in children who present voiceless/voiced-based orthographic errors	PLOS ONE			English	Article							READING DISABILITIES; PROCESSING DISORDER; DISCRIMINATION; ABILITIES; SPEECH; SKILLS	Introduction Studies on children's written production of the Brazilian Portuguese have shown that one of the most frequent phonological-based orthographic errors is the one related to voiceless/voiced phonemes. Children who make this type of error may have auditory temporal processing disorders, which can harm the perception of phonemes with similar characteristics. Aim Verify the effectiveness of an auditory temporal training program based on activities adapted from the software Fast ForWord in the auditory temporal processing, i.e. the temporal ordering skill, and in reducing voiceless/voiced-based orthographic errors and the frequency of occurrence of these errors in the written production of the children. Method Twenty-five children participated on this study. They were divided in two groups: experimental group consisting of 16 participants, who engaged in the auditory temporal training activities; and a placebo group consisting of nine participants, who engaged in passive visual activities. The behavioral measures applied in the pre-training evaluation, post-training and placebo evaluations were: i) auditory skill of temporal ordering by the Pitch Pattern Sequence Test; and ii) analysis of the amount of voiceless/voiced-based orthographic errors and the frequency of occurrence of these errors by the use of dictation. Results No statistically significant differences were found concerning the placebo group in the pre-training and post-training evaluations, in all evaluation measures. However, statistically significant differences were found in the pre-training and post-training evaluations for the pitch pattern sequence test concerning the experimental group. These differences were specifically related to a reduction of the errors regarding fricative graphemes, and the frequency of occurrence of plosive and fricative graphemes. Conclusions The auditory temporal training program was effective in improving the temporal ordering skill and reducing errors in the writing of children who made voiceless/voiced-based orthographic errors.	[Pires, Mayra Monteiro; Schochat, Eliane] Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Occupa, Sao Paulo, Brazil	Universidade de Sao Paulo	Pires, MM (corresponding author), Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Occupa, Sao Paulo, Brazil.	may_pires@hotmail.com			FAPESP; state of Sao Paulo, Brazil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); state of Sao Paulo, Brazil	FAPESP is the research financial of the state of Sao Paulo, Brazil. This study had FAPESP's financial support.	Ahmed SM, 2017, J CURRENT MED RES PR, P86; American Speech-Language-Hearing Association, 2005, CENTR AUD PROC DIS R; Anderson S., 2013, FRONTIERS SYSTEMS NE, P7, DOI [10.3389/fnsys.2013.00007, DOI 10.3389/FNSYS.2013.00007]; Andrade C., 2004, ABFW TESTE LINGUAGEM; Angelelli P, 2010, CORTEX, V46, P1299, DOI 10.1016/j.cortex.2010.06.015; Arnaut Mirian Aratangy, 2014, Audiol., Commun. Res., V19, P264, DOI 10.1590/S2317-643120140003000010; Capellini Simone Aparecida, 2011, J. Soc. Bras. Fonoaudiol., V23, P227, DOI 10.1590/S2179-64912011000300008; Cristofolini C., 2008, THESIS; Ellis A. W., 1998, HUMAN COGNITIVE NEUR; Ferguson MA, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpg.2015.00556, 10.3389/fpsyg.2015.00556]; Filippini R, 2012, FOLIA PHONIATR LOGO, V64, P217, DOI 10.1159/000342139; Fritz J., 2006, HEARING RES, V206, P159; Gillarn RB, 2008, J SPEECH LANG HEAR R, V51, P97, DOI 10.1044/1092-4388(2008/007); Grunwell P., 1990, DESVIOS FONOLOGICOS; Halliday LF, 2011, ATTEN PERCEPT PSYCHO, V73, P1329, DOI 10.3758/s13414-011-0148-0; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; Kwong T, 2014, PLOS ONE, V9, P107; McArthur G, 2007, DYSLEXIA, V13, P240, DOI 10.1002/dys.355; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; Moojen SM, 2009, ESCRITA ORTOGRA FICA; Moore DR, 2009, PHILOS T R SOC B, V364, P409, DOI 10.1098/rstb.2008.0187; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; Morais AA, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00078; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Murphy CFB, 2011, FOLIA PHONIATR LOGO, V63, P147, DOI 10.1159/000316327; Murphy CFB, 2010, BRAZ J MED BIOL RES, V43, P359, DOI 10.1590/S0100-879X2010000400007; Murphy C.T., 2009, THESIS; Murphy CBF, 2009, REV SOC BRASILEIRA F; Murphy CB, 2015, J AM ACAD AUDIOL, V26, P19, DOI 10.3766/jaaa.26.1.3; Musiek F E, 1994, J Am Acad Audiol, V5, P265; Musiek FE, 2002, SEMIN HEAR, V23, P263, DOI DOI 10.1055/S-2002-35862; Nobile GG, 2009, PSICOL REV, V15, P36; Pires MM, 2017, EFICACIA PROGRAMA TR; Samelli AG, 2008, INT J AUDIOL, V47, P238, DOI 10.1080/14992020801908244; Schaffler T, 2004, DYSLEXIA, V10, P119, DOI 10.1002/dys.267; Schochat E, 2000, PRO FONO REV ATUALI, V2; Scliar-Cabral L., 2003, GUIA PRACTICO ALFABE; Sharma M, 2012, INT J AUDIOL, V51, P506, DOI 10.3109/14992027.2012.670272; Shinn J.B., 2003, HEAR J, V56, P52, DOI [10.1097/01.HJ.0000292557.52409.67, DOI 10.1097/01.HJ.0000292557.52409.67]; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Stevens KN., 1997, HDB PHONETIC SCI, P462; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Tomlin D, 2015, EAR HEARING, V36, P527, DOI 10.1097/AUD.0000000000000172; Tormanen MRK, 2009, SCAND J PSYCHOL, V50, P277, DOI 10.1111/j.1467-9450.2009.00708.x; Veuillet E, 2007, BRAIN, V130, P2915, DOI 10.1093/brain/awm235; Woodhead ZVJ, 2017, J NEUROL NEUROSUR PS, V88, P586, DOI 10.1136/jnnp-2016-314621; Ziegler W, 2015, CORTEX, V69, P24, DOI 10.1016/j.cortex.2015.04.001; Zuanetti Patrícia Aparecida, 2008, Rev. soc. bras. fonoaudiol., V13, P240, DOI 10.1590/S1516-80342008000300007; 2013, BRAZ J OTORHINOLAR, V79, P753, DOI DOI 10.5935/1808-8694.20130137	50	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216782	10.1371/journal.pone.0216782	http://dx.doi.org/10.1371/journal.pone.0216782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY7BF	31107920	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200017
J	Thurman, AR; Schwartz, JL; Ravel, J; Gajer, P; Marzinke, MA; Yousefieh, N; Anderson, SM; Doncel, GF				Thurman, Andrea Ries; Schwartz, Jill L.; Ravel, Jacques; Gajer, Pawel; Marzinke, Mark A.; Yousefieh, Nazita; Anderson, Sharon M.; Doncel, Gustavo F.			Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; BACTERIAL-VAGINOSIS; PREEXPOSURE PROPHYLAXIS; UNINTENDED PREGNANCY; TOPICAL TENOFOVIR; UNITED-STATES; HIV; EPIDEMIOLOGY; PREVALENCE; PREVENTION	Recent data support that the vaginal microbiota may alter mucosal pharmacokinetics (PK) of topically delivered microbicides. Our team developed an intravaginal ring (IVR) that delivers tenofovir (TFV) (8-10 mg/day) alone or with levonorgestrel (LNG) (20 ug/day). We evaluated the effect of IVRs on the vaginal microbiota, and describe how the vaginal microbiota impacts mucosal PK of TFV. CONRAD A13-128 was a randomized, placebo controlled phase I study. We randomized 51 women to TFV, TFV/LNG or placebo IVR. We assessed the vaginal microbiota by sequencing the V3-V4 regions of 16S rRNA genes prior to IVR insertion and after approximately 15 days of use. We measured the concentration of TFV in the cervicovaginal (CV) aspirate, and TFV and TFV-diphosphate (TFV-DP) in vaginal tissue at the end of IVR use. The change in relative or absolute abundance of vaginal bacterial phylotypes was similar among active and placebo IVR users (all q values >0.13). TFV concentrations in CV aspirate and vaginal tissue, and TFV-DP concentrations in vaginal tissue were not significantly different among users with community state type (CST) 4 versus those with Lactobacillus dominated microbiota (all p values >0.07). The proportions of participants with CV aspirate concentrations of TFV >200,000 ng/mL and those with tissue TFV-DP concentrations >1,000 fmol/mg were similar among women with anaerobe versus Lactobacillus dominated microbiota (p = 0.43, 0.95 respectively). There were no significant correlations between the CV aspirate concentration of TFV and the relative abundances of Gardnerella vaginalis or Prevotella species. Tissue concentrations of TFV-DP did not correlate with any the relative abundances of any species, including Gardnerella vaginalis. In conclusion, active IVRs did not differ from the placebo IVR on the effect on the vaginal microbiota. Local TFV and TFV-DP concentrations were high and similar among IVR users with Lactobacillus dominated microbiota versus CST IV vaginal microbiota.	[Thurman, Andrea Ries; Yousefieh, Nazita; Anderson, Sharon M.] Eastern Virginia Med Sch, CONRAD, Norfolk, VA 23501 USA; [Schwartz, Jill L.; Doncel, Gustavo F.] Eastern Virginia Med Sch, CONRAD, Arlington, VA USA; [Ravel, Jacques; Gajer, Pawel] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Marzinke, Mark A.] Johns Hopkins Univ, Sch Med Clin Pharmacol Analyt Lab, Baltimore, MD USA	Eastern Virginia Medical School; Eastern Virginia Medical School; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Thurman, AR (corresponding author), Eastern Virginia Med Sch, CONRAD, Norfolk, VA 23501 USA.	thurmaar@evms.edu	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233; Thurman, Andrea/0000-0001-9826-6664	United States Agency for International Development (USAID); PEPFAR [AID-OAA-A-10-00068, AID-OAA-A-4-00010, GPO-A-00-08-00005-00]; NIAID, NIH [U19AI084044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); PEPFAR; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the United States Agency for International Development (USAID) and (PEPFAR) under Cooperative Agreements (AID-OAA-A-10-00068, AID-OAA-A-4-00010 and GPO-A-00-08-00005-00). JR was supported by NIAID, NIH under award number U19AI084044. The contents are the sole responsibility of the authors and do not necessarily reflect the views of their institutions, USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author reports any conflict of interest or any competing interests which interfered with the conduct of this study or interpretation of results.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Clark JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088509; DAVIES GC, 1992, CONTRACEPTION, V45, P511, DOI 10.1016/0010-7824(92)90163-N; De Seta F, 2012, CONTRACEPTION, V86, P526, DOI 10.1016/j.contraception.2012.02.012; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; El-Sahn M., 2018, UNDERSTANDING POTENT; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faulkner JR, 2018, BAYESIAN ANAL, V13, P225, DOI 10.1214/17-BA1050; Fichorova RN, 2011, MBIO, V2, P6; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178324; Hendrix CW, 2016, AIDS RES HUM RETROV, V32, P32, DOI [10.1089/aid.2015.0182, 10.1089/AID.2015.0182]; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Herold BC, 2016, CLIN INFECT DIS, V62, P375, DOI 10.1093/cid/civ913; Herold BC, 2014, JAIDS-J ACQ IMM DEF, V66, P65, DOI 10.1097/QAI.0000000000000110; Hillier S, 2017, CROI 2017; Huang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134460; Johnson LF, 2005, SEX TRANSM INFECT, V81, P287, DOI 10.1136/sti.2004.013904; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2015, NEW ENGL J MED, V373, P530, DOI 10.1056/NEJMoa1410649; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kashuba ADM, 2015, JAIDS-J ACQ IMM DEF, V69, P264, DOI 10.1097/QAI.0000000000000607; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Kott A., 2011, INT PERSPECTIVES SEX, V37; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Kuczynski J, 2012, CURR PROTOC CHEM BIO, V1, P1, DOI DOI 10.1002/9780471729259.MC01E05S27.USING; Liu CJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-168; Marrazzo J, 2014, AIDS RES HUM RETROV, V30, pA31, DOI 10.1089/aid.2014.5047a.abstract; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Paz-Bailey G, 2008, POSTGRAD MED J, V84, P299, DOI 10.1136/sti.2006.020966; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rosen GH, 2017, J INFECT DIS, V216, P744, DOI 10.1093/infdis/jix395; Roumen FJME, 1996, HUM REPROD, V11, P2443; ROY S, 1981, CONTRACEPTION, V24, P481, DOI 10.1016/0010-7824(81)90011-1; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Thurman AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199778; Thurman AR, 2018, JAIDS-J ACQ IMM DEF, V78, P82, DOI [10.1097/QAI.0000000000001648, 10.1097/qai.0000000000001648]; United Nations, 2016, PREV GAP REP; Ursell LK, 2014, ANTIVIR RES, V102, P87, DOI 10.1016/j.antiviral.2013.12.004; Veres S, 2004, OBSTET GYNECOL, V104, P555, DOI 10.1097/01.AOG.0000136082.59644.13; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	50	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217229	10.1371/journal.pone.0217229	http://dx.doi.org/10.1371/journal.pone.0217229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107913	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200038
J	Bosma, TJ; Karagiannis, K; Santana-Quintero, L; Ilyushina, N; Zagorodnyaya, T; Petrovskaya, S; Laassri, M; Donnelly, RP; Rubin, S; Simonyan, V; Sauder, CJ				Bosma, Trent J.; Karagiannis, Konstantinos; Santana-Quintero, Luis; Ilyushina, Natalia; Zagorodnyaya, Tatiana; Petrovskaya, Svetlana; Laassri, Majid; Donnelly, Raymond P.; Rubin, Steven; Simonyan, Vahan; Sauder, Christian J.			Identification and quantification of defective virus genomes in high throughput sequencing data using DVG-profiler, a novel post-sequence alignment processing algorithm	PLOS ONE			English	Article							INTERFERING PARTICLES; C PROTEIN; RIG-I; MOLECULAR-CLONING; VACCINE STRAINS; VIRAL-RNA; WILD-TYPE; GENERATION; ACTIVATION; REPLICATION	Most viruses are known to spontaneously generate defective viral genomes (DVG) due to errors during replication. These DVGs are subgenomic and contain deletions that render them unable to complete a full replication cycle in the absence of a co-infecting, non-defective helper virus. DVGs, especially of the copyback type, frequently observed with para-myxoviruses, have been recognized to be important triggers of the antiviral innate immune response. DVGs have therefore gained interest for their potential to alter the attenuation and immunogenicity of vaccines. To investigate this potential, accurate identification and quantification of DVGs is essential. Conventional methods, such as RT-PCR, are labor intensive and will only detect primer sequence-specific species. High throughput sequencing (HTS) is much better suited for this undertaking. Here, we present an HTS-based algorithm called DVG-profiler to identify and quantify all DVG sequences in an HTS data set generated from a virus preparation. DVG-profiler identifies DVG breakpoints relative to a reference genome and reports the directionality of each segment from within the same read. The specificity and sensitivity of the algorithm was assessed using both in silico data sets as well as HTS data obtained from parainfluenza virus 5, Sendai virus and mumps virus preparations. HTS data from the latter were also compared with conventional RT-PCR data and with data obtained using an alternative algorithm. The data presented here demonstrate the high specificity, sensitivity, and robustness of DVG-profiler. This algorithm was implemented within an open source cloud-based computing environment for analyzing HTS data. DVG-profiler might prove valuable not only in basic virus research but also in monitoring live attenuated vaccines for DVG content and to assure vaccine lot to lot consistency.	[Bosma, Trent J.; Zagorodnyaya, Tatiana; Petrovskaya, Svetlana; Laassri, Majid; Rubin, Steven; Sauder, Christian J.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Karagiannis, Konstantinos] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Karagiannis, Konstantinos; Simonyan, Vahan] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Santana-Quintero, Luis] US FDA, Off Hematol & Oncol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Ilyushina, Natalia; Petrovskaya, Svetlana; Donnelly, Raymond P.] US FDA, Ctr Drug Evaluat & Res, Div Biotechnol Review & Res 2, Silver Spring, MD USA; [Simonyan, Vahan] CRISPR Therapeut, Dept Bioinformat, Cambridge, MA USA	US Food & Drug Administration (FDA); George Washington University; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Sauder, CJ (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	christian.sauder@fda.hhs.gov	Donnelly, Raymond P./AFT-8600-2022	Donnelly, Raymond P./0000-0002-0695-5276; Santana, Luis/0000-0002-4290-1021; Karagiannis, Konstantinos/0000-0002-4776-5137				Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Beauclair G, 2018, RNA, V24, P1285, DOI 10.1261/rna.066910.118; BELLOCQ C, 1990, BIOLOGICALS, V18, P337, DOI 10.1016/1045-1056(90)90039-3; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CALAIN P, 1992, VIROLOGY, V191, P62, DOI 10.1016/0042-6822(92)90166-M; CALAIN P, 1988, J VIROL, V62, P2859, DOI 10.1128/JVI.62.8.2859-2866.1988; CAVE DR, 1985, J VIROL, V55, P366, DOI 10.1128/JVI.55.2.366-373.1985; Dimmock NJ, 2014, J VIROL, V88, P5217, DOI 10.1128/JVI.03193-13; Frensing T, 2015, BIOTECHNOL J, V10, P681, DOI 10.1002/biot.201400429; Henle W, 1943, SCIENCE, V98, P87, DOI 10.1126/science.98.2534.87; Ho TH, 2016, J VIROL, V90, P1557, DOI 10.1128/JVI.02161-15; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Ilyushina NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181999; Ilyushina NA, 2014, ANTIVIR RES, V111, P112, DOI 10.1016/j.antiviral.2014.09.008; Killip MJ, 2013, J VIROL, V87, P4798, DOI 10.1128/JVI.03383-12; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOLAKOFSKY D, 1976, CELL, V8, P547, DOI 10.1016/0092-8674(76)90223-3; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LAZZARINI RA, 1981, CELL, V26, P145, DOI 10.1016/0092-8674(81)90298-1; Lopez CB, 2014, J VIROL, V88, P8720, DOI 10.1128/JVI.00707-14; Malik T, 2007, J GEN VIROL, V88, P2533, DOI 10.1099/vir.0.82935-0; Manzoni TB, 2018, FUTURE VIROL, V13, P493, DOI 10.2217/fvl-2018-0021; MARCUS PI, 1977, NATURE, V266, P815, DOI 10.1038/266815a0; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Mura M, 2017, J VIROL, V91, DOI 10.1128/JVI.00643-17; NAYAK DP, 1985, CURR TOP MICROBIOL, V114, P103; OKAZAKI K, 1992, VIROLOGY, V188, P926, DOI 10.1016/0042-6822(92)90555-4; Perrault J, 1981, Curr Top Microbiol Immunol, V93, P151; PERRAULT J, 1978, J GEN VIROL, V38, P35, DOI 10.1099/0022-1317-38-1-35; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2014, J VIROL, V88, P456, DOI 10.1128/JVI.02572-13; Sanchez-Aparicio MT, 2017, J GEN VIROL, V98, P1282, DOI 10.1099/jgv.0.000815; Santana-Quintero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099033; Sauder CJ, 2006, VIROLOGY, V350, P48, DOI 10.1016/j.virol.2006.01.035; Sauder Christian J, 2011, J Virol, V85, P7059, DOI 10.1128/JVI.00245-11; Schuetze H, 1999, FDN STAT NATURAL LAN; Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123; Simonyan V, 2016, DATABASE, V17, P1; Simonyan V, 2014, GENES-BASEL, V5, P957, DOI 10.3390/genes5040957; Smith CM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080237; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; van den Hoogen BG, 2014, J GEN VIROL, V95, P1625, DOI 10.1099/vir.0.066100-0; VONMAGNUS P, 1951, ACTA PATHOL MIC SC, V28, P278; Whistler T, 1996, VIROLOGY, V220, P480, DOI 10.1006/viro.1996.0335; Xu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00909-6; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216944	10.1371/journal.pone.0216944	http://dx.doi.org/10.1371/journal.pone.0216944			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100083	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600022
J	Juarez, OE; Lopez-Galindo, L; Perez-Carrasco, L; Lago-Leston, A; Rosas, C; Di Cosmo, A; Galindo-Sanchez, CE				Juarez, Oscar E.; Lopez-Galindo, Laura; Perez-Carrasco, Leonel; Lago-Leston, Asuncion; Rosas, Carlos; Di Cosmo, Anna; Galindo-Sanchez, Clara E.			Octopus maya white body show sex-specific transcriptomic profiles during the reproductive phase, with high differentiation in signaling pathways	PLOS ONE			English	Article							NERVOUS-SYSTEM; CEPHALOPOD MOLLUSK; GENE-EXPRESSION; IMMUNE-SYSTEM; OPTIC GLAND; VULGARIS; FMRFAMIDE; GLUCOCORTICOIDS; NEUROPEPTIDES; MORPHOLOGY	White bodies (WB), multilobulated soft tissue that wraps the optic tracts and optic lobes, have been considered the hematopoietic organ of the cephalopods. Its glandular appearance and its lobular morphology suggest that different parts of the WB may perform different functions, but a detailed functional analysis of the octopus WB is lacking. The aim of this study is to describe the transcriptomic profile of WB to better understand its functions, with emphasis on the difference between sexes during reproductive events. Then, validation via qPCR was performed using different tissues to find out tissue-specific transcripts. High differentiation in signaling pathways was observed in the comparison of female and male transcriptomic profiles. For instance, the expression of genes involved in the androgen receptorsignaling pathway were detected only in males, whereas estrogen receptor showed higher expression in females. Highly expressed genes in males enriched oxidation-reduction and apoptotic processes, which are related to the immune response. On the other hand, expression of genes involved in replicative senescence and the response to cortisol were only detected in females. Moreover, the transcripts with higher expression in females enriched a wide variety of signaling pathways mediated by molecules like neuropeptides, integrins, MAPKs and receptors like TNF and Toll-like. In addition, these putative neuropeptide transcripts, showed higher expression in females' WB and were not detected in other analyzed tissues. These results suggest that the differentiation in signaling pathways in white bodies of O. maya influences the physiological dimorphism between females and males during the reproductive phase.	[Juarez, Oscar E.; Lopez-Galindo, Laura; Perez-Carrasco, Leonel; Galindo-Sanchez, Clara E.] Ctr Invest Cient & Educ Super Ensenada, Dept Biotecnol Marina, Ensenada, Baja California, Mexico; [Lago-Leston, Asuncion] Ctr Invest Cient & Educ Super Ensenada, Dept Innovac Biomed, Ensenada, Baja California, Mexico; [Rosas, Carlos] Univ Nacl Autonoma Mexico, Unidad Acad Sisal, Puerto Abrigo S-N, Sisal, Yucatan, Mexico; [Di Cosmo, Anna] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Nacional Autonoma de Mexico; University of Naples Federico II	Galindo-Sanchez, CE (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Biotecnol Marina, Ensenada, Baja California, Mexico.	cgalindo@cicese.mx	Galindo, Laura Liliana López/E-1517-2015; Lago-Lestón, Asunción/AFR-8125-2022; Juárez, Oscar E/A-2120-2017; Lago, Asuncion/AFS-1438-2022; Galindo-Sánchez, Clara E./B-8196-2015; Galindo, Laura Liliana López/Y-4228-2019; Rosas, Carlos/A-7052-2009	Galindo, Laura Liliana López/0000-0001-5300-0846; Lago-Lestón, Asunción/0000-0003-4361-7732; Juárez, Oscar E/0000-0002-8007-1671; Galindo-Sánchez, Clara E./0000-0001-7514-2327; Galindo, Laura Liliana López/0000-0001-5300-0846; 	Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia (Mexico) [SEP-CONACYT-CB-2014-01/241690]; Centro de Investigacion Cientifica y Educacion Superior de Ensenada, Baja California (Mexico) [CICESE-682123]; Universidad Nacional Autonoma de Mexico [PAPIIT IN219116]; CONACYT	Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Centro de Investigacion Cientifica y Educacion Superior de Ensenada, Baja California (Mexico); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia (Mexico, grant: SEP-CONACYT-CB-2014-01/241690 to CEG), Centro de Investigacion Cientifica y Educacion Superior de Ensenada, Baja California (Mexico, grant: CICESE-682123 to CEG), and Universidad Nacional Autonoma de Mexico (grant: PAPIIT IN219116 to CR). We also thank CONACYT for the postdoc grant to OEJ and the PhD grant to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson Roland C., 2002, Journal of Applied Animal Welfare Science, V5, P275, DOI 10.1207/S15327604JAWS0504_02; Andrews PLR, 2013, J EXP MAR BIOL ECOL, V447, P46, DOI 10.1016/j.jembe.2013.02.010; Barcellos LJG, 2010, AQUACULTURE, V300, P231, DOI 10.1016/j.aquaculture.2010.01.013; baron Cuvier G., 1817, MEMOIRES SERVIR ANAT; Bertapelle C, 2017, J EXP ZOOL PART B, V328, P347, DOI 10.1002/jez.b.22735; Boletsky S.v., 1989, Advances in Marine Biology, V25, P85, DOI 10.1016/S0065-2881(08)60188-1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolognari A., 1951, ARCH ZOOL ITAL, V36, P252; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; BOUMPAS DT, 1991, CLIN EXP RHEUMATOL, V9, P413; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castaneda SF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214906; Castillo MG, 2015, FISH SHELLFISH IMMUN, V46, P145, DOI 10.1016/j.fsi.2015.05.029; Cazal P, 1943, B I OCEANOGRAPHIQUE, V40, P1; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chun CK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-154; Claes MF, 1996, ACTA ZOOL-STOCKHOLM, V77, P173, DOI 10.1111/j.1463-6395.1996.tb01262.x; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Lisa E, 2012, J NEUROENDOCRINOL, V24, P275, DOI 10.1111/j.1365-2826.2011.02240.x; De Lisa E, 2013, J EXP BIOL, V216, P2229, DOI 10.1242/jeb.081885; Di Cosmo A, 1998, J COMP NEUROL, V398, P1, DOI 10.1002/(SICI)1096-9861(19980817)398:1<1::AID-CNE1>3.0.CO;2-5; Di Cosmo A, 2001, J EXP ZOOL, V289, P33, DOI 10.1002/1097-010X(20010101/31)289:1<33::AID-JEZ4>3.0.CO;2-A; Di Cosmo A, 2014, NEUROECOLOGY NEUROET, P117; Di Cosmo A, 2013, HDB BIOL ACTIVE PEPT, P2033; Di Cosmo A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00434; Di Cristo C, 2003, PEPTIDES, V24, P1525, DOI 10.1016/j.peptides.2003.07.018; Di Cristo C, 2002, J EXP ZOOL, V292, P267, DOI 10.1002/jez.90000; Di Cristo C, 2013, INVERTEBR NEUROSCI, V13, P27, DOI 10.1007/s10158-013-0149-x; Di Cristo Carlo, 2010, Front Biosci (Elite Ed), V2, P673; Elenkov IJ, 1999, ANN NY ACAD SCI, V876, P1, DOI 10.1111/j.1749-6632.1999.tb07618.x; Estefanell J, 2011, AQUAC RES, V42, P399, DOI 10.1111/j.1365-2109.2010.02634.x; Faussek V., 1893, MEM ACAD IMP SCI ST, V41, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FROESCH D, 1975, PROC R SOC SER B-BIO, V188, P95, DOI 10.1098/rspb.1975.0005; Furukawa Y, 2003, J NEUROPHYSIOL, V89, P3114, DOI 10.1152/jn.00014.2003; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; Gestal C, 2015, FISH SHELLFISH IMMUN, V46, P120, DOI 10.1016/j.fsi.2015.05.005; Gleadall IG, 2013, J EXP MAR BIOL ECOL, V447, P23, DOI 10.1016/j.jembe.2013.02.008; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HARRISON FM, 1965, J EXP BIOL, V42, P71; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hilbe JM, 2007, AM STAT, V61, P365, DOI 10.1198/000313007X248723; Hoek RM, 1997, P NATL ACAD SCI USA, V94, P14072, DOI 10.1073/pnas.94.25.14072; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jagadish N, 2005, J REPROD IMMUNOL, V67, P69, DOI 10.1016/j.jri.2005.06.004; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson SE, 2010, J AQUAT ANIM HEALTH, V22, P152, DOI 10.1577/H09-027.1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; MARX J, 1995, SCIENCE, V270, P232, DOI 10.1126/science.270.5234.232; Mather JA, 2007, DIS AQUAT ORGAN, V75, P119, DOI 10.3354/dao075119; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; NOEL R., 1933, ARCH ZOOL EXP ET GEN, V75, P485; Noyola J, 2013, J THERM BIOL, V38, P14, DOI 10.1016/j.jtherbio.2012.09.001; Ogura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01432; Ohta H, 2000, REGULATION PROLIFERA, V2131, P2125; PALIOGIANNI F, 1993, J IMMUNOL, V151, P4081; Peterson BC, 2004, DOMEST ANIM ENDOCRIN, V26, P231, DOI 10.1016/j.domaniend.2003.10.005; Polese G, 2016, BIOL OPEN, V5, P611, DOI 10.1242/bio.017764; Polese G, 2015, GEN COMP ENDOCR, V210, P55, DOI 10.1016/j.ygcen.2014.10.006; R Development Core Team, 2009, R LANG ENV STAT COMP; Ratajczak MZ, 2017, LEUKEMIA, V31, P1671, DOI 10.1038/leu.2017.148; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosas C., 2014, CEPHALOPOD CULTURE, DOI [10.1007/978-94-017-8648-5_20, DOI 10.1007/978-94-017-8648-5_20]; Sahtout AH, 2001, DIS AQUAT ORGAN, V44, P155, DOI 10.3354/dao044155; Salazar KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119949; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Tardif S, 2010, J BIOL CHEM, V285, P24863, DOI 10.1074/jbc.M110.123125; Troncone L, 2015, J NAT HIST, V49, P1457, DOI 10.1080/00222933.2013.826830; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal EAG, 2014, ADV MAR BIOL, V67, P1, DOI 10.1016/B978-0-12-800287-2.00001-9; Wenda JM, 2017, DEV CELL, V41, P623, DOI 10.1016/j.devcel.2017.05.021; Winlow W, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01147; WODINSKY J, 1977, SCIENCE, V198, P948, DOI 10.1126/science.198.4320.948; Wollesen T, 2010, EVOL DEV, V12, P113, DOI 10.1111/j.1525-142X.2010.00398.x; Young J. Z., 1971, ANATOMY NERVOUS SYST; Zhang JY, 2019, MAR GENOM, V43, P54, DOI 10.1016/j.margen.2018.08.008; Zhang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029084, 10.1371/journal.pone.0031868]; ZHOU MY, 1995, ENDOCRINOLOGY, V136, P3729, DOI 10.1210/en.136.9.3729; AQUAT TOXICOL, V48, P265, DOI DOI 10.1016/S0166-445X(99)00031-4; 1972, J INVERTEBR PATHOL, V19, P113, DOI DOI 10.1016/0022-2011(72)90196-6; 2008, PEPTIDES, V29, P310, DOI DOI 10.1016/J.PEPTIDES.2007.09.025; 2015, AQUACULTURE, V448, P234, DOI DOI 10.1016/J.AQUACULTURE.2015.05.023; 2006, ENDOCRINOLOGY, V147, P4339, DOI DOI 10.1210/EN.2005-1625	96	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216982	10.1371/journal.pone.0216982	http://dx.doi.org/10.1371/journal.pone.0216982			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095623	gold, Green Submitted, Green Published			2022-12-27	WOS:000468030100062
J	Billings, E; Heipertz, RA; Varleva, T; Sanders-Buell, E; O'Sullivan, AM; Bose, M; Howell, S; Kijak, GH; Taskov, H; Elenkov, I; Nenova, M; Popivanova, N; Valenzuela, AB; Myles, O; Bautista, CT; Robb, ML; Michael, NL; Kim, JH; Scott, PT; Tovanabutra, S; Ake, JA				Billings, Erik; Heipertz, Richard A.; Varleva, Tonka; Sanders-Buell, Eric; O'Sullivan, Anne Marie; Bose, Meera; Howell, Shana; Kijak, Gustavo H.; Taskov, Hristo; Elenkov, Ivailo; Nenova, Marina; Popivanova, Nedialka; Valenzuela, Aimee Bolen; Myles, Otha; Bautista, Christian T.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Scott, Paul T.; Tovanabutra, Sodsai; Ake, Julie A.			HIV-1 genetic diversity and demographic characteristics in Bulgaria	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENOTYPING ASSAY; HIGH-THROUGHPUT; TYPE-1; INFECTIONS; RECOMBINANTS; SPREAD	HIV-1 strain diversity in Bulgaria is extensive and includes contributions from nearly all major subtypes and the Circulating Recombinant Forms (CRF): 01_AE, 02_AG, and 05_DF. Prior to this study, HIV-1 sequence information from Bulgaria has been based solely on the pro-RT gene, which represent less than 15% of the viral genome. To further characterize HIV-1 in Bulgaria, assess participant risk behaviors, and strengthen knowledge of circulating strains in the region, the study "Genetic Subtypes of HIV-1 in Bulgaria (RV240)" was conducted. This study employed the real time-PCR based Multi-region Hybridization Assay (MHA) B/non-B and HIV-1 sequencing to survey 215 of the approximately 1100 known HIV-1 infected Bulgarian adults (2008-2009) and determine if they were infected with subtype B HIV-1. The results indicated a subtype B prevalence of 40% and demonstrate the application of the MHA B/non-B in an area containing broad HIV-1 strain diversity. Within the assessed risk behaviors, the proportion of subtype B infection was greatest in men who have sex with men and lowest among those with drug use risk factors. During this study, 15 near full-length genomes and 22 envelope sequences were isolated from study participants. Phylogenetic analysis shows the presence of subtypes A1, B, C, F1, and G, CRF01_AE, CRF02_AG, CRF05_DF, and one unique recombinant form (URF). These sequences also show the presence of two strain groups containing participants with similar risk factors. Previous studies in African and Asian cohorts have shown that co-circulation of multiple subtypes can lead to viral recombination within super-infected individuals and the emergence of new URFs. The low prevalence of URFs in the presence of high subtype diversity in this study, may be the result of successful infection prevention and control programs. Continued epidemiological monitoring and support of infection prevention programs will help maintain control of the HIV-1 epidemic in Bulgaria.	[Billings, Erik; Heipertz, Richard A.; Sanders-Buell, Eric; O'Sullivan, Anne Marie; Bose, Meera; Howell, Shana; Kijak, Gustavo H.; Valenzuela, Aimee Bolen; Myles, Otha; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Scott, Paul T.; Tovanabutra, Sodsai; Ake, Julie A.] US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Billings, Erik; Sanders-Buell, Eric; O'Sullivan, Anne Marie; Bose, Meera; Howell, Shana; Kijak, Gustavo H.; Valenzuela, Aimee Bolen; Bautista, Christian T.; Robb, Merlin L.; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Heipertz, Richard A.; Myles, Otha; Bautista, Christian T.; Michael, Nelson L.; Scott, Paul T.; Ake, Julie A.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Varleva, Tonka] Minist Hlth, Dept Prevent & Control AIDS TB&STIs, Sofia, Bulgaria; [Taskov, Hristo] Natl Ctr Infect & Parasit Dis, Sofia, Bulgaria; [Elenkov, Ivailo] Hosp Infect Dis Prof Iv Kirov, Dept Patients Acquired Immune Deficiencies, Sofia, Bulgaria; [Nenova, Marina] Med Univ Hosp, Infect Dis Clin, St Marina, Varna, Bulgaria; [Popivanova, Nedialka] Med Univ Hosp St Georg, Infect Dis Clin, Plovdiv, Bulgaria; [Heipertz, Richard A.] US Army, Off Regulated Activ, Med Res & Materiel Command, Ft Detrick, MD USA; [Kijak, Gustavo H.] GSK Vaccines, Rockville, MD USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Ministry of Health Bulgaria; Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Medical University Varna; Medical University Plovdiv; GlaxoSmithKline; International Vaccine Institute	Tovanabutra, S (corresponding author), US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Tovanabutra, S (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	stovanabutra@hivresearch.org	Varleva, Tonka/AAY-6476-2020	Billings, Erik/0000-0002-8963-0484; Bautista, Christian/0000-0002-1228-0754	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; GlaxoSmithKline (GSK) Vaccines; United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine)	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); GlaxoSmithKline (GSK) Vaccines; United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine)	Authors ESB, AOS, MB, SH, GHK, ABV, CTB, MLB, and ST received funding support in the form of money paid to the institution by cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). Additionally, author GHK is currently a paid employee of GlaxoSmithKline (GSK) Vaccines and receives financial support in the form of a salary. However, his contribution to the research reported on in this paper took place prior to this commercial affiliation. The specific roles of this author are articulated in the ' author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The material has been reviewed by the Walter Reed Army Institute of Research and there is no objection to its presentation and/or publication. The Walter Reed Army Institute of Research Institutional Research Board human use protocol #W1424 (RV240), "Genetic Subtypes of HIV-1 in Bulgaria from 2008-2009'' was funded through the United States Military HIV Research Program (the Walter Reed Army Institute of Research and the Henry M. Jackson Foundation for the Advancement of Military Medicine).	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Alexiev I, 2016, INFECT GENET EVOL, V46, P269, DOI 10.1016/j.meegid.2016.05.029; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033; Billings E, 2017, AIDS RES HUM RETROV, V33, P373, DOI [10.1089/aid.2016.0111, 10.1089/AID.2016.0111]; Billings E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135124; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; Frentz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094495; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Heipertz RA, 2013, AIDS RES HUM RETROV, V29, P1310, DOI [10.1089/aid.2013.0087, 10.1089/AID.2013.0087]; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Inan D, 2014, J INT AIDS SOC, V17, P126, DOI 10.7448/IAS.17.4.19684; Ivanov IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059666; Kijak GH, 2004, AIDS RES HUM RETROV, V20, P521, DOI 10.1089/088922204323087778; Kijak GH, 2007, VIROLOGY, V358, P178, DOI 10.1016/j.virol.2006.07.055; Kijak GH, 2010, AIDS RES HUM RETROV, V26, P1317, DOI 10.1089/aid.2010.0127; Los Alamos National Laboratory, 2016, HIV SEQ DAT; Paraschiv S, 2012, INFECT GENET EVOL, V12, P1052, DOI 10.1016/j.meegid.2012.03.003; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Siljic M, 2013, INFECT GENET EVOL, V19, P378, DOI 10.1016/j.meegid.2013.06.015; Singer DE, 2010, AIDS RES HUM RETROV, V26, P889, DOI 10.1089/aid.2009.0289; Stanojevic M, 2012, AIDS REV, V14, P28; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; UNAIDS, 2014, GAP REP 2014; US Department of State, 2015, TRAFF PERS REP 2015	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217063	10.1371/journal.pone.0217063	http://dx.doi.org/10.1371/journal.pone.0217063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136611	gold, Green Submitted, Green Published			2022-12-27	WOS:000469224300015
J	Saito, H; Sakakibara, Y; Sakata, A; Kurashige, R; Murakami, D; Kageshima, H; Saito, A; Miyazaki, Y				Saito, Hiroaki; Sakakibara, Yumi; Sakata, Ayumi; Kurashige, Rie; Murakami, Daisuke; Kageshima, Hiroki; Saito, Akira; Miyazaki, Yasunari			Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus	PLOS ONE			English	Article							COLI OUTER-MEMBRANE; ESCHERICHIA-COLI; FUNCTIONAL-PROPERTIES; BACTERICIDAL ACTION; GALACTOMANNAN; MECHANISMS; SUSCEPTIBILITY; DERIVATIVES; INDUSTRIAL; PROTEINS	The recent emergence of antibiotic-resistant bacteria requires the development of new antibiotics or new agents capable of enhancing antibiotic activity. This study evaluated the antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus (MRSA), which should resolve the problem of antibiotic-resistant bacteria. Bactericidal tests showed that LYZOX killed 50% more P. aeruginosa (NBRC 13275), A. baumannii and MRSA than the control treatment after 60 min. In addition, LYZOX was shown to inhibit the growth of P. aeruginosa (NBRC 13275 and PAO1), A. baumannii and MRSA better than its components. To elucidate the antibacterial mechanism of LYZOX, we performed cell membrane integrity assays, N-phenyl-1-naphthylamine assays, 2-nitrophenyl beta-D-galactopyranoside assays and confocal laser scanning microscopy. These results showed that LYZOX affected bacterial cell walls and increased the permeability of the outer membrane and the plasma membrane. Furthermore, each type of bacteria treated with LYZOX was observed by electron microscopy. Electron micrographs revealed that these bacteria had the morphological features of both lysozyme-treated and chitosan oligosaccharide-treated bacteria and that LYZOX destroyed bacterial cell walls, which caused the release of intracellular contents from cells. An acquired drug resistance test revealed that these bacteria were not able to acquire resistance to LYZOX. The hemolytic toxicity test demonstrated the low hemolytic activity of LYZOX. In conclusion, LYZOX exhibited antibacterial activity and low drug resistance in the presence of P. aeruginosa, A. baumannii and MRSA and showed low hemolytic toxicity. LYZOX affected bacterial membranes, leading to membrane disruption and the release of intracellular contents and consequent bacterial cell death. LYZOX may serve as a novel candidate drug that could be used for the control of refractory infections.	[Saito, Hiroaki; Sakakibara, Yumi; Sakata, Ayumi; Kurashige, Rie; Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan; [Murakami, Daisuke] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka, Fukuoka, Japan; [Kageshima, Hiroki; Saito, Akira] Wako Filter Technol Co Ltd, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kyushu University	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan.	miyazaki.pilm@tmd.ac.jp	MIYAZAKI, YASUNARI/B-7847-2015	MIYAZAKI, YASUNARI/0000-0002-9073-9815	Wako Filter Technology Co., Ltd.	Wako Filter Technology Co., Ltd.	Y. M. and D. M. are funded by Wako Filter Technology Co., Ltd. A. Saito and H. K. are employees of Wako Filter Technology Co., Ltd. A. Saito and H. K. made lysozyme-chitosan oligosaccharide conjugates (LYZOX) and lysozyme-galactomannan conjugates. H. K. performed SDS-PAGE analysis, heat stability tests, determination of minimal inhibitory concentrations and acquired drug resistance tests. The funders (A. Saito and H. K.) had roles in performing SDS-PAGE analysis, heat stability tests, determination of minimal inhibitory concentrations and acquired drug resistance tests, and producing lysozymechitosan oligosaccharide conjugates (LYZOX) and lysozyme-galactomannan conjugates. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.r We express sincere thanks to the staff of the Research Core in Tokyo Medical and Dental University for photographing the samples using electron microscopy. WAKO FILTER TECHNOLOGY Co. Ltd. provided lysozyme-chitosan oligosaccharide conjugates (LYZOX) and lysozyme-galactomannan conjugates for this study free of charge and supported this study financially.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Aminlari L, 2014, J FOOD SCI, V79, pR1077, DOI 10.1111/1750-3841.12460; [Anonymous], 2016, TACKLING DRUG RESIST; [Anonymous], 2015, M07A10 CLIN LAB STAN; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Chen LC, 2012, FOOD CHEM, V135, P2397, DOI 10.1016/j.foodchem.2012.06.122; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; Chung YC, 2011, MOLECULES, V16, P8504, DOI 10.3390/molecules16108504; Costa EM, 2017, CARBOHYD POLYM, V178, P347, DOI 10.1016/j.carbpol.2017.09.055; Costa EM, 2017, J APPL MICROBIOL, V122, P1547, DOI 10.1111/jam.13457; Costa EM, 2017, CARBOHYD POLYM, V174, P369, DOI 10.1016/j.carbpol.2017.06.087; Deng JD, 2016, IND CROP PROD, V94, P281, DOI 10.1016/j.indcrop.2016.09.004; DEPAMPHILIS ML, 1971, J BACTERIOL, V105, P1184, DOI 10.1128/JB.105.3.1184-1199.1971; Fernandes MM, 2017, ACS APPL MATER INTER, V9, P15022, DOI 10.1021/acsami.7b00217; Fujimura T, 2005, JPN J CHEMOTHER, V53, P57; Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hoque J, 2016, MOL PHARMACEUT, V13, P3578, DOI 10.1021/acs.molpharmaceut.6b00764; Kato A, 2002, FOOD SCI TECHNOL RES, V8, P193, DOI 10.3136/fstr.8.193; Kong M, 2008, COLLOID SURFACE B, V65, P197, DOI 10.1016/j.colsurfb.2008.04.003; Kumar ABV, 2005, BIOCHEM J, V391, P167, DOI 10.1042/BJ200580093; Lee Joongjae, 2018, Prev Nutr Food Sci, V23, P60, DOI 10.3746/pnf.2018.23.1.60; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Ma ZX, 2016, ACS APPL MATER INTER, V8, P10700, DOI 10.1021/acsami.6b00894; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; NAKAMURA K, 1975, BIOCHIM BIOPHYS ACTA, V413, P371, DOI 10.1016/0005-2736(75)90122-4; Nakamura S, 1996, FEBS LETT, V383, P251, DOI 10.1016/0014-5793(96)00260-8; Nakamura S, 2000, NAHRUNG, V44, P201, DOI [10.1002/1521-3803(20000501)44:3<201::AID-FOOD201>3.0.CO;2-S, 10.1002/1521-3803(20000501)44:3&lt;201::AID-FOOD201&gt;3.0.CO;2-S]; Paterson GK, 2014, TRENDS MICROBIOL, V22, P42, DOI 10.1016/j.tim.2013.11.003; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Rahman MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07651-7; Ramezani R, 2008, J SCI FOOD AGR, V88, P2730, DOI 10.1002/jsfa.3400; Ryu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132619; Sahariah P, 2017, BIOMACROMOLECULES, V18, P3846, DOI 10.1021/acs.biomac.7b01058; Saito A, 2003, BIOSCI BIOTECH BIOCH, V67, P2334, DOI 10.1271/bbb.67.2334; Shen SX, 2015, FOOD CONTROL, V47, P196, DOI 10.1016/j.foodcont.2014.07.003; Song Y, 2002, FOOD RES INT, V35, P459, DOI 10.1016/S0963-9969(01)00144-2; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4; VENTOLA, 2015, J PHARM THERAPEUTICS, V40, P277, DOI DOI 10.5796/ELECTR0CHEMISTRY.82.749; Wang JJ, 2019, MED RES REV, V39, P831, DOI 10.1002/med.21542; WARREN GH, 1955, J BACTERIOL, V70, P614, DOI 10.1128/JB.70.5.614-619.1955; Xing K, 2009, CARBOHYD POLYM, V76, P17, DOI 10.1016/j.carbpol.2008.09.016; Xu C, 2017, FOOD CONTROL, V73, P1445, DOI 10.1016/j.foodcont.2016.10.048; Yang JE, 2017, FOOD CHEM, V227, P149, DOI 10.1016/j.foodchem.2017.01.076	46	34	34	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217504	10.1371/journal.pone.0217504	http://dx.doi.org/10.1371/journal.pone.0217504			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136634	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300047
J	Padra, JT; Murugan, AVM; Sundell, K; Sundh, H; Benktander, J; Linden, SK				Padra, Janos Tamas; Murugan, Abarna V. M.; Sundell, Kristina; Sundh, Henrik; Benktander, John; Linden, Sara K.			Fish pathogen binding to mucins from Atlantic salmon and Arctic char differs in avidity and specificity and is modulated by fluid velocity	PLOS ONE			English	Article							AEROMONAS-HYDROPHILA; VIBRIO-HARVEYI; RAINBOW-TROUT; HELICOBACTER-PYLORI; YERSINIA-RUCKERI; WINTER ULCER; SALAR L; INFECTION; SKIN; IDENTIFICATION	Disease outbreaks are limiting factors for an ethical and economically sustainable aquaculture industry. The first point of contact between a pathogen and a host occurs in the mucus, which covers the epithelial surfaces of the skin, gills and gastrointestinal tract. Increased knowledge on host-pathogen interactions at these primary barriers may contribute to development of disease prevention strategies. The mucus layer is built of highly glycosylated mucins, and mucin glycosylation differs between these epithelial sites. We have previously shown that A. salmonicida binds to Atlantic salmon mucins. Here we demonstrate binding of four additional bacteria, A. hydrophila, V. harveyi, M. viscosa and Y. ruckeri, to mucins from Atlantic salmon and Arctic char. No specific binding could be observed for V. salmonicida to any of the mucin groups. Mucin binding avidity was highest for A. hydrophila and A. salmonicida, followed by V. harveyi, M. viscosa and Y. ruckeri in decreasing order. Four of the pathogens showed highest binding to either gills or intestinal mucins, whereas none of the pathogens had preference for binding to skin mucins. Fluid velocity enhanced binding of intestinal mucins to A. hydrophila and A. salmonicida at 1.5 and 2 cm/s, whereas a velocity of 2 cm/s for skin mucins increased binding of A. salmonicida and decreased binding of A. hydrophila. Binding avidity, specificity and the effect of fluid velocity on binding thus differ between salmonid pathogens and with mucin origin. The results are in line with a model where the short skin mucin glycans contribute to contact with pathogens whereas pathogen binding to mucins with complex glycans aid the removal of pathogens from internal epithelial surfaces.	[Padra, Janos Tamas; Murugan, Abarna V. M.; Benktander, John; Linden, Sara K.] Univ Gothenburg, Dept Med Chem & Cell Biol, Gothenburg, Sweden; [Sundell, Kristina; Sundh, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Linden, SK (corresponding author), Univ Gothenburg, Dept Med Chem & Cell Biol, Gothenburg, Sweden.	sara.linden@gu.se	Sundell, Kristina/F-8884-2016; Sundh, Henrik/C-2477-2008; Linden, Sara/A-3271-2011	Sundell, Kristina/0000-0002-7643-2083; Sundh, Henrik/0000-0002-1459-5450; sharba, sinan/0000-0003-0531-2137; Linden, Sara/0000-0002-7751-9586	Swedish Research Council Formas [2018-01419]; Swedish Research Council [2016-05154_3]; Olle Engkvists Byggmastare foundation; Wilhelm and Martina Lundgrens foundation [2017-1768]; Norwegian Research Council (CtrlAQUA SFI) [237856/O30]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Olle Engkvists Byggmastare foundation; Wilhelm and Martina Lundgrens foundation; Norwegian Research Council (CtrlAQUA SFI)	This work was supported by: SL, KS, Swedish Research Council Formas (2018-01419), http://www.formas.se/en/; SL, KS, Swedish Research Council (2016-05154_3), https://www.vr.se/english/en_-sidfot/about-the-swedish-research-council/the-swedish-research-council.html; SL, Olle Engkvists Byggmastare foundation, http://engkviststiftelserna.se/; JP, Wilhelm and Martina Lundgrens foundation (2017-1768), http://www.wmlundgren.se/; KS, Norwegian Research Council (CtrlAQUA SFI, #237856/O30), https://www.forskningsradet.no; and Swedish Research Council Formas (2018-01419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01519; Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Anderson JK, 2015, MBIO, V6, DOI 10.1128/mBio.00379-15; Ascencio F, 1998, FEMS IMMUNOL MED MIC, V20, P219, DOI 10.1111/j.1574-695X.1998.tb01130.x; Benediktsdottir E, 1998, J FISH DIS, V21, P19, DOI 10.1046/j.1365-2761.1998.00065.x; Bjelland AM, 2012, MICROB PATHOGENESIS, V52, P77, DOI 10.1016/j.micpath.2011.10.007; Bjornsdottir B, 2004, J FISH DIS, V27, P645, DOI 10.1111/j.1365-2761.2004.00579.x; Bruno DW, 1998, DIS AQUAT ORGAN, V34, P161, DOI 10.3354/dao034161; BULGER RJ, 1966, ARCH INTERN MED, V118, P562, DOI 10.1001/archinte.118.6.562; BURNSTOCK G, 1958, BRIT J PHARM CHEMOTH, V13, P216, DOI 10.1111/j.1476-5381.1958.tb00894.x; Cagatay T, 2014, FARMS TURKEY, P435; Chisada S, 2013, FEMS MICROBIOL LETT, V341, P18, DOI 10.1111/1574-6968.12082; Cipriano RC, FAR SUPERFICIAL MICR; Diggles BK, 2000, DIS AQUAT ORGAN, V43, P127, DOI 10.3354/dao043127; EGIDIUS E, 1981, J FISH DIS, V4, P353, DOI 10.1111/j.1365-2761.1981.tb01143.x; ENGER O, 1989, APPL ENVIRON MICROB, V55, P2815, DOI 10.1128/AEM.55.11.2815-2818.1989; ESTERABADI AH, 1973, CAN J COMP MED, V37, P418; Eva Brannas SL, 2011, ARCTIC CHARR FARMING; Fan Wen-hui, 2005, Weishengwu Xuebao, V45, P665; Furusu A, 1997, NEPHROL DIAL TRANSPL, V12, P1730, DOI 10.1093/ndt/12.8.1730; Grini A, 2011, J FISH DIS, V34, P531, DOI 10.1111/j.1365-2761.2011.01265.x; Gudmundsdottir BK, 2007, VACCINE, V25, P5512, DOI 10.1016/j.vaccine.2007.02.009; HIRD DW, 1981, LAB ANIM SCI, V31, P166; HJELTNES B, 1987, J FISH DIS, V10, P21, DOI 10.1111/j.1365-2761.1987.tb00714.x; HOFF KA, 1989, J FISH DIS, V12, P595, DOI 10.1111/j.1365-2761.1989.tb00570.x; Horne MT, 1999, FISH DISEASES AND DISORDERS, VOL 3, P455; Jin CS, 2015, J PROTEOME RES, V14, P3239, DOI 10.1021/acs.jproteome.5b00232; Lee KK, 2002, MAR BIOTECHNOL, V4, P267, DOI 10.1007/s10126-002-0018-9; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden S, 2010, HELICOBACTER, V15, P251, DOI 10.1111/j.1523-5378.2010.00765.x; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Llewellyn MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43465; Lovoll M, 2009, FISH SHELLFISH IMMUN, V26, P877, DOI 10.1016/j.fsi.2009.03.019; Lunder T, 2000, INT J SYST EVOL MICR, V50, P427, DOI 10.1099/00207713-50-2-427; LUNDER T, 1995, DIS AQUAT ORGAN, V23, P39, DOI 10.3354/dao023039; MITTAL KR, 1980, CAN J MICROBIOL, V26, P1501, DOI 10.1139/m80-248; MONTGOMERY MT, 1993, APPL ENVIRON MICROB, V59, P373, DOI 10.1128/AEM.59.2.373-379.1993; Nilsson J, 2010, HYDROBIOLOGIA, V650, P275, DOI 10.1007/s10750-010-0232-9; ONARHEIM AM, 1994, SYST APPL MICROBIOL, V17, P370, DOI 10.1016/S0723-2020(11)80053-6; Padra JT, 2014, INFECT IMMUN, V82, P5235, DOI 10.1128/IAI.01931-14; Padra JT, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00189-17, 10.1128/iai.00189-17]; Padra M, 2018, VIRULENCE, V9, P898, DOI 10.1080/21505594.2018.1460979; Zepeda-Velazquez AP, 2015, CAN J VET RES, V79, P250; PLUMB J A, 1976, Journal of Wildlife Diseases, V12, P247; QADRI SMH, 1976, J CLIN MICROBIOL, V3, P102; Raeder ILU, 2007, MICROB PATHOGENESIS, V42, P36, DOI 10.1016/j.micpath.2006.10.003; Ringo E, 1997, AQUAC RES, V28, P901; Sather B. S., 2013, Journal of Ichthyology, V53, P833, DOI 10.1134/S0032945213100081; Saulnier D, 2010, MICROB ECOL, V59, P787, DOI 10.1007/s00248-009-9620-y; SHANE SM, 1985, AVIAN DIS, V29, P681, DOI 10.2307/1590659; SIRINAVIN S, 1984, PEDIATR INFECT DIS J, V3, P122, DOI 10.1097/00006454-198403000-00008; Sitja-Bobadilla A, 2006, VET PARASITOL, V142, P248, DOI 10.1016/j.vetpar.2006.07.002; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Solstorm F, 2015, AQUACULT ENV INTERAC, V7, P125, DOI 10.3354/aei00143; Stephens FJ, 2006, AUST VET J, V84, P173, DOI 10.1111/j.1751-0813.2006.tb12774.x; Talagrand-Reboul E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00037; Tharntada S, 2008, FISH SHELLFISH IMMUN, V24, P46, DOI 10.1016/j.fsi.2007.07.010; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2010, DIS AQUAT ORGAN, V90, P175, DOI 10.3354/dao02230; Tobback E, 2010, J FISH DIS, V33, P197, DOI 10.1111/j.1365-2761.2009.01106.x; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; Travers MA, 2008, FISH SHELLFISH IMMUN, V25, P800, DOI 10.1016/j.fsi.2008.08.003; Watts JEM, 2017, MAR DRUGS, V15, DOI 10.3390/md15060158; Wrobel A, 2017, J STRUCTURAL BIOL; Zha SJ, 2017, FISH SHELLFISH IMMUN, V71, P393, DOI 10.1016/j.fsi.2017.10.034; Zhang DH, 2016, AQUACULT REP, V3, P18, DOI 10.1016/j.aqrep.2015.11.003; Zhang DH, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw080; Zhang XH, 2000, J FISH DIS, V23, P93, DOI 10.1046/j.1365-2761.2000.00214.x	71	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0215583	10.1371/journal.pone.0215583	http://dx.doi.org/10.1371/journal.pone.0215583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125340	gold, Green Published, Green Submitted			2022-12-27	WOS:000468865700003
J	Dinc, N; Won, SY; Brawanski, N; Eibach, M; Quick-Weller, J; Konczalla, J; Berkefeld, J; Seifert, V; Marquardt, G				Dinc, Nazife; Won, Sae-Yeon; Brawanski, Nina; Eibach, Michael; Quick-Weller, Johanna; Konczalla, Juergen; Berkefeld, Joachim; Seifert, Volker; Marquardt, Gerhard			Differences in bleeding patterns and outcome after intracerebral hemorrhage due to vascular malformations	PLOS ONE			English	Article							INITIAL CONSERVATIVE TREATMENT; HEALTH-CARE PROFESSIONALS; QUALITY-OF-LIFE; EARLY SURGERY; NATURAL-HISTORY; HEMATOMA VOLUME; MANAGEMENT; GUIDELINES; ANTICOAGULANTS; PRESSURE	Background Atypical intracerebral hemorrhage is a common form of primary manifestation of vascular malformations. Objective The aim of the present study is to determine clues to the cause of bleeding according to hemorrhage pattern (lobar, basal ganglia, infratentorial). Methods We retrospectively evaluated 343 consecutive neurosurgical patients with intracerebral hemorrhage (ICH), who were admitted to our neurosurgical department between 2006 and 2016. The study cohort includes only neurosurgical patients. Patients who underwent treatment by neurologists are not represented in this study. We assessed location of hemorrhage, hematoma volumes to rule out differences and predicitve variables for final outcome. Results In 171 cases (49.9%) vascular malformations, such as arteriovenous malformations (AVMs), cavernomas, dural fistulas and aneurysms were the cause of bleeding. 172 (50.1%) patients suffered from an intracerebral hemorrhage due to amyloid angiopathy or long standing hypertension. In patients with infratentorial hemorrhage a malformation was more frequently detected as in patients with supratentorial hemorrhage (36% vs. 16%, OR 2.9 [1.8; 4.9], p<0.001). Among the malformations AVMs were most common (81%). Hematoma expansion was smaller in vascular malformation than non-malformation caused bleeding (24.1 cm(3) vs. 64.8 cm(3), OR 0.5 [0.4; 0.7], p < 0.001,). In 6 (2.1%) cases diagnosis remained unclear. Final outcome was more favorable in patients with vascular malformations (63% vs. 12%, OR 12.8 [4.5; 36.2], p<0.001). Conclusion Localization and bleeding patterns are predictive factors for origin of the hemorrhage. These predictive factors should quickly lead to appropriate vascular diagnostic measures. However, due to the inclusion criteria the validity of the study is limited and multicentre studies with further testing in general ICH patients are required.	[Dinc, Nazife; Won, Sae-Yeon; Brawanski, Nina; Eibach, Michael; Quick-Weller, Johanna; Konczalla, Juergen; Seifert, Volker; Marquardt, Gerhard] Goethe Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Berkefeld, Joachim] Goethe Univ Hosp, Dept Neuroradiol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Dinc, N (corresponding author), Goethe Univ Hosp, Dept Neurosurg, Frankfurt, Germany.	nazife.dinc@kgu.de	Brawanski, Nina/AAL-7455-2020; Won, Sae-Yeon/AAK-3408-2020; Won, Sae-Yeon/AFQ-0295-2022; Konczalla, Juergen/AAJ-8528-2021	Brawanski, Nina/0000-0003-1502-4980; Konczalla, Juergen/0000-0001-9771-7806				Banerjee G, 2017, J NEUROL NEUROSUR PS, V88, P982, DOI 10.1136/jnnp-2016-314697; Boulouis G, 2018, J NEUROL NEUROSUR PS, V89, P263, DOI 10.1136/jnnp-2017-316631; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brown RD, 2005, MAYO CLIN PROC, V80, P269, DOI 10.4065/80.2.269; Choi JH, 2006, STROKE, V37, P1243, DOI 10.1161/01.STR.0000217970.18319.7d; Christensen MC, 2009, CEREBROVASC DIS, V27, P353, DOI 10.1159/000202012; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; da Costa L, 2009, STROKE, V40, P100, DOI 10.1161/STROKEAHA.108.524678; Delcourt C, 2017, J NEUROL NEUROSUR PS, V88, P70, DOI 10.1136/jnnp-2016-314414; Dinc N, 2017, SPECIAL FEATURES AVM, V4; Dinc N, 2018, J CLIN NEUROSCI, V53, P171, DOI 10.1016/j.jocn.2018.04.010; Falcone GJ, 2014, NEUROCRIT CARE, V21, P192, DOI 10.1007/s12028-013-9839-9; Gupta VP, 2017, WORLD NEUROSURG, V101, P577, DOI 10.1016/j.wneu.2017.02.082; Hartmann A, 1998, STROKE, V29, P931, DOI 10.1161/01.STR.29.5.931; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hernesniemi JA, 2008, NEUROSURGERY, V63, P823, DOI 10.1227/01.NEU.0000330401.82582.5E; Hokari M, 2018, J STROKE CEREBROVASC, V27, P53, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.016; KADER A, 1994, NEUROSURGERY, V34, P801, DOI 10.1227/00006123-199405000-00003; Kuhmonen J, 2005, ACT NEUR S, V94, P111; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Moon JS, 2008, CRIT CARE MED, V36, P172, DOI 10.1097/01.CCM.0000297876.62464.6B; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Morgenstern PF, 2016, J NEUROSURG-PEDIATR, V17, P134, DOI 10.3171/2015.6.PEDS14708; Murthy SB, 2017, NEUROLOGY, V88, P1882, DOI 10.1212/WNL.0000000000003935; Murthy SB, 2015, STROKE, V46, P3088, DOI 10.1161/STROKEAHA.115.010054; Neidert MC, 2018, J NEUROL NEUROSUR PS, V89, P1163, DOI 10.1136/jnnp-2017-316259; Planchon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178437; Qureshi AI, 2007, NEUROCRIT CARE, V6, P56, DOI 10.1385/NCC:6:1:56; Rectenwald JE, 2007, J VASC SURG, V45, p131A, DOI 10.1016/j.jvs.2007.02.028; Ross J., 1994, BOOK REV C4 5 PROGRA, V240, P235, DOI [10.3109/02699206.2010.515375, DOI 10.3109/02699206.2010.515375]; SPETZLER RF, 1992, J NEUROSURG, V76, P918, DOI 10.3171/jns.1992.76.6.0918; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; TEASDALE G, 1974, LANCET, V2, P81; Beijnum J, 2009, BRAIN, V132, P537, DOI 10.1093/brain/awn318	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217017	10.1371/journal.pone.0217017	http://dx.doi.org/10.1371/journal.pone.0217017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120937	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700049
J	Hancox, JE; van der Wardt, V; Pollock, K; Booth, V; Vedhara, K; Harwood, RH				Hancox, Jennie E.; van der Wardt, Veronika; Pollock, Kristian; Booth, Vicky; Vedhara, Kavita; Harwood, Rowan H.			Factors influencing adherence to home-based strength and balance exercises among older adults with mild cognitive impairment and early dementia: Promoting Activity, Independence and Stability in Early Dementia (PrAISED)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; PEOPLE; EXPERIENCES; PROGRAM	Background Older adults with dementia are at a high risk of losing abilities and of accidental falls. Promoting Activity, Independence and Stability in Early Dementia (PrAISED) is a 12-month person-centred exercise and activity programme which aims to increase activity and independence whilst reducing falls in people with early dementia. In this patient group, as well as many others, poor adherence to exercise interventions can undermine treatment effectiveness. We aimed to explore patterns of barriers and facilitators influencing PrAISED participants' adherence to home-based strength and balance exercises. Methods Participants were a subsample of 20 individuals with mild cognitive impairment or early dementia and their carer(s) taking part in the PrAISED programme. Participants (with the support of a carer where necessary) kept a daily exercise diary. Participants' adherence were categorised based upon reported number of times a week they undertook the PrAISED strength and balance exercises over a 4 month period (<3 times a week = low adherence, 3-4 = meeting adherence expectations, >5 = exceeding adherence expectations). Semi-structured interviews were conducted in month 4 of the PrAISED programme to explore barriers and facilitators to adherence. A mixture of deductive and inductive thematic analysis was employed with themes categorised using the Theoretical Domains Framework. Findings Participants completed on average 98 minutes of home-based strength and balance exercises per week, 3.8 sessions per week, for an average of 24 minutes per session. Five participants were categorised as exceeding adherence expectations, 7 as meeting adherence expectations, and 8 as low adherers. Analysis of interview data based on self-reported adherence revealed six interacting themes: 1) routine, 2) practical and emotional support, 3) memory support, 4) purpose, 5) past experiences of sport and exercise, and 6) belief in and experience of benefits. Conclusions Identifiable cognitive, psychological, and practical factors influence adherence to exercise, and should be addressed in future development of interventions with this population.	[Hancox, Jennie E.; Vedhara, Kavita] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England; [van der Wardt, Veronika; Booth, Vicky] Univ Nottingham, Sch Med, Div Rehabil Ageing & Well Being, Nottingham, England; [Pollock, Kristian; Harwood, Rowan H.] Univ Nottingham, Sch Hlth Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Hancox, JE (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England.	jennie.hancox@nottingham.ac.uk	Pollock, Kristian/B-9734-2008; van der Wardt, Veronika/ABF-3836-2021; Hancox, Jennie/F-4551-2015	Pollock, Kristian/0000-0002-6836-8595; van der Wardt, Veronika/0000-0003-3995-7056; Vedhara, Kavita/0000-0002-9940-7534; Hancox, Jennie/0000-0001-5938-5265; Harwood, Rowan/0000-0002-4920-6718; Booth, Vicky/0000-0002-5338-0196	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-0614-20007]	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference Number RP-PG-0614-20007). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was awarded to Professor Rowan H Harwood.	Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Barreto PD, 2015, AGEING RES REV, V24, P274, DOI 10.1016/j.arr.2015.09.001; Bollen JC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005044; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burton E, 2015, CLIN INTERV AGING, V10, P421, DOI 10.2147/CIA.S71691; Campbell J, 2003, OTAGO EXERCISE PROGR, P1; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cedervall Y, 2015, AGING MENT HEALTH, V19, P679, DOI 10.1080/13607863.2014.962004; Clemson L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4547; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dening T, 2013, OXFORD TXB OLD AGE P, V2nd; Di Lorito C, 2019, MATURITAS, V122, P8, DOI 10.1016/j.maturitas.2019.01.001; Feilzer MY, 2010, J MIX METHOD RES, V4, P6, DOI 10.1177/1558689809349691; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gardner B, 2011, ANN BEHAV MED, V42, P174, DOI 10.1007/s12160-011-9282-0; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Harwood Rowan H, 2018, Pilot Feasibility Stud, V4, P49, DOI 10.1186/s40814-018-0239-y; Hernandez SSS, 2015, J AGING PHYS ACTIV, V23, P659, DOI 10.1123/japa.2014-0180; Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; Middleton LE, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-017-0684-0; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Pitkala KH, 2013, JAMA INTERN MED, V173, P894, DOI 10.1001/jamainternmed.2013.359; Power V, 2013, EUR REV AGING PHYS A, V10, P95, DOI 10.1007/s11556-012-0108-2; Prince M., 2015, WORLD ALZHEIMER REPO, DOI DOI 10.1111/j.0963-7214.2004.00293.x; Sabia S, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2709; Sherrington C, 2017, BRIT J SPORT MED, V51, P1749, DOI 10.1136/bjsports-2016-096547; Sparkes AC., 2013, QUALITATIVE RES METH; Suttanon P, 2012, INT PSYCHOGERIATR, V24, P1172, DOI 10.1017/S1041610211002729; Taylor ME, 2017, INT PSYCHOGERIATR, V29, P81, DOI 10.1017/S1041610216001629; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trombetti Andrea, 2011, Rev Med Suisse, V7, P1305; van Alphen HJM, 2016, ARCH GERONTOL GERIAT, V66, P109, DOI 10.1016/j.archger.2016.05.008; van der Wardt Veronika, 2017, Prev Med Rep, V7, P38, DOI 10.1016/j.pmedr.2017.05.007; Vertesi A, 2001, CAN FAM PHYSICIAN, V47, P2018; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	40	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217387	10.1371/journal.pone.0217387	http://dx.doi.org/10.1371/journal.pone.0217387			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120953	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700096
J	Meneghel, J; Kilbride, P; Morris, JG; Fonseca, F				Meneghel, Julie; Kilbride, Peter; Morris, John G.; Fonseca, Fernanda			Physical events occurring during the cryopreservation of immortalized human T cells	PLOS ONE			English	Article							LIPID PHASE-TRANSITIONS; BEHAVIOR; PROTEIN; FROZEN; WATER	Cryopreservation is key for delivery of cellular therapies, however the key physical and biological events during cryopreservation are poorly understood. This study explored the entire cooling range, from membrane phase transitions above 0 degrees C to the extracellular glass transition at -123 degrees C, including an endothermic event occurring at -47 degrees C that we attributed to the glass transition of the intracellular compartment. An immortalised, human suspension cell line (Jurkat) was studied, using the cryoprotectant dimethyl sulfoxide. Fourier transform infrared spectroscopy was used to determine membrane phase transitions and differential scanning calorimetry to analyse glass transition events. Jurkat cells were exposed to controlled cooling followed by rapid, uncontrolled cooling to examine biological implications of the events, with post-thaw viable cell number and functionality assessed up to 72 h post-thaw. The intracellular glass transition observed at -47 degrees C corresponded to a sharp discontinuity in biological recovery following rapid cooling. No other physical events were seen which could be related to post-thaw viability or performance significantly. Controlled cooling to at least -47 degrees C during the cryopreservation of Jurkat cells, in the presence of dimethyl sulfoxide, will ensure an optimal post-thaw viability. Below -47 degrees C, rapid cooling can be used. This provides an enhanced physical and biological understanding of the key events during cryopreservation and should accelerate the development of optimised cryobiological cooling protocols.	[Meneghel, Julie; Kilbride, Peter; Morris, John G.] Gen Elect Healthcare, Asymptote, Cambridge, England; [Fonseca, Fernanda] Univ Paris Saclay, INRA, AgroParisTech, UMR GMPA, Thiverval Grignon, France	General Electric; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Meneghel, J (corresponding author), Gen Elect Healthcare, Asymptote, Cambridge, England.	julie.meneghel@ge.com	Fonseca, Fernanda/AAR-9094-2020; FONSECA, FERNANDA/HDN-9451-2022	Fonseca, Fernanda/0000-0003-3394-182X; FONSECA, FERNANDA/0000-0002-0315-6479; Meneghel, Julie/0000-0002-1510-8642	European Union [777657]; Advanced Treatment Therapy Centres (ATTC) programme - A Co-ordinated Strategy to Scale-up Advanced Therapies for Patients in Manchester, Innovate UK Project [6239]	European Union(European Commission); Advanced Treatment Therapy Centres (ATTC) programme - A Co-ordinated Strategy to Scale-up Advanced Therapies for Patients in Manchester, Innovate UK Project	All authors have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 777657 (https://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowska-curie-actions).JM, PK and JGM received funding from the Advanced Treatment Therapy Centres (ATTC) programme - A Co-ordinated Strategy to Scale-up Advanced Therapies for Patients in Manchester, Innovate UK Project Number: 6239 (https://apply-for-innovation-funding.service.gov.uk/competition/search).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789; Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; [Anonymous], R LANG ENV STAT COMP; Baboo J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39957-x; Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207; CROWE JH, 1989, CRYOBIOLOGY, V26, P76, DOI 10.1016/0011-2240(89)90035-7; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Findenegg GH, 2008, CHEMPHYSCHEM, V9, P2651, DOI 10.1002/cphc.200800616; Fonseca F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152939; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gao C, 2005, THERMOCHIM ACTA, V435, P38, DOI 10.1016/j.tca.2005.03.024; Gautier J, 2013, J DAIRY SCI, V96, P5591, DOI 10.3168/jds.2013-6802; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Kilbride P, 2017, CRYOBIOLOGY, V76, P92, DOI 10.1016/j.cryobiol.2017.04.003; KORBER C, 1991, J MICROSC-OXFORD, V161, P313, DOI 10.1111/j.1365-2818.1991.tb03092.x; Lewis RNAH, 2013, BBA-BIOMEMBRANES, V1828, P2347, DOI 10.1016/j.bbamem.2012.10.018; Manka A, 2012, PHYS CHEM CHEM PHYS, V14, P4505, DOI 10.1039/c2cp23116f; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Mika JT, 2011, CURR OPIN BIOTECH, V22, P117, DOI 10.1016/j.copbio.2010.09.009; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Morris GJ, 2006, CRYOBIOLOGY, V52, P323, DOI 10.1016/j.cryobiol.2006.01.003; Mourao MA, 2014, BIOPHYS J, V107, P2761, DOI 10.1016/j.bpj.2014.10.051; Ragoonanan V, 2010, J PHYS CHEM B, V114, P16752, DOI 10.1021/jp103960r; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SHALAEV EY, 1995, J CHEM SOC FARADAY T, V91, P1511, DOI 10.1039/ft9959101511; Suzuki Y, 2015, NANO LETT, V15, P1987, DOI 10.1021/nl504855z; WALTER CA, 1975, CRYOBIOLOGY, V12, P103, DOI 10.1016/S0011-2240(75)80001-0; Wang WX, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4512-5; Wolkers WF, 2015, METHODS MOL BIOL, V1257, P147, DOI 10.1007/978-1-4939-2193-5_5; Wu JY, 2014, ANDROLOGIA, V46, P308, DOI 10.1111/and.12084; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	33	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217304	10.1371/journal.pone.0217304	http://dx.doi.org/10.1371/journal.pone.0217304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120989	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700085
J	Pruss, D; Fujinuma, Y; Daughton, AR; Paul, MJ; Arnot, B; Szafir, DA; Boyd-Graber, J				Pruss, Dasha; Fujinuma, Yoshinari; Daughton, Ashlynn R.; Paul, Michael J.; Arnot, Brad; Szafir, Danielle Albers; Boyd-Graber, Jordan			Zika discourse in the Americas: A multilingual topic analysis of Twitter	PLOS ONE			English	Article							SOCIAL MEDIA	This work examines Twitter discussion surrounding the 2015 outbreak of Zika, a virus that is most often mild but has been associated with serious birth defects and neurological syndromes. We introduce and analyze a collection of 3.9 million tweets mentioning Zika geolocated to North and South America, where the virus is most prevalent. Using a multilingual topic model, we automatically identify and extract the key topics of discussion across the dataset in English, Spanish, and Portuguese. We examine the variation in Twitter activity across time and location, finding that rises in activity tend to follow to major events, and geographic rates of Zika-related discussion are moderately correlated with Zika incidence (rho =.398).	[Pruss, Dasha] Univ Pittsburgh, Dept Hist & Philosophy Sci, Pittsburgh, PA USA; [Fujinuma, Yoshinari; Paul, Michael J.; Arnot, Brad; Szafir, Danielle Albers] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Daughton, Ashlynn R.; Paul, Michael J.; Szafir, Danielle Albers] Univ Colorado, Dept Informat Sci, Boulder, CO 80309 USA; [Daughton, Ashlynn R.] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA; [Boyd-Graber, Jordan] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Maryland; University of Maryland College Park	Paul, MJ (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.; Paul, MJ (corresponding author), Univ Colorado, Dept Informat Sci, Boulder, CO 80309 USA.	mpaul@colorado.edu			National Science Foundation Graduate Research Fellowship; National Science Foundation [IIS-1564275]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	Pruss was supported in part by a National Science Foundation Graduate Research Fellowship. Fujinuma, Paul, and Boyd-Graber were supported in part by National Science Foundation grant IIS-1564275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allem Jon-Patrick, 2017, JMIR Public Health Surveill, V3, pe98, DOI 10.2196/publichealth.8641; [Anonymous], 2000, J RISK RES, DOI [10.1080/136698700376699, DOI 10.1080/136698700376699]; [Anonymous], 2017, HIST ZIK VIR; Baumer EPS, 2017, J ASSOC INF SCI TECH, V68, P1397, DOI 10.1002/asi.23786; Blei, 2009, P 25 C UNC ART INT, P75; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boyd-Graber J, 2017, FOUND TRENDS INF RET, V11, P144; Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263; Brody Samuel, 2010, AMIA Annu Symp Proc, V2010, P202; Broniatowski DA, 2016, VACCINE, V34, P3225, DOI 10.1016/j.vaccine.2016.04.044; Burke Daniel Burke, 2016, CNN; CDC, 2014, ZIK SYMPT; CDC, 2014, ZIK; Chang J., 2009, ADV NEURAL INFORM PR, P288, DOI [DOI 10.5555/2984093.2984126, 10.5555/2984093.2984126]; Chen L, 2015, DATA MIN KNOWL DISC; Cohen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087555; Cook J., 2013, P 22 INT C WORLD WID, P225; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duggan M, 2015, SOCIAL MEDIA UPDATE; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Ghosh D, 2013, CARTOGR GEOGR INF SC, V40, P90, DOI 10.1080/15230406.2013.776210; Giabbanelli PJ, 2016, LECT NOTES COMPUT SC, V9742, P188, DOI 10.1007/978-3-319-39910-2_18; Gomide J., 2011, P 3 INT WEB SCI C, V3, DOI DOI 10.1145/2527031.2527049; Graham P, 2017, STOPWORDS JSON; Hao S, 2018, N AM CHAPTER ASS COM; Hong L., 2010, PROC 1 WORKSHOP SOCI, P80, DOI DOI 10.1145/1964858.1964870; Jagarlamudi J, 2010, ECIR; Ji X, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), P335, DOI 10.1109/ICHI.2013.47; Johnson I, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P1167, DOI 10.1145/3025453.3026015; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; King G, 2017, AM J POLIT SCI, V61, P971, DOI 10.1111/ajps.12291; Koehn P., 2009, STAT MACHINE TRANSLA; Lampos V., 2010, 2010 2nd International Workshop on Cognitive Information Processing (CIP 2010), P411, DOI 10.1109/CIP.2010.5604088; Lau J.H, 2014, P 14 C EUROPEAN CHAP, P530, DOI DOI 10.3115/V1/E14-1056; Lau JH, 2017, COMPUTATION SEMANTIC; Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025; Levow GA, 2005, INFORM PROCESS MANAG, V41, P523, DOI 10.1016/j.ipm.2004.06.012; Lu Y, 2011, INFORM RETRIEVAL, V14, P178, DOI 10.1007/s10791-010-9141-9; Lucas C, 2015, POLIT ANAL, V23, P254, DOI 10.1093/pan/mpu019; Lui Marco, 2012, P ACL 2012 SYST DEM; MALLET, 2019, TOP MOD; Mayhew Stephen, 2017, P 2017 C EMP METH NA, P2536, DOI DOI 10.18653/V1/D17-1269; McCallum, 2002, MALLET MACHINE LEARN; McCallum, 2009, P 2009 C EMP METH NA, P880, DOI DOI 10.3115/1699571.1699627; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295; Microsoft, 2019, TRANSL TEXT DOC; Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157; Mimno D.M., 2011, P C EMPIRICAL METHOD, DOI DOI 10.5555/2145432.2145462; Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863; Muralidhara S, 2018, JMIR PUBLIC HLTH SUR, V4, P148, DOI 10.2196/10150; Newman David, 2010, HUMAN LANGUAGE TECHN, P100, DOI DOI 10.5555/1857999.1858011; Ni Xiaochuan, 2009, P WORLD WID WEB C; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Paul M.J., 2017, SYNTH LECT INF CONCE, V9, P1, DOI [10.2200/s00791ed1v01y201707icr060, DOI 10.2200/S00791ED1V01Y201707ICR060]; Paul MJ, 2014, PLOS ONE, V9, DOI [10.1371/currents.outbreaks.90b9ed0f59bae4ccaa683a39865d9117, 10.1371/journal.pone.0103408]; Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990; Prier KW, 2011, LECT NOTES COMPUT SC, V6589, P18; Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P100, DOI 10.1016/j.tmaid.2014.11.004; Rolston Leanne, 2016, COLLECTION BILINGUAL; Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063; Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513; Schofield A., 2016, T ASS COMPUTATIONAL, V4, P287; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Shipman SA, 2011, PEDIATRICS, V127, P19, DOI 10.1542/peds.2010-0150; Smith M., 2016, AAAI SPRING S OBS ST; Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925; Sun L., 2016, WASHINGTON POST; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Tran H., 2013, P AAAI WORKSH EXP BO, P45; Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015; Wallace BC, 2014, J AM MED INFORM ASSN, V21, P1098, DOI 10.1136/amiajnl-2014-002711; Wallach H. M., 2009, ADV NEURAL INFORM PR, P1973, DOI DOI 10.1007/S10708-008-9161-9; Xing L, 2018, AAAI C ART INT AAAI	77	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216922	10.1371/journal.pone.0216922	http://dx.doi.org/10.1371/journal.pone.0216922			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120935	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700040
J	Weinberg, D; Stevens, GWJM; Finkenauer, C; Brunekreef, B; Smit, HA; Wijga, AH				Weinberg, Dominic; Stevens, Gonneke W. J. M.; Finkenauer, Catrin; Brunekreef, Bert; Smit, Henriette A.; Wijga, Alet H.			The pathways from parental and neighbourhood socioeconomic status to adolescent educational attainment: An examination of the role of cognitive ability, teacher assessment, and educational expectations	PLOS ONE			English	Article							INTERGENERATIONAL TRANSMISSION; SOCIAL-CLASS; SECONDARY-EDUCATION; ACHIEVEMENT; SCHOOL; NETHERLANDS; INEQUALITY; HEALTH; TERM; INTELLIGENCE	Adolescents with high educational attainment generally have better outcomes across the lifespan than adolescents with lower educational attainment. This study investigated how three measures of socioeconomic status (SES)-maternal education, paternal education, and neighbourhood SES-combined to predict adolescent educational attainment (track level at age 17). We proposed three mechanisms for this pathway: cognitive ability (at age 11), primary school teacher assessment (stating the secondary education level suitable for a child at age 11), and educational expectations (at age 14). Using the data of 2,814 Dutch adolescents from the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) study, logistic regressions tested associations between SES and educational attainment. Structural equation modelling (SEM) tested mediational pathways between SES and educational attainment. In models with three SES measures, having a medium-educated mother was associated with higher educational attainment relative to having a low-educated mother (OR; 95% CI: 1.83; 1.41-2.38), and having a high-educated mother was associated with higher educational attainment relative to having a low-educated mother (OR; 95% CI: 3.44; 2.59-4.55). The odds ratios for paternal education showed a similar pattern. We found no association between neighbourhood SES and adolescent educational attainment, so neighbourhood SES was removed from further analyses. Mediational analyses revealed that cognitive ability (30.0%), teacher assessment (28.5%), and educational expectations (1.2%) explained 59.8% of the total association between parental SES and educational attainment. The results showed that mother education and father education were both important for understanding the strong association between parental SES and adolescent educational attainment. In the Netherlands, the association between parental SES and educational attainment can be largely explained by cognitive ability and teacher assessments.	[Weinberg, Dominic; Stevens, Gonneke W. J. M.; Finkenauer, Catrin] Univ Utrecht, Fac Social & Behav Sci, Dept Interdisciplinary Social Sci, Utrecht, Netherlands; [Finkenauer, Catrin] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Brunekreef, Bert] Univ Utrecht, IRAS, Div Environm Epidemiol, Utrecht, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands	Utrecht University; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Weinberg, D (corresponding author), Univ Utrecht, Fac Social & Behav Sci, Dept Interdisciplinary Social Sci, Utrecht, Netherlands.	d.w.weinberg@uu.nl	Weinberg, Dom/AAE-3251-2019; Stevens, Gonneke/AAU-7716-2020; Finkenauer, Catrin/N-4867-2019	Weinberg, Dom/0000-0003-3422-9500; Finkenauer, Catrin/0000-0002-5429-0627; Stevens, Gonneke/0000-0001-9929-7972	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Lung Foundation Netherlands; Netherlands Ministry of Spatial Planning, Housing and the Environment; Netherlands Ministry of Health, Welfare and Sports; Utrecht University	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Lung Foundation Netherlands; Netherlands Ministry of Spatial Planning, Housing and the Environment; Netherlands Ministry of Health, Welfare and Sports; Utrecht University	The PIAMA study was supported by the Netherlands Organization for Health Research and Development, the Netherlands Organization for Scientific Research, Lung Foundation Netherlands, the Netherlands Ministry of Spatial Planning, Housing and the Environment, and the Netherlands Ministry of Health, Welfare and Sports. This particular work was supported by funding from Dynamics of Youth (Utrecht University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth JW, 2002, SOC FORCES, V81, P117, DOI 10.1353/sof.2002.0038; [Anonymous], HDB ADOLESCENT PSYCH; Atkinson AB, 2015, EMPIRICA, V42, P211, DOI 10.1007/s10663-015-9288-0; Autor DH, 2014, SCIENCE, V344, P843, DOI 10.1126/science.1251868; Ayorech Z, 2017, PSYCHOL SCI, V28, P1302, DOI 10.1177/0956797617707270; Baars SW, 2014, PLACE SPACE IMAGINED; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; Beal SJ, 2010, DEV PSYCHOL, V46, P258, DOI 10.1037/a0017416; Belsky DW, 2018, PNAS; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Black SE, 2005, AM ECON REV, V95, P437, DOI 10.1257/0002828053828635; Blossfeld PN, 2015, EUR SOCIOL REV, V31, P144, DOI 10.1093/esr/jcv017; Bollen KA, 2001, ANNU REV SOCIOL, V27, P153, DOI 10.1146/annurev.soc.27.1.153; Boone S, 2013, BRIT J SOCIOL EDUC, V34, P20, DOI 10.1080/01425692.2012.704720; Boudon Raymond, 1974, ED OPPORTUNITY SOCIA; Bourdieu P., 1990, REPROD ED SOC CULTUR; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Breen R, 2005, ANNU REV SOCIOL, V31, P223, DOI 10.1146/annurev.soc.31.041304.122232; Bronfenbrenner U, 2000, SOC DEV, V9, P115, DOI 10.1111/1467-9507.00114; Buchmann Claudia, 2009, RES SOCIAL STRATIFIC, V27, P245, DOI [DOI 10.1016/J.RSSM.2009.10.003, 10.1016/j.rssm.2009.10.003]; Buis ML, 2013, EUR SOCIOL REV, V29, P593, DOI 10.1093/esr/jcs009; Centraal Bureau voor de Statistiek (CBS), 2018, VO LEERL OND DET LEE; Chetty R, 2016, AM EC REV, V106; Cito, 2014, INT LEERL 2014; Cito, 2008, TER RES EINDT BAS 20; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Conley D, 2015, SOCIOL SCI, V2, P82, DOI 10.15195/v2.a6; Conroy K, 2010, J DEV BEHAV PEDIATR, V31, P154, DOI 10.1097/DBP.0b013e3181c21a1b; Crul M, 2018, EUR J EDUC, V53, P481, DOI 10.1111/ejed.12310; de Boer H, 2010, J EDUC PSYCHOL, V102, P168, DOI 10.1037/a0017289; De Graaf ND, 2000, SOCIOL EDUC, V73, P92; de Vuijst E, 2017, ENVIRON PLANN A, V49, P2135, DOI 10.1177/0308518X17715638; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Diamantopoulos A, 2006, J MODEL MANAG, V1, P7, DOI 10.1108/17465660610667775; Diamantopoulos A, 2008, J BUS RES, V61, P1203, DOI 10.1016/j.jbusres.2008.01.009; Driessen G, 2008, EUR SOCIOL REV, V24, P527, DOI 10.1093/esr/jcn018; Dubow EF, 2009, MERRILL PALMER QUART, V55, P224; Dupere V, 2010, DEV PSYCHOL, V46, P1227, DOI 10.1037/a0020211; Easterbrook MJ, 2016, SOC INDIC RES, V126, P1261, DOI 10.1007/s11205-015-0946-1; Elbers E, 2014, LEARN CULT SOC INTER, V3, P252, DOI 10.1016/j.lcsi.2014.01.004; Esser H, 9082 IZA; Feinstein L, 2006, P COP S OECD PAR, P171; Fergusson D.M., 2008, RES SOCIAL STRATIFIC, V26, P277, DOI [DOI 10.1016/J.RSSM.2008.05.001, 10.1016/j.rssm.2008.05.001]; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Frome PM, 1998, J PERS SOC PSYCHOL, V74, P435, DOI 10.1037/0022-3514.74.2.435; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Greenwood J, 2014, AM ECON REV, V104, P348, DOI 10.1257/aer.104.5.348; Harding DJ, 2011, SOCIOL EDUC, V84, P322, DOI 10.1177/0038040711417008; Hernan MA, 2018, AM J PUBLIC HEALTH, V108, P616, DOI 10.2105/AJPH.2018.304337; Hertz T, 2007, BE J ECON ANAL POLI, V7, DOI 10.2202/1935-1682.1775; Holt-Lunstad J, 2018, ANNU REV PSYCHOL, V69, P437, DOI 10.1146/annurev-psych-122216-011902; Hout M, 2012, ANNU REV SOCIOL, V38, P379, DOI 10.1146/annurev.soc.012809.102503; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inspectorate of Education (The Netherlands), 2014, KWAL BAS; Inspectorate of Education (The Netherlands), 2018, STAAT OND OND 2016 2; Jencks C., 1990, INNER CITY POVERTY U; Johnson Sarah R Lindstrom, 2014, Int J Adolesc Med Health, V26, P459, DOI 10.1515/ijamh-2013-0333; Jussim L, 2005, PERS SOC PSYCHOL REV, V9, P131, DOI 10.1207/s15327957pspr0902_3; Kalff AC, 2001, J EPIDEMIOL COMMUN H, V55, P246, DOI 10.1136/jech.55.4.246; Knol F., 2012, STATUSONTWIKKELING W; Korupp SE, 2002, QUAL QUANT, V36, P17, DOI 10.1023/A:1014393223522; Krapohl E, 2014, P NATL ACAD SCI USA, V111, P15273, DOI 10.1073/pnas.1408777111; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Ladd HF, 2011, J POLICY ANAL MANAG, V30, P470, DOI 10.1002/pam.20589; Lareau Annette, 2003, UNEQUAL CHILDHOODS C; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Marks GN, 2008, SOC INDIC RES, V85, P293, DOI 10.1007/s11205-007-9132-4; Massey EK, 2008, DEV REV, V28, P421, DOI 10.1016/j.dr.2008.03.002; McDool EM, 2017, 2017002 U SHEFF DEP; Minh A, 2017, HEALTH PLACE, V46, P155, DOI 10.1016/j.healthplace.2017.04.012; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Moreno-Maldonado C, 2018, SOC INDIC RES, V136, P517, DOI 10.1007/s11205-017-1567-7; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Nieuwenhuis J, 2016, J HOUS BUILT ENVIRON, V31, P321, DOI 10.1007/s10901-015-9460-7; Nieuwenhuis J, 2016, GEOFORUM, V70, P89, DOI 10.1016/j.geoforum.2016.02.017; Nieuwenhuis J, 2015, SOC SCI RES, V50, P100, DOI 10.1016/j.ssresearch.2014.11.011; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; NURMI JE, 1991, DEV REV, V11, P1, DOI 10.1016/0273-2297(91)90002-6; OECD, 2017, OECD EMPL OUTL 2017, DOI [10.1787/empl_outlook-2017-en, DOI 10.1787/EMPL_OUTLOOK-2017-EN]; Owens A, 2010, SOCIOL EDUC, V83, P287, DOI 10.1177/0038040710383519; Oyserman D, 2011, SELF IDENTITY, V10, P474, DOI 10.1080/15298868.2010.487651; Patacchini E, 2011, J REGIONAL SCI, V51, P987, DOI 10.1111/j.1467-9787.2011.00722.x; Ruijsbroek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134780; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; Schnabel KU, 2002, J VOCAT BEHAV, V60, P178, DOI 10.1006/jvbe.2001.1863; Schoon I, 2017, YOUNG PEOPLES DEV GR; Schoon I, 2011, INT J BEHAV DEV, V35, P210, DOI 10.1177/0165025411398183; Schulz W, 2017, J YOUTH ADOLESCENCE, V46, P2194, DOI 10.1007/s10964-017-0718-0; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; SHAVIT Y, 1993, PERSISTING INEQUALIT; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, https://doi.org/10.2307/270723]; Sorhagen NS, 2013, J EDUC PSYCHOL, V105, P465, DOI 10.1037/a0031754; Stephens NM, 2014, ANNU REV PSYCHOL, V65, P611, DOI 10.1146/annurev-psych-010213-115143; Stevens PAJ, 2011, BRIT EDUC RES J, V37, P5, DOI 10.1080/01411920903342053; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Sykes B, 2011, URBAN STUD, V48, P1307, DOI 10.1177/0042098010371393; Sykes B, 2009, ENVIRON PLANN A, V41, P2417, DOI 10.1068/a41255; Tieben N, 2010, HIGH EDUC, V60, P85, DOI 10.1007/s10734-009-9289-7; Tieben N, 2010, RES SOC STRAT MOBIL, V28, P77, DOI 10.1016/j.rssm.2009.12.004; Timmermans AC, 2015, BRIT J EDUC PSYCHOL, V85, P459, DOI 10.1111/bjep.12087; Trejo S, 2018, SOCIOL SCI, V5, P513, DOI 10.15195/v5.a22; Van de Werfhorst HG, 2010, ANNU REV SOCIOL, V36, P407, DOI 10.1146/annurev.soc.012809.102538; van der Heide I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168110; van Ham M, 2009, ENVIRON PLANN A, V41, P1442, DOI 10.1068/a4182; Visser K, 2015, J YOUTH STUD, V18, P36, DOI 10.1080/13676261.2014.933196; Wijga AH, 2014, INT J EPIDEMIOL, V43, P527, DOI 10.1093/ije/dys231; Wilson R., 1987, TRULY DISADVANTAGED; Wood D, 2007, J YOUTH ADOLESCENCE, V36, P417, DOI 10.1007/s10964-007-9186-2; WRR Netherlands Scientific Council for Government Policy, 2014, EC IN NETH 8 FIG; Zajacova A, 2018, ANNU REV PUBL HEALTH, V39, P273, DOI 10.1146/annurev-publhealth-031816-044628; Zarrett Nicole, 2006, New Dir Youth Dev, P13	113	8	8	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216803	10.1371/journal.pone.0216803	http://dx.doi.org/10.1371/journal.pone.0216803			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116770	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400030
J	Escribano, E; Saralegui, C; Moles, L; Montes, MT; Alba, C; Alarcon, T; Lazaro-Perona, F; Rodriguez, JM; de Pipaon, MS; del Campo, R				Escribano, Esperanza; Saralegui, Claudia; Moles, Laura; Teresa Montes, Maria; Alba, Claudio; Alarcon, Teresa; Lazaro-Perona, Fernando; Miguel Rodriguez, Juan; Saenz de Pipaon, Miguel; del Campo, Rosa			Influence of a Serratia marcescens outbreak on the gut microbiota establishment process in low-weight preterm neonates	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INTESTINAL MICROBIOME; TIME TRENDS; BIRTH; INFANT; HEALTH; COLONIZATION; ASSOCIATION; SEPSIS	Adequate gut microbiota establishment is important for lifelong health. The aim was to sequentially analyze the gut microbiota establishment in low-birth-weight preterm neonates admitted to a single neonatal intensive care unit during their first 3 weeks of life, comparing two epidemiological scenarios. Seven control infants were recruited, and another 12 during a severe S. marcescens outbreak. Meconium and feces from days 7, 14, and 21 of life were collected. Gut microbiota composition was determined by 16S rDNA massive sequencing. Cultivable isolates were genotyped by pulsed-field gel electrophoresis, with four S. marcescens submitted for whole-genome sequencing. The expected bacterial ecosystem expansion after birth is delayed, possibly related to antibiotic exposure. The Proteobacteria phylum dominates, although with marked interindividual variability. The outbreak group considerably differed from the control group, with higher densities of Escherichia coli and Serratia to the detriment of Enterococcus and other Firmicutes. Curiously, obligate predators were only detected in meconium and at very low concentrations. Genotyping of cultivable bacteria demonstrated the high bacterial horizontal transmission rate that was confirmed with whole-genome sequencing for S. marcescens. Preterm infants admitted at NICU are initially colonized by homogeneous microbial communities, most of them from the nosocomial environment, which subsequently evolve according to the individual conditions. Our results demonstrate the hospital epidemiology pressure, particularly during outbreak situations, on the gut microbiota establishing process.	[Escribano, Esperanza; Teresa Montes, Maria; Saenz de Pipaon, Miguel] Hosp Univ La Paz, Serv Neonatol, Madrid, Spain; [Escribano, Esperanza; Teresa Montes, Maria; Alba, Claudio; Alarcon, Teresa; Saenz de Pipaon, Miguel] Univ Autonoma Madrid, Madrid, Spain; [Saralegui, Claudia; Moles, Laura; del Campo, Rosa] Hosp Univ Ramon & Cajal, Serv Microbiol & Parasitol, Madrid, Spain; [Saralegui, Claudia; Moles, Laura; del Campo, Rosa] Inst Ramon & Cajal Invest Sanitarias IRYCIS, Madrid, Spain; [Moles, Laura; Miguel Rodriguez, Juan] Univ Complutense Madrid, Dept Bromatol, Fac Vet Nutr & Ciencia Alimentos, Madrid, Spain; [Alba, Claudio; Alarcon, Teresa] Hosp Univ La Princesa, Microbiol Serv, Madrid, Spain; [Lazaro-Perona, Fernando] Hosp Univ La Paz, Microbiol Serv, Madrid, Spain; [Saenz de Pipaon, Miguel] Inst Salud Carlos III, Red Salud Materno Infantil & Desarrollo, Madrid, Spain	Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario Ramon y Cajal; Complutense University of Madrid; Hospital de La Princesa; Hospital Universitario La Paz; Instituto de Salud Carlos III	del Campo, R (corresponding author), Hosp Univ Ramon & Cajal, Serv Microbiol & Parasitol, Madrid, Spain.; del Campo, R (corresponding author), Inst Ramon & Cajal Invest Sanitarias IRYCIS, Madrid, Spain.	rosacampo@yahoo.com	Alegre, Laura Moles/AAX-5445-2020; Rodriguez, Juan Miguel/ABB-6650-2020; de Pipaón, Miguel Sáenz/AAA-3851-2019; del Campo, Rosa/M-9628-2013	Alegre, Laura Moles/0000-0001-6902-2097; Rodriguez, Juan Miguel/0000-0002-1285-9686; de Pipaón, Miguel Sáenz/0000-0002-4793-1561; Lazaro Perona, Fernando/0000-0002-3714-525X; Alba, Claudio/0000-0003-0620-0313; Saralegui-Diez, Claudia/0000-0002-8348-9408; del Campo, Rosa/0000-0003-1147-7923	Consejeria de Educacion, Juventud y Deporte de la Comunidad de Madrid; European Social Funds; Fundacion Mutua Madrilena [AP165902017]	Consejeria de Educacion, Juventud y Deporte de la Comunidad de Madrid; European Social Funds(European Social Fund (ESF)); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	Claudio Alba was supported by "Consejeria de Educacion, Juventud y Deporte de la Comunidad de Madrid" and European Social Funds. Claudia Saralegui was supported by "Fundacion Mutua Madrilena" grant to Rosa del Campo achieved in 2017 call with reference number AP165902017.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Alcon-Giner C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4229-x; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Berkhout DJC, 2019, CLIN INFECT DIS, V68, P70, DOI 10.1093/cid/ciy383; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chernikova DA, 2018, PEDIATR RES, V84, P71, DOI 10.1038/s41390-018-0022-z; Cong XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152751; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Elgin TG, 2016, CLIN THER, V38, P706, DOI 10.1016/j.clinthera.2016.01.005; Groer MW, 2015, BIRTH DEFECTS RES C, V105, P252, DOI 10.1002/bdrc.21115; Groer MW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-38; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Hill CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0213-y; Iebba V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061608; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Johnson J, 2017, CURR OPIN INFECT DIS, V30, P395, DOI 10.1097/QCO.0000000000000383; Kadouri DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063397; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Liu J, 2015, WORLD J MICROB BIOT, V31, P1387, DOI 10.1007/s11274-015-1890-6; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martineau C, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.00235-18, 10.1128/JCM.00235-18]; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Moles L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.06.003; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Montagnani C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0734-6; Moukarzel S, 2017, CLIN PERINATOL, V44, P193, DOI 10.1016/j.clp.2016.11.014; Nogacka A, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0313-3; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Patel AL, 2016, J PEDIATR GASTR NUTR, V62, P292, DOI 10.1097/MPG.0000000000000913; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Ruiz L, 2016, J PEDIATR GASTR NUTR, V63, pE193, DOI 10.1097/MPG.0000000000001196; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharma D, 2018, J MATERN-FETAL NEO M, V31, P1646, DOI 10.1080/14767058.2017.1322060; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stinson LF, 2017, CRIT REV MICROBIOL, V43, P352, DOI 10.1080/1040841X.2016.1211088; Underwood MA, 2017, CLIN PERINATOL, V44, P407, DOI 10.1016/j.clp.2017.01.005; Unger S, 2015, PEDIATR RES, V77, P205, DOI 10.1038/pr.2014.162; Walker WA, 2017, PEDIATR RES, V82, P387, DOI 10.1038/pr.2017.111; Young GR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00237; Yusef D, 2018, PEDIATR NEONATOL, V59, P35, DOI 10.1016/j.pedneo.2017.06.001; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281; 2013, PHARM RES, V69, P1, DOI DOI 10.1016/J.PHRS.2012.09.001; 2015, CELL HOST MICROBE, V17, P690, DOI DOI 10.1016/J.CHOM.2015.04.004	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216581	10.1371/journal.pone.0216581	http://dx.doi.org/10.1371/journal.pone.0216581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112570	gold, Green Submitted, Green Published			2022-12-27	WOS:000468451000017
J	Ferrara, MA; Filograna, A; Ranjan, R; Corda, D; Valente, C; Sirleto, L				Ferrara, Maria Antonietta; Filograna, Angela; Ranjan, Rajeev; Corda, Daniela; Valente, Carmen; Sirleto, Luigi			Three-dimensional label-free imaging throughout adipocyte differentiation by stimulated Raman microscopy	PLOS ONE			English	Article							LIPID DROPLETS; SCATTERING MICROSCOPY; IN-VIVO; SPECTRAL-RESOLUTION; LIVING CELLS; SENSITIVITY; METABOLISM; CARS; SPECTROSCOPY; EXPRESSION	Lipid droplets are lipid-storage organelles with a key role in lipid accumulation pathologies such as diabetes, obesity and atherosclerosis. Despite their important functions many aspects of lipid droplets biology are still unknown. This is partially due to the current use of exogenous labels to monitor their formation and remodelling by invasive imaging methods. Here, we apply stimulated Raman scattering microscopy to acquire images with high spatial resolution along with resolving capabilities of lipids and proteins and three-dimensional sectioning. Our images and data analysis demonstrate an increase in the number of large (>15 mu m(2)) lipid droplets in human adipocyte cells during differentiation process. In addition, spatially-resolved maps of lipids and proteins inside cells and three dimensional reconstructions of lipids at the initial and final steps of adipocyte differentiation are reported, too.	[Ferrara, Maria Antonietta; Ranjan, Rajeev; Sirleto, Luigi] CNR, Natl Res Council, Inst Microelect & Microsyst, Naples, Italy; [Filograna, Angela; Corda, Daniela; Valente, Carmen] CNR, Natl Res Council, Inst Prot Biochem, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Microelettronica e Microsistemi (IMM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Sirleto, L (corresponding author), CNR, Natl Res Council, Inst Microelect & Microsyst, Naples, Italy.; Valente, C (corresponding author), CNR, Natl Res Council, Inst Prot Biochem, Naples, Italy.	c.valente@ibp.cnr.it; luigi.sirleto@na.imm.cnr.it	Sirleto, Luigi/AAX-8024-2020; Ferrara, Maria Antonietta/E-5111-2016; Valente, Carmen/AAH-5261-2019; CORDA, DANIELA/K-6385-2016	Sirleto, Luigi/0000-0003-3894-8959; Ferrara, Maria Antonietta/0000-0001-5291-1373; Valente, Carmen/0000-0002-6244-9108; Ranjan, Rajeev/0000-0002-4131-6656; CORDA, DANIELA/0000-0002-3614-751X	Italian National Operative Programs [PONa3_00025]; Euro-bioimaging large scale pan-European research infrastructure project; TRansforming IDEas in Oncological research award (TRIDEO, AIRC-Fondazione Cariplo, Milan, Italy) [IG17524]	Italian National Operative Programs(Ministry of Education, Universities and Research (MIUR)); Euro-bioimaging large scale pan-European research infrastructure project; TRansforming IDEas in Oncological research award (TRIDEO, AIRC-Fondazione Cariplo, Milan, Italy)	This work was supported by Italian National Operative Programs PONa3_00025 (BIOforIU); Euro-bioimaging large scale pan-European research infrastructure project, http://www.eurobioimaging.eu/content-page/italy; TRansforming IDEas in Oncological research award (TRIDEO, AIRC-Fondazione Cariplo, Milan, Italy, IG17524 to C.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Garcia A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071407; Andresen ER, 2011, OPT LETT, V36, P2387, DOI 10.1364/OL.36.002387; Beier HT, 2011, OPT EXPRESS, V19, P18885, DOI 10.1364/OE.19.018885; Bruckner L, 2016, J OPT SOC AM B, V33, DOI 10.1364/JOSAB.33.001482; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; Chen XL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15117; Cheng JX, 2015, SCIENCE, V350, DOI 10.1126/science.aaa8870; Cole RA, 2018, J OPT SOC AM B, V35, P842, DOI 10.1364/JOSAB.35.000842; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Dou W, 2012, BIOPHYS J, V102, P1666, DOI 10.1016/j.bpj.2012.01.057; Fam TK, 2018, MATERIALS BASEL, V18, P11; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Francis A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178750; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2012, J AM CHEM SOC, V134, P3623, DOI 10.1021/ja210081h; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Hellerer T, 2004, APPL PHYS LETT, V85, P25, DOI 10.1063/1.1768312; Ito T, 2017, J OPT SOC AM B, V34, P1004, DOI 10.1364/JOSAB.34.001004; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040; Ji MB, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0195; Ji MB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005954; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; Lee HJ, 2017, METHODS, V128, P119, DOI 10.1016/j.ymeth.2017.07.020; Li MQ, 2012, CURR OPIN BIOTECH, V23, P56, DOI 10.1016/j.copbio.2011.11.019; Lu FK, 2015, P NATL ACAD SCI USA, V112, P11624, DOI 10.1073/pnas.1515121112; Melo RCN, 2011, METHODS MOL BIOL, V689, P149, DOI 10.1007/978-1-60761-950-5_9; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Ohsaki Y, 2010, HISTOCHEM CELL BIOL, V133, P477, DOI 10.1007/s00418-010-0678-x; Orringer DA, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0027; Ozeki Y, 2009, OPT EXPRESS, V17, P3651, DOI 10.1364/OE.17.003651; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; Ranjan R, 2018, OPT EXPRESS, V26, P26317, DOI 10.1364/OE.26.026317; Rizzatti V, 2013, EUR J HISTOCHEM, V57, P159, DOI 10.4081/ejh.2013.e24; Rocha-Mendoza I, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3028346; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Saar BG, 2011, MOL PHARMACEUT, V8, P969, DOI 10.1021/mp200122w; Saar BG, 2010, SCIENCE, V330, P1368, DOI 10.1126/science.1197236; Schultz C, 2010, COLD SPRING HARB PRO; SHEN YR, 1965, PHYS REV, V137, P1787, DOI 10.1103/PhysRev.137.A1787; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Streets AM, 2014, ANAL CHEM, V86, P8506, DOI 10.1021/ac5013706; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sultana A, 2016, FASEB J, V30, P2324, DOI 10.1096/fj.201500026R; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Tirinato L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1656053; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Wang P, 2014, ANGEW CHEM INT EDIT, V53, P11787, DOI 10.1002/anie.201406029; Wei L, 2015, ACS CHEM BIOL, V10, P901, DOI 10.1021/cb500787b; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yu Y, 2014, BBA-MOL CELL BIOL L, V1841, P1120, DOI 10.1016/j.bbalip.2014.02.003; Yu ZL, 2012, CHEM SCI, V3, P2646, DOI 10.1039/c2sc20316b; Zhang C, 2017, ANAL CHEM, V89, P4502, DOI 10.1021/acs.analchem.6b04699; Zhang DL, 2014, ACCOUNTS CHEM RES, V47, P2282, DOI 10.1021/ar400331q; Zhang D, 2011, J PHYS CHEM LETT, V2, P1248, DOI 10.1021/jz200516n; Zumbusch A, 2013, PROG LIPID RES, V52, P615, DOI 10.1016/j.plipres.2013.07.003	61	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216811	10.1371/journal.pone.0216811	http://dx.doi.org/10.1371/journal.pone.0216811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112567	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000025
J	Koreny, M; Demeyer, H; Arbillaga-Etxarri, A; Gimeno-Santos, E; Barberan-Garcia, A; Benet, M; Balcells, E; Borrell, E; Marin, A; Chiaradia, DAR; Vall-Casas, P; Vilaro, J; Rodriguez-Roisin, R; Garcia-Aymerich, J				Koreny, Maria; Demeyer, Heleen; Arbillaga-Etxarri, Ane; Gimeno-Santos, Elena; Barberan-Garcia, Anael; Benet, Marta; Balcells, Eva; Borrell, Eulalia; Marin, Alicia; Rodriguez Chiaradia, Diego A.; Vall-Casas, Pere; Vilaro, Jordi; Rodriguez-Roisin, Robert; Garcia-Aymerich, Judith			Determinants of study completion and response to a 12-month behavioral physical activity intervention in chronic obstructive pulmonary disease: A cohort study	PLOS ONE			English	Article							COPD; PEOPLE; LIFE; REHABILITATION; IMPUTATION; PROGRAM	Objectives Physical activity is key to improve the prognosis of chronic obstructive pulmonary disease (COPD). To help to tailor future interventions we aimed to identify the baseline characteristics of COPD patients which predict 12-month completion and response to a behavioral physical activity intervention. Methods This is a 12-month cohort study of the intervention arm of the Urban Training randomized controlled trial (NCT01897298), an intervention proven to be efficacious to increase physical activity. We considered baseline sociodemographic, interpersonal, environmental, clinical and psychological characteristics as potential determinants of completion and response. We defined completion as attending the 12-month study visit. Among completers, we defined response as increasing physical activity >= 1100 steps/day from baseline to 12 months, measured by accelerometer. We estimated the factors independently for completion and response using multivariable logistic regression models. Results Of a total of 202 patients (m (SD) 69 (9) years, 84% male), 132 (65%) completed the study. Among those, 37 (28%) qualified as responders. Higher numbers of baseline steps/day (OR [95% CI] 1.11 [1.02-1.21] per increase of 1000 steps, p<0.05) and living with a partner (2.77 [1.41-5.48], p<0.01) were related to a higher probability of completion while more neighborhood vulnerability (0.70 [0.57-0.86] per increase of 0.1 units in urban vulnerability index, p<0.01) was related to a lower probability. Among the completers, working (3.14 [1.05-9.33], p<0.05) and having an endocrino-metabolic disease (4.36 [1.49-12.80], p<0.01) were related to a higher probability of response while unwillingness to follow the intervention (0.21 [0.05-0.98], p<0.05) was related to a lower probability. Conclusions This study found that 12-month completion of a behavioral physical activity intervention was generally determined by previous physical activity habits as well as interpersonal and environmental physical activity facilitators while response was related to diverse factors thought to modify the individual motivation to change to an active lifestyle.	[Koreny, Maria; Benet, Marta; Garcia-Aymerich, Judith] ISGlobal, Barcelona, Spain; [Koreny, Maria; Benet, Marta; Balcells, Eva; Rodriguez Chiaradia, Diego A.; Garcia-Aymerich, Judith] Pompeu Fabra Univ UPF, Barcelona, Spain; [Koreny, Maria; Benet, Marta; Garcia-Aymerich, Judith] CIBERESP, Barcelona, Spain; [Demeyer, Heleen] Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium; [Demeyer, Heleen] Univ Hosp KU Leuven, Dept Resp Dis, Leuven, Belgium; [Arbillaga-Etxarri, Ane] Univ Deusto, Phys Act & Sports Sci, Fac Psychol & Educ, Donostia San Sebastian, Spain; [Gimeno-Santos, Elena; Barberan-Garcia, Anael] Hosp Clin Barcelona, Resp Clin Inst, Barcelona, Spain; [Gimeno-Santos, Elena; Barberan-Garcia, Anael; Rodriguez-Roisin, Robert] August Pi & Sunyer Biomed Res Inst & DIBAPS, Barcelona, Spain; [Barberan-Garcia, Anael; Balcells, Eva; Marin, Alicia; Rodriguez Chiaradia, Diego A.] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Balcells, Eva; Rodriguez Chiaradia, Diego A.] Hosp Mar, Inst Hosp Mar Invest Med IMIM, Pneumol Dept, Barcelona, Spain; [Borrell, Eulalia] ICS, St Roc Primary Hlth Care Ctr, Badalona, Spain; [Marin, Alicia] Hosp Badalona Germans Trias & Pujol, Dept Pulm Med, Badalona, Spain; [Marin, Alicia] Fdn Inst Invest Ciencies Salut Germans Tria & Puj, Badalona, Spain; [Vall-Casas, Pere] Univ Int Catalunya, Barcelona, Spain; [Vilaro, Jordi] Ramon Llull Univ, Blanquerna Hlth Sci Sch, Global Res Wellbeing GRoW, Barcelona, Spain	ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; KU Leuven; KU Leuven; University Hospital Leuven; University of Deusto; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Germans Trias i Pujol; Universitat Internacional de Catalunya (UIC); Universitat Ramon Llull	Garcia-Aymerich, J (corresponding author), ISGlobal, Barcelona, Spain.; Garcia-Aymerich, J (corresponding author), Pompeu Fabra Univ UPF, Barcelona, Spain.; Garcia-Aymerich, J (corresponding author), CIBERESP, Barcelona, Spain.	judith.garcia@isglobal.org	J, Garcia-Aymerich/G-6867-2014	J, Garcia-Aymerich/0000-0002-7097-4586; Arbillaga-Etxarri, Ane/0000-0003-3565-0751; Demeyer, Heleen/0000-0001-8925-0564	ERS/SEPAR Fellowship; FWO-Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (ISCIII) [NCT01897298, PI11/01283, PI14/0419]; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) [147/2011, 201/2011]; Societat Catalana de Pneumologia; Generalitat de Catalunya (El programa de centres de recerca de Catalunya); AGAUR [2014-SGR-661]; Catalan Government (Agencia de Gestion de Ayudas Universitarias y de Investigacion)	ERS/SEPAR Fellowship; FWO-Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen)(FWO); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Pneumologia; Generalitat de Catalunya (El programa de centres de recerca de Catalunya); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Catalan Government (Agencia de Gestion de Ayudas Universitarias y de Investigacion)	HD is the recipient of a joint ERS/SEPAR Fellowship (LTRF 2015) (Sociedad Espanola De Neumologia Y Cirugia Toracica (Separ) www.separ.es) and is a post-doctoral research fellow of the FWO-Flanders (Fonds voor Wetenschappelijk Onderzoek - Vlaanderen https://www.fwo.be/en).The Urban TrainingTM study (NCT01897298) was funded by grants from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (ISCIII, PI11/01283 and PI14/0419) (Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III http://www.isciii.es), integrated into Plan Estatal I+D+I 2013-2016 and co-funded by ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion and Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR, 147/2011 and 201/2011), Societat Catalana de Pneumologia (Ajuts al millor projecte en fisioterapia respiratoria 2013). ISGlobal is a member of the CERCA Program, Generalitat de Catalunya (El programa de centres de recerca de Catalunya http://cerca.cat/). Anael Barberan-Garcia had personal funding from AGAUR 2014-SGR-661, Catalan Government (Agencia de Gestion de Ayudas Universitarias y de Investigacion http://agaur.gencat.cat/es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg WA, 2015, RESP MED, V109, P112, DOI 10.1016/j.rmed.2014.10.020; Arbillaga-Etxarri A, 2017, THORAX, P1; Arbillaga-Etxarri A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00063-2018; Arbillaga-Etxarri A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146705; Arnold E, 2006, RESP MED, V100, P1716, DOI 10.1016/j.rmed.2006.02.007; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Centers for Disease Control and Prevention, 2012, OV BARR PHYS ACT; Demeyer H, 2017, THORAX, V72, P415, DOI 10.1136/thoraxjnl-2016-209026; Demeyer H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154587; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; European Lung Foundation-ELF, FACTSH LIV ACT COPD; Garcia-Aymerich J., 2015, BRN REV, V1, P92; Gimeno-Santos E, 2015, EUR RESPIR J, V46, P988, DOI 10.1183/09031936.00183014; Gimeno-Santos E, 2014, THORAX, V69, P731, DOI 10.1136/thoraxjnl-2013-204763; Global Initiative for Chronic Obstructive Lung Disease, 2017, GLOB STRAT DIAGN MAN; Hartman JE, 2013, J PHYSIOTHER, V59, P117, DOI 10.1016/S1836-9553(13)70164-4; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kantorowski A, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00054-2018; Keating A, 2011, CHRON RESP DIS, V8, P89, DOI 10.1177/1479972310393756; Kosteli MC, 2017, INT J CHRONIC OBSTR, V12, DOI 10.2147/COPD.S119806; Mendoza L, 2015, EUR RESPIR J, V45, P347, DOI 10.1183/09031936.00084514; Mesquita R, 2017, CHEST, V151, P1028, DOI 10.1016/j.chest.2016.12.021; Moy ML, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5622; Moy ML, 2015, CHEST, V148, P128, DOI 10.1378/chest.14-1466; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Thorpe O, 2014, INT J CHRONIC OBSTR, V9, P115, DOI 10.2147/COPD.S54457; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Van Remoortel H, 2013, THORAX, V68, P962, DOI 10.1136/thoraxjnl-2013-203534; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Walsh JR, 2013, J CARDIOPULM REHABIL, V33, P249, DOI 10.1097/HCR.0b013e31829501b7; Waschki B, 2015, AM J RESP CRIT CARE, V192, P295, DOI 10.1164/rccm.201501-0081OC; WHO, 2002, INNOVATIVE CARE CHRO; 2014, CHEST, V146, P318, DOI DOI 10.1378/CHEST.13-1968	37	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217157	10.1371/journal.pone.0217157	http://dx.doi.org/10.1371/journal.pone.0217157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107900	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000468285200033
J	Waziri, B; Musenge, E; Duarte, R; Dickens, C; Dix-Peek, T; Rekhviashvili, V; Paget, G; Naicker, S				Waziri, Bala; Musenge, Eustasius; Duarte, Raquel; Dickens, Caroline; Dix-Peek, Therese; Rekhviashvili, Vakhtang; Paget, Graham; Naicker, Saraladevi			Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease-Mineral and bone disorder with all cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ALKALINE-PHOSPHATASE; RACIAL-DIFFERENCES; VASCULAR CALCIFICATION; VITAMIN-D; METABOLISM; PHOSPHORUS; CALCIUM; FGF-23; FGF23	Introduction Few studies have linked high levels of plasma C-terminal fibroblast growth factor 23 (FGF23) with poor clinical outcomes in patients on maintenance haemodialysis (MHD), while the association between intact FGF23 and mortality in this group of patients remains inconclusive. Therefore, the aim of this study was to evaluate the association between plasma levels of intact FGF23 and mortality in dialysis patients. Methods A prospective multicenter study involving patients undergoing dialysis at three dialysis centers in Johannesburg was undertaken between 1st October 2014 and 31st December 2017. Results The study comprised 165 chronic dialysis patients (111 blacks, 54 whites) with a mean age of 46.6 +/- 14.2 years. During a three year follow up period, there were 46 deaths (1.03 per 100 person-years). The median plasma FGF 23 level was 382 pg/ml (interquartile range [IQR], 145-2977). In adjusted multivariable analyses, there was a non-statistically significant increase in the risk of mortality with higher quartiles of FGF 23 levels: the adjusted hazard ratios (HR) for the second, third and fourth quantiles were HR 3.20 (95% CI, 0.99-10.35; P = 0.052), HR 2.43(95% CI, 0.65-9.09; P = 0.19), and HR 2.09 (95% CI, 0.66-7.32; P = 0.25), respectively. Corrected serum calcium 2.38-2.5 mmol/l [HR 2.98 (95% CI, 1.07-8.29; P = 0.04] and > 2.50 mmol/l [HR 5.50 (95% CI, 1.84-16.48; P = 0.002] were independently associated with increased risk of death. Likewise, patients with intact parathyroid hormone > 600 pg/ml had a 3.46-fold higher risk of death (HR 3.46, 95% CI, 1.22-9.82 P = 0.019). These findings persisted in time-dependent analyses. Conclusion Higher levels of intact FGF 23 appear not to be independently associated with all-cause mortality in our dialysis patients, while hypercalcaemia and severe hyperparathyroidism were found to be independent predictors of mortality in this cohort of patients.	[Waziri, Bala; Musenge, Eustasius] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Waziri, Bala; Duarte, Raquel; Dickens, Caroline; Dix-Peek, Therese; Paget, Graham; Naicker, Saraladevi] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa; [Waziri, Bala] Ibrahim Badamasi Babangida Specialist Hosp, Dept Med, Minna, Nigeria; [Rekhviashvili, Vakhtang] Univ Witwatersrand, Donald Gordon Med Ctr, Renal Unit, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Waziri, B (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.; Waziri, B (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa.; Waziri, B (corresponding author), Ibrahim Badamasi Babangida Specialist Hosp, Dept Med, Minna, Nigeria.	balawaziri@gmail.com		Naicker, Saraladevi/0000-0002-7058-9725	AstraZeneca Research Trust Fund [ACWAZ1]; Bala Waziri's International Society of Nephrology (ISN) fellowship training at the University of the Witwatersrand	AstraZeneca Research Trust Fund; Bala Waziri's International Society of Nephrology (ISN) fellowship training at the University of the Witwatersrand	This study was funded by the AstraZeneca Research Trust Fund (ACWAZ1) to Dr Bala Waziri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has also been made possible through Bala Waziri's International Society of Nephrology (ISN) fellowship training at the University of the Witwatersrand.	Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Bolasco P, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/758450; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Drechsler C, 2011, CLIN J AM SOC NEPHRO, V6, P1752, DOI 10.2215/CJN.10091110; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Fouque D, 2013, NEPHROL DIAL TRANSPL, V28, P360, DOI 10.1093/ndt/gfs404; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2010, NEPHROL DIAL TRANSPL, V25, P3970, DOI 10.1093/ndt/gfq316; Gutierrez OM, 2010, CLIN J AM SOC NEPHRO, V5, P1710, DOI 10.2215/CJN.02640310; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Halle MP, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0377-5; Isakova T, 2018, J AM SOC NEPHROL, V29, P579, DOI 10.1681/ASN.2017070772; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Isla RAT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156642; Ito N, 2005, J BONE MINER METAB, V23, P435, DOI 10.1007/s00774-005-0625-4; Jovanovich A, 2012, CLIN J AM SOC NEPHRO, V7, P640, DOI 10.2215/CJN.07020711; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; Kobayashi I, 2012, LIFE SCI, V90, P212, DOI 10.1016/j.lfs.2011.11.006; Kovesdy CP, 2010, NEPHROL DIAL TRANSPL, V25, P3003, DOI 10.1093/ndt/gfq144; Levin A, 2003, SEMIN DIALYSIS, V16, P101, DOI 10.1046/j.1525-139X.2003.16025.x; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; Naves-Diaz M, 2011, NEPHROL DIAL TRANSPL, V26, P1938, DOI 10.1093/ndt/gfq304; Olauson H, 2010, NEPHROL DIAL TRANSPL, V25, P3033, DOI 10.1093/ndt/gfq191; Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; Shardlow A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016528; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Souma N, 2016, J CLIN ENDOCR METAB, V101, P3779, DOI 10.1210/jc.2016-2215; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Waziri B, 2018, KIDNEY INT REP, V3, P583, DOI 10.1016/j.ekir.2017.12.004; Waziri B, 2017, INT J NEPHROL, V2017, DOI 10.1155/2017/2795432; Wesseling-Perry K, 2011, CLIN CHEM, V57, P1476, DOI 10.1373/clinchem.2011.172890; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yang HL, 2016, BIOMARK MED, V10, P547, DOI 10.2217/bmm.16.11	41	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216656	10.1371/journal.pone.0216656	http://dx.doi.org/10.1371/journal.pone.0216656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107896	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200013
J	Xanthis, CG; Aletras, AH				Xanthis, Christos G.; Aletras, Anthony H.			coreMRI: A high-performance, publicly available MR simulation platform on the cloud	PLOS ONE			English	Article							MAGNETIC-RESONANCE; MOLLI; T1; QUANTIFICATION; T2	Introduction A Cloud-ORiented Engine for advanced MRI simulations (coreMRI) is presented in this study. The aim was to develop the first advanced MR simulation platform delivered as a web service through an on-demand, scalable cloud-based and GPU-based infrastructure. We hypothesized that such an online MR simulation platform could be utilized as a virtual MRI scanner but also as a cloud-based, high-performance engine for advanced MR simulations in simulation-based quantitative MR (qMR) methods. Methods and results The simulation framework of coreMRI was based on the solution of the Bloch equations and utilized a ground-up-approach design based on the principles already published in the literature. The development of a front-end environment allowed the connection of the end-users to the GPU-equipped instances on the cloud. The coreMRI simulation platform was based on a modular design where individual modules (such as the Gadgetron reconstruction framework and a newly developed Pulse Sequence Designer) could be inserted in the main simulation framework. Different types and sources of pulse sequences and anatomical models were utilized in this study revealing the flexibility that the coreMRI simulation platform offers to the users. The performance and scalability of coreMRI were also examined on multi-GPU configurations on the cloud, showing that a multi-GPU computer on the cloud equipped with a newer generation of GPU cards could significantly mitigate the prolonged execution times that accompany more realistic MRI and qMR simulations. Conclusions coreMRI is available to the entire MR community, whereas its high performance and scalability allow its users to configure advanced MRI experiments without the constraints imposed by experimentation in a true MRI scanner (such as time constraint and limited availability of MR scanners), without upfront investment for purchasing advanced computer systems and without any user expertise on computer programming or MR physics. coreMRI is available to the users through the webpage https://www.coreMRI.org.	[Xanthis, Christos G.; Aletras, Anthony H.] Lund Univ, Skane Univ Hosp, Clin Physiol, Dept Clin Sci Lund, Lund, Sweden; [Aletras, Anthony H.] Aristotle Univ Thessaloniki, Sch Med, Lab Comp Med Informat & Biomed Imaging Technol, Thessaloniki, Greece	Lund University; Skane University Hospital; Aristotle University of Thessaloniki	Aletras, AH (corresponding author), Lund Univ, Skane Univ Hosp, Clin Physiol, Dept Clin Sci Lund, Lund, Sweden.; Aletras, AH (corresponding author), Aristotle Univ Thessaloniki, Sch Med, Lab Comp Med Informat & Biomed Imaging Technol, Thessaloniki, Greece.	aletras@auth.gr	Aletras, Anthony/ABE-9967-2020	Aletras, Anthony/0000-0002-3786-3817				Aubert-Broche B, 2006, IEEE T MED IMAGING, V25, P1410, DOI 10.1109/TMI.2006.883453; Benoit-Cattin H, 2005, J MAGN RESON, V173, P97, DOI 10.1016/j.jmr.2004.09.027; Chow K, 2014, MAGN RESON MED, V71, P2082, DOI 10.1002/mrm.24878; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Fortin A, 2018, MAGN RESON MED, V80, P1655, DOI 10.1002/mrm.27114; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Hacklander T, 2004, ROFO-FORTSCHR RONTG, V176, P1151, DOI 10.1055/s-2004-813215; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Hanson Lars G, 2007, Radiographics, V27, pe27; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; Inati SJ, 2017, MAGN RESON MED, V77, P411, DOI 10.1002/mrm.26089; Jochimsen TH, 2004, J MAGN RESON, V170, P67, DOI 10.1016/j.jmr.2004.05.021; Kantasis G, 2017, J MAGN RESON, V274, P80, DOI 10.1016/j.jmr.2016.11.007; Kawel N, 2012, CIRC-CARDIOVASC IMAG, V5, P500, DOI 10.1161/CIRCIMAGING.112.973560; Kellman P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-2; Kellman P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-63; Kellman P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-63; Kose R, 2017, J MAGN RESON, V281, P51, DOI 10.1016/j.jmr.2017.05.007; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Layton KJ, 2017, MAGN RESON MED, V77, P1544, DOI 10.1002/mrm.26235; Liu F, 2017, IEEE T MED IMAGING, V36, P527, DOI 10.1109/TMI.2016.2620961; Liu YL, 2016, MED PHYS, V43, P179, DOI 10.1118/1.4938066; Magland JF, 2016, MAGN RESON MED, V75, P257, DOI 10.1002/mrm.25640; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Narayanan K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001193; Roujol S, 2014, RADIOLOGY, V272, P683, DOI 10.1148/radiol.14140296; Rundle D, 1990, J Digit Imaging, V3, P226; Shkarin P, 1997, INT J IMAG SYST TECH, V8, P419, DOI 10.1002/(SICI)1098-1098(1997)8:5<419::AID-IMA1>3.0.CO;2-D; Stocker T, 2011, J PHYS CONF SER, V295, DOI 10.1088/1742-6596/295/1/012020; Stocker T, 2010, MAGN RESON MED, V64, P186, DOI 10.1002/mrm.22406; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; Wissmann L, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0063-3; Xanthis CG, 2018, MAGN RESON IMAGING, V48, P96, DOI 10.1016/j.mri.2017.12.020; Xanthis CG, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0206-1; Xanthis CG, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-48; Xanthis CG, 2014, IEEE T MED IMAGING, V33, P607, DOI 10.1109/TMI.2013.2292119; 2013, NATURE, V495, P187, DOI DOI 10.1038/NATURE11971	38	6	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216594	10.1371/journal.pone.0216594	http://dx.doi.org/10.1371/journal.pone.0216594			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100074	Green Submitted, Green Published, gold			2022-12-27	WOS:000468176600010
J	Yuan, JX; Hou, XD; Barlow, A; Preick, M; Taron, UH; Alberti, F; Basler, N; Deng, T; Lai, XL; Hofreiter, M; Sheng, GL				Yuan, Jun-Xia; Hou, Xin-Dong; Barlow, Axel; Preick, Michaels; Taron, Ulrike H.; Alberti, Federica; Basler, Nikolas; Deng, Tao; Lai, Xu-Long; Hofreiter, Michael; Sheng, Gui-Lian			Molecular identification of late and terminal Pleistocene Equus ovodovi from northeastern China	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; CHAGYRSKAYA CAVE; ALTAI MOUNTAINS; READ ALIGNMENT; PERISSODACTYLA; SUSSEMIONUS; SEQUENCE; DEPOSITS; SUBGENUS; ANCIENT	The extant diversity of horses (family Equidae) represents a small fraction of that occurring over their evolutionary history. One such lost lineage is the subgenus Sussemionus, which is thought to have become extinct during the Middle Pleistocene. However, recent molecular studies and morphological analysis have revealed that one of their representatives, E. ovodovi, did exist in Siberia during the Late Pleistocene. Fossil materials of E. ovodovi have thus far only been found in Russia. In this study, we extracted DNA from three equid fossil specimens excavated from northeastern China dated at 12,770-12,596, 29,525-28,887 and 40,201-38,848 cal. yBP, respectively, and retrieved three near-complete mitochondrial genomes from the specimens. Phylogenetic analyses cluster the Chinese haplotypes together with previously published Russian E. ovodovi, strongly supporting the assignment of these samples to this taxon. The molecular identification of E. ovodovi in northeastern China extends the known geographical range of this fossil species by several thousand kilometers to the east. The estimated coalescence time of all E. ovodovi haplotypes is approximately 199 Kya, with the Chinese haplotypes coalescing approximately 130 Kya. With a radiocarbon age of 12,770-12,596 cal. yBP, the youngest sample in this study represents the first E. ovodovi sample dating to the terminal Pleistocene, moving the extinction date of this species forwards considerably compared to previously documented fossils. Overall, comparison of our three mitochondrial genomes with the two published ones suggests a genetic diversity similar to several extant species of the genus Equus.	[Yuan, Jun-Xia] China Univ Geosci, Fac Mat Sci & Chem, Wuhan, Hubei, Peoples R China; [Yuan, Jun-Xia; Hou, Xin-Dong; Lai, Xu-Long; Sheng, Gui-Lian] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan, Hubei, Peoples R China; [Barlow, Axel; Preick, Michaels; Taron, Ulrike H.; Alberti, Federica; Basler, Nikolas; Hofreiter, Michael] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Deng, Tao] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, IVPP, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences; University of Potsdam; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Sheng, GL (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan, Hubei, Peoples R China.; Hofreiter, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	michael.hofreiter@uni-potsdam.de; glsheng@cug.edu.cn	Basler, Nikolas/GZL-5209-2022	Basler, Nikolas/0000-0003-0791-4369; Barlow, Axel/0000-0002-5532-9458; Taron, Ulrike Helene/0000-0001-7558-4766; Sheng, Gui-Lian/0000-0003-2314-1650; Lai, Xulong/0000-0002-2837-0885	National Natural Science Foundation of China [41472014, 41672017]; China Scholarship Council [2016-2041]; DAAD [2016-2041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This research was financially supported by the National Natural Science Foundation of China (Nos. 41472014; 41672017) and the "PPP" project jointly funded by China Scholarship Council and DAAD (No. 2016-2041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler Nikolas, 2017, BMC Research Notes, V10, P754, DOI 10.1186/s13104-017-3061-3; Cai B, 1992, B CHIN ACAD GEOL SCI, V25, P131; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Deng T, 1998, SCI CHINA, V28, P505; Deng T., 1999, VERTEBRAT PALASIATIC, V23, P51; Dong Wei, 1996, Vertebrata Palasiatica, V34, P58; Dong Wei, 2009, Acta Anthropologica Sinica, V28, P95; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Druzhkova AS, 2017, MITOCHONDRIAL DNA B, V2, P79, DOI 10.1080/23802359.2017.1285209; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenmann V, 2011, GEODIVERSITAS, V33, P519, DOI 10.5252/g2011n3a5; Eisenmann V, 2010, CR BIOL, V333, P235, DOI 10.1016/j.crvi.2009.12.013; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Jiang P., 1982, J NE NORMAL U NAT SC, V1, P105; Jin Changzhu, 1998, Vertebrata Palasiatica, V36, P47; JIN CZ, 1984, VERTEBRAT PALASIATIC, V22, P314; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuzmin YV, 2017, QUATERNARY SCI REV, V161, P117, DOI 10.1016/j.quascirev.2017.02.010; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LU YQ, 1986, VERTEBRAT PALASIATIC, V24, P152; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; [聂宗笙 Nie Zongsheng], 2008, [第四纪研究, Quaternary Sciences], V28, P14; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Ouyang Lian, 1993, Vertebrata Palasiatica, V31, P208; Paijmans JLA, 2017, SEQUENCING SINGLE ST; Qiu Zhan-Xiang, 2006, Vertebrata Palasiatica, V44, P109; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rudaya N, 2017, PALAEOGEOGR PALAEOCL, V467, P265, DOI 10.1016/j.palaeo.2015.12.007; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tang Zhuo-Wei, 2003, Vertebrata Palasiatica, V41, P137; Vasiliev SK, 2013, ARCHAEOL ETHNOL ANTH, V41, P28, DOI 10.1016/j.aeae.2013.07.003; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Wei H., 1986, LIAONING GEOLOGY, V1, P69; Xue Xiangxu, 1994, Acta Theriologica Sinica, V14, P15; [张俊辉 Zhang Junhui], 2012, [地球科学进展, Advance in Earth Sciences], V27, P42; Zheng Jia-jian, 1992, Journal of Stratigraphy, V16, P171; ZHOW XX, 1985, VERTEBRAT PALASIATIC, V23, P69; 董为, 2010, [科学通报, Chinese Science Bulletin], V55, P1376	41	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216883	10.1371/journal.pone.0216883	http://dx.doi.org/10.1371/journal.pone.0216883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095634	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000468030100050
J	Taffoni, F; Focaroli, V; Keller, F; Iverson, JM				Taffoni, Fabrizio; Focaroli, Valentina; Keller, Flavio; Iverson, Jana Marie			Motor performance in a shape sorter task: A longitudinal study from 14 to 36 months of age in children with an older sibling ASD	PLOS ONE			English	Article							HIGH-RISK; 6-MONTH-OLD INFANTS; RESEARCH CONSORTIUM; KINEMATIC ANALYSIS; HAND ORIENTATION; POSTURAL CONTROL; AUTISM; SPECTRUM; OBJECT; GOAL	During development, motor skills are fundamental in supporting interactions with the external world. The ability to plan actions is a particularly important aspect of motor skill since it is involved in many daily activities. In this work, we studied the development of motor planning longitudinally in children with an older sibling with Autism Spectrum Disorder (ASD) who are at heightened risk (HR) for the disorder and children with no such risk (low risk; LR) using a shape sorter task. Children were observed at 14, 18, 24 and 36 months. Three HR children with a later diagnosis of ASD (HR-ASD) were analyzed separately from the rest of the sample. Behavioral and kinematic data indicated that precision demands significantly influenced children's actions, and that children's performance improved with age. No differences were found between the HR and LR groups, but a descriptive analysis of data from the three HR-ASD suggested differences in the variables describing children's action (as reaching time and acceleration) as well as variables describing children's performance (as the adjustment of the shapes).	[Taffoni, Fabrizio] Univ Campus Biomed Roma, Lab Biomed Robot & Biomicrosyst, Rome, Italy; [Focaroli, Valentina; Keller, Flavio] Univ Campus Biomed Roma, Lab Dev Neurosci, Rome, Italy; [Iverson, Jana Marie] Univ Pittsburgh, Dept Psychol, Infant Commun Lab, Pittsburgh, PA 15260 USA	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Focaroli, V (corresponding author), Univ Campus Biomed Roma, Lab Dev Neurosci, Rome, Italy.	v.focaroli@unicampus.it	Taffoni, Fabrizio/AAC-2572-2019	Taffoni, Fabrizio/0000-0003-3215-1375; Keller, Flavio/0000-0002-6449-6960	National Institutes of Health [R01 HD054979, R21 HD068584];  [HD35469];  [HD055748]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This research was supported by grants from the National Institutes of Health (R01 HD054979 and R21 HD068584) to JMI. Additional support was provided by HD35469 and HD055748 to NJ Minshew.; This research was supported by grants from the National Institutes of Health (R01 HD054979 and R21 HD068584) to JMI. Additional support was provided by HD35469 and HD055748 to N.J. Minshew. We thank members of the Infant Communication Lab at the University of Pittsburgh for help with data collection and coding, Special thanks to the children and their families, without whose enthusiastic and dedicated participation the study could not have been completed.	Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Berthier NE, 1996, DEV PSYCHOL, V32, P811; Campolo D, 2011, IEEE T BIO-MED ENG, V58, P1499, DOI 10.1109/TBME.2011.2105871; Chen YP, 2010, CHILD DEV, V81, P1846, DOI 10.1111/j.1467-8624.2010.01514.x; Claxton LJ, 2003, PSYCHOL SCI, V14, P354, DOI 10.1111/1467-9280.24421; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Corbetta D, 2000, INFANT BEHAV DEV, V23, P351, DOI 10.1016/S0163-6383(01)00049-2; Corbetta D., 2019, REACH TO GRASP BEHAV, P18, DOI DOI 10.4324/9780429467875-2; Corbetta D, 2009, INFANT BEHAV DEV, V32, P44, DOI 10.1016/j.infbeh.2008.10.004; ELAN, 2017, COMPUTER SOFTWARE; Fabbri-Destro M, 2009, EXP BRAIN RES, V192, P521, DOI 10.1007/s00221-008-1578-3; Fagard J, 1996, BRIT J DEV PSYCHOL, V14, P65, DOI 10.1111/j.2044-835X.1996.tb00694.x; Fallang B, 2000, BEHAV BRAIN RES, V115, P9, DOI 10.1016/S0166-4328(00)00231-X; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Focaroli V, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00724; Forti S, 2011, RES AUTISM SPECT DIS, V5, P834, DOI 10.1016/j.rasd.2010.09.013; Gentilucci M, 1997, EXP BRAIN RES, V114, P130, DOI 10.1007/PL00005612; Glazebrook CM, 2006, MOTOR CONTROL, V10, P244, DOI 10.1123/mcj.10.3.244; HALLETT M, 1993, ARCH NEUROL-CHICAGO, V50, P1304, DOI 10.1001/archneur.1993.00540120019007; Heathcock J. C., 2005, AM J OCCUP THER, V69; Iverson JM, 2019, J ABNORM PSYCHOL, V128, P69, DOI 10.1037/abn0000390; Iverson JM, 2018, J AUTISM DEV DISORD, V48, P55, DOI 10.1007/s10803-017-3297-8; Iverson JM, 2010, J CHILD LANG, V37, P229, DOI 10.1017/S0305000909990432; Lausberg H, 2009, BEHAV RES METHODS, V41, P841, DOI 10.3758/BRM.41.3.841; Leonard HC, 2014, CHILD ADOL MENT H-UK, V19, P163, DOI 10.1111/camh.12055; Leonard HC, 2014, AUTISM, V18, P281, DOI 10.1177/1362361312470037; Libertus K, 2014, CHILD DEV, V85, P2218, DOI 10.1111/cdev.12262; LOCKMAN JJ, 1984, J EXP CHILD PSYCHOL, V37, P176, DOI 10.1016/0022-0965(84)90065-1; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Messinger D, 2013, J AM ACAD CHILD PSY, V52, P300, DOI 10.1016/j.jaac.2012.12.011; Minshew NJ, 2004, NEUROLOGY, V63, P2056, DOI 10.1212/01.WNL.0000145771.98657.62; Ornkloo H, 2007, DEV PSYCHOL, V43, P404, DOI 10.1037/0012-1649.43.2.404; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Ransburg N, 2017, INFANT BEHAV DEV, V48, P164, DOI 10.1016/j.infbeh.2017.04.003; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schum N, 2011, J EXP CHILD PSYCHOL, V109, P218, DOI 10.1016/j.jecp.2011.01.007; Sheinkopf SJ, 2012, AUTISM RES, V5, P331, DOI 10.1002/aur.1244; Snijders T., 1999, MULTILEVEL MODELING; Spencer JP, 2000, DEVELOPMENTAL SCI, V3, P216, DOI 10.1111/1467-7687.00115; Taffoni F, 2009, IEEE ENG MED BIO, P210, DOI 10.1109/IEMBS.2009.5333127; Taffoni F, 2012, P IEEE RAS-EMBS INT, P1879, DOI 10.1109/BioRob.2012.6290922; Thelen E., 1993, DYNAMIC SYSTEMS APPR; VONHOFSTEN C, 1984, J EXP CHILD PSYCHOL, V38, P208, DOI 10.1016/0022-0965(84)90122-X; Weigelt M., 2018, DEV ANTICIPATORY PLA; West K. L., CHILD DEV; Whyatt C, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00051; Wilmut K, 2013, EXP BRAIN RES, V226, P421, DOI 10.1007/s00221-013-3453-0; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606	52	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217416	10.1371/journal.pone.0217416	http://dx.doi.org/10.1371/journal.pone.0217416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136606	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300038
J	Rutherford, C; Sharp, H; Hill, J; Pickles, A; Taylor-Robinson, D				Rutherford, Callum; Sharp, Helen; Hill, Jonathan; Pickles, Andrew; Taylor-Robinson, David			How does perinatal maternal mental health explain early social inequalities in child behavioural and emotional problems? Findings from the Wirral Child Health and Development Study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; EXTERNALIZING PROBLEMS; TRAJECTORIES; POVERTY; PSYCHOPATHOLOGY; CHECKLIST; POSITION; SCALE	Background This study aimed to assess how maternal mental health mediates the association between childhood socio-economic conditions at birth and subsequent child behavioural and emotional problem scores. Methods Analysis of the Wirral Child Health and Development Study (WCHADS), a prospective epidemiological longitudinal study of the early origins of child mental health (n = 664). Household income at 20-weeks gestation, a measure of socio-economic conditions (SECs) in pregnancy, was the main exposure. The outcome measure was externalising and internalising problems, as measured by the Child Behaviour Checklist at 5 years. We assessed the association of household income with child behavioural outcomes in sequential linear models adjusting for maternal mental health in the pre- and post-natal period. Results Children of mothers in more disadvantaged households had higher scores for externalising behaviour with a difference of 3.6 points comparing the most affluent to the most disadvantaged families (the socio-economic (SEC) gap). In our regression model adjusting for baseline confounders, comparing children of mothers in the most disadvantaged households to the least disadvantaged, we found that most disadvantaged children scored 45 percentage points (95% CI 9, 93) higher for externalising problems, and 42% of this difference was explained in the fully adjusted model. Adjusting for prenatal maternal depressive symptomology attenuated the SEC gap in externalising problems by about a third, rendering the association non-significant, whilst adjusting for pre- and post-natal maternal mental health attenuated the SEC gap by 42%. There was no significant relationship between household income and internalising problems. Conclusion Social disadvantage is associated with higher child externalising behaviour problems score at age 5, and about 40% of this was explained by maternal perinatal mental health. Policies supporting maternal mental health in pregnancy are important to address the early emergence of inequalities in child mental health.	[Rutherford, Callum; Taylor-Robinson, David] Univ Liverpool, Farr Inst, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Sharp, Helen] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England; [Hill, Jonathan] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Pickles, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, Biostat Dept, London, England	University of Liverpool; University of Liverpool; University of Reading; University of London; King's College London	Rutherford, C (corresponding author), Univ Liverpool, Farr Inst, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.	C.Rutherford@liverpool.ac.uk	Pickles, Andrew/A-9625-2011; Sharp, Helen/GOG-8045-2022	Pickles, Andrew/0000-0003-1283-0346; Hill, Jonathan/0000-0003-2801-0449; Sharp, Helen/0000-0002-0988-8718; Taylor-Robinson, David/0000-0002-5828-7724	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC); UK Medical Research Council [G0900654, G0400577]; MRC on a Clinician Scientist Fellowship [MR/P008577/1]; MRC [MR/P008577/1, G0400577, G0802448, G0900654] Funding Source: UKRI	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC on a Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CR is funded by The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC). WCHADS is funded by grants from the UK Medical Research Council (G0900654; G0400577). DTR is funded by the MRC on a Clinician Scientist Fellowship (MR/P008577/1). The views expressed here are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AchAchenbach T. M., 1991, MANUAL CHILD BEHAV C; Allin S, 2012, HEALTH ECON POLICY L, V7, P227, DOI 10.1017/S174413311100034X; Alvarado-Esquivel C, 2016, MENT ILLN, V8, P10, DOI 10.4081/mi.2016.6021; Amone-P'Olak K, 2009, SOC PSYCH PSYCH EPID, V44, P231, DOI 10.1007/s00127-008-0424-z; Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE; Bauer A, 2014, CENT MENT HEAL; Boe T, 2012, SOC PSYCH PSYCH EPID, V47, P1557, DOI 10.1007/s00127-011-0462-9; Carneiro A, 2016, J CHILD FAM STUD, V25, P2941, DOI 10.1007/s10826-016-0456-z; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Diderichsen F, 2019, INT J EPIDEMIOL, V48, P268, DOI 10.1093/ije/dyy167; Essex MJ, 2006, ARCH GEN PSYCHIAT, V63, P1246, DOI 10.1001/archpsyc.63.11.1246; Fanti KA, 2010, DEV PSYCHOL, V46, P1159, DOI 10.1037/a0020659; Fisher SD, 2015, COUPLE FAM PSYCHOL, V4, P61, DOI 10.1037/cfp0000037; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Gavin N.I., 2015, IS POPULATION BASED; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Graham H, 2004, J SOC POLICY, V33, P115, DOI 10.1017/S0047279403007220; Green H, 2004, NATL STAT, Vi-xxviii, P1, DOI DOI 10.1037/E557702010-001; Gunnell D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2608; Holmes J, 2013, POLICY POLIT, V41, P19, DOI 10.1332/030557312X645810; Horowitz JA, 2013, JOGNN-J OBST GYN NEO, V42, P287, DOI 10.1111/1552-6909.12038; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lloyd, 2004, ENGLISH INDICES DEPR; Mantymaa M, 2012, CHILD PSYCHIAT HUM D, V43, P153, DOI 10.1007/s10578-011-0255-0; Marmot MG, 2010, FAIR SOC HLTH LIVES, DOI [10.1016/j. puhe.2012.05.014, DOI 10.1016/J.PUHE.2012.05.014, 10.1016/j.puhe.2012.05.014]; Marryat L, 2017, J EPIDEMIOL COMMUNIT, P1; Mazza JRSE, 2016, SOC PSYCH PSYCH EPID, V51, P1083, DOI 10.1007/s00127-016-1252-1; McLeod JD, 1996, J HEALTH SOC BEHAV, V37, P207, DOI 10.2307/2137292; Menting ATA, 2013, CLIN PSYCHOL REV, V33, P901, DOI 10.1016/j.cpr.2013.07.006; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; Murray L, 1997, PSYCHOL MED, V27, P253, DOI 10.1017/S0033291796004564; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Patalay P., 2017, MENTAL ILL HLTH CHIL; Pearce A, 2019, ARCH DIS CHILD, V104, P998, DOI 10.1136/archdischild-2018-314808; Pike A, 2006, INT J BEHAV DEV, V30, P55, DOI 10.1177/0165025406062124; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Robinson M, 2008, J CHILD PSYCHOL PSYC, V49, P1118, DOI 10.1111/j.1469-7610.2008.01955.x; Schmied V, 2013, WOMEN BIRTH, V26, P167, DOI 10.1016/j.wombi.2013.02.006; Sharp H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045446; Society TC, 2015, GOOD CHILDH REP; Strohschein L, 2005, J HEALTH SOC BEHAV, V46, P359, DOI 10.1177/002214650504600404; Taylor-Robinson DC, 2016, EUR RESPIR J, V47, P818, DOI 10.1183/13993003.01117-2015; VELEZ CN, 1989, J AM ACAD CHILD PSY, V28, P861, DOI 10.1097/00004583-198911000-00009; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Wickham S, 2017, LANCET PUBLIC HEALTH, V2667, P30011, DOI [10.1016/S2468-2667(17), DOI 10.1016/S2468-2667(17)]	48	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217342	10.1371/journal.pone.0217342	http://dx.doi.org/10.1371/journal.pone.0217342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125387	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000468865700030
J	Tuck, GN; Richards, SA				Tuck, Geoffrey N.; Richards, Shane A.			Risk equivalence as an alternative to balancing mean value when trading draft selections and players in major sporting leagues	PLOS ONE			English	Article							NFL; MARKET	In sports leagues that use an annual draft to assign eligible players to clubs, having a value associated with a draft selection can allow clubs to anticipate future growth of players and, if a trading period exists, assist negotiations when exchanging draft selections and players. Typically, mean draft values often decline in either an exponential or geometric manner with increasing draft selection number. Aggregate mean values have been used to compare trade packages. However, clubs may also want to ensure that a trade does not increase the probability of obtaining poor players in the draft. This paper therefore considers equivalence of risk as an alternative trading strategy for club list managers. Here, risk is defined as the probability of the aggregate value of the received draft selections being below a minimum acceptable level. For risk equivalence, a premium over and above mean market value may need to be provided when trading to secure higher draft selections.	[Tuck, Geoffrey N.] CSIRO, Data 61, Hobart, Tas, Australia; [Tuck, Geoffrey N.] CSIRO, Oceans & Atmosphere, CSIRO Marine Labs, Hobart, Tas, Australia; [Richards, Shane A.] Univ Tasmania, Sch Nat Sci, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Tuck, GN (corresponding author), CSIRO, Data 61, Hobart, Tas, Australia.; Tuck, GN (corresponding author), CSIRO, Oceans & Atmosphere, CSIRO Marine Labs, Hobart, Tas, Australia.	geoff.tuck@csiro.au	Tuck, Geoff/E-2356-2012	Tuck, Geoff/0000-0002-3640-6147; Richards, Shane/0000-0002-9638-5827				AFL Bidding System Review- Father- Son and Academy, 2015, AUSTR FOOTBALL LEAGU; Barzilai A., 2007, ASSESSING RELATIVE V; Borland J, 2011, LABOUR ECON, V18, P371, DOI 10.1016/j.labeco.2010.12.004; Boulier BL, 2010, INT J FORECASTING, V26, P589, DOI 10.1016/j.ijforecast.2009.10.009; Dichmont CM, 2016, FISH FISH, V17, P731, DOI 10.1111/faf.12142; Fay G, 2013, STOCK ASSESSMENT S 2, P1; Hendricks W, 2003, J LABOR ECON, V21, P857, DOI 10.1086/377025; Hersch PL, 2016, APPL ECON LETT, V23, P516, DOI 10.1080/13504851.2015.1085629; Hubley R., 2012, THESIS; Hurley WJ, 2012, J OPER RES SOC, V63, P890, DOI 10.1057/jors.2011.93; Kahane L, 2006, HDB EC SPORT, P643, DOI DOI 10.4337/9781847204073.00082; Kattan MW, 2009, ENCY MED DECISION MA, V1; Little LR, 2016, ICES J MAR SCI, V73, P494, DOI 10.1093/icesjms/fsv206; Macdonald R., 2007, GAMES ARE NOT SAME P, P236; Massey C, 2013, MANAGE SCI, V59, P1479, DOI 10.1287/mnsc.1120.1657; Nividi W., 2014, STAT ENG SCI; O'Shaughnessy D., 2010, 10 MATH COMP SPORT C, P113; Quayle E., 2015, AGE; Quinn K. G., 2008, BUSINESS SPORTS, V3, P191; Reynolds Z, 2015, J APPL SPORT MANAG, V7, P73; Ryan P., 2015, DANGER DEAL DONE SUP; Sargent J, 2010, INT J FORECASTING, V26, P489, DOI 10.1016/j.ijforecast.2009.10.003; Schuckers M, 2011, J QUANT ANAL SPORTS, V7, DOI 10.2202/1559-0410.1329; Stewart MF, 2007, INT J SPORT FINANC, V2, P231; Tingling P, 2011, SPORT BUS MANAG, V1, P155, DOI 10.1108/20426781111146754; Tuck GN, 2015, NEW HORIZ ECON SPORT, P50; Tuck GN, 2015, SPORT MANAG REV, V18, P596, DOI 10.1016/j.smr.2015.02.004; Tuck GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080798; Weir K, 2014, J SPORT ECON, V15, P617, DOI 10.1177/1527002513487739; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang Z., 2013, FINANCE FUNDAMENTAL, P51	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217151	10.1371/journal.pone.0217151	http://dx.doi.org/10.1371/journal.pone.0217151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125362	Green Published, gold, Green Accepted			2022-12-27	WOS:000468865700022
J	Wieghaus, A; Prufer, D; Gronover, CS				Wieghaus, Annika; Pruefer, Dirk; Gronover, Christian Schulze			Loss of function mutation of the Rapid Alkalinization Factor (RALF1)-like peptide in the dandelion Taraxacum koksaghyz entails a high-biomass taproot phenotype	PLOS ONE			English	Article							RUSSIAN DANDELION; ALTERNATIVE SOURCES; SILENCING AFFECTS; NATURAL-RUBBER; PLANT-GROWTH; L. RODIN; RALF; INULIN; PROTEINS; HORMONE	The Russian dandelion (Taraxacum koksaghyz) is a promising source of inulin and natural rubber because large amounts of both feedstocks can be extracted from its roots. However, the domestication of T. koksaghyz requires the development of stable agronomic traits such as higher yields of inulin and natural rubber, a higher root biomass, and an agronomically preferable root morphology which is more suitable for cultivation and harvesting. Arabidopsis thaliana Rapid Alkalinisation Factor 1 (RALF1) has been shown to suppress root growth. We identified the T. koksaghyz orthologue TkRALF-like 1 and knocked out the corresponding gene (TkRALFL1) using the CRISPR/Cas9 system to determine its impact on root morphology, biomass, and inulin and natural rubber yields. The TkRALFL1 knockout lines more frequently developed a taproot phenotype which is easier to cultivate and harvest, as well as a higher root biomass and greater yields of both inulin and natural rubber. The TkRALFL1 gene could therefore be suitable as a genetic marker to support the breeding of profitable new dandelion varieties with improved agronomic traits. To our knowledge, this is the first study addressing the root system of T. koksaghyz to enhance the agronomic performance.	[Wieghaus, Annika; Pruefer, Dirk] Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany; [Pruefer, Dirk; Gronover, Christian Schulze] Fraunhofer Inst Mol Biol & Appl Ecol IME, Munster, Germany	University of Munster; Fraunhofer Gesellschaft	Gronover, CS (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Munster, Germany.	christian.schulze.gronover@ime.fraunhofer.de		Schulze Gronover, Christian/0000-0001-6398-2265	Federal Ministry of Education and Research [031A285A]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Annika Wieghaus was financed by a grant from the Federal Ministry of Education and Research (grant no. 031A285A).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arias M, 2016, IND CROP PROD, V83, P316, DOI 10.1016/j.indcrop.2016.01.023; Bedinger PA, 2010, PLANT SIGNAL BEHAV, V5, P1342, DOI 10.4161/psb.5.11.12954; Bergonci T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.976146; Bergonci T, 2014, J EXP BOT, V65, P2219, DOI 10.1093/jxb/eru099; Campbell L, 2017, FRONT PLANT SCI, V8, P1, DOI [10.3389/fpls.2017.00001, DOI 10.3389/FPLS.2017.00001]; Cao J, 2012, EVOL BIOINFORM, V8, P271, DOI 10.4137/EBO.S9652; Chandler PM, 1999, PLANT PHYSIOL, V120, P623, DOI 10.1104/pp.120.2.623; do Canto AM, 2014, PLANT PHYSIOL BIOCH, V75, P45, DOI 10.1016/j.plaphy.2013.12.005; Dressano K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007053; Du CQ, 2016, P NATL ACAD SCI USA, V113, pE8326, DOI 10.1073/pnas.1609626113; Eggert M, 2018, EUR J AGRON, V93, P126, DOI 10.1016/j.eja.2017.12.003; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge ZX, 2017, SCIENCE, V358, P1596, DOI 10.1126/science.aao3642; Grienenberger E, 2015, CURR OPIN PLANT BIOL, V23, P8, DOI 10.1016/j.pbi.2014.09.013; Gronover CS, 2011, BIOTECHNOLOGY OF BIOPOLYMERS, P75; Haruta M, 2008, BIOCHEMISTRY-US, V47, P6311, DOI 10.1021/bi8001488; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Javorsky L., 1944, TROPENPFLANZER, V1, P1; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kreuzberger M, 2016, EUR J AGRON, V80, P66, DOI 10.1016/j.eja.2016.06.011; KROTKOV G, 1945, BOT REV, V11, P417, DOI 10.1007/BF02861139; Laibach N, 2015, PLANT J, V82, P609, DOI 10.1111/tpj.12836; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lin T, 2018, NATL SCI REV, V5, P78, DOI 10.1093/nsr/nwx101; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mecchia MA, 2017, SCIENCE, V358, P1600, DOI 10.1126/science.aao5467; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627; Morre DJ, 2000, J APPL TOXICOL, V20, P157, DOI 10.1002/(SICI)1099-1263(200003/04)20:2<157::AID-JAT648>3.0.CO;2-9; Munt O, 2012, IND CROP PROD, V36, P289, DOI 10.1016/j.indcrop.2011.10.014; Murphy E, 2016, J EXP BOT, V67, P4863, DOI 10.1093/jxb/erw281; Murphy E, 2014, TRENDS PLANT SCI, V19, P664, DOI 10.1016/j.tplants.2014.06.005; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; OHTA K, 1993, APPL ENVIRON MICROB, V59, P729, DOI 10.1128/AEM.59.3.729-733.1993; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Pearce G, 2010, PEPTIDES, V31, P1973, DOI 10.1016/j.peptides.2010.08.012; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Putter KM, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1036-0; Ramirez-Cadavid DA, 2017, IND CROP PROD, V107, P624, DOI 10.1016/j.indcrop.2017.05.043; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt T, 2010, PLANT MOL BIOL REP, V28, P277, DOI 10.1007/s11105-009-0145-9; Sharma A, 2016, PLANT PHYSIOL BIOCH, V106, P82, DOI 10.1016/j.plaphy.2016.03.037; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shih HW, 2014, CURR BIOL, V24, P1887, DOI 10.1016/j.cub.2014.06.064; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Stolze A, 2017, PLANT BIOTECHNOL J, V15, P740, DOI 10.1111/pbi.12672; Uhlmann M., 1951, WERTVOLLE KAUTSCHUKP; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Wu Xuebing, 2014, Quant Biol, V2, P59; Yu YQ, 2018, PLANT PHYSIOL, V176, P2426, DOI 10.1104/pp.17.01277	61	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217454	10.1371/journal.pone.0217454	http://dx.doi.org/10.1371/journal.pone.0217454			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125376	gold, Green Submitted, Green Published			2022-12-27	WOS:000468865700043
J	Barroso, S; Moren, C; Gonzalez-Segura, A; Riba, N; Arnaiz, JA; Manriquez, M; Santana, G; Blanco, JL; Larousse, M; Lonca, M; de Lazzari, E; Llopis, J; Mallolas, J; Miro, O; Carne, X; Gatell, JM; Garrabou, G; Martinez, E				Barroso, Sergio; Moren, Constanza; Gonzalez-Segura, Alex; Riba, Neus; Arnaiz, Joan A.; Manriquez, Marcela; Santana, Gemina; Blanco, Jose L.; Larousse, Maria; Lonca, Montse; de lazzari, Elisa; Llopis, Jaume; Mallolas, Josep; Miro, Oscar; Carne, Xavier; Gatell, Jose M.; Garrabou, Gloria; Martinez, Esteban			Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HIV-INFECTED PATIENTS; EFFICACY; LIPODYSTROPHY; APOPTOSIS; TOXICITY; RISK; PHARMACOKINETICS; TOLERABILITY; PATHOGENESIS	Context Classical antiretroviral agents may acutely impact on metabolic, mitochondrial, renal and hepatic function in HIV-infected and uninfected persons. Fusion and integrase inhibitors are supposed to be safer, but have been scarcely investigated. To avoid any interference with HIV or other antiretrovirals, we assessed markers of these toxicities in healthy adult volunteers treated with Enfuvirtide (T20) or Raltegravir (RAL). Methods Twenty-six healthy participants were randomized to T20/90mg vs. placebo (n = 12) or RAL/400mg vs. placebo (n = 14) every 12h in two 7-day periods separated by a 4-week washout period. Major end-points were changes in lipid profile (total cholesterol, high-density-lipoprotein (HDL)-cholesterol, low-density-lipoprotein (LDL)-cholesterol, triglycerides), insulin resistance (glucose) and mitochondrial toxicity (mitochondrial DNA content-mtDNA-in peripheral blood mononuclear cells). Renal and hepatic toxicity (creatinine, alanine transaminase (AST), alanine aminotransferase (ALT), bilirubin and total plasma proteins) and overall safety were also analysed. Effect of period, treatment, and basal measures were evaluated for each end-point. Results Neither T20-administration nor RAL-administration yielded to any statistic significant change in the markers of metabolic, mitochondrial, renal or hepatic toxicity assessed. No symptoms indicative of drug toxicity were neither found in any subject. Conclusions In absence of HIV infection, or concomitant treatment, short-term exposure to T20 or RAL in healthy adult volunteers did not lead to any indicative changes in toxicity markers thus presuming the safe profile of both drugs.	[Barroso, Sergio; Moren, Constanza; Gonzalez-Segura, Alex; Garrabou, Gloria] Univ Barcelona, Fac Med & Hlth Sci, Cellex IDIBAPS, Muscle Res & Mitochondrial Funct Lab, Barcelona, Spain; [Barroso, Sergio; Moren, Constanza; Gonzalez-Segura, Alex; Garrabou, Gloria] HCB, Internal Med Dept, Barcelona, Spain; [Barroso, Sergio; Moren, Constanza; Gonzalez-Segura, Alex; Garrabou, Gloria] Biomed Res Networking Ctr Rare Dis CIBERER ISCIII, Barcelona, Spain; [Barroso, Sergio] Pompeu Fabra Univ, Barcelona, Spain; [Barroso, Sergio] Autonomous Univ Barcelona, Barcelona, Spain; [Riba, Neus; Arnaiz, Joan A.; Manriquez, Marcela; Santana, Gemina; Carne, Xavier] HCB, Clin Pharmacol Dept, Phase Unit 1, Barcelona, Spain; [Blanco, Jose L.; Larousse, Maria; Lonca, Montse; Mallolas, Josep; Gatell, Jose M.; Martinez, Esteban] HCB, Infect Dis Dept, Barcelona, Spain; [de lazzari, Elisa; Llopis, Jaume] Univ Barcelona, Dept Stat, Barcelona, Spain; [Miro, Oscar] HCB, Emergency Dept, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pompeu Fabra University; Autonomous University of Barcelona; University of Barcelona	Moren, C; Garrabou, G (corresponding author), Univ Barcelona, Fac Med & Hlth Sci, Cellex IDIBAPS, Muscle Res & Mitochondrial Funct Lab, Barcelona, Spain.; Moren, C; Garrabou, G (corresponding author), HCB, Internal Med Dept, Barcelona, Spain.; Moren, C; Garrabou, G (corresponding author), Biomed Res Networking Ctr Rare Dis CIBERER ISCIII, Barcelona, Spain.	cmoren1@clinic.ub.es; garrabou@clinic.ub.es	Gatell, Jose M/ABC-3607-2020; Morén, Constanza/AAB-6895-2021	Morén, Constanza/0000-0001-6848-7407; Garrabou, Gloria/0000-0001-8973-9933; Mallolas Masferrer, Josep/0000-0002-8365-141X; Segura, Alex G/0000-0002-9398-2183; De Lazzari, Elisa/0000-0003-2614-6545	Fundacion para la Investigacion y la Prevencion del SIDA en Espana [FIPSE 360982/10]; Fondo de Investigacion Sanitaria [FIS 01199/11, FIS 00462/11, FIS 01199/12, FIS 01738/13, FIS 01455/13, PI00005/14, PI00817/15, PI00903/15, PI00130/15]; CIBERER - Instituto de Salud Carlos III [PIE1400061]; InterCIBER - Instituto de Salud Carlos III [PIE1400061]; Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa"; Suports a Grups de Recerca [SGR 2014/376, 2014/SGR928]; CERCA Programme from the Generalitat de Catalunya; CONACyt; Marato de TV3 [87/C/2015]; Fundacio Cellex; "la Caixa" Foundation	Fundacion para la Investigacion y la Prevencion del SIDA en Espana; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBERER - Instituto de Salud Carlos III(Instituto de Salud Carlos III); InterCIBER - Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa"; Suports a Grups de Recerca; CERCA Programme from the Generalitat de Catalunya; CONACyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marato de TV3; Fundacio Cellex(Foundation CELLEX); "la Caixa" Foundation(La Caixa Foundation)	This work was supported by: Fundacion para la Investigacion y la Prevencion del SIDA en Espana [FIPSE 360982/10]; Fondo de Investigacion Sanitaria [FIS 01199/11, FIS 00462/11, FIS 01199/12, FIS 01738/13, FIS 01455/13, PI00005/14, PI00817/15, PI00903/15 and PI00130/15]; CIBERER and InterCIBER [PIE1400061], both supported granted by Instituto de Salud Carlos III and cofinanced by the Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa"; Suports a Grups de Recerca [SGR 2014/376 and 2014/SGR928] and CERCA Programme from the Generalitat de Catalunya; CONACyt; Marato de TV3 [87/C/2015]; Fundacio Cellex; and "la Caixa" Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GD, 2008, INT REV NEUROBIOL, V83, P1, DOI 10.1016/S0074-7742(08)00001-9; Atta MG, 2019, CLIN J AM SOC NEPHRO, V14, P435, DOI 10.2215/CJN.02240218; Bernardino JI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209911; Blonk MI, 2015, CLIN INFECT DIS, V61, P809, DOI 10.1093/cid/civ366; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Carr A, 2000, CLIN INFECT DIS, V30, pS135, DOI 10.1086/313854; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Curtin F, 2002, STAT MED, V21, P2161, DOI 10.1002/sim.1207; de Castro N, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0101-3; de la Concepcion MLR, 2005, ANTIVIR THER, V10, P515; De Lazzari E, 2008, HIV MED, V9, P221, DOI 10.1111/j.1468-1293.2008.00552.x; de Miguel R, 2018, EXPERT OPIN DRUG SAF, V17, P217, DOI 10.1080/14740338.2018.1411903; Diaz-Delfin J, 2012, ANTIMICROB AGENTS CH, V56, P3369, DOI 10.1128/AAC.00104-12; Domingo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089088; Fagard C, 2012, JAIDS-J ACQ IMM DEF, V59, P489, DOI 10.1097/QAI.0b013e31824bb720; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funk MJ, 2007, DRUG SAFETY, V30, P845; Gallego-Escuredo JM, 2013, JAIDS-J ACQ IMM DEF, V64, P142, DOI 10.1097/QAI.0b013e31829bdb67; Gallien S, 2011, J ANTIMICROB CHEMOTH, V66, P2099, DOI 10.1093/jac/dkr269; Ganta KK, 2017, CELL BIOL TOXICOL, V33, P69, DOI 10.1007/s10565-016-9362-9; Gardner K, 2014, TOXICOL PATHOL, V42, P811, DOI 10.1177/0192623313503519; Garrabou G, 2009, JAIDS-J ACQ IMM DEF, V52, P443, DOI 10.1097/QAI.0b013e3181bd564c; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hargreaves IP, 2016, DRUG SAFETY, V39, P661, DOI 10.1007/s40264-016-0417-x; Hernandez S, 2017, JAIDS J ACQUIR IMMUN, V75; Hill A, 2019, J VIRUS ERAD, V5, P41; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Kakuda TN, 2010, ANTIVIR THER, V15, P817, DOI 10.3851/IMP1652; Klinge CM, 2017, J BIOENERG BIOMEMBR, V49, P307, DOI 10.1007/s10863-017-9704-1; Krambovitis E, 2005, ACTA PHARMACOL SIN, V26, P1165, DOI 10.1111/j.1745-7254.2005.00193.x; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Mallon PWG, 2005, J INFECT DIS, V191, P1686, DOI 10.1086/429697; MARCOVINA SM, 1994, CLIN CHEM, V40, P574; Margolis AM, 2014, J MED TOXICOL, V10, P26, DOI 10.1007/s13181-013-0325-8; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; Mbita Z, 2014, VIRUSES-BASEL, V6, P3181, DOI 10.3390/v6083181; Minami R, 2011, J INFECT CHEMOTHER, V17, P183, DOI 10.1007/s10156-010-0101-5; Miro O, 2005, AIDS RES HUM RETROV, V21, P702, DOI 10.1089/aid.2005.21.702; Moren C, 2012, JAIDS-J ACQ IMM DEF, V60, P111, DOI 10.1097/QAI.0b013e318250455e; Negredo E, 2009, CLIN INFECT DIS, V49, P892, DOI 10.1086/605440; Neijzen RW, 2016, INT J CLIN PHARM-NET, V38, P749, DOI 10.1007/s11096-016-0316-3; Nolan D, 2004, ANTIVIR THER, V9, P849; Noor MA, 2002, AIDS, V16, pF1, DOI 10.1097/00002030-200203290-00002; Noor MA, 2006, AIDS, V20, P1813, DOI 10.1097/01.aids.0000244200.11006.55; Oldfield V, 2005, DRUGS, V65, P1139, DOI 10.2165/00003495-200565080-00007; Pilon AA, 2002, ANTIMICROB AGENTS CH, V46, P2687, DOI 10.1128/AAC.46.8.2687-2691.2002; Savarino A, 2006, EXPERT OPIN INV DRUG, V15, P1507, DOI 10.1517/13543784.15.12.1507; Vispo E, 2010, J ANTIMICROB CHEMOTH, V65, P543, DOI 10.1093/jac/dkp446; Wang F, 2017, ACTA PHARMACOL SIN, V38, P1554, DOI 10.1038/aps.2017.54; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wheeler DA, 2004, J CLIN VIROL, V30, P183, DOI 10.1016/j.jcv.2003.10.006; World Health Organization, 2016, US ANT DRUGS TREAT P	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216712	10.1371/journal.pone.0216712	http://dx.doi.org/10.1371/journal.pone.0216712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120908	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700024
J	Cohen, O; Schejter, E; Agizim, R; Schonman, R; Chodick, G; Fishman, A; Klement, AH				Cohen, Omer; Schejter, Edwardo; Agizim, Regina; Schonman, Ron; Chodick, Gabby; Fishman, Ami; Klement, Anat Hershko			Postcoital bleeding is a predictor for cervical dysplasia	PLOS ONE			English	Article							WOMEN; PATHOLOGY; SYMPTOMS; RISK	Background Postcoital bleeding (PCB) is a common gynecological symptom that may cause concern among both patients and physicians. Current literature is inconclusive regarding management recommendations. Objective To identify risk-factors for dysplasia/cancer among patients presenting post-coital bleeding (PCB). Methods Using large health maintenance organization (HMO) database, all women reporting PCB in 2012-2015 were identified. PCB patient records in a single colposcopy center were reviewed. Age, marital status, ethnicity, gravidity, parity, BMI, smoking, PAP smear result (within 1 year of PCB presentation), colposcopy and biopsy results were recorded. Cases were matched by age and socio-economic enumeration area to controls accessing primary care clinics for routine care. Results Yearly incidence of PCB ranged from 400 to 900 per 100,000 women; highest among patients aged 26-30 years. Among the sample of 411 PCB cases with colposcopy, 201 (48.9%) had directed biopsy. Biopsy results included 68 cervicitis (33.8%), 61 koilocytosis/CIN 1/condyloma (30.3%), 44 normal tissue (21.9%), 25 cervical polyp (12.4%), 2 CIN 2/3 (1%) and 1 carcinoma (0.5%). Positive predictive value for koilocytosis/CIN 1 or higher pathology was 15.6% (64/411) and 0.7% for CIN 2 or higher grade pathology (3/411). In conditional logistic regression, multiparty was a protective factor: OR 0.39 (95% CI 0.22-0.88, P = 0.02), while pathological PAP smear was a related risk-factor: OR 3.3 (95% CI 1.31-8.35, P = 0.01). When compared to controls, PCB patients were significantly (P = 0.04) more likely to present CIN 1 or higher grade pathology (OR 1.82, 95% CI 1.02-3.33). Conclusions Study results indicate that PCB may require colposcopy, especially for nulliparous women with an abnormal PAP smear.	[Cohen, Omer; Agizim, Regina; Schonman, Ron; Fishman, Ami; Klement, Anat Hershko] Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel; [Schejter, Edwardo; Agizim, Regina; Chodick, Gabby] Maccabi Hlth Serv, Tel Aviv, Israel; [Schonman, Ron; Fishman, Ami; Klement, Anat Hershko] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Klement, AH (corresponding author), Meir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel.; Klement, AH (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	anat.klement@gmail.com	schonman, ron/AAX-1723-2020	/0000-0002-5189-8995				Abu J, 2006, J Obstet Gynaecol, V26, P45; Alfhaily F, 2010, J OBSTET GYNAECOL, V30, P190, DOI 10.3109/01443610903420259; Alfhaily F, 2009, EUR J OBSTET GYN R B, V144, P72, DOI 10.1016/j.ejogrb.2009.01.014; [Anonymous], BULLETIN, V101; Anorlu Rose I, 2003, J Obstet Gynaecol, V23, P285, DOI 10.1080/01443610310000100114; Gulumser C, 2015, EUR J OBSTET GYN R B, V193, P83, DOI 10.1016/j.ejogrb.2015.06.012; LINDNER LE, 1988, J REPROD MED, V33, P684; Liu HL, 2017, ARCH GYNECOL OBSTET, V295, P935, DOI 10.1007/s00404-017-4327-7; Rosenthal AN, 2001, BRIT J OBSTET GYNAEC, V108, P103, DOI 10.1111/j.1471-0528.2001.00008.x; Sahu Banchhita, 2007, Archives of Gynecology and Obstetrics, V276, P471, DOI 10.1007/s00404-007-0362-0; Shalini R, 1998, GYNECOL OBSTET INVES, V45, P205, DOI 10.1159/000009957; Shapley M, 2004, BRIT J GEN PRACT, V54, P359; Shapley M, 2013, BJOG-INT J OBSTET GY, V120, P1348, DOI 10.1111/1471-0528.12218; Shapley M, 2006, BRIT J GEN PRACT, V56, P453; SOLOMON D, 1989, JAMA-J AM MED ASSOC, V262, P931; Tarney CM, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/192087; Vikki M, 1998, ACTA OBSTET GYN SCAN, V77, P564	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217396	10.1371/journal.pone.0217396	http://dx.doi.org/10.1371/journal.pone.0217396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120980	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700099
J	Anchuelo, AC; Martinez-Larrad, MT; Serrano-Garcia, I; Perez, CF; Serrano-Rios, M				Corbaton Anchuelo, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Garcia, Irene; Fernandez Perez, Cristina; Serrano-Rios, Manuel			Body fat anthropometric indexes: Which of those identify better high cardiovascular risk subjects? A comparative study in Spanish population	PLOS ONE			English	Article							TO-HEIGHT RATIO; CORONARY-HEART-DISEASE; WAIST CIRCUMFERENCE; MASS INDEX; CARDIOMETABOLIC RISK; INSULIN-RESISTANCE; SCREENING TOOL; PREDICTOR; OBESITY; PREVALENCE	Aim To determine the association of body mass index ( BMI), waist circumference ( WC), waist to hip ratio ( WHR), waist to height ratio ( WHtr) and Body Shape Index ( ABSI) with high cardiovascular risk ( CVR), as well as to determine whether how strong are these relationships. Material and methods A cross-sectional study was carried out in Spanish Caucasian adults. 3,456 subjects completed the study, 45.78% males, aged <65 years and non-diabetic subjects. Anthropometric/biochemical variables were measured. We determined ABSI based on WC adjusted for height and weight. High CVR was defined as >= 20% according to the Framingham chart, >= 5% with the SCORE chart, and >= 7.5% with the ACC/AHA guide. Areas under the receiver operating characteristic curves ( AUCs) were estimated for each anthropometric measure. Results Most significant AUCs in males were: WHtr and ABSI for Framingham >= 20% and SCORE >= 5%. Also significant were WHtr, WC and ABSI for ACCA/AHA >= 7.5%. On the other hand, most significant AUCs in females were: WHtr and WC for Framingham >= 20%; and WHtr and WHR for SCORE >= 5%, WHtr, and WC for ACC/AHA guide >= 7.5%. Conclusions Overall, the best anthropometric index identifying Spanish males and females who are at high risk for CV events is WHtr. ABSI was also found to be a good anthropometric index to predict high CVR in Spanish males according to FR, SCORE and ACC/AHA charts. For Spanish females, WC is a good anthropometric index according to FR and ACC/AHA guide, while WHR is better according to SCORE.	[Corbaton Anchuelo, Arturo; Teresa Martinez-Larrad, Maria; Fernandez Perez, Cristina; Serrano-Rios, Manuel] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Corbaton Anchuelo, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Garcia, Irene; Fernandez Perez, Cristina; Serrano-Rios, Manuel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain; [Serrano-Garcia, Irene; Fernandez Perez, Cristina] Hosp Clin San Carlos, UGC Med Prevent, Madrid, Spain; [Fernandez Perez, Cristina] Univ Complutense Madrid, Fac Enfermeria, Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid	Anchuelo, AC (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.; Anchuelo, AC (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain.	arturocorbaton@yahoo.es	Corbatón-Anchuelo, Arturo/I-4390-2013; Fernandez Perez, Cristina/I-2220-2015	Corbatón-Anchuelo, Arturo/0000-0002-8775-4766; Fernandez Perez, Cristina/0000-0001-9853-6257; Serrano Garcia, Irene/0000-0001-7184-5447	Fondo Europeo para el Desarrollo Regional [FEDER 2FD 1997/2309]; Red de Centros RCMN [C03/08]; Instituto de Salud Carlos III, Ministerio de Ciencia, Innovacion y Universidades, Spanish Government [FIS 03/1618]; Instituto de Salud Carlos III (Madrid, Spain) [RETIC RD06/0015/0012]; Mechanisms of Insulin Resistance from Madrid Autonomous Community [MOIR S2010/BMD-2423]; Eli Lilly Lab [2010-115-B99]; Bayer Pharmaceutical Co. [2005-115-B99]; Fundacion Mutua Madrilena (FMM-2008), Spain	Fondo Europeo para el Desarrollo Regional; Red de Centros RCMN; Instituto de Salud Carlos III, Ministerio de Ciencia, Innovacion y Universidades, Spanish Government; Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Mechanisms of Insulin Resistance from Madrid Autonomous Community; Eli Lilly Lab(Eli Lilly); Bayer Pharmaceutical Co.; Fundacion Mutua Madrilena (FMM-2008), Spain	For this research, MSR has been supported by grants from the Fondo Europeo para el Desarrollo Regional (FEDER 2FD 1997/2309), from Red de Centros RCMN (C03/08), from Instituto de Salud Carlos III (FIS 03/1618, Ministerio de Ciencia, Innovacion y Universidades, Spanish Government) and from Instituto de Salud Carlos III (RETIC RD06/0015/0012, Madrid, Spain). MSR and MTML also acknowledge CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia, Innovacion y Universidades, Spanish Government). MTML was funded by Mechanisms of Insulin Resistance (MOIR S2010/BMD-2423) from Madrid Autonomous Community. MSR received grants funding from Eli Lilly Lab (2010-115-B99) and Bayer Pharmaceutical Co. (2005-115-B99), respectively. CFP also received partial support for this study from Fundacion Mutua Madrilena (FMM-2008), Spain. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino Sr RB, 2008, CIRCULATION, V18, P499; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amor AJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004803; Aranceta J, 2004, MED CLIN-BARCELONA, V123, P686, DOI 10.1016/S0025-7753(04)75331-2; Armellini F, 1996, EUR J CLIN NUTR, V50, P290; Ascaso JF, 2001, MED CLIN-BARCELONA, V117, P530, DOI 10.1016/S0025-7753(01)72168-9; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 1996, BRIT MED J, V312, P377; Ashwell M, 1996, BRIT MED J, V313, P559; Ashwell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103483; Baena-Diez JM, 2009, REV ESP CARDIOL, V62, P1134, DOI 10.1016/S0300-8932(09)72382-6; Silva MIB, 2014, NUTRITION, V30, P279, DOI 10.1016/j.nut.2013.08.004; Bertoli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185013; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Chen Z, 2017, J AM GERIATR SOC, V65, P1907, DOI 10.1111/jgs.14790; Cheng CH, 2010, NUTR RES, V30, P585, DOI 10.1016/j.nutres.2010.08.007; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Correa MM, 2016, ARCH GERONTOL GERIAT, V65, P174, DOI 10.1016/j.archger.2016.03.021; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Garaulet M, 2006, J PHYSIOL BIOCHEM, V62, P245, DOI 10.1007/BF03165753; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Han TS, 1997, INT J OBESITY, V21, P587, DOI 10.1038/sj.ijo.0800446; Hsieh SD, 1995, INTERNAL MED, V34, P1147, DOI 10.2169/internalmedicine.34.1147; Hsieh SD, 1995, TOHOKU J EXP MED, V177, P223, DOI 10.1620/tjem.177.223; HSIEH SD, 1995, INT J OBESITY, V19, P585; Krakauer JC, 2016, CASE REP MED, V2016, DOI 10.1155/2016/1526175; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee J S, 1995, Sangyo Eiseigaku Zasshi, V37, P9; Li WC, 2013, EUR J NUTR, V52, P57, DOI 10.1007/s00394-011-0286-0; Lorenzo C, 2002, HYPERTENSION, V39, P203, DOI 10.1161/hy0202.103439; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Lumsden MA, 2016, CLIMACTERIC, V19, P426, DOI 10.1080/13697137.2016.1222483; Majed B, 2013, PREV MED, V57, P49, DOI 10.1016/j.ypmed.2013.04.003; Marrugat J, 2002, REV ESP CARDIOL, V55, P337, DOI 10.1016/S0300-8932(02)76611-6; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medrano MJ, 2005, MED CLIN-BARCELONA, V124, P606; Millar SR, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0069-5; Peiris A N, 1988, Acta Med Scand Suppl, V723, P179; Redon J, HIG BLOOD PRESS CARD, V23, P87; Sato Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177779; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Martinez-Larrad MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106641; Martinez-Larrad MT, 2011, AV DIABETOL, V27, P168, DOI 10.1016/j.avdiab.2011.09.003; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 1990, MONICA MAN; Wu HY, 2009, CHINESE J PHYSIOL, V52, P441, DOI 10.4077/CJP.2009.AMH064	50	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216877	10.1371/journal.pone.0216877	http://dx.doi.org/10.1371/journal.pone.0216877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120940	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700036
J	Fu, X; Yang, H; Liu, CX; Wang, JW; Wang, YH				Fu, Xin; Yang, Hao; Liu, Chenxi; Wang, Jianwei; Wang, Yinhai			A hybrid neural network for large-scale expressway network OD prediction based on toll data	PLOS ONE			English	Article							TRAVEL-TIME PREDICTION	Accurate Origin-Destination (OD) prediction is significant for effective traffic monitor, which can support operation decision in traffic planning and management field. The enclosed expressway network system like toll gates system in China can collect mounts of trip records which can be gathered for OD prediction. The paper develops a novel neural network, which is named Expressway OD Prediction Neural Network (EODPNN) for toll data-based prediction. The network consists of the following three modules: The Feature Extension Module, the Memory Module, and the Prediction Module. In the process, the attributes data which can reflect the city attribute such as GDP, population, and the number of vehicles are considered to embeded into the notwork to increase the accuracy of the model. For the applicability improvment of the model, we categorize the cities in multiple classes based on their economy and population scales in this paper, which can provide a higher accurate prediction of OD by EODPNN. The results shows that, comparing to the traditional model like ARIMA and SVM, or typical neural networks like Bidirectional Long Short-term Memory, the EODPNN delivers a better prediction performance. The method proposed in this paper has been fully verified and has a potential to transplant to the other OD data-based management systems for a more accurate and flexible prediction.	[Fu, Xin; Wang, Jianwei] Changan Univ, Dept Econ & Management, Xian, Shaanxi, Peoples R China; [Yang, Hao; Liu, Chenxi; Wang, Yinhai] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	Chang'an University; University of Washington; University of Washington Seattle	Yang, H; Wang, YH (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	haoya@uw.edu; yinhai@uw.edu			Fundamental Research Funds for the Central Universities of China [310823161001, 310823170434]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The author XF is funded through research projects granted by the Fundamental Research Funds for the Central Universities of China, grant number is 310823161001 and 310823170434. http://xxgk.chd.edu.cn The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura Y, 2000, TRANSPORTATION, V27, P419, DOI 10.1023/A:1005239823771; [常云涛 Chang Yuntao], 2003, [交通运输工程学报, Journal of triffic and transportation engineering], V3, P89; Cui Z., 2018, ARXIV180102143; Cui Zhiyong, 2017, P 6 INT WORKSH URB C; Du W, 2009, INT C TRANSP ENG, P2707; El Faouzi NE, 2010, IET INTELL TRANSP SY, V4, P338, DOI 10.1049/iet-its.2009.0140; Elhenawy M, 2014, TRANSPORT RES C-EMER, V42, P82, DOI 10.1016/j.trc.2014.02.016; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Jozefowicz R, 2015, PR MACH LEARN RES, V37, P2342; Karlaftis MG, 2011, TRANSPORT RES C-EMER, V19, P387, DOI 10.1016/j.trc.2010.10.004; Kikuchi S, 2000, TRANSPORT RES REC, P59; Liang C, 2010, J U SHANGHAI SCI TEC, V32, P471; Lv YS, 2015, IEEE T INTELL TRANSP, V16, P865, DOI 10.1109/TITS.2014.2345663; Ma X, TRANSPORTATION RES C; Ma XL, 2018, COMPUT ENVIRON URBAN, V70, P113, DOI 10.1016/j.compenvurbsys.2018.03.001; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040818; Miska M, 2009, P INFRASTRUCTURE PLA, V39, P1; Mussone Lorenzo, 2013, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V13, P84; MUSSONE Lorenzo, 2010, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V10, P88; Qu TT, 2014, TRANSPORT RES REC, P77, DOI 10.3141/2451-09; Remya KP, 2013, CONTRIBUTORY PAPERS, P287; Sutskever I., 2014, ADV NEURAL INFORM PR, V3104, P3112, DOI DOI 10.1007/S10107-014-0839-0; Tang JJ, 2019, ACCIDENT ANAL PREV, V122, P226, DOI 10.1016/j.aap.2018.10.016; van Lint JWC, 2005, TRANSPORT RES C-EMER, V13, P347, DOI 10.1016/j.trc.2005.03.001; Vinyals O, 2015, PROC CVPR IEEE, P3156, DOI 10.1109/CVPR.2015.7298935; Wang JG, 2010, 2010 INTERNATIONAL CONFERENCE ON INFORMATION, ELECTRONIC AND COMPUTER SCIENCE, VOLS 1-3, P5; Wang K, 2007, TRAFFIC COMPUTER, V25, P35; [王元庆 Wang Yuanqing], 2010, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V10, P83; Yamazaki H, 2012, IET INTELL TRANSP SY, V6, P306, DOI 10.1049/iet-its.2009.0145; Ye Q, 2012, IEEE T INTELL TRANSP, V13, P1727, DOI 10.1109/TITS.2012.2203122; Yu HL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010013; Zhang HB, 2012, J TEST EVAL, V40, P1220, DOI 10.1520/JTE20120145; Zhang XP, 2005, TRANSPORT RES REC, P108; Zhao NL, 2014, PROCD SOC BEHV, V138, P632, DOI 10.1016/j.sbspro.2014.07.250; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zou YJ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020418	36	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217241	10.1371/journal.pone.0217241	http://dx.doi.org/10.1371/journal.pone.0217241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120962	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700076
J	Geboy, AG; Nichols, WL; Fernandez, SJ; Desale, S; Basch, P; Fishbein, DA				Geboy, Alexander G.; Nichols, Whitney L.; Fernandez, Stephen J.; Desale, Sameer; Basch, Peter; Fishbein, Dawn A.			Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system	PLOS ONE			English	Article							LINKAGE-TO-CARE; VIRUS-INFECTION; UNITED-STATES; BABY BOOMERS; PERSONS BORN; STRATEGIES; CASCADE; ACCESS	Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today, increasing the feasibility of disease elimination. However, large healthcare systems may not be fully prepared for supporting recommended actions due to knowledge gaps, inadequate infrastructure and uninformed policy direction. Additionally, the HCV cascade of care is complex, with many embedded barriers, and a significant number of patients do not progress through the cascade and are thus not cured. The aim of this retrospective cohort study was to evaluate a large healthcare system's HCV screening rates, linkage to care efficiency, and provider testing preferences. Patients born during 1945-1965, not previously HCV positive or tested from within the Electronic Health Record (EHR), were identified given that three-quarters of HCV-infected persons in the United States are from this Birth Cohort (BC). In building this HCV testing EHR prompt, non-Birth Cohort patients were excluded as HCV-specific risk factors identifying this population were not usually captured in searchable, structured data fields. Once completed, the BC prompt was released to primary care locations. From July 2015 through December 2016, 11.5% of eligible patients (n = 9,304/80,556) were HCV antibody tested (anti-HCV), 3.8% (353/9,304) anti-HCV positive, 98.1% (n = 311/317) HCV RNA tested, 59.8% (n = 186/311) HCV RNA positive, 86.6% (161/186) referred and 76.4% (n = 123/161) seen by a specialist, and 34.1% (n = 42/123) cured of their HCV. Results from the middle stages of the cascade in this large healthcare system are encouraging; however, entry into the cascade-HCV testing-was performed for only 11% of the birth cohort, and the endpoint-HCV cure-accounted for only 22% of all infected. Action is needed to align current practice with recommendations for HCV testing and treatment given that these are significant barriers toward elimination.	[Geboy, Alexander G.; Nichols, Whitney L.; Fernandez, Stephen J.; Desale, Sameer; Basch, Peter; Fishbein, Dawn A.] MedStar Hlth Res Inst, Hyattsville, MD 20782 USA; [Basch, Peter] MedStar Inst Innovat, Washington, DC USA; [Basch, Peter] MedStar Qual & Safety Inst, Washington, DC USA; [Fishbein, Dawn A.] MedStar Washington Hosp Ctr, Washington, DC USA	MedStar Health Research Institute; MedStar Washington Hospital Center	Geboy, AG (corresponding author), MedStar Hlth Res Inst, Hyattsville, MD 20782 USA.	Alexander.G.Geboy@medstar.net		Fernandez, Stephen/0000-0002-5112-1844	Gilead Sciences, Inc. FOCUS award (MHRI award) [GM005771]	Gilead Sciences, Inc. FOCUS award (MHRI award)	Senior author, Dawn A. Fishbein, MD, MS, was the recipient of a Gilead Sciences, Inc. FOCUS award (MHRI award number GM005771) to support "HIV and/or hepatitis C testing and testing-related services". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.gilead.com/.	Almario CV, 2012, J VIRAL HEPATITIS, V19, pE163, DOI 10.1111/j.1365-2893.2011.01539.x; Alter M. J., 1998, MMWR MORB MORTAL WKL, V47; [Anonymous], 2013, SCREENING HEPATITIS; [Anonymous], 2017, HEP C FACT SHEET; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Bourgi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161241; Buckley GJ, 2017, NATL STRATEGY PREVEN; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Coyle C, 2016, PUBLIC HEALTH REP, V131, P65, DOI 10.1177/00333549161310S211; Falade-Nwulia O, 2016, J VIRAL HEPATITIS, V23, P366, DOI 10.1111/jvh.12507; Ford MM, 2017, J PUBLIC HEALTH MAN, P1; Geboy AG, 2016, PUBLIC HEALTH REP, V131, P49, DOI 10.1177/00333549161310S209; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Isenhour CJ, 2017, AM J PREV MED, V52, P625, DOI 10.1016/j.amepre.2016.12.016; Jewett A, 2015, HEALTH PROMOT PRACT, V16, P256, DOI 10.1177/1524839914532291; Jonas MC, 2016, CLIN INFECT DIS, V62, P1290, DOI 10.1093/cid/ciw086; Linas BP, 2014, AM J MED, V127, P398, DOI 10.1016/j.amjmed.2014.01.012; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Maier MM, 2016, AM J PUBLIC HEALTH, V106, P353, DOI 10.2105/AJPH.2015.302927; Miller LS, 2016, PUBLIC HEALTH REP, V131, P84, DOI 10.1177/00333549161310S213; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Patel RC, 2016, PUBLIC HEALTH REP, V131, P12, DOI 10.1177/00333549161310S203; Roblin DW, 2011, AM J MANAG CARE, V17, P548; Rodriguez C V, 2015, 2015 NAT SUMM HCV HI; Sena AC, 2016, PUBLIC HEALTH REP, V131, P57, DOI 10.1177/00333549161310S210; Smith BD, 2015, CLIN INFECT DIS, V60, P1145, DOI 10.1093/cid/civ002; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Southern WN, 2011, J VIRAL HEPATITIS, V18, P474, DOI 10.1111/j.1365-2893.2010.01327.x; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Taylor BS, 2016, PUBLIC HEALTH REP, V131, P74, DOI 10.1177/00333549161310S212; Trooskin SB, 2015, J GEN INTERN MED, V30, P950, DOI 10.1007/s11606-015-3209-6; Turner BJ, 2015, J HOSP MED, V10, P510, DOI 10.1002/jhm.2376; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Ward JW, 2016, PUBLIC HEALTH REP, V131, P1, DOI 10.1177/00333549161310S201; Ward JW, 2013, CLIN LIVER DIS, V17, P1, DOI 10.1016/j.cld.2012.09.011; World Health Organization, 2016, COMB HEP B C REACH E; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	39	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216459	10.1371/journal.pone.0216459	http://dx.doi.org/10.1371/journal.pone.0216459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120906	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700017
J	Janssen, CE; Globig, AM; Grawitz, AB; Bettinger, D; Hasselblatt, P				Janssen, Christine Elisabeth; Globig, Anna Maria; Grawitz, Andrea Busse; Bettinger, Dominik; Hasselblatt, Peter			Seasonal variability of vitamin D status in patients with inflammatory bowel disease - A retrospective cohort study	PLOS ONE			English	Article							CROHNS-DISEASE; D DEFICIENCY; REDUCED RISK; ASSOCIATION; PREVALENCE; PREDICTORS; REMISSION; IMPACT	Objectives Vitamin D deficiency predicts unfavorable disease outcomes in inflammatory bowel disease. Endogenous vitamin D synthesis is affected by seasonal factors including sunlight exposure, raising the question whether seasonality determines the risk of vitamin D deficiency and may mask other clinical risk factors. Methods Univariable and multiple regression analyses were performed in a retrospective cohort of 384 patients to determine risk factors for vitamin D deficiency. Since the observed 25-hydroxyvitamin D [25(OH) D] concentrations followed a sinusoidal pattern over the year, all 25 (OH) D concentrations were normalized for the predicted variability of the respective day of analysis based on a sinusoidal regression analysis of 25(OH) D test results obtained in more than 86,000 control serum samples. Results Vitamin D deficiency was highly prevalent in patients with Crohn's disease or ulcerative colitis (63% and 55%, respectively) and associated with winter/spring seasons. After normalization of 25(OH) D concentrations for the day of analysis, vitamin D deficiency was associated with histories of complications related to inflammatory bowel disease, surgery, smoking and ongoing diarrhea while initial disease manifestation during adulthood, ongoing vitamin D supplementation and diagnosis of ulcerative colitis vs. Crohn's disease appeared to be protective. Multiple regression analyses revealed that vitamin D deficiency was associated with disease activity in Crohn's disease and anemia in ulcerative colitis patients. Only few deficient patients achieved sufficient 25(OH) D concentrations over time. However, increasing 25(OH) D concentrations correlated with improved Crohn's disease activity. Conclusions Vitamin D deficiency was highly prevalent in patients with Crohn's disease and ulcerative colitis and dependent on the season of the year. Following normalization for seasonality by sinusoidal regression analysis, vitamin D deficiency was found to be associated with parameters of complicated disease course while increasing 25(OH) D concentrations over time correlated with reduced activity of Crohn's disease.	[Janssen, Christine Elisabeth; Globig, Anna Maria; Bettinger, Dominik; Hasselblatt, Peter] Univ Freiburg, Fac Med, Med Ctr, Dept Med 2, Freiburg, Germany; [Globig, Anna Maria; Bettinger, Dominik] Univ Freiburg, Fac Med, Berta Ottenstein Programme, Freiburg, Germany; [Grawitz, Andrea Busse] Univ Freiburg, Fac Med, Med Ctr, Inst Clin Chem & Lab Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Hasselblatt, P (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Med 2, Freiburg, Germany.	Peter.Hasselblatt@uniklinik-freiburg.de	Bettinger, Dominik/ABB-3929-2020; Hasselblatt, Peter/AAF-3681-2021	Bettinger, Dominik/0000-0002-8782-8729	German Research Foundation (DFG); University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was sponsored by the authors' institution. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P1921, DOI 10.1097/MIB.0b013e3182902ad9; Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; Arihiro S, 2019, INFLAMMATORY BOWEL D; Bossuyt T, 2018, UNITED EUROPEAN GA S, V6, pA449; Bours PHA, 2011, OSTEOPOROSIS INT, V22, P2857, DOI 10.1007/s00198-010-1484-y; Colotta F, 2017, J AUTOIMMUN, V85, P78, DOI 10.1016/j.jaut.2017.07.007; de Bruyn JR, 2014, J CROHNS COLITIS, V8, P1267, DOI 10.1016/j.crohns.2014.03.004; Frigstad SO, 2017, SCAND J GASTROENTERO, V52, P100, DOI 10.1080/00365521.2016.1233577; Grant WB, 2018, J STEROID BIOCHEM, V177, P266, DOI 10.1016/j.jsbmb.2017.08.009; Gubatan J, 2018, CURR OPIN GASTROEN, V34, P217, DOI 10.1097/MOG.0000000000000449; Ham M, 2014, INFLAMM BOWEL DIS, V20, P856, DOI 10.1097/MIB.0000000000000016; Hartl C, 2017, J NEUROL SCI, V375, P160, DOI 10.1016/j.jns.2017.01.059; HARVEY RF, 1980, LANCET, V1, P514; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jorgensen SP, 2010, ALIMENT PHARM THER, V32, P377, DOI 10.1111/j.1365-2036.2010.04355.x; Jorgensen Soren Peter, 2013, J Crohns Colitis, V7, pe407, DOI 10.1016/j.crohns.2013.01.012; Kabbani TCA, 2016, AM J GASTROENTEROL, V111, P712, DOI 10.1038/ajg.2016.53; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Narula N, 2017, DIGEST DIS SCI, V62, P448, DOI 10.1007/s10620-016-4396-7; Nielsen OH, 2018, J CROHNS COLITIS, V12, P742, DOI 10.1093/ecco-jcc/jjy025; O'Sullivan F., 2019, PHOTOCHEM PHOTOBIOL; Opstelten JL, 2018, INFLAMM BOWEL DIS, V24, P633, DOI 10.1093/ibd/izx050; Pallav K, 2017, WORLD J GASTROENTERO, V23, P638, DOI 10.3748/wjg.v23.i4.638; Raftery T, 2015, DIGEST DIS SCI, V60, P2427, DOI 10.1007/s10620-015-3620-1; Raftery T, 2015, P NUTR SOC, V74, P56, DOI 10.1017/S0029665114001591; Schaffler H, 2018, J DIGEST DIS, V19, P24, DOI 10.1111/1751-2980.12565; Schaffler H, 2018, J DIGEST DIS, V19, P225, DOI 10.1111/1751-2980.12591; Schardey J, 2019, J CROHNS COLITIS; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P847; Suibhne TN, 2012, J CROHNS COLITIS, V6, P182, DOI 10.1016/j.crohns.2011.08.002; Torki M, 2015, DIGEST DIS SCI, V60, P3085, DOI 10.1007/s10620-015-3727-4; Ulitsky A, 2011, JPEN-PARENTER ENTER, V35, P308, DOI 10.1177/0148607110381267; Winter RW, 2017, ALIMENT PHARM THER, V45, P653, DOI 10.1111/apt.13936; Zullow S, 2017, DIGEST DIS SCI, V62, P2072, DOI 10.1007/s10620-017-4614-y	34	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217238	10.1371/journal.pone.0217238	http://dx.doi.org/10.1371/journal.pone.0217238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120977	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700074
J	Kang, JJ; Treadwell, TA; Bodary, PF; Shayman, JA				Kang, Justin J.; Treadwell, Taylour A.; Bodary, Peter F.; Shayman, James A.			Voluntary wheel running activates Akt/AMPK/eNOS signaling cascades without improving profound endothelial dysfunction in mice deficient in alpha-galactosidase A	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FABRY-DISEASE; OXIDATIVE STRESS; PHYSICAL-ACTIVITY; MITOCHONDRIAL BIOGENESIS; CEREBRAL HYPERPERFUSION; SUPEROXIDE-DISMUTASE; PROTEIN-KINASE; UP-REGULATION; MOUSE MODEL	Fabry disease is caused by loss of activity of the lysosomal hydrolase alpha-galactosidase A (GLA). Premature life-threatening complications in Fabry patients arise from cardiovascular disease, including stroke and myocardial infarction. Exercise training has been shown to improve endothelial dysfunction in various settings including coronary artery disease. However, the effects of exercise training on endothelial dysfunction in Fabry disease have not been investigated. Gla knockout mice were single-housed in a cage equipped with a voluntary wheel (EX) or no wheel (SED) for 12 weeks. Exercised mice ran 10 km/day on average during the voluntary running intervention (VR) period. Despite significantly higher food intake in EX than SED, body weights of EX and SED remained stable during the VR period. After the completion of VR, citrate synthase activity in gastrocnemius muscle was significantly higher in EX than SED. VR resulted in greater phosphorylation of Akt (S473) and AMPK (T172) in the aorta of EX compared to SED measured by western blot. Furthermore, VR significantly enhanced eNOS protein expression and phosphorylation at S1177 by 20% and 50% in the aorta of EX when compared with SED. Similarly, plasma nitrate and nitrite levels were 77% higher in EX than SED. In contrast, measures of anti- and pro-oxidative enzymes (superoxide dismutase and p67phox subunit of NADPH oxidase) and overall oxidative stress (plasma oxidized glutathione) were not different between groups. Although the aortic endothelial relaxation to acetylcholine was slightly increased in EX, it did not reach statistical significance. This study provides the first evidence that VR improves Akt/AMPK/eNOS signaling cascades, but not endothelial function in the aorta of aged Gla deficient mice.	[Kang, Justin J.; Bodary, Peter F.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Treadwell, Taylour A.] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA; [Shayman, James A.] Univ Michigan, Med Ctr, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shayman, JA (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA.	jshayman@umich.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK 055823]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK 055823 (https://www.niddk.nih.gov/) to JAS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Barbosa VA, 2013, INT J CARDIOL, V167, P2983, DOI 10.1016/j.ijcard.2012.08.050; Bellamy TC, 2002, BRIT J PHARMACOL, V136, P95, DOI 10.1038/sj.bjp.0704687; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Boutouyrie P, 2001, J MED GENET, V38, P629, DOI 10.1136/jmg.38.9.629; Bowles DK, 2011, J APPL PHYSIOL, V111, P308, DOI 10.1152/japplphysiol.00634.2011; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Cacicedo JM, 2011, AM J PHYSIOL-HEART C, V301, pH1255, DOI 10.1152/ajpheart.01279.2010; Chimenti C, 2015, HUM PATHOL, V46, P1760, DOI 10.1016/j.humpath.2015.07.017; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; El Dib RP, 2013, COCHRANE DB SYST REV, V2; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Eng CM, 2006, GENET MED, V8, P539, DOI 10.1097/01.gim.0000237866.70357.c6; Fentz J, 2015, AM J PHYSIOL-ENDOC M, V309, pE900, DOI 10.1152/ajpendo.00157.2015; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Heinecke JW, 2002, FREE RADICAL BIO MED, V32, P1090, DOI 10.1016/S0891-5849(02)00792-X; Kang JJ, 2014, AM J PHYSIOL-GASTR L, V306, pG140, DOI 10.1152/ajpgi.00185.2013; Kitzman DW, 2013, J AM COLL CARDIOL, V62, P584, DOI 10.1016/j.jacc.2013.04.033; Kojda G, 2001, CIRCULATION, V103, P2839; Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Linhart A, 2006, FABRY DIS PERSPECTIV, P198; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; McAllister RM, 2006, ESSAYS BIOCHEM, V42, P119, DOI 10.1042/bse0420119; Moore DF, 2007, J NEUROL SCI, V257, P258, DOI 10.1016/j.jns.2007.01.053; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Neo BH, 2010, AM J PHYSIOL-HEART C, V299, pH1235, DOI 10.1152/ajpheart.00513.2010; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Schmitz B, 2016, INT J SPORTS MED, V37, P1066, DOI 10.1055/s-0042-110205; Seals DR, 2008, J APPL PHYSIOL, V105, P1323, DOI 10.1152/japplphysiol.90553.2008; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Sheppard MN, 2010, CARDIOVASC PATHOL, V19, P293, DOI 10.1016/j.carpath.2009.05.003; Shu LM, 2014, KIDNEY INT, V86, P58, DOI 10.1038/ki.2013.520; Shu LM, 2009, J AM SOC NEPHROL, V20, P1975, DOI 10.1681/ASN.2008111190; Silva JF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00386; Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599; Weidemann F, 2005, EUR HEART J, V26, P1221, DOI 10.1093/eurheartj/ehi143; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Woodman CR, 1999, AM J PHYSIOL-HEART C, V276, pH1058, DOI 10.1152/ajpheart.1999.276.3.H1058; Woodman CR, 1997, AM J PHYSIOL-HEART C, V273, pH2575, DOI 10.1152/ajpheart.1997.273.6.H2575; Zhang QJ, 2009, J PHYSIOL-LONDON, V587, P3911, DOI 10.1113/jphysiol.2009.172916	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217214	10.1371/journal.pone.0217214	http://dx.doi.org/10.1371/journal.pone.0217214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120949	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700068
J	Padilla, ACH; Trampont, T; Lafon, T; Daix, T; Cailloce, D; Barraud, O; Dalmay, F; Vignon, P; Francois, B				Padilla, Ana Catalina Hernandez; Trampont, Timothee; Lafon, Thomas; Daix, Thomas; Cailloce, Dominique; Barraud, Olivier; Dalmay, Francois; Vignon, Philippe; Francois, Bruno			Is prehospital endobronchial intubation a risk factor for subsequent ventilator associated pneumonia? A retrospective analysis	PLOS ONE			English	Article							ACCIDENTAL BRONCHIAL INTUBATION; RAPID-SEQUENCE INTUBATION; TRAUMA; ENDOTRACHEAL; AUSCULTATION; GUIDELINES; MORTALITY; IMPACT	More than half of patients under mechanical ventilation in the intensive care unit (ICU) are field-intubated, which is a known risk factor for ventilator associated pneumonia (VAP). We assessed whether field endobronchial intubation (EBI) is associated with the development of subsequent VAP during the ICU stay. This retrospective, nested case-control study was conducted in a cohort of field-intubated patients admitted to an ICU of a teaching hospital during a three-year period. Cases were defined as field-intubated patients with EBI and controls corresponded to field-intubated patients with proper position of the tracheal tube on admission chest X-ray. Primary endpoint was the development of early VAP. Secondary endpoints included the development of early ventilator associated tracheo-bronchitis, late VAP, duration of mechanical ventilation, length of stay and mortality in the ICU. A total of 145 patients were studied (mean age: 54 +/- 19 years; men: 74%). Reasons for field intubation were predominantly multiple trauma (49%) and cardiorespiratory arrest (38%). EBI was identified in 33 patients (23%). Fifty-three patients (37%) developed early or late VAP. EBI after field intubation was associated with a nearly two-fold increase of early VAP, though not statistically significant (30% vs. 17%: p = 0.09). No statistically significant difference was found regarding secondary outcomes. The present study suggests that inadvertent prehospital EBI could be associated with a higher incidence of early-onset VAP. Larger studies are required to confirm this hypothesis. Whether strategies aimed at decreasing the incidence and duration of EBI could reduce the incidence of subsequent VAP remains to be determined.	[Padilla, Ana Catalina Hernandez; Lafon, Thomas; Daix, Thomas; Vignon, Philippe; Francois, Bruno] CHU Dupuytren, INSERM, CIC 1435, Limoges, France; [Trampont, Timothee; Lafon, Thomas] CHU Dupuytren, Serv Accueil Urgences, Limoges, France; [Daix, Thomas; Vignon, Philippe; Francois, Bruno] CHU Dupuytren, Reanimat Polyvalente, Limoges, France; [Daix, Thomas; Barraud, Olivier; Francois, Bruno] Univ Limoges, INSERM, UMR 1092, Limoges, France; [Cailloce, Dominique] CHU Dupuytren, SAMU, SMUR, Limoges, France; [Barraud, Olivier] CHU Dupuytren, Lab Bacteriol Virol Hyg, Limoges, France; [Dalmay, Francois] Univ Limoges, INSERM, UMR 1094, Limoges, France	CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Limoges; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; CHU Limoges; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges	Padilla, ACH (corresponding author), CHU Dupuytren, INSERM, CIC 1435, Limoges, France.	AnaCatalina.HERNANDEZPADILLA@chu-limoges.fr	François, Bruno/O-8404-2016; Vignon, Philippe/O-8886-2016; BARRAUD, Olivier/O-7532-2016	François, Bruno/0000-0002-2531-1652; Vignon, Philippe/0000-0003-4551-5772; BARRAUD, Olivier/0000-0003-2015-9206				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Bhat R, 2014, WEST J EMERG MED, V15, P708, DOI 10.5811/westjem.2014.7.22292; BISSINGER U, 1989, ANN EMERG MED, V18, P853, DOI 10.1016/S0196-0644(89)80211-2; Blaivas M, 2008, J ULTRAS MED, V27, P785, DOI 10.7863/jum.2008.27.5.785; Cavalcanti M, 2006, CRIT CARE MED, V34, P1067, DOI 10.1097/01.CCM.0000206471.44161.A0; Cornelius Bryant, 2015, Anesth Prog, V62, P66, DOI 10.2344/0003-3006-62.1.66; Craven DE, 2009, CHEST, V135, P521, DOI 10.1378/chest.08-1617; Decelle L, 2013, EUR J EMERG MED, V20, P61, DOI 10.1097/MEJ.0b013e3283501677; Eckert MJ, 2004, J TRAUMA, V57, P750, DOI 10.1097/01.TA.0000147499.73570.12; Evans HL, 2011, SURG INFECT, V12, P339, DOI 10.1089/sur.2010.074; Evans HL, 2010, ARCH SURG-CHICAGO, V145, P1041, DOI 10.1001/archsurg.2010.239; Ezri T, 2006, J CLIN ANESTH, V18, P118, DOI 10.1016/j.jclinane.2005.08.008; Fouche PF, 2017, ANN EMERG MED, V70, P449, DOI 10.1016/j.annemergmed.2017.03.026; Hossein-Nejad H, 2013, AM J EMERG MED, V31, P1181, DOI 10.1016/j.ajem.2013.04.032; Joseph NM, 2009, J INFECT DEV COUNTR, V3, P771, DOI 10.3855/jidc.396; Jung B, 2008, REANIMATION, V17, P753, DOI DOI 10.1016/J.REAURG.2008.09.009; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Kallet RH, 2015, RESP CARE, V60, P1495, DOI 10.4187/respcare.03774; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Klompas M, 2014, INFECT CONT HOSP EP, V35, P915, DOI [10.1017/S0899823X00193894, 10.1086/677144]; Klompas M, 2010, AM J INFECT CONTROL, V38, P237, DOI 10.1016/j.ajic.2009.10.003; Lau ACW, 2015, HONG KONG MED J, V21, P61, DOI 10.12809/hkmj144367; McCoy EP, 1997, ANAESTHESIA, V52, P24, DOI 10.1111/j.1365-2044.1997.007-az007.x; McGillicuddy DC, 2009, INT J EMERG MED, V2, P247, DOI 10.1007/s12245-009-0133-8; Michetti CP, 2017, AM J SURG, V213, P405, DOI 10.1016/j.amjsurg.2016.05.019; Mohr NM, 2014, J CRIT CARE, V29, P539, DOI 10.1016/j.jcrc.2014.03.030; Neumar RW, 2015, CIRCULATION, V132, pS315, DOI 10.1161/CIR.0000000000000252; OWEN RL, 1987, ANESTHESIOLOGY, V67, P255, DOI 10.1097/00000542-198708000-00019; Ramsingh D, 2016, ANESTHESIOLOGY, V124, P1012, DOI 10.1097/ALN.0000000000001073; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; Zilberberg MD, 2010, CLIN INFECT DIS, V51, pS131, DOI 10.1086/653062	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217466	10.1371/journal.pone.0217466	http://dx.doi.org/10.1371/journal.pone.0217466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120987	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700107
J	Vardy, Y; Day, NJS; Grenyer, BFS				Vardy, Yvette; Day, Nicholas J. S.; Grenyer, Brin F. S.			Development and validation of an experience of time alone scale for borderline personality disorder	PLOS ONE			English	Article							ATTACHMENT; COMPONENTS; ALONENESS; INSECURE; ANXIETY; NUMBER; PSYCHOTHERAPY; METAANALYSIS; FEATURES; 5-ITEM	Background/Objective Intolerance of aloneness is considered a core feature of borderline personality disorder (BPD) that is clinically significant, yet under-researched. This study developed a measure of aloneness for individuals with BPD. Method Interviews investigating the experience of aloneness for BPD participants (n = 12) formed the basis for the development of the measure. Pilot testing then occurred with BPD participants, control participants and qualified respondents. Validity, reliability and factor analysis of an Experience of Time Alone Scale (ETAS) was conducted with BPD participants (n = 112) and a comparison control group (n = 105). Results A three factor structure was revealed: (a) Cannot Cope Alone (alpha = .92), (b) Need to Escape from Others (alpha = .90), and (c) Consumed in Intolerable Distress (alpha = .88). The measure correlated significantly (p < .01) with the Mental Health Inventory, the Aloneness and Evocative Memory Scale, and the Hurvich Experience Inventory- Revised. Comparisons revealed highly significant differences between the BPD sample and control group on all subscales and the total score (U = 75.5, p = <.001, r = -.85). Conclusions This study represents one of the first empirical examinations of a construct that has largely only been studied theoretically. This newly developed measure may contribute to diagnosis and therapy.	[Vardy, Yvette; Day, Nicholas J. S.; Grenyer, Brin F. S.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Vardy, Yvette; Day, Nicholas J. S.; Grenyer, Brin F. S.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong	Grenyer, BFS (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	grenyer@uow.edu.au	Day, Nicholas/AAD-4496-2020; Grenyer, Brin FS/AAB-6452-2020	Day, Nicholas/0000-0002-2090-9778; Grenyer, Brin FS/0000-0003-1501-4336	New South Wales Ministry of Health [DOH09-33]	New South Wales Ministry of Health	This study is part of a larger project funded by the New South Wales Ministry of Health (Grant DOH09-33) to BFSG. The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER G, 1993, AM J PSYCHOTHER, V47, P194, DOI 10.1176/appi.psychotherapy.1993.47.2.194; ADLER G, 1979, INT J PSYCHOANAL, V60, P83; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; Benveniste PS, 1998, PSYCHOANAL PSYCHOL, V15, P536, DOI 10.1037/0736-9735.15.4.536; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Blatt SJ, 2003, PSYCHOANAL INQ, V23, P102, DOI 10.1080/07351692309349028; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Buchholz E. S., 1994, PSYCHOANAL PSYCHOL, V11, P357, DOI DOI 10.1037/H0079555; Buchholz ES, 1999, B MENNINGER CLIN, V63, P143; Buie D H, 1982, Int J Psychoanal Psychother, V9, P51; Carter PE, 2012, J PERS DISORD, V26, P305, DOI 10.1521/pedi.2012.26.3.305; CHESSICK RD, 1974, INT J PSYCHOANAL PSY, V3, P73; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colonnesi C, 2011, J CLIN CHILD ADOLESC, V40, P630, DOI 10.1080/15374416.2011.581623; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; Cuijpers P, 2009, PSYCHIAT RES, V168, P250, DOI 10.1016/j.psychres.2008.05.012; Davies J., 1994, TREATING ADULT SURVI; Davis L.L., 1992, APPL NURS RES, V5, P194, DOI [10.1016/S0897-1897(05)80008-4, DOI 10.1016/S0897-1897(05)80008-4]; Dazzi S, 1998, J Am Acad Psychoanal, V26, P69; Dinsdale N, 2013, J PERS DISORD, V27, P172, DOI 10.1521/pedi.2013.27.2.172; Ebel R.L., 1979, ESSENTIALS ED MEASUR; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; FERKETICH S, 1990, RES NURS HEALTH, V13, P437, DOI 10.1002/nur.4770130612; First M.B., 2016, STRUCTURED CLIN INTE; FONAGY P, 1991, INT J PSYCHOANAL, V72, P639; Fonagy P, 2003, PSYCHOANAL INQ, V23, P412, DOI 10.1080/07351692309349042; Fonagy P., 2002, AFFECT REGULATION ME; FRAIBERG S, 1975, J AM ACAD CHILD PSY, V14, P387, DOI 10.1016/S0002-7138(09)61442-4; Freud S., 1926, STANDARD EDITION COM, V20, P77, DOI DOI 10.1080/21674086.1936.11925270; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; FROMMREICHMANN F, 1959, PSYCHIATR, V22, P1; George D., 2003, SPSS WINDOWS STEP ST; Giorgi A, 1985, PHENOMENOL PSYCHOLOG, V1, P23; Giorgi A, 1987, RECENT TRENDS THEORE; Grenyer BFS., 2014, ACPARIAN, V9, P8; Grenyer BFS, 2017, AUST NZ J PSYCHIAT, V51, P872, DOI 10.1177/0004867417717798; Groh AM, 2012, CHILD DEV, V83, P591, DOI 10.1111/j.1467-8624.2011.01711.x; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gunderson J.G., 2008, BORDERLINE PERSONALI; GUNDERSON JG, 1978, AM J PSYCHIAT, V135, P792; Gunderson JG, 1996, AM J PSYCHIAT, V153, P752; Gunderson JG, 2008, J PERS DISORD, V22, P22, DOI 10.1521/pedi.2008.22.1.22; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hurvich M, 2000, Psychoanal Rev, V87, P615; Hurvich M, 2007, HURVICH EXPERIENCE I; Hurvich M., 1990, HURVICH EXPERI UNPUB; Hurvich M, 1991, PSYCHOANALYTIC REFLE, P135; Kernberg O., 1992, AGGRESSION PERSONALI; KERNBERG OF, 1994, PSYCHIAT CLIN N AM, V17, P701; Kohling J, 2016, J PERS DISORD, V30, P776; Lingiardi V., 2017, PSYCHODYNAMIC DIAGNO; Lucassen N, 2011, J FAM PSYCHOL, V25, P986, DOI 10.1037/a0025855; LYNN MR, 1986, NURS RES, V35, P382; Madigan S, 2013, DEV PSYCHOL, V49, P672, DOI 10.1037/a0028793; MASTERSON JF, 1971, B MENNINGER CLIN, V35, P5; Masterson JF, 2000, PERSONALITY DISORDER; McCarthy KL, 2013, J MENT HEALTH, V22, P482, DOI 10.3109/09638237.2013.779367; McWilliams N, 2018, PSYCHOANAL PSYCHOL, V35, P299, DOI 10.1037/pap0000198; Meares R, 1999, AUST NZ J PSYCHIAT, V33, P831, DOI 10.1046/j.1440-1614.1999.00637.x; Mesman J, 2009, DEV REV, V29, P120, DOI 10.1016/j.dr.2009.02.001; Miller CE, 2018, PERSONAL MENT HEALTH, V12, P334, DOI 10.1002/pmh.1432; Miller JD, 2017, PERSONAL DISORD, V8, P26, DOI 10.1037/per0000191; MODELL AH, 1963, INT J PSYCHOANAL, V44, P282; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Pallini S, 2014, J FAM PSYCHOL, V28, P118, DOI 10.1037/a0035736; Pazzagli A, 2000, PSYCHOPATHOLOGY, V33, P220, DOI 10.1159/000029147; Richetin J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186695; Richman NE, 1986, THESIS; Richman NE., 1992, PSYCHOANAL PSYCHOL, V9, P77, DOI [10.1037/h0079323, DOI 10.1037/H0079323]; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Singer M., 1977, INT REV PSYCHOANAL, V4, P471; Singer M, 1977, INT REV PSYCHOANALYS, V4, P459; Southward MW, 2018, CLIN PSYCHOL SCI, V6, P685, DOI 10.1177/2167702618769560; Tabachnick B. G., 2007, USING MULTIVARIATE S, V5th; Tyrer P, 2010, WORLD PSYCHIATRY, V9, P56; Vardy Y, 2011, EXPERIENCE ALONENESS; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WINNICOTT DW, 1958, INT J PSYCHOANAL, V39, P416; Winnicott DW., 1960, MATURATIONAL PROCESS, P1; Winsper C, 2018, CURR OPIN PSYCHOL, V21, P105, DOI 10.1016/j.copsyc.2017.10.005; Zanarini MC, 2003, J PERS DISORD, V17, P568, DOI 10.1521/pedi.17.6.568.25355; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	83	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217350	10.1371/journal.pone.0217350	http://dx.doi.org/10.1371/journal.pone.0217350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120954	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700117
J	Ayalew, H; Tsang, PW; Chu, CG; Wang, JZ; Liu, SY; Chen, CF; Ma, XF				Ayalew, Habtamu; Tsang, Pak Wah; Chu, Chenggen; Wang, Junzhou; Liu, Shuyu; Chen, Caifu; Ma, Xue-Feng			Comparison of TaqMan, KASP and rhAmp SNP genotyping platforms in hexaploid wheat	PLOS ONE			English	Article							TRAITS; ASSAYS	Advances in high-throughput genotyping enable the generation of genome-scale data much more easily and at lower cost than ever before. However, small-scale and cost-effective high-throughput single-nucleotide polymorphism (SNP) genotyping technologies are still under development. In this study, we compared the performances of TaqMan, KASP and rhAmp SNP genotyping platforms in terms of their assay design flexibility, assay design success rate, allele call rate and quality, ease of experiment run and cost per sample. Fifty SNP markers linked to genes governing various agronomic traits of wheat were chosen to design SNP assays. Design success rates were 39/50, 49/50, and 49/50 for TaqMan, KASP, and rhAmp, respectively, and 30 SNP assays were manufactured for genotyping comparisons across the three platforms. rhAmp showed 97% of samples amplified while TaqMan and KASP showed 93% and 93.5% of amplifications, respectively. Allele call quality of rhAmp was 97%, while it was 98% for both TaqMan and KASP. rhAmp and KASP showed significantly better (p < 0.001) allele discrimination than TaqMan; however, TaqMan showed the most compact cluster. Based on the current market, rhAmp was the least expensive technology followed by KASP. In conclusion, rhAmp provides a reliable and cost-effective option for targeted genotyping and marker-assisted selection in crop genetic improvement.	[Ayalew, Habtamu; Ma, Xue-Feng] Noble Res Inst, Ardmore, OK 73401 USA; [Tsang, Pak Wah; Wang, Junzhou; Chen, Caifu] Integrated DNA Technol, Ctr Excellence Res & Dev, Redwood City, CA USA; [Chu, Chenggen; Liu, Shuyu] Texas A&M AgriLife Res, Amarillo, TX USA	Noble Research Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Ma, XF (corresponding author), Noble Res Inst, Ardmore, OK 73401 USA.	xma@noble.org	Ayalew, Habtamu/AAI-7307-2021; chu, chenggen/AAM-1126-2020; Liu, Shuyu/J-2022-2019; Ma, Xue-Feng/AAO-7225-2020	Ayalew, Habtamu/0000-0002-4778-9008; Liu, Shuyu/0000-0003-4748-2900; Ma, Xue-Feng/0000-0002-0942-9116	Integrated DNA Technologies; Samuel Roberts Noble Foundation; Integrated DNA Technologies (IDT)	Integrated DNA Technologies; Samuel Roberts Noble Foundation; Integrated DNA Technologies (IDT)	The Integrated DNA Technologies provided support in the form of research materials for rhAmp SNP genotyping platform and salaries for authors PWT, JW and CC. In addition, the Samuel Roberts Noble Foundation provided support for this study. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The Samuel Roberts Noble Foundation and Integrated DNA Technologies (IDT) supported this study. We would like to thank Andrea Mongler for proofreading the manuscript.	[Anonymous], 2017, IWGSC REF SEQ V1 0; Bac-Molenaar JA, 2015, J EXP BOT, V66, P5567, DOI 10.1093/jxb/erv176; Bellucci A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01046; Braae A, COMP CUSTOM DESIGNED, DOI [10.1007/s00122-016-2743-x, DOI 10.1007/S00122-016-2743-X]; Broccanello C, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0295-6; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Ertiro BT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2180-2; Huang XQ, 2012, MOL BREEDING, V30, P627, DOI 10.1007/s11032-011-9649-8; IDT, 2017, RHAMP SNP GEN GEN RH; Lopes MS, 2013, THEOR APPL GENET, V126, P971, DOI 10.1007/s00122-012-2030-4; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rasheed A, 2017, MOL PLANT, V10, P1047, DOI 10.1016/j.molp.2017.06.008; Rasheed A, 2016, THEOR APPL GENET, V129, P1843, DOI 10.1007/s00122-016-2743-x; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Tabone T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-580; Thomson M. J., 2014, Plant Breeding and Biotechnology, V2, P195, DOI 10.9787/PBB.2014.2.3.195; Bui TGT, 2017, HEREDITAS, V154, DOI 10.1186/s41065-016-0024-y; Woodward AE, 2014, GENDER POLIT, P67	21	23	23	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217222	10.1371/journal.pone.0217222	http://dx.doi.org/10.1371/journal.pone.0217222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116793	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400053
J	Chang, TY; Kajackaite, A				Chang, Tom Y.; Kajackaite, Agne			Battle for the thermostat: Gender and the effect of temperature on cognitive performance	PLOS ONE			English	Article							THERMAL COMFORT; REFLECTION; HEURISTICS; ALTRUISM; WOMEN; MEN	This paper studies differences in the effect of temperature on cognitive performance by gender in a large controlled lab experiment (N = 543). We study performance in math, verbal and cognitive reflection tasks and find that the effects of temperature vary significantly across men and women. At higher temperatures, women perform better on a math and verbal task while the reverse effect is observed for men. The increase in female performance in response to higher temperature is significantly larger and more precisely estimated than the corresponding decrease in male performance. In contrast to math and verbal tasks, temperature has no impact on a measure of cognitive reflection for either gender. Our findings suggest that gender mixed workplaces may be able to increase productivity by setting the thermostat higher than current standards.	[Chang, Tom Y.] USC Marshall Sch Business, Los Angeles, CA USA; [Kajackaite, Agne] WZB Berlin Social Sci Ctr, Berlin, Germany		Kajackaite, A (corresponding author), WZB Berlin Social Sci Ctr, Berlin, Germany.	agne.kajackaite@wzb.eu		Kajackaite, Agne/0000-0002-6414-6741				Abeler J, ECONOMETRICA; ANDERSON CA, 1989, PSYCHOL BULL, V106, P74, DOI 10.1037/0033-2909.106.1.74; [Anonymous], 2018, 2018 SAT SUITE ASSES; Blattman C, 2017, AM ECON REV, V107, P1165, DOI 10.1257/aer.20150503; Borghans L, 2009, J EUR ECON ASSOC, V7, P649, DOI 10.1162/JEEA.2009.7.2-3.649; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Eckartz, 2012, CESIFO WORKING PAPER, V4049; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Friesdorf R, 2015, PERS SOC PSYCHOL B, V41, P696, DOI 10.1177/0146167215575731; Gneezy U, 2003, Q J ECON, V118, P1049, DOI 10.1162/00335530360698496; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Hancock PA, 2007, HUM FACTORS, V49, P851, DOI 10.1518/001872007X230226; Hesse M, 2018, WASH POST; Kahn M, 2018, WORKING PAPER; Karjalainen S, 2007, BUILD ENVIRON, V42, P1594, DOI 10.1016/j.buildenv.2006.01.009; Kingma B, 2015, NAT CLIM CHANGE, V5, P1054, DOI 10.1038/NCLIMATE2741; Knapton S, 2015, TELEGRAPH; Mishra AK, 2016, BUILD ENVIRON, V109, P82, DOI 10.1016/j.buildenv.2016.09.016; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Pager T, 2018, NY TIMES; Pilcher JJ, 2002, ERGONOMICS, V45, P682, DOI 10.1080/00140130210158419; Rand DG, 2017, J EXP SOC PSYCHOL, V73, P164, DOI 10.1016/j.jesp.2017.06.013; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Tiihonen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06720-z; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Yeganeh AJ, 2018, BUILD ENVIRON, V143, P701, DOI 10.1016/j.buildenv.2018.07.002; Zivin JG, 2018, J ASSOC ENVIRON RESO, V5, P77, DOI 10.1086/694177	30	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216362	10.1371/journal.pone.0216362	http://dx.doi.org/10.1371/journal.pone.0216362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116745	Green Published, gold			2022-12-27	WOS:000468607400020
J	Kendall-Bar, JM; Vyssotski, AL; Mukhametov, LM; Siegel, JM; Lyamin, OI				Kendall-Bar, Jessica M.; Vyssotski, Alexei L.; Mukhametov, Lev M.; Siegel, Jerome M.; Lyamin, Oleg, I			Eye state asymmetry during aquatic unihemispheric slow wave sleep in northern fur seals (Callorhinus ursinus)	PLOS ONE			English	Article							INTERHEMISPHERIC EEG ASYMMETRY; PIGEON COLUMBA; BIRDS SLEEP; STIMULATION; CETACEANS; PATTERNS; BEHAVIOR; CLOSURE; WAKING; PUPS	Unihemispheric slow wave sleep (USWS) is a unique form of sleep in which one brain hemisphere maintains low voltage electrical activity indicative of waking while the opposite exhibits slow wave electrical activity indicative of sleep. USWS is present in several marine mammals and in some species of birds. One proposed biological function of USWS is to enable the animal to monitor the environment to detect predators or conspecifics. While asymmetrical eye state was often observed during behavioral sleep in birds and marine mammals, electrophysiological (electroencephalogram, EEG) correlates between the asymmetry of eye state and EEG of two cortical hemispheres have not been reliably established. This study examined the association between eye state and EEG activity during aquatic sleep in two subadult northern fur seals (Callorhinus ursinus), taking advantage of the simultaneous visibility of both eyes when the seals were in the prone position. We found that during USWS the eye contralateral to the sleeping hemisphere was closed on average 99.4 +/- 0.1% of the recording time. The eye contralateral to the waking hemisphere opened briefly for on average 1.9 +/- 0.1 sec with a rate of 8.2 +/- 1.0 per min. This eye was open on average 24.8 +/- 2.5% of the USWS time and it was closed no longer than 3 sec, on average 39.4 +/- 5.6% of the time. These data indicate that fur seals sleep in seawater by having intermittent visual monitoring. Our findings document the extent of visual monitoring of both eyes during USWS and support the idea that USWS allows intermittent visual vigilance. Thus, USWS serves two functions in the fur seal, facilitating movement and visual vigilance, which may also be the case in cetaceans.	[Kendall-Bar, Jessica M.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Vyssotski, Alexei L.] Univ Zurich, Swiss Fed Inst Technol, ETH, Inst Neuroinformat, Zurich, Switzerland; [Mukhametov, Lev M.; Lyamin, Oleg, I] RAS, AN Severtsov Inst Ecol & Evolut, Moscow, Russia; [Mukhametov, Lev M.; Lyamin, Oleg, I] Utrish Dolphinarium 84 Ltd, Moscow, Russia; [Siegel, Jerome M.; Lyamin, Oleg, I] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA	University of California System; University of California Santa Cruz; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; University of California System; University of California Los Angeles	Lyamin, OI (corresponding author), RAS, AN Severtsov Inst Ecol & Evolut, Moscow, Russia.; Lyamin, OI (corresponding author), Utrish Dolphinarium 84 Ltd, Moscow, Russia.; Lyamin, OI (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA.	olyamin@ucla.edu	Lyamin, Oleg/AAO-4881-2020; Kendall-Bar, Jessica/AAZ-6063-2021	Lyamin, Oleg/0000-0003-2049-0943; Kendall-Bar, Jessica/0000-0003-4758-1386	National Science Foundation [0919929]; National Institutes of Health [DA034748]; Russian Foundation for Basic Research [13-04-1704]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the National Science Foundation (grant no. 0919929) to OIL, National Institutes of Health (grant DA034748) to JMS, and Russian Foundation for Basic Research (grant no. 13-04-1704) to OIL. Utrish Dolphinarium-84 Ltd. provided support in the form of salary for LMM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1994, PRINCIPLES PRACTICE; Ball N.J., 1988, Sleep (Stuttgart), V1986, P151; BARTHOLOMEW G. A., 1956, JOUR MAMMAL, V37, P327, DOI 10.2307/1376731; CASTELLINI MA, 1994, AM J PHYSIOL, V266, pR863, DOI 10.1152/ajpregu.1994.266.3.R863; Castellini M, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1166; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Karamanlidis AA, 2017, AQUAT MAMM, V43, P82, DOI 10.1578/AM.43.1.2017.82; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Kelly ML, 2015, J EXP BIOL, V218, P3175, DOI 10.1242/jeb.127605; Krueger JM, 2019, SLEEP MED REV, V43, P14, DOI 10.1016/j.smrv.2018.10.001; Lilly J. C., 1964, HDB PHYSL ENV, P741; Liwanag HEM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P898, DOI 10.1086/656426; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Lyamin O I, 2012, Dokl Biol Sci, V444, P188, DOI 10.1134/S0012496612030143; LYAMIN OI, 1993, J SLEEP RES, V2, P163, DOI 10.1111/j.1365-2869.1993.tb00081.x; Lyamin OI, 2004, ARCH ITAL BIOL, V142, P557; Lyamin OI, 2002, BEHAV BRAIN RES, V129, P125, DOI 10.1016/S0166-4328(01)00346-1; LYAMIN OI, 1998, NO FUR SEAL SYSTEMAT, P280; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Lyamin OI, 2008, J SLEEP RES, V17, P154, DOI 10.1111/j.1365-2869.2008.00639.x; Lyamin OI, 2018, CURR BIOL, V28, P2000, DOI 10.1016/j.cub.2018.05.022; Lyamin OI, 2016, SLEEP, V39, P625, DOI 10.5665/sleep.5540; Mascetti GG, 2007, EXP BRAIN RES, V176, P70, DOI 10.1007/s00221-006-0595-3; Mascetti GG, 2016, NAT SCI SLEEP, V8, P221, DOI 10.2147/NSS.S71970; Mathews CG, 2006, ETHOLOGY, V112, P286, DOI 10.1111/j.1439-0310.2006.01138.x; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; MUKHAMETOV LM, 1977, BRAIN RES, V134, P581, DOI 10.1016/0006-8993(77)90835-6; OOKAWA T, 1968, JPN J PHYSIOL, V18, P87; PETERS J, 1965, J EXP ZOOL, V160, P255, DOI 10.1002/jez.1401600303; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Rattenborg NC, 2000, NEUROSCI BIOBEHAV R, V24, P817, DOI 10.1016/S0149-7634(00)00039-7; Rattenborg NC, 2001, BRAIN BEHAV EVOLUT, V58, P323, DOI 10.1159/000057573; Rattenborg NC, 2006, NATURWISSENSCHAFTEN, V93, P413, DOI 10.1007/s00114-006-0120-3; Rattenborg NC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12468; TOBLER I, 1988, J COMP PHYSIOL A, V163, P729, DOI 10.1007/BF00604050; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; Weller DW, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P923	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217025	10.1371/journal.pone.0217025	http://dx.doi.org/10.1371/journal.pone.0217025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116774	Green Submitted, gold, Green Published			2022-12-27	WOS:000468607400038
J	Li, RH; Teng, ZW; Lang, CL; Zhou, HZ; Zhong, WG; Ban, ZB; Yan, XG; Yang, HM; Farouk, MH; Lou, YJ				Li, Runhang; Teng, Zhanwei; Lang, Chaoli; Zhou, Haizhu; Zhong, Weiguang; Ban, Zhibin; Yan, Xiaogang; Yang, Huaming; Farouk, Mohammed Hamdy; Lou, Yujie			Effect of different forage-to-concentrate ratios on ruminal bacterial structure and real-time methane production in sheep	PLOS ONE			English	Article							DAIRY-COWS; IN-VITRO; GUT MICROBIOTA; CORN-SILAGE; RUMEN; EMISSIONS; CARBOHYDRATE; POPULATIONS; DIVERSITY; COMMUNITY	Emission from ruminants has become one of the largest sources of anthropogenic methane emission in China. The structure of the rumen flora has a significant effect on methane production. To establish a more accurate prediction model for methane production, the rumen flora should be one of the most important parameters. The objective of the present study was to investigate the relationship among changes in rumen flora, nutrient levels, and methane production in sheep fed with the diets of different forage-to-concentration ratios, as well as to screen for significantly different dominant genera. Nine rumen-cannulated hybrid sheep were separated into three groups and fed three diets with forage-to-concentration ratios of 50:50, 70:30, and 90:10. Three proportions of the diets were fed according to a 3 x 3 incomplete Latin square, design during three periods of 15d each. The ruminal fluid was collected for real-time polymerase chain reaction (real-time PCR), high-throughput sequencing and in vitro rumen fermentation in a new real-time fermentation system wit. Twenty-two genera were screened, the abundance of which varied linearly with forage-to-concentration ratios and methane production. In addition, during the 12-hour in vitro fermentation, the appearance of peak concentration was delayed by 26-27min with the different structure of rumen bacteria. The fiber-degrading bacteria were positively correlated with this phenomenon, but starch-degrading and protein-degrading bacteria were negative correlated. These results would facilitate macro-control of rumen microorganisms and better management of diets for improved nutrition in ruminants. In addition, our findings would help in screening bacterial genera that are highly correlated with methane production.	[Li, Runhang; Teng, Zhanwei; Lang, Chaoli; Zhou, Haizhu; Lou, Yujie] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Zhong, Weiguang; Ban, Zhibin; Yan, Xiaogang; Yang, Huaming] Jilin Acad Agr Sci, Changchun, Jilin, Peoples R China; [Farouk, Mohammed Hamdy] Al Azhar Univ, Fac Agr, Anim Prod Dept, Cairo, Egypt	Jilin Agricultural University; Jilin Academy of Agricultural Sciences; Egyptian Knowledge Bank (EKB); Al Azhar University	Lou, YJ (corresponding author), Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China.	lyjjlau@126.com	Farouk, Mohammed Hamdy/R-7566-2019	Farouk, Mohammed Hamdy/0000-0001-5989-1782; Li, Runhang/0000-0002-1402-1983; Lou, Yujie/0000-0002-0297-2861				AKIN DE, 1988, APPL ENVIRON MICROB, V54, P1117, DOI 10.1128/AEM.54.5.1117-1125.1988; AOAC International, 2006, AOAC OFFICIAL METHOD; Bennetzen EH, 2016, GLOBAL CHANGE BIOL, V22, P763, DOI 10.1111/gcb.13120; Bodine TN, 2003, J ANIM SCI, V81, P304; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Castro-Montoya J, 2012, ANIM FEED SCI TECH, V176, P47, DOI 10.1016/j.anifeedsci.2012.07.007; CLARK JH, 1975, J DAIRY SCI, V58, P1178, DOI 10.3168/jds.S0022-0302(75)84696-0; Cunha IS, 2011, ANAEROBE, V17, P118, DOI 10.1016/j.anaerobe.2011.04.018; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; DIJKSTRA J, 1992, J NUTR, V122, P2239, DOI 10.1093/jn/122.11.2239; Dong RL, 2013, ASIAN AUSTRAL J ANIM, V26, P1708, DOI 10.5713/ajas.2013.13245; Drackley JK, 2001, J DAIRY SCI, V84, P1231, DOI 10.3168/jds.S0022-0302(01)74584-5; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellis JL, 2007, J DAIRY SCI, V90, P3456, DOI 10.3168/jds.2006-675; Fan WG, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0279-2; GILL JW, 1958, J BACTERIOL, V75, P666, DOI 10.1128/JB.75.6.666-673.1958; Grinberg IR, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu047; GROVUM WL, 1988, PEPTIDES, V9, P519, DOI 10.1016/0196-9781(88)90158-1; Hobson P. N., 2012, RUMEN MICROBIAL ECOS, V2nd; HOLTER JB, 1992, J DAIRY SCI, V75, P2165, DOI 10.3168/jds.S0022-0302(92)77976-4; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jentsch W, 2007, ARCH ANIM NUTR, V61, P10, DOI 10.1080/17450390601106580; Jiao JZ, 2015, BRIT J NUTR, V113, P888, DOI 10.1017/S0007114514004413; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kinsman R, 1995, J DAIRY SCI, V78, P2760, DOI 10.3168/jds.S0022-0302(95)76907-7; KNAPP DM, 1991, J DAIRY SCI, V74, P2563, DOI 10.3168/jds.S0022-0302(91)78434-8; Kononoff PJ, 2003, J DAIRY SCI, V86, P2438, DOI 10.3168/jds.S0022-0302(03)73838-7; Lan YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032491; Lange M, 2001, FEMS MICROBIOL REV, V25, P553, DOI 10.1111/j.1574-6976.2001.tb00591.x; Lee HJ, 2012, APPL ENVIRON MICROB, V78, P5983, DOI 10.1128/AEM.00104-12; LENG RA, 1984, J DAIRY SCI, V67, P1072, DOI 10.3168/jds.S0022-0302(84)81409-5; Lengowski MB, 2016, ANAEROBE, V42, P6, DOI 10.1016/j.anaerobe.2016.07.004; Li XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126473; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Meng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089862; Menke K.H., 1988, ANIMAL RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Mills JAN, 2003, J ANIM SCI, V81, P3141; Mills JAN, 2001, J ANIM SCI, V79, P1584; MOE PW, 1979, J DAIRY SCI, V62, P1583, DOI 10.3168/jds.S0022-0302(79)83465-7; MOULD FL, 1983, ANIM FEED SCI TECH, V10, P15, DOI 10.1016/0377-8401(83)90003-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NCCC. National coordination committee on climate change, 2017, 2 NAT COMM CLIM CHAN; Niu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09938; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Petri RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104167; Preston TR, 1998, ANIMAL PRODUCTION HL, P126; Rathgeber C, 2007, CURR MICROBIOL, V55, P356, DOI 10.1007/s00284-007-0275-y; RUSSELL JB, 1983, APPL ENVIRON MICROB, V45, P1566, DOI 10.1128/AEM.45.5.1566-1574.1983; RUSSELL JB, 1992, J ANIM SCI, V70, P3551, DOI 10.2527/1992.70113551x; Sakai S, 2009, APPL ENVIRON MICROB, V75, P4892, DOI 10.1128/AEM.02835-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sun BH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26035; Sun YK, 2017, ANIM FEED SCI TECH, V232, P49, DOI 10.1016/j.anifeedsci.2017.03.016; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Taguchi Hidenori, 2004, Animal Science Journal, V75, P325, DOI 10.1111/j.1740-0929.2004.00193.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; van Haarlem RP, 2008, CAN J ANIM SCI, V88, P641, DOI 10.4141/CJAS08034; Vlkova E, 2006, FOLIA MICROBIOL, V51, P325, DOI 10.1007/BF02931825; Wolfe RS, 1990, ANNU REV BIOCHEM, V10, P396; Wolin M. J., 1979, Advances in Microbial Ecology, V3, P49; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zhou M, 2011, ANIM FEED SCI TECH, V166-67, P76, DOI 10.1016/j.anifeedsci.2011.04.005	69	15	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0214777	10.1371/journal.pone.0214777	http://dx.doi.org/10.1371/journal.pone.0214777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116757	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400004
J	Morina, A				Morina, Anabel			The keys to learning for university students with disabilities: Motivation, emotion and faculty-student relationships	PLOS ONE			English	Article							HIGHER-EDUCATION STUDENTS; PEDAGOGY; SUCCESS	The affective-emotional dimension may constitute a key element in teaching and learning processes. It is linked to relationship between faculty and students and may help foster students with disabilities' motivation to learn and remain at university. This is the approach adopted in this article, which aims to fill a gap detected in the literature, since very little attention has hitherto been paid to motivation, emotion and the importance of faculty-student relationships in the learning processes of students with disabilities. In this study, 119 faculty members from 10 Spanish universities who engage in inclusive practices in all areas of knowledge recounted, in response to questions asked during a semi-structured interview, how they motivated and related to their students. The conclusion reached is that students with disabilities are more motivated than their fellow classmates, meaning that very few extra actions need to be taken to engage them in the learning process. Nevertheless, participants reported having a knowledge of strategies based on motivation and emotion and using them to develop a sense of belonging among students, thus fostering their learning.	[Morina, Anabel] Univ Seville, Dept Teaching & Educ Org, Seville, Spain	University of Sevilla	Morina, A (corresponding author), Univ Seville, Dept Teaching & Educ Org, Seville, Spain.	anabelm@us.es	Moriña, Anabel/E-8266-2016	Moriña, Anabel/0000-0002-0852-7523	Ministry of Economy and Competitiveness of Spain; FEDER funds European Union [EDU2016-76587-R]	Ministry of Economy and Competitiveness of Spain(Spanish Government); FEDER funds European Union(European Commission)	A. Morina, this work was supported by the Ministry of Economy and Competitiveness of Spain and FEDER funds European Union [grant numbers EDU2016-76587-R].	Almarghani EM, 2017, TEACH HIGH EDUC, V22, P940, DOI 10.1080/13562517.2017.1319808; [Anonymous], 2013, PRACTICE EVIDENCE SC; Bain K., 2004, WHAT BEST COLL TEACH; Bye D, 2007, ADULT EDUC QUART, V57, P141, DOI 10.1177/0741713606294235; Clement F, 2017, EMOT REV, V9, P253, DOI 10.1177/1754073916661634; Cohen L, 2008, RES METHODS ED, DOI DOI 10.4324/9780203224342; Collins A, 2019, STUD HIGH EDUC, V44, P1475, DOI 10.1080/03075079.2018.1450852; Cotterall S, 2013, HIGH EDUC RES DEV, V32, P174, DOI 10.1080/07294360.2012.680017; Gibson S, 2015, INT J INCLUSIVE EDUC, V19, P875, DOI 10.1080/13603116.2015.1015177; Griffiths S., 2010, TEACHING INCLUSION H; Griful-Freixenet J, 2017, DISABIL SOC, V32, P1627, DOI 10.1080/09687599.2017.1365695; Hagenauer G., 2016, FRONTLINE LEARNING R, V4, P44, DOI DOI 10.14786/FLR.V4I3.236; Hagenauer G, 2014, OXFORD REV EDUC, V40, P370, DOI 10.1080/03054985.2014.921613; Hitch D, 2015, INT J FIRST YEAR HIG, V6, P135, DOI 10.5204/intjfyhe.v6i1.254; Kezar A., 2014, THOUGHT ACTION, P29; Klauda SL, 2015, READ WRIT, V28, P239, DOI 10.1007/s11145-014-9523-2; Kordts-Freudinger R., 2017, INT J SUSTAINABILITY, V6, P217, DOI [DOI 10.5430/IJHE.V6N1P217, 10.5430/ijhe.v6n1p217]; Lbove T.S., 2015, J ED TRAINING STUDIE, V3, P27, DOI [10.11114/jets.v3i1.573, DOI 10.11114/JETS.V3I1.573]; Lipka O, 2019, INT J INCLUSIVE EDUC, V23, P142, DOI 10.1080/13603116.2018.1427151; Lourens H, 2016, DISABIL SOC, V31, P240, DOI 10.1080/09687599.2016.1158092; MacLeod A, 2018, INT J INCLUSIVE EDUC, V22, P683, DOI 10.1080/13603116.2017.1396502; Madriaga M, 2010, STUD HIGH EDUC, V35, P647, DOI 10.1080/03075070903222633; Martins MH, 2018, INT J INCLUSIVE EDUC, V22, P527, DOI 10.1080/13603116.2017.1377299; Mayer J. D., 2000, HDB INTELLIGENCE, P369; McKay J, 2016, WIDENING HIGHER EDUCATION PARTICIPATION: A GLOBAL PERSPECTIVE, P161, DOI 10.1016/B978-0-08-100213-1.00010-X; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Morina A, 2015, TEACH TEACH EDUC, V52, P91, DOI 10.1016/j.tate.2015.09.008; OECD, 2011, INCL STUD DIS TERT E; Postareff L, 2017, HIGH EDUC, V73, P441, DOI 10.1007/s10734-016-0096-7; Quinlan K.M., 2016, COLL TEACH, V64, P101, DOI DOI 10.1080/87567555.2015.1088818; Regan K, 2012, INTERNET HIGH EDUC, V15, P204, DOI 10.1016/j.iheduc.2011.12.001; Ruiz-Alfonso Z, 2016, EDUC RES REV-NETH, V19, P173, DOI 10.1016/j.edurev.2016.09.001; Scott S. S., 2003, J POSTSECONDARY ED D, V16, P78; Seatter CS, 2017, CAN J HIGH EDUC, V47, P47; Stein, 2014, INT J TEACH LEARN HI, V26, P55; Thomas L, 2016, WIDENING HIGHER EDUCATION PARTICIPATION: A GLOBAL PERSPECTIVE, P135, DOI 10.1016/B978-0-08-100213-1.00009-3; Titsworth S, 2010, COMMUN EDUC, V59, P431, DOI 10.1080/03634521003746156; Uiboleht K, 2016, TEACH HIGH EDUC, V21, P854, DOI 10.1080/13562517.2016.1183615; Umbach PD, 2005, RES HIGH EDUC, V46, P153, DOI 10.1007/s11162-004-1598-1; UNESCO, 2017, ED SUST DEV GOALS LE; Walker J, 2016, TEACH HIGH EDUC, V21, P175, DOI 10.1080/13562517.2015.1136280; Weedon E, 2016, WIDENING HIGHER EDUCATION PARTICIPATION: A GLOBAL PERSPECTIVE, P49, DOI 10.1016/B978-0-08-100213-1.00004-4; Willis E, 2013, HIGH EDUC RES DEV, V32, P660, DOI 10.1080/07294360.2012.706747; Woodhouse HR, 2012, COLLECTED ESSAYS LEA, V5, P1, DOI [10.22329/celt.v5i0.3353, DOI 10.22329/CELT.V5I0.3353]	44	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215249	10.1371/journal.pone.0215249	http://dx.doi.org/10.1371/journal.pone.0215249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116748	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400006
J	Teisen, MN; Niclasen, J; Vuholm, S; Lundbye-Jensen, J; Stark, KD; Damsgaard, CT; Geertsen, SS; Lauritzen, L				Teisen, Marie N.; Niclasen, Janni; Vuholm, Stine; Lundbye-Jensen, Jesper; Stark, Ken D.; Damsgaard, Camilla T.; Geertsen, Svend S.; Lauritzen, Lotte			Exploring correlations between neuropsychological measures and domain-specific consistency in associations with n-3 LCPUFA status in 8-9 year-old boys and girls	PLOS ONE			English	Article							FATTY-ACID SUPPLEMENTATION; SCHOOL-AGED CHILDREN; QUALITY-OF-LIFE; COGNITIVE PERFORMANCE; DOCOSAHEXAENOIC ACID; WHOLE-BLOOD; FISH INTAKE; PUFA SUPPLEMENTATION; WORKING-MEMORY; DOUBLE-BLIND	Long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) have in some studies been associated with cognitive and socioemotional outcomes in children, but results are inconsistent possibly due to the use of different tests and potential gender-specific effects. The objective of this cross-sectional study was to explore overall patterns in neuropsychological scores as well as correlations between scores within specific domains, and to examine potential gender differences and consistency in associations with n-3 LCPUFA status. In 199 Danish 8-9 year-old children, we performed a large battery of tests and questionnaires on attention, processing speed, executive functions, memory, and socioemotional traits, and measured erythrocyte fatty acid composition. Principal component analyses (PCA) showed that most of the variation in both cognitive performance and socioemotional traits was explained by overall performance, followed by speed-accuracy trade off and externalizing vs. internalizing problems, respectively. Boys had higher speed, lower attention and higher externalizing problem scores than girls. Measures of performance within both processing speed and attention domains correlated moderately, whereas no correlations were found for measures of executive functions apart from some weak correlations for impulsivity. Parent-rated scores for both externalizing and internalizing problems correlated strongly, whereas correlations with child-rated scores were weak. Scores within specific domains did not consistently associate with n-3 LCPUFA, except for processing speed measures which all pointed to faster processing with increased n-3 LCPUFA status. Gender differences in the associations were observed for attention and impulsivity. Child-but not parent-rated internalizing and social problems tended to associate directly with n-3 LCPUFA, supported by increased internalizing problems measured by the PCA component. In conclusion, measures of speed and attention seem to represent these domains in general, whereas single measures of more complex cognitive functions should be interpreted with caution. One approach could be to use multiple tests and create multivariate scores to guide interpretations. Furthermore, the results indicate a need to consider both parent- and child-rated socioemotional scores and gender differences in neuropsychological functions e.g. in investigations of n-3 LCPUFA effects.	[Teisen, Marie N.; Vuholm, Stine; Lundbye-Jensen, Jesper; Damsgaard, Camilla T.; Geertsen, Svend S.; Lauritzen, Lotte] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Niclasen, Janni] Steno Diabet Ctr Copenhagen, Diabet Prevent Res, Hlth Promot, Copenhagen, Denmark; [Niclasen, Janni] Frederikshoj Dagbehandlingsskole, Copenhagen, Denmark; [Stark, Ken D.] Univ Waterloo, Fac Appl Hlth Sci, Dept Kinesiol, Waterloo, ON, Canada	University of Copenhagen; Steno Diabetes Center; University of Waterloo	Teisen, MN (corresponding author), Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark.	mte@nexs.ku.dk	Lundbye-Jensen, Jesper/ABH-4025-2020; Lauritzen, Lotte/F-2921-2013; Damsgaard, Camilla T/B-4866-2015; Geertsen, Svend/ABG-6254-2020; Stark, Ken/I-1347-2016	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Lauritzen, Lotte/0000-0001-7184-5949; Geertsen, Svend/0000-0003-4497-3616; Damsgaard, Camilla T/0000-0002-5013-0562; Stark, Ken/0000-0001-7828-4072; Vuholm, Stine/0000-0002-7074-5564; Teisen, Marie Nygaard/0000-0003-2500-5951	Nordea-fonden [02-2015-1429]	Nordea-fonden	The FiSK Junior study is supported by Nordea-fonden (https://nordeafonden.dk), grant number: 02-2015-1429 to Camilla T. Damsgaard. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MA, 2009, ACTA PAEDIATR, V98, P555, DOI 10.1111/j.1651-2227.2008.01103.x; Bates ME, 2004, J INT NEUROPSYCH SOC, V10, P392, DOI 10.1017/S135561770410307X; Baumgartner J, 2012, AM J CLIN NUTR, V96, P1327, DOI 10.3945/ajcn.112.041004; Beck MM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00645; Boat TF, 2015, MENTAL DISORDERS DIS, Vxix; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Bullinger M, 2008, EUR CHILD ADOLES PSY, V17, P125, DOI 10.1007/s00787-008-1014-z; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Collins CT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007314; Cooper RE, 2015, J PSYCHOPHARMACOL, V29, P753, DOI 10.1177/0269881115587958; Dalton A, 2009, PROSTAG LEUKOTR ESS, V80, P143, DOI 10.1016/j.plefa.2008.12.006; Damsgaard CT, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1647-z; de Groot RHM, 2012, PROSTAG LEUKOTR ESS, V86, P113, DOI 10.1016/j.plefa.2012.01.002; Eilander A, 2007, PROSTAG LEUKOTR ESS, V76, P189, DOI 10.1016/j.plefa.2007.01.003; Engel S, 2013, MATERN CHILD NUTR, V9, P499, DOI 10.1111/j.1740-8709.2012.00411.x; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Geertsen SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161960; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gispert-Llaurado M, 2016, CLIN NUTR, V35, P1301, DOI 10.1016/j.clnu.2016.02.008; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Handeland K, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0287-9; Jiao JJ, 2014, AM J CLIN NUTR, V100, P1422, DOI 10.3945/ajcn.114.095315; Kennedy DO, 2009, NUTR NEUROSCI, V12, P48, DOI 10.1179/147683009X388887; Kirby A, 2010, RES DEV DISABIL, V31, P718, DOI 10.1016/j.ridd.2010.01.014; Lassek William D, 2011, Front Evol Neurosci, V3, P5, DOI 10.3389/fnevo.2011.00005; Lattka E, 2012, ANN NUTR METAB, V60, P8, DOI 10.1159/000337308; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Metherel AH, 2012, NUTR RES, V32, P547, DOI 10.1016/j.nutres.2012.06.016; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Montgomery P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066697; Muthayya S, 2009, AM J CLIN NUTR, V89, P1766, DOI 10.3945/ajcn.2008.26993; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Parletta N, 2013, PROSTAG LEUKOTR ESS, V89, P71, DOI 10.1016/j.plefa.2013.05.001; Portillo-Reyes V, 2014, RES DEV DISABIL, V35, P861, DOI 10.1016/j.ridd.2014.01.013; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Skogli EW, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-298; Smuts CM, 2015, BRIT J NUTR, V113, P212, DOI 10.1017/S0007114514003493; Sorensen LB, 2016, EUR J CLIN NUTR, V70, P1155, DOI 10.1038/ejcn.2016.99; Sorensen LB, 2015, BRIT J NUTR, V113, P1280, DOI 10.1017/S0007114515000033; Sorensen LB, 2015, BRIT J NUTR, V114, P1623, DOI 10.1017/S0007114515003323; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; Stark KD, 2016, PROSTAG LEUKOTR ESS, V104, P1, DOI 10.1016/j.plefa.2015.11.002; Starling P, 2015, NUTRIENTS, V7, P2001, DOI 10.3390/nu7032001; Stins JF, 2005, CHILD NEUROPSYCHOL, V11, P191, DOI 10.1080/092970490911351; Stroop JR, 1935, THESIS; Suades-Gonzalez E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00655; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Tinggaard J, 2014, ACTA PAEDIATR, V103, P214, DOI 10.1111/apa.12468; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Vesga-Lopez O, 2008, J CLIN PSYCHIAT, V69, P1606, DOI 10.4088/JCP.v69n1011; Wassenberg R, 2008, CHILD NEUROPSYCHOL, V14, P195, DOI 10.1080/09297040601187940; Weinstein A., 2015, CURR BEHAV NEUROSCI, V2, P9, DOI [10.1007/s40473-015-0031-8, DOI 10.1007/S40473-015-0031-8]; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Wickens MM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00197; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P47, DOI 10.1007/s00787-004-2008-0; Wolters M, 2014, INT J OBESITY, V38, pS86, DOI 10.1038/ijo.2014.139; Zhang J, 2005, J NUTR, V135, P1967, DOI 10.1093/jn/135.8.1967; 2007, AM J CLIN NUTR, V86, P1082	63	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216696	10.1371/journal.pone.0216696	http://dx.doi.org/10.1371/journal.pone.0216696			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116782	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400026
J	Solomon, AM; Han, K; Lee, JH; Lee, HY; Jang, S; Kang, BC				Solomon, Abate Mekonnen; Han, Koeun; Lee, Joung-Ho; Lee, Hea-Young; Jang, Siyoung; Kang, Byoung-Cheorl			Genetic diversity and population structure of Ethiopian Capsicum germplasms	PLOS ONE			English	Article							READ ALIGNMENT; LANDRACES; TRAITS	We established a collection of 142 Capsicum genotypes from different geographical areas of Ethiopia with the aim of capturing genetic diversity. Morphological traits and high-resolution melting analysis distinguished one Capsicum baccatum, nine Capsicum frutescens and 132 Capsicum annuum accessions in the collection. Measurement of plant growth parameters revealed variation between germplasms in parameters including plant height, stem thickness, internode length, number of side branches, fruit width, and fruit length. Broadsense heritability was maximum for fruit weight, followed by length and width of leaves. We used genotyping by sequencing (GBS) to identify single-nucleotide polymorphisms (SNPs) in the panel of 142 Capsicum germplasms and found 2,831,791 genome-wide SNP markers. Among these, we selected 53,284 high-quality SNPs and used them to estimate the level of genetic diversity, population structure, and phylogenetic relationships. From model-based ancestry analysis, the phylogenetic tree and principal-coordinate analysis (PCoA), we identified two distinct genetic populations: one comprising 132 C. annuum accessions and the other comprising the nine C. frutescens accessions. GWAS analysis detected 509 SNP markers that were significantly associated with fruit-, stem- and leaf-related traits. This is the first comprehensive report of the analysis of genetic variation in Ethiopian Capsicum species involving a large number of accessions. The results will help breeders utilize the germplasm collection to improve existing commercial cultivars.	[Solomon, Abate Mekonnen; Han, Koeun; Lee, Joung-Ho; Lee, Hea-Young; Jang, Siyoung; Kang, Byoung-Cheorl] Seoul Natl Univ, Vegetable Breeding Res Ctr, Plant Genom & Breeding Inst, Dept Plant Sci,Coll Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU)	Kang, BC (corresponding author), Seoul Natl Univ, Vegetable Breeding Res Ctr, Plant Genom & Breeding Inst, Dept Plant Sci,Coll Agr & Life Sci, Seoul, South Korea.	bk54@snu.ac.kr	Lee, Hea-Young/GVT-7830-2022; Mekonnen, Solomon/AAC-1955-2021	Mekonnen, Solomon/0000-0002-8501-4449; Kang, Byoung-Cheorl/0000-0002-7606-7258	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the Agriculture, Food and Rural Affairs Research Center Support Program (Vegetable Breeding Research Center - Ministry of Agriculture, Food and Rural [710011-03]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the Agriculture, Food and Rural Affairs Research Center Support Program (Vegetable Breeding Research Center - Ministry of Agriculture, Food and Rural	Capsicum germplasms were provided by the Ethiopian Biodiversity Institute (EBI) (URL: http://www.ebi.gov.et/). This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) (URL: http://eng.ipet.re.kr/) through the Agriculture, Food and Rural Affairs Research Center Support Program (Vegetable Breeding Research Center, 710011-03, funded by the Ministry of Agriculture, Food and Rural Affairs, URL: http://www.mafra.go.kr/english/index.do, MAFRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-68; Annicchiarico P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00679; [Anonymous], [No title captured]; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Biazzi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169234; Birhanu H, 2017, INT J RES STUD SCI E, V4, P4; BURTON GW, 1953, AGRON J, V45, P478, DOI 10.2134/agronj1953.00021962004500100005x; Clarke JD, 2009, COLD SPRING HARBOR P, V2009; Dagnoko S., 2013, AFR J AGR RES, V8, P1108, DOI [DOI 10.5897/AJAR2012.1758, 10.5897/AJAR2012.1758]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ertiro BT, 2017, BMC GENO, V18, P1; ESHBAUGH W H, 1983, Bothalia, V14, P845; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Geleta LF, 2005, BIODIVERS CONSERV, V14, P2361, DOI 10.1007/s10531-004-1669-9; Gonzalez-Perez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116276; Han K., 2018, ACM MOBIHOC, P1, DOI 10.1109/ICC.2018.8422275; Han K, 2016, DNA RES, V23, P81, DOI 10.1093/dnares/dsv038; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ince AG, 2010, BIOCHEM GENET, V48, P83, DOI 10.1007/s10528-009-9297-4; Iquira E, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0408-y; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Jo J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02090; Khan A. S. M. Mahbubur Rahman, 2016, Agriculture and Natural Resources, V50, P483, DOI 10.1016/j.anres.2016.07.005; Kumbhar SD, 2015, RICE SCI, V22, P99, DOI 10.1016/j.rsci.2015.05.013; Lee HY, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0452-8; Lee JH, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0717-6; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Marame F, 2009, HEREDITAS, V146, P131, DOI 10.1111/j.1601-5223.2009.02101.x; Marame F, 2009, EUPHYTICA, V168, P235, DOI 10.1007/s10681-009-9912-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nimmakayala P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38081; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; Pailles Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00138; Panda Ramesh C., 2004, Cytologia (Tokyo), V69, P203, DOI 10.1508/cytologia.69.203; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Popovsky-Sarid S, 2017, THEOR APPL GENET, V130, P445, DOI 10.1007/s00122-016-2825-9; Pritchard JK, 2000, GENETICS, V155, P945; Rodriguez GR, 2010, JOVE; Sacco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137139; Shimeles Aklilu, 2016, Journal of Agricultural Sciences, Belgrade, V61, P19, DOI 10.2298/JAS1601019A; Shumbulo A., 2017, ADV CROP SCI TECHNOL, V5, P1, DOI [10.4172/2329-8863.1000277, DOI 10.4172/2329-8863.1000277]; Song M, 2016, SCI REP, V6; Tang W, 2016, BMC PLANT BIOL, V16, P1; Taranto F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3297-7; Tsaballa A, 2015, BIOCHEM SYST ECOL, V59, P256, DOI 10.1016/j.bse.2015.02.005; Usman M. G., 2014, The Scientific World Journal, V2014, P308042; van Zonneveld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134663; Wong MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122025; Zewdie Y., 1998, ETHIOPIAN CHILES DEE; Zhang D, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0477-6	55	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216886	10.1371/journal.pone.0216886	http://dx.doi.org/10.1371/journal.pone.0216886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112575	gold, Green Submitted, Green Published			2022-12-27	WOS:000468451000030
J	Malik, NA				Malik, Nadeem A.			Turbulent particle pair diffusion: Numerical simulations	PLOS ONE			English	Article							HOMOGENEOUS TURBULENCE; ATMOSPHERIC DIFFUSION; 2-PARTICLE DISPERSION; KINEMATIC SIMULATION; INTERMITTENCY; SEPARATION; FLOWS	A theory for turbulent particle pair diffusion in the inertial subrange [Malik NA, PLoS ONE 13 (10):e0202940 (2018)] is investigated numerically using a Lagrangian diffusion model, Kinematic Simulations [Kraichnan RH, Phys. Fluids 13:22 (1970); Malik NA, PLoS ONE 12(12): e0189917 (2017)]. All predictions of the theory are observed in flow fields with generalised energy spectra of the type, E(k) similar to k(-p). Most importantly, two non-Richardson regimes are observed: for short inertial subrange of size 10(2) the simulations yield quasi-local regimes for the pair diffusion coefficient, K(l) similar to sigma((1+p)/2)(l); and for asymptotically infinite inertial subrange the simulations yield non-local regimes K(l) similar to sigma(gamma)(l), with gamma intermediate between the purely local scaling gamma(l) = (1 + p)/2 and the purely non-local scaling gamma(nl) = 2. For intermittent turbulence spectra, E(k) similar to k(-1.72), the simulations yield K similar to sigma(1.556)(l) in agreement with the revised 1926 dataset K similar to sigma(1.564)(I) [Richardson LF, Proc. Roy. Soc. Lond. A 100:709 (1926); Malik NA, PLoS ONE 13(10):e0202940 (2018)]. These results lend support to the physical picture proposed in the new theory that turbulent diffusion in the inertial subrange is governed by both local and non-local diffusion transport processes.	[Malik, Nadeem A.] King Fahd Univ Petr & Minerals, Dept Math & Stat, Dhahran, Saudi Arabia; [Malik, Nadeem A.] Texas Tech Univ, Dept Mech Engn, Edward E Whitacre Jr Coll Engn, Lubbock, TX 79409 USA	King Fahd University of Petroleum & Minerals; Texas Tech University System; Texas Tech University	Malik, NA (corresponding author), King Fahd Univ Petr & Minerals, Dept Math & Stat, Dhahran, Saudi Arabia.; Malik, NA (corresponding author), Texas Tech Univ, Dept Mech Engn, Edward E Whitacre Jr Coll Engn, Lubbock, TX 79409 USA.	nadeem_Malik@cantab.net	Malik, Nadeem/D-4883-2015	Malik, Nadeem/0000-0001-5053-9360	SABIC (Saudi Arabian Basic Industries Corporation) [SB101011]; SABIC [SB101011]; ITC Department at KFUPM	SABIC (Saudi Arabian Basic Industries Corporation); SABIC; ITC Department at KFUPM	NAM received funding from SABIC (Saudi Arabian Basic Industries Corporation) through grant number SB101011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank SABIC for funding this work through project number SB101011, and the ITC Department at KFUPM for making available the High Performance Computing facility for this project. The author would also like to thank Mr. K. A. K. K. Daoud for producing the parallel version of the KS code.	Anselmet F, 2001, PLANET SPACE SCI, V49, P1177, DOI 10.1016/S0032-0633(01)00059-9; Berloff PS, 2002, J PHYS OCEANOGR, V32, P764, DOI 10.1175/1520-0485(2002)032<0764:MTIOGP>2.0.CO;2; Boradwell J. F., 1988, J FLUID MECH, V125, P397, DOI [10.1017/S0022112082003401, DOI 10.1017/S0022112082003401]; Bragg AD, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4939694; Buaria D, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4931602; Eyink GL, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.023011; Farhan M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.043021; Fung JCH, 1998, PHYS REV E, V57, P1677, DOI 10.1103/PhysRevE.57.1677; FUNG JCH, 1992, J FLUID MECH, V236, P281, DOI 10.1017/S0022112092001423; Fung JCH, 1996, FLUID MEC A, V36, P617; Huber M, 2001, J ATMOS SCI, V58, P2377, DOI 10.1175/1520-0469(2001)058<2377:ACOTDI>2.0.CO;2; Jorgensen JB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1863259; KRAICHNAN RH, 1970, PHYS FLUIDS, V13, P22, DOI 10.1063/1.1692799; Malik NA, 1999, PHYS FLUIDS, V11, P1572, DOI 10.1063/1.870019; Malik NA, 1996, FLUID MEC A, V36, P619; Malik NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202940; Malik NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189917; MAXEY MR, 1987, J FLUID MECH, V174, P441, DOI 10.1017/S0022112087000193; Meneguz E, 2011, J FLUID MECH, V686, P338, DOI 10.1017/jfm.2011.333; Meyers J, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2936312; Murray S, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4942815; Nicolleau FCGA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056317; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V5, P453; PERKINS RJ, 1993, APPL SCI RES, V51, P539, DOI 10.1007/BF01082588; Peters N, 1988, 22 P S COMB SEATTL, P163, DOI [10.1146/annurev.fl.26.010194.000323, DOI 10.1146/ANNUREV.FL.26.010194.000323]; POPE SB, 1994, ANNU REV FLUID MECH, V26, P23, DOI 10.1146/annurev.fl.26.010194.000323; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Salazar JPLC, 2009, ANNU REV FLUID MECH, V41, P405, DOI 10.1146/annurev.fluid.40.111406.102224; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Thomson DJ, 2005, J FLUID MECH, V526, P277, DOI 10.1017/S0022112004002915; Tsuji Y, 2004, PHYS FLUIDS, V16, pL43, DOI 10.1063/1.1689931; Tsuji Y, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/6/064003; Turfus C., 1987, Advances in Turbulence. Proceedings of the First European Turbulence Conference, P191; Vaillancourt PA, 2000, B AM METEOROL SOC, V81, P285, DOI 10.1175/1520-0477(2000)081<0285:ROPIAC>2.3.CO;2; Virant M, 1997, MEAS SCI TECHNOL, V8, P1539, DOI 10.1088/0957-0233/8/12/017; Vosskuhle M, 2015, J TURBUL, V16, P15, DOI 10.1080/14685248.2014.948628; WILKINS EM, 1958, J METEOROL, V15, P324, DOI 10.1175/1520-0469(1958)015<0324:OOTSOP>2.0.CO;2; Wolf MC, 2004, J CHEM ECOL, V30, P501, DOI 10.1023/B:JOEC.0000018625.83906.95; 1952, MATH P CAMB PHIL SOC, V48, P345; 1974, J ATMOS SCI, V31, P2189, DOI DOI 10.1175/1520-0469(1974)031%3C2189	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216207	10.1371/journal.pone.0216207	http://dx.doi.org/10.1371/journal.pone.0216207			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107877	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200007
J	Inada, M; Shindo, M; Kobayashi, K; Sato, A; Yamamoto, Y; Akasaki, Y; Ichimura, K; Tanuma, SI				Inada, Mana; Shindo, Mika; Kobayashi, Kyousuke; Sato, Akira; Yamamoto, Yohei; Akasaki, Yasuharu; Ichimura, Koichi; Tanuma, Sei-ichi			Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MALIGNANT GLIOMA; CYCLE ARREST; DISCOVERY; GROWTH; HMGB1	The interaction between high-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) is important for tumor cell growth. We investigated the tumor biological effects of HMGB1 and RAGE interaction. Previously, we identified an inhibitor of HMGB1/RAGE interaction, papaverine (a non-narcotic opium alkaloid), using a unique drug design system and drug repositioning approach. In the present study, we examined the anticancer effects of papaverine in human glioblastoma (GBM) temozolomide (TMZ; as a first-line anticancer medicine)-sensitive U87MG and TMZ-resistant T98G cells. HMGB1 supplementation in the culture medium promoted tumor cell growth in T98G cells, and this effect was canceled by papaverine. In addition, papaverine in T98G cells suppressed cancer cell migration. As an HMGB1/RAGE inhibitor, papaverine also significantly inhibited cell proliferation in U87MG and T98G cells. The effects of papaverine were evaluated in vivo in a U87MG xenograft mouse model by determining tumor growth delay. The results indicate that papaverine, a smooth muscle relaxant, is a potential anticancer drug that may be useful in GBM chemotherapy.	[Inada, Mana; Shindo, Mika; Kobayashi, Kyousuke; Sato, Akira; Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda Ku, Chiba, Japan; [Shindo, Mika] Natl Canc Ctr, Chuo Ku, Tokyo, Japan; [Yamamoto, Yohei; Akasaki, Yasuharu] Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Tokyo, Japan; [Ichimura, Koichi] Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, Tokyo, Japan; [Tanuma, Sei-ichi] Tokyo Univ Sci, Dept Genom Med Sci, Res Inst Sci & Technol, Org Res Adv, Chiba, Japan	Tokyo University of Science; National Cancer Center - Japan; Jikei University; National Cancer Center - Japan; Tokyo University of Science	Sato, A; Tanuma, SI (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda Ku, Chiba, Japan.	akirasat@rs.tus.ac.jp; tanuma@rs.noda.tus.ac.jp		Sato, Akira/0000-0002-2239-6208	JSPS KAKENHI [26670648]; Education Research Fund for Tokyo University of Science	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Education Research Fund for Tokyo University of Science	This work was supported by a JSPS KAKENHI grant number 26670648 (T.A.) and an Education Research Fund for Tokyo University of Science (A.S. and S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali M, 2015, DARU, V23, DOI 10.1186/s40199-015-0101-1; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Benej M, 2018, P NATL ACAD SCI USA, V115, P10756, DOI 10.1073/pnas.1808945115; Bhattacharjee AK, 2001, BIOCHEM BIOPH RES CO, V289, P548, DOI 10.1006/bbrc.2001.6029; Chappie TA, 2007, J MED CHEM, V50, P182, DOI 10.1021/jm060653b; Goto T, 1999, INT J UROL, V6, P314, DOI 10.1046/j.1442-2042.1999.00069.x; Huang H, 2017, J BUON, V22, P112; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Keyrouz SG, 2007, CRIT CARE, V11, DOI 10.1186/cc5958; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Liu HM, 2002, J CLIN NEUROSCI, V9, P561, DOI 10.1054/jocn.2001.1036; Liu JK, 2005, NEUROCRIT CARE, V2, P124, DOI 10.1385/NCC:2:2:124; Merck G, 1848, LIEBIGS ANN CHEM, V66, P125, DOI DOI 10.1002/JLAC.18480660121; Ogino Yoko, 2018, Oncotarget, V9, P16451, DOI 10.18632/oncotarget.24731; Sajadian S, 2015, TOXICOL MECH METHOD, V25, P388, DOI 10.3109/15376516.2015.1045656; Sakai J, 2008, BIOORGAN MED CHEM, V16, P4854, DOI 10.1016/j.bmc.2008.03.046; Sato A, 2010, J PROTEOME RES, V9, P2329, DOI 10.1021/pr9010537; Sayama Christina M, 2006, Neurosurg Focus, V21, pE12, DOI 10.3171/foc.2006.21.3.12; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Tamada K, 2019, BIOCHEM BIOPH RES CO, V511, P665, DOI 10.1016/j.bbrc.2019.01.136; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Xue HL, 1998, CHINESE MED J-PEKING, V111, P751; Yi GZ, 2016, J NEUROL SCI, V367, P101, DOI 10.1016/j.jns.2016.05.054; Yildiz N, 2011, INT J REHABIL RES, V34, P44, DOI 10.1097/MRR.0b013e32833d6cb2; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102; 2018, ONCOLOGY LETT, V15, P4627, DOI DOI 10.3892/OL.2018.7902; ANTICANCER RES, V20, P761; 2018, ONCOLOGY LETT, V15, P6799, DOI DOI 10.3892/OL.2018.8215; 2017, ONCOTARGET, V8, P6453, DOI DOI 10.18632/ONCOTARGET.17885; 2014, MOL BASEL SWITZERLAN, V19, P1184, DOI DOI 10.3390/MOLECULES190811846	30	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216358	10.1371/journal.pone.0216358	http://dx.doi.org/10.1371/journal.pone.0216358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100066	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600006
J	Tolera, H; Gebre-Egziabher, T; Kloos, H				Tolera, Habtamu; Gebre-Egziabher, Tegegne; Kloos, Helmut			Utilization of decentralized health facilities and factors influencing women's choice of a delivery site in Gida Ayana Woreda, western Ethiopia	PLOS ONE			English	Article							CARE SERVICE UTILIZATION; MATERNAL MORTALITY; ANTENATAL CARE; DEVELOPING-COUNTRIES; SAFE; SCALE; BIRTH	Introduction Despite the government's efforts to decentralize and expand health institutions to promote facility-based child delivery, home delivery and maternal mortality are still widespread problems in Ethiopia. Most mothers continue to give birth at home. This study aims at identifying the socio-cultural practices, perceived benefit or need, and accessibility factors influencing women's choice of health facilities for delivery services in Gida Ayana Woreda, western Ethiopia. Methods We conducted a cross-sectional survey to assess women's use of delivery care services in Gida Ayana Woreda, from November 2016 to January 2017; 459 women who were selected randomly participated in the study. We evaluated the socio-cultural, perceived benefit or need, and economic and physical accessibility factors in women's choice of delivery care and used adjusted logistic regression analysis to examine significant predictors of delivery site use decisions. Results Over half (56.6%) of the women self-reported using institutional delivery care; 80.9% gave birth at a health center. A socio-cultural variable, maternal education, significantly influenced women's choice of health facility for delivery care services (AOR 3.4; 95% CI 2.0-5.9). Mothers' knowledge level of obstetric complications and experience of complications during the last birth were the two perceived benefits or need factors associated with higher odds of receiving delivery care from decentralized local facilities. Utilization of health centers for maternal delivery care was significantly higher than of health posts (AOR 5.0; 95% CI 2.4-10.2). Availability of motorized transportation during labor to nearby delivery site was a significant predictor of institutional delivery. Conclusion This study demonstrates the under-utilization of decentralized health facilities for maternal delivery care services in Gida Ayana Woreda, which was significantly influenced by sociocultural, perceived need, and accessibility factors of women during childbirth. This suggests the need for tailored intervention to improve childbirth services use for mothers in this kind of rural settings.	[Tolera, Habtamu] Wollega Univ, Dept Geog & Environm Studies, Nekemete, Ethiopia; [Tolera, Habtamu; Gebre-Egziabher, Tegegne] Addis Ababa Univ, Dept Geog & Environm Studies, Addis Ababa, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Addis Ababa University; University of California System; University of California San Francisco	Tolera, H (corresponding author), Wollega Univ, Dept Geog & Environm Studies, Nekemete, Ethiopia.; Tolera, H (corresponding author), Addis Ababa Univ, Dept Geog & Environm Studies, Addis Ababa, Ethiopia.	habtol@yahoo.com		Tolera, Habtamu/0000-0001-5967-1237	Addis Ababa University; Wollega University	Addis Ababa University; Wollega University	Mr. Habtamu Tolera, was the author who recieved financial supports. The research was financed by Addis Ababa University and Wollega University. Addis Ababa University supported to this work by allocating budget for data collection. Wollega University supported the project by providing fuel costs for transportation service during data collection and allowing full salary for the corresponding author for his study leave. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Fantu, 2012, BMC Res Notes, V5, P653, DOI 10.1186/1756-0500-5-653; Abera M, 2011, ETHIOP J HEALTH SCI, V21, P95; Abosse Z, 2010, ETHIOP J HEALTH SCI, V20, P75; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Aktar S., 2012, Bangladesh e-Journal of Sociology, V9, P57; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2014, ETH DEM HLTH SURV ET; Arba MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151082; Awash Teklehaimanot, 2007, Ethiopian Journal of Health Development, V21, P246; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bhandari TR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182485; Bitew T, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1099-1; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CSA [ Central Statistical Agency], 2013, POP PROJ ETH ALL REG, DOI [10.1186/1746, DOI 10.1186/1746]; Dejene G, 2015, J WOMENS HEALTHCARE, V4, DOI [10.4172/2167-0420, DOI 10.4172/2167-0420]; Dickson K, 2018, MATERN HLTH NEONAT P, V4, DOI [10.1186/s40748, DOI 10.1186/S40748]; EPRDF [ Ethiopian People Revolutionary Democratic Front], 1995, CONST FED GOV ETH 19; Ethiopia CSA (CSA) [Ethiopia], 2017, ETH DEM HLTH SURV 20; Federal Ministry of Health Ethiopia (FMoH), 2015, HLTH SECT TRANSF PLA; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fisseha G, 2017, INT J WOMENS HEALTH, V9, P749, DOI 10.2147/IJWH.S140366; FMoH, 2014, EP DISTR MAL; FMOH, 2010, HLTH SECT DEV PROGR; Gabriel SA, 2009, BE J ECON ANAL POLI, V9, DOI 10.1186/1471-2393-9-34; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ikamari Lawrence D, 2004, Afr J Health Sci, V11, P21; Jayaweera RT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191412; Kaba M, 2016, INT J WOMENS HEALTH, V8, P93, DOI 10.2147/IJWH.S98722; Karkee R, 2015, BMJ OPEN, DOI [10.1136/bmjopen, DOI 10.1136/BMJOPEN]; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Kebede A, 2016, INT J WOMENS HEALTH, V8, P463, DOI 10.2147/IJWH.S109498; Kelsey JL., 1996, METHODS OBSERVATIONA; Kidanu S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0359-5; Kloos H., 1998, NE AFR STUD, V5, P83, DOI [10.1353/nas.1998.0016, DOI 10.1353/NAS.1998.0016]; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S7; Moyer C, 2016, REPROD HLTH, DOI [10.1186/1742, DOI 10.1186/1742]; Nathan LM, 2015, MATERN CHILD HLTH J, V19, P1949, DOI 10.1007/s10995-015-1702-5; OBERMEYER CM, 1991, STUD FAMILY PLANN, V22, P177, DOI 10.2307/1966644; Oromia Health Bureau (OHB), 2015, GID AYAN WOR BAS HLT; Oromia Resgional State [ORS], 2015, OR REG STAT E WOLL Z; Regassa N, 2011, AFR HEALTH SCI, V11, P390; Regassa T, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shahram MS, 2015, NAGOYA J MED SCI, V77, P595; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh PK, 2012, PLOS ONE, V7, DOI [10.1371/e0031666, DOI 10.1371/E0031666]; Tadele N, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2057-y; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; Tessu M, 2015, HLTH SCI J, V10; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Transitional Government of Ethiopia, 1993, HLTH POL TRANS GOV E; USAID, 2012, CULT BARR SEEK MAT H; Wako WG, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1325-5; Woldegiorgis MA., 2017, INT J HEALTHCARE, V3, P17, DOI [10.5430/ijh.v3n1p17, DOI 10.5430/IJH.V3N1P17]; Worku AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060171; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20; Yebyo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124718	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216714	10.1371/journal.pone.0216714	http://dx.doi.org/10.1371/journal.pone.0216714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100070	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600014
J	Stowie, A; Ellis, I; Adams, K; Castanon-Cervantes, O; Davidson, AJ				Stowie, Adam; Ellis, Ivory; Adams, Kandis; Castanon-Cervantes, Oscar; Davidson, Alec J.			A reductionist, in vitro model of environmental circadian disruption demonstrates SCN-independent and tissue-specific dysregulation of inflammatory responses	PLOS ONE			English	Article							REV-ERB-ALPHA; SHIFT-WORK; SUPRACHIASMATIC NUCLEUS; JET-LAG; CLOCK; MISALIGNMENT; RHYTHMS; MACROPHAGES; BEHAVIOR; PROTEIN	Environmental circadian disruption (ECD), characterized by repeated or long-term disruption in environmental timing cues which require the internal circadian clock to change its phase to resynchronize with the environment, is associated with numerous serious health issues in humans. While animal and isolated cell models exist to study the effects of destabilizing the relationship between the circadian system and the environment, neither approach provides an ideal solution. Here, we developed an in vitro model which incorporates both elements of a reductionist cellular model and disruption of the clock/environment relationship using temperature as an environmental cue, as occurs in vivo. Using this approach, we have demonstrated that some effects of in vivo ECD can be reproduced using only isolated peripheral oscillators. Specifically, we report exaggerated inflammatory responses to endotoxin following repeated environmental circadian disruption in explanted spleens. This effect requires a functional circadian clock but not the master brain clock, the suprachiasmatic nucleus (SCN). Further, we report that this is a result of cumulative, rather than acute, circadian disruption as has been previously observed in vivo. Finally, such effects appear to be tissue specific as it does not occur in lung, which is less sensitive to the temperature cycles employed to induce ECD. Taken together, the present study suggests that this model could be a valuable tool for dissecting the causes and effects of circadian disruption both in isolated components of physiological systems as well as the aggregated interactions of these systems that occur in vivo.	[Stowie, Adam; Ellis, Ivory; Adams, Kandis; Castanon-Cervantes, Oscar; Davidson, Alec J.] Morehouse Sch Med, Neurosci Inst, Dept Neurobiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Davidson, AJ (corresponding author), Morehouse Sch Med, Neurosci Inst, Dept Neurobiol, Atlanta, GA 30310 USA.	adavidson@msm.edu		Stowie, Adam/0000-0002-7007-9135	National Institute of General Medical Sciences of the National Institute of Health [SC1GM112567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM125493, SC1GM112567] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD007589] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute of General Medical Sciences of the National Institute of Health (https://www.nigms.nih.gov/) grant number SC1GM112567 to Alec J Davidson. The funding agency played no role in study design, data collection or analysis, decision to publish, or preparation of this manuscript.	Adams KL, 2013, J BIOL RHYTHM, V28, P272, DOI 10.1177/0748730413494561; Beker MC, 2018, MOL NEUROBIOL, V55, P2565, DOI 10.1007/s12035-017-0524-4; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Brager AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063752; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gossan N, 2013, ARTHRITIS RHEUM-US, V65, P2334, DOI 10.1002/art.38035; Guerrero-Vargas NN, 2015, J BIOL RHYTHM, V30, P318, DOI 10.1177/0748730415586482; Guerrero-Vargas NN, 2014, J NEUROIMMUNOL, V273, P22, DOI 10.1016/j.jneuroim.2014.05.012; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kervezee L, 2018, P NATL ACAD SCI USA, V115, P5540, DOI 10.1073/pnas.1720719115; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Magrini A, 2006, Int J Immunopathol Pharmacol, V19, P31; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morales-Nebreda L, 2015, EUR RESPIR REV, V24, P505, DOI 10.1183/16000617.0031-2015; Morikawa Y, 2005, SCAND J WORK ENV HEA, V31, P179, DOI 10.5271/sjweh.867; Morris CJ, 2017, J BIOL RHYTHM, V32, P154, DOI 10.1177/0748730417697537; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402, DOI 10.1073/pnas.1516953113; Morris CJ, 2016, J CLIN ENDOCR METAB, V101, P1066, DOI 10.1210/jc.2015-3924; Nakazato R, 2017, GLIA, V65, P198, DOI 10.1002/glia.23087; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Sender Vicky, 2014, Commun Integr Biol, V7, pe29053, DOI 10.4161/cib.29053; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	45	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217368	10.1371/journal.pone.0217368	http://dx.doi.org/10.1371/journal.pone.0217368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136603	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300031
J	Al-Shaghdali, K; Durante, B; Hayward, C; Beal, J; Foey, A				Al-Shaghdali, Khalid; Durante, Barbara; Hayward, Christopher; Beal, Jane; Foey, Andrew			Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED KINASE; ENDOTOXIN TOLERANCE; PORPHYROMONAS-GINGIVALIS; ANTIINFLAMMATORY CYTOKINE; ALTERNATIVE ACTIVATION; DIFFERENTIAL INDUCTION; GENE-EXPRESSION; INTERLEUKIN-10; CELLS; IL-6	Macrophages (M phi s) play a central role in mucosal immunity by pathogen sensing and instruction of adaptive immune responses. Prior challenge to endotoxin can render M phi s refractory to secondary exposure, suppressing the inflammatory response. Previous studies demonstrated a differential subset-specific sensitivity to endotoxin tolerance (ET), mediated by LPS from the oral pathogen, Porphyromonas gingivalis (PG). The aim of this study was to investigate ET mechanisms associated with M phi subsets responding to entropathogenic E. coli K12-LPS. M1- and M2-like M phi s were generated in vitro from the THP-1 cell line by differentiation with PMA and Vitamin D-3, respectively. This study investigated ET mechanisms induced in M1 and M2 M phi subsets, by measuring modulation of expression by RT-PCR, secretion of cytokines by sandwich ELISA, LPS receptor, TLR4, as well as endogenous TLR inhibitors, IRAK-M and Tollip by Western blotting. In contrast to PG-LPS tolerisation, E. coli K12-LPS induced ET failed to exhibit a subset-specific response with respect to the pro-inflammatory cytokine, TNF alpha, whereas exhibited a differential response for IL-10 and IL-6. TNFa expression and secretion was significantly suppressed in both M1- and M2-like Mfs. IL-10 and IL-6, on the other hand, were suppressed in M1s and refractory to suppression in M2s. ET suppressed TLR4 mRNA, but not TLR4 protein, yet induced differential augmentation of the negative regulatory molecules, Tollip in M1 and IRAK-M in M2 M phi s. In conclusion, E. coli K12-LPS differentially tolerises M phi subsets at the level of anti-inflammatory cytokines, associated with a subset-specific divergence in negative regulators and independent of TLR4 down-regulation.	[Al-Shaghdali, Khalid; Durante, Barbara; Foey, Andrew] Univ Plymouth, Fac Med & Dent, Sch Biomed Sci, Plymouth, Devon, England; [Al-Shaghdali, Khalid] Univ Hail, Coll Med, Hail, Saudi Arabia; [Hayward, Christopher] Derriford Hosp, Dept Gastroenterol, Plymouth, Devon, England; [Beal, Jane] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England	University of Plymouth; University Ha'il; Derriford Hospital; University of Plymouth	Foey, A (corresponding author), Univ Plymouth, Fac Med & Dent, Sch Biomed Sci, Plymouth, Devon, England.	andrew.foey@plymouth.ac.uk	Alshaghdali, khalid/AAR-9408-2021	Durante, Barbara/0000-0003-4096-0340	University of Hail, Kingdom of Saudi Arabia	University of Hail, Kingdom of Saudi Arabia	This work was funded by a research PhD studentship bursary from the University of Hail, Kingdom of Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Aman MJ, 1996, BLOOD, V87, P4731, DOI 10.1182/blood.V87.11.4731.bloodjournal87114731; Bainbridge BW, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P899; Baker B, 2015, J BIOL CHEM, V290, P6670, DOI 10.1074/jbc.M114.611442; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chanput W, 2013, FOOD FUNCT, V4, P266, DOI 10.1039/c2fo30156c; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Fleming SD, 1996, J IMMUNOL, V156, P1143; Fleming SD, 1999, J LEUKOCYTE BIOL, V66, P961, DOI 10.1002/jlb.66.6.961; Foey A.D., 2012, HDB MACROPHAGES LIFE, P121; Foey AD, 2017, ARCH ORAL BIOL, V73, P282, DOI 10.1016/j.archoralbio.2016.10.029; Foey AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067955; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Habil N, 2013, THESIS; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HENRICSON BE, 1991, INFECT IMMUN, V59, P1188, DOI 10.1128/IAI.59.3.1188-1191.1991; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; PORRINI AM, 1995, J NEUROIMMUNOL, V61, P27, DOI 10.1016/0165-5728(95)00070-I; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Shah JA, 2012, J IMMUNOL, V189, P1737, DOI 10.4049/jimmunol.1103541; Sun Y, 2014, INFLAMMATION, V37, P268, DOI 10.1007/s10753-013-9737-5; TILG H, 1994, BLOOD, V83, P113; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	43	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0214681	10.1371/journal.pone.0214681	http://dx.doi.org/10.1371/journal.pone.0214681			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120887	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700005
J	Megahed, A; Aldridge, B; Lowe, J				Megahed, Ameer; Aldridge, Brian; Lowe, James			Comparative study on the efficacy of sodium hypochlorite, aqueous ozone, and peracetic acid in the elimination of Salmonella from cattle manure contaminated various surfaces supported by Bayesian analysis	PLOS ONE			English	Article							WASTE-WATER; DISINFECTION; INACTIVATION; EMISSIONS; BACTERIA; QUALITY; MODEL	Providing the dairy industry with an effective and safe disinfectant is considered a key step in improving the farm hygiene and biosecurity. Salmonella infection via foodborne transmission remains a major public health threat. The main objective of this study was therefore to characterize and compare the decontamination power of NaOCl, aqueous-O-3, and PAA against cattle manure based-Salmonella heavily contaminated various surfaces (plastic, nylon, rubber, and wood) using Bayesian analysis. In a crossover design, 14 strips of each material were randomly assigned between 3 groups, treatment (n = 6), positive-control (contaminated with feces-Salmonella mixture, but not exposed to disinfectants, n = 6), and negative control (laboratory blank, inoculated only with sterile water, n = 2). The strips were soaked in cattle manure inoculated with 10(7)-10(8) of Salmonella Typhimurium-Choleraesuis (aSTC) and exposed to 50 mL of 200 ppm NaOCl, 9 ppm aqueous-O-3, or 400 ppm PAA for 4 minutes. Bayesian methods were used for analysis. On plastic and nylon surfaces, NaOCl, aqueous-O-3, or PAA reduce aSTC population to a safe level (>5.0-log(10)) within 4 minutes. On rubber surface, PAA and aqueous-O3 can produce a reduction in aSTC population 50% and 30% higher than NaOCl with posterior probabilities of 97% and 90%, respectively. However, PAA can produce reduction factor on wood surface 40% higher than aqueous-O-3 and NaOCl with posterior probabilities of 97% and 73%, respectively. We conclude that smooth surfaces were most effectively decontaminated. Peracetic acid of 400 ppm can provide an effective means for controlling Salmonella population heavily contaminated various surfaces in dairy operations. However, the safe residues and strong reactivity makes aqueous-O3 and PAA attractive alternative disinfectants for improving farm hygiene and biosecurity.	[Megahed, Ameer; Aldridge, Brian; Lowe, James] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA; [Megahed, Ameer] Benha Univ, Fac Vet Med, Dept Anim Med, Internal Med, Moshtohor Toukh, Kalyobiya, Egypt	University of Illinois System; University of Illinois Urbana-Champaign; Egyptian Knowledge Bank (EKB); Benha University	Lowe, J (corresponding author), Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA.	jlowe@illinois.edu	Megahed, Ameer/ABI-2425-2020	Megahed, Ameer/0000-0003-2006-8873	Origin, Inc. (Princeton, NJ, USA)	Origin, Inc. (Princeton, NJ, USA)	This work was supported by Origin, Inc. (Princeton, NJ, USA)-technical testing agreement with the Board of Trustees of the University of Illinois to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, E287112 ASTM; Aydogan A, 2006, J AIR WASTE MANAGE, V56, P179, DOI 10.1080/10473289.2006.10464443; Bauermeister LJ, 2008, POULTRY SCI, V87, P2390, DOI 10.3382/ps.2008-00087; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Block S., 1991, DISINFECTION STERILI; Bremer P.J., 2010, ENCY IND BIOTECHNOLO, P1; Carvajal G, 2017, WATER RES, V109, P144, DOI 10.1016/j.watres.2016.11.008; Chia TWR, 2009, FOOD MICROBIOL, V26, P853, DOI 10.1016/j.fm.2009.05.012; Coory MD, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-30; DICKENS JA, 1995, POULTRY SCI, V74, P1044, DOI 10.3382/ps.0741044; Feliciano L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050273; FRASER J A L, 1985, Water Science and Technology, V17, P451; Frenzen P. D., 1999, FoodReview, V22, P10; Gabry J., 2017, RSTANARM BAYESIAN AP; Gao A, 2018, J AOAC INT, V102, DOI [10.5740/jaoacint.17-0399, DOI 10.5740/JAOACINT.17-0399]; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GLAZE WH, 1989, IND ENG CHEM RES, V28, P1573, DOI 10.1021/ie00095a001; Greenberg AE, 1980, SEMIN P, P2; Himathongkham S, 1999, FEMS MICROBIOL LETT, V178, P251, DOI 10.1111/j.1574-6968.1999.tb08684.x; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Howard G, 2005, STROKE, V36, P1622, DOI 10.1161/01.STR.0000170638.55491.bb; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim JG, 2000, J FOOD SCI, V65, P521, DOI 10.1111/j.1365-2621.2000.tb16040.x; Kitis M, 2004, ENVIRON INT, V30, P47, DOI 10.1016/S0160-4120(03)00147-8; Kryinski EP, 1992, J FOOD PROTECT, V55, P246, DOI [10.4315/0362-028X-55.4.246, DOI 10.4315/0362-028X-55.4.246]; Lee M, 2006, J APPL POLYM SCI, V100, P1344, DOI 10.1002/app.23382; McKee SR, 2011, SALMONELLA CAMPYLOBA, P24; Megahed A, 2018, J ADV DAIRY RES, V6, P205; Megahed A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196555; Mircioiu C, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5020026; Molhave L, 2000, INDOOR AIR, V10, P315, DOI 10.1034/j.1600-0668.2000.010004315.x; Morey RD, 2011, J MATH PSYCHOL, V55, P368, DOI 10.1016/j.jmp.2011.06.004; Morrison GC, 2002, ENVIRON SCI TECHNOL, V36, P2185, DOI 10.1021/es0113089; MUSTAPHA A, 1989, J FOOD PROTECT, V52, P306, DOI 10.4315/0362-028X-52.5.306; Nicholas R, 2013, J APPL MICROBIOL, V115, P555, DOI 10.1111/jam.12239; Perkins J., 2004, J MOD APPL STAT METH, V3, P227, DOI [DOI 10.22237/JMASM/1083371040, 10.22237/jmasm/1083371040]; RICE RG, 1981, J AM WATER WORKS ASS, V73, P44; Ritter AC, 2012, J FOOD PROTECT, V75, P437, DOI 10.4315/0362-028X.JFP-11-286; Russel, 1999, PRINCIPLES PRACTICE; Rutala WA, 2001, J HOSP INFECT, V48, pS64, DOI 10.1016/S0195-6701(01)90017-9; Sczepanski Felipe, 2014, Eur J Dent, V8, P533, DOI 10.4103/1305-7456.143638; Singla R, 2014, J BIOSCI BIOENG, V118, P34, DOI 10.1016/j.jbiosc.2013.12.025; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiehs M, 2009, BEST MANAGEMENT PRAC; Su Y-S, R2JAGS PACKAGE RUNNI; Tuson HH, 2013, SOFT MATTER, V9, P4368, DOI 10.1039/c3sm27705d; van de Schoot R, 2017, PSYCHOL METHODS, V22, P217, DOI 10.1037/met0000100; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Wang H, 2010, INDOOR AIR, V20, P224, DOI 10.1111/j.1600-0668.2010.00648.x; Wang LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15159; WESTERN B, 1994, AM POLIT SCI REV, V88, P412, DOI 10.2307/2944713; Wideman N, 2016, POULTRY SCI, V95, P306, DOI [10, 10.3382/ps/pev328]; ZHU QS, 1989, OZONE-SCI ENG, V11, P169	53	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217428	10.1371/journal.pone.0217428	http://dx.doi.org/10.1371/journal.pone.0217428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120988	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700102
J	Warthi, G; Seligmann, H				Warthi, Ganesh; Seligmann, Herve			Transcripts with systematic nucleotide deletion of 1-12 nucleotide in human mitochondrion suggest potential non-canonical transcription	PLOS ONE			English	Article							CIRCULAR CODE MOTIFS; DNA-SEQUENCE DIFFERENCES; RNA SELF-HYBRIDIZATION; NON-COMPLEMENTARY RNA; ADENOSINE DEAMINASES; EXCHANGES; GENES; REPLICATION; PEPTIDES; POLYMERIZATION	Raw transcriptomic data contain numerous RNA reads whose homology with template DNA doesn't match canonical transcription. Transcriptome analyses usually ignore such noncanonical RNA reads. Here, analyses search for noncanonical mitochondrial RNAs systematically deleting 1 to 12 nucleotides after each transcribed nucleotide triplet, producing deletion-RNAs (delRNAs). We detected delRNAs in the human whole cell and purified mitochondrial transcriptomes, and in Genbank's human EST database corresponding to systematic deletions of 1 to 12 nucleotides after each transcribed trinucleotide. DelRNAs detected in both transcriptomes mapped along with 55.63% of the EST delRNAs. A bias exists for delRNAs covering identical mitogenomic regions in both transcriptomic and EST datasets. Among 227 delRNAs detected in these 3 datasets, 81.1% and 8.4% of delRNAs were mapped on mitochondrial coding and hypervariable region 2 of dloop. Del-transcription analyses of GenBank's EST database confirm observations from whole cell and purified mitochondrial transcriptomes, eliminating the possibility that detected delRNAs are false positives matches, cytosolic DNA/RNA nuclear contamination or sequencing artefacts. These detected delRNAs are enriched in frameshift-inducing homopolymers and are poor in frameshift-preventing circular code codons (a set of 20 codons which regulate reading frame detection, over-and underrepresented in coding and other frames of genes, respectively) suggesting a motif-based regulation of non-canonical transcription. These findings show that rare non-canonical transcripts exist. Such non canonical del-transcription does increases mitochondrial coding potential and non-coding regulation of intracellular mechanisms, and could explain the dark DNA conundrum.	[Warthi, Ganesh] Aix Marseille Univ, IRD, VITROME, Inst Hosp Univ Mediterranee Infect, Marseille, France; [Seligmann, Herve] Aix Marseille Univ, IRD, MEPHI, Inst Hosp Univ IHU Mediterranee Infect, Marseille, France; [Seligmann, Herve] Hebrew Univ Jerusalem, Natl Nat Hist Collect, Jerusalem, Israel	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Hebrew University of Jerusalem	Warthi, G (corresponding author), Aix Marseille Univ, IRD, VITROME, Inst Hosp Univ Mediterranee Infect, Marseille, France.	g.warthi6791@gmail.com	Warthi, Ganesh/AAL-6221-2020; Seligmann, Herve/D-4720-2012	Warthi, Ganesh/0000-0002-7497-601X; 	A. MIDEX project - "Investissements d'Avenir" French Government program [ANR-11-IDEX-0001-02]	A. MIDEX project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR))	This work has been carried out thanks to the support of the A. MIDEX project (no ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani VM, 2016, BIOESSAYS, V38, P21, DOI 10.1002/bies.201500131; Ahmed Ahmed, 2007, In Silico Biology, V7, P155; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; [Anonymous], MITOCHONDRIAL DNA; Ariel F, 2015, TRENDS PLANT SCI, V20, P362, DOI 10.1016/j.tplants.2015.03.003; Arques DG, 1997, J THEOR BIOL, V189, P273, DOI 10.1006/jtbi.1997.0513; Arques DG, 1996, J THEOR BIOL, V182, P45, DOI 10.1006/jtbi.1996.0142; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bar-Yaacov D, 2013, GENOME RES, V23, P1789, DOI 10.1101/gr.161265.113; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazin J, 2017, P NATL ACAD SCI USA, V114, pE10018, DOI 10.1073/pnas.1708433114; BLANK A, 1986, BIOCHEMISTRY-US, V25, P5920, DOI 10.1021/bi00368a013; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-616; CRICK FHC, 1957, P NATL ACAD SCI USA, V43, P416, DOI 10.1073/pnas.43.5.416; Di Giacomo M, 2013, MOL CELL, V50, P601, DOI 10.1016/j.molcel.2013.04.026; Dila G, 2019, BIOSYSTEMS, V175, P57, DOI 10.1016/j.biosystems.2018.10.014; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El Houmami N, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00036; El Soufi K, 2015, COMPUT BIOL CHEM, V59, P158, DOI 10.1016/j.compbiolchem.2015.07.015; Fimmel Elena, 2016, Life-Basel, V6, P14, DOI 10.3390/life6010014; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002; Garzon R, 2014, P NATL ACAD SCI USA, V111, P18679, DOI 10.1073/pnas.1422050112; Gonzalez DL, 2011, J THEOR BIOL, V275, P21, DOI 10.1016/j.jtbi.2011.01.028; Hargreaves AD, 2017, P NATL ACAD SCI USA, V114, P7677, DOI 10.1073/pnas.1702930114; Harish A, 2017, J THEOR BIOL, V434, P88, DOI 10.1016/j.jtbi.2017.07.011; Jestin JL, 1997, FEBS LETT, V419, P153, DOI 10.1016/S0014-5793(97)01422-1; Ketteler Robin, 2012, Frontiers in Genetics, V3, P242, DOI 10.3389/fgene.2012.00242; Khanna M, 2009, RNA, V15, P2174, DOI 10.1261/rna.1790509; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; Knippa K, 2013, BIOCHEMISTRY-US, V52, P7807, DOI 10.1021/bi4009566; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21597; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lacan J, 2001, J THEOR BIOL, V213, P159, DOI 10.1006/jtbi.2001.2416; Lee SY, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S2-S8; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lovell PV, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0565-1; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Michel Christian J, 2017, Life (Basel), V7, DOI 10.3390/life7020020; Michel CJ, 2015, J THEOR BIOL, V380, P156, DOI 10.1016/j.jtbi.2015.04.009; Michel CJ, 2013, COMPUT BIOL CHEM, V45, P17, DOI 10.1016/j.compbiolchem.2013.02.004; Michel CJ, 2012, COMPUT BIOL CHEM, V37, P24, DOI 10.1016/j.compbiolchem.2011.10.002; MICHEL CJ, 2017, LIFE-BASEL, V7, DOI DOI 10.3390/LIFE7040052; NINIO J, 1991, BIOCHIMIE, V73, P1517, DOI 10.1016/0300-9084(91)90186-5; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Seligmann H, 2018, VIRUS RES, V253, P77, DOI 10.1016/j.virusres.2018.06.004; Seligmann H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00101; Seligmann H, 2017, BIOSYSTEMS, V160, P10, DOI 10.1016/j.biosystems.2017.08.002; Seligmann H, 2017, J THEOR BIOL, V414, P76, DOI 10.1016/j.jtbi.2016.11.021; Seligmann H, 2016, COMPUT STRUCT BIOTEC, V14, P391, DOI 10.1016/j.csbj.2016.09.004; Seligmann H, 2016, BIOSYSTEMS, V147, P78, DOI 10.1016/j.biosystems.2016.07.010; Seligmann H, 2016, COMPUT STRUCT BIOTEC, V14, P283, DOI 10.1016/j.csbj.2016.06.005; Seligmann H, 2016, MITOCHONDRIAL DNA A, V27, P2440, DOI 10.3109/19401736.2015.1033691; Seligmann H, 2016, J THEOR BIOL, V399, P84, DOI 10.1016/j.jtbi.2016.04.007; Seligmann H, 2016, BIOSYSTEMS, V142, P43, DOI 10.1016/j.biosystems.2016.03.009; Seligmann H, 2016, BIOSYSTEMS, V140, P38, DOI 10.1016/j.biosystems.2015.11.009; Seligmann H, 2015, J THEOR BIOL, V387, P154, DOI 10.1016/j.jtbi.2015.09.030; Seligmann H, 2015, BIOSYSTEMS, V135, P1, DOI 10.1016/j.biosystems.2015.07.003; Seligmann H, 2014, J THEOR BIOL, V363, P216, DOI 10.1016/j.jtbi.2014.08.036; Seligmann H, 2014, BIOSYSTEMS, V125, P22, DOI 10.1016/j.biosystems.2014.09.012; Seligmann H, 2013, J COMPUT BIOL, V20, P660, DOI 10.1089/cmb.2012.0134; Seligmann H, 2013, J THEOR BIOL, V324, P1, DOI 10.1016/j.jtbi.2013.01.024; Seligmann H, 2013, BIOSYSTEMS, V111, P156, DOI 10.1016/j.biosystems.2013.01.011; Seligmann H, 2012, J THEOR BIOL, V315, P38, DOI 10.1016/j.jtbi.2012.08.044; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Strathern JN, 2012, BBA-GENE REGUL MECH, V1819, P694, DOI 10.1016/j.bbagrm.2012.02.005; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wang IX, 2016, GENOME RES, V26, P1544, DOI 10.1101/gr.207878.116; Wang IX, 2014, CELL REP, V6, P906, DOI 10.1016/j.celrep.2014.01.037; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Zhou YN, 2013, J BIOL CHEM, V288, P2700, DOI 10.1074/jbc.M112.429464	77	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217356	10.1371/journal.pone.0217356	http://dx.doi.org/10.1371/journal.pone.0217356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120958	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700094
J	Zhang, YY; Nayga, RM; Depositario, DPT				Zhang, Yu Yvette; Nayga, Rodolfo M., Jr.; Depositario, Dinah Pura T.			Learning and the possibility of losing own money reduce overbidding: Delayed payment in experimental auctions	PLOS ONE			English	Article							HOUSE MONEY; RISK-AVERSION; ENDOWMENT; 1ST-PRICE; EQUILIBRIUM	In this study, we designed a delayed payment mechanism in laboratory second price auctions (SPAs), under which subjects received a cash endowment two weeks after the experiment day and had to use their own money to pay the experimental losses (if any) on the experiment day. We compared the effect of delayed payment on overbidding in the induced value SPAs with the conventional "on-the-spot" payment mechanism where the subjects received an endowment on the experiment day, and the prepaid mechanism where the subjects received the endowment two weeks before the experiment day. Each auction was repeated for 20 rounds to provide sufficient learning opportunities to the bidders. Our results showed that bids converged to the corresponding values over auction rounds and overbidding was reduced by previous losses, consistently with the adaptive learning theory. Moreover, overbidding seems to depend significantly on bidders' cash holding, and the magnitude of the payment treatment effects depends crucially on liquidity constraints. In the presence of liquidity constraints, both delayed and prepaid payment mechanisms reduced overbidding, while in the absence of liquidity constraints, only the delayed endowment mechanism reduced overbidding. Furthermore, when controlling the degree of liquidity constraints, subjects with higher GPAs were less likely to overbid and the delayed endowment mechanism significantly reduced overbidding compared to other payment mechanisms. These results suggest that overbidding in SPAs might be caused by bounded rationality and could be reduced by adaptive learning especially when overbidding becomes "truly" costly to subjects.	[Zhang, Yu Yvette] Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA; [Nayga, Rodolfo M., Jr.] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Depositario, Dinah Pura T.] Univ Philippines Los Banos, Coll Econ & Management, Dept Agribusiness Management & Entrepreneurship, College Los Banos, Laguna, Philippines	Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville; University of the Philippines System; University of the Philippines Los Banos	Zhang, YY (corresponding author), Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA.	yzhang@tamu.edu	Depositario, Dinah Pura T./ABG-5379-2021	ZHANG, YU YVETTE/0000-0003-2708-338X	Tyson Endowment Fund in Food Policy Economics	Tyson Endowment Fund in Food Policy Economics	This study was supported by Tyson Endowment Fund in Food Policy Economics for Rodolfo M. Nayga, Jr.; This work was funded by Tyson Endowment Fund in Food Policy Economics for Rodolfo M. Nayga, Jr. The authors would like to thank Dr. Giovanni Ponti and two anonymous reviewers for their thoughtful comments and insightful suggestions that have helped improve our manuscript significantly.	Andersen S, 2008, ECONOMETRICA, V76, P583, DOI 10.1111/j.1468-0262.2008.00848.x; Clark J, 2002, EXP ECON, V5, P223, DOI 10.1023/A:1020832203804; Coller M., 1999, Experimental Economics, V2, P107, DOI 10.1007/BF01673482; Cooper DJ, 2008, ECON J, V118, P1572, DOI 10.1111/j.1468-0297.2008.02181.x; COX DR, 1972, J R STAT SOC B, V34, P187; COX JC, 1992, AM ECON REV, V82, P1392; Davis LR, 2010, EXP ECON, V13, P189, DOI 10.1007/s10683-010-9235-7; Depositario DPT, 2014, ASIAN ECON J, V28, P201, DOI 10.1111/asej.12033; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Fox J, 2002, COX PROPORTIONAL HAZ; FRANKEN RE, 1995, PERS INDIV DIFFER, V19, P175, DOI 10.1016/0191-8869(95)00035-5; Georganas S, WORKING PAPER; Goeree JK, 2002, J ECON THEORY, V104, P247, DOI 10.1006/jeth.2001.2914; Harrison GW, 2007, EXP ECON, V10, P429, DOI 10.1007/s10683-006-9145-x; Harrison GW, 2002, AM ECON REV, V92, P1606, DOI 10.1257/000282802762024674; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Jacobson S, 2009, J RISK UNCERTAINTY, V38, P143, DOI 10.1007/s11166-009-9063-3; KAGEL JH, 1987, ECONOMETRICA, V55, P1275, DOI 10.2307/1913557; KAGEL JH, 1993, ECON J, V103, P868, DOI 10.2307/2234706; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LOEWENSTEIN G, 1992, Q J ECON, V107, P573, DOI 10.2307/2118482; Loureiro ML, 2003, APPL ECON LETT, V10, P271, DOI 10.1080/1350485032000056855; Lusk J. L., 2006, USING EXP METHODS EN, P20; Martinez A, 2010, ITS NOT MY MONEY EXP; Mengel F, 2014, J ECON BEHAV ORGAN, V108, P59, DOI 10.1016/j.jebo.2014.08.001; Morgan J., 2003, BE J ECON ANAL POLI, V2, P5; Neilson WS, 2002, J RISK UNCERTAINTY, V24, P131, DOI 10.1023/A:1014015926103; Ockenfels A, 2005, GAME ECON BEHAV, V51, P155, DOI 10.1016/j.geb.2004.04.002; Rosenboim M, 2012, EXP ECON, V15, P145, DOI 10.1007/s10683-011-9294-4; SMITH VL, 1976, AM ECON REV, V66, P274; THALER RH, 1990, MANAGE SCI, V36, P643, DOI 10.1287/mnsc.36.6.643; Udvari S. J., 2000, ROEPER REV, V22, P212, DOI DOI 10.1080/02783190009554040; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633	35	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0213568	10.1371/journal.pone.0213568	http://dx.doi.org/10.1371/journal.pone.0213568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120871	Green Published, gold			2022-12-27	WOS:000468775700002
J	Muller, S; Rau, HA				Mueller, Stephan; Rau, Holger A.			Too cold for warm glow? Christmas-season effects in charitable giving	PLOS ONE			English	Article							IMPURE ALTRUISM; EMPATHY; STRESS; PRICE	This paper analyzes seasonal effects and their potential drivers in charitable giving. We conduct two studies to analyze whether donations to the German Red Cross differ between the Christmas season and summer. In study 1 we find that in the pre-Christmas shopping season prosocial subjects almost donate 50% less compared to prosocials in summer. In study 2 we replicate the low donations in the Christmas season. In an extensive questionnaire we control for several causes of this effect. The data suggest that the higher prosocials' self-reported stress level, the lower the donations. The higher their relative savings, the lower the giving. Our questionnaire rules out that "donation fatigue" matters. That is, donations do not depend on the number of charitable campaigns subjects are confronted with and their engagement in these activities during Christmas season outside the lab.	[Mueller, Stephan; Rau, Holger A.] Univ Gottingen, Gottingen, Germany; [Mueller, Stephan; Rau, Holger A.] Pl Gottinger Sieben 3, Gottingen, Germany	University of Gottingen	Rau, HA (corresponding author), Univ Gottingen, Gottingen, Germany.; Rau, HA (corresponding author), Pl Gottinger Sieben 3, Gottingen, Germany.	holger.rau@uni-goettingen.de	Rau, Holger Andreas/AFJ-2184-2022; Rau, Holger Andreas/AAF-4536-2022; Mueller, Stephan/AAM-9760-2021	Rau, Holger Andreas/0000-0003-3382-6127; Rau, Holger Andreas/0000-0003-3382-6127; Mueller, Stephan/0000-0003-4890-3981	University of Gottingen	University of Gottingen	Financial support was provided by the University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1989, J POLIT ECON, V97, P1447, DOI 10.1086/261662; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; Cairns J, 2011, ECON LETT, V111, P173, DOI 10.1016/j.econlet.2011.01.028; Center on Philanthropy at Indiana University, 2012, 2012 BANK AM STUD HI; Davis MH, 1999, J PERS, V67, P469, DOI 10.1111/1467-6494.00062; Declerck CH, 2008, J SOC PSYCHOL, V148, P711, DOI 10.3200/SOCP.148.6.711-726; Duquette NJ, 2016, J PUBLIC ECON, V137, P51, DOI 10.1016/j.jpubeco.2016.02.002; Eckel CC, 2003, J PUBLIC ECON, V87, P681, DOI 10.1016/S0047-2727(01)00094-9; Ek C, 2017, J ECON BEHAV ORGAN, V136, P45, DOI 10.1016/j.jebo.2017.01.007; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Exadaktylos F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01213; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Gneezy U, 2014, SCIENCE, V346, P632, DOI 10.1126/science.1253932; Greenberg AE, 2014, J ECON BEHAV ORGAN, V97, P103, DOI 10.1016/j.jebo.2013.10.014; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Grosch K, 2017, J ECON PSYCHOL, V62, P258, DOI 10.1016/j.joep.2017.07.008; Hager M., 2002, ANN C ASS RES NONPR; Kloner RA, 2004, CIRCULATION, V110, P3744, DOI 10.1161/01.CIR.0000151786.03797.18; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Lilley A, 2014, J PUBLIC ECON, V114, P58, DOI 10.1016/j.jpubeco.2013.12.004; MacDonnell R, 2015, J CONSUM RES, V42, P551, DOI 10.1093/jcr/ucv042; MacLaughlin S, 2014, CHARITABLE GIVING RE, P1; Meer J, 2014, J ECON BEHAV ORGAN, V103, P113, DOI 10.1016/j.jebo.2014.04.010; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Null C, 2011, J PUBLIC ECON, V95, P455, DOI 10.1016/j.jpubeco.2010.06.018; Park KH, 2015, INT J MED EDUC, V6, P103, DOI 10.5116/ijme.55e6.0d44; Raihani NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113826; Singh J, 2019, MANAGE SCI, V65, P913, DOI 10.1287/mnsc.2017.2887; Sonntag A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134705; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P1330; WALDFOGEL J, 1993, AM ECON REV, V83, P1328; Winking J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115419	36	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215844	10.1371/journal.pone.0215844	http://dx.doi.org/10.1371/journal.pone.0215844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116743	gold, Green Submitted, Green Published			2022-12-27	WOS:000468607400010
J	He, CY; Zhang, YH; Zhou, W; Guo, QY; Bai, B; Shen, SB; Huang, GB				He, Chunyu; Zhang, Yanhong; Zhou, Wei; Guo, Qingyi; Bai, Bin; Shen, Sanbao; Huang, Gaobao			Study on stripe rust (Puccinia striiformis) effect on grain filling and seed morphology building of special winter wheat germplasm Huixianhong	PLOS ONE			English	Article								Stripe rust, caused by Puccinia striiformis f. sp. tritici (Pst), is an airborne fungal disease which always destructs leaf and leads to stagnation of grain filling, decreasing of kernel weight, thin seed and yield loss. Winter wheat Huixianhong is a special germplasm with special characteristics of tolerance or resistance against stripe rust. In order to understand the effect on Huixianhong from stripe rust, we designed two kinds of treatment, inoculation of stripe rust fungi (IH) and artificial immune by bactericide (CK) to study the dynamic of disease process, the grain filling and the thousand-kernel weight (TKW). Our results showed that the incubation period of Hongxinahui was 13.5 days. The prevalence increased from 32.9% at 15 days after jointing to 80.0% at 9 days after booting, and reached to 97.0% at the heading stage. The infection type (IT) was 7 to 9 at the beginning of anthesis. The severity, leaf withered area ratio and disease index at the 15th day after anthesis were 67.17%, 98.17% and 0.6717, respectively. The IH maximum increasing rate of leaf necrosis and chlorosis area was from heading beginning stage to anthesis beginning stage, which increased from 18.66 mm(2).d(-1) to 21.04 mm(2).d(-1). The maximum rate of grain filling was 1.25 mg.d(-1) at the 18th day after anthesis, which was earlier than that of CK by 3.3 days. The IH thousand-kernel weight Loss (TKWL) was more than that of CK by 6.19%, the stage of heading and amature were 3.0 days and 4.5 days earlier than CK, respectively. The stripe rust infection seriously destructed the photosynthetic function of leaf at the earlier stage of grain filling, i.e. at the beginning of anthesis, which led to the most important biomass loss and the grain filling rate decrease. As far as stripe rust is concerned, Huixianhong is a high susceptible, easily been infected, seriously showing symptoms and most quickly epidemic type but can successfully complete grain filling in high quality. It is a very useful germplasm for creating and selecting special breeding materials against stripe rust.	[He, Chunyu; Zhang, Yanhong; Guo, Qingyi] Gansu Univ Chinese Med, Dept Pharm, Lanzhou, Gansu, Peoples R China; [He, Chunyu; Huang, Gaobao] Gansu Agr Univ, Dept Agron, Gansu Prov Key Lab Arid Land Crop Sci, Lanzhou, Gansu, Peoples R China; [Zhou, Wei] Univ Arkansas, Div Agr, Dept Hort, 316 PTSC, Fayetteville, AR 72701 USA; [Bai, Bin] Gansu Agr Sci Acad, Wheat Inst, Lanzhou, Gansu, Peoples R China; [Shen, Sanbao] Qinshui Stn Popularizing Agr Tech, Tianshui, Gansu, Peoples R China	Gansu University of Chinese Medicine; Gansu Agricultural University; University of Arkansas System; University of Arkansas Fayetteville	He, CY; Zhang, YH (corresponding author), Gansu Univ Chinese Med, Dept Pharm, Lanzhou, Gansu, Peoples R China.; He, CY (corresponding author), Gansu Agr Univ, Dept Agron, Gansu Prov Key Lab Arid Land Crop Sci, Lanzhou, Gansu, Peoples R China.	hcy9087@163.com; zhyh456789@163.com			Science and Technology Support Program of Gansu Province [1304NKCA133]	Science and Technology Support Program of Gansu Province	Chunyu He has been supported by the Science and Technology Support Program of Gansu Province. (NO. 1304NKCA133).	Bancal MO, 2007, ANN BOT-LONDON, V100, P777, DOI 10.1093/aob/mcm163; Cao ShuQing, 2000, Scientia Agricultura Sinica, V33, P19; [陈青 Chen Qing], 2002, [植物保护, Plant Protection], V28, P19; Chen X M, 2017, STRIPE RUST, P9; [董云 DONG Yun], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P96; Du JY, 2004, CROPS, V24, P35; Erik H., 2002, J EXP BOT, V53, P2217; Gong YueHua, 2004, Scientia Agricultura Sinica, V37, P1288; Han DeJun, 2010, Scientia Agricultura Sinica, V43, P2889; [何春雨 HE Chunyu], 2011, [麦类作物学报, Journal of Triticeae Crops], V31, P757; Huang Z.-R., 1981, Acta Agronomica Sinica, V7, P27; Li H, 2010, ACTA AGR BOREALI S S, V25, P93; [李强 Li Qiang], 2005, [麦类作物学报, Journal of Triticeae Crops], V25, P112; Li Z Q, 2000, CHINESE WHEAT RUST, p[1, 109, 204]; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Maydup ML, 2010, FIELD CROP RES, V119, P48, DOI 10.1016/j.fcr.2010.06.014; Qiu H Z, 2013, QUANTITATIVE RES STA, p[25, 101]; Roman A S, 2010, FIELD CROPS RES, V3, P352; Serrago RA, 2014, CROP PASTURE SCI, V65, P185, DOI 10.1071/CP13248; Serrago RA, 2013, FIELD CROP RES, V150, P42, DOI 10.1016/j.fcr.2013.05.016; Serrago RA, 2011, FIELD CROP RES, V120, P352, DOI 10.1016/j.fcr.2010.11.004; Wang BaoTong, 2000, Acta Phytophylacica Sinica, V27, P53; [谢连杰 XIE Lianjie], 2008, [华北农学报, Acta Agriculturae Boreali-Sinica], V23, P91; Yuan WenHuan, 1995, Scientia Agricultura Sinica, V28, P35; [张莹花 Zhang Yinghua], 2005, [甘肃农业大学学报, Journal of Gansu Agricultural University], V40, P521; Zhou XiangChun, 2006, Journal of Triticeae Crops, V26, P108	26	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0215066	10.1371/journal.pone.0215066	http://dx.doi.org/10.1371/journal.pone.0215066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112545	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000007
J	Oliva-Moreno, J; Pena-Longobardo, LM; Garcia-Mochon, L; Lozano, MD; Metcalfe, IM; Garcia-Calvente, MD				Oliva-Moreno, Juan; Maria Pena-Longobardo, Luz; Garcia-Mochon, Leticia; del Rio Lozano, Maria; Mosquera Metcalfe, Isabel; del Mar Garcia-Calvente, Maria			The economic value of time of informal care and its determinants (The CUIDARSE Study)	PLOS ONE			English	Article							OPPORTUNITY COSTS; VALUATION; PEOPLE; SUBSTITUTION; ASSISTANCE; EMPLOYMENT; SERVICES; HEALTH; IMPACT	Objective The main aims of this paper are to analyse the monetary value of informal care time using different techniques and to identify significant variables associated with the number of care-giving hours. Data and methods A multicentre study in two Spanish regions in adult caregivers was conducted. A total sample of 604 people was available. A multivariate analysis was performed to identify the variables associated with the number of hours of caregiving time. In the monetary valuation of informal care provided, three approaches were used: replacement cost method, opportunity cost and contingent valuation (willingness to pay and willingness to accept). Results The main determinants of the amount of time of informal care provided were age, gender, the level of care receiver's dependence and the professional care services received (at home and out of home). The value estimated for informal care time ranges from EUROS 80,247 (replacement cost method) to EUROS 14,325 (willingness to pay), with intermediate values of EUROS 27,140 and EUROS 29,343 (opportunity cost and willingness to accept, respectively). Several sensitivity analyses were performed over the base cases, confirming the previous results. Conclusions Time of informal care represents a great social value, regardless of the applied technique. However, the results can differ strongly depending on the technique chosen. Therefore, the choice of technique of valuation is not neutral. Among the determinants of informal care time, the professional care received at home has a complementary character to informal care, while the formal care outside the home has a substitute character.	[Oliva-Moreno, Juan; Maria Pena-Longobardo, Luz] Univ Castilla La Mancha, Dept Econ Anal, Toledo, Spain; [Oliva-Moreno, Juan; Maria Pena-Longobardo, Luz] Univ Castilla La Mancha, Seminar Res Econ & Hlth SIES, Toledo, Spain; [Garcia-Mochon, Leticia; del Rio Lozano, Maria; del Mar Garcia-Calvente, Maria] Andalusian Sch Publ Hlth EASP, Granada, Spain; [Garcia-Mochon, Leticia; del Rio Lozano, Maria; del Mar Garcia-Calvente, Maria] Biomed Res Ctr Ibs GRANADA, Granada, Spain; [Mosquera Metcalfe, Isabel] Univ Basque Country, Dept Sociol, Gipuzkoa, Spain; [Mosquera Metcalfe, Isabel] Univ Basque Country, Res Grp Social Determinants Hlth & Demog Change O, Gipuzkoa, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Escuela Andaluza de Salud Publica; University of Basque Country; University of Basque Country	Pena-Longobardo, LM (corresponding author), Univ Castilla La Mancha, Dept Econ Anal, Toledo, Spain.; Pena-Longobardo, LM (corresponding author), Univ Castilla La Mancha, Seminar Res Econ & Hlth SIES, Toledo, Spain.	luzmaria.pena@uclm.es	Oliva, Juan/A-1299-2011; Garcia, Leticia/AGV-7679-2022; del Mar Garcia-Calvente, María/AAB-8235-2020; del Mar García-Calvente, María/H-8097-2012; Pena Longobardo, Luz Maria/K-6413-2017	Oliva, Juan/0000-0002-8997-0307; del Mar Garcia-Calvente, María/0000-0003-3108-4633; Pena Longobardo, Luz Maria/0000-0001-7224-2189; Garcia-Mochon, Leticia/0000-0002-6300-2738	Instituto de Salud Carlos III; European Regional Development Fund [PI12/00498]; Ministry of Economy [ECO2017-83771-C3-1-R]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); Ministry of Economy	This work has received funding from the Instituto de Salud Carlos III and the European Regional Development Fund (PI12/00498) and Ministry of Economy (ECO2017-83771-C3-1-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Bauer JM, 2015, J POPUL AGEING, V8, P113, DOI 10.1007/s12062-015-9116-0; Bolin K, 2008, HEALTH ECON, V17, P393, DOI 10.1002/hec.1275; Calvente MG., 2011, GAC SANIT, V25, P100, DOI [10.1016/j.gaceta.2011.09.006, DOI 10.1016/J.GACETA.2011.09.006, DOI 10.1016/J.GACETA.2011.09.006.]; Carrera F., 2013, REFORMS LONG TERM CA; Chappell N., 1991, AGEING SOC, V11, P299, DOI [DOI 10.1017/S0144686X00004189, 10.1017/S0144686X00004189]; Chari AV, 2015, HEALTH SERV RES, V50, P871, DOI 10.1111/1475-6773.12238; Commission European, 2007, HLTH AG KEYST SUST E; Courtin E, 2014, HEALTH POLICY, V118, P84, DOI 10.1016/j.healthpol.2014.07.013; del Rio Lozano M, 2017, QUALITY LIFE RES, V26; EUnetHT, METH GUID METH HLTH; European Commission, 2017, AG REP 2018 2018 AG; European Commission, 2018, REP INF CAR EUR EXPL; GREENE VL, 1983, MED CARE, V21, P609, DOI 10.1097/00005650-198306000-00003; Hoefman RJ, 2013, PHARMACOECONOMICS, V31, P1105, DOI 10.1007/s40273-013-0104-z; Hollander Marcus J, 2009, Healthc Q, V12, P42; Jimenez-Martin S, 2012, EUR J HEALTH ECON, V13, P461, DOI 10.1007/s10198-011-0317-z; Kehusmaa S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-317; Lacey L, 2017, NEUROL THER, V6, P11, DOI 10.1007/s40120-016-0056-2; Lopez-Bastida J, 2016, EUR J HEALTH ECON, V17, P1, DOI 10.1007/s10198-016-0780-7; Lundsgaard J., 2005, OECD HLTH WORKING PA; Pena-Longobardo LM, 2016, HEALTH POLICY, V120, P1177, DOI 10.1016/j.healthpol.2016.08.012; Pena-Longobardo LM, 2015, EUR J HEALTH ECON, V16, P507, DOI 10.1007/s10198-014-0604-6; Mentzakis E, 2009, REV ECON HOUSEHOLD, V7, P283, DOI 10.1007/s11150-008-9047-0; MOSCOVICE I, 1988, MED CARE, V26, P971, DOI 10.1097/00005650-198810000-00005; Mosquera I, 2016, QUAL LIFE RES, V25, P1059, DOI 10.1007/s11136-015-1159-4; MSSSI Ministerio de Sanidad Servicios Sociales e Igualdad, 2014, INF EST INV ESTR NAC; Muramatsu N, 2002, J HEALTH SOC BEHAV, V43, P107, DOI 10.2307/3090248; Navaie-Waliser M., 2002, MED CARE, P40; Neubauer S, 2008, INT PSYCHOGERIATR, V20, P1160, DOI 10.1017/S1041610208007564; OECD.Stat, 2018, HLTH STAT 2018; Oliva-Moreno J, 2017, PHARMACOECONOMICS, V35, P331, DOI 10.1007/s40273-016-0468-y; Oliva-Moreno J, 2015, APPL HEALTH ECON HEA, V13, P223, DOI 10.1007/s40258-015-0161-x; Paraponaris A, 2012, EUR J HEALTH ECON, V13, P327, DOI 10.1007/s10198-011-0305-3; PENNING MJ, 1990, GERONTOLOGIST, V30, P220, DOI 10.1093/geront/30.2.220; Pickard L, 2012, LONG TERM CARE USE S, V116, P114; Pickard L., 2011, 94 ENEPRI; Pickard L, 2015, J SOC POLICY, V44, P567, DOI 10.1017/S0047279415000069; Pickard L, 2015, AGEING SOC, V35, P96, DOI 10.1017/S0144686X13000512; Saltman RB, 2006, INT J HEALTH SERV, V36, P719, DOI 10.2190/AUL1-4LAM-4VNB-3YH0; SMITH K, 1994, HEALTH ECON, V3, P137, DOI 10.1002/hec.4730030303; Trepel D, 2011, ECON SOC REV, V42, P479; Triantafillou J., 2010, INFORMAL CARE LONG T; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van den Berg B, 2006, HEALTH ECON, V15, P447, DOI 10.1002/hec.1075; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; van Exel Job, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P557, DOI 10.1586/14737167.8.6.557; Yabroff KR, 2009, CANCER, V115, P4362, DOI 10.1002/cncr.24588; 2013, QUALITATIVE HLTH RES, V23, P1506, DOI DOI 10.1177/1049732313507144; 1996, HEALTH ECON, V5, P13, DOI DOI 10.1002/(SICI)1099-1050(199601)5:1<13::AID	50	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217016	10.1371/journal.pone.0217016	http://dx.doi.org/10.1371/journal.pone.0217016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112587	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000033
J	Al-Hadidi, F; Bsisu, I; AlRyalat, SA; Al-Zu'bi, B; Bsisu, R; Hamdan, M; Kanaan, T; Yasin, M; Samarah, O				Al-Hadidi, Fadi; Bsisu, Isam; AlRyalat, Saif Aldeen; Al-Zu'bi, Belal; Bsisu, Rasha; Hamdan, Mohammad; Kanaan, Tareq; Yasin, Mohamad; Samarah, Omar			Association between mobile phone use and neck pain in university students: A cross-sectional study using numeric rating scale for evaluation of neck pain	PLOS ONE			English	Article							YOUNG-ADULTS; RISK-FACTORS; VALIDATION	Objective Mobile phones are reliable devices for communication and entertainment. However, their utilization for prolonged periods in flexed neck position is linked to neck and shoulders pain. The main purpose of this study is to investigate the association between neck pain and the duration of device use, taking into consideration gender, age, and the most frequent position in which students use their devices. Subjects and methods Based on a self-administered online questionnaire, we filled 500 questionnaires between February 15th, 2017 and March 18th, 2017. The study sample included healthy students from health care faculties regardless of their age, gender, or handedness. Results Analysis of the predictors for pain severity showed that age (p = 0.04) and duration of use (p = 0.001) were significantly associated with the severity of neck pain, while only the duration of use was significantly associated with pain duration (p = 0.036). Subjects were divided into two groups according to the pain score, 75.8% had pain severity equal or less than 4/10 and 24.2% had pain severity more than 4/10. Of those with pain severity >4, 5.8% of students sought medical help at the emergency department and 12.4% visited clinics, compared to only 0.3% seeking medical advice at an emergency department and 4.2% visiting clinics in the group with pain severity of <= 4 (p<0.001). Regarding the use of analgesia in the two groups, 44.6% of subjects with pain severity of >4 used analgesia, compared to only 12.1% in subjects with pain severity of <= 4 (p< 0.001). Conclusion This study demonstrates a significant positive correlation between the duration of mobile phone use and the duration and severity of neck pain. Furthermore, the increased severity of neck pain places a huge burden on the healthcare system.	[Al-Hadidi, Fadi; AlRyalat, Saif Aldeen; Al-Zu'bi, Belal; Hamdan, Mohammad; Kanaan, Tareq; Yasin, Mohamad; Samarah, Omar] Univ Jordan, Sch Med, Dept Special Surg, Amman, Jordan; [Bsisu, Isam] Univ Jordan, Sch Med, Amman, Jordan; [Bsisu, Rasha] Univ Jordan, Sch Pharm, Dept Clin Pharm, Amman, Jordan	University of Jordan; University of Jordan; University of Jordan	Bsisu, I (corresponding author), Univ Jordan, Sch Med, Amman, Jordan.	isam_bsisu@hotmail.com	hadidi, Fadi/J-3063-2016; Samarah, Omar Q./AAK-5639-2020; AlRyalat, Saif Aldeen/J-7528-2016; Hamdan, Mohammad/V-7979-2018	hadidi, Fadi/0000-0002-7456-9377; Samarah, Omar Q./0000-0003-4136-5017; AlRyalat, Saif Aldeen/0000-0001-5588-9458; Hamdan, Mohammad/0000-0003-2382-5585; Yasin, Mohamad/0000-0002-9216-9705; Bsisu, Isam/0000-0002-8999-8334				Alfven G, 1997, Eur J Pain, V1, P5; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1111/j.1553-2712.2003.tb01355.x; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Gold JE, 2012, APPL ERGON, V43, P408, DOI 10.1016/j.apergo.2011.06.015; Gustafsson E, 2010, J ELECTROMYOGR KINES, V20, P127, DOI 10.1016/j.jelekin.2008.11.010; Hartrick Craig T, 2003, Pain Pract, V3, P310; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kim MS, 2015, J PHYS THER SCI, V27, P15, DOI 10.1589/jpts.27.15; KLUSSMANN A, 2008, BMC MUSCULOSKEL DIS, V9; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Korpinen L, 2011, INT J OCCUP SAF ERGO, V17, P361, DOI 10.1080/10803548.2011.11076899; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Lee S, 2015, ERGONOMICS, V58, P220, DOI 10.1080/00140139.2014.967311; Neupane S., 2017, IMPERIAL J INTERDISC, V3; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; Simons DG, 1998, PAIN, V75, P1, DOI 10.1016/S0304-3959(97)00102-4; Skierkowski D, 2012, COMPUT HUM BEHAV, V28, P744, DOI 10.1016/j.chb.2011.11.023; Thomsen JF, 2007, OCCUP ENVIRON MED, V64, P527, DOI 10.1136/oem.2005.021170; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Xie YF, 2018, APPL ERGON, V68, P160, DOI 10.1016/j.apergo.2017.10.018; Xie YF, 2017, APPL ERGON, V59, P132, DOI 10.1016/j.apergo.2016.08.020; 2011, ERGONOMICS, V54, P477, DOI DOI 10.1080/00140139.2011.568634	26	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217231	10.1371/journal.pone.0217231	http://dx.doi.org/10.1371/journal.pone.0217231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY7BF	31107910	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200039
J	Doerken, S; Avalos, M; Lagarde, E; Schumacher, M				Doerken, Sam; Avalos, Marta; Lagarde, Emmanuel; Schumacher, Martin			Penalized logistic regression with low prevalence exposures beyond high dimensional settings	PLOS ONE			English	Article							LIKELIHOOD; SHRINKAGE; SELECTION	Estimating and selecting risk factors with extremely low prevalences of exposure for a binary outcome is a challenge because classical standard techniques, markedly logistic regression, often fail to provide meaningful results in such settings. While penalized regression methods are widely used in high-dimensional settings, we were able to show their usefulness in low-dimensional settings as well. Specifically, we demonstrate that Firth correction, ridge, the lasso and boosting all improve the estimation for low-prevalence risk factors. While the methods themselves are well-established, comparison studies are needed to assess their potential benefits in this context. This is done here using the dataset of a large unmatched case-control study from France (2005-2008) about the relationship between prescription medicines and road traffic accidents and an accompanying simulation study. Results show that the estimation of risk factors with prevalences below 0.1% can be drastically improved by using Firth correction and boosting in particular, especially for ultra-low prevalences. When a moderate number of low prevalence exposures is available, we recommend the use of penalized techniques.	[Doerken, Sam; Schumacher, Martin] Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Freiburg, Germany; [Doerken, Sam; Schumacher, Martin] Univ Freiburg, Med Ctr, Freiburg, Germany; [Doerken, Sam] Univ Freiburg, Freiburg Ctr Data Anal & Modeling, Freiburg, Germany; [Avalos, Marta; Lagarde, Emmanuel] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, UMR 1219, Bordeaux, France; [Avalos, Marta] INRIA Bordeaux Sud Ouest, SISTM Team, Talence, France	University of Freiburg; University of Freiburg; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Doerken, S (corresponding author), Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Freiburg, Germany.; Doerken, S (corresponding author), Univ Freiburg, Med Ctr, Freiburg, Germany.; Doerken, S (corresponding author), Univ Freiburg, Freiburg Ctr Data Anal & Modeling, Freiburg, Germany.	doerken@imbi.uni-freiburg.de	AVALOS, Marta/T-5017-2019	Doerken, Sam/0000-0002-9223-8045	French National Research Agency (ANR, DAA) [0766CO204]; French Medical Research Foundation (Equipe FRM); French National Medical Research Institute (Equipe INSERM Avenir); French Direction Generale de la Sante (DGS); University of Freiburg; German Research Foundation (DFG); Afssaps	French National Research Agency (ANR, DAA)(French National Research Agency (ANR)); French Medical Research Foundation (Equipe FRM)(Fondation pour la Recherche Medicale); French National Medical Research Institute (Equipe INSERM Avenir); French Direction Generale de la Sante (DGS); University of Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG)); Afssaps	The CESIR-A project was funded by the Afssaps, the French National Research Agency (ANR, DAA no 0766CO204), the French Medical Research Foundation (Equipe FRM), the French National Medical Research Institute (Equipe INSERM Avenir) and the French Direction Generale de la Sante (DGS) to EL. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding program Open Access Publishing.	[Anonymous], 2008, MULTIVARIABLE MODEL; Austin PC, 2002, DRUG SAFETY, V25, P677, DOI 10.2165/00002018-200225090-00006; Avalos M, 2012, EPIDEMIOLOGY, V23, P706, DOI 10.1097/EDE.0b013e31825fa528; Cole SR, 2014, AM J EPIDEMIOL, V179, P252, DOI 10.1093/aje/kwt245; Desai RJ, 2017, EPIDEMIOLOGY, V28, P249, DOI 10.1097/EDE.0000000000000595; Devika S, 2016, J POSTGRAD MED, V62, P26, DOI 10.4103/0022-3859.173193; Doerken S, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0197-0; Ewald K, 2018, ELECTRON J STAT, V12, P1358, DOI 10.1214/18-EJS1425; Gordis L., 2013, EPIDEMIOLOGY; Hastie T., 2009, UNSUPERVISED LEARNIN; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; HILDESHEIM A, 1991, INT J CANCER, V49, P335, DOI 10.1002/ijc.2910490304; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Mansournia MA, 2018, AM J EPIDEMIOL, V187, P864, DOI 10.1093/aje/kwx299; Mayr A, 2014, METHOD INFORM MED, V53, P419, DOI 10.3414/ME13-01-0122; Orriols L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000366; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Sauerbrei W, 2014, STAT MED, V33, P5413, DOI 10.1002/sim.6265; Schuz J, 1999, INT J EPIDEMIOL, V28, P631, DOI 10.1093/ije/28.4.631; Sullivan SG, 2013, INT J EPIDEMIOL, V42, P308, DOI 10.1093/ije/dys213; Sun H, 2012, BIOINFORMATICS, V28, P1368, DOI 10.1093/bioinformatics/bts145; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutz G, 2006, BIOMETRICS, V62, P961, DOI 10.1111/j.1541-0420.2006.00578.x; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604	28	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217057	10.1371/journal.pone.0217057	http://dx.doi.org/10.1371/journal.pone.0217057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107924	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200029
J	Webster, AJ				Webster, Anthony J.			Multi-stage models for the failure of complex systems, cascading disasters, and the onset of disease	PLOS ONE			English	Article							CLONAL EVOLUTION; CANCER ETIOLOGY; MUTATION; CARCINOGENESIS; RISK; TISSUES; NUMBER	Complex systems can fail through different routes, often progressing through a series of (rate-limiting) steps and modified by environmental exposures. The onset of disease, cancer in particular, is no different. Multi-stage models provide a simple but very general mathematical framework for studying the failure of complex systems, or equivalently, the onset of disease. They include the Armitage-Doll multi-stage cancer model as a particular case, and have potential to provide new insights into how failures and disease, arise and progress. A method described by E.T. Jaynes is developed to provide an analytical solution for a large class of these models, and highlights connections between the convolution of Laplace transforms, sums of random variables, and Schwinger/Feynman parameterisations. Examples include: exact solutions to the Armitage-Doll model, the sum of Gamma-distributed variables with integer-valued shape parameters, a clonal-growth cancer model, and a model for cascading disasters. Applications and limitations of the approach are discussed in the context of recent cancer research. The model is sufficiently general to be used in many contexts, such as engineering, project management, disease progression, and disaster risk for example, allowing the estimation of failure rates in complex systems and projects. The intended result is a mathematical toolkit for applying multi-stage models to the study of failure rates in complex systems and to the onset of disease, cancer in particular.	[Webster, Anthony J.] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England	University of Oxford	Webster, AJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	anthony.webster@ndph.ox.ac.uk	/ABF-8326-2020	/0000-0002-0903-7614	Nuffield Department of Population Health, University of Oxford; Cancer Research UK [C570/A16491]	Nuffield Department of Population Health, University of Oxford; Cancer Research UK(Cancer Research UK)	This research was funded by a fellowship from the Nuffield Department of Population Health, University of Oxford, and with support from Cancer Research UK (grant no. C570/A16491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; Thanks to Benjamin Cairns and Andrii Rozhok for helpful comments. This research was funded by a fellowship from the Nuffield Department of Population Health, University of Oxford, and with support from Cancer Research UK (grant no. C570/A16491).	AghaKouchak A, 2018, NATURE, V561, P458, DOI 10.1038/d41586-018-06783-6; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1965, BRIT MED J, V1, P723, DOI 10.1136/bmj.1.5436.723-b; ASHLEY DJB, 1969, BRIT J CANCER, V23, P313, DOI 10.1038/bjc.1969.41; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Calabrese P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-3; Chio A, 2018, NEUROLOGY, V91, pE635, DOI 10.1212/WNL.0000000000005996; Collett D., 2015, MODELLING SURVIVAL D, DOI DOI 10.1201/B18041; Corcia P, 2018, REV NEUROL-FRANCE, V174, P669, DOI 10.1016/j.neurol.2018.11.001; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jaynes E.T., 2003, PROBABILITY THEORY L; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Licher S, 2019, AGING-US, V11, P1163, DOI 10.18632/aging.101816; Little MP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-19; Lopez-Lazaro M, 2018, GENE CHROMOSOME CANC, V57, P281, DOI 10.1002/gcc.22530; Lopez-Lazaro M, 2018, CRIT REV ONCOL HEMAT, V123, P95, DOI 10.1016/j.critrevonc.2018.01.010; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Maley CC, 2017, NAT REV CANCER, V17, P605, DOI 10.1038/nrc.2017.69; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Michor F, 2006, P NATL ACAD SCI USA, V103, P14931, DOI 10.1073/pnas.0607006103; MOOLGAVKAR SH, 1978, J NATL CANCER I, V61, P49, DOI 10.1093/jnci/61.1.49; Moolgavkar SH, 2016, INT J EPIDEMIOL, V45, P645, DOI 10.1093/ije/dyv204; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Nunney L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1743; Peto R, 2016, INT J EPIDEMIOL, V45, P621, DOI 10.1093/ije/dyv199; Rozhok AI, 2015, P NATL ACAD SCI USA, V112, P8914, DOI 10.1073/pnas.1501713112; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; Soto-Ortiz L, 2012, AIP ADV, V2, DOI 10.1063/1.3699050; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinberg S., 1995, QUANTUM THEORY FIELD, Vvol 1; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Zhang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01968-5; Zhang X., 2018, SCI REPORTS, V8; 2017, RADIOLOGY, V284, P1, DOI DOI 10.1148/RADIOL.2017171004; 2014, LANCET NEUROL, V13, P1108, DOI DOI 10.1016/S1474-4422(14)70219-4	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216422	10.1371/journal.pone.0216422	http://dx.doi.org/10.1371/journal.pone.0216422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107895	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200009
J	Delfin, C; Krona, H; Andine, P; Ryding, E; Wallinius, M; Hofvander, B				Delfin, Carl; Krona, Hedvig; Andine, Peter; Ryding, Erik; Wallinius, Marta; Hofvander, Bjorn			Prediction of recidivism in a long-term follow-up of forensic psychiatric patients: Incremental effects of neuroimaging data	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MENTALLY DISORDERED OFFENDERS; LIMITED ANTISOCIAL PATHWAYS; LIFE-COURSE-PERSISTENT; VIOLENT OFFENDERS; CRIMINAL BEHAVIOR; RISK-FACTORS; PERSONALITY-DISORDER; RESPONSE-INHIBITION; BRAIN ABNORMALITIES	One of the primary objectives in forensic psychiatry, distinguishing it from other psychiatric disciplines, is risk management. Assessments of the risk of criminal recidivism are performed on a routine basis, as a baseline for risk management for populations involved in the criminal justice system. However, the risk assessment tools available to clinical practice are limited in their ability to predict recidivism. Recently, the prospect of incorporating neuroimaging data to improve the prediction of criminal behavior has received increased attention. In this study we investigated the feasibility of including neuroimaging data in the prediction of recidivism by studying whether the inclusion of resting-state regional cerebral blood flow measurements leads to an incremental increase in predictive performance over traditional risk factors. A subsample (N = 44) from a cohort of forensic psychiatric patients who underwent single-photon emission computed tomography neuroimaging and clinical psychiatric assessment during their court-ordered forensic psychiatric investigation were included in a long-term (ten year average time at risk) follow-up. A Baseline model with eight empirically established risk factors, and an Extended model which also included resting-state regional cerebral blood flow measurements from eight brain regions were estimated using random forest classification and compared using several predictive performance metrics. Including neuroimaging data in the Extended model increased the area under the receiver operating characteristic curve (AUC) from .69 to .81, increased accuracy from .64 to .82 and increased the scaled Brier score from .08 to .25, supporting the feasibility of including neuroimaging data in the prediction of recidivism in forensic psychiatric patients. Although our results hint at potential benefits in the domain of risk assessment, several limitations and ethical challenges are discussed. Further studies with larger, carefully characterized clinical samples utilizing higher-resolution neuroimaging techniques are warranted.	[Delfin, Carl; Andine, Peter; Wallinius, Marta] Univ Gothenburg, Ctr Eth Law & Mental Hlth, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Gothenburg, Sweden; [Delfin, Carl; Wallinius, Marta] Reg Forens Psychiat Clin, Vaxjo, Sweden; [Krona, Hedvig; Wallinius, Marta; Hofvander, Bjorn] Lund Univ, Fac Med, Dept Clin Sci Lund, Child & Adolescent Psychiat, Lund, Sweden; [Andine, Peter] Sahlgrens Univ Hosp, Forens Psychiat Clin, Gothenburg, Sweden; [Andine, Peter] Natl Board Forens Med, Dept Forens Psychiat, Gothenburg, Sweden; [Ryding, Erik] Skane Univ Hosp, Dept Clin Neurophysiol, Lund, Sweden; [Hofvander, Bjorn] Reg Skane, Div Forens Psychiat, Trelleborg, Sweden	University of Gothenburg; Lund University; Sahlgrenska University Hospital; Swedish National Board of Forensic Medicine; Lund University; Skane University Hospital	Delfin, C (corresponding author), Univ Gothenburg, Ctr Eth Law & Mental Hlth, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Gothenburg, Sweden.; Delfin, C (corresponding author), Reg Forens Psychiat Clin, Vaxjo, Sweden.	carl.delfin@gu.se	Delfin, Carl/AAQ-2205-2021	Delfin, Carl/0000-0003-4827-7650; Andine, Peter/0000-0002-6748-9619	Regional Forensic Psychiatric Clinic in Vaxjo; Region Skane; Region Kronoberg, Sodra sjukvardsregionen; Stiftelsen Lindhaga; Region Skane and Lund University	Regional Forensic Psychiatric Clinic in Vaxjo; Region Skane; Region Kronoberg, Sodra sjukvardsregionen; Stiftelsen Lindhaga; Region Skane and Lund University	The work was supported by the Regional Forensic Psychiatric Clinic in Vaxjo, grants from Region Skane, Region Kronoberg, Sodra sjukvardsregionen, Stiftelsen Lindhaga, and through the regional agreement on medical training and clinical research (ALF) between the Region Skane and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanerud J, 2012, J CEREBR BLOOD F MET, V32, P1177, DOI 10.1038/jcbfm.2012.18; af Klinteberg Britt, 2011, BMC Public Health, V11, P756, DOI 10.1186/1471-2458-11-756; Aharoni E, 2013, P NATL ACAD SCI USA, V110, P6223, DOI 10.1073/pnas.1219302110; Andreasson H, 2014, INT J LAW PSYCHIAT, V37, P635, DOI 10.1016/j.ijlp.2014.02.038; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Asselmann E, 2018, ACTA PSYCHIAT SCAND, V137, P6, DOI 10.1111/acps.12792; Assink M, 2015, CLIN PSYCHOL REV, V42, P47, DOI 10.1016/j.cpr.2015.08.002; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Balyakina E, 2014, COMMUNITY MENT HLT J, V50, P288, DOI 10.1007/s10597-013-9624-4; BARNARD GA, 1945, NATURE, V156, P783, DOI 10.1038/156783b0; Bartholomeusz CF, 2017, AUST NZ J PSYCHIAT, V51, P455, DOI 10.1177/0004867416670522; Birur B, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0013-9; Boccardi M, 2013, INT J LAW PSYCHIAT, V36, P157, DOI 10.1016/j.ijlp.2013.01.008; Boccardi M, 2011, PSYCHIAT RES-NEUROIM, V193, P85, DOI 10.1016/j.pscychresns.2010.12.013; Boccardi M, 2010, HUM BRAIN MAPP, V31, P438, DOI 10.1002/hbm.20877; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Bonta J, 2014, AGGRESS VIOLENT BEH, V19, P278, DOI 10.1016/j.avb.2014.04.014; Borgwardt SJ, 2008, SCHIZOPHR RES, V106, P108, DOI 10.1016/j.schres.2008.08.007; Brazil KJ, 2016, ENCY PERSONALITY IND, P1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Buchanan A, 2008, PSYCHIAT SERV, V59, P184, DOI 10.1176/ps.2008.59.2.184; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; Chang Z, 2015, LANCET PSYCHIAT, V2, P891, DOI 10.1016/S2215-0366(15)00234-5; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Coid J, 2006, BRIT J PSYCHIAT, V188, P423, DOI 10.1192/bjp.188.5.423; Constantinou AC, 2015, DECIS SUPPORT SYST, V80, P42, DOI 10.1016/j.dss.2015.09.006; Currie J, 2012, J HUM RESOUR, V47, P509; da Cunha-Bang Sofi, 2019, Soc Neurosci, V14, P162, DOI 10.1080/17470919.2017.1421262; da Cunha-Bang S, 2017, SOC COGN AFFECT NEUR, V12, P802, DOI 10.1093/scan/nsx006; Dean K, 2012, PSYCHOL MED, V42, P571, DOI 10.1017/S0033291711001395; Delacre M, 2017, PERS SOC PSYCHOL REV, DOI [10.5334/irsp.82/, DOI 10.5334/IRSP.82/]; Dotterer HL, 2017, DEV COGN NEUROS-NETH, V24, P84, DOI 10.1016/j.dcn.2017.02.008; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P924, DOI 10.1111/jcpp.12102; Fanning JR, 2011, PSYCHIAT RES, V186, P210, DOI 10.1016/j.psychres.2010.09.010; Farrington DP, 2015, EUR J CRIMINOL, V12, P386, DOI 10.1177/1477370815584262; Farrington DP, 2009, AGGRESSIVE BEHAV, V35, P150, DOI 10.1002/ab.20296; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; First M.G., 1997, STRUCTURED CLIN INTE; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Gandrud C., 2015, REPRODUCIBLE RES R R; Gkotsi GM, 2016, INT J LAW PSYCHIAT, V46, P58, DOI 10.1016/j.ijlp.2016.02.030; Glenn AL, 2014, NAT REV NEUROSCI, V15, P54, DOI 10.1038/nrn3640; Gordon N, 2007, EUR J PAEDIATR NEURO, V11, P232, DOI 10.1016/j.ejpn.2007.02.003; Gregory S, 2012, ARCH GEN PSYCHIAT, V69, P962, DOI 10.1001/archgenpsychiatry.2012.222; HAGSTADIUS S, 1989, BRAIN COGNITION, V10, P28, DOI 10.1016/0278-2626(89)90073-0; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; Hart S.D., 1995, MANUAL HARE PSYCHOPA; Hirono N, 2000, ARCH NEUROL-CHICAGO, V57, P861, DOI 10.1001/archneur.57.6.861; HIRSCHI T, 1983, AM J SOCIOL, V89, P552, DOI 10.1086/227905; HODGINS S, 1992, ARCH GEN PSYCHIAT, V49, P476, DOI 10.1001/archpsyc.1992.01820060056009; HODGKINS S, 1994, J FORENSIC PSYCHIATR, V5, P473, DOI 10.1080/09585189408410840; Johnson JG, 2000, AM J PSYCHIAT, V157, P1406, DOI 10.1176/appi.ajp.157.9.1406; Kamarajan C, 2005, CLIN NEUROPHYSIOL, V116, P1049, DOI 10.1016/j.clinph.2004.12.015; Kilroy E, 2011, J COGN SCI, V12, P151; Kretschmann HJ, 1985, NEUROANATOMY CRANIAL; Krona H, 2017, NORD J PSYCHIAT, V71, P102, DOI 10.1080/08039488.2016.1236400; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Lawrence AJ, 2009, PSYCHOPHARMACOLOGY, V207, P163, DOI 10.1007/s00213-009-1645-x; Leutgeb V, 2015, NEUROSCIENCE, V308, P194, DOI 10.1016/j.neuroscience.2015.09.011; Leutgeb V, 2016, NEUROSCI LETT, V610, P160, DOI 10.1016/j.neulet.2015.10.063; Liberg B, 2016, EUR J CLIN INVEST, V46, P658, DOI 10.1111/eci.12641; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Lund C, 2013, INT J LAW PSYCHIAT, V36, P250, DOI 10.1016/j.ijlp.2013.04.015; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Maas C, 2008, TRAUMA VIOLENCE ABUS, V9, P56, DOI 10.1177/1524838007311105; MARTIN AJ, 1991, J CEREBR BLOOD F MET, V11, P684, DOI 10.1038/jcbfm.1991.121; Martin MS, 2012, LAW HUMAN BEHAV, V36, P1, DOI 10.1037/h0093963; McGovern J., 2002, LEGAL CRIMINOL PSYCH, V7, P141, DOI DOI 10.1348/135532502760274756; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; Meijers J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00043; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Meynen G, 2016, J PSYCHIATR NEUROSCI, V41, P3, DOI 10.1503/jpn.150317; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097; MOFFITT TE, 1987, PSYCHIATRY, V50, P346, DOI 10.1080/00332747.1987.11024366; Morgan RD, 2012, LAW HUMAN BEHAV, V36, P37, DOI 10.1037/h0093964; Mori K, 1999, NEUROPSYCHOBIOLOGY, V39, P117, DOI 10.1159/000026570; Murray J, 2010, CAN J PSYCHIAT, V55, P633, DOI 10.1177/070674371005501003; Nadelhoffer T, 2012, NEUROETHICS-NETH, V5, P67, DOI 10.1007/s12152-010-9095-z; Nicholls TL, 2004, BEHAV SCI LAW, V22, P127, DOI 10.1002/bsl.579; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Nilsson T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025768; Pawliczek CM, 2013, NEUROIMAGE, V79, P264, DOI 10.1016/j.neuroimage.2013.04.104; Pedersen L., 2010, INT J FORENSIC MENTA, V9, P308, DOI [10.1080/14999013.2010.526681, DOI 10.1080/14999013.2010.526681]; Pflueger MO, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0447-4; Phillips HK, 2005, J INTERPERS VIOLENCE, V20, P833, DOI 10.1177/0886260504272898; Pitzer M, 2010, ACTA PSYCHIAT SCAND, V121, P52, DOI 10.1111/j.1600-0447.2009.01411.x; Poldrack RA, 2018, TRENDS COGN SCI, V22, P111, DOI 10.1016/j.tics.2017.11.003; R Development Core Team, 2009, R LANG ENV STAT COMP; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Schultz SK, 2002, J NEUROPSYCH CLIN N, V14, P19, DOI 10.1176/appi.neuropsych.14.1.19; Scornet E, 2015, ANN STAT, V43, P1716, DOI 10.1214/15-AOS1321; Sedgwick O, 2016, CNS SPECTRUMS, V21, P430, DOI 10.1017/S1092852915000723; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Sjostedt G., 2002, INT J FORENSIC MENT, V1, P179, DOI [DOI 10.1080/14999013.2002.10471172, https://doi.org/10.1080/14999013.2002.10471172]; SODERSTROM H, PSYCHIAT RES, V98, P29; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; Steele VR, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00425; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sweeten G, 2013, J YOUTH ADOLESCENCE, V42, P921, DOI 10.1007/s10964-013-9926-4; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025532; Tiihonen J, 2008, PSYCHIAT RES-NEUROIM, V163, P201, DOI 10.1016/j.pscychresns.2007.08.012; van der Gronde T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110672; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; VOLKOW ND, 1987, BRIT J PSYCHIAT, V151, P668, DOI 10.1192/bjp.151.5.668; Wahlund K, 2009, INT J LAW PSYCHIAT, V32, P266, DOI 10.1016/j.ijlp.2009.04.007; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Wolf A, 2018, EUR PSYCHIAT, V47, P88, DOI 10.1016/j.eurpsy.2017.07.011; Wu YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091249; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393; Zhang RB, 2017, BRAIN STRUCT FUNCT, V222, P3973, DOI 10.1007/s00429-017-1443-x; 2013, J CHILD PSYCHOL PSYC, V54, P619, DOI DOI 10.1111/JCPP.12006; 2014, INT J LAW PSYCHIAT, V37, P231, DOI DOI 10.1016/J.IJLP.2013.11.013; 1998, J PERS ASSESS, V70, P416, DOI DOI 10.1207/S15327752JPA7003_2; 2009, EUR J DEV PSYCHOL, V6, P100, DOI DOI 10.1080/17405620701669871; 2014, NEUROSCI BIOBEHAV R, V43, P118, DOI DOI 10.1016/J.NEUBIOREV.2014.03.014	129	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217127	10.1371/journal.pone.0217127	http://dx.doi.org/10.1371/journal.pone.0217127			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY3MG	31095633	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100077
J	Hosseinzadeh, S; Ramsey, J; Mann, M; Bennett, L; Hunter, WB; Shams-Bakhsh, M; Hall, DG; Heck, M				Hosseinzadeh, Saeed; Ramsey, John; Mann, Marina; Bennett, Lily; Hunter, Wayne B.; Shams-Bakhsh, Masoud; Hall, David G.; Heck, Michelle			Color morphology of Diaphorina citri influences interactions with its bacterial endosymbionts and 'Candidatus Liberibacter asiaticus'	PLOS ONE			English	Article							ABDOMINAL COLOR; HEMIPTERA PSYLLIDAE; WING DIMORPHISM; APHID; VECTOR; TRANSMISSION; POPULATION; HEMOCYANIN; SYMBIONTS; LIVIIDAE	Diaphorina citri is a vector of 'Candidatus Liberibacter asiaticus,' (CLas), associated with Huanglongbing, (HLB, or citrus greening) disease in citrus. D. citri exhibits three different color morph variants, blue, gray and yellow. Blue morphs have a greater capacity for long-distance flight as compared to non-blue morphs, but little else is known about how color morphology influences vector characteristics. In this study, we show that the color morphology of the insect is derived from pigmented cells of the fat body. Blue morphs acquire a lower level of CLas in their bodies from infected trees as compared to their gray and yellow con-specifics, referred to in this paper collectively as non-blue morphs. Accordingly, CLas titer in citrus leaves inoculated by non-blue insects was 6-fold higher than in leaves inoculated by blue insects. Blue color morphs harbored lower titers of Wolbachia and ' Candidatus Profftella armatura,' two of the D. citri bacterial endosymbionts. Expression of hemocyanin, a copper-binding oxygen transport protein responsible for the blue coloration of hemolymph of other arthropods and mollusks, was previously correlated with blue color morphology and is highly up-regulated in insects continuously reared on CLas infected citrus trees. Based on our results, we hypothesized that a reduction of hemocyanin expression would reduce the D. citri immune response and an increase in the titer of CLas would be observed. Surprisingly, a specific 3-fold reduction of hemocyanin-1 transcript levels using RNA silencing in blue adult D. citri morphs had an approximately 2-fold reduction on the titer of CLas. These results suggest that hemocyanin signaling from the fat body may have multiple functions in the regulation of bacterial titers in D. citri, and that hemocyanin is one of multiple psyllid genes involved in regulating CLas titer.	[Hosseinzadeh, Saeed; Ramsey, John; Mann, Marina; Bennett, Lily; Heck, Michelle] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hosseinzadeh, Saeed; Shams-Bakhsh, Masoud] Tarbiat Modares Univ, Dept Plant Pathol, Tehran, Iran; [Ramsey, John; Heck, Michelle] ARS, USDA, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Hunter, Wayne B.; Hall, David G.] ARS, USDA, Ft Pierce, FL USA; [Heck, Michelle] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA	Cornell University; Boyce Thompson Institute for Plant Research; Tarbiat Modares University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Cornell University	Heck, M (corresponding author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.; Heck, M (corresponding author), ARS, USDA, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.; Heck, M (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA.	mlc68@cornell.edu	hunter, wayne/AAB-9096-2020; Shamsbakhsh, Masoud/Z-5451-2019; Hosseinzadeh, saeed/T-6370-2018	hunter, wayne/0000-0001-8603-3337; Shamsbakhsh, Masoud/0000-0002-4336-7705; Hosseinzadeh, saeed/0000-0001-7414-8591; Heck, Michelle/0000-0003-0921-4489	California Citrus Research Board grants [5300-163, 5300-155]; USDA NIFA Specialty Crops Program [60-8062-6-002]; USDA Agricultural Research Service projects [8062-22410-006-00D, 6618-22320-001-00D]	California Citrus Research Board grants; USDA NIFA Specialty Crops Program; USDA Agricultural Research Service projects	Funding for this project was provided to Michelle Heck and David Hall by the California Citrus Research Board grants 5300-163 and 5300-155, USDA NIFA Specialty Crops Program grant 60-8062-6-002 and the USDA Agricultural Research Service projects 8062-22410-006-00D and 6618-22320-001-00D. The funding organizations played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Dossi FCA, 2014, MICROB ECOL, V68, P881, DOI 10.1007/s00248-014-0463-9; Ammar E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195804; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; California Citrus Pest and Disease Prevention Program, 2019, CAL DET HUANGL 160 P; California Department of Food and Agriculture, INT PEST PAN AN ALT; Casteel CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035191; Chin EM, 2014, CITROGRAPH MAGAZINE, P28; Cilia M, 2009, J Biomol Tech, V20, P201; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Decker H, 2004, DEV COMP IMMUNOL, V28, P673, DOI 10.1016/j.dci.2003.11.007; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Farhoudi F, 2014, J INSECT BEHAV, V27, P776, DOI 10.1007/s10905-014-9470-4; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Hall DG, 2018, J APPL ENTOMOL, V142, P97, DOI 10.1111/jen.12466; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hardie J, 2007, INSECT BIOCHEM MOLEC, V37, P886, DOI 10.1016/j.ibmb.2007.05.005; HONGOH Y, 1994, ZOOL SCI, V11, P731; Hosseinzadeh S, 2019, MICROB ECOL, V78, P206, DOI 10.1007/s00248-018-1290-1; Hunter WB, 2018, ADV INSECT PHYSIOL, V55, P163, DOI 10.1016/bs.aiip.2018.08.001; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jain M, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00171-17; Kruse A, 2018, J PROTEOME RES, V17, P2995, DOI 10.1021/acs.jproteome.8b00183; Kruse A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179531; Lee SY, 2003, J BIOL CHEM, V278, P7927, DOI 10.1074/jbc.M209239200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Mann M, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00889-17, 10.1128/iai.00889-17]; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Marriott CG, 1998, J INSECT PHYSIOL, V44, P113, DOI 10.1016/S0022-1910(97)00097-8; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; ONEILL KM, 1983, BEHAV ECOL SOCIOBIOL, V14, P39, DOI 10.1007/BF00366654; Pinheiro PV, 2017, MOL CELL PROTEOMICS, V16, pS230, DOI [10.1074/mcp.M116.063495, 10.1074/mcp.m116.063495]; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; Raiol- Junior LL, 2016, PLANT DIS, V101, P409; Ramsey JS, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160545; Ramsey JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140826; Saha SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032134; Sandre SL, 2007, EUR J ENTOMOL, V104, P745, DOI 10.14411/eje.2007.095; Simon JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021831; Srigiriraju L, 2010, PEST MANAG SCI, V66, P676, DOI 10.1002/ps.1929; Tahmasebi A, 2012, ACTA VIROL, V56, P139, DOI 10.4149/av_2012_02_139; Tiwari S, 2013, PEST MANAG SCI, V69, P535, DOI 10.1002/ps.3407; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Wenninger EJ, 2008, ANN ENTOMOL SOC AM, V101, P585, DOI 10.1603/0013-8746(2008)101[585:DASPIA]2.0.CO;2; Wenninger EJ, 2009, ANN ENTOMOL SOC AM, V102, P476, DOI 10.1603/008.102.0318; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zhang FM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00155; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; 2006, EVOL ECOL, V20, P235, DOI DOI 10.1007/S10682-006-6178-8; 2018, CURR OPIN VIROL, V33, P24, DOI DOI 10.1016/J.COVIRO.2018.07.007	61	13	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216599	10.1371/journal.pone.0216599	http://dx.doi.org/10.1371/journal.pone.0216599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095639	Green Published, gold, Green Submitted			2022-12-27	WOS:000468030100032
J	Jekayinoluwa, T; Gueye, B; Bhattacharjee, R; Osibanjo, O; Shah, T; Abberton, M				Jekayinoluwa, Temitope; Gueye, Badara; Bhattacharjee, Ranjana; Osibanjo, Oladele; Shah, Trushar; Abberton, Michael			Agromorphologic, genetic and methylation profiling of Dioscorea and Musa species multiplied under three micropropagation systems	PLOS ONE			English	Article							PLANT-GROWTH REGULATORS; DNA METHYLATION; CYTOSINE METHYLATION; STATISTICAL-ANALYSIS; AMPLIFICATION; DIFFERENTIATION; REGENERATION; CULTURES; HORMONES	Plant in vitro vegetative propagation using classical semi-solid culture medium is limited due to the low degree of automation, suboptimal nutrient availability and induced physiological stress which often reduce its efficiency. Temporary Immersion System (TIS) emerged as an innovative approach to optimize and eliminate the drawbacks associated with the conventional system of micropropagation. In this study, both Dioscorea and Musa spp. were subjected to conventional semi-solid culture media, complete immersion in shaking liquid culture media and TIS using RITA bioreactor. In vitro grown plantlets were screened for possible vegetative changes using agro-morphological descriptors while genetic and methylation differences were assessed using amplified fragment length polymorphism (AFLP) and methylation-sensitive amplification polymorphism (MSAP). In vitro results showed that the number of shoots produced in Musa spp. varied significantly (P <= 0.001) with the type of culture system. The highest mean shoot produced was observed with TIS (28.40) and the least using semi-solid culture medium (1.13). For Dioscorea spp., there was no significant interaction between the hormone combination and the culture system. However, the lowest mean shoot value (1.55) was observed in the semi-solid culture medium. Genetic analysis via AFLP using 15 primer pair combinations revealed that the 3 culture systems maintained genetic variation for Musa and Dioscorea spp. under in vitro and field conditions. Results showed 99% and 91% of the total bands were polymorphic under in vitro and field conditions respectively for Musa and 100% polymorphism for Dioscorea under in vitro and field conditions. Methylation investigation via MSAP using 12 primer pair combinations showed 25% and 46% polymorphic methylated-sensitive loci, 100% and 78% of non-methylated loci of the total bands generated under in vitro and field conditions respectively. Unmethylated (HPA+/MSP+) levels were highest in TIS (0.0842) as compared to CI (0.0227) and SS (0.0161) while full methylation or absence of target (HPA-/MSP-) was lowest in TIS (0.5890) and highest in SS (0.7138). For Dioscorea, 52% and 53% methylated sensitive loci and 100% non-methylated loci were polymorphic under in vitro and field conditions respectively. Although in vitro plant tissue culture techniques led to methylation at some loci of both species, there were no observable changes in the phenotype of both crops under field conditions. This also confirmed that not all methylation events lead to phenotypic changes.	[Jekayinoluwa, Temitope; Gueye, Badara; Bhattacharjee, Ranjana; Abberton, Michael] Int Inst Trop Agr, Ibadan, Oyo State, Nigeria; [Jekayinoluwa, Temitope; Osibanjo, Oladele] Univ Ibadan, Dept Chem, Ibadan, Oyo State, Nigeria; [Shah, Trushar] Int Inst Trop Agr, Nairobi, Kenya	CGIAR; International Institute of Tropical Agriculture (IITA); University of Ibadan	Abberton, M (corresponding author), Int Inst Trop Agr, Ibadan, Oyo State, Nigeria.	M.Abberton@cgiar.org	Bhattacharjee, Ranjana/AAN-1979-2020	Shah, Trushar/0000-0002-0091-7981; Jekayinoluwa, Temitope/0000-0001-6362-0053	IITA Genetic Resources Center	IITA Genetic Resources Center	The research was funded by the IITA Genetic Resources Center.	Aitken-Christie J, ISHS ACTA HORTICULTU, DOI [10.17660/ActaHortic1988.230.7, DOI 10.17660/ACTAHORTIC1988.230.7]; Anike FN, 2012, PLANT CELL TISS ORG, V111, P303, DOI 10.1007/s11240-012-0195-9; Arinaitwe G, 2000, SCI HORTIC-AMSTERDAM, V86, P13, DOI 10.1016/S0304-4238(00)00124-2; ARNHOLDTSCHMITT B, 1993, THEOR APPL GENET, V85, P793, DOI 10.1007/BF00225021; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P101, DOI 10.1007/s10725-011-9565-2; Baranek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126638; Bernabe-Antonio A, 2012, PLANT GROWTH REGUL, V68, P293, DOI 10.1007/s10725-012-9717-z; Berthouly M, 2005, LIQ CULT SYST VITR P, P165, DOI [DOI 10.1007/1-4020-3200-5_11, 10.1007/1-4020-3200-5_11]; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Buah JN, BIOTECHNOLOGY, V9, P343, DOI [10.3923/bioteh.2010.343.347, DOI 10.3923/BIOTEH.2010.343.347]; Businge E, 2017, FORESTS, V8, DOI 10.3390/f8060196; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Jova MC, 2011, BIOTECHNOL AGRON SOC, V15, P515; Channeliere S, ISHS ATA HORTICULTUR, V897, P11, DOI [10.17660/ActaHortic.2011.897.11, DOI 10.17660/ACTAHORTIC.2011.897.11]; Chen CC, 2014, F1000RESEARCH, V3, P298, DOI [10.12688/11000research.5919.1, DOI 10.12688/11000RESEARCH.5919.1]; Colwell R. K., 2009, PRINCETON GUIDE ECOL, V663, P257, DOI DOI 10.1515/9781400833023.257; Dann AL, 2011, PLANT CELL REP, V30, P631, DOI 10.1007/s00299-010-0983-9; Das S, MICROPROPAGATION DIO, DOI [10.5897/AJB2013.12191, DOI 10.5897/AJB2013.12191]; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Ezeibekew IO, 2009, J MOL GENET, V1, P18; Gaspar T, 1996, IN VITRO CELL DEV-PL, V32, P272; Georgieva L., 2016, Bulgarian Journal of Agricultural Science, V22, P745; GUPTA PP, 1986, PLANT CELL TISS ORG, V6, P33, DOI 10.1007/BF00037756; Hafiz IA, 2001, ACTA PHYSIOL PLANT, V23, P491, DOI 10.1007/s11738-001-0060-7; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Hui AV, 2013, J PLANT NUTR, V36, P529, DOI 10.1080/01904167.2012.748068; Hvoslef-Eide AK, 2005, LIQUID CULTURE SYSTE, P41; IPGRI/ IITA, 1997, DESCR YAM DIOSC SPP; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JARRET RL, 1985, SCI HORTIC-AMSTERDAM, V25, P137, DOI 10.1016/0304-4238(85)90085-8; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kana EBG, 2010, BIOTECHNOL BIOTEC EQ, V24, P2149, DOI 10.2478/V10133-010-0093-4; Kitimu SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00590; Lai CC, 2005, J PLANT PHYSIOL, V162, P355, DOI 10.1016/j.jplph.2004.07.015; Li W, 2007, IN VITRO CELL DEV, V38, P285; LOSCHIAVO F, 1989, THEOR APPL GENET, V77, P325, DOI 10.1007/BF00305823; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Muhammad A, 2007, HORTSCIENCE, V42, P1253, DOI 10.21273/HORTSCI.42.5.1253; Murashige T, 1962, PHYSL PLANTARUM; Ngomuo M., 2013, American Journal of Plant Sciences, V4, P2174; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Polzin F, 2014, IN VITRO CELL DEV-PL, V50, P210, DOI 10.1007/s11627-013-9552-6; Rathore MS, 2015, PLANT GROWTH REGUL, V75, P11, DOI 10.1007/s10725-014-9926-8; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Rico L, 2014, PLANT BIOLOGY, V16, P419, DOI 10.1111/plb.12049; SAHAY NS, CURRENT SCI, V78, P126; SAS Institute Inc, 2007, SAS ONLINEDOC 9 2; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; SIMONTON W, 1991, PLANT CELL TISS ORG, V27, P211, DOI 10.1007/BF00041292; Steinmacher DA, 2011, ANN BOT-LONDON, V108, P1463, DOI 10.1093/aob/mcr033; Teisson C, 1995, CURR PLANT SCI BIOT, V22, P105; TISSERAT B, 1985, PLANT CELL TISS ORG, V5, P107, DOI 10.1007/BF00040307; Vinson C, 2012, EPIGENOMICS-UK, V4, P655, DOI [10.2217/EPI.12.55, 10.2217/epi.12.55]; Vroh-Bi I, 2011, PLANT MOL BIOL REP, V29, P440, DOI 10.1007/s11105-010-0250-9; Vuylsteke D, 1998, SHOOT TIP CULTURE PR, P82; WATSON JC, 1987, J MOL BIOL, V193, P15, DOI 10.1016/0022-2836(87)90622-X; Yan HB, 2011, AFR J BIOTECHNOL, V10, P19444, DOI 10.5897/AJB11.2684; 2012, BIOINFORMATICS, V28, P2537, DOI DOI 10.1093/BIOINFORMATICS/BTS460; 2005, PLANT CELL TISSUE OR, V82, P57, DOI DOI 10.1007/S11240-004-6746-Y; 1995, NUCLEIC ACIDS RES, V23, P4407, DOI DOI 10.1093/NAR/23.21	60	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216717	10.1371/journal.pone.0216717	http://dx.doi.org/10.1371/journal.pone.0216717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095626	Green Submitted, Green Published, gold			2022-12-27	WOS:000468030100042
J	Tu, CF; Chuang, CK; Hsiao, KH; Chen, CH; Chen, CM; Peng, SH; Su, YH; Chiou, MT; Yen, CH; Hung, SW; Yang, TS; Chen, CM				Tu, Ching-Fu; Chuang, Chin-kai; Hsiao, Kai-Hsuan; Chen, Chien-Hong; Chen, Chi-Min; Peng, Su-Hei; Su, Yu-Hsiu; Chiou, Ming-Tang; Yen, Chon-Ho; Hung, Shao-Wen; Yang, Tien-Shuh; Chen, Chuan-Mu			Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression	PLOS ONE			English	Article							ISOLATE US/IOWA/18984/2013; AMINOPEPTIDASE-N; SIALIC ACIDS; EDITED PIGS; INFECTION; RECEPTOR; CORONAVIRUS; OUTBREAK; BINDING; SWINE	The porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene is mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques. This hypothesis was tested by using KO piglets that were challenged with PEDV. Two single-guide RNAs targeting the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertilized eggs. Four live founders generated and proven to be biallelic KO, lacking detectable N-glycolylneuraminic acid (NGNA). The founders were bred, and homozygous offspring were obtained. Two-day-old (in exps. I, n = 6, and III, n = 15) and 3-day-old (in exp. II, n = 9) KO and wild- type (WT, same ages in respective exps.) piglets were inoculated with TCID50 1x10(3) PEDV and then fed 20 mL of infant formula (in exps. I and II) or sow's colostrum (in exp. III) every 4 hours. In exp. III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution. At 72 hours post-PEDV inoculation (hpi), the animals either deceased or euthanized were necropsied and intestines were sampled. In all 3 experiments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO. In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi. Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte vacuolization was observed in KO piglets. In exp. II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II. These results suggest that porcine CMAH KO with nullified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.	[Tu, Ching-Fu; Chuang, Chin-kai; Hsiao, Kai-Hsuan; Chen, Chien-Hong; Peng, Su-Hei; Su, Yu-Hsiu; Yen, Chon-Ho; Yang, Tien-Shuh] Agr Technol Res Inst, Anim Technol Labs, Div Anim Technol, Hsinchu, Taiwan; [Hsiao, Kai-Hsuan; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chen, Chi-Min] Agr Technol Res Inst, Div Anim Med, Anim Technol Labs, Hsinchu, Taiwan; [Chiou, Ming-Tang] Natl Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung, Taiwan; [Hung, Shao-Wen] Agr Technol Res Inst, Anim Technol Labs, Div Anim Ind, Hsinchu, Taiwan; [Yang, Tien-Shuh] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Yilan, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsinh Univ, iEGG & Anim Biotechnol Ctr, Taichung, Taiwan; [Chen, Chien-Hong] Lee Womens Hosp, Reprod Med Ctr, Taichung, Taiwan; [Chen, Chi-Min] Chao Kun Biotech Ltd, Taipei, Taiwan	Agricultural Technology Research Institute; National Chung Hsing University; Agricultural Technology Research Institute; Agricultural Technology Research Institute; National Ilan University	Tu, CF (corresponding author), Agr Technol Res Inst, Anim Technol Labs, Div Anim Technol, Hsinchu, Taiwan.	cftu@mail.atri.org.tw	Chen, Chien-Hong/GOP-2714-2022; Chen, Chuan-Mu/K-7049-2013	Chen, Chien-Hong/0000-0002-6352-3437; Chen, Chuan-Mu/0000-0003-2461-9150	Ministry of Science and Technology, Executive Yuan, Taiwan, ROC [MOST 104-2321-B-866-001, MOST 105-2321-B-886-002, MOST 106-2321-B-866-002]	Ministry of Science and Technology, Executive Yuan, Taiwan, ROC	The financial assistances (MOST 104-2321-B-866-001, MOST 105-2321-B-886-002 and MOST 106-2321-B-866-002, all to CFT) were provided by the Ministry of Science and Technology, Executive Yuan, Taiwan, ROC to support the research and salaries for the author of [YHS]. After approval, the granting institution has no any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002; Annamalai T, 2015, VET IMMUNOL IMMUNOP, V168, P193, DOI 10.1016/j.vetimm.2015.09.006; Burkard C, 2018, J VIROL, V92, DOI [10.1128/JVI.00415-18, 10.1128/jvi.00415-18]; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Chen C., 2017, CONTROL PEDV TAIWAN; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chuang CK, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2321; Chuang CK, 2017, ANIM BIOTECHNOL, V28, P174, DOI 10.1080/10495398.2016.1246453; Chuang Ck, 2016, J CHIN ANIM SCI, V45, P223; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong YY, 2015, VIROLOGY, V478, P1, DOI 10.1016/j.virol.2015.01.020; Cooper DKC, 2016, J PATHOL, V238, P288, DOI 10.1002/path.4635; Council N.R., 2012, NUTR REQ SWIN; Deng F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030055; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hernaez B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005595; Ju XD, 2018, J CELL BIOCHEM, V119, P52, DOI 10.1002/jcb.26154; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kamau AN, 2017, VIRUS RES, V227, P150, DOI 10.1016/j.virusres.2016.10.004; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li BX, 2007, VIROLOGY, V365, P166, DOI 10.1016/j.virol.2007.03.031; Lin CN, 2014, J VET MED SCI, V76, P1297, DOI 10.1292/jvms.14-0098; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Madson DM, 2016, VET PATHOL, V53, P44, DOI 10.1177/0300985815591080; Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Oh J, 2014, ARCH VIROL, V159, P2977, DOI 10.1007/s00705-014-2163-7; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Popescu L, 2017, VIROLOGY, V501, P102, DOI 10.1016/j.virol.2016.11.012; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; RHOADS JM, 1986, PEDIATR RES, V20, P879, DOI 10.1203/00006450-198609000-00015; Schultze B, 1996, J VIROL, V70, P5634, DOI 10.1128/JVI.70.8.5634-5637.1996; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Su YH, 2015, ANIM BIOTECHNOL, V26, P279, DOI 10.1080/10495398.2015.1027774; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Sun RQ, 2014, SCI WORLD J, DOI 10.1155/2014/208439; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XY, 2019, ARCH VIROL, V164, P83, DOI 10.1007/s00705-018-4061-x; Whitworth KM, 2019, TRANSGENIC RES, V28, P21, DOI 10.1007/s11248-018-0100-3; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Yang HQ, 2018, ANTIVIR RES, V151, P63, DOI 10.1016/j.antiviral.2018.01.004	52	13	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217236	10.1371/journal.pone.0217236	http://dx.doi.org/10.1371/journal.pone.0217236			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141512	Green Submitted, gold, Green Published			2022-12-27	WOS:000469323000046
J	Kashiyama, N; Miyagawa, S; Fukushima, S; Kawamura, T; Kawamura, A; Yoshida, S; Nakamura, Y; Harada, A; Masuda, H; Toda, K; Asahara, T; Sawa, Y				Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Nakamura, Yuki; Harada, Akima; Masuda, Haruchika; Toda, Koichi; Asahara, Takayuki; Sawa, Yoshiki			Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANSPLANTATION; IMMUNOSUPPRESSION; SURVIVAL; THERAPY	Allogeneic transplantation of induced pluripotent stem cell (iPSC)-derived cardiomyocytes is a promising treatment for cardiac diseases, although immune rejection by the recipient poses a concern. In this study, we aimed to investigate whether concomitant transplantation of vasculogenically conditioned peripheral blood mononuclear cells, which are otherwise immunosuppressive, may enhance graft survival. Luciferase-transduced, iPSC-derived cardiomyocytes from C57BL/6 mice were transplanted to the dorsal subcutaneous space of syngeneic C57BL/6 mice (n = 19), allogeneic Balb/c mice treated with (n = 20) or without (n = 20) immunosuppressants, and those injected with vasculogenically conditioned peripheral blood mononuclear cells (n = 20). Although graft survival, assessed by bioluminescence, was comparable among the groups initially, it improved significantly at days 7 and 10 in allogeneic transplanted mice treated with vasculogenically conditioned peripheral blood mononuclear cells than in others (P < 0.01). Our results proved that cell-based immunosuppression may boost clinical outcomes from allogeneic cell therapy.	[Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Nakamura, Yuki; Harada, Akima; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Masuda, Haruchika; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa, Japan	Osaka University; Tokai University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Miyagawa, Shigeru/0000-0003-0015-6569	AMED Japan Regenerative Medicine Project [15bk0104012h003]	AMED Japan Regenerative Medicine Project	This work was supported by AMED Japan Regenerative Medicine Project Grant numbers 15bk0104012h003 (https://www.amed.go.jp/en/index.html) to T.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Shinya Yamanaka and Keisuke Okita of the Center for iPS Cell Research and Application, Kyoto University, Japan who kindly provided murine iPSCs. We also thank Seiko Eiraku and Hitomi Nishinaka for technical assistance. This work was supported by AMED Japan Regenerative Medicine Project (Grant 15bk0104012h003).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Cai JC, 2010, TRANSPLANTATION, V90, P1511, DOI 10.1097/TP.0b013e3181fecfcb; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hotta K, 2018, TRANSPLANTATION, V102, pE128, DOI 10.1097/TP.0000000000002078; Ichise H, 2017, STEM CELL REP, V9, P853, DOI 10.1016/j.stemcr.2017.07.020; Kashiyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165748; Katabathina V, 2016, RADIOL CLIN N AM, V54, P303, DOI 10.1016/j.rcl.2015.09.009; Kawamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19464; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kawamura T, 2016, STEM CELL REP, V6, P312, DOI 10.1016/j.stemcr.2016.01.012; Kawamura T, 2015, STEM CELL TRANSL MED, V4, P1258, DOI 10.5966/sctm.2015-0029; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Manilay JO, 1998, TRANSPLANTATION, V66, P96, DOI 10.1097/00007890-199807150-00015; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; Michael M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/608951; Mizukami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098319; Morizane A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00926-5; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Sasaki H, 2015, TRANSPLANTATION, V99, P2301, DOI 10.1097/TP.0000000000000875; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Soares MA, 2018, AM J TRANSPLANT, V18, P1657, DOI 10.1111/ajt.14668; Sugita S, 2016, STEM CELL REP, V7, P635, DOI 10.1016/j.stemcr.2016.08.010	28	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217076	10.1371/journal.pone.0217076	http://dx.doi.org/10.1371/journal.pone.0217076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136599	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300016
J	Ruggieri, M; Berini, C; Ducasa, N; Malkovsky, M; Fisch, P; Biglione, M				Ruggieri, Matias; Berini, Carolina; Ducasa, Nicolas; Malkovsky, Miroslav; Fisch, Paul; Biglione, Mirna			Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective view	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HTLV-II INFECTIONS; BLOOD-DONORS; DIFFERENTIAL-DIAGNOSIS; MULTIPLEX PCR; EPIDEMIOLOGY; PREVALENCE; TRANSMISSION; MYELOPATHY; ASSAY	Human T-cell lymphotropic virus (HTLV) belongs to a larger group of primate T-cell lymphotropic viruses (PTLVs) within the family Retroviridae. It is estimated that 10 to 20 million people worldwide may be infected with HTLV-1. Although most of them are asymptomatic, around 5% of infected individuals may develop either HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) or Adult T-cell Leukaemia/Lymphoma (ATLL). Public Health authorities in many countries have implemented routine blood-donor tests for HTLV-specific antibodies; but this is not the case for Germany since the reported prevalence is very low (7/100,000). With the aim to evaluate retrospectively the presence of HTLV-1 among oncology patients in this country, samples stored at the Universitatsklinikum Freiburg, were analyzed. For this purpose, two different nested-PCR (n-PCR) protocols have been modified and set up for HTLV-1 detection. One positive case was detected by n-PCR among 406 samples (0,25%) in a period of 5 years (2008-2012) corresponding to a T-Cell Lymphoma. Despite the low prevalence, this virus is circulating in Germany, probably due to the increasing numbers of immigrants in these last years. Physicians should consider HTLV-1 infection and suspect it taking in account the ethnic and relation to endemic regions regardless the patient's residence.	[Ruggieri, Matias; Fisch, Paul] Univ Klinikum Freiburg, Inst Klin Pathol, Freiburg, Germany; [Berini, Carolina; Ducasa, Nicolas; Biglione, Mirna] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Malkovsky, Miroslav] UW Sch Med & Publ Hlth, Madison, WI USA	University of Freiburg; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Wisconsin System	Ruggieri, M (corresponding author), Univ Klinikum Freiburg, Inst Klin Pathol, Freiburg, Germany.	matias.ruggieri@uniklinik-freiburg.de		Malkovsky, Miroslav/0000-0002-5056-5224; Ruggieri, Matias/0000-0002-5959-9092	International Cooperation Project MINCYT-BMBF 2014 (Bilateral project ArgentinaGermany) [AL/14/08-01DN15025]; National Scientific and Technical Research Council [CONICET: PICT 20161033]; German Academic Exchange Service (DAAD); University of Freiburg; German Research Foundation (DFG)	International Cooperation Project MINCYT-BMBF 2014 (Bilateral project ArgentinaGermany); National Scientific and Technical Research Council; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are grateful for the funding support by the International Cooperation Project MINCYT-BMBF 2014 (Bilateral project ArgentinaGermany AL/14/08-01DN15025) (MB and PF); National Scientific and Technical Research Council (CONICET: PICT 20161033) (MB) and German Academic Exchange Service (DAAD) for the scholarship (MR). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding program Open Access Publishing. The funders had no role in the study design, the collection, analysis and interpretation of the data, nor in the decision to publish, or preparation of the manuscript.	Biglione MM, 2005, AIDS RES HUM RETROV, V21, P1, DOI 10.1089/aid.2005.21.1; Canepa C, 2015, VIRUSES-BASEL, V7, P5643, DOI 10.3390/v7112897; ec. europa. eu [Internet], EUR COMM MAPP MOR ST; Egan JF, 1999, AIDS RES HUM RETROV, V15, P699, DOI 10.1089/088922299310782; Einsiedel L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006281; Einsiedel L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3366-5; Ellerbrok H, 1998, AIDS RES HUM RETROV, V14, P1199, DOI 10.1089/aid.1998.14.1199; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; eur- lex. europa. eu [Internet], EUROPEAN UNION LAW; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Glowacka I, 2013, CLIN INFECT DIS, V57, P1417, DOI 10.1093/cid/cit545; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Heneine W, 1996, J ACQ IMMUN DEF SYND, V13, pS236, DOI 10.1097/00042560-199600001-00035; HENEINE W, 1992, J CLIN MICROBIOL, V30, P1605, DOI 10.1128/JCM.30.6.1605-1607.1992; HENRARD DR, 1995, J CLIN MICROBIOL, V33, P1735, DOI 10.1128/JCM.33.7.1735-1738.1995; Heredia A, 1996, CLIN DIAGN VIROL, V7, P85, DOI 10.1016/S0928-0197(96)00255-3; Hitzler W, PREVALENCE HTLV 1 2, P211; Hohn O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183496; Karimi G, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0693-9; KITZE B, 1992, CLIN INVESTIGATOR, V70, P1013; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Tagaya Y, 2019, F1000RESEARCH, P8, DOI [10.12688/f1000research.17047.1, DOI 10.12688/F1000RESEARCH.17047.1]; Toro C, 2003, TRANSPLANTATION, V75, P102, DOI 10.1097/00007890-200301150-00019; TUKE PW, 1992, J VIROL METHODS, V40, P163, DOI 10.1016/0166-0934(92)90065-L; Umeki K, 2017, CLIN LAB, V63, P227, DOI 10.7754/Clin.Lab.2016.160501; VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337; Vrielink H, 2004, TRANSFUS MED REV, V18, P46, DOI 10.1016/j.tmrv.2003.10.004; WATTEL E, 1992, J INFECT DIS, V165, P369, DOI 10.1093/infdis/165.2.369	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217560	10.1371/journal.pone.0217560	http://dx.doi.org/10.1371/journal.pone.0217560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136642	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300050
J	Clucas, GV; Kerr, LA; Cadrin, SX; Zemeckis, DR; Sherwood, GD; Goethel, D; Whitener, Z; Kovach, AI				Clucas, G., V; Kerr, L. A.; Cadrin, S. X.; Zemeckis, D. R.; Sherwood, G. D.; Goethel, D.; Whitener, Z.; Kovach, A., I			Adaptive genetic variation underlies biocomplexity of Atlantic Cod in the Gulf of Maine and on Georges Bank	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; GADUS-MORHUA; WESTERN GULF; GENOMIC DIVERGENCE; STOCK IDENTIFICATION; STATIONARY ECOTYPES; SPATIAL STRUCTURE; SNP ANALYSIS; FRESH-WATER; US WATERS	Atlantic cod (Gadus morhua) populations in the Gulf of Maine (GoM) are at a fraction of their historical abundance, creating economic hardships for fishermen and putting at risk the genetic diversity of the remaining populations. An understanding of the biocomplexity among GoM populations will allow for adaptive genetic diversity to be conserved to maximize the evolutionary potential and resilience of the fishery in a rapidly changing environment. We used restriction-site-associated DNA sequencing (RADseq) to characterize the population structure and adaptive genetic diversity of five spawning aggregations from the western GoM and Georges Bank. We also analyzed cod caught in the eastern GoM, an under-sampled area where spawning aggregations have been extirpated. Using 3,128 single nucleotide polymorphisms (SNPs), we confirmed the existence of three genetically separable spawning groups: (1) winter spawning cod from the western GoM, (2) spring spawning cod, also from the western GoM, and (3) Georges Bank cod. Non-spawning cod from the eastern GoM could not be decisively linked to either of the three spawning groups and may represent a unique component of the resource, a mixed sample, or cod from other unsampled source populations. The genetic differentiation among the three major spawning groups was primarily driven by loci putatively under selection, particularly loci in regions known to contain genomic inversions on linkage groups (LG) 7 and 12. These LGs have been found to be linked to thermal regime in cod across the Atlantic, and so it is possible that variation in timing of spawning in western GoM cod has resulted in temperature-driven adaptive divergence. This complex population structure and adaptive genetic differentiation could be crucial to ensuring the long-term productivity and resilience of the cod fishery, and so it should be considered in future management plans.	[Clucas, G., V; Kovach, A., I] Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; [Kerr, L. A.; Sherwood, G. D.; Whitener, Z.] Gulf Maine Res Inst, Portland, ME USA; [Cadrin, S. X.] Univ Massachusetts Dartmouth, Sch Marine Sci & Technol, New Bedford, MA USA; [Zemeckis, D. R.] Rutgers State Univ, Dept Agr & Nat Resources, Toms River, NJ USA; [Goethel, D.] FV Ellen Diane, Hampton, NH USA	University System Of New Hampshire; University of New Hampshire; Gulf of Maine Research Institute; University of Massachusetts System; University Massachusetts Dartmouth; Rutgers State University New Brunswick	Clucas, GV; Kovach, AI (corresponding author), Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA.	gemma.clucas@cornell.edu; adrienne.kovach@unh.edu	Clucas, Gemma/ABF-9073-2021	Goethel, David/0000-0003-1525-6060; Kovach, Adrienne/0000-0002-6791-0610; Clucas, Gemma/0000-0002-4305-1719	National Oceanic and Atmospheric Administration Saltonstall-Kennedy grant [NA14NMF4270014]; National Oceanic and Atmospheric Administration College Sea Grant program through the New Hampshire Sea Grant project R/SFA-3 [NA14OAR4170083]	National Oceanic and Atmospheric Administration Saltonstall-Kennedy grant; National Oceanic and Atmospheric Administration College Sea Grant program through the New Hampshire Sea Grant project R/SFA-3	This work was funded by a National Oceanic and Atmospheric Administration Saltonstall-Kennedy grant (NA14NMF4270014; LK, GS, SC, AK, DG; https://www.fisheries.noaa.gov/national/funding-and-financial-services/saltonstall-kennedy-grant-program-application-process-and-deadlines) and the National Oceanic and Atmospheric Administration College Sea Grant program through the New Hampshire Sea Grant project R/SFA-3 (AK, SC, LK, #NA14OAR4170083, https://seagrant.unh.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by National Oceanic and Atmospheric Administration Saltonstall-Kennedy Grant number NA14NMF4270014 and the National Oceanic and Atmospheric Administration College Sea Grant program through the New Hampshire Sea Grant project R/SFA-3 (#NA14OAR4170083). We are grateful to Yong Chen, Anna Henry, Mattie Rodrigue, John Carlucci, Robin Alden, and Ted Ames for cod samples from the sentinel fishery, and the Massachusetts Department of Marine Fisheries sample collection in the Gulf of Maine. We also thank Ted Ames and Karen Alexander for their inspiration and insightful conversations about cod in the eastern Gulf of Maine and David Berlinsky for introducing us to the spring and winter spawners in the Gulf of Maine. Kris Wojtusik and Katie Shink provided assistance with sample preparation in the laboratory.	Alexander KE, 2009, FISH FISH, V10, P428, DOI 10.1111/j.1467-2979.2009.00334.x; Ames EP, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:ACSSIT]2.0.CO;2; Andrews S., 2010, FASTQC QUALITY CONTR; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barney BT, 2017, BMC GENOMICS, V18, P1, DOI [10.1186/s12864-016-3406-7, DOI 10.1186/S12864-016-3406-7]; Barth JMI, 2017, MOL ECOL, V26, P4452, DOI 10.1111/mec.14207; Begg GA, 1999, FISH RES, V43, P141, DOI 10.1016/S0165-7836(99)00071-5; Benestan L, 2016, MOL ECOL, V25, P5073, DOI 10.1111/mec.13811; Berg PR, 2017, HEREDITY, V119, P418, DOI 10.1038/hdy.2017.54; Berg PR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23246; Berg PR, 2015, GENOME BIOL EVOL, V7, P1644, DOI 10.1093/gbe/evv093; Berrien P., 1999, NOAA TECH REP, V145, P310; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bradbury IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106380; Bradbury IR, 2013, EVOL APPL, V6, P450, DOI 10.1111/eva.12026; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; Burnett J, 1989, NMFSFNEC76 NOAA, V76, P14; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Churchill JH, 2011, FISH OCEANOGR, V20, P32, DOI 10.1111/j.1365-2419.2010.00563.x; Conroy CW, 2018, ICES J MAR SCI, V75, P122, DOI 10.1093/icesjms/fsx101; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; Dean MJ, 2014, ICES J MAR SCI, V71, P1474, DOI 10.1093/icesjms/fsu040; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Di Gaetano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091237; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eaton D. A. R., 2015, IPYRAD INTERACTIVE A; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Goode G.B., 1887, FISHERIES FISHERY IN; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Harrisson KA, 2014, EVOL APPL, V7, P1008, DOI 10.1111/eva.12149; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hemmer-Hansen J, 2013, MOL ECOL, V22, P2653, DOI 10.1111/mec.12284; Henry A. M., 2013, E COMMUNICATION, P130; Herbinger CM, 1997, CAN J FISH AQUAT SCI, V54, P11, DOI 10.1139/cjfas-54-S1-11; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Howe A, 2002, TR12 MASS DIV MAR FI; Howell WH, 2008, FISH RES, V91, P123, DOI 10.1016/j.fishres.2007.11.021; HUDSON RR, 1992, GENETICS, V132, P583; Hunt J, 1999, FISH B, V97; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Jombart T, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jorde PE, 2015, MOL ECOL, V24, P1742, DOI 10.1111/mec.13158; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kerr LA, 2014, ICES J MAR SCI, V71, P1366, DOI 10.1093/icesjms/fsu113; Kerr LA, 2010, ICES J MAR SCI, V67, P1631, DOI 10.1093/icesjms/fsq053; Kirubakaran TG, 2016, MOL ECOL, V25, P2130, DOI 10.1111/mec.13592; Klein ES, 2017, REV FISH BIOL FISHER, V27, P317, DOI 10.1007/s11160-016-9444-z; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Kovach AI, 2010, MAR ECOL PROG SER, V410, P177, DOI 10.3354/meps08612; Lage C, 2004, FISH B-NOAA, V102, P289; Langton R.W., 1997, B NATL RES I AQUAC S, P101; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Li H., 2013, ARXIV PREPRINT; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Loehrke JL, 2013, MOVEMENT PATTERNS AT; Lough RG, 2006, MAR ECOL PROG SER, V310, P193, DOI 10.3354/meps310193; Love RR, 2016, MOL ECOL, V25, P5889, DOI 10.1111/mec.13888; Lowry DB, 2017, MOL ECOL RESOUR, V17, P366, DOI 10.1111/1755-0998.12677; Momigliano P, 2017, HEREDITY, V119, P142, DOI 10.1038/hdy.2017.21; NEFSC (Northeast Fisheries Science Centre), OP ASS 19 NE GROUNDF; Nicotra AB, 2015, CONSERV BIOL, V29, P1268, DOI 10.1111/cobi.12522; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pespeni MH, 2013, MOL ECOL, V22, P3580, DOI 10.1111/mec.12337; Peterson DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4696; Picq S, 2016, ECOL EVOL, V6, P2109, DOI 10.1002/ece3.2028; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Righton DA, 2010, MAR ECOL PROG SER, V420, P1, DOI 10.3354/meps08889; Robichaud D, 2004, FISH FISH, V5, P185, DOI 10.1111/j.1467-2679.2004.00141.x; Rodrigue M., 2017, THESIS; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Ruzzante DE, 1998, MOL ECOL, V7, P1663, DOI 10.1046/j.1365-294x.1998.00497.x; Saba VS, 2016, J GEOPHYS RES-OCEANS, V121, P118, DOI 10.1002/2015JC011346; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Sherwood GD, 2010, ICES J MAR SCI, V67, P1640, DOI 10.1093/icesjms/fsq094; Siceloff L, 2013, FISH RES, V141, P31, DOI 10.1016/j.fishres.2012.04.001; Sinclair-Waters M, 2017, MOL ECOL, P1, DOI [10.1111/mec.13947, DOI 10.1111/MEC.13947]; Sodeland M, 2016, GENOME BIOL EVOL, V8, P1012, DOI 10.1093/gbe/evw057; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Tallack S. M., 2011, P 2 INT S ADV FISH T, P1; Tallack SML, 2009, FISH RES, V99, P137, DOI 10.1016/j.fishres.2009.05.014; TALLACK SML, 2009, P WORKSH ID FUT RES; Team RC, 2016, R LANG ENV STAT COMP; Therkildsen NO, 2013, MOL ECOL, V22, P2424, DOI 10.1111/mec.12260; Therkildsen NO, 2013, EVOL APPL, V6, P690, DOI 10.1111/eva.12055; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Thomas AC, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.240; Torresen OK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3448-x; Van Wyngaarden M, 2017, EVOL APPL, V10, P102, DOI 10.1111/eva.12432; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weiss E, 2005, POPULATION STRUCTURE; Wirgin I, 2007, T AM FISH SOC, V136, P375, DOI 10.1577/T06-068.1; Wise J. P., 1963, Fishery Bulletin United States, V63, P189; Zemeckis DR, 2017, ICES J MAR SCI, V74, P1780, DOI 10.1093/icesjms/fsw190; Zemeckis DR, 2014, ICES J MAR SCI, V71, P1490, DOI 10.1093/icesjms/fsu032; Zemeckis DR, 2014, ICES J MAR SCI, V71, P1356, DOI 10.1093/icesjms/fsu117	110	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216992	10.1371/journal.pone.0216992	http://dx.doi.org/10.1371/journal.pone.0216992			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125344	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700012
J	Filippi, MG; Lima, MDF; Paes, AC; Aleixo, ASC; Oba, E; de Souza, FF; Takahira, RK; Lourenco, MLG				Filippi, Mauricio Gianfranchesco; Ferreira Lima, Mayra de Castro; Paes, Antonio Carlos; Cruz Aleixo, Amanda Satita; Oba, Eunice; de Souza, Fabiana Ferreira; Takahira, Regina Kiomi; Gomes Lourenco, Maria Lucia			Evaluation of heart rate variability and behavior of electrocardiographic parameters in dogs affected by chronic Monocytic Ehrlichiosis	PLOS ONE			English	Article							CARDIAC TROPONIN-I; SUDDEN-DEATH; MYOCARDITIS; ASSAY; PATHOGENESIS; CANIS	Canine Monocytic Ehrlichiosis (CME) is a systemic disease prevalent in the entire world caused by the obligate intracellular bacteria Ehrlichia canis. The occurrence of myocarditis with a high prevalence of arrhythmias in dogs affected by this disease in the cytopenic phase has already been proven. This study aims to evaluate the concentrations of CK MB, cTnI and NT-proBNP in dogs affected by Ehrlichia canis in the chronic phase since the intense stimulation of the immune system can lead to myocarditis; to evaluate if the condition can lead to arrhythmic events and, if so, define their frequency and classification through conventional and ambulatory electrocardiogram tests (Holter method) for a period of 24 hours; to analyze heart rate variability in the time domain and whether the condition can lead to autonomic imbalance; and to determine the survival rate of affected dogs, identifying possible risk factors for mortality at this stage of the disease. For this purposes, we evaluated clinical, hematological and biochemical data, as well as the concentrations of cardiac biomarkers Creatine Kinase-MB (CK MB), Cardiac Troponin I (cTnI) and N-terminal pro-peptide natriuretic type B (NT-proBNP). We also analyzed conventional and ambulatory electrocardiography (24-hour Holter) and heart rate variability (HRV) in 20 dogs afflicted by cytopenic CME in the chronic phase of the disease (G1) and compared the results with a control group comprised of ten healthy dogs (G2). G1 was monitored during the treatment for 28 days, during which eight (8) of the 20 infected dogs died (40%). Anorexia, vomiting, fatigue, hypoalbuminemia, heart murmurs and increased concentrations of alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were common clinical signs. The mean concentrations of cTnI and CKMB were significant (0.24 ng / mL +/- 0.5, 229 +/- 205 IU / mL) in comparison to the control group (0.042 +/- 0.07 ng / mL, 126 +/- 46.12 IU / mL). No significant differences were observed between NT-proBNP concentrations in G1 (135.46 +/- 29.7) and G2 (138.28 +/- 19.77). Nine of the twenty dogs (45%) presented a high frequency of arrhythmias during 24-hour recording, ranging from first and second-degree atrioventricular block, ventricular and supraventricular ectopic events and sinus tachycardia. No sinus pause was observed. One dog had 120 episodes of unsustained ventricular tachycardia and two episodes of sustained ventricular tachycardia. The short-term and long-term HRV data, represented by SDNN (ms), SDANN (ms) and pnn50 (%) were also significant lower (83 +/- 65, 56.05 +/- 37.3 and 14.56 +/- 20, respectively) in comparison to the healthy animals (268 +/- 74.6, 168.3 +/- 39.14 and 55.87 +/- 12.8, respectively). These results suggest that cytopenic CME is characterized by an arrhythmogenic component and intense stimulation of the sympathetic autonomic nervous system in the heart, reflecting an imbalance in the activity of the ANS.	[Filippi, Mauricio Gianfranchesco; Cruz Aleixo, Amanda Satita; Takahira, Regina Kiomi; Gomes Lourenco, Maria Lucia] Sao Paulo State Univ Unesp, Dept Vet Clin, Sch Vet Med & Anim Sci, Botucatu, SP, Brazil; [Ferreira Lima, Mayra de Castro; Paes, Antonio Carlos] Sao Paulo State Univ Unesp, Sch Vet Med & Anim Sci, Dept Vet Hyg & Publ Hlth, Botucatu, SP, Brazil; [Oba, Eunice; de Souza, Fabiana Ferreira] Sao Paulo State Univ Unesp, Dept Anim Reprod & Vet Radiol, Sch Vet Med & Anim Sci, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Lourenco, MLG (corresponding author), Sao Paulo State Univ Unesp, Dept Vet Clin, Sch Vet Med & Anim Sci, Botucatu, SP, Brazil.	maria-lucia.lourenco@unesp.br	Lourenço, Maria Lucia/GYR-1165-2022; Souza, Fabiana Ferreira/ABE-9398-2021; Takahira, Regina/D-6935-2012	Souza, Fabiana Ferreira/0000-0003-4721-1801; Takahira, Regina/0000-0003-3323-4199	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo/SP - Brazil [2014/11219-6, 2015/16376-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo/SP - Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - Process no 2014/11219-6; 2015/16376-5 Sao Paulo/SP - Brazil.	Bavegems VC, 2001, J AM VET MED ASSOC, V238, P468; Brown S, 2007, J VET INTERN MED, V21, P542, DOI 10.1892/0891-6640(2007)21[542:GFTIEA]2.0.CO;2; Chetboul V, 2009, J VET INTERN MED, V23, P984, DOI 10.1111/j.1939-1676.2009.0347.x; CODNER EC, 1985, J AM VET MED ASSOC, V186, P166; Costagliola A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8016186; Diniz PPVP, 2008, J VET INTERN MED, V22, P1136, DOI 10.1111/j.1939-1676.2008.0145.x; Diniz PPVP, 2006, THESIS; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Dunn ME, 2011, TOXICOL SCI, V123, P368, DOI 10.1093/toxsci/kfr190; Edwards NJ, BOLTONS HDB CANINE F; Elamm C, 2012, HEART, V98, P835, DOI 10.1136/heartjnl-2012-301686; Everman JF, 2011, INFECT DIS DOG CAT; Filippi LH, 2001, ELETROCARDIOGRAMA ME, P128; FOWLER NO, 1975, J APPL PHYSIOL, V39, P453, DOI 10.1152/jappl.1975.39.3.453; Frank JR, 1999, J VET INTERN MED, V13, P194, DOI 10.1892/0891-6640(1999)013&lt;0194:ARSOEI&gt;2.3.CO;2; Garofalo NA, 2012, VET ANAESTH ANALG, V39, P324, DOI 10.1111/j.1467-2995.2012.00711.x; Goldman LE, 1999, CAN J CARDIOL, V15, P811; Haberman CE, 2006, CAN J VET RES, V70, P211; Hadlock DJ, 5 MINUTE VET CONSULT, P380; Harrus S, 2015, VET J, V204, P239, DOI 10.1016/j.tvjl.2015.04.027; Harrus S, 2011, VET J, V187, P292, DOI 10.1016/j.tvjl.2010.02.001; HAYES MA, 1979, J AM VET MED ASSOC, V174, P1197; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kellihan HB, 2009, J VET CARDIOL, V11, P593; Kobayashi K, 2014, J VET MED SCI, V76, P827, DOI 10.1292/jvms.13-0554; Krejci J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4087632; LANG H, 1982, CLIN CHEM, V28, P1439; Lobetti RG, 2005, J S AFR VET ASSOC, V76, P4; Mylonakis ME, 2004, J AM ANIM HOSP ASSOC, V40, P174, DOI 10.5326/0400174; Noszczyk-Nowak A, 2011, POL J VET SCI, V14, P551, DOI 10.2478/v10181-011-0082-z; Nucifora G, 2013, CLIN CARDIOL, V36, P146, DOI 10.1002/clc.22088; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Oyama MA, 2004, J VET INTERN MED, V18, P831, DOI 10.1892/0891-6640(2004)18&lt;831:CTCIDW&gt;2.0.CO;2; Pereira YM, 2008, J SMALL ANIM PRACT, V49, P587, DOI 10.1111/j.1748-5827.2008.00654.x; Pino O, 2008, REV INVESTIG VET PER, V19, P144; Saltykova MM, 2007, TERAPEVT ARKH, V79, P18; Sanches CDC, 2015, ESTUDO HISTOPATOLOGI; Serres Francois, 2009, J Vet Cardiol, V11, P103, DOI 10.1016/j.jvc.2009.07.001; Singletary GE, 2012, J VET INTERN MED, V26, P1330, DOI 10.1111/j.1939-1676.2012.1000.x; Sjostrand K, 2014, J VET INTERN MED, V28, P451, DOI 10.1111/jvim.12310; Sjostrand K, J VET INTERN MED, V014, P451, DOI [10.1111/jvim, DOI 10.1111/JVIM]; Spotswood TC, 2006, VET RADIOL ULTRASOUN, V47, P358, DOI 10.1111/j.1740-8261.2006.00154.x; Stanojevic M, 1997, SRP ARK CELOK LEK, V126, P461; Szatmari V, 2015, J VET INTERN MED, V29, P1524, DOI 10.1111/jvim.13632; Taralov Zdravko Z, 2015, Folia Med (Plovdiv), V57, P173, DOI 10.1515/folmed-2015-0036; Tavora MZP, 1999, ARQ BRAS CARDIOL, V72, P463; Tharwat M, 2012, THERIOGENOLOGY, V78, P1500, DOI 10.1016/j.theriogenology.2012.06.013; Tilley LP, 1992, ESSENTIALS CANINE FE, V470; Vitt JP, 2016, J VET INTERN MED, V30, P1210, DOI 10.1111/jvim.13967; Ware WA, SMALL ANIMAL INTERNA, P13; Weiss DJ, 2010, SCHALMS VET HEMATOLO; Wen BH, 1997, J CLIN MICROBIOL, V35, P1852, DOI 10.1128/JCM.35.7.1852-1855.1997	52	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216552	10.1371/journal.pone.0216552	http://dx.doi.org/10.1371/journal.pone.0216552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125348	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700006
J	Liu, HJ; Lei, MY; Zhang, NX; Du, GJ				Liu, Huajun; Lei, Mingyu; Zhang, Naixin; Du, Guangjie			The causal nexus between energy consumption, carbon emissions and economic growth: New evidence from China, India and G7 countries using convergent cross mapping	PLOS ONE			English	Article							ENVIRONMENTAL KUZNETS CURVE; CO2 EMISSIONS; GRANGER CAUSALITY; FINANCIAL DEVELOPMENT; DIOXIDE EMISSIONS; COINTEGRATION; INCOME; OUTPUT; GNP	Understanding the causality between energy consumption, carbon emissions and economic growth is helpful for policymakers to formulate energy, environmental and economic policies. For the first time, based on nonlinear dynamics, this paper employs multispatial convergent cross mapping (CCM) to revisit the energy-carbon-economy causation for China, India and the G7 countries using both aggregate data and per capita data. The findings indicate that there are significant differences between developing countries and developed countries. A bidirectional nexus between energy consumption, carbon emissions and economic growth is found in China and India, but various causal relationships are identified in the G7 countries, including bidirectional, unidirectional and neutral nexus. The results confirm that the decoupling phenomenon is common in most G7 countries. By leveraging a variety of samples and a new approach, this study provides new evidence for policy authorities to formulate country-specific policies to obtain better environmental quality while achieving sustainable economic growth.	[Liu, Huajun; Lei, Mingyu] Shandong Univ Finance & Econ, Sch Econ, Jinan, Shandong, Peoples R China; [Zhang, Naixin] Cent Univ Finance & Econ, Chinese Acad Finance & Dev, Beijing, Peoples R China; [Du, Guangjie] Shanghai Univ Finance & Econ, Inst Finance & Econ Res, Shanghai, Peoples R China	Shandong University of Finance & Economics; Central University of Finance & Economics; Shanghai University of Finance & Economics	Liu, HJ (corresponding author), Shandong Univ Finance & Econ, Sch Econ, Jinan, Shandong, Peoples R China.	huajun99382@163.com			National Social Science Foundation of China [18BJY140]; Humanities and Social Science Research Project of China's Ministry of Education [17YJA790054]; Nature Science Foundation of Shandong [ZR2016GM03]; Social Science Foundation of Shandong [18CZKJ13]	National Social Science Foundation of China; Humanities and Social Science Research Project of China's Ministry of Education; Nature Science Foundation of Shandong; Social Science Foundation of Shandong	This study has received funding from the National Social Science Foundation of China (http://www.npopss-cn.gov.cn/) under grant agreement No. 18BJY140, the Humanities and Social Science Research Project of China's Ministry of Education (http://www.moe.gov.cn/) under grant agreement No. 17YJA790054, the Nature Science Foundation of Shandong (http://www.sdstc.gov.cn/) under grant agreement No. ZR2016GM03, and the Social Science Foundation of Shandong (http://sdsk.sdchina.com/) under grant agreement No. 18CZKJ13.	Ajmi AN, 2015, ENERG ECON, V49, P629, DOI 10.1016/j.eneco.2015.02.007; AKARCA AT, 1980, J ENERGY DEV, V5, P326; Alper A, 2016, RENEW SUST ENERG REV, V60, P953, DOI 10.1016/j.rser.2016.01.123; Ang JB, 2008, J POLICY MODEL, V30, P271, DOI 10.1016/j.jpolmod.2007.04.010; Ang JB, 2007, ENERG POLICY, V35, P4772, DOI 10.1016/j.enpol.2007.03.032; [Anonymous], 2017, WMO GREENH GAS B; Appiah MO, 2018, ENERG POLICY, V112, P198, DOI 10.1016/j.enpol.2017.10.017; Baek J, 2015, APPL ENERG, V145, P133, DOI 10.1016/j.apenergy.2015.01.074; BECKERMAN W, 1992, WORLD DEV, V20, P481, DOI 10.1016/0305-750X(92)90038-W; Cai YF, 2018, J CLEAN PROD, V182, P1001, DOI 10.1016/j.jclepro.2018.02.035; Clark AT, 2015, ECOLOGY, V96, P1174, DOI 10.1890/14-1479.1; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Erol U., 1987, J ENERGY DEV, V13, P113; Grossman G., 1991, NBER WORK PAP, V1991, P3914, DOI [DOI 10.3386/W3914, 10.3386/w3914]; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; Ha JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197785; HIEMSTRA C, 1994, J FINANC, V49, P1639, DOI 10.2307/2329266; HOLTZEAKIN D, 1995, J PUBLIC ECON, V57, P85, DOI 10.1016/0047-2727(94)01449-X; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Inglesi-Lotz R, 2016, ENERG ECON, V53, P58, DOI 10.1016/j.eneco.2015.01.003; Karanfil F, 2009, ENERG POLICY, V37, P1191, DOI 10.1016/j.enpol.2008.11.029; KRAFT J, 1978, J ENERGY DEV, V3, P401; Ma H., 2010, ECON SYST, V34, P105, DOI DOI 10.1016/J.ECOSYS.2009.12.001; Mehrara M, 2007, ENERG POLICY, V35, P2939, DOI 10.1016/j.enpol.2006.10.018; Menegaki AN, 2011, ENERG ECON, V33, P257, DOI 10.1016/j.eneco.2010.10.004; Mirza FM, 2017, RENEW SUST ENERG REV, V72, P1233, DOI 10.1016/j.rser.2016.10.081; Moomaw WR., 1997, ENVIRON DEV ECON, V2, P451, DOI [10.1017/S1355770X97000247, DOI 10.1017/S1355770X97000247]; Mutascu M, 2016, RENEW SUST ENERG REV, V63, P166, DOI 10.1016/j.rser.2016.05.055; Naminse EY, 2018, POL J ENVIRON STUD, V27, P2193, DOI 10.15244/pjoes/78619; Ouedraogo NS, 2013, ENERG ECON, V36, P637, DOI 10.1016/j.eneco.2012.11.011; Ouyang YF, 2018, ENERG ECON, V71, P238, DOI 10.1016/j.eneco.2018.02.015; Pao G, 2015, QUANTA MAGAZINE; Rahman MM, 2017, ENERG POLICY, V110, P600, DOI 10.1016/j.enpol.2017.09.006; Schmalensee R, 1998, REV ECON STAT, V80, P15, DOI 10.1162/003465398557294; Shahbaz M, 2016, ENERG POLICY, V98, P33, DOI 10.1016/j.enpol.2016.08.011; Shahbaz M, 2015, RENEW SUST ENERG REV, V44, P576, DOI 10.1016/j.rser.2015.01.017; Shahbaz M, 2014, RENEW SUST ENERG REV, V34, P325, DOI 10.1016/j.rser.2014.03.022; Shahbaz M, 2013, RENEW SUST ENERG REV, V25, P494, DOI 10.1016/j.rser.2013.05.021; Shahbaz M, 2013, RENEW SUST ENERG REV, V25, P109, DOI 10.1016/j.rser.2013.04.009; Small M, 2004, PHYSICA D, V194, P283, DOI 10.1016/j.physd.2004.03.006; Soytas U, 2007, ECOL ECON, V62, P482, DOI 10.1016/j.ecolecon.2006.07.009; Stern DI, 2013, ENERG ECON, V39, P135, DOI 10.1016/j.eneco.2013.05.007; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Sugihara G., 2012, SCIENCE; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F., 1981, DYNAMICAL SYSTEMS TU; Tiwari A, 2011, STRUCTURAL VAR ANAL; WEF, 2018, FOST EFF EN TRANS; WMO, 2018, WHO CONF 2017 3 WARM; Yu E.S., 1985, J ENERGY DEV, P249, DOI DOI 10.1016/0360-5442(85)90045-3; YU ESH, 1984, ENERG ECON, V6, P186, DOI 10.1016/0140-9883(84)90015-X	52	25	26	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217319	10.1371/journal.pone.0217319	http://dx.doi.org/10.1371/journal.pone.0217319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120991	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700089
J	Matejka, K; Stuckler, F; Salomon, M; Ensenauer, R; Reischl, E; Hoerburger, L; Grallert, H; Kastenmuller, G; Peters, A; Daniel, H; Krumsiek, J; Theis, FJ; Hauner, H; Laumen, H				Matejka, Kerstin; Stueckler, Ferdinand; Salomon, Michael; Ensenauer, Regina; Reischl, Eva; Hoerburger, Lena; Grallert, Harald; Kastenmueller, Gabi; Peters, Annette; Daniel, Hannelore; Krumsiek, Jan; Theis, Fabian J.; Hauner, Hans; Laumen, Helmut			Dynamic modelling of an ACADS genotype in fatty acid oxidation - Application of cellular models for the analysis of common genetic variants	PLOS ONE			English	Article							CHAIN ACYL-COA; GENOME-WIDE ASSOCIATION; MOLECULAR PATHOGENESIS; BETA-OXIDATION; POPULATION; DEHYDROGENASES; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; MUTATIONS	Background Genome-wide association studies of common diseases or metabolite quantitative traits often identify common variants of small effect size, which may contribute to phenotypes by modulation of gene expression. Thus, there is growing demand for cellular models enabling to assess the impact of gene regulatory variants with moderate effects on gene expression. Mitochondrial fatty acid oxidation is an important energy metabolism pathway. Common noncoding acyl-CoA dehydrogenase short chain (ACADS) gene variants are associated with plasma C4-acylcarnitine levels and allele-specific modulation of ACADS expression may contribute to the observed phenotype. Methods and findings We assessed ACADS expression and intracellular acylcarnitine levels in human lymphoblastoid cell lines (LCL) genotyped for a common ACADS variant associated with plasma C4-acylcarnitine and found a significant genotype-dependent decrease of ACADS mRNA and protein. Next, we modelled gradual decrease of ACADS expression using a tetracy-cline- regulated shRNA-knockdown of ACADS in Huh7 hepatocytes, a cell line with high fatty acid oxidation-(FAO)-capacity. Assessing acylcarnitine flux in both models, we found increased C4-acylcarnitine levels with decreased ACADS expression levels. Moreover, assessing time-dependent changes of acylcarnitine levels in shRNA-hepatocytes with altered ACADS expression levels revealed an unexpected effect on long-and medium-chain fatty acid intermediates. Conclusions Both, genotyped LCL and regulated shRNA-knockdown are valuable tools to model moderate, gradual gene-regulatory effects of common variants on cellular phenotypes. Decreasing ACADS expression levels modulate short and surprisingly also long/medium chain acylcarnitines, and may contribute to increased plasma acylcarnitine levels.	[Matejka, Kerstin; Hauner, Hans; Laumen, Helmut] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Else Kroner Fresenius Ctr Nutr Med, Chair Nutr Med, Freising Weihenstephan, Germany; [Matejka, Kerstin; Daniel, Hannelore; Hauner, Hans; Laumen, Helmut] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Matejka, Kerstin; Grallert, Harald; Peters, Annette; Hauner, Hans; Laumen, Helmut] German Ctr Diabet Res DZD, Neuherberg, Germany; [Matejka, Kerstin; Grallert, Harald; Hauner, Hans; Laumen, Helmut] Helmholtz Zentrum Munchen, Clin Cooperat Grp Nutrigen & Type 2 Diabet, Neuherberg, Germany; [Matejka, Kerstin; Grallert, Harald; Hauner, Hans; Laumen, Helmut] Tech Univ Munich, Clin Cooperat Grp Nutrigen & Type 2 Diabet, Freising Weihenstephan, Germany; [Stueckler, Ferdinand; Krumsiek, Jan; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Salomon, Michael] SIRION Biotech GmbH, Martinsried, Germany; [Ensenauer, Regina] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Res Ctr, Munich, Germany; [Ensenauer, Regina] Heinrich Heine Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, Expt Pediat & Metab, Dusseldorf, Germany; [Ensenauer, Regina] Max Rubner Inst, Inst Child Nutr, Karlsruhe, Germany; [Reischl, Eva; Grallert, Harald] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Reischl, Eva; Grallert, Harald; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Hoerburger, Lena; Laumen, Helmut] Tech Univ Munich, Paediat Nutr Med, Else Kroner Fresenius Ctr Nutr Med, TUM Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Kastenmueller, Gabi] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Peters, Annette] DZHK Munich Partner Site, German Res Ctr Cardiovasc Dis, Neuherberg, Germany; [Daniel, Hannelore] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Chair Physiol Human Nutr, Freising Weihenstephan, Germany; [Krumsiek, Jan] Weill Cornell Med, Dept Physiol & Biophys, Englander Inst Precis Med, Inst Computat Biomed, New York, NY USA; [Theis, Fabian J.] Tech Univ Munich, Dept Math Sci, Garching, Germany; [Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, Munich, Germany; [Laumen, Helmut] Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Laumen, Helmut] Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Technical University of Munich; Cornell University; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Laumen, H (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Else Kroner Fresenius Ctr Nutr Med, Chair Nutr Med, Freising Weihenstephan, Germany.; Laumen, H (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany.; Laumen, H (corresponding author), German Ctr Diabet Res DZD, Neuherberg, Germany.; Laumen, H (corresponding author), Helmholtz Zentrum Munchen, Clin Cooperat Grp Nutrigen & Type 2 Diabet, Neuherberg, Germany.; Laumen, H (corresponding author), Tech Univ Munich, Clin Cooperat Grp Nutrigen & Type 2 Diabet, Freising Weihenstephan, Germany.; Theis, FJ (corresponding author), Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany.; Laumen, H (corresponding author), Tech Univ Munich, Paediat Nutr Med, Else Kroner Fresenius Ctr Nutr Med, TUM Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany.; Theis, FJ (corresponding author), Tech Univ Munich, Dept Math Sci, Garching, Germany.; Laumen, H (corresponding author), Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany.; Laumen, H (corresponding author), Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany.	fabian.theis@helmholtz-zentrum.de; helmut.laumen@tum.de	Grallert, Harald/B-3424-2013; Kastenmüller, Gabi/ABF-5987-2020; Peters, Annette/A-6117-2011; Theis, Fabian J/ABD-5212-2021; Laumen, Helmut/M-5140-2013	Peters, Annette/0000-0001-6645-0985; Theis, Fabian J/0000-0002-2419-1943; Laumen, Helmut/0000-0002-5885-5242	Else Kroner-Fresenius Foundation, Bad Homburg v. d. H., Germany; German Federal Ministry of Education and Research (BMBF) [01EA1307, 0315494A]; Clinical Cooperation Group 'Nutrigenomics and type 2 diabetes' from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen, Freising-Weihenstephan, Germany; European Union [FP7-Health-F5-2012, 305280]; "Studienstiftung des Deutschen Volkes"; German Helmholtz Association, "Initiative and Networking Fund"; European Research Council (starting grant "LatentCauses"); German Research Foundation (DFG) [LA2595/3-1]; Technical University of Munich (TUM)	Else Kroner-Fresenius Foundation, Bad Homburg v. d. H., Germany; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Clinical Cooperation Group 'Nutrigenomics and type 2 diabetes' from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen, Freising-Weihenstephan, Germany; European Union(European Commission); "Studienstiftung des Deutschen Volkes"; German Helmholtz Association, "Initiative and Networking Fund"; European Research Council (starting grant "LatentCauses"); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	The study was supported by the Else Kroner-Fresenius Foundation, Bad Homburg v. d. H., Germany; by a grant from the German Federal Ministry of Education and Research (BMBF) Grant no. 0315494A (project SysMBo); and by the grant Clinical Cooperation Group 'Nutrigenomics and type 2 diabetes' received from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany, and the Technische Universitat Munchen, Freising-Weihenstephan, Germany. RE was supported by the German Federal Ministry of Education and Research (BMBF) Grant 01EA1307; FS by the European Union's Seventh Framework Program (FP7-Health-F5-2012) under grant agreement n degrees 305280 (MIMOmics) and by a PhD student fellowships from the "Studienstiftung des Deutschen Volkes"; JK by a grant from the German Helmholtz Association, "Initiative and Networking Fund"; FJT by the European Research Council (starting grant "LatentCauses"); LH by the grant LA2595/3-1 from the German Research Foundation (DFG). This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author Dr. Michael Salomon (MS) declares commercial affiliation / employment with the commercial company SIRION Biotech GmbH (Martinsried, Germany). The funder provided support in the form of salaries for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author was related to Investigation, Methodology, and Writing - review & editing, as articulated in the author contributions section'.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amoli MM, 2008, INT J EPIDEMIOL, V37, P41, DOI 10.1093/ije/dym285; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Corydon MJ, 2001, PEDIATR RES, V49, P18; Corydon MJ, 1996, PEDIATR RES, V39, P1059, DOI 10.1203/00006450-199606000-00021; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Ensenauer R, 2012, J LIPID RES, V53, P1012, DOI 10.1194/jlr.D022608; FINOCCHIARO G, 1987, J BIOL CHEM, V262, P7982; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hong MG, 2013, HUM MUTAT, V34, P515, DOI 10.1002/humu.22267; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kastenmuller G, 2015, HUM MOL GENET, V24, pR93, DOI 10.1093/hmg/ddv263; Kirk P, 2013, CURR OPIN BIOTECH, V24, P767, DOI 10.1016/j.copbio.2013.03.012; KOHN MC, 1983, ANN BIOMED ENG, V11, P361, DOI 10.1007/BF02584214; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mirkov S, 2012, METABOLISM, V61, P1523, DOI 10.1016/j.metabol.2012.05.004; Modre-Osprian R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-2; Mootha VK, 2010, NAT GENET, V42, P97, DOI 10.1038/ng0210-97; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nagan N, 2003, MOL GENET METAB, V78, P239, DOI 10.1016/S1096-7192(03)00034-9; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Nguyen TV, 2002, BIOCHEMISTRY-US, V41, P11126, DOI 10.1021/bi026030r; Nicholson G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002270; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Pedersen CB, 2008, HUM GENET, V124, P43, DOI 10.1007/s00439-008-0521-9; Raue A, 2015, BIOINFORMATICS, V31, P3558, DOI 10.1093/bioinformatics/btv405; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186; Violante S, 2013, FASEB J, V27, P2039, DOI 10.1096/fj.12-216689; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; YAQOOB P, 1994, BIOCHEM SOC T, V22, pS116, DOI 10.1042/bst022116s	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216110	10.1371/journal.pone.0216110	http://dx.doi.org/10.1371/journal.pone.0216110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120904	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700008
J	Promraksa, B; Phetcharaburanin, J; Namwat, N; Techasen, A; Boonsiri, P; Loilome, W				Promraksa, Bundit; Phetcharaburanin, Jutarop; Namwat, Nisana; Techasen, Anchalee; Boonsiri, Patcharee; Loilome, Watcharin			Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENT; IN-VITRO EVALUATION; DRUG-RESISTANCE; ANTIOXIDANT ACTIVITY; CANCER-CELLS; DNA-DAMAGE; CYTOTOXICITY; METABOLOMICS; MECHANISMS; PREVENTION	Although cholangiocarcinoma ( CCA) has a low incidence globally, this is extremely high in Northeast Thailand. The lack of both early detection measures and effective therapeutic drugs is the major problem for the poor prognosis of CCA patients. Based on regional knowledge, it would be advantageous to search for effective natural phyto-products for the treatment of CCA. Cardiospermum halicacabum L., Gomphrena celosioides Mart. and Scoparia dulcis L., very well-known medicinal herbs in Asian countries, were selected for the investigation of inhibitory effects on CCA cells. Of the three different ethanolic extracts, S. dulcis L extract showed most inhibitory effects on cell growth of CCA cell lines KKU-100 and KKU-213, at percentages of 56.06 and 74.76, respectively, compared to the untreated group after treatment with 250 mu g/mL of extracts for 72 hrs. At 400 and 500 mu g/mL of the extracts, the inhibitory effect of KKU-213 was indicated by a significant increase in the BAX/Bcl-2 ratio and cell membrane permeability. Moreover, metabolic profiling-based screening employed in the current study revealed a significant positive association between the lignin compound and a decrease in CCA cell viability. Our study suggests, for the first time, that ESD has the ability to inhibit CCA cell growth through the induction of apoptosis.	[Promraksa, Bundit; Phetcharaburanin, Jutarop; Namwat, Nisana; Boonsiri, Patcharee; Loilome, Watcharin] Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand; [Promraksa, Bundit; Phetcharaburanin, Jutarop; Namwat, Nisana; Techasen, Anchalee; Loilome, Watcharin] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Fac Med, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop] Mahidol Univ, Ctr Excellence Innovat Chem, Bangkok, Thailand; [Techasen, Anchalee] Khon Kaen Univ, Fac Associated Med Sci, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Mahidol University; Khon Kaen University	Loilome, W (corresponding author), Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand.; Loilome, W (corresponding author), Khon Kaen Univ, Cholangiocarcinoma Res Inst, Fac Med, Khon Kaen, Thailand.	watloi@yahoo.com	Loilome, Watcharin/AAW-6203-2021; Promraksa, Bundit/AAI-5552-2021	Phetcharaburanin, Jutarop/0000-0003-4727-8395	Khon Kaen University (KKU) [592JH216]; Thailand Research Fund [RSA5980013]; Khon Kaen University through the Cholangiocarcinoma Screening Care Program (CASCAP) [CASCAP-09]; Khon Kaen University in Thailand	Khon Kaen University (KKU); Thailand Research Fund(Thailand Research Fund (TRF)); Khon Kaen University through the Cholangiocarcinoma Screening Care Program (CASCAP); Khon Kaen University in Thailand	This work was supported by the research fund for supporting lecturers to admit high potential students to study and research on the expert program, Khon Kaen University (KKU) (grant number 592JH216); the Thailand Research Fund (Grant No. RSA5980013); a grant from Khon Kaen University through the Cholangiocarcinoma Screening Care Program (CASCAP, Grant No. CASCAP-09); and a grant from Khon Kaen University in Thailand to WL.	Aishwarya V, 2014, INT J PHARM PHARM SC, V6, P263; Al-Sharif I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-600; Anderson CD, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-1-43; Ando H, 2004, TOXICOL IN VITRO, V18, P765, DOI 10.1016/j.tiv.2004.03.011; Barapatre A, 2016, INT J BIOL MACROMOL, V86, P443, DOI 10.1016/j.ijbiomac.2016.01.109; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Butthongkomvong K, 2013, ASIAN PAC J CANCER P, V14, P3565, DOI 10.7314/APJCP.2013.14.6.3565; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Catalan U, 2017, GENOM PROTEOM BIOINF, V15, P236, DOI 10.1016/j.gpb.2016.12.007; Chassagne F, 2018, FITOTERAPIA, V127, P226, DOI 10.1016/j.fitote.2018.02.021; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Vasconcelos PCD, 2017, J ETHNOPHARMACOL, V202, P85, DOI 10.1016/j.jep.2017.03.007; Do QD, 2014, J FOOD DRUG ANAL, V22, P296, DOI 10.1016/j.jfda.2013.11.001; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Figueiredo P, 2017, BIOMATERIALS, V121, P97, DOI 10.1016/j.biomaterials.2016.12.034; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Graziani V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23704-9; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; HASWELLELKINS MR, 1991, CLIN EXP IMMUNOL, V84, P213, DOI 10.1111/j.1365-2249.1991.tb08151.x; HAYASHI T, 1988, CHEM PHARM BULL, V36, P4849; Hientz K, 2017, ONCOTARGET, V8, P8921, DOI 10.18632/oncotarget.13475; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jaganathan SK, 2012, MOLECULES, V17, P6290, DOI 10.3390/molecules17066290; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Johnson SR, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00022; Kankanamalage TNM, 2014, J ETHNOPHARMACOL, V155, P679, DOI 10.1016/j.jep.2014.06.016; Kerbel RS, 2001, CANCER METAST REV, V20, P1, DOI 10.1023/A:1013129128673; Khuntikeo N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1475-7; Kim HK, 2010, PLANTA MED, V76, P1094, DOI 10.1055/s-0030-1249898; Liang WQ, 2017, ONCOTARGET, V8, P109094, DOI 10.18632/oncotarget.22618; Lundquist K., 1992, SPRINGER SERIES WOOD; Luo J, 2010, INT J BIOL SCI, V6, P784; Mahmood N, 2018, ONCOTARGET, V9, P5169, DOI 10.18632/oncotarget.23704; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nakabayashi R, 2013, ANAL BIOANAL CHEM, V405, P5005, DOI 10.1007/s00216-013-6869-2; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NISHINO H, 1993, ONCOLOGY, V50, P100; Njiojob CN, 2016, CHEM-EUR J, V22, P12506, DOI 10.1002/chem.201601592; Pinlaor S, 2005, WORLD J GASTROENTERO, V11, P4644, DOI 10.3748/wjg.v11.i30.4644; Poomphakwaen K, 2009, ASIAN PAC J CANCER P, V10, P251; Promraksa Bundit, 2015, Asian Pac J Cancer Prev, V16, P7155; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ratnasooriya WD, 2005, FITOTERAPIA, V76, P220, DOI 10.1016/j.fitote.2004.06.012; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Semenas J, 2012, CURR DRUG TARGETS, V13, P1308, DOI 10.2174/138945012802429615; Singh K, 2018, SAUDI PHARM J, V26, P177, DOI 10.1016/j.jsps.2017.12.013; Tangkawattana S, 2008, ASIAN PAC J CANCER P, V9, P101; Verpoorte R., 2008, Phytochemistry Reviews, V7, P525, DOI 10.1007/s11101-008-9091-7; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Worley B, 2016, CURR METABOL, V4, P97, DOI 10.2174/2213235X04666160613122429; Yongvanit P, 2012, PARASITOL INT, V61, P130, DOI 10.1016/j.parint.2011.06.011; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133	56	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216721	10.1371/journal.pone.0216721	http://dx.doi.org/10.1371/journal.pone.0216721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120926	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700025
J	Verhees, RAF; Thijs, C; Ambergen, T; Dinant, GJ; Knottnerus, JA				Verhees, Ruud Andreas Fritz; Thijs, Carel; Ambergen, Ton; Dinant, Geert Jan; Knottnerus, Johannes Andreas			Influenza vaccination in the elderly: 25 years follow-up of a randomized controlled trial. No impact on long-term mortality	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL-VIRUS; SEASONAL INFLUENZA; PEOPLE; HOSPITALIZATIONS; METAANALYSIS; BENEFITS; DISEASE; DEATHS; BIAS; US	Influenza vaccination is proven effective in preventing influenza. However, long-term effects on mortality have never been supported by direct evidence. In this study we assessed the long-term outcome of influenza vaccination on mortality in the elderly by conducting a 25-year follow-up study of a RCT on the efficacy of influenza vaccination as baseline. The RCT had been conducted in the Netherlands 5 years before vaccination was recommended for those aged >65 and 17 years before recommending it for those aged >60. The RCT included 1838 community-dwelling elderly aged. 60 that had received an intramuscular injection with the inactivated quadrivalent influenza vaccine ( n = 927) or placebo ( n = 911) during the 1991/1992 winter. In our follow-up study, outcomes included all-cause mortality, influenza-related mortality and seasonal mortality. Unadjusted and adjusted hazard ratios ( HRs) were estimated by Cox regression and sub-hazard ratios ( SHRs) by competing risk models. Secondary analyses included subgroup analyses by age and disease status. The vital status up to January 1, 2017 was provided in 1800/1838 ( 98%) of the cases. Single influenza vaccination did not reduce all-cause mortality when compared to placebo ( adjusted HR 0.95, 95% CI 0.85-1.05). Also, no differences between vaccination and placebo group were shown for underlying causes of death or seasonal mortality. In those aged 60-64, median survival increased with 20.1 months ( 95% CI 2.4-37.9), although no effects on all-cause mortality ( adjusted HR 0.86, 95% CI 0.72-1.03) could be demonstrated in survival analysis. In conclusion, this study did not demonstrate a statistically significant effect following single influenza vaccination on long-term mortality in community-dwelling elderly in general. We propose researchers designing future studies on influenza vaccination in the elderly to fit these studies for longer-term follow-up, and suggest age-group comparisons in observational research.	[Verhees, Ruud Andreas Fritz; Dinant, Geert Jan; Knottnerus, Johannes Andreas] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Family Med, Maastricht, Netherlands; [Thijs, Carel] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Epidemiol, Maastricht, Netherlands; [Ambergen, Ton] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Verhees, RAF (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Family Med, Maastricht, Netherlands.	ruud.verhees@maastrichtuniversity.nl		Thijs, Carel/0000-0001-6646-5458	Maastricht University; Bavo Foundation, Heemstede, the Netherlands	Maastricht University; Bavo Foundation, Heemstede, the Netherlands(Netherlands Government)	Ruud Andreas Fritz Verhees (RAFV) received funding for this research. Funding was provided by Maastricht University (https://www.maastrichtuniversity.nl/) and Bavo Foundation, Heemstede, the Netherlands (http://www.bavostichting.nl/).Grant numbers are not applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsup S, 2004, VACCINE, V23, P639, DOI 10.1016/j.vaccine.2004.07.008; Armstrong BG, 2004, BMJ-BRIT MED J, V329, P660, DOI 10.1136/bmj.38198.594109.AE; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Chan TC, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.10.008; Claas E C, 1995, Ned Tijdschr Geneeskd, V139, P2154; Darvishian M, 2017, LANCET RESP MED, V5, P200, DOI 10.1016/S2213-2600(17)30043-7; Darvishian M, 2014, J CLIN EPIDEMIOL, V67, P734, DOI 10.1016/j.jclinepi.2014.02.009; Demicheli V, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub4; Dou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121258; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; GOVAERT TME, 1993, BMJ-BRIT MED J, V307, P988, DOI 10.1136/bmj.307.6910.988; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Groenwold RHH, 2008, INT J EPIDEMIOL, V37, P1422, DOI 10.1093/ije/dyn173; Haralambieva IH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122282; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Jansen AGSC, 2008, VACCINE, V26, P5567, DOI 10.1016/j.vaccine.2008.08.003; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Luytjes W, 2012, VACCINE, V30, P5262, DOI 10.1016/j.vaccine.2012.05.060; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Praditsuwan Rungnirand, 2005, Journal of the Medical Association of Thailand, V88, P256; Rees K, 2015, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD005050.PUB3; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Tessmer A, 2011, EUR RESPIR J, V38, P147, DOI 10.1183/09031936.00133510; Thomas RE, 2014, VACCINE, V32, P6884, DOI 10.1016/j.vaccine.2014.08.090; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Verhees RAF, 2018, VACCINE, V36, P2991, DOI 10.1016/j.vaccine.2018.04.027; Voordouw BCG, 2003, ARCH INTERN MED, V163, P1089, DOI 10.1001/archinte.163.9.1089; World Health Organization, 1977, INT CLASS DIS; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	41	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216983	10.1371/journal.pone.0216983	http://dx.doi.org/10.1371/journal.pone.0216983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120943	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700043
J	Rindelaub, JD; Baird, Z; Lindner, BA; Strantz, AA				Rindelaub, Joel D.; Baird, Zane; Lindner, Bruce A.; Strantz, Angela A.			Identifying extractable profiles from 3D printed medical devices	PLOS ONE			English	Article							DESIGN; LEACHABLES	With the ability to create customizable products tailored to individual patients, the use of 3D printed medical devices has rapidly increased in recent years. Despite such interest in these materials, a risk assessment based on the material characterization of final device extracts-as per regulatory guidance-has not yet been completed, even though the printing process may potentially impact the leachability of polymer components. To further our understanding of the chemical impact of 3D printed medical devices, this study investigated the extractable profiles of four different materials, including a PLA polymer advertised as "FDA-approved". The fusion deposition modeling (FDM) printing process created distinct chemical and physical signatures in the extracts of certain materials. The application of an annealing procedure to printed devices led to a substantial decrease in extractable components by as much as a factor of 50. In addition, the use of a brass printing nozzle led to an increase in the amount of Pb detected in 3D printed device extracts. The data generated provides valuable information that can be used to help assess extractable risks of 3D printed medical devices, assist with future 3D printing designs, and may provide insight for agencies tasked with governing 3D printed medical device regulations.	[Rindelaub, Joel D.] Univ Auckland, Sch Chem Sci, Auckland, New Zealand; [Baird, Zane] Train Ind, Bloomington, IN USA; [Lindner, Bruce A.; Strantz, Angela A.] Pace Analyt Life Sci, Oakdale, MN USA	University of Auckland	Rindelaub, JD (corresponding author), Univ Auckland, Sch Chem Sci, Auckland, New Zealand.	j.rindelaub@auckland.ac.nz		Rindelaub, Joel/0000-0002-8445-8582	Pace Analytical Life Sciences, LLC (PLS)	Pace Analytical Life Sciences, LLC (PLS)	The authors would like to thank Pace Analytical Life Sciences, LLC (PLS) for providing the funding and resources necessary for this study. The authors would also like to thank Catherine Hobbis at the University of Auckland for assistance with SEM-EDS analysis, as well as PLS employees Rachael Hellman, Jonathan Steege, Robert Campbell, Ru Xu, and Kyle Wuornos for their assistance with data acquisition.	[Anonymous], 2015, INT C HARM TECHN REQ; [Anonymous], 2012, 1099312 ISO; [Anonymous], 2016, TECHN CONS ADD MAN D; [Anonymous], 2015, ASSESSMENT EXTRACTAB; Arealis G, 2015, INJURY, V46, pS20, DOI 10.1016/S0020-1383(15)30050-4; Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155; Center for Devices and Radiological Health U. S. Food and Drug Administration, 2001, SAF ASS DI 2 ETH PHT; Colasante C, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0127-4; Davies CT, 2015, CISC VIS NETW IND GL; Dawood A, 2015, BRIT DENT J, V219, P521, DOI 10.1038/sj.bdj.2015.914; Dodziuk H, 2016, KARDIOCHIR TORAKOCHI, V13, P283, DOI 10.5114/kitp.2016.62625; Ekelund M, 2010, POLYM DEGRAD STABIL, V95, P1789, DOI 10.1016/j.polymdegradstab.2010.05.007; Goyanes A, 2015, MOL PHARMACEUT, V12, P4077, DOI 10.1021/acs.molpharmaceut.5b00510; Goyanes A, 2014, INT J PHARMACEUT, V476, P88, DOI 10.1016/j.ijpharm.2014.09.044; Guvendiren M, 2016, ACS BIOMATER SCI ENG, V2, P1679, DOI 10.1021/acsbiomaterials.6b00121; Huang Y, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600734; Jenke D, 2015, PHARM RES-DORDR, V32, P1105, DOI 10.1007/s11095-014-1523-z; Lee K, 2002, POLYMER, V43, P2249, DOI 10.1016/S0032-3861(02)00024-1; Letourneau C, 2015, 3D PRINTING MED DEV, P7; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Mertz L, 2013, IEEE PULSE, V4, P15, DOI 10.1109/MPUL.2013.2279616; MIGLIARESI C, 1991, J APPL POLYM SCI, V43, P83, DOI 10.1002/app.1991.070430109; Mobbs RJ, 2017, J NEUROSURG-SPINE, V26, P513, DOI 10.3171/2016.9.SPINE16371; Morrison RJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010825; Norwood DL, 2008, PHARM RES, V25, P727, DOI 10.1007/s11095-007-9521-z; Norwood DL, 2009, J LIQ CHROMATOGR R T, V32, P1768, DOI 10.1080/10826070902959497; O'Donovan M, 2012, MUTAGENESIS, V27, P615, DOI 10.1093/mutage/ges045; Perego G, 1996, J APPL POLYM SCI, V59, P37, DOI 10.1002/(SICI)1097-4628(19960103)59:1<37::AID-APP6>3.3.CO;2-7; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Schubert C, 2014, BRIT J OPHTHALMOL, V98, P159, DOI 10.1136/bjophthalmol-2013-304446; Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Tack P, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0236-4; The United States Pharmacopeia, 2012, 788 PART MATT INJ; The United States Pharmacopeia, 2015, 232 EL IMP LIM; U. S. Department of Health and Human Services, 2016, ISO10993 US DEP HLTH; Ventola C Lee, 2014, P T, V39, P704; Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076; Wohlers Associates, 2013, WHAT IS 3D PRINT WOH	39	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217137	10.1371/journal.pone.0217137	http://dx.doi.org/10.1371/journal.pone.0217137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116763	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400044
J	Suguiyama, VF; Vasconcelos, LAB; Rossi, MM; Biondo, C; de Setta, N				Suguiyama, Vanessa Fuentes; Baciega Vasconcelos, Luiz Augusto; Rossi, Maria Magdalena; Biondo, Cibele; de Setta, Nathalia			The population genetic structure approach adds new insights into the evolution of plant LTR retrotransposon lineages	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; GENOME SEQUENCE; FOXTAIL MILLET; RICE; SEARCH; RECOMBINATION; DYNAMICS; HISTORY; DOMAIN	Long terminal repeat retrotransposons (LTR-RTs) in plant genomes differ in abundance, structure and genomic distribution, reflecting the large number of evolutionary lineages. Elements within lineages can be considered populations, in which each element is an individual in its genomic environment. In this way, it would be reasonable to apply microevolutionary analyses to understand transposable element (TE) evolution, such as those used to study the genetic structure of natural populations. Here, we applied a Bayesian method to infer genetic structure of populations together with classical phylogenetic and dating tools to analyze LTR-RT evolution using the monocot Setaria italica as a model species. In contrast to a phylogeny, the Bayesian clusterization method identifies populations by assigning individuals to one or more clusters according to the most probabilistic scenario of admixture, based on genetic diversity patterns. In this work, each LTR-RT insertion was considered to be one individual and each LTR-RT lineage was considered to be a single species. Nine evolutionary lineages of LTR-RTs were identified in the S. italica genome that had different genetic structures with variable numbers of clusters and levels of admixture. Comprehensive analysis of the phylogenetic, clusterization and time of insertion data allowed us to hypothesize that admixed elements represent sequences that harbor ancestral polymorphic sequence signatures. In conclusion, application of microevolutionary concepts in genome evolution studies is suitable as a complementary approach to phylogenetic analyses to address the evolutionary history and functional features of TEs.	[Suguiyama, Vanessa Fuentes; Baciega Vasconcelos, Luiz Augusto; Biondo, Cibele; de Setta, Nathalia] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, SP, Brazil; [Rossi, Maria Magdalena] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	de Setta, N (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, SP, Brazil.	nathalia.setta@ufabc.edu.br	Suguiyama, Vanessa Fuentes/N-9249-2015; Rossi, Magdalena/B-7847-2012; Biondo, Cibele/G-3811-2015; de Setta, Nathalia/C-6069-2012	Suguiyama, Vanessa Fuentes/0000-0002-8043-6116; Rossi, Magdalena/0000-0003-3650-772X; de Setta, Nathalia/0000-0002-4807-5410; Biondo, Cibele/0000-0003-4020-4246	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/16975-6]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Universidade Federal do ABC (UFABC)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Federal do ABC (UFABC)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br, grant number 2015/16975-6 to NS). VFS and LABV were supported by scholarships from Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES, www.capes.gov.br) and Universidade Federal do ABC (UFABC, www.ufabc.edu.br), respectively.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aparicio A, 2012, DIVERS DISTRIB, V18, P226, DOI 10.1111/j.1472-4642.2011.00823.x; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Beule T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2023-1; Chaparro C, 2015, GENOME BIOL EVOL, V7, P493, DOI 10.1093/gbe/evv001; Chitwood J, 2016, HORTSCIENCE, V51, P481, DOI 10.21273/HORTSCI.51.5.481; Cruz GMQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097099; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Domingues DS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-137; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Dupeyron M, 2017, MOL GENET GENOMICS, V292, P741, DOI 10.1007/s00438-017-1308-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El Baidouri M, 2013, GENOME BIOL EVOL, V5, P954, DOI 10.1093/gbe/evt025; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao DY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00216; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huang Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165953; Jordan IK, 1998, J MOL EVOL, V47, P14, DOI 10.1007/PL00006358; Jurka J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-44; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kolano B, 2013, PLANT CELL REP, V32, P1575, DOI 10.1007/s00299-013-1468-4; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Lopez A, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx017; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Mizuno H, 2006, DNA RES, V13, P267, DOI 10.1093/dnares/dsm001; Nunes RD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00175; Ochoa Cruz EA, 2016, MOBILE DNA-UK, V7, P1, DOI [10.1186/s13100-016-0058-8, DOI 10.1186/S13100-016-0058-8]; Orsini L, 2013, MOL ECOL, V22, P5983, DOI 10.1111/mec.12561; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rebollo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044253; Ribeiro PL, 2018, FLORA, V238, P60, DOI 10.1016/j.flora.2017.09.013; SABOT F, 2007, BMC GENOMICS, V8, P1, DOI DOI 10.1186/1471-2164-8-1; Sanchez DH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01374-x; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Santos ESL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145276; Santos FC, 2015, CHROMOSOME RES, V23, P571, DOI 10.1007/s10577-015-9492-6; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Setta N, 2012, PLANT TRANSPOSABLE E, P169, DOI [10.1007/978-3-642-31842-9, DOI 10.1007/978-3-642-31842-9]; Shiposha V, 2016, PEERJ, V4, DOI 10.7717/peerj.2407; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Venner S, 2009, TRENDS GENET, V25, P317, DOI 10.1016/j.tig.2009.05.003; Vicient CM, 2005, J MOL EVOL, V61, P275, DOI 10.1007/s00239-004-0168-7; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Wu FQ, 2014, AOB PLANTS, V7, P82, DOI DOI 10.1093/A0BPLA/PLU082; Xu YX, 2014, PLANT J, V80, P582, DOI 10.1111/tpj.12656; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yadav CB, 2015, DNA RES, V22, P79, DOI 10.1093/dnares/dsu039; Yin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17644; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang QJ, 2017, G3-GENES GENOM GENET, V7, P1875, DOI 10.1534/g3.116.037572; Zhao MX, 2013, PROTEIN CELL, V4, P493, DOI 10.1007/s13238-013-3037-6; Zhou MB, 2018, J PLANT RES, V131, P203, DOI 10.1007/s10265-017-0983-8; Zhou MB, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1114-3; 2010, PLANT J, V63, P584, DOI DOI 10.1111/J.1365-313X.2010	70	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0214542	10.1371/journal.pone.0214542	http://dx.doi.org/10.1371/journal.pone.0214542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107873	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200001
J	Chatio, S; Ansah, NA; Awuni, DA; Oduro, A; Ansah, PO				Chatio, Samuel; Ansah, Nana Akosua; Awuni, Denis A.; Oduro, Abraham; Ansah, Patrick O.			Community acceptability of Seasonal Malaria Chemoprevention of morbidity and mortality in young children: A qualitative study in the Upper West Region of Ghana	PLOS ONE			English	Article							DRUG-THERAPY; ADHERENCE	Background Malaria remains a major public health problem, especially in sub-Sahara African countries. The Malaria Control Program of Ghana has implemented Seasonal Malaria Chemoprevention (SMC) intervention in the Upper West Region in 2015. This preventive drug has been recommended by WHO as very safe and effective in preventing malaria in children under five years. This study assessed community acceptability of the SMC intervention in the Lawra district of Northern Ghana. Methodology This was a qualitative study where focus group discussions and in-depth interviews were conducted with community-based health volunteers and parents whose children received the SMC drug. Purposive sampling method was used to select study participants. The interviews were recorded with consent of study participants. All interviews were transcribed and coded into emergent themes using Nvivo 10 software before thematic content analysis. Results Study participants perceived that the introduction of the SMC intervention in the area had helped to reduce the prevalence of malaria among children less than five years of age. Parents held the view that the drug was very good in preventing malaria. The results also showed high acceptability of the SMC intervention by parents and other community members. Parents reported that they were willing to allow their children to receive the drug and wished the intervention could continue in the district for children to continue to benefit. Nonetheless, negative attitude on the part of few parents made them not to allow their children to receive the drug. Conclusion The interpretation of our data showed high acceptability of the SMC by stakeholders in the study area. However, intensive and continued health education on the benefits of the SMC drug could help to further improve acceptability of the program.	[Chatio, Samuel; Ansah, Nana Akosua; Awuni, Denis A.; Oduro, Abraham; Ansah, Patrick O.] Navrongo Hlth Res Ctr, Navrongo, Ghana	Navrongo Health Research Center	Chatio, S (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.	schatio@yahoo.co.uk		Chatio, Samuel Tamti/0000-0001-9998-748X; ODURO, ABRAHAM/0000-0002-4191-7419	National Malaria Control Programme of Ghana	National Malaria Control Programme of Ghana	The study was funded by National Malaria Control Programme of Ghana. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ANN REPORT; [Anonymous], 2013, ANN REPORT GHANA HLT; [Anonymous], 2012, A FIELD GUIDE; [Anonymous], 2011, HEAL SCI J; [Anonymous], 2011, COST EFFECTIVENESS A; Anto F, 2014, J BACTERIOL PARASITO, V5, P180, DOI [10.4172/2155-9597.1000180, DOI 10.4172/2155-9597.1000180]; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Chatio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116856; George AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141091; Ghana Health Service, 2016, ROLL BACK MAL 2016; Ghana Health Service, 2009, ANT DRUG POL 2009; Ghana Statistical Service, 2012, POP HOUS CENS SUMM R; Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4; Kisoka WJ, 2014, PLOS ONE, V9, DOI [10.1371/j, 10.1371/journal.pone.0109316]; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Onyango EO, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-143; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; QSR International, 2010, NVIVO QUAL DAT AN SO; Silumbwe A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4414-5; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; WASH Cluster, 2020, STATE WORLDS CHILDRE; WHO, 2012, POLICY RECOMMENDATIO; WHO, 2020, GLOB REP ANT DRUG EF; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; World Health Organization, 2017, DEPRESSION	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216486	10.1371/journal.pone.0216486	http://dx.doi.org/10.1371/journal.pone.0216486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100072	Green Submitted, Green Published, gold			2022-12-27	WOS:000468176600009
J	van de Putte, R; Wijers, CHW; Reutter, H; Vermeulen, SH; Marcelis, CLM; Brosens, E; Broens, PMA; Homberg, M; Ludwig, M; Jenetzky, E; Zwink, N; Sloots, CEJ; de Klein, A; Brooke, AS; Hofstra, RMW; Holsink, SAC; van Der Zanden, LFM; Galesloot, TE; Tam, PKH; Steehouwer, M; Acuna-Hidalgo, R; van de Vorst, M; Kiemeney, LA; Garcia-Barcelo, MM; de Blaauw, I; Brunner, HG; Roeleveld, N; van Rooij, IALM				van de Putte, Romy; Wijers, Charlotte H. W.; Reutter, Heiko; Vermeulen, Sita H.; Marcelis, Carlo L. M.; Brosens, Erwin; Broens, Paul M. A.; Homberg, Markus; Ludwig, Michael; Jenetzky, Ekkehart; Zwink, Nadine; Sloots, Cornelius E. J.; de Klein, Annelies; Brooke, Alice S.; Hofstra, Robert M. W.; Holsink, Sophie A. C.; van Der Zanden, Loes F. M.; Galesloot, Tessel E.; Tam, Paul Kwong-Hang; Steehouwer, Marloes; Acuna-Hidalgo, Rocio; van de Vorst, Maartje; Kiemeney, Lambertus A.; Garcia-Barcelo, Maria-Merce; de Blaauw, Ivo; Brunner, Han G.; Roeleveld, Nel; van Rooij, Iris A. L. M.			Exome chip association study excluded the involvement of rare coding variants with large effect sizes in the etiology of anorectal malformations	PLOS ONE			English	Article							BIRTH-DEFECTS; CANDIDATE GENE; RISK; ANOMALIES; EXCLUSION; REGISTRY; OBESITY; FGF10	Introduction Anorectal malformations (ARM) are rare congenital malformations, resulting from disturbed hindgut development. A genetic etiology has been suggested, but evidence for the involvement of specific genes is scarce. We evaluated the contribution of rare and low-frequency coding variants in ARM etiology, assuming a multifactorial model. Methods We analyzed 568 Caucasian ARM patients and 1,860 population-based controls using the Illumina Human Exome Beadchip array, which contains >240,000 rare and low-frequency coding variants. GenomeStudio clustering and calling was followed by re-calling of 'no-calls' using zCall for patients and controls simultaneously. Single variant and gene-based analyses were performed to identify statistically significant associations, applying Bonferroni correction. Following an extra quality control step, candidate variants were selected for validation using Sanger sequencing. Results When we applied a MAF of >= 1.0%, no variants or genes showed statistically significant associations with ARM. Using a MAF cut-off at 0.4%, 13 variants initially reached statistical significance, but had to be discarded upon further inspection: ten variants represented calling errors of the software, while the minor alleles of the remaining three variants were not confirmed by Sanger sequencing. Conclusion Our results show that rare and low-frequency coding variants with large effect sizes, present on the exome chip do not contribute to ARM etiology.	[van de Putte, Romy; Wijers, Charlotte H. W.; Vermeulen, Sita H.; Holsink, Sophie A. C.; van Der Zanden, Loes F. M.; Galesloot, Tessel E.; Kiemeney, Lambertus A.; Roeleveld, Nel; van Rooij, Iris A. L. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands; [Reutter, Heiko] Univ Bonn, Inst Human Genet, Bonn, Germany; [Reutter, Heiko] Univ Bonn, Childrens Hosp, Dept Neonatol, Bonn, Germany; [Marcelis, Carlo L. M.; Steehouwer, Marloes; Acuna-Hidalgo, Rocio; van de Vorst, Maartje; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; [Brosens, Erwin; de Klein, Annelies; Brooke, Alice S.; Hofstra, Robert M. W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Brosens, Erwin; Sloots, Cornelius E. J.] Erasmus MC, Sophias Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Broens, Paul M. A.] Univ Med Ctr Groningen, Dept Surg, Div Pediat Surg, Groningen, Netherlands; [Homberg, Markus; Jenetzky, Ekkehart] Johannes Gutenberg Univ Mainz, Dept Child & Adolescent Psychiat & Psychotherapy, Mainz, Germany; [Ludwig, Michael; Zwink, Nadine] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Bonn, Germany; [Jenetzky, Ekkehart] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Tam, Paul Kwong-Hang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Peoples R China; [Tam, Paul Kwong-Hang] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Peoples R China; [Tam, Paul Kwong-Hang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Peoples R China; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Urol, Nijmegen, Netherlands; [Garcia-Barcelo, Maria-Merce] Univ Med Ctr Utrecht, Expt Cardiol Lab, Div Heart & Lungs, Utrecht, Netherlands; [Garcia-Barcelo, Maria-Merce] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [de Blaauw, Ivo; van Rooij, Iris A. L. M.] Radboud Univ Nijmegen, Radboudumc Amalia Childrens Hosp, Med Ctr, Dept Surg Pediat Surg, Nijmegen, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands	Radboud University Nijmegen; University of Bonn; University of Bonn; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Johannes Gutenberg University of Mainz; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hong Kong; University of Hong Kong; University of Hong Kong; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Maastricht University	van de Putte, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands.	Romy.vandePutte@radboudumc.nl	de Blaauw, Ivo/L-4203-2015; Vermeulen, Sita H./L-4716-2015; Marcelis, C.L.M./L-4504-2015; Brosens, Erwin/AAP-1913-2020; Roeleveld, Nel/B-4242-2008; van der Zanden, Loes/M-4795-2015; Jenetzky, Ekkehart/AAA-5207-2020; van de Putte, Romy/M-4277-2015; /C-4405-2009	Vermeulen, Sita H./0000-0003-4913-8601; Marcelis, C.L.M./0000-0001-7095-4641; Brosens, Erwin/0000-0001-8235-4010; Roeleveld, Nel/0000-0002-3390-4466; van der Zanden, Loes/0000-0003-3914-7491; Jenetzky, Ekkehart/0000-0001-5415-8784; van de Putte, Romy/0000-0003-0977-2771; /0000-0001-6231-3035	Radboud university medical center, Nijmegen, The Netherlands; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01GM08107]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [JE681/3-1]; Netherlands Organization for Scientific Research [184021007]; Rainbow Project of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL); Sophia foundations [SSWO S13-9]	Radboud university medical center, Nijmegen, The Netherlands(Netherlands Government); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Rainbow Project of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL); Sophia foundations	The work of RvdP and CW was supported by a personal research grant from the Radboud university medical center, Nijmegen, The Netherlands. CURE-Net was supported by a research grant from the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF), funding-sign 01GM08107 (2009-2012) and is now supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) under the funding sign JE681/3-1 (2013-2015). EB was supported by a grant (SSWO S13-9) of the Sophia foundations. Part of the funding for this project was provided by the Netherlands Organization for Scientific Research under award number 184021007, dated July 9, 2009 and made available as a Rainbow Project of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels T, 2017, IEEE TOPIC CONF WIRE, P1, DOI 10.1109/WISNET.2017.7878740; Blomberg MI, 2010, BIRTH DEFECTS RES A, V88, P35, DOI 10.1002/bdra.20620; Carter TC, 2013, ANN HUM GENET, V77, P31, DOI 10.1111/j.1469-1809.2012.00734.x; Correa A, 2003, PEDIATRICS, V111, P1146; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Cuschieri A, 2002, AM J MED GENET, V110, P122, DOI 10.1002/ajmg.10371; de Blaauw I, 2013, J PEDIATR SURG, V48, P2530, DOI 10.1016/j.jpedsurg.2013.07.022; Draaken M, 2012, INT J MOL MED, V30, P1459, DOI 10.3892/ijmm.2012.1124; Dworschak GC, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0729-7; Falcone RA, 2007, J PEDIATR SURG, V42, P124, DOI 10.1016/j.jpedsurg.2006.09.012; Frias JL, 2007, AM J MED GENET A, V143A, P2904, DOI 10.1002/ajmg.a.32071; Galesloot TE, 2017, INT J EPIDEMIOL, V46, P1099, DOI 10.1093/ije/dyw268; Gao RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074000; Garcia-Barcelo MM, 2008, BIRTH DEFECTS RES A, V82, P644, DOI 10.1002/bdra.20482; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Hartman EE, 2004, AM J GASTROENTEROL, V99, P907, DOI 10.1111/j.1572-0241.2004.04149.x; Holschneider A, 2005, J PEDIATR SURG, V40, P1521, DOI 10.1016/j.jpedsurg.2005.08.002; Hong HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044483; InternationalClearinghouse, 2014, ANN REP 2014 INT CLE; Kruger V, 2008, PEDIATR SURG INT, V24, P893, DOI 10.1007/s00383-008-2193-x; Papapetrou C, 1999, J MED GENET, V36, P208; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; Saisawat P, 2012, KIDNEY INT, V81, P196, DOI 10.1038/ki.2011.315; Seri M, 1999, HUM GENET, V104, P108, DOI 10.1007/s004390050919; Stoll C, 2007, EUR J MED GENET, V50, P281, DOI 10.1016/j.ejmg.2007.04.002; Svenningsson A, 2018, J PEDIATR SURG, V53, P2183, DOI 10.1016/j.jpedsurg.2018.04.021; Teerlink CC, 2018, J HUM GENET, V63, P1029, DOI 10.1038/s10038-018-0487-y; van de Putte R, 2017, HUM REPROD, V32, P299, DOI 10.1093/humrep/dew327; van de Putte R, 2015, EUR J PEDIATR, V174, P583, DOI 10.1007/s00431-014-2436-x; van Rooij IALM, 2016, BIRTH DEFECTS RES A, V106, P675, DOI 10.1002/bdra.23512; van Rooij IALM, 2010, BIRTH DEFECTS RES A, V88, P152, DOI 10.1002/bdra.20649; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745; Wijers CHW, 2013, BJOG-INT J OBSTET GY, V120, P1066, DOI 10.1111/1471-0528.12235; Wijers CHW, 2015, EPIDEMIOLOGY, V26, P169, DOI 10.1097/EDE.0000000000000226; Wijers CHW, 2014, BIRTH DEFECTS RES C, V102, P382, DOI 10.1002/bdrc.21068; Wong EHM, 2013, HUM MOL GENET, V22, P621, DOI 10.1093/hmg/dds451; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang J, 2009, J INT MED RES, V37, P1842, DOI 10.1177/147323000903700620; Zwink N, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-65	40	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217477	10.1371/journal.pone.0217477	http://dx.doi.org/10.1371/journal.pone.0217477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136621	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300043
J	Zeitlyn, D; Hook, DW				Zeitlyn, David; Hook, Daniel W.			Perception, prestige and PageRank	PLOS ONE			English	Article							ACADEMIC GENEALOGY; FIELD	Academic prestige is difficult to quantify in objective terms. Network theory offers the opportunity to use a mathematical formalism to model both the prestige associated with an academic and the relationships between academic colleagues. Early attempts using this line of reasoning have focused on intellectual genealogy as constituted by supervisor student networks. The process of examination is critical in many areas of study but has not played a part in existing models. A network theoretical "social" model is proposed as a tool to explore and understand the dynamics of prestige in the academic hierarchy. It is observed that such a model naturally gives rise to the idea that the prestige associated with a node in the graph (the prestige of an individual academic) can be viewed as a dynamic quantity that evolves with time based on both local and non-local changes in the properties in the network. The toy model studied here includes both supervisor-student and examiner-student relationships. This gives an insight into some of the key features of academic genealogies and naturally leads to a proposed model for "prestige propagation" on academic networks. This propagation is not solely directed forward in time (from teacher to progeny) but sometimes also flows in the other direction. As collaborators do well, this reflects well on those with whom they choose to collaborate and those that taught them. Furthermore, prestige as a quantity continues to be dynamic even after the end of a relationship or career. Given that time ordering of relationships on the network are implicit but that measures such as betweenness are independent of this implicit time dependence: the success of a PhD student later in their career can improve the prestige of their doctoral supervisor. Thus, prestige can be interpreted to have dynamics that flow both forward and backward in time.	[Zeitlyn, David] Univ Oxford, Sch Anthropol & Museum Ethnog, Inst Social & Cultural Anthropol, Oxford, England; [Hook, Daniel W.] Digital Sci, London, England; [Hook, Daniel W.] Imperial Coll London, Ctr Complex Sci, London, England; [Hook, Daniel W.] Washington Univ, Dept Phys, St Louis, MO 63130 USA	University of Oxford; Imperial College London; Washington University (WUSTL)	Zeitlyn, D (corresponding author), Univ Oxford, Sch Anthropol & Museum Ethnog, Inst Social & Cultural Anthropol, Oxford, England.	david.zeitlyn@anthro.ox.ac.uk	Zeitlyn, David/F-5961-2013	Zeitlyn, David/0000-0001-5853-7351; Hook, Daniel/0000-0001-9746-1193	Digital Science	Digital Science	Digital Science provided support in the form of salary for DWH and provided funding to support data analysis and travel to meetings, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work, conducted in 2015 and 2016, has led to and informed some consideration of product prototypes at Digital Science. At the date of submission no product has been brought to market that makes use of this research.	Blackmore P., 2015, PRESTIGE ACAD LIFE E; Bloudoff-Indelicato M., 2015, RES HIGHLIGHTS SOCIA, DOI [10.1038/nature.2015.18734, DOI 10.1038/NATURE.2015.18734]; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; David Stephen V, 2012, PLoS One, V7, pe46608, DOI 10.1371/journal.pone.0046608; Dores W, 2016, ACM-IEEE J CONF DIG, P163, DOI 10.1145/2910896.2910916; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Ferguson Niall, 2017, SQUARE TOWER NETWORK; Godechot O, 2004, REV FR SOCIOL, V45, P243, DOI 10.2307/3323157; Godechot O., 2011, HIST MESURE, P223, DOI [10.4000/histoiremesure.4268, DOI 10.4000/HISTOIREMESURE.4268]; Godechot O, 2003, COMMENT CHOISIR SON; Godechot O, 2010, SOCIOLOGIE, V1; Godechot O, 2003, PALAESTRA, V9, P62; Godechot O, 2010, ACAD INBREEDING EVAL; Goydar J., 2009, B SOCIOLOGICAL METHO, V101, P28, DOI [10.1177/075910630910100102, DOI 10.1177/075910630910100102]; Hamberger K., SAGE HDB SOCIAL NETW, P533, DOI [10.4135/9781446294413.n35, DOI 10.4135/9781446294413.N35]; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hutchins BI, 2016, BIORXIV, P29629, DOI [10.1101/029629, DOI 10.1101/029629]; KEENER JP, 1993, SIAM REV, V35, P80, DOI 10.1137/1035004; Kelley EA, 2007, AM J PHYS ANTHROPOL, V132, P406, DOI 10.1002/ajpa.20532; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Langville AN, 2012, SCI RATING RANKING; Ma YF, 2019, NATURE, V565, P287, DOI 10.1038/d41586-019-00091-3; Masuda N, 2016, GUIDE TEMPORAL NETWO; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; Overing J, 2015, INT ENCY SOCIAL BEHA, P36, DOI [10.1016/b978-0-08-097086-8.12098-7, DOI 10.1016/B978-0-08-097086-8.12098-7]; Russell Terrell G., 2009, Journal of Education for Library and Information Science, V50, P248; Sugimoto CR, 2011, J AM SOC INF SCI TEC, V62, P1808, DOI 10.1002/asi.21568; Wilsdon J., 2016, METRIC TIDE	28	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216783	10.1371/journal.pone.0216783	http://dx.doi.org/10.1371/journal.pone.0216783			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136588	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300009
J	Somda, S; Lebrun, A; Tranchart, H; Lamouri, K; Prevot, S; Njike-Nakseu, M; Gaillard, M; Lainas, P; Balian, A; Dagher, I; Perlemuter, G; Naveau, S; Voican, CS				Somda, Sosthene; Lebrun, Amandine; Tranchart, Hadrien; Lamouri, Karima; Prevot, Sophie; Njike-Nakseu, Micheline; Gaillard, Martin; Lainas, Panagiotis; Balian, Axel; Dagher, Ibrahim; Perlemuter, Gabriel; Naveau, Sylvie; Voican, Cosmin Sebastian			Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DIAGNOSTIC-ACCURACY; SCORING SYSTEM; STEATOSIS; FIBROSIS; CANDIDATES	Background and aim The controlled attenuation parameter (CAP) using FibroScan (Echosens, Paris, France) M or XL probe has been developed for liver steatosis assessment. However, CAP performs poorly in patients with high body mass index. The aim of our study was to assess whether CAP is overestimated using the standard XL probe in patients with morbid obesity, and in the case of an overestimation, to reprocess the data at a greater depth to obtain the appropriate CAP (CAPa). Patients and methods We conducted an observational prospective cohort study on a total of 249 severely obese patients admitted to our institution to undergo sleeve gastrectomy. Patients had a liver biopsy performed during the surgery and a CAP measurement during the 15 days preceding biopsy. Patient files were reprocessed retrospectively by an algorithm, blinded to the patients' clinical data. The algorithm automatically assessed the probe-to-capsula distance (PCD) by analysing the echogenicity of ultrasound signals on the time-motion mode. In the case of a distance >35 mm, the algorithm automatically selected a deeper measurement for CAP (CAPa). When PCD was less than 35 mm, the measured CAP was considered as appropriated (CAPa) and no further reprocessing was performed. Results CAP recording was not performed at a sufficient depth in 130 patients. In these patients, the CAPa obtained at the adapted depth was significantly lower than CAP (298 +/- 3.9 versus 340 +/- 4.2 dB/m; p<0.0001) measured at the standard depth (35 to 75 mm). Multiple linear regression analysis revealed that both body mass index and hepatic steatosis were independently correlated with CAP values. After reprocessing the CAP in patients with PCD > 35 mm, steatosis stage was the only parameter independently correlated with CAP values. For the diagnosis of steatosis (S >= 1), moderate to severe steatosis (S >= 2) and severe steatosis (S = 3), the AUROC curves of CAPa (measured CAP in patients with PCD<35 mm and reprocessed CAP in those with PCD>35 mm) were 0.86, 0.83 and 0.79, respectively. The Obuchowski measure for the diagnosis of steatosis was 0.90 +/- 0.013. Conclusion CAP was overestimated in a half of morbidly obese patients using an XL probe, but CAP can be performed correctly in these patients after adapting the measurement depth.	[Somda, Sosthene; Tranchart, Hadrien; Prevot, Sophie; Gaillard, Martin; Lainas, Panagiotis; Dagher, Ibrahim; Perlemuter, Gabriel; Naveau, Sylvie; Voican, Cosmin Sebastian] Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, Le Kremlin Bicetre, France; [Somda, Sosthene; Lebrun, Amandine; Lamouri, Karima; Njike-Nakseu, Micheline; Balian, Axel; Perlemuter, Gabriel; Naveau, Sylvie; Voican, Cosmin Sebastian] Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Hepato Gastroenterol & Nutr, Clamart, France; [Lebrun, Amandine; Prevot, Sophie; Perlemuter, Gabriel; Naveau, Sylvie; Voican, Cosmin Sebastian] DHU Hepatinov, Labex LERMIT, INSERM U996, Clamart, France; [Tranchart, Hadrien; Gaillard, Martin; Lainas, Panagiotis; Dagher, Ibrahim] Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Chirurg Digest Minimale Invas, Clamart, France; [Prevot, Sophie] Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Anat Pathol, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Voican, CS (corresponding author), Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, Le Kremlin Bicetre, France.; Voican, CS (corresponding author), Hop Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Hepato Gastroenterol & Nutr, Clamart, France.; Voican, CS (corresponding author), DHU Hepatinov, Labex LERMIT, INSERM U996, Clamart, France.	cosmin.voican@aphp.fr	Lainas, Panagiotis/Z-4112-2019	Lainas, Panagiotis/0000-0002-2438-8519				Audiere S, 2010, LECT NOTES COMPUT SC, V6362, P34; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Ciocan D, 2016, EUR J GASTROEN HEPAT, V28, P1014, DOI 10.1097/MEG.0000000000000671; de Ledinghen V, 2017, DIGEST DIS SCI, V62, P2569, DOI 10.1007/s10620-017-4638-3; de Ledinghen V, 2016, J GASTROEN HEPATOL, V31, P848, DOI 10.1111/jgh.13219; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hintze J., 2001, NCSS USERS GUIDE 1 U; Imajo K, 2016, GASTROENTEROLOGY, V150, P626, DOI 10.1053/j.gastro.2015.11.048; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lambert J, 2008, CLIN CHEM, V54, P1372, DOI 10.1373/clinchem.2007.097923; Merriman RB, 2006, HEPATOLOGY, V44, P874, DOI 10.1002/hep.21346; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Naveau S, 2017, EUR J GASTROEN HEPAT, V29, P1022, DOI 10.1097/MEG.0000000000000919; Obuchowski NA, 2001, STAT MED, V20, P3261, DOI 10.1002/sim.944.abs; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; R Core Team, 2020, R LANG ENV STAT COMP; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Shen F, 2015, LIVER INT, V35, P2392, DOI 10.1111/liv.12809; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217093	10.1371/journal.pone.0217093	http://dx.doi.org/10.1371/journal.pone.0217093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125357	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700017
J	Lee, HS; Park, M; Min, BW				Lee, Hyo-Sung; Park, Mingyo; Min, Byung-Wook			A 26-GHz transmitter front-end using double quadrature architecture	PLOS ONE			English	Article							MILLIMETER-WAVE COMMUNICATIONS; CMOS RECEIVER	A 26-GHz transmitter front-end is designed using 65 nm CMOS technology. The double frequency conversion transmitter consists of an intermediate frequency(IF) mixer, an millimeter-wave(mm-wave) mixer, and a pre-power amplifier. A double quadrature architecture is employed to accomplish image rejection without using an image rejection filter for the first time in the mm-wave frequency band. The IF mixer cores are designed as harmonic rejection mixers to avoid using IF filters. The measured conversion gain is 26.85 +/- 0.65 dB, with LO2 (IF LO) at 1-1.5 GHz and 26.9 +/- 0.6 dB with LO1 (mm-wave LO) at 27-29 GHz. The measured output return loss is less than -10 dB at 25.7-27.2 GHz. The output 1-dB compression point and the saturation output power measured at 26 GHz are 10 dBm and 14.1 dBm, respectively. The output-referred third-order intercept point (OIP3) measured at 26 GHz is 15.76 dBm. The third-order distortion, suppressed by the harmonic rejection mixer, is -60.5 dBc at an output power of 10 dBm. The error vector magnitude measured for OFDM 16-QAM with a 110-MHz signal bandwidth is -17.7 dB at an average output power of 3.5 dBm. The total power consumption of the proposed 26-GHz transmitter front-end is 267 mW, and it occupies a chip area of 2.31 mm(2).	[Lee, Hyo-Sung; Min, Byung-Wook] Yonsei Univ, Sch Elect & Elect Engn, Seoul 03722, South Korea; [Park, Mingyo] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA	Yonsei University; University System of Georgia; Georgia Institute of Technology	Min, BW (corresponding author), Yonsei Univ, Sch Elect & Elect Engn, Seoul 03722, South Korea.	bmin@yonsei.ac.kr	Min, Byung-Wook/AAM-9955-2020	Min, Byung-Wook/0000-0001-7456-8713	YSSRC; Space Core Technology Program through the National Research Foundation of Korea - Ministry of Science and ICT [NRF-2017M1A3A3A02016255]	YSSRC; Space Core Technology Program through the National Research Foundation of Korea - Ministry of Science and ICT	This work was supported by YSSRC and Space Core Technology Program through the National Research Foundation of Korea funded by the Ministry of Science and ICT (NRF-2017M1A3A3A02016255). The CAD tools were supported by IDEC.	3rd Generation Partnership Prject (3GPP), 381012 3GPP TS; [Anonymous], 2018, TECHNOLOGY NEWS 1023; Bae J, 2014, I C INF COMM TECH CO, P847, DOI 10.1109/ICTC.2014.6983310; Cao CH, 2008, IEEE J SOLID-ST CIRC, V43, P1394, DOI 10.1109/JSSC.2008.922734; Cha HK, 2010, IEEE T MICROW THEORY, V58, P2143, DOI 10.1109/TMTT.2010.2053072; Crols J, 1995, IEEE J SOLID-ST CIRC, V30, P1483, DOI 10.1109/4.482196; Elkashlan M, 2014, IEEE COMMUN MAG, V52, P52, DOI 10.1109/MCOM.2014.6894452; Haider SS, 2018, 2018 18 INT S ANT TE, P1; HARTLEY R, 1928, Patent No. 1666206; Jen YN, 2009, IEEE MICROW WIREL CO, V19, P42, DOI 10.1109/LMWC.2008.2008591; Joo S, 2009, IEEE J SOLID-ST CIRC, V44, P3019, DOI 10.1109/JSSC.2009.2031912; Lee JW, 2008, IEEE MICROW WIREL CO, V18, P755, DOI 10.1109/LMWC.2008.2005236; Martineau Baudouin, 2010, 2010 IEEE International Solid-State Circuits Conference (ISSCC), P428, DOI 10.1109/ISSCC.2010.5433879; Natarajan AL, 2005, IEEE J SOLID-ST CIRC, V40, P2502, DOI 10.1109/JSSC.2005.857420; Niu Y, 2015, WIREL NETW, V21, P2657, DOI 10.1007/s11276-015-0942-z; Okada K, 2014, ISSCC DIG TECH PAP I, V57, P346, DOI 10.1109/ISSCC.2014.6757463; Patzold M, 2018, IEEE VEH TECHNOL MAG, V13, P4, DOI 10.1109/MVT.2018.2849038; Pi ZY, 2011, IEEE COMMUN MAG, V49, P101, DOI 10.1109/MCOM.2011.5783993; Razavi B, 1996, IEEE CIRCUIT DEVIC, V12, P12, DOI 10.1109/101.537352; Roh W, 2014, IEEE COMMUN MAG, V52, P106, DOI 10.1109/MCOM.2014.6736750; Rudell JC, 1997, IEEE J SOLID-ST CIRC, V32, P2071, DOI 10.1109/4.643665; Saito N, 2013, IEEE J SOLID-ST CIRC, V48, P3146, DOI 10.1109/JSSC.2013.2279573; Siligaris A, 2011, IEEE J SOLID-ST CIRC, V46, P3005, DOI 10.1109/JSSC.2011.2166662; Terrovitis MT, 2000, IEEE J SOLID-ST CIRC, V35, P1461, DOI 10.1109/4.871323; Vidojkovic V, 2013, ISSCC DIG TECH PAP I, V56, P236, DOI 10.1109/ISSCC.2013.6487715; WEAVER DK, 1956, P IRE, V44, P1703, DOI 10.1109/JRPROC.1956.275061; Wei LL, 2014, IEEE WIREL COMMUN, V21, P136, DOI 10.1109/MWC.2014.7000981; Weldon JA, 2001, IEEE J SOLID-ST CIRC, V36, P2003, DOI 10.1109/4.972151; Zhao DX, 2012, IEEE J SOLID-ST CIRC, V47, P3172, DOI 10.1109/JSSC.2012.2216692	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216474	10.1371/journal.pone.0216474	http://dx.doi.org/10.1371/journal.pone.0216474			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120917	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700019
J	Mckay, B; Castellanos, M; Ebell, M; Whalen, CC; Handel, A				Mckay, Brian; Castellanos, Maria; Ebell, Mark; Whalen, Christopher C.; Handel, Andreas			An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OBSERVED TREATMENT DOT; VARIANCE ESTIMATORS; CLINICAL-TRIALS; HEALTH-WORKERS; EFFICACY; HETEROGENEITY; NONCOMPLIANCE; URBAN; BIAS	Directly observed therapy (DOT) is almost universally used for the treatment of TB. Several meta-analyses using different methods have assessed the effectiveness of DOT compared to self-administered therapy (SAT). The results of these meta-analyses often conflict with some concluding DOT is superior and others that there is little or no difference. Meta-analyses can guide policymaking, but such analyses must be reliable. To assess the validity of a previous meta-analysis, we tried to reproduce it. We encountered problems with the previous analysis that did not allow for a meaningful reproduction. We describe the issues we encountered here. We then performed a new meta-analysis comparing the treatment outcomes of adults given treatment with SAT versus DOT. Outcomes in the new analysis are loss to follow-up, treatment failure, cure, treatment completed, and all-cause mortality. All data, documentation, and code used to generate our results is provided. Our new analysis included four randomized and three observational studies with 1603 and 1626 individuals respectively. The pooled relative risks (RR) are as follows: Lost to follow-up (RR = 1.2, 95% CI 0.9, 1.7), Treatment Failure (RR = 1.1, 95% CI 0.6, 2), Cure (RR = 0.9, 95% CI 0.8, 1.1), Treatment Completion (RR = 1, 95% CI 0.9, 1.1), Mortality (RR = 0.9, 95% CI 0.6, 1.3). Based on data from our new meta-analysis, the magnitude of the difference between DOT and SAT for all reported outcomes is small, and none of the differences are statistically significant.	[Mckay, Brian; Castellanos, Maria; Ebell, Mark; Whalen, Christopher C.; Handel, Andreas] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Mckay, B; Handel, A (corresponding author), Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	bmckay52@uga.edu; ahandel@uga.edu		Handel, Andreas/0000-0002-4622-1146; Castellanos, Maria Eugenia/0000-0002-8181-6321; McKay, Brian/0000-0003-3859-7634				Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Alvarez-Gordillo GD, 1998, SALUD PUBLICA MEXICO, V40, P272, DOI 10.1590/S0036-36341998000300008; [Anonymous], 1997, Int J Tuberc Lung Dis, V1, P509; [Anonymous], R LANG ENV STAT COMP; Anuwatnonthakate A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003089; Borenstein M., 2009, INTRO METAANALYSIS, P69, DOI DOI 10.1002/9780470743386.CH12; de Steenwinkel JEM, 2012, ANTIMICROB AGENTS CH, V56, P4937, DOI 10.1128/AAC.00124-12; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Denkinger CM, 2013, INT J TUBERC LUNG D, V17, P719, DOI 10.5588/ijtld.12.0638; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Garner P, 2003, BRIT MED J, V327, P823, DOI 10.1136/bmj.327.7419.823; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Green S, 2008, COCHRANE HDB SYSTEMA, V5; Jackson D, 2010, J STAT PLAN INFER, V140, P961, DOI 10.1016/j.jspi.2009.09.017; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P561, DOI 10.1164/rccm.200401-095OC; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kironde Samson, 2002, Afr Health Sci, V2, P16; Lwilla F, 2003, TROP MED INT HEALTH, V8, P204, DOI 10.1046/j.1365-3156.2003.00999.x; MacIntyre CR, 2003, INT J TUBERC LUNG D, V7, P848; Macq JCM, 2003, INT J TUBERC LUNG D, V7, P103; Mathema B, 2001, INT J TUBERC LUNG D, V5, P912; McLaren ZM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1862-y; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moonan PK, 2013, CLIN INFECT DIS, V57, P1062, DOI 10.1093/cid/cit431; Muller AM, 2018, INT J TUBERC LUNG D, V22, P731, DOI 10.5588/ijtld.17.0596; Nunn AJ, 2013, CLIN INFECT DIS, V57, P1064, DOI 10.1093/cid/cit433; Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762; Ormerod LP, 2002, INT J TUBERC LUNG D, V6, P662; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P1223, DOI 10.1093/cid/cit487; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Pungrassami P, 2002, TROP MED INT HEALTH, V7, P271, DOI 10.1046/j.1365-3156.2002.00849.x; Schwab M, 2000, COMPUT SCI ENG, V2, P61, DOI 10.1109/5992.881708; Seaworth BJ, 2013, CLIN INFECT DIS, V57, P1063, DOI 10.1093/cid/cit432; Sidik K, 2007, STAT MED, V26, P1964, DOI 10.1002/sim.2688; Srivastava S, 2011, J INFECT DIS, V204, P1951, DOI 10.1093/infdis/jir658; Tandon Monika, 2002, Indian J Med Sci, V56, P19; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thorlund K, 2011, RES SYNTH METHODS, V2, P238, DOI 10.1002/jrsm.53; Tian JH, 2014, INT J TUBERC LUNG D, V18, P1092, DOI 10.5588/ijtld.13.0867; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Viswanathan M., 2013, AHRQ METHODS EFFECTI; Volmink J., 2007, COCHRANE DATABASE SY, V4; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; WHO, 2017, TREATMENT TUBERCULOS; World Health Organization, 1999, WHAT IS DOTS GUID UN; Wright J, 2004, TROP MED INT HEALTH, V9, P559, DOI 10.1111/j.1365-3156.2004.01230.x; Zwarenstein M, 2000, INT J TUBERC LUNG D, V4, P550; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	56	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217219	10.1371/journal.pone.0217219	http://dx.doi.org/10.1371/journal.pone.0217219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120965	gold, Green Published, Green Accepted			2022-12-27	WOS:000468775700071
J	Yang, MC; Liu, HK; Su, YT; Tsai, CC; Wu, JR				Yang, Ming-Chun; Liu, Hsien-Kuan; Su, Yu-Tsun; Tsai, Ching-Chung; Wu, Jiunn-Ren			Serum apoptotic marker M30 is positively correlated with early diastolic dysfunction in adolescent obesity	PLOS ONE			English	Article							HIGH-SENSITIVITY C; CARDIOVASCULAR RISK; CHILDHOOD OBESITY; REACTIVE PROTEIN; CARDIAC GEOMETRY; HEART-FAILURE; CHILDREN; PRESSURE; HYPERTROPHY; ASSOCIATION	Purpose Obesity in adolescence has been shown to be related to cardiac geometric and functional changes. Cardiac dysfunction in adults with obesity could be attributed to chronic low-grade inflammation, apoptosis of cardiomyocyte, and glucose metabolic disorder. The aforementioned association in adolescents with obesity have never been well studied. Our aim was to determine the types of cardiac dysfunction in adolescents with obesity and survey the association between cardiac dysfunction and chronic low-grade inflammation, apoptosis, and glucose dysregulation in adolescents with obesity. Methods Adolescents aged between 10 and 20 years were enrolled in this study. Body mass index, waist-to-hip ratio, blood pressure, glucose metabolism, and high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-alpha), and apoptosis marker M30 levels were measured. Echocardiographic indices were also measured. The association between serum biomarkers and echocardiographic function parameters was analyzed. Results Diastolic dysfunction was the major finding in the cardiac functional assessment. The main changes in glucose metabolism were elevated C-peptide level and insulin resistance. HsCRP, IL-6, and M30 levels also increased with adolescent obesity. M30 was the major biomarker that was highly correlated to diastolic dysfunction indices in adolescents with obesity. Conclusions Diastolic dysfunction was the main change in adolescent obesity. Insulin resistance, apoptotic marker M30, hs-CRP, and IL-6 were all elevated in adolescents with obesity. Only M30 was related to indices of left ventricular diastolic dysfunction among adolescents with obesity, rather than inflammation or insulin resistance.	[Yang, Ming-Chun; Liu, Hsien-Kuan; Su, Yu-Tsun; Tsai, Ching-Chung; Wu, Jiunn-Ren] E Da Hosp, Dept Pediat, Kaohsiung, Taiwan; [Yang, Ming-Chun; Tsai, Ching-Chung] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Yang, Ming-Chun; Su, Yu-Tsun; Tsai, Ching-Chung] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; I Shou University	Tsai, CC; Wu, JR (corresponding author), E Da Hosp, Dept Pediat, Kaohsiung, Taiwan.; Tsai, CC (corresponding author), I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan.; Tsai, CC (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.	u101130@gmail.com.tw; jirewu@gmail.com		Yang, Ming-chun/0000-0002-5981-5728	E-Da hospital [EDAHP105034, EDAHP104041, EDAHP107046]	E-Da hospital	This study was supported by intramural funding provided by the E-Da hospital (EDAHP105034, EDAHP104041, and EDAHP107046). The sponsor had no involvement in study design, the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	Andersen OS, 2017, J AM COLL CARDIOL, V69, P1938, DOI 10.1016/j.jacc.2017.01.058; [Anonymous], 2003, Paediatr Child Health, V8, P577; Bajaj NS, 2018, J AM COLL CARDIOL, V72, P707, DOI 10.1016/j.jacc.2018.05.049; Balagopal P, 2011, CIRCULATION, V123, P2749, DOI 10.1161/CIR.0b013e31821c7c64; BING OHL, 1994, J MOL CELL CARDIOL, V26, P943, DOI 10.1006/jmcc.1994.1115; Brady TM, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0608-3; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Chinali M, 2006, J AM COLL CARDIOL, V47, P2267, DOI 10.1016/j.jacc.2006.03.004; Cloward TV, 2003, CHEST, V124, P594, DOI 10.1378/chest.124.2.594; Cote AT, 2013, J AM COLL CARDIOL, V62, P1309, DOI 10.1016/j.jacc.2013.07.042; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Dhuper S, 2011, OBESITY, V19, P128, DOI 10.1038/oby.2010.134; Di Salvo G, 2006, EUR HEART J, V27, P2689, DOI 10.1093/eurheartj/ehl163; Dinh W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-58; Dusan P, 2015, PEDIATR NEPHROL, V30, P645, DOI 10.1007/s00467-014-2992-3; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Ingul CB, 2010, ARCH PEDIAT ADOL MED, V164, P852, DOI 10.1001/archpediatrics.2010.158; Ippisch HM, 2008, J AM COLL CARDIOL, V51, P1342, DOI 10.1016/j.jacc.2007.12.029; James TN, 1996, CIRCULATION, V93, P1588, DOI 10.1161/01.CIR.93.8.1588; Jyothirmayi, 1998, J Cardiovasc Pharmacol Ther, V3, P319, DOI 10.1177/107424849800300407; KAJSTURA J, 1995, EXP CELL RES, V219, P110, DOI 10.1006/excr.1995.1211; Khoury PR, 2009, J AM SOC ECHOCARDIOG, V22, P709, DOI 10.1016/j.echo.2009.03.003; Li X, 2004, ZHONG NAN DA XUE XUE, V29, P41923; Mahfouz RA, 2012, ECHOCARDIOGR-J CARD, V29, P984, DOI 10.1111/j.1540-8175.2012.01736.x; Mangner N, 2014, JACC-CARDIOVASC IMAG, V7, P1198, DOI 10.1016/j.jcmg.2014.08.006; Masugata H, 2011, TOHOKU J EXP MED, V223, P263, DOI 10.1620/tjem.223.263; McMahon CJ, 2004, CIRCULATION, V109, P1756, DOI 10.1161/01.CIR.0000124723.16433.31; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Morka A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002820; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Piccini JP, 2004, AM J MED, V116, P64, DOI 10.1016/j.amjmed.2003.10.021; Rajaram V, 2011, OPEN CARDIOVASC MED, V5, P188, DOI 10.2174/1874192401105010188; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; Tei C, 1995, J Cardiol, V26, P135; Turkoglu C, 2016, CORONARY ARTERY DIS, V27, P690, DOI 10.1097/MCA.0000000000000416; Ya J, 1998, CIRC RES, V82, P464, DOI 10.1161/01.RES.82.4.464; Yilmaz Y, 2009, ALIMENT PHARM THER, V30, P1103, DOI 10.1111/j.1365-2036.2009.04148.x; Zhang LP, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6967853	41	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217429	10.1371/journal.pone.0217429	http://dx.doi.org/10.1371/journal.pone.0217429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120986	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700103
J	Loreck, K; Mitrenga, S; Meemken, D; Heinze, R; Reissig, A; Mueller, E; Ehricht, R; Engemann, C; Greiner, M				Loreck, Katharina; Mitrenga, Sylvia; Meemken, Diana; Heinze, Regina; Reissig, Annett; Mueller, Elke; Ehricht, Ralf; Engemann, Claudia; Greiner, Matthias			Development of a miniaturized protein microarray as a new serological IgG screening test for zoonotic agents and production diseases in pigs	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; RESPIRATORY SYNDROME VIRUS; REAL-TIME PCR; MULTIPLEX PCR; MEAT JUICE; MONOCLONAL-ANTIBODY; ELISA; PATHOGENS; ARRAY	In order to monitor the occurrence of zoonotic agents in pig herds as well as to improve herd health management, the development of new cost-effective diagnostic methods for pigs is necessary. In this study, a protein microarray-based assay for the simultaneous detection of immunoglobulin G (IgG) antibodies against different zoonotic agents and pathogens causing production diseases in pigs was developed. Therefore, antigens of ten different important swine pathogens (Toxoplasma gondii, Yersinia enterocolitica, Salmonella spp., Trichinella spp., Mycobacterium avium, Hepatitis E virus, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, the porcine reproductive and respiratory syndrome virus, Influenza A virus) were spotted and covalently immobilized as 'antigen-spots' on microarray chips in order to test pig serum for the occurrence of antibodies. Pig serum was sampled at three German abattoirs and ELISA tests for the different pathogens were conducted with the purpose of creating a panel of reference samples for microarray analysis. To evaluate the accuracy of the antigens on the microarray, receiver operating characteristic (ROC) curve analysis using the ELISA test results as reference was performed for the different antigens. High area under curve values were achieved for the antigens of two zoonotic agents: Toxoplasma gondii (0.91), Yersinia enterocolitica (0.97) and for three production diseases: Actinobacillus pleuropneumoniae (0.77), Mycoplasma hyopneumoniae (0.94) and the porcine reproductive and respiratory syndrome virus (0.87). With the help of the newly developed microarray assay, collecting data on the occurrence of antibodies against zoonotic agents and production diseases in pig herds could be minimized to one measurement, resulting in an efficient screening test.	[Loreck, Katharina; Mitrenga, Sylvia; Greiner, Matthias] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Meemken, Diana] Free Univ Berlin, Inst Food Safety & Food Hyg, Berlin, Germany; [Heinze, Regina] Abbott Alere Technol GmbH, Jena, Germany; [Reissig, Annett; Mueller, Elke; Ehricht, Ralf] Leibniz Inst Photon Technol IPHT, Dept Opt Mol Diagnost & Syst Technol, Jena, Germany; [Reissig, Annett; Mueller, Elke; Ehricht, Ralf] Ctr Appl Res, InfectoGnost Res Campus, Jena, Germany; [Engemann, Claudia] Ind Biosci GmbH, Leipzig, Germany; [Greiner, Matthias] German Fed Inst Risk Assessment BfR, Dept Exposure, Berlin, Germany	University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; Alere; Leibniz Institut fur Photonische Technologien; Federal Institute for Risk Assessment	Loreck, K (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	katharina.loreck@tiho-hannover.de			European Innovation Partnership for Agricultural Productivity and Sustainability (EIP-AGRI); Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover; Abbott/Alere Technologies GmbH; Indical Bioscience GmbH	European Innovation Partnership for Agricultural Productivity and Sustainability (EIP-AGRI); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover; Abbott/Alere Technologies GmbH; Indical Bioscience GmbH	This work has received funding from the European Innovation Partnership for Agricultural Productivity and Sustainability (EIP-AGRI, https://ec.europa.eu/eip/agriculture/) to DM. The funder provided support in the form of salaries for authors KL and SM. This publication was also supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. Both funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Abbott/Alere Technologies GmbH and Indical Bioscience GmbH provided support in the form of salaries for authors RH and CE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agdestein A, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-46; Alban L, 2011, EFSA SUPP PUBL, V8, p190E, DOI [10.2903/sp.efsa.2011.EN-190, DOI 10.2903/SP.EFSA.2011.EN-190]; Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2351; Berger SS, 2017, J VET DIAGN INVEST, V29, P797, DOI 10.1177/1040638717719481; Berthe F, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.s1002; Bokken GCAM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-36; Cannon R.M., 1982, LIVESTOCK DIS SURVEY; Chang CY, 2014, J VIROL METHODS, V201, P13, DOI 10.1016/j.jviromet.2014.01.016; Chen X, 2015, PARASITE IMMUNOL, V37, P10, DOI 10.1111/pim.12151; Chu JQ, 2009, J MICROBIOL, V47, P582, DOI 10.1007/s12275-009-0033-x; de Brevern AG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-114; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; EKINS RP, 1989, J PHARMACEUT BIOMED, V7, P155, DOI 10.1016/0731-7085(89)80079-2; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Felin E, 2015, ZOONOSES PUBLIC HLTH, V62, P456, DOI 10.1111/zph.12174; Felin E, 2017, VET PARASITOL, V238, P30, DOI 10.1016/j.vetpar.2017.03.012; Fraile L, 2010, VET J, V184, P326, DOI 10.1016/j.tvjl.2009.03.029; Fredriksson-Ahomaa M, 2006, J MED MICROBIOL, V55, P747, DOI 10.1099/jmm.0.46523-0; Fredriksson-Ahomaa M, 2001, EPIDEMIOL INFECT, V127, P37, DOI 10.1017/S0950268801005611; Gardner IA, 2006, VET CLIN PATH, V35, P8, DOI 10.1111/j.1939-165X.2006.tb00082.x; Giammarioli M, 2008, VET RES COMMUN, V32, P255, DOI 10.1007/s11259-007-9026-6; Hahne S., 2014, ELEKT RESSOURCE; Haines FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071019; Huelseweh B, 2006, PROTEOMICS, V6, P2972, DOI 10.1002/pmic.200500721; Kohler C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004847; Liu MJ, 2016, J VET MED SCI, V78, P1319, DOI 10.1292/jvms.15-0438; Lung O, 2017, TRANSBOUND EMERG DIS, V64, P834, DOI 10.1111/tbed.12449; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; Meemken D, 2014, PREV VET MED, V113, P589, DOI 10.1016/j.prevetmed.2013.12.006; Merialdi G, 2012, VET J, V193, P234, DOI 10.1016/j.tvjl.2011.11.009; Monecke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100427; OIE-WHO, 2014, MANUAL DIAGNOSTIC TE; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Salines M, 2017, VET RES, V48, DOI 10.1186/s13567-017-0436-3; Selle M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24754; Shi M, 2010, VIRUS RES, V154, P7, DOI 10.1016/j.virusres.2010.08.014; STAQUET M, 1981, J CHRON DIS, V34, P599, DOI 10.1016/0021-9681(81)90059-X; Staudt N, 2014, BIOCHEM BIOPH RES CO, V445, P785, DOI 10.1016/j.bbrc.2013.12.033; Steinparzer R, 2015, ZOONOSES PUBLIC HLTH, V62, P119, DOI 10.1111/zph.12122; Stieber B, 2014, MOL CELL PROBE, V28, P123, DOI 10.1016/j.mcp.2013.11.003; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Team RC, 2016, R LANG ENV STAT COMP; Thibodeau V, 2001, VET MICROBIOL, V82, P249, DOI 10.1016/S0378-1135(01)00356-X; Tizard I.R., 2004, VET IMMUNOLOGY INTRO, P67; van der Wal FJ, 2013, VET J, V196, P439, DOI 10.1016/j.tvjl.2012.10.029; Vanantwerpen G, 2015, VET MICROBIOL, V178, P114, DOI 10.1016/j.vetmic.2015.05.004; Wang HJ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-11; Wang XQ, 2013, J VIROL METHODS, V191, P9, DOI 10.1016/j.jviromet.2013.03.023; Wu HG, 2014, MOL CELL PROBE, V28, P264, DOI 10.1016/j.mcp.2014.07.001; Wutz K, 2013, ANAL CHEM, V85, P5279, DOI 10.1021/ac400781t; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	54	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217290	10.1371/journal.pone.0217290	http://dx.doi.org/10.1371/journal.pone.0217290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116794	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400056
J	Di Falco, S; Lokina, R; Martinsson, P; Pin, P				Di Falco, Salvatore; Lokina, Razack; Martinsson, Peter; Pin, Paolo			Altruism and the pressure to share: Lab evidence from Tanzania	PLOS ONE			English	Article							RISK; NETWORKS; BEHAVIOR; KINSHIP; PREFERENCES; RECIPROCITY; COMMITMENT; INSURANCE; EVOLUTION; ECONOMICS	We propose a novel laboratory experiment to document the pressure to share income within social networks in Africa. We find that the redistributive pressure exerted via the possibility of receiving a claim increases altruism, while the possibility of hiding from such claim reduces it. Our results indicate that sharing norms are crucial drivers of giving to other members of the network. We also find that pressure to share has a detrimental effect on the undertaking of profitable but risky investments.	[Di Falco, Salvatore] Univ Geneva, Inst Econ & Econometr, Geneva Sch Econ & Management, Geneva, Switzerland; [Lokina, Razack] Univ Dar Es Salaam, Dept Econ, Dar Es Salaam, Tanzania; [Martinsson, Peter] Univ Gothenburg, Dept Econ, Gothenburg, Sweden; [Pin, Paolo] Univ Siena, Dipartimento Econ Polit & Stat, Siena, Italy; [Pin, Paolo] Univ Bocconi, IGIER, Milan, Italy; [Pin, Paolo] Univ Bocconi, BIDSA, Milan, Italy	University of Geneva; University of Dar es Salaam; University of Gothenburg; University of Siena; Bocconi University; Bocconi University	Di Falco, S (corresponding author), Univ Geneva, Inst Econ & Econometr, Geneva Sch Econ & Management, Geneva, Switzerland.	Salvatore.difalco@unige.ch		Pin, Paolo/0000-0001-9907-4947; Lokina, Razack/0000-0001-7180-5541; Martinsson, Peter/0000-0002-1146-9248; Di Falco, Salvatore/0000-0001-9554-6791	World Bank via the Environment for Development Initiative (EfD); Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN) [2015592CTH]	World Bank via the Environment for Development Initiative (EfD); Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR))	Financial support from the World Bank via the Environment for Development Initiative (EfD), and by the Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN) Grant 2015592CTH, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger I., 2008, ARGUMENTS BETTER W 2, VII; Alger I, 2010, AM ECON REV, V100, P1725, DOI 10.1257/aer.100.4.1725; Anderson S, 2002, Q J ECON, V117, P963, DOI 10.1162/003355302760193931; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Andreoni J., 2011, NBER WORKING PAPER S; Angelucci M, 2010, J PUBLIC ECON, V94, P197, DOI 10.1016/j.jpubeco.2009.12.002; Angelucci M, 2009, AM ECON REV, V99, P486, DOI 10.1257/aer.99.1.486; Attanasio O, 2012, AM ECON J-APPL ECON, V4, P134, DOI 10.1257/app.4.2.134; Attanasio OP, 2011, ECONOMETRICA, V79, P1027, DOI 10.3982/ECTA7063; Baland JM, 2011, ECON DEV CULT CHANGE, V60, P1, DOI 10.1086/661220; Barr A., 2008, WPS200826 CSAE; Barr A, 2012, ECON DEV CULT CHANGE, V60, P677, DOI 10.1086/665599; Batista C, 2015, J ECON BEHAV ORGAN, V118, P2, DOI 10.1016/j.jebo.2015.03.008; BECKER GS, 1976, J ECON LIT, V14, P817; Benabou R, 2002, Q J ECON, V117, P871, DOI 10.1162/003355302760193913; BERGSTROM TC, 1995, AM ECON REV, V85, P58; Berte N. A., 1988, HUMAN REPROD BEHAV D, P83; Bowles S, 2005, NATURE, V434, P380, DOI 10.1038/nature03420; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Brocas I, 2014, J ECON PSYCHOL, V41, P45, DOI 10.1016/j.joep.2013.01.004; Buchan NR, 2006, J ECON BEHAV ORGAN, V60, P373, DOI 10.1016/j.jebo.2004.03.017; Cain DLM, 2014, ACAD MANAG ANN, V8, P505, DOI 10.1080/19416520.2014.911576; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Charness G, 2007, AM ECON REV, V97, P1340, DOI 10.1257/aer.97.4.1340; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Chuang YT, 2015, ANNU REV RESOUR ECON, V7, P451, DOI 10.1146/annurev-resource-100814-125123; COATE S, 1993, J DEV ECON, V40, P1, DOI 10.1016/0304-3878(93)90102-S; Comola M, 2014, ECON J, V124, P954, DOI 10.1111/ecoj.12071; Cox D, 2008, HBK ECON, V9, P3711, DOI 10.1016/S1573-4471(07)04058-2; Curry O, 2013, BRIT J PSYCHOL, V104, P283, DOI 10.1111/j.2044-8295.2012.02119.x; Dana J, 2006, ORGAN BEHAV HUM DEC, V100, P193, DOI 10.1016/j.obhdp.2005.10.001; DellaVigna S, 2012, Q J ECON, V127, P1, DOI 10.1093/qje/qjr050; Di Falco S, 2018, J DEV ECON, V131, P123, DOI 10.1016/j.jdeveco.2017.12.001; Di Falco S, 2013, WORLD DEV, V43, P100, DOI 10.1016/j.worlddev.2012.10.011; di Falco S, 2011, J DEV STUD, V47, P1128, DOI 10.1080/00220388.2010.514328; Fafchamps M, 2003, J DEV ECON, V71, P261, DOI 10.1016/S0304-3878(03)00029-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Foster AD, 2001, REV ECON STAT, V83, P389, DOI 10.1162/00346530152480054; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Fudenberg D, 2011, AM ECON J-MICROECON, V3, P34, DOI 10.1257/mic.3.3.34; Genicot G, 2016, ECON LETT, V145, P92, DOI 10.1016/j.econlet.2016.05.027; Goldberg J., 2013, LESSER 2 EVILS UNPUB; Greif A, 2006, AM ECON REV, V96, P308, DOI 10.1257/000282806777212602; Grimm M., 2013, J SMALL BUSINESS ENT, V26, P125, DOI DOI 10.1080/08276331.2013.771854; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hoff K., 2006, TRAPS POVERTY; Jakiela P., 2015, REV ECON STUD, P1; Kinnan C., 2022, JOURNAL; Knutsson M, 2013, J ECON BEHAV ORGAN, V93, P71, DOI 10.1016/j.jebo.2013.07.015; La Ferrara E, 2003, AM ECON REV, V93, P1730; La Ferrara E, 2007, J DEV ECON, V83, P280, DOI 10.1016/j.jdeveco.2006.09.001; Laferrere A., 2006, HDB EC GIVING ALTRUI, V2, DOI DOI 10.1016/S1574-0714(06)02013-6; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Ligon E, 2012, J DEV ECON, V99, P13, DOI 10.1016/j.jdeveco.2011.12.002; List JA, 2007, J POLIT ECON, V115, P482, DOI 10.1086/519249; Mullainathan S, 2008, Q J ECON, V123, P577, DOI 10.1162/qjec.2008.123.2.577; Platteau J. P., 1991, Social security in developing countries., P112; Platteau J.P., 2000, I SOCIAL NORMS EC DE; Platteau J.-P., 2014, AFRICAS DEV HIST PER; Platteau J.-P., 1996, IEA ROUND TABL C I F; RABIN M, 1993, AM ECON REV, V83, P1281; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Rosenzweig M. R., 1988, HDB DEV EC, V1, P713; Scott J.C, 2008, WEAPONS WEAK EVERYDA, DOI DOI 10.12987/9780300153620; SIMON HA, 1990, SCIENCE, V250, P1665, DOI 10.1126/science.2270480; Squires M, 2016, KINSHIP TAXATI UNPUB; TOWNSEND RM, 1994, ECONOMETRICA, V62, P539, DOI 10.2307/2951659; Udry C, 1995, AM ECON REV, V85, P1287; Verschoor A, 2016, J ECON BEHAV ORGAN, V128, P134, DOI 10.1016/j.jebo.2016.05.009; Vischer T, 2013, ECON LETT, V120, P142, DOI 10.1016/j.econlet.2013.04.007; ZELLNER A, 1962, J AM STAT ASSOC, V57, P348, DOI 10.2307/2281644; 2017, ECONOMETRICA, V85, P521, DOI DOI 10.3982/ECTA13636; 2006, AM EC REV, V96, P1652; 2015, AM ECON REV, V105, P272, DOI DOI 10.1257/AER.20130047	74	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0212747	10.1371/journal.pone.0212747	http://dx.doi.org/10.1371/journal.pone.0212747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112534	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000004
J	Karafin, MS; Chen, GY; Wandersee, NJ; Brandow, AM; Hurley, RW; Simpson, P; Ward, D; Li, SJ; Field, JJ				Karafin, Matthew S.; Chen, Guangyu; Wandersee, Nancy J.; Brandow, Amanda M.; Hurley, Robert W.; Simpson, Pippa; Ward, Doug; Li, Shi-Jiang; Field, Joshua J.			Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; PERIAQUEDUCTAL GRAY; CLINICAL PAIN; STATE; REPRESENTATION; ABNORMALITIES; SENSITIZATION; MECHANISMS; EXPERIENCE; ANATOMY	Chronic pain affects 50% of adults with sickle cell disease (SCD). Although central sensitization is thought to contribute to the pathogenesis of this chronic pain, no studies have examined differences in functional connectivity of the brain between patients with SCD with and without chronic pain. We performed an observational cohort study using resting-state functional MRI (rsfMRl) of the brain on adults with SCD with and without chronic pain. We tested the hypothesis that, compared to those without chronic pain, those with chronic pain would have differences in functional connectivity between the periaqueductal grey (PAG) and other regions of the brain. Twenty-two adults with SCD, 15 with chronic pain and 7 without chronic pain, as well as 10 African-American controls, underwent rsfMRl of the brain. When SCD patients with chronic pain were compared to those without chronic pain, significant differences in connectivity were noted between the PAG and 9 regions of the brain, including several in the default mode network, a network involved in introspection that has been implicated in other chronic pain syndromes. Changes in functional connectivity between patients with SCD with and without chronic pain suggest a mechanism for chronic pain that involves neuro-plastic changes to the brain.	[Karafin, Matthew S.; Wandersee, Nancy J.; Field, Joshua J.] Bloodctr Wisconsin, Med Sci Inst, Milwaukee, WI 53214 USA; [Karafin, Matthew S.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Chen, Guangyu; Ward, Doug; Li, Shi-Jiang] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Brandow, Amanda M.; Field, Joshua J.] Med Coll Wisconsin, Dept Hematol, Milwaukee, WI 53226 USA; [Hurley, Robert W.] Wake Forest Sch Med, Dept Anesthesia, Winston Salem, NC USA; [Simpson, Pippa] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Wake Forest University; Medical College of Wisconsin	Karafin, MS (corresponding author), Bloodctr Wisconsin, Med Sci Inst, Milwaukee, WI 53214 USA.; Karafin, MS (corresponding author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.	matthew.karafin@bcw.edu	MD/PhD, Robert W. Hurley/V-6619-2019; simpson, pippa/AAI-8172-2020	simpson, pippa/0000-0003-1458-3748	Clinical and Translational Sciences Institute and Advancing a Healthier Wisconsin Research and Education Program Fund [UL1TR001436]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001436] Funding Source: NIH RePORTER	Clinical and Translational Sciences Institute and Advancing a Healthier Wisconsin Research and Education Program Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by: A grant from the Clinical and Translational Sciences Institute and Advancing a Healthier Wisconsin Research and Education Program Fund (UL1TR001436) (JJF). Funder website: https://www.mcw.edu/Graduate-School/Academic-Bulletin/Clinical-Translational-Science-Institute-CTSI.htm. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Brandow AM, 2014, PEDIATR BLOOD CANCER, V61, P512, DOI 10.1002/pbc.24838; Brandow AM, 2013, AM J HEMATOL, V88, P37, DOI 10.1002/ajh.23341; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Case M, 2017, NEUROIMAGE-CLIN, V14, P1, DOI 10.1016/j.nicl.2016.12.024; Cataldo G, 2015, PAIN, V156, P722, DOI 10.1097/j.pain.0000000000000104; Cauda F, 2010, J NEUROL NEUROSUR PS, V81, P806, DOI 10.1136/jnnp.2009.188631; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Coloigner J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184860; Colombatti R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157090; Coulombe MA, 2016, HUM BRAIN MAPP, V37, P1514, DOI 10.1002/hbm.23117; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dampier C, 2017, J PAIN, V18, P490, DOI 10.1016/j.jpain.2016.12.016; Darbari DS, 2015, J PAIN, V16, P1077, DOI 10.1016/j.jpain.2015.07.005; Ezenwa MO, 2016, PAIN PRACT, V16, P282, DOI 10.1111/papr.12279; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FRANCIS RB, 1991, BLOOD, V77, P1405; Hemington KS, 2015, J NEUROPHYSIOL, V114, P2080, DOI 10.1152/jn.00998.2014; Hsiao FJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0799-x; Tran H, 2017, BLOOD, V130, P2377, DOI 10.1182/blood-2017-05-782003; Ichesco E, 2014, J PAIN, V15, P815, DOI 10.1016/j.jpain.2014.04.007; Jarrahi B, 2017, IEEE ENG MED BIO, P497, DOI 10.1109/EMBC.2017.8036870; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Khalili-Mahani N, 2013, NEUROIMAGE, V65, P499, DOI 10.1016/j.neuroimage.2012.09.044; Kim JY, 2013, PAIN, V154, P1792, DOI 10.1016/j.pain.2013.05.040; Kornelsen J, 2013, J PAIN, V14, P483, DOI 10.1016/j.jpain.2012.12.018; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Letzen JE, 2013, J PAIN, V14, P1077, DOI 10.1016/j.jpain.2013.04.003; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Napadow V, 2012, ARTHRITIS RHEUM-US, V64, P2398, DOI 10.1002/art.34412; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sethna NF, 2007, PAIN, V131, P153, DOI 10.1016/j.pain.2006.12.028; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Tanabe J, 2011, PSYCHOPHARMACOLOGY, V216, P287, DOI 10.1007/s00213-011-2221-8; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xie CM, 2012, HUM BRAIN MAPP, V33, P1352, DOI 10.1002/hbm.21291; 2006, PAIN, V126, P79, DOI DOI 10.1016/J.PAIN.2006.06.017; 2013, ACTA PSYCHIAT SCAND, V127, P269, DOI DOI 10.1111/J.1600-0447.2012.01896.X; 2012, PSYCHOSOM MED, V74, P55, DOI DOI 10.1097/PSY.0B013E3182408F04	61	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216994	10.1371/journal.pone.0216994	http://dx.doi.org/10.1371/journal.pone.0216994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107926	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200023
J	Moreno-Bayona, DA; Gomez-Mendez, LD; Blanco-Vargas, A; Castillo-Toro, A; Herrera-Carlosama, L; Poutou-Pinales, RA; Salcedo-Reyes, JC; Diaz-Ariza, LA; Castillo-Carvajal, LC; Rojas-Higuera, NS; Pedroza-Rodriguez, AM				Moreno-Bayona, Diana A.; Gomez-Mendez, Luis D.; Blanco-Vargas, Andrea; Castillo-Toro, Alejandra; Herrera-Carlosama, Laura; Poutou-Pinales, Raul A.; Salcedo-Reyes, Juan C.; Diaz-Ariza, Lucia A.; Castillo-Carvajal, Laura C.; Rojas-Higuera, Naydu S.; Pedroza-Rodriguez, Aura M.			Simultaneous bioconversion of lignocellulosic residues and oxodegradable polyethylene by Pleurotus ostreatus for biochar production, enriched with phosphate solubilizing bacteria for agricultural use	PLOS ONE			English	Article							LOW-DENSITY POLYETHYLENE; LIGNIN-DEGRADING BASIDIOMYCETE; PINE SAWDUST; BIOTIC DEGRADATION; POLY(LACTIC ACID); SOLID-WASTE; WOOD DECAY; BIODEGRADATION; SOIL; RECOVERY	A simultaneous treatment of lignocellulosic biomass (LCB) and low density oxodegradable polyethylene (LDPEoxo) was carried-out using Pleurotus ostreatus at microcosm scale to obtain biotransformed plastic and oxidized lignocellulosic biomass. This product was used as raw matter (RM) to produce biochar enriched with phosphate solubilizing bacteria (PSB). Biochar potential as biofertilizer was evaluated in Allium cepa culture at greenhouse scale. Experiments including lignocellulosic mix and LDPEoxo were performed for 75 days in microcosm. Biotransformation progress was performed by monitoring total organic carbon (TOC), CO2 production, laccase (Lac), manganese peroxidase (MnP), and lignin peroxidase (LiP) enzymatic activities. Physical LDPEoxo changes were assessed by atomic force microscopy (AFM), scanning electron microscopy (SEM) and static contact angle (SCA) and chemical changes by Fourier transform infrared spectroscopy (FTIR). Results revealed P. ostreatus was capable of LCB and LDPEoxo biotransformation, obtaining 41% total organic carbon (TOC) removal with CO2 production of 2,323 mg Kg(-1) and enzyme activities of 169,438 UKg(-1), 5,535 UKg(-1) and 5,267 UKg(-1) for LiP, MnP and Lac, respectively. Regarding LDPEoxo, SCA was decreased by 84%, with an increase in signals at 1,076 cm(-1) and 3,271 cm(-1), corresponding to C-O and CO-H bonds. A decrease in signals was observed related to material degradation at 2,928 cm(-1), 2,848 cm(-1), agreeing with CH2 asymmetrical and symmetrical stretching, respectively. PSB enriched biochar favored A. cepa plant growth during the five-week evaluation period. To the best of our knowledge, this is the first report of an in vitro circular production model, where P. ostreatus was employed at a microcosmos level to bioconvert LCB and LDPEoxo residues from the agroindustrial sector, followed by thermoconversion to produce an enriched biochar with PSB to be used as a biofertilizer to grow A. cepa at greenhouse scale.	[Moreno-Bayona, Diana A.; Gomez-Mendez, Luis D.; Blanco-Vargas, Andrea; Castillo-Toro, Alejandra; Herrera-Carlosama, Laura; Pedroza-Rodriguez, Aura M.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Unidad Invest Agr UNIDIA,Lab Microbiol Ambiental, Bogota, DC, Colombia; [Moreno-Bayona, Diana A.; Gomez-Mendez, Luis D.; Poutou-Pinales, Raul A.] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, GBAI,Lab Biotecnol Mol, Bogota, DC, Colombia; [Gomez-Mendez, Luis D.; Salcedo-Reyes, Juan C.] Pontificia Univ Javeriana, Fac Ciencias, Dept Fis, Lab Peliculas Delgadas & Nanofoton, Bogota, DC, Colombia; [Blanco-Vargas, Andrea; Diaz-Ariza, Lucia A.] Pontificia Univ Javeriana, Dept Biol, Lab Asociac Suelo Planta Microorganismos LAMIC, Grp Invest Agr Biol,Fac Ciencias, Bogota, DC, Colombia; [Castillo-Carvajal, Laura C.] Univ Anahuac Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Rojas-Higuera, Naydu S.] Fdn Univ Agr Colombia, Fac Ciencias, Bogota, DC, Colombia	Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Fundacion Universitaria Agraria de Colombia	Pedroza-Rodriguez, AM (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Unidad Invest Agr UNIDIA,Lab Microbiol Ambiental, Bogota, DC, Colombia.	apedroza@javeriana.edu.co	Canela-Garayoa, Ramon/E-2975-2013; Poutou-Piñales, Raúl A./AAF-2962-2019; Diaz-Ariza, Lucía/AAF-8166-2019; Salcedo-Reyes, Juan Carlos/AAC-3347-2020; Marina, Aura/AAF-7657-2019; GÃmez, David/AAF-2969-2019	Canela-Garayoa, Ramon/0000-0003-1095-6607; Poutou-Piñales, Raúl A./0000-0001-8841-2357; Salcedo-Reyes, Juan Carlos/0000-0002-6209-0502; Diaz Ariza, Lucia Ana/0000-0001-5736-6335; Moreno, Diana/0000-0002-4321-5197; Castillo Carvajal, Laura Catalina/0000-0002-1531-2504	Pontificia Universidad Javeriana Bogota, D.C. Colombia" [00007681, 00006736, 00008626, 04861-18, 212, 00778]	Pontificia Universidad Javeriana Bogota, D.C. Colombia"	This work was financed by "Pontificia Universidad Javeriana Bogota, D.C. Colombia"; as part of Grant ID: 00007681, titled "Uso combinado de hongos ligninoliticos y pirolisis para la obtencion de biochar modificado empleando el modelo de bioferineria", Grant ID: 00006736, titled "Transformacion de polietileno de baja densidad (LDPE) por medio de ablacion con plasma y actividad enzimatica de Pleurotus ostreatus", Grant ID: 00008626, titled "Desarrollo de un biofertilizante a base de biochar y bacterias fosfato solubilizadoras para el cultivo de Allium cepa" and Cooperation agreement No 04861-18 between "Pontificia Universidad Javeriana (Bogota), Colombia" and "Universidad Anahuac de Mexico". Phosphate solubilizing bacteria employed in this study are deposited in the microorganism collection at "Pontificia Universidad Javeriana". Their use in research was authorized according to genetic resource and derived products access contract No. 212, resolution 00778, subscribed between the "Ministerio delMedio Ambiente y Desarrollo Sostenible de Colombia" and the "Pontificia Universidad Javeriana". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Rich S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/6/065203; Ahmad M, 2013, BIORESOURCE TECHNOL, V143, P615, DOI 10.1016/j.biortech.2013.06.033; Alozie N, 2018, SCI TOTAL ENVIRON, V630, P1188, DOI 10.1016/j.scitotenv.2018.02.319; Ataeefard M, 2008, PLASMA CHEM PLASMA P, V28, P377, DOI 10.1007/s11090-008-9126-2; Awad YM, 2018, SCI TOTAL ENVIRON, V625, P147, DOI 10.1016/j.scitotenv.2017.12.194; Baiocco P, 2003, ORG BIOMOL CHEM, V1, P191, DOI 10.1039/b208951c; Balart JF, 2018, J POLYM ENVIRON, V26, P701, DOI 10.1007/s10924-017-0988-3; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Beiyuan J, 2017, CHEMOSPHERE, V178, P110, DOI 10.1016/j.chemosphere.2017.03.022; Bellettini MB, 2019, SAUDI J BIOL SCI, V26, P633, DOI 10.1016/j.sjbs.2016.12.005; Benitez A, 2013, POLYM DEGRAD STABIL, V98, P490, DOI 10.1016/j.polymdegradstab.2012.12.011; BOURBONNAIS R, 1988, BIOCHEM J, V255, P445, DOI 10.1042/bj2550445; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Castro-Aguirre E, 2018, POLYM DEGRAD STABIL, V154, P46, DOI 10.1016/j.polymdegradstab.2018.05.017; Dang T.C.H., 2018, ADV, DOI DOI 10.1088/2043-6254/AAABAF; de Campos SX, 2014, WASTE MANAGE RES, V32, P1186, DOI 10.1177/0734242X14543817; Diaz-Ariza LA, 2015, PROCESO INMOVILIZACI; ElMekawy A, 2015, FOOD RES INT, V73, P213, DOI 10.1016/j.foodres.2014.11.045; Esmaeili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071720; Eyheraguibel B, 2017, CHEMOSPHERE, V184, P366, DOI 10.1016/j.chemosphere.2017.05.137; Fatemeh B, 2015, INT J PLANT SOIL SCI, V4, P281; Forster-Carneiro T, 2013, RESOUR CONSERV RECY, V77, P78, DOI 10.1016/j.resconrec.2013.05.007; Foster EJ, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8100158; Fox A, 2014, FEMS MICROBIOL ECOL, V90, P78, DOI 10.1111/1574-6941.12374; Gajendiran A, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0394-x; Gomez-Mendez LD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203786; Gulmine JV, 2002, POLYM TEST, V21, P557, DOI 10.1016/S0142-9418(01)00124-6; Ha HC, 2001, APPL MICROBIOL BIOT, V55, P704, DOI 10.1007/s002530100653; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Helal AA, 2011, ARAB J CHEM, V4, P51, DOI 10.1016/j.arabjc.2010.06.018; Hetemi D, 2016, LANGMUIR, V32, P512, DOI 10.1021/acs.langmuir.5b03669; Hui DF, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8090143; Illinois Department of Transportation Central Bureau of Materials, 2013, MAN TEST PROC MAT, P197; International A, 2007, D17621784 INT A; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P167, DOI 10.1016/0038-0717(76)90001-8; Jesus J, 2016, J HAZARD MATER, V309, P37, DOI 10.1016/j.jhazmat.2016.01.065; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Krueger MC, 2015, APPL MICROBIOL BIOT, V99, P8857, DOI 10.1007/s00253-015-6879-4; Kumanayaka TO, 2010, THESIS; Kumar BM, 2016, INDIAN J ADV CHEM S, V1, P297; Li X, 2017, BIOTECHNOL ADV, V35, P466, DOI 10.1016/j.biotechadv.2017.03.010; Makarichi L, 2018, RENEW SUST ENERG REV, V91, P812, DOI 10.1016/j.rser.2018.04.088; Manzur A, 2004, J APPL POLYM SCI, V92, P265, DOI 10.1002/app.13644; Martinez M, 2011, MANUAL MICROBIOLOGIA; Martinez-Romo A, 2015, J SPECTROSC, V2015, DOI 10.1155/2015/586514; Mendes GD, 2014, APPL ENVIRON MICROB, V80, P3081, DOI 10.1128/AEM.00241-14; Mohan SV, 2015, BIORESOURCE TECHNOL, V184, P169, DOI 10.1016/j.biortech.2014.10.056; Morent R, 2007, SURF COAT TECH, V201, P7847, DOI 10.1016/j.surfcoat.2007.03.018; Mortazavi M, 2012, APPL SURF SCI, V258, P6876, DOI 10.1016/j.apsusc.2012.03.122; Moya D, 2017, ENRGY PROCED, V134, P286, DOI 10.1016/j.egypro.2017.09.618; Munk L, 2015, BIOTECHNOL ADV, V33, P13, DOI 10.1016/j.biotechadv.2014.12.008; Ojeda T., 2013, POLYM ENV, V23, DOI [10.5772/51057, DOI 10.5772/51057]; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Perez-Echavarria N, 2018, REV FACULTAD CIENCIA, V7, P40, DOI [10.15446/rev.fac.cienc.v7n1.68243, DOI 10.15446/REV.FAC.CIENC.V7N1.68243]; Pollegioni L, 2015, FEBS J, V282, P1190, DOI 10.1111/febs.13224; Portillo F, 2016, POLYM TEST, V53, P58, DOI 10.1016/j.polymertesting.2016.04.022; Reddy S., 2014, ANN PLANT SOIL RES, V16, P89; da Luz JMR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126047; da Luz JMR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107438; da Luz JMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069386; Rubenacker A, 2011, AV CIENC ING, V2, P83; Santoyo F, 2008, ENZYME MICROB TECH, V43, P137, DOI 10.1016/j.enzmictec.2007.11.007; Schwarze Francis W. M. R., 2007, Fungal Biology Reviews, V21, P133, DOI 10.1016/j.fbr.2007.09.001; Seidl PR, 2016, CURR OPIN GREEN SUST, V2, P48, DOI 10.1016/j.cogsc.2016.09.003; Sen SK, 2015, J ENVIRON CHEM ENG, V3, P462, DOI 10.1016/j.jece.2015.01.003; Sheik S, 2015, INT BIODETER BIODEGR, V105, P21, DOI 10.1016/j.ibiod.2015.08.006; Rojas-Higuera NS, 2017, EUR J WOOD WOOD PROD, V75, P263, DOI 10.1007/s00107-016-1099-x; Siddiqui AR, 2016, J APPL AGR BIOTECHNO, V1, P27; Szajdak LW, 2016, TRANSFORMATIONS ORGA, P211; Tchegueni S., 2013, African Journal of Biotechnology, V12, P3466; Tinoco R, 2001, LETT APPL MICROBIOL, V32, P331, DOI 10.1046/j.1472-765X.2001.00913.x; Vaverkova M, 2014, ECOL CHEM ENG S, V21, P45, DOI 10.2478/eces-2014-0004; Wan CX, 2012, BIOTECHNOL ADV, V30, P1447, DOI 10.1016/j.biotechadv.2012.03.003; Wei YQ, 2019, BIORESOURCE TECHNOL, V271, P66, DOI 10.1016/j.biortech.2018.09.081; Wei YQ, 2018, BIORESOURCE TECHNOL, V247, P190, DOI 10.1016/j.biortech.2017.09.092; Yang XG, 2015, RENEW SUST ENERG REV, V49, P335, DOI 10.1016/j.rser.2015.04.114; Yoon LW, 2014, BIOMASS BIOENERG, V67, P319, DOI 10.1016/j.biombioe.2014.05.013; Zahra S, 2010, WASTE MANAGE, V30, P396, DOI 10.1016/j.wasman.2009.09.027; Zhang JG, 2016, CRIT REV BIOTECHNOL, V36, P1066, DOI 10.3109/07388551.2015.1084262; Zhang L, 2018, BIORESOURCE TECHNOL, V267, P182, DOI 10.1016/j.biortech.2018.07.040; Zhou C, 2015, WASTE MANAGE, V40, P38, DOI 10.1016/j.wasman.2015.03.016; 2012, U SCI, V17, P43; 2013, FUNGAL BIOL REV, V27, P67, DOI DOI 10.1016/J.FBR.2013.07.001.	85	12	12	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217100	10.1371/journal.pone.0217100	http://dx.doi.org/10.1371/journal.pone.0217100			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095642	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100075
J	Yitbarek, K; Woldie, M; Abraham, G				Yitbarek, Kiddus; Woldie, Mirkuzie; Abraham, Gelila			Time for action: Intimate partner violence troubles one third of Ethiopian women	PLOS ONE			English	Article							DOMESTIC VIOLENCE; INTERVENTION; AUTONOMY; MARRIAGE; AFRICA	Background Intimate partner violence is a major challenges faced by women especially in developing world. Its consequences range from personal health problems up to countrywide loss of productivity and poverty. There is limited empirical evidence documenting intimate partner violence and underlying reasons in Ethiopia. Therefore, the aim of this study was to assess the magnitude of intimate partner violence and associated factors in Ethiopia. Methods We analyzed the 2016 Ethiopian demographic and health survey data. About 2,750 women aged 15-49 years were included in the survey. Intimate partner violence was measured in three dimensions: physical, emotional and sexual violence. Multiple logistic regression was conducted to identify independent predictors. Variables with p-value less than 0.05 were considered as significantly associated with dimensions of violence. All analysis were adjusted for clusters and sample weights. Results Overall 32.5% of Ethiopian women experienced at least one type of intimate partner violence. Physical and emotional violence were each experienced by 22.5% of the women, while 9.6% of the study participants encountered sexual violence. The age difference between a woman and her intimate partner has a positive effect on emotional and sexual violence while the opposite is true for physical violence. Moreover, physical violence was significantly associated with place of residence, and husband education. Both emotional and sexual violence were predicted by wealth of the household and husband's employment status. In addition to these, lower educational status of the partner affects emotional violence positively. Conclusion Substantial proportion of women in Ethiopia continue to suffer from intimate partner violence. Physical and emotional violence were much more common than sexual violence. In the light of determinants, we have reported in here, we recommend empowering women in all realm of life by improving their socio-economic status with focus to their educational and economic status.	[Yitbarek, Kiddus; Woldie, Mirkuzie; Abraham, Gelila] Jimma Univ, Dept Hlth Policy & Management, Inst Hlth, Jimma, Ethiopia; [Woldie, Mirkuzie] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Jimma University; Harvard University; Harvard T.H. Chan School of Public Health	Yitbarek, K (corresponding author), Jimma Univ, Dept Hlth Policy & Management, Inst Hlth, Jimma, Ethiopia.	kiddus.yitbarek@yahoo.com	Woldie, Mirkuzie/S-4086-2017	Woldie, Mirkuzie/0000-0002-1777-0816; Yitbarek, Kiddus/0000-0002-4935-6871				Abeya SG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-913; Abeya SG, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-14; Adebowale AS, 2018, BMC PUBLIC HEALTH, V18, P1; Adinew Y, 2017, INT HLTH HUMAN RIGHT, V17, P1; Al-Atrushi HH, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-37; [Anonymous], 2016, WOMEN UNE GE E WOMEN, DOI [10.1108/eb010586, DOI 10.1108/EB010586]; [Anonymous], 2013, J BUS MANAGE ADM; Bayeh E., 2016, PACIFIC SCI REV B HU, V2, P37, DOI [10.1016/j.psrb.2016.09.013, DOI 10.1016/J.PSRB.2016.09.013]; Bourey C, 2013, INT PERSPECT SEX R H, V39, P215, DOI 10.1363/3921513; Central Statistical Agency (Ethiopia) and ICF International, 2016, ETH DEM HLTH SURV 20, P1; Central Statistical Agency of Ethiopia, 2010, NAT STAT ABSTR; Cherinet H, 2003, PROFILE GENDER RELAT; Debsu D., 2009, AFRICAN STUDY MONOGR, V30, P15, DOI DOI 10.14989/71111; Deribe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036189; Desa U, 2016, TRANSF OUR WORLD 203; Deyessa Negussie, 2009, Clin Pract Epidemiol Ment Health, V5, P8, DOI 10.1186/1745-0179-5-8; Ellsberg M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25658; Eneyew A, 2013, SOCIETIES, V3, P104, DOI 10.3390/soc3010104; Feseha G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-125; Furuta M, 2016, MIDWIFERY, V43, P7, DOI 10.1016/j.midw.2016.10.005; Hassen Fatuma, 2013, BMC Res Notes, V6, P271, DOI 10.1186/1756-0500-6-271; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Ismayilova L, 2013, J INTERPERS VIOLENCE, V28, P2521, DOI 10.1177/0886260513479026; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kabeer N., 2013, WOMENS EC EMPOWERMEN; Kapiga S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4119-9; Kibria G., 2016, RESEARCHGATE; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Machisa MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175240; McCloskey LA, 2016, PARTN ABUSE, V7, P277, DOI 10.1891/1946-6560.7.3.277; Olayanju L, 2013, AGGRESS VIOLENT BEH, V18, P101, DOI 10.1016/j.avb.2012.11.003; Organisation for Economic Cooperation and Development-OECD, 2008, GEND SUST DEV MAX EC, DOI 10(410.22059/JWDP.2013.30574; Pambe M. W., 2014, African Population Studies, V28, P1146; Panamerican Health Organization, 2013, PAN AM HEAL ORGAN, V1, P1; Raj Anita, 2015, Int J Gynaecol Obstet, V130 Suppl 3, pE56, DOI 10.1016/j.ijgo.2015.03.013; Sabarwal S, 2014, J INTERPERS VIOLENCE, V29, P332, DOI 10.1177/0886260513505144; Schuler SR, 2018, WORLD DEV; Schuler SR, 2017, VIOLENCE AGAINST WOM; Semahegn A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0072-1; Semahegn A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-63; Shanko W, 2013, E MEDITERR HEALTH J, V19, P18, DOI 10.26719/2013.19.1.18; The Community Foundation of Frederick County, 2011, FRED COUNT HUM NEEDS; UNICEF, 2015, UPD NAT EQ SIT AN CH; UNICEF Ethiopia, 2016, BRIEF NOT ETH COUNTR, P4; Vyas S, 2017, SEX REPROD HEALTHC, V13, P68, DOI [10.1016/j.sr, 10.1016/j.srhc.2017.06.002]; Wilson Ben, 2008, Popul Trends, P17; 2016, B WORLD HEALTH ORGAN, V94, P396, DOI DOI 10.2471/BLT.16.172205	47	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216962	10.1371/journal.pone.0216962	http://dx.doi.org/10.1371/journal.pone.0216962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY3MG	31095629	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100060
J	Mills, D; Fattebert, J; Hunter, L; Slotow, R				Mills, David; Fattebert, Julien; Hunter, Luke; Slotow, Rob			Maximising camera trap data: Using attractants to improve detection of elusive species in multi-species surveys	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; CARNIVORE COMMUNITY; GRIZZLY BEARS; GOLDEN CAT; OCCUPANCY; LANDSCAPE; CAPTURE; FOREST; PATTERNS; PREY	Camera traps are a key tool in ecological studies, and are increasingly being used to understand entire communities. However, robust inferences continue to be hampered by low detection of rare and elusive species. Attractants can be used to increase detection rates, but may also alter behaviour, and little research has evaluated short-term, localized response to the presence of attractants. We conducted three camera trap surveys in Kibale National Park, Uganda, using food baits and scent lures (" attractants") at each camera station to entice small carnivores to pass in front of camera stations. To examine the interrelationship between scavenging and response to attractants, we also placed camera traps at five food refuse pits. We modelled the effect of attractant and duration of trap placement on the detection probability of small carnivores and selected African golden cat Caracal aurata prey items. We examine transient site response of each species, by comparing our observed likelihood of detection in each 24 h period from 1-7 d following refreshing of attractants to randomly generated capture histories. African civet Civettictis civetta, rusty-spotted genet Genetta maculata, African palm civet Nandinia binotata, and marsh mongoose Atilax paludinosus detection probabilities were highest and Weyns's red duiker Cephalophus wenysi detection probability was lowest immediately after attractants were placed. Within 24 h after attractant was placed, rusty-spotted genet and African palm civet were more likely to be detected and African golden cat, red duiker, and blue duiker Philantomba monticola were less likely to be detected. Our results suggest that attractants can increase detection of small-bodied species and include some arboreal species in terrestrial camera trap sampling. However, attractants may also alter short-term visitation rates of some species, with potentially cascading effects on others. Community level and intraguild interaction studies should control for the potentially confounding effects of attractants on spatial activity patterns.	[Mills, David; Fattebert, Julien; Hunter, Luke; Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Mills, David; Hunter, Luke] Panthera, New York, NY 10018 USA; [Slotow, Rob] UCL, Dept Genet Evolut & Environm, London, England	University of Kwazulu Natal; University of London; University College London	Mills, D (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.; Mills, D (corresponding author), Panthera, New York, NY 10018 USA.	africanleopard@gmail.com	Fattebert, Julien/I-8126-2019; Mills, David/GXF-1821-2022; Slotow, Rob/AAM-9053-2020	Fattebert, Julien/0000-0001-5510-6804; 	Panthera's Kaplan Graduate Award; Small Cat Action Fund; John D. and Catherine T. MacArthur Foundation Grant through the Wildlife Conservation Society (WCS), Uganda	Panthera's Kaplan Graduate Award; Small Cat Action Fund; John D. and Catherine T. MacArthur Foundation Grant through the Wildlife Conservation Society (WCS), Uganda	This work was supported by Panthera's Kaplan Graduate Award (DM) and Small Cat Action Fund (DM) https://www.panthera.org/grants-and-fellowships.Additional funding was provided through a John D. and Catherine T. MacArthur Foundation Grant through the Wildlife Conservation Society (WCS), Uganda. (DM). https://www.macfound.org/info-grantseekers/.https://uganda.wcs.org. Luke Hunter was both President of Panthera and co-supervisor of this work, which is part of a PhD thesis. He participated in discussions on survey locations and design, did not participate in data collection or analysis, approved our decision to publish, and provided comments on the manuscript. Since the mission of Panthera is to increase our knowledge and promote conservation of the worlds cats, we do not feel this is a conflict of interest.	Ahumada JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073707; Alexander JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134815; [Anonymous], 2012, HDB WILDLIFE MONITOR; Bahaa-el-din L, 2015, MAMMAL REV, V45, P63, DOI 10.1111/mam.12033; Balme G, 2014, BIOL CONSERV, V179, P144, DOI 10.1016/j.biocon.2014.09.021; Beaudrot L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002357; Belbachir F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115136; Braczkowski AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151033; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chapman CA, 2000, AM J PRIMATOL, V50, P169, DOI 10.1002/(SICI)1098-2345(200003)50:3&lt;169::AID-AJP1&gt;3.0.CO;2-P; Chapman CA, 2012, AM J PRIMATOL, V74, P510, DOI 10.1002/ajp.20992; CHARLESDOMINIQUE P, 1978, TERRE VIE-REV ECOL A, V32, P477; Cove M, 2014, HYSTRIX, V25, P113, DOI 10.4404/hystrix-25.2-9945; Cusack JJ, 2017, OIKOS, V126, P812, DOI 10.1111/oik.03403; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; du Preez BD, 2014, BIOL CONSERV, V176, P153, DOI 10.1016/j.biocon.2014.05.021; Echeverria-Londono S, 2016, DIVERS DISTRIB, V22, P1099, DOI 10.1111/ddi.12478; Edwards S, 2018, AFR J ECOL, V56, P885, DOI 10.1111/aje.12511; Edwards S, 2016, J ARID ENVIRON, V124, P304, DOI 10.1016/j.jaridenv.2015.09.009; Efford MG, 2016, ECOGRAPHY, V39, P676, DOI 10.1111/ecog.01511; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Farris ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136456; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Galvez N, 2016, BIOL CONSERV, V204, P350, DOI 10.1016/j.biocon.2016.10.019; Gerber BD, 2012, J MAMMAL, V93, P667, DOI 10.1644/11-MAMM-A-265.1; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gompper ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146055; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hart JA, 1996, AFR J ECOL, V34, P364, DOI 10.1111/j.1365-2028.1996.tb00632.x; Hearn AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151046; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Kilshaw K, 2015, ORYX, V49, P207, DOI 10.1017/S0030605313001154; Kingdon J., 2013, MAMMALS AFRICA, Vv; Kittle AM, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0082-9; Laundre JW, 2014, ECOLOGY, V95, P1141, DOI 10.1890/13-1083.1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Michalski F, 2010, ORYX, V44, P300, DOI 10.1017/S0030605309990871; Moreira-Arce D, 2016, FOREST ECOL MANAG, V369, P135, DOI 10.1016/j.foreco.2016.03.024; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Nagy-Reis MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168441; Noss A, 2013, EVALUATING JAGUAR DE; O'Connor KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175684; Ososky JJ, 1998, DIET LEOPARDS GOLDEN; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Rich LN, 2017, GLOBAL ECOL BIOGEOGR, V26, P918, DOI 10.1111/geb.12600; Rocha DG, 2016, J ZOOL, V300, P205, DOI 10.1111/jzo.12372; Ryan AM, 2013, AFR J ECOL, V51, P1, DOI 10.1111/j.1365-2028.2012.01346.x; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Srbek-Araujo AC, 2013, BIOTA NEOTROP, V13, P51, DOI 10.1590/S1676-06032013000200005; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Swanson A, 2016, ECOL EVOL, V6, P8534, DOI 10.1002/ece3.2569; Theimer TC, 2015, URBAN ECOSYST, V18, P895, DOI 10.1007/s11252-015-0436-x; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Van Rompaey H, 2013, MAMMALS AFRICA CARNI, V5, P140; Vargas LEP, 2016, BIODIVERS CONSERV, V25, P739, DOI 10.1007/s10531-016-1089-7; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694	65	29	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216447	10.1371/journal.pone.0216447	http://dx.doi.org/10.1371/journal.pone.0216447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141506	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000012
J	Savi, S; Poni, S; Moncalvo, A; Frioni, T; Rodschinka, I; Arata, L; Gatti, M				Savi, Sara; Poni, Stefano; Moncalvo, Alessandro; Frioni, Tommaso; Rodschinka, Irene; Arata, Linda; Gatti, Matteo			Destructive and optical non-destructive grape ripening assessment: Agronomic comparison and cost-benefit analysis	PLOS ONE			English	Article							BERRY ANTHOCYANINS; WINE; RED; ACCUMULATION; SPECTROSCOPY; SANGIOVESE; FLAVONOLS; SENSORS	Reliability and economic assessment of the Multiplex (R) optical sensor employed for non-destructive grape parameters estimates was evaluated in 2017 against a wet chemistry approach in mature vineyards including five cultivars (two whites, two red and one pink colored) assuring a broad range of variation in both technological and phenolic maturity parameters. Among the five Multiplex (Mx) indices evaluated (SFR_R, FLAV, FLAV- UV, ANTH_RG and FERARI) in all cultivars with the exception of Barbera SFR_R showed a significant and linear correlation with total soluble solids (TSS) for TSS >= 10 degrees Brix. Conversely, no significant correlation was found between FLAV and total flavonols concentration, whereas a significant linear correlation was found in Barbera (R-2 = 0.66) and Ervi (R-2 = 0.63) when the FLAV index was replaced with the FLAV_UV index. Within each cultivar, both ANTH_RG and FERARI showed close correlations with total anthocyanins concentration determined by wet chemistry although under different model shapes. Expressing berry color accumulation on a per skin mass basis rather than for whole berry mass basis, allowed for better separation of behavior of single cultivars and improved accuracy of model fitting for the combination of Barbera and ANTH_RG. A strict linear correlation was always found, within each index, for Mx readings taken on the two opposite sides of the same cluster, implying no significant within-cluster differences in sugar, color and flavonol concentrations. Economic assessment of Mx by means of the Net Present Value (NPV) approach showed that Mx is economically viable for a two hectare vineyard cultivating three red grape varieties (90 samples per year) if its lifetime is at least 7 years. Conversely, if only two red varieties are grown Mx should be used at least 11 years to make it economic suitable. Bigger properties growing a higher number of red varieties are the more interested in Mx as the expected NPV assumes positive values with a Mx usage of minimum 3 years.	[Savi, Sara; Poni, Stefano; Moncalvo, Alessandro; Frioni, Tommaso; Rodschinka, Irene; Gatti, Matteo] Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, Italy; [Arata, Linda] Univ Cattolica Sacro Cuore, Dept Agr & Food Econ, Piacenza, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart	Poni, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, Italy.	stefano.poni@unicatt.it	Gatti, Matteo/D-6614-2018	Gatti, Matteo/0000-0003-4195-7709; Frioni, Tommaso/0000-0002-8663-3022				Adusumilli N, 2016, AGR WATER MANAGE, V174, P61, DOI 10.1016/j.agwat.2016.04.024; Agati G, 2007, J AGR FOOD CHEM, V55, P1053, DOI 10.1021/jf062956k; Agati G, 2013, J AGR FOOD CHEM, V61, P12211, DOI 10.1021/jf405099n; Agati G, 2011, ENVIRON EXP BOT, V73, P3, DOI 10.1016/j.envexpbot.2010.10.002; Baluja J, 2012, AUST J GRAPE WINE R, V18, P173, DOI 10.1111/j.1755-0238.2012.00186.x; Barnuud NN, 2014, INT J BIOMETEOROL, V58, P1279, DOI 10.1007/s00484-013-0724-1; Beghi R, 2015, J SCI FOOD AGR, V95, P3144, DOI 10.1002/jsfa.7053; Ben Ghozlen N, 2010, SENSORS-BASEL, V10, P10040, DOI 10.3390/s101110040; Bondada B, 2017, SCI HORTIC-AMSTERDAM, V219, P135, DOI 10.1016/j.scienta.2017.03.002; Bramley RGV, 2011, AUST J GRAPE WINE R, V17, P316, DOI 10.1111/j.1755-0238.2011.00158.x; Cerovic ZG, 2008, J FOOD COMPOS ANAL, V21, P650, DOI 10.1016/j.jfca.2008.03.012; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; Dambergs R, 2015, APPL SPECTROSC REV, V50, P261, DOI 10.1080/05704928.2014.966380; Downey M, 2008, J CHROMATOGR A, V1201, P43, DOI 10.1016/j.chroma.2008.06.002; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Ferrandino A, 2017, AUST J GRAPE WINE R, V23, P207, DOI 10.1111/ajgw.12276; Francis IL, 1998, P 10 AUSTR WIN IND T, P104; Frioni T, 2016, AM J ENOL VITICULT, V67, P419, DOI 10.5344/ajev.2016.15120; Gatti M, 2016, AUST J GRAPE WINE R, V22, P245, DOI 10.1111/ajgw.12212; Iland P, 2011, GRAPEVINE SCI PRACTI, P310; Kennedy AM, 2001, P 11 AUSTR WIN IND T; Kliewer WM, 2005, AM J ENOL VITICULT, V56, P170; Liang NN, 2012, EUR FOOD RES TECHNOL, V235, P1187, DOI 10.1007/s00217-012-1850-4; Mabrouk H., 1998, Australian Journal of Grape and Wine Research, V4, P2, DOI 10.1111/j.1755-0238.1998.tb00129.x; Matese A., 2015, INT J WINE RES, P69, DOI [10.2147/IJWR.S69405, DOI 10.2147/IJWR.S69405]; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Palliotti A, 2017, AM J ENOL VITICULT, V68, P412, DOI 10.5344/ajev.2017.17011; Pinelli P, 2018, FOOD CHEM, V244, P213, DOI 10.1016/j.foodchem.2017.10.021; Poni S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05530-7; Poni S, 2013, AUST J GRAPE WINE R, V19, P378, DOI 10.1111/ajgw.12040; Poni S, 2018, SCI HORTIC-AMSTERDAM, V234, P445, DOI 10.1016/j.scienta.2017.12.035; PRICE SF, 1995, AM J ENOL VITICULT, V46, P187; Sadras VO, 2012, AUST J GRAPE WINE R, V18, P115, DOI 10.1111/j.1755-0238.2012.00180.x; Sardaro R, 2017, LAND USE POLICY, V68, P160, DOI 10.1016/j.landusepol.2017.07.045; dos Santos CAT, 2017, TRAC-TREND ANAL CHEM, V88, P100, DOI 10.1016/j.trac.2016.12.012; Tuccio L, 2011, AUST J GRAPE WINE R, V17, P181, DOI 10.1111/j.1755-0238.2011.00139.x	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216421	10.1371/journal.pone.0216421	http://dx.doi.org/10.1371/journal.pone.0216421			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141501	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000008
J	Xu, Y; Sun, FY; Ji, C; Hu, QW; Wang, CY; Wu, DX; Sun, GL				Xu, Yi; Sun, Fang-Yao; Ji, Chun; Hu, Quan-Wen; Wang, Cheng-Yu; Wu, De-Xiang; Sun, Genlou			Nucleotide diversity patterns at the DREB1 transcriptional factor gene in the genome donor species of wheat (Triticum aestivum L)	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; BINDING DOMAIN; WILD RELATIVES; DNA; POLYMORPHISM; EVOLUTION; TOLERANCE; EXPRESSION; AEGILOPS; DROUGHT	Bread wheat (AABBDD) originated from the diploid progenitor Triticum urartu (AA), a relative of Aegilops speltoides (BB), and Ae. tauschii (DD). The DREB1 transcriptional factor plays key regulatory role in low-temperature tolerance. The modern breeding strategies resulted in serious decrease of the agricultural biodiversity, which led to a loss of elite genes underlying abiotic stress tolerance in crops. However, knowledge of this gene's natural diversity is largely unknown in the genome donor species of wheat. We characterized the dehydration response element binding protein 1 (DREB1) gene-diversity pattern in Ae. speltoides, Ae. tauschii, T. monococcum and T. urartu. The highest nucleotide diversity value was detected in Ae. speltoides, followed by Ae. tauschii and T. monococcum. The lowest nucleotide diversity value was observed in T. urartu. Nucleotide diversity and haplotype data might suggest no reduction of nucleotide diversity during T. monococcum domestication. Alignment of the 68 DREB1 sequences found a large-size (70 bp) insertion/deletion in the accession PI486264 of Ae. speltoides, which was different from the copy of sequences from other accessions of Ae. speltoides, suggesting a likely existence of two different ancestral Ae. speltoides forms. Implication of sequences variation of Ae. speltoides on origination of B genome in wheat was discussed.	[Xu, Yi; Sun, Fang-Yao; Ji, Chun; Hu, Quan-Wen; Wang, Cheng-Yu; Wu, De-Xiang; Sun, Genlou] Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China; [Sun, Genlou] St Marys Univ, Biol Dept, Halifax, NS, Canada	Anhui Agricultural University; Saint Marys University - Canada	Wu, DX; Sun, GL (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China.; Sun, GL (corresponding author), St Marys Univ, Biol Dept, Halifax, NS, Canada.	dexiangwu198@163.com; genlou.sun@smu.ca			National Key Research and Development Program of China [2017YFD0301304]; Research Foundation for Talented Scholars from Anhui Agricultural University; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05817, RGPIN-2018-05433]; Senate Research Grant at Saint Mary's University; introduced leading talent research team for Universities in Anhui Province	National Key Research and Development Program of China; Research Foundation for Talented Scholars from Anhui Agricultural University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Senate Research Grant at Saint Mary's University; introduced leading talent research team for Universities in Anhui Province	This project was supported in part by the National Key Research and Development Program of China (2017YFD0301304), a Research Foundation for Talented Scholars from Anhui Agricultural University and the introduced leading talent research team for Universities in Anhui Province, the Natural Sciences and Engineering Research Council of Canada (grant No: RGPIN-2017-05817 and RGPIN-2018-05433) and a Senate Research Grant at Saint Mary's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Burke EJ, 2006, J HYDROMETEOROL, V7, P1113, DOI 10.1175/JHM544.1; Challam C, 2015, J GENET, V94, P231, DOI 10.1007/s12041-015-0507-z; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Alves GSC, 2018, TROP PLANT BIOL, V11, P31, DOI 10.1007/s12042-018-9199-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DVORAK J, 1990, P NATL ACAD SCI USA, V87, P9640, DOI 10.1073/pnas.87.24.9640; Dwivedi SL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01461; Edae EA, 2013, PLANT GEN, V6, P2, DOI DOI 10.3835/PLANTGEN0ME2013.04.0010; El Baidouri M, 2017, NEW PHYTOL, V213, P1477, DOI 10.1111/nph.14113; El-Shazly H, 2012, J GENET ENG BIOTECHN, V10, P1, DOI [10.1016/j.jgeb.2011.08.002, DOI 10.1016/J.JGEB.2011.08.002]; FAO (Food Agriculture Organization of the United Nations), 2004, FAO PROD YB; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Filiz E, 2014, APPL BIOCHEM BIOTECH, V174, P1272, DOI 10.1007/s12010-014-1093-x; FU YX, 1993, GENETICS, V133, P693; Ganeva G., 2000, Genetika, V36, P71; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Gulbitti-Onarici S, 2007, BOT J LINN SOC, V153, P67, DOI 10.1111/j.1095-8339.2007.00585.x; Haider N, 2013, Genetika, V49, P303; Harmon LJ, 2005, EVOLUTION, V59, P2705; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Hirosawa S, 2004, GENES GENET SYST, V79, P271, DOI 10.1266/ggs.79.271; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jadhao KR, 2014, HEREDITARY GENET, V3, P3; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kurahashi Y, 2009, INT J MOL SCI, V10, P2733, DOI 10.3390/ijms10062733; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02163; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu FF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31706; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Luo GB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0322-3; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Morrell PL, 2014, J HERED, V105, P253, DOI 10.1093/jhered/est083; Munoz-Amatriain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-653; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Qi PF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-168; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Salina EA, 2006, GENOME, V49, P1023, DOI 10.1139/G06-050; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Sasanuma T, 2002, EUPHYTICA, V127, P81, DOI 10.1023/A:1019941817057; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Swofford D.L., 2003, PAUP VERSION 40 B10; TAJIMA F, 1989, GENETICS, V123, P585; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Wang GZ, 1997, P NATL ACAD SCI USA, V94, P14570, DOI 10.1073/pnas.94.26.14570; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei B, 2009, MOL BREEDING, V23, P13, DOI 10.1007/s11032-008-9209-z; Wiens JJ, 1998, SYST BIOL, V47, P228, DOI 10.1080/106351598260897; Wu DX, 2014, GENE, V546, P11, DOI 10.1016/j.gene.2014.05.049; Xu ZS, 2009, J PLANT RES, V122, P121, DOI 10.1007/s10265-008-0195-3	65	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217081	10.1371/journal.pone.0217081	http://dx.doi.org/10.1371/journal.pone.0217081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136598	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300017
J	Braun, N; Goudbeek, M; Krahmer, E				Braun, Nadine; Goudbeek, Martijn; Krahmer, Emiel			Language and Emotion - A Foosball Study: The Influence of Affective State on Language Production in a Competitive Setting	PLOS ONE			English	Article							REFLECTED GLORY; GROUP SUCCESS; FAILURE; BASKING; BENEFITS; WORDS; MOOD; CONSEQUENCES; ATTRIBUTION; DEPRESSION	Our affective state is influenced by daily events and our interactions with other people, which, in turn, can affect the way we communicate. In two studies, we investigated the influence of experiencing success or failure in a foosball (table soccer) game on participants' affective state and how this in turn influenced the way they report on the game itself. Winning or losing a match can further influence how they view their own team (compared to the opponent), which may also impact how they report on the match. In Study 1, we explored this by having participants play foosball matches in two dyads. They subsequently reported their affective state and team cohesiveness, and wrote two match reports, one from their own and one from their opponent's perspective. Indeed, while the game generally improved participants' moods, especially winning made them happier and more excited and losing made them more dejected, both in questionnaires and in the reports, which were analyzed with a word count tool. Study 2 experimentally investigated the effect of affective state on focus and distancing behavior. After the match, participants chose between preselected sentences (from Study 1) that differed in focus (mentioning the own vs. other team) or distancing (using we vs. the team name). Results show an effect for focus: winning participants preferred sentences that described their own performance positively while losing participants chose sentences that praised their opponent over negative sentences about themselves. No effect of distancing in pronoun use was found: winning and losing participants equally preferred the use of we vs. the use of their own team name. We discuss the implications of our findings with regard to models of language production, the self-serving bias, and the use of games to induce emotions in a natural way.	[Braun, Nadine; Goudbeek, Martijn; Krahmer, Emiel] Tilburg Univ, Sch Humanities & Digital Sci, Dept Commun & Cognit, Tilburg Ctr Cognit & Commun, Tilburg, Netherlands	Tilburg University	Braun, N (corresponding author), Tilburg Univ, Sch Humanities & Digital Sci, Dept Commun & Cognit, Tilburg Ctr Cognit & Commun, Tilburg, Netherlands.	N.Braun@uvt.nl	Goudbeek, Martijn/J-4442-2019	Goudbeek, Martijn/0000-0002-7787-4123; Braun, Nadine/0000-0002-0383-1163	Netherlands Organization for Scientific Research (NWO) [PR-14-87]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	E.K. received Grant PR-14-87 from The Netherlands Organization for Scientific Research (NWO); https://www.nwo.nl/en/research-and-results/research-projects/i/45/13545.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Ward LE, 2005, J COGN DEV, V6, P507, DOI 10.1207/s15327647jcd0604_4; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Beukeboom CJ, 2006, J EXP SOC PSYCHOL, V42, P553, DOI 10.1016/j.jesp.2005.09.005; Boen F, 2002, J SOC PSYCHOL, V142, P769, DOI 10.1080/00224540209603935; BOWER GH, 1983, PHILOS T ROY SOC B, V302, P387, DOI 10.1098/rstb.1983.0062; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Bower GH, 2014, AFFECT COGNITION, V13, P291; Branscombe N. R., 1991, Journal of Sport and Social Issues, V15, P115, DOI 10.1177/019372359101500202; Braun N, 2016, MULTILINGUAL AFFECTI; Breuer J, 2015, PSYCHOL POP MEDIA CU, V4, P126, DOI 10.1037/ppm0000020; Campbell WK, 1999, SELF THREAT MAGNIFIE; CIALDINI RB, 1976, J PERS SOC PSYCHOL, V34, P366, DOI 10.1037//0022-3514.34.3.366; Coan J. A., 2007, HDB EMOTION ELICITAT; Downs E, 2011, ENTERTAIN COMPUT, V2, P23, DOI 10.1016/j.entcom.2011.03.012; Forgas JP, 2013, CURR DIR PSYCHOL SCI, V22, P225, DOI 10.1177/0963721412474458; Forgas JP, 1999, J PERS SOC PSYCHOL, V76, P928, DOI 10.1037/0022-3514.76.6.928; Forges JP, 1999, PERS SOC PSYCHOL B, V25, P850, DOI 10.1177/0146167299025007007; Goldie P., 2002, Phenomenology and the Cognitive Sciences, V1, P235, DOI 10.1023/A:1021306500055; Gortner EM, 2006, BEHAV THER, V37, P292, DOI 10.1016/j.beth.2006.01.004; Goudbeek M, 2010, J ACOUST SOC AM, V128, P1322, DOI 10.1121/1.3466853; GUNDEL JK, 1993, LANGUAGE, V69, P274, DOI 10.2307/416535; Hancock JT, 2007, P SIGCHI C HUM FACT; HASTORF AH, 1954, J ABNORM SOC PSYCH, V49, P129, DOI 10.1037/h0057880; HOLBROOK MB, 1984, J CONSUM RES, V11, P728, DOI 10.1086/209009; Jones MV, 2005, J SPORT EXERCISE PSY, V27, P407, DOI 10.1123/jsep.27.4.407; Koch AS, 2013, EUR J SOC PSYCHOL, V43, P326, DOI 10.1002/ejsp.1950; Krohne HW, 2002, COGNITION EMOTION, V16, P217, DOI 10.1080/02699930143000301; Kross E, 2012, J ABNORM PSYCHOL, V121, P559, DOI 10.1037/a0028808; Kross E, 2011, CURR DIR PSYCHOL SCI, V20, P187, DOI 10.1177/0963721411408883; Krpan KM, 2013, J AFFECT DISORDERS, V150, P1148, DOI 10.1016/j.jad.2013.05.065; Lee M. J., 1985, Journal of Sport Behavior, V8, P210; Lepore SJ, 1997, J PERS SOC PSYCHOL, V73, P1030, DOI 10.1037/0022-3514.73.5.1030; MANN L, 1974, AUST J PSYCHOL, V26, P37, DOI 10.1080/00049537408254634; Miller CB, 2009, ANAL SOC ISS PUB POL, V9, P283, DOI 10.1111/j.1530-2415.2009.01194.x; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Morgan J.L., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1163/9789004368811_003; Nook EC, 2017, J EXP PSYCHOL GEN, V146, P337, DOI 10.1037/xge0000263; Owren M. J., 2007, HDB EMOTION ELICITAT, P239; Pennebaker J.W., 2015, DEV PSYCHOMETRIC PRO, DOI [10.15781/T29G6Z, DOI 10.15781/T29G6Z]; Pennebaker J. W., 2011, OXFORD HDB HLTH PSYC, DOI [10.1093/oxfordhb/9780195342819.013.0018, DOI 10.1093/OXFORDHB/9780195342819.013.0018]; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; Pennebaker JW, 1996, COGNITION EMOTION, V10, P601, DOI 10.1080/026999396380079; Pennebaker JW., 2001, LINGUISTIC INQUIRY W; Quigley KS, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P220; Rude SS, 2004, COGNITION EMOTION, V18, P1121, DOI 10.1080/02699930441000030; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schumaker RP, 2016, DECIS SUPPORT SYST, V88, P76, DOI 10.1016/j.dss.2016.05.010; SNYDER CR, 1986, J PERS SOC PSYCHOL, V51, P382, DOI 10.1037/0022-3514.51.2.382; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Torre JB, 2018, EMOT REV, V10, P116, DOI 10.1177/1754073917742706; Wann D. L., 1990, Journal of Sport and Social Issues, V14, P103, DOI 10.1177/019372359001400203; WANN DL, 1995, SOC BEHAV PERSONAL, V23, P377, DOI 10.2224/sbp.1995.23.4.377; Winter B, 2013, ARXIV13085499; Wolf M, 2008, DIAGNOSTICA, V54, P85, DOI 10.1026/0012-1924.54.2.85; Yu Y, 2015, COMPUT HUM BEHAV, V48, P392, DOI 10.1016/j.chb.2015.01.075; Zijlstra H., 2005, NEDERLANDS TIJDSCHRI, V60, P50, DOI DOI 10.1007/BF03062342; ZUCKERMAN M, 1979, J PERS, V47, P245, DOI 10.1111/j.1467-6494.1979.tb00202.x	57	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217419	10.1371/journal.pone.0217419	http://dx.doi.org/10.1371/journal.pone.0217419			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125388	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700039
J	Callaghan, T; Sylvester, S				Callaghan, Timothy; Sylvester, Steven			Autism spectrum disorder, politics, and the generosity of insurance mandates in the United States	PLOS ONE			English	Article							HEALTH-INSURANCE; SERVICE USE; EARLY IMPLEMENTATION; PUBLIC-OPINION; YOUNG-CHILDREN; IMPACT; POLICY; COVERAGE; BENEFIT; COSTS	The study of Autism Spectrum Disorder (ASD) in the United States has identified a growing prevalence of the disorder across the country, a high economic burden for necessary treatment, and important gaps in insurance for individuals with autism. Confronting these facts, states have moved quickly in recent years to introduce mandates that insurers provide coverage for autism care. This study analyzes these autism insurance mandates and demonstrates that while states have moved swiftly to introduce them, the generosity of the benefits they mandate insurers provide varies dramatically across states. Furthermore, our research finds that controlling for policy need, interest group activity, economic circumstances, the insurance environment, and other factors, the passage of these mandates and differences in their generosity are driven by the ideology of state residents and politicians-with more generous benefits in states with more liberal citizens and increased Democratic control of state government. We conclude by discussing the implications of these findings for the study of health policy, politics, and autism in America.	[Callaghan, Timothy] Texas A&M Univ, Dept Hlth Policy & Management, Sch Publ Hlth, College Stn, TX 77843 USA; [Sylvester, Steven] Utah Valley Univ, Dept Hist & Polit Sci, Orem, UT USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Utah System of Higher Education; Utah Valley University	Callaghan, T (corresponding author), Texas A&M Univ, Dept Hlth Policy & Management, Sch Publ Hlth, College Stn, TX 77843 USA.	callaghan@tamu.edu		Callaghan, Timothy/0000-0002-9056-9123; Sylvester, Steven/0000-0002-2132-3082				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andersen M, 2015, J HEALTH ECON, V43, P74, DOI 10.1016/j.jhealeco.2015.06.008; Autism Speaks, AUT LAW SUMM RES HUB; Autism Speaks, STAT IN; Bafumi J, 2009, J POLIT, V71, P1, DOI 10.1017/S0022381608090014; Bagley N, 2014, J HEALTH POLIT POLIC, V39, P441, DOI 10.1215/03616878-2416325; Baller JB, 2016, AUTISM, V20, P796, DOI 10.1177/1362361315605972; BERRY FS, 1990, AM POLIT SCI REV, V84, P395, DOI 10.2307/1963526; Berry KN, 2017, J HEALTH POLIT POLIC, V42, P1065, DOI 10.1215/03616878-4193630; Berry WD, 1998, AM J POLIT SCI, V42, P327, DOI 10.2307/2991759; Bouder JN, 2009, J AUTISM DEV DISORD, V39, P953, DOI 10.1007/s10803-009-0701-z; Boushey Graeme., 2010, POLICY DIFFUSION DYN; Bowen DC, 2014, STATE POLIT POLICY Q, V14, P277, DOI 10.1177/1532440014536407; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Callaghan TH, 2017, J HEALTH POLIT POLIC, V42, P215, DOI 10.1215/03616878-3766710; Campbell C, NEW INSURANCE MANDAT; Carter DB, 2010, POLIT ANAL, V18, P271, DOI 10.1093/pan/mpq013; Cason M, BILL REQUIRE AUTISM; Caughey D, 2016, AM J POLIT SCI, V60, P899, DOI 10.1111/ajps.12219; Centers for Disease Control and Prevention, AUST SPECTR DIS ASD; Centers for Disease Control and Prevention, AUT SPECTR DIS ASD T; Chiri G, 2012, MATERN CHILD HLTH J, V16, P1081, DOI 10.1007/s10995-011-0833-6; Davies G, 1997, POLIT SCI QUART, V112, P217, DOI 10.2307/2657939; Department of Health and Human Services, HLTH BEN COV WHAT MA; Enns PK, 2013, STATE POLIT POLICY Q, V13, P349, DOI 10.1177/1532440013496439; Frank RG, 1997, HEALTH AFFAIR, V16, P108, DOI 10.1377/hlthaff.16.4.108; Frean M, 2016, PREMIUM SUBSIDIES MA; GABEL JR, 1989, INQUIRY-J HEALTH CAR, V26, P419; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Grace AM, 2014, HEALTH AFFAIR, V33, P2136, DOI 10.1377/hlthaff.2014.0743; Gray V, 2013, ORG INTERESTS HLTH P; HaiderMarkel DP, 1996, J POLIT, V58, P332, DOI 10.2307/2960229; Harris SL, 2000, J AUTISM DEV DISORD, V30, P137, DOI 10.1023/A:1005459606120; Howard Christopher, 2008, WELFARE STATE NOBODY; Jacobs LR, 2013, J HEALTH POLIT POLIC, V38, P1023, DOI 10.1215/03616878-2334889; Jacobs Lawrence R., 2010, AM DEMOCRACY; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Jensen GA, 1999, MILBANK Q, V77, P425, DOI 10.1111/1468-0009.00147; Johnson RA, 2014, AUTISM, V18, P803, DOI 10.1177/1362361314529191; Kennedy-Hendricks A, 2018, J AM ACAD CHILD PSY, V57, P125, DOI 10.1016/j.jaac.2017.10.019; Klick J, 2006, HEALTH ECON, V15, P83, DOI 10.1002/hec.1023; Kohler F. W., 1999, FOCUS AUTISM OTHER D, V14, P150, DOI [DOI 10.1177/108835769901400304, 10.1177/108835769901400304]; Kurth J, 2010, J SPEC EDUC, V44, P146, DOI 10.1177/0022466908329825; Laugesen MJ, 2006, HEALTH SERV RES, V41, P1081, DOI 10.1111/j.1475-6773.2006.00521.x; Lavelle TA, 2014, PEDIATRICS, V133, pE520, DOI 10.1542/peds.2013-0763; Lax JR, 2012, AM J POLIT SCI, V56, P148, DOI 10.1111/j.1540-5907.2011.00537.x; Lee WS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194723; Leigh JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151970; Leslie DL, 2007, ARCH PEDIAT ADOL MED, V161, P350, DOI 10.1001/archpedi.161.4.350; Lowery D, 2015, STATE POLIT POLICY Q, V15, P263, DOI 10.1177/1532440015574477; MacFarlane JR, 2009, J CHILD FAM STUD, V18, P662, DOI 10.1007/s10826-009-9268-8; Mandell DS, 2006, J AUTISM DEV DISORD, V36, P475, DOI 10.1007/s10803-006-0088-z; Mandell DS, 2016, JAMA PEDIATR, V170, P887, DOI 10.1001/jamapediatrics.2016.1049; Marmor TR, 2017, J HEALTH POLIT POLIC, V42, P1143, DOI 10.1215/03616878-4193678; Nathenson RA, 2020, HEALTH ECON POLICY L, V15, P173, DOI 10.1017/S1744133118000294; National Conference of State Legislatures, AUT INS COV STAT LAW; Oberlander J, 2011, NEW ENGL J MED, V364, P1085, DOI 10.1056/NEJMp1101240; Pacheco J, 2013, STATE POLIT POLICY Q, V13, P306, DOI 10.1177/1532440013487388; Petroski W, IOWA LEGISLATURE BAC; Pitney John J., 2015, POLITICS AUTISM NAVI; Rathore SS, 2000, AM J PREV MED, V19, P71, DOI 10.1016/S0749-3797(00)00179-3; Rigby E, 2013, PUBLIUS J FEDERALISM, V43, P368, DOI 10.1093/publius/pjt012; Rocco P, 2018, PUBLIUS J FEDERALISM, V48, P425, DOI 10.1093/publius/pjy010; Sabik LM, 2012, INQUIRY-J HEALTH CAR, V49, P37, DOI 10.5034/inquiryjrnl_49.01.05; Schauffler HH, 2000, AM J PREV MED, V19, P136, DOI 10.1016/S0749-3797(00)00190-2; Schlozman Kay Lehman, 1986, ORG INTERESTS AM DEM; Schmidt L, 2007, J HEALTH ECON, V26, P431, DOI 10.1016/j.jhealeco.2006.10.012; Silverman C., 2011, UNDERSTANDING AUTISM; SQUIRE P, 1993, J POLIT, V55, P479, DOI 10.2307/2132277; SQUIRE P, 1992, LEGIS STUD QUART, V17, P69, DOI 10.2307/440081; Squire P, 2007, STATE POLIT POLICY Q, V7, P211, DOI 10.1177/153244000700700208; Stahmer AC, 2007, ADM POLICY MENT HLTH, V34, P29, DOI 10.1007/s10488-006-0060-4; Stein BD, 2012, J AM ACAD CHILD PSY, V51, P771, DOI 10.1016/j.jaac.2012.06.006; Stuart EA, 2017, HEALTH AFFAIR, V36, P337, DOI 10.1377/hlthaff.2016.0824; SUMMERS LH, 1989, AM ECON REV, V79, P177; Sylvester SM, 2016, POLICY STUD J, V44, P491, DOI 10.1111/psj.12128; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Turnbull HR, 2002, J AUTISM DEV DISORD, V32, P479; Unumb L., 2017, COMMUNICATION; Volden C, 2006, AM J POLIT SCI, V50, P294, DOI 10.1111/j.1540-5907.2006.00185.x; WALKER JL, 1969, AM POLIT SCI REV, V63, P880, DOI 10.2307/1954434; Wang L, 2013, J AUTISM DEV DISORD, V43, P1057, DOI 10.1007/s10803-012-1649-y; Wei X, 2014, J SPEC EDUC, V48, P167, DOI 10.1177/0022466913483576; WELCH S, 1980, AM J POLIT SCI, V24, P715, DOI 10.2307/2110955; White SW, 2007, J AUTISM DEV DISORD, V37, P1403, DOI 10.1007/s10803-006-0281-0; Zane T., 2008, J EARLY INTENSIVE BE, V5, P44, DOI [DOI 10.1037/H0100418, 10.1037/h0100418]	86	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217064	10.1371/journal.pone.0217064	http://dx.doi.org/10.1371/journal.pone.0217064			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125366	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700015
J	da Silva, CA; Callegari, MA; Dias, CP; Bridi, AM; Pierozan, CR; Foppa, L; Martins, CCD; Dias, FTF; Passos, A; Hermes, R				da Silva, Caio Abercio; Callegari, Marco Aurelio; Dias, Cleandro Pazinato; Bridi, Ana Maria; Pierozan, Carlos Rodolfo; Foppa, Luciana; da Silva Martins, Claudia Cassimira; Falleiros Dias, Francine Taniguchi; Passos, Adsos; Hermes, Rafael			Increasing doses of phytase from Citrobacter braakii in diets with reduced inorganic phosphorus and calcium improve growth performance and lean meat of growing and finishing pigs	PLOS ONE			English	Article							TRACT NUTRIENT DIGESTIBILITY; SOYBEAN-MEAL; AMINO-ACIDS; MINERAL DIGESTIBILITY; ILEAL DIGESTIBILITY; PLASMA METABOLITES; MICROBIAL PHYTASE; 6-PHYTASE; AVAILABILITY; DEPOSITION	The objective of this study was to evaluate the effect of increasing doses of bacterial phytase (RONOZYME HiPhos) on performance and carcass characteristics of growing and finishing pigs. The study included 120 castrated males with initial weight of 23.21 +/- 1.91 kg and 68 days of age, distributed in a randomized block design with five treatments and eight replicates with three animals each. The pigs were fed five corn-soybean meal-based diets: positive control (PC), supplemented with inorganic phosphorus and calcium; negative control (NC), with 0.13% reduction in available phosphorus and 0.11% in calcium; and three NC diets supplemented with 1,000, 2,000, and 3,000 phytase units (FYT)/kg in the feed. Compared with the NC diets without phytase, diets with 1,000, 2,000, and 3,000 FYT/kg inclusion increased the daily weight gain by +12% (quadratic, p<0.05) during the growing I period; +2.9, +2.9, and +10.5% (linear, p<0.01), respectively, during the growing II period; and +4.1, +5.1, and +8.2% (linear, p<0.001), respectively, over the entire experimental period. The daily feed intake increased by 0, +2.8, and +4.3% (linear, p<0.05), respectively, considering the entire experimental period; and the final live weight increased by +3.2, +4.2, and +6.1% (linear, p<0.001), respectively. The phytase treatments did not influence feed conversion ratio, carcass weight and yield, backfat thickness, loin depth and carcass lean meat. According to the European Carcass Classification (SEUROP), however, the animals fed the PC diet and the three phytase levels had more carcasses classified as E (between 55-60% lean meat) when compared to carcasses of pigs fed the NC. Supplementing increasing levels of phytase to a corn-and soybean meal-based diet with inorganic P and Ca reduction improved daily weight gain and feed intake of growing pigs, and such effects were maintained until slaughter age.	[da Silva, Caio Abercio; Callegari, Marco Aurelio; Bridi, Ana Maria; Pierozan, Carlos Rodolfo; Foppa, Luciana] Univ Estadual Londrina, Ctr Agrarian Sci, Dept Zootechnol, Londrina, Parana, Brazil; [Dias, Cleandro Pazinato] Akei Anim Res, Fartura, SP, Brazil; [da Silva Martins, Claudia Cassimira; Falleiros Dias, Francine Taniguchi; Passos, Adsos; Hermes, Rafael] DSM Nutr Prod Ltda, Jaguare, SP, Brazil	Universidade Estadual de Londrina	da Silva, CA; Pierozan, CR (corresponding author), Univ Estadual Londrina, Ctr Agrarian Sci, Dept Zootechnol, Londrina, Parana, Brazil.	casilva@uel.br; carlospierozan@hotmail.com	BRIDI, ANA/ABC-5253-2021	Silva, Claudia/0000-0003-3822-5611; Foppa, Luciana/0000-0002-8353-6470; Pierozan, Carlos Rodolfo/0000-0003-2703-1387				Adeola O, 2011, J ANIM SCI, V89, P3189, DOI 10.2527/jas.2010-3715; Almeida FN, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-8; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2527; Brady SM, 2003, IRISH J AGR FOOD RES, V42, P101; Brana DV, 2006, J ANIM SCI, V84, P1839, DOI 10.2527/jas.2005-565; Cowieson AJ, 2017, ANIM FEED SCI TECH, V225, P182, DOI 10.1016/j.anifeedsci.2017.01.008; Cowieson A, 2016, ANIM FEED SCI TECH, V222, P180, DOI 10.1016/j.anifeedsci.2016.10.016; Cowieson AJ, 2011, WORLD POULTRY SCI J, V67, P225, DOI 10.1017/S0043933911000250; Cowieson AJ, 2017, BRIT J NUTR, V118, P897, DOI [10.1017/s0007114517003026, 10.1017/S0007114517003026]; Dersjant-Li YueMing, 2017, Journal of Applied Animal Nutrition, V5, pe4, DOI 10.1017/JAN.2017.3; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; Fandrejewski H, 1999, J ANIM FEED SCI, V8, P533; Goncalves MAD, 2016, J SWINE HEALTH PROD, V24, P97; Guggenbuhl P, 2007, LIVEST SCI, V109, P261, DOI 10.1016/j.livsci.2007.01.110; Guggenbuhl P, 2016, J ANIM SCI, V94, P286, DOI 10.2527/jas.2015-9806; Guggenbuhl P, 2016, J ANIM SCI, V94, P307, DOI 10.2527/jas.2015-9807; Guggenbuhl P, 2012, J ANIM SCI, V90, P182, DOI 10.2527/jas.53892; Guggenbuhl P., 2012, J ANIM SCI ADV, V2, P438; Haefner S, 2005, APPL MICROBIOL BIOT, V68, P588, DOI 10.1007/s00253-005-0005-y; Johnston SL, 2004, J ANIM SCI, V82, P705; Jongbloed AW, 2004, LIVEST PROD SCI, V91, P143, DOI 10.1016/j.livprodsci.2004.07.017; Kerr BJ, 2010, J ANIM SCI, V88, P238, DOI 10.2527/jas.2009-2146; KETAREN PP, 1993, BRIT J NUTR, V70, P289, DOI 10.1079/BJN19930123; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Lozano A.P., 2011, Arch. zootec., V60, P839, DOI 10.4321/s0004-05922011000400001; Madrid J, 2013, LIVEST SCI, V154, P144, DOI 10.1016/j.livsci.2013.03.003; Menezes-Blackburn D, 2015, J AGR FOOD CHEM, V63, P6142, DOI 10.1021/acs.jafc.5b01996; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Romero LF, 2016, POULTR SCI ASS P 1 L; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Saraiva A, 2009, REV BRAS ZOOTECN, V38, P1279, DOI 10.1590/S1516-35982009000700017; Schmeisser J, 2017, J ANIM PHYSIOL AN N, V101, P563, DOI 10.1111/jpn.12482; Selle PH, 2008, LIVEST SCI, V113, P99, DOI 10.1016/j.livsci.2007.05.014; Selle PH, 2012, NUTR RES REV, V25, P1, DOI 10.1017/S0954422411000151; Selle PH, 2009, LIVEST SCI, V124, P126, DOI 10.1016/j.livsci.2009.01.006; Shelton JL, 2003, J ANIM SCI, V81, P2053; Silva CA, 2014, PRODUCAO SUINOS TEOR, P707; Traylor SL, 2001, J ANIM SCI, V79, P2634; Velayudhan DE, 2015, ANIM FEED SCI TECH, V210, P217, DOI 10.1016/j.anifeedsci.2015.10.005; Wiseman TG, 2007, J ANIM SCI, V85, P1825, DOI 10.2527/jas.2006-407; Wu F, 2017, KANS AES RES PUBL, V3, P19	41	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217490	10.1371/journal.pone.0217490	http://dx.doi.org/10.1371/journal.pone.0217490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125379	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700044
J	Elkasabi, M				Elkasabi, Mahmoud			Calculating fertility and childhood mortality rates from survey data using the DHS. rates R package	PLOS ONE			English	Article								The Demographic and Health Surveys (DHS) are a major source for many demographic and health indicators in developing countries. Although these indicators are well defined in the literature, using survey data to calculate some of these indicators has never been an easy task for data users. This paper presents the DHS. rates software, a user-friendly R package developed to calculate fertility indicators, such as the total fertility rate, general fertility rate, and age-specific fertility rates, and childhood mortality indicators, such as the neonatal mortality rate, post-neonatal mortality rate, infant mortality rate, child mortality rate, and under-5 mortality rate, from the DHS data. The package allows for national and subnational indicators. In addition, the package calculates sampling error indicators such as standard error, design effect, relative standard error, and confidence interval for each demographic indicator. The package can also be used to calculate the same indicators from other population surveys such as the Multiple Indicator Cluster Survey (MICS).	[Elkasabi, Mahmoud] ICF, Demog & Hlth Surveys Program, Rockville, MD 20850 USA		Elkasabi, M (corresponding author), ICF, Demog & Hlth Surveys Program, Rockville, MD 20850 USA.	Mahmoud.elkasabi@icf.com	Elkasabi, Mahmoud/ABA-1651-2020	Elkasabi, Mahmoud/0000-0002-0720-4319	United States Agency for International Development (USAID) through The DHS Program [AID-OAA-C-13-00095]	United States Agency for International Development (USAID) through The DHS Program(United States Agency for International Development (USAID))	This research is carried out with support provided by the United States Agency for International Development (USAID) through The DHS Program (#AID-OAA-C-13-00095). The views expressed are those of the authors and do not necessarily reflect the views of USAID or the United States Government.	Abela GJ, 2016, P NATL ACAD SCI USA, V113, P14294, DOI 10.1073/pnas.1611386113; Child Trends Databank, 2018, SEXUALLY TRANSMITTED; Croft TN, 2018, GUIDE DHS STAT; Elkasabi M., 2018, DHS RATES CALCULATES; Hill Kenneth., 2013, TOOLS DEMOGRAPHIC ES, P166; ICF, 2012, DHS PROGR STATCOMPIL; ICF International, 2012, DEM HLTH SURV SAMPL; Masset Edoardo., 2016, STAT SOFTWARE COMPON, P2016; Moultrie TomA., 2013, TOOLS DEMOGRAPHIC ES; R Core Team, 2018, R LANG ENV STAT COMP; Rutstein SO, 1984, WORLD FERTILITY SURV, V43; Rutstein SO, 1983, WORLD FERTILITY SURV, V24; Schoumaker B, 2013, DEMOGR RES, V28, P1093, DOI 10.4054/DemRes.2013.28.38; United Nations Department of Economic and Social Affairs Population Division, 2011, UN TECHN PAP SER; Wickham H, 2018, HAVEN IMPORT EXPORT; Wickham H, 2007, J STAT SOFTW, V21, P1	16	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216403	10.1371/journal.pone.0216403	http://dx.doi.org/10.1371/journal.pone.0216403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125337	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700004
J	Melendez, DM; Marti, S; Pajor, EA; Sidhu, PK; Gellatly, D; Janzen, ED; Schwinghamer, TD; Coetzee, JF; Schwartzkopf-Genswein, KS				Melendez, Daniela M.; Marti, Sonia; Pajor, Edmond A.; Sidhu, Pritam K.; Gellatly, Desiree; Janzen, Eugene D.; Schwinghamer, Timothy D.; Coetzee, Johann F.; Schwartzkopf-Genswein, Karen S.			Pharmacokinetics of oral and subcutaneous meloxicam: Effect on indicators of pain and inflammation after knife castration in weaned beef calves	PLOS ONE			English	Article							SURGICAL CASTRATION; SUBSTANCE-P; PLASMA-CORTISOL; ADULT GOATS; BEHAVIOR; PERFORMANCE; BAND; ANESTHESIA; MITIGATION; BIOMARKERS	Oral meloxicam is labelled for reducing pain and inflammation associated with castration in cattle in Canada, however, subcutaneous meloxicam is only labelled for pain associated with dis-budding and abdominal surgery. The aim of this project was to determine the pharmacokinetic profile of oral (PO; 1.0 mg/kg BW) and subcutaneous meloxicam (SC; 0.5 mg/kg BW), and to assess the effect of meloxicam on physiological and behavioural indicators of pain associated with knife castration in 7-8 month old calves. Twenty-three Angus crossbred beef calves (328 +/- 4.4 kg BW) were randomly assigned to two treatments: PO n = 12 or SC n = 11 administration of meloxicam immediately before knife castration. Physiological parameters included salivary and hair cortisol, substance P, haptoglobin, serum amyloid-A, weight, complete blood count, scrotal and rectal temperature. Behavioural parameters included standing and lying behaviour, pen behaviour and feeding behaviour. Data were analyzed using PROC GLIMMIX (SAS), with repeated measures using mixed procedures including treatment as a fixed effect and animal and pen as a random effect. The pharmacokinetic profile of the drug including area under the curve, volume of distribution and clearance was greater (P < 0.05) in PO than SC calves. After surgery, substance P concentrations, white blood cell counts (WBC), weight and lying duration were greater (P < 0.05) in PO than SC calves, while scrotal circumference was lower (P < 0.05) in PO calves than SC calves. Although statistical differences were observed for pharmacokinetic, physiological and behavioural parameters differences were small and may lack biological relevance.	[Melendez, Daniela M.; Marti, Sonia; Gellatly, Desiree; Schwinghamer, Timothy D.; Schwartzkopf-Genswein, Karen S.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Marti, Sonia] IRTA, Dept Ruminant Prod, Barcelona, Spain; [Pajor, Edmond A.; Janzen, Eugene D.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Sidhu, Pritam K.; Coetzee, Johann F.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Agriculture & Agri Food Canada; IRTA; University of Calgary; Kansas State University	Schwartzkopf-Genswein, KS (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	Karen.genswein@agr.gc.ca	Marti, Sonia/S-1799-2019; Coetzee, Hans/GOK-3477-2022; MartÍ, Sonia/P-9800-2016; Meléndez, Daniela/AAT-9279-2020	Coetzee, Hans/0000-0003-1802-3991; MartÍ, Sonia/0000-0002-8115-0582; Meléndez, Daniela/0000-0002-0153-9708; Schwinghamer, Timothy/0000-0001-7727-7284	Agriculture and Agri-Food Canada; Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster [ANH.21.13AIP-CL01]; CERCA program from Generalitat de Catalunya	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster; CERCA program from Generalitat de Catalunya	Funding was provided by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/eng/home/?id=1395690825741) and the Beef Cattle Research Council (http://www.beefresearch.ca/) through the Canadian Beef Cattle Industry Science Cluster (ANH.21.13AIP-CL01). The co-author Sonia Marti was partly supported by the CERCA program from Generalitat de Catalunya. This is Lethbridge Research Centre contribution #38719006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou MA, 2013, VET IMMUNOL IMMUNOP, V151, P285, DOI 10.1016/j.vetimm.2012.11.018; Barrier AC, 2014, APPL ANIM BEHAV SCI, V155, P28, DOI 10.1016/j.applanim.2014.02.015; Brown AC, 2015, J ANIM SCI, V93, P2460, DOI 10.2527/jas.2014-8695; CCAC, 2009, CCAC GUID AN US PROT; CHASE CC, 1995, J ANIM SCI, V73, P975; Coetzee JF, 2008, AM J VET RES, V69, P751, DOI 10.2460/ajvr.69.6.751; Coetzee JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-153; Coetzee JF, 2009, VET THER, V10; Currah JM, 2009, CAN VET J, V50, P375; de Grauw JC, 2009, EQUINE VET J, V41, P693, DOI 10.2746/042516409X436286; DeVane CL, 2001, PHARMACOTHERAPY, V21, P1061, DOI 10.1592/phco.21.13.1061.34612; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Fisher AD, 1996, J ANIM SCI, V74, P2336; Gonzalez LA, 2010, J ANIM SCI, V88, P802, DOI 10.2527/jas.2008-1752; Ingvast-Larsson C, 2011, J VET PHARMACOL THER, V34, P64, DOI 10.1111/j.1365-2885.2010.01195.x; Karademir U, 2016, NEW ZEAL VET J, V64, P165, DOI 10.1080/00480169.2015.1124811; Kreuder AJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-85; Lees P, 2004, J VET PHARMACOL THER, V27, P479, DOI 10.1111/j.1365-2885.2004.00617.x; Marti S, 2018, CANADIAN J ANIMAL SC, V21, P1; Marti S, 2018, J ANIM SCI, V96, P4136, DOI 10.1093/jas/sky291; Marti S, 2017, CAN VET J, V58, P1081; Martin P., 2007, RECORDING METHODS ME, V3rd, P48; McFarlane D., 2008, LARGE ANIMAL INTERNA, V4th, P1478; Melendez DM, 2018, J ANIM SCI, V96, P1268, DOI 10.1093/jas/sky034; Melendez DM, 2017, J ANIM SCI, V95, P5218, DOI 10.2527/jas2017.1978; Melendez DM, 2017, J ANIM SCI, V95, P4352, DOI 10.2527/jas2017.1762; Melendez DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207289; Melendez DM, 2018, J ANIM SCI, V96, P3606, DOI 10.1093/jas/sky245; Molony V, 1995, APPL ANIM BEHAV SCI, V46, P33, DOI 10.1016/0168-1591(95)00635-4; Moya D, 2014, J ANIM SCI, V92, P1684, DOI 10.2527/jas.2013-7298; Moya D, 2013, LIVEST SCI, V158, P138, DOI 10.1016/j.livsci.2013.10.007; NFACC, 2013, COD PRACT CAR HANDL; NICOL GD, 1992, J NEUROSCI, V12, P1917; NRC (National Research Council), 2016, NUTR REQ BEEF CATTL; PERRIER D, 1982, J PHARM SCI, V71, P372, DOI 10.1002/jps.2600710332; Repenning PE, 2013, J ANIM SCI, V91, P4975, DOI 10.2527/jas.2012-6061; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roberts SL, 2015, J ANIM SCI, V93, P4123, DOI 10.2527/jas.2015-9160; Schwartzkopf-Genswein KS, 2003, CAN J ANIM SCI, V83, P29, DOI 10.4141/A02-027; SEIDEMAN SC, 1982, J ANIM SCI, V55, P826, DOI 10.2527/jas1982.554826x; Shukla M, 2007, COMP BIOCHEM PHYS C, V145, P528, DOI 10.1016/j.cbpc.2007.01.020; Sowell BF, 1998, APPL ANIM BEHAV SCI, V59, P277, DOI 10.1016/S0168-1591(98)00110-5; Stock ML, 2013, AM J VET RES, V74, P779, DOI 10.2460/ajvr.74.5.779; Theurer ME, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-48; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Toutain PL, 2004, AM J VET RES, V65, P1542, DOI 10.2460/ajvr.2004.65.1542; Tripathi K., 2013, ESSENTIALS MED PHARM, P5; UBC AWP (University of British Columbia Animal Welfare Program), 2013, UBC AN WELF PROGR SO, P1; Van Engen NK, 2014, J ANIM SCI, V92, P498, DOI 10.2527/jas.2013-6857; White BJ, 2008, AM J VET RES, V69, P1005, DOI 10.2460/ajvr.69.8.1005	50	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217518	10.1371/journal.pone.0217518	http://dx.doi.org/10.1371/journal.pone.0217518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125384	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700047
J	Song, M; Zhao, J; Wen, HS; Li, Y; Li, JF; Li, LM; Tao, YX				Song, Min; Zhao, Ji; Wen, Hai-Shen; Li, Yun; Li, Ji-Fang; Li, Lan-Min; Tao, Ya-Xiong			The impact of acute thermal stress on the metabolome of the black rockfish (Sebastes schlegelii)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; GENE-EXPRESSION; RAINBOW-TROUT; SKELETAL-MUSCLE; LOW-TEMPERATURE; ANTARCTIC FISH; RESPONSES; HYPOXIA; COLD; OXYGEN	Acute change in water temperature causes heavy economic losses in the aquaculture industry. The present study investigated the metabolic and molecular effects of acute thermal stress on black rockfish (Sebastes schlegelii). Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics was used to investigate the global metabolic response of black rockfish at a high water temperature (27 degrees C), low water temperature (5 degrees C) and normal water temperature (16 degrees C). Metabolites involved in energy metabolism and basic amino acids were significantly increased upon acute exposure to 27 degrees C (P < 0.05), and no change in metabolite levels occurred in the low water temperature group. However, certain fatty acid levels were elevated after cold stress (P < 0.05), and this effect was not observed in the 27 degrees C group, suggesting that acute high and low temperature exposures caused different physiological responses. Using quantitative real-time PCR, we analyzed the expression of ubiquitin (ub), hypoxia-inducible factor (hif), lactate dehydrogenase (ldh), and acetyl-CoA carboxylase (acac). Higher expression levels of ub, hif, and ldh (P < 0.05) were observed in the high water temperature group, but no changes in these expression levels occurred in the low water temperature group. Our findings provide a potential metabolic profile for black rockfish when exposed to acute temperature stress and provide some insights into host metabolic and molecular responses to thermal stress.	[Song, Min; Zhao, Ji; Wen, Hai-Shen; Li, Yun; Li, Ji-Fang; Li, Lan-Min] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Shandong, Peoples R China; [Tao, Ya-Xiong] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA	Ocean University of China; Auburn University System; Auburn University	Wen, HS; Li, Y (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Shandong, Peoples R China.	wenhaishen@ouc.edu.cn; yunli0116@ouc.edu.cn	Tao, Ya-Xiong/K-4939-2019	Tao, Ya-Xiong/0000-0003-4737-749X	National Natural Science Foundation of China [41476110]; Fundamental Research Funds for the Central Universities in China [841712004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This study was supported by The National Natural Science Foundation of China (41476110) and the Fundamental Research Funds for the Central Universities in China (841712004). HW, YL, JZ, MS has been funded by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2002, J EXP BIOL, V205, P1831; ARCHER SD, 1991, PHYSIOL ZOOL, V64, P242, DOI 10.1086/physzool.64.1.30158522; Artigaud S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2132-x; Bagnyukova TV, 2007, J THERM BIOL, V32, P227, DOI 10.1016/j.jtherbio.2007.01.004; BAILEY JR, 1993, CAN J ZOOL, V71, P2167, DOI 10.1139/z93-304; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Battersby BJ, 1998, AM J PHYSIOL-REG I, V275, pR905, DOI 10.1152/ajpregu.1998.275.3.R905; Behrooz A, 1997, J BIOL CHEM, V272, P5555, DOI 10.1074/jbc.272.9.5555; Behrooz A, 1999, NEWS PHYSIOL SCI, V14, P105; Bohle B, 1974, TEMPERATURPREFERANSE; Bowden LA, 1996, COMP BIOCHEM PHYS B, V115, P375, DOI 10.1016/S0305-0491(96)00129-0; Brownsey RW, 1997, BIOCHEM SOC T, V25, P1232, DOI 10.1042/bst0251232; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; BUTTA NV, 1987, J PHARMACOL EXP THER, V240, P277; Cabiscol Elisa, 2000, International Microbiology, V3, P3; CHAVIN W, 1970, COMP BIOCHEM PHYSIOL, V33, P629, DOI 10.1016/0010-406X(70)90376-2; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Chowanski S, 2015, COMP BIOCHEM PHYS A, V183, P57, DOI 10.1016/j.cbpa.2015.01.007; Cochrane K., 2009, FAO FISH AQUAC TECH, V530, P212; Costa IASF, 2013, PHYSIOL BIOCHEM ZOOL, V86, P233, DOI 10.1086/669538; DRIEDZIC WR, 1987, AM J PHYSIOL, V252, pR930, DOI 10.1152/ajpregu.1987.252.5.R930; Ege R., 1914, Internationale Revue der Hydrobiologie Leipzig, V7, DOI 10.1002/iroh.19140070105; Egginton S, 2000, AM J PHYSIOL-REG I, V279, pR375, DOI 10.1152/ajpregu.2000.279.2.R375; EVERSE J, 1973, ADV ENZYMOL RAMB, V37, P61; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feidantsis K, 2015, J COMP PHYSIOL B, V185, P185, DOI 10.1007/s00360-014-0875-3; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; Galafassi S, 2015, ANTON LEEUW INT J G, V107, P1145, DOI 10.1007/s10482-015-0406-6; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guderley H, 2004, BIOL REV, V79, P409, DOI 10.1017/S1464793103006328; Hart JS, 1971, RODENT, V2, P1; HAZEL JR, 1974, PHYSIOL REV, V54, P620, DOI 10.1152/physrev.1974.54.3.620; Healy TM, 2017, J COMP PHYSIOL B, V187, P463, DOI 10.1007/s00360-016-1042-9; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hsieh SL, 2003, AQUACULTURE, V220, P903, DOI 10.1016/S0044-8486(02)00579-3; Ibarz A, 2005, AQUACULTURE, V249, P477, DOI 10.1016/j.aquaculture.2005.02.056; JAENICKE R, 1990, PHILOS T R SOC B, V326, P535, DOI 10.1098/rstb.1990.0030; Jayasundara N, 2013, J EXP BIOL, V216, P2111, DOI 10.1242/jeb.083873; Kemppainen J, 2002, J PHYSIOL-LONDON, V542, P403, DOI 10.1113/jphysiol.2002.018135; Killen SS, 2012, FUNCT ECOL, V26, P134, DOI 10.1111/j.1365-2435.2011.01920.x; Kim KH, 2001, AQUACULTURE, V192, P93, DOI 10.1016/S0044-8486(00)00460-9; Kim Y. S., 2004, COMMERCIAL FISHES CO; Kyprianou TD, 2010, J COMP PHYSIOL B, V180, P1005, DOI 10.1007/s00360-010-0481-y; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Love M. S., 2002, ROCKFISHES NE PACIFI; Madeira D, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2803-9; Mark FC, 2002, AM J PHYSIOL-REG I, V283, pR1254, DOI 10.1152/ajpregu.00167.2002; Marshall D. J, 2010, P ROY SOC LOND B BIO; Marshall N, 2013, ECOSYSTEMS, V16, P797, DOI 10.1007/s10021-013-9651-6; MOMMSEN TP, 1986, CAN J ZOOL, V64, P1110, DOI 10.1139/z86-166; Monselise EB, 2003, BIOCHEM BIOPH RES CO, V302, P427, DOI 10.1016/S0006-291X(03)00194-3; Nicholson J.K., 2007, HDB METABONOMICS MET, P1; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Purac J, 2011, PHYSIOL ENTOMOL, V36, P135, DOI 10.1111/j.1365-3032.2010.00772.x; Qin GZ, 2007, MOL CELL PROTEOMICS, V6, P425, DOI 10.1074/mcp.M600179-MCP200; Rebelein A, 2018, COMP BIOCHEM PHYS A, V217, P43, DOI 10.1016/j.cbpa.2017.12.012; Riddle SR, 2000, AM J PHYSIOL-LUNG C, V278, pL407, DOI 10.1152/ajplung.2000.278.2.L407; Rimoldi S, 2012, MOL BIOL REP, V39, P4009, DOI 10.1007/s11033-011-1181-8; Rissanen E, 2006, J EXP BIOL, V209, P994, DOI 10.1242/jeb.02103; ROBIN ED, 1984, J CELL PHYSIOL, V118, P287, DOI 10.1002/jcp.1041180311; Samuelsson LM, 2008, MOL BIOSYST, V4, P974, DOI 10.1039/b804196b; Schulte PM, 2015, J EXP BIOL, V218, P1856, DOI 10.1242/jeb.118851; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEPHTON DH, 1991, CAN J ZOOL, V69, P258, DOI 10.1139/z91-040; St-Pierre J, 1998, J EXP BIOL, V201, P2961; Terova G, 2008, AQUACULTURE, V279, P150, DOI 10.1016/j.aquaculture.2008.03.041; Todgham AE, 2007, J COMP PHYSIOL B, V177, P857, DOI 10.1007/s00360-007-0183-2; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Trueman RJ, 2000, J EXP BIOL, V203, P641; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Weber JM, 1996, COMP BIOCHEM PHYS A, V113, P33, DOI 10.1016/0300-9629(95)02063-2; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Windisch HS, 2011, AM J PHYSIOL-REG I, V301, pR1453, DOI 10.1152/ajpregu.00158.2011; Yan XJ, 2012, METABOLOMICS, V8, P299, DOI 10.1007/s11306-011-0307-2; YIN MC, 1987, J EXP MAR BIOL ECOL, V107, P279, DOI 10.1016/0022-0981(87)90044-X; Zhao XL, 2015, FISH SHELLFISH IMMUN, V44, P33, DOI 10.1016/j.fsi.2015.01.025	84	21	24	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217133	10.1371/journal.pone.0217133	http://dx.doi.org/10.1371/journal.pone.0217133			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125355	gold, Green Published, Green Submitted			2022-12-27	WOS:000468865700021
J	Mitra, S; Saha, S				Mitra, Sayantan; Saha, Sriparna			A multiobjective multi-view cluster ensemble technique: Application in patient subclassification	PLOS ONE			English	Article							GENE-EXPRESSION DATA; LATENT VARIABLE MODEL; DATA INTEGRATION; CANCER TYPES; BREAST; OPTIMIZATION; CLASSIFICATION; ALGORITHM	Recent high throughput omics technology has been used to assemble large biomedical omics datasets. Clustering of single omics data has proven invaluable in biomedical research. For the task of patient sub-classification, all the available omics data should be utilized combinedly rather than treating them individually. Clustering of multi-omics datasets has the potential to reveal deep insights. Here, we propose a late integration based multiobjective multi-view clustering algorithm which uses a special perturbation operator. Initially, a large number of diverse clustering solutions ( called base partitionings) are generated for each omic dataset using four clustering algorithms, viz., k means, complete linkage, spectral and fast search clustering. These base partitionings of multi-omic datasets are suitably combined using a special perturbation operator. The perturbation operator uses an ensemble technique to generate new solutions from the base partitionings. The optimal combination of multiple partitioning solutions across different views is determined after optimizing the objective functions, namely conn-XB, for checking the quality of partitionings for different views, and agreement index, for checking agreement between the views. The search capability of a multiobjective simulated annealing approach, namely AMOSA is used for this purpose. Lastly, the non-dominated solutions of the different views are combined based on similarity to generate a single set of non-dominated solutions. The proposed algorithm is evaluated on 13 multi-view cancer datasets. An elaborated comparative study with several baseline methods and five state-of-the-art models is performed to show the effectiveness of the algorithm.	[Mitra, Sayantan; Saha, Sriparna] Indian Inst Technol Patna, Dept Comp Sci & Engn, Patna, Bihar, India	Indian Institute of Technology (IIT) - Patna; Indian Institute of Technology System (IIT System)	Mitra, S (corresponding author), Indian Inst Technol Patna, Dept Comp Sci & Engn, Patna, Bihar, India.	sayantaniem@gmail.com	Mitra, Dr. Sayantan/ABE-2111-2021	Mitra, Dr. Sayantan/0000-0001-8140-6499	Young Faculty Research Fellowship (YFRF) Award; Visvesvaraya PhD scheme for Electronics and IT, Ministry of Electronics and Information Technology (MeitY), Government of India	Young Faculty Research Fellowship (YFRF) Award; Visvesvaraya PhD scheme for Electronics and IT, Ministry of Electronics and Information Technology (MeitY), Government of India	Dr. Sriparna Saha gratefully acknowledges the Young Faculty Research Fellowship (YFRF) Award, supported by Visvesvaraya PhD scheme for Electronics and IT, Ministry of Electronics and Information Technology (MeitY), Government of India, being implemented by Digital India Corporation (formerly Media Lab Asia) for carrying out this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Lingling, 2012, ISRN Bioinform, V2012, P537217, DOI 10.5402/2012/537217; Bandyopadhyay S, 2008, IEEE T EVOLUT COMPUT, V12, P269, DOI 10.1109/TEVC.2007.900837; Buffa FM, 2011, CANCER RES, DOI [10.1158/0008-5472-CAN-11-0489, DOI 10.1158/0008-5472-CAN-11-0489]; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chikhi NF, 2016, INFORM PROCESS MANAG, V52, P618, DOI 10.1016/j.ipm.2015.12.007; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Faceli K., 2007, INT J HYBRID INTELL, V4, P145; Faceli K, 2009, NEUROCOMPUTING, V72, P2763, DOI 10.1016/j.neucom.2008.09.025; Faceli Katti, 2008, PATTERN RECOGN, P325; Fern X. Z., 2004, PROC 21 INT C MACH L, P36; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Karypis G., 1995, METIS UNSTRUCTURED G; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Li Y, 2018, ENERGY, V162, P237, DOI 10.1016/j.energy.2018.07.200; Mo Q., 2013, P NATL ACAD SCI USA; Mo QX, 2018, BIOSTATISTICS, V19, P71, DOI 10.1093/biostatistics/kxx017; Nguyen T, 2017, GENOME RES, V27, P2025, DOI 10.1101/gr.215129.116; Nie FP, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2022, DOI 10.1145/3219819.3220049; Nie FP, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2564; Nielsen KV, 2008, ACTA ONCOL, V47, P725, DOI 10.1080/02841860801995396; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Paul S, 2013, LECT NOTES COMPUT SC, V8298, P387, DOI 10.1007/978-3-319-03756-1_35; Rappoport N, 2018, NUCLEIC ACIDS RES, V46, P10546, DOI 10.1093/nar/gky889; Ray B, 2014, SCI REP-UK, V4, DOI 10.1038/srep04411; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Saha S, 2018, ACM T KNOWL DISCOV D, V12, DOI 10.1145/3182181; Saha S, 2016, SOFT COMPUT, V20, P3381, DOI 10.1007/s00500-015-1783-5; Saha S, 2013, COMPUT BIOL MED, V43, P1965, DOI 10.1016/j.compbiomed.2013.07.021; Saha S, 2012, APPL SOFT COMPUT, V12, P1555, DOI 10.1016/j.asoc.2011.12.013; Serra A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0680-3; Shapira O, 2004, P 4 INT S INT MAN SY, P958; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Studholme C., 1997, MEASURES 3D MED IMAG; Suman B, 2006, J OPER RES SOC, V57, P1143, DOI 10.1057/palgrave.jors.2602068; Sun SL, 2013, NEURAL COMPUT APPL, V23, P2031, DOI 10.1007/s00521-013-1362-6; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Villalobos-Arias M, 2006, MATH METHOD OPER RES, V64, P353, DOI 10.1007/s00186-006-0082-4; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/nmeth.2810, 10.1038/NMETH.2810]; Wang XS, 2013, PROC EUR S-STATE DEV, P234, DOI 10.1109/ESSDERC.2013.6818862; Wang YL, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-7; Wu DM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2223-8; Zhang XC, 2015, AAAI CONF ARTIF INTE, P3174	50	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216904	10.1371/journal.pone.0216904	http://dx.doi.org/10.1371/journal.pone.0216904			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120942	gold, Green Submitted, Green Published			2022-12-27	WOS:000468775700039
J	Pijnacker, R; Mangen, MJJ; van den Bunt, G; Franz, E; van Pelt, W; Mughini-Gras, L				Pijnacker, Roan; Mangen, Marie-Josee J.; van den Bunt, Gerrita; Franz, Eelco; van Pelt, Wilfrid; Mughini-Gras, Lapo			Incidence and economic burden of community-acquired gastroenteritis in the Netherlands: Does having children in the household make a difference?	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; ACUTE GASTROINTESTINAL ILLNESS; COSTS; TRANSMISSION; ENGLAND; COHORT	This study aimed at estimating gastroenteritis (GE) incidence in all age groups of the Netherlands' general population, with special emphasis on the role of children in GE burden, and the associated costs. Monthly from November 2014 to November 2016, a random sample of 2000 residents in the Netherlands was invited to complete a questionnaire on household characteristics and health complaints. We calculated GE incidence rates standardized to the Dutch population and used multivariable logistic regression models to identify potential risk factors. We calculated the costs related to resources used within the healthcare sector, the resources used by patients and their families, and productivity losses (paid worktime) due to GE. The overall standardized incidence rate was 0.81 GE episodes/person-year, with the highest rate in children <= 4 years (1.96 episodes/person-year). GE was observed more often in households with children (<= 17 years), especially if children attended out-of-home childcare services, and among individuals with non-native Dutch ethnic background. Less GE was observed among employed persons aged 25-64 years, compared with those unemployed, but the opposite was observed in persons >= 65 years. The average costs per GE episode was (sic)191, resulting in (sic)945 million annual total costs for GE in the Netherlands ((sic)55 per inhabitant). The majority of costs (55%) were attributable to productivity losses of the ill or their caregivers. In conclusion, GE still poses a significant burden, particularly in preschool children and adults living in households with children. Similar to other industrialized countries, the major factor driving the costs due to GE was the loss of productivity. This study also provides up-to-date baseline GE incidence rates and associated societal costs to better contextualize the burden of the disease in support of policy making.	[Pijnacker, Roan; Mangen, Marie-Josee J.; van den Bunt, Gerrita; Franz, Eelco; van Pelt, Wilfrid; Mughini-Gras, Lapo] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van den Bunt, Gerrita] UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Mughini-Gras, Lapo] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Unilever; Utrecht University; Utrecht University Medical Center; Utrecht University	Pijnacker, R (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	roan.pijnacker@rivm.nl		van den Bunt, Gerrita/0000-0002-4429-6486	Dutch Ministry of Health, Welfare, and Sport; Dutch Ministry of Economic Affairs through the 1Health4Food (1H4F) project under the ESBL Attribution (ESBLAT) consortium [TKI-AF-12067]	Dutch Ministry of Health, Welfare, and Sport; Dutch Ministry of Economic Affairs through the 1Health4Food (1H4F) project under the ESBL Attribution (ESBLAT) consortium	This work was supported by the Dutch Ministry of Health, Welfare, and Sport and by the Dutch Ministry of Economic Affairs through the 1Health4Food (1H4F) project under the ESBL Attribution (ESBLAT) consortium [project number: TKI-AF-12067]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, CLIN GASTROENTEROL H, V11, P1050, DOI 10.1016/j.cgh.2013.02.024; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; Bischoff S, 2005, GASTROENTEROLOGY, V128, P1089, DOI 10.1053/j.gastro.2004.08.015; Bruijning-Verhagen P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1134-3; Caffarelli C, 2000, ARCH DIS CHILD, V82, P131, DOI 10.1136/adc.82.2.131; Care Institute Netherlands, 2017, MED COSTS PRIC INF Z; Central Bureau for Statistics, 2018, CONS PRIC IND; Central Bureau for Statistics, 2016, HOURL WAG EMPL PROF; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Den Dulk C J, 1992, Maandstat Bevolking, V40, P14; Doorduyn Y, 2012, EPIDEMIOL INFECT, V140, P1185, DOI 10.1017/S0950268811001099; Enserink R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089496; Euser AM, 2009, NEPHRON CLIN PRACT, V113, pC214, DOI 10.1159/000235241; Friesema IHM, 2012, EUR J CLIN MICROBIOL, V31, P1895, DOI 10.1007/s10096-011-1518-1; Gauci C, 2007, EPIDEMIOL INFECT, V135, P1282, DOI 10.1017/S0950268806007795; Hakkaart-van Roijen L, 2016, MANUAL EC EVALUATION; Hall GV, 2006, EPIDEMIOL INFECT, V134, P111, DOI 10.1017/S0950268805004656; Hellard ME, 2003, J GASTROEN HEPATOL, V18, P322, DOI 10.1046/j.1440-1746.2003.02959.x; Henson SJ, 2008, INT J FOOD MICROBIOL, V127, P43, DOI 10.1016/j.ijfoodmicro.2008.06.007; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P9, DOI 10.1017/S0950268801006628; Hooiveld M, 2018, WEKELIJKSE SURVEILLA; Kemmeren J. M., 2006, PRIORITY SETTING FOO; Kuusi M, 2003, EPIDEMIOL INFECT, V131, P591, DOI 10.1017/S0950268803008744; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; Mangen M. J., 2017, DIS BURDEN FOOD RELA; Mangen MJJ, 2015, INT J FOOD MICROBIOL, V196, P84, DOI 10.1016/j.ijfoodmicro.2014.11.022; Ministry of Health WaS, 2018, KAM AANB ROT RIS; Mughini-Gras L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22144; Muller L, 2012, EPIDEMIOL INFECT, V140, P290, DOI 10.1017/S0950268811000471; Perry S, 2005, EMERG INFECT DIS, V11, P1093, DOI 10.3201/eid1107.040889; Roberts JA, 2003, EPIDEMIOL INFECT, V130, P1, DOI 10.1017/S0950268802007690; Sacri AS, 2014, PEDIATR INFECT DIS J, V33, P583, DOI 10.1097/INF.0000000000000220; Sargeant JM, 2008, EPIDEMIOL INFECT, V136, P451, DOI 10.1017/S0950268807008837; Scallan E, 2004, Commun Dis Public Health, V7, P61; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; te Riele S, 2015, FAMILY SOLIDARITY HE; Van Cauteren D, 2012, EPIDEMIOL INFECT, V140, P697, DOI 10.1017/S0950268811000999; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; van den Bunt G, 2018, J ANTIMICROB CHEMOTH, V73, P607, DOI 10.1093/jac/dkx455; Verberk JDM, 2017, ROTAVIRUS NETHERLAND; Vieira WA, 2010, J ASTHMA ALLERGY, V3, P123, DOI 10.2147/JAA.S10592; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	44	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217347	10.1371/journal.pone.0217347	http://dx.doi.org/10.1371/journal.pone.0217347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120975	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700092
J	Abagandura, GO; Senturklu, S; Singh, N; Kumar, S; Landblom, DG; Ringwall, K				Abagandura, Gandura Omar; Senturklu, Songul; Singh, Navdeep; Kumar, Sandeep; Landblom, Douglas G.; Ringwall, Kris			Impacts of crop rotational diversity and grazing under integrated crop-livestock system on soil surface greenhouse gas fluxes	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; N2O EMISSIONS; CARBON-DIOXIDE; TILLAGE; CO2; INTENSITY; STEPPE; RATES; CORN; RESPIRATION	Integrated crop-livestock (ICL) system is beneficial in enhancing soil organic carbon and nutrient cycling. However, the benefits of the ICL system on mitigation of GHG emissions are poorly understood. Thus, the present study was initiated in 2011 to assess the effect of crop rotation diversity and grazing managed under the ICL system on GHG emissions. The cropping system investigated here included spring wheat grown continuously for five years and a 5-yr crop rotation (spring wheat-cover crops-corn-pea/barley-sunflower). Each phase was present each year. Yearling steers grazed only the pea/barley, corn and cover crops plots in 2016 and 2017. Exclusion areas avoided the grazing in these crops to compare the GHG fluxes under grazed vs. non-grazed areas. The GHG fluxes were measured weekly from all crop phases during the growing season for both years using a static chamber. Cumulative CO2 and CH4 fluxes were similar from all crop phases over the study period. However, continuous spring wheat recorded higher cumulative N2O fluxes (671 g N ha(-1)) than that under spring wheat in rotation (571 g N ha(-1)). Grazing decreased cumulative CO2 fluxes (359 kg C ha(-1)) compared to ungrazed (409 kg C ha(-1)), however, no effect from grazing on cumulative CH4 and N2O fluxes over the study period were found. The present study shows that grazing and crop rotational diversity affected carbon and nitrogen inputs, which in turn affected soil CO2 and N2O fluxes. Long-term monitoring is needed to evaluate the response of soil GHG emissions to grazing and crop rotation interactions under the ICL system.	[Abagandura, Gandura Omar; Singh, Navdeep; Kumar, Sandeep] South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA; [Senturklu, Songul; Landblom, Douglas G.; Ringwall, Kris] North Dakota State Univ, Dickinson Res Extens Ctr, Dickinson, ND USA; [Senturklu, Songul] Canakkale Onsekiz Mart Univ, Anim Sci Dept, Canakkale, Turkey	South Dakota State University; North Dakota State University Fargo; Canakkale Onsekiz Mart University	Kumar, S (corresponding author), South Dakota State Univ, Dept Agron Hort & Plant Sci, Brookings, SD 57007 USA.	sandeep.kumar@sdstate.edu	KUMAR, SANDEEP/GZA-7182-2022; Abagandura, Gandura/AAU-1385-2020; Singh, Navdeep/AAO-9129-2021; kumar, sandeep/GMX-3097-2022	Singh, Navdeep/0000-0001-7955-6930; Abagandura, Gandura/0000-0003-0487-8374	USDA-CAP project	USDA-CAP project	The authors received funding from USDA-CAP project.	Alluvione F, 2009, J ENVIRON QUAL, V38, P2023, DOI 10.2134/jeq2008.0517; [Anonymous], 2010, CHAMBER BASED TRACE; [Anonymous], 2018, AGRICULTURE BASEL, DOI DOI 10.3390/agriculture8050062; Barsotti JL, 2013, SOIL SCI SOC AM J, V77, P1012, DOI 10.2136/sssaj2012.0386; Barton L, 2013, AGR ECOSYST ENVIRON, V167, P23, DOI 10.1016/j.agee.2013.01.003; Behnke GD, 2018, AGR ECOSYST ENVIRON, V261, P62, DOI 10.1016/j.agee.2018.03.007; Benitez MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15955-9; Boon A, 2014, EGU GEN ASS C; Brock PM, 2016, CROP PASTURE SCI, V67, P812, DOI 10.1071/CP15260; Buller LS, 2015, AGR SYST, V137, P206, DOI 10.1016/j.agsy.2014.11.004; Cai YJ, 2016, SCI TOTAL ENVIRON, V572, P185, DOI 10.1016/j.scitotenv.2016.07.222; Campbell B, 2014, J SOIL WATER CONSERV, V69, P543, DOI 10.2489/jswc.69.6.543; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; Cardoso AD, 2017, ECOSYSTEMS, V20, P845, DOI 10.1007/s10021-016-0065-0; Chatskikh D, 2007, SOIL TILL RES, V97, P5, DOI 10.1016/j.still.2007.08.004; Chen WW, 2013, ATMOS ENVIRON, V64, P141, DOI 10.1016/j.atmosenv.2012.10.004; Chiavegato MB, 2015, J ANIM SCI, V93, P1350, DOI 10.2527/jas.2014-8134; de Carvalho AM, 2016, PESQUI AGROPECU BRAS, V51, P1213, DOI [10.1590/S0100-204X2016000900021, 10.1590/s0100-204x2016000900021]; Denef K., 2011, GS23F8182H USDA; Drewry JJ, 2008, AUST J SOIL RES, V46, P237, DOI 10.1071/SR07125; Drury CF, 2014, CAN J SOIL SCI, V94, P421, DOI [10.4141/CJSS2013-101, 10.4141/cjss2013-101]; Fu HD, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020317; Fu X, 2017, SOIL SCI SOC AM J, V81, P503, DOI 10.2136/sssaj2016.04.0122; Ghosh S, 2002, BIOL FERT SOILS, V35, P473, DOI 10.1007/s00374-002-0498-9; Grossman R.B., 2002, METHODS SOIL ANAL 4, V5, P201, DOI DOI 10.2136/SSSABOOKSER5.4.C9; Hafner S, 2012, GLOBAL CHANGE BIOL, V18, P528, DOI 10.1111/j.1365-2486.2011.02557.x; Hegymegi P, 2005, CEREAL RES COMMUN, V33, P373, DOI 10.1556/CRC.33.2005.1.92; Hewins DB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19785-1; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; Kebreab E, 2006, CAN J ANIM SCI, V86, P135, DOI 10.4141/A05-010; King AE, 2018, ECOL APPL, V28, P249, DOI 10.1002/eap.1648; Kremen C., 2012, ECOLOGY SOC, V17; Lecain DR, 2000, J RANGE MANAGE, V53, P199, DOI 10.2307/4003283; Lee J, 2018, SOIL SYST, V2, DOI 10.3390/soilsystems2010013; Lehman RM, 2017, SOIL SCI SOC AM J, V81, P76, DOI 10.2136/sssaj2016.01.0021; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep40857; Nawaz MF, 2013, AGRON SUSTAIN DEV, V33, P291, DOI 10.1007/s13593-011-0071-8; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Omonode RA, 2011, SOIL SCI SOC AM J, V75, P152, DOI 10.2136/sssaj2009.0147; Ozlu E, 2018, SCI TOTAL ENVIRON, V626, P817, DOI 10.1016/j.scitotenv.2018.01.120; Paz-Ferreiro J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014027; Rafique R, 2011, ECOSYSTEMS, V14, P563, DOI 10.1007/s10021-011-9434-x; Risch AC, 2007, PLANT SOIL, V298, P191, DOI 10.1007/s11104-007-9354-x; Rochette P, 2005, NUTR CYCL AGROECOSYS, V73, P171, DOI 10.1007/s10705-005-0357-9; Sainju UM, 2016, PLOS ONE, V11; Sainju UM, 2014, J ENVIRON QUAL, V43, P777, DOI 10.2134/jeq2013.10.0405; Sainju UM, 2012, J ENVIRON QUAL, V41, P1774, DOI 10.2134/jeq2012.0176; Salton JC, 2014, AGR ECOSYST ENVIRON, V190, P70, DOI 10.1016/j.agee.2013.09.023; Schwenke GD, 2015, AGR ECOSYST ENVIRON, V202, P232, DOI 10.1016/j.agee.2015.01.017; Shaaban M, 2016, INT J ENVIRON SCI TE, V13, P179, DOI 10.1007/s13762-015-0843-9; Sulc RM, 2014, EUR J AGRON, V57, P21, DOI 10.1016/j.eja.2013.10.007; Tang SM, 2015, ATMOS ENVIRON, V122, P343, DOI 10.1016/j.atmosenv.2015.09.073; Tiemann LK, 2015, ECOL LETT, V18, P761, DOI 10.1111/ele.12453; USEPA, 2018, SOURC GREENH GAS EM; Wang XY, 2013, ATMOS ENVIRON, V79, P576, DOI 10.1016/j.atmosenv.2013.07.003; Wegner BR, 2018, J ENVIRON QUAL, V47, P1146, DOI [10.2134/jeq2018.03.0093, 10.2134/jeq]; Wei D, 2012, PLANT SOIL, V359, P45, DOI 10.1007/s11104-011-1105-3; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Wu X, 2010, SOIL BIOL BIOCHEM, V42, P773, DOI 10.1016/j.soilbio.2010.01.013; Zhao Y, 2011, PLANT SOIL, V340, P89, DOI 10.1007/s11104-010-0460-9; Zhong L, 2014, SOIL BIOL BIOCHEM, V69, P1, DOI 10.1016/j.soilbio.2013.10.028; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	65	14	14	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217069	10.1371/journal.pone.0217069	http://dx.doi.org/10.1371/journal.pone.0217069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116765	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400042
J	Quintana-Villamandos, B; Gonzalez, MD; Delgado-Martos, MJ; Gutierrez-Arzapalo, PY; Boger, RH; Luneburg, N; Munoz, D; Delgado-Baeza, E				Quintana-Villamandos, Begona; del Carmen Gonzalez, Maria; Jesus Delgado-Martos, Maria; Yareli Gutierrez-Arzapalo, Perla; Boeger, Rainer H.; Lueneburg, Nicole; Munoz, David; Delgado-Baeza, Emilio			The protective effect of dronedarone on the structure and mechanical properties of the aorta in hypertensive rats by decreasing the concentration of symmetric dimethylarginine (SDMA)	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; RISK; HYPERTROPHY; REGRESSION; MORTALITY; EVENTS; ARTERY	Background and aims Dronedarone is a new multichannel-blocking antiarrhythmic for the treatment of patients with atrial fibrillation. Our group has demonstrated that dronedarone produces regression of cardiac remodeling; however, its effect on the remodeling of the elastic arteries has not yet been reported. We aim to assess the effects of dronedarone on the regression of thoracic aortic remodeling in spontaneously hypertensive rats (SHRs). Method Ten-month-old male SHRs were randomly assigned to an intervention group (SHR-D), where the animals received dronedarone treatment (100 mg/kg), to a control group (SHR) where rats were given vehicle, or to a group (SHR-A) where they were given amiodarone. A fourth group of normotensive control rats (Wistar-Kyoto rats, WKY) was also added. After two weeks of treatment, we studied the structure, the elastic fiber content of the thoracic aorta using histological techniques and confocal microscopy, and the vascular mechanical properties using an organ bath and isometric tension analysis. A mass spectrometric determination of symmetric dimethylarginine (SDMA) concentrations was performed. Results SHR group developed the classic remodeling expected from the experimental model: outward hypertrophic remodeling, increased elastic fiber content and wall stiffness. However, the SHR-D group showed statistically significantly lower values for aortic tunica media thickness, wall to lumen ratio, external diameter, cross-sectional area, volume density of the elastic fibers, wall stiffness, and aortic SDMA concentration when compared to the SHR group. These parameters were similar in the SHR and SHR-A groups. Interestingly, the values for tunica media thickness, volume density of the elastic fibers, wall stiffness, and SDMA concentration obtained from the SHR-D group were similar to those measured in the WKY group. Conclusion These results suggest that dronedarone improves the structure and passive mechanical properties of the thoracic aorta in hypertensive rats, and that this protective effect could be associated with a reduction in the concentration of aortic SDMA.	[Quintana-Villamandos, Begona] Hosp Gregorio Maranon, Dept Anesthesiol, Madrid, Spain; [Quintana-Villamandos, Begona] Univ Complutense Madrid, Dept Pharmacol & Toxicol, Fac Med, Madrid, Spain; [del Carmen Gonzalez, Maria] Univ Autonoma Madrid, Fac Med, Dept Physiol, Madrid, Spain; [Jesus Delgado-Martos, Maria; Delgado-Baeza, Emilio] Hosp Gregorio Maranon, Dept Expt Med & Surg, Mol Biol Lab, Madrid, Spain; [Yareli Gutierrez-Arzapalo, Perla] Autonomous Univ Sinaloa, Ctr Res & Teaching Hlth Sci CIDOCS, Sinaloa, Mexico; [Boeger, Rainer H.; Lueneburg, Nicole] Univ Med Ctr Hamburg Eppendorf, Dept Clin Pharmacol & Toxicol, Hamburg, Germany; [Munoz, David] Univ Autonoma Madrid, Dept Expt Surg, Madrid, Spain; [Quintana-Villamandos, Begona] Hosp Gregorio Maranon, Dept Anaesthesiol, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; Autonomous University of Madrid; General University Gregorio Maranon Hospital; Universidad Autonoma de Sinaloa; University of Hamburg; University Medical Center Hamburg-Eppendorf; Autonomous University of Madrid; General University Gregorio Maranon Hospital	Quintana-Villamandos, B (corresponding author), Hosp Gregorio Maranon, Dept Anesthesiol, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Univ Complutense Madrid, Dept Pharmacol & Toxicol, Fac Med, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Hosp Gregorio Maranon, Dept Anaesthesiol, Madrid, Spain.	begoquinti@gmail.com		Gutierrez Arzapalo, Perla Yareli/0000-0002-3713-3056	Spanish Health Ministry [FIS 16/02069]; Fondos Feder	Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Fondos Feder(European Commission)	Funded by grant from the Spanish Health Ministry (number FIS 16/02069) and Fondos Feder (BQV).	Agabiti-Rosei E, 2010, CURR HYPERTENS REP, V12, P80, DOI 10.1007/s11906-010-0093-7; Andrade GP, 2013, EXP BIOL MED, V238, P7, DOI 10.1258/ebm.2012.012243; Angus JA, 2000, J PHARMACOL TOX MET, V44, P395, DOI 10.1016/S1056-8719(00)00121-0; Bahls M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131293; Boger RH, 2003, ATHEROSCLEROSIS SUPP, V4, P23, DOI 10.1016/S1567-5688(03)00030-8; Brown IAM, 2018, ARTERIOSCL THROM VAS, V38, P1969, DOI 10.1161/ATVBAHA.118.311229; Connolly SJ, 2009, CIRCULATION, V120, P1174, DOI 10.1161/CIRCULATIONAHA.109.875252; deBlois D, 1997, HYPERTENSION, V29, P340, DOI 10.1161/01.HYP.29.1.340; Fernandes-Santos C, 2009, HEART VESSELS, V24, P219, DOI 10.1007/s00380-008-1104-3; Giummelly P, 1999, HYPERTENSION, V34, P207, DOI 10.1161/01.HYP.34.2.207; Gore MO, 2013, ARTERIOSCL THROM VAS, V33, P2682, DOI 10.1161/ATVBAHA.113.301219; Gundersen HJ, 1998, APMIS, V96, P379; Heijman J, 2013, CLIN MED INSIGHTS-CA, V7, P127, DOI 10.4137/CMC.S8445; HODEIGE D, 1995, EUR J PHARMACOL, V279, P25, DOI 10.1016/0014-2999(95)00130-D; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Kiechl S, 2009, ATHEROSCLEROSIS, V205, P261, DOI 10.1016/j.atherosclerosis.2008.10.040; Lee EJ, 2014, J CLIN PHARM THER, V39, P112, DOI 10.1111/jcpt.12128; Marchand EL, 2003, CIRC RES, V92, P777, DOI 10.1161/01.RES.0000065619.36118.20; Martinez-Quinones P, 2018, AM J HYPERTENS, V31, P1067, DOI 10.1093/ajh/hpy083; Mels CMC, 2017, AMINO ACIDS, V49, P1843, DOI 10.1007/s00726-017-2483-5; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Oktay AA, 2016, PROG CARDIOVASC DIS, V59, P235, DOI 10.1016/j.pcad.2016.09.001; Quintana-Villamandos B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188442; Quintana-Villamandos B, 2016, EUR J PHARMACOL, V791, P502, DOI 10.1016/j.ejphar.2016.09.020; Rehman A, 2010, CURR HYPERTENS REP, V12, P226, DOI 10.1007/s11906-010-0117-3; Riccioni G, 2014, INT J MOL SCI, V15, P6391, DOI 10.3390/ijms15046391; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schiffrin EL, 1998, SCAND CARDIOVASC J, V32, P15, DOI 10.1080/140174398428009; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Shenasa M, 2017, INT J CARDIOL, V237, P60, DOI 10.1016/j.ijcard.2017.03.002; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Sobrado LF, 2013, J CARDIOVASC ELECTR, V24, P914, DOI 10.1111/jce.12155; Su JZ, 1999, ACTA PHARMACOL SIN, V20, P923; Tadros Rafik, 2016, Card Electrophysiol Clin, V8, P453, DOI 10.1016/j.ccep.2016.02.008; Tomek J, 2017, J PHYSIOL-LONDON, V595, P4027, DOI 10.1113/JP273043; Vaja V, 2009, EUR J PHARMACOL, V619, P85, DOI 10.1016/j.ejphar.2009.08.003; Wang YS, 2018, CELL PHYSIOL BIOCHEM, V51, P842, DOI 10.1159/000495376; Yokoyama H, 2005, AM J HYPERTENS, V18, P922, DOI 10.1016/j.amjhyper.2005.01.009; 2011, J INTERN MED, V269, P349, DOI DOI 10.1111/J.1365-2796.2010.02322.X; 2012, CLIN SCI, V122, P105, DOI DOI 10.1042/CS20110013; 2010, EXPERT OPIN DRUG SAF, V9, P189, DOI DOI 10.1517/14740330903514105; 2014, CIRC-CARDIOVASC GENE, V7, P864, DOI DOI 10.1161/CIRCGENETICS.113.000264	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216820	10.1371/journal.pone.0216820	http://dx.doi.org/10.1371/journal.pone.0216820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112581	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000026
J	Cleveland, KH; Liang, S; Chang, A; Huang, KM; Chen, S; Guo, L; Huang, Y; Andresen, BT				Cleveland, Kristan H.; Liang, Sherry; Chang, Andy; Huang, Kevin M.; Chen, Si; Guo, Lei; Huang, Ying; Andresen, Bradley T.			Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors	PLOS ONE			English	Article							PARTIAL AGONIST ACTIVITY; CYCLIC-AMP ACCUMULATION; BETA-BLOCKERS; INVERSE AGONISTS; CANCER-CELLS; ANTIOXIDANT; ANTAGONISTS; BINDING; MICE; PATHWAYS	Carvedilol is reported to prevent cancers in humans and animal models. However, a molecular mechanism has yet to be established, and the extent to which other P-blockers are chemopreventive remains relatively unknown. A comparative pharmacological approach was utilized with the expectation that a mechanism of action could be devised. JB6 CI 41-5a (JB6 P+) murine epidermal cells were used to elucidate the chemopreventative properties of beta-blockers, as JB6 P+ cells recapitulate in vivo tumor promotion and chemoprevention. The initial hypothesis was that beta-blockers that are GRK/beta-arrestin biased agonists, like carvedilol, are chemopreventive. Sixteen beta-blockers of different classes, isoproterenol, and HEAT HCI were individually co-administered with epidermal growth factor (EGF) to JB6 P+ cells to examine the chemopreventative properties of each ligand. Cytotoxicity was examined to ensure that the anti-transformation effects of each ligand were not due to cellular growth inhibition. Many of the examined p-blockers suppressed EGF-induced JB6 P+ cell transformation in a non-cytotoxic and concentration-dependent manner. However, the IC50 values are high for the most potent inhibitors (243, 326, and 431 nM for carvedilol, labetalol, and alprenolol, respectively) and there is no correlation between pharmacological properties and inhibition of transformation. Therefore, the role of alpha 1- and beta 2-adrenergic receptors (AR) was examined by standard competition assays and shRNA targeting beta 2-ARs, the only beta-AR expressed in JB6 P+ cells. The results reveal that pharmacological inhibition of alpha 1- and beta 2-ARs and genetic knockdown of beta 2-ARs did not abrogate carvedilol-mediated inhibition of EGF-induced JB6 P+ cell transformation. Furthermore, topical administration of carvedilol protected mice from UV-induced skin damage, while genetic ablation of beta 2-ARs increased carvedilol-mediated effects. Therefore, the prevailing hypothesis that the chemopreventive property of carvedilol is mediated through P-ARs is not supported by this data.	[Cleveland, Kristan H.; Liang, Sherry; Chang, Andy; Huang, Kevin M.; Huang, Ying; Andresen, Bradley T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA; [Chen, Si; Guo, Lei] US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Cleveland, Kristan H.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Liang, Sherry] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Huang, Kevin M.] Ohio State Univ, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA	Western University of Health Sciences; US Food & Drug Administration (FDA); University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; Ohio State University	Huang, Y; Andresen, BT (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	yhuang@westernu.edu; bandresen@westernu.edu		guo, lei/0000-0002-0402-4152; Huang, Kevin/0000-0001-6561-3295; Andresen, Bradley/0000-0002-3948-7456	National Cancer Institute of the National Institutes of Health [R15CA227946]; Western University of Health Sciences; Summer Student Research Program (National Center for Toxicological Research, US. FDA); NATIONAL CANCER INSTITUTE [R15CA227946] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Western University of Health Sciences; Summer Student Research Program (National Center for Toxicological Research, US. FDA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The National Cancer Institute of the National Institutes of Health under Award Number R15CA227946 supported research reported in this publication (YH), and this work was supported by two separate Western University of Health Sciences intramural student funds as part of the Graduate Program (BTA, YH). Additionally, Kristan Cleveland was supported by the Summer Student Research Program (National Center for Toxicological Research, US. FDA).	Andresen Bradley T., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P92; ARMAIZPENA GN, 2013, NAT COMMUN, V4; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2002, BRIT J PHARMACOL, V137, P400, DOI 10.1038/sj.bjp.0704855; BENSON MK, 1978, BRIT J CLIN PHARMACO, V5, P415, DOI 10.1111/j.1365-2125.1978.tb01647.x; Bhat KPL, 2002, ANN NY ACAD SCI, V957, P210, DOI 10.1111/j.1749-6632.2002.tb02918.x; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Bryant JA, 2004, CANCER BIOL THER, V3, P1243, DOI 10.4161/cbt.3.12.1233; Bunch KP, 2015, CANCER-AM CANCER SOC, V121, P3380, DOI 10.1002/cncr.29394; Cakir Y, 2002, INT J ONCOL, V21, P153; Cata JP, 2014, J CLIN ANESTH, V26, P106, DOI 10.1016/j.jclinane.2013.10.004; Chang A, 2015, CANCER PREV RES, V8, P31, DOI 10.1158/1940-6207.CAPR-14-0193; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; Chung JF, 2016, EXPERT OPIN INV DRUG, V25, P501, DOI 10.1517/13543784.2016.1164141; Cleveland KH, 2018, MOL CARCINOGEN, V57, P997, DOI 10.1002/mc.22820; Cmarik J.L., 1997, FOOD FACTORS CANC PR, P67, DOI [10.1007/978-4-431-67017-9_13, DOI 10.1007/978-4-431-67017-9_13]; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Curtis BM, 2002, MAYO CLIN PROC, V77, P45, DOI 10.4065/77.1.45; Dandona P, 2007, J HYPERTENS, V25, P731, DOI 10.1097/HJH.0b013e3280127948; Dickey BF, 2010, CURR OPIN PHARMACOL, V10, P254, DOI 10.1016/j.coph.2010.03.002; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; Eng JWL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7426; Eng JWL, 2014, CANCER IMMUNOL IMMUN, V63, P1115, DOI 10.1007/s00262-014-1617-9; Erickson CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071980; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Hopkinson HE, 2000, BRIT J PHARMACOL, V131, P124, DOI 10.1038/sj.bjp.0703535; Huang KM, 2017, CANCER PREV RES, V10, P598, DOI 10.1158/1940-6207.CAPR-17-0132; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Lin CS, 2015, INT J CARDIOL, V184, P9, DOI 10.1016/j.ijcard.2015.02.015; Lysko PG, 2000, J CARDIOVASC PHARM, V36, P277, DOI 10.1097/00005344-200008000-00020; Maack C, 2003, CIRCULATION, V108, P348, DOI 10.1161/01.CIR.0000080325.94345.8B; MANALAN AS, 1981, CIRC RES, V49, P326, DOI 10.1161/01.RES.49.2.326; MEUNIER H, 1982, EUR J PHARMACOL, V81, P411, DOI 10.1016/0014-2999(82)90106-6; Ong HT, 2007, BMJ-BRIT MED J, V334, P946, DOI 10.1136/bmj.39185.440382.47; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Reddy KT, 2014, INDIAN J CHEM B, V53, P1615; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; RILEY AJ, 1980, BRIT J CLIN PHARMACO, V9, P517, DOI 10.1111/j.1365-2125.1980.tb05849.x; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Schevzov G, 2015, MOL BIOL CELL, V26, P2475, DOI 10.1091/mbc.E14-10-1453; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; STEINKRAUS V, 1991, ARCH DERMATOL RES, V283, P328, DOI 10.1007/BF00376622; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; YUE TL, 1992, J PHARMACOL EXP THER, V263, P92; YUE TL, 1992, ATHEROSCLEROSIS, V97, P209, DOI 10.1016/0021-9150(92)90133-2; Zhang D, 2010, CANCER BIOL THER, V10, P19, DOI 10.4161/cbt.10.1.11944; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406; 2007, P NATL ACAD SCI USA, V104, P1665, DOI DOI 10.1073/PNAS.0707936104; 1978, J PHARM PHARM, V30, P390; 2004, CARDIOVASC RES, V63, P662, DOI DOI 10.1016/J.CARDIORES.2004.05.014; 2013, NATURE, V495, P534, DOI DOI 10.1038/NATURE12000; 2003, P NATL ACAD SCI USA, V100, P1140, DOI DOI 10.1073/PNAS.1936664100; 1991, BIOCH PHARM, V42, P1683	57	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217038	10.1371/journal.pone.0217038	http://dx.doi.org/10.1371/journal.pone.0217038			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107911	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200026
J	Fin, G; Moreno-Murcia, JA; Leon, J; Baretta, E; Nodari, RJ				Fin, Gracielle; Antonio Moreno-Murcia, Juan; Leon, Jaime; Baretta, Elisabeth; Nodari Junior, Rudy Jose			Interpersonal autonomy support style and its consequences in physical education classes	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; STUDENTS AUTONOMY; TEACHERS; MOTIVATION; INTERVENTION; RELATEDNESS; BEHAVIORS; EXERCISE; BENEFITS; BELIEFS	This intervention study investigates the effects of teacher autonomy support on basic psychological needs, self-determined motivation for giving physical education classes and satisfaction from engaging in physical activity. The sample consisted of 61 students (32 in the experimental group and 29 in the control group), aged 12 to 14 years. Two physical education teachers were part of the group, one who was trained to give autonomy-support classes and the other used the usual class model. The experimental group teacher gave classes based on the autonomy support style, while his control group counterpart did not follow any model. The students, assessed before and after the 8-month intervention, were measured for perception of interpersonal teaching style, basic psychological needs, self-determined motivation and satisfaction from engaging in physical activity. The results showed that the experimental group exhibited higher indices for autonomy, competence and relatedness, self-determined motivation and satisfaction from engaging in physical activity, when compared to the control group. The study provides evidence of the effectiveness of programs that support autonomy in physical education classes, emphasizing the importance of pedagogical strategies and educational programs that promote the development of basic psychological needs, self-determined motivation and its positive consequences in relation to physical education classes.	[Fin, Gracielle; Antonio Moreno-Murcia, Juan] Univ Miguel Hernandez, Sports Res Ctr CID, Alicante, Spain; [Fin, Gracielle; Baretta, Elisabeth; Nodari Junior, Rudy Jose] Univ West Santa Catarina, Dept Phys Educ, Joacaba, SC, Brazil; [Leon, Jaime] Univ Las Palmas Gran Canaria, Dept Educ, Las Palmas Gran Canaria, Spain	Universidad Miguel Hernandez de Elche; Universidade do Oeste de Santa Catarina; Universidad de Las Palmas de Gran Canaria	Fin, G (corresponding author), Univ Miguel Hernandez, Sports Res Ctr CID, Alicante, Spain.; Fin, G (corresponding author), Univ West Santa Catarina, Dept Phys Educ, Joacaba, SC, Brazil.	gracielle.fin@unoesc.edu.br	Leon, Jaime/M-5888-2016; Fin, Gracielle/Q-3380-2017	Leon, Jaime/0000-0002-9587-4047; Fin, Gracielle/0000-0001-7860-4451; Baretta, Elisabeth/0000-0002-4857-9256				Aelterman N, 2013, TEACH TEACH EDUC, V29, P64, DOI 10.1016/j.tate.2012.09.001; Aelterman N, 2014, J SPORT EXERCISE PSY, V36, P595, DOI 10.1123/jsep.2013-0229; Barrachina-Peris J., 2017, THESIS; Bassett DR, 2013, AM J PREV MED, V44, P108, DOI 10.1016/j.amepre.2012.10.017; Campbell D, 1996, EXPT QUASIEXPERIMENT; Chang YK, 2016, J SPORT SCI MED, V15, P460; Cheon SH, 2015, CONTEMP EDUC PSYCHOL, V40, P99, DOI 10.1016/j.cedpsych.2014.06.004; Cheon SH, 2014, J SPORT EXERCISE PSY, V36, P331, DOI 10.1123/jsep.2013-0231; Cheon SH, 2013, PSYCHOL SPORT EXERC, V14, P508, DOI 10.1016/j.psychsport.2013.02.002; Cheon SH, 2012, J SPORT EXERCISE PSY, V34, P365, DOI 10.1123/jsep.34.3.365; Deci E.L., 2002, HDB SELF DETERMINATI; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Escriva-Boulley G, 2018, SPORT EXERC PERFORM, V7, P218, DOI 10.1037/spy0000119; Fin Gracielle, 2019, Rev. Bras. Ciênc. Esporte, V41, P427, DOI 10.1016/j.rbce.2018.07.005; GOUDAS M, 1994, EUR J PSYCHOL EDUC, V9, P241, DOI 10.1007/BF03172783; Haerens L, 2015, PSYCHOL SPORT EXERC, V16, P26, DOI 10.1016/j.psychsport.2014.08.013; Haerens L, 2013, J SPORT EXERCISE PSY, V35, P3, DOI 10.1123/jsep.35.1.3; Jang H, 2016, J EXP EDUC, V84, P686, DOI 10.1080/00220973.2015.1083522; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Lonsdale C, 2019, BRIT J SPORT MED, V53, P341, DOI 10.1136/bjsports-2017-097904; Lonsdale C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2583-7; Montanha T., 2013, THESIS; Moreno-Murcia JA, RICYDE; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Ntoumanis N, 2018, PERSUASION COMMUNICA, P302; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Pires A., 2010, Motri., V6, P33; Reeve J, 2006, J EDUC PSYCHOL, V98, P209, DOI 10.1037/0022-0663.98.1.209; Reeve J, 2004, MOTIV EMOTION, V28, P147, DOI 10.1023/B:MOEM.0000032312.95499.6f; Reeve J, 2016, PSYCHOL SPORT EXERC, V22, P178, DOI 10.1016/j.psychsport.2015.08.001; Reeve J, 2014, MOTIV EMOTION, V38, P93, DOI 10.1007/s11031-013-9367-0; Reeve J, 2009, EDUC PSYCHOL-US, V44, P159, DOI 10.1080/00461520903028990; Roberts, 2001, ADV MOTIVATION SPORT, P263; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Sarrazin PG, 2006, INT J SPORT EXERC PS, V4, P283, DOI 10.1080/1612197X.2006.9671799; Slingerland M, 2011, J PHYS ACT HEALTH, V8, P866, DOI 10.1123/jpah.8.6.866; Sparks C, 2015, SPORT EXERC PERFORM, V4, P219, DOI 10.1037/spy0000039; Standage M, 2005, BRIT J EDUC PSYCHOL, V75, P411, DOI 10.1348/000709904X22359; Standage M, 2012, J SPORT EXERCISE PSY, V34, P37, DOI 10.1123/jsep.34.1.37; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Su YL, 2011, EDUC PSYCHOL REV, V23, P159, DOI 10.1007/s10648-010-9142-7; Tenorio M., 2014, THESIS; Tessier D, 2008, EUR J PSYCHOL EDUC, V23, P239, DOI 10.1007/BF03172998; Tessier D, 2010, CONTEMP EDUC PSYCHOL, V35, P242, DOI 10.1016/j.cedpsych.2010.05.005; Ulstad SO, 2018, MOTIV EMOTION, V42, P497, DOI 10.1007/s11031-018-9694-2; Vallerand R. J., 2001, HDB SPORT PSYCHOL, V2nd, P389, DOI DOI 10.4135/9781483332222.N163; Vallerand R. J., 2007, HDB SPORT PSYCHOL, V3, P59, DOI DOI 10.1002/9781118270011.CH3; Vallerand RJ, 2000, PSYCHOL INQ, V11, P312; Van den Berghe L, 2016, PHYS EDUC SPORT PEDA, V21, P653, DOI 10.1080/17408989.2015.1115008; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; World Health Organization, 2010, Global recommendations on physical activity for health	52	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216609	10.1371/journal.pone.0216609	http://dx.doi.org/10.1371/journal.pone.0216609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY7BF	31107894	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200012
J	Zhou, R; Wu, JP; Zhang, LP; Liu, LS; Casper, DP; Jiao, T; Liu, T; Wang, JF; Lang, X; Song, SZ; Gong, XY				Zhou, Rui; Wu, Jianping; Zhang, Liping; Liu, Lishan; Casper, David P.; Jiao, Ting; Liu, Ting; Wang, Jianfu; Lang, Xia; Song, Shuzhen; Gong, Xuyin			Effects of oregano essential oil on the ruminal pH and microbial population of sheep	PLOS ONE			English	Article							VULGARE L. LEAVES; RUMEN FERMENTATION; METHANE PRODUCTION; ANTIOXIDANT ACTIVITY; PLANT-EXTRACTS; DIGESTIBILITY; ANTIBACTERIAL; BACTERIA; ECOLOGY; SUPPLEMENTATION	Oregano essential oil (OEO), which has antimicrobial properties, may be used for altering the ruminal pH and microbial populations of sheep, as observed by the altered volatile fatty acid patterns. To further elucidate the effects of OEO on ruminal pH and microbial populations of sheep, 3 German merino sheep x local sheep crossbred rams with permanent ruminal fistulas were randomly assigned to a 3 x 3 Latin square design with 12-d periods. The treatments were as follows: control (CON); OEO4: OEO supplied at 4 g.d(-1); and OEO4: OEO supplied at 7 g.d(-1). Starting on day 11, rumen fluid was collected at 0 h, and at 4, 8, 12, 24 and 48 h after supplying OEO, and then pH values of rumen fluid were immediately measured. The abundance of microbial populations was determined by using qPCR. The ruminal pH values were similar among the sheep from all treatments. The abundance of ruminal fungi was higher for the sheep supplied OEO4 compared with the sheep supplied CON and OEO4, especially at 4 and 12 h. The abundance of ruminal protozoa decreased with supplied OEO, indicating that OEO could inhibit the protozoa. The abundance of the total ruminal bacteria was similar for the sheep from all treatments, but R. flavefaciens, R. albus and F. succinogenes increased in the sheep supplied OEO4 compared with those in the sheep supplied CON, however, the sheep supplied OEO4 had higher abundances of R. flavefadiens than the sheep supplied CON. These results demonstrated that supplying OEO to sheep did not affect the ruminal pH but could shift the rumen microbial population to one with less protozoa. Supplying OEO can preferentially enhance the growth of certain rumen microbial populations, but the shifts were influenced by the supply rate. Therefore, supplying low amount (i.e. 4 g.d(-1)) of OEO could have positive effects on ruminal microbial populations, whereas supplying elevated doses of OEO could be detrimental to those same ruminal microbial populations.	[Zhou, Rui; Wu, Jianping; Zhang, Liping; Liu, Ting; Wang, Jianfu] Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Gansu, Peoples R China; [Liu, Lishan; Lang, Xia; Song, Shuzhen; Gong, Xuyin] Gansu Acad Agr Sci, Anim Husb Pasture & Green Agr Inst, Lanzhou, Gansu, Peoples R China; [Casper, David P.] Furst McNess Co, Freeport, IL USA; [Jiao, Ting] Gansu Agr Univ, Coll Grassland Sci, Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Wu, JP (corresponding author), Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Gansu, Peoples R China.	wujp@gsagr.ac.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Zhou, Rui/0000-0003-3249-9670; Wu, Jian/0000-0002-3394-1507	China's Natural Science Fund [31460592]; China's Agricultural Research system [CARS-39-18]; Agro-scientific Research in the Public Interest [201503134]; Gansu Academy of Agricultural Science Fund [2017GAAS30]; Chinese government	China's Natural Science Fund; China's Agricultural Research system; Agro-scientific Research in the Public Interest; Gansu Academy of Agricultural Science Fund; Chinese government	This study was funded by four research grants including China's Natural Science Fund (#31460592), China's Agricultural Research system (CARS-39-18), Agro-scientific Research in the Public Interest (201503134), and Gansu Academy of Agricultural Science Fund (2017GAAS30). All of these funds were from Chinese government. The funder provided support in the form of research materials, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author David P Casper analysed data and corrected the manuscript. Furst-McNess Company didn't apply any financial support for the present study in the form of authors' salaries and/or research materials.	Agarwal N, 2009, ANIM FEED SCI TECH, V148, P321, DOI 10.1016/j.anifeedsci.2008.04.004; Amorati R, 2013, J AGR FOOD CHEM, V61, P10835, DOI 10.1021/jf403496k; Ando S, 2003, LIVEST PROD SCI, V82, P245, DOI 10.1016/S0301-6226(03)00012-5; Ayala RS, 2001, FOOD CHEM, V75, P109; Baser K.H.C., 2002, OREGANO GENERA ORIGA, P109; Benchaar C, 2008, ANIM FEED SCI TECH, V145, P209, DOI 10.1016/j.anifeedsci.2007.04.014; Benchaar C, 2007, J DAIRY SCI, V90, P886, DOI 10.3168/jds.S0022-0302(07)71572-2; Bendini A, 2002, ITAL J FOOD SCI, V14, P17; BERNALIER A, 1992, CURR MICROBIOL, V25, P143, DOI 10.1007/BF01571022; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Busquet M, 2006, J DAIRY SCI, V89, P761, DOI 10.3168/jds.S0022-0302(06)72137-3; Chaves AV, 2008, CAN J ANIM SCI, V88, P117, DOI 10.4141/CJAS07061; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; FINLAY BJ, 1994, FEMS MICROBIOL LETT, V117, P157, DOI 10.1111/j.1574-6968.1994.tb06758.x; Hart KJ, 2008, ANIM FEED SCI TECH, V147, P8, DOI 10.1016/j.anifeedsci.2007.09.007; Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Hristov AN, 2013, J DAIRY SCI, V96, P1189, DOI 10.3168/jds.2012-5975; IRVINE HL, 1991, LETT APPL MICROBIOL, V12, P62, DOI 10.1111/j.1472-765X.1991.tb00504.x; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Koike S, 2009, ASIAN AUSTRAL J ANIM, V22, P131, DOI 10.5713/ajas.2009.r.01; Kongmun P, 2011, LIVEST SCI, V135, P84, DOI 10.1016/j.livsci.2010.06.131; Kongmun P, 2010, LIVEST SCI, V127, P38, DOI 10.1016/j.livsci.2009.08.008; Kumar S, 2013, ANN MICROBIOL, V63, P541, DOI 10.1007/s13213-012-0501-0; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Lettat A, 2013, J DAIRY SCI, V96, P5237, DOI 10.3168/jds.2012-6481; Lin B, 2013, ANIM FEED SCI TECH, V184, P24, DOI 10.1016/j.anifeedsci.2013.05.011; Lin B, 2013, J ANIM PHYSIOL AN N, V97, P1, DOI 10.1111/j.1439-0396.2011.01236.x; LINDMARK DG, 1973, J BIOL CHEM, V248, P7724; McIntosh FM, 2003, APPL ENVIRON MICROB, V69, P5011, DOI 10.1128/AEM.69.8.5011-5014.2003; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Newbold CJ, 2004, ANIM FEED SCI TECH, V114, P105, DOI 10.1016/j.anifeedsci.2003.12.006; NEWBOLD CJ, 1995, LETT APPL MICROBIOL, V21, P230, DOI 10.1111/j.1472-765X.1995.tb01048.x; NRC, 2007, NUTR REQ SMALL RUM S, DOI [10.17226/11654, DOI 10.17226/11654]; Patra AK, 2014, APPL MICROBIOL BIOT, V98, P897, DOI 10.1007/s00253-013-4930-x; Patra AK, 2012, APPL ENVIRON MICROB, V78, P4271, DOI 10.1128/AEM.00309-12; Patra AK, 2011, ASIAN J ANIM VET ADV, V6, P416, DOI 10.3923/ajava.2011.416.428; Preuss HG, 2005, MOL CELL BIOCHEM, V272, P29, DOI 10.1007/s11010-005-6604-1; Simitzis Panagiotis E, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4020035; Soultos N, 2009, MEAT SCI, V81, P474, DOI 10.1016/j.meatsci.2008.10.001; Steel RGD, 1980, PRINCIPLES PROCEDURE, P137; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Tekippe JA, 2011, J DAIRY SCI, V94, P5065, DOI 10.3168/jds.2010-4095; Thao NT, 2014, ASIAN AUSTRAL J ANIM, V27, P46, DOI 10.5713/ajas.2013.13301; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; VOGELS GD, 1980, APPL ENVIRON MICROB, V40, P608, DOI 10.1128/AEM.40.3.608-612.1980; Wallace RJ, 2004, P NUTR SOC, V63, P621, DOI 10.1079/PNS2004393; Wallace RJ, 2002, ASIAN AUSTRAL J ANIM, V15, P1458, DOI 10.5713/ajas.2002.1458; Wanapat M, 2008, J SCI FOOD AGR, V88, P2231, DOI 10.1002/jsfa.3333; Wang J, 2018, GANSU NONG YE DA XUE, V53, P8; Wilkinson JM, 2003, J AGR FOOD CHEM, V51, P76, DOI 10.1021/jf0258003; Yang WZ, 2007, J DAIRY SCI, V90, P5671, DOI 10.3168/jds.2007-0369; Yang WZ, 2010, J ANIM SCI, V88, P1082, DOI 10.2527/jas.2008-1608; Yu Z, 2005, APPL ENVIRON MICROB, V71, P692; 2007, J AGR FOOD CHEM, V55, P6300, DOI DOI 10.1021/JF070094X	57	20	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217054	10.1371/journal.pone.0217054	http://dx.doi.org/10.1371/journal.pone.0217054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107883	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200028
J	Lee, J; Jimenez, AM; Horan, WP; Green, MF				Lee, Junghee; Jimenez, Amy M.; Horan, William P.; Green, Michael F.			fMRI biomarkers of social cognitive skills training in psychosis: Extrinsic and intrinsic functional connectivity	PLOS ONE			English	Article							DEFAULT MODE NETWORK; PREFRONTAL CORTEX; BRAIN; SCHIZOPHRENIA; RECOGNITION; AMYGDALA; ROBUST; OPTIMIZATION; REGISTRATION	Social cognitive skills training interventions for psychotic disorders have shown improvement in social cognitive performance tasks, but little was known about brain-based biomarkers linked to treatment effects. In this pilot study, we examined whether social cognitive skills training could modulate extrinsic and intrinsic functional connectivity in psychosis using functional magnetic resonance imaging (fMRI). Twenty-six chronic outpatients with psychotic disorders were recruited from either a Social Cognitive Skills Training (SCST) or an activity-and time-matched control intervention. At baseline and the end of intervention (12 weeks), participants completed two social cognitive tasks: a Facial Affect Matching task and a Mental State Attribution Task, as well as resting-state fMRI (rs-fMRI). Extrinsic functional connectivity was assessed using psychophysiological interaction (PPI) with amygdala and temporo-parietal junction as a seed region for the Facial Affect Matching Task and the Mental State Attribution task, respectively. Intrinsic functional connectivity was assessed with independent component analysis on rs-fMRI, with a focus on the default mode network (DMN). During the Facial Affect Matching task, we observed stronger PPI connectivity in the SCST group after intervention (compared to baseline), but no treatment-related change in the Control group. Neither group showed treatment-related changes in PPI connectivity during the Mental State Attribution task. During rs-fMRI, we found treatment-related changes in the DMN in the SCST group, but not in Control group. This study found that social cognitive skills training modulated both extrinsic and intrinsic functional connectivity in individuals with psychotic disorders after a 12-week intervention. These findings suggest treatment-related changes in functional connectivity as a potential brain-based biomarker of social cognitive skills training.	[Lee, Junghee; Jimenez, Amy M.; Horan, William P.; Green, Michael F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Lee, Junghee; Jimenez, Amy M.; Horan, William P.; Green, Michael F.] Vet Affairs Greater Los Angeles Healthcare Syst, Desert Pacific Mental Illness Res Educ & Clin Ctr, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lee, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Lee, J (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Desert Pacific Mental Illness Res Educ & Clin Ctr, Los Angeles, CA 90073 USA.	jungheelee@g.ucla.edu	Horan, William/V-7495-2019; Lee, Junghee/AAX-6124-2021; Lee, Junghee/C-5226-2014; Jimenez, Amy M./AAX-6262-2021	Lee, Junghee/0000-0001-9567-8700; Lee, Junghee/0000-0001-9567-8700; Jimenez, Amy/0000-0001-6077-1307	Brain & Behavior Research Foundation NARSAD Young Investigator Award; VA Merit Award; VA Research Enhancement Award Program (REAP) on Enhancing Community Integration for Homeless Veterans; VA Desert Pacific Mental Illness Research, Education, and Clinical Center (MIRECC)	Brain & Behavior Research Foundation NARSAD Young Investigator Award; VA Merit Award(US Department of Veterans Affairs); VA Research Enhancement Award Program (REAP) on Enhancing Community Integration for Homeless Veterans; VA Desert Pacific Mental Illness Research, Education, and Clinical Center (MIRECC)	This work was supported by a Brain & Behavior Research Foundation NARSAD Young Investigator Award (to J.L.), a VA Merit Award (to M.F.G), and the VA Research Enhancement Award Program (REAP) on Enhancing Community Integration for Homeless Veterans, and Desert Pacific Mental Illness Research, Education, and Clinical Center (MIRECC). fMRI data analysis for this study used computational and storage services associated with the Hoffman2 Shared Cluster provided by UCLA Institute for Digital Research and Education's Research Technology Group. The funder did not play any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bitsch F, 2019, SCHIZOPHRENIA BULL, V45, P934, DOI 10.1093/schbul/sby132; Bjorkquist OA, 2016, SCHIZOPHR RES, V175, P35, DOI 10.1016/j.schres.2016.04.003; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dodell-Feder D, 2014, SCHIZOPHR RES, V156, P87, DOI 10.1016/j.schres.2014.03.031; Fox JM, 2017, J ABNORM PSYCHOL, V126, P392, DOI 10.1037/abn0000253; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Habel U, 2010, SOC NEUROSCI-UK, V5, P92, DOI 10.1080/17470910903170269; Hooker CI, 2013, PSYCHIAT RES-NEUROIM, V213, P99, DOI 10.1016/j.pscychresns.2013.04.001; Horan WP, 2018, SCHIZOPHRENIA BULL, V44, P1254, DOI 10.1093/schbul/sbx167; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kurtz MM, 2016, CLIN PSYCHOL REV, V43, P80, DOI 10.1016/j.cpr.2015.09.003; Kurtz MM, 2012, SCHIZOPHRENIA BULL, V38, P1092, DOI 10.1093/schbul/sbr036; Lee JS, 2011, APPL ECON, V43, P717, DOI 10.1080/00036840802599792; Lee J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165546; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; LIBERMAN RP, 1986, SCHIZOPHRENIA BULL, V12, P631, DOI 10.1093/schbul/12.4.631; Mars RB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00189; Moessnang C, 2017, HUM BRAIN MAPP, V38, P3791, DOI 10.1002/hbm.23626; Mukherjee P, 2016, SCHIZOPHRENIA BULL, V42, P1056, DOI 10.1093/schbul/sbw012; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; Quintana J, 2011, PSYCHIAT RES-NEUROIM, V191, P44, DOI 10.1016/j.pscychresns.2010.09.005; Schilbach L, 2016, NEUROIMAGE-CLIN, V10, P326, DOI 10.1016/j.nicl.2015.11.021; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Spunt RP, 2017, NAT REV NEUROSCI, V18, P559, DOI 10.1038/nrn.2017.76; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; 2016, SCHIZOPHR RES, V170, P55, DOI DOI 10.1016/J.SCHRES.2015.11.021; 2014, NEUROIMAGE, V92, P381, DOI DOI 10.1016/J.NEUROIMAGE.2014.01.060; 2009, NEUROIMAGE, V48, P63, DOI DOI 10.1016/J.NEUROIMAGE.2009.06.060; 2009, ANNU REV PSYCHOL, V60, P693, DOI DOI 10.1146/ANNUREV.PSYCH.60.110707.163514	37	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0214303	10.1371/journal.pone.0214303	http://dx.doi.org/10.1371/journal.pone.0214303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100068	Green Submitted, Green Published, gold			2022-12-27	WOS:000468176600002
J	Sobti, A; Sharif-Askari, FS; Khan, S; Sharif-Askari, NS; Hachim, MY; Williams, L; Zhou, YP; Hopper, C; Hamoudi, R				Sobti, Aastha; Sharif-Askari, Fatemeh Saheb; Khan, Saif; Sharif-Askari, Narjes Saheb; Hachim, Mahmood Yaseen; Williams, Luke; Zhou, Yuanping; Hopper, Colin; Hamoudi, Rifat			Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinoma	PLOS ONE			English	Article							PERIODONTAL-DISEASE; CANCER; HPV; RISK; COHORT; WORLDWIDE; DIAGNOSIS	Background HPV-16-positive HNSCC and HPV-16-negative HNSCC have different clinical factors, representing distinct forms of cancers. The study aimed to identify patient-specific factors for HPV-16-positive HNSCC based on baseline clinical data. Method Factors associated with HPV-16-positive HNSCC were identified using the data from 210 patients diagnosed with HNSCC at University College of London Hospital between January 1, 2003, and April 30, 2015, inclusive. A series of models were developed using logistic regression methods, and the overall model fit was compared using Akaike Information Criterion. Survival analysis was carried with Cox proportional hazards model for survival-time outcomes. The survival time for individual patients was defined as the time from diagnosis of HNSCC to the date of death from any cause. For patients who did not die, they were censored at the end of study on April 30, 2015. Results Of the 210 patients, 151 (72%) were found to have HPV-16-positive HNSCC. The logistic regression model showed that the prevalence of developing HPV-16-positive HNSCC was 3.79 times higher in patients with Type 2 Diabetes Mellitus (T2DM) (odd ratio [OR], 3.79; 95% CI, 1.70-8.44) than in those without T2DM, and 8.84 times higher in patients with history of primary HNSCC (OR, 8.84; 95% CI, 2.30-33.88) than in those without a history of primary HNSCC. HPV-16-positive HNSCC was also observed more in tonsils (OR, 4.02; 95% CL, 1.56-10.36) and less in non-alcohol drinker's oral cavity (OR, 0.14; 95% CI, 0.03-0.56). Furthermore, individual patients were followed-up for 1 to 13 years (median of 1 year). Patients with HPV-positive HNSCC had a median survival of 5 years (95% CI, 2.6-7.3 years). Among HPV-16-positive HNSCC cohort, T2DM was a risk for poorer prognosis (hazard ratio, 2.57; 95% Cl, 1.09-6.07), and had lower median survival of 3 years (95% CI, 1.8-4.1 years), as compared to 6 years (95% CI, 2.8-9.1 years) in non-T2DM. Conclusions Patient-specific factors for HPV-positive HNSCC are T2DM, history of primary HNSCC and tonsillar site. T2DM is associated with poorer prognosis. These findings suggest that it might be beneficial if routine HPV-16 screening is carried out in T2DM patients which can provide better therapeutic and management strategies.	[Sobti, Aastha; Williams, Luke; Hopper, Colin] UCL Eastman Dent Inst, Acad Unit Oral & Maxillofacial Surg, London, England; [Sharif-Askari, Fatemeh Saheb; Sharif-Askari, Narjes Saheb; Hachim, Mahmood Yaseen; Hamoudi, Rifat] Univ Sharjah, Sharjah Inst Med Res, Coll Med, Sharjah, U Arab Emirates; [Khan, Saif; Hamoudi, Rifat] UCL, Div Surg & Intervent Sci, Res Dept Targeted Intervent, London, England; [Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China	University of London; University College London; University of Sharjah; University of London; University College London; Southern Medical University - China; Southern Medical University - China	Hamoudi, R (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Coll Med, Sharjah, U Arab Emirates.; Hamoudi, R (corresponding author), UCL, Div Surg & Intervent Sci, Res Dept Targeted Intervent, London, England.	rhamoudi@sharjah.ac.ae	Hachim, Mahmood/V-9662-2019; Sharif-Askari, Narjes Saheb/I-1743-2019	Sharif-Askari, Narjes Saheb/0000-0003-0482-6777; Hamoudi, Rifat/0000-0002-1402-0868; HACHIM, MAHMOOD/0000-0002-7096-0731	National Natural Science Foundation of China [81772923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Yuanping Zhou was supported by National Natural Science Foundation of China (81772923). We also acknowledge Dangoor Education for their support towards this work. There was no additional external funding received for this study.	Ahlqvist E, 2018, LANCET DIABETES ENDO; Alshehri AA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.e17040; Bishop JA, 2012, AM J SURG PATHOL, V36, P1874, DOI 10.1097/PAS.0b013e318265fb2b; Byrd JK, 2012, ARCH OTOLARYNGOL, V138, P1155, DOI 10.1001/jamaoto.2013.850; Casanova L, 2014, BRIT DENT J, V217, P433, DOI 10.1038/sj.bdj.2014.907; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2017, JAMA ONCOL, V3, P169, DOI 10.1001/jamaoncol.2016.3067; D'Souza G, 2011, PREV MED, V53, pS5, DOI 10.1016/j.ypmed.2011.08.001; D'Souza G, 2010, ORAL ONCOL, V46, P100, DOI 10.1016/j.oraloncology.2009.11.004; Diaz DA, 2016, HEAD NECK, V38; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.6003; Hormia M, 2005, J PERIODONTOL, V76, P358, DOI 10.1902/jop.2005.76.3.358; Jain KS, 2013, CANCER-AM CANCER SOC, V119, P1832, DOI 10.1002/cncr.27988; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Liu CJ, 2015, ONCOTARGET, V6, P29268, DOI 10.18632/oncotarget.4922; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; Paz IB, 1997, CANCER-AM CANCER SOC, V79, P595, DOI 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PREHN RT, 1987, CANCER RES, V47, P927; Reid BC, 2001, HEAD NECK-J SCI SPEC, V23, P985, DOI 10.1002/hed.1143; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; Smola Sigrun, 2017, Ther Adv Vaccines, V5, P69, DOI 10.1177/2051013617717914; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Syrjanen S, 2004, J CLIN PATHOL, V57, P449, DOI 10.1136/jcp.2003.008656; Syrjanen S., 2007, HUMAN PAPILLOMAVIRUS; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tezal M., 2012, INT J OTOLARYNGOLOGY, V2012; Tezal M, 2009, ARCH OTOLARYNGOL, V135, P391, DOI 10.1001/archoto.2009.6; Tsai S, 2018, CELL METAB, V28, P922, DOI 10.1016/j.cmet.2018.08.003; Tseng KS, 2014, JAMA OTOLARYNGOL, V140, P746, DOI 10.1001/jamaoto.2014.1258; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Ujpa LM, 2004, DIABETES CARE, V27, P770; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; 2015, JAMA NEUROLOGY, V72, P874, DOI DOI 10.1001/JAMANEUROL.2015.0749; 2010, LANCET ONCOLOGY, V11, P781, DOI DOI 10.1016/S1470-2045(10)70017-6; 2011, NAT MED, V17, P610, DOI DOI 10.1038/NM.2353	41	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217000	10.1371/journal.pone.0217000	http://dx.doi.org/10.1371/journal.pone.0217000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095649	Green Submitted, Green Published, gold			2022-12-27	WOS:000468030100064
J	Callahan, RL; Brunie, A; Mackenzie, ACL; Wayack-Pambe, M; Guiella, G; Kibira, SPS; Makumbi, F				Callahan, Rebecca L.; Brunie, Aurelie; Mackenzie, Amelia C. L.; Wayack-Pambe, Madeleine; Guiella, Georges; Kibira, Simon P. S.; Makumbi, Fredrick			Potential user interest in new long-acting contraceptives: Results from a mixed methods study in Burkina Faso and Uganda	PLOS ONE			English	Article							ACCEPTABILITY; PREVENTION; HIV	Method-related concerns represent an important cause of contraceptive non-use and discontinuation. User preferences must be incorporated into the design of new contraceptive technologies to ensure product success and improve family planning outcomes. We assessed preferences among potential users in Burkina Faso and Uganda for six contraceptive methods currently under development or ready for introduction: a new copper intra-uterine device (IUD), a levonorgestrel intra-uterine system, a new single-rod implant, a biodegradable implant, a longer-acting injectable, and a method of non-surgical permanent contraception. Questions were added to nationally-representative PMA2020 household surveys that asked 2,743 and 2,403 women in Burkina Faso and Uganda, respectively, their interest in using each new method. We assessed factors associated with interest through multivariable logistic regression models. We conducted qualitative interviews and focus groups with 398 women, 78 men, and 52 family planning providers and key informants to explore perceived advantages and disadvantages of the methods. Respondents expressed interest in using all new methods, with greatest interest in the longer-acting injectable (77% in Burkina Faso, 61% in Uganda), followed by a new single-rod implant. Least interest was expressed in a new copper IUD (26% Burkina Faso, 15% in Uganda). In both countries, women with less education had higher odds of interest in a longer-acting injectable. Interest in most new methods was associated with desiring a method lasting longer than one year and acceptance of lack of menstrual bleeding as a contraceptive side effect. Perceived advantages and disadvantages were similar between countries, including concerns about menstrual side effects and fear of the biodegradable nature of the biodegradable implant. Potential users, their partners, and providers are interested in new longer-acting methods, however, familiar forms including the injectable and implant may be the most immediately acceptable. A biodegradable implant will require clear counseling messages to allay potential fears.	[Callahan, Rebecca L.; Mackenzie, Amelia C. L.] Contracept Technol Innovat, Durham, NC 27701 USA; [Brunie, Aurelie] Hlth Serv Res, Washington, DC USA; [Wayack-Pambe, Madeleine; Guiella, Georges] Univ Ouagadougou, Inst Super Sci Populat, Ouagadougou, Burkina Faso; [Kibira, Simon P. S.; Makumbi, Fredrick] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Makerere University	Callahan, RL (corresponding author), Contracept Technol Innovat, Durham, NC 27701 USA.	rcallahan@fhi360.org		Mackenzie, Amelia/0000-0003-1721-805X; Kibira, Simon Peter Sebina/0000-0002-7385-423X; Brunie, Aurelie/0000-0002-9515-1420	Bill & Melinda Gates Foundation [OPP1055878]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation through grant #OPP1055878. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, POPULATION COUNCIL F; Bailey MJ, 2013, BROOKINGS PAP ECO AC, P341; Bill and Melinda Gates Foundation, FAM PLANN STRAT OV; Brauner-Otto SR, 2013, POPUL RES POLICY REV, V32, P1, DOI 10.1007/s11113-012-9261-6; Brunie A, DEV ACCEPTABLE CONTR; Casterline J, 2009, UNWANTED FERTILITY L; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Darroch JacquelineE., 2011, CONTRACEPTIVE TECHNO; FHI 360, CONTR TECHN INN IN; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P90, DOI 10.1363/3909007; Guthrie KM, 2018, PHARM DEV TECHNOL, V23, P311, DOI 10.1080/10837450.2017.1339085; Heise L, 1997, ACCEPTABILITY USERS, P6; Moran M, 2014, REPROD HLTH R D DEV; Nass SJ, 2004, NAT REV DRUG DISCOV, V3, P885, DOI 10.1038/nrd1526; Performance Monitoring and Accountability 2020, SAMPL OV; Performance Monitoring and Accountability 2020, SURVEY METHODOLOGY; Performance Monitoring and Accountability 2020, UG ROUND 4 FAM PLANN; Performance Monitoring and Accountability 2020, BURK FAS ROUND 4 FAM; Polis CB, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0561-0; Ross J, 2013, GLOB HEALTH-SCI PRAC, V1, P203, DOI 10.9745/GHSP-D-13-00010; Sedgh G., 2016, UNMET NEED CONTRACEP; Singh S, 2015, ADD COSTS BEN INV SE; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Tolley EE, 2013, ANTIVIR RES, V100, pS54, DOI 10.1016/j.antiviral.2013.09.029; Van Lith LM, 2013, GLOB HEALTH-SCI PRAC, V1, P97, DOI 10.9745/GHSP-D-12-00036; Woodsong C, 2015, ADV DRUG DELIVER REV, V92, P146, DOI 10.1016/j.addr.2015.02.004	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217333	10.1371/journal.pone.0217333	http://dx.doi.org/10.1371/journal.pone.0217333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136612	gold, Green Submitted, Green Published			2022-12-27	WOS:000469224300027
J	Baker, CA; De, J; Bertoldi, B; Dunn, L; Chapin, T; Jay-Russell, M; Danyluk, MD; Schneider, KR				Baker, Christopher A.; De, Jaysankar; Bertoldi, Bruna; Dunn, Laurel; Chapin, Travis; Jay-Russell, Michele; Danyluk, Michelle D.; Schneider, Keith R.			Prevalence and concentration of stx plus E. coli and E. coli O157 in bovine manure from Florida farms	PLOS ONE			English	Article							ESCHERICHIA-COLI; SHIGA TOXIN; UNITED-STATES; CATTLE FECES; BEEF-CATTLE; PRODUCE; GENES; ENUMERATION; SALMONELLA; QUANTIFICATION	Fresh produce outbreaks due to Shiga toxin-producing Escherichia coli (STEC) continue to occur in the United States (US). Manure-amended soils can pose a public health risk when used for growing raw agricultural commodities. Knowing the prevalence and concentration of STEC in untreated biological soil amendments of animal origin (BSAAO) is important to help guide the most appropriate pre-harvest interval(s) following application to limit risks from these soil amendments. Bovine manure samples were collected from 12 farms in Florida, including samples from piles, lagoons, barns, and screened solids. Two methods were used to detect stx1/2 and rfbE genes in samples. A prevalence rate of 9% for stx1 and/or stx2 and 19% for rfbE was observed from the 518 bovine manure samples evaluated. A most probable number (MPN) assay was performed on stx+ samples when applicable. The geometric mean for stx+ samples (n = 20) was 3.37 MPN g(-1) (0.53 log MPN g(-1)) with a maximum value of 6,800 MPN g(-1) (3.83 log MPN g(-1)). This research was part of a larger nationwide geographical study on the prevalence and concentration of STEC in bovine manure to help guide regulations on feasible pre-harvest intervals for the application of untreated BSAAO.	[Baker, Christopher A.; De, Jaysankar; Bertoldi, Bruna; Danyluk, Michelle D.; Schneider, Keith R.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Dunn, Laurel; Chapin, Travis; Danyluk, Michelle D.] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Jay-Russell, Michele] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA; [Dunn, Laurel] Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis; University System of Georgia; University of Georgia	Schneider, KR (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	keiths29@ufl.edu	Baker, Christopher/AAG-7217-2019; De, Jaysankar/G-8386-2011	De, Jaysankar/0000-0001-9799-9401; Dunn, Laurel/0000-0003-0786-5253	Western Center for Food Safety from the U.S. Food and Drug Administration [U19-FD004995]; FOOD AND DRUG ADMINISTRATION [U19FD004995] Funding Source: NIH RePORTER	Western Center for Food Safety from the U.S. Food and Drug Administration; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This work was supported by the Western Center for Food Safety contract U19-FD004995 from the U.S. Food and Drug Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminabadi P, ANN INT ASS FOOD PRO; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Atwill ER, 2015, J FOOD PROTECT, V78, P240, DOI 10.4315/0362-028X.JFP-14-277; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; Benjamin LA, 2015, EPIDEMIOL INFECT, V143, P81, DOI 10.1017/S0950268814000521; Besser TE, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.EHEC-0021-2013, 10.1128/microbiolspec.EHEC-0021]; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brichta-Harhay DM, 2007, J APPL MICROBIOL, V103, P1657, DOI 10.1111/j.1365-2672.2007.03405.x; Callejon RM, 2015, FOODBORNE PATHOG DIS, V12, P32, DOI 10.1089/fpd.2014.1821; Centers for Disease Control and Prevention, 2006, MULT OUTBR E COL O15; Centers for Disease Control and Prevention, 2018, MULT OUTBR E COL O15; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Desmarchelier PM, 1998, J CLIN MICROBIOL, V36, P1801, DOI 10.1128/JCM.36.6.1801-1804.1998; Dewey-Mattia D, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6710a1; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fegan N, 2004, LETT APPL MICROBIOL, V38, P56, DOI 10.1046/j.1472-765X.2003.01439.x; Fox JT, 2008, J FOOD PROTECT, V71, P1761, DOI 10.4315/0362-028X-71.9.1761; Fox JT, 2007, APPL ENVIRON MICROB, V73, P5253, DOI 10.1128/AEM.00554-07; Franz E, 2007, APPL ENVIRON MICROB, V73, P2180, DOI 10.1128/AEM.01950-06; Gutierrez-Rodriguez E, 2019, FOOD MICROBIOL, V77, P173, DOI 10.1016/j.fm.2018.08.013; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Himathongkham S, 1999, FEMS MICROBIOL LETT, V178, P251, DOI 10.1111/j.1574-6968.1999.tb08684.x; Hirvonen JJ, 2012, J CLIN MICROBIOL, V50, P3586, DOI 10.1128/JCM.01754-12; Hutchison ML, 2004, LETT APPL MICROBIOL, V39, P207, DOI 10.1111/j.1472-765X.2004.01564.x; Jacob ME, 2012, FOODBORNE PATHOG DIS, V9, P79, DOI 10.1089/fpd.2011.0947; Jay-Russell MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113433; Joris MA, 2011, TOXINS, V3, P672, DOI 10.3390/toxins3060672; KARCH H, 1992, INFECT IMMUN, V60, P3464, DOI 10.1128/IAI.60.8.3464-3467.1992; Karmali MA, 2017, CLIN INFECT DIS, V64, P371, DOI 10.1093/cid/ciw708; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; Li M, 2018, J FOOD PROTECT, V81, P1171, DOI [10.4315/0362-028X.JFP-17-465, 10.4315/0362-028x.jfp-17-465]; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590; Mir RA, 2015, VET MICROBIOL, V175, P325, DOI 10.1016/j.vetmic.2014.12.016; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Noll LW, 2015, FOODBORNE PATHOG DIS, V12, P787, DOI 10.1089/fpd.2015.1951; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Parsons BD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00478; Preussel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078180; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Robinson SE, 2004, J APPL MICROBIOL, V97, P581, DOI 10.1111/j.1365-2672.2004.02339.x; Sargeant JM, 2000, AM J VET RES, V61, P1375, DOI 10.2460/ajvr.2000.61.1375; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sharma M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.PFS-0010-2015; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; U. S. Food and Drug Administration (FDA) Department of Health and Human Services, 2015, STAND GROW HARV PACK; US Food and Drug Administration (FDA), 2017, BACT AN MAN CHAPT 4A; US Food and Drug Administration (FDA), 2016, RAW MAN FSMA FIN RUL; US Food and Drug Administration (FDA), 2009, DRAFT GUID IND GUID; Wallace JS, 1996, J APPL BACTERIOL, V81, P663; Wetzel AN, 2007, LETT APPL MICROBIOL, V45, P504, DOI 10.1111/j.1472-765X.2007.02228.x; Wylie JL, 2013, J CLIN MICROBIOL, V51, P466, DOI 10.1128/JCM.02329-12; Zelyas N, 2016, DIAGN MICR INFEC DIS, V85, P302, DOI 10.1016/j.diagmicrobio.2016.03.013; ZHAO T, 1995, APPL ENVIRON MICROB, V61, P1290, DOI 10.1128/AEM.61.4.1290-1293.1995	58	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217445	10.1371/journal.pone.0217445	http://dx.doi.org/10.1371/journal.pone.0217445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125367	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700042
J	Singh, S; Gupta, K; Shukla, S; Sampathkumar, SG; Roy, RP				Singh, Shikha; Gupta, Kanchan; Shukla, Shagun; Sampathkumar, Srinivasa-Gopalan; Roy, Rajendra P.			Sortase-click strategy for defined protein conjugation on a heptavalent cyclodextrin scaffold	PLOS ONE			English	Article							SCHARDINGER DEXTRIN; BETA-CYCLODEXTRIN; PEPTIDE; LIGATION; SYSTEM	Multivalent proteins or protein dendrimers are useful for clinical and biotechnological applications. However, assembly of chemically defined protein dendrimers is a challenging endeavor. In the past, majority of protein dendrimers have been developed on branched lysine scaffolds and are usually limited to a valency of two to four. The naturally occurring cyclodextrin (CD) scaffold composed of 6-8 glucose units offers the possibility of expanding the valency. Here we have adapted a chemoenzymatic-click strategy for displaying heptavalent peptides and large proteins on the beta-cyclodextrin (beta-CD) scaffold. We demonstrate that recombinant proteins (engineered with a LPXTG pentapeptide motif at the carboxy terminus), labeled with an alkyne moiety by sortase-mediated ligation, can be easily clicked on to the azide-derivatized beta-cyclodextrin through the Huisgen cycloaddition reaction yielding a well-defined heptavalent display of proteins.	[Singh, Shikha; Gupta, Kanchan; Shukla, Shagun; Sampathkumar, Srinivasa-Gopalan; Roy, Rajendra P.] Natl Inst Immunol, Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Roy, RP (corresponding author), Natl Inst Immunol, Delhi, India.	rproy@nii.ac.in	Singh, Shikha/AAM-4407-2021; shukla, shagun/AAZ-7923-2021; Sampathkumar, Srinivasa-Gopalan/C-9951-2017	Sampathkumar, Srinivasa-Gopalan/0000-0002-0616-8977; gupta, kanchan/0000-0002-8411-881X; Roy, Rajendra/0000-0002-7796-7047	J. C. Bose Fellowship grant [SB/S2/JCB-016/2016]; National Institute of Immunology from Department of Biotechnology (Government of India)	J. C. Bose Fellowship grant; National Institute of Immunology from Department of Biotechnology (Government of India)	This work was supported by J. C. Bose Fellowship grant (#SB/S2/JCB-016/2016) to RPR (Department of Science and Technology, Government of India) and intramural grants of National Institute of Immunology from Department of Biotechnology (Government of India). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelidou C, 2014, BEILSTEIN J ORG CHEM, V10, P2414, DOI 10.3762/bjoc.10.251; Alt K, 2015, ANGEW CHEM INT EDIT, V54, P7515, DOI 10.1002/anie.201411507; Ashton PR, 1996, J ORG CHEM, V61, P903, DOI 10.1021/jo951396d; Bertolla C, 2008, BIOORG MED CHEM LETT, V18, P1855, DOI 10.1016/j.bmcl.2008.02.017; Boykins RA, 2000, PEPTIDES, V21, P9, DOI 10.1016/S0196-9781(99)00172-2; Freudenberg K, 1939, NATURWISSENSCHAFTEN, V27, P850, DOI 10.1007/BF01489430; Freudenberg K, 1935, LIEBIGS ANN CHEM, V518, P102; Freudenberg K, 1938, BER DTSCH CHEM GES, V71, P1596, DOI 10.1002/cber.19380710809; Garcia YR, 2015, ORG BIOMOL CHEM, V13, P5273, DOI 10.1039/c5ob00609k; Gupta K, 2012, CHEMBIOCHEM, V13, P2489, DOI 10.1002/cbic.201200559; Helms BA, 2009, J AM CHEM SOC, V131, P11683, DOI 10.1021/ja902285m; Jiang RJ, 2014, CARBOHYD RES, V400, P19, DOI 10.1016/j.carres.2014.08.018; Joshi A, 2011, BIOMACROMOLECULES, V12, P791, DOI 10.1021/bm101396u; KARUPPIAH N, 1995, BIOCHEM BIOPH RES CO, V211, P60, DOI 10.1006/bbrc.1995.1778; Loftsson T., 2004, AM J DRUG DELIV, V2, P261, DOI [10.2165/00137696-200402040-00006, DOI 10.2165/00137696-200402040-00006]; Ma D, 2013, J COLLOID INTERF SCI, V405, P305, DOI 10.1016/j.jcis.2013.05.017; Maciollek A, 2013, BEILSTEIN J ORG CHEM, V9, P827, DOI 10.3762/bjoc.9.94; Motoyama K, 2014, J DRUG TARGET, V22, P211, DOI 10.3109/1061186X.2013.856012; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; van Baal I, 2005, ANGEW CHEM INT EDIT, V44, P5052, DOI 10.1002/anie.200500635; Wang YW, 2010, MACROMOLECULES, V43, P1651, DOI 10.1021/ma902377g; Werlen RC, 1996, CANCER RES, V56, P809; Xiao JP, 2009, ORG LETT, V11, P4144, DOI 10.1021/ol9016468	26	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217369	10.1371/journal.pone.0217369	http://dx.doi.org/10.1371/journal.pone.0217369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125361	Green Submitted, gold, Green Published			2022-12-27	WOS:000468865700031
J	Chen, PM; Kwong, PWH; Lai, CKY; Ng, SSM				Chen, Pei-ming; Kwong, Patrick W. H.; Lai, Claudia K. Y.; Ng, Shamay S. M.			Comparison of bilateral and unilateral upper limb training in people with stroke: A systematic review and meta-analysis	PLOS ONE			English	Review							INDUCED MOVEMENT THERAPY; CONSTRAINT-INDUCED THERAPY; MOTOR FUNCTION-TEST; TRANSCRANIAL MAGNETIC STIMULATION; UPPER EXTREMITY FUNCTION; RESEARCH ARM TEST; POST-STROKE; INTERHEMISPHERIC FACILITATION; CORTEX ACTIVATION; RANDOMIZED-TRIAL	Background and objectives Bilateral upper limb training (BULT) and unilateral upper limb training (UULT) are two effective strategies for the recovery of upper limb motor function after stroke. This meta-analysis aimed to compare the improvements in motor impairment and functional performances of people with stroke after BULT and UULT. Research design and methods This systematic review and meta-analysis identified 21 randomized controlled trials (RCTs) met the eligibility criteria from CINAHL, Medline, Embase, Cochrane Library and PubMed. The outcome measures were the Fugl-Meyer Assessment of Upper Extremity (FMA-UE), Wolf Motor Function Test (WMFT), Action Research Arm Test (ARAT) and Box and Block Test (BBT), which are validated measures of upper limb function. Results Twenty-one studies involving 842 subjects with stroke were included. Compared with UULT, BULT yielded a significantly greater mean difference (MD) in the FMA-UE (MD = 2.21, 95% Confidence Interval (CI), 0.12 to 4.30, p = 0.04; l(2) = 86%, p<0.001). However, a comparison of BULT and UULT yielded insignificant mean difference (MD) in terms of the time required to complete the WMFT (MD = 0.44; 95%CI, -2.22 to 3.10, p = 0.75; l(2) = 55%, p = 0.06) and standard mean difference (SMD) in terms of the functional ability scores on the WMFT, ARAT and BBT (SMD = 0.25; 95%CI, -0.02 to 0.52, p = 0.07; l(2) = 54%, p = 0.02). Discussion and implications Compared to UULT, BULT yielded superior improvements in the improving motor impairment of people with stroke, as measured by the FMA-UE. However, these strategies did not yield significant differences in terms of the functional performance of people with stroke, as measured by the WMFT, ARAT and BBT. More comparative studies of the effects of BULT and UULT are needed to increase the reliability of these conclusions.	[Chen, Pei-ming; Kwong, Patrick W. H.; Ng, Shamay S. M.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Peoples R China; [Lai, Claudia K. Y.] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Ng, SSM (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Peoples R China.	Shamay.Ng@polyu.edu.hk	Kwong, Wai Hang/AAZ-5331-2020; Kwong, Patrick W.H./AAY-2084-2020; NG, Sheung Mei Shamay/E-2731-2016	Kwong, Wai Hang/0000-0002-1834-5715; Kwong, Patrick W.H./0000-0002-1834-5715; Lai, Claudia KY/0000-0001-8503-5429; NG, Sheung Mei Shamay/0000-0003-1660-0548	Health and Medical Research Fund [12131821]; Food and Health Bureau, Hong Kong SAR Government	Health and Medical Research Fund; Food and Health Bureau, Hong Kong SAR Government	This study was supported by Health and Medical Research Fund 12131821 from the Food and Health Bureau, Hong Kong SAR Government, to Dr. Shamay Ng and her team.	Arya KN, 2012, TOP STROKE REHABIL, V19, P193, DOI 10.1310/tsr1903-193; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Blanton S, 1999, PHYS THER, V79, P847, DOI 10.1093/ptj/79.9.847; Boddington LJ, 2017, BRAIN STIMUL, V10, P214, DOI 10.1016/j.brs.2017.01.006; Bohannon RW, 2007, J REHABIL MED, V39, P14, DOI 10.2340/16501977-0018; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Brogardh C, 2006, CONSTRAINT INDUCED M; Brunner IC, 2012, CLIN REHABIL, V26, P1078, DOI 10.1177/0269215512443138; Buchner DM, 1996, AGE AGEING, V25, P386, DOI 10.1093/ageing/25.5.386; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Carson RG, 1999, HUM MOVEMENT SCI, V18, P307, DOI 10.1016/S0167-9457(99)00013-5; Cattaert D, 1999, BIOL CYBERN, V81, P343, DOI 10.1007/s004220050567; Cauraugh JH, 2008, CEREBROVASC DIS, V25, P115, DOI 10.1159/000112321; Cauraugh JH, 2010, HUM MOVEMENT SCI, V29, P853, DOI 10.1016/j.humov.2009.09.004; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Chang JJ, 2007, ARCH PHYS MED REHAB, V88, P1332, DOI 10.1016/j.apmr.2007.07.016; Chang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133192; Coupar F, 2010, COCHRANE DATABASE SY, V4; Desrosiers J, 2005, CLIN REHABIL, V19, P581, DOI 10.1191/0269215505cr896oa; Edwards DF, 2012, ARCH PHYS MED REHAB, V93, P660, DOI 10.1016/j.apmr.2011.10.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FERBERT A, 1992, J NEUROL NEUROSUR PS, V55, P294, DOI 10.1136/jnnp.55.4.294; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Grefkes C, 2014, NEUROSCIENTIST, V20, P56, DOI 10.1177/1073858413491147; Grotta JC, 2004, STROKE, V35, P2699, DOI 10.1161/01.STR.0000143320.64953.c4; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Hammer AM, 2009, PHYS THER, V89, P526, DOI 10.2522/ptj.20080017; Han Kyoung Ju, 2016, J Phys Ther Sci, V28, P2299, DOI 10.1589/jpts.28.2299; Hanajima R, 2001, J PHYSIOL-LONDON, V531, P849, DOI 10.1111/j.1469-7793.2001.0849h.x; Harris JE, 2007, PHYS THER, V87, P88, DOI 10.2522/ptj.20060065; Hesse S, 2005, STROKE, V36, P1960, DOI 10.1161/01.STR.0000177865.37334.ce; Hodics TM, 2012, ARCH PHYS MED REHAB, V93, P1963, DOI 10.1016/j.apmr.2012.05.002; Hsieh YW, 2017, CLIN REHABIL, V31, P225, DOI 10.1177/0269215516633275; Hubbard IJ, 2015, NEUROREHAB NEURAL RE, V29, P703, DOI 10.1177/1545968314562647; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Kim H., 2013, T NEURAL SYSTEMS REH, V21, P153; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Latimer CP, 2010, DISABIL REHABIL, V32, P1221, DOI 10.3109/09638280903483877; Lee MJ, 2017, J STROKE CEREBROVASC, V26, P1020, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.008; Lee Y, 2017, NEUROREHABILITATION, V40, P301, DOI 10.3233/NRE-161418; Liao WW, 2012, CLIN REHABIL, V26, P111, DOI 10.1177/0269215511416383; Lin KC, 2007, CLIN REHABIL, V21, P1075, DOI 10.1177/0269215507079843; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P42, DOI 10.1177/1545968309345268; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P441, DOI 10.1177/1545968308328719; Lin LF, 2018, J GEN INTERN MED, V33, P1260, DOI 10.1007/s11606-018-4425-7; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Lum PS, 2006, J REHABIL RES DEV, V43, P631, DOI 10.1682/JRRD.2005.02.0044; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Meng GL, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00726; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Morris JH, 2008, ARCH PHYS MED REHAB, V89, P1237, DOI 10.1016/j.apmr.2007.11.039; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Netz J, 1997, BRAIN, V120, P1579, DOI 10.1093/brain/120.9.1579; Page SJ, 2002, CLIN REHABIL, V16, P55, DOI 10.1191/0269215502cr473oa; Page SJ, 2008, PHYS THER, V88, P333, DOI 10.2522/ptj.20060029; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Richards LG, 2008, NEUROREHAB NEURAL RE, V22, P180, DOI 10.1177/1545968307305355; Salter K, 2005, DISABIL REHABIL, V27, P507, DOI 10.1080/0963828040008552; Santisteban L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154792; Shahine EM, 2014, EGYPT RHEUMATOL REHA, V41, P8, DOI [10.4103/1110-161X.128128, DOI 10.4103/1110-161X.128128]; Singer BJ, 2013, RESTOR NEUROL NEUROS, V31, P681, DOI 10.3233/RNN-130319; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Stinear CM, 2008, BRAIN, V131, P1381, DOI 10.1093/brain/awn051; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Stoykov ME, 2009, NEUROREHAB NEURAL RE, V23, P945, DOI 10.1177/1545968309338190; Summers JJ, 2007, J NEUROL SCI, V252, P76, DOI 10.1016/j.jns.2006.10.011; Suputtitada Areerat, 2004, Journal of the Medical Association of Thailand, V87, P1482; Swinnen S.P., 2012, NEUROBEHAVIORAL DETE; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; Thielman GT, 2004, ARCH PHYS MED REHAB, V85, P1613, DOI 10.1016/j.apmr.2004.01.028; Turton A, 1996, ELECTROMYOGR MOTOR C, V101, P316, DOI 10.1016/0924-980X(96)95560-5; UGAWA Y, 1993, NEUROSCI LETT, V160, P153, DOI 10.1016/0304-3940(93)90401-6; van Delden AEQ, 2012, J REHABIL MED, V44, P106, DOI 10.2340/16501977-0928; van Delden AEQ, 2013, STROKE, V44, P2613, DOI 10.1161/STROKEAHA.113.001969; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Waller SM, 2008, HUM MOVEMENT SCI, V27, P749, DOI 10.1016/j.humov.2008.03.006; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Whitall J, 2011, NEUROREHAB NEURAL RE, V25, P118, DOI 10.1177/1545968310380685; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wu CY, 2007, NEUROREHAB NEURAL RE, V21, P460, DOI 10.1177/1545968307303411; Wu CY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-35; Wu CY, 2011, NEUROREHAB NEURAL RE, V25, P130, DOI 10.1177/1545968310380686; Yang CL, 2012, AM J OCCUP THER, V66, P198, DOI 10.5014/ajot.2012.003103; Ziemann U, 2001, CLIN NEUROPHYSIOL, V112, P107, DOI 10.1016/S1388-2457(00)00502-2	91	26	28	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216357	10.1371/journal.pone.0216357	http://dx.doi.org/10.1371/journal.pone.0216357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120910	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700014
J	Chen, X; Dimitrov, NB; Meyers, LA				Chen, Xi; Dimitrov, Nedialko B.; Meyers, Lauren Ancel			Uncertainty analysis of species distribution models	PLOS ONE			English	Article							AEDES-AEGYPTI	The maximum entropy model, a commonly used species distribution model (SDM) normally combines observations of the species occurrence with environmental information to predict the geographic distributions of animal or plant species. However, it only produces point estimates for the probability of species existence. To understand the uncertainty of the point estimates, we analytically derived the variance of the outputs of the maximum entropy model from the variance of the input. We applied the analytic method to obtain the standard deviation of dengue importation probability and Aedes aegypti suitability. Dengue occurrence data and Aedes aegypti mosquito abundance data, combined with demographic and environmental data, were applied to obtain point estimates and the corresponding variance. To address the issue of not having the true distributions for comparison, we compared and contrasted the performance of the analytical expression with the bootstrap method and Poisson point process model which proved of equivalence of maximum entropy model with the assumption of independent point locations. Both Dengue importation probability and Aedes aegypti mosquito suitability examples show that the methods generate comparatively the same results and the analytic method we introduced is dramatically faster than the bootstrap method and directly apply to maximum entropy model.	[Chen, Xi; Dimitrov, Nedialko B.] Univ Texas Austin, Grad Program Operat Res Ind Engn, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; The Santa Fe Institute	Chen, X (corresponding author), Univ Texas Austin, Grad Program Operat Res Ind Engn, Austin, TX 78712 USA.	carol.chen@utexas.edu			Centers for Disease Control and Prevention [U01CK000512]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by Cooperative Agreement Number U01CK000512, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.; This publication was supported by Cooperative Agreement Number U01CK000512, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.	[Anonymous], 2003, ARTIFICIAL INTELLIGE; Asmussen S., 2007, STOCHASTIC MODELLING, V57, DOI [10.1007/978-0-387-69033-9, DOI 10.1007/978-0-387-69033-9]; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barney CE, 2008, THESIS; Cano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9670; Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9; Davison AC, 1997, BOOTSTRAP METHODS TH, V1; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Endo T, 2015, J NUCL SCI TECHNOL, V52, P993, DOI 10.1080/00223131.2015.1034216; Gorrochotegui-Escalante N, 2002, AM J TROP MED HYG, V66, P213, DOI 10.4269/ajtmh.2002.66.213; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kapur J. N., 1992, ENTROPY OPTIMIZATION; Kavanaugh MD, INFLUENCE STORMWATER; Kyung M, 2010, BAYESIAN ANAL, V5, P369, DOI 10.1214/10-BA607; Manly B. F, 2006, RANDOMIZATION BOOTST, V70; McPhatter LP, 2012, J AM MOSQUITO CONTR, V28, P240, DOI 10.2987/12-6230R.1; Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Neyman J., 1937, PHILOS T R SOC S-A, V236, P333, DOI DOI 10.1098/RSTA.1937.0005; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Shannon CE, 1997, M D COMPUT, V14, P306; Soto D, 2015, COMMUNICATION; Vitek CJ, 2014, J MED ENTOMOL, V51, P1019, DOI 10.1603/ME13005; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x	30	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0214190	10.1371/journal.pone.0214190	http://dx.doi.org/10.1371/journal.pone.0214190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120909	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700004
J	Collignon, B; Seguret, A; Chemtob, Y; Cazenille, L; Halloy, J				Collignon, Bertrand; Seguret, Axel; Chemtob, Yohann; Cazenille, Leo; Halloy, Jose			Collective departures and leadership in zebrafish	PLOS ONE			English	Article							DECISION-MAKING; DISTRIBUTED LEADERSHIP; CONSENSUS DECISION; GOLDEN SHINERS; SHOALS; INDIVIDUALS; FISH; MOVEMENTS; BEHAVIOR; RUTILUS	In social animals, morphological and behavioural traits may give to some individuals a stronger influence on the collective decisions, even in groups assumed to be leaderless such as fish shoals. Here, we studied and characterized the leadership in collective movements of shoals of zebrafish Danio rerio by observing groups of 2, 3, 5, 7 and 10 zebrafish swimming in a two resting sites arena during one hour. We quantified the number of collective departures initiated by each fish and the number of attempts that they made. To do so, we developed an automated pipeline that analysed the individual trajectories generated by the tracking software. For all shoal sizes, the leadership was distributed among several individuals. However, it was equally shared among all the fish in some shoals while other groups showed a more asymmetrical sharing of the initiation of collective departures. To quantify this distribution, we computed the entropy associated with the time series of the identity of all initiators for each experiment and confirmed the presence of a continuum between a homogeneous and a heterogeneous distribution of the leadership. While some fish led more departures than others, an individual analysis showed that all fish had actually the same success rate to lead the shoal out of a resting site after an attempt. Thus, some individuals monopolized the leadership by attempting more often than others to exit a resting site. Finally, we highlight that the intra-group ranking of a fish for the initiative is correlated to its intra-group ranking for the average speed with mobile individuals more prone to lead the shoal. These results demonstrate that the collective behaviour of a shoal can be mainly driven by a subset of individuals even in the absence of higher influence of a fish on its congeneers.	[Collignon, Bertrand; Seguret, Axel; Chemtob, Yohann; Cazenille, Leo; Halloy, Jose] Univ Paris Diderot, Sorbonne Paris Cite, Lab Interdisciplinaire Energies Demain, UMR 8236, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite	Collignon, B (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Lab Interdisciplinaire Energies Demain, UMR 8236, F-75013 Paris, France.	bcollign@gmail.com		Halloy, Jose/0000-0003-1555-2484; Collignon, Bertrand/0000-0003-2463-1512	European Union Information and Communication Technologies project ASSISIbf [Fp7-ICT-FET n. 601074]	European Union Information and Communication Technologies project ASSISIbf	This work was supported by European Union Information and Communication Technologies project ASSISIbf, (Fp7-ICT-FET n. 601074). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUMANN D, 1993, BEHAVIOUR, V125, P189, DOI 10.1163/156853993X00236; Collignon B, 2010, P ROY SOC B-BIOL SCI, V277, P1267, DOI 10.1098/rspb.2009.1976; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Engeszer RE, 2007, ANIM BEHAV, V74, P1269, DOI 10.1016/j.anbehav.2007.01.032; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Furrer RD, 2012, ANIM BEHAV, V84, P205, DOI 10.1016/j.anbehav.2012.04.034; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Jolles JW, 2014, BEHAV ECOL, V25, P1395, DOI 10.1093/beheco/aru146; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Krause J, 1998, J FISH BIOL, V52, P494, DOI 10.1006/jfbi.1997.0595; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; KRAUSE J, 1993, J FISH BIOL, V43, P309, DOI 10.1111/j.1095-8649.1993.tb01194.x; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Lecheval V, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0251; Miller NY, 2008, BEHAV BRAIN RES, V193, P148, DOI 10.1016/j.bbr.2008.05.004; Nakayama S, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0207; Nakayama S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1724; Parichy DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05635; PARTRIDGE BL, 1980, ANIM BEHAV, V28, P68, DOI 10.1016/S0003-3472(80)80009-1; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pettit B, 2015, CURR BIOL, V25, P3132, DOI 10.1016/j.cub.2015.10.044; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; RASA OAE, 1983, BEHAV ECOL SOCIOBIOL, V12, P181; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; Rogers H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043446; Seguret A, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160451; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2013, AM NAT, V181, P748, DOI 10.1086/670242; Zienkiewicz A, 2015, EUR PHYS J-SPEC TOP, V224, P3343, DOI 10.1140/epjst/e2015-50093-5	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216798	10.1371/journal.pone.0216798	http://dx.doi.org/10.1371/journal.pone.0216798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120920	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700028
J	Monsalve-Lancheros, A; Ibanez-Pinilla, M; Ramirez-Clavijo, S				Monsalve-Lancheros, Ana; Ibanez-Pinilla, Milciades; Ramirez-Clavijo, Sandra			Detection of mammagloblin by RT-PCR as a biomarker for lymph node metastasis in breast cancer patients: A systematic review and meta-analysis	PLOS ONE			English	Review							MESSENGER-RNA MARKERS; CHAIN-REACTION ASSAY; MOLECULAR ASSAY; INTRAOPERATIVE ASSESSMENT; MICROMETASTASES; CARCINOMA; METASIN; VALIDATION	Background This meta-analysis presents evidence regarding the diagnostic accuracy of mammaglobin detected using the RT-PCR technique, related to the presence of sentinel node metastasis in breast cancer patients. Methods The following databases were consulted: Cochrane, Lilacs, Scielo, Hinary, PubMed, Elsevier, Embase, ProQuest, the Universidad del Rosario's Centro de Recursos Para el Aprendizaje y la Investigacion (CRAI-UR) [ Resource Center for Learning and Research], and the Google Scholar search engine. The quality of the studies was assessed using the QUA-DAS-2 and CASpe tools. The selected studies presented the necessary data to calculate diagnostic validity index of mammaglobin detection using RT-PCR, compared with the reference standard test. Global values for the sensitivity, specificity, positive predictive value, negative predictive value, probability ratios, diagnostic ORs, and summary ROC curves of this meta-analysis were obtained using the Meta-DiSc 1.4 program. Results Initially, 731 articles were obtained; but only 25 were included in the meta-analysis. Sensitivity was 84% (95% CI: 83%-86%), and specificity was 92% (95% CI: 91%-93%). Positive and negative predictive values were 9.26 (95% CI: 6.47-13.26) and 0.17 (95% CI: 0.13-0.23), respectively. The diagnostic OR was 66.34 (95% CI: 42.52-103.52). The predictive area under the sROC curve was 94.78 (Q = 0.8876). Conclusions The evaluated diagnostic index showed that the expression of the mammaglobin biomarker has diagnostic prediction for detecting lymph node metastasis in breast cancer patients, when analyzed using RT-PCR, although more than 50% heterogeneity was found.	[Monsalve-Lancheros, Ana; Ramirez-Clavijo, Sandra] Univ Rosario, Fac Nat Sci & Math, Bogota, Colombia; [Ibanez-Pinilla, Milciades] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Universidad del Rosario; Universidad del Rosario	Ramirez-Clavijo, S (corresponding author), Univ Rosario, Fac Nat Sci & Math, Bogota, Colombia.	sandra.ramirez@urosario.edu.co	; Ramirez-Clavijo, Sandra/G-5268-2016	Monsalve Lancheros, Ana Milena/0000-0002-2170-0562; Ramirez-Clavijo, Sandra/0000-0003-0336-5614	School of Medicine and Health Sciences; Faculty of Natural Science and Mathematics at the Universidad del Rosario	School of Medicine and Health Sciences; Faculty of Natural Science and Mathematics at the Universidad del Rosario	This study was supported by the School of Medicine and Health Sciences and the Faculty of Natural Science and Mathematics at the Universidad del Rosario.	Aihara T, 1999, BREAST CANCER RES TR, V58, P137, DOI 10.1023/A:1006335817889; Al-Ramadhani S, 2013, INT J MOL SCI, V14, P12931, DOI 10.3390/ijms140712931; American Cancer Society, 2013, CANC FACTS FIG 2013, P1, DOI DOI 10.1017/CB09781107415324.004; [Anonymous], 2012, REV ESP PATOL; Backus J, 2005, J MOL DIAGN, V7, P327, DOI 10.1016/S1525-1578(10)60561-2; Berger J, 2006, ANTICANCER RES, V26, P3855; Bernet, 2014, REV ESP PATOL, DOI 10.1016/j.patol.2013.11.001; Branagan G, 2002, BRIT J SURG, V89, P86, DOI 10.1046/j.0007-1323.2001.01970.x; Brown NM, 2006, BREAST CANCER RES TR, V97, P41, DOI 10.1007/s10549-005-9085-8; Choi AH, 2015, JAMA SURG, V150, P1141, DOI 10.1001/jamasurg.2015.1687; De Sousa M., 2009, ARQ BRAS CARDIOL, V92, P235, DOI [10.1590/S0066-782X2009000300013, DOI 10.1590/S0066-782X2009000300013]; Dell'Orto P, 2006, BREAST CANCER RES TR, V98, P185, DOI 10.1007/s10549-005-9148-x; Douglas-Jones AG, 2009, HISTOPATHOLOGY, V55, P107, DOI 10.1111/j.1365-2559.2008.03218.x; Funasako Y, 2010, CANCER-AM CANCER SOC, V116, P4450, DOI 10.1002/cncr.25479; Gonzalez L, 2007, REV COLOMB CANCEROL, V11, P40; Julian TB, 2008, J CLIN ONCOL, V26, P3338, DOI 10.1200/JCO.2007.14.0665; Kataoka A, 2000, INT J ONCOL, V16, P1147; Li Da-li, 2010, Chinese Journal of Pathology, V39, P729, DOI 10.3760/cma.j.jssn.0529-5807.2010.11.004; Liu ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103910; Madeira K, 2016, AN ACAD BRAS CIENC, V88, P923, DOI 10.1590/0001-3765201620150107; Mansel RE, 2009, BREAST CANCER RES TR, V115, P595, DOI 10.1007/s10549-008-0155-6; Manzotti M, 2001, INT J CANCER, V95, P307, DOI 10.1002/1097-0215(20010920)95:5<307::AID-IJC0153>3.0.CO;2-Q; Marchetti A, 2001, J PATHOL, V195, P186, DOI 10.1002/path.943; Martinez J, 2016, I NAC SALUD, V2, P1; Martinez MDM, 2009, EJSO-EUR J SURG ONC, V35, P387, DOI 10.1016/j.ejso.2008.05.008; Massague J, 2009, SEBBM, V160, P22; Menezes A, 2005, DETECCAO MAMAGLOBINA; Nissan A, 2006, BRIT J CANCER, V94, P681, DOI 10.1038/sj.bjc.6602992; Nottegar A, 2016, EJSO-EUR J SURG ONC, V42, P919, DOI 10.1016/j.ejso.2016.02.259; OMS Centro de prensa, 2015, CANC NOT DESCR NO 29; Ooka M, 2000, ONCOL REP, V7, P561; Ouellette RJ, 2004, AM J CLIN PATHOL, V121, P637, DOI 10.1309/MMACTXT55L8QTKC1; Ruiz-Aragon J, 2010, ACTAS UROL ESP, V34, P346, DOI 10.1016/S2173-5786(10)70081-0; Sai-Giridhar P, 2016, HISTOPATHOLOGY, V68, P875, DOI 10.1111/his.12863; Smith GJ, 2017, J CLIN PATHOL, V70, P134, DOI 10.1136/jclinpath-2016-203728; Tafra L, 2000, ACCURACY SIGNIFICANC; Veys I, 2009, AM J SURG, V198, P203, DOI 10.1016/j.amjsurg.2008.09.012; Viale G, 2008, ANN SURG, V247, P136, DOI 10.1097/SLA.0b013e318157d22b; Vinagre Martinez L. M, ANATOMIA QUIRURGICA, P26; Wallwiener CW, 2011, BREAST CANCER RES TR, V130, P833, DOI 10.1007/s10549-011-1710-0; WHO (World Health Organization), 2011, TACKL ANT RES FOOD S, V3, P1; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216989	10.1371/journal.pone.0216989	http://dx.doi.org/10.1371/journal.pone.0216989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120936	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700044
J	Nelson-Coffey, SK; Ruberton, PM; Chancellor, J; Cornick, JE; Blascovich, J; Lyubomirsky, S				Nelson-Coffey, S. Katherine; Ruberton, Peter M.; Chancellor, Joseph; Cornick, Jessica E.; Blascovich, Jim; Lyubomirsky, Sonja			The proximal experience of awe	PLOS ONE			English	Article							POSITIVE EMOTIONS; SMALL SELF; GRATITUDE; MOTIVATION; OTHERS; SCALE; US	Research on awe has grown exponentially in recent decades; however, few studies have considered whether awe-inspiring experiences also inspire other emotions. In two studies, we explored whether interventions targeting awe also evoke other discrete emotions. Additionally, we considered two constructs that may be associated with increases in each emotion-self-relevant thoughts and connectedness. In Study 1, we manipulated awe in virtual reality and examined the potential effects of a prototypical awe experience-a spacewalk accompanied by an audio clip of Carl Sagan's Pale Blue Dot. In Study 2, we manipulated awe with a video depicting scenes of Earth from outer space paired with the same audio clip. Across both studies, a prototypical awe experience was associated not only with awe, but with compassion, gratitude, love, and optimism, along with connectedness and self-relevant thoughts. Furthermore, we found that increases in self-relevant thoughts and connectedness in response to the awe induction predicted increases in each emotion evoked and vice-versa. These findings suggest that experiences that are commonly considered awe-inspiring-such as viewing a picturesque landscape-may be more appropriately conceptualized more broadly as self-transcendent. More work is needed to determine whether the documented benefits of awe may be more appropriately interpreted as the benefits of self-transcendent emotions.	[Nelson-Coffey, S. Katherine] Univ South, Dept Psychol, Sewanee, TN 37375 USA; [Ruberton, Peter M.; Chancellor, Joseph; Lyubomirsky, Sonja] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Cornick, Jessica E.; Blascovich, Jim] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Ruberton, Peter M.] Penn State Univ, Dept Psychol, State Coll, PA USA	Sewanee: University of the South; University of California System; University of California Riverside; University of California System; University of California Santa Barbara; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Nelson-Coffey, SK (corresponding author), Univ South, Dept Psychol, Sewanee, TN 37375 USA.	sknelson@sewanee.edu		Nelson-Coffey, S. Katherine/0000-0002-9958-6819	National Science Foundation Graduate Research Fellowship Program [1326120]; John Templeton Foundation [58430]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); John Templeton Foundation	This research is based on work in part supported by the National Science Foundation Graduate Research Fellowship Program (Grant 1326120) and the John Templeton Foundation (Grant 58430). The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; Bai Y, 2017, J PERS SOC PSYCHOL, V113, P185, DOI 10.1037/pspa0000087; Chirico A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01766; Danvers AF, 2017, EMOTION, V17, P938, DOI 10.1037/emo0000277; Darbor KE, 2016, COGNITION EMOTION, V30, P1188, DOI 10.1080/02699931.2015.1042836; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Fredrickson BL, 2013, ADV EXP SOC PSYCHOL, V47, P1, DOI 10.1016/B978-0-12-407236-7.00001-2; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Goh JX, 2016, SOC PERSONAL PSYCHOL, V10, P535, DOI 10.1111/spc3.12267; Gordon AM, 2017, J PERS SOC PSYCHOL, V113, P310, DOI 10.1037/pspp0000120; Grant AM, 2010, J PERS SOC PSYCHOL, V98, P946, DOI 10.1037/a0017935; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hornsey MJ, 2018, J EXP SOC PSYCHOL, V76, P198, DOI 10.1016/j.jesp.2018.02.009; Johnson KA, 2017, J PUBLIC POLICY MARK, V36, P362, DOI 10.1509/jppm.16.108; Joye Y, 2016, J ENVIRON PSYCHOL, V47, P112, DOI 10.1016/j.jenvp.2016.05.001; Keltner D, 2003, COGNITION EMOTION, V17, P297, DOI 10.1080/02699930302297; Kruse E, 2017, SELF IDENTITY, V16, P399, DOI 10.1080/15298868.2016.1267662; Kruse E, 2014, SOC PSYCHOL PERS SCI, V5, P805, DOI 10.1177/1948550614534700; Layous K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179123; LAZARUS RS, 1991, AM PSYCHOL, V46, P352, DOI 10.1037/0003-066X.46.4.352; Nelson SK, 2016, EMOTION, V16, P850, DOI 10.1037/emo0000178; Piff PK, 2015, J PERS SOC PSYCHOL, V108, P883, DOI 10.1037/pspi0000018; Pilgrim L, 2017, J CONSUM BEHAV, V16, P442, DOI 10.1002/cb.1645; Prade C, 2016, J POSIT PSYCHOL, V11, P522, DOI 10.1080/17439760.2015.1127992; Preston JL, 2017, J EXP SOC PSYCHOL, V70, P212, DOI 10.1016/j.jesp.2016.11.006; Reis HT, 2000, PERS SOC PSYCHOL B, V26, P419, DOI 10.1177/0146167200266002; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Rosenthal R., 2008, ESSENTIALS BEHAV RES; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SCHEIER MF, 1985, J APPL SOC PSYCHOL, V15, P687, DOI 10.1111/j.1559-1816.1985.tb02268.x; Scherer K. R., 1999, HDB COGNITION EMOTIO, P637, DOI [10.1002/0470013494.ch30, DOI 10.1002/0470013494.CH30]; Schneider K.J., 2017, HUMANIST PSYCHOL, V45, P103, DOI [10.1037/hum0000060, DOI 10.1037/HUM0000060]; Sheldon KM, 2012, MOTIV EMOTION, V36, P439, DOI 10.1007/s11031-012-9279-4; Shiota MN, 2007, COGNITION EMOTION, V21, P944, DOI 10.1080/02699930600923668; Stellar JE, 2018, J PERS SOC PSYCHOL, V114, P258, DOI 10.1037/pspi0000109; Stellar JE, 2017, EMOT REV, V9, P200, DOI 10.1177/1754073916684557; Stellar JE, 2015, EMOTION, V15, P129, DOI 10.1037/emo0000033; Valdesolo P, 2017, EMOT REV, V9, P215, DOI 10.1177/1754073916673212; Valdesolo P, 2016, EMOTION, V16, P937, DOI 10.1037/emo0000213; Valdesolo P, 2014, PSYCHOL SCI, V25, P170, DOI 10.1177/0956797613501884; Van Cappellen P, 2012, PSYCHOL RELIG SPIRIT, V4, P223, DOI 10.1037/a0025986; Yaden David B., 2016, PSYCHOL CONSCIOUSNES, V3, P1, DOI 10.1037/cns0000086; Yaden DB, 2017, REV GEN PSYCHOL, V21, P143, DOI 10.1037/gpr0000102	46	21	21	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216780	10.1371/journal.pone.0216780	http://dx.doi.org/10.1371/journal.pone.0216780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31121008	Green Published, gold			2022-12-27	WOS:000468775700027
J	Steenhaut, P; Demeyer, I; Rossi, G; De Raedt, R				Steenhaut, Priska; Demeyer, Ineke; Rossi, Gina; De Raedt, Rudi			The relationship between attentional processing of emotional information and personality: A comparison between older and younger adults	PLOS ONE			English	Article							MINI-MENTAL-STATE; AGE-DIFFERENCES; GAZE; TEMPERAMENT; VALIDATION; DEPRESSION; VALENCE; TRAITS; BIAS	Older adults have been found to focus more on positive and less on negative information compared to younger adults. Yet, results on this attentional positivity effect are inconsistent. Since personality has been related to attentional processing in younger adults, we explored whether (mal) adaptive personality traits are also linked to the occurrence of the positivity effect measured with eye tracking paradigms. We performed two studies with different experimental tasks and recruited for each study 60 community dwelling younger (aged 2450) and 60 older (age 65-91) adults. We found some indication for a positivity effect with a free-viewing task (study 2), but not with a task measuring engagement and disengagement with emotional information (study 1). Although this effect should be interpreted with caution, it corroborates evidence that the positivity effect is more robust in situations without cognitive constraints. No evidence was found for personality traits to be related to the occurrence of the effect. Further research is needed to further clarify conditions that influence older adults' attention for emotional information.	[Steenhaut, Priska; Rossi, Gina] VUB, Dept Clin & Life Span Psychol, Brussels, Belgium; [Steenhaut, Priska; Demeyer, Ineke; De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University	Steenhaut, P (corresponding author), VUB, Dept Clin & Life Span Psychol, Brussels, Belgium.; Steenhaut, P (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.	Priska.Steenhaut@vub.be	Rossi, Gina/K-8355-2012; De Raedt, Rudi/AAL-4093-2021; De Raedt, Rudi/A-3269-2012	Rossi, Gina/0000-0002-6803-9820; De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808	Research Foundation - Flanders (FWO) [11ZV517N]; Psychopathology and Information Processing in Older Adults (PIPO) alliance grant [IV1: I/00125/01]	Research Foundation - Flanders (FWO)(FWO); Psychopathology and Information Processing in Older Adults (PIPO) alliance grant	This research is part of the doctoral project of the first author (S.P.) funded by The Research Foundation - Flanders http://www.fwo.be/(FWO; 11ZV517N). The research was also funded by the Psychopathology and Information Processing in Older Adults (PIPO) alliance grant [IV1: I/00125/01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Borkenau P, 2007, EUR J PERSONALITY, V21, P169, DOI 10.1002/per.613; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Czerwon B, 2011, EXP AGING RES, V37, P503, DOI 10.1080/0361073X.2011.619468; Debast I, 2014, CLIN GERONTOLOGIST, V37, P253, DOI 10.1080/07317115.2014.885917; Demeyer I, 2017, J BEHAV THER EXP PSY, V55, P49, DOI 10.1016/j.jbtep.2016.11.012; Denissen JJA, 2008, J PERS ASSESS, V90, P152, DOI 10.1080/00223890701845229; Derksen J, 2013, MMPI 2 RF HDB ASSESS; English T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00185; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox E., 2011, COGNITIVE METHODS SO, P15; Goeleven E, 2010, AGING MENT HEALTH, V14, P129, DOI 10.1080/13607860903228754; Gomez R, 2002, EUR J PERSONALITY, V16, P333, DOI 10.1002/per.459; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Gross J.J., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Harkness AR, ANN M CAR PSYCH ASS; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Isaacowitz DM, 2008, PSYCHOL SCI, V19, P848, DOI 10.1111/j.1467-9280.2008.02167.x; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; John O.P., 1999, HDB PERSONALITY THEO, V2nd, P102, DOI DOI 10.1037/A0019265; Keltner D., 1996, HDB EMOTION AGING LI, P385, DOI [10.1016/B978-012464995-8/50022-4, DOI 10.1016/B978-012464995-8/50022-4]; Kok R, 2002, GESTANDAARDISEERDE V; Lockenhoff CE, 2007, PSYCHOL AGING, V22, P134, DOI 10.1037/0882-7974.22.1.134; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mauer N, 2007, PERS INDIV DIFFER, V43, P1063, DOI 10.1016/j.paid.2007.02.025; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Nikitin J, 2011, PSYCHOL AGING, V26, P695, DOI 10.1037/a0023281; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Overbeek T., 1999, MINI INT NEUROPSYCHI; Paelecke M, 2012, EUR J PERSONALITY, V26, P111, DOI 10.1002/per.1848; Rammstedt B, 2013, PSYCHOL ASSESSMENT, V25, P1137, DOI 10.1037/a0033323; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Sanchez A, 2013, J ABNORM PSYCHOL, V122, P303, DOI 10.1037/a0031529; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Statistics Belgium, 2016, STATB CIJF; Steinmetz KRM, 2010, PSYCHOL AGING, V25, P239, DOI 10.1037/a0018297; Williams PG, 2009, ANN BEHAV MED, V37, P126, DOI 10.1007/s12160-009-9100-0; World Health Organization, 1992, INT CLASS DIS 10 REV	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217382	10.1371/journal.pone.0217382	http://dx.doi.org/10.1371/journal.pone.0217382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120952	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700095
J	Omony, J; de Jong, A; Kok, J; van Hijum, SAFT				Omony, Jimmy; de Jong, Anne; Kok, Jan; van Hijum, Sacha A. F. T.			Reconstruction and inference of the Lactococcus lactis MG1363 gene co-expression network	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; REGULATORY NETWORKS; MICROARRAY DATA; COMMUNITY STRUCTURE; FUNCTIONAL MODULES; ESCHERICHIA-COLI; EXPRESSION; MODULARITY; REGULON; MODELS	Lactic acid bacteria are Gram-positive bacteria used throughout the world in many industrial applications for their acidification, flavor and texture formation attributes. One of the species, Lactococcus lactis, is employed for the production of fermented milk products like cheese, buttermilk and quark. It ferments lactose to lactic acid and, thus, helps improve the shelf life of the products. Many physiological and transcriptome studies have been performed in L. lactis in order to comprehend and improve its biotechnological assets. Using large amounts of transcriptome data to understand and predict the behavior of biological processes in bacterial or other cell types is a complex task. Gene networks enable predicting gene behavior and function in the context of transcriptionally linked processes. We reconstruct and present the gene co-expression network (GCN) for the most widely studied L. lactis strain, MG1363, using publicly available transcriptome data. Several methods exist to generate and judge the quality of GCNs. Different reconstruction methods lead to networks with varying structural properties, consequently altering gene clusters. We compared the structural properties of the MG1363 GCNs generated by five methods, namely Pearson correlation, Spearman correlation, GeneNet, Weighted Gene Co-expression Network Analysis (WGCNA), and Sparse PArtial Correlation Estimation (SPACE). Using SPACE, we generated an L. lactis MG1363 GCN and assessed its quality using modularity and structural and biological criteria. The L. lactis MG1363 GCN has structural properties similar to those of the gold-standard networks of Escherichia coli K-12 and Bacillus subtilis 168. We showcase that the network can be used to mine for genes with similar expression profiles that are also generally linked to the same biological process.	[Omony, Jimmy; de Jong, Anne; Kok, Jan; van Hijum, Sacha A. F. T.] TIFN, Wageningen, Netherlands; [Omony, Jimmy; de Jong, Anne; Kok, Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands; [van Hijum, Sacha A. F. T.] NIZO, Ede, Netherlands	Top Institute Food & Nutrition; University of Groningen; NIZO Food Research	Kok, J (corresponding author), TIFN, Wageningen, Netherlands.; Kok, J (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands.	Jan.Kok@rug.nl		Omony, Jimmy/0000-0001-9983-1039	TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition	TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition	The research was funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen XH, 2006, BIOINFORMATICS, V22, P2952, DOI 10.1093/bioinformatics/btl491; de Jong A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1834-4; Deijfen M, 2009, PHYSICA A, V388, P4297, DOI 10.1016/j.physa.2009.06.032; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Fu Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-233; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jiang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28422; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Larsen R, 2008, APPL ENVIRON MICROB, V74, P4768, DOI 10.1128/AEM.00117-08; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Michalopoulos Ioannis, 2012, BMC Res Notes, V5, P265, DOI 10.1186/1756-0500-5-265; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Murphy K., 2001, COMPUTING SCI STAT, V33, P1024; Myllymaki P., 2002, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V11, P369, DOI 10.1142/S0218213002000940; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Omony J, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000157; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tran TD, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0771; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Wildenhain J, 2006, IEE P SYST BIOL, V153, P247, DOI 10.1049/ip-syb:20050092; Yang EW, 2013, BIOINFORMATICS, V29, P2153, DOI 10.1093/bioinformatics/btt363; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	56	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0214868	10.1371/journal.pone.0214868	http://dx.doi.org/10.1371/journal.pone.0214868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116749	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400005
J	Tavakoli, F; Ganjalikhany, MR				Tavakoli, Feria; Ganjalikhany, Mohamad Reza			Structure-based inhibitory peptide design targeting peptide-substrate binding site in EGFR tyrosine kinase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ONCOGENIC MUTATIONS; RECEPTOR; SIMULATIONS; COMPLEXES; MECHANISM; INSIGHTS	EGFR (epidermal growth factor receptor) plays the critical roles in the vital cell activities, proliferation, differentiation, migration and survival in response to polypeptide growth factor ligands. Aberrant activation of this receptor has been demonstrated in many human cancers, particularly in non-small cell lung carcinoma (NSCLC). L858R point mutation is the most common oncogenic mutation in EGFR tyrosine kinase domain in patients with EGFR-mutated NSCLC. A feedback inhibitor of EGFR is MIG6 molecule which binds peptide-substrate binding site of the receptor and leads to degradation of activated EGFR. In this in silico study, the peptide-substrate binding site of EGFRL858R mutant has been targeted to inhibit it using molecular docking, MD simulation and MM-PBSA method. Finally, physicochemical properties of the designed peptides have been evaluated. A peptide library was provided composed of 31 peptides which were designed based on the MIG6 structure. The results indicated that, two peptides were able to inhibit EGFRL858R mutant selectively. This computational study could be helpful in designing novel inhibitory peptides to inhibit oncogenic EGFR mutants which do not respond to available EGFR TKIs.	[Tavakoli, Feria; Ganjalikhany, Mohamad Reza] Univ Isfahan, Fac Sci, Dept Biol, Esfahan, Iran	University of Isfahan	Ganjalikhany, MR (corresponding author), Univ Isfahan, Fac Sci, Dept Biol, Esfahan, Iran.	m.ganjalikhany@sci.ui.ac.ir	Ganjalikhany, Mohamad Reza/AAB-7845-2021	Ganjalikhany, Mohamad Reza/0000-0002-6865-0814; Tavakoli, Farial/0000-0003-3537-5534				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Begley MJ, 2015, NAT STRUCT MOL BIOL, V22, P983, DOI 10.1038/nsmb.3117; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Breen ME, 2015, ACS CHEM BIOL, V10, P175, DOI 10.1021/cb5008376; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fanaei-Kahrani Z, 2018, J CELL BIOCHEM, V119, P1780, DOI 10.1002/jcb.26339; Ganjalikhany MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040327; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Jafary F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38854-7; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lagorce D, 2017, BIOINFORMATICS, V33, P3658, DOI 10.1093/bioinformatics/btx491; Lamba V, 2012, CURR PHARM DESIGN, V18, P2936, DOI 10.2174/138161212800672813; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Marqus S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0328-x; Michael N, 2015, NAT STRUCT MOL BIOL, V22, P945, DOI 10.1038/nsmb.3137; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Park E, 2015, NAT STRUCT MOL BIOL, V22, P703, DOI 10.1038/nsmb.3074; Peng YH, 2013, J MED CHEM, V56, P3889, DOI 10.1021/jm400072p; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shirazi AN, 2013, BIOORG MED CHEM LETT, V23, P3230, DOI 10.1016/j.bmcl.2013.03.124; Singh A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21435-5; Sjin RTT, 2014, MOL CANCER THER, V13, P1468, DOI 10.1158/1535-7163.MCT-13-0966; Songtawee N, 2015, J MOL GRAPH MODEL, V58, P16, DOI 10.1016/j.jmgm.2015.03.002; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Yari H, 2015, COMPUT BIOL CHEM, V59, P185, DOI 10.1016/j.compbiolchem.2015.09.013; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhao HT, 2015, EUR J MED CHEM, V91, P4, DOI 10.1016/j.ejmech.2014.08.004	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217031	10.1371/journal.pone.0217031	http://dx.doi.org/10.1371/journal.pone.0217031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116768	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400040
J	Lin, XY; Bai, DP; Wei, ZX; Zhang, Y; Huang, YF; Deng, H; Huang, XH				Lin, Xinyu; Bai, Dingping; Wei, Zixi; Zhang, Ying; Huang, Yifan; Deng, Hui; Huang, Xiaohong			Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway	PLOS ONE			English	Article							HEME OXYGENASE-1; PHASE-2 ENZYMES; HIGH-FAT; NRF2; INDUCTION; APOPTOSIS; CAPACITY	Large-scale breeding environments often lead to oxidative stress. Macrophages play an important role in the immune system and are vulnerable to reactive oxygen species (ROS), which result in macrophage death. Curcumin is the main active component of turmeric and exerts antioxidant effects. Here, we measured the activity of some antioxidant enzymes and chose the Nrf2-Keap1 signaling pathway to study the protective effects of curcumin on macrophages under oxidative stress in vitro. We used RAW264.7 cells as a research model, and oxidative damage was induced by hydrogen peroxide (H2O2). Cell viability was measured by an MTT assay. Flow cytometry was used to measure cellular ROS and apoptosis. The effect of curcumin on Nrf2-Keap1 signaling pathway-related genes was analyzed by qRT-PCR. Furthermore, the translocation of Nrf2 protein was also investigated by Western blot analysis of total and nuclear proteins. All curcumin-treated groups exhibited increased activity of catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSHPX). Low- and middle-dose curcumin decreased malondialdehyde (MDA) and ROS levels, but high-dose curcumin increased MDA and ROS production. We found that low-dose curcumin protected cells from apoptosis, while apoptosis in the middle- and high-dose curcumin-treated groups were stagnant in the early stage. Furthermore, middle-dose curcumin upregulated Nrf2 expression after H2O2 treatment for 4 h. Low- and middle-dose curcumin could activate Nrf2 and promote it to migrate into nuclei. The translocation of Nrf2 to the nucleus to upregulate the expression of haemoxygenase-1 (HO-1) was promoted in the low- and middle-dose curcumin-treated groups. The middle-dose curcumin-treated group also exhibited enhanced expression of glutamate-cysteine ligase, a modifier subunit (GLCM), but inhibited transcription of glutamate-cysteine ligase, a catalytic subunit (GCLC). Curcumin resisted oxidants by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway, which could potentially promote cell survival.	[Lin, Xinyu] Fujian Agr & Forestry Univ, Dept Zool, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Lin, Xinyu; Bai, Dingping; Zhang, Ying; Huang, Yifan; Deng, Hui; Huang, Xiaohong] Fujian Agr & Forestry Univ, Fujian Key Lab Tradit Chinese Vet Med & Anim Hlth, Fuzhou, Fujian, Peoples R China; [Wei, Zixi] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Nanjing Agricultural University	Huang, XH (corresponding author), Fujian Agr & Forestry Univ, Fujian Key Lab Tradit Chinese Vet Med & Anim Hlth, Fuzhou, Fujian, Peoples R China.	xhhuang138@hotmail.com			Discipline Development Grant from the College of Animal Sciences FAFU [2018DK006]; Natural Science Foundation of Fujian Province, China [2017J01598]	Discipline Development Grant from the College of Animal Sciences FAFU; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	This work was supported by a Discipline Development Grant from the College of Animal Sciences FAFU (2018DK006) and Natural Science Foundation of Fujian Province, China (2017J01598).	Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Boyanapalli SSS, 2014, CHEM RES TOXICOL, V27, P2036, DOI 10.1021/tx500234h; Cheng CH, 2015, J THERM BIOL, V53, P172, DOI 10.1016/j.jtherbio.2015.08.002; Cui J, 2012, NUTRITION, V28, P275, DOI 10.1016/j.nut.2011.10.016; Dai PP, 2017, CELL PHYSIOL BIOCHEM, V41, P661, DOI 10.1159/000457945; Daverey A, 2018, BRAIN RES, V1692, P45, DOI 10.1016/j.brainres.2018.05.001; Devaraj S, 2008, METABOLISM, V57, P867, DOI 10.1016/j.metabol.2008.02.016; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 1999, CARCINOGENESIS, V20, P911, DOI 10.1093/carcin/20.5.911; Dinstel R. R., 2013, INT J CIRCUMPOLAR HL, V72; Grom AA, 2010, CURR OPIN RHEUMATOL, V22, P561, DOI 10.1097/01.bor.0000381996.69261.71; Iles KE, 2005, FREE RADICAL BIO MED, V38, P547, DOI 10.1016/j.freeradbiomed.2004.11.012; JOE B, 1994, BBA-MOL CELL RES, V1224, P255, DOI 10.1016/0167-4889(94)90198-8; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Lee MT, 2017, ASIAN AUSTRAL J ANIM, V30, P299, DOI 10.5713/ajas.16.0438; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; McDermott J H, 2000, J Am Pharm Assoc (Wash), V40, P785; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Sikalidis AK, 2014, AMINO ACIDS, V46, P1285, DOI 10.1007/s00726-014-1687-1; Singh PP, 2010, INDIAN J CLIN BIOCHE, V25, P225, DOI 10.1007/s12291-010-0078-y; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304; Zhu W, 2015, DRUG DES DEV THER, V9, P5337, DOI 10.2147/DDDT.S84979; 2012, LIFE SCI, V90, P1027, DOI DOI 10.1016/J.LFS.2012.05.019	29	96	104	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216711	10.1371/journal.pone.0216711	http://dx.doi.org/10.1371/journal.pone.0216711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112588	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000018
J	McKenzie, BA; Wilson, AE; Zohdy, S				McKenzie, Benjamin A.; Wilson, Alan E.; Zohdy, Sarah			Aedes albopictus is a competent vector of Zika virus: A meta-analysis	PLOS ONE			English	Article							SEXUAL TRANSMISSION; DIPTERA-CULICIDAE; FEEDING PATTERNS; AMERICAN STRAINS; GLOBAL RISK; AEGYPTI; MOSQUITOS; NORTH; IDENTIFICATION; CHIKUNGUNYA	Background Much work has been done in recent years to determine the vector competence of Aedes albopictus (Skuse) for Zika virus (ZIKV). If competent, Ae. albopictus could become an important vector in the spread of ZIKV to areas which until now have been considered safe from the virus. Despite much speculation about Ae. albopictus' competence for ZIKV, there have been, to date, no quantitative syntheses of Ae. albopictus' competence, nor have the potentially confounding differences between studies been addressed. Methodology/principle findings This study represents a quantitative meta-analysis of the literature surrounding this topic by examining infection rates (IR) and transmission rates (TR) among sample populations of Ae. albopictus at 7 and 14 days post infection (dpi) across 15 journal articles comprising 23 studies. Our analyses examined potentially confounding variables in the studies contained therein, including: geographic origin of viral strain or mosquito population tested, whether sympatry of the tested viral strain and mosquito population was important, and freshness of blood meal. Our results suggest 1) Ae albopictus is a competent vector for ZIKV and 2) that origin of Ae. albopictus population and origin of viral strain had significant effects on the competence of Ae. albopictus to transmit ZIKV. Conclusions/significance These results indicate a need to further explore the effects of methodology on vector competence studies and to examine in more detail the geographic variation in the competence of Ae. albopictus for ZIKV as well as the underlying causes of said variation. The ability of Ae. albopictus to carry and transmit ZIKV also points to a need to create new vector control strategies in case of a ZIKV outbreak in an area where Ae. albopictus is prominent. Finally, this study represents a potential template for future meta-analyses in the field of vector competence, where this type of study has been under-utilized despite the abundance of relevant studies.	[McKenzie, Benjamin A.; Zohdy, Sarah] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Wilson, Alan E.] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Zohdy, Sarah] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	McKenzie, BA; Zohdy, S (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.; Zohdy, S (corresponding author), Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA.	bam0073@auburn.edu; zohdy@auburn.edu		McKenzie, Benjamin/0000-0001-5525-0646; Wilson, Alan/0000-0003-1080-0354; Zohdy, Sarah/0000-0001-5316-0567	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding was provided by the United States Department of Agriculture to AW and SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333; [Anonymous], 2014, CDC; Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6; Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Christophers, 1960, AEDES AEGYPTI L YELL; Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Di Luca M, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.18.30223, DOI 10.2807/1560-7917.ES.2016.21.18.30223]; Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duchemin JB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0772-y; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056; Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102; Egger M., 2001, SYSTEMATIC REV HLTH, V2nd ed., P23, DOI DOI 10.1002/9780470693926.CH2; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599; Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487; Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6; Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59; Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302; Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102; Haddad N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-300; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901; Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57; Kim KS, 2009, J MED ENTOMOL, V46, P1230, DOI 10.1603/033.046.0535; Knecht H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030067; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188; Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528; Lozano-Fuentes S, 2019, J MED ENTOMOL, V56, P233, DOI 10.1093/jme/tjy114; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087; Oehler E, 2014, Euro Surveill, V19; Oliveira ARS, 2018, AM J TROP MED HYG, V98, P883, DOI 10.4269/ajtmh.17-0622; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]; Pick J.L., 2018, REPRODUCIBLE FLEXIBL, P1, DOI [10.1101/247775, DOI 10.1101/247775]; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024; Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Richards SL, 2017, RES REP TROP MED, V8, P53, DOI 10.2147/RRTM.S133411; Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484; Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384; Sardelis MR, 2002, J AM MOSQUITO CONTR, V18, P284; Silva GS, 2018, J CRIT CARE, V46, P106, DOI 10.1016/j.jcrc.2018.03.030; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546; Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350; Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007; Vazeille M, 2018, MED VET ENTOMOL, V32, P251, DOI 10.1111/mve.12284; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; World Health Organization, VECT BORN DIS; Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548; 2014, J VIROL, V88, P6294, DOI DOI 10.1128/JVI.00370-14; 2016, NEW ENGL J MED, V374, P951, DOI DOI 10.1056/NEJMOA1600651; 2003, ADV VIRUS RES, V59, P315, DOI DOI 10.1016/S0065-3527(03)	88	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216794	10.1371/journal.pone.0216794	http://dx.doi.org/10.1371/journal.pone.0216794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112569	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000024
J	Senthilkumaran, M; Nazari, G; MacDermid, JC; Roche, K; Sopko, K				Senthilkumaran, Maya; Nazari, Goris; MacDermid, Joy C.; Roche, Karen; Sopko, Kim			Effectiveness of home fire safety interventions. A systematic review and meta-analysis	PLOS ONE			English	Review							QUALITY; RISK; KNOWLEDGE; TRIAL; INJURIES; CHILDREN; DEATHS	Purpose To assess the effectiveness of Home Fire Safety (HFS) interventions versus other interventions/no interventions/controls on HFS knowledge and behaviour at short-, intermediate- and long-term follow ups. Design Systematic review and meta-analysis of randomized controlled trials. Data sources MEDLINE, EMBASE and PubMed databases were searched from January 1998 to July 2018, and studies retrieved. Participants Toddlers, children (primary or secondary school), teenagers or adults. Interventions/Comparison HFS interventions compared to other interventions / no interventions / controls. Outcomes HFS knowledge and behaviour. Results 10 studies were identified (8 RCTs and 2 prospective cohort). Two studies assessed the effects of HFS interventions vs no interventions on HFS knowledge at up to 4 months follow up in school children and demonstrated significant difference between groups (very low quality, 2 RCTs, 535 participants, SMD 0.38, 95% CI: 0.21 to 0.55, p < 0.001). One study examined the effects of different modes of HFS interventions (computer-based vs instructor-led) on HFS knowledge and behaviour immediately post-intervention in adults and displayed no significant difference between groups (HFS knowledge; very low quality, 1 RCT, 68 participants, SMD -0.02, 95% CI: -0.50 to 0.45, p = 0.92) and (HFS behaviour; very low quality, 1 RCT, 68 participants, SMD 0.06, 95% CI: -0.41 to 0.54, p = 0.79) respectively. Conclusion The limited evidence supports the use of HFS interventions to improve HFS knowledge and behaviour in children, families with children and adults.	[Senthilkumaran, Maya] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Nazari, Goris; MacDermid, Joy C.] Western Univ, Sch Phys Therapy Hlth & Rehabil Sci, London, ON, Canada; [Nazari, Goris; MacDermid, Joy C.] Western Univ, Bone & Joint Inst, Collaborat Program Musculoskeletal Hlth Res, London, ON, Canada; [MacDermid, Joy C.] St Josephs Hosp, Roth McFarlane Hand & Upper Limb Ctr, London, ON, Canada; [Roche, Karen; Sopko, Kim] Burlington Fire Dept, Burlington, ON, Canada	McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario)	Nazari, G (corresponding author), Western Univ, Sch Phys Therapy Hlth & Rehabil Sci, London, ON, Canada.; Nazari, G (corresponding author), Western Univ, Bone & Joint Inst, Collaborat Program Musculoskeletal Hlth Res, London, ON, Canada.	gnazari@uwo.ca	MacDermid, Joy C/H-7837-2013	MacDermid, Joy C/0000-0001-9311-7379				Ahrens M., 2021, HOME STRUCTURE FIRES; Alsubheen SA, 2019, ARCH PHYS MED REHAB, V100, P350, DOI 10.1016/j.apmr.2018.08.181; Bobos P, 2019, J HAND THER, V32, P194, DOI 10.1016/j.jht.2018.09.012; Cooper NJ, 2012, EPIDEMIOL REV, V34, P32, DOI 10.1093/epirev/mxr015; Deave T, 2016, INJURY PREV, V22, pA44, DOI 10.1136/injuryprev-2016-042156.119; Deave T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172584; Diekman ST, 2008, INJURY PREV, V14, P228, DOI 10.1136/ip.2007.017004; DiGuiseppi C, 2000, Inj Prev, V6, P250, DOI 10.1136/ip.6.4.250; DiGuiseppi C, 2000, ARCH DIS CHILD, V82, P341, DOI 10.1136/adc.82.5.341; DiGuiseppi C., 2001, COCHRANE DB SYST REV, V2001, DOI [10.1002/14651858.CD002246, DOI 10.1002/14651858.CD002246]; Gaught P, 2016, FIRE STAT ENGLAND; Gilbert SW, 2017, INJ PREV; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Harrington Susan S, 2003, J Nurses Staff Dev, V19, P147, DOI 10.1097/00124645-200305000-00007; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hwang V, 2006, INJURY PREV, V12, P344, DOI 10.1136/ip.2005.011197; Istre GR, 2002, INJ PREV, V8, P128, DOI 10.1136/ip.8.2.128; Johnston B D, 2000, Inj Prev, V6, P305, DOI 10.1136/ip.6.4.305; Kendrick D, 2007, INJURY PREV, V13, P93, DOI 10.1136/ip.2006.013862; Lamb R, 2006, INJURY PREV, V12, P161, DOI 10.1136/ip.2005.010769; Lehna C, 2014, BURNS, V40, P1179, DOI 10.1016/j.burns.2013.12.019; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Morrongiello BA, 2012, HEALTH PSYCHOL, V31, P496, DOI 10.1037/a0027779; Muller MJ, 2013, J TRAUMA ACUTE CARE, V74, P652, DOI 10.1097/TA.0b013e31827d5f42; Nazari G, 2019, ARCH PHYS MED REHAB, V100, P1726, DOI 10.1016/j.apmr.2019.01.017; Nazari G, 2018, BMC SPORTS SCI MED R, V10, DOI 10.1186/s13102-018-0094-4; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Omaki E, 2017, INJURY PREV, V23, P58, DOI 10.1136/injuryprev-2016-042161; Posner JC, 2004, PEDIATRICS, V113, P1603, DOI 10.1542/peds.113.6.1603; Schachterle SE, 2012, INJURY PREV, V18, P98, DOI 10.1136/injuryprev-2011-040022; Turner S, 2010, INJURY PREV, V16, pA63, DOI 10.1136/ip.2010.029215.230; Turner SL, 2017, INJURY PREV, V23, P131, DOI 10.1136/injuryprev-2016-042174; Wang Y, 2018, INJURY PREV, V24, P41, DOI 10.1136/injuryprev-2016-042178; Warda L, 1999, Inj Prev, V5, P145; Warda L, 1999, Inj Prev, V5, P217	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0215724	10.1371/journal.pone.0215724	http://dx.doi.org/10.1371/journal.pone.0215724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107902	Green Submitted, gold, Green Published			2022-12-27	WOS:000468285200003
J	Lakes, KD; Vaughan, J; Radom-Aizik, S; Lucas, CT; Stehli, A; Cooper, D				Lakes, Kimberley D.; Vaughan, Jessica; Radom-Aizik, Shlomit; Lucas, Candice Taylor; Stehli, Annamarie; Cooper, Dan			Development of the Parent Perceptions of Physical Activity Scale (PPPAS): Results from two studies with parents of infants and toddlers	PLOS ONE			English	Article								Physical activity (PA) is important from birth to promote health and motor development. Parents of young children are gatekeepers of opportunities for PA, yet little is known about their perceptions of PA. We describe the development of the Parent Perceptions of Physical Activity Scale (PPPAS) across two studies (N = 241 parents). In Study 1, 143 parents of infants and toddlers recruited from neonatal intensive care units (NICUs) and childcare centers completed a 48-item PPPAS. In Study 2, 98 parents of premature infants completed the revised 34-item PPPAS. Study 1 principal components analysis (PCA) identified three components (benefits of, barriers to, and perceived influence on PA), and the scale was reduced. Scores for Perceived Barriers to PA were significantly different between groups, U = 1,108, z = -4.777, p <.0001, with NICU parents reporting more barriers to PA than childcare parents. In Study 2, PCA revealed the same components, and the scale was further reduced to 25 items. Three subscales measuring perceived benefits of, barriers to, and influence over an infant's PA produced Cronbach's alphas of .93,.85,.81, respectively. Results demonstrated sufficient construct validity and internal consistency of PPPAS scores, supporting its use in future PA research.	[Lakes, Kimberley D.] Univ Calif Riverside, Sch Med, Dept Psychiat & Neurosci, Riverside, CA 92521 USA; [Lakes, Kimberley D.; Vaughan, Jessica; Radom-Aizik, Shlomit; Lucas, Candice Taylor; Stehli, Annamarie; Cooper, Dan] Univ Calif Irvine, Dept Pediat, Pediat Exercise & Genom Res Ctr PERC, Irvine, CA 92717 USA; [Vaughan, Jessica] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of California System; University of California Riverside; University of California System; University of California Irvine; Children's Hospital Los Angeles	Lakes, KD (corresponding author), Univ Calif Riverside, Sch Med, Dept Psychiat & Neurosci, Riverside, CA 92521 USA.; Lakes, KD (corresponding author), Univ Calif Irvine, Dept Pediat, Pediat Exercise & Genom Res Ctr PERC, Irvine, CA 92717 USA.	klakes@medsch.ucr.edu	Cooper, Dan/AAA-6699-2022	Lakes, Kimberley/0000-0003-3698-274X	National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000153]; National Heart Lung and Blood Institute, National Institutes of Health [RO1 HL110163NIH]; National Institutes of Health [L60 MD002127]; Memorial Care Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110163] Funding Source: NIH RePORTER	National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health; National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Care Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153, National Heart Lung and Blood Institute, National Institutes of Health, through RO1 HL110163NIH, National Institutes of Health, through L60 MD002127 and the Memorial Care Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153, National Heart Lung and Blood Institute, National Institutes of Health, through RO1 HL110163NIH, National Institutes of Health, through L60 MD002127 and the Memorial Care Foundation.	Alderman BL, 2010, J PHYS ACT HEALTH, V7, P60, DOI 10.1123/jpah.7.1.60; American Academy of Pediatrics, 2002, CAR OUR CHILDR NAT H; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clark JE, 2002, ACT START STAT PHYS, P304; Gravern D, 2009, JOGNN-J OBST GYN NEO, V38, P527, DOI 10.1111/j.1552-6909.2009.01055.x; Ho M, 2012, PEDIATRICS; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Laerd Statistics, 2015, PRINC COMP AN PCA US; McQueen D, 2013, J PERINAT NEONAT NUR, V27, P184, DOI 10.1097/JPN.0b013e31828b244a; Olshansky Ellen, 2012, Int J Educ Psychol Assess, V10, P36; Patrick K, 2001, BRIGHT FUTURES PRACT; Ponterotto JG, 2007, PERCEPT MOTOR SKILL, V105, P997, DOI 10.2466/PMS.105.3.997-1014; Saunders RP, 1997, PREV MED, V26, P241, DOI 10.1006/pmed.1996.0134; Shea Catherine, 2010, Can J Diet Pract Res, V71, pe87, DOI 10.3148/71.3.2010.e87; Thurstone LL, MULTIPLE FACTOR ANAL; Zecevic CA, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/468526; Zhao J, 2013, FAM COMMUNITY HEALTH, V36, P77, DOI 10.1097/FCH.0b013e31826d7601	20	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0213570	10.1371/journal.pone.0213570	http://dx.doi.org/10.1371/journal.pone.0213570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141511	gold, Green Submitted, Green Published			2022-12-27	WOS:000469323000002
J	Ben Gibson, C; Buchler, N; Hoffman, B; La Fleur, CG				Ben Gibson, C.; Buchler, Norbou; Hoffman, Blaine; La Fleur, Claire-Genevieve			Participation shifts explain degree distributions in a human communications network	PLOS ONE			English	Article							MODELS	Human interpersonal communications drive political, technological, and economic systems, placing importance on network link prediction as a fundamental problem of the sciences. These systems are often described at the network-level by degree counts -the number of communication links associated with individuals in the network-that often follow approximate Pareto distributions, a divergence from Poisson-distributed counts associated with random chance. A defining challenge is to understand the inter-personal dynamics that give rise to such heavy-tailed degree distributions at the network-level; primarily, these distributions are explained by preferential attachment, which, under certain conditions, can create power law distributions; preferential attachment's prediction of these distributions breaks down, however, in conditions with no network growth. Analysis of an organization's email network suggests that these degree distributions may be caused by the existence of individual participation-shift dynamics that are necessary for coherent communication between humans. We find that the email network's degree distribution is best explained by turn-taking and turn-continuing norms present in most social network communication. We thus describe a mechanism to explain a long-tailed degree distribution in conditions with no network growth.	[Ben Gibson, C.; Buchler, Norbou; Hoffman, Blaine; La Fleur, Claire-Genevieve] Army Res Lab, Aberdeen, MD 21005 USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Ben Gibson, C (corresponding author), Army Res Lab, Aberdeen, MD 21005 USA.	charles.b.gibson18.ctr@mail.mil		Gibson, C. Ben/0000-0003-2561-9574				[Anonymous], 2010, COMPLEX WEBS ANTICIP; Barabasi A.-L., 2016, NETWORK SCI; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Buchler N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02133; Butts C.T., 2010, RELEVANT R PACKAGE V, P1; Butts CT, 2008, SOCIOL METHODOL, V38, P155, DOI 10.1111/j.1467-9531.2008.00203.x; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; DuBois C., 2013, P 16 INT C ARTIFICIA, P238; Gardner L., 2010, HDB SOCIAL PSYCHOL; Gelman, 2010, PHYS TODAY, V63, P46, DOI 10.1063/1.3431332; Gibson DR, 2005, AM J SOCIOL, V110, P1561, DOI 10.1086/428689; Gibson DR, 2003, SOC FORCES, V81, P1335, DOI 10.1353/sof.2003.0055; Hamilton DT, 2015, EPIDEMICS-NETH, V11, P56, DOI 10.1016/j.epidem.2015.02.003; Hanneke S, 2010, ELECTRON J STAT, V4, P585, DOI 10.1214/09-EJS548; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MAYHEW BH, 1984, J MATH SOCIOL, V9, P259, DOI 10.1080/0022250X.1984.9989948; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137796; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Sacks H. H., 1978, STUDIES ORG CONVERSA, P7, DOI DOI 10.1016/B978-0-12-623550-0.50008-2; SCHEGLOFF EA, 1992, AM J SOCIOL, V97, P1295, DOI 10.1086/229903; SIMON HA, 1955, BIOMETRIKA, V42, P425; Zhou T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046141	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217240	10.1371/journal.pone.0217240	http://dx.doi.org/10.1371/journal.pone.0217240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120969	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700075
J	Takheaw, N; Earwong, P; Laopajon, W; Pata, S; Kasinrerk, W				Takheaw, Nuchjira; Earwong, Papawadee; Laopajon, Witida; Pata, Supansa; Kasinrerk, Watchara			Interaction of CD99 and its ligand upregulates IL-6 and TNF-alpha upon T cell activation	PLOS ONE			English	Article							CO-STIMULATION; HLA-DR; ENGAGEMENT; EXPRESSION; RECEPTOR; ANTIGEN; MOLECULE; CONTACT; SURFACE; ADHESION	CD99 has been reported to be involved in T cell regulation. CD99 ligand involvement in the regulation of T cell activation has been postulated. In this study, recombinant CD99 proteins were produced and used as a tool for determining the role of CD99 and its ligand interaction. Recombinant CD99 proteins induced the upregulation of IL-6 and TNF-alpha expression, but not IFN-gamma, in anti-CD3 monoclonal antibody activated T cells. The cytokine alteration was not observed in unstimulated T cells indicating the cytokine upregulation required the signal from T cell activation. The upregulation of IL-6 and TNF-alpha was, in addition, observed in CD3(-) mononuclear cell population including monocytes and NK cells. The recombinant CD99 proteins, however, did not affect either CD25, CD69 or MHC class II expression or T cell proliferation, upon T cell activation. The CD99 ligands were demonstrated to be expressed on monocytes, NK cells and dendritic cells, but not on B and T cells. Our results indicated the presence of CD99 ligands on leukocyte surface. Interaction between CD99 and its ligands involves the regulation of cytokine production.	[Takheaw, Nuchjira; Earwong, Papawadee; Laopajon, Witida; Pata, Supansa; Kasinrerk, Watchara] Chiang Mai Univ, Fac Associated Med Sci, Div Clin Immunol, Dept Med Technol, Chiang Mai, Thailand; [Laopajon, Witida; Pata, Supansa; Kasinrerk, Watchara] Chiang Mai Univ, Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Biomed Technol Res Ctr,Fac Associated Med Sci, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Pata, S (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Div Clin Immunol, Dept Med Technol, Chiang Mai, Thailand.; Pata, S (corresponding author), Chiang Mai Univ, Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Biomed Technol Res Ctr,Fac Associated Med Sci, Chiang Mai, Thailand.	supansa_pata@hotmail.com		Takheaw, Nuchjira/0000-0002-7239-9482	TRF [RTA5980007]; Thailand Office of Higher Education Commission [MRG6080269, MRG6180253]; Chiang Mai University under the CMU Center of Excellence Project; Graduate school, Chiang Mai University; Royal Golden Jubilee Ph.D. program [PHD/0121/2557]	TRF(Thailand Research Fund (TRF)); Thailand Office of Higher Education Commission; Chiang Mai University under the CMU Center of Excellence Project; Graduate school, Chiang Mai University; Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF))	This work was supported by the TRF and the Thailand Office of Higher Education Commission [Grant numbers MRG6080269] to SP; the TRF and the Thailand Office of Higher Education Commission [Grant numbers MRG6180253] to WL; the TRF Senior Research Scholar [Grant number RTA5980007] to WK. The study was also partially supported by Chiang Mai University under the CMU Center of Excellence Project. PE obtained Teaching Assistant/Research Assistant (TA/RA) Scholarship supported by Graduate school, Chiang Mai University. NT is a doctoral candidate of the Royal Golden Jubilee Ph.D. program [Grant number PHD/0121/2557]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti I, 2002, FASEB J, V16, P1946, DOI 10.1096/fj.02-0049fje; AUBRIT F, 1989, EUR J IMMUNOL, V19, P1431, DOI 10.1002/eji.1830190813; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; BERNARD A, 1988, J IMMUNOL, V140, P1802; Bremond A, 2009, BLOOD, V113, P347, DOI 10.1182/blood-2008-02-137745; Brennan FM, 2002, ARTHRITIS RES THER, V4, pS177, DOI 10.1186/ar556; Brennan FM, 2006, CURR TOP MICROBIOL, V305, P177, DOI 10.1007/3-540-29714-6_9; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choi FY, 1998, J IMMUNOL, V161, P749; Dufour EM, 2008, CELL COMMUN ADHES, V15, P351, DOI 10.1080/15419060802442191; Dumont J, 2016, CRIT REV BIOTECHNOL, V36, P1110, DOI 10.3109/07388551.2015.1084266; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; EFFROS RB, 1983, HUM IMMUNOL, V8, P249, DOI 10.1016/0198-8859(83)90051-4; Feigerlova E, 2017, CYTOKINE GROWTH F R, V37, P57, DOI 10.1016/j.cytogfr.2017.03.003; Ferenczi K, 2000, J AUTOIMMUN, V14, P63, DOI 10.1006/jaut.1999.0343; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Gil M, 2015, IMMUNE NETW, V15, P260, DOI 10.4110/in.2015.15.5.260; Gizinski AM, 2010, BEST PRACT RES CL RH, V24, P463, DOI 10.1016/j.berh.2009.12.015; Grosso Joseph F, 2013, Cancer Immun, V13, P5; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Huang X, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-22; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kannicht C, 2013, THROMB RES, V131, P78, DOI 10.1016/j.thromres.2012.09.011; KASINRERK W, 1992, J IMMUNOL, V149, P847; Kasinrerk W, 2000, IMMUNOL LETT, V71, P33, DOI 10.1016/S0165-2478(99)00165-0; Khunkaewla P, 2007, HYBRIDOMA, V26, P241, DOI 10.1089/hyb.2007.0504; Koch C, 1999, INT IMMUNOL, V11, P777, DOI 10.1093/intimm/11.5.777; Krisanaprakornkit S, 2013, ARCH ORAL BIOL, V58, P82, DOI 10.1016/j.archoralbio.2012.06.011; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Llombart-Bosch A, 2009, VIRCHOWS ARCH, V455, P397, DOI 10.1007/s00428-009-0842-7; Manara MC, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030159; MANIE S, 1993, EUR CYTOKINE NETW, V4, P7; Oh KI, 2007, EXP MOL MED, V39, P176, DOI 10.1038/emm.2007.20; Oranger A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/156787; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park CK, 1999, J KOREAN MED SCI, V14, P600, DOI 10.3346/jkms.1999.14.6.600; Pasello M, 2018, J CELL COMMUN SIGNAL, V12, P55, DOI 10.1007/s12079-017-0445-z; Pata S, 2018, JAMS, V51, P85; Pata Supansa, 2011, BMC Res Notes, V4, P293, DOI 10.1186/1756-0500-4-293; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Seol Ho Jun, 2012, Genes Cancer, V3, P535, DOI 10.1177/1947601912473603; Shatrova AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167215; Sohn HW, 1998, AM J PATHOL, V153, P1937, DOI 10.1016/S0002-9440(10)65707-0; Suzuki M, 2017, ALLERGOL INT, V66, P351, DOI 10.1016/j.alit.2016.08.014; TESTI R, 1989, J IMMUNOL, V143, P1123; Vallon M, 2018, CELL REP, V25, P339, DOI 10.1016/j.celrep.2018.09.045; Waclavicek M, 1998, J IMMUNOL, V161, P4671; WAGNER DH, 1994, EUR J IMMUNOL, V24, P3148, DOI 10.1002/eji.1830241235; Watson RL, 2015, J EXP MED, V212, P1021, DOI 10.1084/jem.20150354; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yoon SS, 2004, MOL CELLS, V18, P186	57	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217393	10.1371/journal.pone.0217393	http://dx.doi.org/10.1371/journal.pone.0217393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120992	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700098
J	Olsen, NL; Herren, P; Markussen, B; Jensen, AB; Eilenberg, J				Olsen, Niels Lundtorp; Herren, Pascal; Markussen, Bo; Jensen, Annette Bruun; Eilenberg, Jorgen			Statistical modelling of conidial discharge of entomophthoralean fungi using a newly discovered Pandora species	PLOS ONE			English	Article							SPORULATION; PATHOGEN; TEMPERATURES; PERSISTENCE; GERMINATION; HOMOPTERA; CONSTANT; CADAVERS	Entomophthoralean fungi are insect pathogenic fungi and are characterized by their active discharge of infective conidia that infect insects. Our aim was to study the effects of temperature on the discharge and to characterize the variation in the associated temporal pattern of a newly discovered Pandora species with focus on peak location and shape of the discharge. Mycelia were incubated at various temperatures in darkness, and conidial discharge was measured over time. We used a novel modification of a statistical model (pavpop), that simultaneously estimates phase and amplitude effects, into a setting of generalized linear models. This model is used to test hypotheses of peak location and discharge of conidia. The statistical analysis showed that high temperature leads to an early and fast decreasing peak, whereas there were no significant differences in total number of discharged conidia. Using the proposed model we also quantified the biological variation in the timing of the peak location at a fixed temperature.	[Olsen, Niels Lundtorp; Markussen, Bo] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Herren, Pascal; Jensen, Annette Bruun; Eilenberg, Jorgen] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Olsen, NL (corresponding author), Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.	niels.olsen@math.ku.dk	Markussen, Bo/M-2161-2014; Eilenberg, Jorgen/F-7444-2014; Jensen, Annette Bruun/AAH-1732-2021; Olsen, Niels/G-5061-2015	Markussen, Bo/0000-0001-7793-9620; Eilenberg, Jorgen/0000-0002-9273-5252; Jensen, Annette Bruun/0000-0002-2044-2274; Olsen, Niels/0000-0002-4597-3952; Herren, Pascal/0000-0002-8358-9636				AOKI J, 1981, APPL ENTOMOL ZOOL, V16, P216, DOI 10.1303/aez.16.216; Boomsma JJ, 2014, ANNU REV ENTOMOL, V59, P467, DOI 10.1146/annurev-ento-011613-162054; EILENBERG J, 1987, ENTOMOPHAGA, V32, P425, DOI 10.1007/BF02372452; Eilenberg J, J INVERTEBRATE PATHO, V19; Friedman Jerome, 2009, ELEMENTS STAT LEARNI, V2nd; Furlong MJ, 1997, J INVERTEBR PATHOL, V69, P223, DOI 10.1006/jipa.1996.4649; Hajek A. E., 2018, ECOLOGY INVERTEBRATE; Hajek AE, 2002, J INVERTEBR PATHOL, V79, P37, DOI 10.1016/S0022-2011(02)00010-1; Hajek AE, 2018, NATURAL ENEMIES INTR, V2nd, DOI DOI 10.1017/9781107280267; Hajek AE, 2012, MANUAL TECHNIQUES IN, P285, DOI DOI 10.1016/B978-0-12-386899-2.00009-9; Hemmati F, 2001, MYCOL RES, V105, P715, DOI 10.1017/S0953756201004014; Herren P., 2018, THESIS; Hesketh H, 2010, BIOCONTROL, V55, P55, DOI 10.1007/s10526-009-9249-2; Holtslag QA, 2004, CAN J PLANT PATHOL, V26, P304; Jensen A., 2017, THESIS; Kalsbeek V, 2001, J INVERTEBR PATHOL, V77, P149, DOI 10.1006/jipa.2001.5012; Li W, 2006, BIOCONTROL SCI TECHN, V16, P647, DOI 10.1080/09583150500532840; Money Nicholas P., 2016, P67, DOI 10.1016/B978-0-12-382034-1.00003-7; Olsen NL, 2018, J R STAT SOC C-APPL, V67, P1147, DOI 10.1111/rssc.12276; Patel A., 2015, ENTWICKLUNG NEUARTIG; Raket LL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005092; Raket LL, 2014, PATTERN RECOGN LETT, V38, P1, DOI 10.1016/j.patrec.2013.10.018; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ronn BB, 2001, J ROY STAT SOC B, V63, P243, DOI 10.1111/1467-9868.00283; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Shah PA, 2002, ENTOMOL EXP APPL, V103, P257, DOI 10.1023/A:1021137227931; Strauss E, 2009, SCIENCE, V325, P388, DOI 10.1126/science.325_388; Wraight SP, 2003, BIOL CONTROL, V28, P60, DOI 10.1016/S1049-9644(03)00035-5; Yeo H, 1998, P NZ PLANT PROT C, P47; YU Z, 1995, ENVIRON ENTOMOL, V24, P962, DOI 10.1093/ee/24.4.962; Zhou X, 2014, MYCOSCIENCE, V55, P21, DOI 10.1016/j.myc.2013.03.005	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215914	10.1371/journal.pone.0215914	http://dx.doi.org/10.1371/journal.pone.0215914			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116738	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400012
J	Wang, CC; Shen, MY; Chang, KC; Wang, GJ; Liu, SH; Chang, CT				Wang, Chun-Cheng; Shen, Ming-Yi; Chang, Kuan-Cheng; Wang, Guei-Jane; Liu, Shu-Hui; Chang, Chiz-Tzung			Skin autofluorescence is associated with rapid renal function decline in subjects at increased risk of coronary artery disease	PLOS ONE			English	Article							KIDNEY-FUNCTION DECLINE; GLYCATION END-PRODUCTS; PULSE PRESSURE; STIFFNESS; INJURY	Skin autofluorescence (AF) has been validated as a tool for estimating tissue advanced glycation end products (AGEs) accumulation and predicting long-term cardiovascular outcomes. However, whether measurements of skin AF could predict renal function decline remains controversial. From April, 2014 to April, 2015, we enrolled 245 subjects with at least two conventional risk factors for coronary artery disease (CAD). All were measured for body height and weight, blood pressure, plasma creatinine level, and skin AF at the start of the study. Baseline demographics and laboratory tests data were obtained by chart reviews and patient interviews. Serial plasma creatinine levels were followed regularly every 6-12 months for 2 years. In a stepwise multivariate linear regression analysis, skin AF, was an independent factor for predicting the relative renal function decline rate after adjustment of multiple covariates (beta = -0.036 +/- 0.016; p = 0.03). Subgroups analysis revealed that skin AF was a significant factor for relative renal function decline rate in subgroups of age < 65 years (beta = -0.068 +/- 0.024; p = 0.02), male sex (beta = -0.053 +/- 0.016; p<0.01), body mass index >= 25 Kg/m(2) (beta = -0.042 +/- 0.021; p = 0.04), and estimated glomerular filtration rate >= 60 ml/min/1.73m(2) (beta = -0.043 +/- 0.020; p = 0.04). However, only an interaction between skin AF and age attained significance (p for interaction = 0.04). Skin AF is a useful predictor for renal function decline in patients at increased risk of CAD.	[Wang, Chun-Cheng; Shen, Ming-Yi; Chang, Kuan-Cheng; Wang, Guei-Jane; Chang, Chiz-Tzung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Chun-Cheng; Chang, Kuan-Cheng] China Med Univ Hosp, Dept Internal Med, Div Cardiovasc Med, Taichung, Taiwan; [Wang, Chun-Cheng; Shen, Ming-Yi; Chang, Kuan-Cheng; Liu, Shu-Hui; Chang, Chiz-Tzung] China Med Univ Hosp, Cardiovasc Res Lab, Taichung, Taiwan; [Chang, Kuan-Cheng; Chang, Chiz-Tzung] China Med Univ, Coll Med, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CT (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ Hosp, Cardiovasc Res Lab, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ, Coll Med, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan.	d19863@mail.cmuh.org.tw	Shen, Ming-Yi/L-6861-2019	Shen, Ming-Yi/0000-0002-9351-1912	China Medical University Hospital [DMR-107-012]	China Medical University Hospital	CCW currently received a grant (DMR-107-012) from China Medical University Hospital. There was no additional external funding received for this study.	Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; de Vos LC, 2014, ARTERIOSCL THROM VAS, V34, P933, DOI 10.1161/ATVBAHA.113.302731; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Georgianos PI, 2015, AM J HYPERTENS, V28, P958, DOI 10.1093/ajh/hpv004; Gerrits EG, 2008, DIABETES CARE, V31, P517, DOI 10.2337/dc07-1755; Gosse P, 2009, J HYPERTENS, V27, P1303, DOI 10.1097/HJH.0b013e32832a5ab3; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lazzeri Chiara, 2011, Int J Nephrol, V2011, P634903, DOI 10.4061/2011/634903; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mureddu GF, 2001, J HYPERTENS, V19, P1113; Peralta CA, 2012, AM J KIDNEY DIS, V59, P41, DOI 10.1053/j.ajkd.2011.08.015; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Polonia J, 2017, VASC HEALTH RISK MAN, V13, P231, DOI 10.2147/VHRM.S135253; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Sedaghat S, 2015, CLIN J AM SOC NEPHRO, V10, P2190, DOI 10.2215/CJN.03000315; Soro-Paavonen A, 2012, J HYPERTENS, V8, P780; Striker LJ, 1996, NEPHROL DIAL TRANSPL, V11, P62; Tanaka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083799; Tanaka K, 2010, THER APHER DIAL, V14, P334, DOI 10.1111/j.1744-9987.2009.00782.x; Tomiyama H, 2015, INTERNAL MED, V54, P1465, DOI 10.2169/internalmedicine.54.4502; U. S. Renal Data system, 2015, USRDS2013 ANN DAT RE, V4, P2; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wang CC, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0495-9; Wang C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151633, 10.1371/journal.pone.0148017]; Young BA, 2016, AM J KIDNEY DIS, V68, P229, DOI 10.1053/j.ajkd.2016.02.046; Zhou LL, 2012, KIDNEY INT, V82, P759, DOI 10.1038/ki.2012.184; Zieman Susan, 2004, Congest Heart Fail, V10, P144, DOI 10.1111/j.1527-5299.2004.03223.x	30	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217203	10.1371/journal.pone.0217203	http://dx.doi.org/10.1371/journal.pone.0217203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116778	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400051
J	Kim, HW; Kim, DH; Kim, YH; Lee, EJ; Kang, SY; Lee, DB; Kim, Y				Kim, Hae Won; Kim, Duck Hee; Kim, Yeon Hee; Lee, Eun Ju; Kang, Saem Yi; Lee, Da Bit; Kim, Youngji			Clinical nurses' awareness and caring experiences for patients with cervical cancer: A qualitative study	PLOS ONE			English	Article							ATTITUDES; CARE; KNOWLEDGE	To determine the degree to which nurses are aware of cervical cancer and to describe nurses' experiences of caring for patients with cervical cancer. To promote quality of nursing care of cervical cancer, we need to explore their perceptions and nursing experience in doing cervical-cancer care. This study was a qualitative descriptive design. Interviews were conducted with 14 registered nurses. The interviews were audiotaped, transcribed and analyzed. Content analysis was performed. Fourteen nurses who had been working at wards and cancer education centers were recruited in this study. Nine key themes emerged from three categories such as nurses' awareness of cervical cancer, awareness of cervical cancer patient and caring experience. Nurses expressed fear of cervical cancer and helplessness in the face of a life-threatening prognosis. Nurses stated that they might have prejudice about cervical cancer, since it is caused by a sexually transmitted disease. They also recalled that patients with cervical cancer were more sensitive and demanding. Our findings provide a comprehensive and in-depth perspective in understanding the experience of caring for cervical cancer patients. Clinical nurses showed complex emotional reactions to cervical cancer, and expressed prejudice against the sex life of cervical-cancer patients. More education is required to ensure that clinical nurses can provide a nurse-led intervention with patients by managing nurses' fear, prejudice, and the care burden.	[Kim, Hae Won; Lee, Eun Ju] Seoul Natl Univ, Res Inst Nursing Sci, Coll Nursing, Seoul, South Korea; [Kim, Duck Hee] Woosuk Univ, Dept Nursing, Wonju, South Korea; [Kim, Yeon Hee] Univ Ulsan, Dept Clin Nursing, Ulsan, South Korea; [Kang, Saem Yi; Lee, Da Bit] Seoul Natl Univ, Coll Nursing, Seoul, South Korea; [Kim, Youngji] Kongju Natl Univ, Dept Nursing, Coll Nursing & Hlth, Gongju, South Korea	Seoul National University (SNU); Woosuk University; University of Ulsan; Seoul National University (SNU); Kongju National University	Kim, Y (corresponding author), Kongju Natl Univ, Dept Nursing, Coll Nursing & Hlth, Gongju, South Korea.	superdr1@hanmail.net	kim, hae won/E-9905-2015	kim, hae won/0000-0002-6730-1575; Kang, Saem Yi/0000-0003-0033-4628	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015-R1-A1-A3A0-4001267]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was funded by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning [grant number 2015-R1-A1-A3A0-4001267 to HWK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NE, 2015, INT J NURS STUD, V52, P695, DOI 10.1016/j.ijnurstu.2014.12.005; Baqeas M., 2018, AM J NURSING RES, V6, P82, DOI [10.12691/ajnr-6-3-1, DOI 10.12691/AJNR-6-3-1]; Daibes MA, 2017, INT J MENT HEALTH AD, V15, P588, DOI 10.1007/s11469-016-9682-2; Delobelle P, 2009, J ADV NURS, V65, P1061, DOI 10.1111/j.1365-2648.2009.04973.x; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Dunn KS, 2005, ONCOL NURS FORUM, V32, P97, DOI 10.1188/05.ONF.97-104; Ersin F, 2017, INT J CARING SCI, V10, P421; Fahami Fariba, 2017, J Educ Health Promot, V6, P56, DOI 10.4103/jehp.jehp_186_14; Gosselin TK, 2011, ONCOL NURS FORUM, V38, P729, DOI [10.1188/11.ONF.729-737, 10.1188/11.ONF.E11-E19]; Hagemeister MH, 2018, PUBLIC HEALTH, V154, P102, DOI 10.1016/j.puhe.2017.10.027; Izycki D, 2016, MENOPAUSE REV, V15, P112, DOI 10.5114/pm.2016.61194; Kellogg Marni B, 2014, Pediatr Nurs, V40, P297; Kessler TA, 2017, SEMIN ONCOL NURS, V33, P172, DOI 10.1016/j.soncn.2017.02.005; Lee KN, 2017, J KOREAN MED SCI, V32, P130, DOI 10.3346/jkms.2017.32.1.130; Miller DA, 2017, THESIS; Mwaka AD, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-193; National Cancer Information Center, 2017, CANC MORT GEND; 박혜민, 2014, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V14, P307, DOI 10.5392/JKCA.2014.14.08.307; Sandsund C, 2020, BMJ SUPPORT PALLIAT, V10, DOI 10.1136/bmjspcare-2016-001207; Shepherd MA, 2014, PSYCHOL HEALTH, V29, P94, DOI 10.1080/08870446.2013.834057; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; Spencer K, 2012, ANN RHEUM DIS, V71, P1490, DOI 10.1136/annrheumdis-2011-200801; Tanaka M, 2016, J NURS MANAGE, V24, P12, DOI 10.1111/jonm.12264; Vermeer WM, 2015, PSYCHO-ONCOLOGY, V24, P458, DOI 10.1002/pon.3663; Williams MS, 2018, HEALTH CARE WOMEN IN, V39, P584, DOI 10.1080/07399332.2018.1424169; Zamanzadeh V, 2014, INDIAN J PALLIAT CAR, V20, P12, DOI 10.4103/0973-1075.125549; 신미아, 2016, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V16, P359, DOI 10.5392/JKCA.2016.16.04.359; 이미향, 2011, [Korean J Women Health Nurs, 여성건강간호학회지], V17, P1; 2016, CULT HEALTH SEX, V18, P1192, DOI DOI 10.1080/13691058.2016.1177203	29	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217201	10.1371/journal.pone.0217201	http://dx.doi.org/10.1371/journal.pone.0217201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112578	gold, Green Published, Green Submitted			2022-12-27	WOS:000468451000043
J	Jentzer, JC; Bennett, C; Wiley, BM; Murphree, DH; Keegan, MT; Barsness, GW				Jentzer, Jacob C.; Bennett, Courtney; Wiley, Brandon M.; Murphree, Dennis H.; Keegan, Mark T.; Barsness, Gregory W.			Predictive value of individual Sequential Organ Failure Assessment sub-scores for mortality in the cardiac intensive care unit	PLOS ONE			English	Article							ACUTE PHYSIOLOGY; APACHE-III; EPIDEMIOLOGY; SURVEILLANCE; VALIDATION; PATTERNS; ILLNESS	Purpose To determine the impact of Sequential Organ Failure Assessment (SOFA) organ sub-scores for hospital mortality risk stratification in a contemporary cardiac intensive care unit (CICU) population. Materials and methods Adult CICU admissions between January 1, 2007 and December 31, 2015 were reviewed. The SOFA score and organ sub-scores were calculated on CICU day 1; patients with missing SOFA sub-score data were excluded. Discrimination for hospital mortality was assessed using area under the receiver-operator characteristic curve (AUROC) values, followed by multivariable logistic regression. Results We included 1214 patients with complete SOFA sub-score data. The mean age was 67 +/- 16 years (38% female); all-cause hospital mortality was 26%. Day 1 SOFA score predicted hospital mortality with an AUROC of 0.72. Each SOFA organ sub-score predicted hospital mortality (all p < 0.01), with AUROC values of 0.53 to 0.67. On multivariable analysis, only the cardiovascular, central nervous system, renal and respiratory SOFA sub-scores were associated with hospital mortality (all p < 0.01). A simplified SOFA score containing the cardiovascular, central nervous system and renal sub-scores had an AUROC of 0.72. Conclusions In CICU patients with complete SOFA sub-score data, risk stratification for hospital mortality is determined primarily by the cardiovascular, central nervous system, renal and respiratory SOFA sub-scores.	[Jentzer, Jacob C.; Bennett, Courtney; Wiley, Brandon M.; Barsness, Gregory W.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Jentzer, Jacob C.; Bennett, Courtney; Wiley, Brandon M.] Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Murphree, Dennis H.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Keegan, Mark T.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Jentzer, JC (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.; Jentzer, JC (corresponding author), Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	jentzer.jacob@mayo.edu	Wiley, Brandon/Z-5879-2019; Bennett, Courtney/Z-6306-2019; Wiley, Brandon M./AAG-6306-2020	Wiley, Brandon/0000-0003-3651-7231; Jentzer, Jacob/0000-0002-6366-2859				Aakre C, 2017, INT J MED INFORM, V103, P1, DOI 10.1016/j.ijmedinf.2017.04.001; Afessa B, 2005, INTENS CARE MED, V31, P1537, DOI 10.1007/s00134-005-2751-9; Argyriou G, 2015, J CRIT CARE, V30, P752, DOI 10.1016/j.jcrc.2015.04.014; Casella G, 2010, J CARDIOVASC MED, V11, P450, DOI 10.2459/JCM.0b013e328335233e; Chandra S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000216; Fonarow GC, 2012, REV CARDIOVASC MED, V13, pE14, DOI 10.3909/ricm0595; Goldfarb M, 2019, J INTENSIVE CARE MED, V34, P537, DOI 10.1177/0885066617741873; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Harrison AM, 2015, MAYO CLIN PROC, V90, P166, DOI 10.1016/j.mayocp.2014.11.014; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Holland EM, 2017, J AM COLL CARDIOL, V69, P1999, DOI 10.1016/j.jacc.2017.02.033; Jentzer JC, 2018, J AM HEART ASSOC, V7, P254, DOI [10.4065/mcp.2009.0479, DOI 10.4065/MCP.2009.0479]; Johnson AEW, 2013, CRIT CARE MED, V41, P1711, DOI 10.1097/CCM.0b013e31828a24fe; Katz JN, 2016, J AM COLL CARDIOL, V68, P67, DOI 10.1016/j.jacc.2016.04.036; Katz JN, 2010, CRIT CARE MED, V38, P375, DOI 10.1097/CCM.0b013e3181cb0a63; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; Keegan MT, 2011, CRIT CARE MED, V39, P163, DOI 10.1097/CCM.0b013e3181f96f81; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Knox DB, 2014, J CRIT CARE, V29, P780, DOI 10.1016/j.jcrc.2014.05.009; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Toma T, 2008, ARTIF INTELL MED, V43, P47, DOI 10.1016/j.artmed.2008.01.002; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; VINCENT JL, 2010, CRIT CARE, V14	26	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216177	10.1371/journal.pone.0216177	http://dx.doi.org/10.1371/journal.pone.0216177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107889	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200006
J	Rice, FL; Houk, G; Wymer, JP; Gosline, SJC; Guinney, J; Wu, JQ; Ratner, N; Jankowski, MP; La Rosa, S; Dockum, M; Storey, JR; Carroll, SL; Albrecht, PJ; Riccardi, VM				Rice, Frank L.; Houk, George; Wymer, James P.; Gosline, Sara J. C.; Guinney, Justin; Wu, Jianqiang; Ratner, Nancy; Jankowski, Michael P.; La Rosa, Salvo; Dockum, Marilyn; Storey, James R.; Carroll, Steven L.; Albrecht, Phillip J.; Riccardi, Vincent M.			The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; GLABROUS SKIN; GDNF FAMILY; GLIAL-CELLS; TYPE-1; PAIN; INNERVATION; EXPRESSION; BETA; PROLIFERATION	In addition to large plexiform neurofibromas (pNF), NF1 patients are frequently disfigured by cutaneous neurofibromas (cNF) and are often afflicted with chronic pain and itch even from seemingly normal skin areas. Both pNFs and cNF consist primarily of benign hyperproliferating nonmyelinating Schwann cells (nSC). While pNF clearly arise within deep nerves and plexuses, the role of cutaneous innervation in the origin of cNF and in chronic itch and pain is unknown. First, we conducted a comprehensive, multi-molecular, immunofluorescence (IF) analyses on 3mm punch biopsies from three separate locations in normal appearing, cNF-free skin in 19 NF1 patients and skin of 16 normal subjects. At least one biopsy in 17 NF1 patients had previously undescribed micro-lesions consisting of a small, dense cluster of nonpeptidergic C-fiber endings and the affiliated nSC consistently adjoining adnexal structures-dermal papillae, hair follicles, sweat glands, sweat ducts, and arterioles-where C-fiber endings normally terminate. Similar micro-lesions were detected in hind paw skin of mice with conditionally-induced SC Nf1(-/-) mutations. Hypothesizing that these microlesions were pre-cNF origins of cNF, we subsequently analyzed numerous overt, small cNF (s-cNF, 3-6 mm) and discovered that each had an adnexal structure at the epicenter of vastly increased nonpeptidergic C-fiber terminals, accompanied by excessive nSC. The IF and functional genomics assays indicated that neurturin (NTRN) and artemin (ARTN) signaling through cRET kinase and GFR alpha 2 and GFR alpha 3 co-receptors on the aberrant C-fiber endings and nSC may mutually promote the onset of pre-cNF and their evolution to s-cNF. Moreover, TrpA1 and TrpV1 receptors may, respectively, mediate symptoms of chronic itch and pain. These newly discovered molecular characteristics might be targeted to suppress the development of cNF and to treat chronic itch and pain symptoms in NF1 patients.	[Rice, Frank L.; Houk, George; Dockum, Marilyn; Albrecht, Phillip J.] Integrated Tissue Dynam LLC, Rensselaer, NY 12144 USA; [Rice, Frank L.; Albrecht, Phillip J.] SUNY Albany, Div Hlth Sci, Albany, NY 12222 USA; [Wymer, James P.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Gosline, Sara J. C.; Guinney, Justin] Sage Bionetworks, Seattle, WA USA; [Wu, Jianqiang] Univ Cincinnati, Canc & Blood Dis Inst, Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Ratner, Nancy; Jankowski, Michael P.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Jankowski, Michael P.] Univ Cincinnati, Dept Anesthesia, Div Pain Management, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [La Rosa, Salvo] Childrens Tumor Fdn, New York, NY USA; [Storey, James R.] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; [Carroll, Steven L.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Riccardi, Vincent M.] Neurofibromatosis Inst, La Crescenta, CA USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University System of Florida; University of Florida; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Albany Medical College; Medical University of South Carolina	Rice, FL (corresponding author), Integrated Tissue Dynam LLC, Rensselaer, NY 12144 USA.; Rice, FL (corresponding author), SUNY Albany, Div Hlth Sci, Albany, NY 12222 USA.	FrankRice@INTiDYN.com	Albrecht, Phillip J./AAC-6144-2021	RATNER, NANCY/0000-0001-5030-9354; La Rosa, Salvatore/0000-0003-2010-4328	Rosenblatt Family to The St. Peter's Hospital Foundation; Children's Tumor Foundation; National Institute of Health [R56NS103179, R01 NS28840, R37 NS083580]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083580, R01NS028840, R56NS103179] Funding Source: NIH RePORTER	Rosenblatt Family to The St. Peter's Hospital Foundation; Children's Tumor Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this research project was provided by owner equity research support to Integrated Tissue Dynamics, LLC (INTiDYN) by FLR, a private donation from the Rosenblatt Family to The St. Peter's Hospital Foundation to JPW and FLR, The Children's Tumor Foundation to SJCG, and the National Institute of Health Grants R56NS103179 to MPJ and R01 NS28840 and R37 NS083580 to NR. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Akiyama T., 2014, SPINAL CODING ITCH P; Albrecht PJ, 2013, PAIN MED, V14, P895, DOI 10.1111/pme.12139; Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Aquino JB, 2018, GLIA, V66, P465, DOI 10.1002/glia.23262; Awatramani R, 2002, MOL CELL NEUROSCI, V19, P307, DOI 10.1006/mcne.2001.1094; Barohn RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1505, DOI 10.1001/archneur.55.12.1505; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Bowsher D, 2009, PAIN, V147, P287, DOI 10.1016/j.pain.2009.09.007; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; Carrero G, 2003, REGION ANESTH PAIN M, V28, P72, DOI 10.1053/rapm.2003.50013; Carriel V, 2017, J TISSUE ENG REGEN M, V11, P553, DOI 10.1002/term.1949; Caterina MJ, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040077; Cheng YR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0448-y; Choi JE, 2018, SEMIN IMMUNOPATHOL, V40, P249, DOI 10.1007/s00281-018-0675-z; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Coulpier F, 2009, GLIA, V57, P1450, DOI 10.1002/glia.20862; Creange A, 1999, BRAIN, V122, P473, DOI 10.1093/brain/122.3.473; Darling Thomas N, 2006, Adv Dermatol, V22, P181, DOI 10.1016/j.yadr.2006.09.004; Drouet A, 2004, BRAIN, V127, P1993, DOI 10.1093/brain/awh234; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gosline SJC, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.45; Gresset A, 2015, STEM CELL REP, V5, P278, DOI 10.1016/j.stemcr.2015.06.005; Hou QZ, 2011, PAIN, V152, P2036, DOI 10.1016/j.pain.2011.04.033; Ikeda-Miyagawa Y, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0004-7; Ito K, 2016, J BIOCHEM, V160, P77, DOI 10.1093/jb/mvw037; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; Jacob C, 2015, GLIA, V63, P1883, DOI 10.1002/glia.22816; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jankowski MP, 2009, J NEUROSCI, V29, P1636, DOI 10.1523/JNEUROSCI.3474-08.2009; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jouhilahti EM, 2011, AM J PATHOL, V178, P500, DOI 10.1016/j.ajpath.2010.10.041; KADONO T, 1994, BIOCHEM BIOPH RES CO, V198, P827, DOI 10.1006/bbrc.1994.1118; Karvonen SL, 2000, ARCH DERMATOL, V136, P1207, DOI 10.1001/archderm.136.10.1207; Kupari J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104764; Lauria G, 2009, HISTOPATHOLOGY, V54, P273, DOI 10.1111/j.1365-2559.2008.03096.x; Liao CP, 2018, J CLIN INVEST, DOI [10.1172/JCI9942499424, DOI 10.1172/JCI9942499424]; Longo JF, 2018, ADV ANAT PATHOL, V25, P353, DOI 10.1097/PAP.0000000000000197; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Moore C, 2018, NEUROSCI BULL, V34, P120, DOI 10.1007/s12264-017-0200-8; O'Brien DE, 2013, J PAIN, V14, P628, DOI 10.1016/j.jpain.2013.01.770; Pare M, 2007, J COMP NEUROL, V501, P543, DOI 10.1002/cne.21262; Patmore DM, 2012, CANCER RES, V72, P5317, DOI 10.1158/0008-5472.CAN-12-1972; Petersen KL, 2010, PAIN, V150, P75, DOI 10.1016/j.pain.2010.04.002; Petersen KL, 2002, PAIN, V98, P119, DOI 10.1016/S0304-3959(02)00029-5; Rhodes SD, 2013, J BONE MINER RES, V28, P2476, DOI 10.1002/jbmr.1992; Ribeiro S, 2013, CELL REP, V5, P126, DOI 10.1016/j.celrep.2013.08.033; Riccardi Vincent M, 2007, Neurosurg Focus, V22, pE3, DOI 10.3171/foc.2007.22.6.4; Riccardi VM, 2010, BIRTH DEFECTS RES A, V88, P9, DOI 10.1002/bdra.20616; RICCARDI VM, 1988, NEUROLOGY, V38, P1810, DOI 10.1212/WNL.38.11.1810; Riccardi VM, 2017, J TRANSL GENET GENOM, V1, P1; Riccardi VM, 1992, NEUROFIBROMATOSIS PH, P1; RICE FL, 1993, J COMP NEUROL, V337, P366, DOI 10.1002/cne.903370303; Rice FL, 2008, SENSES COMPREHENSIVE, P1, DOI 10.1016/B978-0-12-805408-6.00340-7; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; Stepanova DS, 2017, CANCER RES, V77, P5026, DOI 10.1158/0008-5472.CAN-16-2834; Stonecypher MS, 2005, ONCOGENE, V24, P5589, DOI 10.1038/sj.onc.1208730; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Tucker T, 2011, J NEUROSCI RES, V89, P1451, DOI 10.1002/jnr.22654; Tucker T, 2011, J HISTOCHEM CYTOCHEM, V59, P584, DOI 10.1369/0022155411407340; Verze L, 2003, ANAT REC PART A, V272A, P467, DOI 10.1002/ar.a.10056; Vilensky JA, 2005, ARCH NEUROL-CHICAGO, V62, P499, DOI 10.1001/archneur.62.3.499; Wang HT, 2012, NEURAL REGEN RES, V7, P620, DOI 10.3969/j.issn.1673-5374.2012.08.010; Wang Shuying, 2008, Shengli Xuebao, V60, P565; Wang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028908; Wang XQ, 2013, BBA-PROTEINS PROTEOM, V1834, P2205, DOI 10.1016/j.bbapap.2012.10.008; Wilson SR, 2014, ROLE TRANSIENT RECEP; Wolkenstein P, 2001, ARCH DERMATOL, V137, P1421, DOI 10.1001/archderm.137.11.1421; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Zhao P, 2008, PAIN, V139, P90, DOI 10.1016/j.pain.2008.03.016; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; CURR OPIN NEUROBIOL, V10, P103; 1990, CELL TISSUE RES, V261, P25; 2006, EXP NEUROL, V198, P438, DOI DOI 10.1016/J.EXPNEUROL.2005.12.015; 2016, REV ENV HLTH, V31, P281, DOI DOI 10.1515/REVEH-2015-0040; 1999, DEVELOPMENT, V126, P2597; 2009, EMBO MOL MED, V1, P236, DOI DOI 10.1002/EMMM.200900027; 1991, ACTA NEUROPATHOL, V81, P491; 1995, SOMATOSENS MOT RES, V12, P49; 2006, NEUROSCI LETT, V404, P61, DOI DOI 10.1016/J.NEULET.2006.05.041; J NEUROSCI, V20, P427; 1997, J COMP NEUROL, V387, P489; 2009, J NEUROSCI, V29, P7667, DOI DOI 10.1523/JNEUROSCI.6053-08.2009; TERATOLOGY, V62, P4, DOI DOI 10.1002/1096-9926(200007)62:4::AID-3.0.CO;2-Q; AM J EPIDEMIOL, V151, P33; 2008, AM J SURG PATHOL, V32, P1291, DOI DOI 10.1097/PAS.0B013E3181658C14; 1998, NEURON, V20, P245; 2003, J CLIN INVEST, V112, P1851, DOI DOI 10.1172/JCI19195; 1997, TRENDS NEUROSCI, V20, P84; 1997, J COMP NEUROL, V385, P185, DOI DOI 10.1002/(SICI)1096-9861; 2012, ANTICANCER RES, V32, P2139; 2003, ANN ANAT, V185, P35; 2002, CURR OPIN NEUROBIOL, V12, P523; 2001, J NEUROSCI, V21, P9655; 2001, GENE DEV, V15, P66, DOI DOI 10.1101/GAD.186601; 1980, ANAT REC, V198, P643, DOI DOI 10.1002/AR.; J COMP NEUROL, V417, P467, DOI DOI 10.1002/(SICI)1096-9861(20000221)417:3.0.CO;2-Q; 2007, ONCOGENE, V26, P4609, DOI DOI 10.1038/SJ.ONC.1210261; 2009, J NEUROSCI, V29, P4808, DOI DOI 10.1523/JNEUROSCI.5380-08.2009; 2004, J NEUROSCI, V24, P9250, DOI DOI 10.1523/JNEUROSCI.3649-04.2004; 1997, NEURON, V19, P849; 2008, GLIA, V56, P1590, DOI DOI 10.1002/GLIA.20776; 2015, NEUROSCI LETT, V604, P36, DOI DOI 10.1016/J.NEULET.2015.07.031; 2010, NEUROSCI LETT, V469, P135, DOI DOI 10.1016/J.NEULET.2009.11.060; 2017, CURR OPIN NEUROBIOL, V47, P209, DOI DOI 10.1016/J.CONB.2017.11.; 2006, PAIN, V120, P235, DOI DOI 10.1016/J.PAIN.2005; 2005, J NEUROPATHOL EXP NE, V64, P1; 2001, CELL MOL LIFE SCI, V58, P1021, DOI DOI 10.1007/; 2006, J NEUROSCI, V26, P8578, DOI DOI 10.1523/JNEUROSCI.2185-06.2006; 2009, CELL STEM CELL, V4, P453, DOI DOI 10.1016/J.STEM.2009.03.017; 2017, J NEUROPHYSIOL, V117, P1258, DOI DOI 10.1152/JN.00731.2016; 2017, ONCOTARGET, V8, P8203, DOI DOI 10.18632/ONCOTARGET.; 1992, J INVEST DERMATOL, V99, P734; 2016, ACTA DERM-VENEREOL, V96, P398, DOI DOI 10.2340/00015555-2241; 1986, BRAIN RES, V367, P39; 2010, CURR PAIN HEADACHE R, V14, P179, DOI DOI 10.1007/S11916-010-0105-Y; 1999, J NEUROSCI, V19, P9322; 2012, J NEUROSCI, V32, P1786, DOI DOI 10.1523/JNEUROSCI.3148-12.2012; 2008, ACTA HISTOCHEM, V110, P351, DOI DOI 10.1016/J.ACTHIS.2007.12.004; 2006, J CELL BIOL, V175, P1005, DOI DOI 10.1083/JCB.200606062; 2019, CANCER DISCOV, V9, P130, DOI DOI 10.1158/2159-8290.CD-18-0156; 2002, SCIENCE, V296, P920, DOI DOI 10.1126/SCIENCE.1068452; 2010, J NEUROSCI, V30, P1627, DOI DOI 10.1523/JNEUROSCI.2195-10.2010; 1992, J NEUROBIOL, V23, P143, DOI DOI 10.1002/NEU.480230205; 2011, AM J PATHOL, V178, P1932, DOI DOI 10.1016/J.AJPATH.2010.12.056(11); 2014, EXP MOL PATHOL, V96, P230, DOI DOI 10.1016/J.YEXMP.2014.02.006; 1989, J CELL BIOL 2, V109, P3419, DOI DOI 10.1083/JCB.109.6.3419; 2009, METHOD MOL BIOL, V482, P159, DOI DOI 10.1007/978-1-59745-060-7; 1998, DEV BIOL, V198, P57; 1997, J COMP NEUROL, V389, P545; 1999, CANC GENET CYTOGENET, V113, P65; 2008, NEOPLASIA, V10, P1204, DOI DOI 10.1593/NEO.08642; 2001, CURR OPIN NEUROBIOL, V11, P272; 2005, STEM CELLS, V23, P727, DOI DOI 10.1634/STEMCELLS.2004-0134; 1998, ANAT REC, V251, P351, DOI DOI 10.1002/(SICI)1097-0185(199807)251:3.0.CO;2-N; 2016, J NEUROIMMUNOL, V295, P122, DOI DOI 10.1016/J.JNEUROIM.2016.04.008	141	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216527	10.1371/journal.pone.0216527	http://dx.doi.org/10.1371/journal.pone.0216527			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107888	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200011
J	Cheng, AW; Tan, X; Sun, JY; Gu, CM; Liu, C; Guo, X				Cheng, An-Wei; Tan, Xin; Sun, Jin-Yue; Gu, Chun-Mei; Liu, Chao; Guo, Xu			Catechin attenuates TNF-alpha induced inflammatory response via AMPK-SIRT1 pathway in 3T3-L1 adipocytes	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM STRESS; ANTIINFLAMMATORY ACTIVITY; TEA POLYPHENOL; SIRT1; AMPK; MECHANISMS; EXPRESSION	Chronic inflammation is a fundamental symptom of many diseases. Catechin possesses anti-oxidant and anti-inflammatory properties. However, the mechanism of catechin to prevent inflammation in 3T3-L1 adipocytes caused by TNF-alpha remains unknown. Therefore, the effects of catechin on the gene expression of cytokines and the activation of cell signals in TNF-alpha induced 3T3-L1 adipocytes were investigated. The effects of catechin on adipogenesis and cell viability were detected by Oil Red O staining and CCK-8 assay, respectively. The genes expression of cytokines was determined by real-time RT-PCR. The expression of NF-kappa B, AMPK, FOXO3a and SIRT1 on translation level was determined by western blotting analysis. The results demonstrated that catechin significantly enhanced adipogenesis and cell viability. catechin inhibited the gene expression of pro-inflammatory cytokines including IL-1 alpha, IL-1 beta, IL-6, IL-12p35, and inflammatory enzymes including iNOS and COX2, but enhanced the gene expression of anti-inflammatory cytokines including IL-4 and IL-10. Catechin also inhibited the activation of NF-kappa B, AMPK, FOXO3a and SIRT1, but increased the phosphorylation level of the above factors. All these results indicated that as a potential therapeutic strategy catechin has the ability of attenuating inflammatory response triggered by TNF-alpha through signaling cascades involved in inflammation and cytokines.	[Cheng, An-Wei; Tan, Xin; Sun, Jin-Yue; Liu, Chao; Guo, Xu] Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Jinan, Shandong, Peoples R China; [Cheng, An-Wei; Tan, Xin; Sun, Jin-Yue; Liu, Chao; Guo, Xu] Minist Agr, Key Lab Novel Food Resources Proc, Jinan, Shandong, Peoples R China; [Cheng, An-Wei; Tan, Xin; Sun, Jin-Yue; Liu, Chao; Guo, Xu] Key Lab Agroprod Proc Technol Shandong Prov, Jinan, Shandong, Peoples R China; [Tan, Xin; Gu, Chun-Mei] Jilin Agr Univ, Coll Food Sci & Engn, Changchun, Jilin, Peoples R China	Shandong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Jilin Agricultural University	Cheng, AW; Sun, JY (corresponding author), Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Jinan, Shandong, Peoples R China.; Cheng, AW; Sun, JY (corresponding author), Minist Agr, Key Lab Novel Food Resources Proc, Jinan, Shandong, Peoples R China.; Cheng, AW; Sun, JY (corresponding author), Key Lab Agroprod Proc Technol Shandong Prov, Jinan, Shandong, Peoples R China.	anweich@126.com; moon_s731@hotmail.com			Taishan Talents Introduction Program of Shandong, China [tsxz2018]; Young Talents Training Program of Shandong Academy of Agricultural Sciences [SAAS2015-06]	Taishan Talents Introduction Program of Shandong, China; Young Talents Training Program of Shandong Academy of Agricultural Sciences	This research was supported by Taishan Talents Introduction Program of Shandong, China (tsxz2018) to JS, and Young Talents Training Program of Shandong Academy of Agricultural Sciences (SAAS2015-06) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayissi VBO, 2014, MOL NUTR FOOD RES, V58, P22, DOI 10.1002/mnfr.201300195; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cattelan A, 2015, VASC PHARMACOL, V70, P35, DOI 10.1016/j.vph.2015.02.004; Ellis LZ, 2011, BIOCHEM BIOPH RES CO, V414, P551, DOI 10.1016/j.bbrc.2011.09.115; Fujishiro M, 2003, MOL ENDOCRINOL, V17, P487, DOI 10.1210/me.2002-0131; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang BP, 2015, DNA CELL BIOL, V34, P133, DOI 10.1089/dna.2014.2630; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Ichikawa D, 2004, BIOL PHARM BULL, V27, P1353, DOI 10.1248/bpb.27.1353; Jung TW, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0431-7; Ko HJ, 2014, J FUNCT FOODS, V11, P36, DOI 10.1016/j.jff.2014.09.003; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Liu ZF, 2016, J DIABETES, V8, P324, DOI 10.1111/1753-0407.12296; Morita N, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9256482; Pan MH, 2010, FOOD FUNCT, V1, P15, DOI 10.1039/c0fo00103a; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Rashid K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27209-3; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shin HY, 2007, INT ARCH ALLERGY IMM, V142, P335, DOI 10.1159/000097503; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talero E, 2016, INT IMMUNOPHARMACOL, V35, P248, DOI 10.1016/j.intimp.2016.03.046; Tian YL, 2016, MOL CELL BIOCHEM, V422, P75, DOI 10.1007/s11010-016-2807-x; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vazquez-Prieto MA, 2012, ARCH BIOCHEM BIOPHYS, V527, P113, DOI 10.1016/j.abb.2012.02.019; Wang JQ, 2016, INT IMMUNOPHARMACOL, V39, P287, DOI 10.1016/j.intimp.2016.07.036; Yang CS, 2000, J NUTR, V130, p472S, DOI 10.1093/jn/130.2.472S; Zhang HS, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0056-4; Zhong Y, 2012, FOOD CHEM, V134, P742, DOI 10.1016/j.foodchem.2012.02.172; 2018, MOLECULAR CELLULAR B, V439, P213, DOI DOI 10.1007/S11010-017-3149-Z; 2004, IMMUNITY, V21, P203, DOI DOI 10.1016/J.IMMUNI.2004.06; 2014, FITOTERAPIA, V92, P260, DOI DOI 10.1016/J.FITOTE.2013.12.003; BIOCHEM PHARMACOL, V59, P357, DOI DOI 10.1016/S0006-2952(99)00335-4	36	37	41	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217090	10.1371/journal.pone.0217090	http://dx.doi.org/10.1371/journal.pone.0217090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100089	Green Submitted, gold, Green Published			2022-12-27	WOS:000468176600027
J	Schwerdtfeger, LA; Nealon, NJ; Ryan, EP; Tobet, SA				Schwerdtfeger, Luke A.; Nealon, Nora Jean; Ryan, Elizabeth P.; Tobet, Stuart A.			Human colon function ex vivo: Dependence on oxygen and sensitivity to antibiotic	PLOS ONE			English	Article							ENTERIC GLIAL-CELLS; GUT MICROBIOTA; MOUSE MODEL; METABOLITES; HYPOXIA; HEALTH; IMMUNE; PENICILLIN; DIVERSITY; RESPONSES	Background Human intestines contain a heterogeneous collection of cells that include immune, neural and epithelial elements interacting in a highly complex physiology that is challenging to maintain ex vivo. There is an extreme oxygen gradient across the intestinal wall due in part to microbiota in the lumen and close to the gut wall, which complicates the design of tissue culture systems. The current study established the use of an organotypic slice model of human intestinal tissue derived from colonoscopy biopsies to study host-microbial interactions after antibiotic treatment, and the influence of oxygen concentration on gut wall function. Methods Organotypic slices from human colon biopsies collected during routine colonoscopy provided three-dimensional environments that maintained cellular morphology ex vivo. Biopsy slices were used to study impacts of oxygen concentrations and antibiotic treatments on epithelial proliferation rates, and metabolites from tissue culture supernatants. Results Immune function was validated via demonstration of a T lymphocyte response to Salmonella enterica serovar Typhimurium. Following 24 h of Salmonella exposure there was a significant increase in CD3(+) T-lymphocytes in biopsy slices. Metabolite profiling of tissue culture supernatants validated the influence of antibiotic treatment under varied oxygen culture conditions on both host and microbiome-mediated metabolism. Epithelial health was influenced by oxygen and antibiotic. Increased epithelial proliferation was measured in lowered oxygen conditions (1% = 5.9 mmHg) compared to atmospheric conditions standard at 5000 feet above sea level in Colorado (similar to 17% = 100 mmHg). Antibiotic treatment reduced epithelial proliferation only in 5.9 mmHg oxygen cultured slices. Conclusions A human colon organotypic slice model was established for applications ranging from gut epithelial proliferation to enteric pathogen influence on mucosal immune functions ex vivo. The results further support the need to account for oxygen concentration in primary tissue cultures, and that antibiotic use impacts gut-microbe-immune interactions.	[Schwerdtfeger, Luke A.; Tobet, Stuart A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Nealon, Nora Jean; Ryan, Elizabeth P.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Nealon, Nora Jean; Ryan, Elizabeth P.] Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Tobet, Stuart A.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University	Tobet, SA (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.; Tobet, SA (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	stuart.tobet@colostate.edu		Tobet, Stuart/0000-0002-1615-7331; Schwerdtfeger, Luke/0000-0001-8030-3164	University of Colorado Cancer Center, Division of Cancer Control and Prevention; NSF NRT -GAUSSI fellowship; National Science Foundation NRT Grant [1450032]; NIH T32 Pre-Doctoral Training Fellowship [5T32OD012201-05]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD012201] Funding Source: NIH RePORTER	University of Colorado Cancer Center, Division of Cancer Control and Prevention; NSF NRT -GAUSSI fellowship; National Science Foundation NRT Grant; NIH T32 Pre-Doctoral Training Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support for the colon tissue biopsy collection was provided from the University of Colorado Cancer Center, Division of Cancer Control and Prevention. LAS was supported by an NSF NRT -GAUSSI fellowship; Results presented in this paper are based upon collaborative work supported by a National Science Foundation NRT Grant No. 1450032. Any opinions, findings, conclusions or recommendations expressed in this paper are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. NJN was supported by an NIH T32 Pre-Doctoral Training Fellowship under award number 5T32OD012201-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2013, AM FAM PHYSICIAN, V87, P699; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; AUTRUP H, 1978, GASTROENTEROLOGY, V74, P1248; Bai SP, 2014, VET IMMUNOL IMMUNOP, V160, P235, DOI 10.1016/j.vetimm.2014.05.015; Bakirtzi K, 2014, AM J PATHOL, V184, P3405, DOI 10.1016/j.ajpath.2014.08.015; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Brown JM, 2017, J BIOL CHEM, V292, P8560, DOI 10.1074/jbc.R116.765388; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Drew JE, 2015, BIORESEARCH OPEN ACC, V4, P425, DOI 10.1089/biores.2015.0029; Garner CD, 2009, INFECT IMMUN, V77, P2691, DOI 10.1128/IAI.01570-08; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Kelly CJ, 2016, CELL HOST MICROBE, V19, P427, DOI 10.1016/j.chom.2016.03.014; KHAN S, 1988, J SURG ONCOL, V39, P114, DOI 10.1002/jso.2930390209; Kumar A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-71; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Li XY, 2016, INT IMMUNOPHARMACOL, V36, P305, DOI 10.1016/j.intimp.2016.04.036; Liu YA, 2013, NEUROGASTROENT MOTIL, V25, pe324, DOI 10.1111/nmo.12115; Lopez-Medina M, 2015, IMMUNOBIOLOGY, V220, P1369, DOI 10.1016/j.imbio.2015.07.005; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Moreno-Indias I, 2015, EUR RESPIR J, V45, P1055, DOI 10.1183/09031936.00184314; National Institutes of Health U.S. Department of Health and Human Services, 2009, NIH PUBLICATION, V08-6514; Nealon NJ, 2017, J APPL MICROBIOL, V122, P1639, DOI 10.1111/jam.13459; Nealon NJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00653; Pochard C, 2018, AM J PHYSIOL-GASTR L, V315, pG1, DOI 10.1152/ajpgi.00016.2018; POTTEN CS, 1992, GUT, V33, P71, DOI 10.1136/gut.33.1.71; Rodriguez-Hernandez CO, 2014, INT J CURR RES ACA R, V2, P188; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Schwerdtfeger LA, 2016, AM J PHYSIOL-GASTR L, V310, pG240, DOI 10.1152/ajpgi.00299.2015; Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Singh P, 2013, POULTRY SCI, V92, P272, DOI 10.3382/ps.2012-02603; Sun JC, 2013, J CHROMATOGR B, V932, P134, DOI 10.1016/j.jchromb.2013.05.030; THERMANN M, 1985, LANGENBECK ARCH CHIR, V363, P179, DOI 10.1007/BF01261291; Tulstrup MVL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144854; von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001; Wessel AK, 2014, MBIO, V5, DOI 10.1128/mBio.00992-14; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Yu YB, 2014, WORLD J GASTROENTERO, V20, P11273, DOI 10.3748/wjg.v20.i32.11273; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015; 2014, PHYSIOL GENOMICS, V46, P302, DOI DOI 10.1152/PHYSIOLGENOMICS.00194.2013	43	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217170	10.1371/journal.pone.0217170	http://dx.doi.org/10.1371/journal.pone.0217170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095647	Green Published, gold, Green Submitted			2022-12-27	WOS:000468030100079
J	Asada, S; Yoshida, K; Fukuma, S; Nomura, T; Wada, M; Onishi, Y; Kurita, N; Fukagawa, M; Fukuhara, S; Akizawa, T				Asada, Shinji; Yoshida, Kazuki; Fukuma, Shingo; Nomura, Takanobu; Wada, Michihito; Onishi, Yoshihiro; Kurita, Noriaki; Fukagawa, Masafumi; Fukuhara, Shunichi; Akizawa, Tadao			Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; CHRONIC KIDNEY-DISEASE; CLINICAL-PRACTICE GUIDELINE; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; CHRONIC DIALYSIS; EVENTS; MANAGEMENT; MORTALITY; SURVIVAL	Objectives To elucidate the effect of cinacalcet use on all-cause and cause-specific hospitalization outcomes using a prospective cohort of maintenance hemodialysis patients. Methods We used data from a prospective cohort of Japanese hemodialysis patients with secondary hyperparathyroidism and examined baseline characteristics as well as longitudinal changes. All patients were cinacalcet-naive at study enrollment. Further, we used a marginal structural model to account for time-varying confounders on cinacalcet initiation and hospitalization outcomes, and an Andersen-Gill-type recurrent event model to account for any recurring events of hospitalization in the outcome analysis using the weighted dataset. Results Among the 3,276 patients, cinacalcet treatment was initiated in 1,384 patients during the entire follow-up. Cinacalcet users were slightly younger, included more patients with chronic glomerulonephritis and fewer patients with diabetes, were more likely to have a history of parathyroidectomy, and were more often used receiving vitamin D receptor activator, phosphate binders, and iron supplements. The overall hospitalization analysis yielded a hazard ratio (HR) of 0.97 (95% confidence interval [CI]: 0.80, 1.18). A trend toward a mild protective association was observed for cardiovascular-related hospitalizations (HR: 0.85; 95% CI: 0.64, 1.14). In the subgroup analysis, a protective association was seen due to cinacalcet use for infection-related hospitalizations in the lowest intact parathyroid hormone group (HR: 0.36; 95% CI: 0.14, 0.95). Conclusions Cinacalcet initiation in patients on maintenance hemodialysis had no effect on all-cause and cause-specific hospitalizations. Although the overall association was statistically not significant, cinacalcet may have a protective association on cardiovascular-related hospitalization in all patients and infection-related hospitalization in patient with low intact parathyroid hormone.	[Asada, Shinji; Nomura, Takanobu; Wada, Michihito] Kyowa Hakko Kirin, Med Affairs Dept, Chiyoda Ku, Tokyo, Japan; [Yoshida, Kazuki] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Yoshida, Kazuki] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Fukuma, Shingo] Kyoto Univ, Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Fukuma, Shingo] Keihanshin Consortium Fostering Next Generat Glob, Kyoto, Japan; [Onishi, Yoshihiro] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan; [Kurita, Noriaki] Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence CiRC 2, Fukushima, Japan; [Kurita, Noriaki] Fukushima Med Univ Hosp, Dept Innovat Res & Educ Clinicians & Trainees DiR, Fukushima, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Tokyo, Japan; [Fukuhara, Shunichi] Kyoto Univ, Sch Publ Hlth, Dept Healthcare Epidemiol, Fac Med, Kyoto, Japan; [Akizawa, Tadao] Showa Univ, Shinagawa Ku, Tokyo, Japan	Kyowa Kirin Ltd; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Kyoto University; Fukushima Medical University; Fukushima Medical University; Tokai University; Kyoto University; Showa University	Asada, S (corresponding author), Kyowa Hakko Kirin, Med Affairs Dept, Chiyoda Ku, Tokyo, Japan.	shinji.asada@kyowa-kirin.co.jp	Kurita, Noriaki/I-6023-2019	Kurita, Noriaki/0000-0003-4127-7500; Asada, Shinji/0000-0002-7717-8945; Fukuma, Shingo/0000-0002-8379-8761	Kyowa Hakko Kirin	Kyowa Hakko Kirin(Kyowa Kirin Ltd)	The MBD-5D study was funded by Kyowa Hakko Kirin.	Akizawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19612; Amorim LDAF, 2015, INT J EPIDEMIOL, V44, P324, DOI 10.1093/ije/dyu222; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Block GA, 2010, KIDNEY INT, V78, P578, DOI 10.1038/ki.2010.167; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Choi SR, 2012, NEPHRON CLIN PRACT, V122, P1, DOI 10.1159/000347145; Cole SR, 2005, AM J EPIDEMIOL, V162, P471, DOI 10.1093/aje/kwi216; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Fukagawa M, 2014, AM J KIDNEY DIS, V63, P979, DOI 10.1053/j.ajkd.2013.08.011; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Fukuhara S, 2011, THER APHER DIAL, V15, P169, DOI 10.1111/j.1744-9987.2010.00906.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2018, CAUSAL INFERENCE; Komaba H, 2015, SEMIN DIALYSIS, V28, P594, DOI 10.1111/sdi.12413; Komaba H, 2012, NAT REV NEPHROL, V8, P484, DOI 10.1038/nrneph.2012.116; Komaba H, 2011, CLIN EXP NEPHROL, V15, P797, DOI 10.1007/s10157-011-0502-5; Masakane I., 2018, RENAL REPLACEMENT TH, V4, P45, DOI DOI 10.1186/S41100-018-0183-6; Mieno MN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-80; Moe SM, 2015, CIRCULATION, V132, P27, DOI 10.1161/CIRCULATIONAHA.114.013876; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Nishikawa K, 2017, CLIN EXP NEPHROL, V21, P316, DOI 10.1007/s10157-016-1293-5; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; van Buuren S, 2011, J STAT SOFTW, V45, P1; Yoshida K, 2015, NAT REV RHEUMATOL, V11, P437, DOI 10.1038/nrrheum.2015.30; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048070	31	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216399	10.1371/journal.pone.0216399	http://dx.doi.org/10.1371/journal.pone.0216399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141505	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000007
J	Kaur, N; Sinha, PK; Sahni, G				Kaur, Navneet; Sinha, Prakash Kumar; Sahni, Girish			Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL MODIFICATION; PROTEIN PEGYLATION; ANTIBODY FRAGMENTS; MOLECULAR-WEIGHT; PEG; MICROPLASMIN; SUBSTRATE; CHEMISTRY; PEPTIDE; DOMAIN	The relatively rapid inhibition of microplasmin by alpha(2)-AP leads to short functional half-life of the molecule in vivo, causing inefficient clot dissolution, even after site-specific, local catheter-based delivery. Here, we describe a PEGylation approach for improving the therapeutic potential via improving the survival of microplasmin in presence of its cognate inhibitor, alpha(2)-AP, wherein a series of strategically designed cysteine analogs of micro-plasminogen were prepared and expressed in E. coli, and further modified by covalent grafting in vitro with PEG groups of different molecular sizes so as to select single or double PEG chains that increase the molecular weight and hydrodynamic radii of the conjugates, but with a minimal discernible effect on intrinsic plasmin activity and structural framework, as explored by amidolytic activity and CD-spectroscopy, respectively. Interestingly, some of the purified PEG-coupled proteins after conversion to their corresponding proteolytically active forms were found to exhibit significantly reduced inhibition rates (up to 2-fold) by alpha(2)-AP relative to that observed with wild-type microplasmin. These results indicate an interesting, and not often observed, effect of PEG groups through reduced/altered dynamics between protease and inhibitor, likely through a steric hindrance mechanism. Thus, the present study successfully identifies single- and double-site PEGylated muteins of microplasmin with significantly enhanced functional half-life through enhanced resistance to inactivation by its in vivo plasma inhibitor. Such an increased survival of bioactivity in situ, holds unmistakable potential for therapeutic exploitation, especially in ischemic strokes where a direct, catheter-based deposition within the cranium has been shown to be promising, but is currently limited by the very short in vivo bioactive half-life of the fibrin dissolving agent/s.	[Kaur, Navneet; Sinha, Prakash Kumar; Sahni, Girish] CSIR Inst Microbial Technol, Chandigarh, India; [Kaur, Navneet; Sinha, Prakash Kumar] Panjab Univ, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Panjab University	Sahni, G (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	girishsahni@gmail.com	Sinha, Prakash Kumar/K-6048-2013	Sinha, Prakash Kumar/0000-0002-2067-5676	Council of Scientific and Industrial Research (CSIR), New Delhi, India; ICMR Junior Research fellowship	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); ICMR Junior Research fellowship	R and D funding was provided by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. GS is a Bhatnagar Research Fellow of the CSIR and a Honorary Professor, Punjab University, Chandigarh, India. NK was supported by ICMR Junior Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; Adivitiya, 2017, BIOENGINEERED, V8, P331, DOI 10.1080/21655979.2016.1229718; AMBRUS JL, 1957, ANN NY ACAD SCI, V68, P97, DOI 10.1111/j.1749-6632.1957.tb42616.x; Aneja R, 2009, J BIOL CHEM, V284, P32642, DOI 10.1074/jbc.M109.046573; Aoki N, 2005, J THROMB HAEMOST, V3, P623, DOI 10.1111/j.1538-7836.2004.01055.x; Bailon P, 1998, PHARM SCI TECHNOL TO, V1, P352, DOI 10.1016/S1461-5347(98)00086-8; BOYLES PW, 1960, AM J CARDIOL, V6, P439, DOI 10.1016/0002-9149(60)90337-4; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; CLIFFTON EE, 1957, ANN NY ACAD SCI, V68, P209, DOI 10.1111/j.1749-6632.1957.tb42627.x; Collen D, 2000, CIRCULATION, V102, P1766; COLLEN D, 1991, BLOOD, V78, P3114; Crumrine R Christian, 2012, Exp Transl Stroke Med, V4, P10, DOI 10.1186/2040-7378-4-10; DELGADO C, 1992, CRIT REV THER DRUG, V9, P249; Doherty DH, 2005, BIOCONJUGATE CHEM, V16, P1291, DOI 10.1021/bc050172r; Dong XB, 2018, MEMBRANES-BASEL, V8, DOI 10.3390/membranes8020023; DREBORG S, 1990, CRIT REV THER DRUG, V6, P315; Erel O, 2014, CLIN BIOCHEM, V47, P326, DOI 10.1016/j.clinbiochem.2014.09.026; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242; GEIER GE, 1979, J BIOL CHEM, V254, P1408; Gladysheva IP, 2002, J BIOL CHEM, V277, P26846, DOI 10.1074/jbc.M202999200; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Hao Y, 2006, BIODRUGS, V20, P357, DOI 10.2165/00063030-200620060-00006; Harris JM, 2003, ADV DRUG DELIVER REV, V55, P1259, DOI 10.1016/S0169-409X(03)00107-8; Harris JM, 1997, ACS SYM SER, P680; Hoefer IE, 2009, J VASC INTERV RADIOL, V20, P951, DOI 10.1016/j.jvir.2009.03.043; Hu Y, 2007, J CONTROL RELEASE, V118, P7, DOI 10.1016/j.jconrel.2006.11.028; Hunt JA, 2008, THROMB HAEMOSTASIS, V100, P413, DOI 10.1160/TH08-04-0225; Jahan R, 2008, STROKE, V39, P1613, DOI 10.1161/STROKEAHA.107.507376; Jensen VJ, 1976, US patent, Patent No. 3950513; Joshi KK, 2010, PROCESS BIOCHEM, V45, P1251, DOI 10.1016/j.procbio.2010.04.014; KATRE NV, 1993, ADV DRUG DELIVER REV, V10, P91, DOI 10.1016/0169-409X(93)90005-O; Kerwin BA, 2002, PROTEIN SCI, V11, P1825, DOI 10.1110/ps.0208102; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Kusterle M, 2008, ACTA CHIM SLOV, V55, P594; Lapchak PA, 2002, STROKE, V33, P2279, DOI 10.1161/01.STR.0000028267.09604.7B; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Lawrence PB, 2016, CURR OPIN CHEM BIOL, V34, P88, DOI 10.1016/j.cbpa.2016.08.006; Lee P, 2015, MACROMOL BIOSCI, V15, P1332, DOI 10.1002/mabi.201500143; Lin XT, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-2; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Marder VJ, 2011, J THROMB HAEMOST, V9, P364, DOI 10.1111/j.1538-7836.2011.04370.x; Marder VJ, 2010, J THROMB HAEMOST, V8, P433, DOI 10.1111/j.1538-7836.2009.03701.x; MAXFIELD J, 1975, POLYMER, V16, P505, DOI 10.1016/0032-3861(75)90008-7; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Morgenstern J, 2017, INT J PHARMACEUT, V519, P408, DOI 10.1016/j.ijpharm.2017.01.040; Mu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068559; Nagai N, 2003, J THROMB HAEMOST, V1, P307, DOI 10.1046/j.1538-7836.2003.00078.x; Nagai N, 2001, BLOOD, V97, P3086, DOI 10.1182/blood.V97.10.3086; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Neffendorf JE, 2018, ACTA OPHTHALMOL, V96, P685, DOI 10.1111/aos.13547; Ozbakir HF, 2018, AICHE J, V64, P12, DOI 10.1002/aic.15893; PETERSEN TE, 1990, J BIOL CHEM, V265, P6104; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Rodriguez-Martinez JA, 2008, BIOTECHNOL BIOENG, V101, P1142, DOI 10.1002/bit.22014; Sadeghi S, 2003, J THROMB HAEMOST, V1, P2621, DOI 10.1046/j.1538-7836.2003.00441.x; Sawhney P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155831; SEHON AH, 1991, ADV DRUG DELIVER REV, V6, P203, DOI 10.1016/0169-409X(91)90041-A; Suzuki Y, 2004, STROKE, V35, P2402, DOI 10.1161/01.STR.0000140628.00927.1a; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Turecek PL, 2016, J PHARM SCI-US, V105, P460, DOI 10.1016/j.xphs.2015.11.015; Turner RB, 2002, J BIOL CHEM, V277, P33068, DOI 10.1074/jbc.M203782200; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; WIMAN B, 1978, EUR J BIOCHEM, V87, P143, DOI 10.1111/j.1432-1033.1978.tb12360.x; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WIMAN B, 1979, J BIOL CHEM, V254, P9291; WU HL, 1987, P NATL ACAD SCI USA, V84, P8292, DOI 10.1073/pnas.84.23.8292; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yang C, 2011, BIOCHEMISTRY-US, V50, P2585, DOI 10.1021/bi101926u; Yang K, 2003, PROTEIN ENG, V16, P761, DOI 10.1093/protein/gzg093; ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z; Zheng JC, 2012, IMMUNOPHARM IMMUNOT, V34, P866, DOI 10.3109/08923973.2012.666979	78	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217234	10.1371/journal.pone.0217234	http://dx.doi.org/10.1371/journal.pone.0217234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141522	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000045
J	Mustafa, HMJ; Ayob, M; Nazri, MZA; Kendall, G				Mustafa, Hossam M. J.; Ayob, Masri; Nazri, Mohd Zakree Ahmad; Kendall, Graham			An improved adaptive memetic differential evolution optimization algorithms for data clustering problems	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; HYBRIDIZATION; STABILITY; SEARCH	The performance of data clustering algorithms is mainly dependent on their ability to balance between the exploration and exploitation of the search process. Although some data clustering algorithms have achieved reasonable quality solutions for some datasets, their performance across real-life datasets could be improved. This paper proposes an adaptive memetic differential evolution optimisation algorithm (AMADE) for addressing data clustering problems. The memetic algorithm (MA) employs an adaptive differential evolution (DE) mutation strategy, which can offer superior mutation performance across many combinatorial and continuous problem domains. By hybridising an adaptive DE mutation operator with the MA, we propose that it can lead to faster convergence and better balance the exploration and exploitation of the search. We would also expect that the performance of AMADE to be better than MA and DE if executed separately. Our experimental results, based on several real-life benchmark datasets, shows that AMADE outperformed other compared clustering algorithms when compared using statistical analysis. We conclude that the hybridisation of MA and the adaptive DE is a suitable approach for addressing data clustering problems and can improve the balance between global exploration and local exploitation of the optimisation algorithm.	[Mustafa, Hossam M. J.; Ayob, Masri; Nazri, Mohd Zakree Ahmad] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Data Min & Optimizat Res Grp, Bangi, Malaysia; [Kendall, Graham] Univ Nottingham Malaysia, Asap Res Grp, Semenyih, Selangor, Malaysia	Universiti Kebangsaan Malaysia; University of Nottingham Malaysia	Mustafa, HMJ (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Data Min & Optimizat Res Grp, Bangi, Malaysia.	hasa.mustafa@gmail.com	Ayob, Masri/AAH-9732-2019; Kendall, Graham/B-8249-2008	Mustafa, Hossam/0000-0003-2015-7497; Kendall, Graham/0000-0003-2006-5103	FRGS of Ministry of Higher Education, Malaysia [FRGS/1/2018/ICT02/UKM/01/1]; Universiti Kebangsaan Malaysia grant Dana Impak Perdana [DIP-2014-039]	FRGS of Ministry of Higher Education, Malaysia; Universiti Kebangsaan Malaysia grant Dana Impak Perdana	This work was supported by the FRGS of Ministry of Higher Education, Malaysia. Ref. No: FRGS/1/2018/ICT02/UKM/01/1. Additionally, this work was supported by Universiti Kebangsaan Malaysia grant Dana Impak Perdana [DIP-2014-039].	Abbasi AA, 2007, COMPUT COMMUN, V30, P2826, DOI 10.1016/j.comcom.2007.05.024; Abdeyazdan M, 2014, J SUPERCOMPUT, V68, P574, DOI 10.1007/s11227-013-1053-1; Abualigah LM, 2017, APPL SOFT COMPUT, V60, P423, DOI 10.1016/j.asoc.2017.06.059; Ali MZ, 2017, IEEE T CYBERNETICS, V47, P2768, DOI 10.1109/TCYB.2016.2617301; Arivudainambi D, 2014, IEEE INT C NETW SENS, P261, DOI 10.1109/ICNSC.2014.6819636; Bouyer A, 2018, APPL SOFT COMPUT, V67, P172, DOI 10.1016/j.asoc.2018.03.011; Chandrasekar P, 2014, 2014 INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING APPLICATIONS (ICICA 2014), P138, DOI 10.1109/ICICA.2014.38; Das S, 2008, IEEE T SYST MAN CY A, V38, P218, DOI 10.1109/TSMCA.2007.909595; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng J, 2016, INT J PROD RES, V54, P3561, DOI 10.1080/00207543.2015.1084063; Esfandiari N, 2014, EXPERT SYST APPL, V41, P4434, DOI 10.1016/j.eswa.2014.01.011; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fan QQ, 2015, EXPERT SYST APPL, V42, P1551, DOI 10.1016/j.eswa.2014.09.046; Gong A., 2016, INT J CONTROL AUTOM, V9, P107, DOI [10.14257/ijca.2016.9.4.11, DOI 10.14257/IJCA.2016.9.4.11]; Gu XP, 2015, INT J ELEC POWER, V64, P664, DOI 10.1016/j.ijepes.2014.07.070; Gupta T., 2014, INT J ADV RES COMPUT, V4, P491; Han XH, 2017, ENG APPL ARTIF INTEL, V61, P1, DOI 10.1016/j.engappai.2016.11.003; Han Y, 2017, ENERGIES, V10, DOI 10.3390/en10010136; Hatamlou A, 2013, INFORM SCIENCES, V222, P175, DOI 10.1016/j.ins.2012.08.023; Hatamlou A, 2011, LECT NOTES ARTIF INT, V6954, P337, DOI 10.1007/978-3-642-24425-4_44; Holland J. H., 1992, ADAPTATION NATURAL A, DOI 10.7551/mitpress/1090.001.0001; Jaddi NS, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATICS AND CREATIVE MULTIMEDIA (ICICM), P278, DOI 10.1109/ICICM.2013.54; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jamil NA, 2015, PROCEEDINGS 5TH IEEE INTERNATIONAL CONFERENCE ON CONTROL SYSTEM, COMPUTING AND ENGINEERING (ICCSCE 2015), P287, DOI 10.1109/ICCSCE.2015.7482199; Jaradat G, 2016, APPL SOFT COMPUT, V44, P45, DOI 10.1016/j.asoc.2016.01.002; Jiang B, 2013, COMMUN NONLINEAR SCI, V18, P3134, DOI 10.1016/j.cnsns.2013.03.011; Kheng CW, 2012, INT J SYST SCI, V43, P1193, DOI 10.1080/00207721.2011.617526; Khurana R, 2013, ADV E-BUS RES, P1, DOI 10.4018/978-1-4666-4209-6; Kumar Y, 2015, SOFT COMPUT, V19, P3621, DOI 10.1007/s00500-015-1719-0; Kushwaha N, 2018, PATTERN RECOGN LETT, V115, P59, DOI 10.1016/j.patrec.2017.10.031; Langdon W, 2002, FDN GENETIC PROGRAMM, DOI [10.1162/evco.1998.6.3.253, DOI 10.1162/EVCO.1998.6.3.253]; Li Y, 2018, ENERGY, V162, P237, DOI 10.1016/j.energy.2018.07.200; Li Y, 2018, ENERGY, V147, P286, DOI 10.1016/j.energy.2018.01.036; Li YY, 2014, NEUROCOMPUTING, V134, P132, DOI 10.1016/j.neucom.2012.12.068; Lin JB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203071; Miller B. L., 1995, Complex Systems, V9, P193; Muller H, 2014, FOOD QUAL PREFER, V34, P70, DOI 10.1016/j.foodqual.2013.12.004; Mustafa HMJ, 2019, J INF COMMUN TECHNOL, V18, P77; Mustafi D, 2017, ADV INTELL SYST, V509, P123, DOI 10.1007/978-981-10-2525-9_12; Neri F, 2012, STUD COMPUT INTELL, V379, P3; Nikbakht H, 2015, IRAN CONF ELECTR ENG, P662, DOI 10.1109/IranianCEE.2015.7146297; Niu B, 2017, NAT COMPUT, V16, P45, DOI 10.1007/s11047-016-9542-9; Pandey AC, 2017, 2016 9 INT C CONT  C; Piotrowski AP, 2013, INFORM SCIENCES, V241, P164, DOI 10.1016/j.ins.2013.03.060; Popoola E., 2017, INT J NETW SECUR, V19, P660; Ramadan RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193142; Renders J. M., 1994, P 1 IEEE C EV COMP, P312, DOI DOI 10.1109/ICEC.1994.349948; Rodriguez-Lopez M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178528; Sabar NR, 2017, IEEE T EVOLUT COMPUT, V21, P315, DOI 10.1109/TEVC.2016.2602860; Sabar NR, 2013, P 6 MULTIDISCIPLINAR, P549; Sheng WG, 2014, IEEE T EVOLUT COMPUT, V18, P721, DOI 10.1109/TEVC.2013.2283513; Shi H, 2013, PROCEEDINGS OF THE 9TH INTERNATIONAL PIPELINE CONFERENCE - 2012, VOL 1, P139; Sivanandam S., 2008, INTRO GENETIC ALGORI, DOI DOI 10.1007/978-3-540-73190-0; Smith MR, 2014, MACH LEARN, V95, P225, DOI 10.1007/s10994-013-5422-z; Sorensen K, 2006, COMPUT OPER RES, V33, P1214, DOI 10.1016/j.cor.2004.09.011; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Taguchi G., 1987, SYSTEM EXPT DESIGN E; Talbi E., 2013, HYBRID METAHEURISTIC, DOI [10.1007/978-3-642-30671-6, DOI 10.1007/978-3-642-30671-6]; Tanabe R, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P71; Venkatakrishnan GR, 2018, LECT NOTES ELECTR EN, V446, P153, DOI 10.1007/978-981-10-4852-4_14; Wang C, 2018, SOFT COMPUT, V22, P1263, DOI 10.1007/s00500-016-2413-6; Wang HB, 2018, SOFT COMPUT, V22, P1313, DOI 10.1007/s00500-016-2418-1; Wang ZR, 2015, APPL SOFT COMPUT, V37, P572, DOI 10.1016/j.asoc.2015.08.003; Wangchamhan T, 2017, EXPERT SYST APPL, V90, P146, DOI 10.1016/j.eswa.2017.08.004; Wu M., 2012, INT J INNOV MANAG IN, V3, P99; Xiang WL, 2015, NEUROCOMPUTING, V158, P144, DOI 10.1016/j.neucom.2015.01.058; Yassen Esam Taha, 2015, Journal of Theoretical and Applied Information Technology, V73, P43; Yassen ET, 2017, COMPUT IND ENG, V113, P382, DOI 10.1016/j.cie.2017.09.034; Zhang CP, 2017, IOP C SER EARTH ENV, V63, DOI 10.1088/1755-1315/63/1/012020; Zhang CM, 2013, APPL SOFT COMPUT, V13, P2947, DOI 10.1016/j.asoc.2012.02.028; Zhang YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206832; Zhu ZX, 2011, IEEE T EVOLUT COMPUT, V15, P643, DOI 10.1109/TEVC.2011.2160399	72	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216906	10.1371/journal.pone.0216906	http://dx.doi.org/10.1371/journal.pone.0216906			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31137034	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300011
J	Nakakura, S; Nagata, Y; Shimizu, Y; Kawai, A; Tabuchi, H; Kiuchi, Y				Nakakura, Shunsuke; Nagata, Yuki; Shimizu, Yukiko; Kawai, Akiko; Tabuchi, Hitoshi; Kiuchi, Yoshiaki			Determination of iris thickness development in children using swept-source anterior-segment optical coherence tomography	PLOS ONE			English	Article							CHOROIDAL THICKNESS; OCULAR COMPONENTS; REFRACTIVE ERROR; ANGLE	Purpose The uvea comprises the iris, ciliary body, and choroid. However, the development of the anterior part (iris and ciliary body) in children is not yet fully elucidated. We investigated the iris thickness (IT) in children using swept-source anterior-segment optical coherence tomography (ASOCT). Methods In this retrospective, clinic-based study, we enrolled 41 children (mean +/- standard deviation: 6.8 +/- 3.3 years; range: 3-16; 17 males) with normal or mild refractive error. Horizontal scanning images of swept-source ASOCT were analyzed in temporal and nasal angle areas. The ITs at 1 and 2 mm from the pupil edge were measured using swept-source ASOCT. The association between IT and age, sex, and ocular morphological parameters (i.e., axial length, average corneal curvature, central corneal thickness, inter-scleral spur distance, and anterior chamber depth) was assessed using Pearson's correlation coefficient (r) and linear regression analysis. Results The average IT (temporal and nasal) at 1 and 2 mm were 0.432 +/- 0.060 (0.302-0.569 mm) and 0.337 +/- 0.045 (0.229-0.414 mm), respectively. There was a significant correlation between age and average IT (r = 0.45, P = 0.002 at 1 mm and r = 0.31, P = 0.042 at 2 mm). Multiple linear regression analysis revealed that age (coefficient: 0.01), axial length (-0.02), average corneal curvature (0.01), and anterior chamber depth (0.01) at 1 mm as well as age (0.00), average corneal curvature (0.09), anterior chamber depth (0.06), and male (-0.02) at 2 mm were identified as predictors of IT. Conclusions IT in children increases with age. Additionally, IT was thinner with longer axial length and in males, thicker in eyes with deeper anterior chamber and flatter corneal curvature. Our study may partly explain the development of eyeball structures in children.	[Nakakura, Shunsuke; Nagata, Yuki; Shimizu, Yukiko; Kawai, Akiko; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Tabuchi, Hitoshi; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Hiroshima University	Nakakura, S (corresponding author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	shunsukenakakura@yahoo.co.jp		Nakakura, Shunsuke/0000-0002-1094-1862				Akkaya S, 2018, INT OPHTHALMOL, V38, P2239, DOI 10.1007/s10792-017-0666-4; Bailey MD, 2008, INVEST OPHTH VIS SCI, V49, P4353, DOI 10.1167/iovs.08-2008; Batur M, 2017, CURR EYE RES, V42, P1445, DOI 10.1080/02713683.2017.1338349; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cheung CMG, 2019, EYE, V33, P14, DOI 10.1038/s41433-018-0158-4; GOTO H, 1990, INT OPHTHALMOL CLIN, V30, P279, DOI 10.1097/00004397-199030040-00014; Gupta V, 2007, J AAPOS, V11, P546, DOI 10.1016/j.jaapos.2007.06.014; Hashemi H, 2015, ACTA OPHTHALMOL, V93, pE74, DOI 10.1111/aos.12498; Invernizzi A, 2015, INVEST OPHTH VIS SCI, V56, P4796, DOI 10.1167/iovs.15-16483; Invernizzi A, 2014, BRIT J OPHTHALMOL, V98, P1245, DOI 10.1136/bjophthalmol-2013-304481; Jin PY, 2016, J GLAUCOMA, V25, P692, DOI 10.1097/IJG.0000000000000404; Jin PY, 2016, AM J OPHTHALMOL, V168, P164, DOI 10.1016/j.ajo.2016.05.008; Kobayashi Y, 2018, CASE REP OPHTHALM, V9, P449, DOI 10.1159/000493418; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Nakakura S, 2018, J GLAUCOMA, V27, P415, DOI 10.1097/IJG.0000000000000921; Phasukkijwatana N, 2018, RETINA-J RET VIT DIS, V38, P1652, DOI 10.1097/IAE.0000000000001907; Pucker AD, 2013, INVEST OPHTH VIS SCI, V54, P4710, DOI 10.1167/iovs.13-11658; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P7578, DOI 10.1167/iovs.13-12772; Shimizu Y, 2016, J AAPOS, V21, P57, DOI 10.1016/j.jaapos.2016.10.005; Sng CC, 2013, INVEST OPHTH VIS SCI, V54, P2829, DOI 10.1167/iovs.12-11250; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Twelker JD, 2009, OPTOMETRY VISION SCI, V86, P918, DOI 10.1097/OPX.0b013e3181b2f903; Xiong SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45059	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217656	10.1371/journal.pone.0217656	http://dx.doi.org/10.1371/journal.pone.0217656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136628	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300054
J	Toksvang, LN; Schmidt, MS; Arup, S; Larsen, RH; Frandsen, TL; Schmiegelow, K; Rank, CU				Toksvang, Linea Natalie; Schmidt, Magnus Stroh; Arup, Sofie; Larsen, Rikke Hebo; Frandsen, Thomas Leth; Schmiegelow, Kjeld; Rank, Cecilie Utke			Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review	PLOS ONE			English	Review							NODULAR REGENERATIVE HYPERPLASIA; SINUSOIDAL OBSTRUCTION SYNDROME; VENOOCCLUSIVE DISEASE; LONG-TERM; THIOPURINE METHYLTRANSFERASE; MAINTENANCE THERAPY; VARICEAL HEMORRHAGE; ORAL 6-THIOGUANINE; LIVER TOXICITY; IBD PATIENTS	Background The recently established association between higher levels of DNA-incorporated thioguanine nucleotides and lower relapse risk in childhood acute lymphoblastic leukaemia (ALL) calls for reassessment of prolonged 6-thioguanine (6TG) treatment, while avoiding the risk of hepatotoxicity. Objectives To assess the incidence of hepatotoxicity in patients treated with 6TG, and to explore if a safe dose of continuous 6TG can be established. Data sources Databases, conference proceedings, and reference lists of included studies were systematically searched for 6TG and synonyms from 1998-2018. Methods We included studies of patients with ALL or inflammatory bowel disorder (IBD) treated with 6TG, excluding studies with 6TG as part of an intensive chemotherapy regimen. We uploaded a protocol to PROSPERO (registration number CRD42018089424). Database and manual searches yielded 1823 unique records. Of these, 395 full-texts were screened for eligibility. Finally, 134 reports representing 42 studies were included. Results and conclusions We included data from 42 studies of ALL and IBD patients; four randomised controlled trials (RCTs) including 3,993 patients, 20 observational studies including 796 patients, and 18 case reports including 60 patients. Hepatotoxicity in the form of sinusoidal obstruction syndrome (SOS) occurred in 9-25% of the ALL patients in two of the four included RCTs using 6TG doses of 40-60 mg/m(2)/day, and long-term hepatotoxicity in the form of nodular regenerative hyperplasia (NRH) was reported in 2.5%. In IBD patients treated with 6TG doses of approximately 23 mg/m(2)/day, NRH occurred in 14% of patients. At a 6TG dose of approximately 12 mg/m(2)/day, NRH was reported in 6% of IBD patients, which is similar to the background incidence. According to this review, doses at or below 12 mg/m(2)/day are rarely associated with notable hepatotoxicity and can probably be considered safe.	[Toksvang, Linea Natalie; Schmidt, Magnus Stroh; Arup, Sofie; Larsen, Rikke Hebo; Frandsen, Thomas Leth; Schmiegelow, Kjeld] Univ Copenhagen, Rigshosp, Dept Paediat & Adolescent Med, Copenhagen, Denmark; [Schmiegelow, Kjeld] Univ Copenhagen, Fac Med, Inst Clin Med, Copenhagen, Denmark; [Rank, Cecilie Utke] Univ Copenhagen, Rigshosp, Dept Haematol, Copenhagen, Denmark; [Rank, Cecilie Utke] Univ Copenhagen, Rigshosp, Paediat Oncol Res Lab, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Schmiegelow, K (corresponding author), Univ Copenhagen, Rigshosp, Dept Paediat & Adolescent Med, Copenhagen, Denmark.; Schmiegelow, K (corresponding author), Univ Copenhagen, Fac Med, Inst Clin Med, Copenhagen, Denmark.	Kjeld.schmiegelow@regionh.dk	Toksvang, Linea Natalie/GMW-5495-2022; Frandsen, Thomas/H-7784-2017	Utke Rank, Cecilie/0000-0003-0578-3887; Schmidt, Magnus Stroh/0000-0003-3425-9881; Toksvang, Linea Natalie/0000-0002-9871-7637; Schmiegelow, Kjeld/0000-0002-0829-4993; Frandsen, Thomas/0000-0001-8495-5274	Danish Childhood Cancer Foundation; Danish Cancer Society	Danish Childhood Cancer Foundation; Danish Cancer Society(Danish Cancer Society)	The Danish Childhood Cancer Foundation and the Danish Cancer Society supported this work financially. The funders were not involved in the protocol development, review conduct, data analysis and interpretation, or dissemination of the systematic review.	ADAMSON PC, 1994, LEUKEMIA RES, V18, P805, DOI 10.1016/0145-2126(94)90159-7; Bisschop D, 2001, THERAPIE, V56, P67; Broxson EH, 2005, PEDIATR BLOOD CANCER, V44, P226, DOI 10.1002/pbc.20202; Cheung TK, 2003, INTERN MED J, V33, P44, DOI 10.1046/j.1445-5994.2003.00321.x; Chojnacki C, 2012, PRZ GASTROENTEROL, V7, P52, DOI 10.5114/pg.2012.27224; De Boer NKH, 2008, SCAND J GASTROENTERO, V43, P604, DOI 10.1080/00365520701800266; de Boer NKH, 2007, NAT CLIN PRACT GASTR, V4, P686, DOI 10.1038/ncpgasthep1000; de Boer NKH, 2006, DIGESTION, V73, P25, DOI 10.1159/000091662; de Boer NKH, 2005, LIVER TRANSPLANT, V11, P1300, DOI 10.1002/lt.20554; De Boer NKH, 2005, ALIMENT PHARM THERAP, V22, P447, DOI 10.1111/j.1365-2036.2005.02581.x; Deibert P, 2003, ALIMENT PHARM THERAP, V18, P183, DOI 10.1046/j.1365-2036.2003.01652.x; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DeLeve LD, 2011, VASCULAR LIVER DISEASE: MECHANISMS AND MANAGEMENT, P25, DOI 10.1007/978-1-4419-8327-5_2; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dubinsky MC, 2003, GASTROENTEROLOGY, V125, P298, DOI 10.1016/S0016-5085(03)00938-7; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Engen RM, 2006, CURR DRUG TARGETS, V7, P1641, DOI 10.2174/138945006779025446; Escherich G, 2011, LEUKEMIA, V25, P953, DOI 10.1038/leu.2011.37; Ferlitsch A, 2007, AM J GASTROENTEROL, V102, P2495, DOI 10.1111/j.1572-0241.2007.01530.x; Fritz E, 2008, INFLAMM BOWEL DIS, V14, P582, DOI 10.1002/ibd.20323; Geller SA, 2004, AM J SURG PATHOL, V28, P1204, DOI 10.1097/01.pas.0000128665.12063.97; Ghabril M, 2014, SEMIN LIVER DIS, V34, P240, DOI 10.1055/s-0034-1375963; Gilissen LPL, 2007, DIGEST LIVER DIS, V39, P156, DOI 10.1016/j.dld.2006.10.007; Gisbert JP, 2007, AM J GASTROENTEROL, V102, P1518, DOI 10.1111/j.1572-0241.2007.01187.x; GRINER PF, 1976, ANN INTERN MED, V85, P578, DOI 10.7326/0003-4819-85-5-578; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Hartleb M, 2011, WORLD J GASTROENTERO, V17, P1400, DOI 10.3748/wjg.v17.i11.1400; Hasyagar CP, 2007, AM J GASTROENTEROL, V102, pS490, DOI 10.14309/00000434-200709002-01012; Ivastinovic D, 2004, GASTROENTEROLOGY, V126, pA630; Jacobs SS, 2007, PEDIATR BLOOD CANCER, V49, P250, DOI 10.1002/pbc.20964; Jharap B, 2011, BRIT J PHARMACOL, V163, P722, DOI 10.1111/j.1476-5381.2011.01265.x; Kane S, 2004, INFLAMM BOWEL DIS, V10, P652, DOI 10.1097/00054725-200409000-00023; Karim H, 2013, BIOCHEM BIOPH RES CO, V437, P280, DOI 10.1016/j.bbrc.2013.06.067; Kornbluth A, 2002, GASTROENTEROLOGY, V122, pA221; Lancaster DL, 2001, BRIT J CLIN PHARMACO, V51, P531, DOI 10.1046/j.0306-5251.2001.01391.x; Lennard L, 2006, CLIN PHARMACOL THER, V80, P375, DOI 10.1016/j.clpt.2006.07.002; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mao Jun-Qing, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P788; Marasco G, 2016, AM J GASTROENTEROL, V111, P767, DOI 10.1038/ajg.2016.210; Mares WGN, 2009, J CROHNS COLITIS, V3, P128, DOI 10.1016/j.crohns.2009.02.002; Meijer B, 2018, DIGEST LIVER DIS, V50, P48, DOI 10.1016/j.dld.2017.09.128; Meijer B, 2017, UNITED EUR GASTROENT, V5, P658, DOI 10.1177/2050640616680550; Merino JM, 2000, PEDIATR HEMAT ONCOL, V17, P429, DOI 10.1080/08880010050034391; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moriyama T, 2016, NAT GENET, V48, P367, DOI 10.1038/ng.3508; Moulik NR, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26495; Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853; Musumba CO, 2013, ALIMENT PHARM THER, V38, P1025, DOI 10.1111/apt.12490; National Institutes of Health (NIH), STUD QUAL ASS TOOLS; Nielsen SN, 2015, J PEDIAT HEMATOL ONC, V37, pE206, DOI 10.1097/MPH.0000000000000246; Nielsen SN, 2017, LANCET ONCOL, V18, P515, DOI 10.1016/S1470-2045(17)30154-7; Oancea I, 2013, GUT, V62, P594, DOI 10.1136/gutjnl-2012-302274; Omer OS, 2015, UNITED EUR GASTROENT, V1, pA437; Oskarsson T, 2016, HAEMATOLOGICA, V101, P68, DOI 10.3324/haematol.2015.131680; Pavlidis P, 2014, INFLAMM BOWEL DIS, V20, P2239, DOI 10.1097/MIB.0000000000000206; Qasim A, 2007, SCAND J GASTROENTERO, V42, P194, DOI 10.1080/00365520600825166; Radys W., 2006, PEDIAT WSPOLCZESNA, V8, P131; Ravikumara M, 2006, J PEDIATR GASTR NUTR, V42, P535, DOI 10.1097/01.mpg.0000221901.76404.07; Rawat D, 2011, J PEDIATR GASTR NUTR, V53, P478, DOI 10.1097/MPG.0b013e31822960e9; Relling M V, 2018, CLIN PHARM THER; Rulyak SJ, 2003, J CLIN GASTROENTEROL, V36, P234, DOI 10.1097/00004836-200303000-00010; Saleem R, 2013, UNITED EUR GASTROENT, V1, pA526; Salerno A., 2014, British Journal of Medical Practitioners, V7, pa711; Sanderson J, 2004, ANN CLIN BIOCHEM, V41, P294, DOI 10.1258/0004563041201455; Santiago R, 2017, EXPERT OPIN PHARMACO, V18, P1081, DOI 10.1080/14656566.2017.1340938; Schmiegelow K, 2016, LANCET ONCOL, V17, pE231, DOI 10.1016/S1470-2045(16)30035-3; Seiderer J, 2005, J HEPATOL, V43, P303, DOI 10.1016/j.jhep.2005.02.051; Shastri S, 2004, ARCH PATHOL LAB MED, V128, P49; Stoneham S, 2003, BRIT J HAEMATOL, V123, P100, DOI 10.1046/j.1365-2141.2003.04578.x; Stork LC, 2010, BLOOD, V115, P2740, DOI 10.1182/blood-2009-07-230656; Teml A, 2007, WIEN KLIN WOCHENSCHR, V119, P519, DOI 10.1007/s00508-007-0841-0; Thomson B, 2004, PEDIATR BLOOD CANCER, V43, P571, DOI 10.1002/pbc.20128; Toksvang LN, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26519; van Asseldonk DP, 2016, INFLAMM BOWEL DIS, V22, P2112, DOI 10.1097/MIB.0000000000000869; van den Berg SA, 2016, J CROHNS COLITIS, V10, P159, DOI 10.1093/ecco-jcc/jjv189; Vora A, 2006, LANCET, V368, P1339, DOI 10.1016/S0140-6736(06)69558-5; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; Ward MG, 2013, J GASTROEN HEPATOL, V28, P99; Ward MG, 2017, UNITED EUR GASTROENT, V5, P563, DOI 10.1177/2050640616663438; Wenzl HH, 2004, AM J GASTROENTEROL, V99, P1195, DOI 10.1111/j.1572-0241.2004.30292.x; Wray L, 2014, PEDIATR BLOOD CANCER, V61, P2086, DOI 10.1002/pbc.25057	82	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0212157	10.1371/journal.pone.0212157	http://dx.doi.org/10.1371/journal.pone.0212157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125338	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700002
J	Aoun, L; Larnier, S; Weiss, P; Cazales, M; Herbulot, A; Ducommun, B; Vieu, C; Lobjois, V				Aoun, Laurene; Larnier, Stanislas; Weiss, Pierre; Cazales, Martine; Herbulot, Ariane; Ducommun, Bernard; Vieu, Christophe; Lobjois, Valerie			Measure and characterization of the forces exerted by growing multicellular spheroids using microdevice arrays	PLOS ONE			English	Article							TUMOR SPHEROIDS; SOLID STRESS; CELLS; GROWTH	Growing multicellular spheroids recapitulate many features of expanding microtumours, and therefore they are an attractive system for biomechanical studies. Here, we report an original approach to measure and characterize the forces exerted by proliferating multicellular spheroids. As force sensors, we used high aspect ratio PDMS pillars arranged as a ring that supports a growing breast tumour cell spheroid. After optical imaging and determination of the force application zones, we combined 3D reconstruction of the shape of each deformed PDMS pillar with the finite element method to extract the forces responsible for the experimental observation. We found that the force exerted by growing spheroids ranges between 100nN and 300nN. Moreover, the exerted force was dependent on the pillar stiffness and increased over time with spheroid growth.	[Aoun, Laurene; Weiss, Pierre; Cazales, Martine; Ducommun, Bernard; Lobjois, Valerie] Univ Toulouse, CNRS, UT3, ITAV, Toulouse, France; [Aoun, Laurene; Larnier, Stanislas; Herbulot, Ariane; Vieu, Christophe] CNRS, LAAS, Toulouse, France; [Aoun, Laurene; Larnier, Stanislas; Herbulot, Ariane; Vieu, Christophe] Univ Toulouse, LAAS, Toulouse, France; [Ducommun, Bernard] CHU Toulouse, Toulouse, France; [Vieu, Christophe] Univ Toulouse, INSA, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; CHU de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse	Lobjois, V (corresponding author), Univ Toulouse, CNRS, UT3, ITAV, Toulouse, France.; Vieu, C (corresponding author), CNRS, LAAS, Toulouse, France.; Vieu, C (corresponding author), Univ Toulouse, LAAS, Toulouse, France.; Vieu, C (corresponding author), Univ Toulouse, INSA, Toulouse, France.	cvieu@laas.fr; valerie.lobjois@itav.fr		Lobjois, Valerie/0000-0003-2428-2084; DUCOMMUN, Bernard/0000-0002-7126-8368	CNRS; Universite Paul Sabatier; 2RITC foundation (Toulouse, France); Region MidiPyrenees	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; 2RITC foundation (Toulouse, France); Region MidiPyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	This work was supported by the CNRS, Universite Paul Sabatier and Region MidiPyrenees. LA was a recipient of a phD fellowship from the 2RITC foundation (Toulouse, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110; Aoun L, 2014, LAB CHIP, V14, P2344, DOI 10.1039/c4lc00197d; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Costa EC, 2016, BIOTECHNOL ADV, V34, P1427, DOI 10.1016/j.biotechadv.2016.11.002; Delarue M, 2014, BIOPHYS J, V107, P1821, DOI 10.1016/j.bpj.2014.08.031; Dolega ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14056; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Lemmon Christopher A, 2005, Mech Chem Biosyst, V2, P1; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Northey JJ, 2017, CANCER DISCOV, V7, P1224, DOI 10.1158/2159-8290.CD-16-0733; Pillet F, 2014, BBA-GEN SUBJECTS, V1840, P1028, DOI 10.1016/j.bbagen.2013.11.019; Soubies E, 2013, ICPRAM INT C PATT RE; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109	21	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217227	10.1371/journal.pone.0217227	http://dx.doi.org/10.1371/journal.pone.0217227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120960	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700073
J	Cid, L; Pires, A; Borrego, C; Duarte-Mendes, P; Teixeira, DS; Moutao, JM; Monteiro, D				Cid, Luis; Pires, Ana; Borrego, Carla; Duarte-Mendes, Pedro; Teixeira, Diogo S.; Moutao, Joao M.; Monteiro, Diogo			Motivational determinants of physical education grades and the intention to practice sport in the future	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; BASIC PSYCHOLOGICAL NEEDS; ACHIEVEMENT GOAL; FIT INDEXES; ORIENTATIONS; QUESTIONNAIRE; COMPETENCE; VALIDATION; AUTONOMY; EXERCISE	Self-Determination Theory (SDT) is amongst motivational frameworks the most popular and contemporary approach to human motivation, being applied in the last decades in several domains, including sport, exercise and physical education (PE). Additionally, Achievement Goal Theory (AGT) has presented evidence of how contextual factors may influence student's behavior in this particular context. The main purpose of this study was to analyze the motivational climate created by the teacher in the classroom, students' satisfaction of Basic Psychological Needs (BPN), and how their behavioral regulation could explain PE grades and intention to practice sports in the future. Method: A total of 618 students (290 female; 328 male) from the 6th to the 9th school level, aged between 10 and 18 years (M = 13.3; SD = 1.7) participated in this study. The following surveys were used for the proposed variables: Learning and Performance Orientations in Physical Education Classes Questionnaire (LAPOPECQ); the Basic Psychological Needs in Exercise Scale (BPNESp); and the Perceived Locus of Causality (PLOCp). Intentions to practice sport/physical activity in the future were assessed through a single item. Students' PE grade was obtained through his/her teacher final assessment. Structural Equation Analysis was performed via AMOS 23.0. Results: After analyzing modification indices and model adjustment, the final model emerged: learning climate > BPN > autonomous motivation > intentions/PE grade. Results interpretation seems to indicate that i) the satisfaction of BPN are influenced by motivational climate (i.e., learning climate), ii) the individuals' motivation is influenced by the satisfaction of three basic psychological needs (i.e., particularly competence), and iii) the motivational regulations have direct and significant effects with intention to practice sports outside school in the future and PE grades. Discussion & Conclusion: The main results showed that a climate oriented for learning has a positive impact on basic psychological needs satisfaction of students. However, only competence satisfaction had a significant positive relationship with students' autonomous motivation, which in turn had a significant positive relation with PE grade, as well as for intentions for leisure-time sport/physical activity practice.	[Cid, Luis; Borrego, Carla; Moutao, Joao M.; Monteiro, Diogo] Polytech Inst Santarem ESDRM IPSantarem, Sport Sci Sch Rio Maior, Rio Maior, Portugal; [Cid, Luis; Moutao, Joao M.; Monteiro, Diogo] Res Ctr Sports Sci Hlth & Human Dev CIDESD, Vila Real, Portugal; [Pires, Ana] Sch Grp D Antonio Ataide Castanheira Ribatejo, Vila Franca Xira, Portugal; [Borrego, Carla] Life Qual Res Ctr CIEQV, Santarem, Portugal; [Duarte-Mendes, Pedro] Polytech Inst Castelo Branco ESE IPCB, Dept Sport & Well Being, Castelo Branco, Portugal; [Duarte-Mendes, Pedro] Polytech Inst Castelo Branco, Sport Hlth & Exercise Res Unit SHERU, Castelo Branco, Portugal; [Teixeira, Diogo S.] Lusofona Univ ULHT, Fac Phys Educ & Sport, Lisbon, Portugal	Polytechnic Institute of Castelo Branco; Lusofona University	Cid, L (corresponding author), Polytech Inst Santarem ESDRM IPSantarem, Sport Sci Sch Rio Maior, Rio Maior, Portugal.; Cid, L (corresponding author), Res Ctr Sports Sci Hlth & Human Dev CIDESD, Vila Real, Portugal.	luiscid@esdrm.ipsantarem.pt	Teixeira, Diogo/J-5489-2019; Duarte-Mendes, Pedro/AAA-5539-2019; Cid, Luis/K-3281-2012; Monteiro, Diogo/F-1202-2015; Moutao, Joao/C-9679-2018	Teixeira, Diogo/0000-0003-4587-5903; Cid, Luis/0000-0001-8156-3291; Monteiro, Diogo/0000-0002-7179-6814; Duarte-Mendes, Pedro/0000-0001-5055-2696; Moutao, Joao/0000-0003-0457-0070; Borrego, Carla Chicau/0000-0002-7881-3453	National Funds through FCT - Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Fund for Regional Development (FEDER) [POCI-01-0145FEDER-006969]	National Funds through FCT - Portuguese Foundation for Science and Technology; European Fund for Regional Development (FEDER)(European Commission)	This project was supported by the National Funds through FCT - Portuguese Foundation for Science and Technology (UID/DTP/04045/2013) - and the European Fund for Regional Development (FEDER) allocated byEuropean Union through the COMPETE 2020 Programme (POCI-01-0145FEDER-006969) - Competitiveness and Internationalization (POCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 2006, CONSTRUCTING TPB QUE; Almagro BJ, 2015, SPORT PSYCHOL, V29, P15, DOI 10.1123/tsp.2013-0045; Baena-Extremera A, 2016, UNIV PSYCHOL, V15, DOI 10.11144/Javeriana.upsy15-2.mpsd; Biddle S, 1999, EUR PSYCHOL, V4, P83, DOI 10.1027//1016-9040.4.4.83; Chatzisarantis N., 2007, INTRINSIC MOTIVATION, P281; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cid L, 2013, 3 C GAL PORT PSIC AT; Cid L, 2016, SPAN J PSYCHOL, V19, DOI 10.1017/sjp.2016.6; Deci E., 2002, HDB DELF DETERMINATI, P3; Deci E. L., 1985, INTRINSIC MOTIVATION; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Duda J. L., 2007, Social psychology in sport, P117; Duda J. L., 2001, ADV MOTIVATION SPORT, P129, DOI DOI 10.1007/978-1-4899-2271-7; DUDA JL, 1992, J EDUC PSYCHOL, V84, P290, DOI 10.1037/0022-0663.84.3.290; Duda JL, 2013, INT J SPORT EXERC PS, V11, P311, DOI 10.1080/1612197X.2013.839414; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fernandes H, 2004, CUADERNOS PSICOLOGIA, V4, P67; Fernandes Helder Miguel, 2005, Estud. psicol. (Natal), V10, P385, DOI 10.1590/S1413-294X2005000300007; Georgiadis M. M., 2001, EUROPEAN J SPORT SCI, V1, P1, DOI [10. 1080/17461390100071502, DOI 10.1080/17461390100071502]; GOUDAS M, 1994, BRIT J EDUC PSYCHOL, V64, P453, DOI 10.1111/j.2044-8279.1994.tb01116.x; Hagger M., 2008, INT REV SPORT EXER P, V1, P79, DOI [10.1080/17509840701827437, DOI 10.1080/17509840701827437]; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hanton S, 2006, LIT REV SPORT PSYCHO, P159; Hein V, 2007, J SPORT SCI, V25, P149, DOI 10.1080/02640410600598315; Keshtidar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171673; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Monteiro D, 2018, INT J SPORT PSYCHOL, V49, P484, DOI 10.7352/IJSP.2018.49.484; Monteiro D, 2019, PERCEPT MOTOR SKILL, V126, P323, DOI 10.1177/0031512519825700; Monteiro D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01575; Mota J, 2018, J PHYS ACT HEALTH, V15, pS398, DOI 10.1123/jpah.2018-0541; MOUTAO JMRP, 2012, SPAN J PSYCHOL, V15, P399, DOI DOI 10.5209/REV_SJOP.2012.V15.N1; Nevitt J, 2001, STRUCT EQU MODELING, V8, P353, DOI 10.1207/S15328007SEM0803_2; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Ntoumanis N, 2001, BRIT J EDUC PSYCHOL, V71, P225, DOI 10.1348/000709901158497; Ntoumanis N, 1999, J SPORT SCI, V17, P643, DOI 10.1080/026404199365678; Ntoumanis N, 2005, J EDUC PSYCHOL, V97, P444, DOI 10.1037/0022-0663.97.3.444; PAPAIOANNOU A, 1994, RES Q EXERCISE SPORT, V65, P11, DOI 10.1080/02701367.1994.10762203; Papaioannou A, 1998, RES Q EXERCISE SPORT, V69, P267, DOI 10.1080/02701367.1998.10607693; Pelletier LG, 2001, MOTIV EMOTION, V25, P279, DOI 10.1023/A:1014805132406; Pires A., 2010, Motri., V6, P33; Rodrigues F, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02141; Ryan R., 2007, INTRINSIC MOTIVATION, P1; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Sarrazin P, 2002, EUR J SOC PSYCHOL, V32, P395, DOI 10.1002/ejsp.98; Sevil-Serrano J, 2016, SPORT TK, V5, P103; Spray CM, 2006, EUR J SPORT SCI, V6, P43, DOI 10.1080/17461390500422879; Standage M, 2005, BRIT J EDUC PSYCHOL, V75, P411, DOI 10.1348/000709904X22359; Standage M, 2003, J EDUC PSYCHOL, V95, P97, DOI 10.1037/0022-0663.95.1.97; Standage M., 2007, PERCEPT MOT SKI, V111, P407; Vierling KK, 2007, PSYCHOL SPORT EXERC, V8, P795, DOI 10.1016/j.psychsport.2006.12.006; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; Wang JCK, 2016, PSYCHOL SPORT EXERC, V23, P13, DOI 10.1016/j.psychsport.2015.10.004; Wu M.L, 2010, STRUCTURAL EQUATION	56	24	25	9	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217218	10.1371/journal.pone.0217218	http://dx.doi.org/10.1371/journal.pone.0217218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120973	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700070
J	Dias, BS; Frisk, MG; Jordaan, A				Dias, Beatriz S.; Frisk, Michael G.; Jordaan, Adrian			Opening the tap: Increased riverine connectivity strengthens marine food web pathways	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; HERRING CLUPEA-HARENGUS; COD GADUS-MORHUA; FORAGE FISH; HYDROLOGIC CONNECTIVITY; EXPLOITED ECOSYSTEMS; ANADROMOUS FISH; GULF; MODEL; PREY	Reduction of ecosystem connectivity has long-lasting impacts on food webs. Anadromous fish, which migrate from marine to freshwater ecosystems to complete reproduction, have seen their historically larger ecosystem role undercut by widespread riverine habitat fragmentation and other impacts mainly derived from anthropogenic sources. The result has been extensive extirpations and increased susceptibility to a suite of environmental factors that currently impede recovery. Under this present-day context of reduced productivity and connectivity, aggressive management actions and enforcement of catch limits including bycatch caps and complete moratoria on harvest have followed. What remains less understood are the implications of changes to food webs that co-occurred. What benefits restoration could provide in terms of ecosystem functioning in relation to economic costs associated with dam removal and remediation is unknown and can limit the scope and value of restoration activities. Here we employ, historical landscape-based biomass estimates of anadromous alosine for the first time in an ecosystem modeling of the Northeast US large marine ecosystem ( LME), to evaluate the value of improving connectivity by measuring the increase in energy flow and population productivity. We compared a restored alosine model to a contemporary model, analyzing the impacts of the potential increase of connectivity between riverine and oceanic systems. There was the potential for a moderate biomass increase of piscivorous species with high economic value, including Atlantic cod, and for a major increase for species of conservation concern such as pelagic sharks, seabirds and marine mammals. Our study highlights the benefits of increased connectivity between freshwater and ocean ecosystems. We demonstrate the significant role anadromous forage fish could play in improving specific fisheries and overall ecosystem functioning, mainly through the diversification of species capable of transferring primary production to upper trophic levels, adding to benefits associated with their restoration.	[Dias, Beatriz S.; Jordaan, Adrian] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Dias, Beatriz S.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Frisk, Michael G.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	University of Massachusetts System; University of Massachusetts Amherst; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Dias, BS (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.; Dias, BS (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	bdossantosdi@eco.umass.edu	Jordaan, Adrian/GRF-1661-2022; Jordaan, Adrian/E-6962-2011	dos Santos Dias, Beatriz/0000-0001-5905-4044; Jordaan, Adrian/0000-0001-9510-8011	CAPES [99999.001096/2013-03]; Lenfest Ocean Program at Pew Charitable Trusts [CID 00025472]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Lenfest Ocean Program at Pew Charitable Trusts	CAPES supported BSD through a PhD grant (99999.001096/2013-03). This research was also funded by the Lenfest Ocean Program at Pew Charitable Trusts (CID 00025472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames EP, 2013, FISH RES, V141, P70, DOI 10.1016/j.fishres.2012.09.011; Banaru D, 2013, J MARINE SYST, V111, P45, DOI 10.1016/j.jmarsys.2012.09.010; Barber BL, 2018, MAR COAST FISH, V10, P236, DOI 10.1002/mcf2.10021; Bethoney ND, 2014, ICES J MAR SCI, V71, P1246, DOI 10.1093/icesjms/fst013; Bowden AA, 2014, ICES J MAR SCI, V71, P666, DOI 10.1093/icesjms/fst130; Bozeman EL Jr, 1989, SPECIES PROFILES LIF; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Christensen V., 2008, ECOPATH ECOSIM VERSI, V281, P1; Coll M, 2007, J MARINE SYST, V67, P119, DOI 10.1016/j.jmarsys.2006.10.002; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P128, DOI 10.1093/icesjms/fst075; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Engelhard GH, 2014, ICES J MAR SCI, V71, P90, DOI 10.1093/icesjms/fst087; Essington TE, 2015, P NATL ACAD SCI USA, V112, pE3316, DOI 10.1073/pnas.1508822112; Field GW, 1914, T AM FISH SOC, V43, P143, DOI 10.1577/1548-8659(1913)43[143:AFOM]2.0.CO;2; Freon P, 2005, B MAR SCI, V76, P385; Furey NB, 2017, T AM FISH SOC, V146, P450, DOI 10.1080/00028487.2017.1285353; Gahagan BI, 2010, T AM FISH SOC, V139, P1069, DOI 10.1577/T09-128.1; Garrison LP, 2000, ICES J MAR SCI, V57, P723, DOI 10.1006/jmsc.2000.0713; Gascuel D, 2008, ECOL MODEL, V217, P33, DOI 10.1016/j.ecolmodel.2008.05.012; Golet WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075480; Guan L, 2017, ICES J MAR SCI, V74, P2379, DOI 10.1093/icesjms/fsx064; Hall CJ, 2012, BIOSCIENCE, V62, P723, DOI 10.1525/bio.2012.62.8.5; Hall CJ, 2011, LANDSCAPE ECOL, V26, P95, DOI 10.1007/s10980-010-9539-1; Heymans JJ, 2007, ECOSYSTEMS, V10, P488, DOI 10.1007/s10021-007-9034-y; Heymans JJ, 2016, ECOL MODEL, V331, P173, DOI 10.1016/j.ecolmodel.2015.12.007; Hilborn R, 2017, FISH RES, V191, P211, DOI 10.1016/j.fishres.2017.01.008; Hunt GL, 2006, PROG OCEANOGR, V68, P115, DOI 10.1016/j.pocean.2006.02.008; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Iafrate J, 2008, ENVIRON BIOL FISH, V81, P101, DOI 10.1007/s10641-006-9178-1; Kearney KA., 2017, J OPEN SOURCE SOFTW, V2; Koehn LE, 2016, ECOL MODEL, V335, P87, DOI 10.1016/j.ecolmodel.2016.05.010; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Link J.S., 2006, DOCUMENTATION ENERGY; Link J, 2008, J MARINE SYST, V74, P453, DOI 10.1016/j.jmarsys.2008.03.007; Link JS, 2010, ECOL MODEL, V221, P1580, DOI 10.1016/j.ecolmodel.2010.03.012; Mattocks S, 2017, BIOSCIENCE, V67, P713, DOI 10.1093/biosci/bix069; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McClatchie S, 2017, GEOPHYS RES LETT, V44, P1877, DOI 10.1002/2016GL071751; McClenachan L, 2015, ECOL SOC, V20, DOI 10.5751/ES-07585-200231; McDermott SP, 2015, J FISH BIOL, V86, P1811, DOI 10.1111/jfb.12692; Munroe TA., 2000, OVERVIEW BIOL ECOLOG; NEFSC, 2018, 65 NE REG STOCK ASS; NOAA, NOAA NAT MAR FISH SE; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz WJ, 2002, FISH RES, V57, P237, DOI 10.1016/S0165-7836(01)00359-9; Palkovacs EP, 2014, EVOL APPL, V7, P212, DOI 10.1111/eva.12111; PALOMARES ML, 1989, AUST J MAR FRESH RES, V40, P259, DOI 10.1071/MF9890259; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Penton PM, 2012, CAN J ZOOL, V90, P248, DOI 10.1139/Z11-132; Penton PM, 2014, CAN J ZOOL, V92, P377, DOI 10.1139/cjz-2013-0261; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; POLOVINA JJ, 1984, CORAL REEFS, V3, P1, DOI 10.1007/BF00306135; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Pringle C, 2003, HYDROL PROCESS, V17, P2685, DOI 10.1002/hyp.5145; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Richardson DE, 2014, CAN J FISH AQUAT SCI, V71, P1349, DOI 10.1139/cjfas-2013-0489; Rose GA, 2002, ICES J MAR SCI, V59, P1018, DOI 10.1006/jmsc.2002.1252; Rose GA, 2015, CAN J FISH AQUAT SCI, V72, P1789, DOI 10.1139/cjfas-2015-0346; Roy SG, 2018, P NATL ACAD SCI USA, V115, P12069, DOI 10.1073/pnas.1807437115; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Selden RL, 2018, GLOBAL CHANGE BIOL, V24, P117, DOI 10.1111/gcb.13838; Sherwood GD, 2007, DEEP-SEA RES PT II, V54, P2794, DOI 10.1016/j.dsr2.2007.08.007; Smith KM, 2016, MAR COAST FISH, V8, P476, DOI 10.1080/19425120.2016.1194920; Song CH, 2019, SCI TOTAL ENVIRON, V669, P833, DOI 10.1016/j.scitotenv.2019.03.042; Trippel NA, 2015, T AM FISH SOC, V144, P140, DOI 10.1080/00028487.2014.982177; Turner SM, 2017, MAR COAST FISH, V9, P13, DOI 10.1080/19425120.2016.1255683; Turner SM, 2016, ICES J MAR SCI, V73, P1912, DOI 10.1093/icesjms/fsv166; Ulanowicz Robert E., 1995, P549; Waldman J, 2016, FISHERIES, V41, P116, DOI 10.1080/03632415.2015.1134501; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Watson JM, 2018, T AM FISH SOC, V147, P525, DOI 10.1002/tafs.10053; Willis TV, 2017, ESTUAR COAST, V40, P889, DOI 10.1007/s12237-016-0187-9; Willson MF, 2006, REV FISH BIOL FISHER, V16, P183, DOI 10.1007/s11160-006-9009-7; Zhang YY, 2007, ECOL MODEL, V203, P475, DOI 10.1016/j.ecolmodel.2006.12.019	80	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217008	10.1371/journal.pone.0217008	http://dx.doi.org/10.1371/journal.pone.0217008			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120934	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700048
J	Jones, MB; Alvarez, CA; Johnson, JL; Zhou, JY; Morris, N; Cobb, BA				Jones, Mark B.; Alvarez, Carlos A.; Johnson, Jenny L.; Zhou, Julie Y.; Morris, Nathan; Cobb, Brian A.			CD45Rb-low effector T cells require IL-4 to induce IL-10 in FoxP3 Tregs and to protect mice from inflammation	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; INTERLEUKIN-4; POLYSACCHARIDE; ASTHMA; GAMMA; PHENOTYPES; STABILITY; RESPONSES; PREVENTS; GENE	CD4(+) effector/memory T cells (Tem) represent a leading edge of the adaptive immune system responsible for protecting the body from infection, cancer, and other damaging processes. However, a subset of Tem cells with low expression of CD45Rb (Rb(Lo)Tem) has been shown to suppress inflammation despite their effector surface phenotype and the lack of FoxP3 expression, the canonical transcription factor found in most regulatory T cells. In this report, we show that Rb(Lo)Tem cells can suppress inflammation by influencing Treg behavior. Co-culturing activated Rb(Lo)Tem and Tregs induced high expression of IL-10 in vitro, and conditioned media from Rb(Lo)Tem cells induced IL-10 expression in FoxP3(+) Tregs in vitro and in vivo, indicating that Rb(Lo)Tem cells communicate with Tregs in a cell-contact independent fashion. Transcriptomic and multi-analyte Luminex data identified both IL-2 and IL-4 as potential mediators of Rb(Lo)Tem-Treg communication, and antibody-mediated neutralization of either IL-4 or CD124 (IL-4Ra) prevented IL-10 induction in Tregs. Moreover, isolated Tregs cultured with recombinant IL-2 and IL-4 strongly induced IL-10 production. Using house dust mite (HDM)-induced airway inflammation as a model, we confirmed that the in vivo suppressive activity of Rb(Lo)Tem cells was lost in IL-4-ablated Rb(Lo)Tem cells. These data support a model in which Rb(Lo)Tem cells communicate with Tregs using a combination of IL-2 and IL-4 to induce robust expression of IL-10 and suppression of inflammation.	[Jones, Mark B.; Alvarez, Carlos A.; Johnson, Jenny L.; Zhou, Julie Y.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Morris, Nathan] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University	Cobb, BA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	brian.cobb@case.edu		Zhou, Julie/0000-0002-1533-5183; Cobb, Brian/0000-0003-1055-2530	National Institutes of Health [T32-AI089474, R01-GM082916, R01-GM115234, F32-AI114109, T32-AI007024]; American Asthma Foundation [10-0187]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007024, T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors declare no financial competing interests. This work was supported from grants from: The National Institutes of Health (R01-GM082916, R01-GM115234), the American Asthma Foundation (#10-0187), and the Hartwell Foundation to BC, the National Institutes of Health (F32-AI114109, T32-AI007024) to MJ, and the National Institutes of Health (T32-AI089474) to JJ, JZ, and CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkinson N F Jr, 1992, Trans Am Clin Climatol Assoc, V103, P218; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Frankish A, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S2; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Iftikhar IH, 2018, LUNG, V196, P517, DOI 10.1007/s00408-018-0151-5; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Johnson JL, 2018, GLYCOBIOLOGY, V28, P50, DOI 10.1093/glycob/cwx093; Johnson JL, 2015, GLYCOBIOLOGY, V25, P368, DOI 10.1093/glycob/cwu117; Johnson JL, 2015, J BIOL CHEM, V290, P5007, DOI 10.1074/jbc.M114.621771; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kreisman LSC, 2011, J BIOL CHEM, V286, P8810, DOI 10.1074/jbc.M110.206011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubberts E, 1999, J IMMUNOL, V163, P4546; Maerten P, 2005, J AUTOIMMUN, V25, P112, DOI 10.1016/j.jaut.2005.04.001; Mak T., 2013, PRIMER IMMUNE RESPON; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; MORRISSEY PJ, 1994, RES IMMUNOL, V145, P357, DOI 10.1016/S0923-2494(94)80200-9; MOSMANN TR, 1991, INT ARCH ALLER A IMM, V94, P110, DOI 10.1159/000235340; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Rackemann FM, 1918, BOSTON MED SURG J, V178, P770, DOI 10.1056/NEJM191806061782302; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Ruiz-Perez B, 2005, P NATL ACAD SCI USA, V102, P16753, DOI 10.1073/pnas.0505688102; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Shevach EM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01048; Shimada A, 1996, J AUTOIMMUN, V9, P263, DOI 10.1006/jaut.1996.0033; Smart V, 2003, J IMMUNOL, V171, P2116, DOI 10.4049/jimmunol.171.4.2116	42	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216893	10.1371/journal.pone.0216893	http://dx.doi.org/10.1371/journal.pone.0216893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120919	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700038
J	Majerova, P; Michalicova, A; Cente, M; Hanes, J; Vegh, J; Kittel, A; Kosikova, N; Cigankova, V; Mihaljevic, S; Jadhav, S; Kovac, A				Majerova, Petra; Michalicova, Alena; Cente, Martin; Hanes, Jozef; Vegh, Jozef; Kittel, Agnes; Kosikova, Nina; Cigankova, Viera; Mihaljevic, Sandra; Jadhav, Santosh; Kovac, Andrej			Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRUNCATED TAU; AMYLOID-BETA; RAT MODEL; ACTIVATION; EXPRESSION; MICROGLIA; NEUROINFLAMMATION; MACROPHAGES; TANGLES	Tauopathies represent a heterogeneous group of neurodegenerative disorders characterized by abnormal deposition of the hyperphosphorylated microtubule-associated protein tau. Chronic neuroinflammation in tauopathies is driven by glial cells that potentially trigger the disruption of the blood-brain barrier (BBB). Pro-inflammatory signaling molecules such as cytokines, chemokines and adhesion molecules produced by glial cells, neurons and endothelial cells, in general, cooperate to determine the integrity of BBB by influencing vascular permeability, enhancing migration of immune cells and altering transport systems. We considered the effect of tau about vascular permeability of peripheral blood cells in vitro and in vivo using primary rat BBB model and transgenic rat model expressing misfolded truncated protein tau. Immunohistochemistry, electron microscopy and transcriptomic analysis were employed to characterize the structural and functional changes in BBB manifested by neurofibrillary pathology in a transgenic model. Our results show that misfolded protein tau ultimately modifies the endothelial properties of BBB, facilitating blood-to-brain cell transmigration. Our results suggest that the increased diapedesis of peripheral cells across the BBB, in response to tau protein, could be mediated by the increased expression of endothelial signaling molecules, namely ICAM-1, VCAM-1, and selectins. We suggest that the compensation of BBB in the diseased brain represents a crucial factor in neurodegeneration of human tauopathies.	[Majerova, Petra; Michalicova, Alena; Cente, Martin; Hanes, Jozef; Vegh, Jozef; Kosikova, Nina; Mihaljevic, Sandra; Jadhav, Santosh; Kovac, Andrej] Slovak Acad Sci, AD Ctr, Inst Neuroimmunol, Bratislava, Slovakia; [Majerova, Petra; Michalicova, Alena; Cente, Martin; Hanes, Jozef; Jadhav, Santosh; Kovac, Andrej] AXON Neurosci R&D Serv SE, Bratislava, Slovakia; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Cigankova, Viera] Univ Vet Med & Pharm, Dept Anat Histol & Physiol, Kosice, Slovakia; [Kovac, Andrej] Univ Vet Med & Pharm, Dept Pharmacol & Toxicol, Kosice, Slovakia	Slovak Academy of Sciences; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Veterinary Medicine Kosice; University of Veterinary Medicine Kosice	Kovac, A (corresponding author), Slovak Acad Sci, AD Ctr, Inst Neuroimmunol, Bratislava, Slovakia.; Kovac, A (corresponding author), AXON Neurosci R&D Serv SE, Bratislava, Slovakia.; Kovac, A (corresponding author), Univ Vet Med & Pharm, Dept Pharmacol & Toxicol, Kosice, Slovakia.	andrej.kovac@savba.sk	Hanes, Jozef/ABE-6106-2020; Jadhav, Santosh/K-5767-2019	Cente, Martin/0000-0003-1420-1017; Jadhav, Santosh/0000-0001-9667-0137; Kittel, Agnes/0000-0002-6888-7731	grants Agentura Ministerstva Skolstva, Vedy, Vyskumu a Sportu [SR VEGA 2/0088/18, VEGA 2/0147/19, VEGA 2/0150/19, 2/0118/19]; Ministerstvo zdravotnictva Slovenskej Republiky [2018/24-SAV-2]; Agentura na Podporu Vyskumu a Vyvoja [APVV-16-0531]; Axon Neuroscience RD Services SE	grants Agentura Ministerstva Skolstva, Vedy, Vyskumu a Sportu; Ministerstvo zdravotnictva Slovenskej Republiky; Agentura na Podporu Vyskumu a Vyvoja; Axon Neuroscience RD Services SE	This work was supported by research grants Agentura Ministerstva Skolstva, Vedy, Vyskumu a Sportu (SR VEGA 2/0088/18, VEGA 2/0147/19, VEGA 2/0150/19, 2/0118/19), Ministerstvo zdravotnictva Slovenskej Republiky (2018/24-SAV-2), Agentura na Podporu Vyskumu a Vyvoja (APVV-16-0531) and Axon Neuroscience R&D Services SE. The Axon Neuroscience R&D Services SE provided support in the form of salaries for PM, AM, JH, MC, SJ and AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asai H, 2014, AM J PATHOL, V184, P808, DOI 10.1016/j.ajpath.2013.11.026; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Bowman Gene L, 2008, Aging health, V4, P47, DOI 10.2217/1745509X.4.1.47; Britschgi M, 2007, INT REV NEUROBIOL, V82, P205, DOI 10.1016/S0074-7742(07)82011-3; Carrano A, 2012, NEURODEGENER DIS, V10, P329, DOI 10.1159/000334916; Dickson D. W., 1999, Journal of Neurology, V246; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; DiPatre PL, 1997, J NEUROPATH EXP NEUR, V56, P143, DOI 10.1097/00005072-199702000-00004; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Filipcik P, 2015, BBA-MOL BASIS DIS, V1852, P1219, DOI 10.1016/j.bbadis.2015.03.003; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Gate D, 2010, J NEURAL TRANSM, V117, P961, DOI 10.1007/s00702-010-0422-7; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Imamura K, 2001, ALZ DIS ASSOC DIS, V15, P45, DOI 10.1097/00002093-200101000-00006; Iqbal K, 2014, BIOCHEM PHARMACOL, V88, P631, DOI 10.1016/j.bcp.2014.01.002; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Kovari E, 2011, ANN NY ACAD SCI, V1225, pE131, DOI 10.1111/j.1749-6632.2011.06008.x; Koson P, 2008, EUR J NEUROSCI, V28, P239, DOI 10.1111/j.1460-9568.2008.06329.x; Kovac A, 2011, J IMMUNOL, V187, P2732, DOI 10.4049/jimmunol.1100216; Kovac A, 2009, J ALZHEIMERS DIS, V18, P897, DOI 10.3233/JAD-2009-1197; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee VMY, 1999, METHOD ENZYMOL, V309, P81; Maccioni RB, 2010, ARCH MED RES, V41, P226, DOI 10.1016/j.arcmed.2010.03.007; Majerova P, 2018, J NEURAL TRANSM, V125, P1013, DOI 10.1007/s00702-018-1883-3; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; McGeer PL, 2002, J NEUROVIROL, V8, P529, DOI 10.1080/13550280290100969; Michalicova A, 2017, CURR ALZHEIMER RES, V14, P790, DOI 10.2174/1567205014666170203143336; Ohara Y, 2000, ACT NEUR S, V76, P117; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Schwab C, 1996, BRAIN RES, V707, P196, DOI 10.1016/0006-8993(95)01257-5; Sheffield LG, 2000, NEUROSCI LETT, V285, P165, DOI 10.1016/S0304-3940(00)01037-5; Sonar SA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01695; Soto C, 2012, NEURON, V73, P621, DOI 10.1016/j.neuron.2012.02.006; Stanimirovic D, 2006, BRAIN PATHOL, V10, P113, DOI [10.1111/j.1750-3639.2000.tb00248.x, DOI 10.1111/j.1750-3639.2000.tb00248.x]; Trickler WJ, 2005, BRAIN RES, V1048, P24, DOI 10.1016/j.brainres.2005.04.028; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Watson PMD, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-59; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866; Wu BH, 2010, TRANSL STROKE RES, V1, P57, DOI 10.1007/s12975-009-0002-z; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yang YM, 2013, NEUROCHEM RES, V38, P2295, DOI 10.1007/s11064-013-1138-5; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029; Zilka N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-47; Zilka N, 2009, J NEUROIMMUNOL, V209, P16, DOI 10.1016/j.jneuroim.2009.01.013; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217216	10.1371/journal.pone.0217216	http://dx.doi.org/10.1371/journal.pone.0217216			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120951	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700069
J	Yotsumoto, T; Morozumi, N; Furuya, M; Fujii, T; Hirota, K; Ueda, Y; Nakao, K; Yamanaka, S; Yoshikiyo, K; Yoshida, S; Nishimura, T; Abe, Y; Jindo, T; Ogasawara, H; Yasoda, A				Yotsumoto, Takafumi; Morozumi, Naomi; Furuya, Mayumi; Fujii, Toshihito; Hirota, Keisho; Ueda, Yohei; Nakao, Kazumasa; Yamanaka, Shigeki; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nishimura, Tomonari; Abe, Yasuyuki; Jindo, Toshimasa; Ogasawara, Hiroyuki; Yasoda, Akihiro			Foramen magnum stenosis and midface hypoplasia in C-type natriuretic peptidedeficient rats and restoration by the administration of human C-type natriuretic peptide with 53 amino acids	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; THERAPEUTIC STRATEGY; SKELETAL GROWTH; CNP; ACHONDROPLASIA; MICE; OSSIFICATION; DEFICIENCY; CLOSURE; SYSTEM	C-type natriuretic peptide (CNP)-knockout (KO) rats exhibit impaired skeletal growth, with long bones shorter than those in wild-type (WT) rats. This study compared craniofacial morphology in the CNP-KO rat with that in the Spontaneous Dwarf Rat (SDR), a growth hormone (GH)-deficient model. The effects of subcutaneous administration of human CNP with 53 amino acids (CNP-53) from 5 weeks of age for 4 weeks on craniofacial morphology in CNP-KO rats were also investigated. Skulls of CNP-KO rats at 9 weeks of age were longitudinally shorter and the foramen magnum was smaller than WT rats. There were no differences in foramen magnum stenosis and midface hypoplasia between CNP-KO rats at 9 and 33 weeks of age. These morphological features were the same as those observed in CNP-KO mice and activated fibroblast growth factor receptor 3 achondroplasia-phenotype mice. In contrast, SDR did not exhibit foramen magnum stenosis and midface hypoplasia, despite shorter stature than in control rats. After administration of exogenous CNP-53, the longitudinal skull length and foramen magnum size in CNP-KO rats were significantly greater, and full or partial rescue was confirmed. The synchondrosis at the cranial base in CNP-KO rats is closed at 9 weeks, but not at 4 weeks of age. In contrast, synchondrosis closure in CNP-KO rats treated with CNP-53 was incomplete at 9 weeks of age. Administration of exogenous CNP-53 accelerated craniofacial skeletogenesis, leading to improvement in craniofacial morphology. As these findings in CNP-KO rats are similar to those in patients with achondroplasia, treatment with CNP-53 or a CNP analog may be able to restore craniofacial morphology and foramen magnum size as well as short stature.	[Yotsumoto, Takafumi; Morozumi, Naomi; Furuya, Mayumi; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nishimura, Tomonari; Abe, Yasuyuki; Jindo, Toshimasa; Ogasawara, Hiroyuki] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Yotsumoto, Takafumi; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nishimura, Tomonari; Abe, Yasuyuki; Jindo, Toshimasa; Ogasawara, Hiroyuki] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Fujii, Toshihito; Hirota, Keisho; Ueda, Yohei] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Nakao, Kazumasa; Yamanaka, Shigeki] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Yasoda, Akihiro] Natl Hosp Org Kyoto Med Ctr, Clin Res Ctr, Kyoto, Japan	Asubio Pharma Co., Ltd.; Daiichi Sankyo Company Limited; Kyoto University; Kyoto University	Yotsumoto, T (corresponding author), Asubio Pharma Co Ltd, Kobe, Hyogo, Japan.; Yotsumoto, T (corresponding author), Daiichi Sankyo Co Ltd, Tokyo, Japan.	yotsumoto.takafumi.ur@daiichisankyo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21591176, JP 17K09881]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21591176 and JP 17K09881), and the Uehara Memorial Foundation. Asubio Pharma Co., Ltd. and/or Daiichi Sankyo Co., Ltd. provided support in the form of salaries for authors TY, NM, MF, KY, SY, TN, YA, TJ and HO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Fujii T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194812; Fujii T, 2010, ENDOCRINOLOGY, V151, P4381, DOI 10.1210/en.2010-0078; Grugni G, 2016, BEST PRACT RES CL EN, V30, P785, DOI 10.1016/j.beem.2016.11.003; Hirota K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204172; Kahana T, 2003, J FORENSIC SCI, V48, P504; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Kondo E, 2012, CALCIFIED TISSUE INT, V90, P307, DOI 10.1007/s00223-011-9567-0; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Kuramoto K, 2010, GERIATR GERONTOL INT, V10, P94, DOI 10.1111/j.1447-0594.2009.00559.x; Laederich MB, 2010, CURR OPIN PEDIATR, V22, P516, DOI 10.1097/MOP.0b013e32833b7a69; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; LUO GB, 1995, J BONE MINER RES, V10, P325; MADELINE LA, 1995, RADIOLOGY, V196, P747, DOI 10.1148/radiology.196.3.7644639; Marulanda J, 2017, J BIOL CHEM, V292, P11400, DOI 10.1074/jbc.M116.769802; Matsushita M, 2017, J NEUROSURG-PEDIATR, V19, P91, DOI 10.3171/2016.7.PEDS16199; Matsushita T, 2009, HUM MOL GENET, V18, P227, DOI 10.1093/hmg/ddn339; NAKAO K, 1992, J HYPERTENS, V10, P907; Nakao K, 2017, J ORAL MAX SURG MED, V29, P10, DOI 10.1016/j.ajoms.2016.07.007; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; Naski MC, 1998, DEVELOPMENT, V125, P4977; Okamoto K, 1996, AM J NEURORADIOL, V17, P117; Shirley ED, 2009, J AM ACAD ORTHOP SUR, V17, P231, DOI 10.5435/00124635-200904000-00004; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Tsuji T, 2008, BIOCHEM BIOPH RES CO, V376, P186, DOI 10.1016/j.bbrc.2008.08.139; Yamanaka S, 2017, J DENT RES, V96, P1526, DOI 10.1177/0022034517716437; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216340	10.1371/journal.pone.0216340	http://dx.doi.org/10.1371/journal.pone.0216340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120905	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700012
J	Espunyes, J; Espunya, C; Chaves, S; Calleja, JA; Bartolome, J; Serrano, E				Espunyes, Johan; Espunya, Carme; Chaves, Sara; Calleja, Juan Antonio; Bartolome, Jordi; Serrano, Emmanuel			Comparing the accuracy of PCR-capillary electrophoresis and cuticle microhistological analysis for assessing diet composition in ungulates: A case study with Pyrenean chamois	PLOS ONE			English	Article							BOTANICAL COMPOSITION; MOLECULAR ANALYSIS; FECAL ANALYSIS; ANCIENT DNA; IDENTIFICATION; LIVESTOCK; TECHNOLOGIES; PREFERENCES; VEGETATION; HERBIVORY	The study of diet composition is required to understand the interactions between animal and plant ecosystems. Different non-invasive techniques applied on faecal samples have commonly been used for such purposes, with cuticle microhistological analysis (CMA) and emerging DNA-based methods being the most relevant. In this work, we refined and optimized a qualitative DNA-based approach combining PCR amplification of long trnL(UAA) and ITS2 fragments and capillary electrophoresis (PCR-CE), instead of short trnL(UAA) fragments and massive sequencing technologies commonly reported. To do so, we developed a controlled diet assay using a stabled Pyrenean chamois specimen (Rupicapra pyrenaica pyrenaica), which included representative herbaceous and shrubby plant species. We also assessed the impact of sample freshness on the diet determination of this mountain caprinae by exposing faecal samples to the outdoor environment for three weeks. Faecal samples from both experiments were analysed by qualitative PCR-CE and semi-quantitative CMA in order to compare the pros and cons of both approaches. Our results show that all of the offered plant species were detected by both methodologies although CMA over-detected shrubs compared to herbaceous species. At the same time, sample degradation due to sustained climate exposure is a limiting factor for molecular analysis, but not for CMA. Taken all together, our results suggest that the qualitative information obtained by CMA and PCR-CE can be interchangeable when faecal samples are fresh (less than one week after deposition) but, afterwards, molecular analysis underestimates diet composition probably due to DNA degradation. CMA, however, can accurately be used at least three weeks after defecation. Moreover, by combining the results of simultaneous PCR amplification of two complementary genes, this optimized PCR-CE methodology provides a reliable, feasible and more affordable alternative for multiple and routine analyses of complex samples. Neither CMA nor PCR-CE seems to solve comprehensively the quatification of herbivore diets and thus further research needs to be done.	[Espunyes, Johan; Chaves, Sara; Serrano, Emmanuel] UAB, Dept Med & Cirurgia Anim, Wildlife Ecol & Hlth Grp WE&H, Bellaterra, Spain; [Espunyes, Johan; Chaves, Sara; Serrano, Emmanuel] UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain; [Espunya, Carme] UAB, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Calleja, Juan Antonio] CREAF, Cerdanyola Del Valles, Spain; [Bartolome, Jordi] UAB, Dept Ciencia Anim & Dels Aliments, Grup Recerca Remugants, Bellaterra, Spain; [Serrano, Emmanuel] Univ Torino, Dipartimento Sci Vet, Turin, Italy	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; University of Turin	Serrano, E (corresponding author), UAB, Dept Med & Cirurgia Anim, Wildlife Ecol & Hlth Grp WE&H, Bellaterra, Spain.; Serrano, E (corresponding author), UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain.; Serrano, E (corresponding author), Univ Torino, Dipartimento Sci Vet, Turin, Italy.	emmanuel.serrano@uab.cat	Bartolomé, Jordi/AAB-4362-2020; Espunyes, Johan/AAV-9517-2020; Alarcón, Juan Antonio Calleja/T-2297-2019; SERRANO-FERRON, Emmanuel/J-4489-2013	Bartolomé, Jordi/0000-0002-3784-5248; Espunyes, Johan/0000-0002-8692-1593; Alarcón, Juan Antonio Calleja/0000-0002-6586-0939; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804	Spanish Government [CGL2011-30307, CGL2015-70449-R]; Government of Andorra [ATC015-AND-2015/2018]; Spanish Ministerio de Economia y Competitividad (MINECO)	Spanish Government(Spanish GovernmentEuropean Commission); Government of Andorra; Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government)	This work was funded by Spanish Government projects CGL2011-30307 and CGL2015-70449-R. J. Espunyes acknowledges a predoctoral grant from the Government of Andorra, ATC015-AND-2015/2018, E. Serrano was funded by the Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal agreement (RYC-2016-2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angers-Loustau A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147692; ANTHONY RG, 1974, J WILDLIFE MANAGE, V38, P535, DOI 10.2307/3800886; Asshoff R, 2005, OECOLOGIA, V142, P191, DOI 10.1007/s00442-004-1714-0; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Bartolome J, 1998, J RANGE MANAGE, V51, P383, DOI 10.2307/4003322; Bazakos C, 2012, FOOD CHEM, V134, P2411, DOI 10.1016/j.foodchem.2012.04.031; Bellemain E, 2013, ENVIRON MICROBIOL, V15, P1176, DOI 10.1111/1462-2920.12020; Bergstrom R., 2006, LARGE HERBIVORE ECOL; Bison M, 2015, OECOLOGIA, V179, P835, DOI 10.1007/s00442-015-3390-7; Brookshire ENJ, 2002, OECOLOGIA, V132, P559, DOI 10.1007/s00442-002-1007-4; Burkepile D.E., 2017, F1000 RES, V6, P119, DOI DOI 10.12688/F1000RESEARCH.10313.1; Canty A., 2017, R PACKAGE VERSION 1, P3; Carriere S, 2002, ARCTIC, V55, P247; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Czernik M, 2013, ACTA THERIOL, V58, P379, DOI 10.1007/s13364-013-0146-9; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Espunyes J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210819; GORDON IJ, 1995, SMALL RUMINANT RES, V16, P203, DOI 10.1016/0921-4488(95)00635-X; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hayes F, 2016, SCI TOTAL ENVIRON, V543, P336, DOI 10.1016/j.scitotenv.2015.10.128; Heggberget Thrine Moen, 2002, Rangifer, V22, P13; Hendriks RJJ, 1999, PLANT ECOL, V143, P141, DOI 10.1023/A:1009832621516; Hibert F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060799; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P267, DOI 10.2307/3898409; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Illius Andrew W., 2006, Conservation Biology Series (Cambridge), V11, P71; Johnson MK, 1983, SAE831684 TECH PAP S, P1; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; LESLIE DM, 1983, J RANGE MANAGE, V36, P730, DOI 10.2307/3898197; Marinas A, 2006, PIRINEOS, V161, P85, DOI DOI 10.3989/pirineos.2006.v161.4; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; MOHAMMAD AG, 1995, J RANGE MANAGE, V48, P202, DOI 10.2307/4002421; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Newmaster SG, 2013, CAN J FOREST RES, V43, P897, DOI 10.1139/cjfr-2013-0108; Nichols RV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157977; Parveen I, 2016, PLANTA MED, V82, P1225, DOI 10.1055/s-0042-111208; Pastor John, 2006, Conservation Biology Series (Cambridge), V11, P289; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pierce BM, 2000, ECOLOGY, V81, P1533; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Rivera L, 2014, HOLOCENE, V24, P876, DOI 10.1177/0959683614530445; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Spaniolas S, 2006, J AGR FOOD CHEM, V54, P7466, DOI 10.1021/jf061164n; Staats M, 2016, ANAL BIOANAL CHEM, V408, P4615, DOI 10.1007/s00216-016-9595-8; STEWART DRM, 1967, J APPL ECOL, V4, P83, DOI 10.2307/2401411; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tanentzap AJ, 2009, J APPL ECOL, V46, P1064, DOI 10.1111/j.1365-2664.2009.01683.x; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; VAVRA M, 1980, J RANGE MANAGE, V33, P371, DOI 10.2307/3897886; Velamazan M, 2017, BIODIVERS CONSERV, V26, P917, DOI 10.1007/s10531-016-1279-3; Villamuelas M, 2016, ECOL INDIC, V61, P658, DOI 10.1016/j.ecolind.2015.10.017; Virtanen R, 2002, J APPL ECOL, V39, P572, DOI 10.1046/j.1365-2664.2002.00734.x; Zar J.H., 1996, BIOSTAT ANAL; Zuur Alain F., 2009, P1	68	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216345	10.1371/journal.pone.0216345	http://dx.doi.org/10.1371/journal.pone.0216345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116750	gold, Green Submitted, Green Published			2022-12-27	WOS:000468607400019
J	Lei, JH; Hu, DB; Xue, SJ; Mao, FX; Obeng, E; Quan, YP; Yu, W				Lei, Jihai; Hu, Dongbing; Xue, Shengjie; Mao, Fuxiang; Obeng, Enoch; Quan, Yanping; Yu, Wei			HN1L is essential for cell growth and survival during nucleopolyhedrovirus infection in silkworm, Bombyx mori	PLOS ONE			English	Article							BREAST-CANCER; SEQUENCE; PROMOTES; PROTEIN; GENOME; GENES; BCL-2	Hematological and neurological expressed 1-like (HN1L) protein is an evolutionarily conserved protein that plays an important role in embryonic development. It has been reported that HN1L is involved in the process of cell growth and cancer formation and that cell cycle arrest occurs during suppression of HN1L expression. Previous studies have demonstrated that the expression levels of the Bombyx mori HN1L protein were significantly downregulated in Bombyx mori Nucleopolyhedrovirus (BmNPV) infected silkworm cells. Transient transfections were performed with plasmids for pIEX-1-HN1L expression in Bombyx mori ovarian cells (BmN) in order to explore the effect of the HN1L protein on the growth of silkworm cells and its regulatory role in the process of viral infection. Cellular localization analysis revealed that HN1L was localized in the cytoplasm and that its upregulation could significantly enhance cellular activity. Furthermore, HN1L could promote G1/S phase conversion, thereby contributing to cell proliferation. Upon infection of BmN cells with BmNPV, the induction of apoptosis increased, although HN1L overexpression could inhibit DNA fragmentation, suggesting that the HN1L protein could inhibit cell apoptosis induced by viral invasion. In addition, Western blotting indicated that the HN1L protein inhibited the activation of caspase-9 zymogen and the expression of Bax protein, although it promoted Bcl-2 expression. Flow cytometry analysis further confirmed that overexpression of HN1L significantly inhibited apoptosis induced by BmNPV infection. Consequently, we demonstrated that BmN HN1L is a protein with multiple functions, which enhanced cell activity, regulated the cell cycle and induced an anti-apoptotic response by BmNPV infection.	[Lei, Jihai; Hu, Dongbing; Xue, Shengjie; Mao, Fuxiang; Obeng, Enoch; Quan, Yanping; Yu, Wei] Zhejiang Sci Tech Univ, Coll Life Sci & Med, Inst Biochem, Hangzhou, Zhejiang, Peoples R China; [Lei, Jihai; Hu, Dongbing; Xue, Shengjie; Mao, Fuxiang; Obeng, Enoch; Quan, Yanping; Yu, Wei] Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Quan, YP; Yu, W (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci & Med, Inst Biochem, Hangzhou, Zhejiang, Peoples R China.; Quan, YP; Yu, W (corresponding author), Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou, Zhejiang, Peoples R China.	qyping2002@163.com; mikkyu@163.com		OBENG, ENOCH/0000-0002-9246-8721; Yu, Wei/0000-0002-0105-4639; Mao, Fuxiang/0000-0002-4829-2730	Natural Science Foundation of Zhejiang Province [LY17C170006]; National High-tech R&D program (863 Program) [2011AA100603]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National High-tech R&D program (863 Program)	This work was supported by the Natural Science Foundation of Zhejiang Province (No. LY17C170006) and National High-tech R&D program (863 Program) (No. 2011AA100603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Decraene C, 2002, GENOME BIOL, V3; Etebari K, 2007, ISJ-INVERT SURVIV J, V4, P13; Goto T, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/436042; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hu DB, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700133; Laughlin KM, 2009, DIFFERENTIATION, V78, P35, DOI 10.1016/j.diff.2009.04.001; Liu Y, 2018, STEM CELL REP, V10, P212, DOI 10.1016/j.stemcr.2017.11.010; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Nathan SS, 2005, PESTIC BIOCHEM PHYS, V83, P46, DOI 10.1016/j.pestbp.2005.03.009; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tang WZ, 1997, MAMM GENOME, V8, P695, DOI 10.1007/s003359900540; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Varisli L, 2011, DNA CELL BIOL, V30, P419, DOI 10.1089/dna.2010.1128; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu M, 2015, ISJ-INVERT SURVIV J, V12, P13; Zhang ZG, 2014, BIOCHEM BIOPH RES CO, V454, P109, DOI 10.1016/j.bbrc.2014.10.049; Zhou GJ, 2004, GENE, V331, P115, DOI 10.1016/j.gene.2004.02.025	22	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216719	10.1371/journal.pone.0216719	http://dx.doi.org/10.1371/journal.pone.0216719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116759	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400027
J	Zheng, XL; Yue, P; Liu, L; Tang, CQ; Ma, F; Zhang, Y; Wang, C; Duan, HY; Zhou, KY; Hua, YM; Wu, G; Li, YF				Zheng, Xiaolan; Yue, Peng; Liu, Lei; Tang, Changqing; Ma, Fan; Zhang, Yi; Wang, Chuan; Duan, Hongyu; Zhou, Kaiyu; Hua, Yimin; Wu, Gang; Li, Yifei			Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis	PLOS ONE			English	Article							LONG-TERM MANAGEMENT; INTRAVENOUS IMMUNOGLOBULIN; CARDIOVASCULAR-DISEASE; HEALTH-PROFESSIONALS; ACUTE-PHASE; DIAGNOSIS; CYCLOOXYGENASES; PREVENTION; GUIDELINES; STATEMENT	Background Kawasaki disease (KD) is now the leading cause of acquired heart disease in children in developed countries. Intravenous immunoglobulin (IVIG) and aspirin were considered as the standard initial treatment of KD for decades. However, the optimal dose of aspirin has remained controversial. In recent years, many studies compared the efficacy of low-dose with high-dose aspirin in the acute phase of KD, but the results have not always been consistent. Therefore, we performed this meta-analysis to evaluate the efficacy of low-dose aspirin compared with high-dose for the initial treatment of KD. Methods Studies related to aspirin therapy for KD were selected from PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, and Google scholar through Mar 25th, 2019. Data were analyzed using STATA Version 15.1. Additionally, publication bias and sensitivity analysis were also performed by STATA version 15.1. Results Six studies were included in our analysis of the rate of coronary artery lesion (CAL), five reports for IVIG-resistant KD (rKD), and four for the duration of fever and hospitalization. However, no significant differences were found between low-dose and high-dose aspirin groups in the incidence of CAL (risk ratio (RR), 0.85; 95% CI (0.63, 1.14); P = 0.28), the risk of rKD (RR, 1.39; 95% CI (1.00, 1.93); P = 0.05), and duration of fever and hospitalization (the mean standard deviation (SMD), 0.03; 95% CI (-0.16, 0.22); P = 0.78). Conclusion Low-dose aspirin (3-5 mg.kg(-1).d(-1)) may be as effective as the use of high-dose aspirin (>= 30 mg.kg(-1).d(-1)) for the initial treatment of KD. Further well-designed randomized clinical trials are needed to evaluate the efficacy of low-dose aspirin for the initial treatment of KD.	[Zheng, Xiaolan; Yue, Peng; Liu, Lei; Tang, Changqing; Ma, Fan; Zhang, Yi; Wang, Chuan; Duan, Hongyu; Zhou, Kaiyu; Hua, Yimin; Wu, Gang; Li, Yifei] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China; [Zheng, Xiaolan; Yue, Peng; Liu, Lei; Tang, Changqing; Ma, Fan; Zhang, Yi; Wang, Chuan; Duan, Hongyu; Zhou, Kaiyu; Hua, Yimin; Wu, Gang; Li, Yifei] Sichuan Univ, Minist Educ, Key Lab Women & Childrens Dis & Birth Defects, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China; [Zheng, Xiaolan; Yue, Peng; Liu, Lei; Tang, Changqing; Ma, Fan] Sichuan Univ, West China Med Sch, Chengdu, Sichuan, Peoples R China; [Zhou, Kaiyu; Hua, Yimin] Sichuan Univ, Program Changjiang Scholars & Innovat Res Team Un, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Li, YF (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China.; Li, YF (corresponding author), Sichuan Univ, Minist Educ, Key Lab Women & Childrens Dis & Birth Defects, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China.	liyfwcsh@scu.edu.cn		Yue, Peng/0000-0002-8541-0265; zheng, xiaolan/0000-0001-5971-4284	National Natural Science Foundation of China [81700360, 81741025, 81570369, 81571515]; Technology Project of Sichuan Province of China [2016SZ0056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Project of Sichuan Province of China	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (No. 81700360, 81741025, 81570369 and 81571515) and the Technology Project of Sichuan Province of China (http://www.scst.edu.cn/) (2016SZ0056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1990, Kurume Medical Journal, V37, P203; Amarilyo G, 2017, CLIN EXP RHEUMATOL, V35, pS209; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; BURNS JC, 1984, J PEDIATR-US, V105, P206, DOI 10.1016/S0022-3476(84)80114-6; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Dallaire F, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0098; Dallaire F, 2011, J AM SOC ECHOCARDIOG, V24, P60, DOI 10.1016/j.echo.2010.10.004; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Desborough MJR, 2017, BRIT J HAEMATOL, V177, P674, DOI 10.1111/bjh.14520; Dhanrajani A, 2018, ARTHRIT CARE RES, V70, P1536, DOI 10.1002/acr.23504; Dietz SM, 2017, EUR J PEDIATR, V176, P995, DOI 10.1007/s00431-017-2937-5; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; Han JW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007583; Hara T, 2016, CLIN EXP IMMUNOL, V186, P134, DOI 10.1111/cei.12832; Hsieh KS, 2004, PEDIATRICS, V114, pE689, DOI 10.1542/peds.2004-1037; Huang XJ, 2018, J PAEDIATR CHILD H, V54, P661, DOI 10.1111/jpc.13816; Kim GB, 2017, J PEDIATR-US, V184, P125, DOI 10.1016/j.jpeds.2016.12.019; Kuo HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144603; Lee G, 2013, KOREAN CIRC J, V43, P182, DOI 10.4070/kcj.2013.43.3.182; Lee J H, 1992, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V33, P67; Matsubara T, 1996, J PEDIATR-US, V128, P701, DOI 10.1016/S0022-3476(96)80140-5; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; MONCADA S, 1976, PROSTAGLANDINS, V12, P715, DOI 10.1016/0090-6980(76)90048-4; Nakada T, 2015, PEDIATR CARDIOL, V36, P335, DOI 10.1007/s00246-014-1010-7; Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Ng QX, 2018, J INFLAMM RES, V11, P135, DOI 10.2147/JIR.S160964; Ogawa S, 2010, CIRC J, V74, P1989, DOI 10.1253/circj.CJ-10-74-0903; Pietraforte D, 2014, INT J CARDIOL, V172, P526, DOI 10.1016/j.ijcard.2014.01.022; Rahbarimanesh A, 2014, INDIAN J PEDIATR, V81, P1403, DOI 10.1007/s12098-014-1437-0; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Saneeymehri Seyyedeh, 2015, J Pediatr Pharmacol Ther, V20, P163, DOI 10.5863/1551-6776-20.3.163; Saulsbury FT, 2002, CLIN PEDIATR, V41, P597, DOI 10.1177/000992280204100807; Singh S, 2016, CLIN EXP RHEUMAT S97, V34, DOI [10.1016/j.jacc.2015.12.073, DOI 10.1016/J.JACC.2015.12.073]; Singh S, 2015, ARCH DIS CHILD, V100, P1084, DOI 10.1136/archdischild-2014-307536; Takahashi K, 2018, INT J RHEUM DIS, V21, P31, DOI 10.1111/1756-185X.13207; Taki M, 2003, PEDIATR INT, V45, P649, DOI 10.1111/j.1442-200X.2003.01810.x; Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wells G.A., 2000, VIS COMMUN Q; Yeo WS, 2018, ANN ACAD MED SINGAP, V47, P388; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	45	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217274	10.1371/journal.pone.0217274	http://dx.doi.org/10.1371/journal.pone.0217274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31117119	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400055
J	DeMarco, B; Stefanovic, S; Williams, A; Moss, KR; Anderson, BR; Bassell, GJ; Mihailescu, MR				DeMarco, Brett; Stefanovic, Snezana; Williams, Allison; Moss, Kathryn R.; Anderson, Bart R.; Bassell, Gary J.; Mihailescu, Mihaela Rita			FMRP - G-quadruplex mRNA - miR-125a interactions: Implications for miR-125a mediated translation regulation of PSD-95 mRNA	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; RECEPTOR-DEPENDENT TRANSLATION; FRAGILE-X-SYNDROME; G-QUARTET; MOLECULAR INSIGHTS; BINDING-SITE; MOUSE MODEL; KH DOMAINS; PHOSPHORYLATION; 2-AMINOPURINE	Fragile X syndrome, the most common inherited form of intellectual disability, is caused by the CGG trinucleotide expansion in the 5'-untranslated region of the Fmr1 gene on the X chromosome, which silences the expression of the fragile X mental retardation protein (FMRP). FMRP has been shown to bind to a G-rich region within the PSD-95 mRNA, which encodes for the postsynaptic density protein 95, and together with microRNA-125a to mediate the reversible inhibition of the PSD-95 mRNA translation in neurons. The miR-125a binding site within the PSD-95 mRNA 3'-untranslated region (UTR) is embedded in a G-rich region bound by FMRP, which we have previously demonstrated folds into two parallel G-quadruplex structures. The FMRP regulation of PSD-95 mRNA translation is complex, being mediated by its phosphorylation. While the requirement for FMRP in the regulation of PSD-95 mRNA translation is clearly established, the exact mechanism by which this is achieved is not known. In this study, we have shown that both unphosphorylated FMRP and its phosphomimic FMRP S500D bind to the PSD-95 mRNA G-quadruplexes with high affinity, whereas only FMRP S500D binds to miR-125a. These results point towards a mechanism by which, depending on its phosphorylation status, FMRP acts as a switch that potentially controls the stability of the complex formed by the miR-125a-guided RNA induced silencing complex (RISC) and PSD-95 mRNA.	[DeMarco, Brett; Stefanovic, Snezana; Williams, Allison; Mihailescu, Mihaela Rita] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15219 USA; [Moss, Kathryn R.; Anderson, Bart R.; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA	Duquesne University; Emory University	Mihailescu, MR (corresponding author), Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15219 USA.	mihailescum@duq.edu	Anderson, Bart/GRF-1496-2022	Moss, Kathryn/0000-0002-3726-4056; Mihailescu, Mihaela Rita/0000-0002-1162-7699; Williams, Allison/0000-0002-9886-9163; Anderson, Bart/0000-0002-8471-1381	National Institutes of Health [9R15GM127307-04, R01MH109026]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM127307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (https://www.nih.gov) grants 9R15GM127307-04 to M.R.M. and R01MH109026 to G.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bharill S, 2008, ANAL BIOCHEM, V377, P141, DOI 10.1016/j.ab.2008.03.034; Blice-Baum AC, 2014, RNA, V20, P103, DOI 10.1261/rna.041442.113; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Cao S, 2012, NUCLEIC ACIDS RES, V40, P4681, DOI 10.1093/nar/gks052; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cheever A, 2009, RNA, V15, P362, DOI 10.1261/rna.1500809; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Clery A., 2012, RNA BINDING PROTEINS, P137; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; Evans TL, 2010, PROTEIN EXPRES PURIF, V74, P242, DOI 10.1016/j.pep.2010.06.002; Faehnle CR, 2010, EMBO REP, V11, P564, DOI 10.1038/embor.2010.110; Feng Y, 1997, J NEUROSCI, V17, P1539; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043; Kang DH, 2013, INT J MOL MED, V32, P1187, DOI 10.3892/ijmm.2013.1488; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kenny PJ, 2014, CELL REP, V9, P1729, DOI 10.1016/j.celrep.2014.10.054; LaFauci G, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120121; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li PTX, 2006, P NATL ACAD SCI USA, V103, P15847, DOI 10.1073/pnas.0607202103; Li Y, 2014, MOL BIOSYST, V10, P1757, DOI 10.1039/c4mb00066h; Menon L, 2007, NUCLEIC ACIDS RES, V35, P5379, DOI 10.1093/nar/gkm581; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Myrick LK, 2015, HUM MOL GENET, V24, P1733, DOI 10.1093/hmg/ddu586; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Plante I, 2006, DICER DERIVED MICROR; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Serrano-Andres L, 2006, P NATL ACAD SCI USA, V103, P8691, DOI 10.1073/pnas.0602991103; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Stefanovic S, 2015, MOL BIOSYST, V11, P3222, DOI 10.1039/c5mb00423c; Stefanovic S, 2015, RNA, V21, P48, DOI 10.1261/rna.046722.114; Tarrant MK, 2009, ANNU REV BIOCHEM, V78, P797, DOI 10.1146/annurev.biochem.78.070907.103047; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Vollmeister E, 2009, RNA, V15, P2206, DOI 10.1261/rna.1817609; Wan RP, 2017, MOL NEUROBIOL, V54, P2585, DOI 10.1007/s12035-016-9855-9; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang Y, 2014, RNA BIOL, V11, P1364, DOI 10.1080/15476286.2014.996464; 2010, NEURON, V65, P373, DOI DOI 10.1016/J.NEURON.2010.01.005; 2008, NUCLEIC ACIDS RES, V36, P5290, DOI DOI 10.1093/NAR/GKN509; 1990, NATURE, V344, P410, DOI DOI 10.1038/344410A0	66	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217275	10.1371/journal.pone.0217275	http://dx.doi.org/10.1371/journal.pone.0217275			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112584	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000044
J	de Oliveira, UDR; Gomes, PB; Cordeiro, RTS; de Lima, GV; Perez, CD				Rodrigues de Oliveira, Umberto Diego; Gomes, Paula Braga; Silva Cordeiro, Ralf Tarciso; de Lima, Gislaine Vanessa; Perez, Carlos Daniel			Modeling impacts of climate change on the potential habitat of an endangered Brazilian endemic coral: Discussion about deep sea refugia	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ANTHOZOA SCLERACTINIA; TUBASTRAEA-COCCINEA; MUSSISMILIA CORALS; CNIDARIA ANTHOZOA; LAND-USE; REEFS; DISTRIBUTIONS; PREDICTION; IMPROVE	Climate and environmental conditions are determinant for coral distribution and their very existence. When changes in such conditions occur, their effects on distribution can be predicted through species distribution models, anticipating suitable habitats for the subsistence of species. Mussismilia harttii is one of the most endangered Brazilian endemic reef-building corals, and in increasing risk of extinction. Herein, species distribution models were used to determine the present and future potential habitats for M. harttii. Estimations were made through the maximum entropy approach, predicting suitable habitat losses and gains by the end of the 21st century. For this purpose, species records published in the last 20 years and current and future environmental variables were correlated. The best models were chosen according to the Akaike information criterion (AIC) and evaluated through the partial ROC (AUCratio), a new approach which uses independent occurrence data. Both approaches showed that the models performed satisfactorily in predicting potential habitat areas for the species. Future projections were made using the International Panel on Climate Change (IPCC) scenarios for 2100, with different levels of greenhouse gas emission. Representative Concentration Pathways (RCPs) were used to model the Future Potential Habitat (FPH) of M. harttii in two different scenarios: stabilization of emissions (RCP 4.5) and increase of emissions (RCP 8.5). According to the results, shallow waters to the south of the study area concentrate most of the current potential habitats for the species. However, in future scenarios, there was a loss of suitable areas in relation to the Current Potential Habitat (RCP 4.5 46% and RCP 8.5 59%), whereas there is a southward shift of the suitable areas. In all scenarios of FPH, the temperature was the variable with the greatest contribution to the models (> 35%), followed by the current velocity (> 33%) and bathymetry (>29%). In contrast, there is an increase of deep (50-75 m) suitable areas FPH scenarios, mainly in the southern portion of its distribution, at Abrolhos Bank (off Espirito Santo State). These deeper sites might serve as refugia for the species in global warming scenarios. Coral communities at such depths would be less susceptible to impacts of climate change on temperature and salinity. However, the deep sea is not free from human impacts and measures to protect deeper ecosystems should be prioritized in environmental policies for Brazilian marine conservation, especially the Abrolhos Bank, due to its importance for M. harttii.	[Rodrigues de Oliveira, Umberto Diego; Gomes, Paula Braga; Silva Cordeiro, Ralf Tarciso; Perez, Carlos Daniel] Univ Fed Rural Pernambuco, Programa Posgrad Ecol, Recife, PE, Brazil; [Gomes, Paula Braga; de Lima, Gislaine Vanessa; Perez, Carlos Daniel] Univ Fed Pernambuco, Programa Posgrad Biol Anim, Recife, PE, Brazil; [Gomes, Paula Braga] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil; [Perez, Carlos Daniel] Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco	de Oliveira, UDR; Perez, CD (corresponding author), Univ Fed Rural Pernambuco, Programa Posgrad Ecol, Recife, PE, Brazil.; Perez, CD (corresponding author), Univ Fed Pernambuco, Programa Posgrad Biol Anim, Recife, PE, Brazil.; Perez, CD (corresponding author), Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil.	udr.deoliveira@gmail.com; cdperez@ufpe.br	Cordeiro, R./E-8980-2018; de Oliveira, Umberto/AAZ-7712-2021; Cordeiro, Ralf/AAY-7308-2021; PEREZ, CARLOS DANIEL/G-3887-2010	Cordeiro, R./0000-0002-3164-5333; Cordeiro, Ralf/0000-0002-3164-5333; PEREZ, CARLOS DANIEL/0000-0002-0866-1183	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES) [001]; National Council for Scientific and Technological Development (CNPq) [408934/2013-1]; Fundacao Grupo Boticario de Protecao a Natureza [1031_20151]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Grupo Boticario de Protecao a Natureza	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES), Finance Code 001. Funding was provided to CDP by the National Council for Scientific and Technological Development (CNPq), grant no. 408934/2013-1 and the Fundacao Grupo Boticario de Protecao a Natureza, grant no. 1031_20151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2018, CURR SCI INDIA, V114, P519, DOI 10.18520/cs/v114/i03/519-531; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; [Anonymous], 2010, MAPPING SPECIES DIST; [Anonymous], P 8 INT COR REEF S, P263; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Ashraf U, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1825; Assis J, 2018, GLOBAL ECOL BIOGEOGR, V27, P277, DOI 10.1111/geb.12693; Assis RC, 2009, GEST COSTEIRA INTEG, V9, P71; Aued AW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198452; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barroso CX, 2016, J BIOGEOGR, V43, P2477, DOI 10.1111/jbi.12821; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Basher Z, 2016, PEERJ, V4, DOI 10.7717/peerj.1713; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Booth TH, 2018, AUSTRAL ECOL, V43, P852, DOI 10.1111/aec.12628; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Buddemeier RW, 2004, POTENTIAL CONTRIBUTI; Cacciapaglia C, 2015, GLOBAL CHANGE BIOL, V21, P2272, DOI 10.1111/gcb.12851; Canario R, 2015, MAR BIOL RES, V11, P76, DOI 10.1080/17451000.2014.894243; Castro CB, 2010, J NAT HIST, V44, P763, DOI 10.1080/00222930903441160; Castro C.B., 2006, BIODIVERSIDADE BENTO, V18, P147; Castro CB, 2001, B MAR SCI, V69, P357; Cavalcante FR, TROP OCEANOGR, V42, DOI [10.5914/to.2014.0112, DOI 10.5914/TO.2014.0112]; Claudia Penichet, 2019, DIVERS DISTRIB; Costantini F., 2016, CNIDARIA PRESENT FUT, P717, DOI [10.1007/978-3-319-31305-4_44, DOI 10.1007/978-3-319-31305-4_44]; Costantini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160678; Creed JC, 2006, CORAL REEFS, V25, P350, DOI 10.1007/s00338-006-0105-x; Cruz I., 2014, MARINE ECOLOGY, V36, P318, DOI DOI 10.1111/MAEC.12141; de Souza JN, 2017, CORAL REEFS, V36, P701, DOI 10.1007/s00338-017-1562-0; do Nascimento CW, 2015, CHECK LIST, V11, P1704; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Durante LM, 2018, PEERJ, V6, DOI 10.7717/peerj.4777; Eakin C., 2016, REEF ENCOUNTER, V31, P20, DOI DOI 10.1007/S00338-019-01844-2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Ferreira BP, 2006, MONITORAMENTO RECIFE; Ficetola GF, 2014, INT J GEOGR INF SCI, V28, P1723, DOI 10.1080/13658816.2014.891222; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Fourcade Y, 2018, GLOBAL ECOL BIOGEOGR, V27, P245, DOI 10.1111/geb.12684; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Frieler K, 2012, J CLIMATE, V25, P3117, DOI 10.1175/JCLI-D-11-00199.1; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Giannini Tereza C., 2012, Rodriguésia, V63, P733; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Heron S.F., 2017, IMPACTS CLIMATE CHAN; Hetzel B., 1994, CORAIS BAHIA; Hijmans Robert J., 2013, DISMO SPECIES DISTRI; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Huang C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02561-y; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johns WE, 1998, J PHYS OCEANOGR, V28, P103, DOI 10.1175/1520-0485(1998)028<0103:ACAVOT>2.0.CO;2; JOKIEL PL, 1993, CORAL REEFS, V12, P177, DOI 10.1007/BF00334477; Jorge Soberon, 2005, INTERPRETATION MODEL; Kavousi J, 2018, ICES J MAR SCI, V75, P43, DOI 10.1093/icesjms/fsx124; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kikuchi RK, 2008, REC TINH BOIP CAM BA, P1; Kuhn T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30246; Kumar S, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00050.1; Kuria MW, 2017, INT J INNOVATIVE RES, V2, P61; Laborel J, 1970, RESULTATES SCI CAMPA, P171; Leao ZMAN, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL I: EUROPE, THE AMERICAS AND WEST AFRICA, 2ND EDITION, P813, DOI 10.1016/B978-0-12-805068-2.00048-6; Leao ZMAN, 2016, BRAZ J OCEANOGR, V64, DOI 10.1590/S1679-875920160916064sp2; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lima GV, 2017, THESIS; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Maida M., 1994, J EXPT MARINE BIOL E, V2, P189; Manzanilla Quinones Ulises, 2019, ACTA BOT MEX, V126; Mariath R, 2012, ALGAE-SEOUL, V27, P249, DOI 10.4490/algae.2012.27.4.249; Winter APM, 2016, BRAZ J OCEANOGR, V64, P203, DOI 10.1590/S1679-87592016080806403; Mazzei EF, 2017, MAR POLLUT BULL, V114, P123, DOI 10.1016/j.marpolbul.2016.08.059; Melo RD, 2005, CAD VIRT TURIS, V5, P34; Miloslavich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014631; Moura RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501252; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Nakamura M., 2011, ECOLOGICAL NICHES GE, V56; Nava H, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12456; Nogueira MM, 2015, HELGOLAND MAR RES, V69, P221, DOI 10.1007/s10152-015-0431-x; Nunes FLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022298; Osorio-Olvera L., 2016, NICHETOOLBOX GETTING; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peluso L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21010-y; Peterson AT, 2018, ANN NY ACAD SCI, V1429, P66, DOI 10.1111/nyas.13873; Peterson AT, 2017, J MED ENTOMOL, V54, P1080, DOI 10.1093/jme/tjx095; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2012, ECOLOGICAL NICHES GE, DOI [10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2005, T RES; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Pires D, 1868, LIVRO VERMELHO FAUNA, P660; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Raftery AE, 2017, NAT CLIM CHANGE, V7, P637, DOI [10.1038/nclimate3352, 10.1038/NCLIMATE3352]; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; RCoreTeam, 2014, R LANG ENV STAT COMP; Reddy M., 2015, AGR BIOL SCI J, V1, P62; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riul P, 2013, MAR ECOL PROG SER, V480, P73, DOI 10.3354/meps10200; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Rogers R, 2014, MAR BIOL RES, V10, P612, DOI 10.1080/17451000.2013.841944; Santos Patricia Souza, 2012, Nauplius, V20, P145; Sartor D., 2015, THESIS; Cruz ICS, 2016, MAR ENVIRON RES, V115, P28, DOI 10.1016/j.marenvres.2016.01.008; Silveira CB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00784; Smith TB, 2014, ECOLOGY, V95, P1663, DOI 10.1890/13-0468.1; SOARES Regina Celia Silva, 2013, THESIS; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Tessarolo G, 2017, ECOL EVOL, V7, P6863, DOI 10.1002/ece3.3259; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vasanthan Raghavan, 2019, IEEE T MICROW THEORY; Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; Zilberberg C, 2014, J HERED, V105, P572, DOI 10.1093/jhered/esu023; 2018, MAR POLLUT B, V135, P551, DOI DOI 10.1016/J.MARPOLBUL.2018.07.043; 2001, CORAL REEFS, V20, P347; 2013, NATURE CLIMATE CHANG, V3, P508, DOI DOI 10.1038/NCLIMATE1829; 2008, ECOL MODEL, V213, P63, DOI DOI 10.1016/J.ECOLMODEL.2007.11.008; 2018, THERYA, V9, P137, DOI DOI 10.12933/THERYA-18-581; 2017, GENET RESOUR CROP EV, V64, P1383, DOI DOI 10.1007/S10722-016-0443-7; 2003, NATURE, V426, P837, DOI DOI 10.1038/NATURE02205; 1999, MARINE BIOL, V135, P463; 2018, J GEOPHYS RES-OCEANS, V123, P2554, DOI DOI 10.1002/2017JC012824; 2003, LATIN AM CORAL REEFS, P9	152	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0211171	10.1371/journal.pone.0211171	http://dx.doi.org/10.1371/journal.pone.0211171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112555	Green Submitted, gold, Green Published			2022-12-27	WOS:000468451000002
J	Perrier-Groult, E; Peres, E; Pasdeloup, M; Gazzolo, L; Dodon, MD; Mallein-Gerin, F				Perrier-Groult, Emeline; Peres, Eleonore; Pasdeloup, Marielle; Gazzolo, Louis; Dodon, Madeleine Duc; Mallein-Gerin, Frederic			Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; HUMAN NASAL CHONDROCYTES; HUMAN IMMUNE-SYSTEM; ARTICULAR CHONDROCYTES; ALLOGRAFT CHONDROCYTES; INFECTIOUS-DISEASE; COLLAGEN SPONGE; MOUSE MODELS; AGAROSE-GEL; IMPLANTATION	Articular cartilage (AC) has poor capacities of regeneration and lesions often lead to osteoarthritis. Current AC reconstruction implies autologous chondrocyte implantation which requires tissue sampling and grafting. An alternative approach would be to use scaffolds containing off-the-shelf allogeneic human articular chondrocytes (HACs). To investigate tolerance of allogeneic HACs by the human immune system, we developed a humanized mouse model implanted with allogeneic cartilage constructs generated in vitro. A prerequisite of the study was to identify a scaffold that would not provoke inflammatory reaction in host. Therefore, we first compared the response of hu-mice to two biomaterials used in regenerative medicine, collagen sponge and agarose hydrogel. Four weeks after implantation in hu-mice, acellular collagen sponges, but not acellular agarose hydrogels, showed positive staining for CD3 (T lymphocytes) and CD68 (macrophages), suggesting that collagen scaffold elicits weak inflammatory reaction. These data led us to deepen our evaluation of the biocompatibility of allogeneic tissue-engineered cartilage by using agarose as scaffold. Agarose hydrogels were combined with allogeneic HACs to reconstruct cartilage in vitro. Particular attention was paid to HLA-A2 compatibility between HACs to be grafted and immune human cells of humice: HLA-A2(+) or HLA-A2(-) HACs agarose hydrogels were cultured in the presence of a chondrogenic cocktail and implanted in HLA-A2(+) hu-mice. After four weeks implantation and regardless of the HLA-A2 phenotype, chondrocytes were well-differentiated and produced cartilage matrix in agarose. In addition, no sign of T-cell or macrophage infiltration was seen in the cartilaginous constructs and no significant increase in subpopulations of T lymphocytes and monocytes was detected in peripheral blood and spleen. We show for the first time that humanized mouse represents a useful model to investigate human immune responsiveness to tissue-engineered cartilage and our data together indicate that allogeneic cartilage constructs can be suitable for cartilage engineering.	[Perrier-Groult, Emeline; Pasdeloup, Marielle; Mallein-Gerin, Frederic] CNRS, UMR5305, Lab Tissue Biol & Therapeut Engn LBTI, Lyon, France; [Peres, Eleonore; Gazzolo, Louis; Dodon, Madeleine Duc] Ecole Normale Super ENS Lyon, INSERM U1210, CNRS UMR5239, Lab Biol & Modeling Cell, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Perrier-Groult, E (corresponding author), CNRS, UMR5305, Lab Tissue Biol & Therapeut Engn LBTI, Lyon, France.	emeline.groult@ibcp.fr		Perrier-Groult, Emeline/0000-0002-0252-8461	CNRS-Lyon 1 University; Fondation ARTHRITIS [105335]	CNRS-Lyon 1 University; Fondation ARTHRITIS	This work was supported by CNRS-Lyon 1 University and Fondation ARTHRITIS (Grant obtained by Arthritis Fondation Courtin AO 2013 #105335 for EP-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2018, CELL MOL IMMUNOL; ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605; Bougault C, 2009, NAT PROTOC, V4, P928, DOI 10.1038/nprot.2009.63; Bougault C, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-71; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; BROOKS N, 1982, J DERMATOL SURG ONC, V8, P111, DOI 10.1111/j.1524-4725.1982.tb00247.x; Cachat A, 2012, M S-MED SCI, V28, P63, DOI 10.1051/medsci/2012281018; Cegielski M, 2008, IN VIVO, V22, P203; CHVAPIL M, 1986, J SURG RES, V41, P410, DOI 10.1016/0022-4804(86)90055-7; Claus S, 2012, TISSUE ENG PART C-ME, V18, P104, DOI [10.1089/ten.TEC.2011.0259, 10.1089/ten.tec.2011.0259]; D'Agostino A, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0064-6; Dewan AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/272481; Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0; FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808; Hautier A, 2008, GROWTH FACTORS, V26, P201, DOI 10.1080/08977190802242488; He XM, 2010, TISSUE ENG PART C-ME, V16, P329, DOI [10.1089/ten.tec.2008.0703, 10.1089/ten.TEC.2008.0703]; KAWABE N, 1991, CLIN ORTHOP RELAT R, P279; Kim YS, 2015, AM J SPORT MED, V43, P176, DOI 10.1177/0363546514554190; Koh YG, 2016, ARTHROSCOPY, V32, P97, DOI 10.1016/j.arthro.2015.09.010; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; LANGER F, 1974, J BONE JOINT SURG AM, VA 56, P297, DOI 10.2106/00004623-197456020-00007; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695, DOI 10.1007/BF00158202; MALEJCZYK J, 1991, CLIN ORTHOP RELAT R, P266; Mayer N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161479; Narayanan J, 2006, J PHYS CONF SER, V28, P83, DOI 10.1088/1742-6596/28/1/017; Neethu M, 2017, INT J BIOL MACROMOL, V104, P1936, DOI 10.1016/j.ijbiomac.2017.03.142; Neybecker P, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1071-2; NOGUCHI T, 1994, CLIN ORTHOP RELAT R, P251; OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X; Ollitrault D, 2015, TISSUE ENG PART C-ME, V21, P133, DOI [10.1089/ten.TEC.2013.0724, 10.1089/ten.tec.2013.0724]; Osti E, 2008, Ann Burns Fire Disasters, V21, P73; Percher F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15890; Peres E, 2015, VIRUSES-BASEL, V7, P6371, DOI 10.3390/v7122944; Perrier-Groult E, 2013, TISSUE ENG PART C-ME, V19, P652, DOI [10.1089/ten.tec.2012.0396, 10.1089/ten.TEC.2012.0396]; Pluen A, 1999, BIOPHYS J, V77, P542, DOI 10.1016/S0006-3495(99)76911-0; Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092; SATSUMA S, 1993, RHEUMATOL INT, V13, P71, DOI 10.1007/BF00307737; Schreiber RE, 1999, CLIN ORTHOP RELAT R, pS382; Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360; Shangkai C, 2007, TISSUE ENG, V13, P483, DOI 10.1089/ten.2006.0181; Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52; Shultz LD, 2011, ANN NY ACAD SCI, V1245, P50, DOI 10.1111/j.1749-6632.2011.06310.x; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Stellavato A, 2016, J CELL BIOCHEM, V117, P2158, DOI 10.1002/jcb.25556; Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x; van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3; Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867; Vinatier C, 2009, BIOTECHNOL BIOENG, V102, P1259, DOI 10.1002/bit.22137; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429; Wang RM, 2017, BIOMATERIALS, V129, P98, DOI 10.1016/j.biomaterials.2017.03.016; Zhang BJ, 2009, J CELL MOL MED, V13, P1043, DOI 10.1111/j.1582-4934.2008.00347.x; 2006, J BONE JOINT SURG AM, V88, P1374; 2019, J BIOMED MATER RES A, V107, P893, DOI DOI 10.1056/NEJM199410063311401	58	11	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217183	10.1371/journal.pone.0217183	http://dx.doi.org/10.1371/journal.pone.0217183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107916	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200036
J	Sencanic, I; Gazibara, T; Dotlic, J; Stamenkovic, M; Jaksic, V; Bozic, M; Grgurevic, A				Sencanic, Ivan; Gazibara, Tatjana; Dotlic, Jelena; Stamenkovic, Miroslav; Jaksic, Vesna; Bozic, Marija; Grgurevic, Anita			Glaucoma Symptom Scale: Psychometric properties of the Serbian version	PLOS ONE			English	Article							QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; CROSS-CULTURAL ADAPTATION; VISUAL FUNCTION; RASCH ANALYSIS; QUESTIONNAIRE; VALIDATION; TRANSLATION; IMPACT; INDEX	Purpose The study aim was to translate and validate the Glaucoma Symptom Scale (GSS) in Serbian language. Methods Clinical parameters and socio-demographic data were collected for each of the 177 enrolled glaucoma patients. Each eye was classified according to the Glaucoma staging system by Mills into 6 stages. Patients filled out the GSS and National Eye Institute Visual Function Questionnaire (NEI-VFQ 25). The GSS comprises 10 complaints common for glaucoma patients on a topical treatment, grouped into two subscales: SYMP-6 (non-visual) and FUNC-4 (visual problems). The GSS was translated following the customary methodology and its psychometric properties were assessed by using both Classical Test Theory (CTT) and Rasch analysis. Results The internal consistency of the Serbian GSS for the whole scale was very good (Cronbach's alpha = 0.81). On factor analysis items were clustered into 2 factors (48.92% of variance) which corresponded to the original scale. The total and subscale GSS scores correlated significantly with measures of disease severity and also with total score and analogous NEI-VFQ 25 subscale scores. In Rasch analysis we obtained adequate item reliability index (0.90). Almost all items had infit and outfit mean squares in the accepted range. However, measurement precision was poor (low person separation reliability) and targeting revealed a ceiling effect. Conclusion When analyzed with CTT the Serbian version of the GSS seems to be a valid instrument, but Rasch analysis revealed some serious measurement flaws, therefore it should not be used in its current format. Further studies to modify and improve GSS are needed prior to its application for Serbian glaucoma patients.	[Sencanic, Ivan; Stamenkovic, Miroslav; Jaksic, Vesna] Univ Med Ctr Zvezdara, Clin Eye Dis Prof Dr Ivan Stankovic, Belgrade, Serbia; [Gazibara, Tatjana; Grgurevic, Anita] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Gazibara, Tatjana; Dotlic, Jelena; Jaksic, Vesna; Bozic, Marija; Grgurevic, Anita] Univ Belgrade, Fac Med, Belgrade, Serbia; [Dotlic, Jelena] Clin Ctr Serbia, Clin Obstet & Gynecol, Belgrade, Serbia; [Stamenkovic, Miroslav] Univ Belgrade, Fac Special Educ & Rehabil, Belgrade, Serbia; [Bozic, Marija] Clin Ctr Serbia, Clin Eye Dis Prof Dr Djordje Nesic, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; Clinical Centre of Serbia	Grgurevic, A (corresponding author), Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia.; Grgurevic, A (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.	anita.grgurevic@gmail.com		Gazibara, Tatjana/0000-0002-9621-8375; Bozic, Marija/0000-0002-0367-5906				Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Blumenthal EZ, 2003, OPHTHALMOLOGY, V110, P196, DOI 10.1016/S0161-6420(02)01297-6; Bond T. G., 2012, APPL RASCH MODEL FUN; Boone WJ, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-04-0148; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Crocker L, 1986, INTRO CLASSICAL MODE; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; DeVellis RF, 2006, MED CARE, V44, pS50, DOI 10.1097/01.mlr.0000245426.10853.30; European Glaucoma Society Terminology and Guidelines for Glaucoma, 2017, BR J OPHTHALMOL, V101, P84; Gothwal VK, 2013, BRIT J OPHTHALMOL, V97, P379, DOI 10.1136/bjophthalmol-2012-302041; Gothwal VK, 2012, INVEST OPHTH VIS SCI, V53, P6081, DOI 10.1167/iovs.12-9885; Gothwal VK, 2011, J CATARACT REFR SURG, V37, P1208, DOI 10.1016/j.jcrs.2011.01.028; Gothwal VK, 2010, ACTA OPHTHALMOL, V88, P797, DOI 10.1111/j.1755-3768.2009.01562.x; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P1160, DOI 10.1097/OPX.0b013e3181bab10c; GUILLEMIN F, 1995, SCAND J RHEUMATOL, V24, P61, DOI 10.3109/03009749509099285; GURALNICK MJ, 1989, J MENT DEFIC RES, V33, P275; Kandel H, 2017, OPTOMETRY VISION SCI, V94, P1102, DOI 10.1097/OPX.0000000000001143; Khadka J, 2016, OPTOMETRY VISION SCI, V93, P1485, DOI 10.1097/OPX.0000000000000992; Khadka J, 2015, J GLAUCOMA, V24, P12, DOI 10.1097/IJG.0b013e318287ac11; Khadka J, 2014, INVEST OPHTH VIS SCI, V55, P4413, DOI 10.1167/iovs.14-14017; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Khadka J, 2012, INVEST OPHTH VIS SCI, V53, P4042, DOI 10.1167/iovs.12-9728; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Kovac B, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0330-5; Lamoureux EL, 2007, OPTOMETRY VISION SCI, V84, P789, DOI 10.1097/OPX.0b013e3181334b83; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Lee BL, 1998, ARCH OPHTHALMOL-CHIC, V116, P861, DOI 10.1001/archopht.116.7.861; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Lichter PR, 2008, ARCH OPHTHALMOL-CHIC, V126, P122, DOI 10.1001/archophthalmol.2007.25; Linacre JM., 2003, RASCH MEAS T, V17, P918; Loon SC, 2015, J GLAUCOMA, V24, pe36, DOI 10.1097/IJG.0000000000000007; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Massof RW, 2001, SURV OPHTHALMOL, V45, P531, DOI 10.1016/S0039-6257(01)00194-1; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Morales J, 2000, OPHTHALMOLOGY, V107, P134, DOI 10.1016/S0161-6420(99)00026-3; Nelson P, 2003, J GLAUCOMA, V12, P139, DOI 10.1097/00061198-200304000-00009; Quaranta L, 2016, ADV THER, V33, P959, DOI 10.1007/s12325-016-0333-6; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Riva I, 2018, J GLAUCOMA, V27, P776, DOI 10.1097/IJG.0000000000000989; Rossi GCM, 2013, J GLAUCOMA, V22, P44, DOI 10.1097/IJG.0b013e318225406c; Rossi GCM, 2009, EUR J OPHTHALMOL, V19, P572, DOI 10.1177/112067210901900409; Ruiz MA, 2009, MED CLIN-BARCELONA, V132, P89, DOI 10.1016/j.medcli.2008.06.005; Rulli E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19113-z; Spaeth G, 2006, AM J OPHTHALMOL, V141, pS3, DOI 10.1016/j.ajo.2005.07.075; Stein Joshua D, 2004, Curr Opin Ophthalmol, V15, P238, DOI 10.1097/01.icu.0000120712.35941.ad; VANALPHEN A, 1994, J ADV NURS, V20, P196	49	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216920	10.1371/journal.pone.0216920	http://dx.doi.org/10.1371/journal.pone.0216920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107903	Green Submitted, Green Published, gold			2022-12-27	WOS:000468285200020
J	Shepherd, LD; Brownsey, PJ; Stowe, C; Newell, C; Perrie, LR				Shepherd, Lara D.; Brownsey, Patrick J.; Stowe, Chris; Newell, Claire; Perrie, Leon R.			Genetic and morphological identification of a recurrent Dicksonia tree fern hybrid in New Zealand	PLOS ONE			English	Article							GENUS; EVOLUTION; DNA; HYBRIDIZATION; SEQUENCES; INFERENCE; NETWORKS; ORIGINS; MARKERS	Hybridization is common in many ferns and has been a significant factor in fern evolution and speciation. However, hybrids are rare between the approximately 30 species of Dicksonia tree ferns world-wide, and none are well documented. In this study we examine the relationship of a newly-discovered Dicksonia tree fern from Whirinaki, New Zealand, which does not fit the current taxonomy of the three species currently recognized in New Zealand. Our microsatellite genotyping and ddRAD-seq data indicate these plants are F1 hybrids that have formed multiple times between D. fibrosa and D. lanata subsp. lanata. The Whirinaki plants have intermediate morphology between D. fibrosa and D. lanata subsp. lanata and their malformed spores are consistent with a hybrid origin. The Whirinaki plants Dicksonia fibrosa x D. lanata subsp. lanata are an example of hybridization between distantly related fern lineages, with the two parent species estimated to have diverged 55-25 mya. Our chloroplast sequencing indicates asymmetric chloroplast inheritance in the Whirinaki morphology with D. lanata subsp. lanata always contributing the chloroplast genome.	[Shepherd, Lara D.; Brownsey, Patrick J.; Perrie, Leon R.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Stowe, Chris] Urt Ecol, Riverton, New Zealand; [Newell, Claire] Korowai Ecol, Springfield, New Zealand		Shepherd, LD (corresponding author), Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand.	Lara.Shepherd@tepapa.govt.nz		Shepherd, Lara/0000-0002-7136-0017; Perrie, Leon/0000-0002-2118-3534	Te Papa; Ministry of Business, Innovation and Employment's Science and Innovation Group; Royal Society of New Zealand Rutherford Discovery Fellowship [RDF-MNZ1201]	Te Papa; Ministry of Business, Innovation and Employment's Science and Innovation Group(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Royal Society of New Zealand Rutherford Discovery Fellowship(Royal Society of New Zealand)	This research was supported by Te Papa, Core funding for Crown Research Institutes from the Ministry of Business, Innovation and Employment's (https://www.mbie.govt.nz) Science and Innovation Group to PB, and a Royal Society of New Zealand (https://www.royalsociety.org.nz) Rutherford Discovery Fellowship (contract number RDF-MNZ1201) to LDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brock JMR, 2016, FOREST ECOL MANAG, V375, P112, DOI 10.1016/j.foreco.2016.05.030; Brownsey PJ, 2014, NEW ZEAL J BOT, V52, P343, DOI 10.1080/0028825X.2014.928331; Brownsey PJ., 2015, FLORA NZ FERNS LYCOP; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Department of Conservation, 2017, WHIR TE PUA A TAN CO; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eaton D., 2017, IPYRAD INTERACTIVE A; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Large MF., 2004, TREE FERNS; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Moore T., 1885, GARD CHRON, V24, P584; Moore T., 1885, GARD CHRON, V24, P689; Nagalingum NS, 2007, SYST BOT, V32, P16, DOI 10.1600/036364407780360256; Nazareno AG, 2013, BIOL PLANTARUM, V57, P563, DOI 10.1007/s10535-013-0311-7; Noben S, 2018, SYST BOT, V43, P839, DOI 10.1600/036364418X697634; Noben S, 2017, J BIOGEOGR, V44, P2648, DOI 10.1111/jbi.13056; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pritchard JK, 2000, GENETICS, V155, P945; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Rothfels CJ, 2015, AM NAT, V185, P433, DOI 10.1086/679662; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schneider H, 2005, P ROY SOC B-BIOL SCI, V272, P455, DOI 10.1098/rspb.2004.2965; Schneider H, 2017, J SYST EVOL, V55, P353, DOI 10.1111/jse.12271; Sessa EB, 2018, ANN MO BOT GARD, V103, P175, DOI 10.3417/2018108; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V49, P240, DOI 10.1016/j.ympev.2008.06.015; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Smith AR, 2002, AM FERN J, V92, P131, DOI 10.1640/0002-8444(2002)092[0131:IROTTF]2.0.CO;2; Tate JA, 2003, SYST BOT, V28, P723; Testo WL, 2015, NEW PHYTOL, V206, P785, DOI 10.1111/nph.13213; Townsend A.J., 2008, NZ THREAT CLASSIFICA; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yang GQ, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0139-1; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; 1998, BOT ACTA, V111, P241	41	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216903	10.1371/journal.pone.0216903	http://dx.doi.org/10.1371/journal.pone.0216903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107899	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200019
J	Zhang, J; Peng, CA				Zhang, Jun; Peng, Ching-An			Enhanced proliferation and differentiation of mesenchymal stem cells by astaxanthin-encapsulated polymeric micelles	PLOS ONE			English	Article							ACCUMULATION	Astaxanthin is a highly potent antioxidant which can be extracted from Haematococcus pluvialis when cultivated and induced at high stress conditions. Due to astaxanthin's hydrophobicity, methoxypolyethylene glycol-polycaprolactone (mPEG-PCL) copolymer was synthesized to form polymeric micelles for the encapsulation of astaxanthin. Astaxanthin-loaded polymeric micelles were then used to examine the effects on the proliferation and differentiation of human mesenchymal stem cells (MSCs). Dynamic light scattering (DLS) and Fourier transform infrared spectroscopy (FT-IR) confirmed astaxanthin was encapsulated into mPEG-PCL micelles. Astaxanthin loading and encapsulation efficiency, determined by UV/Vis spectroscopy, were 3.27% and 96.67%, respectively. After 48 h, a total of 87.31% of astaxanthin was released from the polymeric micelles. The drug release profile was better fit by the Michaelis-Menten type model than the power law model. The MSC culture results showed that culture medium supplemented with 0.5 mu g/mL astaxanthin-encapsulated polymeric micelles led to a 26.3% increase in MSC proliferation over an 8-day culture period. MSC differentiation results showed that 20 ng/mL astaxanthin-encapsulated polymeric micelles enhanced adipogenesis, chondrogenesis, and osteogenesis of MSCs by 52%, 106%, and 182%, respectively.	[Zhang, Jun; Peng, Ching-An] Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA	Idaho; University of Idaho	Peng, CA (corresponding author), Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA.	capeng@uidaho.edu		Zhang, Jun/0000-0003-0788-1915				Adams ML, 2003, J PHARM SCI-US, V92, P1343, DOI 10.1002/jps.10397; Anarjan N, 2014, MOLECULES, V19, P14257, DOI 10.3390/molecules190914257; BOUSSIBA S, 1991, PLANT CELL PHYSIOL, V32, P1077, DOI 10.1093/oxfordjournals.pcp.a078171; BOUSSIBA S, 1992, METHOD ENZYMOL, V213, P386; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Christian D, 2018, BIORESOURCE TECHNOL, V256, P548, DOI 10.1016/j.biortech.2018.02.074; Danafar H, 2014, ADV PHARM BULL, V4, P501, DOI 10.5681/apb.2014.074; Denu RA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2989076; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan GK, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-30; Gou ML, 2009, PHARM RES-DORDR, V26, P2164, DOI 10.1007/s11095-009-9929-8; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Kim JH, 2010, FOOD CHEM TOXICOL, V48, P1741, DOI 10.1016/j.fct.2010.04.002; Naguib YMA, 2000, J AGR FOOD CHEM, V48, P1150, DOI 10.1021/jf991106k; Paiva KBS, 2017, PROG MOL BIOL TRANSL, V148, P203, DOI 10.1016/bs.pmbts.2017.05.001; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004; Sun LY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-53; Tachaprutinun A, 2009, INT J PHARMACEUT, V374, P119, DOI 10.1016/j.ijpharm.2009.03.001; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Yang Y., 2013, J HUM NUTR FOOD SCI, V1, P1003; Yuan C, 2012, CARBOHYD POLYM, V89, P492, DOI 10.1016/j.carbpol.2012.03.033; 2006, CRIT REV FOOD SCI NU, V46, P185, DOI DOI 10.1080/10408690590957188; 2012, BIOL PHARM BULL, V35, P2238, DOI DOI 10.1248/BPB.B12-00715; 2013, CARBOHYD POLYM, V91, P385, DOI DOI 10.1016/J.CARBPOL.2012.08.059; 2013, CURR STEM CELL RES T, V8, P156, DOI DOI 10.2174/1574888X11308020006; 2014, COLLOID SURFACE B, V122, P738, DOI DOI 10.1016/J.COLSURFB.2014.08.011; 2001, J BIOTECHNOL, V89, P65; APPL MICROBIOL BIOT, V54, P550, DOI DOI 10.1007/S002530000416; 2012, J BIOMED NANOTECHNOL, V8, P80, DOI DOI 10.1166/JBN.2012.1358; 2003, J PHARM SCI, V92, P922, DOI DOI 10.1002/JPS.10359; 2014, FASEB J, V28, P1317, DOI DOI 10.1096/FJ.13-235440	35	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216755	10.1371/journal.pone.0216755	http://dx.doi.org/10.1371/journal.pone.0216755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107886	Green Submitted, gold, Green Published			2022-12-27	WOS:000468285200015
J	Apostolakos, I; Mughini-Gras, L; Fasolato, L; Piccirillo, A				Apostolakos, Ilias; Mughini-Gras, Lapo; Fasolato, Luca; Piccirillo, Alessandra			Assessing the occurrence and transfer dynamics of ESBL/pAmpC-producing Escherichia coli across the broiler production pyramid	PLOS ONE			English	Article							E. COLI; AMPC; CEPHALOSPORINS; TRANSMISSION; RESISTANCE; ANIMALS; IMPACT; GENES; MEAT	Extended-spectrum beta-lactamase (ESBL)- and plasmid mediated AmpC-type cephalosporinase (pAmpC)-producing Escherichia coli (ESBL/pAmpC E. coli) in food-producing animals is a major public health concern. This study aimed at quantifying ESBL/pAmpC-E. coli occurrence and transfer in Italy's broiler production pyramid. Three production chains of an integrated broiler company were investigated. Cloacal swabs were taken from parent stock chickens and offspring broiler flocks in four fattening farms per chain. Carcasses from sampled broiler flocks were collected at slaughterhouse. Samples were processed on selective media, and E. coli colonies were screened for ESBL/pAmpC production. ESBL/pAmpC genes and E. coli phylogroups were determined by PCR and sequencing. Average pairwise overlap of ESBL/pAmpC E. coli gene and phylogroup occurrences between subsequent production stages was estimated using the proportional similarity index, modelling uncertainty in a Monte Carlo simulation setting. In total, 820 samples were processed, from which 513 ESBL/pAmpC E. coli isolates were obtained. We found a high prevalence (92.5%, 95% CI 72.1-98.3%) in day-old parent stock chicks, in which bla(CMY-2) predominated; prevalence then dropped to 20% (12.9-29.6%) at laying phase. In fattening broilers, prevalence was 69.2% (53.6-81.3%) at the start of production, 54.2% (38.9-68.6%) at slaughter time, and 61.3% (48.1-72.9%) in carcasses. Significantly decreasing and increasing trends for respectively bla(CMY-2) and bla(CTX-M-1) gene occurrences were found across subsequent production stages. ESBL/pAmpC E. coli genetic background appeared complex and bla-gene/phylogroup associations indicated clonal and horizontal transmission. Modelling revealed that the average transfer of ESBL/pAmpC E. coli genes between subsequent production stages was 47.7% (42.3-53.4%). We concluded that ESBL/pAmpC E. coli in the broiler production pyramid is prevalent, with substantial transfer between subsequent production levels.	[Apostolakos, Ilias; Fasolato, Luca; Piccirillo, Alessandra] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Mughini-Gras, Lapo] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Mughini-Gras, Lapo] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	University of Padua; Netherlands National Institute for Public Health & the Environment; Utrecht University	Piccirillo, A (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	alessandra.piccirillo@unipd.it	Apostolakos, Ilias/AAN-7559-2020; Piccirillo, Alessandra/AAI-8464-2020	Apostolakos, Ilias/0000-0002-9840-5318; FASOLATO, Luca/0000-0002-7746-1150; Piccirillo, Alessandra/0000-0002-6207-4721	University of Padua (Fondi Investimento Strategico di Dipartimento (SID)) [BIRD167540]	University of Padua (Fondi Investimento Strategico di Dipartimento (SID))	This work was supported by the University of Padua (Fondi Investimento Strategico di Dipartimento (SID), Anno 2016 - prot. BIRD167540) to AP.	Baron S, 2014, ANTIMICROB AGENTS CH, V58, P5428, DOI 10.1128/AAC.03106-14; Berg ES, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.12.035; Brolund A, 2016, INFECT DIS-NOR, V48, P18, DOI 10.3109/23744235.2015.1062536; Carmo Luis P., 2014, Infection Ecology & Epidemiology, V4, P22924, DOI 10.3402/iee.v4.22924; Ceccarelli D, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.03439-16, 10.1128/AEM.03439-16]; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2022, PERFORMANCE STANDARD, V32nd ed; Daehre K, 2018, MICROB DRUG RESIST, V24, P511, DOI 10.1089/mdr.2017.0150; Dame-Korevaar A, 2019, PREV VET MED, V162, P136, DOI 10.1016/j.prevetmed.2018.12.002; Dame-Korevaar A, 2017, VET MICROBIOL, V203, P211, DOI 10.1016/j.vetmic.2017.03.024; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dierikx CM, 2018, VET MICROBIOL, V222, P64, DOI 10.1016/j.vetmic.2018.07.001; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; Evers EG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169589; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Haldorsen B, 2008, J ANTIMICROB CHEMOTH, V62, P694, DOI 10.1093/jac/dkn257; Johnson JR, 2017, J CLIN MICROBIOL, V55, P1116, DOI 10.1128/JCM.01949-16; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Lazarus B, 2015, CLIN INFECT DIS, V60, P439, DOI 10.1093/cid/ciu785; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; McDaniels AE, 1998, APPL ENVIRON MICROB, V64, P4113; Mo SS, 2014, VET MICROBIOL, V171, P315, DOI 10.1016/j.vetmic.2014.02.002; Niero G, 2018, VET MICROBIOL, V216, P93, DOI 10.1016/j.vetmic.2018.02.012; Nilsson O, 2014, J ANTIMICROB CHEMOTH, V69, P1497, DOI 10.1093/jac/dku030; OlE (World Organisation for Animal Health), 2015, LIST ANT AG VET IMP; Osman KM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23962-7; Projahn M, 2019, FOOD MICROBIOL, V77, P185, DOI 10.1016/j.fm.2018.09.010; Projahn M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02364-16; Reich F, 2016, FOOD MICROBIOL, V54, P1, DOI 10.1016/j.fm.2015.10.020; Saliu EM, 2017, ANIM HEALTH RES REV, V18, P46, DOI 10.1017/S1466252317000020; Van Duijkeren E, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0019-2017; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; WHO, 2017, WHO GUID ETH ISS PUB; 2016, PREV VET MED, V131, P12, DOI DOI 10.1016/J.PREVETMED2016.07.001; 2011, EMERG INFECT DIS, V17, P1216, DOI DOI 10.3201/EID1707.110209; 2018, VET MICROBIOL, V213, P123, DOI DOI 10.1016/J.VETMIC.2017.11.015; 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI DOI 10.1093/JAC/DKX146; 2014, FOODBORNE PATHOG DIS, V11, P740, DOI DOI 10.1089/FPD.2014.1742; 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI DOI 10.1093/JAC/DKS049; 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI DOI 10.1093/JAC/DKP498; 2007, J APPL MICROBIOL, V103, P2113, DOI DOI 10.1111/J.1365-2672.2007.03437.X; 2015, INT J FOOD MICROBIOL, V215, P57, DOI DOI 10.1016/J.IJFOODMICRO.2015.08.010; 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI DOI 10.1093/JAC/DKS349; 2006, VET MICROBIOL, V118, P299, DOI DOI 10.1016/J.VETMIC.2006.08.002; 2018, INT J FOOD MICROBIOL, V281, P82, DOI DOI 10.1016/J.IJIFOODMICRO.2018.08.032	46	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217174	10.1371/journal.pone.0217174	http://dx.doi.org/10.1371/journal.pone.0217174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100096	gold, Green Published, Green Submitted			2022-12-27	WOS:000468176600034
J	Jumeau, C; Awad, F; Assrawi, E; Cobret, L; Duquesnoy, P; Giurgea, I; Valeyre, D; Grateau, G; Amselem, S; Bernaudin, JF; Karabina, SA				Jumeau, Claire; Awad, Fawaz; Assrawi, Eman; Cobret, Laetitia; Duquesnoy, Philippe; Giurgea, Irina; Valeyre, Dominique; Grateau, Gilles; Amselem, Serge; Bernaudin, Jean-Francois; Karabina, Sonia-Athina			Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages	PLOS ONE			English	Article							SERUM-AMYLOID-A; ACUTE-PHASE; TRANSCRIPTIONAL ACTIVATION; RHEUMATOID-ARTHRITIS; CELLS; PROTEIN; DIFFERENTIATION; GLUCOCORTICOIDS; APOLIPOPROTEIN; INDUCTION	Circulating serum amyloid A (SAA) is increased in various inflammatory conditions. The human SAA protein family comprises the acute phase SAA1/SAA2, known to activate a large set of innate and adaptive immune cells, and the constitutive SAA4. The liver synthesis of SAA1/SAA2 is well-established but there is still an open debate on extrahepatic SAA expression especially in macrophages. We aimed to investigate the ability of human primary monocytes and monocyte-derived macrophages to express SAA1, SAA2 and SAA4 at both the transcriptional and protein levels, as previous studies almost exclusively dealt with monocytic cell lines. Monocytes and derived macrophages from healthy donors were stimulated under various conditions. In parallel with SAA, pro-inflammatory IL1A, IL1B and IL6 cytokine expression was assessed. While LPS alone was non-effective, a combined LPS/dexamethasone treatment induced SAA1 and to a lesser extent SAA2 transcription in human monocytes and macrophages. In contrast, as expected, pro-inflammatory cytokine expression was strongly induced following stimulation with LPS, an effect which was dampened in the presence of dexamethasone. Furthermore, in monocytes polarized towards a pro-inflammatory M1 phenotype, SAA expression in response to LPS/dexamethasone was potentiated; a result mainly seen for SAA1. However, a major discrepancy was observed between SAA mRNA and intracellular protein levels under the experimental conditions used. Our results demonstrate that human monocytes and macrophages can express SAA genes, mainly SAA1 in response to an inflammatory environment. While SAA is considered as a member of a large cytokine network, its expression in the monocytes-macrophages in response to LPS-dexamethasone is strikingly different from that observed for classic pro-inflammatory cytokines. As monocytes-macrophages are major players in chronic inflammatory diseases, it may be hypothesized that SAA production from macrophages may contribute to the local inflammatory microenvironment, especially when macrophages are compactly organized in granulomas as in sarcoidosis.	[Jumeau, Claire; Awad, Fawaz; Assrawi, Eman; Cobret, Laetitia; Duquesnoy, Philippe; Giurgea, Irina; Grateau, Gilles; Amselem, Serge; Bernaudin, Jean-Francois; Karabina, Sonia-Athina] Sorbonne Univ, AP HP, Serv Genet & Embryol Med, INSERM,Hop Trousseau,UMR S 933, Paris, France; [Valeyre, Dominique; Bernaudin, Jean-Francois] Hop Avicenne, AP HP, Serv Pneumol, Bobigny, France; [Valeyre, Dominique; Bernaudin, Jean-Francois] Univ Paris 13, INSERM, UMR 1272, Lab Hypoxie & Poumon, Bobigny, France; [Grateau, Gilles] Hop Tenon, AP HP, Serv Med Interne, Paris, France; [Awad, Fawaz] Al Quds Univ, Fac Med, Biochem & Mol Biol Dept, Abu Deis, East Jerusalem, Palestine	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Amselem, S; Bernaudin, JF; Karabina, SA (corresponding author), Sorbonne Univ, AP HP, Serv Genet & Embryol Med, INSERM,Hop Trousseau,UMR S 933, Paris, France.; Bernaudin, JF (corresponding author), Hop Avicenne, AP HP, Serv Pneumol, Bobigny, France.; Bernaudin, JF (corresponding author), Univ Paris 13, INSERM, UMR 1272, Lab Hypoxie & Poumon, Bobigny, France.	serge.amselem@inserm.fr; jean-francois.bernaudin@aphp.fr; sonia.karabina@upmc.fr	AWAD, Fawaz/AAB-1825-2019; Giurgea, Irina/AGX-6879-2022	Giurgea, Irina/0000-0002-5035-2958; BERNAUDIN, Jean-Francois/0000-0002-4893-0106; Valeyre, dominique/0000-0003-4470-1776; Awad, Fawaz/0000-0002-8214-394X	Doctoral School "Complexite du vivant"; French government; An-Najah University (Palestine); Alquds University (Palestine); Fondation pour la Recherche Medicale [FDT20130928419]	Doctoral School "Complexite du vivant"; French government; An-Najah University (Palestine); Alquds University (Palestine); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Claire Jumeau was supported by a grant from the Doctoral School "Complexite du vivant". Eman Assrawi was supported by a grant from the French government and An-Najah University (Palestine). Fawaz Awad was supported by a grant from the French government and Alquds University (Palestine) and from the "Fondation pour la Recherche Medicale" (FDT20130928419).	Anthony D, 2014, FASEB J, V28, P3867, DOI 10.1096/fj.14-250332; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; BAINTON DF, 1978, J CLIN INVEST, V61, P1555, DOI 10.1172/JCI109076; BANKA CL, 1995, J LIPID RES, V36, P1058; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Beringer A, 2018, AUTOIMMUN REV, V17, P1176, DOI 10.1016/j.autrev.2018.06.008; BERNAUDIN JF, 1988, J IMMUNOL, V140, P3822; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chen ES, 2015, CLIN REV ALLERG IMMU, V49, P6, DOI 10.1007/s12016-015-8481-z; Chen ES, 2011, NAT REV RHEUMATOL, V7, P457, DOI 10.1038/nrrheum.2011.93; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; Couderc E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181486; De Buck M, 2016, CYTOKINE GROWTH F R, V30, P55, DOI 10.1016/j.cytogfr.2015.12.010; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Frame NM, 2016, FEBS LETT, V590, P866, DOI 10.1002/1873-3468.12116; Gouwy M, 2015, EUR J IMMUNOL, V45, P101, DOI 10.1002/eji.201444818; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Han CY, 2016, J CLIN INVEST, V126, P266, DOI 10.1172/JCI83475; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Huho A, 2017, RESP MED, V126, P1, DOI 10.1016/j.rmed.2017.03.009; Ishii W, 2013, AMYLOID, V20, P61, DOI 10.3109/13506129.2013.775941; JIANG SL, 1995, J CLIN INVEST, V95, P1253, DOI 10.1172/JCI117775; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Kluve-Beckerman B, 2001, SCAND J IMMUNOL, V53, P393, DOI 10.1046/j.1365-3083.2001.00879.x; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kumon Y, 2001, SCAND J IMMUNOL, V53, P7, DOI 10.1046/j.1365-3083.2001.00829.x; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; Lopalco G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001858; Lucherini OM, 2018, IMMUNOL LETT, V201, P38, DOI 10.1016/j.imlet.2018.10.013; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; MARHAUG G, 1994, BAILLIERE CLIN RHEUM, V8, P553, DOI 10.1016/S0950-3579(05)80115-3; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; NATSUKA S, 1992, BLOOD, V79, P460; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Patterson KC, 2018, CHEST, V153, P1432, DOI 10.1016/j.chest.2017.11.030; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Sack GH, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0047-0; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SOLER P, 1976, ANN NY ACAD SCI, V278, P147, DOI 10.1111/j.1749-6632.1976.tb47026.x; STEEL DM, 1993, GENOMICS, V16, P447, DOI 10.1006/geno.1993.1209; Sun L, 2016, GENE, V583, P48, DOI 10.1016/j.gene.2016.02.044; Sun L, 2015, J IMMUNOL, V194, P4891, DOI 10.4049/jimmunol.1402164; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Yamada T, 1996, PATHOL INT, V46, P797, DOI 10.1111/j.1440-1827.1996.tb03552.x; Yamada T, 2000, SCAND J IMMUNOL, V52, P7; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R; 2006, ATHEROSCLEROSIS, V188, P433, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.11.015; 2012, ENDOCRINOLOGY, V153, P3701, DOI DOI 10.1210/EN.2012-1020; 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI DOI 10.1177/002215549804601206; 2015, J LEUKOCYTE BIOL, V98, P1049, DOI DOI 10.1189/JLB.3A0315-085R; 2004, SCAND J IMMUNOL, V59, P152; 1998, ANN REV IMMUNOL, V16, P225; 2014, LANCET, V383, P1155, DOI DOI 10.1016/S0140-6736(13)60680-7	76	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217005	10.1371/journal.pone.0217005	http://dx.doi.org/10.1371/journal.pone.0217005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100086	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600024
J	Rhie, YJ; Yoo, JH; Choi, JH; Chae, HW; Kim, JH; Chung, S; Hwang, IT; Shin, CH; Kim, EY; Kim, HS				Rhie, Young-Jun; Yoo, Jae-Ho; Choi, Jin-Ho; Chae, Hyun-Wook; Kim, Jae Hyun; Chung, Sochung; Hwang, Il Tae; Shin, Choong Ho; Kim, Eun Young; Kim, Ho-Seong			Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; TURNER-SYNDROME; PEDIATRIC-PATIENTS; CANCER INCIDENCE; SHORT STATURE; FACTOR-I; CHILDHOOD; GUIDELINES; RISK; NEOPLASIA	Purpose The aim of this registry study was to analyze the long-term safety and effectiveness of recombinant human growth hormone (rhGH) in South Korean pediatric patients (>= 2 years of age) with growth hormone deficiency GHD) of idiopathic or organic etiology, idiopathic short stature, Turner syndrome, small for gestational age and chronic renal failure. Methods The study patients were followed-up till two years after the epiphyseal closure, with visits scheduled every six months. The outcome measures included the incidence of adverse events (AEs, in particular, neoplasia, glucose intolerance and hypothyroidism), as well as height standard deviation score (Ht SDS) and annual height velocity. The results of the interim analysis of a 5-year accumulated data for 2,024 patients (7,342 patient-years, PY) are presented. Results A total of 14 neoplasms were diagnosed (191/100,000 PY); 7 out of 9 malignancies were recurrent craniopharyngioma found in patients with organic GHD. Seven cases of glucose intolerance (95/100,000 PY) and 22 cases of hypothyroidism (300/100,000 PY) were detected; about half of the cases (4 and 10 cases each) were considered to be related with rhGH treatment. Most of the growth-retarded patients showed continuous improvement in Ht SDS, with the most prominent effect observed within a year of treatment initiation. The beneficial effect of rhGH on Ht SDS gain was maintained for 2-4 years. Conclusions The incidence of AEs of interest in rhGH-treated patients was low, and most of the neoplasms were benign and/or non-related to rhGH. Most patients benefited from the therapy in terms of height increment.	[Rhie, Young-Jun] Korea Univ, Dept Pediat, Coll Med, Ansan, South Korea; [Yoo, Jae-Ho] Dong A Univ, Dept Pediat, Coll Med, Busan, South Korea; [Choi, Jin-Ho] Univ Ulsan, Dept Pediat, Asan Med Ctr, Coll Med, Seoul, South Korea; [Chae, Hyun-Wook; Kim, Ho-Seong] Yonsei Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Kim, Jae Hyun] Seoul Natl Univ, Dept Pediat, Bundang Hosp, Seongnam, South Korea; [Chung, Sochung] Konkuk Univ, Dept Pediat, Sch Med, Seoul, South Korea; [Hwang, Il Tae] Hallym Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Shin, Choong Ho] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Kim, Eun Young] LG Chem Ltd, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Dong A University; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Hallym University; Seoul National University (SNU); LG Chem	Kim, HS (corresponding author), Yonsei Univ, Dept Pediat, Coll Med, Seoul, South Korea.	kimho@yuhs.ac	Rhie, Young-Jun/AAV-4929-2020; Kim, Jae Hyun/S-1459-2019	Rhie, Young-Jun/0000-0002-1250-6469; Kim, Jae Hyun/0000-0002-0203-7443; Chae, Hyun Wook/0000-0001-5016-8539; Kim, Ho-Seong/0000-0003-1135-099X	LG Chem, Ltd	LG Chem, Ltd	This cohort study was sponsored by LG Chem, Ltd (http://www.lgchem.com/global/main).LG Chem, Ltd provided support in the form of salary for author EYK and involved with the study design, interpretation of data, decision to publish, and preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Albertsson-Wikland K, 2016, J CLIN ENDOCR METAB, V101, P2149, DOI 10.1210/jc.2015-3951; Allen DB, 2016, EUR J ENDOCRINOL, V174, pP1, DOI 10.1530/EJE-15-0873; Allen DB, 2017, HORM RES PAEDIAT, V87, P145, DOI 10.1159/000458526; Bell J, 2010, J CLIN ENDOCR METAB, V95, P167, DOI 10.1210/jc.2009-0178; Child CJ, 2016, HORM RES PAEDIAT, V85, P198, DOI 10.1159/000444124; Chung S, 2018, ANN PEDIATR ENDOCRIN, V23, P43, DOI 10.6065/apem.2018.23.1.43; Clayton PE, 2007, J CLIN ENDOCR METAB, V92, P804, DOI 10.1210/jc.2006-2017; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; El-Mansoury M, 2005, J CLIN ENDOCR METAB, V90, P2131, DOI 10.1210/jc.2004-1262; Gravholt CH, 2017, EUR J ENDOCRINOL, V177, pG1, DOI 10.1530/EJE-17-0430; Grimberg A, 2016, HORM RES PAEDIAT, V86, P361, DOI 10.1159/000452150; Hoybye Charlotte, 2013, Clin Epidemiol, V5, P119, DOI 10.2147/CLEP.S42602; Hwang Jun-Won, 2015, Ann Pediatr Endocrinol Metab, V20, P79, DOI 10.6065/apem.2015.20.2.79; Hyun SE, 2012, CLIN BIOCHEM, V45, P16, DOI 10.1016/j.clinbiochem.2011.10.003; Indini A, 2017, J NEURO-ONCOL, V131, P349, DOI 10.1007/s11060-016-2306-7; Kim JY, 2001, J PEDIATR ORTHOPED, V21, P765, DOI 10.1097/00004694-200111000-00012; Korea Center for Disease Control and Prevention The Korean Pediatric Society The Committee for the Development of Growth Standard for Korean Children and Adolescents, 2007, KOR CHILDR AD GROWTH; Libruder C, 2016, CLIN ENDOCRINOL, V85, P813, DOI 10.1111/cen.13131; Mahan JD, 2006, PEDIATR NEPHROL, V21, P917, DOI 10.1007/s00467-006-0020-y; Maneatis T, 2000, J PEDIATR ENDOCR MET, V13, P1035; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; Pekic S, 2017, BEST PRACT RES CL EN, V31, P35, DOI 10.1016/j.beem.2017.02.004; Raman S, 2015, J CLIN ENDOCR METAB, V100, P2192, DOI 10.1210/jc.2015-1002; Ranke MB, 2000, J CLIN ENDOCR METAB, V85, P4212, DOI 10.1210/jc.85.11.4212; Savendahl L, 2016, EUR J ENDOCRINOL, V174, P681, DOI 10.1530/EJE-15-1017; Shen L, 2015, NEUROL SCI, V36, P1859, DOI 10.1007/s10072-015-2269-z; Swerdlow AJ, 2017, J CLIN ENDOCR METAB, V102, P1661, DOI 10.1210/jc.2016-2046; Swerdlow AJ, 2015, HORM RES PAEDIAT, V84, P172, DOI 10.1159/000435856; van der Steen M, 2017, LANCET DIABETES ENDO, V5, P106, DOI 10.1016/S2213-8587(16)30422-3; Wilton P, 2010, J PEDIATR-US, V157, P265, DOI 10.1016/j.jpeds.2010.02.028; Wyatt D, 2004, EUR J ENDOCRINOL, V151, pS55, DOI 10.1530/eje.0.151S055; 2017, HORM RES PAEDIAT, V87, P30, DOI DOI 10.1159/000452887	32	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216927	10.1371/journal.pone.0216927	http://dx.doi.org/10.1371/journal.pone.0216927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095622	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100053
J	Mekonnen, B; Mihret, A; Getahun, M; Hailu, T; Sidiki, S; Kelley, HV; Scordo, JM; Hunt, WG; Pan, XL; Balada-Llasat, JM; Gebreyes, W; Evans, CA; Aseffa, A; Torrelles, JB; Wang, SH; Abebe, T				Mekonnen, Biruk; Mihret, Adane; Getahun, Muluwork; Hailu, Tsegaye; Sidiki, Sabeen; Kelley, Holden, V; Scordo, Julia M.; Hunt, W. Garrett; Pan, Xueliang; Balada-Llasat, Joan-Miquel; Gebreyes, Wondwossen; Evans, Carlton A.; Aseffa, Abraham; Torrelles, Jordi B.; Wang, Shu-Hua; Abebe, Tamrat			Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia	PLOS ONE			English	Article							DIAGNOSIS; ACCURACY; AGAR	Timely diagnosis of tuberculosis (TB) is limited in Ethiopia. We evaluated the performance of a low technology, thin layer agar, Mycobacterium tuberculosis (M.tb) culture color plate (TB-CX) test with concurrent drug susceptibility testing (DST) to isoniazid (INH), rifampin (RIF), and pyrazinamide (PZA) directly from sputum specimens. Patients undergoing examination for TB and multidrug-resistant (MDR)-TB were enrolled in Addis Ababa, Ethiopia from March 2016 to February 2017. All subjects received a GeneXpert MTB/RIF PCR test. TB-CX test results were compared to reference Lowenstein-Jensen (LJ) culture for M.tb detection and DST for susceptibility to INH and RIF. Kappa statistic was applied to test agreement between results for TB-CX test and the reference methods, a cut-off Kappa value of 0.75 was considered as high level of agreements. A total of 137 participants were analyzed: 88 (64%) were new TB cases, 49 (36%) were re-treatment cases. The TB-CX test detected M.tb and DST in an average of 13 days compared to 50 days for the conventional DST result. The sensitivity and specificity of the TB-CX test for detecting M.tb were 94% and 98%, respectively (concordance, 96%; kappa 0.91). The sensitivity of the TB-CX test to detect drug resistance to INH, RIF, and MDR-TB was 91%, 100%, and 90% respectively. The specificity of the TB-CX test for detecting INH, RIF, and MDR-TB was 94%, 40%, and 94% respectively. Overall agreement between TB-CX test and LJ DST for detection of MDR-TB was 93%. The TB-CX test showed strong agreement with the GeneXpert test for detecting M.tb (89%, kappa 0.76) but low agreement for the detection of RIF resistance (57%, kappa 0.28). The TB-CX test was found to be a good alternative method for screening of TB and selective drug resistant-TB in a timely and cost-efficient manner.	[Mekonnen, Biruk; Abebe, Tamrat] Addis Ababa Univ, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Mihret, Adane; Hailu, Tsegaye; Aseffa, Abraham] AHRI, Addis Ababa, Ethiopia; [Getahun, Muluwork] EPHI, Addis Ababa, Ethiopia; [Sidiki, Sabeen; Kelley, Holden, V; Scordo, Julia M.; Torrelles, Jordi B.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun Coll Med, Columbus, OH 43210 USA; [Hunt, W. Garrett] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Pan, Xueliang] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Balada-Llasat, Joan-Miquel] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Balada-Llasat, Joan-Miquel; Gebreyes, Wondwossen; Wang, Shu-Hua] Ohio State Univ, Global One Hlth Initiat GOHi, Columbus, OH USA; [Evans, Carlton A.] Imperial Coll London, Infect Dis & Immun, London, England; [Evans, Carlton A.] Wellcome Trust Imperial Coll Ctr Global Hlth Res, London, England; [Evans, Carlton A.] Univ PeruanaCayetano Heredia, Innovat Hlth & Dev IFHAD, Lab Res & Dev, Lima, Peru; [Evans, Carlton A.] Asociac Benefice PRISMA, Innovac Por Salud & Desarrollo & PSYD, Lima, Peru; [Wang, Shu-Hua] Ohio State Univ, Coll Med, Dept Internal Med, Div Infect Dis, Columbus, OH 43210 USA; [Mekonnen, Biruk] Mekelle Univ, Coll Vet Med, Mekelle, Ethiopia; [Kelley, Holden, V; Scordo, Julia M.; Torrelles, Jordi B.] Texas Biomed Res Inst, San Antonio, TX USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Imperial College London; Universidad Peruana Cayetano Heredia; University System of Ohio; Ohio State University; Mekelle University; Texas Biomedical Research Institute	Mekonnen, B (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.; Mekonnen, B (corresponding author), Mekelle Univ, Coll Vet Med, Mekelle, Ethiopia.	mbiruk1972@gmail.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Mihret, Adane/0000-0003-3183-4772; Woldie, Biruk Mekonnen/0000-0001-6114-8656; Evans, Carlton/0000-0002-6873-5447; Pan, Xueliang/0000-0002-2342-3212	National Center for Advancing Translational Sciences [UL1TR001070]; Mekelle University; Addis Ababa Universities, Ethiopia; MRC [MR/K007467/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mekelle University; Addis Ababa Universities, Ethiopia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the National Center for Advancing Translational Sciences (UL1TR001070 to S-HW, WG, JBT, XP, WGH, J-MB-L). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The project is also funded in part by Mekelle University and Addis Ababa Universities, Ethiopia (to BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Dereje, 2012, BMC Res Notes, V5, P462, DOI 10.1186/1756-0500-5-462; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Armauer Hansen Research Institute, 2012, STAND OP PROC TUB DI; Biadglegne F, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-31; Boehme CC, 2010, NEW ENGL J MED, V10, P1056; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Cepheid, 2011, GENEXPERTDX SYST XPE; Ethiopian Health and Nutrition Research Institute/ Ethiopian Public Health Institute, 2013, LAB MAN WORK TUB ETH; Federal Democratic Republic of Ethiopia Ministry of Health/ Ethiopian Public Health Institute, 2012, IMPL GUID GENEXPERT; Hamid S, 2012, ANN TROP MED PUBLIC, V5, P317, DOI 10.4103/1755-6783.102035; Herrera B, 2007, S TB FIELD DIAGN DYI, P15; Jeremy W, 2013, INT J TB LUNG DIS, V17, pS271; Lee S, 2006, J MICROBIOL METH, V66, P548, DOI 10.1016/j.mimet.2006.02.004; Marco A, 2015, INT J TB LUNG DIS, V19, pS368; Martin A, 2009, PROCEDURE MANUAL THI; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Mokaddas E, 2015, J CLIN MICROBIOL, V53, P1351, DOI 10.1128/JCM.03412-14; Molicotti P, 2014, J INFECT DEV COUNTR, V8, P24, DOI 10.3855/jidc.3295; Nepali S, 2010, SAARC J TUBER LUNG D, V5, P25, DOI [10.3126/saarctb.v5i1.3080., DOI 10.3126/SAARCTB.V5I1.3080]; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Robledo J, 2008, INT J TUBERC LUNG D, V12, P1482; SCHABERG T, 1995, EUR RESPIR J, V8, P1688, DOI 10.1183/09031936.95.08101688; Shibabaw A, 2019, TUBERCULOSIS, V114, P54, DOI 10.1016/j.tube.2018.11.007; Ssengooba W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037650; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Toit K, 2012, INT J TUBERC LUNG D, V16, P1113, DOI 10.5588/ijtld.11.0609; Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2017, GLOB TUB REP 2017; Wilson ML, 2011, CLIN INFECT DIS, V52, P1350, DOI 10.1093/cid/cir146; World Health Organization, 2016, GLOB TUB REP 2015; Zhang A, 2018, AFR J LAB MED, V7, DOI 10.4102/ajlm.v7i1.690; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446	36	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0215679	10.1371/journal.pone.0215679	http://dx.doi.org/10.1371/journal.pone.0215679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136575	Green Published, gold			2022-12-27	WOS:000469224300002
J	Allen, P; Calcagni, A; Robson, AG; Claridge, E				Allen, Piers; Calcagni, Antonio; Robson, Anthony G.; Claridge, Ela			Investigating the potential of Zernike polynomials to characterise spatial distribution of macular pigment	PLOS ONE			English	Article							OPTICAL-DENSITY MEASUREMENT; FUNDUS AUTOFLUORESCENCE; QUANTITATIVE-ANALYSIS; EYE DISEASE; AGE; DEGENERATION; CAROTENOIDS; ZEAXANTHIN; LUTEIN; REFLECTANCE	It has been postulated that particular patterns of macular pigment (MP) distribution may be associated with the risk for eye diseases such as age-related macular degeneration (AMD). This work investigates the potential of Zernike polynomials (ZP) to characterise the level and distribution of MP, and their suitability as a representation for analysis of the effects of age and AMD on MP patterns. As the case study, MP distribution maps computed using an experimental method based on fundus reflectance (MRIA) were obtained for ninety volunteers representing three groups: under-fifty without AMD, fifty and over without AMD, and fifty and over with AMD. ZP with 105 coefficients were fitted to the maps using least-squares optimisation and found to represent MP maps accurately (RMSE<10-1). One-way MANOVA analysis carried out on ZP representations showed that the three subject groups have significantly different means (Wilk's Lambda 0.125, p<0.0001). Linear discriminant analysis with leave-one-out scheme resulted in accuracy, sensitivity and specificity of classification according to, respectively, disease status regardless of age (81% all); disease status in the age-matched groups (87%, 88%, 86%); age irrespective of disease status (81%, 83%, 73%); and age for subjects without AMD (83%, 88%, 80%). Mean MP distributions computed from ZP coefficients for the three groups showed more elevated and more peaked MP for the healthy under-fifty group; more irregular and more elevated peripheral levels in over-fifty AMD group than in over-fifty non-AMD group; and moderate radial asymmetry in non-AMD over-50 group. The results suggest that ZP coefficients are capable of accurately representing MP in a way that captures certain spatial patterns of its distribution. Using the ZP representation MP maps could be classified according to both age and disease status with accuracy significantly greater than chance, with peak elevation, pattern irregularity and radial asymmetry identified as important features.	[Allen, Piers; Calcagni, Antonio; Claridge, Ela] Univ Birmingham, Sch Comp Sci, Birmingham, W Midlands, England; [Calcagni, Antonio] Aston Univ, Ophthalm Res Grp, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Calcagni, Antonio; Robson, Anthony G.] Moorfields Eye Hosp NHS Fdn Trust, Dept Electrophysiol, London, England; [Robson, Anthony G.] UCL, Inst Ophthalmol, London, England; [Allen, Piers] Univ Birmingham, Res & Training Ctr Phys Sci Hlth, Birmingham, W Midlands, England	University of Birmingham; Aston University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Birmingham	Claridge, E (corresponding author), Univ Birmingham, Sch Comp Sci, Birmingham, W Midlands, England.	e.claridge@cs.bham.ac.uk		Robson, Anthony/0000-0002-8391-6123; Calcagni, Antonio Salvatore Pio/0000-0002-1446-3546	Dunhill Medical Trust [R116/0509]; Paul & Yuanbi Ramsay Research Fund, University of Birmingham; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	Dunhill Medical Trust(Dunhill Medical Trust); Paul & Yuanbi Ramsay Research Fund, University of Birmingham; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	This work was supported by the Dunhill Medical Trust, grant number R116/0509, (http://dunhillmedical.org.uk) to EC, AC; Paul & Yuanbi Ramsay Research Fund, University of Birmingham to PA. AGR wishes to acknowledge support by the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge contributions that the following colleagues made to the development of the Multispectral Retinal Image Analysis technique and to image data collection: Professor Jonathan M Gibson, Dr Frank Eperjesi, Dr Hannah Bartlett ( Aston University, Birmingham, U.K.), Dr Iain B Styles and Dr Yuan Shen ( University of Birmingham, U.K.). Anthony G Robson wishes to acknowledge support by the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.	Ach T, 2014, INVEST OPHTH VIS SCI, V55, P4832, DOI 10.1167/iovs.14-14802; Agarwal A, 2012, GASS ATLAS MACULAR D; Alabboud I, 2007, EUR C BIOM OPT INT S; Alassane S, 2016, INVEST OPHTH VIS SCI, V57, P4469, DOI 10.1167/iovs.16-19958; ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1; Beatty S, 2008, INVEST OPHTH VIS SCI, V49, P843, DOI 10.1167/iovs.07-1276; Berendschot TT, 2005, EXP EYE RES, V81, P602, DOI 10.1016/j.exer.2005.03.019; Berendschot TTJM, 2004, ARCH BIOCHEM BIOPHYS, V430, P149, DOI 10.1016/j.abb.2004.04.029; Bernstein PS, 2012, INVEST OPHTH VIS SCI, V53, P6178, DOI 10.1167/iovs.12-10275; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Bernstein PS, 2004, ARCH BIOCHEM BIOPHYS, V430, P163, DOI 10.1016/j.abb.2004.07.004; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Calcagni A, 2011, EYE, V25, P1562, DOI 10.1038/eye.2011.202; Chen SF, 2001, CURR EYE RES, V23, P422, DOI 10.1076/ceyr.23.6.422.6963; Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Ciulla TA, 2001, OPHTHALMOLOGY, V108, P730, DOI 10.1016/S0161-6420(00)00655-2; Claridge E, 2003, LECT NOTES COMPUT SC, V2732, P306; Ctori I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169520; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Curran-Celentano J, 2001, AM J CLIN NUTR, V74, P796; Degli Esposti S, 2012, INVEST OPHTH VIS SCI, V53, P6568, DOI 10.1167/iovs.12-9756; Delori F, 2011, INVEST OPHTH VIS SCI, V52, P9379, DOI 10.1167/iovs.11-8319; Demirel S, 2014, GRAEF ARCH CLIN EXP, V252, P213, DOI 10.1007/s00417-013-2424-2; Dietzel M, 2011, INVEST OPHTH VIS SCI, V52, P8016, DOI 10.1167/iovs.11-7610; Dysli C, 2017, PROG RETIN EYE RES, V60, P120, DOI 10.1016/j.preteyeres.2017.06.005; Eandi CM, 2017, INVEST OPHTH VIS SCI, V58, P2284, DOI 10.1167/iovs.16-20510; Everdell NL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478001; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hammond BR, 2002, INVEST OPHTH VIS SCI, V43, P47; Hammond BR, 1997, J OPT SOC AM A, V14, P1187, DOI 10.1364/JOSAA.14.001187; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; Jorgensen JB, 2006, INTRO OPTIMIZATION D; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Lakshminarayanan V, 2011, J MOD OPTIC, V58, P545, DOI 10.1080/09500340.2011.554896; Landrum JT, 2004, ARCH BIOCHEM BIOPHYS, V430, P135, DOI 10.1016/j.abb.2004.07.008; Lima Veronica Castro, 2016, Int J Retina Vitreous, V2, P19; MacKay D. J. C., 1998, Neural Networks and Machine Learning. Proceedings, P133; Meyers KJ, 2014, INVEST OPHTH VIS SCI, V55, P587, DOI 10.1167/iovs.13-13216; Moreland J., 1982, COLOR DEFICIENCIES, V33, P61; Nolan JM, 2007, INVEST OPHTH VIS SCI, V48, P571, DOI 10.1167/iovs.06-0864; Obana A, 2014, GRAEF ARCH CLIN EXP, V252, P1221, DOI 10.1007/s00417-014-2574-x; Preece SJ, 2004, IEEE T PATTERN ANAL, V26, P913, DOI 10.1109/TPAMI.2004.36; Preece SJ, 2002, PHYS MED BIOL, V47, P2863, DOI 10.1088/0031-9155/47/16/303; Preece SJ, 2005, INT C MED IM COMP CO; Putnam CM, 2017, CLIN EXP OPTOM, V100, P333, DOI 10.1111/cxo.12500; Robson AG, 2003, VISION RES, V43, P1765, DOI 10.1016/S0042-6989(03)00280-3; Sauer L, 2018, INVEST OPHTH VIS SCI, V59, P3094, DOI 10.1167/iovs.18-23886; Seth R, 2004, DOC OPHTHALMOL, V108, P197, DOI 10.1007/s10633-004-5182-y; Sharifzadeh M, 2006, J OPT SOC AM A, V23, P2373, DOI 10.1364/JOSAA.23.002373; Shen Y, 2013, P MED IM UND AN 2013, V2013; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P660; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; Styles IB, 2006, MED IMAGE ANAL, V10, P578, DOI 10.1016/j.media.2006.05.007; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Trieschmann M, 2006, GRAEF ARCH CLIN EXP, V244, P1565, DOI 10.1007/s00417-006-0289-3; Trieschmann M, 2003, GRAEF ARCH CLIN EXP, V241, P1006, DOI 10.1007/s00417-003-0796-4; van de Kraats J, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398925; Van Der Veen RL, 2012, NEW DESKTOP INSTRUME; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; Wolf-Schnurrbusch UEK, 2007, INVEST OPHTH VIS SCI, V48, P3783, DOI 10.1167/iovs.06-1218; Wustemeyer H, 2002, GRAEF ARCH CLIN EXP, V240, P666, DOI 10.1007/s00417-002-0515-6; Wyant J. C., 1992, APPL OPTICS OPTICAL, V11, P28; You QS, 2016, RETINA-J RET VIT DIS, V36, P1381, DOI 10.1097/IAE.0000000000000893; Zeimer M, 2012, INVEST OPHTH VIS SCI, V53, P4852, DOI 10.1167/iovs.12-9713	68	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217265	10.1371/journal.pone.0217265	http://dx.doi.org/10.1371/journal.pone.0217265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125363	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000468865700026
J	Huik, K; Soodla, P; Pauskar, M; Owen, SM; Luo, W; Murphy, G; Jogeda, EL; Kallas, E; Rajasaar, H; Avi, R; Masciotra, S; Lutsar, I; Del Amo, J; Meyer, L; Bucher, HC; Chene, G; Hamouda, O; Pillay, D; Prins, M; Rosinska, M; Sabin, C; Touloumi, G; Porter, K; Olson, A; Cartier, A; Fradette, L; Walker, S; Babiker, A; De Luca, A; Fisher, M; Muga, R; Kelleher, T; Cooper, D; Grey, P; Finlayson, R; Bloch, M; Ramacciotti, T; Gelgor, L; Smith, D; Zangerle, R; Gill, J; Dabis, F; Thiebaut, R; Costagliola, D; Guiguet, M; Vanhems, P; Chaix, ML; Ghosn, J; Boufassa, F; Meixenberger, K; Bannert, N; Bartmeyer, B; Antoniadou, A; Chrysos, G; Daikos, GL; Pantazis, N; Katsarou, O; Rezza, G; Dorrucci, M; Monforte, AD; Geskus, R; van der Helm, J; Schuitemaker, H; Sannes, M; Dyrhol-Riise, AM; Kran, AMB; Rosinska, M; Tor, J; de Olalla, PG; Cayla, J; del Amo, J; Moreno, S; Monge, S; del Romero, J; Perez-Hoyos, S; Sonnerborg, A; Gunthard, H; Scherrer, A; Malyuta, R; Johnson, A; Phillips, A; Morrison, C; Salata, R; Mugerwa, R; Chipato, T; Price, MA; Gilmour, J; Kamali, A; Karita, E; Burns, F; Giaquinto, C; Grarup, J; Kirk, O; Bailey, H; Anne, AV; Panteleev, A; Thorne, C; Aboulker, JP; Albert, J; Asandi, S; De Wit, S; Reiss, P; Gatell, J; Karpov, I; Ledergerber, B; Lundgren, J; Moller, C; Rakhma-nova, A; Rockstroh, J; Sandhu, M; Dedes, N; Fenton, K; Pizzuti, D; Vitoria, M; Faggion, S; Frost, R; Raben, D; Schwimmer, C; Scott, M				Huik, Kristi; Soodla, Pilleriin; Pauskar, Merit; Owen, S. Michele; Luo, Wei; Murphy, Gary; Jogeda, Ene-Ly; Kallas, Eveli; Rajasaar, Heli; Avi, Radko; Masciotra, Silvina; Lutsar, Irja; Del Amo, Julia; Meyer, Laurence; Bucher, Heiner C.; Chene, Genevieve; Hamouda, Osamah; Pillay, Deenan; Prins, Maria; Rosinska, Magda; Sabin, Caroline; Touloumi, Giota; Porter, Kholoud; Olson, Ashley; Cartier, Andrea; Fradette, Lorraine; Walker, Sarah; Babiker, Abdel; De Luca, Andrea; Fisher, Martin; Muga, Roberto; Kelleher, Tony; Cooper, David; Grey, Pat; Finlayson, Robert; Bloch, Mark; Ramacciotti, Tim; Gelgor, Linda; Smith, Don; Zangerle, Robert; Gill, John; Dabis, Francois; Thiebaut, Rodolphe; Costagliola, Dominique; Guiguet, Marguerite; Vanhems, Philippe; Chaix, Marie-Laure; Ghosn, Jade; Boufassa, Faroudy; Meixenberger, Karolin; Bannert, Norbert; Bartmeyer, Barbara; Antoniadou, Anastasia; Chrysos, Georgios; Daikos, Georgios L.; Pantazis, Nikos; Katsarou, Olga; Rezza, Giovanni; Dorrucci, Maria; Monforte, Antonella d'Arminio; Geskus, Ronald; van der Helm, Jannie; Schuitemaker, Hanneke; Sannes, Mette; Dyrhol-Riise, Anne Ma; Kran, Anne-Marte Bakken; Rosinska, Magdalena; Tor, Jordi; de Olalla, Patricia Garcia; Cayla, Joan; del Amo, Julia; Moreno, Santiago; Monge, Susana; del Romero, Jorge; Perez-Hoyos, Santiago; Sonnerborg, Anders; Guenthard, Huldrych; Scherrer, Alexandra; Malyuta, Ruslan; Johnson, Anne; Phillips, Andrew; Morrison, Charles; Salata, Robert; Mugerwa, Roy; Chipato, Tsungai; Price, Matt A.; Gilmour, Jill; Kamali, Anatoli; Karita, Etienne; Burns, Fiona; Giaquinto, Carlo; Grarup, Jesper; Kirk, Ole; Bailey, Heather; Anne, Alain Volny; Panteleev, Alex; Thorne, Claire; Aboulker, Jean-Pierre; Albert, Jan; Asandi, Silvia; De Wit, Stephane; Reiss, Peter; Gatell, Jose; Karpov, Igor; Ledergerber, Bruno; Lundgren, Jens; Moller, Claus; Rakhma-nova, Aza; Rockstroh, Juergen; Sandhu, Manjinder; Dedes, Nikos; Fenton, Kevin; Pizzuti, David; Vitoria, Marco; Faggion, Silvia; Frost, Richard; Raben, Dorthe; Schwimmer, Christine; Scott, Martin		CASCADE Collaboration EuroCoord	The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; ANTIBODY AVIDITY; DRUG-RESISTANCE; SEROCONVERSION	Background Serological assays to determine HIV incidence have contributed to estimates of HIV incidence, monitoring of HIV spread, and evaluation of prevention strategies. Two frequently used incidence assays are the Sedia HIV-1 LAg-Avidity EIA (LAg) and the Bio-Rad avidity incidence (BRAI) assays with a mean duration of recent infection (MDRI) of 130 and 240 days for subtype B infections, respectively. Little is known about how these assays perform with recombinant HIV-1 strains. We evaluated the concordance of these assays in a population infected mainly with HIV-1 CRF06_cpx. Material/Methods Remnant serum samples (n = 288) collected from confirmed, newly-diagnosed HIV-positive persons from Estonia in 2013 were tested. Demographic and clinical data were extracted from clinical databases. LAg was performed according to the manufacturer's protocol and BRAI testing was done using a validated protocol. Samples with LAg-pending or BRAI-invalid results were reclassified as recent if they were from persons with viral loads <1000 copies/mL or were reclassified as long-term if presenting with AIDS. Results In total 325 new HIV infections were diagnosed in 2013 in Estonia. Of those 276 persons were tested with both LAg and BRAI. Using assay results only, the recency rate was 44% and 70% by LAg and BRAI, respectively. The majority of samples (92%) recent by LAg were recent by BRAI. Similarly, 89% of samples long-term by BRAI were long-term by LAg. After clinical information was included in the analysis, the recency rate was 44% and 62% for LAg and BRAI, respectively. The majority of samples (86%) recent by LAg were recent by BRAI and 91% of long-term infections by BRAI were long-term by LAg. Conclusions Comparison of LAg and BRAI results in this mostly CRF06_cpx-infected population showed good concordance for incidence classification. Our finding of a higher recency rate with BRAI in this population is likely related to the longer MDRI for this assay.	[Huik, Kristi; Soodla, Pilleriin; Pauskar, Merit; Jogeda, Ene-Ly; Kallas, Eveli; Rajasaar, Heli; Avi, Radko; Lutsar, Irja] Univ Tartu, Inst Biomed & Translat Med, Dept Microbiol, Tartu, Estonia; [Huik, Kristi] NCI, Clin Retrovirol Sect, HIV Dynam & Replicat Program, NIH, Frederick, MD 21701 USA; [Owen, S. Michele; Luo, Wei; Masciotra, Silvina] Ctr Dis Control & Prevent, Lab Branch, Div HIV HIV Aids Prevent, Atlanta, GA USA; [Murphy, Gary] Publ Hlth England, Virus Reference Dept, London, England; [Kelleher, Tony; Cooper, David; Grey, Pat; Finlayson, Robert; Bloch, Mark] Australia PHAEDRA Cohort, Sydney, NSW, Australia; [Kelleher, Tony; Cooper, David; Ramacciotti, Tim; Gelgor, Linda; Smith, Don] Sydney AIDS Prospect Study & Sydney Primary HIV I, Sydney, NSW, Australia; [Zangerle, Robert] Austria Austrian HIV Cohort Study, Innsbruck, Austria; [Gill, John] Canada South Alberta Clin, Calgary, AB, Canada; [Lutsar, Irja] Estonia Tartu Ulikool, Tartu, Estonia; [Chene, Genevieve; Dabis, Francois; Thiebaut, Rodolphe] France ANRS CO3 Aquitaine Cohort, Paris, France; [Costagliola, Dominique; Guiguet, Marguerite] ANRS CO4 French Hosp Database, Paris, France; [Vanhems, Philippe] Lyon Primary Infect Cohort, Lyon, France; [Chaix, Marie-Laure; Ghosn, Jade] French ANRS CO6 PRIMO Cohort, Paris, France; [Meyer, Laurence; Boufassa, Faroudy] ANRS CO2 SER OCO Cohort, Paris, France; [Hamouda, Osamah; Meixenberger, Karolin; Bannert, Norbert; Bartmeyer, Barbara] Germany German HIV 1 Seroconverter Cohort, Berlin, Germany; [Antoniadou, Anastasia; Chrysos, Georgios; Daikos, Georgios L.] Greece AMACS, Athens, Greece; [Touloumi, Giota; Pantazis, Nikos; Katsarou, Olga] Greek Haemophilia Cohort, Athens, Greece; [Rezza, Giovanni; Dorrucci, Maria] Italy Italian Seroconvers Study, Aviano, Italy; [De Luca, Andrea; Monforte, Antonella d'Arminio] ICONA Cohort, Milan, Italy; [Prins, Maria; Geskus, Ronald; van der Helm, Jannie; Schuitemaker, Hanneke] Netherlands Amsterdam Cohort Studies Homosexual M, Netherlands Amsterdam Co, Netherlands; [Sannes, Mette; Dyrhol-Riise, Anne Ma; Kran, Anne-Marte Bakken] Oslo Univ Hosp Cohorts, Oslo, Norway; [Rosinska, Magdalena] Poland Natl Inst Hyg, Warsaw, Poland; [Muga, Roberto; Tor, Jordi] Spain Badalona IDU Hosp Cohort, Badalona, Spain; [de Olalla, Patricia Garcia; Cayla, Joan] Barcelona IDU Cohort, Barcelona, Spain; [del Amo, Julia; Moreno, Santiago; Monge, Susana] CoRIS Scv, Madrid, Spain; [del Amo, Julia; del Romero, Jorge] Madrid Cohort, Madrid, Spain; [Perez-Hoyos, Santiago] Valencia IDU Cohort, Valencia, Spain; [Sonnerborg, Anders] Sweden Swedish InfCare HIV Cohort, Malmo, Sweden; [Bucher, Heiner C.; Guenthard, Huldrych; Scherrer, Alexandra] Switzerland Swiss HIV Cohort Study, Lausanne, Switzerland; [Malyuta, Ruslan] Ukraine Perinatal Prevent Aids Initiat, Odessa, Ukraine; [Murphy, Gary] United Kingdom Publ Hlth England, London, England; [Porter, Kholoud; Babiker, Abdel; Johnson, Anne; Phillips, Andrew] UK Register HIV Seroconverters, London, England; [Pillay, Deenan; Porter, Kholoud; Cartier, Andrea; Fradette, Lorraine; Phillips, Andrew; Burns, Fiona; Bailey, Heather; Thorne, Claire; Frost, Richard] UCL, London, England; [Morrison, Charles] Family Hlth Int, Durham, NC USA; [Salata, Robert] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Mugerwa, Roy] Makerere Univ, Kampala, Uganda; [Chipato, Tsungai] Univ Zimbabwe, Harare, Zimbabwe; [Price, Matt A.] IAVI, New York, NY USA; [Gilmour, Jill] IAVI, London, England; [Kamali, Anatoli] IAVI, Nairobi, Kenya; [Karita, Etienne] Projet San Francisco, Kigali, Rwanda; [Chene, Genevieve; Schwimmer, Christine] Univ Bordeaux, Bordeaux, France; [Meyer, Laurence; Costagliola, Dominique; Aboulker, Jean-Pierre] INSERM, Paris, France; [Giaquinto, Carlo] Fdn PENTA, Padua, Italy; [Anne, Alain Volny] European AIDS Treatment Grp, Paris, France; [Panteleev, Alex; Rakhma-nova, Aza] St Petersburg City AIDS Ctr, St Petersburg, Russia; [Albert, Jan] Karolinska Inst, Stockholm, Sweden; [Asandi, Silvia] Romanian Angel Appeal Fdn, Bucharest, Romania; [Monforte, Antonella d'Arminio] ICoNA Fdn, Milan, Italy; [De Wit, Stephane] St Pierre Univ Hosp, Brussels, Belgium; [Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Del Amo, Julia] Inst Salud Carlos III, Madrid, Spain; [Gatell, Jose] Fundacio Privada Clin Recerca Biomed, Madrid, Spain; [Hamouda, Osamah] Robert Koch Inst, Berlin, Germany; [Karpov, Igor] Univ Minsk, Minsk, BELARUS; [Ledergerber, Bruno] Univ Zurich, Zurich, Switzerland; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Moller, Claus] Cadpeople AS, Aarhus, Denmark; [Prins, Maria] Acad Med Ctr, Amsterdam, Netherlands; [Rockstroh, Juergen] Univ Bonn, Bonn, Germany; [Rosinska, Magda] Natl Inst Hyg, Natl Inst Publ Hlth, Warsaw, Poland; [Sandhu, Manjinder] Genome Res Ltd, Hinxton, England; [Touloumi, Giota] Univ Athens, Athens, Greece; [Cooper, David] Univ New South Wales, Sydney, NSW, Australia; [Dedes, Nikos] Posit Voice, Athens, Greece; [Fenton, Kevin] Publ Hlth England, London, England; [Pizzuti, David] Gilead Sci, Foster City, CA USA; [Vitoria, Marco] WHO, Geneva, Switzerland; [Faggion, Silvia] Fdn PENTA, Milan, Italy; [Scott, Martin] UCL European Res & Innovat Off, London, England	University of Tartu; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA; Public Health England; University of London; University College London; Case Western Reserve University; Makerere University; University of Zimbabwe; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Instituto de Salud Carlos III; Robert Koch Institute; Belarusian State University; University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam; University of Bonn; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Wellcome Trust Sanger Institute; National & Kapodistrian University of Athens; University of New South Wales Sydney; Public Health England; Gilead Sciences; World Health Organization; University of London; University College London	Huik, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Microbiol, Tartu, Estonia.; Huik, K (corresponding author), NCI, Clin Retrovirol Sect, HIV Dynam & Replicat Program, NIH, Frederick, MD 21701 USA.	kristi.huik@ut.ee	Giaquinto, Carlo/AAB-5016-2020; Price, Matt/AAK-6881-2021; Sönnerborg, Anders/W-2011-2019; kirk, ole/ABB-4746-2021; Muga, Roberto/AAY-8655-2021; ANTONIADOU, ANASTASIA/AAB-8680-2020; Gatell, Jose M/ABC-3607-2020; Lundgren, Jens/AAE-6876-2019; Huik, Kristi/AGY-9109-2022; Rosinska, Magdalena/Q-2068-2018	Price, Matt/0000-0002-2918-1373; Sönnerborg, Anders/0000-0001-8928-3374; Muga, Roberto/0000-0001-6301-431X; ANTONIADOU, ANASTASIA/0000-0003-0991-9198; Soodla, Pilleriin/0000-0003-1445-7653; Johnson, Anne/0000-0003-1330-7100; Rosinska, Magdalena/0000-0002-6256-7809; Huik, Kristi/0000-0002-1569-8830; GIAQUINTO, CARLO/0000-0001-9365-0413	European Union through the European Regional Development Fund; Estonian Ministry of Education and Research [IUT34-24, PUT1580]; Estonian Ministry of Social Affairs; European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement [260694]	European Union through the European Regional Development Fund(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Ministry of Social Affairs; European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement	The study was supported by the European Union through the European Regional Development Fund; Basic Financing, Institutional research funding (IUT34-24) and Personal research funding (PUT1580) of Estonian Ministry of Education and Research; Estonian Ministry of Social Affairs; and the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adojaan M, 2005, JAIDS-J ACQ IMM DEF, V39, P598; Avi R, 2014, AIDS RES HUM RETROV, V30, P278, DOI [10.1089/aid.2012.0357, 10.1089/AID.2012.0357]; Avi R, 2009, J MED VIROL, V81, P953, DOI 10.1002/jmv.21482; CEPHIA Project Team, EV BIORAD GS HIV 1 H; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; Curtis KA, 2016, AIDS RES HUM RETROV, V32, P561, DOI [10.1089/aid.2015.0247, 10.1089/AID.2015.0247]; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Hanson DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152327; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Huang XJ, 2013, JAIDS-J ACQ IMM DEF, V62, P441, DOI 10.1097/QAI.0b013e31827f5c9a; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Laeyendecker O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025899; Longosz AF, 2015, AIDS RES HUM RETROV, V31, P421, DOI [10.1089/aid.2014.0081, 10.1089/AID.2014.0081]; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Soodla P, 2015, INFECT DIS-NOR, V47, P768, DOI 10.3109/23744235.2015.1061203; Soodla Simmons R, 2017, HIV MED; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133	24	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217048	10.1371/journal.pone.0217048	http://dx.doi.org/10.1371/journal.pone.0217048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125356	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700014
J	Nagayach, A; Singh, A; De Blas, AL; Geller, AI				Nagayach, Aarti; Singh, Anshuman; De Blas, Angel L.; Geller, Alfred, I			Delivery of different genes into pre- and post-synaptic neocortical interneurons connected by GABAergic synapses	PLOS ONE			English	Article							LONG-TERM EXPRESSION; FREE HSV-1 VECTORS; VESICULAR GLUTAMATE TRANSPORTER-1; REGULATED SECRETORY PATHWAY; TYPE-1 PLASMID VECTORS; RAT POSTRHINAL CORTEX; PROTEIN-KINASE-C; GABA-A RECEPTOR; TYROSINE-HYDROXYLASE; FUNCTIONAL ARCHITECTURE	Local neocortical circuits play critical roles in information processing, including synaptic plasticity, circuit physiology, and learning, and GABAergic inhibitory interneurons have key roles in these circuits. Moreover, specific neurological disorders, including schizophrenia and autism, are associated with deficits in GABAergic transmission in these circuits. GABAergic synapses represent a small fraction of neocortical synapses, and are embedded in complex local circuits that contain many neuron and synapse types. Thus, it is challenging to study the physiological roles of GABAergic inhibitory interneurons and their synapses, and to develop treatments for the specific disorders caused by dysfunction at these GABAergic synapses. To these ends, we report a novel technology that can deliver different genes into pre- and post-synaptic neocortical interneurons connected by a GABAergic synapse: First, standard gene transfer into the presynaptic neurons delivers a synthetic peptide neurotransmitter, containing three domains, a dense core vesicle sorting domain, a GABA(A) receptor-binding domain, a single-chain variable fragment anti-GABA(A) beta 2 or beta 3, and the His tag. Second, upon release, this synthetic peptide neurotransmitter binds to GABA(A) receptors on the postsynaptic neurons. Third, as the synthetic peptide neurotransmitter contains the His tag, antibody-mediated, targeted gene transfer using anti-His tag antibodies is selective for these neurons. We established this technology by expressing the synthetic peptide neurotransmitter in GABAergic neurons in the middle layers of postrhinal cortex, and the delivering the postsynaptic vector into connected GABAergic neurons in the upper neocortical layers. Targeted gene transfer was 61% specific for the connected neurons, but untargeted gene transfer was only 21% specific for these neurons. This technology may support studies on the roles of GABAergic inhibitory interneurons in circuit physiology and learning, and support gene therapy treatments for specific disorders associated with deficits at GABAergic synapses.	[Nagayach, Aarti; Singh, Anshuman; Geller, Alfred, I] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Geller, Alfred, I] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; [Singh, Anshuman] Univ Mississippi, Sch Med, Dept Neurobiol & Anat Sci, Jackson, MS USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Connecticut; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Mississippi	Geller, AI (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA.; Geller, AI (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA.	agelle@lsuhsc.edu	Nagayach, Aarti/AAC-2577-2022; Nagayach, Aarti/ABC-6486-2021	Nagayach, Aarti/0000-0002-3283-5788; Geller, Alfred I/0000-0001-6313-5250	NIH [NS086960]; Research to Prevent Blindness; Lions Eye Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Lions Eye Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grant NS086960 (AIG). Assistance from the Research to Prevent Blindness and the Lions Eye Foundation is gratefully acknowledged.	Agster KL, 2009, HIPPOCAMPUS, V19, P1159, DOI 10.1002/hipo.20578; Bergman I, 2003, VIROLOGY, V316, P337, DOI 10.1016/j.virol.2003.07.010; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Cao HY, 2011, BRAIN RES, V1415, P127, DOI 10.1016/j.brainres.2011.08.010; Cao HY, 2010, BRAIN RES, V1351, P1, DOI 10.1016/j.brainres.2010.06.045; COOL DR, 1994, BIOCHIMIE, V76, P265, DOI 10.1016/0300-9084(94)90156-2; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dudai Y., 1989, NEUROBIOLOGY MEMORY; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; EWERT M, 1992, BRAIN RES, V569, P57, DOI 10.1016/0006-8993(92)90368-J; Feng L, 2014, NAT PROTOC, V9, P2425, DOI 10.1038/nprot.2014.166; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Gao QS, 2007, BRAIN RES, V1130, P1, DOI 10.1016/j.brainres.2006.10.018; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huston J. S., 1991, METHOD ENZYMOL, V203, P46; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kobayashi T, 2003, BBA-GENE STRUCT EXPR, V1628, P156, DOI 10.1016/S0167-4781(03)00138-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kubota Y, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00027; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Morizono K, 2005, CELL CYCLE, V4, P854, DOI 10.4161/cc.4.7.1789; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Morizono K, 2001, J VIROL, V75, P8016, DOI 10.1128/JVI.75.17.8016-8020.2001; Moskal JR, 2005, NEUROPHARMACOLOGY, V49, P1077, DOI 10.1016/j.neuropharm.2005.06.006; Moskal JR, 2001, CURR DRUG TARGETS, V2, P331, DOI 10.2174/1389450013348399; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Nagayach A, 2019, J MOL NEUROSCIENCE; Nagayach A, 2019, UNPUB; Nagayach A, 2019, BRAIN RES, V1712, P16, DOI 10.1016/j.brainres.2019.01.038; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Ohno K, 1997, NAT BIOTECHNOL, V15, P763, DOI 10.1038/nbt0897-763; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Rasmussen M, 2007, BRAIN RES, V1144, P19, DOI 10.1016/j.brainres.2007.01.125; Ried MU, 2002, J VIROL, V76, P4559, DOI 10.1128/JVI.76.9.4559-4566.2002; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Song S, 1998, J NEUROSCI, V18, P4119; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Sun M, 2004, HUM GENE THER, V15, P1177, DOI 10.1089/hum.2004.15.1177; Sun M, 1999, HUM GENE THER, V10, P2005, DOI 10.1089/10430349950017365; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tai CK, 2003, HUM GENE THER, V14, P789, DOI 10.1089/104303403765255174; VITORICA J, 1988, J NEUROSCI, V8, P615; Volpers C, 2003, J VIROL, V77, P2093, DOI 10.1128/JVI.77.3.2093-2104.2003; Wang XD, 2005, MOL BRAIN RES, V139, P88, DOI 10.1016/j.molbrainres.2005.05.029; Yang TZ, 2001, MOL BRAIN RES, V90, P1, DOI 10.1016/S0169-328X(01)00059-6; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang GR, 2005, J NEUROSCI, V25, P8468, DOI 10.1523/JNEUROSCI.2271-05.2005; Zhang GR, 2000, MOL BRAIN RES, V84, P17, DOI 10.1016/S0169-328X(00)00197-2; Zhang GR, 2012, HIPPOCAMPUS, V22, P2276, DOI 10.1002/hipo.22045; Zhang GR, 2012, BRAIN RES, V1473, P173, DOI 10.1016/j.brainres.2012.07.024; Zhang GR, 2012, BRAIN RES, V1436, P157, DOI 10.1016/j.brainres.2011.12.011; Zhang GR, 2010, BRAIN RES, V1361, P1, DOI 10.1016/j.brainres.2010.09.030; Zhang GR, 2010, P NATL ACAD SCI USA, V107, P14478, DOI 10.1073/pnas.0912950107	66	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217094	10.1371/journal.pone.0217094	http://dx.doi.org/10.1371/journal.pone.0217094			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125364	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700018
J	Yi, S; Hu, ZJ; Huang, ZL; Chen, HP; Qin, SZ; Zhong, JN; Chen, SY; Xue, Q; Yi, Y; Wang, CB				Yi Sun; Hu, Zuojian; Huang, Zhili; Chen, Huaping; Qin, Shanzi; Zhong Jianing; Chen, Siyuan; Xue Qin; Yi Ye; Wang, Chengbin			Compare the accuracy and precision of Coulter LH780, Mindray BC-6000 Plus, and Sysmex XN-9000 with the international reference flow cytometric method in platelet counting	PLOS ONE			English	Article							ANALYZERS; THROMBOCYTOPENIA; IMPEDANCE; LEUKEMIA; IMPACT; VOLUME	Objective The aim of this study is to evaluate the performance of different platelet counting methods (optical, impedance, fluorescence and hand counting) applied in different analysers by comparing with the international flow cytometric reference method (IRM). Methods A total of 333 blood samples from different subgroups (168 cases with thrombocytopenia, 136 cases with normal platelet counts and 29 cases with thrombocytosis) were tested. Regarding IRM as the gold standard, we compared the accuracy and precision of different platelet count methods; i.e. LH780 (impedance), BC-6000 Plus (optical (O) and impedance (I)), Sysmex XN-9000 (optical (O), impedance (I), fluorescence (F)), and hand counting. Results Sysmex XN-9000-F (r = 0.988) had the best correlation with IRM for thrombocytopenic samples; BC-6000 Plus-I (r = 0.966) was more relevant to IRM than any other method for samples with normal platelet counts. Correlation between Sysmex XN-9000-I (r = 0.960) and IRM was the highest among these methods for samples with thrombocytosis. For bias evaluation, the average bias of Sysmex XN-9000-F was -1.5 x 10(9)/L (95% LA = -9.4 to +6.4) for samples with thrombocytopenia, compared with IRM. BC-6000 Plus-I had a small mean difference with IRM for samples with normal platelet counts or thrombocytosis. Moreover, all evaluated methods had acceptable sensitivity, specificity, and concordance rates as compared with IRM in the diagnosis of thrombocytopenia and thrombocytosis. Conclusions Platelet counting by Sysmex XN-9000-F is more accurate than other methods for thrombocytopenic samples. BC-6000 Plus-I has superior association and consistency for normal platelet counts. As for thrombocytosis patients, Sysmex XN-9000-I has the highest correlation with IRM while Sysmex XN-9000-O has the highest diagnosis efficacy.	[Yi Sun; Wang, Chengbin] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Hu, Zuojian; Chen, Huaping; Qin, Shanzi; Zhong Jianing; Chen, Siyuan; Xue Qin] Guangxi Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanning, Guangxi, Peoples R China; [Huang, Zhili] Guangxi Med Univ, Affiliated Hosp 2, Dept Blood Transfus, Nanning, Guangxi, Peoples R China; [Yi Ye] Shenzhen Mindray Biomed Elect Co Ltd, Hematol Prod Dev Dept, Shenzhen, Peoples R China	Chinese People's Liberation Army General Hospital; Guangxi Medical University; Guangxi Medical University	Wang, CB (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China.	wcb301@126.com			Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; National Key Scientific Instrument and Equipment Development Project of China [2012YQ18011708]	Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; National Key Scientific Instrument and Equipment Development Project of China	The study was sponsored by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Mindray provided BC-6000Plus hematology analyzer, reagents and other consumable materials, in addition to operational training for the instrument. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, this work was supported by the National Key Scientific Instrument and Equipment Development Project of China (NO. 2012YQ18011708).	Boulassel Mohamed-Rachid, 2015, Sultan Qaboos Univ Med J, V15, pe463, DOI 10.18295/squmj.2015.15.04.004; Briggs C, 2007, INT J LAB HEMATOL, V29, P77, DOI 10.1111/j.1751-553X.2007.00909.x; Buoro S, 2017, INT J LAB HEMATOL, V39, P337, DOI 10.1111/ijlh.12632; Claesson K, 2016, THROMB HAEMOSTASIS, V115, P1178, DOI 10.1160/TH15-10-0799; DALTON WT, 1980, AM J CLIN PATHOL, V74, P119; De la Salle BJ, 2012, AM J CLIN PATHOL, V137, P65, DOI 10.1309/AJCP86JMBFUCFCXA; Demirtas S, 2014, VASCULAR, V22, P427, DOI 10.1177/1708538114522227; Harrison P, 2005, CYTOM PART B-CLIN CY, V67B, P1, DOI 10.1002/cyto.b.20058; Harrison P, 2001, Hematology, V5, P421, DOI 10.1080/10245332.2001.11746538; He YZ, 2016, AM J MED SCI, V352, P502, DOI 10.1016/j.amjms.2016.08.011; Johannessen B, 2001, TRANSFUS APHER SCI, V25, P93, DOI 10.1016/S1473-0502(01)00099-4; Kim SY, 2010, AM J CLIN PATHOL, V134, P634, DOI 10.1309/AJCP88JYLRCSRXPP; Lippi G, 2015, EXPERT REV HEMATOL, V8, P555, DOI 10.1586/17474086.2015.1069703; Lippi G, 2015, BLOOD COAGUL FIBRIN, V26, P235, DOI 10.1097/MBC.0000000000000220; Medical Administration Department Of Ministry Of Public Health P. R. C., 2006, NAT GUID CLIN LAB PR; O'Shea CM, 2015, VET SURG, V44, P304, DOI 10.1111/j.1532-950X.2014.12290.x; Pathak S, 2013, EXPERT OPIN DRUG MET, V9, P1667, DOI 10.1517/17425255.2013.858119; Riond B, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0590-7; Schoorl M, 2013, AM J CLIN PATHOL, V140, P495, DOI 10.1309/AJCPUAGGB4URL5XO; Segal HC, 2005, BRIT J HAEMATOL, V128, P520, DOI 10.1111/j.1365-2141.2004.05352.x; Sehgal K, 2010, CYTOM PART B-CLIN CY, V78B, P279, DOI 10.1002/cyto.b.20515; Sora F, 2018, BRIT J HAEMATOL, V181, P267, DOI 10.1111/bjh.14553; Stein BL, 2011, HAEMATOL-HEMATOL J, V96, P1462, DOI 10.3324/haematol.2011.045591; Tantanate C, 2017, ARCH PATHOL LAB MED, V141, P830, DOI 10.5858/arpa.2016-0222-OA	24	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217298	10.1371/journal.pone.0217298	http://dx.doi.org/10.1371/journal.pone.0217298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125378	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700028
J	Arnold, M; Pfeifer, K; Quante, AS				Arnold, Matthias; Pfeifer, Katharina; Quante, Anne S.			Is risk-stratified breast cancer screening economically efficient in Germany?	PLOS ONE			English	Article							QUALITY-OF-LIFE; COST-EFFECTIVENESS; FILM MAMMOGRAPHY; PERCEIVED RISK; BENEFITS; DENSITY; ADHERENCE; PROGRAM; WOMEN; HARMS	Objectives Risk stratification has so far been evaluated under the assumption that women fully adhere to screening recommendations. However, the participation in German cancer screening programs remains low at 54%. The question arises whether risk-stratified screening is economically efficient under the assumption that adherence is not perfect. Method We have adapted a micro-simulation Markov model to the German context. Annual, biennial, and triennial routine screening are compared with five risk-adapted strategies using thresholds of relative risk to stratify screening frequencies. We used three outcome variables (mortality reduction, quality-adjusted life years, and false-positive results) under the assumption of full adherence vs. an adherence rate of 54%. Strategies are evaluated using efficiency frontiers and probabilistic sensitivity analysis (PSA). Results The reduced adherence rate affects both performance and cost; incremental cost-effectiveness ratios remain constant. The results of PSA show that risk-stratified screening strategies are more efficient than biennial routine screening under certain conditions. At any willingness-to-pay (WTP), there is a risk-stratified alternative with a higher likelihood of being the best choice. However, without explicit decision criteria and WTP, risk-stratified screening is not more efficient than biennial routine screening. Potential improvements in the adherence rates have significant health gains and budgetary implications. Conclusion If the participation rate for mammographic screening is as low as in Germany, stratified screening is not clearly more efficient than routine screening but dependent on the WTP. A more promising design for future stratified strategies is the combination of risk stratification mechanisms with interventions to improve the low adherence in selected high-risk groups.	[Arnold, Matthias] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Arnold, Matthias] Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci, Munich, Germany; [Arnold, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Pfeifer, Katharina; Quante, Anne S.] TUM, Klinikum Rechts Isar, Frauenklin, Munich, Germany	University of York - UK; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Arnold, M (corresponding author), Univ York, Ctr Hlth Econ, York, N Yorkshire, England.; Arnold, M (corresponding author), Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci, Munich, Germany.; Arnold, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	Matthias.arnold@york.ac.uk		Arnold, Matthias/0000-0002-9736-7233				Arnold M, 2018, VALUE HEALTH, V21, P799, DOI 10.1016/j.jval.2017.12.022; BCSC. Breast Cancer Surveillance Consortium (BCSC), RISK FACT DAT 2016; Bundred SM, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150504; Caro JJ, 2010, HEALTH ECON, V19, P1117, DOI 10.1002/hec.1629; DeKoven M, 2012, J COMP EFFECT RES, V1, P453, DOI [10.2217/cer.12.43, 10.2217/CER.12.43]; Deutsches Mammographie-Screening-Programm, 2016, JAHR EV 2014; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Domeyer PJ, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-11; Engel J, 2002, EUR J CANCER, V38, P578, DOI 10.1016/S0959-8049(01)00407-5; Federal Statistical Office, 2017, GENESIS ONL; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hay JL, 2006, PREV MED, V42, P401, DOI 10.1016/j.ypmed.2006.03.002; Hofvind S, 2014, RADIOLOGY, V272, P52, DOI 10.1148/radiol.14131502; IQWIG, 2017, GEN METH VERS 5 0; Kassenarztliche Bundesvereinigung, 2017, EINH BEW ARZTL LEIST; Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kreienberg R., 2012, INTERDISZIPLINARE S3, P1; KVRLP, 2016, GE BER DMP BRUSTKR 0; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Liedtke C, 2015, BREAST CANCER RES TR, V152, P667, DOI 10.1007/s10549-015-3491-3; Lux MP, 2010, ONKOLOGIE, V33, P155, DOI 10.1159/000286233; Malek D, 2014, JAHRESBERICHT EVALUA; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Maxwell James R., 2000, Breast J, V6, P53, DOI 10.1046/j.1524-4741.2000.98079.x; McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Muller D, 2018, EUR J HEALTH ECON, V19, P341, DOI 10.1007/s10198-017-0887-5; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Sprague BL, 2015, ANN INTERN MED, V162, P157, DOI 10.7326/M14-0692; Stollenwerk B, 2015, HEALTH ECON, V24, P481, DOI 10.1002/hec.3041; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tagliafico A, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150593; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; Tumorregister Munchen, 2016, ICD 10 C50 MAMM FRAU; Verkooijen HM, 2002, SURG ONCOL, V10, P177, DOI 10.1016/S0960-7404(02)00021-X; Vetter L, 2016, BREAST CANCER RES TR, V156, P289, DOI 10.1007/s10549-016-3748-5; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; Walker MJ, 2013, BREAST, V22, P395, DOI 10.1016/j.breast.2012.12.005; Weigel S, 2017, EUR RADIOL, V27, P2744, DOI 10.1007/s00330-016-4636-4; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; WIdO, 2017, ARZN REP; ZfKD Robert Koch Institute, 2016, KREBSR GERM CTR CANC; Ziv E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168601	53	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217213	10.1371/journal.pone.0217213	http://dx.doi.org/10.1371/journal.pone.0217213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120970	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700067
J	Cabezas, F; Farfan, P; Marzolo, MP				Cabezas, Felipe; Farfan, Pamela; Marzolo, Maria-Paz			Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ss1)	PLOS ONE			English	Article							TGF-BETA; PROXIMAL-TUBULE; MEDIATED ENDOCYTOSIS; EPITHELIAL-CELLS; VITAMIN-D; E-CADHERIN; INTRAMEMBRANE PROTEOLYSIS; EXTRACELLULAR-MATRIX; CUBILIN EXPRESSION; GALLBLADDER CANCER	Megalin/LRP2 is a receptor that plays important roles in the physiology of several organs, such as kidney, lung, intestine, and gallbladder and also in the physiology of the nervous system. Megalin expression is reduced in diseases associated with fibrosis, including diabetic nephropathy, hepatic fibrosis and cholelithiasis, as well as in some breast and prostate cancers. One of the hallmarks of these conditions is the presence of the cytokine transforming growth factor beta (TGF-ss). Although TGF-ss has been implicated in the reduction of megalin levels, the molecular mechanism underlying this regulation is not well understood. Here, we show that treatment of two epithelial cell lines (from kidney and gallbladder) with TGF-ss1 is associated with decreased megalin mRNA and protein levels, and that these effects are reversed by inhibiting the TGF-ss1 type I receptor (TGF-ssRI). Based on in silico analyses, the two SMAD-binding elements (SBEs) in the megalin promoter are located at positions -57 and -605. Site-directed mutagenesis of the SBEs and chromatin immunoprecipitation (ChIP) experiments revealed that SMAD2/3 transcription factors interact with SBEs. Both the presence of SMAD2/3 and intact SBEs were associated with repression of the megalin promoter, in the absence as well in the presence of TGF-ss1. Also, reduced megalin expression and promoter activation triggered by high concentration of albumin are dependent on the expression of SMAD2/3. Interestingly, the histone deacetylase inhibitor Trichostatin A (TSA), which induces megalin expression, reduced the effects of TGF-ss1 on megalin mRNA levels. These data show the significance of TGF-ss and the SMAD2/3 signalling pathway in the regulation of megalin and explain the decreased megalin levels observed under conditions in which TGF-ss is upregulated, including fibrosis-associated diseases and cancer.	[Cabezas, Felipe; Farfan, Pamela; Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Lab Traf Intracelular & Senalizac, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Marzolo, MP (corresponding author), Pontificia Univ Catolica Chile, Lab Traf Intracelular & Senalizac, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile.	mmarzolo@bio.puc.cl		Marzolo, Maria-Paz/0000-0002-2328-2464	FONDECYT [1150444]; CONICYT	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	MPM was funded by FONDECYT 1150444 from CONICYT (https://www.conicyt.cl/fondecyt/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alvira-Botero X, 2010, MOL CELL NEUROSCI, V45, P306, DOI 10.1016/j.mcn.2010.07.005; Aseem O, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-405; Bay AEP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11550; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Biemesderfer D, 2006, KIDNEY INT, V69, P1717, DOI 10.1038/sj.ki.5000298; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Briffa JF, 2015, MOL CELL ENDOCRINOL, V401, P25, DOI 10.1016/j.mce.2014.11.024; Buchackert Y, 2012, J PHYSIOL-LONDON, V590, P5167, DOI 10.1113/jphysiol.2012.233403; Cabezas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016794; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Cho IJ, 2010, HEPATOLOGY, V52, P2053, DOI 10.1002/hep.23931; Christakos S, 2013, ANN NY ACAD SCI, V1287, P45, DOI 10.1111/nyas.12129; Christensen EI, 1998, RENAL FAILURE, V20, P191, DOI 10.3109/08860229809045102; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cui H, 2018, ONCOGENE, V37, P4358, DOI 10.1038/s41388-018-0285-1; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; CZEKAY RP, 1995, J CELL SCI, V108, P1433; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Dizin E, 2013, AM J PHYSIOL-RENAL, V305, pF1053, DOI 10.1152/ajprenal.00006.2013; Erranz B, 2004, J LIPID RES, V45, P2185, DOI 10.1194/jlr.M400235-JLR200; Fabregat I, 2014, CURR PHARM DESIGN, V20, P2934, DOI 10.2174/13816128113199990591; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Flisiak I, 2003, BIOMARKERS, V8, P437, DOI 10.1080/13547500310001599061; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; Hermo L, 1999, MOL REPROD DEV, V53, P282, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;282::AID-MRD4&gt;3.0.CO;2-A; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Knutson A, 2000, BIOL CHEM, V381, P433, DOI 10.1515/BC.2000.056; Knutson A, 1998, DNA CELL BIOL, V17, P551, DOI 10.1089/dna.1998.17.551; Kolleck I, 2002, AM J RESP CRIT CARE, V166, pS62, DOI 10.1164/rccm.2206019; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee BH, 2009, PEDIATR NEPHROL, V24, P2211, DOI 10.1007/s00467-009-1238-2; Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774; Lee HS, 2014, BIOCHEM BIOPH RES CO, V452, P1084, DOI 10.1016/j.bbrc.2014.09.055; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu W, 1998, EUR J CLIN INVEST, V28, P100; Luciakova K, 2008, BIOCHEM J, V412, P123, DOI 10.1042/BJ20071440; Lundgren S, 1997, J HISTOCHEM CYTOCHEM, V45, P383, DOI 10.1177/002215549704500306; Marino M, 1999, J BIOL CHEM, V274, P12898, DOI 10.1074/jbc.274.18.12898; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; Marzolo MP, 2003, TRAFFIC, V4, P273, DOI 10.1034/j.1600-0854.2003.00081.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Mazzocchi LC, 2017, AM J PHYSIOL-LUNG C; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Odera K, 2007, BIOGERONTOLOGY, V8, P505, DOI 10.1007/s10522-007-9093-7; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips AO, 1997, AM J PATHOL, V150, P1101; Pieper-Furst U, 2011, BBA-MOL BASIS DIS, V1812, P1640, DOI 10.1016/j.bbadis.2011.09.003; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Rowling MJ, 2006, J NUTR, V136, P2754, DOI 10.1093/jn/136.11.2754; Russo LM, 2007, DIABETES, V56, P380, DOI 10.2337/db06-1018; Saito A, 2005, NEPHROLOGY, V10, pS26, DOI 10.1111/j.1440-1797.2005.00453.x; Schiffer M, 2000, KIDNEY INT, V58, pS45, DOI 10.1046/j.1523-1755.2000.07708.x; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shetty S, 2010, AM J RESP CELL MOL, V43, P358, DOI 10.1165/rcmb.2009-0046OC; Shin JM, 2018, AM J RHINOL ALLERGY, V32, P228, DOI 10.1177/1945892418770291; Siddiqui SS, 2004, AM J PHYSIOL-LUNG C, V286, pL1016, DOI 10.1152/ajplung.00356.2003; Slattery C, 2013, BRIT J PHARMACOL, V169, P1239, DOI 10.1111/bph.12214; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Takir M, 2016, NEFROLOGIA, V36, P653, DOI 10.1016/j.nefro.2016.06.011; Ternes SB, 2013, NUTR CANCER, V65, P900, DOI 10.1080/01635581.2013.805422; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Tsaroucha AK, 2008, CLIN EXP MED, V8, P165, DOI 10.1007/s10238-008-0174-y; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Welsh J, 2011, MOL CELL ENDOCRINOL, V347, P55, DOI 10.1016/j.mce.2011.05.020; Wen L, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181578; Wen L, 2017, AM J PHYSIOL-RENAL, V313, pF210, DOI 10.1152/ajprenal.00585.2016; Whaley-Connell A, 2011, AM J NEPHROL, V34, P115, DOI 10.1159/000329327; Wicher G, 2006, J NEUROSCI RES, V83, P864, DOI 10.1002/jnr.20774; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wolf G, 2006, CONTRIB NEPHROL, V151, P175, DOI 10.1159/000095328; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yoshida K, 2014, INT J ONCOL, V45, P1363, DOI 10.3892/ijo.2014.2552; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang B, 2016, FEBS LETT, V590, P2190, DOI 10.1002/1873-3468.12229; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhang ZF, 2011, J HUAZHONG U SCI-MED, V31, P749, DOI 10.1007/s11596-011-0671-1; Zhao J, 2001, GENE, V265, P123, DOI 10.1016/S0378-1119(01)00351-1; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou L, 2011, AM J NEPHROL, V34, P468, DOI 10.1159/000332040; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9; ZIYADEH FN, 1993, KIDNEY INT, V43, P114, DOI 10.1038/ki.1993.19; Zong HJ, 2014, MOL BIOL REP, V41, P4507, DOI 10.1007/s11033-014-3321-4; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	114	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0213127	10.1371/journal.pone.0213127	http://dx.doi.org/10.1371/journal.pone.0213127			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120873	gold, Green Submitted, Green Published			2022-12-27	WOS:000468775700001
J	Husen, SC; Koning, IV; Go, ATJI; van Graafeiland, AW; Willemsen, SP; Groenenberg, IAL; Steegers-Theunissen, RPM				Husen, Sofie C.; Koning, Irene V.; Go, Attie T. J. I.; van Graafeiland, Anne W.; Willemsen, Sten P.; Groenenberg, Irene A. L.; Steegers-Theunissen, Regine P. M.			Three-dimensional ultrasound imaging of fetal brain fissures in the growth restricted fetus	PLOS ONE			English	Article							CORTICAL FOLDING ABNORMALITIES; NORMAL GESTATIONAL LANDMARKS; AGE; GYNECOLOGY; OBSTETRICS; BIOMETRY; PRETERM; INFANTS; MARKER; HEAD	Objectives To examine differences in growth trajectories of fetal brain fissures in the growth restricted fetus (FGR) compared to controls. Methods We selected a subgroup of 227 women with a singleton pregnancy from the Rotterdam Periconceptional Cohort. Participants received three-dimensional ultrasound (3D-US) examinations of the fetal brain at 22, 26 and 32 weeks of gestational age (GA). The left and right Sylvian, insula and parieto-occipital fissures (POF) were measured in standardized planes. Linear mixed models with adjustment for potential confounders were applied to estimate differences between the trajectories of brain fissure depth measurements of FGR and controls. Results 22 FGR and 172 controls provided 31 and 504 3D-US respectively for longitudinal brain fissure depth measurements. Success rates for the Sylvian and insula depth measurements were over 80% and for POF over 62% at all GA. In FGR compared to controls, the trajectory of the right Sylvian fissure depth was significantly decreased (beta = -4.30, 95% CI = -8.03;-0.56, p = 0.024) while its growth rate was slightly increased (beta = 0.02, 95% CI = 0.00; 0.04, p = 0.04), after adjustment for GA, head circumference, gender, educational level and parity. Conclusions The small differences in brain fissure measurements between 22 and 32 weeks GA in FGR warrant further investigation in larger cohorts with postnatal follow-up.	[Husen, Sofie C.; Koning, Irene V.; Go, Attie T. J. I.; van Graafeiland, Anne W.; Willemsen, Sten P.; Groenenberg, Irene A. L.; Steegers-Theunissen, Regine P. M.] Univ Med Ctr, Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Willemsen, Sten P.] Univ Med Ctr, Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P. M.] Sophia Childrens Univ Hosp, Erasmus MC, Div Neonatol, Dept Paediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Steegers-Theunissen, RPM (corresponding author), Univ Med Ctr, Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands.; Steegers-Theunissen, RPM (corresponding author), Sophia Childrens Univ Hosp, Erasmus MC, Div Neonatol, Dept Paediat, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl			Department of Obstetrics and Gynaecology, Erasmus MC; Sophia research foundation for Medical Research, Rotterdam, The Netherlands (SSWO) [644]	Department of Obstetrics and Gynaecology, Erasmus MC; Sophia research foundation for Medical Research, Rotterdam, The Netherlands (SSWO)	This work was funded by the Department of Obstetrics and Gynaecology, Erasmus MC, and Sophia research foundation for Medical Research, Rotterdam, The Netherlands (SSWO grant number 644).	Alonso I, 2010, ULTRASOUND OBST GYN, V36, P693, DOI 10.1002/uog.7660; Benacerraf BR, 2005, J ULTRAS MED, V24, P1587, DOI 10.7863/jum.2005.24.12.1587; Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257; Businelli C, 2015, J MATERN-FETAL NEO M, V28, P1302, DOI 10.3109/14767058.2014.953474; Cachia A, 2008, NEUROIMAGE, V39, P927, DOI 10.1016/j.neuroimage.2007.08.049; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Donofrio MT, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/359390; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Egana-Ugrinovic G, 2014, ULTRASOUND OBST GYN, V44, P322, DOI 10.1002/uog.13360; Egana-Ugrinovic G, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.008; Eixarch E, 2008, ULTRASOUND OBST GYN, V32, P894, DOI 10.1002/uog.6249; Figueras F, 2011, ULTRASOUND OBST GYN, V38, P288, DOI 10.1002/uog.9041; Garel C, 2003, CHILD NERV SYST, V19, P422, DOI 10.1007/s00381-003-0767-4; Garel C, 2001, AM J NEURORADIOL, V22, P184; Ghai S, 2006, RADIOGRAPHICS, V26, P389, DOI 10.1148/rg.262055059; Glenn OA, 2009, SEMIN PERINATOL, V33, P208, DOI 10.1053/j.semperi.2009.04.009; Habas PA, 2012, CEREB CORTEX, V22, P13, DOI 10.1093/cercor/bhr053; HADLOCK FP, 1987, AM J OBSTET GYNECOL, V156, P955, DOI 10.1016/0002-9378(87)90365-6; Kim SH, 2016, NEUROIMAGE, V135, P163, DOI 10.1016/j.neuroimage.2016.04.053; Kivilevitch Z, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.001; Koning IV, 2017, PRENATAL DIAG, V37, P1008, DOI 10.1002/pd.5135; Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909; Masoller N, 2014, ULTRASOUND OBST GYN, V44, P182, DOI 10.1002/uog.13373; Merz E, 2007, ULTRASOUND OBST GYN, V29, P697, DOI 10.1002/uog.4009; Mittal P, 2007, J ULTRAS MED, V26, P347, DOI 10.7863/jum.2007.26.3.347; Monteagudo A, 2000, ULTRASOUND OBST GYN, V16, P307, DOI 10.1046/j.1469-0705.2000.00264.x; Morales-Rosello J, 2014, ULTRASOUND OBST GYN, V43, P303, DOI 10.1002/uog.13319; Mueller GM, 1996, OBSTET GYNECOL, V88, P372, DOI 10.1016/0029-7844(96)00207-4; Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; Pistorius LR, 2010, ULTRASOUND OBST GYN, V36, P700, DOI 10.1002/uog.7705; Quarello E, 2008, ULTRASOUND OBST GYN, V32, P44, DOI 10.1002/uog.5353; ROBINSON HP, 1973, BMJ-BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5883.28; Rolo LC, 2011, ARCH GYNECOL OBSTET, V283, P149, DOI [10.1007/s00404-010-1691-y, 10.1007/s00404-010-1521-2]; Alves CMS, 2013, J ULTRAS MED, V32, P269, DOI 10.7863/jum.2013.32.2.269; Steegers-Theunissen RPM, 2016, INT J EPIDEMIOL, V45, P374, DOI 10.1093/ije/dyv147; Sucksdorff M, 2015, PEDIATRICS, V136, pE599, DOI 10.1542/peds.2015-1043; Wang PH, 2000, PRENATAL DIAG, V20, P518, DOI 10.1002/1097-0223(200006)20:6<518::AID-PD860>3.0.CO;2-T	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217538	10.1371/journal.pone.0217538	http://dx.doi.org/10.1371/journal.pone.0217538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120993	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700110
J	Gejo, NG; Anshebo, AA; Dinsa, LH				Gejo, Negeso Gebeyehu; Anshebo, Abebe Alemu; Dinsa, Leta Hinkosa			Postpartum modern contraceptive use and associated factors in Hossana town	PLOS ONE			English	Article							INTERPREGNANCY INTERVAL; WOMEN	Background Postpartum family planning is the initiation and use of family planning services within the first 12 months following childbirth to impede closely spaced and unintended pregnancies. Globally, spacing pregnancies at least 2 years apart can prevent an estimated 10% of infant deaths and 21% of deaths in children 1-4 years of age. The main purpose of this study was to determine postpartum modern contraceptive use and associated factors in Hossana town, Hadiya zone, Southern nation nationalities peoples region, Ethiopia. Methods Facility based cross-sectional study was conducted from June 03 to July 03, 2018, in Hossana town, Hadiya zone. Data was collected by structured questionnaires using face-to-face interview on 368 women. Systematic random sampling technique was employed to approach the study participants. SPSS version 20 software was used for data analysis. Both bivariate and multiple variable logistic regression analysis were computed. Odds ratio with their 95% confidence intervals were calculated and statistical significance was decided if p < 0.05. Result Two hundred seventy one 972.9%) women used postpartum modern contraception. Educational status of mothers [AOR = 0.26; 95% Cl; 0.09-0.744], resumption of sex [AOR = 4.20; 95% Cl; 1.533-11.517], menses resumption [AOR = 8.48; 95% Cl; 3.072-23.228] and duration postpartum period [AOR = 0.26; 95% Cl; 0.107-0.644] had significant association with postpartum modern contraceptive use. Conclusions The prevalence of postpartum modern contraception use is relatively high. Educational status of mothers, resumption of sex, menses resumption and duration of postpartum period were factors significantly associated with postpartum modern contraceptive use. Improving women education & delivering messages for couples on the risk of getting pregnant prior to menses is crucial.	[Gejo, Negeso Gebeyehu; Anshebo, Abebe Alemu] Wachemo Univ, Coll Med & Hlth Sci, Dept Midwifery, Hosanna, Ethiopia; [Dinsa, Leta Hinkosa] Wollega Univ, Coll Med & Hlth Sci, Dept Midwifery, Nekemte, Ethiopia	University of Gondar; University of Gondar	Gejo, NG (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Dept Midwifery, Hosanna, Ethiopia.	negiyeman@gmail.com	Anshebo, Abebe Alemu/AAH-9750-2020	Anshebo, Abebe Alemu/0000-0002-3697-7468; Dinsa, Leta Hinkosa Dinsa/0000-0003-2691-7071	Wachemo University	Wachemo University	Wachemo University funded the research and it is open for the researchers to publish the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera Y, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0178-1; Abraha TH, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017012; [Anonymous], 2014, CONTR TECHN RESP WOM; [Anonymous], 2020, BMC PUBLIC HEALTH; Borda M, POSTPARTUM FERILITY; Borda M. R., 2010, African Journal of Reproductive Health, V14, P75; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; DaVanzo J, 2007, BJOG-INT J OBSTET GY, V114, P1079, DOI 10.1111/j.1471-0528.2007.01338.x; Gebremedhin AY, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-017-0054-5; Hubacher D, 2015, CONTRACEPTION, V92, P420, DOI 10.1016/j.contraception.2015.08.008; Hunt DP, 2003, J INTELLECTUAL CAPIT, V4; Jackson E, 2011, OBSTET GYNECOL, V117, P657, DOI 10.1097/AOG.0b013e31820ce18c; Mahmood SE, 2011, INDAN J COMMUNITY HE, V23, P56; Mengesha ZB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0598-9; Pasha O, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S11; Rahmanpour H, 2010, J PAK MED ASSOC, V60, P714; Rutaremwa G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1611-y; Rutstein S., 2008, DHS WORKING PAPERS; Singh S, 2012, ADDING IT COSTS BENE; Track 20, 2017, TRENDS UPT POSTP FAM; Vernon R, 2009, STUD FAMILY PLANN, V40, P235, DOI 10.1111/j.1728-4465.2009.00206.x; World Health Organization, 2013, PROGR STRAT POSTP FA	23	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217167	10.1371/journal.pone.0217167	http://dx.doi.org/10.1371/journal.pone.0217167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116800	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400049
J	Affolter, T; Llewellyn, HP; Bartlett, DW; Zong, Q; Xia, SH; Torti, V; Ji, CH				Affolter, Timothy; Llewellyn, Heather P.; Bartlett, Derek W.; Zong, Qing; Xia, Shuhua; Torti, Vince; Ji, Changhua			Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice	PLOS ONE			English	Article							T-CELLS; CANCER; COMBINATION; IPILIMUMAB; HEPATITIS; NIVOLUMAB	Cancer cells harness immune checkpoints such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase 1 (IDO1) to evade immune control. Checkpoint inhibitors have demonstrated durable antitumor efficacy in human and preclinical models. Liver toxicity is one of the common immune-related adverse events associated with checkpoint inhibitors (CPIs) and its frequency and severity often increase significantly during CPI combination therapies. We aim to develop a mouse model to elucidate the immune mechanisms of CPI-associated liver toxicity. Co-administration of CTLA-4 blocking antibody, 9D9, and/or an IDO1 inhibitor, epacadostat in wild-type and PD-1(-/-) mice (to simulate the effect of PD1 blockade) synergistically induced liver injury and immune cell infiltration. Infiltrated cells were primarily composed of CD8+ T cells and positively associated with hepatocyte necrosis. Strikingly, sites of hepatocyte necrosis were frequently surrounded by clusters of mononuclear immune cells. CPI treatments resulted in increased expression of genes associated with hepatocyte cell death, leukocyte migration and T cell activation in the liver. In conclusion, blockade of immune checkpoints PD-1, CTLA-4, and IDO1 act synergistically to enhance T cell infiltration and activity in the liver, leading to hepatocyte death.	[Affolter, Timothy; Llewellyn, Heather P.; Ji, Changhua] Pfizer Drug Safety Res & Dev, Global Pathol, La Jolla, CA 92121 USA; [Bartlett, Derek W.] Pfizer Worldwide Res & Dev, Med Design, La Jolla, CA USA; [Zong, Qing] Pfizer Drug Safety Res & Dev, Biomarkers, La Jolla, CA USA; [Xia, Shuhua] Drug Safety Res & Dev, Invest Toxicol, Groton, CT USA; [Torti, Vince] Drug Safety Res & Dev, Gen Toxicol, La Jolla, CA USA	Pfizer; Pfizer; Pfizer	Ji, CH (corresponding author), Pfizer Drug Safety Res & Dev, Global Pathol, La Jolla, CA 92121 USA.	changhua.ji2@pfizer.com			Drug Safety Research and Development Science and Technology at Pfizer Inc.; Pfizer Inc.	Drug Safety Research and Development Science and Technology at Pfizer Inc.; Pfizer Inc.(Pfizer)	We thank the following Pfizer colleagues for their help on this manuscript: Ellen Evans for her critical review of the manuscript, Dingzhou Li for statistical support, Angela Stauffer, Erick Kindt, Stephanie Scales and Wenlin Li for analytical support, Wesley Scott for in vivo support, and Perrine Hoerter, Qinghai Peng, Christine Taylor and Sanduo Xu for their technical assistance. We are also grateful for Carlos Esparza, Nicholas Wallingford, Jessica Frey, Catherine Lee, Penny Venne and Jeremiah Dragoo for their contributions to necropsy, scanning, histology, trimming and immunohistochemistry. This research was funded by the Drug Safety Research and Development Science and Technology and the Postdoctoral Fellow Program at Pfizer Inc.	Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Baik CS, 2017, CLIN CANCER RES, V23, P4992, DOI 10.1158/1078-0432.CCR-16-3066; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Charlton JJ, 2013, J IMMUNOL, V190, P6104, DOI 10.4049/jimmunol.1201617; Chen SH, 2015, CANCER IMMUNOL RES, V3, P149, DOI 10.1158/2326-6066.CIR-14-0118; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Gibney GT, 2014, ASCO M, V32, P3010, DOI DOI 10.1200/jco.2014.32.15_suppl.3010; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Kleiner DE, 2012, DIGEST DIS SCI, V57, P2233, DOI 10.1007/s10620-012-2140-5; Koelzer VH, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0117-1; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Makarova-Rusher OV, 2015, J HEPATOL, V62, P1420, DOI 10.1016/j.jhep.2015.02.038; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Metushi IG, 2015, HEPATOLOGY, V61, P1332, DOI 10.1002/hep.27549; Nagano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073404; Nawaf MG, 2017, J IMMUNOL, V199, P974, DOI 10.4049/jimmunol.1700088; O'Brien PJ, 2002, LAB ANIM-UK, V36, P313, DOI 10.1258/002367702320162414; Osorio J, 2017, NATURE, V552, pS70, DOI 10.1038/d41586-017-08703-6; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Prendergast GC, 2017, CANCER RES, V77, P6795, DOI 10.1158/0008-5472.CAN-17-2285; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Shi JG, 2017, J CLIN PHARMACOL, V57, P720, DOI 10.1002/jcph.855; Sibaud V, 2018, AM J CLIN DERMATOL, V19, P345, DOI 10.1007/s40257-017-0336-3; Zen Y, 2018, MODERN PATHOL, V31, P965, DOI 10.1038/s41379-018-0013-y; Zheng SJ, 2004, J CLIN INVEST, V113, P58, DOI 10.1172/JCI200419255; 2010, MOL CANCER THER, V9, P489, DOI DOI 10.1158/1535-7163.MCT-09-0628; 2007, J IMMUNOL, V179, P5064; 2015, CHEM RES TOXICOL, V28, P2287, DOI DOI 10.1021/ACS.CHEMRESTOX.5B00305; 1995, IMMUNITY, V3, P541; 2017, CLIN CANCER RES, V23, P3269, DOI DOI 10.1158/1078-0432.CCR-16-2272; 2017, SCIENCE, V357, P409, DOI DOI 10.1126/SCIENCE.AAN6733; 2014, HEPATOLOGY, V60, P2109, DOI DOI 10.1002/HEP.27254; 2010, GASTROENTEROLOGY, V139, P58, DOI DOI 10.1053/J.GASTRO.2010.04.053; 2001, J IMMUNOL, V167, P6654; 2012, J IMMUNOL, V189, P3848, DOI DOI 10.4049/JIMMUNOL.1200819; 1995, SCIENCE, V270, P985	45	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217276	10.1371/journal.pone.0217276	http://dx.doi.org/10.1371/journal.pone.0217276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112568	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000045
J	Pan, Y; Norton, S; Gwinnutt, JM; Kearsley-Fleet, L; Symmons, DPM; Lunt, M; Young, A; Hyrich, KL; Verstappen, SMM; Maiden, N; Price, T; Hopkinson, N; O'Reilly, S; Hordon, L; Griffiths, I; Porter, D; Capell, H; Hassell, A; Benitha, R; Choy, E; Walsh, D; Emery, P; Knight, S; Bruce, I; Hyrich, K; Taggart, A; Scott, D; Thompson, P; McCrae, F; Goodfellow, R; Kitas, G; Jubb, R; Abernethy, R; Clarke, S; Green, S; Sanders, P; Coulson, A; Harrison, B; Bukhari, M; Klimiuk, P				Pan, Yi; Norton, Sam; Gwinnutt, James M.; Kearsley-Fleet, Lianne; Symmons, Deborah P. M.; Lunt, Mark; Young, Adam; Hyrich, Kimme L.; Verstappen, Suzanne M. M.; Maiden, Nicola; Price, Tom; Hopkinson, Neil; O'Reilly, Sheila; Hordon, Lesley; Griffiths, Ian; Porter, Duncan; Capell, Hilary; Hassell, Andy; Benitha, Romela; Choy, Ernest; Walsh, David; Emery, Paul; Knight, Susan; Bruce, Ian; Hyrich, Kimme; Taggart, Allister; Scott, David; Thompson, Paul; McCrae, Fiona; Goodfellow, Rhian; Kitas, George; Jubb, Ronald; Abernethy, Rikki; Clarke, Shane; Green, Sandra; Sanders, Paul; Coulson, Amanda; Harrison, Bev; Bukhari, Marwan; Klimiuk, Peter		BSRBR-RA Control Ctr Consortium	Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity	PLOS ONE			English	Article							THERAPY; METHOTREXATE; ASSOCIATION; ETANERCEPT; BIOLOGICS	Background United Kingdom guidelines for the use of biologic disease modifying anti-rheumatic drugs (bDMARDS) for rheumatoid arthritis (RA) require patients to have active disease (Disease Activity Score [DAS28] >5.1) and have failed >= 2 previous conventional synthetic DMARDs (csDMARD). Patients with moderate disease activity (MDA) do not meet these criteria, yet often have poor outcomes. This study aimed to identify trajectory groups of disability scores over three years in RA patients with MDA. Methods The study included biologic-naive patients receiving csDMARDs only with MDA (3.2 <DAS289 <= 5.1) when recruited to the control cohort of the British Society for Rheumatology Biologics Register RA (BSRBR-RA). Disability scores, measured using the Health Assessment Questionnaire (HAQ), were recorded every six months for three years. Trajectories of HAQ scores over follow-up were assessed using latent class growth models (LCGMs). Baseline age, gender, DAS28, symptom duration, rheumatoid factor status, number of prior csDMARDs and co-morbidities were assessed as potential predictors of group membership. Results In total, 1274 patients were included (mean age: 61 years (standard deviation: 12), 71.4% women). The best fitting model included seven HAQ trajectories. These trajectories were horizontal over follow-up and were related to baseline HAQ: very-low (6.8%, baseline (BL) HAQ: 0.22), low (11.5%, BL HAQ: 0.41), low-moderate (17.0%, BL HAQ: 0.93), moderate (13.4%, BL HAQ: 1.09), high-moderate (19.5%, BL HAQ: 1.61), severe (23.2%, BL HAQ: 1.98) and very-severe (8.6%, BL HAQ: 2.54). Higher DAS28, older age, female gender, longer disease duration and more co-morbidities were independently associated with higher HAQ trajectory group. Conclusion There is substantial heterogeneity in baseline HAQ scores in this population, and the trajectories of HAQ scores after baseline are, on average, relatively flat. As bDMARD therapy has been shown to improve HAQ scores, patients with MDA but high HAQ scores may benefit from a more aggressive approach to therapy.	[Pan, Yi; Gwinnutt, James M.; Kearsley-Fleet, Lianne; Symmons, Deborah P. M.; Lunt, Mark; Hyrich, Kimme L.; Verstappen, Suzanne M. M.; BSRBR-RA Control Ctr Consortium] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Div Musculoskeletal & Dermatol Sci,Manchester Aca, Sch Biol Sci,Fac Biol Med & Hlth,Ctr Musculoskele, Manchester, Lancs, England; [Norton, Sam] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Psychol Sect, London, England; [Norton, Sam] Kings Coll London, Fac Life Sci & Med, Dept Inflammat Biol, London, England; [Young, Adam] Univ Hertfordshire, Ctr Hlth Serv & Clin Res & Post Grad Med, Coll Lane, Hatfield, Herts, England; [Hyrich, Kimme L.; Verstappen, Suzanne M. M.] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Maiden, Nicola] Antrim Area Hosp, Antrim, North Ireland; [Price, Tom] Cannock Chase Hosp, Cannock Chase, England; [Hopkinson, Neil] Christchurch Hosp, Christchurch, New Zealand; [O'Reilly, Sheila] Royal Derby Hosp, Derby, England; [Hordon, Lesley] Dewsbury & Dist Hosp, Dewsbury, England; [Griffiths, Ian] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Porter, Duncan] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Capell, Hilary] Glasgow Royal Infirm, Glasgow, Lanark, Scotland; [Hassell, Andy] Haywood Hosp, Stoke On Trent, Staffs, England; [Benitha, Romela] Hope Hosp, Salford, Lancs, England; [Choy, Ernest] Kings Coll Hosp London, London, England; [Walsh, David] Kings Mill Ctr, Sutton In Ashfield, England; [Emery, Paul] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Knight, Susan] Macclesfield Hosp, Macclesfield, Cheshire, England; [Bruce, Ian; Hyrich, Kimme] Manchester Royal Infirm, Manchester, Lancs, England; [Taggart, Allister] Musgrave Pk Hosp, Belfast, Antrim, North Ireland; [Scott, David] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Thompson, Paul] Poole Gen Hosp, Poole, Dorset, England; [McCrae, Fiona] Queen Alexandra Hosp, Portsmouth, Hants, England; [Goodfellow, Rhian] Royal Glamorgan Hosp, Glamorgan, Wales; [Kitas, George] Russells Hall Hosp, Dudley, England; [Jubb, Ronald] Selly Oak Hosp, Selly Oak, England; [Abernethy, Rikki] St Helens Hosp, St Helens, England; [Clarke, Shane; Green, Sandra] Weston Gen Hosp, Weston Super Mare, England; [Sanders, Paul] Withington Hosp, Manchester, Lancs, England; [Coulson, Amanda] Withybush Gen Hosp, Haverfordwest, Wales; [Harrison, Bev] North Manchester Gen Hosp, Manchester, Lancs, England; [Bukhari, Marwan] Royal Lancaster Infirm, Lancaster, England; [Klimiuk, Peter] Royal Oldham Hosp, Oldham, England	University of Manchester; University of London; King's College London; University of London; King's College London; University of Hertfordshire; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Christchurch Hospital New Zealand; University of Nottingham; Newcastle Freeman Hospital; Newcastle University - UK; Gartnavel Royal Hospital; University of Glasgow; King's College Hospital NHS Foundation Trust; King's College Hospital; Leeds General Infirmary; University of Leeds; University of Manchester; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Poole Hospital; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Russells Hall Hospital	Verstappen, SMM (corresponding author), Univ Manchester, Arthrit Res UK Ctr Epidemiol, Div Musculoskeletal & Dermatol Sci,Manchester Aca, Sch Biol Sci,Fac Biol Med & Hlth,Ctr Musculoskele, Manchester, Lancs, England.; Verstappen, SMM (corresponding author), Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NHR Manchester Biomed Res Ctr, Manchester, Lancs, England.	Suzanne.Verstappen@manchester.ac.uk	Kitas, George/AAO-6396-2020; Norton, Sam J/A-1898-2009; emery, paul/B-3560-2013; Bukhari, Marwan/AAL-1057-2020; Kearsley-Fleet, Lianne/G-4440-2013	Norton, Sam J/0000-0003-1714-9963; Bukhari, Marwan/0000-0003-4311-5222; Gwinnutt, James/0000-0002-1435-8797; Kearsley-Fleet, Lianne/0000-0003-0377-1575; Hyrich, Kimme/0000-0001-8242-9262	Arthritis Research UK [21023, 20380]; National Institute for Health Research; BSR Executive; BSRBR Registers Committee; BSRBR Project Team in London; Versus Arthritis [21023] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR)); BSR Executive; BSRBR Registers Committee; BSRBR Project Team in London; Versus Arthritis(Versus Arthritis)	The British Society for Rheumatology (BSR) commissioned the BSR Biologics Register in Rheumatoid Arthritis (BSRBR-RA) in 2001 as a UK wide national project to investigate the safety of biologic and other targeted therapies in routine medical practice. KLH is the Chief Investigator. BSR currently receives restricted income from UK pharmaceutical companies, including Abbvie, Celltrion, Eli Lilly, Pfizer, Roche, Samsung Bioepis, Sandoz, Sanofi, UCB, and in the past Hospira, MSD and SOBI, to support the register. This income finances a wholly separate contract between the BSR and the University of Manchester (UoM), who oversee the day-today operations and data collection for the BSRBR-RA. The BSR owns the IP of the BSRBR-RA dataset and under license, the UoM has access to all data for scientific analyses. All decisions concerning analyses, interpretation and publication are made autonomously of any industrial contribution. Members of the BSRBR-RA University of Manchester team, BSR trustees, committee members and staff complete an annual declaration in relation to conflicts of interest. All relevant information regarding serious adverse events outlined in the manuscript has been reported to the appropriate pharmaceutical company as per the contractual agreements/standard operating procedures. YP was supported by Arthritis Research UK (grant reference number: 21023) and this research was supported by the Arthritis Research UK Centre for Epidemiology (grant reference number: 20380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the enthusiastic collaboration of all consultant rheumatologists and their specialist nurses in the UK in providing the data (visit www.bsrbr.org for a full list of contributors). The authors would like to gratefully acknowledge the support of the National Institute for Health Research, through the Comprehensive Local Research Networks at participating centres. In addition, the authors acknowledge support from the BSR Executive, the members of the BSRBR Registers Committee and the BSRBR Project Team in London for their active role in enabling the register to undertake its tasks. The authors also acknowledge the seminal role of the BSR Clinical Affairs Committee for establishing national biological guidelines and recommendations for such a register.	Combe B, 2015, ANN RHEUM DIS, V74, P724, DOI 10.1136/annrheumdis-2013-204178; Conaghan PG, 2010, RHEUMATOLOGY, V49, P1894, DOI 10.1093/rheumatology/keq178; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Hyrich KL, 2009, RHEUMATOLOGY, V48, P1323, DOI 10.1093/rheumatology/kep242; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; Kiely P, 2011, RHEUMATOLOGY, V50, P926, DOI 10.1093/rheumatology/keq406; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; Low AS, 2016, ANN RHEUM DIS, V76, P654, DOI DOI 10.1136/ANNRHEUMDIS-2016-209784; Madan J, 2015, RHEUMATOL THER, V2, P113, DOI 10.1007/s40744-015-0020-0; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; National Institute for Health and Care Excellence, 2016, AD ET INFL CERT PEG; Norton S, 2013, RHEUMATOLOGY, V52, P2016, DOI 10.1093/rheumatology/ket253; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Ranzolin A, 2009, ARTHRIT RHEUM-ARTHR, V61, P794, DOI 10.1002/art.24430; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Verstappen SMM, 2010, RHEUMATOLOGY, V49, P1570, DOI 10.1093/rheumatology/keq131; 2014, SEMIN ARTHRITIS RHEU, V44, P131, DOI DOI 10.1016/J.SEMARTHRIT.2014.05.003; 2010, LANCET, V376, P1094, DOI DOI 10.1016/S0140-6736(10)60826-4; 2012, J RHEUMATOL, V39, P22, DOI DOI 10.3899/JRHEUM.110072	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0215999	10.1371/journal.pone.0215999	http://dx.doi.org/10.1371/journal.pone.0215999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107887	gold, Green Published, Green Submitted			2022-12-27	WOS:000468285200005
J	Dundon, M; Madden, O; Comizzoli, P				Dundon, Morgan; Madden, Odile; Comizzoli, Pierre			Three-dimensional culture of endometrial cells from domestic cats: A new in vitro platform for assessing plastic toxicity	PLOS ONE			English	Article							LONG-TERM; MODELS; IDENTIFICATION; LEACHABLES; ORGANOIDS; APOPTOSIS; CHEMICALS; MOUSE; ZINC	Plastic polymers can be combined with additives that modify physical properties and stability of the material. However, the biocompatibility of those additives is not well known. The objective of the study was to characterize the impact of zinc stearate-a common additivethrough the development of a novel three-dimensional (3-D) in vitro platform with endometrial cells from domestic cats. Epithelial and stromal cells from adult uteri were isolated and cultured in medium supplemented with 3% Matrigel for two weeks in plastic tissue culture dishes that had been identified as polystyrene with and without zinc stearate by Raman, FTIR, and X-ray fluorescence spectroscopies. Three-dimensional cell structures that were obtained were measured and categorized by shape. Cell viability, proliferation, differentiation, organization, and apoptosis then were assessed by immuno-staining. Results indicated that zinc stearate did not affect 3-D endometrial cell structure morphology, viability, or cellular composition. This first study of a new in vitro platform will be useful for studies testing the influence of other additives, drugs, or exogenous hormones.	[Dundon, Morgan; Comizzoli, Pierre] Natl Zool Pk, Ctr Species Survival, Conservat Biol Inst, Washington, DC 20008 USA; [Dundon, Morgan; Madden, Odile] Smithsonian Museum Conservat Inst, Suitland, MD USA; [Dundon, Morgan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA USA; [Madden, Odile] Getty Conservat Inst, Los Angeles, CA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; University of California System; University of California Riverside	Comizzoli, P (corresponding author), Natl Zool Pk, Ctr Species Survival, Conservat Biol Inst, Washington, DC 20008 USA.	comizzolip@si.edu	Madden, Odile/N-9909-2015	Madden, Odile/0000-0003-2322-2522	Smithsonian Museum Conservation Institute; Smithsonian Conservation Biology Institute	Smithsonian Museum Conservation Institute; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute)	M.D's fellowship was funded by the Smithsonian Museum Conservation Institute (https://www.si.edu/mci/) and the Smithsonian Conservation Biology Institute (https://nationalzoo.si.edu/conservation).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RTECS ZH5200000 ZINC; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Astashkina A, 2014, ADV DRUG DELIVER REV, V69, P1, DOI 10.1016/j.addr.2014.02.008; Boretto M, 2017, DEVELOPMENT, V144, P1775, DOI 10.1242/dev.148478; Bredhult C, 2009, REPROD TOXICOL, V28, P18, DOI 10.1016/j.reprotox.2009.03.006; Broschard TH, 2016, REGUL TOXICOL PHARM, V81, P201, DOI 10.1016/j.yrtph.2016.08.011; Caserta D, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-37; Chang JY, 2010, PHARM RES-DORDR, V27, P2402, DOI 10.1007/s11095-010-0193-8; Chia SL, 2015, SMALL, V11, P702, DOI 10.1002/smll.201401915; Lima DBC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207317; Deane JA, 2017, BIOL REPROD, V97, P781, DOI 10.1093/biolre/iox139; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Eritja N, 2010, AM J PATHOL, V176, P2722, DOI 10.2353/ajpath.2010.090974; Geravandi S, 2017, CRYOLETTERS, V38, P108; Getachew Paulos, 2016, Toxicology and Environmental Health Sciences, V8, P341, DOI 10.1007/s13530-016-0295-8; Gillespie JL, 2016, MED SCI MONIT BASIC, V22, P91, DOI 10.12659/MSMBR.900656; Groh KJ, 2017, COMPR REV FOOD SCI F, V16, P1123, DOI 10.1111/1541-4337.12280; Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802; Jenke Dennis, 2006, PDA J Pharm Sci Technol, V60, P191; Jenke Dennis, 2010, PDA J Pharm Sci Technol, V64, P200; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Lee PC, 2018, MOL HUM REPROD, V24, P14, DOI 10.1093/molehr/gax059; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Murphy J., 2001, ADDITIVES PLASTICS H; Poncin-Epaillard F, 2012, J FUNCT BIOMATER, V3, P528, DOI 10.3390/jfb3030528; SAUVANT MP, 1994, SCI TOTAL ENVIRON, V156, P159, DOI 10.1016/0048-9697(94)90353-0; Solecki R, 2017, ARCH TOXICOL, V91, P1001, DOI 10.1007/s00204-016-1866-9; Tertemiz F, 2005, BIOL REPROD, V72, P727, DOI 10.1095/biolreprod.104.034975; Tomlinson M, 2005, HUM REPROD, V20, P1751, DOI 10.1093/humrep/deh679; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Watson J, 2009, J BIOMOL SCREEN, V14, P566, DOI 10.1177/1087057109336594	32	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217365	10.1371/journal.pone.0217365	http://dx.doi.org/10.1371/journal.pone.0217365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136609	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300030
J	Holmes, CL; Peyton, CG; Bier, AM; Donlon, TZ; Osman, F; Bartels, CM; Shelef, MA				Holmes, Caitlyn L.; Peyton, Chloe G.; Bier, Amy M.; Donlon, Tobias Z.; Osman, Fauzia; Bartels, Christie M.; Shelef, Miriam A.			Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects	PLOS ONE			English	Article							PNEUMOCOCCAL VACCINES; GENDER-DIFFERENCES; ANTIBODY-RESPONSE; INFLUENZA VACCINE; IMMUNOGENICITY; METHOTREXATE; SEX; DISEASE; SAFETY; IMMUNIZATION	Background The antibody response to pertussis vaccination in rheumatoid arthritis is unknown, a concerning omission given the relatively low efficacy of the pertussis vaccine, a rise in pertussis infections, and a general increased susceptibility to infection in rheumatoid arthritis. Additionally, the contributions from an intrinsically dysregulated immune system in rheumatoid arthritis and immune-suppressing medications to the response to pertussis vaccination is poorly defined. This study examines antibody titers against pertussis in vaccinated rheumatoid arthritis patients and controls as well as evaluates potential contributions from demographic factors, immune suppressing medications, and reactivity against citrullinated pertussis. Methods Serum IgG titers against native and citrullinated pertussis and tetanus were quantified by enzyme-linked immunosorbent assay in rheumatoid arthritis subjects and controls who were vaccinated within 10 years. Titers were compared by t-test and percent immunity by Fisher's exact test. Multivariable logistic regression was used to identify clinical factors that correlate with native pertussis titers. Results Compared to controls, rheumatoid arthritis subjects had lower titers against pertussis, but not tetanus, and reduced immunity to pertussis. These results were even more prominent at 5-10 years post-vaccination, when rheumatoid arthritis patients had 50% lower titers than controls and 2.5x more rheumatoid arthritis subjects were not considered immune to pertussis. Multiple logistic regression demonstrated that female sex and methotrexate use, but not TNF inhibiting medications, correlated with reduced immunity to pertussis. Finally, rheumatoid arthritis patients had higher IgG titers against citrullinated pertussis than native pertussis. Conclusions Pertussis titers are lower in vaccinated rheumatoid arthritis patients with evidence for contributions from female sex, a citrulline-biased immune response, and methotrexate use.	[Holmes, Caitlyn L.; Peyton, Chloe G.; Bier, Amy M.; Donlon, Tobias Z.; Osman, Fauzia; Bartels, Christie M.; Shelef, Miriam A.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Holmes, Caitlyn L.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Shelef, Miriam A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Shelef, MA (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.; Shelef, MA (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.	mshelef@medicine.wisc.edu	Bartels, Christie Michels/ABG-4072-2020; Holmes, Caitlyn L./ABH-9798-2020	Bartels, Christie Michels/0000-0001-6523-0374; Holmes, Caitlyn L./0000-0001-5818-148X; Shelef, Miriam/0000-0002-8842-0303	University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program; Doris Duke Charitable Foundation [2015099]; National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [K08AR065500]; National Institutes of Health, National Heart, Lung, and Blood Institute [T32HL07899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR065500] Funding Source: NIH RePORTER	University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program [https://www.med.wisc.edu/wisconsinpartnership-program/no grant number] and the Doris Duke Charitable Foundation [https://www.ddcf.org/2015099] to MAS. MAS is additionally supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [https://www.niams.nih.gov/K08AR065500].Research by CLH was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute [https://www.nhlbi.nih.gov/T32HL07899].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrisani G, 2013, J CROHNS COLITIS, V7, P301, DOI 10.1016/j.crohns.2012.05.011; Barhamain AS, 2017, OPEN ACCESS RHEUMATO, V9, P139, DOI 10.2147/OARRR.S138830; Brandao AP, 2004, VACCINE, V23, P762, DOI 10.1016/j.vaccine.2004.07.024; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; Caldera F, 2018, DIGEST DIS SCI, V63, P1532, DOI 10.1007/s10620-018-5043-2; Caporuscio S, 2018, CLIN IMMUNOL, V195, P18, DOI 10.1016/j.clim.2018.07.010; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen XQ, 1997, J HEPATOL, V26, P260, DOI 10.1016/S0168-8278(97)80039-6; Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054; Corsiero E, 2016, ANN RHEUM DIS, V75, P1866, DOI 10.1136/annrheumdis-2015-208356; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Damgaard D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203214; DEVEY ME, 1987, CLIN EXP IMMUNOL, V68, P562; Dirix V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/795958; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Elkayam O, 2002, CLIN INFECT DIS, V34, P147, DOI 10.1086/338043; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Fairbanks LD, 1999, BIOCHEM J, V342, P143, DOI 10.1042/0264-6021:3420143; Fedele G, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv051; Ferreira I, 2014, ANN RHEUM DIS, V73, P1446, DOI 10.1136/annrheumdis-2014-205246; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Ge C, 2018, ARTHRITIS RHEUMATOL; Hagihara Y, 2014, J CROHNS COLITIS, V8, P223, DOI 10.1016/j.crohns.2013.08.008; Hua C, 2014, ARTHRIT CARE RES, V66, P1016, DOI 10.1002/acr.22246; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Kaine JL, 2007, J RHEUMATOL, V34, P272; Kapetanovic MC, 2011, ARTHRITIS RHEUM-US, V63, P3723, DOI 10.1002/art.30580; Katz JN, 1997, ARTHRITIS RHEUM, V40, P1594, DOI 10.1002/art.1780400908; Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086; Kilgore PE, 2016, CLIN MICROBIOL REV, V29, P449, DOI 10.1128/CMR.00083-15; Kivitz AJ, 2014, J RHEUMATOL, V41, P648, DOI 10.3899/jrheum.130945; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Krasselt M, 2017, RHEUMATOL INT, V37, P229, DOI 10.1007/s00296-016-3608-y; Liang JL, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6702a1; Mamula P, 2007, CLIN GASTROENTEROL H, V5, P851, DOI 10.1016/j.cgh.2007.02.035; Mease PJ, 2004, J RHEUMATOL, V31, P1356; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Migita K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002184; Milanetti F, 2014, CLIN EXP IMMUNOL, V177, P287, DOI 10.1111/cei.12292; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; MORRIS CA, 1989, EPIDEMIOL INFECT, V103, P387, DOI 10.1017/S0950268800030740; National Center for Immunization and Respiratory Diseases DoBD, 1922, PERT CAS YEAR 1922 2; Park JK, 2018, ANN RHEUM DIS, V77, P898, DOI 10.1136/annrheumdis-2018-213222; Pasteur S., 2019, ADACEL PACKAGE INSER; Rebernick R, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0072-y; RHODES K, 1969, ANN RHEUM DIS, V28, P104, DOI 10.1136/ard.28.2.104; Ribeiro ACM, 2011, ANN RHEUM DIS, V70, P2144, DOI 10.1136/ard.2011.152983; Salemi S, 2010, CLIN IMMUNOL, V134, P113, DOI 10.1016/j.clim.2009.09.014; Shohat T, 2000, ISRAEL MED ASSOC J, V2, P192; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Spengler J, 2015, ARTHRITIS RHEUMATOL, V67, P3135, DOI 10.1002/art.39313; Steen J, 2018, ARTHRITIS RHEUMATOL; Stephen J, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0001-5; Titcombe PJ, 2018, ARTHRITIS RHEUMATOL; Torzsa P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2356-2; Trier NH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22058-6; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	59	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217221	10.1371/journal.pone.0217221	http://dx.doi.org/10.1371/journal.pone.0217221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136605	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300022
J	Khawagi, WY; Steinke, DT; Nguyen, J; Keers, RN				Khawagi, Wael Y.; Steinke, Douglas T.; Nguyen, Joanne; Keers, Richard N.			Identifying potential prescribing safety indicators related to mental health disorders and medications: A systematic review	PLOS ONE			English	Review							DRUG-RELATED MORBIDITY; OLDER PERSONS PRESCRIPTIONS; NORWEGIAN GENERAL-PRACTICE; INAPPROPRIATE MEDICATION; SCREENING TOOL; EXPLICIT CRITERIA; ELDERLY-PATIENTS; AMBULATORY-CARE; DEVELOPING CONSENSUS; QUALITY INDICATORS	Background Prescribing errors and medication related harm may be common in patients with mental illness. However, there has been limited research focusing on the development and application of prescribing safety indicators (PSIs) for this population. Objective Identify potential PSIs related to mental health (MH) medications and conditions. Methods Seven electronic databases were searched (from 1990 to February 2019), including the bibliographies of included studies and of relevant review articles. Studies that developed, validated or updated a set of explicit medication-specific indicators or criteria that measured prescribing safety or quality were included, irrespective of whether they contained MH indicators or not. Studies were screened to extract all MH related indicators before two MH clinical pharmacists screened them to select potential PSIs based on established criteria. All indicators were categorised into prescribing problems and medication categories. Results 79 unique studies were included, 70 of which contained at least one MH related indicator. No studies were identified that focused on development of PSIs for patients with mental illness. A total of 1386 MH indicators were identified (average 20 (SD = 25.1) per study); 245 of these were considered potential PSIs. Among PSIs the most common prescribing problem was 'Potentially inappropriate prescribing considering diagnoses or conditions' (n = 91, 37.1%) and the lowest was 'omission' (n = 5, 2.0%). 'Antidepressant' was the most common PSI medication category (n = 85, 34.7%). Conclusion This is the first systematic review to identify a comprehensive list of MH related potential PSIs. This list should undergo further validation and could be used as a foundation for the development of new suites of PSIs applicable to patients with mental illness.	[Khawagi, Wael Y.; Steinke, Douglas T.; Nguyen, Joanne; Keers, Richard N.] Univ Manchester, Div Pharm & Optometry, Sch Hlth Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Khawagi, Wael Y.] Taif Univ, Coll Pharm, Clin Pharm Dept, At Taif, Saudi Arabia; [Nguyen, Joanne; Keers, Richard N.] Greater Manchester Mental Hlth NHS Fdn Trust, Pharm Dept, Manchester, Lancs, England	University of Manchester; Taif University	Khawagi, WY (corresponding author), Univ Manchester, Div Pharm & Optometry, Sch Hlth Sci, Fac Biol Med & Hlth, Manchester, Lancs, England.; Khawagi, WY (corresponding author), Taif Univ, Coll Pharm, Clin Pharm Dept, At Taif, Saudi Arabia.	wael.khawagi@postgrad.manchester.ac.uk	Khawagi, Wael/AAC-8343-2022; Keers, Richard/D-9136-2012	Keers, Richard/0000-0001-7854-8154; Khawagi, Wael/0000-0002-9489-1697	Taif University	Taif University	WK acknowledges Taif University for funding this systematic review as part of his PhD programme at The University of Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taweel D, 2017, INT J CLIN PHARM-NET, V39, P897, DOI 10.1007/s11096-017-0498-3; Alshehri GH, 2017, DRUG SAFETY, V40, P871, DOI 10.1007/s40264-017-0557-7; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2016, FUND FACTS MENT HLTH; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Avery AJ, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588501; Avery AJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-28; Barnett KN, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0133-9; Barry E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012079; Basger BJ, 2008, DRUG AGING, V25, P777, DOI 10.2165/00002512-200825090-00004; Basger BJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001431; Bazire S., 2018, PSYCHOTROPIC DRUG DI; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; British Medical Association, 2017, BREAK BARR THE CHALL; Campbell SM, 2000, BRIT MED J, V321, P425, DOI 10.1136/bmj.321.7258.425; Castillo-Paramo A, 2013, Semergen, V39, P413, DOI 10.1016/j.semerg.2013.01.017; Caughey GE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004625; Center for Health Policy/ Center for Primary Care and Outcomes Research Battelle Memorial Institute, 2011, 290040020 CTR HLTH P; Chang CB, 2012, PHARMACOEPIDEM DR S, V21, P1269, DOI 10.1002/pds.3274; Chen YF, 2005, DRUG SAFETY, V28, P67, DOI 10.2165/00002018-200528010-00005; Clyne B, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-307; Constantine RJ, 2013, COMMUNITY MENT HLT J, V49, P33, DOI 10.1007/s10597-012-9497-y; Cooper JA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0484-6; Department of Health and Social Care, MED SAF IND SAF PRES; Desnoyer A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016070; Desrochers JF, 2011, AM J KIDNEY DIS, V58, P527, DOI 10.1053/j.ajkd.2011.04.020; Dreischulte Tobias, 2012, BMC Clin Pharmacol, V12, P5, DOI 10.1186/1472-6904-12-5; Duerden M, 2011, QUALITY GP PRESCRIBI; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Elliott Rohan A., 2001, Australian Journal of Hospital Pharmacy, V31, P19; Urrusuno RF, 2013, EUR J CLIN PHARMACOL, V69, P1845, DOI 10.1007/s00228-013-1542-4; Fialova D., 2013, KLIN FARMAKOL FARM, V27, P18; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fitch K., 2001, RAND UCLA APPROPRIAT; Fox A, 2016, BRIT J CLIN PHARMACO, V82, P451, DOI 10.1111/bcp.12954; Galán Retamal C., 2014, Farm Hosp., V38, P305, DOI [10.7399/fh.2014.38.4.1148, 10.7399/FH.2014.38.4.1148]; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Green H., 2005, J RES SPEC EDUC NEED; Guerreiro Mara Pereira, 2007, Acta Med Port, V20, P107; Guthrie B, 2011, BMJ-BRIT MED J, V342, P1; Guthrie B., 2015, HEALTH SERV DELIVERY, V3, P1, DOI [10.3310/hsdr03420, DOI 10.3310/HSDR03420]; Guthrie B, 2015, HLTH SERVICES DELIVE, DOI [10.3399/bjgp14X677806, DOI 10.3399/BJGP14X677806]; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Harper MB, 2014, J PATIENT SAF, V10, P59, DOI 10.1097/PTS.0000000000000050; Helmer-Hirschberg O., 1967, IN; Holmes HM, 2008, J AM GERIATR SOC, V56, P1306, DOI 10.1111/j.1532-5415.2008.01741.x; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Humphrey-Murto S, 2017, MED TEACH, V39, P14, DOI 10.1080/0142159X.2017.1245856; Hurley JS, 2005, J GEN INTERN MED, V20, P331, DOI 10.1111/j.1525-1497.2005.40182.x; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jeffries M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205419; Joint Formulary Committee, 2018, BRIT NATL FORMULARY; Kaufmann CP, 2014, EUR J CLIN PHARMACOL, V70, P1, DOI 10.1007/s00228-013-1575-8; Keers RN, 2015, J CLIN PHARM THER, V40, P645, DOI 10.1111/jcpt.12328; Keers RN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005948; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khodyakov D, 2017, J AM GERIATR SOC, V65, P586, DOI 10.1111/jgs.14689; Kim DS, 2010, HEALTHC INFORM RES, V16, P231, DOI 10.4258/hir.2010.16.4.231; Kim DS, 2015, INT J CLIN PHARM-NET, V37, P76, DOI 10.1007/s11096-014-0042-7; Kim MY, 2018, ANN GERIATR MED RES, V22, P121, DOI 10.4235/agmr.2018.22.3.121; Kim SO, 2015, INT J GERONTOL, V9, P136, DOI 10.1016/j.ijge.2015.05.013; Kojima T, 2016, GERIATR GERONTOL INT, V16, P983, DOI 10.1111/ggi.12890; Kroger E, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.04.002; Kuhn-Thiel AM, 2014, DRUG AGING, V31, P131, DOI 10.1007/s40266-013-0146-0; Laroche ML, 2007, EUR J CLIN PHARMACOL, V63, P725, DOI 10.1007/s00228-007-0324-2; Lavan AH, 2016, CLIN INTERV AGING, V11, P857, DOI 10.2147/CIA.S80280; Lavan AH, 2017, AGE AGEING, V46, P600, DOI 10.1093/ageing/afx005; Lilford R, 2006, QUAL SAF HEALTH CARE, V15, P311, DOI 10.1136/qshc.2005.017178; Lindblad CI, 2006, CLIN THER, V28, P1133, DOI 10.1016/j.clinthera.2006.08.006; Mackinnon Neil J, 2002, J Manag Care Pharm, V8, P365; Maio V, 2010, J CLIN PHARM THER, V35, P219, DOI 10.1111/j.1365-2710.2009.01094.x; Malone Daniel C, 2004, J Am Pharm Assoc (2003), V44, P142, DOI 10.1331/154434504773062591; Mann E, 2012, WIEN KLIN WOCHENSCHR, V124, P160, DOI 10.1007/s00508-011-0061-5; Mann K, 2008, WORLD J BIOL PSYCHIA, V9, P24, DOI 10.1080/15622970601178056; Marzi Marta M, 2018, Value Health Reg Issues, V17, P38, DOI 10.1016/j.vhri.2017.10.002; Mast Ruth, 2015, BMC Res Notes, V8, P642, DOI 10.1186/s13104-015-1566-1; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; McManus S, 2014, MENTAL HLTH WELLBEIN; Mitchell AJ, 2012, BRIT J PSYCHIAT, V201, P435, DOI 10.1192/bjp.bp.111.094532; Morris CJ, 2003, J CLIN PHARM THER, V28, P295, DOI 10.1046/j.1365-2710.2003.00496.x; Morris CJ, 2002, INT J QUAL HEALTH C, V14, P183, DOI 10.1093/oxfordjournals.intqhc.a002610; NICE, NICE GUID NAT I HLTH; NICE, 2015, MED OPT SAF EFF US M; Nyborg G, 2015, SCAND J PRIM HEALTH, V33, P134, DOI 10.3109/02813432.2015.1041833; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Oborne CA, 1997, BRIT J CLIN PHARMACO, V43, P91, DOI 10.1111/j.1365-2125.1997.tb00038.x; Oborne CA, 2003, AGE AGEING, V32, P102; Okechukwu I, 2006, BRIT J CLIN PHARMACO, V62, P218, DOI 10.1111/j.1365-2125.2006.02621.x; Onder G, 2014, J GERONTOL A-BIOL, V69, P430, DOI 10.1093/gerona/glt118; Onder G, 2014, DRUG AGING, V31, P33, DOI 10.1007/s40266-013-0134-4; Paton C, 2004, QUAL SAF HEALTH CARE, V13, P40, DOI 10.1136/qshc.2003.006338; Pazan F, 2018, DRUG AGING, V35, P61, DOI 10.1007/s40266-017-0514-2; Pazan F, 2016, DRUG AGING, V33, P447, DOI 10.1007/s40266-016-0371-4; Phansalkar S, 2012, J AM MED INFORM ASSN, V19, P735, DOI 10.1136/amiajnl-2011-000612; Pontefract SK, 2018, BMJ QUAL SAF, V27, P725, DOI 10.1136/bmjqs-2017-007135; Prot-Labarthe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108007; Quintens C, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0748-5; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Raebel MA, 2006, PHARMACOTHERAPY, V26, P619, DOI 10.1592/phco.26.5.619; Raebel MA, 2007, J AM GERIATR SOC, V55, P977, DOI 10.1111/j.1532-5415.2007.01202.x; Rancourt Carol, 2004, BMC Geriatr, V4, P9, DOI 10.1186/1471-2318-4-9; Renom-Guiteras A, 2015, EUR J CLIN PHARMACOL, V71, P861, DOI 10.1007/s00228-015-1860-9; Robertson HA, 2002, CLIN THER, V24, P1595, DOI 10.1016/S0149-2918(02)80063-7; Rognstad S, 2009, SCAND J PRIM HEALTH, V27, P153, DOI 10.1080/02813430902992215; Ross M K, 2014, Yearb Med Inform, V9, P97, DOI 10.15265/IY-2014-0003; Royal Pharmaceutical Society, 2017, MEDICINESCOMPLETE RO; Ruths S, 2003, QUAL SAF HEALTH CARE, V12, P176, DOI 10.1136/qhc.12.3.176; Saverno KR, 2011, J AM MED INFORM ASSN, V18, P32, DOI 10.1136/jamia.2010.007609; Smits KPJ, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12922; Smits KPJ, 2016, NEPHROL DIAL TRANSPL, V31, P1876, DOI 10.1093/ndt/gfv420; Soerensen AL, 2016, NORD J PSYCHIAT, V70, P365, DOI 10.3109/08039488.2015.1127996; Solberg LI, 2004, AM J MANAG CARE, V10, P753; Song Jie, 2017, J Evid Based Med, V10, P222, DOI 10.1111/jebm.12244; Spencer R, 2014, BRIT J GEN PRACT, V64, pE181, DOI 10.3399/bjgp14X677806; Standage C., 2008, INT J PHARM PRACT, V16, P317, DOI [DOI 10.1211/ijpp.16.5.0007, 10.1211/ijpp.16.5.0007]; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Stocks SJ, 2015, BMJ-BRIT MED J, P351; TAMBLYN RM, 1994, CAN MED ASSOC J, V150, P1801; Taylor DM, 2018, MAUDSLEY PRESCRIBING; The Medicines and Healthcare products Regulatory Agency (MHRA), 2018, DRUG SAFETY UPDATE, V11, P1; Thomas S, DEV ELECT DATA CAPTU; Thomas SK, 2013, BRIT J CLIN PHARMACO, V76, P797, DOI 10.1111/bcp.12087; Tjia J, 2010, AM J MANAG CARE, V16, P489; Tommelein E, 2016, J PUBLIC HEALTH-UK, V38, pE158, DOI 10.1093/pubmed/fdv090; Tully MP, 2005, PHARM WORLD SCI, V27, P407, DOI 10.1007/s11096-005-0340-1; University of Nottingham, PINCER TOOL; Van der Linden L, 2014, EUR GERIATR MED, V5, P175, DOI 10.1016/j.eurger.2013.12.005; van Dijk KN, 2003, ANN PHARMACOTHER, V37, P1136, DOI 10.1345/aph.1C073; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Wessell AM, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.034678; WHO (World Health Organization), 2016, INT STAT CLASS DIS R, V5th; Williams D, 2005, EUR J CLIN PHARMACOL, V61, P127, DOI 10.1007/s00228-004-0876-3; Williams Richard, 2018, J Innov Health Inform, V25, P183, DOI 10.14236/jhi.v25i3.1015; Winit-Watjana W, 2008, ARCH GERONTOL GERIAT, V47, P35, DOI 10.1016/j.archger.2007.06.006; Yu SS, 2011, AM J HEALTH-SYST PH, V68, P407, DOI 10.2146/ajhp100215; Zhen CL, 2001, JAMA-J AM MED ASSOC, V286, P2823, DOI 10.1001/jama.286.22.2823	140	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217406	10.1371/journal.pone.0217406	http://dx.doi.org/10.1371/journal.pone.0217406			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125358	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700036
J	Rath, M; Li, QY; Li, HL; Lindstrom, S; Miron, A; Miron, P; Dowton, AE; Meyer, ME; Larson, BG; Pomerantz, M; Seo, JH; Collins, LC; Vardeh, H; Brachtel, E; Come, SE; Borges, V; Schapira, L; Tamimi, RM; Partridge, AH; Freedman, M; Ruddy, KJ				Rath, Michelle; Li, Qiyuan; Li, Huili; Lindstrom, Sara; Miron, Alexander; Miron, Penelope; Dowton, Anne E.; Meyer, Meghan E.; Larson, Bryce G.; Pomerantz, Mark; Seo, Ji-Heui; Collins, Laura C.; Vardeh, Hilde; Brachtel, Elena; Come, Steven E.; Borges, Virginia; Schapira, Lidia; Tamimi, Rulla M.; Partridge, Ann H.; Freedman, Matthew; Ruddy, Kathryn J.			Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients	PLOS ONE			English	Article							BODY-MASS INDEX; SUSCEPTIBILITY LOCI; MUTATION CARRIERS; GENETIC-VARIANTS; AFRICAN-AMERICAN; COMMON VARIANTS; FGFR2; ALLELES; PROGNOSIS; SUBTYPES	Purpose Genome-wide-association studies (GWAS) have identified numerous single nucleotide polymorphisms (SNPs) that are associated with an increased risk of breast cancer. Most of these studies were conducted primarily in postmenopausal breast cancer patients. Therefore, we set out to assess whether or not these breast cancer variants are also associated with an elevated risk of breast cancer in young premenopausal patients. Methods In 451 women of European ancestry who had prospectively enrolled in a longitudinal cohort study for women diagnosed with breast cancer at or under age 40, we genotyped 44 SNPs that were previously associated with breast cancer risk. A control group was comprised of 1142 postmenopausal healthy women from the Nurses' Health Study (NHS). We assessed if the frequencies of the adequately genotyped SNPs differed significantly (p <= 0.05) between the cohort of young breast cancer patients and postmenopausal controls, and then we corrected for multiple testing. Results Genotyping of the controls or cases was inadequate for comparisons between the groups for seven of the 44 SNPs. 9 of the remaining 37 were associated with breast cancer risk in young women with a p-value <0.05: rs10510102, rs1219648, rs13387042, rs1876206, rs2936870, rs2981579, rs3734805, rs3803662 and rs4973768. The directions of these associations were consistent with those in postmenopausal women. However, after correction for multiple testing (Benjamini Hochberg) none of the results remained statistically significant. Conclusion After correction for multiple testing, none of the alleles for postmenopausal breast cancer were clearly associated with risk of premenopausal breast cancer in this relatively small study.	[Rath, Michelle; Li, Qiyuan; Dowton, Anne E.; Meyer, Meghan E.; Larson, Bryce G.; Pomerantz, Mark; Seo, Ji-Heui; Partridge, Ann H.; Freedman, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Qiyuan; Li, Huili] Shanghai Biochip Ltd Corp, Natl Engn Res Ctr Biochip, Shanghai, Peoples R China; [Lindstrom, Sara] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lindstrom, Sara] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Miron, Alexander; Miron, Penelope] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Collins, Laura C.; Vardeh, Hilde] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Brachtel, Elena] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Brachtel, Elena] Harvard Med Sch, Boston, MA 02115 USA; [Come, Steven E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Borges, Virginia] Univ Colorado Denver, Aurora, CO USA; [Schapira, Lidia] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA; [Tamimi, Rulla M.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Ruddy, Kathryn J.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA	Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Case Western Reserve University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Mayo Clinic	Ruddy, KJ (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	Ruddy.kathryn@mayo.edu	Schapira, Lidia/AAA-1293-2020	/0000-0003-4914-1157	German Research Foundation (Forschungsstipendium DFG) [DI 1772/1-1]; Tracy Starr Breast Cancer Research fund	German Research Foundation (Forschungsstipendium DFG); Tracy Starr Breast Cancer Research fund	MR received funding from the German Research Foundation (Forschungsstipendium DFG), DI 1772/1-1. This work was also supported by the Tracy Starr Breast Cancer Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Andersen SW, 2013, BREAST CANCER RES TR, V140, P427, DOI 10.1007/s10549-013-2646-3; [Anonymous], 1975, SEER CANC STAT REV 1; Antoniou AC, 2010, CANCER RES, V70, P9742, DOI 10.1158/0008-5472.CAN-10-1907; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; Berstad P, 2010, CANCER EPIDEM BIOMAR, V19, P1532, DOI 10.1158/1055-9965.EPI-10-0025; Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Cui F, 2016, BREAST CANCER RES TR, V155, P313, DOI 10.1007/s10549-015-3670-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elematore I, 2014, MOL BIOL REP, V41, P3715, DOI 10.1007/s11033-014-3236-0; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Fu FM, 2012, TOHOKU J EXP MED, V226, P221, DOI 10.1620/tjem.226.221; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Gaudet MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001183; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gorbatenko A, 2016, BIOCHEM J, V473, P4027, DOI 10.1042/BCJ20160054; Gudmundsdottir ET, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-621; Han MR, 2015, BREAST CANCER-TOKYO, V22, P544, DOI 10.1007/s12282-014-0518-2; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jara L, 2013, BREAST CANCER RES TR, V137, P559, DOI 10.1007/s10549-012-2359-z; Kibriya MG, 2009, BREAST CANCER RES TR, V114, P463, DOI 10.1007/s10549-008-0039-9; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Partridge AH, 2012, ONCOLOGIST, V17, P775, DOI 10.1634/theoncologist.2011-0469; Reeves GK, 2010, JAMA-J AM MED ASSOC, V304, P426, DOI 10.1001/jama.2010.1042; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shi M, 2017, BREAST CANCER RES TR, V161, P333, DOI 10.1007/s10549-016-4053-z; Sidoni A, 2003, BREAST, V12, P247, DOI 10.1016/S0960-9776(03)00095-X; Society A.C, 2007, BREAST CANC FACTS FI; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2011, CANCER RES, V71, P6240, DOI 10.1158/0008-5472.CAN-11-1266; Tapper W, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2213; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Walker RA, 1996, BRIT J CANCER, V74, P1796, DOI 10.1038/bjc.1996.632; Wang H, 2013, BREAST CANCER RES TR, V137, P511, DOI 10.1007/s10549-012-2343-7; Xiong QH, 2001, CANCER, V92, P2523, DOI 10.1002/1097-0142(20011115)92:10<2523::AID-CNCR1603>3.0.CO;2-6; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216997	10.1371/journal.pone.0216997	http://dx.doi.org/10.1371/journal.pone.0216997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125336	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700013
J	Zacharioudakis, IM; Zervou, FN; Shehadeh, F; Mylonakis, E				Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Shehadeh, Fadi; Mylonakis, Eleftherios			Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; ANTIBIOTIC-THERAPY; BLOOD; INFECTIONS; PATHOGENS; SURVIVAL; IMPACT	Objectives Sepsis presents a major burden to the emergency department (ED). Because empiric inappropriate antimicrobial therapy (IAAT) is associated with increased mortality, rapid molecular assays may decrease IAAT and improve outcomes. We evaluated the cost-effectiveness of molecular testing as an adjunct to blood cultures in patients with severe sepsis or septic shock evaluated in the ED. Methods We developed a decision analysis model with primary outcome the incremental cost-effectiveness ratio expressed in terms of deaths averted. Costs were dependent on the assay price and the patients' length of stay (LOS). Three base-case scenarios regarding the difference in LOS between patients receiving appropriate (AAT) and IAAT were described. Sensitivity analyses regarding the assay cost and sensitivity, and its ability to guide changes from IAAT to AAT were performed. Results Under baseline assumptions, molecular testing was cost-saving when the LOS differed by 4 days between patients receiving IAAT and AAT (ICER -$7,302/death averted). Our results remained robust in sensitivity analyses for assay sensitivity >= 52%, panel efficiency >= 39%, and assay cost <=$ 270. In the extreme case that the LOS of patients receiving AAT and IAAT was the same, the ICER remained <=$ 20,000/death averted for every studied sensitivity (i.e. 0.5-0.95), panel efficiency >= 34%, and assay cost <=$ 313. For 2 days difference in LOS, the bundle approach was dominant when the assay cost was <=$ 135 and the panel efficiency was >= 77%. Conclusions The incorporation of molecular tests in the management of sepsis in the ED has the potential to improve outcomes and be cost-effective for a wide range of clinical scenarios.	[Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Shehadeh, Fadi; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Infect Dis Div, Providence, RI 02903 USA; [Zacharioudakis, Ioannis M.] NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; New York University	Zacharioudakis, IM; Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Infect Dis Div, Providence, RI 02903 USA.; Zacharioudakis, IM (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA.	ioannis.zacharioudakis@nyulangone.org; emylonakis@lifespan.org		Mylonakis, Eleftherios/0000-0002-4624-0777; Shehadeh, Fadi/0000-0002-9552-4004	Boehringer Ingelheim; T2 Biosystems; Sanofi	Boehringer Ingelheim(Boehringer Ingelheim); T2 Biosystems; Sanofi	EM has received grant support from Boehringer Ingelheim, T2 Biosystems and Sanofi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle SE, 2017, J ANTIMICROB CHEMOTH, V72, P299, DOI 10.1093/jac/dkw402; Bureau of Labor Statistics, CPI INFL CALC; Clancy CJ, 2018, CLIN INFECT DIS, V66, P1678, DOI 10.1093/cid/cix1095; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Greco R, 2018, BONE MARROW TRANSPL, V53, P410, DOI 10.1038/s41409-017-0039-7; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Hershey TB, 2017, NEW ENGL J MED, V376, P2311, DOI 10.1056/NEJMp1611928; Jeng K, 2012, J CLIN MICROBIOL, V50, P3287, DOI 10.1128/JCM.00677-12; Khare R, 2014, J CLIN MICROBIOL, V52, P3667, DOI 10.1128/JCM.01637-14; Kothari A, 2014, CLIN INFECT DIS, V59, P272, DOI 10.1093/cid/ciu292; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Marco F, 2017, ENFERM INFEC MICR CL, V35, P586, DOI 10.1016/j.eimc.2017.03.002; Marquet Kristel, 2015, Crit Care, V19, P63, DOI 10.1186/s13054-015-0795-y; Marschall J, 2008, J ANTIMICROB CHEMOTH, V61, P1376, DOI 10.1093/jac/dkn104; Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P323, DOI 10.1016/j.cmi.2015.02.005; Orszag P, 2014, J CLIN MICROBIOL, V52, P307, DOI 10.1128/JCM.02493-13; Raman G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1123-5; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Riedel S, 2016, CLIN CHEST MED, V37, P191, DOI 10.1016/j.ccm.2016.01.018; Shorr AF, 2008, CRIT CARE MED, V36, P2335, DOI 10.1097/CCM.0b013e31818103ea; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Trinh TD, 2015, INFECT DIS THER, V4, P39, DOI 10.1007/s40121-015-0084-8; Wang HE, 2017, CRIT CARE MED, V45, P1443, DOI 10.1097/CCM.0000000000002538; Wilke MH, 2011, EUR J MED RES, V16, P315, DOI 10.1186/2047-783X-16-7-315; [No title captured]	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217508	10.1371/journal.pone.0217508	http://dx.doi.org/10.1371/journal.pone.0217508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125382	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700046
J	Acevedo, A; Simister, R; McQueen-Mason, SJ; Gomez, LD				Acevedo, Alberto; Simister, Rachael; McQueen-Mason, Simon J.; Gomez, Leonardo D.			Sudangrass, an alternative lignocellulosic feedstock for bioenergy in Argentina	PLOS ONE			English	Article							CELLULOSE; FERMENTATION; SYSTEMS	Sudangrass, Sorghum sudanense (Piper) Stapf, is a vigorous forage crop that has also been used for biogas, paper, and electricity production. Due to the large biomass yields achieved by sudangrass and the large area of potential growth in Argentina seven sudangrass accessions from a collection of S. sudanense were analyzed to evaluate their potential as feedstocks for lignocellulosic bioethanol production, and to assess whether there is an association between the response to biotic and abiotic stresses and the composition of the biomass. The biomass composition was analyzed for major cell wall polymers, monosaccharides, and elemental composition. On average, 68% of stem lignocellulosic biomass was comprised of matrix polysaccharides and crystalline cellulose, representing a potential source of sugars for bioethanol production. Xylose was the predominant matrix polysaccharide monosaccharide comprising, on average, 45% of the total sugars, followed by arabinose, glucose, galactose, galacturonic acid, mannose, glucuronic acid, and fucose. Rhamnose was not detected in any of the biomasses analyzed. Silica was the most abundant element in sudangrass stem, followed by chloride, calcium, phosphorus and sulfur. We performed saccharification analyses after pretreatments. Alkaline pretreatment was more effective than water pretreatment. Sodium hydroxide pretreatment exposed different levels of recalcitrance among sudangrass accessions, whereas the water pretreatment did not. Phenological traits were also evaluated, showing significant variability among accessions. The comparison of major cell wall polymers and monosaccharide composition between tolerant and susceptible accessions to abiotic and biotic stresses suggests an association between the composition of the biomass and the response to stress.	[Acevedo, Alberto] Ctr Invest Recursos Nat, Inst Suelos, Castelar, Buenos Aires, Argentina; [Acevedo, Alberto] Inst Nacl Tecnol Agr, Castelar, Buenos Aires, Argentina; [Simister, Rachael; McQueen-Mason, Simon J.; Gomez, Leonardo D.] Univ York, Dept Biol, Ctr Novel Agr Prod, York, N Yorkshire, England	Instituto Nacional de Tecnologia Agropecuaria (INTA); University of York - UK	Acevedo, A (corresponding author), Ctr Invest Recursos Nat, Inst Suelos, Castelar, Buenos Aires, Argentina.; Acevedo, A (corresponding author), Inst Nacl Tecnol Agr, Castelar, Buenos Aires, Argentina.; Gomez, LD (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York, N Yorkshire, England.	acevedo.alberto@inta.gob.ar; leonardo.gomez@york.ac.uk		Gomez, Leonardo Dario/0000-0001-6382-9447	Biotechnology and Biological Sciences Research Council, UK [BB/R020167/1]; BBSRC [BB/P02372X/1, BB/N023269/1, BB/R020167/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank the Biotechnology and Biological Sciences Research Council, UK, for the Partnering Award that funded, in part, this collaboration (grant number BB/R020167/1, SMM). We are also grateful to INTA for maintaining the sorghum germplasm collection.	[Anonymous], 2008, SORGHUM GERMPLASM CO; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Barbera P, 2017, SERIE TECNICA, V5, P16; Barhnhart S., 1993, MANAGING IMMATURE FR; Bertello F., 2018, NACION; Bhatia R, 2017, PLANT BIOTECHNOL J, V15, P1071, DOI 10.1111/pbi.12764; Bibi A., 2010, Journal of Agricultural Research (Lahore), V48, P369; Chowdhury J, 2014, NEW PHYTOL, V204, P650, DOI 10.1111/nph.12974; Creamer NG, 2000, HORTSCIENCE, V35, P600, DOI 10.21273/HORTSCI.35.4.600; Di Rienzo J., INFOSTAT VERSION 201; Domon JM, 2013, PHYTOCHEMISTRY, V85, P51, DOI 10.1016/j.phytochem.2012.09.001; Foster Cliff E, 2010, J Vis Exp, DOI 10.3791/1745; Gomez LD, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-23; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Jones L, 2003, P NATL ACAD SCI USA, V100, P11783, DOI 10.1073/pnas.1832434100; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776, DOI 10.1007/BF00167144; Lionetti V, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0369-1; Liu BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159117; Marriott PE, 2016, NEW PHYTOL, V209, P1366, DOI 10.1111/nph.13684; Oliver D, 1917, FLORA TROPICAL AFRIC, V9, P113; Reich JM, 2005, P CAL ALF FOR S 2005, P12; Rovira P, 2013, Rev. vet., V24, P91; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Tan HT, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0448-y; Vandenbrink JP, 2012, BIOENERG RES, V5, P387, DOI 10.1007/s12155-011-9146-2; WHITE GA, 1974, ECON BOT, V28, P136, DOI 10.1007/BF02861979; Wisselink HW, 2007, APPL ENVIRON MICROB, V73, P4881, DOI 10.1128/AEM.00177-07	27	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217435	10.1371/journal.pone.0217435	http://dx.doi.org/10.1371/journal.pone.0217435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120985	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000468775700104
J	Chen, YC; Su, MC; Chin, CH; Lin, IC; Hsu, PY; Liou, CW; Huang, KT; Wang, TY; Lin, YY; Zheng, YX; Hsiao, CC; Lin, MC				Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Lin, I-Chun; Hsu, Po-Yuan; Liou, Chia-Wei; Huang, Kuo-Tung; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Hsiao, Chang-Chun; Lin, Meng-Chih			Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; NEUTROPHIL APOPTOSIS; LYMPHOCYTE RATIO; INFLAMMATION; RESOLUTION; EXPRESSION; DYSFUNCTION; ACTIVATION; MORTALITY; PATHWAY	Background This study aims to investigate the role of FPR 1/2/3 expressions in patients with obstructive sleep apnea (OSA). Method We made cross-sectional comparisons of FPR1/2/3 expressions of blood neutrophil, M1/M2a monocyte, and natural killer (NK) cell between 16 healthy subjects (HS), 16 primary snoring (PS) subjects, 46 treatment-naive OSA patients, and 18 severe OSA patients under long-term continuous positive airway pressure treatment (severe OSA on CPAP). Results FPR1 expressions on neutrophil were increased in treatment-naive OSA and severe OSA on CPAP groups versus either HS or PS. FPR2 expressions on neutrophil were decreased in treatment-naive OSA versus HS, and returned to normal in severe OSA on CPAP group. FPR1/FPR2 expression ratio on neutrophil was increased in treatment-naive OSA versus either HS or PS. Serum lipoxin A4, resolvin D1 levels, and FPR3 expressions of M1, M2a and NK cells were all decreased in treatment-naive OSA versus HS. OSA patients with hypertension had decreased FPR2 expressions on neutrophil and FPR3 expressions of NK cell. FPR1 expression, FPR1/FPR2 expression ratio on neutrophil, and FPR3 expression of M1 cell were all reversed after > 6-month CPAP treatment in 9 selected patients. In vitro intermittent hypoxia with re-oxygenation treatment in THP-1 cells resulted in increased FPR1/FPR2 expression ratio of M1 cells, and increased FPR1/FPR3 expression ratio of M2a cells. Conclusions FPR1 over-expression and insufficiency of FPR2 and FPR3 in association with defective lipoxin A4 and resolving D1 production were associated with disease severity of OSA and its adverse consequences.	[Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Hsu, Po-Yuan; Huang, Kuo-Tung; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Hsiao, Chang-Chun; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Lin, I-Chun; Hsu, Po-Yuan; Liou, Chia-Wei; Huang, Kuo-Tung; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Hsiao, Chang-Chun; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Huang, Kuo-Tung; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan; [Chen, Yung-Che] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Su, Mao-Chang] Chang Gung Univ Sci & Technol, Chiayi, Taiwan; [Lin, I-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Hsu, Po-Yuan] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsiao, Chang-Chun] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsiao, CC; Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.; Hsiao, CC; Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan.; Hsiao, CC (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	cchsiao@mail.cgu.edu.tw; linmengchih@hotmail.com	Chen, Yung-Che/AAL-5167-2020	Chen, Yung-Che/0000-0001-8695-5227; Hsiao, Chang-Chun/0000-0002-7275-4675	Ministry of Science and Technology, Taiwan [NMRPG8B6131-6132/103-2314-B-182A-094-MY2];  [CMRPG8C1183/CMRPG8G0281]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); 	This work was supported by grants (NMRPG8B6131-6132/103-2314-B-182A-094-MY2 to M.C. Lin) from the Ministry of Science and Technology, Taiwan, and by grants from the Chang Gung Memorial Hospital (CMRPG8C1183/CMRPG8G0281 to M.C. Lin), Taiwan.	Altintas N, 2015, EUR REV MED PHARMACO, V19, P3234; Bao Y, 2014, J BIOL CHEM, V289, P26794, DOI 10.1074/jbc.M114.572495; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bozinovski S, 2013, PHARMACOL THERAPEUT, V140, P280, DOI 10.1016/j.pharmthera.2013.07.007; Cattaneo F, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2609847; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Chen YC, 2015, SLEEP BREATH, V19, P873, DOI 10.1007/s11325-014-1116-4; Cheng TY, 2014, ANTICANCER RES, V34, P2223; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020; Dyugovskaya L, 2008, AM J RESP CRIT CARE, V177, P544, DOI 10.1164/rccm.200705-675OC; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; El Shamieh S, 2012, CLIN CHIM ACTA, V413, P34, DOI 10.1016/j.cca.2010.11.038; Filep JG, 2013, P NATL ACAD SCI USA, V110, P18033, DOI 10.1073/pnas.1317798110; Gagliardo R, 2016, J ALLERGY CLIN IMMUN, V137, P1796, DOI 10.1016/j.jaci.2015.11.045; Guo ZD, 2016, STROKE, V47, P490, DOI 10.1161/STROKEAHA.115.011223; Han X, 2016, SCI PROGRAMMING-NETH, V2016, DOI 10.1155/2016/5130603; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Heo SC, 2017, STEM CELLS, V35, P654, DOI 10.1002/stem.2535; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Hoyos CM, 2015, SLEEP MED REV, V20, P15, DOI 10.1016/j.smrv.2014.06.003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kendzerska T, 2014, SLEEP MED REV, V18, P49, DOI 10.1016/j.smrv.2013.01.003; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Kossmann S, 2013, ARTERIOSCL THROM VAS, V33, P1313, DOI 10.1161/ATVBAHA.113.301437; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Liao WI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081771; Liu J, 2014, INFLAMMATION, V37, P984, DOI 10.1007/s10753-014-9819-z; Liu LP, 2016, J CLIN HYPERTENS, V18, P153, DOI 10.1111/jch.12639; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Oldekamp S, 2014, IMMUNOLOGY, V143, P447, DOI 10.1111/imm.12324; Oyama J, 2016, J CARDIOL, V67, P295, DOI 10.1016/j.jjcc.2015.06.005; Pan L, 2016, SLEEP BREATH, V20, P345, DOI 10.1007/s11325-015-1295-7; Prevete N, 2015, ONCOGENE, V34, P3826, DOI 10.1038/onc.2014.309; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Raoof M, 2010, J TRAUMA, V68, P32; Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Siarnik P, 2014, NEUROENDOCRINOL LETT, V35, P142; Smith HK, 2015, FASEB J, V29, P2161, DOI 10.1096/fj.14-263160; Stempel H, 2016, J BIOL CHEM, V291, P9762, DOI 10.1074/jbc.M116.714493; Tsai YF, 2016, EXPERT OPIN THER PAT, V26, P1139, DOI 10.1080/13543776.2016.1216546; Wu L, 2015, J MOL NEUROSCI, V56, P848, DOI 10.1007/s12031-015-0525-6; Xu HJ, 2015, RESP CARE, V60, P749, DOI 10.4187/respcare.03739; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	46	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216607	10.1371/journal.pone.0216607	http://dx.doi.org/10.1371/journal.pone.0216607			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116781	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400025
J	Lin, HL; Muo, CH; Lin, CY; Chen, HJ; Chen, PC				Lin, Hui-Lin; Muo, Chih-Hsin; Lin, Cheng-Yu; Chen, Hsuan-Ju; Chen, Pei-Chun			Incidence of stroke in patients with HIV infection: A population-based study in Taiwan	PLOS ONE			English	Article							ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; CEREBROVASCULAR EVENTS; RISK; DISEASE; COHORT; WOMEN	Background Few studies have evaluated whether people infected with human immunodeficiency virus (HIV) are at an increased risk of stroke in an Asian population. We investigated the association between HIV infection and the risk of developing stroke by age, calendar year of HIV diagnosis, and follow-up duration in Taiwan. Methods Using the claims data of a universal health insurance program, we identified 5,961 patients with HIV and 23,844 matched non-HIV subjects without previous stroke from 1998 to 2005 and followed them up until the end of 2011 to measure the incidence of stroke. Cox proportional hazards models adjusted for potential confounders were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), with the non-HIV group as reference. Results During a median follow-up of 8 years, the incidence rates for total, ischemic, and hemorrhagic stroke per 1000 person-years were 2.12, 1.22, and 0.60, respectively, in patients with HIV infection, and 1.98, 1.14, and 0.54, respectively, in the comparison group. HIV infection was associated with an elevated risk of developing total stroke (adjusted HR [95% CI], 1.57 [1.15-2.14]) and ischemic stroke (1.91 [1.25-2.91]) in patients aged less than 45 years, but no association was observed in other age groups (P for interaction with age, p = 0.048 and 0.024, respectively). Patients diagnosed with HIV infection in 1998-1999 had a greater HR for total stroke and ischemic stroke than those diagnosed in 2000-2002 and 2003-2005 (P for interaction, for total stroke p = 0.034, for ischemic stroke p = 0.056). The HRs did not differ by follow-up duration. Conclusions HIV infection among a young age group is associated with increased risk of developing overall and ischemic stroke. The findings highlight the importance of screening and correcting risk factors for young stroke prevention immediately and aggressively.	[Lin, Hui-Lin] China Med Univ, PHD Program Aging, Taichung, Taiwan; [Lin, Hui-Lin] Lin Shin Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Muo, Chih-Hsin; Lin, Cheng-Yu; Chen, Pei-Chun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, PC (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	peichun@mail.cmu.edu.tw		Chen, Pei-Chun/0000-0002-8713-8816	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital, China Medical University [CMU 106-S-01]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital, China Medical University; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), China Medical University Hospital, China Medical University(CMU 106-S-01), Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005-), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ake JA, 2006, CLIN INFECT DIS, V43, pE46, DOI 10.1086/506566; Alvaro-Meca A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179493; Arentzen M, 2015, INT J NEUROSCI, V125, P601, DOI 10.3109/00207454.2014.956870; Behrouz R, 2016, J NEUROVIROL, V22, P634, DOI 10.1007/s13365-016-0439-2; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Berlit P, 1996, J NEUROL SCI, V143, P187, DOI 10.1016/S0022-510X(96)00208-0; Bijker R, 2019, HIV MED, V20, P183, DOI 10.1111/hiv.12687; Bijker Rimke, 2017, Open AIDS J, V11, P52, DOI 10.2174/1874613601711010052; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chetty R, 2001, J CLIN PATHOL, V54, P275, DOI 10.1136/jcp.54.4.275; CHOW FC, 2018, AIDS, V32, P1125, DOI DOI 10.1097/QAD.0000000000001799; Chow FC, 2018, AIDS, V32, P59, DOI [10.1097/QAD.0000000000001650, 10.1097/qad.0000000000001650]; Chow FC, 2016, AIDS, V30, P45, DOI 10.1097/QAD.0000000000000875; Chow FC, 2014, NEUROLOGY, V83, P1705, DOI 10.1212/WNL.0000000000000958; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Correia M, 2013, CEREBROVASC DIS EXTR, V3, P137, DOI 10.1159/000354851; Durand M, 2013, J STROKE CEREBROVASC, V22, pE34, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.014; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Enrique Gonzalez RD, 2001, PNAS, V98, P5199; Forster A, 2012, J NEUROL, V259, P1347, DOI 10.1007/s00415-011-6354-9; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Hatzitolios A, 2008, HIPPOKRATIA, V12, P98; Heikinheimo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033765; LIBMAN RB, 1995, ARCH NEUROL-CHICAGO, V52, P1119, DOI 10.1001/archneur.1995.00540350113023; Marcus JL, 2014, AIDS, V28, P1911, DOI 10.1097/QAD.0000000000000352; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Health Insurance Research Database, LONG HLTH INS DAT ON; Ovbiagele B, 2011, NEUROLOGY, V76, P444, DOI 10.1212/WNL.0b013e31820a0cfc; PARK YD, 1990, ANN NEUROL, V28, P303, DOI 10.1002/ana.410280302; Philip-Ephraim EE, 2015, CEREBROVASC DIS EXTR, V5, P28, DOI 10.1159/000375180; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Roquer J, 1998, CEREBROVASC DIS, V8, P222, DOI 10.1159/000015855; Sico JJ, 2015, NEUROLOGY, V84, P1933, DOI 10.1212/WNL.0000000000001560; Singer EJ, 2013, THER ADV CHRONIC DIS, V4, P61, DOI 10.1177/2040622312471840; Tipping B, 2007, J NEUROL NEUROSUR PS, V78, P1320, DOI 10.1136/jnnp.2007.116103; Vinikoor MJ, 2013, AIDS RES HUM RETROV, V29, P1068, DOI [10.1089/aid.2012.0334, 10.1089/AID.2012.0334]; Yen YF, 2017, JAIDS-J ACQ IMM DEF, V74, P117, DOI 10.1097/qai.0000000000001216; Yen YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151684	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217147	10.1371/journal.pone.0217147	http://dx.doi.org/10.1371/journal.pone.0217147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116762	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400046
J	Carrillo, A; Martinez-Sanchis, M; Etchemendy, E; Banos, RM				Carrillo, Alba; Martinez-Sanchis, Marian; Etchemendy, Ernestina; Banos, Rosa M.			Qualitative analysis of the Best Possible Self intervention: Underlying mechanisms that influence its efficacy	PLOS ONE			English	Article							PSYCHOLOGICAL MECHANISMS; POSITIVE PSYCHOLOGY; HEALTH-BENEFITS; FUTURE; LIFE; NARRATIVES; OPTIMISM; LEISURE; STORY	Background The Best Possible Self is a Positive Psychology Intervention which asks participants to write down about themselves in their best possible future. Previous studies have shown its efficacy to enhance wellbeing, but the mechanisms that underlie its efficacy are still unknown. Objective The aim of this study was to analyze the content of the essays of the BPS intervention and to examine how this content was related to the efficacy of the intervention to increase positive affect. Method Participants (N = 78) were randomized to either the Best Possible Self condition, or one of two variants of the intervention: one's best self in the present, and one's best self in the past. Qualitative analyses of the texts were carried out to explore the main themes and features of the essays. Then, a mixed-methods approach with quantitative and qualitative data was followed, in order to analyze the relationship between the content of the texts and the change in positive affect produced by the interventions. Results Significant differences between conditions were found in the content of the compositions. Regression analyses showed that different variables predicted the change in positive affect depending on the condition. Mediation analyses also found differences among conditions. Conclusions These findings suggest that these interventions respond to different underlying mechanisms which influence their efficacy. This study contributed to a better understanding of how Positive Psychology Interventions work, and how to increment their efficacy.	[Carrillo, Alba; Martinez-Sanchis, Marian; Banos, Rosa M.] Univ Valencia, Dept Personal Assessment & Psychol Treatments, Valencia, Spain; [Etchemendy, Ernestina] Univ Zaragoza, Dept Psychol & Sociol, Teruel, Spain; [Banos, Rosa M.] Inst Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	University of Valencia; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Banos, RM (corresponding author), Univ Valencia, Dept Personal Assessment & Psychol Treatments, Valencia, Spain.; Banos, RM (corresponding author), Inst Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain.	banos@uv.es	BAÑOS, ROSA MARIA/C-6077-2011; Carrillo, Alba/B-7513-2019	BAÑOS, ROSA MARIA/0000-0003-0626-7665; Carrillo, Alba/0000-0003-3478-2699	Conselleria d'Educacio, Investigacio, Cultura i Esport (Spain) [PROMETEO/2018/110]	Conselleria d'Educacio, Investigacio, Cultura i Esport (Spain)	This work was supported by the Conselleria d'Educacio, Investigacio, Cultura i Esport (Spain) under the grant "INTERSABIAS" (PROMETEO/2018/110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KM, 2011, MEM COGNITION, V39, P954, DOI 10.3758/s13421-011-0076-1; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Boselie JJLM, 2016, SCAND J PAIN, V12, P25, DOI 10.1016/j.sjpain.2016.03.001; Bowerman B.L., 1990, LINEAR STAT MODELS A; Carrillo A., 2018, MY BEST SELF EFFICAC; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Grysman A, 2013, CONSCIOUS COGN, V22, P742, DOI 10.1016/j.concog.2013.04.010; Hayes A.F., 2013, INTRO MEDIATION MODE; Hefferon K, 2017, J POSIT PSYCHOL, V12, P211, DOI 10.1080/17439760.2016.1225120; Hill ED, 2015, J HAPPINESS STUD, V16, P1615, DOI 10.1007/s10902-014-9581-9; Holmes EA, 2008, EMOTION, V8, P875, DOI 10.1037/a0013617; King LA, 2001, PERS SOC PSYCHOL B, V27, P798, DOI 10.1177/0146167201277003; Loveday PM, 2018, J POSIT PSYCHOL, V13, P18, DOI 10.1080/17439760.2017.1374441; Loveday PM, 2018, J HAPPINESS STUD, V19, P607, DOI 10.1007/s10902-016-9824-z; Lyubomirsky S, 2013, CURR DIR PSYCHOL SCI, V22, P57, DOI 10.1177/0963721412469809; Meevissen YMC, 2011, J BEHAV THER EXP PSY, V42, P371, DOI 10.1016/j.jbtep.2011.02.012; Mitchell J., 2010, E J APPL PSYCHOL, V6, P30, DOI [10.7790/ejap.v6i2.230, DOI 10.7790/EJAP.V6I2.230]; Myers R., 1990, CLASSICAL MODERN REG; Newman DB, 2014, J HAPPINESS STUD, V15, P555, DOI 10.1007/s10902-013-9435-x; Odou N, 2013, SOC INDIC RES, V110, P111, DOI 10.1007/s11205-011-9919-1; Pennebaker JW, 1999, J CLIN PSYCHOL, V55, P1243, DOI 10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N; Peters ML, 2013, TER PSICOL, V31, P93, DOI 10.4067/S0718-48082013000100009; Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Shao Y, 2010, MEMORY, V18, P855, DOI 10.1080/09658211.2010.514272; Sheldon K. M., 2006, J POSIT PSYCHOL, P73, DOI [10.1080/17439760500510676, DOI 10.1080/17439760500510676]; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Spangler P.T., 2012, CONSENSUAL QUALITATI, P269; Wang RAH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187601; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; 2015, BEHAV PSYCHOL, V23, P529; 2017, J POSIT PSYCHOL, V12, P305, DOI DOI 10.1080/17439760.2016.1262619	35	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216896	10.1371/journal.pone.0216896	http://dx.doi.org/10.1371/journal.pone.0216896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY5OE	31100085	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600020
J	Ross, BE; Sullins, DS; Haukos, DA				Ross, Beth E.; Sullins, Daniel S.; Haukos, David A.			Using an individual-based model to assess common biases in lek-based count data to estimate population trajectories of lesser prairie-chickens	PLOS ONE			English	Article							N-MIXTURE MODELS; ATTENDANCE; SURVIVAL; SIZE; RATES; AGE	Researchers and managers are often interested in monitoring the underlying state of a population (e.g., abundance), yet error in the observation process might mask underlying changes due to imperfect detection and availability for sampling. Additional heterogeneity can be introduced into a monitoring program when male-based surveys are used as an index for the total population. Often, male-based surveys are used for avian species, as males are conspicuous and more easily monitored than females. To determine if male-based lek surveys capture changes or trends in population abundance based on female survival and reproduction, we developed a virtual ecologist approach using the lesser prairie-chicken (Tympanuchus pallidicinctus) as an example. Our approach used an individual-based model to simulate lek counts based on female vital rate data, included models where detection and lek attendance probabilities were <1, and was analyzed using both unadjusted counts and an N-mixture model to compare estimates of population abundance and growth rates. Using lek counts to estimate population growth rates without accounting for detection probability or density-based lek attendance consistently biased population growth rates and abundance estimates. Our results therefore suggest that lek-based surveys used without accounting for lek attendance and detection probability may miss important trends in population changes. Rather than population-level inference, lek-based surveys not accounting for lek attendance and detection probability may instead be better for inferring broad-scale range shifts of lesser prairie-chicken populations in a presence/absence framework.	[Ross, Beth E.] Clemson Univ, US Geol Survey, South Carolina Cooperat Fish & Wildlife Res Unit, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA; [Sullins, Daniel S.; Haukos, David A.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Haukos, David A.] US Geol Survey, Kansas Cooperat Fish & Wildlife Res Unit, Manhattan, KS USA	Clemson University; United States Department of the Interior; United States Geological Survey; Kansas State University; United States Department of the Interior; United States Geological Survey	Ross, BE (corresponding author), Clemson Univ, US Geol Survey, South Carolina Cooperat Fish & Wildlife Res Unit, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA.	bross5@clemson.edu			U.S. Department of Agriculture, Natural Resources Conservation Service through Great Plains Cooperative Ecosystem Studies Unit [68-3A75-16-500]	U.S. Department of Agriculture, Natural Resources Conservation Service through Great Plains Cooperative Ecosystem Studies Unit	D.S.S. was supported by funding to D.A. H. from U.S. Department of Agriculture, Natural Resources Conservation Service through Great Plains Cooperative Ecosystem Studies Unit Agreement Number: 68-3A75-16-500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Behney AC, 2012, WILSON J ORNITHOL, V124, P96, DOI 10.1676/11-079.1; Blomberg EJ, 2013, J WILDLIFE MANAGE, V77, P1583, DOI 10.1002/jwmg.615; Caswell, 2000, MATRIX POPULATION MO; Cummings JW, 2017, PROJECTION LESSER PR; Davis AJ, 2014, ECOL EVOL, V4, P4247, DOI 10.1002/ece3.1290; Duarte A, 2018, ECOL MODEL, V374, P51, DOI 10.1016/j.ecolmodel.2018.02.007; Fremgen AL, 2019, IBIS, V161, P35, DOI 10.1111/ibi.12598; Gervasi V, 2014, ECOL EVOL, V4, P4637, DOI 10.1002/ece3.1258; Gibson R.M., 1986, P379; Grisham B., 2013, PLOS ONE, V8, P1, DOI DOI 10.HTTPS://; Hagen CA, 2005, CONDOR, V107, P78, DOI 10.1650/7502; Hagen CA, 2006, WILDLIFE SOC B, V34, P1064, DOI 10.2193/0091-7648(2006)34[1064:RSEOLP]2.0.CO;2; Hagen CA, 2017, WILDLIFE SOC B, V41, P624, DOI 10.1002/wsb.836; Hagen CA, 2009, J WILDLIFE MANAGE, V73, P1325, DOI 10.2193/2008-225; Haukos DA, 1999, AM MIDL NAT, V142, P415, DOI 10.1674/0003-0031(1999)142[0415:EOLAOA]2.0.CO;2; Kendall WL, 1997, ECOLOGY, V78, P563; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McCaffery R, 2016, J WILDLIFE MANAGE, V80, P1011, DOI 10.1002/jwmg.21094; McDonald L., 2017, RANGE WIDE POPULATIO; McDonald L, 2014, WILDLIFE SOC B, V38, P536, DOI 10.1002/wsb.417; Nuno A, 2013, J APPL ECOL, V50, P488, DOI 10.1111/1365-2664.12051; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Pitman JC, 2006, WILDLIFE SOC B, V34, P675, DOI 10.2193/0091-7648(2006)34[675:SOJLPI]2.0.CO;2; Robinson SG, 2018, J WILDLIFE MANAGE, V82, P413, DOI 10.1002/jwmg.21390; Ross BE, 2018, AUK, V135, P228, DOI 10.1642/AUK-17-113.1; Ross BE, 2016, GLOB ECOL CONSERV, V6, P179, DOI 10.1016/j.gecco.2016.03.003; Ross BE, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1323; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sadoti G, 2016, IBIS, V158, P821, DOI 10.1111/ibi.12391; Shyvers JE, 2018, J WILDLIFE MANAGE, V82, P1689, DOI 10.1002/jwmg.21540; Sullins DS, 2017, REGIONAL VARIATION D; Walsh DP, 2010, J WILDLIFE MANAGE, V74, P1607, DOI 10.2193/2009-353; Wann GT, 2019, POPUL ECOL, V61, P183, DOI 10.1002/1438-390X.1019; Westemeier RL, 1998, WILSON BULL, V110, P190; Winder VL, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00536.1; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217172	10.1371/journal.pone.0217172	http://dx.doi.org/10.1371/journal.pone.0217172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100093	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600033
J	Gomez-Gallego, M; Gommers, R; Bader, MKF; Williams, NM; Adeyrmi, JO				Gomez-Gallego, Mireia; Gommers, Ralf; Bader, Martin Karl-Friedrich; Williams, Nari Michelle; Adeyrmi, Jerry O.			Modelling the key drivers of an aerial Phytophthora foliar disease epidemic, from the needles to the whole plant	PLOS ONE			English	Article							PATHOGEN; RESISTANCE	Understanding the epidemiology of infectious diseases in a host population is a major challenge in forestry. Radiata pine plantations in New Zealand are impacted by a foliar disease, red needle cast (RNC), caused by Phytophthora pluvialis. This pathogen is dispersed by water splash with polycyclic infection affecting the lower part of the tree canopy. In this study, we extended an SI (Susceptible-Infectious) model presented for RNC to analyse the key epidemiological drivers. We conducted two experiments to empirically fit the extended model: a detached-needle assay and an in vivo inoculation. We used the detached-needle assay data to compare resistant and susceptible genotypes, and the in vivo inoculation data was used to inform sustained infection of the whole plant. We also compared isolations and real-time quantitative PCR (qPCR) to assess P. pluvialis infection. The primary infection rate and the incubation time were similar for susceptible and resistant genotypes. The pathogen death rate was 2.5 times higher for resistant than susceptible genotypes. Further, external proliferation of mycelium and sporangia were only observed on 28% of the resistant ramets compared to 90% of the susceptible ones. Detection methods were the single most important factor influencing parameter estimates of the model, giving qualitatively different epidemic outputs. In the early stages of infection, qPCR proved to be more efficient than isolations but the reverse was true at later points in time. Isolations were not influenced by the presence of lesions in the needles, while 19% of lesioned needle maximized qPCR detection. A primary infection peak identified via qPCR occurred at 4 days after inoculation (dai) with a secondary peak observed 22 dai. Our results have important implications to the management of RNC, by highlighting the main differences in the response of susceptible and resistant genotypes, and comparing the most common assessment methods to detect RNC epidemics.	[Gomez-Gallego, Mireia; Bader, Martin Karl-Friedrich] Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Gomez-Gallego, Mireia; Gommers, Ralf; Williams, Nari Michelle; Adeyrmi, Jerry O.] New Zealand Forest Res Inst Scion, Rotorua, New Zealand	Auckland University of Technology	Gomez-Gallego, M (corresponding author), Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand.; Gomez-Gallego, M (corresponding author), New Zealand Forest Res Inst Scion, Rotorua, New Zealand.	mireia.gomez@scionresearch.com		Bader, Martin Karl-Friedrich/0000-0002-3742-9762; Gomez-Gallego, Mireia/0000-0001-6713-1708; Williams, Nari/0000-0003-0493-4954	Forest Owners Association [C04X1305]; Ministry of Business Innovation and Employment	Forest Owners Association; Ministry of Business Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was supported by the Forest Owners Association, C04X1305 (https://www.nzfoa.org.nz/) and Ministry of Business Innovation and Employment (https://www.mbie.govt.nz/) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RN, 1973, T BRIT MYCOL SOC, V61, P287, DOI 10.1016/S0007-1536(73)80152-4; [Anonymous], 2014, P 13 PYTHON SCI C, DOI DOI 10.25080/MAJORA-14BD3278-00E; Australian Bureau of Agricultural and Resource Economics and Sciences, 2018, AUSTR FOR WOOD PROD; Beets P. N., 2013, IMPACT RED NEEDLE CA; CAIRNS AJG, 1990, IMA J MATH APPL MED, V7, P219; Cara M, 2018, PLANT DIS, V102, P253, DOI 10.1094/PDIS-03-17-0353-PDN; Chettri P, 2012, FUNGAL GENET BIOL, V49, P141, DOI 10.1016/j.fgb.2011.11.009; Cunniffe NJ, 2012, PHYTOPATHOLOGY, V102, P365, DOI 10.1094/PHYTO-12-10-0338; Dick MA, 2014, NEW ZEAL J FOR SCI, V44, DOI 10.1186/s40490-014-0006-7; Duran A, 2008, PLANT PATHOL, V57, P715, DOI 10.1111/j.1365-3059.2008.01893.x; Erwin DC, 1996, AM PHYTOPATHOLOGICAL, DOI [10.1016/S0261-2194(97)83220-6, DOI 10.1016/S0261-2194(97)83220-6]; Fawke S, 2015, MICROBIOL MOL BIOL R, V79, P263, DOI 10.1128/MMBR.00010-15; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gilligan CA, 1997, PHILOS T R SOC B, V352, P591, DOI 10.1098/rstb.1997.0040; Gomez-Gallego M, 2017, PLANT DIS, V101, P1259, DOI 10.1094/PDIS-12-16-1738-RE; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Graham NJ, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-018-1266-9; Hader DP, 1999, ADV SPACE RES-SERIES, V24, P843, DOI 10.1016/S0273-1177(99)00965-5; Hansen EM, 2015, PLANT DIS, V99, P727, DOI 10.1094/PDIS-09-14-0943-PDN; Hurley BP, 2017, BIOL INVASIONS, V19, P3273, DOI 10.1007/s10530-017-1488-z; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Latif NSA, 2014, J THEOR BIOL, V347, P144, DOI 10.1016/j.jtbi.2013.12.023; Leclerc M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086568; Mammeri Y, 2014, ECOL MODEL, V290, P178, DOI 10.1016/j.ecolmodel.2014.02.017; Manter DK, 2003, ECOL MODEL, V164, P211, DOI 10.1016/S0304-3800(03)00026-7; Matthiesen RL, 2016, PLANT DIS, V100, P1424, DOI 10.1094/PDIS-08-15-0916-RE; O'Neill R, 2018, NZ PLANT PROTECTION, V71, P30843; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; Reeser P., 2013, North American Fungi, V8, P1; Rolando C, 2014, NZ J FORESTRY SCI, V44, DOI 10.1186/s40490-014-0008-5; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Salas C, 2016, J FOREST, V114, P562, DOI 10.5849/jof.14-062; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; Wake G, 2018, ANZIAM J, V59, P1; Wingfield MJ, 2015, SCIENCE, V349, P832, DOI 10.1126/science.aac6674; Wingfield MJ, 2003, AUSTRALAS PLANT PATH, V32, P133, DOI 10.1071/AP03024; Wood S., 2017, GAMM4 GEN ADDITIVE M; Young GK, 2018, PLANT PATHOL, V67, P1539, DOI 10.1111/ppa.12856; Zangerl AR, 1979, PLANT RESISTANCE HER, P363	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216161	10.1371/journal.pone.0216161	http://dx.doi.org/10.1371/journal.pone.0216161			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136583	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300004
J	Tai, KL; Ng, YG; Lim, PY				Tai, Kwee Ling; Ng, Yee Guan; Lim, Poh Ying			Systematic review on the prevalence of illness and stress and their associated risk factors among educators in Malaysia	PLOS ONE			English	Review							LOW-BACK-PAIN; SUBJECTIVE HEALTH COMPLAINTS; SECONDARY-SCHOOL TEACHERS; MUSCULOSKELETAL DISORDERS; OCCUPATIONAL STRESS; VOICE DISORDERS	Background Despite evidence of physical (illness) and mental (stress) health problems, there appears to be a lack of studies or concern regarding occupational safety and health among educators in Malaysia. Objective To review the prevalence of illness, stress, and corresponding risk factors among educators in Malaysia. Method Scopus, ProQuest, PubMed, ScienceDirect, CAB, and other computerized databases were searched according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify studies published between January 2013 and April 2019 on the prevalence and associated risk factors of illness and stress among educators (S1 Checklist). The keywords used included educator, teacher, lecturer, academic staff, teaching profession, university staff, academician, faculty, illness, injury, disease, pain, WMSD, dysphonia, hoarseness, stress, mental health, strain, health problem, disorder, and/or Malaysia. Selected studies were evaluated by quality assessment. Results Twenty-two articles fulfilled the eligibility criteria. The prevalence of illness and stress was determined for low back pain (33.3-72.9%); upper back pain (33.33-56.4%); neck/shoulder pain (40.4-80.1%); upper arm discomfort (91.3%); forearm pain (89.6%); wrist pain (16.7-93.2%); hip pain (13.2-40.9%); thigh discomfort (91.8%); lower leg discomfort (90.5%); knee pain (23.7-88.0%); ankle/feet pain (19.3-87.7%); elbow pain (3.5-13.0%); voice disorder (10.4-13.0%) and stress (5.5-25.9%). Sex, education level, teaching experience, quality of life, anxiety, depression, coping styles, and others were reported as associated risk factors across the studies. Conclusions There appears to be a cause for concern regarding musculoskeletal disorders, voice disorder, and stress reported among educators in Malaysia. While most risk factors matched those reported in studies elsewhere, others such as school characteristics (school level, government or private school, and location [rural/urban]) have not been investigated.	[Tai, Kwee Ling; Ng, Yee Guan] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang, Selangor Darul, Malaysia; [Lim, Poh Ying] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Lim, PY (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Selangor Darul, Malaysia.	pohying_my@upm.edu.my	Lim, PY/AAO-5799-2021	Lim, PY/0000-0002-7765-4630	Geran Putra-Inisiatif Putra Siswazah (GP-IPS) from Universiti Putra Malaysia	Geran Putra-Inisiatif Putra Siswazah (GP-IPS) from Universiti Putra Malaysia	This study was supported by Geran Putra-Inisiatif Putra Siswazah (GP-IPS) from Universiti Putra Malaysia, received by Tai Kwee Ling with vote no. 9638800 and available from the website http://www.rmc.upm.edu.my/perkhidmatan/permohonan_geran_penyelidikan/geran_universiti_putra_malaysia_geran_putra-2720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Geran Putra-Inisiatif Putra Siswazah (GP-IPS) from Universiti Putra Malaysia.	Abdulmonem A, 2014, PAK J MED SCI, V30, P1191, DOI 10.12669/pjms.306.5778; Achour M, 2016, J RELIG HEALTH, V55, P1300, DOI 10.1007/s10943-015-0050-5; Aguis R., 2007, WHAT IS OCCUPATIONAL; Ahmad R, 2015, MEDITERR J SOC SCI, V6, P593, DOI DOI 10.5901/mjss.2015.v6n5p593; Akinbode R, 2014, OCCUP MED-OXFORD, V64, P382, DOI 10.1093/occmed/kqu052; Altwigry Abdulrahman Mohammed, 2017, Int J Health Sci (Qassim), V11, P59; Ariaratnam S, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0438-1; Azizah A., 2016, IJPHCS, V3, P63; Bandpei MAM, 2014, J MANIP PHYSIOL THER, V37, P702, DOI 10.1016/j.jmpt.2014.09.006; Behlau M, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.09.010; Beyen TK, 2013, OCCUPATIONAL MED HLT, V1, P1; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bogaert I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-534; Cheng HYK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2777-7; Chong EYL, 2010, INT J OCCUP SAF ERGO, V16, P23, DOI 10.1080/10803548.2010.11076825; Claudio L, 2016, J SCHOOL HEALTH, V86, P444, DOI 10.1111/josh.12398; Claus Matthias, 2014, BMC Musculoskelet Disord, V15, P55, DOI 10.1186/1471-2474-15-55; da Rocha LM, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.05.018; da Rocha LM, 2015, J VOICE, V29, P712, DOI 10.1016/j.jvoice.2014.10.011; Darwish Magdy A, 2013, Pain Res Treat, V2013, P878570, DOI 10.1155/2013/878570; Dawn S., 2016, E J PSYCHIAT, V19, P12; Devadas U, 2017, J VOICE, V31; Ehsani F, 2018, J BODYW MOV THER, V22, P64, DOI 10.1016/j.jbmt.2017.04.003; Erick PN, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-359; Ferreira AI, 2012, INT J HUM RESOUR MAN, V23, P4380, DOI 10.1080/09585192.2012.667435; Galgotra M., 2013, INT J HUMANITIES SOC, V2, P20; Ghani MZ, 2014, PROCD SOC BEHV, V114, P4, DOI 10.1016/j.sbspro.2013.12.648; Gonz?lez E.R., 2009, OSH FIGURES STRESS W; Hadi AA, 2009, SE ASIAN J TROP MED, V40, P1359; Hamjah SH, 2015, PROCD SOC BEHV, V174, P1229, DOI 10.1016/j.sbspro.2015.01.741; Huda B. Z., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P210; Ismail A, 2013, J IND ENG MANAG-JIEM, V6, P1188, DOI 10.3926/jiem.858; Ismail N, 2014, IRAN J PUBLIC HEALTH, V43, P125; Jani B., 2017, INT ED RES J, V3, P78; Kalyvea E, 2013, EUR J PSYCHOL, V9, P104, DOI 10.5964/ejop.v9i1.488; Karwan M., 2015, INT J PUBLIC HLTH CL, V2, P133; Kaur S., 2011, INT J ED PLANNING AD, V1, P2249; Korn GP, 2015, J VOICE, V29, DOI 10.1016/j.jvoice.2014.09.008; Kovac M, 2013, KINESIOLOGY, V45, P92; Kovess-Masfety V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-101; Ma YQ, 2014, FRONT AGRIC SCI ENG, V1, P62, DOI 10.15302/J-FASE-2014027; Makhbul Z. M., 2014, JURNAL PENGURUSAN, V40, P103; Moen BE, 2013, OCCUP MED-OXFORD, V63, P38, DOI 10.1093/occmed/kqs188; Mohan V, 2015, J ORTHOP SCI, V20, P410, DOI 10.1007/s00776-014-0682-4; Mohd Anuar NF, 2016, IRAN J PUBLIC HEALTH, V45, P85; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moy FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141963; Mukosolu O., 2015, MALAYSIAN J MED HLTH, V11, P27; Ng YM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6553-3; Noor A., 2016, MALAYSIAN J PUBLIC H, V16, P81; Offord DR, 2003, EVID-BASED MENT HEAL, V3, P70, DOI DOI 10.1136/EBMH.3.3.70; Othman CN, 2014, PROCD SOC BEHV, V153, P700, DOI 10.1016/j.sbspro.2014.10.101; Parker G., 2008, TECHNICAL REPORT SCI; Rajan B, 2016, INT J PHYS ED SPORTS, V3, P35; Ramprasad S, 2016, SIKKIM MANIPAL U SMU, V3, P723; Roscellalnja HAR, 2016, MALAYSIAN J PUBLIC H, V16, P89; Saleem M, 2014, ANN KING EDWARD MED, V20, P245; Salleh, 2015, ASIAN RES PUBLISHING, V10, P17881; Seibt R, 2013, INT J OCCUP MED ENV, V26, P856, DOI 10.2478/s13382-013-0161-8; Seifpanahi S, 2016, J VOICE, V30, DOI 10.1016/j.jvoice.2015.05.019; Sugumaran MNAP, 2019, INT J INNOVATIVE TEC, V8, P904; Taher Y. A, 2016, JORDAN J PHARM SCI, V9, P129, DOI [10.12816/0033311, DOI 10.12816/0033311]; UN, 2019, WORLD EC SIT PROSP 2; Van Houtte E, 2011, J VOICE, V25, P570, DOI 10.1016/j.jvoice.2010.04.008; Wee YG, 2016, INT J APPL BUSINESS, V14, P9283; Yaacob M., 2015, MEDITERR J SOC SCI, V6, P2, DOI [DOI 10.5901/mjss.2015.v6n2s1p81, 10.5901/mjss.2015.v6n2s1p81]; Yue Pengying, 2012, BMC Public Health, V12, P789, DOI 10.1186/1471-2458-12-789; Zadeh NM, 2011, INT P ECON DEV RES, V5, P442; Zamri EN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172195	69	22	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217430	10.1371/journal.pone.0217430	http://dx.doi.org/10.1371/journal.pone.0217430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136594	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000469224300040
J	Alam, MA; Shahjaman, M; Rahman, MF; Hossain, F; Deng, HW				Alam, Md. Ashad; Shahjaman, Mohammd; Rahman, Md. Ferdush; Hossain, Fokhrul; Deng, Hong-Wen			Gene shaving using a sensitivity analysis of kernel based machine learning approach, with applications to cancer data	PLOS ONE			English	Article								Background Gene shaving ( GS) is an essential and challenging tools for biomedical researchers due to the large number of genes in human genome and the complex nature of biological networks. Most GS methods are not applicable to non-linear and multi-view data sets. While the kernel based methods can overcome these problems, a well-founded positive definite kernel based GS method has yet to be proposed for biomedical data analysis. Methods and findings Since the kernel based methods on genomic information can improve the prediction of diseases, here we proposed a noble method, "kernel based gene shaving" which is based on the influence function of kernel canonical correlation analysis. To investigate the performance of the proposed method in comparison to state-of-the-art-method in gene saving, we analyzed extensive simulated and real microarray gene expression data set. The performance metrics including true positive rate, true negative rate, false positive rate, false negative rate, misclassification error rate, the false discovery rate and area under curves were computed for each methods. In colon cancer data analysis, the proposed method identified a significant subsets of 210 genes out of 2000 genes and suggestive superior performance compared with other methods. The proposed method can be applied to the study of other disease process where two view data is a common task. Conclusions We addressed the challenge of finding unique kernel based GS methods by using the influence function of kernel canonical correlation analysis. The proposed method has shown to have better performance than state-of-the-art-methods in gene saving and has identified many more significant gene interactions, suggesting that genes function in a concerted effort in colon cancer. In similar biomedical data analysis, kernel based methods could be applied to select a potential subset of genes. The positive definite kernel based methods can overcome the non-linearity problem and improve the prediction process.	[Alam, Md. Ashad; Deng, Hong-Wen] Tulane Univ, Tulane Ctr Bioinformat & Genom, Dept Global Biostat & Data Sci, New Orleans, LA 70112 USA; [Alam, Md. Ashad] Hajee Mohammad Danesh Sci & Technol Univ, Dept Stat, Dinajpur 5200, Bangladesh; [Shahjaman, Mohammd] Begum Rokeya Univ, Dept Stat, Rangpur 5400, Bangladesh; [Rahman, Md. Ferdush] Begum Rokeya Univ, Dept Mkt, Rangpur 5400, Bangladesh; [Hossain, Fokhrul] Louisiana State Univ, Dept Genet, Stanley S Scott Canc Ctr, LSU Hlth Sci Ctr, New Orleans, LA 70112 USA	Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Alam, MA (corresponding author), Tulane Univ, Tulane Ctr Bioinformat & Genom, Dept Global Biostat & Data Sci, New Orleans, LA 70112 USA.; Alam, MA (corresponding author), Hajee Mohammad Danesh Sci & Technol Univ, Dept Stat, Dinajpur 5200, Bangladesh.	malam@tulane.edu			National Institutes of Health [R01AR057049, R01AR059781, P20 GM109036, R01MH107354, R01MH104680, R01GM109068, U19AG055373, R01AR069055]; Edward G. Schlieder Endowment fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069055, R01AR059781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109036, R01GM109068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107354, R01MH104680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG055373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward G. Schlieder Endowment fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Our research was partially supported by grants from the National Institutes of Health [R01AR057049, R01AR059781, P20 GM109036, R01MH107354, R01MH104680, R01GM109068, U19AG055373, and R01AR069055], and the Edward G. Schlieder Endowment fund to Tulane University.	Akaho S., 2001, INT M PSYCH SOC, P321; Alam Ashad, 2008, 2008 11th International Conference on Computer and Information Technology (ICCIT), P399, DOI 10.1109/ICCITECHN.2008.4802966; Alam M.A., 2014, J COMPUTER SCI, V10, P1139, DOI DOI 10.3844/JCSSP.2014.1139.1150; Alam MA, 2018, NEUROCOMPUTING, V304, P12, DOI 10.1016/j.neucom.2018.04.008; Alam MA, 2016, PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P210, DOI 10.1145/2975167.2975189; Alam MA, 2015, INT J PATTERN RECOGN, V29, DOI 10.1142/S0218001415510052; Alam MA, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P374, DOI 10.1109/ICMLA.2013.76; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alzate C, 2008, NEURAL NETWORKS, V21, P170, DOI 10.1016/j.neunet.2007.12.047; [Anonymous], 2016, FUNDAMENTALS BIOSTAT; ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Castellanos-Garzon JA, 2015, ADCAIJ-ADV DISTRIB C, V4, P1; Charpiat G, 2015, KERNEL METHODS MED I; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Debruyne M, 2010, COMPUT STAT DATA AN, V54, P3007, DOI 10.1016/j.csda.2009.08.018; Filzmoser P, 2008, COMPUT STAT DATA AN, V52, P1694, DOI 10.1016/j.csda.2007.05.018; Fukumizu K., 2009, ADV NEURAL INFORM PR, P1750; Gretton A., 2008, ADV NEURAL INFORM PR, P585; Hampel F., 2011, ROBUST STAT APPROACH; Hastie T, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-2-RESEARCH0003; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SY, 2009, J STAT PLAN INFER, V139, P2162, DOI 10.1016/j.jspi.2008.10.011; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Richfield O, 2016, IEEE INT C BIOINFORM, P507, DOI 10.1109/BIBM.2016.7822570; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROMANAZZI M, 1992, PSYCHOMETRIKA, V57, P237, DOI 10.1007/BF02294507; Ruan LY, 2011, BIOMETRICS, V67, P1617, DOI 10.1111/j.1541-0420.2011.01602.x; Sheng JH, 2011, IEEE ACM T COMPUT BI, V8, P1568, DOI 10.1109/TCBB.2011.71; Song L, 2012, J MACH LEARN RES, V13, P1393; Szklarczyk D, 2007, NUCLEIC ACIDS RES, V43, P531; TANAKA Y, 1989, COMMUN STAT THEORY, V18, P3991, DOI 10.1080/03610928908830137; TANAKA Y, 1988, COMMUN STAT-THEOR M, V17, P3157, DOI 10.1080/03610928808829796; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217027	10.1371/journal.pone.0217027	http://dx.doi.org/10.1371/journal.pone.0217027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120939	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700050
J	Baugh, CW; Faridi, MK; Mueller, EL; Camargo, CA; Pallin, DJ				Baugh, Christopher W.; Faridi, Mohammad Kamal; Mueller, Emily L.; Camargo, Carlos A., Jr.; Pallin, Daniel J.			Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia	PLOS ONE			English	Article							MANAGEMENT; GUIDELINE; SOCIETY; CARE	Importance Febrile neutropenia (FN) is the most common oncologic emergency and is among the most deadly. Guidelines recommend risk stratification and outpatient management of both pediatric and adult FN patients deemed to be at low risk of complications or mortality, but our prior single-center research demonstrated that the vast majority (95%) are hospitalized. Objective From a nationwide perspective, to determine the proportion of cancer patients of all ages hospitalized after an emergency department (ED) visit for FN, and to analyze variability in hospitalization rates. Our a priori hypothesis was that >90% of US cancer-associated ED FN visits would end in hospitalization. Design Analysis of data from the Nationwide Emergency Department Sample, 2006-2014. Setting Stratified probability sample of all US ED visits. Participants Inclusion criteria were: (1) Clinical Classification Software code indicating cancer, (2) diagnostic code indicating fever, and (3) diagnostic code indicating neutropenia. We excluded visits ending in transfer. Exposure The hospital at which the visit took place. Main outcomes and measures Our main outcome is the proportion of ED FN visits ending in hospitalization, with an a priori hypothesis of >90%. Our secondary outcomes are: ( a) hospitalization rates among subsets, and ( b) proportion of variability in the hospitalization rate attributable to which hospital the patient visited, as measured by the intra-class correlation coefficient ( ICC). Results Of 348,868 visits selected to be representative of all US ED visits, 94% ended in hospitalization ( 95% Confidence Interval [CI] 93-94%). Each additional decade of age conferred 1.23x increased odds of hospitalization. Those with private ( 92%), self-pay ( 92%), and other ( 93%) insurance were less likely to be hospitalized than those with public insurance ( 95%, odds ratios [OR] 0.74-0.76). Hospitalization was least likely at non-metropolitan hospitals ( 84%, OR 0.15 relative to metropolitan teaching hospitals), and was also less likely at metropolitan non-teaching hospitals ( 94%, OR 0.64 relative to metropolitan teaching hospitals). The ICC adjusted for hospital random effects and patient and hospital characteristics was 26% ( 95% CI 23-29%), indicating that 26% of the variability in hospitalization rate was attributable to which hospital the patient visited. Conclusions and relevance Nearly all cancer-associated ED FN visits in the US end in hospitalization. Inter-hospital variation in hospitalization practices explains 26% of the limited variability in hospitalization decisions. Simple, objective tools are needed to improve risk stratification for ED FN patients.	[Baugh, Christopher W.; Pallin, Daniel J.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Baugh, Christopher W.; Camargo, Carlos A., Jr.; Pallin, Daniel J.] Harvard Med Sch, Boston, MA 02115 USA; [Faridi, Mohammad Kamal; Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Mueller, Emily L.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington	Baugh, CW (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.; Baugh, CW (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	cbaugh@bwh.harvard.edu	Baugh, Christopher William/AAJ-3688-2021; Camargo, Carlos A./C-2145-2008	Baugh, Christopher William/0000-0002-2360-1891; Camargo, Carlos A./0000-0002-5071-7654				Baugh CW, 2017, ACAD EMERG MED, V24, P83, DOI 10.1111/acem.13079; Baugh CWBG, 2016, NEW ENGL REG SAEM M; Baughmd CW, 2016, AM J EMERG MED, V34, P1704, DOI 10.1016/j.ajem.2016.05.047; Bitar Roger A, 2015, Perm J, V19, P37, DOI 10.7812/TPP/14-188; Brown J, 2016, ANN EMERG MED, V68, P706, DOI 10.1016/j.annemergmed.2016.01.021; Del Greco Maurizio, 2003, Ital Heart J, V4, P99; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Greene J, 2015, ANN EMERG MED, V66, p13A, DOI 10.1016/j.annemergmed.2015.05.015; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Lehrnbecher T, 2017, J CLIN ONCOL, V35, P2082, DOI 10.1200/JCO.2016.71.7017; Mueller EL, 2015, PEDIATR BLOOD CANCER, V62, P490, DOI 10.1002/pbc.25288; Rivera DR, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2450; Weycker D, 2014, J ONCOL PHARM PRACT, V20, P190, DOI 10.1177/1078155213492450	14	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216835	10.1371/journal.pone.0216835	http://dx.doi.org/10.1371/journal.pone.0216835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120893	Green Published, gold			2022-12-27	WOS:000468775700031
J	Kim, J; Choi, KB; Park, JH; Kim, KH				Kim, Jungyeon; Choi, Kum-Boo; Park, Ju Hun; Kim, Kyoung Heon			Metabolite profile changes and increased antioxidative and antiinflammatory activities of mixed vegetables after fermentation by Lactobacillus plantarum	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CANCER-CELL-PROLIFERATION; FUNCTIONAL FOODS; STARTER CULTURES; GABA; PROBIOTICS; STRAINS; LACTATE; MODEL	Fermented vegetables have emerged as prebiotics with various health benefits. However, the possible mechanisms behind their health benefits are unclear. To relate the metabolite profile changes in fermented mixed vegetables with associated health benefits of fermented vegetables, we analyzed the metabolite profiles of mixed vegetables, before and after fermentation by Lactobacillus plantarum, using gas chromatography/time-of-flight-mass spectrometry (GC/TOF-MS). To analyze health benefits of fermented vegetables, antioxidative and antiinflammatory activities were measured using RAW 264.7 cells. Among 78 metabolites identified by GC/TOF-MS in this study, those significantly increased after fermentation include antioxidative and/or antiinflammatory agents such as lactate, 3-phennyllactate, indole-3-lactate, beta-hydroxybutyrate, gamma-aminobutyrate, and glycerol. These metabolites may have been either newly synthesized or depolymerized from high molecular weight polymers from vegetables during fermentation. This is the first metabolomics study to relate metabolite profile changes with increased health benefits of fermented vegetables.	[Kim, Jungyeon; Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea; [Choi, Kum-Boo; Park, Ju Hun] Pulmuone, Pulmuone Inst Technol, Seoul, South Korea	Korea University	Kim, KH (corresponding author), Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea.	khekim@korea.ac.kr	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668	Pulmuone Institute of Technology (Keybase fermented vegetables extract), Pulmuone, Seoul, South Korea; National Research Foundation of Korea - Korean Government (MIST) [NRF-2017R1A2B2005628]; Advanced Biomass R&D Center of Global Frontier Project - Korean Government (MIST) [2011-0031359]; Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall	Pulmuone Institute of Technology (Keybase fermented vegetables extract), Pulmuone, Seoul, South Korea; National Research Foundation of Korea - Korean Government (MIST); Advanced Biomass R&D Center of Global Frontier Project - Korean Government (MIST); Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall	This work was supported by the Pulmuone Institute of Technology (Keybase fermented vegetables extract), Pulmuone, Seoul, South Korea. The analysis of metabolome was supported by the Mid-career Researcher Program (NRF-2017R1A2B2005628) from the National Research Foundation of Korea and the Advanced Biomass R&D Center of Global Frontier Project (2011-0031359), both funded by the Korean Government (MIST), and also by the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HR, 2016, ONCOTARGET, V7, P66444, DOI 10.18632/oncotarget.12119; Baek JG, 2010, BIOSCI BIOTECH BIOCH, V74, P1860, DOI 10.1271/bbb.100269; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Beganovic J, 2011, J FOOD SCI, V76, pM124, DOI 10.1111/j.1750-3841.2010.02030.x; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Deng Y, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-190; Douglas LC, 2008, J AM DIET ASSOC, V108, P510, DOI 10.1016/j.jada.2007.12.009; Fedotcheva NI, 2008, TOXICOL LETT, V180, P182, DOI 10.1016/j.toxlet.2008.06.861; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Goffin P, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.67; Granato D, 2010, COMPR REV FOOD SCI F, V9, P292, DOI 10.1111/j.1541-4337.2010.00110.x; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Haraguchi T, 2014, J AGR FOOD CHEM, V62, P5589, DOI 10.1021/jf501142k; Jia JH, 2010, APPL BIOCHEM BIOTECH, V162, P242, DOI 10.1007/s12010-009-8767-9; Jung JY, 2012, INT J FOOD MICROBIOL, V153, P378, DOI 10.1016/j.ijfoodmicro.2011.11.030; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Koletzko B, 1998, BRIT J NUTR, V80, pS5, DOI 10.1079/BJN19980104; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Lee MH, 2012, FOOD MICROBIOL, V31, P210, DOI 10.1016/j.fm.2012.04.002; Lerch MM, 2014, GASTROENTEROLOGY, V146, P1602, DOI 10.1053/j.gastro.2014.04.025; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; MADSEN HL, 1995, TRENDS FOOD SCI TECH, V6, P271, DOI 10.1016/S0924-2244(00)89112-8; Neves AL, 2015, CURR OPIN PHARMACOL, V25, P36, DOI 10.1016/j.coph.2015.09.013; Oh CH, 2004, J MED FOOD, V7, P19, DOI 10.1089/109662004322984653; Oh YC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-17; Park HD, 2001, BIOTECHNOL LETT, V23, P1583, DOI 10.1023/A:1011921427581; Patel S, 2012, 3 BIOTECH, V2, P115, DOI 10.1007/s13205-012-0044-x; Poeggeler B, 1999, BRAIN RES, V815, P382, DOI 10.1016/S0006-8993(98)01027-0; RUIZBARBA JL, 1994, APPL ENVIRON MICROB, V60, P2059, DOI 10.1128/AEM.60.6.2059-2064.1994; SHAHIDI F, 1992, CRIT REV FOOD SCI, V32, P67, DOI 10.1080/10408399209527581; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Skogerson K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-321; Spence JT, 2006, J FOOD COMPOS ANAL, V19, pS4, DOI 10.1016/j.jfca.2005.11.007; Stanton C, 1998, INT DAIRY J, V8, P491, DOI 10.1016/S0958-6946(98)00080-6; Sun YP, 2009, FOOD CHEM, V115, P912, DOI 10.1016/j.foodchem.2008.12.097; Swain Manas Ranjan, 2014, Biotechnol Res Int, V2014, P250424, DOI 10.1155/2014/250424; Szel E, 2015, J EUR ACAD DERMATOL, V29, P2333, DOI 10.1111/jdv.13225; Tamang JP, 2009, INT J FOOD MICROBIOL, V135, P28, DOI 10.1016/j.ijfoodmicro.2009.07.016; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tripathi MK, 2014, J FUNCT FOODS, V9, P225, DOI 10.1016/j.jff.2014.04.030; Valerio F, 2004, FEMS MICROBIOL LETT, V233, P289, DOI [10.1016/j.femsle.2004.02.020, 10.1111/j.1574-6968.2004.tb09494.x]; Vaughan RA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-14; WADA S, 1992, J FOOD PROCESS PRES, V16, P263, DOI 10.1111/j.1745-4549.1992.tb00207.x; WARD OP, 1989, CRIT REV BIOTECHNOL, V8, P237, DOI 10.3109/07388558909148194; Winter CK, 2006, J FOOD SCI, V71, pR117, DOI 10.1111/j.1750-3841.2006.00196.x	49	6	6	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217180	10.1371/journal.pone.0217180	http://dx.doi.org/10.1371/journal.pone.0217180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116776	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400050
J	Packer, RMA; Davies, AM; Volk, HA; Puckett, HL; Hobbs, SL; Fowkes, RC				Packer, Rowena M. A.; Davies, Alexander M.; Volk, Holger A.; Puckett, Holly L.; Hobbs, Sarah L.; Fowkes, Robert C.			What can we learn from the hair of the dog? Complex effects of endogenous and exogenous stressors on canine hair cortisol	PLOS ONE			English	Article							SALIVARY CORTISOL; EPILEPSY; REACTIVITY; PITUITARY; TESTS; CATS	Hair is an emerging biological matrix in which to measure chronic HPA axis activity, offering a longer term view into an animal's life. We explored effects of exogenous (e.g. lifestyle, medications, social environment) and endogenous (e.g. disease, behaviour) stressors on hair cortisol concentration (HCC) in a population of Border Collies (BCs). Owners of BCs were recruited and reported their dog's lifestyle, clinical history, anxiety-related behaviour, and collected a white hair sample from their dog's dorsal neck region. HCC was determined using established methods with a commercial cortisol assay kit. Samples from 135 BCs were analysed, with 91 healthy controls and 44 diagnosed with epilepsy as a model disease. Factors associated with higher HCC included psychosocial stressors (living with three or more other dogs) and lifestyle (engaging in competitive flyball); while factors associated with lower HCC included anxiety (stranger-directed and non-social), health (epilepsy diagnosis, with number of seizures to date negatively correlated with HCC) and medication (certain anti-epileptic drugs were associated with elevated or reduced HCC). These novel results highlight the potential of chronic stress with frequent or persisting HPA-axis hyperactivity leading to a state of hypocortisolism, and the need to consider stressor recency and recurrence when interpreting HCC data.	[Packer, Rowena M. A.; Davies, Alexander M.; Volk, Holger A.; Puckett, Holly L.; Hobbs, Sarah L.] Royal Vet Coll, Clin Sci & Serv, Hawkshead Lane, N Mymms, Herts, England; [Fowkes, Robert C.] Royal Vet Coll, Endocrine Signalling Grp, Royal Coll St, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Packer, RMA (corresponding author), Royal Vet Coll, Clin Sci & Serv, Hawkshead Lane, N Mymms, Herts, England.	rpacker@rvc.ac.uk	Fowkes, Robert/HHT-0664-2022; Volk, Holger Andreas/B-9965-2011; Fowkes, Robert/AAI-4756-2020	Volk, Holger Andreas/0000-0002-7312-638X; Fowkes, Robert/0000-0002-2222-2056; Packer, Rowena/0000-0002-9988-9828	2018 Animal Welfare Student Scholarship, Universities Federation for Animal Welfare (UFAW); BBSRC [BB/P010881/1]; BBSRC [BB/P001874/1] Funding Source: UKRI	2018 Animal Welfare Student Scholarship, Universities Federation for Animal Welfare (UFAW); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the 2018 Animal Welfare Student Scholarship, Universities Federation for Animal Welfare (UFAW) awarded to AD, supervised by RMAP and RCF. RMAP is funded by BBSRC grant number BB/P010881/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; Agnew RCN, 2016, J WILDLIFE DIS, V52, P459, DOI 10.7589/2015-09-231; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bennett A, 2010, DOMEST ANIM ENDOCRIN, V39, P171, DOI 10.1016/j.domaniend.2010.04.003; Berendt M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0461-2; Bryan HM, 2013, J AM ASSOC LAB ANIM, V52, P189; Carrier LO, 2013, APPL ANIM BEHAV SCI, V146, P96, DOI 10.1016/j.applanim.2013.04.002; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHAUVET AE, 1995, J AM VET MED ASSOC, V207, P1305; Cobb ML, 2016, DOMEST ANIM ENDOCRIN, V57, P31, DOI 10.1016/j.domaniend.2016.04.003; Colussi A, 2018, ITAL J ANIM SCI, V17, P1030, DOI [10.1080/1828051X.2018.1453756, 10.1080/1828051x.2018.1453756]; Corradini S, 2013, J VET INTERN MED, V27, P1268, DOI 10.1111/jvim.12135; Dreschel NA, 2005, APPL ANIM BEHAV SCI, V95, P153, DOI 10.1016/j.applanim.2005.04.009; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; DYER KR, 1994, J AM VET MED ASSOC, V205, P315; Fadel FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22162; Fowkes RC, 2013, PSYCHONEUROENDOCRINO, V38, P722, DOI 10.1016/j.psyneuen.2012.08.003; GALLAGHER BB, 1984, EPILEPSIA, V25, P683, DOI 10.1111/j.1528-1157.1984.tb03477.x; Giannetto C, 2014, J APPL BIOMED, V12, P229, DOI 10.1016/j.jab.2014.01.009; Grigg Emma K, 2017, Vet Rec Open, V4, pe000193, DOI 10.1136/vetreco-2016-000193; Heske L, 2014, VET J, V202, P471, DOI 10.1016/j.tvjl.2014.09.023; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Hulsmeyer V, 2010, J VET INTERN MED, V24, P171, DOI 10.1111/j.1939-1676.2009.0438.x; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kudielka B M, 2006, G Ital Med Lav Ergon, V28, P34; MULLER PB, J VET INTERNAL MED, V14, P157, DOI DOI 10.1111/J.1939-1676.2000; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Nicholson SL, 2015, J VET BEHAV, V10, P489, DOI 10.1016/j.jveb.2015.09.002; Nicolson NA, 2000, J PSYCHOSOM RES, V49, P335, DOI 10.1016/S0022-3999(00)00166-5; Packer R, 2017, 30 ESVN ECVN ANN S 2; Packer RMA, 2017, PHYSIOL BEHAV, V177, P27, DOI 10.1016/j.physbeh.2017.04.008; Park SH, 2016, JPN J VET RES, V64, P123, DOI 10.14943/jjvr.64.2.123; RAO ML, 1989, NEUROENDOCRINOLOGY, V49, P33, DOI 10.1159/000125088; Riemer S, 2016, APPL ANIM BEHAV SCI, V180, P78, DOI 10.1016/j.applanim.2016.04.021; Roth LSV, 2016, SCI REP-UK, V6, DOI 10.1038/srep19631; Selye H, 1950, PHYSL PATHOLOGY EXPO; Selye H., 1985, BASAL FACTS, V7; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Siniscalchi M, 2013, RES VET SCI, V94, P49, DOI 10.1016/j.rvsc.2012.02.017; Slotta-Bachmayr L, 2007, WIEN TIERARZTL MONAT, V94, P110; Stavropoulos I, 2017, EPILEPSY BEHAV, V68, P146, DOI 10.1016/j.yebeh.2016.12.015; Steudte S, 2011, PSYCHIAT RES, V186, P310, DOI 10.1016/j.psychres.2010.09.002; Steudte-Schmiedgen S, 2017, J PSYCHIATR RES, V84, P184, DOI 10.1016/j.jpsychires.2016.09.024; Trivisano M, 2017, EPILEPSIA, V58, pE91, DOI 10.1111/epi.13772; van Campen JS, 2016, BRAIN, V139, P1673, DOI 10.1093/brain/aww071; van Campen JS, 2015, EPILEPSY BEHAV, V47, P132, DOI 10.1016/j.yebeh.2015.04.071; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	49	12	12	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216000	10.1371/journal.pone.0216000	http://dx.doi.org/10.1371/journal.pone.0216000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116735	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000468607400014
J	Saeed, W; Naseem, S; Gohar, D; Ali, Z				Saeed, Wajeeha; Naseem, Saadia; Gohar, Daniyal; Ali, Zahid			Efficient and reproducible somatic embryogenesis and micropropagation in tomato via novel structures - Rhizoid Tubers	PLOS ONE			English	Article							LYCOPERSICON-ESCULENTUM-MILL; AGROBACTERIUM-MEDIATED TRANSFORMATION; VITRO SHOOT REGENERATION; PLANT-GROWTH REGULATORS; IN-VITRO; LEAF EXPLANTS; MICRO-TOM; ORGANOGENESIS; CULTURE; CALLUS	A dual in vitro regeneration system consisting of indirect organogenesis and somatic embryogenesis (SE), applicable to several varieties of tomato-Solanum lycopersicum (cv. Riogrande, cv. Roma, hybrid 17905 and model cv. M82) has been established. This system is both improved and highly reproducible compared to current methods. Callus initiation, plant regeneration and SE was developed for one-week-old cotyledon explants. Indirect organogenesis via callus induction (CI) was developed for all four varieties of tomato used in this study. One-week-old tomato seedlings were used as a source of cotyledon and hypocotyl segments as explants. The explants were subsequently cultured on Murashige and Skoog (MS) medium supplemented with different combination and concentrations of plant growth regulators (PGRs). Substantial trends in regeneration and propagation response were observed among the varieties and treatments. For commercial varieties cvs. Riogrande and Roma, maximum CI was observed at 2 weeks in CIMT9 (0.5 mg/L NAA, 1 mg/L BAP) and CIMT12 (2 mg/L IAA, 2 mg/L NAA, 2 mg/L BAP, 4 mg/L KIN). However, cv. M82 responded after 4 weeks to a combination of treatments CIMT9 (0.5 mg/L NAA + 1 mg/L BAP) and CIMT13 (2 mg/L IAA + 2 mg/L NAA + 2 mg/L BAP + 4 mg/L ZEA) for the production of calli. Subsequent shoot and root organogenesis were optimized for all four varieties. Cv. Riogrande, exhibited fastidious in vitro regeneration potential and selected for induction of somatic embryos via SE involving novel structure: rhizoid tubers (RTBs). Numerous fine hair like rhizoids (similar to 23/explants) were first developed from cotyledon and hypocotyl explants cultured on MS medium supplemented with 0.5 or 2 mg/L NAA at pH 4.0 in dark conditions. Further incubation of each rhizoid under light conditions on MS media supplemented with 5 mg/L TDZ or BAP at pH 4.0 led to the formation of a novel structure-rhizoid Tubers (RTBs). Thus, as evident from histology, SE in Riogrande tomato species requires a medium with pH of (4.0) and higher concentration of cytokinins (BAP/TDZ) to form on average 40-45 RTBs from both explants. Histological and morphological studies revealed that RTBs develop through different stages of embryogenesis to multiple plantlets, on MS medium with 5 mg/L TDZ/BAP at normal pH (5.8). The results obtained indicated that the induced somatic embryos of tomato with lower pH are a more efficient mode of propagation than the organogenesis with or without callus formation. The RTBs led to a complete plantlets regeneration in 45 days compared to indirect organogenesis at 60 days.	[Saeed, Wajeeha; Naseem, Saadia; Gohar, Daniyal; Ali, Zahid] CUI, Dept Biosci, Pk Rd, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Ali, Z (corresponding author), CUI, Dept Biosci, Pk Rd, Islamabad, Pakistan.	zahidali@comsats.edu.pk	Ali, Zahid/AAE-7458-2021; Gohar, Daniyal/AAJ-2843-2021	Gohar, Daniyal/0000-0003-0312-1142; Ali, Zahid/0000-0003-3935-6816; Naseem, Saadia/0000-0003-4464-1486	Higher Education Commission (HEC), Pakistan [2BM2-161]	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan)	WS is highly thankful to the Higher Education Commission (HEC), Pakistan for providing financial support under the HEC Indigenous Ph.D. Scholarship Program (2BM2-161).	Afroz A, 2011, PLANT CELL TISS ORG, V104, P227, DOI 10.1007/s11240-010-9825-2; Andersone U., 2008, ACTA UNILATV, V745, P25; Arah I.K., 2016, ADV AGR, V2016, P1, DOI DOI 10.1155/2016/6436945; Ascencio-Cabral A, 2008, SCI HORTIC-AMSTERDAM, V118, P155, DOI 10.1016/j.scienta.2008.06.014; BEHKI RM, 1980, Z PFLANZENPHYSIOL, V98, P83, DOI 10.1016/S0044-328X(80)80222-4; Bhatia P, 2004, PLANT CELL TISS ORG, V78, P1, DOI 10.1023/B:TICU.0000020430.08558.6e; Bhatia S., 2015, MODERN APPL PLANT BI, P209, DOI [10.1016/B978-0-12-802221-4.00006-6, DOI 10.1016/B978-0-12-802221-4.00006-6]; Botau D., 2002, Cercetari Stiintifice - Facultatea de Horticultura, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului, Timisoara. Seria A: Biotehnologie si Biodiversitate, P57; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; CHEE RP, 1989, J PLANT PHYSIOL, V135, P398, DOI 10.1016/S0176-1617(89)80094-X; Chen LZ, 1994, BREEDING SCI, V44, P337; COMPTON ME, 1991, PLANT CELL TISS ORG, V24, P223, DOI 10.1007/BF00033481; COOKE TJ, 1993, PLANT CELL, V5, P1494, DOI 10.1105/tpc.5.11.1494; Costa G. M., 2000, Ciencia e Agrotecnologia, V24, P671; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; Deo P. C., 2010, The South Pacific Journal of Natural and Applied Sciences, V28, P27, DOI 10.1071/SP10002; DUBOIS T, 1990, ANN BOT-LONDON, V65, P539, DOI 10.1093/oxfordjournals.aob.a087967; Durzan D., 1984, HDB PLANT CELL CULTU, V2, P471; Duzyaman E., 1994, Acta Horticulturae, P235; Farhan A, 2010, POSTHARVEST LOSSES T, V8, P97; Foolad MR, 2007, INT J PLANT GENOM, V2007, P97386, DOI DOI 10.1155/2007/97386; Frary A, 1996, PLANT CELL REP, V16, P235, DOI 10.1007/BF01890875; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Gerszberg A, 2015, PLANT CELL TISS ORG, V120, P881, DOI 10.1007/s11240-014-0664-4; Gill R, 1995, J PLANT PHYSIOL, V147, P273, DOI 10.1016/S0176-1617(11)81518-X; Godishala V., 2011, J CELL TISS RES, V11, P2521; Gow WP, 2009, ACTA PHYSIOL PLANT, V31, P363, DOI 10.1007/s11738-008-0243-6; Guan ZJ, 2012, PHYTON-INT J EXP BOT, V81, P51; Gubis J., 2003, IN VITRO, V39, P9; Gubis J, 2004, EFFECT GROWTH REGULA, P405; HAMZA S, 1993, J EXP BOT, V44, P1837, DOI 10.1093/jxb/44.12.1837; Helminger Martins, 2016, STAT BOOKS, DOI [10.2785/917017, DOI 10.2785/917017]; HSIAO AI, 1984, WEED RES, V24, P411, DOI 10.1111/j.1365-3180.1984.tb00604.x; Hu W, 2001, IN VITRO CELL DEV-PL, V37, P12, DOI 10.1007/s11627-001-0003-4; Hutchinson MJ, 1996, J PLANT PHYSIOL, V149, P573, DOI 10.1016/S0176-1617(96)80336-1; Hutchinson MJ, 1996, PLANT CELL REP, V15, P512, DOI 10.1007/BF00232984; Ishag S, 2009, INT J SUSTAIN CROP P, V6, P7; Jimenez Victor M., 2001, Revista Brasileira de Fisiologia Vegetal, V13, P196, DOI 10.1590/S0103-31312001000200008; Jimenez VM, 2005, PLANT GROWTH REGUL, V47, P91, DOI 10.1007/s10725-005-3478-x; Kaparakis G, 2002, J HORTIC SCI BIOTECH, V77, P186, DOI 10.1080/14620316.2002.11511477; KARTHA KK, 1976, Z PFLANZENPHYSIOL, V77, P292, DOI 10.1016/S0044-328X(76)80002-5; Mencarelli F, 2005, P 5 INT POSTH S VER; Mendez-Hernandez HA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00077; Mirghis E, 1995, ACTA HORTIC, V412, P111; Moghaieb REA, 1999, SOIL SCI PLANT NUTR, V45, P639, DOI 10.1080/00380768.1999.10415827; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naik PM, 2010, PLANT CELL TISS ORG, V100, P235, DOI 10.1007/s11240-009-9639-2; Newman PG, 1996, INT J PLANT SCI, V157, P554, DOI 10.1086/297375; Ning GG, 2007, HORTSCIENCE, V42, P744, DOI 10.21273/HORTSCI.42.3.744; NOVER L, 1982, BIOCHEM PHYSIOL PFL, V177, P483, DOI 10.1016/S0015-3796(82)80041-3; OHKI S, 1978, PLANT CELL PHYSIOL, V19, P27; Osman MG, 2010, AFR J BIOTECHNOL, V9, P4407; Park SH, 2003, J PLANT PHYSIOL, V160, P1253, DOI 10.1078/0176-1617-01103; Pathi KM, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24354; Pinto G, 2013, SOUTH FORESTS, V75, P59, DOI 10.2989/20702620.2013.785115; Plastira VA, 1997, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.1997.447.47; Poonam Bhatia, 2005, Biotechnology, V4, P7; Raiola A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/139873; Rodriguez-Sahagun A, 2011, PLANT CELL TISS ORG, V104, P271, DOI 10.1007/s11240-010-9815-4; Saeed W, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01487; Shah SH, 2015, J ANIM PLANT SCI, V25, P528; Shikata M, 2016, METHODS MOL BIOL, V1363, P47, DOI 10.1007/978-1-4939-3115-6_5; Siddique AB, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977209; SMITH DL, 1990, AM J BOT, V77, P1634, DOI 10.2307/2444495; Sofiari E, 1997, PLANT CELL TISS ORG, V50, P45, DOI 10.1023/A:1005844414258; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Sun S, 2015, BIOTECHNOL BIOTEC EQ, V29, P861, DOI 10.1080/13102818.2015.1056753; The Federal Committee On Agriculture (FCA) TFCOA, 2015, GOV PAK WORK PAP M F; Trujillo-Moya C, 2014, TURK J BOT, V38, P465, DOI 10.3906/bot-1305-16; Victor JMR, 1999, PLANT GROWTH REGUL, V28, P41, DOI 10.1023/A:1006251531319; Vinoth S, 2014, J APPL PHYCOL, V26, P1527, DOI 10.1007/s10811-013-0151-z; Von Aderkas P, 2000, TREE PHYSIOL, V20, P921; Wilkinson S, 1999, PLANT GROWTH REGUL, V29, P87, DOI 10.1023/A:1006203715640; WILLIAMS EG, 1986, ANN BOT-LONDON, V57, P443, DOI 10.1093/oxfordjournals.aob.a087127; Wu YL, 2017, PLANTA, V245, P583, DOI 10.1007/s00425-016-2625-0; Xu KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep08823; Xu KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19811; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098672; Yang XY, 2012, PLANT CELL TISS ORG, V109, P213, DOI 10.1007/s11240-011-0087-4; YOUNG R, 1987, PLANT SCI, V52, P237, DOI 10.1016/0168-9452(87)90057-4; ZAMIR D, 1980, PLANT SCI LETT, V17, P353, DOI 10.1016/0304-4211(80)90168-6; Zhang W, 2012, BIOSCI METHODS, P3, DOI [10.5376/bm.2012.03.0004, DOI 10.5376/BM.2012.03.0004]	82	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215929	10.1371/journal.pone.0215929	http://dx.doi.org/10.1371/journal.pone.0215929			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116740	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400013
J	Zhang, R; Ling, L; Han, DL; Wang, HT; Yu, GL; Jiang, L; Li, D; Chang, ZY				Zhang, Rui; Ling, Lei; Han, Dianlei; Wang, Haitao; Yu, Guolong; Jiang, Lei; Li, Dong; Chang, Zhiyong			FEM analysis in excellent cushion characteristic of ostrich (Struthio camelus) toe pads	PLOS ONE			English	Article							FOOT; HEAD; ANATOMY; TISSUE	African ostrich (Struthio camelus) is the largest and fastest extent bipedal animal. The ostrich mainly relies on the 3rd toe to support the entire body under high-speed motion. The short and severe impact concentrated on the limited area would produce tremendous momentary internal stress and strain, which may contribute to the phalanges disloaction, soft tissue damage and the like. The vibration and excessive negative acceleration caused by the ground reaction force also affect the stability of the touching process. Therefore, ostrich toe pads are required to have excellent cushion characteristics. However, current studies often explains the cushion properties by analyzing the macro-microscopic structure of the pad organism, and there is a paucity of research on its biomechanical behaviour. Consequently, from the perspective of multi-layer structure and biomaterial assembly, this study aims to explain the biomechanical characteristics of the ostrich toe pads by FEM (Finite Element Method) analysis. Based on results, we deem that the ostrich toe pad could absorb energy and reduce vibration effectively. Firstly, the multi-layer structure of the pads make the stress and strain decay from outside to inside. Secondly, the minimal response frequency of the pad is 164.22 Hz, making it effectively avoid resonance phenomenon. Finally, the composite material model has the best performance in decreasing the negative acceleration peak value, the impact force peak value and the maximal equivalent stress value at velocities of 0.669 m/s and 1.339 m/s. These results help to further understand the buffer mechanism of the ostrich toe pad, and also have important inter-species reference value for the pathogenesis of human foot soft tissue injury.	[Zhang, Rui; Ling, Lei; Han, Dianlei; Wang, Haitao; Yu, Guolong; Chang, Zhiyong] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun, Jilin, Peoples R China; [Jiang, Lei] China North Vehicle Res Inst, Beijing, Peoples R China; [Li, Dong] Beijing Inst Spacecraft Environm Engn, Beijing, Peoples R China	Jilin University	Zhang, R; Chang, ZY (corresponding author), Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun, Jilin, Peoples R China.	zhangrui@jlu.edu.cn; zychang@jlu.edu.cn		Zhang, Rui/0000-0001-9933-2475	National Natural Science Foundation of China [51675221, 91748211]; Science and Technology Development Planning Project of Jilin Province of China [20180101077JC]; Science and Technology Research Project in the 13th FiveYear Period of Education Department of Jilin Province [JJKH20190134KJ]; Graduate Innovation Fund of Jilin University [101832018C006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Jilin Province of China; Science and Technology Research Project in the 13th FiveYear Period of Education Department of Jilin Province; Graduate Innovation Fund of Jilin University(Jilin University)	This work was supported by: National Natural Science Foundation of China (No. 51675221, 91748211); Science and Technology Development Planning Project of Jilin Province of China (No. 20180101077JC); Science and Technology Research Project in the 13th FiveYear Period of Education Department of Jilin Province (JJKH20190134KJ); and by The Graduate Innovation Fund of Jilin University (No. 101832018C006). In addition, the biomechanical parameters of the ostrich toe pad were tested with the support of Dr. Lei Ren of the University of Manchester and Dr. Riaz Akhtar of the University of Liverpool.	Alexander R M, 2015, J ZOOL, V209, P405; ALEXANDER RM, 1986, J ZOOL, V209, P405, DOI 10.1111/j.1469-7998.1986.tb03601.x; ALEXANDER RM, 1979, J ZOOL, V187, P169; Behforootan S, 2017, ANN BIOMED ENG, V45, P2750, DOI 10.1007/s10439-017-1918-1; DAVIS BL, 1993, MED HYPOTHESES, V40, P44, DOI 10.1016/0306-9877(93)90195-V; Derbalah Amira Eid, 2012, Research Opinions in Animal & Veterinary Sciences, V2, P19; Egerbacher M, 2005, ANAT HISTOL EMBRYOL, V34, P112, DOI 10.1111/j.1439-0264.2004.00581.x; El-Gendy SAA, 2012, VET RES COMMUN, V36, P129, DOI 10.1007/s11259-012-9522-1; Gefen A, 2003, MED ENG PHYS, V25, P491, DOI 10.1016/S1350-4533(03)00029-8; JAHSS MH, 1992, FOOT ANKLE, V13, P233, DOI 10.1177/107110079201300502; Jan YK, 2013, PHYSIOL MEAS, V34, P53, DOI 10.1088/0967-3334/34/1/53; Ker RF, 1999, J EXP BIOL, V202, P3315; Knight K., 2012, J EXP BIOL, V215, pi; Lucky KM, 2014, INDIAN J ANIM RES, V48, P298, DOI 10.5958/j.0976-0555.48.3.063; Maric M, 2017, PROCESSES, V5, DOI 10.3390/pr5010007; MEYER W, 1990, ARCH DERMATOL RES, V281, P541, DOI 10.1007/BF00412742; Miao HB, 2017, BIOL OPEN, V6, P1889, DOI 10.1242/bio.024828; Minetti A., 2000, BIOMECHANICS BIOL MO, P67; Raber M, 2004, VET J, V167, P258, DOI 10.1016/S1090-0233(03)00053-4; Schaller NU, 2011, J EXP BIOL, V214, P1123, DOI 10.1242/jeb.043596; Wang Y L, 2001, J XIAN JIAOTONG U; Weissengruber GE, 2006, J ANAT, V209, P781, DOI 10.1111/j.1469-7580.2006.00648.x; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Xu Wen, 1998, BASIS MECH VIBRATION; Zhang R, 2016, INDIAN J ANIM RES, V50, P476, DOI 10.18805/ijar.9300; Zhang Xiaopeng, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P1098; Zhu ZD, 2014, J BIONIC ENG, V11, P282, DOI 10.1016/S1672-6529(14)60045-7	27	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216141	10.1371/journal.pone.0216141	http://dx.doi.org/10.1371/journal.pone.0216141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116736	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400016
J	Gattellari, M; Goumas, C; Jalaludin, B; Worthington, J				Gattellari, Melina; Goumas, Chris; Jalaludin, Bind; Worthington, John			The impact of disease severity adjustment on hospital standardised mortality ratios: Results from a service-wide analysis of ischaemic stroke admissions using linked pre-hospital, admissions and mortality data	PLOS ONE			English	Article							30-DAY MORTALITY; MEDICARE BENEFICIARIES; CARDIAC-SURGERY; CONTROL CHARTS; HUNTER REGION; PERFORMANCE; OUTCOMES; QUALITY; SCALE; RISK	Background Administrative data are used to examine variation in thirty-day mortality across health services in several jurisdictions. Hospital performance measurement may be error-prone as information about disease severity is not typically available in routinely collected data to incorporate into case-mix adjusted analyses. Using ischaemic stroke as a case study, we tested the extent to which accounting for disease severity impacts on hospital performance assessment. Methods We linked all recorded ischaemic stroke admissions between July, 2011 and June, 2014 to death registrations and a measure of stroke severity obtained at first point of patient contact with health services, across New South Wales, Australia's largest health service jurisdiction. Thirty-day hospital standardised mortality ratios were adjusted for either comorbidities, as is typically done, or for both comorbidities and stroke severity. The impact of stroke severity adjustment on mortality ratios was determined using 95% and 99% control limits applied to funnel plots and by calculating the change in rank order of hospital risk adjusted mortality rates. Results The performance of the stroke severity adjusted model was superior to incorporating comorbidity burden alone (c-statistic = 0.82 versus 0.75; N = 17,700 patients, 176 hospitals). Concordance in outlier classification was 89% and 97% when applying 95% or 99% control limits to funnel plots, respectively. The sensitivity rates of outlier detection using comorbidity adjustment compared with gold-standard severity and comorbidity adjustment was 74% and 83% with 95% and 99% control limits, respectively. Corresponding positive predictive values were 74% and 91%. Hospital rank order of risk adjusted mortality rates shifted between 0 to 22 places with severity adjustment (Median = 4.0, Inter-quartile Range = 2-7). Conclusions Rankings of mortality rates varied widely depending on whether stroke severity was taken into account. Funnel plots yielded largely concordant results irrespective of severity adjustment and may be sufficiently accurate as a screening tool for assessing hospital performance.	[Gattellari, Melina; Goumas, Chris] Ingham Inst Appl Med Res, Heart & Brain Collaborat, Sydney, NSW, Australia; [Gattellari, Melina; Worthington, John] Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia; [Jalaludin, Bind] South Western Sydney Local Hlth Dist, Populat Hlth Intelligence, Hlth People & Places Unit, Sydney, NSW, Australia; [Jalaludin, Bind] Univ New South Wales, Sch Publ Hlth, Sydney, NSW, Australia; [Worthington, John] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia	Ingham Institute for Applied Medical Research; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Worthington, J (corresponding author), Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia.; Worthington, J (corresponding author), Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.	John.Worthington@health.nsw.gov.au			New South Wales Ministry of Health, Office for Health and Medical Research; New South Wales Neurological Conditions Translational Research Grants Program	New South Wales Ministry of Health, Office for Health and Medical Research; New South Wales Neurological Conditions Translational Research Grants Program	Funding was provided by the New South Wales Ministry of Health, Office for Health and Medical Research. New South Wales Neurological Conditions Translational Research Grants Program to JW, BJ, and MG. http://www.health.nsw.gov.au/ohmr/Pages/contacts.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alexandrescu R, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0029-x; *AUSTR COLL EM MED, GUID IMPL AUSTR TRIA; Australian Bureau of Statistics, 2006, SOC IND AR SEIFA TEC; Australian Consortium for Classification Development, 2015, INT STAT CLASS DIS H; Ayerbe L, 2014, J NEUROL NEUROSUR PS, V85, P514, DOI 10.1136/jnnp-2013-306448; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bray BD, 2014, STROKE, V45, P3374, DOI 10.1161/STROKEAHA.114.006451; Bridgewater B, 2005, BMJ-BRIT MED J, V330, P506, DOI 10.1136/bmj.330.7490.506; Bureau of Health Information, 2017, INS SER EXPL CLIN VA; Cadilhac DA, 2017, MED J AUSTRALIA, V206, P345, DOI 10.5694/mja16.00525; Canadian Institute for Health Information, 2016, HOSP STAND MORT RAT; Dr Foster Intelligence, 2014, UND HSMRS TOOLK HOSP; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Ganesh A, 2016, NEUROLOGY, V86, P898, DOI 10.1212/WNL.0000000000002443; Glance LG, 2003, INTENS CARE MED, V29, P2223, DOI 10.1007/s00134-003-1959-9; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Guthrie B, 2005, QUAL SAF HEALTH CARE, V14, P450, DOI 10.1136/qshc.2005.014456; Hall RE, 2015, CIRC-CARDIOVASC QUAL, V8, pS141, DOI 10.1161/CIRCOUTCOMES.115.002079; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77; Keyhani S, 2012, CIRC-CARDIOVASC QUAL, V5, P508, DOI 10.1161/CIRCOUTCOMES.111.962936; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lichtman JH, 2011, STROKE, V42, P3387, DOI 10.1161/STROKEAHA.111.622613; MacKenzie TA, 2015, ANN THORAC SURG, V99, P757, DOI 10.1016/j.athoracsur.2014.11.039; Marsden DL, 2010, CEREBROVASC DIS, V30, P500, DOI 10.1159/000319022; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Phan TG, 2016, J STROKE CEREBROVASC, V25, P835, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.016; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reeves MJ, 2015, CIRC-CARDIOVASC QUAL, V8, pS90, DOI 10.1161/CIRCOUTCOMES.115.001775; Rixom A, 2002, BMJ-BRIT MED J, V325, P177, DOI 10.1136/bmj.325.7357.177; Sansom LT, 2015, INT J STROKE, V10, pE70, DOI 10.1111/ijs.12577; Saposnik G, 2007, NEUROLOGY, V69, P1142, DOI 10.1212/01.wnl.0000268485.93349.58; Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e; Schwartz J, 2017, STROKE, V48, P3101, DOI 10.1161/STROKEAHA.117.017960; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Siregar S, 2012, CIRC-CARDIOVASC QUAL, V5, P403, DOI 10.1161/CIRCOUTCOMES.111.964460; Spertus JV, 2016, CIRC-CARDIOVASC QUAL, V9, P659, DOI 10.1161/CIRCOUTCOMES.116.002826; TEASDALE G, 1974, LANCET, V2, P81; Tekkis PP, 2003, BMJ-BRIT MED J, V326, P786, DOI 10.1136/bmj.326.7393.786; Thompson MP, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004951; Thompson MP, 2016, CIRC-CARDIOVASC QUAL, V9, P286, DOI 10.1161/CIRCOUTCOMES.115.002352; Wang Y, 2003, STROKE, V34, P1144, DOI 10.1161/01.STR.0000067703.71251.B6; Weir CJ, 2003, QJM-INT J MED, V96, P67, DOI 10.1093/qjmed/hcg008; Worthington JM, 2017, NEUROEPIDEMIOLOGY, V48, P111, DOI 10.1159/000478016; Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation (YNHHSC/CORE), 2014, 2014 MEAS UPD SPEC R; Yu AYX, 2017, NEUROLOGY, V89, P1970, DOI 10.1212/WNL.0000000000004631	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216325	10.1371/journal.pone.0216325	http://dx.doi.org/10.1371/journal.pone.0216325			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112556	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000014
J	Jordaan, K; Comeau, AM; Khasa, DP; Bezuidenhout, CC				Jordaan, K.; Comeau, A. M.; Khasa, D. P.; Bezuidenhout, C. C.			An integrated insight into the response of bacterial communities to anthropogenic contaminants in a river: A case study of the Wonderfonteinspruit catchment area, South Africa	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; HETEROTROPHIC BACTERIA; HEAVY-METALS; URBAN RIVER; DIVERSITY; WATER; POLLUTION; BACTERIOPLANKTON; SEDIMENTS; NETWORKS	Bacterial communities in human-impacted rivers and streams are exposed to multiple anthropogenic contaminants, which can eventually lead to biodiversity loss and function. The Wonderfonteinspruit catchment area is impacted by operational and abandoned gold mines, farms, and formal and informal settlements. In this study, we used 16S rRNA gene high-throughput sequencing to characterize bacterial communities in the lower Wonderfonteinspruit and their response to various contaminant sources. The results showed that composition and structure of bacterial communities differed significantly (P<0.05) between less (downstream) and more (upstream) polluted sites. The taxonomic and functional gene dissimilarities significantly correlated with each other, while downstream sites had more distinct functional genes. The relative abundance of Proteobacteria, Bacteroidetes and Actinobacteria was higher at upstream sites, while Acidobacteria, Cyanobacteria, Firmicutes and Verrucomicrobia were prominent at downstream sites. In addition, upstream sites were rich in genera pathogenic and/or potentially pathogenic to humans. Multivariate and correlation analyses suggest that bacterial diversity was significantly (P<0.05) impacted by pH and heavy metals (cobalt, arsenic, chromium, nickel and uranium). A significant fraction (similar to 14%) of the compositional variation was explained by a combination of anthropogenic inputs, of which mining (similar to 6%) was the main contributor to bacterial community variation. Network analysis indicated that bacterial communities had non-random inter-and intra-phyla associations and that the main taxa showed both positive and negative linkages to environmental parameters. Our results suggest that species sorting, due to environmental parameters, was the main process that structured bacterial communities. Furthermore, upstream sites had higher relative abundances of genes involved in xenobiotic degradation, suggesting stronger removal of polycyclic aromatic hydrocarbons and other organic compounds. This study provides insights into the influences of anthropogenic land use on bacterial community structure and functions in the lower Wonderfonteinspruit.	[Jordaan, K.; Bezuidenhout, C. C.] North West Univ, Microbiol, Unit Environm Sci & Management, Potchefstroom, South Africa; [Comeau, A. M.; Khasa, D. P.] Univ Laval, IBIS, Quebec City, PQ, Canada; [Jordaan, K.] Univ Pretoria, CMEG, Pretoria, South Africa; [Comeau, A. M.] Dalhousie Univ, CGEB Integrated Microbiome Resource, Halifax, NS, Canada	North West University - South Africa; Laval University; University of Pretoria; Dalhousie University	Jordaan, K (corresponding author), North West Univ, Microbiol, Unit Environm Sci & Management, Potchefstroom, South Africa.; Jordaan, K (corresponding author), Univ Pretoria, CMEG, Pretoria, South Africa.	karen.jordaan20@gmail.com	Bezuidenhout, Cornelius C/D-3179-2011	Bezuidenhout, Cornelius C/0000-0002-6047-4991; Jordaan, Karen/0000-0001-9147-9827; Khasa, Damase/0000-0002-9336-7770	Canadian Bureau for International Education (CBIE); Natural Sciences and Engineering Research Council of Canada (NSERC); Water Research Commission (WRC) [K5/1996]; National Research Foundation (NRF); Queen Elizabeth Scholars (QES)	Canadian Bureau for International Education (CBIE); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Water Research Commission (WRC); National Research Foundation (NRF); Queen Elizabeth Scholars (QES)	The study was supported by the Canadian Bureau for International Education (CBIE) (https://cbie.ca) to KJ & DPK, the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (www.nserc-crsng.gc.ca/index_eng.asp) to DPK, the Water Research Commission (WRC) (www.wrc.org.za) through grant K5/1996 to CCB, the National Research Foundation (NRF) (https://www.nrf.ac.za) to CCB, and by Queen Elizabeth Scholars (QES) to DPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bai YH, 2014, APPL MICROBIOL BIOT, V98, P1841, DOI 10.1007/s00253-013-5116-2; Barthel R., 2012, NEW URANIUM MINING B, P517, DOI DOI 10.1007/978-3-642-22122-4_60; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bricheux G, 2013, MICROBIOLOGYOPEN, V2, P402, DOI 10.1002/mbo3.80; Bruneel O, 2011, MICROB ECOL, V61, P793, DOI 10.1007/s00248-011-9808-9; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Choudhary S, 2009, BIORESOURCE TECHNOL, V100, P2482, DOI 10.1016/j.biortech.2008.12.015; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Comte J, 2016, BIOGEOSCIENCES, V13, P175, DOI 10.5194/bg-13-175-2016; Connor N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176751; Costa PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119465; Dell'Amico E, 2008, MICROBIOL RES, V163, P671, DOI 10.1016/j.micres.2006.09.003; Department of Water Affairs and Forestry (DWAF), 1996, S AFR WAT QUAL GUID, V8; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; EXCOFFIER L, 1992, GENETICS, V131, P479; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Gachhui R, 1997, FOLIA MICROBIOL, V42, P337, DOI 10.1007/BF02816946; GARNIER J, 1992, CAN J MICROBIOL, V38, P56, DOI 10.1139/m92-009; Gillan DC, 2007, BIOFOULING, V23, P1, DOI 10.1080/08927010601108725; Goni-Urriza M, 1999, CAN J MICROBIOL, V45, P826, DOI 10.1139/cjm-45-10-826; Gough HL, 2011, ISME J, V5, P543, DOI 10.1038/ismej.2010.132; Hahn MW, 2006, CURR OPIN BIOTECH, V17, P256, DOI 10.1016/j.copbio.2006.05.006; Heino J, 2013, ECOGRAPHY, V36, P926, DOI 10.1111/j.1600-0587.2012.00057.x; Hendriks H, 2009, WAT RES QUAL SIT ASS; Huang Y, 2011, BIOMED ENVIRON SCI, V24, P140, DOI 10.3967/0895-3988.2011.02.008; Ibekwe AM, 2016, SCI TOTAL ENVIRON, V566, P1176, DOI 10.1016/j.scitotenv.2016.05.168; Jie SQ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0800-x; Jordaan K, 2016, ENVIRON SCI POLLUT R, V23, P5868, DOI 10.1007/s11356-015-5786-7; Jose J, 2011, ENVIRON POLLUT, V159, P2775, DOI 10.1016/j.envpol.2011.05.009; Jung J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23012; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Koo H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01347; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leff LG, 1999, OHIO J SCI, V99, P44; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Lemke MJ, 1997, MICROB ECOL, V34, P224, DOI 10.1007/s002489900051; Li D, 2017, WATER-SUI, V9, DOI 10.3390/w9060373; Lin SS, 2014, CLEAN-SOIL AIR WATER, V42, P1376, DOI 10.1002/clen.201200328; Lindh MV, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02078; Liu S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00285; Lovley D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P635, DOI 10.1007/0-387-30742-7_21; Mackintosh TJ, 2016, ENVIRON POLLUT, V208, P221, DOI 10.1016/j.envpol.2015.08.038; Medeiros JD, 2016, BRAZ J MICROBIOL, V47, P835, DOI 10.1016/j.bjm.2016.06.011; Midgley GF, 2012, SCIENCE, V335, P174, DOI 10.1126/science.1217245; Milici M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00649; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Obi CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01213; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Qu XD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15624-x; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Risso C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-447; Roosa S, 2014, RES MICROBIOL, V165, P647, DOI 10.1016/j.resmic.2014.07.011; Ryan RP, 2005, J SOIL SEDIMENT, V5, P95, DOI 10.1065/jss2004.10.120; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schultz GE, 2013, AQUAT MICROB ECOL, V70, P169, DOI 10.3354/ame01646; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00414; Sun MY, 2013, ENVIRON MICROBIOL, V15, P2517, DOI 10.1111/1462-2920.12133; Sun MY, 2012, MAR POLLUT BULL, V64, P1029, DOI 10.1016/j.marpolbul.2012.01.035; Tumanov AA, 2004, J ANAL CHEM+, V59, P788, DOI 10.1023/B:JANC.0000037288.42168.99; Turpeinen R, 2004, FEMS MICROBIOL ECOL, V47, P39, DOI 10.1016/S0168-6496(03)00232-0; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Van Veelen M, 2009, WOND CATCHM AR REM P; Wang SF, 2010, J ENVIRON SCI-CHINA, V22, P23, DOI 10.1016/S1001-0742(09)60070-X; Wang SY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022972, 10.1371/journal.pone.0028443]; Winde F., 2009, INT MIN WAT C OCT 19; Winde F, 2011, WATER-SUI, V3, P391, DOI 10.3390/w3010391; Winde F, 2010, WATER SA, V36, P257; Xiong JB, 2014, APPL ENVIRON MICROB, V80, P1919, DOI 10.1128/AEM.03731-13; Xu JP, 2006, MOL ECOL, V15, P1713, DOI 10.1111/j.1365-294X.2006.02882.x; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yin HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14266; Yun Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01955; Zarraonaindia I, 2013, BIOL PHILOS, V28, P261, DOI 10.1007/s10539-012-9357-8; Zhou JZ, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00002-17; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; 2014, FEMS MICROBIOL ECOL, V87, P102, DOI DOI 10.1111/1574-6941.12195; 2010, ECOL COMPLEX, V7, P36, DOI DOI 10.1016/J.ECOCOM.2009.03.008; 2005, APPL ENVIRON MICROB, V71, P8201, DOI DOI 10.1128/AEM.71.12.8201-8206.2005; 2012, ISME J, V6, P343, DOI DOI 10.1038/ISMEJ.2011.119	89	13	13	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216758	10.1371/journal.pone.0216758	http://dx.doi.org/10.1371/journal.pone.0216758			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112559	Green Published, gold			2022-12-27	WOS:000468451000022
J	Lau, E; Frame, CH; Nolan, EJ; Stewart, FJ; Dillard, ZW; Lukich, DP; Mihalik, NE; Yauch, KE; Kinker, MA; Waychoff, SL				Lau, Evan; Frame, Caitlin H.; Nolan, E. Joseph; Stewart, Frank J.; Dillard, Zachary W.; Lukich, Daniel P.; Mihalik, Nicole E.; Yauch, Katelyn E.; Kinker, Marcus A.; Waychoff, Samantha L.			Diversity and relative abundance of ammonia- and nitrite-oxidizing microorganisms in the offshore Namibian hypoxic zone	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; NITROUS-OXIDE; SOUTH-PACIFIC; OXIDATION; ARCHAEAL; NORTH; NITRIFICATION; BACTERIA; WATER; CRENARCHAEOTA	Nitrification, the microbial oxidation of ammonia (NH3) to nitrite (NO2-) and NO2- to nitrate (NO3-), plays a vital role in ocean nitrogen cycling. Characterizing the distribution of nitrifying organisms over environmental gradients can help predict how nitrogen availability may change with shifting ocean conditions, for example, due to loss of dissolved oxygen (O-2). We characterized the distribution of nitrifiers at 5 depths spanning the oxic to hypoxic zone of the offshore Benguela upwelling system above the continental slope off Namibia. Based on 16S rRNA gene amplicon sequencing, the proportional abundance of nitrifiers (ammonia and nitrite oxidizers) increased with depth, driven by an increase in ammonia-oxidizing archaea (AOA; Thaumarchaeota) to up to 33% of the community at hypoxic depths where O-2 concentrations fell to similar to 25 mu M. The AOA community transitioned from being dominated by a few members at oxic depths to a more even representation of taxa in the hypoxic zone. In comparison, the community of NO2--oxidizing bacteria (NOB), composed primarily of Nitrospinae, was far less abundant and exhibited higher evenness at all depths. The AOA: NOB ratio declined with depth from 41:1 in the oxic zone to 27:1 under hypoxia, suggesting potential variation in the balance between NO2- production and consumption via nitrification. Indeed, in contrast to prior observations from more O-2(-) depleted sites closer to shore, NO2 did not accumulate at hypoxic depths near this offshore site, potentially due in part to a tightened coupling between AOA and NOB.	[Lau, Evan] Menlo Coll, Dept Biol, Atherton, CA 94027 USA; [Lau, Evan; Nolan, E. Joseph; Dillard, Zachary W.; Lukich, Daniel P.; Mihalik, Nicole E.; Yauch, Katelyn E.; Kinker, Marcus A.; Waychoff, Samantha L.] West Liberty Univ, Dept Nat Sci & Math, West Liberty, WV 26074 USA; [Frame, Caitlin H.] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Stewart, Frank J.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	University of Basel; University System of Georgia; Georgia Institute of Technology	Lau, E (corresponding author), Menlo Coll, Dept Biol, Atherton, CA 94027 USA.; Lau, E (corresponding author), West Liberty Univ, Dept Nat Sci & Math, West Liberty, WV 26074 USA.	evanlau28@gmail.com		Lau, Evan/0000-0002-7434-4362; Mihalik, Nicole/0000-0002-8220-6613	National Institutes of Health West Virginia IDeA Network of Biomedical Research Excellence, WV-INBRE [2P20GM103434-14]; West Liberty University Faculty Development Fund; Freiwillige Akademische Gesellschaft of Basel, Switzerland, through University of Basel; Swiss National Science Foundation [NUW1530]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	National Institutes of Health West Virginia IDeA Network of Biomedical Research Excellence, WV-INBRE; West Liberty University Faculty Development Fund; Freiwillige Akademische Gesellschaft of Basel, Switzerland, through University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EL received grants from National Institutes of Health West Virginia IDeA Network of Biomedical Research Excellence, WV-INBRE, award#2P20GM103434-14, http://www.wv-inbre.net. EL received a grant from the West Liberty University Faculty Development Fund, https://westliberty.edu. CHF received a grant from Freiwillige Akademische Gesellschaft of Basel, Switzerland, through University of Basel, https://www.sareco.org/institution/freiwillige-akademische-gesellschaft-basel-fag and Swiss National Science Foundation Grant NUW1530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P861, DOI 10.1007/0-387-30745-1_41; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], VEGAN COMMUNITY ECOL; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Babbin AR, 2014, SCIENCE, V344, P406, DOI 10.1126/science.1248364; Bayer B, 2016, ISME J, V10, P1051, DOI 10.1038/ismej.2015.200; Beaumont HJE, 2002, J BACTERIOL, V184, P2557, DOI 10.1128/JB.184.9.2557-2560.2002; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Beman JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3705; Beman JM, 2013, ISME J, V7, P2192, DOI 10.1038/ismej.2013.96; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Bouskill NJ, 2012, ENVIRON MICROBIOL, V14, P714, DOI 10.1111/j.1462-2920.2011.02623.x; Bristow LA, 2016, P NATL ACAD SCI USA, V113, P10601, DOI 10.1073/pnas.1600359113; Bristow LA, 2015, LIMNOL OCEANOGR, V60, P1733, DOI 10.1002/lno.10130; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Bryant JA, 2012, ECOLOGY, V93, P1659, DOI 10.1890/11-1204.1; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Capone DG, 2013, NAT GEOSCI, V6, P711, DOI 10.1038/NGEO1916; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1986, SCIENCE, V233, P1200, DOI 10.1126/science.233.4769.1200; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costa E, 2006, TRENDS MICROBIOL, V14, P213, DOI 10.1016/j.tim.2006.03.006; Daebeler A, 2014, ISME J, V8, P2397, DOI 10.1038/ismej.2014.81; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fennel W, 1999, J PHYS OCEANOGR, V29, P177, DOI 10.1175/1520-0485(1999)029<0177:TOTBUS>2.0.CO;2; Frame CH, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02104; Frame CH, 2014, GLOBAL BIOGEOCHEM CY, V28, P1262, DOI 10.1002/2013GB004790; Fussel J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700807; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Kindt R, 2005, TREE DIVERSITY ANAL, P196, DOI DOI 10.1198/TAS.2008.S264; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lau Evan, 2015, Microorganisms, V3, P113, DOI 10.3390/microorganisms3020113; Levipan HA, 2014, ENV MICROBIOL REP, V6, P565, DOI 10.1111/1758-2229.12158; Lomas MW, 2006, LIMNOL OCEANOGR, V51, P2453, DOI 10.4319/lo.2006.51.5.2453; Lynch MDJ, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-3; Martens-Habbena W, 2015, ENVIRON MICROBIOL, V17, P2261, DOI 10.1111/1462-2920.12677; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mashifane TB, 2016, CONT SHELF RES, V124, P200, DOI 10.1016/j.csr.2016.05.004; McIlvin MR, 2010, LIMNOL OCEANOGR-METH, V8, P54; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; Mengis M, 1997, BIOGEOCHEMISTRY, V38, P281, DOI 10.1023/A:1005814020322; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Molina V, 2010, ENVIRON MICROBIOL, V12, P2450, DOI 10.1111/j.1462-2920.2010.02218.x; Off S, 2010, APPL ENVIRON MICROB, V76, P4640, DOI 10.1128/AEM.00320-10; Peng XF, 2016, J GEOPHYS RES-OCEANS, V121, P1667, DOI 10.1002/2015JC011455; Peng XF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00177; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Philips Sarah, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P115, DOI 10.1023/A:1020892826575; Rice MC, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0168-4; Ripley B. D, 2016, GGDENDRO CREATE DEND; Santoro AE, 2015, P NATL ACAD SCI USA, V112, P1173, DOI 10.1073/pnas.1416223112; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Schmidtko S, 2017, NATURE, V542, P335, DOI 10.1038/nature21399; Spieck E., 2005, BERGEYS MANUAL SYSTE, V2, P149; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Stein LY, 1998, APPL ENVIRON MICROB, V64, P4098; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Thamdrup B, 2012, DEEP-SEA RES PT I, V65, P36, DOI 10.1016/j.dsr.2012.03.001; Tiano L, 2014, DEEP-SEA RES PT I, V94, P173, DOI 10.1016/j.dsr.2014.10.001; Tolar BB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00072; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Wankel SD, 2011, APPL ENVIRON MICROB, V77, P269, DOI 10.1128/AEM.01318-10; Ward BB, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P199, DOI 10.1016/B978-0-12-372522-6.00005-0; WATSON SW, 1986, ARCH MICROBIOL, V144, P1, DOI 10.1007/BF00454947; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wuchter C, 2007, P NATL ACAD SCI USA, V104, P5704, DOI 10.1073/pnas.0701630104; Zakem EJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03553-w; 2019, GEOPHYS RES LETT, V46, P3317, DOI DOI 10.1029/2018GL081648; 2012, ISME J, V6, P1200, DOI DOI 10.1038/ISMEJ.2011.178; 2012, BIOGEOSCIENCES, V9, P2419, DOI DOI 10.5194/BG-9-2419-2012	90	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217136	10.1371/journal.pone.0217136	http://dx.doi.org/10.1371/journal.pone.0217136			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112557	Green Submitted, gold, Green Published			2022-12-27	WOS:000468451000038
J	Liu, TW; Ng, SSM				Liu, Tai-Wa; Ng, Shamay S. M.			Assessing the fall risks of community-dwelling stroke survivors using the Short-form Physiological Profile Assessment (S-PPA)	PLOS ONE			English	Article							SENSORY ORGANIZATION TEST; TEST-RETEST RELIABILITY; BERG BALANCE SCALE; PSYCHOMETRIC PROPERTIES; FUNCTIONAL REACH; PEOPLE; INDIVIDUALS; STRATIFY; VALIDITY; MOBILITY	Introduction Fall is common after stroke. The Short-form Physiological Profile Assessment (S-PPA) was developed to assess the fall risks and underlying physiological factors, and it has been used in healthy older adults and older adults with stroke. This study aimed to establish the psychometric properties of the S-PPA among cognitively intact and ambulant community-dwelling older adults with stroke. Methods The S-PPA, Chinese version of the Activities-specific Balance Confidence (ABC-C) scale and 3 balance measures, namely the Berg Balance Scale (BBS), Timed "Up & Go" (TUG) and Functional Reach Test (FRT), were administered. Inter- and intra-rater reliability were assessed at baseline and after a 1-week interval, respectively. The validity of the S-PPA was assessed through correlations with balance measures and the ABC-C and by comparing the S-PPA scores between the stroke and healthy groups and between fallers and non-fallers in the stroke group. A receiver operating characteristic (ROC) curve analysis was used to assess the ability of balance measures to distinguish fall status in the stroke group. Results The S-PPA yielded good inter-rater (intraclass correlation coefficient (ICC) = 0.83) and moderate intra-rater reliability (ICC = 0.74), correlated significantly with the 3 balance measures (rho = 0.49-0.70) and ABC-C (rho = 0.35) and revealed significant differences between stroke survivors and controls and between stroke survivors with and without a fall history. However, the ROC analysis revealed that the S-PPA had a poor ability to distinguish the fall statuses of community-dwelling stroke survivors. Conclusions The S-PPA is reliable and valid for evaluating fall risks but cannot adequately distinguish the fall statuses of stroke survivors.	[Liu, Tai-Wa; Ng, Shamay S. M.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China; [Liu, Tai-Wa] Open Univ Hong Kong, Sch Nursing & Hlth Studies, Ho Man Tin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Metropolitan University	Ng, SSM (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China.	Shamay.Ng@polyu.edu.hk	NG, Sheung Mei Shamay/E-2731-2016	NG, Sheung Mei Shamay/0000-0003-1660-0548	General Research Grant of University Grants Council [15101217]	General Research Grant of University Grants Council	This study was supported by the General Research Grant of University Grants Council (grant 15101217) to Dr. Shamay SM Ng and her team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn A, 2008, AGE AGEING, V37, P270, DOI 10.1093/ageing/afn066; Beninato M, 2009, PHYS THER, V89, P816, DOI 10.2522/ptj.20080160; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Breisinger TP, 2014, CLIN REHABIL, V28, P1218, DOI 10.1177/0269215514534276; Dean CM, 2012, NEUROREHAB NEURAL RE, V26, P1046, DOI 10.1177/1545968312441711; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Flansbjer UB, 2012, PM&R, V4, P165, DOI 10.1016/j.pmrj.2011.11.004; Foerch C, 2013, J RES MED SCI, V18, P10; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Forsberg A, 2013, PHYSIOTHER CAN, V65, P141, DOI 10.3138/ptc.2011-54; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Hoang PD, 2016, MULT SCLER J EXP TRA, V2, P1; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Jayakaran P, 2011, PM&R, V3, P723, DOI 10.1016/j.pmrj.2011.01.005; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Liu TW, 2019, STROKE, V50, P148, DOI 10.1161/STROKEAHA.118.022406; Lorbach ER, 2007, DEMENT GERIATR COGN, V24, P260, DOI 10.1159/000107101; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Mackintosh SF, 2006, ARCH PHYS MED REHAB, V87, P1583, DOI 10.1016/j.apmr.2006.09.004; Mak MK, 2007, ARCH PHYS MED REHAB, V88, P496, DOI 10.1016/j.apmr.2007.01.018; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; Marques A, 2016, ARCH PHYS MED REHAB, V97, P2166, DOI 10.1016/j.apmr.2016.07.011; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; Oliver D, 1997, BMJ-BRIT MED J, V315, P1049, DOI 10.1136/bmj.315.7115.1049; Paul SS, 2014, NEUROREHAB NEURAL RE, V28, P282, DOI 10.1177/1545968313508470; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Smith J, 2006, AGE AGEING, V35, P138, DOI 10.1093/ageing/afj027; Smith PS, 2004, CLIN REHABIL, V18, P811, DOI 10.1191/0269215504cr817oa; Stevenson TJ, 2001, AUST J PHYSIOTHER, V47, P29, DOI 10.1016/S0004-9514(14)60296-8; Tilson JK, 2012, STROKE, V43, P446, DOI 10.1161/STROKEAHA.111.636258; Tsang CSL, 2013, PHYS THER, V93, P1102, DOI 10.2522/ptj.20120454; Tsang K, 2008, IEEE ENG MED BIO, P5089, DOI 10.1109/IEMBS.2008.4650358; Wolf SL, 1999, PHYS THER, V79, P1122, DOI 10.1093/ptj/79.12.1122; Xu TM, 2018, ARCH PHYS MED REHAB, V99, P563, DOI 10.1016/j.apmr.2017.06.032; 2009, J ELECTROMYOGR KINES, V19, P380, DOI DOI 10.1016/J.JELEKIN.2007.09.007	42	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216769	10.1371/journal.pone.0216769	http://dx.doi.org/10.1371/journal.pone.0216769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112580	gold, Green Published			2022-12-27	WOS:000468451000023
J	Wagner, ER; Myers, KS; Riley, NM; Coon, JJ; Gasch, AP				Wagner, Ellen R.; Myers, Kevin S.; Riley, Nicholas M.; Coon, Joshua J.; Gasch, Audrey P.			PKA and HOG signaling contribute separable roles to anaerobic xylose fermentation in yeast engineered for biofuel production	PLOS ONE			English	Article							PROTEIN-KINASE-A; RECOMBINANT SACCHAROMYCES-CEREVISIAE; NUTRIENT-INDUCED ACTIVATION; RAS/CYCLIC AMP PATHWAY; IN-VIVO; XYLITOL DEHYDROGENASE; OSMOTIC-STRESS; D-XYLULOKINASE; CARBON FLUXES; ETHANOL	Lignocellulosic biomass offers a sustainable source for biofuel production that does not compete with food-based cropping systems. Importantly, two critical bottlenecks prevent economic adoption: many industrially relevant microorganisms cannot ferment pentose sugars prevalent in lignocellulosic medium, leaving a significant amount of carbon unutilized. Furthermore, chemical biomass pretreatment required to release fermentable sugars generates a variety of toxins, which inhibit microbial growth and metabolism, specifically limiting pentose utilization in engineered strains. Here we dissected genetic determinants of anaerobic xylose fermentation and stress tolerance in chemically pretreated corn stover biomass, called hydrolysate. We previously revealed that loss-of-function mutations in the stress-responsive MAP kinase HOG1 and negative regulator of the RAS/Protein Kinase A (PKA) pathway, IRA2, enhances anaerobic xylose fermentation. However, these mutations likely reduce cells' ability to tolerate the toxins present in lignocellulosic hydrolysate, making the strain especially vulnerable to it. We tested the contributions of Hog1 and PKA signaling via IRA2 or PKA negative regulatory subunit BCY1 to metabolism, growth, and stress tolerance in corn stover hydrolysate and laboratory medium with mixed sugars. We found mutations causing upregulated PKA activity increase growth rate and glucose consumption in various media but do not have a specific impact on xylose fermentation. In contrast, mutation of HOG1 specifically increased xylose usage. We hypothesized improving stress tolerance would enhance the rate of xylose consumption in hydrolysate. Surprisingly, increasing stress tolerance did not augment xylose fermentation in lignocellulosic medium in this strain background, suggesting other mechanisms besides cellular stress limit this strain's ability for anaerobic xylose fermentation in hydrolysate.	[Wagner, Ellen R.; Myers, Kevin S.; Gasch, Audrey P.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Riley, Nicholas M.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Coon, Joshua J.; Gasch, Audrey P.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Coon, Joshua J.] Morgridge Inst Res, Madison, WI USA; [Gasch, Audrey P.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Gasch, AP (corresponding author), Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.; Gasch, AP (corresponding author), Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA.; Gasch, AP (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	agasch@wisc.edu	Myers, Kevin/GZK-8865-2022; Gasch, Audrey P./AAS-5924-2021	Gasch, Audrey P./0000-0002-8182-257X; Wagner, Ellen/0000-0003-0490-7307; Myers, Kevin/0000-0003-3302-3877; Riley, Nicholas/0000-0002-1536-2966	Great Lakes Bioenergy Research Center, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-SC0018409]; National Science Foundation Graduate Research Fellowship Program [DGE-1747503]; Office of the Vice Chancellor for Research and Graduate Education at the University of Wisconsin-Madison; Wisconsin Alumni Research Foundation	Great Lakes Bioenergy Research Center, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Office of the Vice Chancellor for Research and Graduate Education at the University of Wisconsin-Madison; Wisconsin Alumni Research Foundation	This material is based upon work supported by the Great Lakes Bioenergy Research Center, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research under Award Number DE-SC0018409 to APG. ERW is supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1747503. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Support was also provided by the Graduate School and the Office of the Vice Chancellor for Research and Graduate Education at the University of Wisconsin-Madison with funding from the Wisconsin Alumni Research Foundation.	ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Almeida JRM, 2011, BIOTECHNOL J, V6, P286, DOI 10.1002/biot.201000301; Almeida JRM, 2009, APPL MICROBIOL BIOT, V84, P751, DOI 10.1007/s00253-009-2053-1; Ask M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-181; Babazadeh R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04697; Bellissimi E, 2009, FEMS YEAST RES, V9, P358, DOI 10.1111/j.1567-1364.2009.00487.x; BREWSTER JL, 1994, YEAST, V10, P425, DOI 10.1002/yea.320100402; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Caspeta L, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00184; Chundawat SPS, 2010, BIORESOURCE TECHNOL, V101, P8429, DOI 10.1016/j.biortech.2010.06.027; Demeke MM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-120; Demeke MM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-89; Deparis Q, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox036; Diao LY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-110; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dihazi H, 2003, BIOCHEMISTRY-US, V42, P6275, DOI 10.1021/bi034167r; dos Santos LV, 2016, SCI REP-UK, V6, DOI 10.1038/srep38676; Enjalbert B, 2004, MOL GENET GENOMICS, V271, P697, DOI 10.1007/s00438-004-1014-8; Ewald JC, 2016, MOL CELL, V62, P532, DOI 10.1016/j.molcel.2016.02.017; Gomar-Alba M, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov039; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Griffioen G, 2001, MOL CELL BIOL, V21, P511, DOI 10.1128/MCB.21.2.511-523.2001; Heer D, 2008, MICROB BIOTECHNOL, V1, P497, DOI 10.1111/j.1751-7915.2008.00050.x; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Ho YH, 2015, CURR GENET, V61, P503, DOI 10.1007/s00294-015-0491-0; Jayakody LN, 2018, APPL MICROBIOL BIOT, V102, P8121, DOI 10.1007/s00253-018-9216-x; Jin YS, 2000, J MICROBIOL BIOTECHN, V10, P564; Jin YS, 2003, APPL BIOCHEM BIOTECH, V105, P277; Jin YS, 2003, APPL ENVIRON MICROB, V69, P495, DOI 10.1128/AEM.69.1.495-503.2003; Jin YS, 2002, APPL ENVIRON MICROB, V68, P1232, DOI 10.1128/AEM.68.3.1232-1239.2002; Kim SR, 2012, METAB ENG, V14, P336, DOI 10.1016/j.ymben.2012.04.001; Kim SR, 2012, TRENDS BIOTECHNOL, V30, P274, DOI 10.1016/j.tibtech.2012.01.005; Kim SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159899; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Kuhn Clemens, 2008, Genome Inform, V20, P77; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; MacGilvray ME, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006088; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; Merrill AE, 2014, MOL CELL PROTEOMICS, V13, P2503, DOI 10.1074/mcp.M114.040287; Modig T, 2002, BIOCHEM J, V363, P769, DOI 10.1042/0264-6021:3630769; Myers KS, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008037; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; Oh EJ, 2019, J BIOTECHNOL, V292, P1, DOI 10.1016/j.jbiotec.2018.12.013; PAMPULHA ME, 1990, APPL MICROBIOL BIOT, V34, P375; Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200; Parreiras LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107499; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Petelenz-Kurdziel E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003084; Piotrowski JS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00090; Pisithkul T, 2015, APPL ENVIRON MICROB, V81, P5761, DOI 10.1128/AEM.01324-15; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Remize F, 2003, YEAST, V20, P1243, DOI 10.1002/yea.1041; RITTENHOUSE J, 1987, J BIOL CHEM, V262, P10114; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Sasano Y, 2012, J BIOSCI BIOENG, V113, P451, DOI 10.1016/j.jbiosc.2011.11.017; Sato TK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006372; Schepers W, 2012, J BIOL CHEM, V287, P44130, DOI 10.1074/jbc.M112.421503; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith FD, 2017, SCIENCE, V356, P1288, DOI 10.1126/science.aaj1669; Smith J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-41; Stanhill A, 1999, MOL CELL BIOL, V19, P7529; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Toivari MH, 2001, METAB ENG, V3, P236, DOI 10.1006/mben.2000.0191; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Vallejo MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137199; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Wallace-Salinas V, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0056-5; Wei N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3580; Zhang AL, 2012, FEMS MICROBIOL LETT, V331, P10, DOI 10.1111/j.1574-6968.2012.02552.x; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122; 2012, TRAFFIC, V13, P1522, DOI DOI 10.1111/J.1600-0854.2012.01406.X; 2016, APPL ENVIRON MICROB, V82, P5838, DOI DOI 10.1128/AEM.01603-16; 2011, PROTEOMICS, V11, P1064, DOI DOI 10.1002/PMIC.201000616; 2001, FEMS MICROBIOL REV, V25, P125, DOI DOI 10.1111/J.1574-6976.2001.TB00574.X; 2004, J PROTEOME RES, V3, P958, DOI DOI 10.1021/PR0499491; 2003, FEMS YEAST RES, V4, P69, DOI DOI 10.1016/S1567-1356(03)00141-7; 2016, BIOTECHNOL BIOENG, V113, P2587, DOI DOI 10.1002/BIT.26021; 2011, INT J FOOD MICROBIOL, V145, P211, DOI DOI 10.1016/J.IJFOODMICRO.2010.12.023; 2004, J BIOL CHEM, V279, P4671, DOI DOI 10.1074/JBC.M405136200; 2001, APPL ENVIRON MICROB, V67, P4249, DOI DOI 10.1128/AEM.67.9.4249-4255.2001; 2004, J BIOL CHEM, V279, P2201, DOI DOI 10.1074/JBC.M400609200; 1991, J BIOL CHEM, V266, P1970; 1990, CURR GENET, V18, P493; 2003, J BIOL CHEM, V278, P2346, DOI DOI 10.1074/JBC.M210691200; 2014, FEMS MICROBIOL REV, V38, P254, DOI DOI 10.1111/1574-6976.12065; 1994, YEAST, V10, P1049, DOI DOI 10.1002/YEA.320100807	92	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0212389	10.1371/journal.pone.0212389	http://dx.doi.org/10.1371/journal.pone.0212389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112537	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000003
J	Zhang, SZ; Wu, XL; Cui, J; Zhang, F; Wan, XQ; Liu, QL; Zhong, Y; Lin, TT				Zhang, Shuzhen; Wu, Xiaolu; Cui, Jie; Zhang, Fan; Wan, Xueqin; Liu, Qinglin; Zhong, Yu; Lin, Tiantian			Physiological and transcriptomic analysis of yellow leaf coloration in Populus deltoides Marsh	PLOS ONE			English	Article							CHLOROPHYLL-DEFICIENT MUTANT; GERANYLGERANYL REDUCTASE; FUNCTIONAL ASSIGNMENT; ARABIDOPSIS-THALIANA; HIGH LIGHT; GENE; BIOSYNTHESIS; BREAKDOWN; DEGRADATION; SENESCENCE	Populus deltoides Marsh has high ornamental value because its leaves remain yellow during the non-dormant period. However, little is known about the regulatory mechanism of leaf coloration in P. deltoides Marsh. Thus, we analyzed the physiological and transcriptional differences of yellow leaves (mutant) and green leaves (wild-type) of P. deltoides Marsh. Physiological experiments showed that the contents of chlorophyll (Chl) and carotenoid were lower in mutant leaves, and the flavonoid content did not differ significantly between mutant and wild-type leaves. Transcriptomic sequencing was further used to identify 153 differentially expressed genes (DEGs). Functional classifications based on Gene Ontology enrichment and Genome enrichment analysis indicated that the DEGs were involved in Chl biosynthesis and flavonoid biosynthesis pathways. Among these, geranylgeranyl diphosphate (CHLP) genes associated with Chl biosynthesis showed down-regulation, while chlorophyllase (CLH) genes associated with Chl degradation were up-regulated in yellow leaves. The expression levels of these genes were further confirmed using quantitative real-time PCR (RT-qPCR). Furthermore, the estimation of the main precursors of Chl confirmed that CHLP is a vital enzyme for the yellow leaf color phenotype. Consequently, the formation of yellow leaf color is due to the disruption of Chl synthesis or catabolism rather than flavonoid synthesis. These results contribute to our understanding of mechanisms and regulation of leaf color variation in poplar at the transcriptional level.	[Zhang, Shuzhen; Wu, Xiaolu; Cui, Jie; Zhang, Fan; Liu, Qinglin] Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China; [Wan, Xueqin; Zhong, Yu; Lin, Tiantian] Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhang, F (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China.	nolady@163.com	Liu, Qing/GWC-9222-2022; liu, qingqing/HHD-0360-2022	Wan, Xue-Qin/0000-0002-9252-1625	National Natural Science Fund of China [31870645]; 12th Five Year Key Programs for forest breeding in Sichuan Province [2016YZGG]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); 12th Five Year Key Programs for forest breeding in Sichuan Province	This research was funded by the National Natural Science Fund of China (No. 31870645) and by the 12th Five Year Key Programs for forest breeding in Sichuan Province (No. 2016YZGG).	Addlesee HA, 1999, J BACTERIOL, V181, P7248, DOI 10.1128/JB.181.23.7248-7255.1999; Addlesee HA, 1996, FEBS LETT, V389, P126, DOI 10.1016/0014-5793(96)00549-2; Akifumi A., 2009, PLANT SCI, V176, P470, DOI DOI 10.1016/J.PLANTSCI.2008.12.015; Azoulay-Shemer T, 2011, PLANT CELL PHYSIOL, V52, P70, DOI 10.1093/pcp/pcq174; Benedetti CE, 2002, PLANT PHYSIOL, V128, P1255, DOI 10.1104/pp.010813; BOGORAD L, 1962, METHOD ENZYMOL, V5, P885, DOI 10.1016/S0076-6879(62)05334-3; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen LFO, 2008, PLANT SCI, V174, P25, DOI 10.1016/j.plantsci.2007.09.006; Cui K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157362; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; DAmato F, 1997, CARYOLOGIA, V50, P1; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Gao M, 2016, THEOR APPL GENET, V129, P1, DOI [10.1007/s00122-015-2595-9, DOI 10.1007/S00122-015-2595-9]; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hu XY, 2015, PLANT PHYSIOL, V167, P660, DOI 10.1104/pp.114.252023; Jacob-Wilk D, 1999, PLANT J, V20, P653, DOI 10.1046/j.1365-313X.1999.00637.x; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Li CF, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0885-2; Li WX, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0015-4; Li W, 2016, PHYSIOL PLANTARUM, V157, P24, DOI 10.1111/ppl.12405; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Li ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119027; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu WZ, 2007, PLANTA, V226, P785, DOI 10.1007/s00425-007-0525-z; Luo T, 2013, PLANT PHYSIOL BIOCH, V65, P17, DOI 10.1016/j.plaphy.2013.01.006; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Oda-Yamamizo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23609; Peng XP, 2014, FUEL, V134, P485, DOI 10.1016/j.fuel.2014.05.069; Pu YQ, 2009, BIOENERG RES, V2, P198, DOI 10.1007/s12155-009-9056-8; Sakuraba Y, 2014, MOL PLANT, V7, P1288, DOI 10.1093/mp/ssu045; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schenk N, 2007, FEBS LETT, V581, P5517, DOI 10.1016/j.febslet.2007.10.060; SCHMELZER E, 1988, P NATL ACAD SCI USA, V85, P2989, DOI 10.1073/pnas.85.9.2989; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shemer TA, 2008, PLANT PHYSIOL, V148, P108, DOI 10.1104/pp.108.124933; Shpilyov AV, 2005, BBA-BIOENERGETICS, V1706, P195, DOI 10.1016/j.bbabio.2004.11.001; Sobel JM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00321; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanaka Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1760, DOI 10.1271/bbb.100358; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0352-x; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; WASSCHER J., 1956, EUPHYTICA, V5, P163; Wu HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061594; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; YAMASAKI H, 1995, J PLANT RES, V108, P171, DOI 10.1007/BF02344341; Yang YL, 2016, PLANT GROWTH REGUL, V78, P69, DOI 10.1007/s10725-015-0075-5; Zhang K, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2321-5; Zhu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0821-5; 2018, PLANT PHYSIOL BIOCH, V129, P400, DOI DOI 10.1016/J.PLAPHY.2018.06.019; 2009, TRENDS PLANT SCI, V14, P125, DOI DOI 10.1016/J.TPLANTS.2008.12.003; 2013, PLANT MOL BIOL, V82, P505, DOI DOI 10.1007/S11103-012-9940-Z	62	31	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216879	10.1371/journal.pone.0216879	http://dx.doi.org/10.1371/journal.pone.0216879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112574	gold, Green Published, Green Submitted			2022-12-27	WOS:000468451000029
J	Furlong, M; Deming-Halverson, S; Sandler, DP				Furlong, Melissa; Deming-Halverson, Sandra; Sandler, Dale P.			Chronic antibiotic use during adulthood and weight change in the Sister Study	PLOS ONE			English	Article							BODY-MASS INDEX; GUT MICROBIOTA; CHILDHOOD; OBESITY; RISK; INFECTION; NUTRITION; INFANCY	Background/Objectives Antibiotic use in early life has been associated with weight gain in several populations. However, associations between chronic antibiotic use and weight among adults in the general population are unknown. Subjects/Methods The NIEHS Sister Study is a longitudinal cohort of sisters of women with breast cancer. We examined associations between chronic antibiotic use (>= 3 months) during the fourth decade of life (30-39 years) and subsequent obesity at enrollment (mean age = 55) via logistic regression. We also examined associations between chronic antibiotic use in the 5 years and 12 months prior to enrollment and weight gain after enrollment in linear mixed models. Models were adjusted for race/ethnicity, education, urban/rural status, age, and smoking. Results In adjusted analyses (n = 50,237), chronic penicillin use during the 4 th decade of life was associated with obesity at enrollment (OR 2.00, 95% CI 1.40, 2.87), and use in the 5 years prior to enrollment was associated with increased BMI change after enrollment (beta 1.00 95% CI 0.01, 2.00). Use of bactericidals (OR 1.71, 95% CI 1.29, 2.26) during the 4 th decade of life was also associated with obesity at enrollment. Associations for penicillins and bactericidals were consistent across indications for use. Bacteriostatic use in the 5 years prior to enrollment was associated with a reduction in BMI after enrollment (beta -0.52, 95% CI -1.04, 0.00), and tetracycline use during the 4 th decade of life was associated with reduced odds of obesity at enrollment (OR 0.72, 95% CI 0.56, 0.92). However, these inverse associations were only present for those who reported taking antibiotics for skin purposes. Cephalosporins, macrolides, quinolones, and sulfonamides were not associated with BMI change over time. Conclusions Chronic use of antibiotics during adulthood may have long-lasting impacts on BMI. Associations may differ by antibiotic class, and confounding by indication may be important for some antibiotic classes.	[Furlong, Melissa] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27516 USA; [Furlong, Melissa] Univ Arizona, Dept Commun Environm & Policy, Tucson, AZ 85721 USA; [Deming-Halverson, Sandra] Social & Sci Syst Inc, Durham, NC USA; [Deming-Halverson, Sandra] Vanderbilt Univ, Div Epidemiol, Med Ctr, Nashville, TN USA; [Sandler, Dale P.] NIEHS, Epidemiol Branch, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Arizona; Social & Scientific Systems; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Furlong, M (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27516 USA.; Furlong, M (corresponding author), Univ Arizona, Dept Commun Environm & Policy, Tucson, AZ 85721 USA.	mfurlong@email.arizona.edu		Sandler, Dale/0000-0002-6776-0018	Intramural Research Program of the NIH, National Institute of Environmental Sciences [Z01ES044005]; NIEHS [T32ES007018, K99ES028743]; NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044005, K99ES028743, T32ES007018] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Sciences; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Sister Study (DS and SDH) is supported by the Intramural Research Program of the NIH, National Institute of Environmental Sciences (Z01ES044005). Social and Scientific Systems, Inc, a commercial company which employs SDH, is contracted by NIH to provide support services to the NIEHS funded Sister Study. M.F was supported in part by NIEHS institutional training grant T32ES007018, and later by NIEHS K99ES028743. Neither SSI nor the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Azad MB, 2014, INT J OBESITY, V38, P1290, DOI 10.1038/ijo.2014.119; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kadooka Y, 2013, BRIT J NUTR, V110, P1696, DOI 10.1017/S0007114513001037; Korpela K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0245-y; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Lane JA, 2011, ALIMENT PHARM THER, V33, P922, DOI 10.1111/j.1365-2036.2011.04610.x; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li DK, 2017, LANCET DIABETES ENDO, V5, P18, DOI [10.1016/S2213-8587(16)30281-9, 10.1016/s2213-8587(16)30281-9]; Lin CJ, 2012, PUBLIC HEALTH NUTR, V15, P989, DOI 10.1017/S1368980011003193; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Mikkelsen KH, 2017, DIABETIC MED, V34, P272, DOI 10.1111/dme.13262; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P3633, DOI 10.1210/jc.2015-2696; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Murphy R, 2014, INT J OBESITY, V38, P1115, DOI 10.1038/ijo.2013.218; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Poulsen MN, 2017, OBESITY, V25, P438, DOI 10.1002/oby.21719; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Sandler DP, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1923; Schwartz BS, 2016, INT J OBESITY, V40, P615, DOI 10.1038/ijo.2015.218; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; Shapiro DJ, 2013, J ANTIMICROB CHEMOTH, P2007; Sharafedtinov KK, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-138; STOKSTAD ELR, 1954, PHYSIOL REV, V34, P25, DOI 10.1152/physrev.1954.34.1.25; STOKSTAD ELR, 1953, POULTRY SCI, V32, P1054, DOI 10.3382/ps.0321054; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Woodard GA, 2009, J GASTROINTEST SURG, V13, P1198, DOI 10.1007/s11605-009-0891-x	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216959	10.1371/journal.pone.0216959	http://dx.doi.org/10.1371/journal.pone.0216959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095628	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100058
J	Ahedo, V; Caro, J; Bortolini, E; Zurro, D; Madella, M; Galan, JM				Ahedo, Virginia; Caro, Jorge; Bortolini, Eugenio; Zurro, Debora; Madella, Marco; Manuel Galan, Jose			Quantifying the relationship between food sharing practices and socio-ecological variables in small-scale societies: A cross-cultural multi-methodological approach	PLOS ONE			English	Article							HUMAN BEHAVIORAL ECOLOGY; WILCOXON-MANN-WHITNEY; NICHE CONSTRUCTION; EVOLUTIONARY; DISTANCE; DIVERSITY; TESTS; CLASSIFICATION; POPULATIONS; COOPERATION	This article presents a cross-cultural study of the relationship among the subsistence strategies, the environmental setting and the food sharing practices of 22 modern small-scale societies located in America (n = 18) and Siberia (n = 4). Ecological, geographical and economic variables of these societies were extracted from specialized literature and the publicly available D-PLACE database. The approach proposed comprises a variety of quantitative methods, ranging from exploratory techniques aimed at capturing relationships of any type between variables, to network theory and supervised-learning predictive modelling. Results provided by all techniques consistently show that the differences observed in food sharing practices across the sampled populations cannot be explained just by the differential distribution of ecological, geographical and economic variables. Food sharing has to be interpreted as a more complex cultural phenomenon, whose variation over time and space cannot be ascribed only to local adaptation.	[Ahedo, Virginia; Caro, Jorge] Univ Burgos, Dept Ingn Civil, Escuela Politecn Super, Area Org Empresas, Burgos, Spain; [Ahedo, Virginia; Caro, Jorge; Bortolini, Eugenio; Zurro, Debora; Madella, Marco] CSIC, Inst Mila & Fontanals, CaSEs Culture & Socioecol Syst Res Grp, Dept Arqueol & Antropol, Barcelona, Spain; [Ahedo, Virginia; Caro, Jorge; Bortolini, Eugenio; Zurro, Debora; Madella, Marco] UPF, Dept Humanidades, Barcelona, Spain; [Bortolini, Eugenio] Univ Bologna, Dept Cultural Heritage, Ravenna, Italy; [Madella, Marco] ICREA, Barcelona, Spain; [Madella, Marco] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Manuel Galan, Jose] Univ Burgos, Escuela Politecn Super, Dept Ingn Civil, INSISOC,Area Org Empresas, Burgos, Spain	Universidad de Burgos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Pompeu Fabra University; University of Bologna; ICREA; University of Witwatersrand; Universidad de Burgos	Ahedo, V (corresponding author), Univ Burgos, Dept Ingn Civil, Escuela Politecn Super, Area Org Empresas, Burgos, Spain.; Ahedo, V (corresponding author), CSIC, Inst Mila & Fontanals, CaSEs Culture & Socioecol Syst Res Grp, Dept Arqueol & Antropol, Barcelona, Spain.; Ahedo, V (corresponding author), UPF, Dept Humanidades, Barcelona, Spain.	vahedo@ubu.es	Madella, Marco/M-3320-2014; Galán, José Manuel/B-9782-2009; Ahedo, Virginia/U-6406-2017; Zurro, Debora/L-3965-2014	Madella, Marco/0000-0002-9324-1545; Galán, José Manuel/0000-0003-3360-7602; Ahedo, Virginia/0000-0002-9812-388X; Zurro, Debora/0000-0003-2498-9338; BORTOLINI, EUGENIO/0000-0001-6751-5680; Caro Saiz, Jorge/0000-0002-5065-4841	Spanish Ministry of Science, Innovation and Universities [CSD2010-00034 CONSOLIDER-INGENIO 2010, HAR2017-90883-REDC, HAR2016-77672-P]; European Social Fund; Department of Education of Junta de Castilla y Leon	Spanish Ministry of Science, Innovation and Universities; European Social Fund(European Social Fund (ESF)); Department of Education of Junta de Castilla y Leon	The authors acknowledge support from the Spanish Ministry of Science, Innovation and Universities: SimulPast Project (CSD2010-00034 CONSOLIDER-INGENIO 2010), (VA, JC, EB, DZ, MM, JMG), Consolider Excellence Network (HAR2017-90883-REDC) (VA, JC, EB, DZ, MM, JMG), and CULM Project (HAR2016-77672-P) (DZ, JC, MM). In addition, this work was partially supported by the European Social Fund, as the corresponding author is the recipient of a predoctoral grant from the Department of Education of Junta de Castilla y Leon (VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr Stefano Biagetti for his advice and insightful suggestions, as well as the two reviewers of the article (Dr Sandrine Gallois and the anonymous reviewer) for their constructive comments, which helped us to improve the manuscript significantly. The authors especially appreciate the help and support provided by the Human Relations Area Files (HRAF), that gave free access to the eHRAF World Cultures database to Dr Jorge Caro during part of his PhD.	Abdi H., 2007, ENCY MEAS STAT, P1, DOI DOI 10.4135/9781412952644; Adem TA, 2012, CULTURE SUMMARY SAMO; Andersen Raol, 1970, ETHNOHISTORY, VXVII, P49; ANDERSON DG, 1991, ARCTIC, V44, P12; Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021; [Anonymous], 1996, NATURE SOC ANTHR PER; Arhem K., 1981, MAKUNA SOCIAL ORG ST; Austerlitz R., 2010, CULTURE SUMMARY NIVK; Basak D., 2007, NEURAL INF PROCESS L, V11; Basehart H.W., 1974, MESCALERO APACHE SUB; BASEHART HW, 1970, SOUTHWEST J ANTHROP, V26, P87, DOI 10.1086/soutjanth.26.1.3629272; Beierle J., 2002, CULTURE SUMMARY STON; Beierle J., 1998, CULTURE SUMMARY TUKA; Beierle J., 2012, CULTURE SUMMARY CHIR; Beierle John, 2006, CULTURE SUMMARY JIVA; Benz M., 2010, P S HELD 29 31 JAN 2, P330; Berkman E.T., 2012, CONCEPTUAL GUIDE STA; Bhanu B. A., 2014, E ANTHR, V67, P325; Binford L.R., 2001, CONSTRUCTING FRAMES; Bird RLB, 1997, CURR ANTHROPOL, V38, P49, DOI 10.1086/204581; BODENHORN B, 2000, SENRI ETHNOLOGICAL S, V53, P27, DOI DOI 10.15021/00002844; BOHANNAN P, 1963, SOCIAL ANTHR; Borgerhoff Mulder M, 2012, HUMAN BEHAV ECOLOGY, DOI [10.1002/9780470015902.a0003671.pub2, DOI 10.1002/9780470015902.A0003671.PUB2]; Bortolini E, 2017, P NATL ACAD SCI USA, V114, P9140, DOI 10.1073/pnas.1614395114; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown Gillian R., 2014, Journal of Bioeconomics, V16, P105, DOI 10.1007/s10818-013-9166-4; CARACO T, 1986, J THEOR BIOL, V118, P379, DOI 10.1016/S0022-5193(86)80160-6; Caro J., 2017, NORMAS REPARTO RECUR; CASHDAN EA, 1980, AM ANTHROPOL, V82, P116, DOI 10.1525/aa.1980.82.1.02a00100; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Chagnon N., 2000, ADAPTATION HUMAN BEH, P27; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Collings P, 1998, ARCTIC, V51, P301; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Creanza N, 2015, P NATL ACAD SCI USA, V112, P1265, DOI 10.1073/pnas.1424033112; Creanza N, 2014, P NATL ACAD SCI USA, V111, P10830, DOI 10.1073/pnas.1400824111; Crema ER, 2014, J ARCHAEOL SCI, V43, P289, DOI 10.1016/j.jas.2014.01.002; Damas D., 1972, HUNTERS GATHERERS TO, P3; Damas David, 1996, CULTURE SUMMARY COPP; David F., 2010, MAGDALENIAN HOUSEHOL, P245; Davies N.B., 2012, INTRO BEHAV ECOLOGY, V4th; Delaney HD, 2002, PSYCHOL METHODS, V7, P485, DOI 10.1037//1082-989X.7.4.485; Dyble M, 2016, CURR BIOL, V26, P2017, DOI 10.1016/j.cub.2016.05.064; Ember C.R., 2001, CROSS CULTURAL RES M; Ember CR, 2018, EVOL HUM BEHAV, V39, P380, DOI 10.1016/j.evolhumbehav.2018.03.001; Ember M, 2000, ETHNOLOGY, V39, P349, DOI 10.2307/3774051; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Enloe J., 2003, FARMING, V21, P1, DOI [10.3828/bfarm.2003.1.1, DOI 10.3828/BFARM.2003.1.1]; Evans-Pritchard E.E., 1940, NUER DESCRIPTION MOD; Ewers JC, 1955, HORSE BLACKFOOT INDI, Vxv, P374; Fagerland MW, 2009, STAT MED, V28, P1487, DOI 10.1002/sim.3561; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Feltovich N., 2003, Experimental Economics, V6, P273, DOI 10.1023/A:1026273319211; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Flannery K.V., 1972, ANNU REV ECOL SYST, V3, P399, DOI 10.1146/annurev.es.03.110172.002151; FOLEY R, 1985, MAN, V20, P222, DOI 10.2307/2802382; Fort J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0166; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Fortier J, 2001, ETHNOLOGY, V40, P193, DOI 10.2307/3773965; Franzen M, 2007, ECOL ECON, V63, P776, DOI 10.1016/j.ecolecon.2007.02.001; Frey R., 2014, CULTURE SUMMARY CROW; Garfield ZH., 2016, SOCIAL LEARNING INNO, P19; Godoy R, 2005, ANNU REV ANTHROPOL, V34, P121, DOI 10.1146/annurev.anthro.34.081804.120412; Goldman I., 1963, CUBEO INDIANS NW AMA; Gorfine M., 2015, SCIENCE, P1; Grafen A, 2006, J THEOR BIOL, V238, P541, DOI 10.1016/j.jtbi.2005.06.009; Greenfield PJ, 2002, CULTURE SUMMARY W AP; Gregory Christopher, 2015, GIFTS COMMODITIES, VSecond; Grier Colin, 2000, Hierarchies in Action: Cui Bono?, P264; Grinnell GB., 1892, AM ANTHROPOL, V5, P153; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Gurven M, 2000, HUM ECOL, V28, P171, DOI 10.1023/A:1007067919982; GUY J, 1987, J S AFR STUD, V14, P18, DOI 10.1080/03057078708708158; Hames R, 2007, HUM NATURE-INT BIOS, V18, P1, DOI 10.1007/BF02820843; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Harder MNC, 2012, GAMMA RADIATION, P305; Harner Michael J., 1984, JIVARO PEOPLE SACRED; Hastie T., 2009, ELEMENTS STAT LEARNI, P520, DOI DOI 10.1007/978-0-387-84858-7; Heinen HD, 1973, ADAPTIVE CHANGES TRI; Heinen HD, 2001, CULTURE SUMMARY WARA; Heinen HD, 1974, J ANTHROPOL RES, V30, P116; Heller R, 2013, BIOMETRIKA, V100, P503, DOI 10.1093/biomet/ass070; Henriksen G., 1973, HUNTERS BARRENS NASK; Honigmann J.J.B., 1948, CULTURE ETHOS KASKA; Honigmann JJ, 2012, CULTURE SUMMARY KASK; Horne C, 2002, RATION SOC, V14, P285, DOI 10.1177/1043463102014003002; Horne Christine., 2009, REWARDS PUNISHMENT R; Hunt RC, 2000, SENRI ETHNOL STUD, DOI [10.15021/00002843, DOI 10.15021/00002843]; Ihara Y, 2004, THEOR POPUL BIOL, V65, P105, DOI 10.1016/j.tpb.2003.07.003; Ikeya K., 2013, SENRI ETHNOL STUD NA, P121, DOI [10.15021/00002440, DOI 10.15021/00002440]; Jaeggi AV, 2013, EVOL ANTHROPOL, V22, P186, DOI 10.1002/evan.21364; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Kameda T, 2005, CURR DIR PSYCHOL SCI, V14, P331, DOI 10.1111/j.0963-7214.2005.00392.x; Kaplan H., 2005, MORAL SENTIMENTS MAT; Karsten R., 1935, COMMENTATIONES HUMAN, V598, pxvi; Kirby KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158391; Kishigami N, 2004, J ANTHROPOL RES, V60, P341, DOI 10.1086/jar.60.3.3630754; Kitanishi K., 2000, SENRI ETHNOL STUD, V53, P149; Krebs J.R., 1996, BEHAV ECOLOGY EVOLUT; KRUPNIK II, 1987, ARCTIC, V40, P16; Kuncheva LI, 2014, COMBINING PATTERN CLASSIFIERS: METHODS AND ALGORITHMS, 2ND EDITION, P1; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Lancelotti C, 2016, ECOL SOC, V21, DOI 10.5751/ES-08757-210408; Lenoir JD, 1997, PARAMACCA MAROONS ST; LIa Shternberg, 1933, GILYAK OROCHI GOLDI; Loterman G, 2012, INT J FORECASTING, V28, P161, DOI 10.1016/j.ijforecast.2011.01.006; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Macdonald Gaynor, 2000, SOCIAL EC SHARING RE, V53, P87, DOI DOI 10.15021/00002846; Mace R, 2011, PHILOS T R SOC B, V366, P402, DOI 10.1098/rstb.2010.0238; Malinowski Bronislaw., 1922, ARGONAUTS W PACIFIC; Marlowe FW, 2004, RES ECON ANTHROPOL, V23, P69, DOI 10.1016/S0190-1281(04)23003-7; Mauss M., 1954, AM SOCIOLOGICAL REV; Morgan LH, 1959, INDIAN J 1859 62; MURDOCK GP, 1967, ETHNOLOGY, V6, P109, DOI 10.2307/3772751; Murphy RF, 1960, SOCIAL EC CHANGE MUN; Murphy Yolanda, 1985, WOMEN FOREST; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; Nettle D, 2013, BEHAV ECOL, V24, P1031, DOI 10.1093/beheco/ars222; Nettle D, 2009, TRENDS ECOL EVOL, V24, P618, DOI 10.1016/j.tree.2009.05.013; NUGENT D, 1993, AM ETHNOL, V20, P336, DOI 10.1525/ae.1993.20.2.02a00070; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Opler M. E., 1941, APACHE LIFE WAY EC S; Orquera L.A., 1999, ARQUEOLOGIA REGION C; Pardo C, 2013, APPL MATH COMPUT, V219, P9914, DOI 10.1016/j.amc.2013.03.139; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; Pereda M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45574; Perry RJ., 1993, APACHE RESERVATION I; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Polanyi Karl., 1957, TRADE MARKET EARLY E; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Reed Richard K., 1995, PROPHETS AGROFORESTR; Reed RK, 1998, CULTURE SUMMARY GUAR; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reid GF, 2009, CULTURE SUMMARY INNU; Ren Y, 2016, IEEE COMPUT INTELL M, V11, P41, DOI 10.1109/MCI.2015.2471235; Reyes-Garcia V, 2016, CURR ANTHROPOL, V57, P761, DOI 10.1086/689307; Rodnick D., 1938, FORT BELKNAP ASSINIB; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Rousset F, 1997, GENETICS, V145, P1219; Sahlins MarshallD., 1972, STONE AGE EC; Santos JI, 2015, PLOS ONE, DOI [10.2307/282074, DOI 10.2307/282074]; Sharp HS, 1994, INVERTED SACRIFICE, P253; Sharp HS, 1981, NULL CASE CHIPEWYAN, P221; Shennan SJ, 2015, EVOL HUM BEHAV, V36, P103, DOI 10.1016/j.evolhumbehav.2014.09.006; Simon N, 2014, COMMENT DETECTING NO; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Smith BD., 2009, COMMUNICATIVE INTEGR, V2, P533, DOI DOI 10.4161/cib.2.6.9613; Smith EA, 2001, TRENDS ECOL EVOL, V16, P128, DOI 10.1016/S0169-5347(00)02077-2; SMITH EA, 1983, CURR ANTHROPOL, V24, P625, DOI 10.1086/203066; SMITH EA, 2007, MODEL BASED ARCHAEOL; SMITH EF, 1981, KANS AES BULL, P1; Smith EA, 2011, PHILOS T R SOC B, V366, P325, DOI 10.1098/rstb.2010.0233; Snow J., 1977, THESE MOUNTAINS ARE; Sorokowska A, 2017, APPETITE, V116, P291, DOI 10.1016/j.appet.2017.05.015; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Trudeau N., 2002, SUSTAINABLE FOOD SEC, P103; Turchin Peter, 2015, CLIODYNAMICS J QUANT, V6, DOI [10.21237/C7clio6127917, DOI 10.21237/C7CLIO6127917]; van Wetering W, 1999, CULTURE SUMMARY NDYU; VanStone JW, 1963, SNOWDRIFT CHIPEWYAN, V2, P4; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Voget Fred, 1980, POLITICAL ORG NATIVE, P14163; Voget FW, 2001, HDB N AM INDIANS, P695; Widlok T, 2013, HAU-J ETHNOGR THEORY, V3, P11, DOI 10.14318/hau3.2.003; WINTERHALDER B, 1986, J ANTHROPOL ARCHAEOL, V5, P369, DOI 10.1016/0278-4165(86)90017-6; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Witherspoon G., 1975, NAVAJO KINSHIP MARRI; Woodburn James, 1998, PROPERTY RELATIONS R; Wright S, 1943, GENETICS, V28, P114; Zhornitskaya M, 1996, CULTURE SUMMARY CHUK; Ziker J. P., 2002, PEOPLES TUNDRA NO SI; Ziker JP, 2007, ECOL FOOD NUTR, V46, P445, DOI 10.1080/03670240701486743; Ziker JP, 2014, EXPT SOCIAL NORMS FA	182	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216302	10.1371/journal.pone.0216302	http://dx.doi.org/10.1371/journal.pone.0216302			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141510	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000005
J	Campbell, M; Straatmann, VS; Lai, ETC; Potier, J; Pereira, SMP; Wickham, SL; Taylor-Robinson, DC				Campbell, Melisa; Straatmann, Viviane S.; Lai, Eric T. C.; Potier, Joanne; Pereira, Snehal M. Pinto; Wickham, Sophie L.; Taylor-Robinson, David C.			Understanding social inequalities in children being bullied: UK Millennium Cohort Study findings	PLOS ONE			English	Article							ADULT HEALTH; VICTIMIZATION; SCHOOL; RISK; BULLY/VICTIM; PERCEPTIONS; INVOLVEMENT; CHILDHOOD; TEACHERS; BEHAVIOR	Background Children living in disadvantaged socio-economic circumstances (SEC) are more commonly victims of bullying, but pathways leading to social inequalities in being bullied are unclear. We assess how early life risk factors might mediate the increased risk of being bullied at age seven for children living in disadvantaged circumstances. Material and methods Using data from 5,857 children in the UK Millennium Cohort Study (MCS) we calculate risk ratios (RR) for being bullied at age seven (child-reported), by household income quintile. Socially patterned risk factors for being bullied relating to social networks, family relationships and child characteristics from birth to age five were adjusted for to assess if they mediated any association between SEC and being bullied. Results 48.6% of children reported having been bullied. Children living in the lowest income households were at 20% greater risk of being bullied compared to those from the highest (RR1.20, 95% CI 1.06,1.36). Controlling for social networks, family relationships and child characteristics attenuated the increased risk for children in low income households to aRR 1.19 (95% CI 1.05, 1.35), aRR 1.16 (95% CI 1.02,1.32) and aRR 1.13 (95% CI 1.00,1.28) respectively. Our final model adjusted for risk factors across all domains attenuated the RR by 45% (aRR 1.11,95% CI 0.97,1.26). Conclusions About half of children reported being bullied by age seven with a clear social gradient. The excess risk in children growing up in disadvantaged circumstances was partially explained by differences in their early years relating to their social network, family relationships and the child's own abilities and behaviours. Policies to reduce inequalities in these risk factors may also reduce inequalities in the risk of being bullied in childhood.	[Campbell, Melisa; Straatmann, Viviane S.; Lai, Eric T. C.; Wickham, Sophie L.; Taylor-Robinson, David C.] Univ Liverpool, Publ Hlth & Policy, Liverpool, Merseyside, England; [Potier, Joanne] Alder Hey Childrens NHS Fdn Trust, Liverpool Fresh Child & Adolescent Mental Hlth Se, Liverpool, Merseyside, England; [Pereira, Snehal M. Pinto] UCL, Inst Epidemiol & Hlth Care, London, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of London; University College London	Campbell, M (corresponding author), Univ Liverpool, Publ Hlth & Policy, Liverpool, Merseyside, England.	melisa.campbell@liverpool.ac.uk	Lai, Eric/X-8950-2019	Taylor-Robinson, David/0000-0002-5828-7724; Pinto Pereira, Snehal/0000-0002-0876-8757; Campbell, Melisa/0000-0002-7058-4318; /0000-0002-7515-2979	Medical Research Council [MR/P008577/1, MR/M0501633/1, MR/P020372/1]; Health Education England; Wellcome Trust [200335/Z/15/Z]; ESRC [ES/R008930/1] Funding Source: UKRI; MRC [G0802448, MR/P008577/1, MR/P020372/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Education England; Wellcome Trust(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by Medical Research Council (MR/P008577/1 to DCT-R, and MR/M0501633/1, and MR/P020372/1 to SMPP), the Health Education England, and The Wellcome Trust (200335/Z/15/Z to SLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker ED, 2008, J AM ACAD CHILD PSY, V47, P1030, DOI [10.1097/CHI0b013e31817eee98, 10.1097/CHI.ObO13e31817eec98]; Bowes L, 2010, J CHILD PSYCHOL PSYC, V51, P809, DOI 10.1111/j.1469-7610.2010.02216.x; Bowes L, 2009, J AM ACAD CHILD PSY, V48, P545, DOI 10.1097/CHI.0b013e31819cb017; Busch V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1118; Centre for Longitudinal Studies, 2018, MILL COH STUD DAT; Chamberlain T, 2010, DCSFRB218 NAT FDN ED; Chatzitheochari S., 2014, 1411 DEP QUANT SOC S, DOI [10.13140/RG.2.2.31505.63841, DOI 10.13140/RG.2.2.31505.63841]; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Connelly R, 2014, INT J EPIDEMIOL, V43, P1719, DOI 10.1093/ije/dyu001; Demaray MK, 2013, CHILD YOUTH SERV REV, V35, P2091, DOI 10.1016/j.childyouth.2013.10.018; Due P, 2009, EUR J PUBLIC HEALTH, V19, P464, DOI 10.1093/eurpub/ckp099; Georgiou S. N., 2008, SOC PSYCHOL EDUC, V11, P213, DOI [10.1007/s11218-007-9048-5, DOI 10.1007/S11218-007-9048-5]; Hansen TB, 2012, AGGRESS VIOLENT BEH, V17, P383, DOI 10.1016/j.avb.2012.03.008; Holt MK, 2015, PEDIATRICS, V135, pE496, DOI 10.1542/peds.2014-1864; Hong JS, 2012, AGGRESS VIOLENT BEH, V17, P311, DOI 10.1016/j.avb.2012.03.003; Huesmann L. R, 1994, AGGRESSIVE BEHAV PLE, P97, DOI [10.1007/978-1-4757-9116-7_5, DOI 10.1007/978-1-4757-9116-7_5]; Janosz M, 2018, J EPIDEMIOL COMMUN H, V72, P1117, DOI 10.1136/jech-2018-211203; Jansen DEMC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-440; Johnson J, 2014, GUIDE MCS DATASETS; Kendrick K, 2012, J ADOLESCENCE, V35, P1069, DOI 10.1016/j.adolescence.2012.02.014; Klomek AB, 2010, REV CAN PSYCHIAT, V55, P2, DOI [10.1177/070674371005500503, DOI 10.1177/070674371005500503]; Lereya ST, 2013, CHILD ABUSE NEGLECT, V37, P1091, DOI 10.1016/j.chiabu.2013.03.001; Lung FW, 2009, CHILD CARE HLTH DEV, V35, P409, DOI 10.1111/j.1365-2214.2009.00963.x; Menrath I, 2015, J DEV BEHAV PEDIATR, V36, P305, DOI 10.1097/DBP.0000000000000168; Mishna F, 2006, VICTIMS OFFENDERS, V1, P255, DOI 10.1080/15564880600626163; Pearce A, 2019, ARCH DIS CHILD, V104, P998, DOI 10.1136/archdischild-2018-314808; Pontzer D, 2010, J FAM VIOLENCE, V25, P259, DOI 10.1007/s10896-009-9289-5; Rajendran K, 2016, J CHILD PSYCHOL PSYC, V57, P188, DOI 10.1111/jcpp.12433; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Rivers I, 2009, SCHOOL PSYCHOL QUART, V24, P211, DOI 10.1037/a0018164; Roberts C., 2012, HLTH BEHAV SCH AGED; Shakoor S, 2011, J ABNORM CHILD PSYCH, V39, P379, DOI 10.1007/s10802-010-9463-5; Shepherd P., 2019, MILLENNIUM COHORT ST; Steen J, 2017, J STAT SOFTW, V76, DOI 10.18637/jss.v076.i11; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Tippett N, 2014, AM J PUBLIC HEALTH, V104, pE48, DOI 10.2105/AJPH.2014.301960; Winsper C, 2012, J AM ACAD CHILD PSY, V51, P271, DOI 10.1016/j.jaac.2012.01.001; Wolke D, 2013, PSYCHOL SCI, V24, P1958, DOI 10.1177/0956797613481608; Zambon F, 2014, INJURIES INEQUITIES, P1	40	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217162	10.1371/journal.pone.0217162	http://dx.doi.org/10.1371/journal.pone.0217162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141521	Green Submitted, Green Published, gold			2022-12-27	WOS:000469323000042
J	Schultchen, D; Zaudig, M; Krauseneck, T; Berberich, G; Pollatos, O				Schultchen, Dana; Zaudig, Michael; Krauseneck, Till; Berberich, Goetz; Pollatos, Olga			Interoceptive deficits in patients with obsessive-compulsive disorder in the time course of cognitive-behavioral therapy	PLOS ONE			English	Article							DEPRESSION INVENTORY-II; PHYSIOLOGICAL CONDITION; EMOTION REGULATION; NEURAL MARKERS; SENSITIVITY; PERCEPTION; AWARENESS; SCALE; UNCERTAINTY; PERFORMANCE	Interoception is impaired in different psychiatric disorders and is also associated with emotions. Only one study could show a higher interoceptive accuracy (IAcc) in patients with obsessive-compulsive disorder (OCD). Based on the predictive coding system we assume contrary results, indicating a decreased IAcc in patients with OCD. So far, there is no study investigating the effect of cognitive-behavioral therapy on IAcc in patients with OCD. Therefore, we hypothesize that patients with OCD improve their IAcc during the time course of therapy compared to healthy controls. Twenty-six patients with OCD from the Psychosomatic Clinic in Windach were examined in the time course of cognitive-behavioral therapy. They were compared to 26 matched healthy controls. IAcc via the heartbeat perception task as well as questionnaire data (OCD-, depression-and anxiety symptoms) were assessed. Results showed that IAcc, OCD-, depression-and anxiety symptoms were attenuated in patients with OCD. Patients recovered in the time course of therapy regarding OCD-, depression-and anxiety symptoms. Interoceptive deficits did not change in the time course of cognitive-behavioral therapy. We demonstrated that IAcc is affected in patients with OCD and this deficit does not change during the time course of a standardized therapy. Future studies should investigate, whether an inaccuracy in perceiving one's bodily signals constitutes a risk factor for relapse. Further, it could be examined if IAcc can be increased via self- and body focus interventions in patients with OCD.	[Schultchen, Dana; Pollatos, Olga] Ulm Univ, Inst Psychol & Educ, Dept Clin & Hlth Psychol, Ulm, Germany; [Zaudig, Michael; Berberich, Goetz] Klinikum Windach Ammersee, Windach, Germany; [Krauseneck, Till] Kbo Isar Amper Klinikum, Munich, Germany	Ulm University	Schultchen, D (corresponding author), Ulm Univ, Inst Psychol & Educ, Dept Clin & Hlth Psychol, Ulm, Germany.	dana.schultchen@uni-ulm.de		Schultchen, Dana/0000-0001-5623-535X				Ainley V, 2012, PSYCHOPHYSIOLOGY, V49, P1672, DOI 10.1111/j.1469-8986.2012.01468.x; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Beck AT, 1996, PSYCHOL ASSESS; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Canales-Johnson A, 2015, CEREB CORTEX, V25, P4490, DOI 10.1093/cercor/bhv076; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2000, FEELING WHAT HAPPENS; Dunn BD, 2007, BEHAV RES THER, V45, P1921, DOI 10.1016/j.brat.2006.09.008; Dunn BD, 2010, BEHAV RES THER, V48, P1133, DOI 10.1016/j.brat.2010.07.006; Ehlers A, 1996, BIOL PSYCHOL, V42, P165, DOI 10.1016/0301-0511(95)05153-8; Fischer D, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00452; Fischer D, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00199; Friston K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0481; Friston KJ, 2014, LANCET PSYCHIAT, V1, P148, DOI 10.1016/S2215-0366(14)70275-5; Garfinkel S. N., 2017, HDB PSYCHOPHYSIOLOGY, P427; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; Hermans D, 2003, BEHAV RES THER, V41, P383, DOI 10.1016/S0005-7967(02)00015-3; Hermans D, 2008, BEHAV RES THER, V46, P98, DOI 10.1016/j.brat.2007.11.001; James W., 1884, MIND Q REV PSYCHOL P, V9, P188, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188, https://doi.org/10.1093/mind/os-IX.34.188]; Kever A, 2015, PERS INDIV DIFFER, V87, P20, DOI 10.1016/j.paid.2015.07.014; Koch A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01003; Koch A, 2014, PSYCHOPHYSIOLOGY, V51, P932, DOI 10.1111/psyp.12233; Krefetz DG, 2003, PSYCHOL REP, V92, P489, DOI 10.2466/PR0.92.2.489-497; Lazarov A, 2014, J ABNORM PSYCHOL, V123, P695, DOI 10.1037/abn0000004; Lazarov A, 2010, BEHAV RES THER, V48, P516, DOI 10.1016/j.brat.2010.02.007; Liberman N., 2009, PSYCHOL GOALS, P277, DOI DOI 10.1016/J.ENBUILD.2010.10.010; Marcks BA, 2007, BEHAV RES THER, V45, P2640, DOI 10.1016/j.brat.2007.06.012; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Pollatos O, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00786; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Rapoport J., 1991, BOY WHO COULDNT STOP; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Shapiro D., 1965, NEUROTIC STYLES; Song A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022361; Spielberger CD, 1983, MANUAL STATE TRAIN A; Steer RA, 1998, J PSYCHOPATHOL BEHAV, V20, P127, DOI 10.1023/A:1023091529735; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; Steer RA, 2000, BEHAV RES THER, V38, P311, DOI 10.1016/S0005-7967(99)00068-6; Steer RA, 1997, MEAS EVAL COUNS DEV, V30, P128, DOI 10.1080/07481756.1997.12068933; Steketee G, 1996, BEHAV RES THER, V34, P675, DOI 10.1016/0005-7967(96)00036-8; Taylor S, 2011, CLIN PSYCHOL REV, V31, P1083, DOI 10.1016/j.cpr.2011.06.007; Terasawa Y, 2013, HUM BRAIN MAPP, V34, P598, DOI 10.1002/hbm.21458; van den Hout MA, 2009, BEHAV RES THER, V47, P535, DOI 10.1016/j.brat.2009.03.001; van den Hout MA, 2008, BEHAV RES THER, V46, P1300, DOI 10.1016/j.brat.2008.09.002; Weiss S, 2014, PSYCHOPATHOLOGY, V47, P377, DOI 10.1159/000365107; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Wolk J, 2014, BRAIN BEHAV, V4, P238, DOI 10.1002/brb3.206; Yoris A, 2017, PSYCHOL MED, V47, P1957, DOI 10.1017/S0033291717000368; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	60	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217237	10.1371/journal.pone.0217237	http://dx.doi.org/10.1371/journal.pone.0217237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125377	gold, Green Published, Green Submitted			2022-12-27	WOS:000468865700024
J	Allegretti, AS; Frenk, NE; Li, DK; Seethapathy, H; Parada, XFV; Long, J; Endres, P; Pratt, DS; Chung, RT; Ganguli, S; Irani, Z; Yamada, K				Allegretti, Andrew S.; Frenk, Nathan E.; Li, Darrick K.; Seethapathy, Harish; Parada, Xavier F. Vela; Long, Joshua; Endres, Paul; Pratt, Daniel S.; Chung, Raymond T.; Ganguli, Suvranu; Irani, Zubin; Yamada, Kei			Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement	PLOS ONE			English	Article							CHILD-PUGH; MORTALITY; MELD; ALLOCATION; CIRRHOSIS; SCORE	Background/Aims The MELD score was developed to predict survival after transjugular intrahepatic portosystemic shunt (TIPS) placement. Given changes in practice patterns and development of new prognostic tools in cirrhosis, we aimed to evaluate common models to predict mortality after TIPS placement. Methods Analysis of consecutive patients who underwent TIPS placement for ascites or bleeding. Performance to predict 90-day mortality was assessed by C statistic for six models (MELD, MELD-Na, CLIF-C ACLF, Child-Pugh, Platelet-Albumin-Bilirubin, and Emory score). Added predictive value to MELD score was assessed for univariate predictors of 90-day mortality. Stratified analysis by TIPS indication, emergent placement status, and TIPS stent type was performed. Results 413 patients were analyzed (248 with variceal bleeding, 165 with refractory ascites). 90-day mortality was 27% (113/413). Mean MELD score was 15 +/- 7.9. MELD score best predicted mortality for all patients (c = 0.779), for variceal bleeding (c = 0.844), and for emergent TIPS (c = 0.817). CLIF-C ACLF score best predicted mortality for refractory ascites (c = 0.707). Addition of sodium to the MELD score did not improve predictive value across multiple strata. Addition of hemoglobin improved MELD score's predictive value in variceal bleeding. Addition of age improved MELD score's predictive value in refractory ascites. Conclusions MELD score best predicted 90-day mortality. Addition of sodium to the MELD score did not improve its performance, though mortality prediction was improved using Age-MELD for ascites and Hemoglobin-MELD for bleeding. An individualized risk stratification approach may be best when considering candidates for TIPS placement.	[Allegretti, Andrew S.; Seethapathy, Harish; Parada, Xavier F. Vela; Long, Joshua; Endres, Paul] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Frenk, Nathan E.; Ganguli, Suvranu; Irani, Zubin; Yamada, Kei] Massachusetts Gen Hosp, Dept Radiol, Div Intervent Radiol, Boston, MA 02114 USA; [Li, Darrick K.; Pratt, Daniel S.; Chung, Raymond T.] Massachusetts Gen Hosp, Dept Med, Liver Ctr, Boston, MA 02114 USA; [Li, Darrick K.; Pratt, Daniel S.; Chung, Raymond T.] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Div, Boston, MA 02114 USA; [Parada, Xavier F. Vela] Mt Sinai West & St Lukes Hosp, Dept Med, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mount Sinai St. Luke's; Mount Sinai West	Allegretti, AS (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.	aallegretti@mgh.harvard.edu	Parada, Xavier Fernando Vela/I-1620-2019; Frenk, Nathan Elie/G-1088-2017	Parada, Xavier Fernando Vela/0000-0003-0057-1113; Frenk, Nathan Elie/0000-0001-5995-9409; Endres, Paul/0000-0002-8574-1312; Ganguli, Suvranu/0000-0002-3426-4907; Frenk, Carlos/0000-0002-2338-716X	American Heart Association [18CDA34110131]; NIH [K24DK078772]; STFC [ST/P000541/1] Funding Source: UKRI	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	ASA is supported by American Heart Association award 18CDA34110131. RTC is supported by NIH grant K24DK078772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegretti AS, 2018, CLIN J AM SOC NEPHRO, V13, P16, DOI 10.2215/CJN.03610417; Allegretti AS, 2016, AM J KIDNEY DIS OFFI; Angermayr B, 2003, GUT, V52, P879, DOI 10.1136/gut.52.6.879; Bureau C, 2016, GASTROENTEROLOGY; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Elwir Saleh, 2016, Gastroenterol Hepatol (N Y), V12, P166; Gaba RC, 2013, J VASC INTERV RADIOL, V24, P411, DOI 10.1016/j.jvir.2012.10.026; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; Kauffmann GW, 1999, EUR RADIOL, V9, P685, DOI 10.1007/s003300050733; Khabbaz RC, 2018, CARDIOVASC INTER RAD, V41, P1029, DOI 10.1007/s00270-018-1923-2; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Martinez-Cuesta A, 2000, ABDOM IMAGING, V25, P576, DOI 10.1007/s002610000054; Moore KP, 2006, GUT SUPPL 6, V55; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pickering JW, 2012, CLIN J AM SOC NEPHRO, V7, P1355, DOI 10.2215/CJN.09590911; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rodriguez-Luna H, 2005, AM J TRANSPLANT, V5, P2244, DOI 10.1111/j.1600-6143.2005.01008.x; ROSSLE M, 1989, LANCET, V2, P153; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Sarwar A, 2018, HEPATOLOGY, V67, P690, DOI 10.1002/hep.29354; Schepke M, 2003, AM J GASTROENTEROL, V98, P1167, DOI 10.1016/S0002-9270(03)00295-8; Smail A, 2004, J CHIR-PARIS, V141, P21, DOI 10.1016/S0021-7697(04)95289-1; Stewart CA, 2007, LIVER TRANSPLANT, V13, P1366, DOI 10.1002/lt.21129; Volk ML, 2011, AM J TRANSPLANT, V11, P958, DOI 10.1111/j.1600-6143.2011.03487.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	26	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217442	10.1371/journal.pone.0217442	http://dx.doi.org/10.1371/journal.pone.0217442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120995	gold, Green Submitted, Green Published			2022-12-27	WOS:000468775700106
J	Michelsen, MM; Pena, A; Mygind, ND; Host, N; Gustafsson, I; Hansen, PR; Hansen, HS; Kastrup, J; Prescott, E				Michelsen, Marie Mide; Pena, Adam; Mygind, Naja D.; Host, Nis; Gustafsson, Ida; Hansen, Peter Riis; Hansen, Henrik Steen; Kastrup, Jens; Prescott, Eva			Overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction	PLOS ONE			English	Article							MICROVASCULAR DYSFUNCTION; HEART-DISEASE; CHEST-PAIN; WOMEN; RISK; RECOMMENDATIONS; ISCHEMIA; PECTORIS; OUTCOMES; RESERVE	Background A link between angina with no obstructive coronary artery disease (CAD) and heart failure with preserved left ventricular ejection fraction has been proposed, but evidence in support of this is lacking. In a cross-sectional study, we investigated whether left ventricular diastolic function in women with angina pectoris and no obstructive CAD differed from a reference population. Methods We included 956 women with angina and <50% coronary artery stenosis at invasive coronary angiography. Women with cardiovascular risk factors, but no history of chest pain or cardiac disease served as controls (n = 214). Left ventricular diastolic function was assessed by transthoracic echocardiography. Results The women with angina were slightly older, had higher body mass index, higher heart rate, and more had diabetes compared with controls while systolic blood pressure was lower. In age-adjusted analyses, angina patients had significantly lower E/A (Estimated difference -0.13, 95% CI: -0.17; -0.08), higher left ventricular mass index (5.73 g/m(2), 95% CI: 3.71; 7.75), left atrial volume index (2.34 ml/m(2), 95% CI: 1.23; 3.45) and E/e' (0.68, 95% CI: 0.30; 1.05) and a larger proportion had higher estimated left ventricular filling pressure (17% versus 6%, p = 0.001). No between group differences were seen for e' or deceleration time. After adjustment for known cardiovascular risk factors, between group differences for echocardiographic parameters remained statistically significant. Conclusions Patients with angina and no obstructive CAD had a more impaired left ventricular diastolic function compared with an asymptomatic reference population. This suggests some common pathophysiological pathway between the two syndromes.	[Michelsen, Marie Mide; Host, Nis; Prescott, Eva] Univ Copenhagen, Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Pena, Adam; Hansen, Peter Riis] Univ Copenhagen, Herlev Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Mygind, Naja D.; Kastrup, Jens] Univ Copenhagen, Dept Cardiol, Rigshosp, Copenhagen, Denmark; [Gustafsson, Ida] Univ Copenhagen, Hvidovre Hosp, Dept Cardiol, Copenhagen, Denmark; [Hansen, Henrik Steen] Odense Univ Hosp, Dept Cardiol, Odense, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Michelsen, MM (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.	marie.m.michelsen@gmail.com	Prescott, Eva/AAJ-7441-2020; Hansen, Peter Riis/AAR-7659-2020	Michelsen, Marie Mide/0000-0002-3651-3348; Hansen, Peter Riis/0000-0002-9056-535X	Danish Heart Foundation; University of Copenhagen; Bispebjerg/Frederiksberg University Hospital	Danish Heart Foundation; University of Copenhagen; Bispebjerg/Frederiksberg University Hospital	This work was supported by The Danish Heart Foundation (EP), the University of Copenhagen (MMM) and Bispebjerg/Frederiksberg University Hospital (MMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri A, 2012, EUR HEART J-CARD IMG, V13, P109, DOI 10.1093/ejechocard/jer176; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Cho I, 2012, CIRCULATION, V126, P304, DOI 10.1161/CIRCULATIONAHA.111.081380; Crea F, 2017, EUR HEART J, V38, P473, DOI 10.1093/eurheartj/ehw461; D'Andrea A, 2012, INT J CARDIOL, V154, P250, DOI 10.1016/j.ijcard.2010.09.044; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Jespersen L, 2013, CLIN RES CARDIOL, V102, P571, DOI 10.1007/s00392-013-0568-z; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Kato S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002649; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Michelsen MM, 2018, ECHOCARDIOGR-J CARD, V35, P196, DOI 10.1111/echo.13767; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Moreno R, 1999, ECHOCARDIOGR-J CARD, V16, P239, DOI 10.1111/j.1540-8175.1999.tb00808.x; Mygind ND, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003064; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nelson MD, 2014, CIRC-CARDIOVASC IMAG, V7, P510, DOI 10.1161/CIRCIMAGING.114.001714; Prescott E, 2014, AM HEART J, V167, P452, DOI 10.1016/j.ahj.2014.01.003; Sara JD, 2015, JACC-CARDIOVASC INTE, V8, P1445, DOI 10.1016/j.jcin.2015.06.017; Schnohr P, 2015, EUR HEART J, V36, P1385, DOI 10.1093/eurheartj/ehv027; Srivaratharajah K, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002562; Taqueti VR, 2018, EUR HEART J, V39, P840, DOI 10.1093/eurheartj/ehx721	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216240	10.1371/journal.pone.0216240	http://dx.doi.org/10.1371/journal.pone.0216240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120897	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700010
J	Sahlol, NY; Mostafa, MS; Madkour, LA; Salama, DM				Sahlol, Nahla Yassin; Mostafa, Marwa Salah; Madkour, Lamiaa Abd El-Fattah; Salama, Dina Metwally			Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity	PLOS ONE			English	Article							NF-KAPPA-B; A20 RESTRICTS UBIQUITINATION; ZINC-FINGER PROTEIN; IMMUNE HOMEOSTASIS; GENE POLYMORPHISMS; ACTIVE PSORIASIS; ENZYME A20; ALPHA; TNF; CELLS	Psoriasis vulgaris is a systemic disorder with an underlying immune dysregulation that predisposes to inflammatory skin lesions. Meanwhile, tumor necrosis factor alpha-induced protein 3 (TNFAIP3) has been described as a protective molecule against the deleterious effects of uncontrolled inflammation. In this study, we compared the expression levels of TNFAIP3 in blood and psoriatic skin biopsies from psoriatic patients versus those in normal individuals. Additionally, the levels of TNFAIP3 protein in psoriatic skin biopsies were compared to those in normal individuals. Thirty psoriatic patients and 30 healthy participants (control group) were enrolled. The expression levels of TNFAIP3 in blood and skin were measured by quantitative reverse transcription PCR, while the skin levels of TNFAIP3 protein were measured by western blot. Psoriatic patients showed significantly lower expression levels of TNFAIP3 in psoriatic skin and blood (P<0.001) as well as of TNFAIP3 protein in psoriatic skin (P<0.001) compared to controls. A significant lower expression of TNFAIP3 and TNFAIP3 protein in psoriatic skin was detected in moderate/severe cases compared to mild cases (P = 0.004 and 0.003 respectively). Moreover, a significant negative correlation was found between TNFAIP3 mRNA in psoriatic tissue and psoriasis area severity index values (r(s) = -0.382, P-value = 0.037). In conclusion, TNFAIP3 may serve as a predictive and prognostic biomarker in psoriatic patients. Enhancing the expression and/or function of TNFAIP3 in the affected cell type may be a promising therapeutic strategy.	[Sahlol, Nahla Yassin; Mostafa, Marwa Salah; Madkour, Lamiaa Abd El-Fattah] Cairo Univ, Fac Med, Dept Microbiol & Immunol, Cairo, Egypt; [Salama, Dina Metwally] Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Madkour, LA (corresponding author), Cairo Univ, Fac Med, Dept Microbiol & Immunol, Cairo, Egypt.	m_l@kasralainy.edu.eg		Mostafa, Marwa Salah/0000-0002-8906-8938; , Lamiaa/0000-0002-7849-3904	Cairo University	Cairo University(Cairo University)	This work was supported by a fund from Cairo University (http://cu.edu.eg/Home) to NYS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Aki A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180481; Aksentijevich I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00399; Allan AE, 2016, PRINCIPLES PRACTICE; Anderson KS, 2010, BRIT J DERMATOL, V163, P1085, DOI 10.1111/j.1365-2133.2010.09990.x; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chanudet E, 2010, LEUKEMIA, V24, P483, DOI 10.1038/leu.2009.234; Cordoro K M, 2007, Skin Therapy Lett, V12, P4; Devos M, 2019, J INVEST DERMATOL, V139, P135, DOI 10.1016/j.jid.2018.06.191; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Dyring-Andersen B, 2016, BRIT J DERMATOL, V175, P245, DOI 10.1111/bjd.14656; Franco-Jarava C, 2018, CLIN IMMUNOL, V191, P44, DOI 10.1016/j.clim.2018.03.009; Frenzel LP, 2011, INT J CANCER, V128, P2495, DOI 10.1002/ijc.25579; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Gelfand JM, 2011, J INVEST DERMATOL, V131, P1007, DOI 10.1038/jid.2011.32; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Grinberg-Bleyer Y, 2015, J IMMUNOL, V194, P2472, DOI 10.4049/jimmunol.1402608; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Jiang XB, 2012, CLIN VACCINE IMMUNOL, V19, P1938, DOI 10.1128/CVI.00500-12; Kadowaki T, 2018, J ALLERGY CLIN IMMUN, V141, P1485, DOI 10.1016/j.jaci.2017.10.039; Kanelleas A, 2011, CLIN EXP DERMATOL, V36, P845, DOI 10.1111/j.1365-2230.2011.04131.x; Kim J, 2015, DERMATOL CLIN, V33, P13, DOI 10.1016/j.det.2014.09.002; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kingeter LM, 2010, J IMMUNOL, V185, P4520, DOI 10.4049/jimmunol.1001051; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Liu X, 2016, BRIT J DERMATOL, V175, P314, DOI 10.1111/bjd.14481; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Machado-Pinto J, 2016, AN BRAS DERMATOL, V91, P8, DOI 10.1590/abd1806-4841.20164169; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nititham J, 2015, GENES IMMUN, V16, P120, DOI 10.1038/gene.2014.75; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Parisi R, 2017, JAMA DERMATOL, V153, P1256, DOI 10.1001/jamadermatol.2017.3225; Prieto-Perez R, 2013, PHARMACOGENOMICS J, V13, P297, DOI 10.1038/tpj.2012.53; Rasi S, 2009, ATLAS GENETIC CYTOGE; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Reich K, 2012, J EUR ACAD DERMATOL, V26, P3, DOI 10.1111/j.1468-3083.2011.04410.x; Ryan C., 2011, Clinical Investigation, V1, P399, DOI 10.4155/cli.11.11; Ryan C, 2014, J AM ACAD DERMATOL, V70, P146, DOI 10.1016/j.jaad.2013.08.042; Sohn KC, 2016, INT J MOL MED, V37, P1099, DOI 10.3892/ijmm.2016.2514; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Tang YJ, 2016, EXP THER MED, V11, P247, DOI 10.3892/etm.2015.2887; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Tsuruta D, 2009, RECENT PATENTS INFLA, V3, P40, DOI 10.2174/187221309787158399; Usatine RP, 2013, COLOR ATLAS FAMILY M; van den Reek JMPA, 2017, BRIT J DERMATOL, V176, P1288, DOI 10.1111/bjd.15005; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang S, 2016, GENES IMMUN, V17, P165, DOI 10.1038/gene.2016.4; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015	59	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217352	10.1371/journal.pone.0217352	http://dx.doi.org/10.1371/journal.pone.0217352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120955	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700093
J	Ashfaq, M; Blagoev, G; Tahir, HM; Khan, AM; Mukhtar, MK; Akhtar, S; Butt, A; Mansoor, S; Hebert, PDN				Ashfaq, Muhammad; Blagoev, Gergin; Tahir, Hafiz Muhammad; Khan, Arif M.; Mukhtar, Muhammad Khalid; Akhtar, Saleem; Butt, Abida; Mansoor, Shahid; Hebert, Paul D. N.			Assembling a DNA barcode reference library for the spiders (Arachnida: Araneae) of Pakistan	PLOS ONE			English	Article							SPECIES IDENTIFICATION; CHECKLIST; FAUNA; LYCOSIDAE; PERFORMANCE; GERMANY; PUNJAB; MALES	Morphological study of 1,795 spiders from sites across Pakistan placed these specimens in 27 families and 202 putative species. COI sequences > 400 bp recovered from 1,782 specimens were analyzed using neighbor-joining trees, Bayesian inference, barcode gap, and Barcode Index Numbers (BINs). Specimens of 109 morphological species were assigned to 123 BINs with ten species showing BIN splits, while 93 interim species included representatives of 98 BINs. Maximum conspecific divergences ranged from 0-5.3% while congeneric distances varied from 2.8-23.2%. Excepting one species pair (Oxyopes azhari-Oxyopes oryzae), the maximum intraspecific distance was always less than the nearest-neighbor (NN) distance. Intraspecific divergence values were not significantly correlated with geographic distance. Most (75%) BINs detected in this study were new to science, while those shared with other nations mainly derived from India. The discovery of many new, potentially endemic species and the low level of BIN overlap with other nations highlight the importance of constructing regional DNA barcode reference libraries.	[Ashfaq, Muhammad; Blagoev, Gergin; Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada; [Tahir, Hafiz Muhammad] Govt Coll Univ, Dept Zool, Lahore, Pakistan; [Khan, Arif M.] Univ Sargodha, Dept Biotechnol, Sargodha, Pakistan; [Mukhtar, Muhammad Khalid] Univ Sargodha, Dept Zool, Sargodha, Pakistan; [Akhtar, Saleem] Ayub Agr Res Inst, Directorate Entomol, Faisalabad, Pakistan; [Butt, Abida] Univ Punjab, Dept Zool, Lahore, Pakistan; [Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan	University of Guelph; Government College University Lahore; University of Sargodha; University of Sargodha; University of Punjab; Pakistan Institute of Engineering & Applied Science	Ashfaq, M (corresponding author), Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada.	mashfaq@uoguelph.ca	Ashfaq, Muhammad/J-4723-2019; Tahir, Hafiz Muhammad/AAA-9011-2022	Ashfaq, Muhammad/0000-0003-1351-4126; Tahir, Hafiz Muhammad/0000-0002-2631-0651; Mansoor, Shahid/0000-0001-7418-1826; Blagoev, Gergin/0000-0003-1844-0779	International Development Research Centre in Canada [106106001]; grant HEC from the Higher Education Commission of Pakistan [20-1403/RD/09]; Government of Canada through Genome Canada; Ontario Genomics; Canada First Research Excellence Fund	International Development Research Centre in Canada; grant HEC from the Higher Education Commission of Pakistan; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics; Canada First Research Excellence Fund	This study was enabled by grant 106106001 "Engaging Developing Nations in iBOL" from the International Development Research Centre in Canada and by grant HEC No. 20-1403/R&D/09 "Sequencing DNA Barcodes of Economically Important Insect Species from Pakistan" from the Higher Education Commission of Pakistan awarded to MA. Sequence analysis was made possible by a grant from the Government of Canada through Genome Canada and Ontario Genomics in support of the International Barcode of Life (iBOL) project awarded to PDNH. This is a contribution to the Food From Thought project supported by the Canada First Research Excellence Fund awarded to PDNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe TA, 2005, CAN J ZOOL, V83, P432, DOI 10.1139/Z05-030; Ahmad Shahid, 2015, Journal of Entomology and Zoology Studies, V3, P47; Ashfaq M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199965; Ashfaq M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174749; Ashfaq M, 2016, GENOME, V59, P933, DOI 10.1139/gen-2016-0024; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Astrin JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162624; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baig Mirza B., 2009, Biodiversity (Ottawa), V10, P20; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blagoev GA, 2016, MOL ECOL RESOUR, V16, P325, DOI 10.1111/1755-0998.12444; Blagoev GA, 2014, ZOOTAXA, V3894, P152, DOI 10.11646/zootaxa.3894.1.12; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Borges PAV, 2008, SYST BIODIVERS, V6, P249, DOI 10.1017/S1477200008002648; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Cao XW, 2016, SCI REP, V6, P13, DOI [10.1038/s41598-016-0006-3, DOI 10.1038/S41598-016-0006-3]; Dhananjeyan KJ, 2010, TROP BIOMED, V27, P47; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dippenaar-Schoeman AS, 2018, KOEDOE, V60, DOI 10.4102/koedoe.v60i1.1486; Drew LW, 2011, BIOSCIENCE, V61, P942, DOI 10.1525/bio.2011.61.12.4; Duan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182706; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Dyal S., 1935, Bulletin of the Department of Zoology Panjab University Lahore, V1, P119; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaikwad S, 2017, MITOCHONDRIAL DNA A, V28, P638, DOI 10.3109/24701394.2016.1166219; Gall LLE, 2017, EUR J TAXON, V266, P1, DOI 10.5852/ejt.2017.266; Garcia-Robledo C, 2013, BIOL J LINN SOC, V110, P189, DOI 10.1111/bij.12115; Ghazanfar Mobeen, 2016, Journal of Entomology and Zoology Studies, V4, P245; Gottsberger B, 2007, J COMP PHYSIOL A, V193, P703, DOI 10.1007/s00359-007-0225-y; Havemann N, 2018, PEERJ, V6, DOI 10.7717/peerj.4577; Hawlitschek O, 2017, MOL ECOL RESOUR, V17, P1037, DOI 10.1111/1755-0998.12638; Hawlitschek O, 2016, MOL ECOL RESOUR, V16, P242, DOI 10.1111/1755-0998.12416; Hawlitschek O, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-142; Hebert PDN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0333; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Huemer P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206668; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Hume JCC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020156, 10.1371/journal.pone.0026207]; Iftikhar R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146014; Ivanov V, 2018, MOL ECOL, V27, P1681, DOI 10.1111/mec.14564; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Keswani S., 2012, Indian Journal of Arachnology, V1, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King JR, 2005, ENVIRON ENTOMOL, V34, P1566, DOI 10.1603/0046-225X-34.6.1566; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maelfait Jean-Pierre, 1998, P293; Magalhaes ILF, 2017, INVERTEBR SYST, V31, P8, DOI 10.1071/IS15062; Majeed N, ZOOKEYS; MANTEL N, 1967, CANCER RES, V27, P209; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0339; Mirshamsi O, 2015, IRANIAN J ANIMAL BIO, V1, P1, DOI DOI 10.22067/IJAB.VFAUNA.IRANICAI1.50696; Moriniere J, 2017, MOL ECOL RESOUR, V17, P1293, DOI 10.1111/1755-0998.12683; Mukhtar MK, 2012, PAK J ZOOL, V44, P1245; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Nadolny AA, 2016, ZOOTAXA, V4072, P263, DOI 10.11646/zootaxa.4072.2.8; Naseem S, 2018, MITOCHONDRIAL DNA A, V29, P96, DOI 10.1080/24701394.2016.1248428; Piacentini LN, 2017, ARTHROPOD SYST PHYLO, V75, P387; Ortiz AS, 2017, BIODIVERS DATA J, V5, DOI 10.3897/BDJ.5.e19840; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Parveen R., 2003, THESIS; Parveen Razia, 2007, Pakistan Journal of Agricultural Sciences, V44, P625; Pazhenkova EA, 2019, J ZOOL SYST EVOL RES, V57, P298, DOI 10.1111/jzs.12252; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Perveen F., 2012, Arthropods, V1, P35; Porco D, 2018, APPL SOIL ECOL, V124, P362, DOI 10.1016/j.apsoil.2017.11.001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Ren JM, 2018, BIOL INVASIONS, V20, P449, DOI 10.1007/s10530-017-1546-6; RIECHERT SE, 1984, ANNU REV ENTOMOL, V29, P299, DOI 10.1146/annurev.en.29.010184.001503; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rybak J, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2369-7; Sial N, 2012, PAK J AGR SCI, V49, P335; Siliwal Manju, 2007, Zoos Print Journal, V22, P2551; Skalak SL, 2012, METHODS ECOL EVOL, V3, P490, DOI 10.1111/j.2041-210X.2011.00177.x; Slowik Jozef, 2012, Insecta Mundi, V0251, P1; Stein ED, 2014, FRESHW SCI, V33, P302, DOI 10.1086/674782; Tahir HM, 2016, PAK J ZOOL, V48, P159; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telfer AC, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6313; Ubick D, 2017, SPIDERS N AM IDENTIF; van Helsdingen P.J., 2003, ARTHROPODA SEL, V1, P101; Wirta H, 2016, MOL ECOL RESOUR, V16, P809, DOI 10.1111/1755-0998.12489; World Spider Catalog, 2021, WORLD SPIDER CATALOG, DOI [10.24436/2, DOI 10.24436/2]; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zenker MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148423; ZHANG JX, 2012, ZOOTAXA 0920, P1; Zhang YY, 2014, MOL PHYLOGENET EVOL, V79, P353, DOI 10.1016/j.ympev.2014.05.017; Zhou ZJ, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1404-5	96	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217086	10.1371/journal.pone.0217086	http://dx.doi.org/10.1371/journal.pone.0217086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116764	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400043
J	Shinchi, M; Kobayashi, M; Soma, K; Maeda, A				Shinchi, Mikako; Kobayashi, Masanao; Soma, Kaori; Maeda, Akifumi			Comparison of chest compression quality in walking versus straddling cardiopulmonary resuscitation during stretcher transportation: A prospective randomised crossover study using manikins	PLOS ONE			English	Article							BASIC LIFE-SUPPORT; GUIDELINES; DEPTH; COUNCIL; CPR	The optimal strategy to ensure chest compression quality for patients being transported on a stretcher has not been established yet. We hypothesised that straddling cardiopulmonary resuscitation may improve chest compression quality in patients being transported on stretchers. We conducted a prospective randomised crossover study using manikins to investigate whether straddling cardiopulmonary resuscitation improves chest compression quality (depth, recoil, rate, correct hand position) performed on patients during stretcher transportation compared to walking cardiopulmonary resuscitation. Walking and straddling cardiopulmonary resuscitation were performed for 2 minutes each. The mean chest compression depth (mm) for 2 minutes was significantly greater in the straddling cardiopulmonary resuscitation group than in the walking cardiopulmonary resuscitation group (median, 51.3 [interquartile range, 46.7-55.5] versus 40.9 [34.6-50.1], P = 0.003). An adequate depth of chest compressions could not be achieved when walking cardiopulmonary resuscitation was performed by female participants, but the depth of chest compressions was within the acceptable range when female participants performed straddling cardiopulmonary resuscitation. On the other hand, the degree of deterioration was relatively small in male participants, even when they performed walking cardiopulmonary resuscitation. In patients with cardiac arrest being transported on a stretcher, straddling cardiopulmonary resuscitation improved the depth of chest compressions compared to walking cardiopulmonary resuscitation. Female rescuers, in particular, may consider using straddling cardiopulmonary resuscitation.	[Shinchi, Mikako; Soma, Kaori; Maeda, Akifumi] Hirakata City Hosp, Dept Nursing, Hirakata, Osaka, Japan; [Kobayashi, Masanao] Hirakata City Hosp, Dept Emergency Med, Hirakata, Osaka, Japan		Shinchi, M (corresponding author), Hirakata City Hosp, Dept Nursing, Hirakata, Osaka, Japan.	mikako01@ares.eonet.ne.jp		akifumi, maeda/0000-0002-2628-2224				[Anonymous], 2000, Circulation, V102, pI22; Baubin M, 1997, RESUSCITATION, V35, P259, DOI 10.1016/S0300-9572(97)00040-3; Chung SP, 2016, RESUSCITATION, V105, P145, DOI 10.1016/j.resuscitation.2016.05.025; Handley AJ, 2004, RESUSCITATION, V61, P55, DOI 10.1016/j.resuscitation.2003.11.012; Hansen D, 2012, EUR J EMERG MED, V19, P28, DOI 10.1097/MEJ.0b013e328347a2aa; Ho LST, 2017, EUR J EMERG MED, V24, P268, DOI 10.1097/MEJ.0000000000000336; Jaafar Ahmad, 2015, Int Sch Res Notices, V2015, P246398, DOI 10.1155/2015/246398; Kaminska H, 2018, KARDIOL POL, V76, P642, DOI 10.5603/KP.a2018.0003; Kampmeier TG, 2014, RESUSCITATION, V85, P503, DOI 10.1016/j.resuscitation.2013.12.030; Kim JA, 2006, PREHOSP EMERG CARE, V10, P68, DOI 10.1080/10903120500373108; Laerdal Medical, CPR SCOR EXPL REV AP; Leary M, 2017, WORLD J EMERG MED, V8, P12, DOI 10.5847/wjem.j.1920-8642.2017.01.002; Lee CJ, 2015, CLIN EXP EMERG MED, V2, P9, DOI 10.15441/ceem.14.046; Lei Z, 2010, RESUSCITATION, V81, P1562, DOI 10.1016/j.resuscitation.2010.05.017; Mayrand KP, 2015, WEST J EMERG MED, V16, P1135, DOI 10.5811/westjem.2015.9.28167; Peberdy MA, 2009, RESUSCITATION, V80, P1169, DOI 10.1016/j.resuscitation.2009.07.003; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Russo SG, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-20; Sayee Nicole, 2012, Ulster Med J, V81, P14; Shimizu Yoshitaka, 2014, Hiroshima Journal of Medical Sciences, V63, P7; Sim Z, 2017, EMERG MED J, V34, pA889, DOI [10.1136/emermed-2017-207308.42, DOI 10.1136/EMERMED-2017-207308.42]; Song Y, 2015, ANAESTHESIA, V70, P1235, DOI 10.1111/anae.13222; Stiell IG, 2014, CIRCULATION, V130, P1962, DOI 10.1161/CIRCULATIONAHA.114.008671; van Tulder R, 2014, RESUSCITATION, V85, P112, DOI 10.1016/j.resuscitation.2013.08.010; Wang J, 2015, WORLD J EMERG MED, V6, P179, DOI 10.5847/wjem.j.1920-8642.2015.03.003; Yamanaka S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189412; Yasuda Y, 2013, PREHOSP EMERG CARE, V17, P162, DOI 10.3109/10903127.2012.749964; Yoshioka T, 2003, EXERCISE PHYSL SERIE, V5, P128, DOI [10.1016/j.resuscitation.2016.05.025, DOI 10.1016/J.RESUSCITATION.2016.05.025]; Zhang FL, 2013, WORLD J EMERG MED, V4, P54, DOI [10.5847/wjem.j.1920-8642.2013.01.010, 10.5847/wjem.j.issn.1920-8642.2013.01.010]	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216739	10.1371/journal.pone.0216739	http://dx.doi.org/10.1371/journal.pone.0216739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112576	Green Submitted, gold, Green Published			2022-12-27	WOS:000468451000020
J	Tan, B; Yang, F; Lan, LY; You, CM; Zhang, J; Xu, ZF; Liu, Y; Zhang, L; Li, H				Tan, Bo; Yang, Fan; Lan, Liying; You, Chengming; Zhang, Jian; Xu, Zhenfeng; Liu, Yang; Zhang, Li; Li, Han			Naphthalene exerts substantial nontarget effects on soil nitrogen mineralization processes in a subalpine forest soil: A microcosm study	PLOS ONE			English	Article							MICROBIAL BIOMASS NITROGEN; ENZYME-ACTIVITIES; EXTRACTION METHOD; ORGANIC-MATTER; BIODIVERSITY; ASSIMILATION; COMMUNITIES; DEGRADATION; POPULATIONS; ECOSYSTEMS	Naphthalene has been widely used to test the functional roles of soil fauna, but its nontarget effects remain uncertain in various soils. To determine whether there is a potential nontarget effect on soil biochemical properties in subalpine forest soil, soils in a subalpine forest on the western Qinghai-Tibet Plateau were treated by naphthalene in microcosms. The responses of soil microbial activity and nutrients to naphthalene were studied following 52 days of incubation. The results showed that the naphthalene application obviously decreased the microbial respiration rate in the first 10 days of the incubation and then increased the rate in the following days of the incubation. Moreover, the naphthalene application did not significantly affect the microbial activities overall, measured as soil microbial phospholipid fatty acid (PLFA) abundances and biomasses, or most enzyme activities (invertase, nitrate reductase and nitrite reductase) during the whole incubation period. However, naphthalene suppressed increases in the DON, NH4+-N and NO3--N contents and urease activity and led to the net mineralization of inorganic N (NH4+-N + NO3--N), in contrast to the net immobilization result in the controls. These results suggest that naphthalene can exert direct nontarget effects on soil microbial respiration and N mineralization processes in subalpine soils. Caution should be taken when using naphthalene to repel soil animals in field experiments.	[Tan, Bo; Yang, Fan; Lan, Liying; You, Chengming; Zhang, Jian; Xu, Zhenfeng; Liu, Yang; Zhang, Li; Li, Han] Sichuan Agr Univ, Inst Ecol & Forestry,Alpine Forest Ecosyst Res St, Forestry Ecol Engn Upper Reaches Yangtze River Ke, Soil & Water Conservat & Desertificat Control Key, Chengdu, Sichuan, Peoples R China; [Tan, Bo; Yang, Fan; Lan, Liying; You, Chengming; Zhang, Jian; Xu, Zhenfeng; Liu, Yang; Zhang, Li; Li, Han] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Tan, B (corresponding author), Sichuan Agr Univ, Inst Ecol & Forestry,Alpine Forest Ecosyst Res St, Forestry Ecol Engn Upper Reaches Yangtze River Ke, Soil & Water Conservat & Desertificat Control Key, Chengdu, Sichuan, Peoples R China.; Tan, B (corresponding author), Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu, Sichuan, Peoples R China.	bobotan1984@163.com	liu, yang/HHY-8583-2022	Tan, Bo/0000-0003-0019-9446	National Natural Science Foundation of China [31870602, 31700542, 31500509, 31570601, 31500358]; China Scholarship Council [201806915014, 201806910030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (31870602, 31700542, 31500509, 31570601 and 31500358). Bo Tan and Chengming You acknowledge the China Scholarship Council for supporting a visiting scholar program grant (201806915014) and Ph.D. program grant (201806910030), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR JM, 1989, SOIL BIOL BIOCHEM, V21, P507, DOI 10.1016/0038-0717(89)90122-3; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Brussaard L, 2007, PEDOBIOLOGIA, V50, P447, DOI 10.1016/j.pedobi.2006.10.007; Chen CR, 2000, PLANT SOIL, V220, P151, DOI 10.1023/A:1004712401721; Coleman DC, 2005, PEDOBIOLOGIA, V49, P479, DOI 10.1016/j.pedobi.2005.05.006; Cotrufo MF, 2014, APPL SOIL ECOL, V74, P21, DOI 10.1016/j.apsoil.2013.09.008; Cragg RG, 2001, SOIL BIOL BIOCHEM, V33, P2073, DOI 10.1016/S0038-0717(01)00138-9; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; DENOME SA, 1993, J BACTERIOL, V175, P6890, DOI 10.1128/jb.175.21.6890-6901.1993; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Gonod LV, 2016, SOIL BIOL BIOCHEM, V95, P180, DOI 10.1016/j.soilbio.2015.11.027; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; He RY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186053; Huhta V, 2007, PEDOBIOLOGIA, V50, P489, DOI 10.1016/j.pedobi.2006.08.006; INGHAM ER, 1994, J SUSTAIN AGR, V4, P7, DOI 10.1300/J064v04n03_03; IUSS Working Group, 2014, WORLD REF BAS SOIL R; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Kleemann R, 2011, FEMS MICROBIOL ECOL, V78, P488, DOI 10.1111/j.1574-6941.2011.01193.x; Li XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32861; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Liu Q, 2017, J APPL MICROBIOL, V123, P875, DOI 10.1111/jam.13549; Liu YW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39603-6; Lu R.K, 1999, SOIL ARGROCHEMISTRY; Margesin R, 2003, APPL ENVIRON MICROB, V69, P3085, DOI 10.1128/AEM.69.6.3085-3092.2003; Margesin R, 2000, ACTA BIOTECHNOL, V20, P313, DOI 10.1002/abio.370200312; MCCARTY GW, 1992, BIOL FERT SOILS, V12, P261, DOI 10.1007/BF00336041; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; NEWELL K, 1987, BIOL FERT SOILS, V3, P11, DOI 10.1007/BF00260572; Paul E., 2014, SOIL MICROBIOLOGY EC; Roscoe R, 2000, BIOL FERT SOILS, V32, P52, DOI 10.1007/s003740000213; Sardans J, 2008, APPL SOIL ECOL, V39, P223, DOI 10.1016/j.apsoil.2007.12.011; SEASTEDT TR, 1983, SOIL BIOL BIOCHEM, V15, P159, DOI 10.1016/0038-0717(83)90097-4; Sun GD, 2019, CHEMOSPHERE, V215, P461, DOI 10.1016/j.chemosphere.2018.09.160; Swift MJ, 1998, GLOBAL CHANGE BIOL, V4, P729, DOI 10.1046/j.1365-2486.1998.00207.x; Tan B, 2014, APPL SOIL ECOL, V76, P34, DOI 10.1016/j.apsoil.2013.11.015; [谭波 Tan Bo], 2012, [生态学报, Acta Ecologica Sinica], V32, P6670; Trap J, 2016, PLANT SOIL, V398, P1, DOI 10.1007/s11104-015-2671-6; Ushio M, 2013, PLANT SOIL, V365, P157, DOI 10.1007/s11104-012-1365-6; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang QK, 2008, APPL SOIL ECOL, V40, P484, DOI 10.1016/j.apsoil.2008.07.003; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; White DC, 1996, J IND MICROBIOL, V17, P185, DOI 10.1007/BF01574692; Xiong Li, 2014, Yingyong Shengtai Xuebao, V25, P1293; Xiong YM, 2008, SOIL BIOL BIOCHEM, V40, P2706, DOI 10.1016/j.soilbio.2008.07.014; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x; 1993, APPL ENV MICROBIOL, V59, P3605; 2004, CHEMOSPHERE, V57, P673, DOI DOI 10.1016/J.CHEMOSPHERE.2004.07.023; 2003, BIOL FERT SOILS, V37, P190, DOI DOI 10.1007/S00374-002-0574-1; 2003, TRENDS ECOL EVOL, V18, P140, DOI DOI 10.1016/S0169-5347(03)00007-7	50	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217178	10.1371/journal.pone.0217178	http://dx.doi.org/10.1371/journal.pone.0217178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107923	gold, Green Published, Green Submitted			2022-12-27	WOS:000468285200035
J	Hao, F; Xu, QH; Wang, J; Yu, S; Chang, HH; Sinnett-Smith, J; Eibl, G; Rozengurt, E				Hao, Fang; Xu, Qinhong; Wang, Jing; Yu, Shuo; Chang, Hui-Hua; Sinnett-Smith, James; Eibl, Guido; Rozengurt, Enrique			Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in Kras(G12D) mice	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; INSULIN-RECEPTOR; SIGNALING SYSTEMS; MUTANT P53; HIGH-FAT; MEVALONATE; PATHWAY; HIPPO; YAP/TAZ; TAZ	We examined the impact of statins on Yes-associated Protein (YAP) localization, phosphorylation and transcriptional activity in human and mouse pancreatic ductal adenocarcinoma (PDAC) cells. Exposure of sparse cultures of PANC-1 and MiaPaCa-2 cells to cerivastatin or simvastatin induced a striking re-localization of YAP from the nucleus to the cytoplasm and inhibited the expression of the YAP/TEAD-regulated genes Connective Tissue Growth Factor (CTGF) and Cysteine-rich angiogenic inducer 61 (CYR61). Statins also prevented YAP nuclear import and expression of CTGF and CYR61 stimulated by the mitogenic combination of insulin and neurotensin in dense culture of these PDAC cells. Cerivastatin, simvastatin, atorvastatin and fluvastatin also inhibited colony formation by PANC-1 and MiaPaCa-2 cells in a dose-dependent manner. In contrast, the hydrophilic statin pravastatin did not exert any inhibitory effect even at a high concentration (10 mu M). Mechanistically, cerivastatin did not alter the phosphorylation of YAP at Ser(127) in either PANC-1 or MiaPaCa-2 cells incubated without or with neurotensin and insulin but blunted the assembly of actin stress fiber in these cells. We extended these findings with human PDAC cells using primary KC and KPC cells, (expressing KrasG12D or both KrasG12D and mutant p53, respectively) isolated from KC or KPC mice. Using cultures of these murine cells, we show that lipophilic statins induced striking YAP translocation from the nucleus to the cytoplasm, inhibited the expression of Ctgf, Cyr61 and Birc5 and profoundly inhibited colony formation of these cells. Administration of simvastatin to KC mice subjected to diet-induced obesity prevented early pancreatic acini depletion and PanIN formation. Collectively, our results show that lipophilic statins restrain YAP activity and proliferation in pancreatic cancer cell models in vitro and attenuates early lesions leading to PDAC in vivo.	[Hao, Fang; Xu, Qinhong; Wang, Jing; Yu, Shuo; Sinnett-Smith, James; Rozengurt, Enrique] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Hao, Fang] Tianjin Med Univ, Tianjin, Peoples R China; [Xu, Qinhong; Wang, Jing; Yu, Shuo] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China; [Chang, Hui-Hua; Eibl, Guido] UCLA, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Chang, Hui-Hua; Sinnett-Smith, James; Eibl, Guido; Rozengurt, Enrique] CURE Digest Dis Res Ctr, Los Angeles, CA 90073 USA; [Sinnett-Smith, James; Rozengurt, Enrique] VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tianjin Medical University; Xi'an Jiaotong University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Rozengurt, E (corresponding author), UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.; Rozengurt, E (corresponding author), CURE Digest Dis Res Ctr, Los Angeles, CA 90073 USA.; Rozengurt, E (corresponding author), VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA.	erozengurt@mednet.ucla.edu	Hao, Fang/GRJ-3165-2022	xu, qinhong/0000-0003-0654-5290	National Institute of Diabetes and Digestive and Kidney Diseases - National Cancer Institute [R01DK100405, P30DK041301, P01CA163200]; Veterans Affair Merit Award [I01BX003801]; HHG National Institute of Diabetes and Digestive and Kidney Diseases from the CURE: Digestive Diseases Research Center [P30DK041301]; Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100405, P30DK041301] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003801] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases - National Cancer Institute; Veterans Affair Merit Award; HHG National Institute of Diabetes and Digestive and Kidney Diseases from the CURE: Digestive Diseases Research Center; Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Funded by ER National Institute of Diabetes and Digestive and Kidney Diseases https://www.nih.gov/grants-funding R01DK100405, P30DK041301, ER and GE P01CA163200 awarded by the National Cancer Institute; Veterans Affair Merit Award I01BX003801, https://www.research.va.gov/services/shared_docs/resources.cfm#5; HHG National Institute of Diabetes and Digestive and Kidney Diseases, https://www.nih.gov/grants-funding Pilot and Feasibility Study Award from the CURE: Digestive Diseases Research Center (P30DK041301); ER and GE Hirshberg Foundation for Pancreatic Cancer Research, http://pancreatic.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2016, CLIN CANCER RES, V22, P4322, DOI 10.1158/1078-0432.CCR-16-0695; Archibugi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13430-z; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Beckwitt CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197422; Carey FJ, 2013, DIGEST DIS SCI, V58, P3308, DOI 10.1007/s10620-013-2778-7; Chang HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184455; Chang HH, 2015, ENERG BALANCE CANCER, P197, DOI 10.1007/978-3-319-16733-6_10; Chen MJ, 2016, INT J CANCER, V138, P594, DOI 10.1002/ijc.29813; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; Deng YZ, 2018, J EXP MED, V215, P177, DOI 10.1084/jem.20170399; Dobrokhotov O, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0202-9; E JY, 2018, CURR MED CHEM, V25, P2595, DOI 10.2174/0929867324666170412145232; Eibl G, 2019, SEMIN CANCER BIOL, V54, P50, DOI 10.1016/j.semcancer.2017.10.007; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gbelcova H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44219; Gruber R, 2016, GASTROENTEROLOGY, V151, P526, DOI 10.1053/j.gastro.2016.05.006; Gruenbacher G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01714; Hamada T, 2018, CLIN GASTROENTEROL H, V16, P1300, DOI 10.1016/j.cgh.2018.02.022; Hamada T, 2018, J GASTROENTEROL, V53, P959, DOI 10.1007/s00535-018-1430-x; Hao F, 2017, MOL CANCER RES, V15, P929, DOI 10.1158/1541-7786.MCR-17-0023; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Huang BZ, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw275; JEON CY, 2015, PLOS ONE, V10, DOI DOI 10.1371/journal.pone.0121783; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kisfalvi K, 2005, J CELL PHYSIOL, V202, P880, DOI 10.1002/jcp.20187; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Lee HS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003607; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mohammed A, 2012, INT J CANCER, V131, P1951, DOI 10.1002/ijc.27456; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Morvaridi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16759; Murakami S, 2017, ONCOGENE, V36, P1232, DOI 10.1038/onc.2016.288; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Plouffe SW, 2018, J BIOL CHEM, V293, P11230, DOI 10.1074/jbc.RA118.002715; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rozengurt E, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-017-0005-2; Rozengurt E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00357; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Serafimidis I, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000949; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Soares HP, 2015, MOL CANCER THER, V14, P1014, DOI 10.1158/1535-7163.MCT-14-0669; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Walker EJ, 2015, CANCER-AM CANCER SOC, V121, P1287, DOI 10.1002/cncr.29256; Wang J, 2016, J BIOL CHEM, V291, P17988, DOI 10.1074/jbc.M115.711275; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wu BU, 2015, AM J GASTROENTEROL, V110, P1233, DOI 10.1038/ajg.2015.217; Xie D, 2015, HIPPO TRANSDUCER TAZ, DOI [10.18632/oncotarget.5772, DOI 10.18632/ONCOTARGET.5772]; Yang S, 2015, ACTIVE YAP PROMOTES, DOI [10.18632/oncotarget.5935, DOI 10.18632/ONCOTARGET.5935]; Yang SP, 2015, ONCOTARGET, V6, P36019, DOI 10.18632/oncotarget.5935; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Young SH, 2010, BIOCHEM BIOPH RES CO, V401, P154, DOI 10.1016/j.bbrc.2010.09.036; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; 2016, J BIOL CHEM, V291, P6096, DOI DOI 10.1074/JBC.M115.708313; 2015, SCIENCE, V348, P1024, DOI DOI 10.1126/SCIENCE.AAA4559; 2017, INT J CANCER, V140, P1068, DOI DOI 10.1002/IJC.30526; 2012, NATURE, V491, P399, DOI DOI 10.1038/NATURE11547	73	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216603	10.1371/journal.pone.0216603	http://dx.doi.org/10.1371/journal.pone.0216603			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100067	gold, Green Published, Green Submitted			2022-12-27	WOS:000468176600011
J	Voss, S; Beuing, O; Janiga, G; Berg, P				Voss, Samuel; Beuing, Oliver; Janiga, Gabor; Berg, Philipp			Multiple Aneurysms AnaTomy CHallenge 2018 ( MATCH)-Phase Ib: Effect of morphology on hemodynamics	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; BLOOD-FLOW; INTRACRANIAL ANEURYSMS; RUPTURE STATUS; PREDICTION; CFD; STRATEGY; IMPACT	Background Image-based blood flow simulations have been increasingly applied to investigate intracranial aneurysm (IA) hemodynamics. However, the acceptance among physicians remains limited due to the high variability in the underlying assumptions and quality of results. Methods To evaluate the vessel segmentation as one of the most important sources of error, the international Multiple Aneurysms AnaTomy CHallenge 2018 (MATCH) was announced. 26 research groups from 13 different countries segmented three datasets, which contained five IAs in total. Based on these segmentations, 73 time-dependent blood flow simulations under consistent conditions were carried out. Afterwards, relevant flow and shear parameters (e.g., neck inflow rate, parent vessel flow rate, spatial mean velocity, and wall shear stress) were analyzed both qualitatively and quantitatively. Results Regarding the entire vasculature, the variability of the segmented vessel radius is 0.13 mm, consistent and independent of the local vessel radius. However, the centerline velocity shows increased variability in more distal vessels. Focusing on the aneurysms, clear differences in morphological and hemodynamic parameters were observed. The quantification of the segmentation-induced variability showed approximately a 14% difference among the groups for the parent vessel flow rate. Regarding the mean aneurysmal velocity and the neck inflow rate, a variation of 30% and 46% was observed, respectively. Finally, time-averaged wall shear stresses varied between 28% and 51%, depending on the aneurysm in question. Conclusions MATCH reveals the effect of state-of-the-art segmentation algorithms on subsequent hemodynamic simulations for IA research. The observed variations may lead to an inappropriate interpretation of the simulation results and thus, can lead to inappropriate conclusions by physicians. Therefore, accurate segmentation of the region of interest is necessary to obtain reliable and clinically helpful flow information.	[Voss, Samuel; Janiga, Gabor; Berg, Philipp] Univ Magdeburg, Dept Fluid Dynam & Tech Flows, Magdeburg, Germany; [Voss, Samuel; Beuing, Oliver; Janiga, Gabor; Berg, Philipp] Forsch Campus STIMULATE, Magdeburg, Germany; [Beuing, Oliver] Univ Hosp Magdeburg, Inst Neuroradiol, Magdeburg, Germany	Otto von Guericke University; University Hospital Magdeburg	Voss, S (corresponding author), Univ Magdeburg, Dept Fluid Dynam & Tech Flows, Magdeburg, Germany.; Voss, S (corresponding author), Forsch Campus STIMULATE, Magdeburg, Germany.	samuel.voss@ovgu.de	Janiga, Gábor/AAK-8972-2021	Janiga, Gábor/0000-0002-4560-9640; Beuing, Oliver/0000-0001-8033-063X; Voss, Samuel/0000-0002-9757-7564	Federal Ministry of Education and Research in Germany within the Forschungscampus STIMULATE [13GW0095A]; German Research Foundation [399581926]	Federal Ministry of Education and Research in Germany within the Forschungscampus STIMULATE; German Research Foundation(German Research Foundation (DFG))	This work was partly funded by the Federal Ministry of Education and Research in Germany within the Forschungscampus STIMULATE (grant number 13GW0095A) and the German Research Foundation (grant number 399581926).	Axner L, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-23; Bakhshinejad A, 2017, J BIOMECH, V58, P162, DOI 10.1016/j.jbiomech.2017.05.004; Berg P, 2018, J NEUROINTERV SURG, V10, P290, DOI 10.1136/neurintsurg-2017-012996; Berg P, 2019, INT J COMPUT ASS RAD, V14, P1795, DOI 10.1007/s11548-019-01986-2; Berg P, 2018, CARDIOVASC ENG TECHN, V9, P565, DOI 10.1007/s13239-018-00376-0; Berg P, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031794; Cardenes R, 2013, MED BIOL ENG COMPUT, V51, P343, DOI 10.1007/s11517-012-1003-8; Carty G, 2016, J MED BIOL ENG, V36, P396, DOI 10.1007/s40846-016-0142-z; Cebral JR, 2011, AM J NEURORADIOL, V32, P27, DOI 10.3174/ajnr.A2398; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Chnafa C, 2018, AM J NEURORADIOL, V39, P337, DOI 10.3174/ajnr.A5484; Chung B, 2015, ANN BIOMED ENG, V43, P122, DOI 10.1007/s10439-014-1093-6; Detmer FJ, 2018, INT J COMPUT ASS RAD, V13, P1767, DOI 10.1007/s11548-018-1837-0; Detmer FJ, 2018, ACTA NEUROCHIR, V160, P1643, DOI 10.1007/s00701-018-3595-8; Fiorella D, 2011, AJNR Am J Neuroradiol, V32, pE95, DOI 10.3174/ajnr.A2534; Hollnagel DI, 2009, NMR BIOMED, V22, P795, DOI 10.1002/nbm.1389; Janiga G, 2015, AM J NEURORADIOL, V36, P530, DOI 10.3174/ajnr.A4157; Janiga G, 2013, BIOMED ENG-BIOMED TE, V58, P303, DOI 10.1515/bmt-2012-0119; Jiang JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127251; Kallmes DF, 2012, AM J NEURORADIOL, V33, P395, DOI 10.3174/ajnr.A2993; Kleinloog R, 2018, AM J NEURORADIOL, V39, P713, DOI 10.3174/ajnr.A5546; Ma BS, 2004, ANN BIOMED ENG, V32, P264, DOI 10.1023/B:ABME.0000012746.31343.92; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Morales HG, 2013, J BIOMECH, V46, P2158, DOI 10.1016/j.jbiomech.2013.06.034; Piccinelli M, 2009, IEEE T MED IMAGING, V28, P1141, DOI 10.1109/TMI.2009.2021652; Saalfeld S., 2018, INT J COMPUT ASSIST; Steinman DA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023382; Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Tezduyar TE, 2011, INT J NUMER METH BIO, V27, P1665, DOI 10.1002/cnm.1433; Valen-Sendstad K, 2014, AM J NEURORADIOL, V35, P536, DOI 10.3174/ajnr.A3793; Valen-Sendstad K, 2018, CARDIOVASC ENG TECHN, V9, P544, DOI 10.1007/s13239-018-00374-2; Valen-Sendstad K, 2015, ANN BIOMED ENG, V43, P1422, DOI 10.1007/s10439-015-1288-5; Valencia A, 2008, INT J NUMER METH FL, V58, P1081, DOI 10.1002/fld.1786; Vanrossomme AE, 2015, AM J NEURORADIOL, V36, P1796, DOI 10.3174/ajnr.A4310; Voss S, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/9854539; Xiang JP, 2016, J NEUROINTERV SURG, V8, P104, DOI 10.1136/neurintsurg-2014-011477; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; 2010, INT J NUMER METH BIO, V26, P336, DOI DOI 10.1002/CNM.1289	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216813	10.1371/journal.pone.0216813	http://dx.doi.org/10.1371/journal.pone.0216813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100101	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600018
J	Zhang, ST; You, PP; Zhao, P; Liang, LH; Li, RB				Zhang, Songtao; You, Peipei; Zhao, Peng; Liang, Lihua; Li, Rubing			Experimental study on the control form of fin stabilizer at zero speed	PLOS ONE			English	Article							SHIP; DESIGN	The zero-speed fin stabilizer is used to stabilize the roll motion of the ship at full speed. It has two working modes, that is the lift-based normal anti-rolling mode and the drag-based zero-speed anti-rolling mode. Different force generation mechanisms cause different control methods, especially in the form of control. The zero-speed fin stabilizer works in a sinusoidal fashion in normal mode, the same as the conventional fin stabilizer. However, its control form at zero speed is not particularly clear. This paper aims to investigate the control form of fin stabilizer at zero speed through a composite method of theoretical analysis and experimental research. Based on the established reaction force model, the forces generated on the fin flapped in sinusoidal and trapezoidal forms are compared and analyzed. It is found that the trapezoidal form flapping with a small half-cycle ratio generates larger force than the sinusoidal flapping form when the flapping amplitude is the same. The forced rolling tank tests with the fins flapping in sinusoidal and trapezoidal forms were conducted. The test results are consistent with the theoretical analysis results, and the trapezoidal flapping form with a proper small half-cycle ratio is recommended for fin stabilizers at zero speed. The control strategy of fin stabilizer at zero speed is obtained based on the further analysis of the force characteristics of the trapezoidal flapping form and the limitations of the actual fin stabilizer actuation system. The model and full scale roll reduction tests at zero speed were conducted, achieving more than 70% and 60% of the anti-rolling effect respectively. The test results further verify the effectiveness, applicability and practicability of the obtained control form and strategy for fin stabilizers in at-anchor conditions, and can be a reference for engineering practice and other similar studies.	[Zhang, Songtao; Zhao, Peng; Liang, Lihua; Li, Rubing] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China; [You, Peipei] China Ship Dev & Design Ctr, Shanghai, Peoples R China	Harbin Engineering University	Liang, LH (corresponding author), Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China.	heu_zyy@hrbeu.edu.cn						Conolly J.E., 1969, T ROYAL I NAVAL ARCH, V111, P21; Dallinga R.P., 1999, ROLL STABILIZATION M; Dallinga RP, 2014, MERITS FLAPPING ROLL; Fan W, 2009, OCEAN ENG, V36, P1425, DOI 10.1016/j.oceaneng.2009.07.013; Fang MC, 2007, OCEAN ENG, V34, P479, DOI 10.1016/j.oceaneng.2006.03.004; Fang MC, 2010, OCEAN ENG, V37, P529, DOI 10.1016/j.oceaneng.2010.02.013; Giannini M, 2005, GUIDELINES DESIGN AC; Ji M, 2014, CHINESE J SHIP RES, V9, p[8, 42]; Ji M, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (IEEE ICMA 2014), P1757, DOI 10.1109/ICMA.2014.6885966; Jin H., 2015, SHIP ANTIROLLING CON; Jin H. Z., 2013, SHIP CONTROL THEORY; Jin Hong-zhang, 2008, Journal of Harbin Engineering University, V29, P368; [金鸿章 JIN Hongzhang], 2011, [中国造船, Shipbuilding of China], V52, P1; Kong XJ, 2017, RES ANTIROLLING CONT; Koshkouei AJ, 2012, OCEAN ENG, V49, P66, DOI 10.1016/j.oceaneng.2012.04.002; Lewis E.V., 1989, PRINCIPLES NAVAL ARC, VIII; [梁利华 Liang Lihua], 2018, [哈尔滨工程大学学报, Journal of Harbin Engineering University], V39, P1539; Liang LH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204446; Liang LH, 2017, OCEAN ENG, V142, P491, DOI 10.1016/j.oceaneng.2017.07.012; Liang LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168972; Liang LH, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P2413, DOI 10.1109/ICMA.2016.7558944; Martin G. S., 2003, FIN STABILIZERS MANE; Moaleji R, 2007, OCEAN ENG, V34, P103, DOI 10.1016/j.oceaneng.2005.12.013; Ooms J., 2002, USE ROLL STABILIZER; Perez T., 2005, SHIP MOTION CONTROL; Perez T, 2012, ANNU REV CONTROL, V36, P129, DOI 10.1016/j.arcontrol.2012.03.010; Sebastiani L, 2005, DESIGN ANCHOR STABIL; Song Ji-guang, 2015, Control Theory & Applications, V32, P703, DOI 10.7641/CTA.2015.40499; [宋吉广 Song Jiguang], 2013, [中国造船, Shipbuilding of China], V54, P1; Su XY, 2018, INT J FUZZY SYST, V20, P611, DOI 10.1007/s40815-017-0402-2; Talha M, 2017, INT J FUZZY LOG INTE, V17, P210, DOI 10.5391/IJFIS.2017.17.3.210; Toxopeus S, 2011, MANOEUVRING SEAKEEPI; Wang F., 2010, KEY TECHNOLOGIES BIO	33	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216395	10.1371/journal.pone.0216395	http://dx.doi.org/10.1371/journal.pone.0216395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100076	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600007
J	Thin, K; Prum, V; Johns, B				Thin, Kouland; Prum, Virak; Johns, Benjamin			The cost of HIV services at health facilities in Cambodia	PLOS ONE			English	Article								Background Donor funding for HIV/AIDS services is declining in Cambodia, and domestic resources need to be mobilized to sustain and expand these services. However, the cost of delivering HIV/AIDS services is not well studied in Cambodia. This study aims to assess the costs of delivering HIV/AIDS services, identify the major components of costs, and sources of funding. Methods Four of the six highest HIV burden provinces were selected at random for this study. Within each province, four health centers and two hospitals were selected for detailed data collection. A mix of top-down and bottom-up methods were used to assess the costs for HIV testing and antiretroviral therapy (ART) from the provider perspective. We assessed the differences in the quantity and prices of inputs between health facilities of the same type to identify cost-drivers. Results The average cost per visit for HIV testing was $8.92 at health centers and $14.03 at referral hospitals. Differences in the number of visits per staff were the primary determinant of differences in the cost per visit. First-line ART costed about $250 per patient per year, and the number of patients per staff was an important cost driver. Second-line ART costed from $500 to $716 per patient per year, on average, across the types of facilities, with the quantity and mix of second-line antiretroviral drugs being an important cost driver. Inpatient care at referral and provincial hospitals in total represented less than 2 percent of costs of outpatient ART. Discussion Costs are similar to neighboring countries, but over 50% of the costs of ART are financed by donors. Cambodia now is scaling up social health insurance coverage; the data from this study could serve as one input when setting reimbursement rates for HIV/AIDS services to help ensure that providers are adequately reimbursed for their services.	[Thin, Kouland] Swiss Dev Cooperat, Hlth Div, Phnom Penh, Cambodia; [Prum, Virak] Royal Univ Phnom Penh, Dept Geog, Phnom Penh, Cambodia; [Johns, Benjamin] ABT Associates Inc, Int Dev Div, Bethesda, MD USA	ABT Associates	Thin, K (corresponding author), Swiss Dev Cooperat, Hlth Div, Phnom Penh, Cambodia.	koulandthin@hotmail.com			United States Agency for International Development through the Health Finance and Governance Project [AID OAA-A-12-00080]	United States Agency for International Development through the Health Finance and Governance Project(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development through the Health Finance and Governance Project (Cooperative Agreement No: AID OAA-A-12-00080). ABT Associates provided support in the form of salaries for authors KT and BJ. The staff at USAID provided comments on, for example, the sample design, although all final decisions were the responsibility of the authors. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allinder SM, 2017, HIV INVESTMENT CAMBO; Anh DT, 2014, J ACQUIR IMMUNE DEFI; [Anonymous], 2004, MAN ACC SYST HOSP MA; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Dandona L, 2005, NATL MED J INDIA, V18, P26; Health Finance and Governance Project (HFG), 2017, CAMB 5 NAT AIDS SPEN; Ingun P., 2015, J THAI MED INFORM AS, V2, P137; Japan International Cooperation Agency (JICA) Global Link Management (GLM), 2016, DAT COLL SURV SOC HL; Kiet PHT, 2013, COSTING HIV AIDS SER; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Ministry of Labour and Vacational Training (MLVT) and Ministry of Health (MoH), 2016, INT PRAK PROV PAYM M; Minstry of Health (MoH), 2006, NAT GUID COMPL PACK; Minstry of Health (MoH), 2008, NAT GUID MIN PACK AC; Minstry of Health (MoH), 2018, EST HLTH EXP CAMB NA; Nguyen QLT, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2464-0; Robin T, 2012, OXFORD POLICY MANAGE; Royal Government of Cambodia (RGC), 2016, NAT SOC PROT POL FRA; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Slaymaker E, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22789; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; UNAIDS, 2016, FAST TRACK UPD INV N; UNAIDS, 2017, GLOB AIDS UPD 2016; Vietnam Ministry of Health, 2021, INCR ACC TTREATM HIV; Ward WJ, 1994, HLTH CARE BUDGETING; Yi S, 2014, GLOBAL J MED PUBLIC, V3	25	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216774	10.1371/journal.pone.0216774	http://dx.doi.org/10.1371/journal.pone.0216774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141514	Green Published, Green Submitted, gold			2022-12-27	WOS:000469323000022
J	Solarski, M; Williams, D; Mehrabian, M; Wang, HS; Wille, H; Schmitt-Ulms, G				Solarski, Michael; Williams, Declan; Mehrabian, Mohadeseh; Wang, Hansen; Wille, Holger; Schmitt-Ulms, Gerold			The human brain somatostatin interactome: SST binds selectively to P-type family ATPases	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RECEPTOR SUBTYPES; INDUCED INHIBITION; MOLECULAR-CLONING; PROTEIN COMPLEX; CEREBRAL-CORTEX; CELLS; EXPRESSION; K+; PURIFICATION	Somatostatin (SST) is a cyclic peptide that is understood to inhibit the release of hormones and neurotransmitters from a variety of cells by binding to one of five canonical G protein-coupled SST receptors (SSTR1 to SSTR5). Recently, SST was also observed to interact with the amyloid beta (A beta) peptide and affect its aggregation kinetics, raising the possibility that it may bind other brain proteins. Here we report on an SST interactome analysis that made use of human brain extracts as biological source material and incorporated advanced mass spectrometry workflows for the relative quantitation of SST binding proteins. The analysis revealed SST to predominantly bind several members of the P-type family of ATPases. Subsequent validation experiments confirmed an interaction between SST and the sodium-potassium pump (Na+/K+-ATPase) and identified a tryptophan residue within SST as critical for binding. Functional analyses in three different cell lines indicated that SST might negatively modulate the K+ uptake rate of the Na+/K+-ATPase.	[Solarski, Michael; Williams, Declan; Mehrabian, Mohadeseh; Wang, Hansen; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, Toronto, ON, Canada; [Wille, Holger] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Wille, Holger] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Alberta; University of Alberta; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	Wille, Holger/C-2280-2008; Wang, Hansen/H-7703-2014	Wille, Holger/0000-0001-5102-8706; Wang, Hansen/0000-0003-4414-3372; Williams, Declan/0000-0002-6754-1624; Schmitt-Ulms, Gerold/0000-0001-6962-0919	Alberta Prion Research Institute [201600028]	Alberta Prion Research Institute	HoW and GS received funding from the Alberta Prion Research Institute (grant number: 201600028). We are grateful to the Rosiak family for their most generous philanthropic support. The mass spectrometry components of this study were enabled through a major donation by the Irwin family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; BEAL MF, 1985, SCIENCE, V229, P289, DOI 10.1126/science.2861661; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; BOSCH J, 1985, CLIN GASTROENTEROL, V14, P169; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BROWN PJ, 1990, J BIOL CHEM, V265, P17995; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; BRUNO JF, 1992, P NATL ACAD SCI USA, V89, P11151, DOI 10.1073/pnas.89.23.11151; Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI 10.1056/NEJMc1409757; Dalm SU, 2017, J NUCL MED, V58, P1609, DOI 10.2967/jnumed.116.189035; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Duran-Prado M, 2008, MOL CELL ENDOCRINOL, V286, P63, DOI 10.1016/j.mce.2007.12.006; EPELBAUM J, 1979, EUR J PHARMACOL, V58, P493, DOI 10.1016/0014-2999(79)90323-6; Epelbaum J, 2009, PROG NEUROBIOL, V89, P153, DOI 10.1016/j.pneurobio.2009.07.002; EPPLER CM, 1992, J BIOL CHEM, V267, P15603; GABRIEL SM, 1993, NEUROSCI LETT, V155, P116, DOI 10.1016/0304-3940(93)90686-F; Gadelha MR, 2017, PITUITARY, V20, P100, DOI 10.1007/s11102-017-0791-0; Gahete MD, 2010, J ALZHEIMERS DIS, V20, P465, DOI 10.3233/JAD-2010-1385; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; HE HT, 1989, P NATL ACAD SCI USA, V86, P1480, DOI 10.1073/pnas.86.5.1480; Jamshad M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140171; Jean AHW, 2012, METHODS MOL BIOL, V803, P231, DOI 10.1007/978-1-61779-364-6_16; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; KAUPMANN K, 1995, EMBO J, V14, P727, DOI 10.1002/j.1460-2075.1995.tb07051.x; KAZIRO Y, 1960, P NATL ACAD SCI USA, V46, P1319, DOI 10.1073/pnas.46.10.1319; KIMURA N, 1989, J BIOL CHEM, V264, P7033; KNUHTSEN S, 1990, J BIOL CHEM, V265, P1129; KOCH BD, 1988, J BIOL CHEM, V263, P226; Kockskamper J, 1997, BBA-BIOMEMBRANES, V1325, P197, DOI 10.1016/S0005-2736(96)00259-3; Koltsova SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038032; Kumar U, 2010, CELLULAR PEPTIDE HOR, P97; Li M, 2005, WORLD J SURG, V29, P293, DOI 10.1007/s00268-004-7814-5; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Martel Guillaume, 2012, Front Endocrinol (Lausanne), V3, P154, DOI 10.3389/fendo.2012.00154; Minano C, 2010, GASTROENTEROL CLIN N, V39, P681, DOI 10.1016/j.gtc.2010.08.015; MOLLARD P, 1988, ENDOCRINOLOGY, V123, P721, DOI 10.1210/endo-123-2-721; MORRISON JH, 1985, NATURE, V314, P90, DOI 10.1038/314090a0; OCARROLL AM, 1992, MOL PHARMACOL, V42, P939; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Piqueras L, 2004, N-S ARCH PHARMACOL, V370, P510, DOI 10.1007/s00210-004-0992-8; RENSDOMIANO S, 1992, J NEUROCHEM, V58, P1987, DOI 10.1111/j.1471-4159.1992.tb10938.x; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Reynaert H, 2003, ALIMENT PHARM THER, V18, P375, DOI 10.1046/j.1365-2036.2003.01657.x; ROBERTS GW, 1985, NATURE, V314, P92, DOI 10.1038/314092a0; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; SAKAMOTO C, 1988, J BIOL CHEM, V263, P14441; Samson WK, 2008, J BIOL CHEM, V283, P31949, DOI 10.1074/jbc.M804784200; Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061; SCHONBRUNN A, 1993, ENDOCRINOLOGY, V132, P146, DOI 10.1210/en.132.1.146; Shahidullah M, 2017, INVEST OPHTH VIS SCI, V58, P4447, DOI 10.1167/iovs.17-21600; SHEN LP, 1982, P NATL ACAD SCI-BIOL, V79, P4575, DOI 10.1073/pnas.79.15.4575; SIMS SM, 1991, J PHYSIOL-LONDON, V441, P615, DOI 10.1113/jphysiol.1991.sp018770; Solarski M, 2018, PRION, V12, P1, DOI 10.1080/19336896.2017.1405207; Somvanshi RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085193; Strowski MZ, 2008, MOL CELL ENDOCRINOL, V286, P169, DOI 10.1016/j.mce.2008.02.007; Sun LC, 2011, CURR DRUG DELIV, V8, P2, DOI 10.2174/156720111793663633; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Tuboly G, 2013, MINI-REV MED CHEM, V13, P34, DOI 10.2174/138955713804484794; Van Grondelle W, 2007, J STRUCT BIOL, V160, P211, DOI 10.1016/j.jsb.2007.08.006; VEBER DF, 1979, NATURE, V280, P512, DOI 10.1038/280512a0; Vepsalainen S, 2007, J NEUROL, V254, P1504, DOI 10.1007/s00415-007-0539-2; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang HS, 2017, ELIFE, V6, DOI 10.7554/eLife.28401; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; Xue SF, 2009, NEUROSCI LETT, V465, P181, DOI 10.1016/j.neulet.2009.09.002; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; YAMASHITA N, 1988, P NATL ACAD SCI USA, V85, P4924, DOI 10.1073/pnas.85.13.4924; YAMASHITA N, 1986, P NATL ACAD SCI USA, V83, P6198, DOI 10.1073/pnas.83.16.6198; Yang SK, 2007, CLIN EXP PHARMACOL P, V34, P1221, DOI 10.1111/j.1440-1681.2007.04806.x; Yang SK, 2005, ENDOCRINOLOGY, V146, P4975, DOI 10.1210/en.2005-0696; YASUDA K, 1992, J BIOL CHEM, V267, P20422; Yoshimoto Y, 1999, FEBS LETT, V444, P265, DOI 10.1016/S0014-5793(99)00076-9; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	78	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217392	10.1371/journal.pone.0217392	http://dx.doi.org/10.1371/journal.pone.0217392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136617	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300033
J	Bentz, GL; Lowrey, AJ; Home, DC; Nguyen, V; Satterfield, AR; Ross, TD; Harrod, AE; Uchakina, ON; McKallip, RJ				Bentz, Gretchen L.; Lowrey, Angela J.; Home, Dustin C.; Vy Nguyen; Satterfield, Austin R.; Ross, Tabithia D.; Harrod, Abigail E.; Uchakina, Olga N.; McKallip, Robert J.			Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; CONJUGATING ENZYME UBC9; GINKGOLIC ACID; ANTIVIRAL ACTIVITY; KAPOSIS-SARCOMA; GENE-EXPRESSION; KINASE BGLF4; CELL-GROWTH; SUMO; UBIQUITIN	Cellular sumoylation processes are proposed targets for anti-viral and anti-cancer therapies. We reported that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) dysregulates cellular sumoylation processes, contributing to its oncogenic potential in EBV-associated malignancies. Ginkgolic acid and anacardic acid, known inhibitors of sumoylation, inhibit LMP1-induced protein sumoylation; however, both drugs have adverse effects in hosts. Here we test the effects of glycyrrhizic acid, a medicinal botanical extract with anti-inflammatory, anti-carcinogenic, and anti-viral properties, on cellular sumoylation processes. While glycyrrhizic acid is known to inhibit EBV penetration, its affect on cellular sumoylation processes remains to be documented. We hypothesized that glycyrrhizic acid inhibits cellular sumoylation processes and may be a viable treatment for Epstein-Barr virus-associated malignancies. Results showed that glycyrrhizic acid inhibited sumoylation processes (without affecting ubiquitination processes), limited cell growth, and induced apoptosis in multiple cell lines. Similar to ginkgolic acid; glycyrrhizic acid targeted the first step of the sumoylation process and resulted in low levels of spontaneous EBV reactivation. Glycyrrhizic acid did not affect induced reactivation of the virus, but the presence of the extract did reduce the ability of the produced virus to infect additional cells. Therefore, we propose that glycyrrhizic acid may be a potential therapeutic drug to augment the treatment of EBV-associated lymphoid malignancies.	[Bentz, Gretchen L.; Lowrey, Angela J.; Home, Dustin C.; Vy Nguyen; Satterfield, Austin R.; Ross, Tabithia D.; Harrod, Abigail E.; Uchakina, Olga N.; McKallip, Robert J.] Mercer Univ, Sch Med, Div Biomed Sci, Macon, GA 31207 USA	Mercer University	Bentz, GL (corresponding author), Mercer Univ, Sch Med, Div Biomed Sci, Macon, GA 31207 USA.	bentz_GL@mercer.edu			National Cancer Institute [CA160786]; NATIONAL CANCER INSTITUTE [R00CA160786] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (CA160786 to GLB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2005, BIOCHEM BIOPH RES CO, V336, P22, DOI 10.1016/j.bbrc.2005.08.036; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Afnan Q, 2012, PHYTOMEDICINE, V19, P658, DOI 10.1016/j.phymed.2012.03.007; Ahlemeyer B, 2001, EUR J PHARMACOL, V430, P1, DOI 10.1016/S0014-2999(01)01237-7; Alarcon-Vargas D, 2002, CANCER BIOL THER, V1, P237, DOI 10.4161/cbt.74; BABA M, 1987, ANTIVIR RES, V7, P99, DOI 10.1016/0166-3542(87)90025-8; Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538; Bentz GL, 2015, J VIROL, V89, P7465, DOI 10.1128/JVI.00711-15; Bentz GL, 2012, J VIROL, V86, P12251, DOI 10.1128/JVI.01407-12; Bentz GL, 2011, J VIROL, V85, P10144, DOI 10.1128/JVI.05035-11; Bentz GL, 2010, VIROLOGY, V402, P121, DOI 10.1016/j.virol.2010.03.014; Berg K, 2015, TOXICOLOGY, V327, P47, DOI 10.1016/j.tox.2014.10.001; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Brennan P, 2001, J BIOL CHEM, V276, P1195, DOI 10.1074/jbc.M005461200; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CALENDER A, 1990, INT J CANCER, V46, P658, DOI 10.1002/ijc.2910460418; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chen L, 2009, XENOBIOTICA, V39, P955, DOI 10.3109/00498250903271997; Cherney BW, 1998, BLOOD, V91, P2491, DOI 10.1182/blood.V91.7.2491.2491_2491_2500; Chueh FS, 2012, ONCOL REP, V28, P2069, DOI 10.3892/or.2012.2029; Cohen JI, 2005, J CLIN INVEST, V115, P591, DOI 10.1172/JCI200524507; Curreli F, 2005, J CLIN INVEST, V115, P642, DOI 10.1172/JCI200523334; De La Cruz-Herrera CF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007176; De Leo Alessandra, 2018, PLoS Pathog, V14, pe1007027, DOI 10.1371/journal.ppat.1007027; Dirmeier U, 2003, CANCER RES, V63, P2982; Duan XY, 2009, ANTI-CANCER AGENT ME, V9, P51, DOI 10.2174/187152009787047716; Erboga M, 2015, RENAL FAILURE, V37, P1492, DOI 10.3109/0886022X.2015.1074521; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Gao LL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00215; Gershburg E, 2007, J VIROL, V81, P5407, DOI 10.1128/JVI.02398-06; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Hagemeier SR, 2010, J VIROL, V84, P4383, DOI 10.1128/JVI.02369-09; He SQ, 2015, INT J CLIN EXP PATHO, V8, P5175; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; HIRABAYASHI K, 1991, CHEM PHARM BULL, V39, P112; Hirohama M, 2013, ACS CHEM BIOL, V8, P2635, DOI 10.1021/cb400630z; Hostetler BJ, 2017, ANTICANCER RES, V37, P997, DOI 10.21873/anticanres.11409; Huang RY, 2014, CELL PHYSIOL BIOCHEM, V33, P375, DOI 10.1159/000356677; Huang W, 2012, CELL BIOCHEM BIOPHYS, V62, P137, DOI 10.1007/s12013-011-9271-8; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jamroziak K, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0448-2; Jeong EI, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.428; Jiang L, 2016, AM J TRANSL RES, V8, P1064; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang FB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008518; Kang H, 2011, J VIROL, V85, P11159, DOI 10.1128/JVI.00720-11; Kao TC, 2014, J AGR FOOD CHEM, V62, P542, DOI 10.1021/jf404939f; Katayama PL, 2017, FASEB J, V31; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Kieser A., 2008, PROTEOMIC IDENTIFICA; Kim KJ, 2013, PHYTOTHER RES, V27, P841, DOI 10.1002/ptr.4800; Klass CM, 2005, CURR OPIN ONCOL, V17, P447, DOI 10.1097/01.cco.0000172823.01190.6c; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Knipscheer Puck, 2009, V497, P201, DOI 10.1007/978-1-59745-566-4_13; Korenaga M, 2011, LIVER INT, V31, P552, DOI 10.1111/j.1478-3231.2011.02469.x; Kroetz Mary B, 2005, Yale J Biol Med, V78, P197; Kukurtchu Bulent, 2012, Akush Ginekol (Sofiia), V51 Suppl 1, P46; Kuwajima H, 1999, YAKUGAKU ZASSHI, V119, P945, DOI 10.1248/yakushi1947.119.12_945; Lampis G, 2001, ANTIVIR CHEM CHEMOTH, V12, P125, DOI 10.1177/095632020101200206; Lee H, 2016, MOLECULES, V21, DOI 10.3390/molecules21081058; Lee M, 2015, ONCOTARGET, V6, P12603, DOI 10.18632/oncotarget.3687; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Li JY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872139; Li JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006338; Li L, 2016, EXP THER MED, V12, P3381, DOI 10.3892/etm.2016.3768; Li RW, 2012, J VIROL, V86, P5412, DOI 10.1128/JVI.00314-12; Li S, 2014, NEUROL SCI, V35, P1115, DOI 10.1007/s10072-014-1661-4; Lin JC, 2003, ANTIVIR RES, V59, P41, DOI 10.1016/S0166-3542(03)00030-5; Lin JC, 2008, ANTIVIR RES, V79, P6, DOI 10.1016/j.antiviral.2008.01.160; Liu ST, 2006, VIRUS RES, V119, P163, DOI 10.1016/j.virusres.2006.01.004; Liu ZH, 2009, TOXICOL LETT, V187, P131, DOI 10.1016/j.toxlet.2009.02.012; Lowrey AJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0183-0; Ma JQ, 2015, INT IMMUNOPHARMACOL, V28, P531, DOI 10.1016/j.intimp.2015.06.036; Mahadevan S, 2008, J FOOD SCI, V73, pR14, DOI 10.1111/j.1750-3841.2007.00597.x; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Matsuo K, 2001, LEUKEMIA LYMPHOMA, V41, P191, DOI 10.3109/10428190109057970; Miller WE, 1997, J VIROL, V71, P586, DOI 10.1128/JVI.71.1.586-594.1997; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Naesens L, 2006, J CLIN VIROL, V37, pS69, DOI 10.1016/S1386-6532(06)70015-4; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; NUMAZAKI K, 1994, TOHOKU J EXP MED, V172, P147, DOI 10.1620/tjem.172.147; NUMAZAKI K, 1994, J LEUKOCYTE BIOL, V55, P24, DOI 10.1002/jlb.55.1.24; Numazaki Kei, 1993, In Vivo (Athens), V7, P477; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Pattullo V, 2015, WORLD J HEPATOL, V7, P954, DOI 10.4254/wjh.v7.i7.954; POMPEI R, 1980, EXPERIENTIA, V36, P304, DOI 10.1007/BF01952290; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; Qu B, 2017, XENOBIOTICA, V47, P290, DOI 10.1080/00498254.2016.1185195; Radwan MA, 2002, J MICROENCAPSUL, V19, P225, DOI 10.1080/02652040110081406; Ramasubramanyan S, 2012, J VIROL, V86, P1809, DOI 10.1128/JVI.06334-11; Salahuddin S, 2019, SCI REPORTS; Salahuddin S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36312-4; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sekizawa T, 2001, ACTA VIROL, V45, P51; Selyutina OY, 2016, COLLOID SURFACE B, V147, P459, DOI 10.1016/j.colsurfb.2016.08.037; Selyutina OY, 2016, DRUG DELIV, V23, P858, DOI 10.3109/10717544.2014.919544; Shustik C, 2017, ANN HEMATOL, V96, P1185, DOI 10.1007/s00277-017-2982-1; Siegers CP, 1999, PHYTOMEDICINE, V6, P281, DOI 10.1016/S0944-7113(99)80021-X; Sitzia J, 1997, CANCER NURS, V20, P430, DOI 10.1097/00002820-199712000-00007; Son M, 2013, J MICROBIOL, V51, P545, DOI 10.1007/s12275-013-3450-9; Stewart MJ, 2005, J VIROL, V79, P2979, DOI 10.1128/JVI.79.5.2979-2987.2005; Su XT, 2017, BIOMED PHARMACOTHER, V95, P670, DOI 10.1016/j.biopha.2017.08.123; Tabtieng T, 2018, J VIROL, V92; Takemoto M, 2014, J ANTIBIOT, V67, P335, DOI 10.1038/ja.2013.142; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Torres HA, 2018, HEPATOLOGY, V67, P36, DOI 10.1002/hep.29344; Whitehurst CB, 2009, J VIROL, V83, P4345, DOI 10.1128/JVI.02195-08; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xie YR, 2011, J MED VIROL, V83, P879, DOI 10.1002/jmv.22001; Yang FH, 2015, MOLECULES, V20, P4337, DOI 10.3390/molecules20034337; Yang YC, 2013, J BIOL CHEM, V288, P12866, DOI 10.1074/jbc.M112.413393; Yao QQ, 2017, CHIN J NAT MEDICINES, V15, P375, DOI 10.1016/S1875-5364(17)30058-4; Zhang K, 2017, CELL REP, V21, P3445, DOI 10.1016/j.celrep.2017.11.071	130	12	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217578	10.1371/journal.pone.0217578	http://dx.doi.org/10.1371/journal.pone.0217578			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125383	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700048
J	Maignan, M; Chauny, JM; Daoust, R; Duc, L; Mabiala-Makele, P; Collomb-Muret, R; Roustit, M; Maindet, C; Pepin, JL; Viglino, D				Maignan, Maxime; Chauny, Jean-Marc; Daoust, Raoul; Duc, Ludivine; Mabiala-Makele, Prudence; Collomb-Muret, Roselyne; Roustit, Matthieu; Maindet, Caroline; Pepin, Jean-Louis; Viglino, Damien			Pain during exacerbation of chronic obstructive pulmonary disease: A prospective cohort study	PLOS ONE			English	Article							REHABILITATION; VALIDATION; MANAGEMENT; DYSPNEA; PEOPLE; SCALE	Background and objective Pain, a symptom often present in patients with Chronic Obstructive Pulmonary Disease (COPD), alters quality of life. COPD exacerbation augments several mechanisms that may cause pain (dyspnea, hyperinflation and inflammation) and therefore we hypothesized that pain might be increased during exacerbation. Methods A prospective cohort study was conducted in patients admitted for acute exacerbations of COPD (AECOPD) in two emergency departments in France and Canada. Patients with cancer-related pain or recent trauma were not included. The Short Form McGill Pain Questionnaire (SF-MPQ) and the Brief Pain Inventory (BPI) scale were used to evaluate pain intensity and location. Patients also completed the Borg Dyspnea Scale and Hospital Anxiety and Depression Scale. The questionnaires were completed again during an outpatient assessment in the stable phase. The primary outcome was difference in pain intensity (SF-MPQ) between the exacerbation and stable phases. Results Fifty patients were included. During exacerbation, 46 patients (92%) reported pain compared to 29 (58%) in the stable phase (p<0.001). Pain intensity was higher during exacerbation (SF-MPQ 29.7 [13.6-38.2] vs. 1.4 [0.0-11.2]; p<0.001). Pain was predominantly located in the chest during exacerbation and in the limbs during the stable phase. Pain intensity during exacerbation correlated with anxiety score. Conclusion The frequency and intensity of pain were higher during AECOPD, with a specific distribution. Pain should therefore be routinely assessed and treated in patients with AECOPD.	[Maignan, Maxime; Duc, Ludivine; Mabiala-Makele, Prudence; Collomb-Muret, Roselyne; Viglino, Damien] Grenoble Alps Univ Hosp, Emergency Dept, Grenoble, France; [Maignan, Maxime; Duc, Ludivine; Mabiala-Makele, Prudence; Collomb-Muret, Roselyne; Viglino, Damien] Grenoble Alps Univ Hosp, Mobile Intens Care Unit, Grenoble, France; [Maignan, Maxime; Roustit, Matthieu; Pepin, Jean-Louis; Viglino, Damien] Univ Grenoble Alps, INSERM U1042, HP2 Lab, Grenoble, France; [Chauny, Jean-Marc; Daoust, Raoul] Sacre Coeur Hosp Montreal, Dept Emergency Med, Res Ctr, Montreal, PQ, Canada; [Roustit, Matthieu] Univ Hosp, Clin Pharmacol Dept, INSERM CIC1406, Grenoble, France; [Maindet, Caroline] Grenoble Alps Univ Hosp, Pain Med Dept, Grenoble, France; [Pepin, Jean-Louis] Grenoble Alps Univ Hosp, Dept Physiol & Sleep, Grenoble, France	CHU Grenoble Alpes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; CHU Grenoble Alpes	Maignan, M (corresponding author), Grenoble Alps Univ Hosp, Emergency Dept, Grenoble, France.; Maignan, M (corresponding author), Grenoble Alps Univ Hosp, Mobile Intens Care Unit, Grenoble, France.; Maignan, M (corresponding author), Univ Grenoble Alps, INSERM U1042, HP2 Lab, Grenoble, France.	mmaignan@chu-grenoble.fr	VIGLINO, damien/S-2378-2019; Daoust, Raoul/AAS-3221-2020	VIGLINO, damien/0000-0003-0622-7399; Daoust, Raoul/0000-0001-6507-0198; Maignan, Maxime/0000-0002-4301-4213; Pepin, Jean Louis/0000-0003-3832-2358	APICIL foundation; Agir pour les Maladies Chroniques foundation	APICIL foundation; Agir pour les Maladies Chroniques foundation	This study was funded by the APICIL foundation (http://www.fondation-apicil.org/) and the Agir pour les Maladies Chroniques foundation (http://fonds-apmc.org/), both non-profit organisations (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data and had final responsibility for the decision to submit for publication.	Andenaes R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5094-5; Aras YG, 2018, INT J CHRONIC OBSTR, V13, P1857, DOI 10.2147/COPD.S159738; Bentsen SB, 2011, J PAIN, V12, P539, DOI 10.1016/j.jpain.2010.10.014; Borge Christine Raheim, 2011, Heart Lung, V40, pe90, DOI 10.1016/j.hrtlng.2010.10.009; Bratas O, 2014, SCAND J CARING SCI, V28, P413, DOI 10.1111/scs.12054; Chen YW, 2018, COPD, V15, P65, DOI 10.1080/15412555.2017.1401990; Daoust R, 2017, PAIN RES MANAG, V2017, DOI 10.1155/2017/5983721; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, pg445, DOI DOI 10.1136/BMJ.G445; Esteban C, 2016, INT J CHRONIC OBSTR, V11, P251, DOI 10.2147/COPD.S79580; HajGhanbari B, 2013, RESP MED, V107, P1692, DOI 10.1016/j.rmed.2013.06.010; HajGhanbari B, 2012, RESP MED, V106, P998, DOI 10.1016/j.rmed.2012.03.004; Harrison SL, 2017, INT J CHRONIC OBSTR, V12, P3289, DOI 10.2147/COPD.S145442; Janssen DJA, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0210-8; Johnson MJ, 2016, EUR RESPIR J, V47, P1861, DOI 10.1183/13993003.02089-2015; Kelemen L, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.524; Lee AL, 2018, PHYSIOTHER THEOR PR, V34, P765, DOI 10.1080/09593985.2018.1425512; Lohne V, 2010, HEART LUNG, V39, P226, DOI 10.1016/j.hrtlng.2009.08.002; Longrois D, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-56; Lopez-Campos JL, 2014, COPD, V11, P591, DOI 10.3109/15412555.2014.898035; MacLeod N, 2016, PAIN MED, V17, P2119, DOI 10.1093/pm/pnw061; Mason Shawn T, 2008, Eplasty, V8, pe54; Mulhall P, 2016, RESPIROLOGY, V21, P791, DOI 10.1111/resp.12782; Schon D, 2008, AM J RESP CRIT CARE, V178, P1173, DOI 10.1164/rccm.200805-731OC; Strand LI, 2008, EUR J PAIN, V12, P917, DOI 10.1016/j.ejpain.2007.12.013; Tabak YP, 2009, ARCH INTERN MED, V169, P1595, DOI 10.1001/archinternmed.2009.270; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Tang CY, 2014, RESPIROLOGY, V19, P1191, DOI 10.1111/resp.12361; van Dam van Isselt Eleonore F, 2014, BMJ Open, V4, pe005898, DOI 10.1136/bmjopen-2014-005898; Vozoris NT, 2016, EUR RESPIR J, V48, P683, DOI 10.1183/13993003.01967-2015	29	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217370	10.1371/journal.pone.0217370	http://dx.doi.org/10.1371/journal.pone.0217370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125359	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700032
J	Miyake, S; Higuchi, H; Honda-Wakasugi, Y; Fujimoto, M; Kawai, H; Nagatsuka, H; Maeda, S; Miyawaki, T				Miyake, Saki; Higuchi, Hitoshi; Honda-Wakasugi, Yuka; Fujimoto, Maki; Kawai, Hotaka; Nagatsuka, Hitoshi; Maeda, Shigeru; Miyawaki, Takuya			Locally injected ivabradine inhibits carrageenan-induced pain and inflammatory responses via hyperpolarization-activated cyclic nucleotide-gated (HCN) channels	PLOS ONE			English	Article							DIABETIC PERIPHERAL NEUROPATHY; PACEMAKER CHANNELS; ION CHANNELS; FAMILY; DEXMEDETOMIDINE; MECHANISMS; MEDIATORS; PROTEIN; BURDEN; LIFE	Background Recently, attention has been focused on the role of hyperpolarization-activated cyclic nucleotide- gated (HCN) channels in the mechanism of and as a treatment target for neuropathic and inflammatory pain. Ivabradine, a blocker of HCN channels, was demonstrated to have an effect on neuropathic pain in an animal model. Therefore, in the present study, we evaluated the effect of ivabradine on inflammatory pain, and under the hypothesis that ivabradine can directly influence inflammatory responses, we investigated its effect in in vivo and in vitro studies. Methods After approval from our institution, we studied male Sprague-Dawley rats aged 8 weeks. Peripheral inflammation was induced by the subcutaneous injection of carrageenan into the hindpaw of rats. The paw-withdrawal threshold (pain threshold) was evaluated by applying mechanical stimulation to the injected site with von Frey filaments. Ivabradine was subcutaneously injected, combined with carrageenan, and its effect on the pain threshold was evaluated. In addition, we evaluated the effects of ivabradine on the accumulation of leukocytes and TNF-alpha expression in the injected area of rats. Furthermore, we investigated the effects of ivabradine on LPS-stimulated production of TNF-alpha in incubated mouse macrophage-like cells. Results The addition of ivabradine to carrageenan increased the pain threshold lowered by carrageenan injection. Both lamotrigine and forskolin, activators of HCN channels, significantly reversed the inhibitory effect of ivabradine on the pain threshold. Ivabradine inhibited the carrageenan-induced accumulation of leukocytes and TNF-alpha expression in the injected area. Furthermore, ivabradine significantly inhibited LPS-stimulated production of TNFalpha in the incubated cells. Conclusion The results of the present study demonstrated that locally injected ivabradine is effective against carrageenan-induced inflammatory pain via HCN channels. Its effect was considered to involve not only an action on peripheral nerves but also an anti-inflammatory effect.	[Miyake, Saki; Honda-Wakasugi, Yuka; Fujimoto, Maki; Miyawaki, Takuya] Okayama Univ, Dept Dent Anesthesiol & Special Care Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Higuchi, Hitoshi; Maeda, Shigeru] Okayama Univ Hosp, Dept Dent Anesthesiol, Okayama, Japan; [Kawai, Hotaka; Nagatsuka, Hitoshi] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University; Okayama University	Miyawaki, T (corresponding author), Okayama Univ, Dept Dent Anesthesiol & Special Care Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	miyawaki@md.okayama-u.ac.jp		Miyawaki, Takuya/0000-0002-6378-2623	JSPS (Japan Society for the Promotion of Science) KAKENHI [18K09722]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 18K09722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman CJM, 2015, DIABETES RES CLIN PR, V109, P215, DOI 10.1016/j.diabres.2015.04.031; Baron Ralf, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79090-7_1; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Emery EC, 2012, TRENDS PHARMACOL SCI, V33, P456, DOI 10.1016/j.tips.2012.04.004; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Honda Y, 2015, EUR J PHARMACOL, V764, P215, DOI 10.1016/j.ejphar.2015.06.054; JAGELS MA, 1994, IMMUNOPHARMACOLOGY, V28, P1, DOI 10.1016/0162-3109(94)90034-5; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luo L, 2007, NEUROSCIENCE, V144, P1477, DOI 10.1016/j.neuroscience.2006.10.048; Momin A, 2008, J PHYSIOL-LONDON, V586, P5911, DOI 10.1113/jphysiol.2008.163154; Notomi T, 2015, J BONE MINER RES, V30, P1618, DOI 10.1002/jbmr.2507; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Romanelli MN, 2016, CURR TOP MED CHEM, V16, P1764, DOI 10.2174/1568026616999160315130832; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Sartiani L, 2017, PHARMACOL REV, V69, P354, DOI 10.1124/pr.117.014035; Savelieva I, 2006, ADV CARDIOL, V43, P79, DOI 10.1159/000095430; Schnorr S, 2014, PAIN, V155, P1079, DOI 10.1016/j.pain.2014.02.006; Schomberg D, 2012, ANN NEUROSCI, V19, P125, DOI 10.5214/ans.0972.7531.190309; Sommer C, 2018, PAIN, V159, P595, DOI 10.1097/j.pain.0000000000001122; Sukegawa S, 2014, ANESTH ANALG, V118, P473, DOI 10.1213/ANE.0000000000000060; Takasu K, 2010, PAIN, V151, P87, DOI 10.1016/j.pain.2010.06.020; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Tsantoulas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam6072; Vinik A, 2013, CLIN THER, V35, P612, DOI 10.1016/j.clinthera.2013.03.008; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Young GT, 2014, PAIN, V155, P1708, DOI 10.1016/j.pain.2014.05.021; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	39	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217209	10.1371/journal.pone.0217209	http://dx.doi.org/10.1371/journal.pone.0217209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125368	gold, Green Published, Green Submitted			2022-12-27	WOS:000468865700023
J	Song, WW; Qi, NW; Liang, C; Dua, FM; Zha, HH				Song, Wenwen; Qi, Nawei; Liang, Chen; Dua, Fangmeng; Zha, Honghai			Soybean root transcriptome profiling reveals a nonhost resistant response during Heterodera glycines infection	PLOS ONE			English	Article							CYST-NEMATODE; GENE-EXPRESSION; MELOIDOGYNE-INCOGNITA; PHENYLPROPANOID PATHWAY; DISEASE RESISTANCE; NB-ARC; TOMATO; ASSOCIATION; HYPOTAURINE; TAURINE	Heterodera glycines (soybean cyst nematode, SCN) is one of the most devastating pathogens of soybean worldwide. The compatible and in compatible interactions between soybean and SCN have well documented. Nevertheless, the molecular mechanism of a nonhost resistant response in soybean against SCN infection remains obscure. Toward this end, a global transcriptional comparison was conducted between susceptible and resistant reactions of soybean roots infected by taking advantage of finding a new pathotype of SCN (SCNT). The soybean cultivar Lee, which exhibits resistant to SCNT and susceptible to HG 1.2.3.4.7 (SCNs) was utilized in the expriments. The results highlighted a nonhost resistant response of soybean. Transcriptome analysis indicated that the number of differentially expressed genes (DEGs) in the resistant interaction (3746) was much larger than that in the susceptible interaction (602). A great number of genes acting as intrinsic component of membrane, integral component of membrane, cell periphery and plasma membrance were remarkably enriched only in the resistant interaction, while the taurine and hypotaurine, phenylpropanoid pathway, plant-pathogen interaction and transcript factors were modulated in both interactions. This is the first study to examine genes expression patterns in a soybean genotype in response to invasion by a virulent and avirulent SCN population at the transcriptional level, which will provide insights into the complicate molecular mechanism of the nonhost resistant interaction.	[Song, Wenwen; Qi, Nawei; Liang, Chen; Dua, Fangmeng; Zha, Honghai] Qingdao Agr Univ, Coll Plant Hlth & Med, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University	Zha, HH (corresponding author), Qingdao Agr Univ, Coll Plant Hlth & Med, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Shandong, Peoples R China.	hhzhao618@163.com		Liang, Chen/0000-0002-0139-8140	Special Fund for Agro-Scientific Research in the Public Interest, China [201503114]; Taishan Scholar Foundation of Shandong Province	Special Fund for Agro-Scientific Research in the Public Interest, China; Taishan Scholar Foundation of Shandong Province	This work was financially supported by the Special Fund for Agro-Scientific Research in the Public Interest, China (201503114) and the Taishan Scholar Foundation of Shandong Province.	Alkharouf NW, 2006, PLANTA, V224, P838, DOI 10.1007/s00425-006-0270-8; Boba A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01951; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Breen S, 2017, TRENDS PLANT SCI, V22, P871, DOI 10.1016/j.tplants.2017.06.013; [程子超 Cheng Zichao], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P387; EDENS RM, 1995, J NEMATOL, V27, P292; Fuller VL, 2007, MOL PLANT PATHOL, V8, P595, DOI 10.1111/J.1364-3703.2007.00416.X; Grove RQ, 2017, FREE RADICAL BIO MED, V108, P575, DOI 10.1016/j.freeradbiomed.2017.04.342; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hosseini P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0300-9; Ibrahim HMM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-220; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jain S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159338; Kandoth PK, 2011, PLANT PHYSIOL, V155, P1960, DOI 10.1104/pp.110.167536; Khan R, 2004, J NEMATOL, V36, P241; Kim Y. H., 1990, Korean Journal of Plant Pathology, V6, P421; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Klink VP, 2009, PLANT MOL BIOL, V71, P525, DOI 10.1007/s11103-009-9539-1; Lavrova VV, 2017, DOKL BIOCHEM BIOPHYS, V476, P306, DOI [10.1134/S1607672917050064, 10.1134/s1607672917050064]; Lee DH, 2015, ADV EXP MED BIOL, V803, P75, DOI 10.1007/978-3-319-15126-7_7; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Ma YS, 2006, J INTEGR PLANT BIOL, V48, P722, DOI 10.1111/j.1744-7909.2006.00256.x; Magnani E, 2018, PLANT CELL, V87, P46; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Mazarei M, 2011, THEOR APPL GENET, V123, P1193, DOI 10.1007/s00122-011-1659-8; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Noel Gregory R., 1993, Nematologia Brasileira, V17, P103; Pan QL, 2000, GENETICS, V155, P309; Pitari G, 2000, ADV EXP MED BIOL, V483, P157; Puthoff DP, 2007, J EXP BOT, V58, P3407, DOI 10.1093/jxb/erm211; Sekine KT, 2012, MOL PLANT MICROBE IN, V25, P1219, DOI 10.1094/MPMI-11-11-0289; Su JB, 2018, PLANT J, V93, P637, DOI 10.1111/tpj.13798; Tang YH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00306; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Wan JR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1316-8; [王慧敏 Wang Huimin], 2014, [植物保护, Plant Protection], V40, P106; Wen ZF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01087; WRATHER A, 2009, PLANT HLTH PROGR; Wuyts N, 2006, NEMATOLOGY, V8, P89, DOI 10.1163/156854106776179953; Zhang HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09945-0; Zhang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01214; [赵洪海 Zhao Honghai], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P4417; Zhao HongHai, 2013, Acta Phytophylacica Sinica, V40, P529; Zhao M, 2017, BIORXIV	46	8	8	12	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217130	10.1371/journal.pone.0217130	http://dx.doi.org/10.1371/journal.pone.0217130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125369	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700020
J	Zheng, ZJ; Tan, CL; Chen, YH; Ping, J; Wang, MJ				Zheng, Zhenjiang; Tan, Chunlu; Chen, Yonghua; Ping, Jie; Wang, Mojin			Impact of different surgical procedures on survival outcomes of patients with adenocarcinoma of pancreatic neck	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; R0 RESECTION; OPEN-LABEL; CANCER; GEMCITABINE; PANCREATICODUODENECTOMY; MULTICENTER; MORBIDITY; MORTALITY; INVASION	Background The only curative treatment for pancreatic adenocarcinoma is radical surgical resection. Because of the special anatomic features of pancreatic neck, the selection of optimal surgical procedure for treatment of adenocarcinoma of pancreatic neck has always been a dilemma for surgeons. In this paper, we aim to investigate whether different surgical procedures can affect prognosis in the patient with adenocarcinoma of pancreatic neck. Methods We used the surveillance, epidemiology, and end results database to review patients with adenocarcinoma of pancreatic neck diagnosed between 1998 and 2015. We calculated overall survival (OS) and cancer-specific survival (CSS) of these patients using Kaplan-Meier analysis and Cox regression model. Results Overall, 1443 patients were included in the study, with 12.5% treated with surgical resection. Among them, 30 (18.8%) patients underwent distal pancreatectomy (DP), 105 (65.6%) patients underwent pancreatoduodenectomy (PD), and 25 (15.6%) patients underwent total pancreatectomy (TP). Patients underwent DP were older than these underwent TP (70.5 +/- 10.7 vs. 62.2 +/- 14.1, P = 0.027). Patients underwent TP had higher percentages of nodal metastasis (N1 stage) than these underwent DP (68.0% vs. 34.5%, P = 0.014). The surgical procedures did not significantly affect either OS times (P = 0.924) or CSS times (P = 0.786) in Kaplan-Meier analysis, even if in any subgroup of AJCC stage. The multivariate Cox regression model showed that types of surgery were not associated with OS and CSS. Higher tumor grade and AJCC stage are independent prognostic factors for OS and CSS. No radiotherapy was associated with a worse CSS (HR 1.610, 95% CI 1.016-2.554, P = 0.043). Conclusion Different surgical procedures did not affect prognosis in the patients with adenocarcinoma of pancreatic neck. TP should be performed in carefully selective patients in high-volume pancreatic centers.	[Zheng, Zhenjiang; Tan, Chunlu; Chen, Yonghua] Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu, Sichuan, Peoples R China; [Ping, Jie] Vanderbilt Univ, Med Ctr, Div Epidemiol, Nashville, TN USA; [Wang, Mojin] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Inst Digest Surg, Chengdu, Sichuan, Peoples R China; [Wang, Mojin] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China	Sichuan University; Vanderbilt University; Sichuan University; Sichuan University	Wang, MJ (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Inst Digest Surg, Chengdu, Sichuan, Peoples R China.; Wang, MJ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.	wangmojin2001@163.com		Ping, Jie/0000-0001-9907-5819	National Health and Family Planning Commission of Chengdu (CN) [2016002]	National Health and Family Planning Commission of Chengdu (CN)	This research was funded by the National Health and Family Planning Commission of Chengdu (CN) (2016002 to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren-Sandberg A, 2016, DIGEST SURG, V33, P329, DOI 10.1159/000445018; Artinyan A, 2008, HPB, V10, P371, DOI 10.1080/13651820802291233; Bhayani NH, 2014, J GASTROINTEST SURG, V18, P549, DOI 10.1007/s11605-013-2393-0; Bilimoria KY, 2007, ANN SURG, V246, P173, DOI 10.1097/SLA.0b013e3180691579; Boyle J, 2015, J GASTROINTEST ONCOL, V6, P436, DOI 10.3978/j.issn.2078-6891.2015.014; Chen YH, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0042-z; Chen YH, 2013, J AM COLL SURGEONS, V217, pE21, DOI 10.1016/j.jamcollsurg.2013.07.383; Conroy T, 2016, EUR J CANCER, V57, P10, DOI 10.1016/j.ejca.2015.12.026; Del Chiaro M, 2016, UPDATES SURG, V68, P257, DOI 10.1007/s13304-016-0388-6; Desaki R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/219038; Epelboym I, 2014, J SURG RES, V187, P189, DOI 10.1016/j.jss.2013.10.004; Govindarajan A, 2008, ANN SURG ONCOL, V15, P175, DOI 10.1245/s10434-007-9601-7; Hackert T, 2014, LANGENBECK ARCH SURG, V399, P667, DOI 10.1007/s00423-014-1200-z; Hank T, 2018, BRIT J SURG, V105, P1171, DOI 10.1002/bjs.10842; Hartwig W, 2015, ANN SURG, V261, P537, DOI 10.1097/SLA.0000000000000791; Hirono S, 2016, SURGERY, V159, P426, DOI 10.1016/j.surg.2015.07.001; Khorana AA, 2017, J CLIN ONCOL, V35, P2324, DOI 10.1200/JCO.2017.72.4948; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Ling Q, 2017, ONCOTARGET, V8, P15159, DOI 10.18632/oncotarget.14768; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Nathan H, 2009, J SURG ONCOL, V99, P87, DOI 10.1002/jso.21189; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Nikfarjam M, 2014, ANZ J SURG, V84, P823, DOI 10.1111/ans.12640; Park Shin-Young, 2014, Korean J Hepatobiliary Pancreat Surg, V18, P77, DOI 10.14701/kjhbps.2014.18.3.77; Reddy S, 2009, ANN SURG, V250, P282, DOI 10.1097/SLA.0b013e3181ae9f93; Roeder F, 2016, WORLD J GASTRO ONCOL, V8, P186, DOI 10.4251/wjgo.v8.i2.186; Ruess DA, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0110-5; Sajjad M, 2018, AM J CLIN ONCOL-CANC, V41, P236, DOI 10.1097/COC.0000000000000261; Santangelo M, 2016, INT J SURG, V28, pS172, DOI 10.1016/j.ijsu.2015.12.046; Satoi S, 2016, PANCREAS, V45, P1003, DOI 10.1097/MPA.0000000000000579; Schmidt CM, 2007, SURGERY, V142, P572, DOI 10.1016/j.surg.2007.07.016; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Song KB, 2015, SURG ENDOSC, V29, P937, DOI 10.1007/s00464-014-3756-7; Strasberg SM, 2012, J GASTROINTEST SURG, V16, P1048, DOI 10.1007/s11605-012-1841-6; Strobel O, 2019, NAT REV CLIN ONCOL, V16, P11, DOI 10.1038/s41571-018-0112-1; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Werner J, 2013, NAT REV CLIN ONCOL, V10, P323, DOI 10.1038/nrclinonc.2013.66; Xiong JJ, 2017, INT J SURG, V48, P134, DOI 10.1016/j.ijsu.2017.10.065	40	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217427	10.1371/journal.pone.0217427	http://dx.doi.org/10.1371/journal.pone.0217427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125386	gold, Green Submitted, Green Published			2022-12-27	WOS:000468865700041
J	Ferguson, MW; Gerak, CAN; Chow, CCT; Rastelli, EJ; Elmore, KE; Stahl, F; Hosseini-Farahabadi, S; Baradaran-Heravi, A; Coltart, DM; Roberge, M				Ferguson, Michael W.; Gerak, Chloe A. N.; Chow, Christalle C. T.; Rastelli, Ettore J.; Elmore, Kyle E.; Stahl, Florian; Hosseini-Farahabadi, Sara; Baradaran-Heravi, Alireza; Coltart, Don M.; Roberge, Michel			The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418	PLOS ONE			English	Article							PHENOTYPIC SUPPRESSION; P53; PHOSPHORYLATION; INHIBITION; GENTAMICIN; CHALLENGES; MOLECULES; THERAPY; SITE	Nonsense mutations constitute similar to 10% of TP53 mutations in cancer. They introduce a premature termination codon that gives rise to truncated p53 protein with impaired function. The aminoglycoside G418 can induce TP53 premature termination codon readthrough and thus increase cellular levels of full-length protein. Small molecule phthalimide derivatives that can enhance the readthrough activity of G418 have also been described. To determine whether readthrough enhancers exist among drugs that are already approved for use in humans, we tested seven antimalarial drugs for readthrough of the common R213X TP53 nonsense mutation in HDQ-P1 breast cancer cells. Mefloquine induced no TP53 readthrough activity as a single agent but it strongly potentiated readthrough by G418. The two enantiomers composing pharmaceutical mefloquine potentiated readthrough to similar levels in HDQ-P1 cells and also in SW900, NCI-H1688 and HCC1937 cancer cells with different TP53 nonsense mutations. Exposure to G418 and mefloquine increased p53 phosphorylation at Ser15 and P21 transcript levels following DNA damage, indicating p53 produced via readthrough was functional. Mefloquine does not appear to enhance readthrough via lysosomotropic effects as it did not significantly affect lysosomal pH, the cellular levels of G418 or its distribution in organellar or cytosolic fractions. The availability of a readthrough enhancer that is already approved for use in humans should facilitate study of the therapeutic potential of TP53 readthrough in preclinical cancer models.	[Ferguson, Michael W.; Gerak, Chloe A. N.; Chow, Christalle C. T.; Stahl, Florian; Hosseini-Farahabadi, Sara; Baradaran-Heravi, Alireza; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Rastelli, Ettore J.; Elmore, Kyle E.; Coltart, Don M.] Univ Houston, Dept Chem, Houston, TX USA	University of British Columbia; University of Houston System; University of Houston	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	michelr@mail.ubc.ca		Rastelli, Ettore/0000-0003-2778-7635; Roberge, Michel/0000-0002-2100-0793; Gerak, Chloe/0000-0002-5329-9443; Ferguson, Michael/0000-0001-5163-9689	Canadian Cancer Society [704700]; Michael Smith Foundation for Health Research [17224]; National Science Foundation [NSF 1300652]; Welch Foundation [E-1806]; University of Houston	Canadian Cancer Society(Canadian Cancer Society (CCS)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); University of Houston	This work was supported by: MR, Canadian Cancer Society grant 704700, http://www.cancer.ca/research and the Michael Smith Foundation for Health Research grant 17224, https://www.msfhr.org; DMC: National Science Foundation grant NSF 1300652, https://www.nsf.gov/, the Welch Foundation grant E-1806, www.welch1. org and the University of Houston, www.uh.edu.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018; Baradaran-Heravi A, 2016, NUCLEIC ACIDS RES, V44, P6583, DOI 10.1093/nar/gkw638; Bhat P, 2018, BIOCHEM PHARMACOL, V147, P170, DOI 10.1016/j.bcp.2017.11.021; Bidou L, 2017, RNA BIOL, V14, P378, DOI 10.1080/15476286.2017.1285480; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Denamur S, 2011, FREE RADICAL BIO MED, V51, P1656, DOI 10.1016/j.freeradbiomed.2011.07.015; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCELLA M, 1993, ONCOGENE, V8, P1519; Floquet C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002608; Floquet C, 2011, NUCLEIC ACIDS RES, V39, P3350, DOI 10.1093/nar/gkq1277; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Humphrey RW, 2011, JNCI-J NATL CANCER I, V103, P1222, DOI 10.1093/jnci/djr246; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Kuzu OF, 2017, PHARMACOL RES, V117, P177, DOI 10.1016/j.phrs.2016.12.021; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0; Rastelli EJ, 2016, J ORG CHEM, V81, P9567, DOI 10.1021/acs.joc.6b01476; Rastelli EJ, 2015, ANGEW CHEM INT EDIT, V54, P14070, DOI 10.1002/anie.201507304; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SILVERBLATT FJ, 1979, KIDNEY INT, V15, P335, DOI 10.1038/ki.1979.45; SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0; Tickell-Painter M, 2017, TRAVEL MED INFECT DI, V20, P5, DOI 10.1016/j.tmaid.2017.10.011; White E, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026120; Wong W, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.31	31	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216423	10.1371/journal.pone.0216423	http://dx.doi.org/10.1371/journal.pone.0216423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120902	Green Published, gold			2022-12-27	WOS:000468775700016
J	Nongkhlaw, M; Joshi, SR				Nongkhlaw, Macmillan; Joshi, Santa Ram			Molecular insight into the expression of metal transporter genes in Chryseobacterium sp. PMSZPI isolated from uranium deposit	PLOS ONE			English	Article							RALSTONIA-METALLIDURANS; CAULOBACTER-CRESCENTUS; CADMIUM; RESISTANCE; STRESS; ZINC; DETOXIFICATION; HOMEOSTASIS; EXPOSURE; SYSTEM	Metal tolerant bacterium Chryseobacterium sp. PMSZPI previously isolated and characterized from uranium ore deposit was studied for elucidating the role of metal transporter genes belonging to the Cation Diffusion Facilitator (CDF), Root-Nodulation-Division (RND) and P-IB-type ATPase family in cadmium and uranium tolerance. The bacterium showed tolerance towards cadmium (MIC similar to 6mM) and uranium (MIC similar to 2mM) and was found to harbor metal transporter genes belonging to CDF, RND and P-IB-type ATPase family of proteins. Expression studies by real-time PCR showed an upregulation of czcA(RND), czcD(CDF) and cadA(P-IB-type ATPase) genes in presence of cadmium or uranium. Higher expression of czcA and czcD was found when the bacterium was treated with cadmium and uranium respectively. This study provides significant insight into the molecular mechanism that plays a role in cadmium and uranium tolerance in bacteria.	[Nongkhlaw, Macmillan; Joshi, Santa Ram] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India	North Eastern Hill University	Joshi, SR (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India.	srjoshi2006@yahoo.co.in		Joshi, SR/0000-0003-1942-3110	Department of Science and Technology, INDIA, under the DST-INSPIRE faculty program	Department of Science and Technology, INDIA, under the DST-INSPIRE faculty program(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	This work was funded by Department of Science and Technology, INDIA, under the DST-INSPIRE faculty program that was awarded to Dr Macmillan Nongkhlaw.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Faa A, 2018, CURR MED CHEM, V25, P49, DOI 10.2174/0929867324666170426102343; Gallois N, 2018, J PROTEOMICS, V177, P148, DOI 10.1016/j.jprot.2017.11.021; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Hynninen A, 2009, MOL MICROBIOL, V74, P384, DOI 10.1111/j.1365-2958.2009.06868.x; Junier P, 2011, GEOMICROBIOL J, V28, P483, DOI 10.1080/01490451.2010.512031; Kartik VP, 2016, INT J PHYTOREMEDIAT, V18, P1061, DOI 10.1080/15226514.2016.1183576; KIM ND, 1994, SCI TOTAL ENVIRON, V144, P179, DOI 10.1016/0048-9697(94)90437-5; Kirsten A, 2011, J BACTERIOL, V193, P4652, DOI 10.1128/JB.05293-11; Kumar R, 2013, MICROBES ENVIRON, V28, P33, DOI 10.1264/jsme2.ME12074; Legatzki A, 2003, J BACTERIOL, V185, P4354, DOI 10.1128/JB.185.15.4354-4361.2003; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Lu MM, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01244-17, 10.1128/aem.01244-17]; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Maher K, 2013, INORG CHEM, V52, P3510, DOI 10.1021/ic301686d; Maynaud G, 2014, RES MICROBIOL, V165, P175, DOI 10.1016/j.resmic.2014.02.001; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; Miller AC, 2002, J INORG BIOCHEM, V91, P246, DOI 10.1016/S0162-0134(02)00391-4; Monsieurs P, 2011, BIOMETALS, V24, P1133, DOI 10.1007/s10534-011-9473-y; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Newsome L, 2014, CHEM GEOL, V363, P164, DOI 10.1016/j.chemgeo.2013.10.034; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J BACTERIOL, V177, P2707, DOI 10.1128/jb.177.10.2707-2712.1995; Nongkhlaw M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048199; Periyakaruppan A, 2007, ARCH TOXICOL, V81, P389, DOI 10.1007/s00204-006-0167-0; Ribera D, 1996, REV ENVIRON CONTAM T, V146, P53; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Sutcliffe B, 2017, ENVIRON MICROBIOL, V19, P3323, DOI 10.1111/1462-2920.13839; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang B, 2012, CURR MED CHEM, V19, P2611, DOI 10.2174/092986712800492913; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Yazzie M, 2003, CHEM RES TOXICOL, V16, P524, DOI 10.1021/tx025685q; Yung MMC, 2015, J BACTERIOL, V197, P3160, DOI 10.1128/JB.00382-15; Yung MMC, 2014, J PROTEOME RES, V13, P1833, DOI 10.1021/pr400880s	41	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216995	10.1371/journal.pone.0216995	http://dx.doi.org/10.1371/journal.pone.0216995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120947	gold, Green Published			2022-12-27	WOS:000468775700047
J	de la Torre, I; Quinones, V; Salas, M; del Prado, A				de la Torre, Ivan; Quinones, Victor; Salas, Margarita; del Prado, Alicia			Tyrosines involved in the activity of phi 29 single-stranded DNA binding protein	PLOS ONE			English	Article							TERMINAL PROTEIN; PHAGE PHI-29; REPLICATION; POLYMERASE	The genome of Bacillus subtilis phage phi 29 consists of a linear double-stranded DNA with a terminal protein (TP) covalently linked to each 5' end (TP-DNA). phi 29 DNA polymerase is the enzyme responsible for viral DNA replication, due to its distinctive properties: high processivity and strand displacement capacity, being able to replicate the entire genome without requiring the assistance of processivity or unwinding factors, unlike most replicases. phi 29 single-stranded DNA binding protein (SSB) is encoded by the viral gene 5 and binds the ssDNA generated in the replication of the phi 29 TP-DNA. It has been described to stimulate the DNA elongation rate during the DNA replication. Previous studies proposed residues Tyr50, Tyr57 and Tyr76 as ligands of ssDNA. The role of two of these residues has been determined in this work by site-directed mutagenesis. Our results showed that mutant derivative Y57A was unable to bind to ssDNA, to stimulate the DNA elongation and to displace oligonucleotides annealed to M13 ssDNA, whereas mutant Y50A behaved like the wild-type SSB.	[de la Torre, Ivan; Quinones, Victor; Salas, Margarita; del Prado, Alicia] Univ Autonoma Madrid, Univ Autonoma, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Univ Autonoma, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	msalas@cbm.csic.es	del Prado, Alicia/K-4473-2017		Spanish Ministry of Economy and Competitiveness [BFU2014-52656-P]; Fundacion Ramon Areces; Banco Santander	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces; Banco Santander	This work was supported by grant BFU2014-52656-P (to M.S.) from the Spanish Ministry of Economy and Competitiveness and institutional grants from the Fundacion Ramon Areces and Banco Santander to the Centro de Biologia Molecular "Severo Ochoa".	Antony E, 2019, SEMIN CELL DEV BIOL, V86, P102, DOI 10.1016/j.semcdb.2018.03.017; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1994, P NATL ACAD SCI USA, V91, P12198, DOI 10.1073/pnas.91.25.12198; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; Cernooka E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15774-y; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; GUTIERREZ C, 1991, J MOL BIOL, V222, P983, DOI 10.1016/0022-2836(91)90589-X; GUTIERREZ J, 1986, GENE, V43, P1, DOI 10.1016/0378-1119(86)90002-8; INCIARTE MR, 1980, J VIROL, V34, P187, DOI 10.1128/JVI.34.1.187-199.1980; Marceau Aimee H, 2012, Methods Mol Biol, V922, P1, DOI 10.1007/978-1-62703-032-8_1; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SERRANO M, 1994, BIOCHIMIE, V76, P981, DOI 10.1016/0300-9084(94)90023-X; Sun SY, 2006, PROTEINS, V65, P231, DOI 10.1002/prot.21088; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Tone T, 2012, BIOSCI BIOTECH BIOCH, V76, P2351, DOI 10.1271/bbb.120587; 1995, J MOL BIOL, V253, P517, DOI DOI 10.1006/JMBI.1995.0570; 1994, J MOL BIOL, V239, P213; 1995, METHODS ENZYMOL, V262, P42; 1994, J BIOL CHEM, V269, P3194; NUCLEIC ACIDS RES, V28, P2034, DOI DOI 10.1093/NAR/28.10.2034; 1989, NUCLEIC ACIDS RES, V17, P3663, DOI DOI 10.1093/NAR/17.10.3663; J MOL BIOL, V296, P989, DOI DOI 10.1006/JMBI.2000.3521; 1991, J BIOL CHEM, V266, P2104; 2001, MICROBIOL MOL BIOL R, V65, P261, DOI DOI 10.1128/MMBR.65.2.261-287.2001; 1972, MOL GEN GENET, V115, P31; 1997, J BIOL CHEM, V272, P303, DOI DOI 10.1074/JBC.272.1.303; 1997, EMBO J, V16, P2519, DOI DOI 10.1093/EMBOJ/16.9.2519; 2004, PROTEIN SCI, V13, P1594, DOI DOI 10.1110/PS.04634604; 2011, P NATL ACAD SCI USA, V108, P1865, DOI DOI 10.1073/PNAS.1114397108; 1992, P NATL ACAD SCI USA, V89, P9579, DOI DOI 10.1073/PNAS.89.20.9579; 1996, EMBO J, V15, P1182	35	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217248	10.1371/journal.pone.0217248	http://dx.doi.org/10.1371/journal.pone.0217248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107918	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200041
J	Picon, A; Irusta, U; Alvarez-Gila, A; Aramendi, E; Alonso-Atienza, F; Figuera, C; Ayala, U; Garrote, E; Wik, L; Kramer-Johansen, J; Eftestol, T				Picon, Artzai; Irusta, Unai; Alvarez-Gila, Aitor; Aramendi, Elisabete; Alonso-Atienza, Felipe; Figuera, Carlos; Ayala, Unai; Garrote, Estibaliz; Wik, Lars; Kramer-Johansen, Jo; Eftestol, Trygve			Mixed convolutional and long short-term memory network for the detection of lethal ventricular arrhythmia	PLOS ONE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; FIBRILLATION DETECTION; ANALYSIS ALGORITHM; RHYTHM ANALYSIS; ECG SIGNAL; TACHYCARDIA; CLASSIFICATION; DURATION	Early defibrillation by an automated external defibrillator (AED) is key for the survival of out-of-hospital cardiac arrest (OHCA) patients. ECG feature extraction and machine learning have been successfully used to detect ventricular fibrillation (VF) in AED shock decision algorithms. Recently, deep learning architectures based on 1D Convolutional Neural Networks (CNN) have been proposed for this task. This study introduces a deep learning architecture based on 1D-CNN layers and a Long Short-Term Memory (LSTM) network for the detection of VF. Two datasets were used, one from public repositories of Holter recordings captured at the onset of the arrhythmia, and a second from OHCA patients obtained minutes after the onset of the arrest. Data was partitioned patient-wise into training (80%) to design the classifiers, and test (20%) to report the results. The proposed architecture was compared to 1D-CNN only deep learners, and to a classical approach based on VF-detection features and a support vector machine (SVM) classifier. The algorithms were evaluated in terms of balanced accuracy (BAC), the unweighted mean of the sensitivity (Se) and specificity (Sp). The BAC, Se, and Sp of the architecture for 4-s ECG segments was 99.3%, 99.7%, and 98.9% for the public data, and 98.0%, 99.2%, and 96.7% for OHCA data. The proposed architecture outperformed all other classifiers by at least 0.3-points in BAC in the public data, and by 2.2-points in the OHCA data. The architecture met the 95% Sp and 90% Se requirements of the American Heart Association in both datasets for segment lengths as short as 3-s. This is, to the best of our knowledge, the most accurate VF detection algorithm to date, especially on OHCA data, and it would enable an accurate shock no shock diagnosis in a very short time.	[Picon, Artzai; Alvarez-Gila, Aitor; Garrote, Estibaliz] Tecnalia Res & Innovat, Comp Vis Grp, Derio, Spain; [Irusta, Unai; Aramendi, Elisabete] Univ Basque Country, Dept Commun Engn, UPV EHU, Bilbao, Spain; [Alonso-Atienza, Felipe; Figuera, Carlos] Rey Juan Carlos Univ, Dept Signal Theory & Commun, Madrid, Spain; [Alonso-Atienza, Felipe; Figuera, Carlos] BBVA, Client Solut Adv Analyt, Madrid, Spain; [Ayala, Unai] Mondragon Unibertsitatea, Elect & Comp Dept, Fac Engn MU ENG, Arrasate Mondragon, Spain; [Wik, Lars; Kramer-Johansen, Jo] Oslo Univ Hosp, Norwegian Natl Advisory Unit Prehosp Emergency Me, Oslo, Norway; [Wik, Lars; Kramer-Johansen, Jo] Univ Oslo, Oslo, Norway; [Eftestol, Trygve] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway	University of Basque Country; Universidad Rey Juan Carlos; Mondragon Unibertsitatea; University of Oslo; University of Oslo; Universitetet i Stavanger	Irusta, U (corresponding author), Univ Basque Country, Dept Commun Engn, UPV EHU, Bilbao, Spain.	unai.irusta@ehu.eus	Ayala, Unai/ABA-1382-2021; Aramendi, Elisabete/H-8092-2015; Irusta, Unai/T-6327-2019; Figuera, Carlos/F-4228-2016	Ayala, Unai/0000-0003-1079-752X; Aramendi, Elisabete/0000-0002-6409-1429; Irusta, Unai/0000-0001-9521-1852; Alvarez-Gila, Aitor/0000-0002-5955-3211; Picon, Artzai/0000-0002-3316-6571; Alonso-Atienza, Felipe/0000-0002-6442-1643; Figuera, Carlos/0000-0002-2728-3552; Garrote, Estibaliz/0000-0002-0268-0391	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES) [TEC-2015-64678-R]; Euskal Herriko Unibertsitatea (ES) [GIU17/031]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES); Euskal Herriko Unibertsitatea (ES)	This study was supported by the Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES) (TEC-2015-64678-R) to UI and EA and by Euskal Herriko Unibertsitatea (ES) (GIU17/031) to UI and EA. The funders, Tecnalia Research and Innovation and Banco Bilbao Vizcaya Argentaria (BBVA), provided support in the form of salaries for authors AP, AA, FAA, CF, EG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abadi M., 2016, TENSORFLOW LARGE SCA; Abu Anas EM, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-43; Acharya UR, 2018, FUTURE GENER COMP SY, V79, P952, DOI 10.1016/j.future.2017.08.039; Acharya UR, 2017, INFORM SCIENCES, V405, P81, DOI 10.1016/j.ins.2017.04.012; Alonso E, 2016, RESUSCITATION, V99, P56, DOI 10.1016/j.resuscitation.2015.11.014; Alonso-Atienza F, 2014, IEEE T BIO-MED ENG, V61, P832, DOI 10.1109/TBME.2013.2290800; Amann A, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-60; Amann A, 2007, IEEE T BIO-MED ENG, V54, P174, DOI 10.1109/TBME.2006.880909; Arafat MA, 2011, SIGNAL IMAGE VIDEO P, V5, P1, DOI 10.1007/s11760-009-0136-1; Aramendi E, 2010, PHYSIOL MEAS, V31, P749, DOI 10.1088/0967-3334/31/6/002; Atkins DL, 2008, RESUSCITATION, V76, P168, DOI 10.1016/j.resuscitation.2007.06.032; Ayala U, 2015, RESUSCITATION, V89, P25, DOI 10.1016/j.resuscitation.2014.11.022; Ayala U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872470; BARRO S, 1989, J BIOMED ENG, V11, P320, DOI 10.1016/0141-5425(89)90067-8; Berdowski J, 2011, CIRCULATION, V124, P2225, DOI 10.1161/CIRCULATIONAHA.110.015545; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; BROWN CG, 1993, ANN EMERG MED, V22, P70, DOI 10.1016/S0196-0644(05)80253-7; Chaudhry SA, 2017, PEER PEER NETW APPL, V10, P1, DOI 10.1007/s12083-015-0400-9; CHEN S, 1987, MED BIOL ENG COMPUT, V25, P241, DOI 10.1007/BF02447420; Cheng P, 2017, IEEE ACCESS, V5, P14195, DOI 10.1109/ACCESS.2017.2723258; Chicote B, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20080591; Chicote B, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18090313; CLAYTON RH, 1993, MED BIOL ENG COMPUT, V31, P111, DOI 10.1007/BF02446668; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Didon Jean-Philippe, 2011, Resuscitation, V82 Suppl 2, pS8, DOI 10.1016/S0300-9572(11)70145-9; Edelson DP, 2006, RESUSCITATION, V71, P137, DOI 10.1016/j.resuscitation.2006.04.008; Elola A, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21030305; Fagerland MW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-91; Figuera C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159654; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Ilya S., 2013, INT C MACH LEARN, P1139, DOI DOI 10.1007/S00287-015-0911-Z; Ince T, 2017, EMBEC NBC 2017, P551; Irusta U, 2012, RESUSCITATION, V83, P1090, DOI 10.1016/j.resuscitation.2012.01.032; Irusta U, 2009, RESUSCITATION, V80, P1229, DOI 10.1016/j.resuscitation.2009.07.013; Irusta U, 2009, IEEE T BIO-MED ENG, V56, P1052, DOI 10.1109/TBME.2008.2010329; Isasi I, 2019, IEEE T BIO-MED ENG, V66, P263, DOI 10.1109/TBME.2018.2827304; Jekova I, 2000, PHYSIOL MEAS, V21, P429, DOI 10.1088/0967-3334/21/4/301; Jekova I, 2004, PHYSIOL MEAS, V25, P1167, DOI 10.1088/0967-3334/25/5/007; Jekova I, 2009, PHYSIOL MEAS, V30, P695, DOI 10.1088/0967-3334/30/7/012; Kerber RE, 1997, CIRCULATION, V95, P1677; Khadra L, 1997, MED BIOL ENG COMPUT, V35, P626, DOI 10.1007/BF02510970; Kiranyaz S, 2016, IEEE T BIO-MED ENG, V63, P664, DOI 10.1109/TBME.2015.2468589; Kramer-Johansen J, 2006, RESUSCITATION, V71, P283, DOI 10.1016/j.resuscitation.2006.05.011; Krasteva V, 2010, ANN BIOMED ENG, V38, P1326, DOI 10.1007/s10439-009-9885-9; Kuo S., 1978, IEEE COMPUTERS CARDI, P2747; Li Q, 2014, IEEE T BIO-MED ENG, V61, P1607, DOI 10.1109/TBME.2013.2275000; Li YQ, 2008, CRIT CARE MED, V36, P198, DOI 10.1097/01.CCM.0000295589.64729.6B; Li YQ, 2012, IEEE T BIO-MED ENG, V59, P78, DOI 10.1109/TBME.2011.2118755; Lipton Z.C., 2015, ICLR, P1; LUU M, 1989, CIRCULATION, V80, P1675, DOI 10.1161/01.CIR.80.6.1675; Maronna R. A., 2006, ROBUST STAT THEORY M; Mehta C, 2012, AM J EMERG MED, V30, P236, DOI 10.1016/j.ajem.2010.08.017; Minami K, 1999, IEEE T BIO-MED ENG, V46, P179, DOI 10.1109/10.740880; Nguyen MT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33424-9; Nguyen MT, 2017, IEEE T IND INFORM, V13, P3037, DOI 10.1109/TII.2017.2740435; Mjahad A, 2017, COMPUT METH PROG BIO, V141, P119, DOI 10.1016/j.cmpb.2017.02.010; Oh SL, 2018, COMPUT BIOL MED, V102, P278, DOI 10.1016/j.compbiomed.2018.06.002; Rad AB, 2017, IEEE T BIO-MED ENG, V64, P2411, DOI 10.1109/TBME.2017.2688380; Rahhal MMA., 2018, J MED BIOL ENG, V38, P1; Rajpurkar P., 2017, CHEXNET RADIOLOGIST; Ripoll VJR, 2016, APPL SOFT COMPUT, V49, P399, DOI 10.1016/j.asoc.2016.08.013; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Shandilya S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141313; Sherman LD, 2008, RESUSCITATION, V78, P346, DOI 10.1016/j.resuscitation.2008.04.009; Snyder David, 2004, Crit Care Med, V32, pS421, DOI 10.1097/01.CCM.0000134265.35871.2B; Takata TS, 2001, ANN INTERN MED, V135, P990, DOI 10.7326/0003-4819-135-11-200112040-00011; Taskesen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149853; THAKOR NV, 1990, IEEE T BIO-MED ENG, V37, P837, DOI 10.1109/10.58594; Tripathy RK, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0441-5; Ukidave Y, 2015, IEEE INT C CL COMP, P533, DOI 10.1109/CLUSTER.2015.147; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Xia Y, 2018, COMPUT BIOL MED, V93, P84, DOI 10.1016/j.compbiomed.2017.12.007; Yildirim O, 2018, COMPUT BIOL MED, V96, P189, DOI 10.1016/j.compbiomed.2018.03.016; Zhang XS, 1999, IEEE T BIO-MED ENG, V46, P548, DOI 10.1109/10.759055; Zubair M., 2016, P 6 INT C IT CONVERG, P1, DOI DOI 10.1109/ICITCS.2016.7740310; 2013, RESUSCITATION, V84, P1238, DOI DOI 10.1016/J.RESUSCITATION.2013.04.010; 2019, NAT MED, V25, P65, DOI DOI 10.1038/S41591-018-0268-3	82	30	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216756	10.1371/journal.pone.0216756	http://dx.doi.org/10.1371/journal.pone.0216756			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107876	gold, Green Published, Green Submitted			2022-12-27	WOS:000468285200016
J	Li, IC; Lee, LY; Chen, YJ; Chou, MY; Wang, MF; Chen, WP; Chen, YP; Chen, CC				Li, I-Chen; Lee, Li-Ya; Chen, Ying-Ju; Chou, Ming-Yu; Wang, Ming-Fu; Chen, Wan-Ping; Chen, Yen-Po; Chen, Chin-Chu			Erinacine A-enriched Hericium erinaceus mycelia promotes longevity in Drosophila melanogaster and aged mice	PLOS ONE			English	Article							LIONS MANE MUSHROOM; LIFE-SPAN; CANCER-CELLS; MODEL; MAPK; INHIBITION	Erinacine A-enriched Hericium erinaceus mycelia is a well-established potential therapeutic agent for neurodegenerative disorders. However, the effect of erinacine A-enriched H. erinaceus mycelia on promoting longevity remains unclear. This is the first study to investigate the effect of erinacine A-enriched H. erinaceus mycelia on lifespan-prolonging activity in Drosophila melanogaster and senescence-accelerated P8 (SAMP8) mice. Two hundred D. melanogaster and 80 SAMP8 mice of both sexes were randomly divided into four groups and were administered with either the standard, low-dose, mid-dose, or high-dose erinacine A-enriched H. erinaceus mycelia. After treatment, the lifespan was measured in D. melanogaster, and the lifespan, food intake and oxidative damage were evaluated in SAMP8 mice. Results showed that supplementation with erinacine A-enriched H. erinaceus mycelia extended the lifespan in both D. melanogaster and SAMP8 by a maximum of 32% and 23%, respectively, compared to the untreated controls. Moreover, erinacine A-enriched H. erinaceus mycelia decreased TBARS levels and induced the anti-oxidative enzyme activities of superoxide dismutase, catalase, and glutathione peroxidase. Together, these findings suggest that erinacine A-enriched H. erinaceus mycelia supplement could promote longevity, mediated partly through the induction of endogenous antioxidants enzymes.	[Li, I-Chen; Lee, Li-Ya; Chen, Wan-Ping; Chen, Yen-Po; Chen, Chin-Chu] Grape King Bio Ltd, Biotech Res Inst, Taoyuan, Taiwan; [Chen, Ying-Ju; Chou, Ming-Yu; Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chen, Chin-Chu] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei, Taiwan; [Chen, Chin-Chu] Shih Chien Univ, Dept Food Sci Nutr & Nutraceut Biotechnol, Taipei, Taiwan; [Chen, Chin-Chu] Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan	Grape King Bio Ltd; Providence University - Taiwan; National Taiwan University; Shih Chien University; Chung Yuan Christian University	Chen, CC (corresponding author), Grape King Bio Ltd, Biotech Res Inst, Taoyuan, Taiwan.; Chen, CC (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei, Taiwan.; Chen, CC (corresponding author), Shih Chien Univ, Dept Food Sci Nutr & Nutraceut Biotechnol, Taipei, Taiwan.; Chen, CC (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan.	gkbioeng@grapeking.com.tw	Li, Jenny/GSD-3780-2022					Abdulla MA, 2008, INT J MED MUSHROOMS, V10, P325, DOI 10.1615/IntJMedMushr.v10.i4.40; Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Bitto A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025114; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Chang ST, 2012, INT J MED MUSHROOMS, V14, P95, DOI 10.1615/IntJMedMushr.v14.i2.10; Chiu CH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020341; Cui FJ, 2014, PROCESS BIOCHEM, V49, P1362, DOI 10.1016/j.procbio.2014.04.008; Ding AJ, 2017, NAT PRODUCT BIOPROSP, V7, P335, DOI 10.1007/s13659-017-0135-9; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Han ZH, 2013, INT J BIOL MACROMOL, V52, P66, DOI 10.1016/j.ijbiomac.2012.09.009; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Jafari M, 2006, AGING CELL, V5, P17, DOI 10.1111/j.1474-9726.2006.00195.x; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim SP, 2013, J AGR FOOD CHEM, V61, P4898, DOI 10.1021/jf400916c; Kim SP, 2012, J AGR FOOD CHEM, V60, P5590, DOI 10.1021/jf300897w; Kuo HC, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0831-y; Lee KF, 2014, INT J MOL SCI, V15, P15073, DOI 10.3390/ijms150915073; Lee KC, 2017, J CELL MOL MED, V21, P588, DOI 10.1111/jcmm.13004; Leslie W, 2015, HEALTHCARE-BASEL, V3, P648, DOI 10.3390/healthcare3030648; Li IC, 2018, DRUG CHEM TOXICOL, V41, P459, DOI 10.1080/01480545.2017.1381110; Li IC, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/5802634; Li IC, 2014, TOXICOL REP, V1, P1195, DOI 10.1016/j.toxrep.2014.11.009; Li IC, 2014, FOOD CHEM TOXICOL, V70, P61, DOI 10.1016/j.fct.2014.04.040; Liang B, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-253; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Matyi S, 2018, GEROSCIENCE, V40, P139, DOI 10.1007/s11357-018-0011-5; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Ren Z, 2017, INT J BIOL MACROMOL, V105, P879, DOI 10.1016/j.ijbiomac.2017.07.104; Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y; Wanagat J, 2010, MECH AGEING DEV, V131, P527, DOI 10.1016/j.mad.2010.06.002; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Yiin SJ, 1996, SCAND J WORK ENV HEA, V22, P381, DOI 10.5271/sjweh.158; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; 2014, METHODS, V68, P129, DOI DOI 10.1016/J.YMETH.2014.04.008; 2001, FASEB J, V15, P1589, DOI DOI 10.1096/FJ.00-0764FJE; 2002, DEV CELL, V2, P9; 2006, AGING CELL, V5, P515, DOI DOI 10.1111/J.1474-9726.2006.00241.X; 2003, BIOSCIENCE BIOTECHNO, V67, P1292	45	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217226	10.1371/journal.pone.0217226	http://dx.doi.org/10.1371/journal.pone.0217226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100095	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600036
J	Argamany, JR; Lee, GC; Duhon, BD; Zeidan, AR; Young, EH; Reveles, KR				Argamany, Jacqueline R.; Lee, Grace C.; Duhon, Bryson D.; Zeidan, Amina R.; Young, Eric H.; Reveles, Kelly R.			A possible association between statin use and improved Clostridioides difficile infection mortality in veterans	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; CLINICAL-OUTCOMES; RECURRENCE; RISK; CHOLESTEROL	Clostridioides difficile infection (CDI) is the most common cause of nosocomial diarrhea and places a significant burden on patients and the health care system. Statins could lead to improvements in CDI clinical response due their pleiotropic effects, including immunomodulatory and lipid-lowering effects; however, few studies have assessed this association. The primary objective of this study was to compare CDI health outcomes in statin users and nonusers in a national cohort of patients. This was a retrospective cohort study of all adult CDI patients receiving care from the Veterans Health Administration from 2002 to 2014. Patients were divided into two groups based on statin exposure 90 days prior to and during their first CDI encounter. CDI health outcomes, including mortality and CDI recurrence, were compared using a propensity-score matched cohort of statin users and non-users and multivariable logistic regression. A total of 26,149 patients met study inclusion criteria, of which 173 statins-users and 173 non-users were propensity score matched. Thirty-day mortality was significantly lower among statins users with CDI (12.7%) compared to non-users (20.2%) (aOR 0.34; 95% CI 0.16-0.72). Sixty-day CDI recurrence was non-significantly lower among statin-users (9.0%) compared to non-users (16.6%) (aOR 0.68; 95% CI 0.29-1.59). In this nationally-representative study of veterans with CDI, statin use was associated with lower 30-day mortality compared to non-use. Statin use was not associated with 60-day CDI recurrence.	[Argamany, Jacqueline R.; Lee, Grace C.; Duhon, Bryson D.; Zeidan, Amina R.; Young, Eric H.; Reveles, Kelly R.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Argamany, Jacqueline R.; Lee, Grace C.; Zeidan, Amina R.; Young, Eric H.; Reveles, Kelly R.] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Reveles, KR (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Reveles, KR (corresponding author), UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.	kdaniels46@utexas.edu	Reveles, Kelly/AAI-1575-2021		NIA NIH HHS [P30 AG044271] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; Antharam VC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148824; Argamany JR, 2015, AM J INFECT CONTROL, V43, P435, DOI 10.1016/j.ajic.2014.11.018; Atamna A, 2016, EUR J CLIN MICROBIOL, V35, P779, DOI 10.1007/s10096-016-2597-9; Chong PH, 2001, AM J MED, V111, P390, DOI 10.1016/S0002-9343(01)00870-1; De Loecker I, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-19; El Feghaly RE, 2013, CLIN INFECT DIS, V56, P1713, DOI 10.1093/cid/cit147; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Kassam Z, 2016, ALIMENT PHARM THER, V43, P725, DOI 10.1111/apt.13546; Kelly CP, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/1469-0691.12046; Kelsen JR, 2011, INFLAMM BOWEL DIS, V17, P50, DOI 10.1002/ibd.21421; Kerzmann A, 2006, ACS CHEM BIOL, V1, P141, DOI 10.1021/cb600133b; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]; Packard CJ, 1998, CIRCULATION, V97, P1440; Park SW, 2013, ALIMENT PHARM THER, V38, P619, DOI 10.1111/apt.12439; Reveles KR, 2018, PHARMACOTHERAPY, V38, P349, DOI 10.1002/phar.2088; Saliba W, 2014, CLIN MICROBIOL INFEC, V20, P1061, DOI 10.1111/1469-0691.12672; Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wilcox MH, 1998, J HOSP INFECT, V38, P93, DOI 10.1016/S0195-6701(98)90062-7	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217423	10.1371/journal.pone.0217423	http://dx.doi.org/10.1371/journal.pone.0217423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136602	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300039
J	Hom, WW; Tschopp, M; Lin, HA; Nasser, P; Laudier, DM; Hecht, AC; Nicoll, SB; Iatridis, JC				Hom, Warren W.; Tschopp, Melanie; Lin, Huizi A.; Nasser, Philip; Laudier, Damien M.; Hecht, Andrew C.; Nicoll, Steven B.; Iatridis, James C.			Composite biomaterial repair strategy to restore biomechanical function and reduce herniation risk in an ex vivo large animal model of intervertebral disc herniation with varying injury severity	PLOS ONE			English	Article							ANNULUS FIBROSUS REPAIR; CARBOXYMETHYLCELLULOSE HYDROGELS; PUNCTURE INJURY; NEEDLE PUNCTURE; TERM OUTCOMES; LUMBAR DISC; DISKECTOMY; HEIGHT; DEGENERATION; REGENERATION	Back pain commonly arises from intervertebral disc (IVD) damage including annulus fibrosus (AF) defects and nucleus pulposus (NP) loss. Poor IVD healing motivates developing tissue engineering repair strategies. This study evaluated a composite injectable IVD biomaterial repair strategy using carboxymethylcellulose-methylcellulose (CMC-MC) and genipincrosslinked fibrin (FibGen) that mimic NP and AF properties, respectively. Bovine ex vivo caudal IVDs were evaluated in cyclic compression-tension, torsion, and compression-to-failure tests to determine IVD biomechanical properties, height loss, and herniation risk following experimentally-induced severe herniation injury and discectomy (4 mm biopsy defect with 20% NP removed). FibGen with and without CMC-MC had failure strength similar to discectomy injury suggesting no increased risk compared to surgical procedures, yet no biomaterials improved axial or torsional biomechanical properties suggesting they were incapable of adequately restoring AF tension. FibGen had the largest failure strength and was further evaluated in additional discectomy injury models with varying AF defect types (2 mm biopsy, 4 mm cruciate, 4 mm biopsy) and NP removal volume (0%, 20%). All simulated discectomy defects significantly compromised failure strength and biomechanical properties. The 0% NP removal group had mean values of axial biomechanical properties closer to intact levels than defects with 20% NP removed but they were not statistically different and 0% NP removal also decreased failure strength. FibGen with and without CMC-MC failed at super-physiological stress levels above simulated discectomy suggesting repair with these tissue engineered biomaterials may perform better than discectomy alone, although restored biomechanical function may require additional healing with the potential application of these biomaterials as sealants and cell/ drug delivery carriers.	[Hom, Warren W.; Tschopp, Melanie; Nasser, Philip; Laudier, Damien M.; Hecht, Andrew C.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA; [Lin, Huizi A.; Nicoll, Steven B.] CUNY City Coll, Dept Biomed Engn, New York, NY USA	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY)	Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.	james.iatridis@mssm.edu		Iatridis, James/0000-0002-2186-0590; Hom, Warren/0000-0003-0521-596X	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR057397]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057397] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number R01AR057397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DB, 2016, J BIOMECH, V49, P3407, DOI 10.1016/j.jbiomech.2016.09.009; Amin DB, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029698; Azab WA, 2016, ACTA NEUROCHIR, V158, P749, DOI 10.1007/s00701-016-2743-2; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Bezci SE, 2018, J ORTHOP RES, V36, P2266, DOI 10.1002/jor.23870; Bezci SE, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031416; Borde B, 2015, J BIOMED MATER RES A, V103, P2571, DOI 10.1002/jbm.a.35388; Borem R, 2017, ACTA BIOMATER, V58, P254, DOI 10.1016/j.actbio.2017.06.006; Bowles RD, 2017, BIOMATERIALS, V129, P54, DOI 10.1016/j.biomaterials.2017.03.013; Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68; Costi JJ, 2008, SPINE, V33, P1731, DOI 10.1097/BRS.0b013e31817bb116; Cruz MA, 2018, TISSUE ENG PT A, V24, P187, DOI [10.1089/ten.tea.2017.0334, 10.1089/ten.TEA.2017.0334]; Deyo RA, 2016, NEW ENGL J MED, V374, P1763, DOI 10.1056/NEJMcp1512658; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; Fernandez C, 2016, J BIOMED MATER RES A, V104, P3093, DOI 10.1002/jbm.a.35858; Grunert P, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1105-5; Gullbrand SE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau0670; Guterl CC, 2014, TISSUE ENG PT A, V20, P2536, DOI [10.1089/ten.tea.2012.0714, 10.1089/ten.TEA.2012.0714]; Guterl CC, 2013, EUR CELLS MATER, V25, P1; HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Hu MH, 2018, J ORTHOP RES, V36, P202, DOI 10.1002/jor.23628; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Jaumard NV, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004493; Laudier D, 2007, J ORTHOP RES, V25, P390, DOI 10.1002/jor.20304; Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03; Lin HZA, 2016, J BIOMED MATER RES A, V104, P165, DOI 10.1002/jbm.a.35552; Long RG, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032353; Long RG, 2016, ACTA BIOMATER, V30, P116, DOI 10.1016/j.actbio.2015.11.015; Martin JT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15887-4; Masuoka K, 2007, SPINE, V32, P1974, DOI 10.1097/BRS.0b013e318133d591; McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a; MELROSE J, 1992, J ORTHOP RES, V10, P665, DOI 10.1002/jor.1100100509; Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Reza AT, 2010, ACTA BIOMATER, V6, P179, DOI 10.1016/j.actbio.2009.06.004; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Scheibler AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208460; Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28; Sharifi S, 2015, J TISSUE ENG REGEN M, V9, P1120, DOI 10.1002/term.1866; Sherman J, 2010, SPINE J, V10, P108, DOI 10.1016/j.spinee.2009.08.453; Sloan SR, 2017, ACTA BIOMATER, V59, P192, DOI 10.1016/j.actbio.2017.06.045; Varma DM, 2018, EUR CELLS MATER, V35, P300, DOI 10.22203/eCM.v035a21; Varma DM, 2014, ACTA BIOMATER, V10, P4996, DOI 10.1016/j.actbio.2014.08.013; Vergroesen PPA, 2015, SPINE, V40, P622, DOI 10.1097/BRS.0000000000000792; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Yang CH, 2016, EUR SPINE J, V25, P906, DOI 10.1007/s00586-015-4316-0; Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019	52	15	15	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217357	10.1371/journal.pone.0217357	http://dx.doi.org/10.1371/journal.pone.0217357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136604	gold, Green Published			2022-12-27	WOS:000469224300028
J	Wang, YY; Wang, YJ; Fang, L; Zhang, SR; Zhang, TY; Li, DC; Ge, DZ				Wang, Yingying; Wang, Yingjie; Fang, Lei; Zhang, Shengrui; Zhang, Tongyan; Li, Daichao; Ge, Dazhuan			Spatial-temporal characteristics and causes of changes to the county-level administrative toponyms cultural landscape in the eastern plains of China	PLOS ONE			English	Article							PLACE-NAMES	As part of the cultural landscape, administrative toponyms do not only reflect natural and sociocultural phenomena, but also help with related management and naming work. Historically, county-level administrative districts have been stable and basic administrative regions in China, playing a role in the country's management. We explore the spatio-temporal evolutionary characteristics of the county-level administrative toponyms cultural landscape in China's eastern plains areas. A Geographical Information System (GIS) analysis, Geo-Informatic Tupu, Kernel Density Estimation, and correlation coefficients were conducted. We constructed a GIS database of county-level administrative toponyms from the Sui dynasty onward using the Northeast China, North China, and Yangtze Plains as examples. We then summarized the spatio-temporal evolutionary characteristics of the county-level administrative toponyms cultural landscape in China's eastern plains areas. The results indicate that (1) the number of toponyms has roughly increased over time; (2) toponym densities on the three plains are higher than the national average in the corresponding timeframe since the Sui; and (3) county-level administrative toponyms related to mountains and hydrological features accounted for more than 30% of the total in 2010. However, the percentage of county-level administrative toponyms related to natural factors on the three plains has decreased since the Sui. To explore the factors influencing this spatio-temporal evolution, we analyzed the correlations between the toponyms and natural factors and human/social factors. The correlation degree between toponym density and population density is the highest, and that between toponym density and Digital Elevation Model (DEM) the lowest. Temperature changes were important in toponym changes, and population changes have influenced toponym changes over the last 400 years in China.	[Wang, Yingying; Wang, Yingjie; Fang, Lei; Zhang, Shengrui; Zhang, Tongyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Wang, Yingying; Wang, Yingjie; Fang, Lei; Zhang, Shengrui; Zhang, Tongyan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Daichao] Fuzhou Univ, Spatial Informat Res Ctr Fujian, Fuzhou, Fujian, Peoples R China; [Ge, Dazhuan] Nanjing Normal Univ, Coll Geog, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fuzhou University; Nanjing Normal University	Wang, YJ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.; Wang, YJ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	wangyj@lreis.ac.cn	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; wang, yingying/GRS-3058-2022; Ge, Dazhuan/AET-9786-2022; Ge, Dazhuan/M-9145-2017	Ge, Dazhuan/0000-0001-8995-6540	Ministry of Civil Affairs of the People's Republic of China [Y77L0200AJ]	Ministry of Civil Affairs of the People's Republic of China	This work was supported by Ministry of Civil Affairs of the People's Republic of China Y77L0200AJ to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, GEOGRAPHICAL RES; [陈晨 Chen Chen], 2014, [地理科学, Scientia Geographica Sinica], V34, P420; China Encyclopedia Editor Committee Geography Editorial Board, 1992, ENC CHIN GEOGR ART N; Chu YP, 1986, ESSAYS TOPONYMYS; Conedera M, 2007, J HIST GEOGR, V33, P729, DOI 10.1016/j.jhg.2006.11.002; Dai JL, 2005, ENCY DICT ANCIENT MO; Fan KW, 2010, CLIMATIC CHANGE, V101, P565, DOI 10.1007/s10584-009-9702-3; FENG ZM, 2011, JILIN U J SOCIAL SCI, V0051; George RS, 1982, NAMES LAND HIST ACCO; Gu Y., 2017, THEORY, P147; Henry G., 1905, ORIGIN CERTAIN PLACE; Hu HA, 1998, PROGRESS OF CUTTING AND GRINDING, P282; Hu HN, 2013, AREAL RES DEV, V32, P170; [胡辉 Hu Hui], 2012, [地球信息科学学报, Journal of Geo-Information Science], V14, P313; Hu Y, 2008, THESIS; Hua L.F., 2006, RES HIST CHINESE TOP; Hua L.F., 2002, TEXTUAL RES HIST TOP; Ke LIAO, 2002, J GEO INFORM SCI, V3, P14; Liao K., 2003, MODERN CARTOGRAPHY, P294; Liu J.D., 1999, POLITICAL GEOGRAPHY; Liu R., 2011, SCI GEOGRAPHICA SINI, V31, P81; Luo W, 2010, GEOJOURNAL, V75, P93, DOI 10.1007/s10708-009-9291-8; Ma Y.L., 1993, NEW EXPLORATION TOPO; Niu R.C., 2002, NEW CENTURY CHINESE; Niu R.C., 1999, DICT ORIGIN CHINESE; Niu R.C., 2016, CHINAS TOPONYMS ANEC; Population Census Office, 2012, TAB 2010 POP CENS PE; [齐清文 Qi Qingwen], 2004, [测绘科学, Science of surveying and mapping], V29, P15; Shi N.H., 1985, COLLECTIONS ESSAYS C, V1, P36; Shi W.L., 2005, DICT CHINESE HIST TO; Situ S.J., 1992, ESSAYS CHIN HIST GEO, V1, P21; Song JC, 2010, STUDY TOPONYMS CULTU; Sousa A, 2001, LANDSCAPE ECOL, V16, P391, DOI 10.1023/A:1017585101389; Sousa A, 2010, CLIMATIC CHANGE, V100, P525, DOI 10.1007/s10584-009-9794-9; [孙百生 Sun Baisheng], 2017, [地理科学, Scientia Geographica Sinica], V37, P244; Sun D.H., 1997, HIST GEOGRAPHICAL NA; Sweeney S, 2007, LANDSCAPE ECOL, V22, P1007, DOI 10.1007/s10980-007-9085-7; Tan QX., 1982, HIST ATLAS CHINA; Tang GP, 2012, LINGUISTICS TOPONYMS; Tuan Y.-F., 1977, SPACE PLACE PERSPECT; [王彬 WANG Bin], 2007, [地理研究, Geographical Research], V26, P238; [王长松 Wang Changsong], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P18; Wang F, 2013, GEOGR RES-AUST, V32, P487; Wang FH, 2012, T I BRIT GEOGR, V37, P317, DOI 10.1111/j.1475-5661.2011.00471.x; Wang J.T., 1993, INTRO TOPONYMY; [Ye Qinghua 叶庆华], 2004, Journal of Geographical Sciences, V14, P131; Yu Wenhao, 2016, Geomatics and Information Science of Wuhan University, V41, P221, DOI 10.13203/j.whugis20140092; Yu WH, 2015, DONG YUE TRIBUNE, V36, P81; [张荣群 ZHANG Rang-qun], 2009, [测绘科学, Science of Surveying and Mapping], V34, P14; Zhang RQ, 2009, SCI SURVEYING MAPPIN, V34, P24; [郑惠茹 Zheng Huiru], 2016, [生态学报, Acta Ecologica Sinica], V36, P6295; Zhou Z.H., 1998, CHANGES ADM DIVISION; ZHU KZ, 1972, ARCHAEOLOGY, P15	53	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217381	10.1371/journal.pone.0217381	http://dx.doi.org/10.1371/journal.pone.0217381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136593	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300032
J	Eleftheriou, A; Bullock, S; Graham, CA; Skakoon-Sparling, S; Ingham, R				Eleftheriou, Anastasia; Bullock, Seth; Graham, Cynthia A.; Skakoon-Sparling, Shayna; Ingham, Roger			Does attractiveness influence condom use intentions in women who have sex with men?	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; COLLEGE-STUDENTS; SENSATION SEEKING; RISK; PERCEPTIONS; BEHAVIOR; PARTNER; DANGER; HIV	Objectives Attractiveness judgements have been shown to affect interpersonal relationships. The present study explored the relationships between perceived attractiveness, perceived sexual health status, condom use intentions and condom use resistance in women. Setting The study data were collected using an online questionnaire. Participants 480 English-speaking women who have sex with men, between 18-32 years old. Outcome measures Women were asked to rate the attractiveness of 20 men on the basis of facial photographs, to estimate the likelihood that each man had a sexually transmitted infection (STI), and to indicate their willingness to have sex with each man without a condom. Condom resistance tactics were also measured and their influence on condom use intentions was assessed. Results The more attractive a man was judged to be, the more likely it was that participants were willing to have sex with him (r (478) = 0.987, p < .001). Further, the more attractive a man was judged to be, the less likely women were to intend to use a condom during sex (r = -0.552, df = 478, p = .007). The average perceived STI likelihood for a man had no significant association with his average perceived attractiveness or with participants' average willingness to have sex with him. The more attractive a participant judged herself to be, the more she believed that, overall, men are likely to have a STI (r = 0.103, df = 478, p < .05). Conclusions Women's perceptions of men's attractiveness influence their condom use intentions; such risk biases should be incorporated into sexual health education programmes and condom use interventions.	[Eleftheriou, Anastasia] Univ Southampton, Elect & Comp Sci, Southampton, Hants, England; [Eleftheriou, Anastasia] Univ Southampton, Inst Complex Syst Simulat, Southampton, Hants, England; [Bullock, Seth] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Graham, Cynthia A.; Ingham, Roger] Univ Southampton, Ctr Sexual Hlth Res, Psychol, Southampton, Hants, England; [Skakoon-Sparling, Shayna] Univ Guelph, Dept Family Relat & Appl Nutr, Guelph, ON, Canada	University of Southampton; University of Southampton; University of Bristol; University of Southampton; University of Guelph	Eleftheriou, A (corresponding author), Univ Southampton, Elect & Comp Sci, Southampton, Hants, England.; Eleftheriou, A (corresponding author), Univ Southampton, Inst Complex Syst Simulat, Southampton, Hants, England.	eleftheriouanastasia@gmail.com		Eleftheriou, Anastasia/0000-0002-8120-339X	EPSRC Doctoral Training Centre grant [EP/G03690X/1]	EPSRC Doctoral Training Centre grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an EPSRC Doctoral Training Centre grant (EP/G03690X/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Bancroft J, 2009, J SEX RES, V46, P121, DOI 10.1080/00224490902747222; Crosby R, 2013, INT J STD AIDS, V24, P100, DOI 10.1177/0956462412472295; Cushman LF, 1998, FAM PLANN PERSPECT, V30, P240, DOI 10.2307/2991611; Davis KC, 2014, J SEX RES, V51, P454, DOI 10.1080/00224499.2013.776660; Dijkstra P, 2000, J APPL SOC PSYCHOL, V30, P1738, DOI 10.1111/j.1559-1816.2000.tb02465.x; Downing-Matibag TM, 2009, QUAL HEALTH RES, V19, P1196, DOI 10.1177/1049732309344206; Druckman J.N., 2011, CAMBRIDGE HDB EXPT P, V1, P41; Eleftheriou A, 2017, JMIR SERIOUS GAMES, V5; Eleftheriou A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010883; Fishbein M., 2004, PSYCHOL HEALTH MED, V9, P273, DOI [DOI 10.1080/13548500410001721846, 10.1080/13548500410001721846]; Fisher WA, 2003, BLACKW SER HLTH PSYC, P82, DOI 10.1002/9780470753552.ch4; GOLD RS, 1992, AIDS CARE, V4, P305, DOI 10.1080/09540129208253101; Hancock P., 2008, PSYCHOL IMAGE COLLEC; Henderson VR, 2005, PERS INDIV DIFFER, V38, P311, DOI 10.1016/j.paid.2004.04.010; Hennessy M, 2007, AIDS BEHAV, V11, P479, DOI 10.1007/s10461-006-9156-9; Hernandez AL, 2006, AIDS BEHAV, V10, pS5, DOI 10.1007/s10461-006-9129-z; Hong DS, 2006, AIDS EDUC PREV, V18, P150, DOI 10.1521/aeap.2006.18.2.150; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Keller ML, 1993, AIDS ED PREVENTION; Lennon CA, 2013, J HEALTH PSYCHOL, V18, P1166, DOI 10.1177/1359105312462438; Little AC, 2006, PERS INDIV DIFFER, V40, P973, DOI 10.1016/j.paid.2005.09.016; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Lorenzo GL, 2010, PSYCHOL SCI, V21, P1777, DOI 10.1177/0956797610388048; Masaro CL, 2008, SEX TRANSM DIS, V35, P566, DOI 10.1097/OLQ.0b013e3181660c43; MCKENNA FP, 1993, BRIT J PSYCHOL, V84, P39, DOI 10.1111/j.2044-8295.1993.tb02461.x; Milhausen RR, 2013, CAN J HUM SEX, V22, P142, DOI DOI 10.3138/CJHS.2316; Renner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030460; Rupp HA, 2009, EVOL HUM BEHAV, V30, P1, DOI 10.1016/j.evolhumbehav.2008.08.006; Rupp HA, 2009, NEUROSCI LETT, V449, P42, DOI 10.1016/j.neulet.2008.10.083; Sayegh MA, 2006, J ADOLESCENT HEALTH, V39, P388, DOI 10.1016/j.jadohealth.2005.12.027; Schmalzle R, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00043; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Sheeran P, 1998, BRIT J SOC PSYCHOL, V37, P231, DOI 10.1111/j.2044-8309.1998.tb01167.x; Skakoon-Sparling S, 2019, J SEX RES; Sparling S, 2015, CAN J HUM SEX, V24, P237, DOI 10.3138/cjhs.243-A2; Weeden J, 2007, ARCH SEX BEHAV, V36, P79, DOI 10.1007/s10508-006-9075-x; Wegner R, 2018, J SEX RES, V55, P817, DOI 10.1080/00224499.2017.1376305; WILLIAMS SS, 1992, J APPL SOC PSYCHOL, V22, P921, DOI 10.1111/j.1559-1816.1992.tb00934.x; Zeng N, 2017, CYBERPSYCH BEH SOC N, V20, P453, DOI 10.1089/cyber.2017.0042	40	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217152	10.1371/journal.pone.0217152	http://dx.doi.org/10.1371/journal.pone.0217152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120922	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000468775700062
J	Masonou, T; Hokey, DA; Lahey, T; Halliday, A; Berrocal-Almanza, LC; Wieland-Alter, WF; Arbeit, RD; Lalvani, A; von Reyn, CF				Masonou, Tereza; Hokey, David A.; Lahey, Timothy; Halliday, Alice; Berrocal-Almanza, Luis C.; Wieland-Alter, Wendy F.; Arbeit, Robert D.; Lalvani, Ajit; von Reyn, C. Fordham			CD4+T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial	PLOS ONE			English	Article							HIV-INFECTED ADULTS; TUBERCULOSIS VACCINE; MYCOBACTERIUM; PROTECTION; IMMUNOGENICITY; PREVENTION; CORRELATE; AEROSOL; AERAS-402; ANTIGENS	Background DAR-901 is an inactivated whole cell tuberculosis booster vaccine, prepared using a new scalable, broth-grown method from the master cell bank of SRL172, a vaccine previously shown to prevent tuberculosis. This study examined whether DAR-901 (a) induces CD4+ T cell cytokine profiles previously proposed as correlates of protection and (b) has a specific vaccine-induced immunological signature compared to BCG or placebo. Methods We analysed CD4+ T cell cytokine immune responses from 10 DAR-901 recipients, 9 BCG recipients and 9 placebo recipients from the Phase I DAR-901 MDES trial. In that study, HIV-negative, IGRA-negative participants with prior BCG immunization were randomized (double-blind) to receive three intradermal injections of DAR-901 or saline placebo or two injections of saline placebo followed by an intradermal injection of BCG. Antigen-specific functional and phenotypic CD4+ T cell responses along with effector phenotype of responder cells were measured by intracellular cytokine staining. Results DAR-901 recipients exhibited increased DAR-901 antigen-specific polyfunctional or bifunctional T cell responses compared to baseline. Vaccine specific CD4+ IFN gamma, IL2, TNF alpha and any cytokine responses peaked at 7 days post-dose 3. Th1 responses predominated, with most responder cells exhibiting a polyfunctional effector memory phenotype. BCG induced greater CD4+ T cell responses than placebo while the more modest DAR-901 responses did not differ from placebo. Neither DAR-901 nor BCG induced substantial or sustained Th17/Th22 cytokine responses. Conclusion DAR-901, a TB booster vaccine grown from the master cell bank of SRL 172 which was shown to prevent TB, induced low magnitude polyfunctional effector memory CD4+ T cell responses. DAR-901 responses were lower than those induced by BCG, a vaccine that has been shown ineffective as a booster to prevent tuberculosis disease. These results suggest that induction of higher levels of CD4+ cytokine stimulation may not be a critical or pre-requisite characteristic for candidate TB vaccine boosters.	[Masonou, Tereza; Halliday, Alice; Berrocal-Almanza, Luis C.; Lalvani, Ajit] Imperial Coll London, Natl Heart & Lung Inst, Resp Infect Sect, TB Res Ctr, London, England; [Hokey, David A.] Aeras, Rockville, MD USA; [Lahey, Timothy] Univ Vermont, Larner Coll Med, Burlington, VT USA; [Wieland-Alter, Wendy F.; von Reyn, C. Fordham] Geisel Sch Med, Hanover, NH 03755 USA; [Arbeit, Robert D.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Masonou, Tereza] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London, England; [Halliday, Alice] Univ Bristol, Cellular & Mol Med, Bristol, Avon, England; [von Reyn, C. Fordham] DHMC, Infect Dis & Int Hlth, Geisel Sch Med, Lebanon, NH 03766 USA	Imperial College London; University of Vermont; Dartmouth College; Tufts University; Imperial College London; University of Bristol; Dartmouth College	Masonou, T; Lalvani, A (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Resp Infect Sect, TB Res Ctr, London, England.; von Reyn, CF (corresponding author), Geisel Sch Med, Hanover, NH 03755 USA.; Masonou, T (corresponding author), Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London, England.; von Reyn, CF (corresponding author), DHMC, Infect Dis & Int Hlth, Geisel Sch Med, Lebanon, NH 03766 USA.	tereza.masonou16@imperial.ac.uk; a.lalvani@imperial.ac.uk; fvr@dartmouth.edu		Halliday, Alice/0000-0001-8183-1110; Masonou, Tereza/0000-0003-3663-8965; Lalvani, Ajit/0000-0002-2396-246X; Hokey, David/0000-0002-6184-2485	Dartmouth College; Aeras Foundation; Jack and Dorothy Byrne Foundation; Imperial College London; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London; Public Health England (PHE) [10064]; Imperial NIHR BRC (Biomedical Research Centre) [121520013]	Dartmouth College; Aeras Foundation; Jack and Dorothy Byrne Foundation; Imperial College London(General Electric); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London; Public Health England (PHE); Imperial NIHR BRC (Biomedical Research Centre)	Support was provided by: (1) Dartmouth College - university grant (no number), (2) Aeras Foundation - supporting grant (no number), (3) Jack and Dorothy Byrne Foundation (no number), (4) Imperial College London. AL received funding award from the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London in partnership with Public Health England (PHE) - grant code 10064, which supported salaries for the following: AL, TM, LBA. In addition, AL received funding via the Imperial NIHR BRC (Biomedical Research Centre) -grant code 121520013 which supported salaries for AH and AL (https://www.nihr.ac.uk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Behrends J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057379; Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013; Darrah PA, 2014, J IMMUNOL, V193, P1799, DOI 10.4049/jimmunol.1400676; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; de Gijsel D, 2019, INT J INFECT DIS, V80, pS6, DOI 10.1016/j.ijid.2019.02.036; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Desel C, 2011, J INFECT DIS, V204, P1573, DOI 10.1093/infdis/jir592; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; FINE PEM, 1988, T ROY SOC TROP MED H, V82, P810, DOI 10.1016/0035-9203(88)90003-X; Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11290; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Freches D, 2013, IMMUNOLOGY, V140, P220, DOI 10.1111/imm.12130; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Geldenhuys H, 2015, VACCINE, V33, P3592, DOI 10.1016/j.vaccine.2015.05.036; Ginsberg A., 2018, H4 IC31 BCG REVACCIN; Goletti D, 2016, INFECT DIS REP, V8, P24, DOI 10.4081/idr.2016.6568; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Graves AJ, 2014, CYTOM PART A, V85A, P576, DOI 10.1002/cyto.a.22478; Grode L, 2013, VACCINE, V31, P1340, DOI 10.1016/j.vaccine.2012.12.053; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; ight GM, 2014, P NATL ACAD SCI, V111; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lahey T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168521; Lahey T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022074; Lahey T, 2010, VACCINE, V28, P7652, DOI 10.1016/j.vaccine.2010.09.041; Lahey T, 2010, J INFECT DIS, V202, P1265, DOI 10.1086/656332; Maggioli MF, 2016, FRONT IMMUNOL, V7, P1, DOI [10.3389/fimmu.2016.00001, DOI 10.3389/FIMMU.2016.00001]; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Penn-Nicholson A, 2015, VACCINE, V33, P4025, DOI 10.1016/j.vaccine.2015.05.088; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Roy A, 2014, BMJ-BRIT MED J, V349, P1; Schrager L. K., 2018, F1000RES, V7, P1732, DOI DOI 10.12688/F1000RESEARCH.16521.2; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; SEPULVEDA RL, 1992, TUBERCLE LUNG DIS, V73, P372, DOI 10.1016/0962-8479(92)90043-J; Tadokera R, 2013, J INFECT DIS, V207, P1148, DOI 10.1093/infdis/jit002; Tameris M, 2015, VACCINE, V33, P2944, DOI 10.1016/j.vaccine.2015.03.070; Tameris M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087340; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Van der Meeren O, 2018, NEW ENGL J MED, V379, P1621, DOI 10.1056/NEJMoa1803484; von Reyn CF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175215; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; White AD, 2015, CLIN VACCINE IMMUNOL, V22, P992, DOI 10.1128/CVI.00289-15; World Health Organization, 2017, GLOB TUB REP, V2017, P1	51	10	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217091	10.1371/journal.pone.0217091	http://dx.doi.org/10.1371/journal.pone.0217091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120957	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700055
J	Pomastowski, P; Zloch, M; Rodzik, A; Ligor, M; Kostrzewa, M; Buszewski, B				Pomastowski, Pawel; Zloch, Michal; Rodzik, Agnieszka; Ligor, Magda; Kostrzewa, Markus; Buszewski, Boguslaw			Analysis of bacteria associated with honeys of different geographical and botanical origin using two different identification approaches: MALDI-TOF MS and 16S rDNA PCR technique	PLOS ONE			English	Article							MASS-SPECTROMETRY; BACILLUS-CEREUS; MICROBIOLOGICAL QUALITY; MICROORGANISMS; DATABASE; REGION; COMPILATION; BOTULINUM; SUBTILIS; TAXONOMY	In the presented work identification of microorganisms isolated from various types of honeys was performed. Martix-assisted laser desorption/ ionization time-of-flight mass spectrometry ( MALDI-TOF MS) and 16S rDNA sequencing were applied to study environmental bacteria strains. With both approches, problematic spore-forming Bacillus spp, but also Staphylococcus spp., Lysinibacillus spp., Micrococcus spp. and Brevibacillus spp were identified. However, application of spectrometric technique allows for an unambiguous distinction between species/species groups e.g. B. subtilis or B. cereus groups. MALDI TOF MS and 16S rDNA sequencing allow for construction of phyloproteomic and phylogenetic trees of identified bacterial species. Furthermore, the correlation beetween physicochemical properties, geographical and botanical origin and the presence bacterial species in honey samples were investigated.	[Pomastowski, Pawel; Zloch, Michal; Rodzik, Agnieszka; Ligor, Magda; Buszewski, Boguslaw] Nicolaus Copernicus Univ Torun, Interdisciplinary Ctr Modern Technol, Torun, Poland; [Rodzik, Agnieszka; Ligor, Magda; Buszewski, Boguslaw] Nicolaus Copernicus Univ Torun, Dept Environm Chem & Bioanalyt, Fac Chem, Torun, Poland; [Kostrzewa, Markus] Bruker Daltonik GmbH, Bremen, Germany	Nicolaus Copernicus University; Nicolaus Copernicus University; Bruker Corporation; Bruker Daltonik GmbH	Pomastowski, P (corresponding author), Nicolaus Copernicus Univ Torun, Interdisciplinary Ctr Modern Technol, Torun, Poland.	p.pomastowski@umk.pl	Zloch, Michal/D-3655-2018; Buszewski, BogusÅaw/AAT-5316-2020; Ligor, Magdalena/H-6239-2014	Zloch, Michal/0000-0001-6169-3099; Ligor, Magdalena/0000-0001-7059-907X; Rodzik, Agnieszka/0000-0001-6865-4009; Pomastowski, Pawel/0000-0002-1594-0623; Buszewski, Boguslaw/0000-0002-5482-7500	PLANTARUM project from National Centre for Research and Development, Poland [BIOSTRATEG2/298205/9/NCBR/2016]; Bruker Daltonik GmbH company	PLANTARUM project from National Centre for Research and Development, Poland; Bruker Daltonik GmbH company	This study was supported by PLANTARUM project No. BIOSTRATEG2/298205/9/NCBR/2016 from National Centre for Research and Development, Poland to BB; https://www.ncbr.gov.pl/.Bruker Daltonik GmbH company provided support for this study in the form of salaries for MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adadi P, 2017, J FOOD DRUG ANAL, V25, P369, DOI 10.1016/j.jfda.2016.07.005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angolini CFF, 2015, J BRAZIL CHEM SOC, V26, P513, DOI 10.5935/0103-5053.20150004; Branquinho R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110127; Chambers T., 2015, J PROTEOMICS ENZYMOL, V4, P1, DOI DOI 10.4172/2470-1289.1000119; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; da Silva PM, 2016, FOOD CHEM, V196, P309, DOI 10.1016/j.foodchem.2015.09.051; Demirev PA, 2005, ANAL CHEM, V77, P7455, DOI 10.1021/ac051419g; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Doern CD, 2016, J MOL DIAGN, V18, P789, DOI 10.1016/j.jmoldx.2016.07.007; Ecker DJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-19; English RD, 2003, BACILLUS SPORE IDENT, DOI [10.1021/AC034624, DOI 10.1021/AC034624]; Erkan ME, 2015, J HELL VET MED SOC, V66, P22; Estevinho LM, 2012, FOOD CHEM TOXICOL, V50, P258, DOI 10.1016/j.fct.2011.10.034; Estevinho ML, 2013, ACTA ALIMENT HUNG, V42, P36, DOI 10.1556/AAlim.42.2013.1.4; Fach P, 2009, J APPL MICROBIOL, V107, P465, DOI 10.1111/j.1365-2672.2009.04215.x; Fernandez LA, 2017, REV ARGENT MICROBIOL, V49, P55, DOI 10.1016/j.ram.2016.05.010; Fernandez-No IC, 2013, FOOD MICROBIOL, V33, P235, DOI 10.1016/j.fm.2012.09.022; Finola MS, 2007, FOOD CHEM, V100, P1649, DOI 10.1016/j.foodchem.2005.12.046; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gomes S, 2010, FOOD CHEM TOXICOL, V48, P544, DOI 10.1016/j.fct.2009.11.029; Grabowski NT, 2017, CRIT REV FOOD SCI, V57, P1852, DOI 10.1080/10408398.2015.1029041; Hathout Y, 1999, APPL ENVIRON MICROB, V65, P4313; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Iurlina MO, 2005, INT J FOOD MICROBIOL, V105, P297, DOI 10.1016/j.ijfoodmicro.2005.03.017; Iurlina MO, 2006, LWT-FOOD SCI TECHNOL, V39, P105, DOI 10.1016/j.lwt.2005.01.006; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Karabagias IK, 2014, FOOD CHEM, V146, P548, DOI 10.1016/j.foodchem.2013.09.105; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; Kopcakova A, 2014, CHEM PAP, V68, P1435, DOI 10.2478/s11696-014-0612-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laredj H, 2017, ASIAN J PHARM RES HE, V9, P85, DOI 10.18311/ajprhc/2017/15698; Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Lopez AC, 2007, INT J FOOD MICROBIOL, V117, P175, DOI 10.1016/j.ijfoodmicro.2007.03.007; Madras-Majewska B, 2016, MED WETER, V72, P620, DOI 10.21521/mw.5573; Mahendran S, 2015, INT LETT NAT SCI, V34, P15, DOI 10.18052/www.scipress.com/ILNS.34.15; Martins Herminia Marina, 2003, Revista Portuguesa de Ciencias Veterinarias, V98, P85; Maughan H, 2011, INFECT GENET EVOL, V11, P789, DOI 10.1016/j.meegid.2011.02.001; Molan P C, 2001, Am J Clin Dermatol, V2, P13, DOI 10.2165/00128071-200102010-00003; Monetto AM, 1999, ANAEROBE, V5, P185, DOI 10.1006/anae.1999.0267; Nicholson WL, 2002, CELL MOL LIFE SCI, V59, P410, DOI 10.1007/s00018-002-8433-7; Olaitan Peter B, 2007, Afr Health Sci, V7, P159; Omafuvbe BO, 2009, AFR J MICROBIOL RES, V3, P891; Pauker VI, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01900-17, 10.1128/jcm.01900-17]; Pucciarelli AB, 2014, REV ARGENT MICROBIOL, V46, P325, DOI 10.1016/S0325-7541(14)70091-4; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rogowska A, 2018, SCI REP, V8, DOI [10.1038/s41598-017-18329-3, DOI 10.1038/S41598-017-18329-3]; Rooney AP, 2009, INT J SYST EVOL MICR, V59, P2429, DOI 10.1099/ijs.0.009126-0; Rozanska H, 2011, B VET I PULAWY, V55, P443; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos IC, 2016, ANALYST, V141, P2827, DOI 10.1039/c6an00131a; Schubert S, 2015, METHOD MICROBIOL, V42, P501, DOI 10.1016/bs.mim.2015.04.004; Shu LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15808-5; Sinacori M, 2014, FOOD MICROBIOL, V38, P284, DOI 10.1016/j.fm.2013.07.013; Snowdon JA, 1996, INT J FOOD MICROBIOL, V31, P1, DOI 10.1016/0168-1605(96)00970-1; Starostin KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16989; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Torres-Gonzalez A, 2016, NAT PROD RES, V30, P237, DOI 10.1080/14786419.2015.1043631; Vet T.J., 2013, TURK J VET ANIM SCI, V37, P602, DOI [10.3906/vet-1301-46, DOI 10.3906/VET-1301-46]	60	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217078	10.1371/journal.pone.0217078	http://dx.doi.org/10.1371/journal.pone.0217078			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120945	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700053
J	Wang, T; Sun, HL; Ge, HN; Liu, XX; Yu, F; Han, H; Wang, J; Li, WJ				Wang, Teng; Sun, Hualei; Ge, Huina; Liu, Xinxin; Yu, Fei; Han, Han; Wang, Jun; Li, Wenjie			Association between vitamin D and risk of cardiovascular disease in Chinese rural population	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATION; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; METABOLIC SYNDROME; ALL-CAUSE; ATHEROSCLEROSIS; METAANALYSIS; EXPRESSION; MORTALITY; PREGNANCY	Previous studies have suggested that vitamin D is associated with cardiovascular disease (CVD), however, the relationship between vitamin D levels and CVD risk is still unclear. The purpose of this study was to assess the relationship of serum concentration of 25-hydroxyvitamin D (25(OH) D) with CVD in rural residents of Henan province of China. Basic information and medical history were gathered through face-to-face surveys from July 2013 to August 2015, and biochemical indicators were gathered in a laboratory setting. Logistic and restricted cubic splines regression analyses were used to estimate odd ratios (ORs) and 95% confidence intervals (95% CI) of CVD. A total of 1078 participants were included, the mean serum 25(OH) D concentration was determined to be 25 +/- 18 ng/ml, with 54.45% of the participants presenting vitamin D deficiency [25(OH) D < 20 ng/mL]. Moreover, the prevalence of CVD was 59.28% in the vitamin D deficient group, which was higher than in the insufficient (48.55%) and sufficient groups (52.78%). After adjusting for potential confounders, compared with the deficient group, the ORs (95% CI) of CVDs were 0.68 (0.50, 0.91) in the insufficient group and 0.81 (0.56, 1.16) in the sufficient group. A nonlinear (U-shaped) association was observed between the risk of CVD and 25(OH) D concentration. Further research suggested that the risk of CVD was higher in males than in females. In conclusion, a U-shape association between serum levels of 25(OH) D and the risk of CVD was identified in our study, suggesting a nonlinear relationship between vitamin D with the prevalence of CVD.	[Wang, Teng; Sun, Hualei; Ge, Huina; Liu, Xinxin; Yu, Fei; Han, Han; Wang, Jun; Li, Wenjie] Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Li, WJ (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou, Henan, Peoples R China.	lwj@zzu.edu.cn	lei, sun/GPW-9213-2022		National Nature Science Foundation of China [81573151]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China [grant numbers 81573151 to W.L.], and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer M, 2013, AM J MED, V126, P509, DOI 10.1016/j.amjmed.2012.11.021; Barbagallo M, 2001, HYPERTENSION, V37, P142, DOI 10.1161/01.HYP.37.1.142; Caprio M, 2012, ARCH MED SCI, V8, P4, DOI 10.5114/aoms.2012.27271; Chen WW, 2016, EUR HEART J SUPPL, V18, pF2, DOI 10.1093/eurheartj/suw030; Chen YH, 2015, J CLIN ENDOCR METAB, V100, P1912, DOI 10.1210/jc.2014-4407; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Funakoshi Y, 2001, HYPERTENSION, V38, P100, DOI 10.1161/01.HYP.38.1.100; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Grant WB, 2019, HORM-INT J ENDOCRINO, V18, P23, DOI 10.1007/s42000-018-0059-8; Grober U, 2013, DERM-ENDOCRINOL, V5, P331, DOI 10.4161/derm.26738; Hannesdottir P, 2017, LAEKNABLADID, V103, P367, DOI [10.17992/lbl.2017.09.149, /10.17992/lbl.2017.09.149]; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang A, 2004, MICROCIRCULATION, V11, P9, DOI 10.1080/10739680490266162; Kardys I, 2007, AM J EPIDEMIOL, V166, P403, DOI 10.1093/aje/kwm115; Kayama Y, 2015, INT J MOL SCI, V16, P25234, DOI 10.3390/ijms161025234; Kelishadi R, 2014, J PEDIAT-BRAZIL, V90, P28, DOI 10.1016/j.jped.2013.06.006; Khadir Abdelkrim, 2015, Mediators Inflamm, V2015, P512603, DOI 10.1155/2015/512603; Kienreich K, 2013, NUTRIENTS, V5, P3005, DOI 10.3390/nu5083005; Kunutsor SK, 2013, EUR J EPIDEMIOL, V28, P205, DOI 10.1007/s10654-013-9790-2; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Liu LJ, 2012, AM J CARDIOL, V110, P834, DOI 10.1016/j.amjcard.2012.05.013; [刘明波 Liu Mingbo], 2014, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V48, P502; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB DA, P290; Nabi G, 2015, MED HYPOTHESES, V85, P117, DOI 10.1016/j.mehy.2015.04.006; Ng MKC, 2003, J AM COLL CARDIOL, V42, P1306, DOI 10.1016/j.jacc.2003.07.002; Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971; Organization WH, 2003, VET REC, V1, P213; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Raed A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188424; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Welles CC, 2014, AM J EPIDEMIOL, V179, P1279, DOI 10.1093/aje/kwu059; World Health Organization, CARD DIS CVDS FACT S; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang RH, 2017, AM J CLIN NUTR, V105, P810, DOI 10.3945/ajcn.116.140392	45	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217311	10.1371/journal.pone.0217311	http://dx.doi.org/10.1371/journal.pone.0217311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120983	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700088
J	Teng, F; Reynolds, BL				Teng, Feng; Reynolds, Barry Lee			Effects of individual and group metacognitive prompts on EFL reading comprehension and incidental vocabulary learning	PLOS ONE			English	Article							STRATEGIES; ACHIEVEMENT; ACQUISITION; INSTRUCTION; LEARNERS; STUDENTS; TASK	Recent research has highlighted the value of providing metacognitive guidance for learning English in a small group setting. This study investigated the effects that the presence or absence of metacognitive prompts for group or individual learning could have on reading comprehension and the incidental learning of vocabulary through reading. A total of 171 university students were randomly assigned to four treatment conditions: collaborative learning with metacognitive prompts, collaborative learning without metacognitive prompts, individual learning with metacognitive prompts, and individual learning without metacognitive prompts. Results indicated that after the treatment, learners in the collaborative learning with metacognitive prompts group outperformed the other groups on both reading comprehension and incidental vocabulary learning assessments. In addition, the vocabulary knowledge acquired by students in the collaborative learning with metacognitive prompts group was highest for meaning recognition, followed by form recognition, meaning recall, and finally form recall. These findings highlight the importance of training students' self-regulated learning and suggest that the use of metacognitive prompts in a group setting is an effective means to boost EFL reading comprehension and the incidental vocabulary learning for Chinese university students. Pedagogical implications of these and other nuanced findings are discussed.	[Teng, Feng] Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Peoples R China; [Reynolds, Barry Lee] Univ Macau, Fac Educ, Macau, Peoples R China	Hong Kong Baptist University; University of Macau	Reynolds, BL (corresponding author), Univ Macau, Fac Educ, Macau, Peoples R China.	BarryReynolds@um.edu.mo	Teng, Mark Feng/D-6660-2019; Reynolds, Barry Lee/I-5685-2019	Teng, Mark Feng/0000-0002-5134-8504; Reynolds, Barry Lee/0000-0002-3984-2059	University of Macau [SRG2016-00079-FED, MYRG2019-00030-FED]	University of Macau	The research reported in this manuscript was supported by the University of Macau under grant number SRG2016-00079-FED and MYRG2019-00030-FED to BLR. There was no additional external funding received for this study.	Anderson John R, 2005, COGNITIVE PSYCHOL IT, P2; [Anonymous], 1978, SYSTEM, DOI [10.1016/0346-251X(78)90027-1, DOI 10.1016/0346-251X(78)90027-1]; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; Bannert M, 2009, Z PADAGOG PSYCHOL, V23, P139, DOI 10.1024/1010-0652.23.2.139; Bol L, 2012, CONTEMP EDUC PSYCHOL, V37, P280, DOI 10.1016/j.cedpsych.2012.02.004; Borge M, 2016, COGNITION INSTRUCT, V34, P323, DOI 10.1080/07370008.2016.1215722; Boulware-Gooden R, 2007, READ TEACH, V61, P70, DOI 10.1598/RT.61.1.7; Dahl B., 2004, EDUC STUD MATH, V56, P129, DOI [10.1023/B:EDUC.0000040393.88227.05, DOI 10.1023/B:EDUC.0000040393.88227.05]; Davis EA, 2003, J LEARN SCI, V12, P91, DOI 10.1207/S15327809JLS1201_4; Dupuy B., 1993, APPL LANGUAGE LEARNI, V4, P55; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Georghiades P., 2000, ED RES, V41, P129; Gu YQ, 1996, LANG LEARN, V46, P643, DOI 10.1111/j.1467-1770.1996.tb01355.x; Hacker D. J., HDB MEMORY METACOGNI, P429, DOI DOI 10.4324/9780203805503.CH22; Hadwin AF, 2011, EDUC PSYCHOL HANDB, P65; Hulstijin J. H., 2001, COGNITION 2 LANGUAGE, P258, DOI DOI 10.1017/CBO9781139524780.011; Hulstijn J.H., 2013, INCIDENTAL LEARNING, DOI DOI 10.1002/9781405198431.WBEAL0530; JACOBS JE, 1987, EDUC PSYCHOL, V22, P255, DOI 10.1207/s15326985ep2203&4_4; Johnson D., 1994, LEARNING TOGETHER AL; Johnson DW, 2005, GENET SOC GEN PSYCH, V131, P285, DOI 10.3200/MONO.131.4.285-358; Kramarski B, 2003, AM EDUC RES J, V40, P281, DOI 10.3102/00028312040001281; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Laufer B, 2015, LANG TEACH RES, V19, P687, DOI 10.1177/1362168814559797; Mark FT, 2017, PERTANIKA J SOC SCI, V25, P1753; Meyers L. S., 2006, APPL MULTIVARIATE RE; Nation I.S.P., 2013, LEARNING VOCABULARY; Nation I.S.P., 2013, WHAT SHOULD EVERY EF; Nietfeld JL, 2002, J EDUC RES, V95, P131, DOI 10.1080/00220670209596583; Panadero E, 2014, AN PSICOL-SPAIN, V30, P450, DOI 10.6018/analesps.30.2.167221; Qin CH, 2017, CHIN J APPL LINGUIST, V40, P261, DOI 10.1515/cjal-2017-0015; Reynolds B.L., 2016, TESL EJ ELECT J ENGL, V20, P1; Reynolds BL, 2020, IRAL-INT REV APPL LI, V58, P75, DOI 10.1515/iral-2015-0115; Reynolds BL, 2015, APPL LINGUIST REV, V6, P467, DOI 10.1515/applirev-2015-0021; Reynolds BL, 2016, RELC J, V47, P213, DOI [10.1177/0033688215619518, 10.1177/0033688215589886]; Reynolds BL, 2015, READ RES QUART, V50, P111, DOI 10.1002/rrq.88; Reynolds BL, 2014, TESOL QUART, V48, P843, DOI 10.1002/tesq.197; Reynolds BL, 2013, TESOL QUART, V47, P849, DOI 10.1002/tesq.145; Reynolds BL, 2013, BRIT J EDUC TECHNOL, V44, pE42, DOI 10.1111/j.1467-8535.2012.01322.x; Reynolds BL, 2012, TESOL QUART, V46, P812, DOI 10.1002/tesq.64; Rott S., 1999, STUD SECOND LANG ACQ, V21, P589, DOI DOI 10.1017/S0272263199004039; Schraw G, 1998, INSTR SCI, V26, P113, DOI 10.1023/A:1003044231033; Shaaban K, 2006, READ PSYCHOL, V27, P377, DOI 10.1080/02702710600846613; Shih YC, 2018, REV ESP LINGUIST APL, V31, P345, DOI 10.1075/resla.16032.shi; Shih YC, 2018, READ FOREIGN LANG, V30, P130; Shih YC, 2018, APPL LINGUIST REV, V9, P35, DOI 10.1515/applirev-2016-1022; Slavin R. E., 2015, J EXPT ED, V50, P29; Slavin RE, 1996, CONTEMP EDUC PSYCHOL, V21, P43, DOI 10.1006/ceps.1996.0004; Sonbul S, 2010, ELT J, V64, P253, DOI 10.1093/elt/ccp059; Teasley S. D., 1997, DISCOURSE TOOLS REAS, P361, DOI [DOI 10.1007/978-3-662-03362-3_16, 10.1007/978-3-662-03362-3_16]; Teng F., 2019, INNOVATION LANGUAGE; Teng F, 2019, AUST EDUC RES, V46, P113, DOI 10.1007/s13384-018-0279-6; Teng F, 2018, INNOV LANG LEARN TEA, V12, P274, DOI 10.1080/17501229.2016.1203328; Teng F, 2019, LANG LEARN J, V47, P145, DOI 10.1080/09571736.2016.1244217; Teng F, 2017, EDUC SCI-THEOR PRACT, V17, P791, DOI 10.12738/estp.2017.3.0167; Teng F, 2016, THINK SKILLS CREAT, V22, P289, DOI 10.1016/j.tsc.2016.06.005; Teng F, 2020, LANG TEACH RES, V24, P785, DOI 10.1177/1362168819829026; Teng F, 2020, LITERACY, V54, P29, DOI 10.1111/lit.12181; Teng F, 2020, SCAND J EDUC RES, V64, P551, DOI 10.1080/00313831.2019.1595712; Teng F, 2019, TESOL QUART, V53, P232, DOI 10.1002/tesq.462; Teng F, 2018, REV ESP LINGUIST APL, V31, P94, DOI 10.1075/resla.15071.ten; Tseng WT, 2006, APPL LINGUIST, V27, P78, DOI 10.1093/applin/ami046; van Keer H, 2015, USING PEER TUTORING; Vygotsky L S., 1978, MIND SOC; Webb S., 2011, RES ANAL VOCABULARY; Wehmeyer ML, 2017, INTERV SCH CLIN, V52, P295, DOI 10.1177/1053451216676800; Wilkinson M., 1994, CLEARING HOUSE, V67, P221; Winne P., 2008, MOTIVATION SELF REGU, P297, DOI DOI 10.4324/9780203831076; Winne P.H., 2017, HDB SELF REGULATION, P52, DOI DOI 10.4324/9781315697048.CH3; Zhang LJ, 2008, BRIT J EDUC PSYCHOL, V78, P245, DOI 10.1348/000709907X218179; Zhao JJ, 2018, SCI STUD READ, V22, P191, DOI 10.1080/10888438.2017.1414219; Zimmerman B., 2000, HDB SELF REGULATION, P13, DOI [DOI 10.1016/B978-012109890-2/50031-7, 10.1016/B978-012109890-2/50031-7]; Zimmerman BJ, 2002, THEOR PRACT, V41, P64, DOI 10.1207/s15430421tip4102_2; Zimmerman BJ., 2009, HDB METACOGNITION ED, P299	73	11	11	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215902	10.1371/journal.pone.0215902	http://dx.doi.org/10.1371/journal.pone.0215902			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116739	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400011
J	Sales-Dias, J; Silva, G; Lamy, M; Ferreira, A; Barbas, A				Sales-Dias, Joana; Silva, Gabriela; Lamy, Marcia; Ferreira, Andreia; Barbas, Ana			The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells	PLOS ONE			English	Article							SIGNALING PATHWAY; UP-REGULATION; HIGH-LEVEL; CYCLIN D2; EXPRESSION; METASTASIS; MIGRATION; SURVIVIN; PROMOTES	Breast cancer (BC) is the most common type of cancer in women and has a high rate of relapse and death. Notch signaling is crucial for normal breast development and homeostasis. Dysregulation of Notch receptors and ligands has been detected in different BC subtypes and shown to be implicated in tumor development, progression, drug resistance, and recurrence. However, the effects of Notch ligands in various types of BC remain poorly understood. In this study, we investigated the effects of the Notch ligand DLL1 in three different human BC cell lines: MCF-7, BT474, and MDA-MB-231. We showed that DLL1 expression is higher in MCF-7 and BT474 than in MDA-MB-231 cells, and that these cells respond differently to DLL1 downregulation. Functional assays in MCF-7 cells demonstrated that siRNA-mediated DLL1 downregulation reduced colony formation efficiency, migration, proliferation, caused cell cycle arrest at the G1 phase, and induced apoptosis. Gene expression studies revealed that these effects in MCF-7 cells were associated with increased expression of the cell cycle arrest p21 gene and decreased expression of genes that promote cell cycle progression (CDK2, SKP2), and survival (BCL2, BIRC5), unravelling possible mechanisms whereby DLL1 downregulation exerts some of its effects. Moreover, our results demonstrate that treatment with recombinant DLL1 increased MCF-7 cell proliferation and migration, confirming that DLL1 contributes to these processes in this BC cell line. DLL1 downregulation reduced the colony formation efficiency of BT474 cells and decreased the migration and invasion abilities of MDA-MB-231 cells but showed no effects in the proliferation and survival of these cells.	[Sales-Dias, Joana; Silva, Gabriela; Lamy, Marcia; Ferreira, Andreia; Barbas, Ana] Inst Biol Expt & Tecnol, Oeiras, Portugal; [Sales-Dias, Joana] Inst Tecnol Quirn & Biol, Oeiras, Portugal; [Barbas, Ana] Bayer Portugal, Carnaxide, Portugal; [Lamy, Marcia] FairJourney Biol, Porto, Portugal; [Ferreira, Andreia] Univ Nova Lisboa, CEDOC, NOVA Med Sch, Fac Ciencias Med, Lisbon, Portugal	Universidade Nova de Lisboa	Silva, G (corresponding author), Inst Biol Expt & Tecnol, Oeiras, Portugal.	gabrielasilva@ibet.pt		Lamy, Marcia/0000-0002-5985-6650; Silva, Gabriela/0000-0002-4004-9904; Sales Dias, Joana/0000-0001-8768-4166; Barbas, Ana/0000-0002-6245-8549; Ferreira, Andreia/0000-0003-0657-354X	"Fundacao para a Ciencia e Tecnologia", Portugal [PTDC/BBB-BMD/4497/2014, PD/BD/113987/2015]; Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia, through national funds [UID/Multi/04462/2019]; FEDER under the PT2020 Partnership Agreement	"Fundacao para a Ciencia e Tecnologia", Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia, through national funds; FEDER under the PT2020 Partnership Agreement	This work was supported by "Fundacao para a Ciencia e Tecnologia", Portugal, grants PTDC/BBB-BMD/4497/2014 (to AB) and PD/BD/113987/2015 (to JSD). iNOVA4Health -UID/Multi/04462/2019, a program financially supported by Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia, through national funds and co-funded by FEDER under the PT2020 Partnership Agreement is acknowledged. Ana Barbas is employed by Bayer Portugal. Bayer Portugal provided support in the form of salary for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Bettaieb A, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1239-z; Bettinsoli P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3340-3; Boidot R, 2008, GENE CHROMOSOME CANC, V47, P299, DOI 10.1002/gcc.20533; Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chakrabarti R, 2018, SCIENCE, P360; Dai XF, 2015, AM J CANCER RES, V5, P2929; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Evron E, 2001, CANCER RES, V61, P2782; Ferreira AC, 2012, HUM MOL GENET, V21, P334, DOI 10.1093/hmg/ddr469; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hinnis AR, 2007, BRIT J CANCER, V96, P639, DOI 10.1038/sj.bjc.6603616; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang YY, 2013, CANCER RES, V73, P7122, DOI 10.1158/0008-5472.CAN-13-1766; JavanMoghadam S, 2016, CELL CYCLE, V15, P1579, DOI 10.1080/15384101.2016.1166327; Knight BB, 2011, ENDOCR-RELAT CANCER, V18, P413, DOI 10.1530/ERC-11-0075; Kontomanolis E, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0945-0; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumari S, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0031-0; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Padar A, 2003, CLIN CANCER RES, V9, P4730; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Phannasil P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129848; Politi K, 2004, SEMIN CANCER BIOL, V14, P341, DOI 10.1016/j.semcancer.2004.04.013; Qiu XM, 2017, ONCOL LETT, V14, P2912, DOI 10.3892/ol.2017.6516; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Silva G, 2016, MOL CARCINOGEN, V55, P525, DOI 10.1002/mc.22299; Wang N, 2017, ONCOTARGET, V8, P109661, DOI 10.18632/oncotarget.22763; Wang ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136246; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Zhang JP, 2014, BRAZ J MED BIOL RES, V47, P299, DOI 10.1590/1414-431X20143368; Zhiwei W., 2012, FRONT ONCOL, V19, P1; 2018, ONCOL LETT, V15, P5368, DOI DOI 10.3892/OL.2018.7989; 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI DOI 10.1016/J.BBRC.2012.10.071; 2015, CELL REP, V12, P1968, DOI DOI 10.1016/J.CELREP.2015.08.050; 2005, CANCER RES, V65, P2353, DOI DOI 10.1158/0008-5472.CAN-04-1890; 2004, MOL CELL BIOL, V24, P8813, DOI DOI 10.1128/MCB.24.20.8813-8822.2004; 2005, J EXP MED, V202, P157, DOI DOI 10.1084/JEM.20050559; 2005, CANCER RES, V65, P8530, DOI DOI 10.1158/0008-5472.CAN-05-1069; J CELL SCI, V113, P4313; 2010, ONCOL REP, V23, P35, DOI DOI 10.3892/OR_00000603; 2017, GENE, V609, P80, DOI DOI 10.1016/J; 2015, ONCOTARGET, V6, P3519, DOI DOI 10.18632/ONCOTARGET.2792; 2012, LEUKEMIA, V26, P1402, DOI DOI 10.1038/LEU.2011.332; 2015, ANTICANCER RES, V35, P3147; 2001, MOL CELL BIOL, V21, P5925, DOI DOI 10.1128/MCB.21.17.5925-5934.2001	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217002	10.1371/journal.pone.0217002	http://dx.doi.org/10.1371/journal.pone.0217002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107884	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200024
J	Ambrosio, L; Neri, A; Fazio, C; Rossolini, GM; Vacca, P; Riccobono, E; Voller, F; Miglietta, A; Stefanelli, P				Ambrosio, Luigina; Neri, Arianna; Fazio, Cecilia; Rossolini, Gian Maria; Vacca, Paola; Riccobono, Eleonora; Voller, Fabio; Miglietta, Alessandro; Stefanelli, Paola			Genomic analysis of Neisseria meningitidis carriage isolates during an outbreak of serogroup C clonal complex 11, Tuscany, Italy	PLOS ONE			English	Article							URETHRITIS; INCREASE; DISEASE; EUROPE	Background In 2015-2016, a cross-sectional carriage survey was performed in Tuscany Region, Italy, during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C clonal complex 11 (MenC:cc11). This study aims to evaluate the genomic profile of meningococcal carriage isolates collected during the survey. Methods Whole-genome sequencing (WGS) was performed using Illumina MiSeq on 85 cultivated meningococcal carriage isolates received at the Dept. of Infectious Disease, National Institute of Health (Istituto Superiore di Sanita, ISS), as National Reference Laboratory (NRL) for Invasive Meningococcal Disease (IMD). De novo assembled genomes were scanned by the BIGSdb platform to assign: the genotypic profiles, the cgMLST, the vaccine antigen variants and allele types of antimicrobial resistance associated genes, together with denitrification pathway loci. Results Capsule null and non-groupable meningococci accounted for 52.9% and 10.6%, respectively. Among the remaining carriage isolates, serogroup B was the predominant (71.0%). Serogroup C meningococci were culture negative and unavailable for WGS. Overall, 64 genotypic profiles were identified and, based on cgMLST, isolates clustered according to clonal complexes. Eight isolates (9.4%) harbored at least one gene encoding a 4CMenB vaccine antigen. Mutated penA alleles were found in more than 82%. Finally, complete aniA and norB coding sequences were detected among 71.8% of carriage isolates. Conclusions Meningococcal carriage isolates collected during the MenC:cc11 outbreak were characterized by an extensive genetic diversity. The lack of outbreak-related isolates among carriage might be attributable to the high transmissibility with low duration of colonization of MenC: cc11 meningococci.	[Ambrosio, Luigina; Neri, Arianna; Fazio, Cecilia; Vacca, Paola; Stefanelli, Paola] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Rossolini, Gian Maria; Riccobono, Eleonora] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Rossolini, Gian Maria] Careggi Univ Hosp, Clin Microbiol & Virol Unit, Florence, Italy; [Voller, Fabio; Miglietta, Alessandro] Reg Hlth Agcy Tuscany, Epidemiol Observ, Florence, Italy; [Miglietta, Alessandro] Cent Tuscany Hlth Author, Unit Epidemiol, Florence, Italy; [Miglietta, Alessandro] Cent Tuscany Hlth Author, Unit Prevent Med, Florence, Italy	Istituto Superiore di Sanita (ISS); University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Stefanelli, P (corresponding author), Ist Super Sanita, Dept Infect Dis, Rome, Italy.	paola.stefanelli@iss.it	NERI, ARIANNA/B-8726-2016; STEFANELLI, PAOLA/B-8729-2016; FAZIO, CECILIA/ABA-8534-2021; Vacca, Paola/I-4796-2018; Ambrosio, Luigina/O-8154-2018	STEFANELLI, PAOLA/0000-0003-1620-4385; Vacca, Paola/0000-0003-3076-1604; Ambrosio, Luigina/0000-0002-9063-3973; Neri, Arianna/0000-0001-5748-880X				Ala'Aldeen DAA, 2011, EMERG INFECT DIS, V17, P1761, DOI 10.3201/eid1709.101762; Aubert L, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.3.21016; Barth KR, 2009, MICROBIOL-SGM, V155, P4093, DOI 10.1099/mic.0.032961-0; Bazan JA, 2016, MMWR-MORBID MORTAL W, V65, P550, DOI 10.15585/mmwr.mm6521a5; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Broker M, 2012, HUM VACC IMMUNOTHER, V8, P685, DOI 10.4161/hv.20098; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; European Centre for Disease Prevention and Control (ECDC), 2012, SURV INV BACT DIS EU; European Centre for Disease Prevention and Control (ECDC), 2014, INV MEN DIS ANN EP R; Fazio C, 2009, EUROSURVEILLANCE, V14, P16; Fazio C, 2015, EUROSURVEILLANCE, V20, DOI DOI 10.2807/1560-7917; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Harcourt BH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv117; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Italian National Health Institute (Istituto Superiore di ISS), DAT SORV MAL BATT IN; Jones CH, 2016, J CLIN MICROBIOL, V54, P25, DOI 10.1128/JCM.01447-15; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Marcus U, 2013, Euro Surveill, V18; Miglietta A., 2018, Eurosurveillance, V23, P1700636; Miglietta A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3598-3; Muzzi A, 2019, VACCINE, V37, P991, DOI 10.1016/j.vaccine.2018.12.061; Neri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139376; Oldfield NJ, 2016, J INFECT DIS, V213, P1777, DOI 10.1093/infdis/jiw008; Patrick DM, 2003, CLIN INFECT DIS, V37, P1183, DOI 10.1086/378743; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Moura ARSS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185038; Stefanelli P, 2016, J INFECTION, V73, P136, DOI 10.1016/j.jinf.2016.05.003; Stefanelli P, 2012, EUROSURVEILLANCE, V17, P8; Stefanelli P, 2016, EUROSURVEILLANCE, V21; Stefanelli P, 2008, IUBMB LIFE, V60, P629, DOI 10.1002/iub.95; Taha MK, 2007, ANTIMICROB AGENTS CH, V51, P2784, DOI 10.1128/AAC.00412-07; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Toh E, 2017, EMERG INFECT DIS, V23, P336, DOI 10.3201/eid2302.161434; Toros B, 2015, J CLIN MICROBIOL, V53, P2154, DOI 10.1128/JCM.03524-14; Tzeng YL, 2017, P NATL ACAD SCI USA, V114, P4237, DOI 10.1073/pnas.1620971114; Vacca P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00207-18; van Ravenhorst MB, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.008; Vogel U, 2004, INT J MED MICROBIOL, V294, P75, DOI 10.1016/j.ijmm.2004.06.027; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217500	10.1371/journal.pone.0217500	http://dx.doi.org/10.1371/journal.pone.0217500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136624	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300046
J	Kerever, S; Jacquens, A; Smail-Faugeron, V; Gayat, E; Resche-Rigon, M				Kerever, Sebastien; Jacquens, Alice; Smail-Faugeron, Violaine; Gayat, Etienne; Resche-Rigon, Matthieu			Methodological management of end-of-life decision data in intensive care studies: A systematic review of 178 randomized control trials published in seven major journals	PLOS ONE			English	Review							CONVENTIONAL GLUCOSE CONTROL; WITHDRAWAL; UNITS; SUPPORT; ICU	Background End-of-life (EOL) decisions are a serious ethical dilemma and are frequently carried out in intensive care units (ICUs). The aim of this systematic review was to investigated the different approaches used in ICUs and reported in randomized controlled trials (RCTs) to address EOL decisions and compare the impact of these different strategies regarding potential bias and mortality estimates. Methods We identified relevant RCTs published in the past 15 years via PubMed, EMBASE, and CINAHL. In addition, we searched The Cochrane Library and checked registries, including ClinicalTrials.gov to assess concordance between declared and published outcomes. Among the journals we screened were the 3 ICU specialty journals and the four general medicine journals with the highest impact factor. Only RCTs were selected in which in-ICU mortality was the primary or secondary outcome. The primary outcome was information regarding EOL decisions, and the secondary outcome was how EOL decisions were treated in the study analysis. Results A total of 178 relevant trials were identified. The details regarding the methodological aspects resulting from EOL decisions were reported in only 62 articles (35%). The manner in which EOL decisions were considered in the study analysis was very heterogeneous, often leading to a high risk of bias. Conclusion There is a heterogeneity regarding the management of data on EOL decisions in randomized control trials with mortality endpoints. Recommendations or rules are required regarding the inclusion of patients with potential EOL decisions in RCT analyses and how to manage such decisions from a methodological point of view.	[Kerever, Sebastien; Gayat, Etienne] Lariboisiere Univ Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Kerever, Sebastien; Resche-Rigon, Matthieu] Sorbonne Paris Cite, Epidemiol & Stat Ctr, INSERM, ECSTRA Team,CRESS,UMR 1153, Paris, France; [Kerever, Sebastien; Gayat, Etienne; Resche-Rigon, Matthieu] Univ Denis Diderot Paris VII, Paris, France; [Jacquens, Alice] Pitie Salpetriere Univ Hosp, AP HP, Dept Neuroanesthesiol & Intens Care, Paris, France; [Jacquens, Alice] UPMC Paris 6 Univ, Sorbonne Univ, Paris, France; [Smail-Faugeron, Violaine] Hop Bretonneau, AP HP, Serv Odontol, Paris, France; [Smail-Faugeron, Violaine] Unite Rech Biomat Innovants & Interface EA4462, Montrouge, France; [Smail-Faugeron, Violaine] Univ Paris 05, Sorbonne Paris Cite, Fac Chirurg Dent, Paris, France; [Gayat, Etienne] INSERM, UMR S 942, Biomarkers CArdioneuroVASc Dis BioCANVAS, Paris, France; [Resche-Rigon, Matthieu] St Louis Univ Hosp, AP HP, Biostat Dept, Paris, France; [Resche-Rigon, Matthieu] St Louis Univ Hosp, AP HP, Med Informat Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Kerever, S (corresponding author), Lariboisiere Univ Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France.; Kerever, S (corresponding author), Sorbonne Paris Cite, Epidemiol & Stat Ctr, INSERM, ECSTRA Team,CRESS,UMR 1153, Paris, France.; Kerever, S (corresponding author), Univ Denis Diderot Paris VII, Paris, France.	sebastien.kerever@univ-paris-diderot.fr	Gayat, Etienne/ABG-5308-2021; Resche-Rigon, Matthieu/ABA-5374-2021; Kerever, Sébastien/S-1620-2019	Kerever, Sébastien/0000-0003-0764-4370	APHP Assistance Publique Hopitaux de Paris; European Science Foundation Research Networking Programme "REFLECTION" [REFLECTION"-09-RNP-049]; AP-HP Assistance Publique Hopitaux de Paris	APHP Assistance Publique Hopitaux de Paris; European Science Foundation Research Networking Programme "REFLECTION"; AP-HP Assistance Publique Hopitaux de Paris	The authors would like to thank the APHP Assistance Publique Hopitaux de Paris for the PhD funding allocated to SK. This research was supported through the author's (SK) involvement in the European Science Foundation Research Networking Programme "REFLECTION"-09-RNP-049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the AP-HP Assistance Publique Hopitaux de Paris for the PhD funding allocated to SK; This research was supported through the author's (SK) involvement in the European Science Foundation Research Networking Programme "REFLECTION"-09-RNP-049. The views expressed in this article are those of the authors and not necessarily those of the European Science Foundation.	Azoulay E, 2003, INTENS CARE MED, V29, P1895, DOI 10.1007/s00134-003-1989-3; Bertrand P, 2013, LIMITATIONS THERAPEU, pS116; Boulard G, 2001, ANN FR ANESTH, V20, P823, DOI 10.1016/S0750-7658(01)00522-6; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Higgins JPT, 2008, COCHRANE HDB SYSTEMA; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hillman K, 2005, LANCET, V365, P2091; Kalfon P, 2014, INTENS CARE MED, V40, P171, DOI 10.1007/s00134-013-3189-0; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; Leonard JM, 2019, INJURY, V50, P1064, DOI 10.1016/j.injury.2019.01.024; Lesieur O, 2018, J CRIT CARE, V47, P21, DOI 10.1016/j.jcrc.2018.05.018; Mehta S, 2008, CRIT CARE MED, V36, P2092, DOI 10.1097/CCM.0b013e31817bff85; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Nesseler N, 2018, EUR J ANAESTH, V35, P511, DOI 10.1097/EJA.0000000000000783; Oksanen T, 2007, INTENS CARE MED, V33, P2093, DOI 10.1007/s00134-007-0876-8; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Pais FM, 2018, RESP CARE, V63, P1060, DOI 10.4187/respcare.06034; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Resche-Rigon M, 2006, CRIT CARE, V10, DOI 10.1186/cc3921; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217134	10.1371/journal.pone.0217134	http://dx.doi.org/10.1371/journal.pone.0217134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136601	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300019
J	van der Lely, S; Liechti, MD; Popp, WL; Schmidhalter, MR; Kessler, TM; Mehnert, U				van der Lely, Stephanie; Liechti, Martina D.; Popp, Werner L.; Schmidhalter, Melanie R.; Kessler, Thomas M.; Mehnert, Ulrich			Does electrical stimulation in the lower urinary tract increase urine production? A randomised comparative proof-of-concept study in healthy volunteers	PLOS ONE			English	Article							NEURAL-CONTROL; RENAL NERVE; BLADDER; STANDARDIZATION; RELEASE; STRESS	Trial design During electrical stimulation in the lower urinary tract for the purpose of current perception threshold and sensory evoked potential recording, we observed that bladder volume increased rapidly. The aim of this prospective randomised comparative proof-of-concept study was to quantify urine production per time during stimulation of the lower urinary tract using different stimulation frequencies. Methods Ninety healthy subjects (18 to 36 years old) were included. Forty females and 50 males were randomly assigned to one of the following study groups: dome, trigone or proximal, membranous (males only) or distal urethra. Starting from 60mL prefilling, stimulation was performed at two separate visits with a 14 French custom-made catheter using randomly applied frequencies of 0.5Hz, 1.1Hz, 1.6Hz (each with 500 stimuli). After each stimulation cycle per frequency, urine production was assessed. Main outcome measures represented urine production during stimulation, daily life and their ratio. Results Lower urinary tract electrical stimulation increased urine production per time compared to bladder diary baseline values. Linear mixed model showed that frequency (p<0.001), stimulation order (p=0.003), intensity (p=0.042), and gender (p=0.047) had a significant influence on urine production. Location, visit and age had no significant influence. Conclusions Urine production is increased during electrical stimulation with a bigger impact of higher frequencies. This might be relevant for methodological aspects in the assessment of lower urinary tract afferent function and for patients with impaired renal urine output. Inhibition of renal sympathetic nerve activity by vagal afferents may be the underlying mechanism.	[van der Lely, Stephanie; Liechti, Martina D.; Schmidhalter, Melanie R.; Kessler, Thomas M.; Mehnert, Ulrich] Univ Zurich, Balgrist Univ Hosp, Dept Neurourol, Zurich, Switzerland; [Popp, Werner L.] Swiss Fed Inst Technol, Rehabil Engn Lab, Zurich, Switzerland; [Popp, Werner L.] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mehnert, U (corresponding author), Univ Zurich, Balgrist Univ Hosp, Dept Neurourol, Zurich, Switzerland.	ulrich.mehnert@balgrist.ch		Liechti, Martina/0000-0002-3024-0975	Swiss National Science Foundation [32003B_149628/1]; Swiss Continence Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Continence Foundation	This work was supported by the Swiss National Science Foundation (research grant #32003B_149628/1 to UM) and the Swiss Continence Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; De Laet K, 2005, NEUROUROL URODYNAM, V24, P261, DOI 10.1002/nau.20095; De Wachter S, 2003, NEUROUROL URODYNAM, V22, P118, DOI 10.1002/nau.10017; EBNER A, 1992, J UROLOGY, V148, P920, DOI 10.1016/S0022-5347(17)36778-2; ELBADAWI A, 1966, AM J ANAT, V119, P405, DOI 10.1002/aja.1001190305; Erglis A., 2013, SAFETY PERFORMANCE U; FAUVEL JP, 1991, AM J HYPERTENS, V4, P955, DOI 10.1093/ajh/4.12.955; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Gaunt RA, 2006, PROG BRAIN RES, V152, P163, DOI 10.1016/S0079-6123(05)52011-9; GOSLING JA, 1974, J ANAT, V117, P133; Gregorini F, 2013, J UROLOGY, V189, P2179, DOI 10.1016/j.juro.2012.11.151; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Johns EJ, 2011, COMPR PHYSIOL, V1, P731, DOI 10.1002/cphy.c100043; Knupfer SC, 2018, NEUROUROL URODYNAM, V37, P2614, DOI 10.1002/nau.23600; Korobka IE, 2017, J APPL BIOTECHNOL BI, V3; Leitner L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163847; MADERSBACHER H, 1982, PARAPLEGIA, V20, P191, DOI 10.1038/sc.1982.36; Mehnert U, 2007, J UROLOGY, V178, P2495, DOI 10.1016/j.juro.2007.08.043; MORGUNOV N, 1985, CAN J PHYSIOL PHARM, V63, P636, DOI 10.1139/y85-106; Mueller E, 2005, J UROLOGY, V173, P490, DOI 10.1097/01.ju.0000149947.28100.cd; Ramaekers D, 1998, EUR HEART J, V19, P1334, DOI 10.1053/euhj.1998.1084; Rydin H, 1938, Q J EXP PHYSIOL, V27, P343, DOI 10.1113/expphysiol.1938.sp000757; Salman IM, 2017, AUTON NEUROSCI-BASIC, V204, P65, DOI 10.1016/j.autneu.2016.10.001; Spradling K, 2015, J UROLOGY, V194, P1661, DOI 10.1016/j.juro.2015.05.077; van der Lely S, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0188-9; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217503	10.1371/journal.pone.0217503	http://dx.doi.org/10.1371/journal.pone.0217503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125385	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000468865700045
J	Thomas, J; Kim, HR; Rahmatallah, Y; Wiggins, G; Yang, QQ; Singh, R; Glazko, G; Mukherjee, A				Thomas, Jacklyn; Kim, Ha Ram; Rahmatallah, Yasir; Wiggins, Grant; Yang, Qinqing; Singh, Raj; Glazko, Galina; Mukherjee, Arijit			RNA-seq reveals differentially expressed genes in rice (Oryza sativa) roots during interactions with plant-growth promoting bacteria, Azospirillum brasilense	PLOS ONE			English	Article							NODULE-LIKE STRUCTURES; TRANSCRIPTION FACTOR; LATERAL ROOT; NITRATE TRANSPORTERS; ACIDIC CHITINASE; AGC KINASES; AUXIN; STRESS; SYMBIOSIS; REQUIRES	Major non-legume crops can form beneficial associations with nitrogen-fixing bacteria like Azospirillum brasilense. Our current understanding of the molecular aspects and signaling that occur between important crops like rice and these nitrogen-fixing bacteria is limited. In this study, we used an experimental system where the bacteria could colonize the plant roots and promote plant growth in wild type rice and symbiotic mutants (dmi3 and pollux) in rice. Our data suggest that plant growth promotion and root penetration is not dependent on these genes. We then used this colonization model to identify regulation of gene expression at two different time points during this interaction: at 1day post inoculation (dpi), we identified 1622 differentially expressed genes (DEGs) in rice roots, and at 14dpi, we identified 1995 DEGs. We performed a comprehensive data mining to classify the DEGs into the categories of transcription factors (TFs), protein kinases (PKs), and transporters (TRs). Several of these DEGs encode proteins that are involved in the flavonoid biosynthetic pathway, defense, and hormone signaling pathways. We identified genes that are involved in nitrate and sugar transport and are also implicated to play a role in other plant-microbe interactions. Overall, findings from this study will serve as an excellent resource to characterize the host genetic pathway controlling the interactions between non-legumes and beneficial bacteria which can have long-term implications towards sustainably improving agriculture.	[Thomas, Jacklyn; Kim, Ha Ram; Wiggins, Grant; Yang, Qinqing; Singh, Raj; Mukherjee, Arijit] Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA; [Rahmatallah, Yasir; Glazko, Galina] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA	University of Central Arkansas; University of Arkansas System; University of Arkansas Medical Sciences	Mukherjee, A (corresponding author), Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA.	amukherjee@uca.edu		Singh, Raj/0000-0003-1764-2344; Rahmatallah, Yasir/0000-0002-8176-6328	Arkansas INBRE program; National Institute of General Medical Sciences, (NIGMS) [P20 GM103429]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER	Arkansas INBRE program; National Institute of General Medical Sciences, (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the Arkansas INBRE program, supported by a grant from the National Institute of General Medical Sciences, (NIGMS), P20 GM103429 from the National Institutes of Health.	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Bensmihen Sandra, 2015, Plants-Basel, V4, P523, DOI 10.3390/plants4030523; Bezrutczyk M, 2018, PLANT J, V93, P675, DOI 10.1111/tpj.13775; Bible AN, 2015, APPL ENVIRON MICROB, V81, P8346, DOI 10.1128/AEM.02782-15; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brusamarello-Santos LCC, 2012, PLANT SOIL, V356, P113, DOI 10.1007/s11104-011-1044-z; Buendia L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01531; Carvalho TLG, 2014, J EXP BOT, V65, P5631, DOI 10.1093/jxb/eru319; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; Chen CY, 2009, PLANT PHYSIOL, V149, P306, DOI 10.1104/pp.108.131540; Chen T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00973; Courty PE, 2015, CRIT REV PLANT SCI, V34, P4, DOI 10.1080/07352689.2014.897897; de Zelicourt A, 2012, PLANT J, V70, P220, DOI 10.1111/j.1365-313X.2011.04859.x; Denance N, 2014, PLANT CELL PHYSIOL, V55, P469, DOI 10.1093/pcp/pct198; Diedhiou I, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2418-7; Ding YL, 2009, PLANT SIGNAL BEHAV, V4, P89, DOI 10.4161/psb.4.2.7693; Drogue B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00607; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Fan XR, 2017, J EXP BOT, V68, P2463, DOI 10.1093/jxb/erx011; Fang ZM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01338; Ferguson BJ, 2014, J CHEM ECOL, V40, P770, DOI 10.1007/s10886-014-0472-7; Fortunato A, 2007, PHYSIOL PLANTARUM, V130, P418, DOI 10.1111/j.1399-3054.2006.00864.x; Garcia AV, 2012, CELL MOL LIFE SCI, V69, P3259, DOI 10.1007/s00018-012-1093-3; Genre A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00096; Gerhardt LBD, 1997, FEBS LETT, V419, P69, DOI 10.1016/S0014-5793(97)01332-X; Goormachtig S, 1998, PLANT CELL, V10, P905, DOI 10.1105/tpc.10.6.905; Gough C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00923; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Hiltenbrand R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01692; Hirt H, 2011, PLANT SIGNAL BEHAV, V6, P1030, DOI 10.4161/psb.6.7.15580; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Huo XY, 2006, J PLANT GROWTH REGUL, V25, P156, DOI 10.1007/s00344-005-0106-y; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kawaharada Y, 2017, MOL PLANT MICROBE IN, V30, P194, DOI 10.1094/MPMI-11-16-0237-R; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kim HB, 2002, MOL PLANT MICROBE IN, V15, P209, DOI 10.1094/MPMI.2002.15.3.209; Liang Y, 2013, SCIENCE, V341, P1384, DOI 10.1126/science.1242736; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Manck-Gotzenberger J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00487; Mathesius U, 2008, FUNCT PLANT BIOL, V35, P651, DOI 10.1071/FP08177; Mitra S, 2016, J EXP BOT, V67, P5869, DOI 10.1093/jxb/erw354; Miyata K, 2014, PLANT CELL PHYSIOL, V55, P1864, DOI 10.1093/pcp/pcu129; Mukherjee A, 2011, ECOLOGICAL ASPECTS OF NITROGEN METABOLISM IN PLANTS, P354; Mukherjee A, 2011, MOL PLANT MICROBE IN, V24, P260, DOI 10.1094/MPMI-06-10-0146; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Park HL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02099; Pellizzaro A, 2017, PLANTA, V246, P585, DOI 10.1007/s00425-017-2724-6; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Pislariu CI, 2007, PLANT PHYSIOL, V144, P682, DOI 10.1104/pp.106.092494; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; Ripodas C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28847; Ryu H, 2012, MOL CELLS, V34, P117, DOI 10.1007/s10059-012-0131-1; SAMAC DA, 1991, PLANT CELL, V3, P1063, DOI 10.1105/tpc.3.10.1063; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Santos P, 2008, PLANT BIOTECHNOL-NAR, V25, P299, DOI 10.5511/plantbiotechnology.25.299; Schnabel E, 2010, PLANT PHYSIOL, V154, P1390, DOI 10.1104/pp.110.164889; Shen CJ, 2015, FRONT PLANT SCI, V6, P1, DOI 10.3389/fpls.2015.00073; Soto MJ, 2009, CELL MICROBIOL, V11, P381, DOI [10.1111/j.1462-5822.2009.01282.x, 10.1111/j.1462-5822.2008.01282.x]; Stahl Y, 2012, PHILOS T R SOC B, V367, P1453, DOI 10.1098/rstb.2011.0235; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Sugiyama A, 2017, PLANT CELL PHYSIOL, V58, P298, DOI 10.1093/pcp/pcw190; Thomas J, 2018, FUNCT INTEGR GENOMIC, V18, P315, DOI 10.1007/s10142-018-0594-z; Toth K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00401; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Venkateshwaran M, 2012, CURRENT OPINION PLAN; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Vinagre F, 2006, J EXP BOT, V57, P559, DOI 10.1093/jxb/erj041; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Webster G, 2002, PLANT CELL ENVIRON, V21, P373; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13624; Yamada M, 2013, CURR OPIN PLANT BIOL, V16, P56, DOI 10.1016/j.pbi.2012.11.004; Yano K, 2017, DNA RES, V24, P193, DOI 10.1093/dnares/dsw052; Zhang XW, 2015, PLANT J, V81, P258, DOI 10.1111/tpj.12723	84	26	26	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217309	10.1371/journal.pone.0217309	http://dx.doi.org/10.1371/journal.pone.0217309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120967	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700087
J	Wang, AH; Song, DZ; He, XQ; Dou, LM; Li, ZL; Zu, ZY; Lou, Q; Zhao, YJ				Wang, Anhu; Song, Dazhao; He, Xueqiu; Dou, Linming; Li, Zhenlei; Zu, Ziyin; Lou, Quan; Zhao, Yingjie			Investigation of coal and gas outburst risk by microseismic monitoring	PLOS ONE			English	Article							HAZARD; INFORMATION; PREDICTION; MINE	In order to improve the monitoring and prediction of coal and gas outburst, this paper proposes a new method for dynamic regional prediction of coal and gas outburst using microseismic (MS) monitoring. The theoretical basis of this method is presented. An index evaluation system was established and applied, based on which field tests were carried out in a coal mine. The results show that seismic monitoring with frequency and energy indexes can obtain good results for mining disturbance intensity monitoring and geological structure detection; the regional stress distribution detected by seismic wave tomography is consistent with the theoretical stress field, making its use of great significance for optimizing coal and gas outburst drilling parameters and improving overall tunneling efficiency. This approach overcomes the limitations of traditional methods in the temporal and spatial dimensions and realizes dynamic and continuous monitoring of coal and gas outburst- prone areas.	[Wang, Anhu; Song, Dazhao; He, Xueqiu; Li, Zhenlei] Univ Sci & Technol Beijing, Lab Educ Minist High Efficient Min & Safety Menta, Beijing, Peoples R China; [Wang, Anhu; Song, Dazhao; He, Xueqiu; Li, Zhenlei; Zhao, Yingjie] Univ Sci & Technol Beijing, Sch Civil & Resources Engn, Beijing, Peoples R China; [He, Xueqiu] Zhong An Acad Safety Engn, Beijing, Peoples R China; [Dou, Linming] China Univ Min & Technol, Sch Mines, Minist Educ China, Key Lab Deep Coal Resource Min, Xuzhou, Jiangsu, Peoples R China; [Zu, Ziyin] Guizhou Panjiang Refined Coal Co Ltd, Panzhou, Peoples R China; [Lou, Quan] China Univ Min & Technol Beijing, Sch Resources & Safety Engn, Beijing, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing; China University of Mining & Technology; Ministry of Education, China; China University of Mining & Technology	Song, DZ (corresponding author), Univ Sci & Technol Beijing, Lab Educ Minist High Efficient Min & Safety Menta, Beijing, Peoples R China.; Song, DZ (corresponding author), Univ Sci & Technol Beijing, Sch Civil & Resources Engn, Beijing, Peoples R China.	song.dz@163.com	Song, Dazhao/ABC-2914-2021	Song, Dazhao/0000-0002-6725-1598; wang, anhu/0000-0002-1950-7835; He, Xueqiu/0000-0003-2760-582X	State Key Research Development Program of China [2016YFC0801408]; National Natural Science Foundation of China [51634001, 51774023]; Fundamental Research Funds for the Central Universities [06500033]; Guizhou panjiang refined coal co., Ltd	State Key Research Development Program of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guizhou panjiang refined coal co., Ltd	This work was financially supported by the State Key Research Development Program of China (Grant No. 2016YFC0801408), the National Natural Science Foundation of China (Grant No. 51634001, 51774023), and the Fundamental Research Funds for the Central Universities (Grant No. 06500033). Guizhou panjiang refined coal co., Ltd provided support in the form of salaries for author ZZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2013, J MINING SAFETY ENG; Cai W, 2014, CHINESE J GEOPHYS-CH, V57, P2687, DOI 10.6038/cjg20140827; Cao YX, 2001, INT J COAL GEOL, V48, P47, DOI 10.1016/S0166-5162(01)00037-4; [窦林名 Dou Linming], 2017, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V36, P803; Farmer IW., 1967, INT J ROCK MECH MIN, V4, P189, DOI [10.1016/0148-9062(67)90043-5, DOI 10.1016/0148-9062(67)90043-5]; Fisne A, 2014, NAT HAZARDS, V74, P1363, DOI 10.1007/s11069-014-1246-9; Friedel MJ, 1997, ENG GEOL, V46, P131, DOI 10.1016/S0013-7952(96)00107-X; FRIEDEL MJ, 1995, J APPL GEOPHYS, V34, P1, DOI 10.1016/0926-9851(95)00007-O; [郭德勇 GUO Deyong], 2007, [北京科技大学学报, Journal of University Science and Technology Beijing], V29, P660; He MC, 2010, INT J ROCK MECH MIN, V47, P286, DOI 10.1016/j.ijrmms.2009.09.003; He XQ, 2012, SAFETY SCI, V50, P728, DOI 10.1016/j.ssci.2011.08.044; Hosseini N, 2012, J CENT SOUTH UNIV, V19, P2297, DOI 10.1007/s11771-012-1275-z; Kraft T, 2013, GEOPHYS J INT, V195, P474, DOI 10.1093/gji/ggt225; Lei WJ, 2014, J MINING SAFETY ENG, DOI [10.13545/j.issn1673-3363.2014.01.026, DOI 10.13545/J.ISSN1673-3363.2014.01.026]; Li D., 2011, MINING SCI TECHNOLOG, V21, P439, DOI DOI 10.1016/J.MSTC.2011.05.010; Lu CP, 2014, NAT HAZARDS, V73, P1715, DOI 10.1007/s11069-014-1167-7; Lu CP, 2012, INT J ROCK MECH MIN, V53, P101, DOI 10.1016/j.ijrmms.2012.05.009; Qiu LM, 2018, J LOSS PREVENT PROC, V54, P206, DOI 10.1016/j.jlp.2018.04.004; SHEPHERD J, 1981, INT J ROCK MECH MIN, V18, P267, DOI 10.1016/0148-9062(81)91192-X; Si GY, 2015, INT J COAL GEOL, V149, P41, DOI 10.1016/j.coal.2015.06.016; Song DZ, 2018, J GEOPHYS ENG, V15, P1093, DOI 10.1088/1742-2140/aaa26d; Song DZ, 2017, GEOMECH ENG, V12, P53, DOI 10.12989/gae.2017.12.1.053; Song DZ, 2016, ROCK MECH ROCK ENG, V49, P291, DOI 10.1007/s00603-015-0738-6; Song WH, 2009, PROCED EARTH PLAN SC, V1, P347, DOI 10.1016/j.proeps.2009.09.055; Tang J, 2016, J NAT GAS SCI ENG, V34, P412, DOI 10.1016/j.jngse.2016.07.010; Wang SG, 2013, ROCK MECH ROCK ENG, V46, P945, DOI 10.1007/s00603-012-0324-0; Wang Y, 1995, SAFETY COAL MINES, P17; Will R, 2014, ENRGY PROCED, V63, P4424, DOI 10.1016/j.egypro.2014.11.478; [谢广祥 Xie Guangxiang], 2014, [煤炭学报, Journal of China Coal Society], V39, P1089; Yang GQ, 2010, SAFETY COAL MINES, V41, P108; [袁亮 Yuan Liang], 2016, [煤炭学报, Journal of China Coal Society], V41, P1; Zhang RL, 2010, INT J COAL GEOL, V84, P141, DOI 10.1016/j.coal.2010.09.004; Zhu Q. J., 2015, CHINESE J ROCK MECH, V34, P3813	33	7	7	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216464	10.1371/journal.pone.0216464	http://dx.doi.org/10.1371/journal.pone.0216464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120907	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700018
J	Andre, LM; van Cruchten, RTP; Willemse, M; Wansink, DG				Andre, Laurene M.; van Cruchten, Remco T. P.; Willemse, Marieke; Wansink, Derick G.			(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY TYPE-1; NUCLEAR FOCI; RNA; PROTEINS; TRANSCRIPTS; AUTOREGULATION; SEQUESTRATION; LOCALIZATION; DISEASE; BRAIN	Myotonic dystrophy type 1 (DM1) is a severe neuromuscular disorder caused by the expression of trinucleotide repeat-containing DMPK transcripts. Abnormally expanded (CUG)n repeats in these transcripts form hairpin-like structures that cause the RNA to accumulate in the cell nucleus by sequestering isoforms of the Muscleblind (MBNL) family, tissue-specific regulators of developmentally programmed, post-transcriptional processes in RNA metabolism. Through this mechanism, the function of MBNL in RNA processing becomes dominantly perturbed, which eventually leads to aberrant alternative splicing and the expression of foetal splice variants of a wide variety of proteins, including the MBNL isoforms themselves. Here, we employ a patient-derived muscle cell model for DM1 to examine in detail the expression of MBNL RNA and protein variants during myogenic differentiation. This DM1 model consists of a panel of isogenic myoblast cell lines that either contain a pathogenic DMPK allele with a congenital mutation of 2600 triplets, or lack this expanded repeat through CRISPR/Cas9-mediated gene editing. We found that the temporal expression levels of MBNL1, MBNL2 and MBNL3 RNAs are not influenced by presence of the (CTG)2600 repeat during myogenesis in vitro. However, throughout myoblast proliferation and differentiation to myotubes a disproportionate inclusion of MBNL1 exon 5 and MBNL2 exons 5 and 8 occurs in cells with the (CTG)2600 repeat. As a consequence, a reduced quantity and imbalanced collection of splice variants of MBNL1 and MBNL2 accumulates in both the cytoplasm and the nucleus of DM1 myoblasts and myotubes. We thus propose that both the quantitative and qualitative changes in the intracellular partitioning of MBNL proteins are a pivotal cause of skeletal muscle problems in DM1, starting already in muscle progenitor cells.	[Andre, Laurene M.; van Cruchten, Remco T. P.; Willemse, Marieke; Wansink, Derick G.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Dept Cell Biol, Nijmegen, Netherlands	Radboud University Nijmegen	Wansink, DG (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Dept Cell Biol, Nijmegen, Netherlands.	rick.wansink@radboudumc.nl	van Cruchten, Remco T.P./P-8120-2015; André, Laurène/Q-4671-2019	van Cruchten, Remco T.P./0000-0002-2918-1488; André, Laurène/0000-0002-6200-7764	ZonMw [NL91212009]	ZonMw(Netherlands Organization for Health Research and Development)	This work was supported by a grant from ZonMw (TOP grant NL91212009; www.zonmw.nl) to Be Wieringa (main applicant) and Derick G. Wansink (co-applicant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botta A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.291; Cardani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083777; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Dastidar S, 2018, NUCLEIC ACIDS RES, V46, P8275, DOI 10.1093/nar/gky548; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Gates DP, 2011, J BIOL CHEM, V286, P34224, DOI 10.1074/jbc.M111.236547; Goodwin M, 2015, CELL REP, V12, P1159, DOI 10.1016/j.celrep.2015.07.029; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kino Y, 2015, HUM MOL GENET, V24, P740, DOI 10.1093/hmg/ddu492; Konieczny P, 2018, RNA BIOL, V15, P1, DOI 10.1080/15476286.2017.1384119; Konieczny P, 2017, NUCLEIC ACIDS RES, V45, P1760, DOI 10.1093/nar/gkw1158; Konieczny P, 2014, NUCLEIC ACIDS RES, V42, P10873, DOI 10.1093/nar/gku767; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; Lee KS, 2007, BIOCHEM BIOPH RES CO, V361, P151, DOI 10.1016/j.bbrc.2007.06.165; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; Nezu Y, 2007, NEUROMUSCULAR DISORD, V17, P306, DOI 10.1016/j.nmd.2007.01.002; Nicolas D, 2017, MOL BIOSYST, V13, P1280, DOI 10.1039/c7mb00154a; Overby SJ, 2018, DRUG DISCOV TODAY, V23, P2013, DOI 10.1016/j.drudis.2018.08.004; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pettersson OJ, 2015, NUCLEIC ACIDS RES, V43, P2433, DOI 10.1093/nar/gkv029; Poulos MG, 2013, HUM MOL GENET, V22, P3547, DOI 10.1093/hmg/ddt209; Provenzano C, 2017, MOL THER-NUCL ACIDS, V9, P337, DOI 10.1016/j.omtn.2017.10.006; Rio Donald C, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5441; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Sicot G, 2013, BBA-MOL BASIS DIS, V1832, P1390, DOI 10.1016/j.bbadis.2013.03.002; Sznajder LJ, 2016, NUCLEIC ACIDS RES, V44, P10326, DOI 10.1093/nar/gkw915; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Thomas JD, 2017, GENE DEV, V31, P1122, DOI 10.1101/gad.300590.117; Tran H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194928; van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang ET, 2018, HUM MOL GENET, P1; Wang PY, 2018, CELL REP, V22, P2294, DOI 10.1016/j.celrep.2018.02.025; Yum K, 2017, CURR OPIN GENET DEV, V44, P30, DOI 10.1016/j.gde.2017.01.007	46	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217317	10.1371/journal.pone.0217317	http://dx.doi.org/10.1371/journal.pone.0217317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116797	Green Published, gold			2022-12-27	WOS:000468607400058
J	Brough, T; Rayment, W; Dawson, S				Brough, Tom; Rayment, William; Dawson, Steve			Using a recreational grade echosounder to quantify the potential prey field of coastal predators	PLOS ONE			English	Article							PENGUIN EUDYPTULA-MINOR; PELAGIC FISH SCHOOLS; SPATIAL-DISTRIBUTION; SPECIES IDENTIFICATION; SPRATTUS-ANTIPODUM; ACOUSTIC SURVEYS; PHILLIP-ISLAND; DOLPHIN; POPULATION; SEABIRDS	Quantifying the distribution of prey greatly improves models of habitat use by marine predators and can assist in determining threats to both predators and prey. Small epipelagic fishes are important prey for many predators yet their distribution is difficult to quantify due to extreme patchiness. This study explores the use of recreational grade echosounders (RGE) to quantify school characteristics of epipelagic fish and link their distribution to that of their predators at Banks Peninsula, New Zealand. The hydro-acoustic system was groundtruthed with 259 schools of epipelagic fish. During 2015 and 2016, 136 hydro-acoustic surveys were conducted with concurrent observations of Hector's dolphin (Cephalorhynchus hectori) and little penguins (Eudyptula minor). The relative abundance of the two predator species during surveys was modelled according to the relative abundance of potential prey using generalised additive mixed models. Schools of epipelagic fish were readily detected by the RGE system and were more abundant in summer compared to winter. The models performed well, explaining 43% and 37% of the deviance in relative abundances of dolphins and penguins respectively. This is the first study to link the distribution of Hector's dolphin to that of their epipelagic prey and confirms the utility of RGE in studies of habitat use in marine predators. Limitations associated with a lack of formal acoustic calibration and data formatting can be overcome and would make RGE valuable, inexpensive tools for investigating variability in populations of small pelagic fishes.	[Brough, Tom; Rayment, William; Dawson, Steve] Univ Otago, Dept Marine Sci, Dunedin, New Zealand	University of Otago	Brough, T (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	tom.broughnz@gmail.com		Brough, Tom/0000-0003-1835-0490	NZ Whale and Dolphin Trust; University of Otago	NZ Whale and Dolphin Trust; University of Otago	This study was supported by funding from the NZ Whale and Dolphin Trust. TB was funded by a University of Otago Doctoral scholarship and publishing bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142628; Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Baker CS, 2013, NZ THREAT CLASSIF SE, V14, P18; Bedford M, 2015, MAR ECOL PROG SER, V526, P169, DOI 10.3354/meps11203; Benoit-Bird KJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2457; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Brough T, 2019, MAR MAMMAL SCI, V35, P140, DOI 10.1111/mms.12528; Cannell BL, 2012, MAR FRESHWATER RES, V63, P914, DOI 10.1071/MF12139; Certain G, 2011, MAR ECOL PROG SER, V422, P23, DOI 10.3354/meps08932; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Clausen AP, 2002, AQUAT CONSERV, V12, P51, DOI 10.1002/aqc.476; Coetzee J, 2000, AQUAT LIVING RESOUR, V13, P1, DOI 10.1016/S0990-7440(00)00139-X; Collins M, 1999, WILDLIFE RES, V26, P705, DOI 10.1071/WR98003; COLMAN JA, 1979, NEW ZEAL J MAR FRESH, V13, P263, DOI 10.1080/00288330.1979.9515801; CRAWFORD RJM, 1978, BIOL CONSERV, V14, P85, DOI 10.1016/0006-3207(78)90026-5; Cullen JM, 1991, AUSTRAL ORNITHOL, V91, P235; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; D'Elia M, 2009, MAR ECOL-EVOL PERSP, V30, P151, DOI 10.1111/j.1439-0485.2009.00328.x; DANN P, 1992, EMU, V91, P263, DOI 10.1071/MU9910263; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; Dawson S.M., 1988, REPORTS INT WHALING, P315; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; De Robertis A, 2007, ICES J MAR SCI, V64, P1282, DOI 10.1093/icesjms/fsm112; Diner N, 2001, AQUAT LIVING RESOUR, V14, P211, DOI 10.1016/S0990-7440(01)01121-4; Drexler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064458; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Fauchald P, 2002, MAR ECOL PROG SER, V231, P279, DOI 10.3354/meps231279; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Flemming SA, 2013, NEW ZEAL J ECOL, V37, P199; FLETCHER WJ, 1992, AUST J MAR FRESH RES, V43, P1437; Foote K.G., 1987, ICES COOPERATIVE RES, V144, P1, DOI DOI 10.1121/1.396131; Francis MP, 2013, COASTAL FISHES NZ; Fraser Maree M., 2004, Notornis, V51, P7; Freon P, 1993, AQUAT LIVING RESOUR, V6, P221, DOI 10.1051/alr:1993023; Gende SM, 2006, DEEP-SEA RES PT II, V53, P432, DOI 10.1016/j.dsr2.2006.01.005; Godo OR, 2014, ICES J MAR SCI, V71, P2357, DOI 10.1093/icesjms/fsu116; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Griffiths SP, 2013, REV FISH BIOL FISHER, V23, P459, DOI 10.1007/s11160-012-9301-7; Gruss A, 2016, AFR J MAR SCI, V38, P395, DOI 10.2989/1814232X.2016.1218367; Hazen EL, 2013, MAR ECOL PROG SER, V487, P177, DOI 10.3354/meps10477; Hazen EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019269; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; Hoskins AJ, 2008, MAR ECOL PROG SER, V366, P293, DOI 10.3354/meps07507; Jacobson LD, 2001, CAN J FISH AQUAT SCI, V58, P1891, DOI 10.1139/cjfas-58-9-1891; Korneliussen RJ, 2009, ICES J MAR SCI, V66, P1111, DOI 10.1093/icesjms/fsp119; Lawson GL, 1999, ICES J MAR SCI, V56, P370, DOI 10.1006/jmsc.1999.0476; Lawson GL, 2001, ICES J MAR SCI, V58, P275, DOI 10.1006/jmsc.2000.1009; Lotz Josef, 2007, Oceans 2007, P1, DOI 10.1109/OCEANS.2007.4449220; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; McInnes AM, 2017, MAR ECOL PROG SER, V569, P187, DOI 10.3354/meps12089; McInnes AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140936; Miller E., 2015, THESIS U OTAGO NZ; Miller E, 2013, MAR MAMMAL SCI, V29, P606, DOI 10.1111/j.1748-7692.2012.00594.x; Montero-Serra I, 2015, GLOBAL CHANGE BIOL, V21, P144, DOI 10.1111/gcb.12747; Neira FJ, 1999, MAR FRESHWATER RES, V50, P43, DOI 10.1071/MF98067; Nottestad L, 2014, MAR ECOL PROG SER, V499, P275, DOI 10.3354/meps10638; O'Driscoll RL, 1998, NEW ZEAL J MAR FRESH, V32, P203, DOI 10.1080/00288330.1998.9516820; O'Driscoll RL, 1998, DEEP-SEA RES PT II, V45, P1295, DOI 10.1016/S0967-0645(98)00035-6; Parnum IM, 2017, P AC 2017; Paul L.J., 2001, PILCHARD SARDINOPS N; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Rayment W, 2010, AQUAT CONSERV, V20, P106, DOI 10.1002/aqc.1049; Redfern JV, 2008, MAR ECOL PROG SER, V363, P1, DOI 10.3354/meps07495; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Riccialdelli L, 2013, POLAR BIOL, V36, P617, DOI 10.1007/s00300-013-1289-5; Robertson S, 2016, PHYS PLASMAS, V23, DOI 10.1063/1.4947560; Scalabrin C, 1996, ICES J MAR SCI, V53, P181, DOI 10.1006/jmsc.1996.0020; Shears NT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14944-2; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Thompson K.R., 1993, Marine Ornithology, V21, P57; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; WHITEHEAD PJP, 1985, NEW ZEAL J MAR FRESH, V19, P261, DOI 10.1080/00288330.1985.9516093; Wood S., 2017, PACKAGE MGCV, P17; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	78	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217013	10.1371/journal.pone.0217013	http://dx.doi.org/10.1371/journal.pone.0217013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116761	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400035
J	Park, KR; Yun, JS; Park, MH; Jung, YY; Yeo, IJ; Nam, KT; Kim, HD; Song, JK; Choi, DY; Park, PH; Han, SB; Yun, HM; Hong, JT				Park, Kyung-Ran; Yun, Jae Suk; Park, Mi Hee; Jung, Yu Yeon; Yeo, In Jun; Nam, Kyung Tak; Kim, Hae Deun; Song, Ju Kyoung; Choi, Dong-Young; Park, Pil-Hoon; Han, Sang-Bae; Yun, Hyung-Mun; Hong, Jin Tae			Loss of parkin reduces lung tumor development by blocking p21 degradation	PLOS ONE			English	Article							CELL-CYCLE; UBIQUITIN-LIGASE; CANCER; P21(CIP1); INHIBITION; P27(KIP1); SUBUNIT; DISEASE; BINDING; ARREST	Several epidemiological studies have demonstrated the reciprocal relationship between the development of cancer and Parkinson's disease (PD). However, the possible mechanisms underlying this relationship remain unclear. To identify this relationship, we first compared lung tumor growth in parkin knockout (KO) mice and wild-type (WT) mice. Parkin KO mice showed decreased lung tumor growth and increased expression of p21, a cell cycle arrester, as compared with WT mice. We also found that parkin interacts with p21, resulting in its degradation; however, parkin KO, knockdown, as well as mutation (R275W or G430D) reduced the degradation of p21. We investigated whether parkin KO increases the association of p21 with proliferating cell nuclear antigen (PCNA) or CDK2 by reducing p21 degradation, and, thus, arresting the cell cycle. The interaction between p21 and PCNA or CDK2 was also enhanced by parkin knockdown, and this increased interaction induced sub G0/G1 arrest, leading to cell death. Therefore, our data indicate that parkin KO reduces the development of lung tumors via cell cycle arrest by blocking the degradation of p21. These findings suggest that PD could be associated with lower lung cancer incidence.	[Park, Kyung-Ran; Yun, Hyung-Mun] Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea; [Yun, Jae Suk; Park, Mi Hee; Jung, Yu Yeon; Yeo, In Jun; Nam, Kyung Tak; Kim, Hae Deun; Song, Ju Kyoung; Han, Sang-Bae; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Yun, Jae Suk; Park, Mi Hee; Jung, Yu Yeon; Yeo, In Jun; Nam, Kyung Tak; Kim, Hae Deun; Song, Ju Kyoung; Han, Sang-Bae; Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Cheongju, Chungbuk, South Korea; [Choi, Dong-Young; Park, Pil-Hoon] Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea	Kyung Hee University; Chungbuk National University; Chungbuk National University; Yeungnam University	Yun, HM (corresponding author), Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea.; Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea.; Hong, JT (corresponding author), Chungbuk Natl Univ, Med Res Ctr, Cheongju, Chungbuk, South Korea.	yunhm@khu.ac.kr; jinthong@chungbuk.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2017R1A5A2015541]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) No. MRC, 2017R1A5A2015541.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adnane J, 2000, ONCOGENE, V19, P5338, DOI 10.1038/sj.onc.1203956; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Devine MJ, 2011, NAT REV CANCER, V11, P812, DOI 10.1038/nrc3150; Esposito V, 2004, J CLIN PATHOL, V57, P58, DOI 10.1136/jcp.57.1.58; Feng DD, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0043-z; Flak MB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-175; Fukae J, 2009, FEBS LETT, V583, P521, DOI 10.1016/j.febslet.2008.12.055; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gartel AL, 2002, MOL CANCER THER, V1, P639; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Huynh DP, 2007, EXP NEUROL, V203, P531, DOI 10.1016/j.expneurol.2006.09.009; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; JANSSON B, 1985, ANN NEUROL, V17, P505, DOI 10.1002/ana.410170514; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Kim DH, 2015, ARTHRITIS RHEUMATOL, V67, P3058, DOI 10.1002/art.39284; Lin PY, 2015, JAMA ONCOL, V1, P633, DOI 10.1001/jamaoncol.2015.1752; Liu QX, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0646-y; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Park MH, 2017, THERANOSTICS, V7, P2033, DOI 10.7150/thno.19824; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Rawal N, 2009, BIOCHEM BIOPH RES CO, V388, P473, DOI 10.1016/j.bbrc.2009.07.014; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217037	10.1371/journal.pone.0217037	http://dx.doi.org/10.1371/journal.pone.0217037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112565	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000034
J	Zapletal, J; Gupta, H; Erraguntla, M; Adelman, ZN; Myles, KM; Lawley, MA				Zapletal, Josef; Gupta, Himanshu; Erraguntla, Madhav; Adelman, Zach N.; Myles, Kevin M.; Lawley, Mark A.			Predicting aquatic development and mortality rates of Aedes aegypti	PLOS ONE			English	Article							TEMPERATURE-FLUCTUATIONS; ANOPHELES-GAMBIAE; LARVAL DENSITY; DIPTERA; ALBOPICTUS; MOSQUITO; VIRUS; POPULATION; CULICIDAE; VECTOR	Mosquito-borne pathogens continue to be a significant burden within human populations, with Aedes aegypti continuing to spread dengue, chikungunya, and Zika virus throughout the world. Using data from a previously conducted study, a linear regression model was constructed to predict the aquatic development rates based on the average temperature, temperature fluctuation range, and larval density. Additional experiments were conducted with different parameters of average temperature and larval density to validate the model. Using a paired t-test, the model predictions were compared to experimental data and showed that the prediction models were not significantly different for average pupation rate, adult emergence rate, and juvenile mortality rate. The models developed will be useful for modeling and estimating the upper limit of the number of Aedes aegypti in the environment under different temperature, diurnal temperature variations, and larval densities.	[Zapletal, Josef; Gupta, Himanshu; Erraguntla, Madhav; Lawley, Mark A.] Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA; [Adelman, Zach N.; Myles, Kevin M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Zapletal, J (corresponding author), Texas A&M Univ, Dept Ind & Syst Engn, College Stn, TX 77843 USA.	jozinzapletal@tamu.edu			NCEZID CDC HHS [U01 CK000512] Funding Source: Medline	NCEZID CDC HHS		BAKER F. C., 1935, CANADIAN ENL, V67, P149; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021; Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036; Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45; HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389; Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634; HOLZAPFEL CM, 1981, CAN J ZOOL, V59, P1014, DOI 10.1139/z81-141; Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009; LOVE GJ, 1955, ECOLOGY, V36, P340, DOI 10.2307/1933243; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; MORI A, 1979, Tropical Medicine, V21, P85; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Pincebourde S, 2016, INTEGR COMP BIOL, V56, P45, DOI 10.1093/icb/icw016; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177; Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Wada Y, 1965, QUAEST ENTOMOL, P1; Woods HA, 2015, J THERM BIOL, V54, P86, DOI 10.1016/j.jtherbio.2014.10.002; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040; Zapletal J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194025; 1996, ECOL ENTOMOL, V21, P117	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217199	10.1371/journal.pone.0217199	http://dx.doi.org/10.1371/journal.pone.0217199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112566	gold, Green Published, Green Submitted			2022-12-27	WOS:000468451000041
J	Wang, XN; Dong, YL; Zhang, YY; Li, TZ; Xie, ZC				Wang, Xiaoning; Dong, Yuanlin; Zhang, Yiying; Li, Tianzuo; Xie, Zhongcong			Sevoflurane induces cognitive impairment in young mice via autophagy	PLOS ONE			English	Article							DEVELOPING BRAIN; APOPTOSIS; NEUROTOXICITY; ANESTHESIA; RAT; ISOFLURANE; EXPOSURE; ERYTHROPOIETIN; ABNORMALITIES; HIPPOCAMPUS	Background Anesthesia may induce neurotoxicity and neurocognitive impairment in young mice. However, the underlying mechanism remains largely to be determined. Meanwhile, autophagy is involved in brain development and contributes to neurodegenerative diseases. We, therefore, set out to determine the effects of sevoflurane on autophagy in the hippocampus of young mice and on cognitive function in the mice. Methods Six day-old mice received 3% sevoflurane, for two hours daily, on postnatal days (P) 6, 7 and 8. We then decapitated the mice and harvested the hippocampus of the young mice at P8. The level of LC3, the ratio of LC3-II to LC3-I, and SQSTM1/p62 level associated with the autophagy in the hippocampus of the mice were assessed by using Western blotting. We used different groups of mice for behavioral testing via the Morris Water Maze from P31 to P37. Results The anesthetic sevoflurane increased the level of LC3-II and ratio of LC3-II/LC3-I, decreased the p62 level in the hippocampus of the young mice, and induced cognitive impairment in the mice. 3-Methyladenine, the inhibitor of autophagy, attenuated the activation of autophagy and ameliorated the cognitive impairment induced by sevoflurane in the young mice. Conclusion These data showed that sevoflurane anesthesia might induce cognitive impairment in the young mice via activation of autophagy in the hippocampus of the young mice. These findings from the proof of concept studies have established a system and suggest the role of autophagy in anesthesia neurotoxicity and cognitive impairment in the young mice, pending further investigation.	[Wang, Xiaoning; Li, Tianzuo] Capital Med Univ, Beijing Shijitan Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Wang, Xiaoning; Dong, Yuanlin; Zhang, Yiying; Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA; [Wang, Xiaoning; Dong, Yuanlin; Zhang, Yiying; Xie, Zhongcong] Harvard Med Sch, Charlestown, MA 02129 USA	Capital Medical University; Harvard University; Massachusetts General Hospital	Xie, ZC (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA.; Xie, ZC (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	zxie@mgh.harvard.edu		wang, xiaoning/0000-0001-8175-766X; Dong, Yuanlin/0000-0002-4760-0519	National Institutes of Health, Bethesda, Maryland [R01HD086977]; National Natural Science Foundation, Beijing, People's Republic of China [81571037]	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation, Beijing, People's Republic of China	This research was supported by grant R01HD086977 from the National Institutes of Health, Bethesda, Maryland (to Dr. Zhongcong Xie) and was partially supported by grant No. 81571037 (to Dr. Tianzuo Li) from the National Natural Science Foundation, Beijing, People's Republic of China. URL of each funder website: https://grants.nih.gov/funding/searchguide/index.html#/, https://isisn. nsfc. gov. cn/egrantindex/funcindex/prjsearchlist.; This research was supported by grant R01HD086977 from the National Institutes of Health, Bethesda, Maryland (to Dr. Zhongcong Xie) and was partially supported by grant No. 81571037 (to Dr. Tianzuo Li) from the National Natural Science Foundation, Beijing, People's Republic of China. The anesthetic sevoflurane was generously provided by the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.	Amrock LG, 2015, ANESTHESIOLOGY, V122, P87, DOI 10.1097/ALN.0000000000000477; Andropoulos DB, 2018, FETAL DIAGN THER, V43, P1, DOI 10.1159/000475928; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Booth LA, 2014, CELL SIGNAL, V26, P549, DOI 10.1016/j.cellsig.2013.11.028; Budini M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00170; Bussi C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43153; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057870; Cheng AB, 2019, EUR J PHARMACOL, V849, P84, DOI 10.1016/j.ejphar.2019.01.051; Chittaranjan Suganthi, 2015, Cold Spring Harb Protoc, V2015, P743, DOI 10.1101/pdb.prot086256; Cui YS, 2018, TOXICOL LETT, V297, P24, DOI 10.1016/j.toxlet.2018.08.020; DeFrances Carol J, 2007, Vital Health Stat 13, P1; Ghatge S, 2003, ACTA ANAESTH SCAND, V47, P917, DOI 10.1034/j.1399-6576.2003.00196.x; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Huang R, 2015, AUTOPHAGY, V11, P852, DOI 10.1080/15548627.2015.1038016; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Ji MH, 2015, NEUROTOXICOLOGY, V46, P155, DOI 10.1016/j.neuro.2014.11.003; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Ko GJ, 2016, HUM EXP TOXICOL, V35, P724, DOI 10.1177/0960327115604198; Komita M, 2013, ANESTH ANALG, V117, P1197, DOI 10.1213/ANE.0b013e3182a74773; Kvolik S, 2009, ACTA ANAESTH SCAND, V53, P1192, DOI 10.1111/j.1399-6576.2009.02036.x; Li YZ, 2017, AUTOPHAGY, V13, P1145, DOI 10.1080/15548627.2017.1320467; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Liao ZX, 2014, BRAIN RES BULL, V107, P69, DOI 10.1016/j.brainresbull.2014.07.001; Liu WW, 2017, BRIT J CANCER, V117, P1139, DOI 10.1038/bjc.2017.293; Liu YF, 2017, NEUROSCI LETT, V651, P21, DOI 10.1016/j.neulet.2017.04.040; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Pellegrini L, 2014, PEDIATR ANESTH, V24, P749, DOI 10.1111/pan.12372; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Qiu L, 2016, TOXICOL SCI, V149, P121, DOI 10.1093/toxsci/kfv219; Ramage TM, 2013, BRIT J ANAESTH, V110, P39, DOI 10.1093/bja/aet103; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ren GY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11607-0; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Sun W, 2017, ENVIRON TOXICOL PHAR, V50, P151, DOI 10.1016/j.etap.2017.02.006; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tao G, 2016, BIOMED RES INT BIOME, V2016, P2016, DOI DOI 10.1155/2016/7919640; Tao GR, 2014, ANESTHESIOLOGY, V121, P510, DOI 10.1097/ALN.0000000000000278; Valente MJ, 2017, ARCH TOXICOL, V91, P3663, DOI 10.1007/s00204-017-1984-z; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Xie SN, 2017, J NEUROSCI RES, V95, P2367, DOI 10.1002/jnr.24118; Xie ZC, 2005, J MOL NEUROSCI, V25, P67, DOI 10.1385/JMN:25:1:067; Xu G, 2017, BRIT J ANAESTH, V119, P481, DOI 10.1093/bja/aex071; Yamamoto A, 2014, ANNU REV NEUROSCI, V37, P55, DOI 10.1146/annurev-neuro-071013-014149; Yang MR, 2017, NEUROTOXICOL TERATOL, V60, P59, DOI 10.1016/j.ntt.2016.11.004; Zhang DX, 2017, BIOMED PHARMACOTHER, V87, P332, DOI 10.1016/j.biopha.2016.12.115; Zhang J, 2015, MOL NEUROBIOL, V51, P853, DOI 10.1007/s12035-014-8746-1; Zhang L, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-5; Zhang XE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155490; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; 2015, J CLIN INVEST, V125, P33, DOI DOI 10.1172/JCI73940; 2017, NEUROTOX RES, V31, P218, DOI DOI 10.1007/S12640-016-9671-Z; 2014, ANESTHESIOLOGY, V120, P626, DOI DOI 10.1097/ALN.0000000000000037	55	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216372	10.1371/journal.pone.0216372	http://dx.doi.org/10.1371/journal.pone.0216372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107909	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200008
J	Tefera, GM; Feyisa, BB; Kebede, TM				Tefera, Gosaye Mekonen; Feyisa, Beshadu Bedada; Kebede, Tsegaye Melaku			Antimicrobial use-related problems and their costs in surgery ward of Jimma University Medical Center: Prospective observational study	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; ANTIBIOTIC-PROPHYLAXIS; GUIDELINES; UPDATE	Introduction Antibiotics are among the most commonly misused of all drugs, which results in antibiotic resistance and waste of resources and it has not been studied in Ethiopia. Therefore, this study was carried out to assess antibiotic use-related problems and their costs among patients hospitalized at the surgical ward of Jimma University Medical Center. Methods Hospital-based prospective observational study was used to assess the prevalence, cost, and determinants of antibiotic use-related problems; multiple stepwise backward logistic regression analysis was done for a P value of <0.25 to look for predictors of antibiotic use-related problems. Written informed consent was obtained and confidentiality was secured. Results Among 300 participants, antibiotic use-related problems (ABURPs) were found in 69.3% of the study participants. The direct total cost attributed to these problems was approximated to a minimum of 2230.15 US$. Independent predictors for antibiotic use-related problems were: indication for antibiotic use like: use of antibiotic for prophylaxis; p < 0.0001, antibiotic use for both therapeutic & prophylaxis; p < 0.0001, CDC wound class I and II; p = 0.016 and; p = 0.002 respectively, overall poly-pharmacy and greater than 2 antibiotic exposure during hospital stay; p = 0.019and p = 0.006 respectively and hospital stay for >= 21 days; p = 0.007. Conclusion The prevalence of antibiotic use-related problems was high and resulted in extra cost. Antibiotic use for prophylaxis, prophylaxis, and treatment, poly-pharmacy, greater than 2 antibiotic exposures during the hospital stay, CDC wound class I and II, and duration of hospital stay of >= 21 days was found to be independent predictors of antibiotic use-related problems.	[Tefera, Gosaye Mekonen] Ambo Univ, Clin Pharm Course Unit, Dept Pharm, Ambo, Ethiopia; [Feyisa, Beshadu Bedada] Ambo Univ, Dept Publ Hlth, Nutr Course Unit, Ambo, Ethiopia; [Kebede, Tsegaye Melaku] Jimma Univ, Sch Pharm, Dept Clin Pharm, Jimma, Ethiopia	Ambo University; Ambo University; Jimma University	Tefera, GM (corresponding author), Ambo Univ, Clin Pharm Course Unit, Dept Pharm, Ambo, Ethiopia.	Gosi2010pharma@gmail.com	Melaku, Tsegaye/AAD-6981-2021; Mekonen, Gosaye/AAU-8435-2020	Melaku, Tsegaye/0000-0001-8373-5309; Mekonen, Gosaye/0000-0002-7534-2828	Jimma University	Jimma University	Gosaye Mekonen recieved funding for this study from Jimma University (www.ju.edu.et) as a research for post-graduate study. The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrha S., 2015, GLOB J MED RES B, V15, P1; Alemu T, 2009, LIT REV INFECT DIS A, P37; [Anonymous], 2015, REC FDA ANT APPR GOO; [Anonymous], 2014, OPEN SURG J, V8, P1; [Anonymous], 2014, WHO URG COUNTR TAK M; [Anonymous], 2016, GLOBAL GUIDELINES PR; [Anonymous], 2016, 1 NEW ANTIBIOTIC IN; Baiden F, 2010, LANCET, V375, P637, DOI 10.1016/S0140-6736(10)60265-6; Beique Lizanne, 2015, Can J Hosp Pharm, V68, P318; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Burke JP, 2001, CLIN INFECT DIS, V33, pS78, DOI 10.1086/321861; Calbo Esther, 2013, Enferm Infecc Microbiol Clin, V31 Suppl 4, P12, DOI 10.1016/S0213-005X(13)70127-7; Carneiro M, 2011, REV ASSOC MED BRAS, V57, P421, DOI 10.1590/S0104-42302011000400016; Centers for Disease Control and Prevention US Department of Health and Human Services, 2013, ANTIBIOTIC RESISTANC; Cipolle R, 2006, GOOGLE PATENTS; Fehr J, 2006, CLIN MICROBIOL INFEC, V12, P1224, DOI 10.1111/j.1469-0691.2006.01551.x; FSe, 2006, ARCH SURG-CHICAGO, V141, P109; Godebo G, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-17; Golembiewski J, 2014, J PERIANESTH NURS, V29, P155, DOI 10.1016/j.jopan.2014.01.001; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Heddini A, 2009, LANCET, V373, P30, DOI 10.1016/S0140-6736(08)61956-X; Howe LM, 2006, VET CLIN N AM-SMALL, V36, P1049, DOI 10.1016/j.cvsm.2006.05.001; Lim MK, 2015, J INFECT DEV COUNTR, V9, P1264, DOI 10.3855/jidc.6731; Ogbonna B, 2014, INT J ADV INNOV RES, V3, P494; Pollack LA, 2014, CLIN INFECT DIS, V59, pS97, DOI 10.1093/cid/ciu542; Rehan HS, 2009, INT J INFECT CONTROL, V6; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Sahile T, 2016, INT J TROP DIS HLTH, V17, P1, DOI DOI 10.9734/IJTDH/2016/27253; Shrayteh ZM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-717; Sileshi A, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0057-x; Tigabu BM, 2013, FACTORS ASS UNNECESS; Tseng SH, 2011, J MICROBIOL IMMUNOL, V44, P157, DOI 10.1016/j.jmii.2011.03.001; Vessal C., 2011, Eastern Mediterranean Health Journal, V17, P663; Yadesa TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138385; Yang Z., 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.011598925551561, DOI 10.1371/JOURNAL.PONE.011598925551561, DOI 10.1371/J0URNAL.P0NE.0115989]; Young B, 2011, ANTIMICROB AGENTS CH, V55, P4659, DOI 10.1128/AAC.00562-11; Zhang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088971	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216770	10.1371/journal.pone.0216770	http://dx.doi.org/10.1371/journal.pone.0216770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100088	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600015
J	Yuan, JZ; Hasdemirm, B; Tan, TY; Chheda, C; Rivier, J; Pandol, SJ; Bhargava, A				Yuan, Jingzhen; Hasdemirm, Burcu; Tan, Tanya; Chheda, Chintan; Rivier, Jean; Pandol, Stephen J.; Bhargava, Aditi			Protective effects of urocortin 2 against caerulein-induced acute pancreatitis	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; KAPPA-B ACTIVATION; UROTENSIN-I; RECEPTORS; SECRETION; CHOLECYSTOKININ; CYTOSKELETON; INFLAMMATION; RESPONSES; PEPTIDE	Because little is known about the role of corticotropin-releasing factor (CRF) agonists in regulating responses in pancreatitis, we evaluated the effects of urocortin 2 (UCN2) and stressin1 in caerulein-induced acute pancreatitis (AP) model in rats. Male rats were pretreated with UCN2 or stressin1 for 30 min followed by induction of AP with supraphysiologic doses of caerulein. Serum amylase and lipase activity, pancreatic tissue necrosis, immune cell infiltrate, nuclear factor (NF)-kappa B activity, trypsin levels, and intracellular Ca2+ ([Ca2+](i)) were ascertained. UCN2, but not stressin1 attenuated the severity of AP in rats. UCN2, but not stressin1, reduced serum amylase and lipase activity, cell necrosis and inflammatory cell infiltration in AP. NF-kappa B activity in pancreatic nuclear extracts increased in AP and UCN2 treatment reduced caerulein-induced increases in NF-kappa B activity by 42%. UCN2 treatment prevented caerulein-induced degradation of I kappa B-alpha in the cytosolic fraction as well as increased levels of p65 subunit of NF-kappa B in the cytosolic fraction. Pancreatic UCN2 levels decreased in AP compared with saline. UCN2 evoked [Ca2+](i) responses in primary acinar cells and abolished caerulein-evoked [Ca2+](i) responses at 0.1nM, and decreased by similar to 50% at 1.0nM caerulein. UCN2 stimulation resulted in redistribution of a portion of F-actin from the apical to the basolateral pole. UCN2 prevented the massive redistribution of F-actin observed with supraphysiologic doses of caerulein. UCN2, but not stressin1 attenuated severity of an experimental pancreatitis model. The protective effects of UCN2, including anti-inflammatory and anti-necrotic effects involve activation of the CRF2 receptor, [Ca2+](i) signaling, and inhibition of NF-kappa B activity.	[Yuan, Jingzhen; Chheda, Chintan; Pandol, Stephen J.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Yuan, Jingzhen; Tan, Tanya; Pandol, Stephen J.] Univ Calif Los Angeles, Dept Med, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90024 USA; [Hasdemirm, Burcu; Bhargava, Aditi] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Hasdemirm, Burcu; Bhargava, Aditi] Univ Calif San Francisco, Dept OB GYN, San Francisco, CA 94143 USA; [Rivier, Jean] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Salk Institute	Bhargava, A (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.; Bhargava, A (corresponding author), Univ Calif San Francisco, Dept OB GYN, San Francisco, CA 94143 USA.	Aditi.bhargava@ucsf.edu		Bhargava, Aditi/0000-0003-1334-0517	 [P50-AA11999];  [P01 DK098108];  [R01AA024464];  [R56 DK080787];  [DK097518]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK098108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA024464, P50AA011999] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by the following grant support: P50-AA11999 and P01 DK098108 (to SJP); R01AA024464 (to SJP and JY); and R56 DK080787 and DK097518 (to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSI D, 1994, J AM COLL SURGEONS, V179, P257; Bhargava A, 2013, P NATL ACAD SCI USA, V110, P731, DOI 10.1073/pnas.1219733110; Chang J, 2007, PEPTIDES, V28, P1453, DOI 10.1016/j.peptides.2007.05.008; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; Chatzaki E, 2003, J CLIN ENDOCR METAB, V88, P478, DOI 10.1210/jc.2002-020853; Cureton EL, 2009, ENDOCRINOLOGY, V150, P5428, DOI 10.1210/en.2009-0489; Deussing JM, 2018, PHYSIOL REV, V98, P2225, DOI 10.1152/physrev.00042.2017; Gorelick FS, 2017, CELL MOL GASTROENTER, V4, P250, DOI 10.1016/j.jcmgh.2017.05.007; Graf R, 2002, PANCREATOLOGY, V2, P108, DOI 10.1159/000055900; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Guzman EA, 2003, PEPTIDES, V24, P727, DOI 10.1016/S0196-9781(03)00125-6; Hasdemir B, 2017, MOL BIOL CELL, V28, P2386, DOI 10.1091/mbc.E16-11-0778; Hasdemir B, 2016, AM J PHYSIOL-REG I, V310, pR1244, DOI 10.1152/ajpregu.00445.2015; JENSEN RT, 1989, TRENDS PHARMACOL SCI, V10, P418, DOI 10.1016/0165-6147(89)90192-2; Jin SQ, 2015, GASTROENTEROLOGY, V149, P753, DOI 10.1053/j.gastro.2015.05.004; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; Kubat E, 2013, MOL MED, V19, P212, DOI 10.2119/molmed.2013.00036; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubo Y, 2010, DIGEST DIS SCI, V55, P1570, DOI 10.1007/s10620-009-0930-1; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; LERCH MM, 1994, INT J PANCREATOL, V15, P159; Liu YN, 2014, AM J PHYSIOL-GASTR L, V307, pG550, DOI 10.1152/ajpgi.00432.2013; Lugea A, 2017, AM J PATHOL, V187, P2726, DOI 10.1016/j.ajpath.2017.08.017; Lugea A, 2010, ALCOHOL CLIN EXP RES, V34, P1768, DOI 10.1111/j.1530-0277.2010.01264.x; MAETZ J, 1964, GEN COMP ENDOCR, V4, P401, DOI 10.1016/0016-6480(64)90007-3; Marshall I. C. B., 2013, CALCIUM SIGNALING PR, P95, DOI DOI 10.1007/978-1-62703-086-1_; Martinez V, 2004, PEPTIDES, V25, P1733, DOI 10.1016/j.peptides.2004.05.025; OKONSKI MS, 1990, J CLIN INVEST, V86, P1649, DOI 10.1172/JCI114887; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; PETRUSZ P, 1983, P NATL ACAD SCI-BIOL, V80, P1721, DOI 10.1073/pnas.80.6.1721; Pittman QJ, 2009, GEN COMP ENDOCR, V164, P7, DOI 10.1016/j.ygcen.2009.04.024; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; SALUJA AK, 1989, P NATL ACAD SCI USA, V86, P8968, DOI 10.1073/pnas.86.22.8968; SATO S, 1989, AM J PHYSIOL, V257, pG202, DOI 10.1152/ajpgi.1989.257.2.G202; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Scarabelli TM, 2002, J AM COLL CARDIOL, V40, P155, DOI 10.1016/S0735-1097(02)01930-7; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Tao J, 2005, BIOCHEM BIOPH RES CO, V332, P923, DOI 10.1016/j.bbrc.2005.04.076; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Voronina S, 2015, BIOCHEM J, V465, P405, DOI 10.1042/BJ20140398; Wiley KE, 2004, BRIT J PHARMACOL, V143, P508, DOI 10.1038/sj.bjp.0705985	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217065	10.1371/journal.pone.0217065	http://dx.doi.org/10.1371/journal.pone.0217065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100090	Green Published, gold			2022-12-27	WOS:000468176600026
J	Park, JH; Lee, YB; Kim, SY; Kim, HJ; Jung, YS; Jung, HD				Park, Jin Hoo; Lee, Yong-Bin; Kim, Sang Yoon; Kim, Hyung Jun; Jung, Young-Soo; Jung, Hwi-Dong			Accuracy of modified CAD/CAM generated wafer for orthognathic surgery	PLOS ONE			English	Article							COMPUTER-AIDED-DESIGN; TITANIUM PLATES; MODEL SURGERY; SPLINTS; MOVEMENT; PROTOCOL; GUIDES	The aim of this study was to investigate an accuracy of modified CAD/CAM generated wafers for orthognathic surgery. A total of 20 patients who had undergone bimaxillary orthognathic surgery were included and divided into two groups: A conventional CAD/CAM generated intermediate wafer and a modified CAD/CAM generated intermediate wafer. A series of CT images were taken to compare the virtual simulations with the actual postoperative outcomes(1 month after surgery). In conventional group, the mean difference of maxillary position between virtual simulation models and postoperative results was 0.78mm and overall average error within 1mm was observed in 66.4% of the repositioned maxilla. In modified group, the mean difference was 0.77mm and overall average error within 1mm was observed in 68.3%. There were no significant statistic differences between two groups in maxillary position. This study suggests that the CAD/CAM generated wafer provides excellent accuracy. The modified CAD/CAM wafer was only comparable to conventional design in accuracy and it cannot guarantee the superior precision. However, the modified design could be beneficial in cases with unstable condylar position or for inexperienced surgeons.	[Park, Jin Hoo; Kim, Hyung Jun; Jung, Young-Soo; Jung, Hwi-Dong] Yonsei Univ, Dept Oral & Maxillofacial Surg, Oral Sci Res Inst, Coll Dent, Seoul, South Korea; [Lee, Yong-Bin] Hankook Gen Hosp, Dept Oral & Maxillofacial Surg, Cheongju, South Korea; [Kim, Sang Yoon] INOVA Fairfax Hosp, Attending, Falls Church, VA USA; [Kim, Sang Yoon] Harvard MGH Oral & Maxillofacial Surg, Boston, MA USA	Yonsei University; Yonsei University Health System; Inova Fairfax Hospital	Jung, HD (corresponding author), Yonsei Univ, Dept Oral & Maxillofacial Surg, Oral Sci Res Inst, Coll Dent, Seoul, South Korea.	cancer7@yuhs.ac	Jung, Hwi-Dong/ABA-9721-2020	Jung, Hwi-Dong/0000-0003-1025-8323; Jung, Young-Soo/0000-0001-5831-6508; Kim, Hyung Jun/0000-0001-8247-4004	Ministry of Trade, Industry, and Energy (MOTIE), Korea, under the "Regional industry based organization support program" [R0004072]	Ministry of Trade, Industry, and Energy (MOTIE), Korea, under the "Regional industry based organization support program"	This research was financially supported by the Ministry of Trade, Industry, and Energy (MOTIE), Korea, under the "Regional industry based organization support program" (reference number R0004072) supervised by the Korea Institute for Advancement of Technology (KIAT).	Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Bai SZ, 2012, J ORAL MAXIL SURG, V70, P2419, DOI 10.1016/j.joms.2011.12.017; Cousley RRJ, 2014, J ORTHOD, V41, P38, DOI 10.1179/1465313313Y.0000000075; Dai JW, 2014, J CRANIOFAC SURG, V25, pE140, DOI 10.1097/SCS.0000000000000414; ELLIS E, 1990, J ORAL MAXIL SURG, V48, P1161, DOI 10.1016/0278-2391(90)90532-7; FERGUSON JW, 1992, J CRANIO MAXILL SURG, V20, P333, DOI 10.1016/S1010-5182(05)80360-9; Hernandez-Alfaro F, 2013, INT J ORAL MAX SURG, V42, P1547, DOI 10.1016/j.ijom.2013.03.025; Hsu SSP, 2013, J ORAL MAXIL SURG, V71, P128, DOI 10.1016/j.joms.2012.03.027; Jung HD, 2012, J ORAL MAXIL SURG, V70, pE431, DOI 10.1016/j.joms.2012.02.033; Kwon TG, 2014, INT J ORAL MAX SURG, V43, P732, DOI 10.1016/j.ijom.2013.11.009; Li B, 2013, BRIT J ORAL MAX SURG, V51, pE239, DOI 10.1016/j.bjoms.2013.03.007; Marmulla R, 2007, J ORAL MAXIL SURG, V65, P1963, DOI 10.1016/j.joms.2006.11.024; Mazzoni S, 2015, J ORAL MAXIL SURG, V73, P701, DOI 10.1016/j.joms.2014.10.028; Mazzoni S, 2010, J CRANIOFAC SURG, V21, P1698, DOI 10.1097/SCS.0b013e3181f3c6a8; Metzger MC, 2008, ORAL SURG ORAL MED O, V105, pE1, DOI 10.1016/j.tripleo.2007.07.040; Perez D, SEQUENCING BIMAXILLA; Schouman T, 2015, HEAD FACE MED, V11, DOI 10.1186/s13005-015-0082-9; Song KG, 2009, ORAL SURG ORAL MED O, V107, P13, DOI 10.1016/j.tripleo.2008.06.002; Swennen GRJ, 2009, INT J ORAL MAX SURG, V38, P48, DOI 10.1016/j.ijom.2008.11.006; Zinser M, 2015, FACIAL PLAST SURG, V31, P474, DOI 10.1055/s-0035-1565010; Zinser MJ, 2012, OR SURG OR MED OR PA, V113, P673, DOI 10.1016/j.oooo.2011.11.009; 2006, J CRANIOFAC SURG, V17, P661	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216945	10.1371/journal.pone.0216945	http://dx.doi.org/10.1371/journal.pone.0216945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095627	Green Published, gold, Green Submitted			2022-12-27	WOS:000468030100056
J	Havranek, KE; White, LA; Lanchy, JM; Lodmell, JS				Havranek, Katherine E.; White, Luke Adam; Lanchy, Jean-Marc; Lodmell, J. Stephen			Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NSS PROTEIN; HOST; TFIIH; EXPRESSION; LOCALIZATION; REGULATOR; REPAIR; CLK2; P68	Rift Valley fever virus (RVFV) is a negative-sense RNA virus belonging to the Phenuiviridae family that infects both domestic livestock and humans. The NIAID has designated RVFV as a Category A priority emerging pathogen due to the devastating public health outcomes associated with epidemic outbreaks. However, there is no licensed treatment or vaccine approved for human use. Therefore it is of great interest to understand RVFV pathogenesis in infected hosts in order to facilitate creation of targeted therapies and treatment options. Here we provide insight into the host-pathogen interface in human HEK293 cells during RVFV MP-12 strain infection using high-throughput mRNA sequencing technology. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differentially expressed genes showed robust innate immune and cytokine-mediated inflammatory pathway activation as well as alterations in pathways associated with fatty acid metabolism and extracellular matrix receptor signaling. We also analyzed the promoter regions of DEGs for patterns in transcription factor binding sites, and found several that are known to act synergistically to impact apoptosis, immunity, metabolism, and cell growth and differentiation. Lastly, we noted dramatic changes in host alternative splicing patterns in genes associated with mRNA decay and surveillance, RNA transport, and DNA repair. This study has improved our understanding of RVFV pathogenesis and has provided novel insight into pathways and signaling modules important for RVFV diagnostics and therapeutic development.	[Havranek, Katherine E.; White, Luke Adam; Lanchy, Jean-Marc; Lodmell, J. Stephen] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lodmell, J. Stephen] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Lodmell, JS (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.; Lodmell, JS (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	stephen.lodmell@umontana.edu		White, Luke/0000-0003-4548-0661	National Institute of Allergy and Infectious Diseases [R15AI105737]; National Institute of General Medical Sciences [P20GM103546]; NIH [R15AI105737, P20GM103546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI137620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021710] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institute of Allergy and Infectious Diseases (URL: NIH. gov) (grant R15AI105737 to JSL) and National Institute of General Medical Sciences (URL: NIH. gov) (grant P20GM103546) (S. Sprang, P I.; JSL Pilot Project P.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to gratefully acknowledge funding support for this work from NIH grants R15AI105737 to JSL and P20GM103546 (S. Sprang, P.I.; JSL Pilot Project P.I.). We wish to thank Jim Reed and Dr. Scott Wetzel for their gracious help with discussions and analysis of the flow cytometry samples. The following reagent was obtained from the Joel M. Dalrymple-Clarence J. Peters USAMRIID Antibody Collection through BEI Resources, NIAID, NIH: Monoclonal Anti-Rift Valley Fever Virus Gn Glycoprotein, Clone 3C10 (produced in vitro), NR-43186.	Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y; Annese A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22701-2; Aversa R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010121; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Batra R, 2016, NAT STRUCT MOL BIOL, V23, P1101, DOI 10.1038/nsmb.3310; Bauer DLV, 2018, CELL REP, V23, P2119, DOI 10.1016/j.celrep.2018.04.047; Bavelloni A, 2017, ANTICANCER RES, V37, P6511, DOI 10.21873/anticanres.12107; Benferhat R, 2012, J VIROL, V86, P11333, DOI 10.1128/JVI.01549-12; Bing L, 2019, GENOMICS, V111, P242, DOI 10.1016/j.ygeno.2018.11.011; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Blomstrom AL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1538-9; Boudreault S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161914; Brennan B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003922; Coetzer J., 2004, INFECT DIS LIVESTOCK; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; de la Fuente C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191983; De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Dichmann DS, 2015, CELL REP, V10, P527, DOI 10.1016/j.celrep.2014.12.046; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dupuis-Maurin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118551; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14; Frasor J, 2015, MOL CELL ENDOCRINOL, V418, P235, DOI 10.1016/j.mce.2014.09.013; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Glennon NB, 2015, J VIROL, V89, P7550, DOI 10.1128/JVI.00302-15; Guo L, 2018, FUTURE VIROL, V13, P211, DOI 10.2217/fvl-2017-0106; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Han LL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23478-0; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hopkins KC, 2015, P NATL ACAD SCI USA, V112, pE2920, DOI 10.1073/pnas.1418805112; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Indran SV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00131; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koks S, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00046; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Laine JP, 2006, METHOD ENZYMOL, V408, P246, DOI 10.1016/S0076-6879(06)08015-3; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee YJ, 2018, GENE DEV, V32, P1060, DOI 10.1101/gad.316034.118; Lin L, 2016, HUM MOL GENET, V25, P3454, DOI 10.1093/hmg/ddw187; Lin WS, 2017, MOL MED REP, V16, P2075, DOI 10.3892/mmr.2017.6855; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Liu Y. X., 2014, J NATL U DEFENCE TEC, V26, P6, DOI DOI 10.1371/J0URNAL.PPAT.1004199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; McCarthy MK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/236345; McElroy AK, 2012, VIROLOGY, V422, P6, DOI 10.1016/j.virol.2011.09.023; Moore HC, 2011, RNA, V17, P555, DOI 10.1261/rna.2591611; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023; Narayanan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020354; Okumu LA, 2010, REPRODUCTION, V140, P143, DOI 10.1530/REP-10-0113; Pinkham C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14800-3; Rossler OG, 2000, NUCLEIC ACIDS RES, V28, P932, DOI 10.1093/nar/28.4.932; Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Werder RB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0052; Wonderlich Elizabeth R, 2018, J Virol, V92, DOI 10.1128/JVI.01662-17; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida T, 2015, CANCER RES, V75, P1516, DOI 10.1158/0008-5472.CAN-14-2443; Zhong HQ, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-18195-Z, 10.1038/s41598-017-18195-z]	79	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217497	10.1371/journal.pone.0217497	http://dx.doi.org/10.1371/journal.pone.0217497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136639	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300045
J	Al-Hameed, S; Benaissa, M; Christensen, H; Mirheidari, B; Blackburn, D; Reuber, M				Al-Hameed, Sabah; Benaissa, Mohammed; Christensen, Heidi; Mirheidari, Bahman; Blackburn, Daniel; Reuber, Markus			A new diagnostic approach for the identification of patients with neurodegenerative cognitive complaints	PLOS ONE			English	Article							SPONTANEOUS SPEECH ANALYSIS; MINI-MENTAL STATE; REVISED ACE-R; ALZHEIMERS-DISEASE; FEATURE-SELECTION; CENTROID FEATURES; DEMENTIA; IMPAIRMENT; CLASSIFICATION; ALGORITHMS	Neurodegenerative diseases causing dementia are known to affect a person's speech and language. Part of the expert assessment in memory clinics therefore routinely focuses on detecting such features. The current outpatient procedures examining patients' verbal and interactional abilities mainly focus on verbal recall, word fluency, and comprehension. By capturing neurodegeneration-associated characteristics in a person's voice, the incorporation of novel methods based on the automatic analysis of speech signals may give us more information about a person's ability to interact which could contribute to the diagnostic process. In this proof-of-principle study, we demonstrate that purely acoustic features, extracted from recordings of patients' answers to a neurologist's questions in a specialist memory clinic can support the initial distinction between patients presenting with cognitive concerns attributable to progressive neurodegenerative disorders (ND) or Functional Memory Disorder (FMD, i.e., subjective memory concerns unassociated with objective cognitive deficits or a risk of progression). The study involved 15 FMD and 15 ND patients where a total of 51 acoustic features were extracted from the recordings. Feature selection was used to identify the most discriminating features which were then used to train five different machine learning classifiers to differentiate between the FMD/ND classes, achieving a mean classification accuracy of 96.2%. The discriminative power of purely acoustic approaches could be integrated into diagnostic pathways for patients presenting with memory concerns and are computationally less demanding than methods focusing on linguistic elements of speech and language that require automatic speech recognition and understanding.	[Al-Hameed, Sabah; Benaissa, Mohammed] Univ Sheffield, Dept Elect & Elect Engn, Sheffield, S Yorkshire, England; [Christensen, Heidi; Mirheidari, Bahman] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England; [Christensen, Heidi] Univ Sheffield, Ctr Assist Technol & Connected Healthcare, Sheffield, S Yorkshire, England; [Blackburn, Daniel] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England; [Reuber, Markus] Univ Sheffield, Royal Hallamshire Hosp, Acad Neurol Unit, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Al-Hameed, S (corresponding author), Univ Sheffield, Dept Elect & Elect Engn, Sheffield, S Yorkshire, England.	ssaal-hameed1@sheffield.ac.uk		Christensen, Heidi/0000-0003-3028-5062; blackburn, daniel/0000-0001-8886-1283; Al-Hameed, Sabah/0000-0003-3617-9906	NIHR Sheffield Biomedical Research Centre (Translational Neuroscience); NIHR Research for Patient Benefit (RfPB) Programme [PB-PG-0211-24079]	NIHR Sheffield Biomedical Research Centre (Translational Neuroscience); NIHR Research for Patient Benefit (RfPB) Programme	We acknowledge the support of the NIHR Sheffield Biomedical Research Centre (Translational Neuroscience) and funder NIHR Research for Patient Benefit (RfPB) Programme: PB-PG-0211-24079-Using Conversation Analysis in the Differential Diagnosis of Memory Problems: a pilot study. 2013-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hameed S., 2017, P INT C BIOINFORMATI, P57, DOI DOI 10.1145/3175587.3175589; Al-Hameed S., 2016, 7 WORKSH SPEECH LANG, P32, DOI [DOI 10.21437/SLPAT.2016-6, 10.21437/SLPAT.2016-6]; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 2017, REL STAT WIND; ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; Bennys K, 2001, NEUROPHYSIOL CLIN, V31, P153, DOI 10.1016/S0987-7053(01)00254-4; Blackburn DJ, 2014, BRIT MED BULL, V112, P71, DOI 10.1093/bmb/ldu029; Boersma P., 2001, GLOT INT, V5, P341; Brown RKJ, 2014, RADIOGRAPHICS, V34, P684, DOI 10.1148/rg.343135065; Camargo EE, 2001, J NUCL MED, V42, P611; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Commissaris CJAM, 1998, PATIENT EDUC COUNS, V34, P25, DOI 10.1016/S0738-3991(98)00040-8; DAVIS SB, 1980, IEEE T ACOUST SPEECH, V28, P357, DOI 10.1109/TASSP.1980.1163420; de Cheveigne A, 2002, J ACOUST SOC AM, V111, P1917, DOI 10.1121/1.1458024; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Elsey C, 2015, PATIENT EDUC COUNS, V98, P1071, DOI 10.1016/j.pec.2015.05.021; Faure-Bardon V, 2018, AIDS, V32, P321, DOI 10.1097/QAD.0000000000001681; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraser KC, 2016, J ALZHEIMERS DIS, V49, P407, DOI 10.3233/JAD-150520; Gajic B, 2001, INT CONF ACOUST SPEE, P85, DOI 10.1109/ICASSP.2001.940773; Gayraud F, 2011, CLIN LINGUIST PHONET, V25, P198, DOI 10.3109/02699206.2010.521612; Gosztolya G, 2019, COMPUT SPEECH LANG, V53, P181, DOI 10.1016/j.csl.2018.07.007; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hodge S, 2013, ENGLISH NATL MEMORY; Jarrold W., 2014, P WORKSH COMP LING C, P27, DOI [10.3115/v1/W14-3204, DOI 10.3115/V1/W14-3204]; Jones D, 2016, AGING MENT HEALTH, V20, P500, DOI 10.1080/13607863.2015.1021753; Khan T, 2014, BIOCYBERN BIOMED ENG, V34, P35, DOI 10.1016/j.bbe.2013.10.003; Konig Alexandra, 2015, Alzheimers Dement (Amst), V1, P112, DOI 10.1016/j.dadm.2014.11.012; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larner AJ, 2007, AGE AGEING, V36, P685, DOI 10.1093/ageing/afm112; Laske C, 2015, ALZHEIMERS DEMENT, V11, P561, DOI 10.1016/j.jalz.2014.06.004; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Lopez-de-Ipina K, 2015, COGN COMPUT, V7, P44, DOI 10.1007/s12559-013-9229-9; Lopez-de-Ipina K., 2013, 2013 IEEE 17th International Conference on Intelligent Engineering Systems (INES), P61, DOI 10.1109/INES.2013.6632783; Lopez-de-Ipina K, 2015, COMPUT SPEECH LANG, V30, P43, DOI 10.1016/j.csl.2014.08.002; Lopez-de-Ipina K, 2013, SENSORS-BASEL, V13, P6730, DOI 10.3390/s130506730; MacWhinney B, 2007, CREATING AND DIGITIZING LANGUAGE CORPORA VOLUME 1: SYNCHRONIC DATABASES, P163; Mazzoni D, 1999, AUDACITY; Meilan JJG, 2014, DEMENT GERIATR COGN, V37, P327, DOI 10.1159/000356726; Metternich B, 2009, J PSYCHOSOM RES, V66, P435, DOI 10.1016/j.jpsychores.2008.07.005; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mirheidari B, 2017, INTERSPEECH, P3147, DOI 10.21437/Interspeech.2017-690; Mirheidari B, 2016, INTERSPEECH, P1220, DOI 10.21437/Interspeech.2016-857; Mirheidari B, 2017, J ALZHEIMERS DIS, V58, P373, DOI 10.3233/JAD-160507; Paliwal KK, 1998, INT CONF ACOUST SPEE, P617, DOI 10.1109/ICASSP.1998.675340; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Le N, 2011, SPEECH COMMUN, V53, P540, DOI 10.1016/j.specom.2011.01.005; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Raven J.C., 1958, GUIDE USING COLOURED; Roark B, 2011, IEEE T AUDIO SPEECH, V19, P2081, DOI 10.1109/TASL.2011.2112351; Saenz-Lechon N, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P3667; Satt A, 2013, INTERSPEECH, P1691; Schmidtke K, 2008, AM J GERIAT PSYCHIAT, V16, P981, DOI 10.1097/JGP.0b013e318187ddf9; Singh S, 2001, APHASIOLOGY, V15, P571, DOI 10.1080/02687040143000041; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szatloczki G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00195; Toth L, 2018, CURR ALZHEIMER RES, V15, P130, DOI 10.2174/1567205014666171121114930; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Tsanas A, 2010, IEEE T BIO-MED ENG, V57, P884, DOI 10.1109/TBME.2009.2036000; Vergara JR, 2014, NEURAL COMPUT APPL, V24, P175, DOI 10.1007/s00521-013-1368-0; Villarejo A, 2011, NEUROLOGIA, V26, P425, DOI 10.1016/j.nrl.2010.12.002; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Weiner J, 2016, INTERSPEECH, P1938, DOI 10.21437/Interspeech.2016-100	68	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217388	10.1371/journal.pone.0217388	http://dx.doi.org/10.1371/journal.pone.0217388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125389	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000468865700034
J	Midorikawa, K; Kuroda, M; Yamashita, H; Tamura, T; Abe, K; Asakura, T				Midorikawa, Keiko; Kuroda, Masaharu; Yamashita, Haruyuki; Tamura, Tomoko; Abe, Keiko; Asakura, Tomiko			Oryza sativa Brittle Culm 1-like 6 modulates beta-glucan levels in the endosperm cell wall	PLOS ONE			English	Article							ROOT-HAIR MORPHOGENESIS; GPI-ANCHORED PROTEINS; MECHANICAL-PROPERTIES; BINDING-SITE; RICE; ARABIDOPSIS; COBRA; FAMILY; GENES; EXPRESSION	The endosperm cell wall affects post-harvest grain quality by affecting the mechanical fragility and water absorption of the grain. Therefore, understanding the mechanism underlying endosperm cell wall synthesis is important for determining the growth and quality of cereals. However, the molecular machinery mediating endosperm cell wall biosynthesis is not well understood. In this study, we investigated the role of Oryza sativa Brittle Culm 1-like 6 (OsBC1L6), a member of the COBRA-like protein family, in cellulose synthesis in rice. OsBC1L6 mRNA was expressed in ripening seeds during endosperm enlargement. When OsBC1L6-RFP was expressed in Arabidopsis cell cultures, this fusion protein was transported to the plasma membrane. To investigate the target molecules of OsBC1L6, we analyzed the binding interactions of OsBC1L6 with cellohexaose and the analogs using surface plasmon resonance, determining that cellohexaose bound to OsBC1L6. The beta-glucan contents were significantly reduced in OsBC1L6-RNAi calli and OsBC1L6-deficient seeds from a Tos insertion mutant, compared to their wild-type counterparts. These findings suggest that OsBC1L6 modulates beta-glucan synthesis during endosperm cell wall formation by interacting with cellulose moieties on the plasma membrane during seed ripening.	[Midorikawa, Keiko; Yamashita, Haruyuki; Abe, Keiko; Asakura, Tomiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Kuroda, Masaharu] Natl Agr & Food Res Org NARO, Cent Reg Agr Res Ctr, Div Crop Dev, Niigata, Japan; [Tamura, Tomoko] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo, Japan; [Abe, Keiko] Kanagawa Inst Ind Sci & Technol KISTEC, Life Sci & Environm Res Ctr LiSE, Kawasaki, Kanagawa, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; Tokyo University of Agriculture	Asakura, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.; Kuroda, M (corresponding author), Natl Agr & Food Res Org NARO, Cent Reg Agr Res Ctr, Div Crop Dev, Niigata, Japan.	kurodama@affrc.go.jp; asakura@mail.ecc.u-tokyo.ac.jp		Midorikawa, Keiko/0000-0003-2297-1564	Japan Society for the Promotion of Science [15J10210]; Public Foundation of Elizabeth Arnold-Fuji	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Public Foundation of Elizabeth Arnold-Fuji	This work was funded by the Japan Society for the Promotion of Science (external to our organization), Midorikawa Keiko (recipient), 15J10210; and The Public Foundation of Elizabeth Arnold-Fuji, Tomiko Asakura (recipient). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERSHEIM P, 1994, BIOCHEM SOC T, V22, P374, DOI 10.1042/bst0220374; Ben-Tov D, 2015, PLANT PHYSIOL, V167, P711, DOI 10.1104/pp.114.240671; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Burton RA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00456; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/nchembio.439, 10.1038/NCHEMBIO.439]; Dai XX, 2011, PLANT MOL BIOL, V75, P333, DOI 10.1007/s11103-011-9730-z; Dai XX, 2009, PLANT MOL BIOL, V71, P469, DOI 10.1007/s11103-009-9537-3; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Hernandez-Gomez MC, 2015, FEBS LETT, V589, P2297, DOI 10.1016/j.febslet.2015.07.009; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Kanegae H, 2005, PLANT PHYSIOL BIOCH, V43, P669, DOI 10.1016/j.plaphy.2005.06.004; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2001, TRENDS PLANT SCI, V6, P127, DOI 10.1016/S1360-1385(00)01860-4; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Li S, 2013, PLANT J, V74, P486, DOI 10.1111/tpj.12139; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liu LF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003704; MATSUYAMA N, 1975, Annals of the Phytopathological Society of Japan, V41, P56, DOI 10.3186/jjphytopath.41.56; Midorikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098738; Muniz M, 2016, J LIPID RES, V57, P352, DOI 10.1194/jlr.R062760; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Ogawa Y, 2006, CEREAL CHEM, V83, P636, DOI 10.1094/CC-83-0636; Ogden M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092691; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Roberts K, 1990, CURR OPIN CELL BIOL, V2, P920, DOI 10.1016/0955-0674(90)90093-T; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Roudier F, 2002, PLANT PHYSIOL, V130, P538, DOI 10.1104/pp.007468; Sato K, 2010, PLANT SIGNAL BEHAV, V5, P1433, DOI [10.4161/psb.5.11.13342, 10.1007/s00425-010-1171-4]; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; SHIBUYA N, 1982, STARKE, V34, P300, DOI 10.1002/star.19820340906; SHIBUYA N, 1985, CEREAL CHEM, V62, P252; SHIBUYA N, 1984, J JPN SOC FOOD SCI, V31, P656; SHIBUYA N, 1983, AGR BIOL CHEM TOKYO, V47, P2223, DOI 10.1080/00021369.1983.10865940; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Smith-Moritz AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00628; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Tamura T, 2008, FEBS J, V275, P34, DOI 10.1111/j.1742-4658.2007.06170.x; Tamura T, 2007, J PLANT PHYSIOL, V164, P470, DOI 10.1016/j.jplph.2006.02.009; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Vega-Sanchez ME, 2012, PLANT PHYSIOL, V159, P56, DOI 10.1104/pp.112.195495; Yeats TH, 2018, J INTEGR PLANT BIOL, V60, P649, DOI 10.1111/jipb.12659; Zhang WJ, 2017, J PLANT RES, V130, P859, DOI 10.1007/s10265-017-0943-3	54	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217212	10.1371/journal.pone.0217212	http://dx.doi.org/10.1371/journal.pone.0217212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120929	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700066
J	Poli, D; Antonucci, E; Ageno, W; Bertu, L; Migliaccio, L; Martinese, L; Pilato, G; Testa, S; Palareti, G				Poli, Daniela; Antonucci, Emilia; Ageno, Walter; Bertu, Lorenza; Migliaccio, Ludovica; Martinese, Lucia; Pilato, Giuseppe; Testa, Sophie; Palareti, Gualtiero			Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study	PLOS ONE			English	Article							RISK STRATIFICATION; WARFARIN; STROKE; SURVIVAL; EVENTS	Direct oral anticoagulants (DOACs) have shown similar efficacy and safety with respect to warfarin in patients with atrial fibrillation (AF). However, the proportion of patients aged >= 85 years enrolled in clinical trials was low and the applicability of their results to very elderly patients is still uncertain. We have carried out a prospective cohort study on AF patients aged >= 85 years enrolled in the Survey on anticoagulaTed pAtients RegisTer (START2-Register) and treated with either VKAs or DOACs, with the aim to evaluate mortality, bleeding and thrombotic rates during a long-term follow-up. We enrolled 1124 patients who started anticoagulation at >= 85 years with VKA (58.7%) or DOACs (41.3%), Clinical characteristics of patients were similar, except for a higher prevalence of coronary artery disease and renal failure in VKAs patients and of a history of previous bleeding and previous stroke/TIA in patients on DOACs. Median CHA(2)DS(2)VASc and HAS-BLED scores were similar between the two groups. During follow-up, 47 major bleedings (rate 2.3 x100 pt-yrs) and 19 stroke/TIA (0.9 x100 pt-yrs) were recorded. The incidence of bleeding was similar between patients on VKAs and DOACs. Patients on DOACs showed a higher rate of thrombotic events during treatment (rate 1.84 and 0.50, respectively). Mortality rate was higher in patients on VKAs than in patients on DOACs (HR 0.64 (95% CI 0.46-0.91). In conclusion, we confirm the overall safety and effectiveness of anticoagulant treatment in very elderly AF patients, with lower mortality rates in DOACs patients, similar bleeding risk, and a higher risk for cerebral thrombotic events in DOACs patients.	[Poli, Daniela] Azienda Osped Univ Careggi, Ctr Atherothrombot Dis, Florence, Italy; [Antonucci, Emilia; Migliaccio, Ludovica; Palareti, Gualtiero] Arianna Anticoagulaz Fdn, Bologna, Italy; [Ageno, Walter; Bertu, Lorenza] Univ Insubria, Dept Med & Surg, Varese, Italy; [Martinese, Lucia; Pilato, Giuseppe] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Testa, Sophie] Hosp Cremona, Haemostasis & Thrombosis Ctr, Cremona, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Insubria; University of Florence	Poli, D (corresponding author), Azienda Osped Univ Careggi, Ctr Atherothrombot Dis, Florence, Italy.	polida@aou-careggi.toscana.it	Migliaccio, Ludovica/ABD-9241-2021	Migliaccio, Ludovica/0000-0001-7110-4892; poli, daniela/0000-0002-5166-6596	Arianna Anticoagulation Foundation	Arianna Anticoagulation Foundation	The Arianna Anticoagulation Foundation supported the START2 Register and the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnsasra H, 2019, HEART RHYTHM, V16, P31, DOI 10.1016/j.hrthm.2018.08.016; Antonucci E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124719; Arcieri R, 2014, BLOOD TRANSFUS-ITALY, V12, pS563, DOI 10.2450/2014.0036-14s; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Barco S, 2013, BEST PRACT RES CL HA, V26, P215, DOI 10.1016/j.beha.2013.07.011; Camm AJ, 2012, EUR HEART J, V33; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Kooistra HAM, 2016, JAMA INTERN MED, V176, P1176, DOI 10.1001/jamainternmed.2016.3057; Lager KE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009103.pub2; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2013, THROMB RES, V131, P12, DOI 10.1016/j.thromres.2012.10.009; Poli D, 2011, CIRCULATION, V124, P824, DOI 10.1161/CIRCULATIONAHA.110.007864; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Zoppellaro G, 2018, INT J CARDIOL, V265, P103, DOI 10.1016/j.ijcard.2018.04.117	26	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216831	10.1371/journal.pone.0216831	http://dx.doi.org/10.1371/journal.pone.0216831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120890	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700030
J	Qin, LW; Dang, DJ; Wang, XH; Zhang, RG; Feng, HF; Ren, JC; Chen, SY; Zhou, GY; Huang, P; Wang, B; Xi, YL; Wu, WD; Jin, YF; Duan, GC				Qin, Luwei; Dang, Dejian; Wang, Xinhong; Zhang, Rongguang; Feng, Huifen; Ren, Jingchao; Chen, Shuaiyin; Zhou, Guangyuan; Huang, Ping; Wang, Bin; Xi, Yuanlin; Wu, Weidong; Jin, Yuefei; Duan, Guangcai			Identification of immune and metabolic predictors of severe hand-foot-mouth disease	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; HYPONATREMIA; HEALTH	Hand, foot and mouth disease (HFMD) is an infectious disease that affects mostly children. The children with HFMD also have other immune and metabolic disorders. However, the association of these disorders with the severity of HFMD has not yet been determined. In this study, we used a case-control study design to examine the correlation of immune and metabolic disorders with HFMD development in children. 406 mild and severe patients were recruited and divided into different subgroups based on the number of days from the initial onset time to hospitalization (1, 2, 3, 4, and. >= 5 days). Logistic regression model was used to define the predictors of severe HFMD. We found that the patients from rural area (OR = 1.76, 95% CI [ 1.19 similar to 2.63], P = 0.005) or with body temperature of >39 degrees C (OR = 2.14, 95% CI [ 1.12 similar to 4.12], P = 0.022) exhibited higher risk for severe symptoms. In addition, the risk increased with the rise of body temperature by using a Chis-quare trend test (P = 0.01). We also found that a decreased number of eosinophils was an predictor of severe HFMD at 1, 2, 3, and 4 days post infection (dpi). Decreased levels of Na+, Cl-, and creatine kinase were also predictors at 1 and. >= 5 dpi. On the other hand, elevated level of globulin was a predictor for severe HFMD at 4 dpi and. >= 5 dpi, and the increased number of neutrophils or increased level of alkaline phosphatase posed risk for severe HFMD at 3 and. >= 5 dpi. Our results suggested that rural living, hyperpyrexia, changes in the immune system that include the numbers of eosinophils and neutrophils and the levels of IgG and globulin, and metabolic alterations, such as the levels of alkaline phosphatase, Na+, Cl-, and creatine kinase in peripheral blood are predictors of severe HFMD.	[Qin, Luwei; Ren, Jingchao; Zhou, Guangyuan; Wu, Weidong] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China; [Dang, Dejian; Zhang, Rongguang; Chen, Shuaiyin; Xi, Yuanlin; Jin, Yuefei; Duan, Guangcai] Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Wang, Xinhong] Childrens Hosp Zhengzhou City, Dept Infect Dis, Zhengzhou, Henan, Peoples R China; [Feng, Huifen; Huang, Ping; Wang, Bin] Zhengzhou Univ, Affiliated Hosp 5, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China	Xinxiang Medical University; Zhengzhou University; Zhengzhou University	Jin, YF; Duan, GC (corresponding author), Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China.	jinyuefeixuanchuan@163.com; gcduan@zzu.edu.cn	Jin, Yuefei/AES-4089-2022; Chen, Shuaiyin/AAS-7933-2021; Wang, Xin/GYU-1129-2022; Jin, Yuefei/AAL-5163-2020	Wang, Bin/0000-0003-0012-9835	National Natural Science Foundation of China [81172740, 81573205]; key scientific research projects at the Colleges and Universities of Henan Province [15A330003]; Outstanding Doctoral Thesis Training Fund of Zhengzhou University [201511270165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key scientific research projects at the Colleges and Universities of Henan Province; Outstanding Doctoral Thesis Training Fund of Zhengzhou University	This work was supported by National Natural Science Foundation of China, grant numbers: 81172740 and 81573205 (URL: http://www.nsfc.gov.cn/publish/portal1/tab131/); and key scientific research projects at the Colleges and Universities of Henan Province, grant number: 15A330003 (URL: http://www.haedu.gov.cn/); and Outstanding Doctoral Thesis Training Fund of Zhengzhou University, grant number: 201511270165 (URL: http://gs.zzu.edu.cn/xwgz/yxlw.htm).	Carlson G. P., 1997, Clinical biochemistry of domestic animals., P485, DOI 10.1016/B978-012396305-5/50019-1; Cray C, 2009, COMPARATIVE MED, V59, P517; Dolin R, 1999, NEW ENGL J MED, V341, P984, DOI 10.1056/NEJM199909233411309; Duan GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112676; FISHMAN WH, 1990, CLIN BIOCHEM, V23, P99, DOI 10.1016/0009-9120(90)80019-F; Gasper Mason C, 2005, Med Health R I, V88, P400; Gasper MC, 2005, MED HLTH R I, V88, P400; Guerra A.M., 2017, HAND FOOT MOUTH DIS; Han FX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038744; Hau Van Pham, 2017, VirusDisease, V28, P430, DOI 10.1007/s13337-017-0402-8; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsiao HB, 2014, J VIROL, V88, P11658, DOI 10.1128/JVI.00867-14; Huang PN, 2014, CURR OPIN VIROL, V5, P98, DOI 10.1016/j.coviro.2014.03.007; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lewis S, 2001, BMJ-BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603; Liao CC, 2014, J VIROL, V88, P12485, DOI 10.1128/JVI.00692-14; Lu C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/647452; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; PACKER M, 1987, J AM COLL CARDIOL, V10, P837, DOI 10.1016/S0735-1097(87)80278-4; Pemde HK, 2015, INDIAN J PEDIATR, V82, P13, DOI 10.1007/s12098-014-1436-1; Percopo CM, 2014, BLOOD, V123, P743, DOI 10.1182/blood-2013-05-502443; SHAKIB F, 1980, RES CLIN LAB, V10, P463, DOI 10.1007/BF02938793; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang JY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0011-z; Wickham H, GGPLOT2 ELEGANT GRAP; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yu P, 2015, ARCH VIROL, V160, P81, DOI 10.1007/s00705-014-2233-x; Zhang DM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40282; Zhou H, 2015, J COMPUTATIONAL THEO, V12, P3840	32	7	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216993	10.1371/journal.pone.0216993	http://dx.doi.org/10.1371/journal.pone.0216993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120941	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700046
J	Tunsagool, P; Leelasuphakul, W; Jaresitthikunchai, J; Phaonakrop, N; Roytrakul, S; Jutidamrongphan, W				Tunsagool, Paiboon; Leelasuphakul, Wichitra; Jaresitthikunchai, Janthima; Phaonakrop, Narumon; Roytrakul, Sittiruk; Jutidamrongphan, Warangkana			Targeted transcriptional and proteomic studies explicate specific roles of Bacillus subtilis iturin A, fengycin, and surfactin on elicitation of defensive systems in mandarin fruit during stress	PLOS ONE			English	Article							ETHYLENE BIOSYNTHESIS; DIGITATUM SACC.; PROTEINS; IDENTIFICATION; EXPRESSION; PLANTS; LIPOPEPTIDES; QUANTITATION; DATABASES	Application of Bacillus cyclic lipopeptides (CLPs); fengycin, iturin A and surfactin has shown a great potential in controlling the spread of green mold pathogen invasion (Penicillium digitatum) in wounded mandarin fruit during postharvest period. The limited defensive protein profiles followed specific expression of pivotal genes relating to plant hormone mediating signaling pathways of the CLPs' action on stimulating host plant resistance have been exhibited. The present study aimed to elucidate the specific effect of individual CLP obtained from Bacillus subtilis ABS-S14 as elicitor role on activation of plant defensive system at transcriptional and proteomic levels with and without P. digitatum co-application in mandarin fruit. Fengycin and iturin A elevated the gene expression of PAL, ACS1, ACO, CHI, and GLU while significantly stimulating plant POD transcription was only detected in the treatments of surfactin both with and without following P. digitatum. An increase of LOX and PR1 gene transcripts was determined in the treatments of individual CLP with fungal pathogen co-application. Fengycin activated production of unique defensive proteins such as protein involved in ubiquinone biosynthetic process in treated flavedo without P. digitatum infection. Proteins involved in the auxin modulating pathway were present in the iturin A and surfactin treatments. CLP-protein binding assay following proteome analysis reveals that iturin A attached to 12-oxophytodienoate reductase 2 involved in the oxylipin biosynthetic process required for jasmonic acid production which is implicated in induced systemic resistance (ISR). This study suggests specific elicitor action of individual CLP, particularly iturin A showed the most powerful in stimulating the ISR system in response to stresses in postharvest mandarins.	[Tunsagool, Paiboon; Leelasuphakul, Wichitra] Prince Songkla Univ, Dept Biochem, Fac Sci, Hat Yai, Thailand; [Jaresitthikunchai, Janthima; Phaonakrop, Narumon; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Prote Res Lab, Pathum Thani, Thailand; [Jutidamrongphan, Warangkana] Prince Songkla Univ, Fac Environm Management, Hat Yai, Thailand	Prince of Songkla University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Prince of Songkla University	Leelasuphakul, W (corresponding author), Prince Songkla Univ, Dept Biochem, Fac Sci, Hat Yai, Thailand.; Jutidamrongphan, W (corresponding author), Prince Songkla Univ, Fac Environm Management, Hat Yai, Thailand.	wichitra.l@psu.ac.th; warangkana.j@psu.ac.th		Leelasuphakul, Wichitra/0000-0002-9974-8777; Tunsagool, Paiboon/0000-0002-4070-8500; Roytrakul, Sittiruk/0000-0003-3696-8390	National Royal Research Council of Thailand [SCI600214S]; Royal Golden Jubilee Ph.D. student scholarship [PHD/0172]; University Academic Excellence Strengthening Program in Biochemistry at Prince of Songkla University (PSU); PSU Graduate Fund	National Royal Research Council of Thailand; Royal Golden Jubilee Ph.D. student scholarship; University Academic Excellence Strengthening Program in Biochemistry at Prince of Songkla University (PSU); PSU Graduate Fund	This work was financially supported by the National Royal Research Council of Thailand (Grant no. SCI600214S) (http://en.nrct.go.th/en/home.aspx), Paiboon Tunsagool is grateful for a Thailand Research Fund, Royal Golden Jubilee Ph.D. student scholarship (PHD/0172'2557) (https://www.trf.or.th/) (https://rgj.trf.or.th/main/en/), and to the University Academic Excellence Strengthening Program in Biochemistry at Prince of Songkla University (PSU) (https://www.psu.ac.th/th/) (http://www.sci.psu.ac.th/New56/TH/index.asp), and the PSU Graduate Fund (https://grad.psu.ac.th/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2018, MICROBIOL RES, V212, P29, DOI 10.1016/j.micres.2018.04.008; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Belknap WR, 1996, TRENDS PLANT SCI, V1, P331; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Chandler S, 2015, PHYSIOL MOL PLANT P, V91, P20, DOI 10.1016/j.pmpp.2015.05.010; Chen CM, 2017, METHODS MOL BIOL, V1558, P3, DOI 10.1007/978-1-4939-6783-4_1; Deleu M, 2005, J COLLOID INTERF SCI, V283, P358, DOI 10.1016/j.jcis.2004.09.036; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Gimenez E, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110299; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; HOLMES GJ, 1995, PLANT DIS, V79, P1068, DOI 10.1094/PD-79-1068; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Lerma-Garcia MJ, 2016, FOOD CHEM, V196, P739, DOI 10.1016/j.foodchem.2015.10.009; Jiwanit P, 2018, BIOL CONTROL, V117, P43, DOI 10.1016/j.biocontrol.2017.08.023; Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921; John-Karuppiah KJ, 2010, J AM SOC HORTIC SCI, V135, P456, DOI 10.21273/JASHS.135.5.456; Kawagoe Y, 2015, BIOCHEM BIOPH RES CO, V460, P1015, DOI 10.1016/j.bbrc.2015.03.143; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Klinbunga S, 2012, MOL CELL ENDOCRINOL, V355, P143, DOI 10.1016/j.mce.2012.02.005; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Leelasuphakul W, 2006, ENZYME MICROB TECH, V38, P990, DOI 10.1016/j.enzmictec.2005.08.030; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; Liu MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01898; Lopes R, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2479-7; Mitupatum Thantip, 2016, Asian Pac J Cancer Prev, V17, P703; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Pisamai S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200619; Shine MB, 2019, PLANT SCI, V279, P81, DOI 10.1016/j.plantsci.2018.01.001; Thorsell A, 2007, RAPID COMMUN MASS SP, V21, P771, DOI 10.1002/rcm.2898; Tunsagool P, 2019, PLANT CELL REP, V38, P559, DOI 10.1007/s00299-019-02386-1; Waewthongrak W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109386; Waewthongrak W, 2015, POSTHARVEST BIOL TEC, V99, P44, DOI 10.1016/j.postharvbio.2014.07.016; Wang JH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4366-2; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Zhang XB, 2015, MOL PLANT, V8, P17, DOI 10.1016/j.molp.2014.11.001	41	6	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217202	10.1371/journal.pone.0217202	http://dx.doi.org/10.1371/journal.pone.0217202			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120923	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700065
J	Cano, IP; Dionisio, TJ; Cestari, TM; Calvo, AM; Colombini-Ishikiriama, BL; Faria, FAC; Siqueira, WL; Santos, CF				Cano, Isadora Prado; Dionisio, Thiago Jose; Cestari, Tania Mary; Calvo, Adriana Maria; Colombini-Ishikiriama, Bella Luna; Cardoso Faria, Flavio Augusto; Siqueira, Walter Luiz; Santos, Carlos Ferreira			Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands	PLOS ONE			English	Article							II RECEPTOR; KALLIKREIN; SECRETION; TISSUES; BRAIN; TONIN	Renin-angiotensin system (RAS) systemically or locally collaborates with tissue homeostasis, growth and development, which has been extensively studied for its pharmacological implications. This study was primarily aimed at finding and characterizing local RAS in rat parotid, sublingual and submandibular glands. It was also hypothesized that vasoactive drugs could affect the expression of RAS targets, as well as saliva flow and its composition. Therefore, another objective of this study was to compare the effects of losartan (angiotensin II receptor blocker) and isoproterenol (beta-adrenergic receptor agonist). Forty-one Wistar rats were divided into three groups and administered a daily intraperitoneal dose of saline, losartan or isoproterenol solutions for one week. The following RAS targets were studied using qPCR: renin (REN), angiotensinogen (AGT), angiotensin converting enzyme (ACE), ACE-2, elastase-2 (ELA-2), AT1-a and MAS receptors, using RPL-13 as a reference gene. Morphology of glands was analyzed by immunohistochemistry using REN, ACE, ACE-2, AT1, AT2 and MAS antibodies. The volume and total protein content of saliva were measured. Our results revealed that ACE, ACE-2, AT1-a, AT2 and MAS receptors were expressed in all salivary gland samples, but REN and ELA-2 were absent. Losartan decreased mRNA expression of RAS targets in parotid (MAS) and submandibular glands (ACE and both AT receptors), without affecting morphological alterations, and significantly decreased saliva and total protein secretions. Isoproterenol treatment affected gene expression profiles in parotid (ACE, ACE-2, AT1-a, MAS, AGT), and submandibular (ACE, AT2, AGT) glands, thus promoting acinar hypertrophy in serous acini, without significant changes in salivary flow or total protein content. These drugs affected mainly acini, followed by duct systems and myoepithelial cells, whereas blood vessels were not affected. In conclusion, there is a local RAS in major rat salivary glands and losartan, an angiotensin II receptor blocker, affected not only the RAS-target gene expression but also decreased salivary flow and total protein content.	[Cano, Isadora Prado] Univ Sao Paulo, Bauru Sch Dent, Dept Prosthodont & Periodontol, Bauru, SP, Brazil; [Dionisio, Thiago Jose; Cestari, Tania Mary; Calvo, Adriana Maria; Colombini-Ishikiriama, Bella Luna; Santos, Carlos Ferreira] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Cardoso Faria, Flavio Augusto; Siqueira, Walter Luiz] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Cardoso Faria, Flavio Augusto; Siqueira, Walter Luiz] Univ Western Ontario, Schulich Sch Med & Dent, Sch Dent, London, ON, Canada	Universidade de Sao Paulo; Universidade de Sao Paulo; Western University (University of Western Ontario); Western University (University of Western Ontario)	Santos, CF (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil.	cfsantos@fob.usp.br	Dionisio, Thiago Jose/E-6922-2014; Ishikiriama, Bella L C/C-5054-2012; Cano, Isadora Prado/AAN-1094-2021; Ishikiriama, Bella L C/GNH-1701-2022; Calvo, Adriana M/B-7668-2012; Siqueira, Walter/ABE-8924-2020; Santos, Carlos F/B-7676-2012; Siqueira, Walter/ABE-4069-2021; Faria, Flavio Augusto C/J-9994-2013	Dionisio, Thiago Jose/0000-0002-1655-4425; Ishikiriama, Bella L C/0000-0002-6671-0799; Cano, Isadora Prado/0000-0003-2506-8004; Ishikiriama, Bella L C/0000-0002-6671-0799; Calvo, Adriana M/0000-0002-2876-0955; Siqueira, Walter/0000-0003-1921-3658; Santos, Carlos F/0000-0002-0405-3500; Faria, Flavio Augusto C/0000-0001-6325-3716; Cestari, Tania Mary/0000-0003-1287-5974	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP) [2014/12975-9, 2014/22379-4, 2017/17747-2, 2015/03965-2]	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank the Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP http://www.fapesp.br/) for the financial support given to IPC (grants #2014/12975-9, 2014/22379-4 and 2017/17747-2) and CFS (grant #2015/03965-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterman A, 2012, ARCH ORAL BIOL, V57, P663, DOI 10.1016/j.archoralbio.2011.12.008; Amano O, 2012, ACTA HISTOCHEM CYTOC, V45, P241, DOI 10.1267/ahc.12013; ANDERSON LC, 1995, J PHYSIOL-LONDON, V485, P503, DOI 10.1113/jphysiol.1995.sp020746; Andrade LC, 1994, REV FAC ODONTOL BAUR, V2, P61; Andrade LC, REV FAC ODONTOL, V93; Baltatu O, 1998, MOL BRAIN RES, V54, P237, DOI 10.1016/S0169-328X(97)00339-2; BARKA T, 1980, J HISTOCHEM CYTOCHEM, V28, P836, DOI 10.1177/28.8.7003006; BENARDE MELVIN A., 1956, JOUR DENTAL RES, V35, P326, DOI 10.1177/00220345560350022801; Bighetti BB, 2014, INT J EXP PATHOL, V95, P351, DOI 10.1111/iep.12092; Cadnapaphornchai MA, 2004, AM J PHYSIOL-RENAL, V286, pF875, DOI 10.1152/ajprenal.00243.2003; Chalas R, 2018, MED SCI MONITOR, V24, P200, DOI 10.12659/MSM.906618; Chappell MC, 2016, AM J PHYSIOL-HEART C, V310, pH137, DOI 10.1152/ajpheart.00618.2015; Daniels D, 2009, EXP PHYSIOL, V94, P130, DOI 10.1113/expphysiol.2008.044446; de Lucia C, 2018, FRONT PHARMACOL, V9, P1, DOI [10.3389/fphar.2018.00001, DOI 10.3389/FPHAR.2018.00001]; de Ponte MC, 2017, KIDNEY BLOOD PRESS R, V42, P1277, DOI 10.1159/000485931; DZAU VJ, 1987, ENDOCRINOLOGY, V120, P2334, DOI 10.1210/endo-120-6-2334; EKKER M, 1989, P NATL ACAD SCI USA, V86, P5155, DOI 10.1073/pnas.86.13.5155; FAZEKAS A, 1991, ACTA PHYSIOL SCAND, V142, P503, DOI 10.1111/j.1748-1716.1991.tb09186.x; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Francischi JN, 2017, NEUROPEPTIDES, V62, P21, DOI 10.1016/j.npep.2017.01.003; Hall JE, 2017, PAPEL RINS CONTROLE, P227; Hatch M, 1996, J PHARMACOL EXP THER, V276, P187; Heran BS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003822.pub2; Heran BS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003823.pub2; ITO S, 1979, ARCH HISTOL JAPON, V42, P89, DOI 10.1679/aohc1950.42.89; Kon Y, 1999, ANAT HISTOL EMBRYOL, V28, P239, DOI 10.1046/j.1439-0264.1999.00197.x; Masajtis-Zagajewska A, 2009, NEPHRON CLIN PRACT, V112, pC242, DOI 10.1159/000224790; Matsubara S, 2000, BIOL PHARM BULL, V23, P1185; Mulinari-Santos G, 2018, CLIN ORAL IMPLAN RES, V29, P1126, DOI 10.1111/clr.13376; Nadu AP, 2008, J AM SOC HYPERTENS, V2, P341, DOI 10.1016/j.jash.2008.04.012; Nehme A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10035; Othman AI, 2017, EUR J PHARMACOL, V794, P27, DOI 10.1016/j.ejphar.2016.11.014; Ozdemir T, 2017, BIOMATERIALS, V142, P124, DOI 10.1016/j.biomaterials.2017.07.022; Peters J, 1999, ENDOCRINOLOGY, V140, P675, DOI 10.1210/en.140.2.675; Peters J, 2012, PEPTIDES, V34, P427, DOI 10.1016/j.peptides.2012.01.023; Sabino-Silva R, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-64; SAKAMOTO W, 1986, J CLIN CHEM CLIN BIO, V24, P437; Santos CF, 2009, J PERIODONTOL, V80, P130, DOI [10.1902/jop.2009.080264, 10.1902/jop.2009.080264 ]; Santos CF, 2002, J CARDIOVASC PHARM, V39, P628, DOI 10.1097/00005344-200205000-00002; Sato T, 2015, AM J PHYSIOL-REG I, V309, pR1432, DOI 10.1152/ajpregu.00306.2015; SCHILLER PW, 1976, CIRC RES, V39, P629, DOI 10.1161/01.RES.39.5.629; Susa T, 2013, ACTA HISTOCHEM CYTOC, V46, P187, DOI 10.1267/ahc.13037; Thatcher S, 2009, MOL CELL ENDOCRINOL, V302, P111, DOI 10.1016/j.mce.2009.01.019; Thulesen J, 2002, REGUL PEPTIDES, V106, P105, DOI 10.1016/S0167-0115(02)00058-7; Uijl E, 2018, CLIN SCI, V132, P839, DOI 10.1042/CS20180236; Villa A, 2016, ORAL DIS, V22, P365, DOI 10.1111/odi.12402; Wright JW, 2013, PFLUG ARCH EUR J PHY, V465, P133, DOI 10.1007/s00424-012-1102-2; Xie G, 2018, J IMMUNOTHER CANCER, V6, P1, DOI [10.1186/s40425-017-0311-9, DOI 10.1186/S40425-017-0311-9]; Yaguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064724; Yaguchi S, 2012, INVEST OPHTH VIS SCI, V53, P5416, DOI 10.1167/iovs.12-9891; Yamamuro T, 2013, BEHAV BRAIN RES, V236, P236, DOI 10.1016/j.bbr.2012.09.001; Zhang Z, 2017, CRYSTALS, V7, DOI 10.3390/cryst7010005; Zhou R, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12241	53	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217030	10.1371/journal.pone.0217030	http://dx.doi.org/10.1371/journal.pone.0217030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116771	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400039
J	Santhanam, P; Rowe, SP; Dias, JP; Ahima, RS				Santhanam, Prasanna; Rowe, Steven P.; Dias, Jenny Pena; Ahima, Rexford S.			Relationship between DXA measured metrics of adiposity and glucose homeostasis; An analysis of the NHANES data	PLOS ONE			English	Article							INSULIN-RESISTANCE; BODY-COMPOSITION; MODEL ASSESSMENT; CELL FUNCTION; FAT MASS; ASSOCIATION; OBESITY; INDEX	Introduction Obesity is associated with insulin resistance and type 2 diabetes. Dual-energy X-ray absorptiometry (DXA) is a means of determining body composition and body fat distribution at different sites including whole body and trunk-locations where there tends to be high correlation at an individual level. Methods We performed an analysis of DXA-derived metrics of adiposity (truncal fat %, subtotal fat % and total fat %) from the NHANES database and then correlated the findings with markers of insulin resistance. We analyzed the data from DXA scans in NHANES 1999-2004. Homeostatic model assessment-insulin resistance and HOMA-beta (beta-cell function) were estimated. Spearman correlation coefficients were calculated (rho) between HOMA-IR, HOMA-beta and different measures of obesity (Waist circumference(in cm), Body Mass Index (kg/m2), truncal fat %, subtotal fat % as well as total fat %) to gauge the relationship between markers of glucose homeostasis and DXA derived metrics of obesity. We also performed logarithmic transformation of HOMA-IR as well as HOMA-beta to ensure normality of distribution and to meet the criteria for regression analysis. A forward selection model (by outcome and gender) was performed to predict log transformed insulin resistance (log HOMA-IR) as well as log transformed HOMA-beta (log HOMA-beta, measure of beta cell function) from age, serum triglycerides, HDL, trunk fat% and the SBP (in both males and females separately), after reviewing the spearman correlation coefficients. Results There were a total of 6147 men and 6369 women who were part of the study cohort. There was a positive correlation between markers of adiposity and log HOMA-IR and log HOMA-beta in both males and females. Truncal fat % had the highest nonparametric correlation coefficent with log HOMA-IR among the DXA derived fat % (0.54 in males and 048 in females). In the multivariate analysis, truncal fat % was an independent predictor of logHOMA-IR as well as logHOMA-beta. In males, the significant predictors of log HOMA-IR were; age, truncal fat % and HDL cholesterol (Adjusted R square of 0.325 (+/- 0.66), F(3,207) = 34.63, p < .01). In females, the significant predictors of log HOMA-IR were; age, truncal fat %, SBP, Serum triglyceride and HDL cholesterol (Adjusted R square of 0.307 (+/- 0.65), F(5,198) = 18.9, p < .01). In both males and females, the significant predictors of log HOMA-beta were; age, and truncal fat%(Males; adjusted R square of 0.25 (+/- 0.63), F (2,208) = 36.4, p < .01, Females; adjusted R square of 0.27 (+/- 0.62), F (2,201) = 38.4, p < .01). Conclusions Body fat % on DXA is an imaging biomarker for insulin resistance. Incorporating this important information into DXA acquisitions and reporting frameworks may allow for this information to be available to providers who refer patients for these imaging studies.	[Santhanam, Prasanna; Dias, Jenny Pena; Ahima, Rexford S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD 21205 USA; [Rowe, Steven P.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Santhanam, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD 21205 USA.	psantha1@jhmi.edu	Ahima, Rexford/W-1394-2019		Bloomberg Distinguished Professorship in Diabetes	Bloomberg Distinguished Professorship in Diabetes	This work was supported by Bloomberg Distinguished Professorship in Diabetes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Araujo AJS, 2017, J HUM NUTR DIET, V30, P193, DOI 10.1111/jhn.12414; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Centers for Disease Control and Prevention, 2015, NAT HLTH NUTR EX SUR, V2015; DORDEVIC AL, 2018, NUTRIENTS, V10; Glintborg D, 2016, ACTA OBSTET GYN SCAN, V95, P1235, DOI 10.1111/aogs.12964; Gonzalez-Ruiz K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081086; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; Ji BL, 2017, ANGIOLOGY, V68, P716, DOI 10.1177/0003319716682120; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Lee JA, 2016, CAN J DIABETES, V40, P311, DOI 10.1016/j.jcjd.2015.11.009; Martinez KE, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/9502643; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Rothney MP, 2013, OBESITY, V21, P1798, DOI 10.1002/oby.20223; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; Shiel F, 2018, J SCI MED SPORT; Stoklossa CAJ, 2016, CURR OBES REP, V5, P389, DOI 10.1007/s13679-016-0228-5; Upadhyay J, 2018, MED CLIN N AM, V102, P13, DOI 10.1016/j.mcna.2017.08.004; Zhang Y, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0598-z; Zong G, 2016, OBESITY, V24, P2414, DOI 10.1002/oby.21659	22	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216900	10.1371/journal.pone.0216900	http://dx.doi.org/10.1371/journal.pone.0216900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116758	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400032
J	Nachmias, N; Langier, S; Brzezinski, RY; Siterman, M; Stark, M; Etkin, S; Avriel, A; Schwarz, Y; Shenhar-Tsarfaty, S; Bar-Shai, A				Nachmias, Noy; Langier, Sheila; Brzezinski, Rafael Y.; Siterman, Matan; Stark, Moshe; Etkin, Sara; Avriel, Avital; Schwarz, Yehuda; Shenhar-Tsarfaty, Shani; Bar-Shai, Amir			NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE	Background Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized by a progressive and irreversible deterioration of lung function. Exacerbations of COPD have prolonged negative effects on pulmonary function and a major impact on health status and outcomes. NLRP3 inflammasome is a cardinal component of the inflammatory response, with marked evidence in stable and exacerbations of COPD. The aim of our study was to evaluate the NLRP3 inflammasome activity during COPD exacerbation by using an in vitro model. Methods A549 cells were stimulated with different concentrations (10%, 4%, 2%) of cigarette smoke extract (CSE) with or without LPS (0.1 mu g/ml) for 24 hours. Cell viability was assessed by using XTT test. Levels of inflammatory cytokines (IL-8, MCP-1, and IL-1 beta) were measured by ELISA and the activity level of NLRP-3 was evaluated by flow cytometry. Results Cells exposed to CSE present an increase in inflammatory cytokines (IL-8 and MCP-1) production in a dose-dependent manner. Incubation with LPS to these cells results in higher levels of IL-8 and MCP-1 compared to stimulation of CSE alone. NLRP3 inflammasome activity and IL-1 beta levels were significantly increased in cells exposed to both CSE and LPS compared to CSE alone. Conclusions NLRP3 inflammasome is upregulated in an in-vitro model of COPD and COPD exacerbation. Our findings provide novel biomarkers for COPD exacerbation and may present new targets for future research.	[Nachmias, Noy; Avriel, Avital] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr, Div Pulm Med, Ashqelon, Israel; [Nachmias, Noy; Brzezinski, Rafael Y.; Shenhar-Tsarfaty, Shani] Tel Aviv Sourasky Med Ctr, Dept Internal Med C D&E, Tel Aviv, Israel; [Nachmias, Noy; Langier, Sheila; Brzezinski, Rafael Y.; Siterman, Matan; Stark, Moshe; Etkin, Sara; Schwarz, Yehuda; Shenhar-Tsarfaty, Shani; Bar-Shai, Amir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Nachmias, Noy; Langier, Sheila; Siterman, Matan; Stark, Moshe; Etkin, Sara; Schwarz, Yehuda; Bar-Shai, Amir] Tel Aviv Sourasky Med Ctr, Pulm Inst, Tel Aviv, Israel; [Brzezinski, Rafael Y.] Tel Aviv Univ, Sackler Fac Med, Neufeld Cardiac Res Inst, Tel Aviv, Israel; [Brzezinski, Rafael Y.] Sheba Med Ctr, Leviev Heart Ctr, Tamman Cardiovasc Res Inst, Tel Hashomer, Israel	Ben Gurion University; Barzilai Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Bar-Shai, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Bar-Shai, A (corresponding author), Tel Aviv Sourasky Med Ctr, Pulm Inst, Tel Aviv, Israel.	Amir.barshai@gmail.com	Schwarz, Yehuda/GXN-3153-2022					Adamson J, 2011, BRONCHITIS; Bade G, 2014, INT J CHRONIC OBSTR, V9, P759, DOI 10.2147/COPD.S61347; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Basu S, 2011, EXPT MODELS STUDY CI, P401; Brusselle GG, 2014, CHEST, V145, P1121, DOI 10.1378/chest.13-1885; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; Faner Rosa, 2016, ERJ Open Res, V2; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee S, 2016, AM J RESP CELL MOL, V54, P151, DOI 10.1165/rcmb.2015-0231TR; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Lopez-Campos JL, 2015, LANCET RESP MED, V3, P729, DOI 10.1016/S2213-2600(15)00242-8; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Muellerova H, 2015, CHEST, V147, P999, DOI 10.1378/chest.14-0655; Sin DD, 2015, AM J RESP CRIT CARE, V192, P1162, DOI 10.1164/rccm.201505-0871PP; SMITH BT, 1977, AM REV RESPIR DIS, V115, P285; Victoni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085243; Wedzicha JA, 2013, BREATHE, V9, P435, DOI 10.1183/20734735.002913; Zou Y, 2017, INT J CHRONIC OBSTR, V12, P1247, DOI 10.2147/COPD.S131877; 2011, EUROPEAN RESP J, V38, P1019, DOI DOI 10.1183/09031936	24	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0214622	10.1371/journal.pone.0214622	http://dx.doi.org/10.1371/journal.pone.0214622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112544	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000006
J	Monttinen, HAM; Ravantti, JJ; Poranen, MM				Monttinen, Heli A. M.; Ravantti, Janne J.; Poranen, Minna M.			Structural comparison strengthens the higher-order classification of proteases related to chymotrypsin	PLOS ONE			English	Article							PROTEOLYTIC-ENZYMES; CRYSTAL-STRUCTURE; CD-HIT; PROTEIN; VIRUS; INITIATION; EVOLUTION; MEROPS; MECHANISMS; CLEAVAGE	Specific cleavage of proteins by proteases is essential for several cellular, physiological, and viral processes. Chymotrypsin-related proteases that form the PA clan in the MEROPS classification of proteases is one of the largest and most diverse group of proteases. The PA clan comprises serine proteases from bacteria, eukaryotes, archaea, and viruses and chymotrypsin-related cysteine proteases from positive-strand RNA viruses. Despite low amino acid sequence identity, all PA clan proteases share a conserved double beta-barrel structure. Using an automated structure-based hierarchical clustering method, we identified a common structural core of 72 amino acid residues for 143 PA clan proteases that represent 12 protein families and 11 subfamilies. The identified core is located around the catalytic site between the two beta-barrels and resembles the structures of the smallest PA clan proteases. We constructed a structure-based distance tree derived from the properties of the identified common core. Our structure-based analyses support the current classification of these proteases at the subfamily level and largely at the family level. Structural alignment and structure-based distance trees could thus be used for directing objective classification of PA clan proteases and to strengthen their higher order classification. Our results also indicate that the PA clan proteases of positive-strand RNA viruses are related to cellular heat-shock proteases, which suggests that the exchange of protease genes between viruses and cells might have occurred more than once.	[Monttinen, Heli A. M.; Ravantti, Janne J.; Poranen, Minna M.] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Programme, Helsinki, Finland; [Ravantti, Janne J.] Univ Helsinki, Fac Med, Appl Tumor Genom Res Program, Helsinki, Finland; [Monttinen, Heli A. M.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	University of Helsinki; University of Helsinki; Newcastle University - UK	Ravantti, JJ; Poranen, MM (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Programme, Helsinki, Finland.; Ravantti, JJ (corresponding author), Univ Helsinki, Fac Med, Appl Tumor Genom Res Program, Helsinki, Finland.	janne.ravantti@helsinki.fi; minna.poranen@helsinki.fi		Monttinen, Heli/0000-0003-2461-0690; Poranen, Minna/0000-0002-4775-3670; Ravantti, Janne/0000-0002-8578-7230	Academy of Finland [250113, 272507]; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation [170046]; Jenny and Antti Wihuri Foundation; Oskari Huttunen foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; Jenny and Antti Wihuri Foundation; Oskari Huttunen foundation	This work was supported by grants from the Academy of Finland (250113 and 272507 to MMP), the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation (170046), the Jenny and Antti Wihuri Foundation, and the Oskari Huttunen foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bendova-Biedermannova L, 2008, PROTEINS, V72, P402, DOI 10.1002/prot.21938; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Choi HK, 1996, J MOL BIOL, V262, P151, DOI 10.1006/jmbi.1996.0505; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Fackovec B, 2012, J PHYS CHEM B, V116, P12651, DOI 10.1021/jp303088n; Fischer K, 2009, J MOL BIOL, V390, P635, DOI 10.1016/j.jmb.2009.04.082; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gayathri P, 2006, VIROLOGY, V346, P440, DOI 10.1016/j.virol.2005.11.011; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan S, 2011, J MOL BIOL, V413, P985, DOI 10.1016/j.jmb.2011.09.028; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Krupovic M, 2017, P NATL ACAD SCI USA, V114, pE2401, DOI 10.1073/pnas.1621061114; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Laskar Aparna, 2012, BMC Res Notes, V5, P256, DOI 10.1186/1756-0500-5-256; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; Ravantti J, 2013, J STRUCT BIOL, V183, P47, DOI 10.1016/j.jsb.2013.05.007; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Smith SA, 2015, CRIT REV BIOCHEM MOL, V50, P326, DOI 10.3109/10409238.2015.1050550; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soubrier J, 2012, MOL BIOL EVOL, V29, P3345, DOI 10.1093/molbev/mss140; Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zhang JZ, 2015, NAT REV GENET, V16, P409, DOI 10.1038/nrg3950; Zurawa-Janicka D, 2017, ARCH BIOCHEM BIOPHYS, V621, P6, DOI 10.1016/j.abb.2017.04.004; 2016, MOL BIOL EVOL, V33, P1697, DOI DOI 10.1093/MOLBEV/MSS140; 2014, MOL BIOL EVOL, V31, P2741, DOI DOI 10.1093/MOLBEV/MSU219; 1979, J MOL BIOL, V134, P109; 2012, J CHEM THEORY COMPUT, V8, P3257, DOI DOI 10.1021/CT300400X	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216659	10.1371/journal.pone.0216659	http://dx.doi.org/10.1371/journal.pone.0216659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100077	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600013
J	Jansen, MJA; Kuijf, HJ; Veldhuis, WB; Wessels, FJ; Viergever, MA; Pluim, JPW				Jansen, Marielle J. A.; Kuijf, Hugo J.; Veldhuis, Wouter B.; Wessels, Frank J.; Viergever, Max A.; Pluim, Josien P. W.			Automatic classification of focal liver lesions based on MRI and risk factors	PLOS ONE			English	Article							SEGMENTATION	Objectives Accurate classification of focal liver lesions is an important part of liver disease diagnostics. In clinical practice, the lesion type is often determined from the abdominal MR examination, which includes T2-weighted and dynamic contrast enhanced (DCE) MR images. To date, only T2-weighted images are exploited for automatic classification of focal liver lesions. In this study additional MR sequences and risk factors are used for automatic classification to improve the results and to make a step forward to a clinically useful aid for radiologists. Materials and methods Clinical MRI data sets of 95 patients with in total 125 benign lesions (40 adenomas, 29 cysts and 56 hemangiomas) and 88 malignant lesions (30 hepatocellular carcinomas (HCC) and 58 metastases) were included in this study. Contrast curve, gray level histogram, and gray level co-occurrence matrix texture features were extracted from the DCE-MR and T2-weighted images. In addition, risk factors including the presence of steatosis, cirrhosis, and a known primary tumor were used as features. Fifty features with the highest ANOVA F-score were selected and fed to an extremely randomized trees classifier. The classifier evaluation was performed using the leave-one-out principle and receiver operating characteristic (ROC) curve analysis. Results The overall accuracy for the classification of the five major focal liver lesion types is 0.77. The sensitivity/specificity is 0.80/0.78, 0.93/0.93, 0.84/0.82, 0.73/0.56, and 0.62/0.77 for adenoma, cyst, hemangioma, HCC, and metastasis, respectively. Conclusion The proposed classification system using features derived from clinical DCE-MR and T2-weighted images, with additional risk factors is able to differentiate five common types of lesions and is a step forward to a clinically useful aid for focal liver lesion diagnosis.	[Jansen, Marielle J. A.; Kuijf, Hugo J.; Viergever, Max A.; Pluim, Josien P. W.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Jansen, Marielle J. A.; Kuijf, Hugo J.; Viergever, Max A.; Pluim, Josien P. W.] Univ Utrecht, Utrecht, Netherlands; [Veldhuis, Wouter B.; Wessels, Frank J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Jansen, MJA (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.; Jansen, MJA (corresponding author), Univ Utrecht, Utrecht, Netherlands.	M.J.A.Jansen-35@umcutrecht.nl	Kuijf, Hugo J/G-2711-2013	Kuijf, Hugo J/0000-0001-6997-9059; Veldhuis, Wouter/0000-0002-9798-6843; Jansen, Marielle/0000-0001-7722-3817	project BENEFIT (Better Effectiveness aNd Efficiency by measuring and modelling of Interventional Therapy) in the framework of the EU research programme ITEA (Information Technology for European Advancement)	project BENEFIT (Better Effectiveness aNd Efficiency by measuring and modelling of Interventional Therapy) in the framework of the EU research programme ITEA (Information Technology for European Advancement)	This work was financially supported by the project BENEFIT (Better Effectiveness aNd Efficiency by measuring and modelling of Interventional Therapy) in the framework of the EU research programme ITEA (Information Technology for European Advancement). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiin N, 2012, CURR MED IMAGING REV, V8, P107; Ba-Ssalamah A, 2009, EUR RADIOL, V19, P342, DOI 10.1007/s00330-008-1172-x; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Chen WJ, 2004, MED PHYS, V31, P1076, DOI 10.1118/1.1695652; Elsayes KM, 2005, RADIOGRAPHICS, V25, P1299, DOI 10.1148/rg.255045180; Fowler KJ, 2011, HEPATOLOGY, V54, P2227, DOI 10.1002/hep.24679; Gatos I, 2017, MED PHYS, V44, P3695, DOI 10.1002/mp.12291; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gilhuijs KGA, 1998, MED PHYS, V25, P1647, DOI 10.1118/1.598345; HAMM B, 1994, RADIOLOGY, V190, P417, DOI 10.1148/radiology.190.2.8284392; Holalkere NS, 2006, J COMPUT ASSIST TOMO, V30, P591, DOI 10.1097/00004728-200607000-00007; Huizinga W, 2016, MED IMAGE ANAL, V29, P65, DOI 10.1016/j.media.2015.12.004; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jansen MJA, 2018, I S BIOMED IMAGING, P245; Jansen MJA, 2017, PHYS MED BIOL, V62, P7556, DOI 10.1088/1361-6560/aa8848; Kallenberg M, 2016, IEEE T MED IMAGING, V35, P1322, DOI 10.1109/TMI.2016.2532122; Khalifa F, 2014, MED PHYS, V41; Matos AP, 2015, WORLD J HEPATOL, V7, P1987, DOI 10.4254/wjh.v7.i16.1987; Mayerhoefer ME, 2010, J MAGN RESON IMAGING, V32, P352, DOI 10.1002/jmri.22268; Mendrik AM, 2011, PHYS MED BIOL, V56, P3857, DOI 10.1088/0031-9155/56/13/008; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; van Tulder G, 2016, IEEE T MED IMAGING, V35, P1262, DOI 10.1109/TMI.2016.2526687	22	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217053	10.1371/journal.pone.0217053	http://dx.doi.org/10.1371/journal.pone.0217053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095624	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100071
J	van den Tillaar, R; Andersen, V; Saeterbakken, AH				van den Tillaar, Roland; Andersen, Vidar; Saeterbakken, Atle Hole			Comparison of muscle activation and kinematics during free-weight back squats with different loads	PLOS ONE			English	Article							CLOSED KINETIC CHAIN; RESISTANCE; STRENGTH; INTENSITY; VELOCITY; SINGLE; PRESS; KNEE	Although several studies have examined the effects of performing resistance training with different percentages of one-repetition maximum (1-RM), little is known of the neuromuscular effects and kinematics of lifting low to heavy loads with maximal movement velocity. The aim of this study is to compare muscle activation and kinematics in free-weight back squats with different loads. Thirteen resistance-training males (aged 24.2 +/- 2.0 years, body mass 81.5 +/- 9.1 kg, height 1.78 +/- 0.06 m) with 6 +/- 3 years of resistance-training experience conducted squats with 30%-100% of 1-RM. Barbell kinematics and electromyographic (EMG) activity of the vastus lateralis, vastus medialis, rectus femoris, semitendinosus, biceps femoris, and gluteus maximus were measured in the upward phase of each load. With increasing loads, the barbell velocity decreased, the upward phase duration increased, and the peak velocity occurred later. The muscle activation in all muscles increased with increasing loads but was not linear. In general, similar muscle activation in the prime movers was observed for loads between 40% and 60% of 1-RM and between 70% and 90% of 1-RM, with 100% of 1-RM being superior to the other loads when the loads were lifted at maximal intended velocity. However, the timing of maximal muscle activations was not affected by the different loadings for the quadriceps, but the timing was sequential and independent of loading (rectus femoris before vastus medial before vastus lateral). Maximal activation in the gluteus and semitendinosus increased with increasing loads. This means that for muscle activation, maximal lifting velocity may compensate for increased loads, which may allow resistance-trained athletes and individuals in rehabilitation to avoid heavy loads but still get the same muscle activation.	[van den Tillaar, Roland] Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway; [Andersen, Vidar; Saeterbakken, Atle Hole] Western Norway Univ, Fac Teacher Educ Culture & Sport, Dept Sport Food & Nat Sci, Sogndal, Sogn Og Fjordan, Norway	Nord University	van den Tillaar, R (corresponding author), Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway.	roland.v.tillaar@nord.no						Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Andersen V, 2014, INT J SPORTS MED, V35, P1196, DOI 10.1055/s-0034-1382016; Aspe RR, 2014, J STRENGTH COND RES, V28, P2827, DOI 10.1519/JSC.0000000000000462; Bangalore S, 2006, J AM COLL CARDIOL, V48, P1471, DOI 10.1016/j.jacc.2006.07.011; Bloomquist K, 2013, EUR J APPL PHYSIOL, V113, P2133, DOI 10.1007/s00421-013-2642-7; Bosquet L, 2010, J SPORT SCI MED, V9, P459; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Clark DR, 2012, J STRENGTH COND RES, V26, P1169, DOI 10.1519/JSC.0b013e31822d533d; Cochrane DJ, 2015, RES SPORTS MED, V23, P179, DOI 10.1080/15438627.2015.1005299; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Drinkwater EJ, 2007, J STRENGTH COND RES, V21, P841; Ema R, 2016, EUR J APPL PHYSIOL, V116, P1031, DOI 10.1007/s00421-016-3363-5; Escamilla RF, 1998, MED SCI SPORT EXER, V30, P556, DOI 10.1097/00005768-199804000-00014; Escamilla RF, 2001, MED SCI SPORT EXER, V33, P984, DOI 10.1097/00005768-200106000-00019; Farahmand F, 1998, J ORTHOP RES, V16, P136, DOI 10.1002/jor.1100160123; Gomes WA, 2015, J STRENGTH COND RES, V29, P2482, DOI 10.1519/JSC.0000000000000922; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Goodman CA, 2008, J STRENGTH COND RES, V22, P88, DOI 10.1519/JSC.0b013e31815ef6b3; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kaneko M, 1983, SCAND J SPORTS SCI, V5, P50; KOMI PV, 1987, INT J SPORTS MED, V8, P22; Marshall PWM, 2011, EUR J APPL PHYSIOL, V111, P3007, DOI 10.1007/s00421-011-1944-x; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; Newton RU, 1997, EUR J APPL PHYSL, V50, P311; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Saeterbakken AH, 2016, J STRENGTH COND RES, V30, P945, DOI 10.1519/JSC.0000000000001178; Saeterbakken AH, 2014, J STRENGTH COND RES, V28, P3056, DOI 10.1519/JSC.0000000000000516; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P130, DOI 10.1519/JSC.0b013e3182541d43; Sanchez Medina L., 2010, THESIS; Suchomel TJ, 2018, SPORTS MED, V48, P765, DOI 10.1007/s40279-018-0862-z; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; van den Tillaar R, 2014, KINESIOL SLOVENICA, V20, P5; van den Tillaar R, 2015, KINESIOL SLOVEN, V21, P15; van den Tillaar R, 2014, J HUM KINET, V42, P63, DOI 10.2478/hukin-2014-0061; van den Tillaar R, 2009, MED SCI SPORT EXER, V41, P2056, DOI 10.1249/MSS.0b013e3181a8c360; Yavuz HU, 2017, APPL BIONICS BIOMECH, V2017, DOI 10.1155/2017/9084725; 2002, CLIN ANAT, V15, P116; 2008, J BIOMECH, V41, P3127, DOI DOI 10.1016/J.JBIOMECH.2008.09.003; MED SCI SPORTS EXERC, V32, P459; 1981, EUR J APPL PHYSL OCC, V46, P221; 2010, INT J SPORT PHYSIOL, V5, P177	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217044	10.1371/journal.pone.0217044	http://dx.doi.org/10.1371/journal.pone.0217044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095625	Green Submitted, Green Published, gold			2022-12-27	WOS:000468030100070
J	Brant, JO; Boatwright, JL; Davenport, R; Sandoval, AGW; Maden, M; Barbazuk, WB				Brant, Jason O.; Boatwright, J. Lucas; Davenport, Ruth; Sandoval, Aaron Gabriel W.; Maden, Malcolm; Barbazuk, W. Brad			Comparative transcriptomic analysis of dermal wound healing reveals de novo skeletal muscle regeneration in Acomys cahirinus	PLOS ONE			English	Article							RNA-SEQ DATA; COEXPRESSION NETWORK; GENE-EXPRESSION; CYTOKINE PRODUCTION; SMALL-WORLD; MOUSE SKIN; CELL; ACTIVATION; IL-10; ANNOTATION	The African spiny mouse, Acomys spp., is capable of scar-free dermal wound healing. Here, we have performed a comprehensive analysis of gene expression throughout wound healing following full-thickness excisional dermal wounds in both Acomys cahirinus and Mus musculus. Additionally, we provide an annotated, de novo transcriptome assembly of A. cahirinus skin and skin wounds. Using a novel computational comparative RNA-Seq approach along with pathway and co-expression analyses, we identify enrichment of regeneration associated genes as well as upregulation of genes directly related to muscle development or function. Our RT-qPCR data reveals induction of the myogenic regulatory factors, as well as upregulation of embryonic myosin, starting between days 14 and 18 post-wounding in A. cahirinus. In contrast, the myogenic regulatory factors remain downregulated, embryonic myosin is only modestly upregulated, and no new muscle fibers of the panniculus carnosus are generated in M. musculus wounds. Additionally, we show that Col6a1, a key component of the satellite cell niche, is upregulated in A. cahirinus compared to M. musculus. Our data also demonstrate that the macrophage profile and inflammatory response is different between species, with A. cahirinus expressing significantly higher levels of parallel to 10. We also demonstrate differential expression of the upstream regulators Wnt7a, Wnt2 and Wnt6 during wound healing. Our analyses demonstrate that A. cahirinus is capable of de novo skeletal muscle regeneration of the panniculus carnosus following removal of the extracellular matrix. We believe this study represents the first detailed analysis of de novo skeletal muscle regeneration observed in an adult mammal.	[Brant, Jason O.; Boatwright, J. Lucas; Davenport, Ruth; Sandoval, Aaron Gabriel W.; Maden, Malcolm; Barbazuk, W. Brad] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Maden, Malcolm; Barbazuk, W. Brad] Univ Florida, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maden, M; Barbazuk, WB (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Maden, M; Barbazuk, WB (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	malcmaden@ufl.edu; bbarbazuk@ufl.edu	Brant, Jason Orr/GNH-5703-2022; Brant, Jason/AAA-5275-2022	Brant, Jason Orr/0000-0002-9800-9251; Barbazuk, William/0000-0002-0909-4563; Sandoval, Aaron Gabriel/0000-0003-2377-2815; Boatwright, Lucas/0000-0003-4371-2457; Maden, Malcolm/0000-0001-7178-5309	WM Keck Foundation; National Institute of Health [1R210D023210]; Department of Biological Sciences at University of Florida; Florida Genetics Institute; University of Florida College of Liberal Arts and sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD023210] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biological Sciences at University of Florida; Florida Genetics Institute; University of Florida College of Liberal Arts and sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a grant from the WM Keck Foundation (Regenerative Potential of African Spiny Mouse). Additionally, JOB was supported by National Institute of Health R21 award 1R210D023210 to MM & WBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank UF Research Computing for access to computer infrastructure and systems support. The Department of Biological Sciences at University of Florida, the Florida Genetics Institute and the University of Florida College of Liberal Arts and sciences supported this work. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews S., 2010, FASTQC QUALITY CONTR; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayle J, 2008, J INVEST DERMATOL, V128, P871, DOI 10.1038/sj.jid.5701101; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brant JO, 2016, WOUND REPAIR REGEN, V24, P75, DOI 10.1111/wrr.12385; Brant JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142931; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Gawriluk TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11164; Gillespie C. S., 2015, J STAT SOFTW, V64, P2; Gish W., 2002, WU BLAST 2 0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grasman JM, 2015, ACTA BIOMATER, V25, P2, DOI 10.1016/j.actbio.2015.07.038; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; John SJ, SEQPREP TOOL STRIPPI; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maden M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27178-7; Mamrot J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09334-7; Musaro A., 2014, ADV BIOL-GER, V2014, P1, DOI [10.1155/2014/612471, DOI 10.1155/2014/612471]; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Petereit J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0298-8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; R Development Core Team, 2009, R LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simkin J, 2017, ELIFE, V6, DOI 10.7554/eLife.24623; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	70	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216228	10.1371/journal.pone.0216228	http://dx.doi.org/10.1371/journal.pone.0216228			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141508	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000004
J	O'Rourke, JA; Ravichandran, C; Howe, YJ; Mullett, JE; Keary, CJ; Golas, SB; Hureau, AR; McCormick, M; Chung, J; Rose, NR; McDougle, CJ				O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Mullett, Jennifer E.; Keary, Christopher J.; Golas, Sara B.; Hureau, Amrita R.; McCormick, Morgan; Chung, Jeanhee; Rose, Noel R.; McDougle, Christopher J.			Accuracy of self-reported history of autoimmune disease: A pilot study	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; RHEUMATOID-ARTHRITIS; FAMILY-HISTORY; QUESTIONNAIRE INFORMATION; MEDICAL-RECORDS; RISK; VALIDITY; POPULATION; PREVALENCE; VALIDATION	Research associating the increased prevalence of familial autoimmunity with neuropsychiatric disorders is reliant upon the ascertainment of history of autoimmune diseases from relatives. To characterize the accuracy of self-report, we compared self-reported diagnoses of 18 autoimmune diseases using an online self-report questionnaire to the electronic medical record (EMR) diagnoses in 1,013 adult (age 18-70 years) patients of a primary care clinic. For the 11 diseases meeting our threshold observed prevalence, we estimated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for selfreported diagnoses under the assumption that EMR-based diagnoses were accurate. Six diseases out of 11 had either sensitivity or PPV below 50%, with the lowest PPV for dermatological and endocrinological diseases. Common errors included incorrectly self-reporting type 2 diabetes mellitus (DM), when type 1 DM was indicated by the EMR, and reporting rheumatoid arthritis when osteoarthritis was indicated by the EMR. Results suggest that ascertainment of familial autoimmunity through self-report contributes to inconsistencies and inaccuracies in studies of autoimmune disease history and that future studies would benefit from incorporating EMR review and biological measures.	[O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Mullett, Jennifer E.; Keary, Christopher J.; Golas, Sara B.; Hureau, Amrita R.; McDougle, Christopher J.] Lurie Ctr Autism, Lexington, MA 02421 USA; [O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Mullett, Jennifer E.; Keary, Christopher J.; Golas, Sara B.; Hureau, Amrita R.; Chung, Jeanhee; McDougle, Christopher J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Keary, Christopher J.; Chung, Jeanhee; Rose, Noel R.; McDougle, Christopher J.] Harvard Med Sch, Boston, MA 02115 USA; [Ravichandran, Caitlin] McLean Hosp, Program Neuropsychiat Res, 115 Mill St, Belmont, MA 02178 USA; [McCormick, Morgan] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Rose, Noel R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Indiana University System; Indiana University Bloomington; Harvard University; Brigham & Women's Hospital	O'Rourke, JA (corresponding author), Lurie Ctr Autism, Lexington, MA 02421 USA.; O'Rourke, JA (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; O'Rourke, JA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	joorourke@mgh.harvard.edu	Ravichandran, Caitlin/AAH-5562-2020	O'Rourke, Julia/0000-0002-5926-1489	Robert and Donna Landreth Family Foundation; Nancy Lurie Marks Family Foundation	Robert and Donna Landreth Family Foundation; Nancy Lurie Marks Family Foundation	This work was supported by the Robert and Donna Landreth Family Foundation. JAO, CR, YJH, JEM, CJK, SBG, ARH, and CJM received this award. It also received support from the Nancy Lurie Marks Family Foundation; JAO, CR, YJH, JEM, CJK, SBG, ARH, and CJM received this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINO N, 1988, BAILLIERE CLIN ENDOC, V2, P591, DOI 10.1016/S0950-351X(88)80055-7; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Barber J, 2010, FAM PRACT, V27, P25, DOI 10.1093/fampra/cmp098; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777, DOI 10.1210/jc.2011-2038; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Burden-Teh E, 2018, BRIT J DERMATOL, V178, P1035, DOI 10.1111/bjd.16104; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chen SW, 2016, BEHAV BRAIN RES, V296, P61, DOI 10.1016/j.bbr.2015.08.035; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; Cooper GS, 2008, J RHEUMATOL, V35, P2001; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Cumming R., 1998, HDB PUBLIC HLTH METH; Danielsen K, 2013, BRIT J DERMATOL, V168, P1303, DOI 10.1111/bjd.12230; Deane KD, 2014, NAT REV RHEUMATOL, V10, P212, DOI 10.1038/nrrheum.2014.6; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Formica MK, 2010, ARTHRIT CARE RES, V62, P235, DOI 10.1002/acr.20073; Fradkin JE, 2012, HEALTH AFFAIR, V31, P12, DOI 10.1377/hlthaff.2011.1150; Genuth SM, 2017, DIABETES AM; Gilvarry CM, 1996, SCHIZOPHR RES, V19, P33, DOI 10.1016/0920-9964(95)00045-3; Hayter SM, 2012, AUTOIMMUN REV, V11, P754, DOI 10.1016/j.autrev.2012.02.001; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horton M, 2010, NEUROEPIDEMIOLOGY, V35, P83, DOI 10.1159/000311013; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Kelly-Pumarol IJ, 2018, J CLIN TRANSL SCI, V2, P163, DOI 10.1017/cts.2018.32; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Krakowiak P, 2015, MATERN CHILD HLTH J, V19, P1925, DOI 10.1007/s10995-015-1723-0; Kvien TK, 1996, J RHEUMATOL, V23, P1866; Ling SM, 2000, J RHEUMATOL, V27, P1390; Love TJ, 2011, SEMIN ARTHRITIS RHEU, V40, P413, DOI 10.1016/j.semarthrit.2010.05.002; Lyall K, 2014, J AUTISM DEV DISORD, V44, P1546, DOI 10.1007/s10803-013-2017-2; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; Mataix-Cols D, 2018, MOL PSYCHIATR, V23, P1652, DOI 10.1038/mp.2017.215; McDougle CJ, 2015, BRAIN RES, V1617, P72, DOI 10.1016/j.brainres.2014.09.048; Merkin SS, 2007, J CLIN EPIDEMIOL, V60, P634, DOI 10.1016/j.jclinepi.2006.09.003; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; Mikuls TR, 2002, ARTHRITIS RHEUM, V46, P83, DOI 10.1002/1529-0131(200201)46:1<83::AID-ART10042>3.0.CO;2-D; Modalsli EH, 2016, J INVEST DERMATOL, V136, P323, DOI 10.1038/JID.2015.386; Molloy CA, 2006, J AUTISM DEV DISORD, V36, P317, DOI 10.1007/s10803-005-0071-0; Mouridsen SE, 2007, DEV MED CHILD NEUROL, V49, P429, DOI 10.1111/j.1469-8749.2007.00429.x; Murphy TK, 2010, J NEUROIMMUNOL, V229, P243, DOI 10.1016/j.jneuroim.2010.08.017; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nielsen PR, 2017, J AM ACAD CHILD PSY, V56, P234, DOI 10.1016/j.jaac.2016.12.010; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2014, RHEUM DIS CLIN N AM, V40, P569, DOI 10.1016/j.rdc.2014.07.001; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Spinillo A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1076-8; Star VL, 1996, J RHEUMATOL, V23, P1862; Sweeten TL, 2003, PEDIATRICS, V112, pE420, DOI 10.1542/peds.112.5.e420; TRETLI S, 1982, J EPIDEMIOL COMMUN H, V36, P269, DOI 10.1136/jech.36.4.269; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Videm V, 2017, J RHEUMATOL, V44, P1134, DOI 10.3899/jrheum.161396; Walitt BT, 2008, J RHEUMATOL, V35, P811; Wallia A, 2014, JAMA-J AM MED ASSOC, V311, P2315, DOI 10.1001/jama.2014.5951; Wright P, 1996, SCHIZOPHR RES, V20, P261, DOI 10.1016/0920-9964(96)82950-1; Wu SQ, 2015, NEUROSCI BIOBEHAV R, V55, P322, DOI 10.1016/j.neubiorev.2015.05.004	67	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216526	10.1371/journal.pone.0216526	http://dx.doi.org/10.1371/journal.pone.0216526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141520	Green Published, gold			2022-12-27	WOS:000469323000014
J	Escobar-Turriza, P; Hernandez-Guerrero, R; Poot-Hernandez, AC; Rodriguez-Vazquez, K; Ramirez-Prado, J; Perez-Rueda, E				Escobar-Turriza, Pedro; Hernandez-Guerrero, Rafael; Cesar Poot-Hernandez, Augusto; Rodriguez-Vazquez, Katya; Ramirez-Prado, Jorge; Perez-Rueda, Ernesto			Identification of functional signatures in the metabolism of the three cellular domains of life	PLOS ONE			English	Article							ESCHERICHIA-COLI; EVOLUTION; ORGANIZATION; NETWORKS; PATHWAYS; DATABASE; ORIGIN	In order to identify common and specific enzymatic activities associated with the metabolism of the three cellular domains of life, the conservation and variations between the enzyme contents of Bacteria, Archaea, and Eukarya organisms were evaluated. To this end, the content of enzymes belonging to a particular pathway and their abundance and distribution in 1507 organisms that have been annotated and deposited in the KEGG database were assessed. In addition, we evaluated the consecutive enzymatic reaction pairs obtained from metabolic pathway reactions and transformed into sequences of enzymatic reactions, with catalytic activities encoded in the Enzyme Commission numbers, which are linked by a substrate. Both analyses are complementary: the first considers individual reactions associated with each organism and metabolic map, and the second evaluates the functional associations between pairs of consecutive reactions. From these comparisons, we found a set of five enzymatic reactions that were widely distributed in all the organisms and considered here as universal to Bacteria, Archaea, and Eukarya; whereas 132 pairs out of 3151 reactions were identified as significant, only 5 of them were found to be widely distributed in all the taxonomic divisions. However, these universal reactions are not widely distributed along the metabolic maps, suggesting their dispensability to all metabolic processes. Finally, we found that universal reactions are also associated with ancestral domains, such as those related to phosphorus-containing groups with a phosphate group as acceptor or those related to the ribulose-phosphate binding barrel, triosephosphate isomerase, and D-ribose-5-phosphate isomerase (RpiA) lid domain, among others. Therefore, we consider that this analysis provides clues about the functional constraints associated with the repertoire of enzymatic functions per organism.	[Escobar-Turriza, Pedro; Hernandez-Guerrero, Rafael; Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico; [Escobar-Turriza, Pedro; Ramirez-Prado, Jorge] Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico; [Cesar Poot-Hernandez, Augusto; Rodriguez-Vazquez, Katya] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Computacionales & Automatizac, Ciudad Univ, Ciudad De Mexico, Mexico; [Cesar Poot-Hernandez, Augusto] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ciudad Univ, Ciudad De Mexico, Mexico; [Perez-Rueda, Ernesto] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile	Universidad Nacional Autonoma de Mexico; Centro de Investigacion Cientifica de Yucatan; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Mayor	Escobar-Turriza, P; Perez-Rueda, E (corresponding author), Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico.; Escobar-Turriza, P (corresponding author), Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico.; Perez-Rueda, E (corresponding author), Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile.	pedro.escobar@cicy.mx; ernesto.perez@iimas.unam.mx	Ramirez-Prado, Jorge H/A-3012-2011; Rodriguez-Vázquez, Katya/ABF-4715-2020; Perez-Rueda, Ernesto/D-7468-2016	Ramirez-Prado, Jorge H/0000-0003-2780-5223; Rodriguez-Vázquez, Katya/0000-0002-9413-2762; Perez-Rueda, Ernesto/0000-0002-6879-0673; Escobar Turriza, Pedro Javier/0000-0003-1217-0966; Hernandez Guerrero, Rafael/0000-0003-1096-5968	CONACyT-Mexico [338189]; DGAPA-Universidad Nacional Autonoma de Mexico [IN201117]; CYTED [P918PTE0261]	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CYTED	PE-T was supported by a PhD fellowship (338189) from CONACyT-Mexico. DGAPA-Universidad Nacional Autonoma de Mexico (IN201117) and CYTED (P918PTE0261). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva V, 2015, ELIFE, V4, DOI 10.7554/eLife.09410; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Armenta-Medina D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-800; Aziz MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep25058; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Poot-Hernandez AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2113-0; Diaz-Mejia JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r26; Gonzalez RR, 2000, ESTUAR COAST SHELF S, V51, P507, DOI 10.1006/ecss.2000.0693; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hernandez-Montes G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r95; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim HS, 2013, J INTEGR BIOINFORMAT, V10, DOI 10.2390/biecoll-jib-2013-214; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; de la Osa JL, 2007, P NATL ACAD SCI USA, V104, P14941, DOI 10.1073/pnas.0706876104; Oates ME, 2015, NUCLEIC ACIDS RES, V43, pD227, DOI 10.1093/nar/gku1041; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Ortegon P, 2015, COMPUT STRUCT BIOTEC, V13, P277, DOI 10.1016/j.csbj.2015.04.001; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaeffer RD, 2017, NUCLEIC ACIDS RES, V45, pD296, DOI 10.1093/nar/gkw1137; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Yokobori S, 2016, ARCHAEA, V2016, DOI 10.1155/2016/1802675	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217083	10.1371/journal.pone.0217083	http://dx.doi.org/10.1371/journal.pone.0217083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136618	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300018
J	Sugihara, Y; Onoue, S; Tashiro, K; Sato, M; Hasegawa, T; Katakura, Y				Sugihara, Yuka; Onoue, Shiori; Tashiro, Kosuke; Sato, Mikako; Hasegawa, Takanori; Katakura, Yoshinori			Carnosine induces intestinal cells to secrete exosomes that activate neuronal cells	PLOS ONE			English	Article							OUTGROWTH; BRAIN	Recently, we showed that imidazole dipeptide such as carnosine contained abundantly in chicken breast meat improves brain function in a double-blind randomized controlled trial. However, the underlying molecular mechanisms remain unknown. Here, we investigated whether carnosine activates intestinal epithelial cells and induces the secretion of factors that activate brain function. We focused on exosomes derived from intestinal epithelial cells as mediators of brain-gut interaction. Results showed that exosomes derived from Caco-2 cells treated with carnosine significantly induced neurite growth in SH-SY5Y cells. To clarify the molecular basis of this finding, we performed integrated analysis of microRNAs (miRNAs) with altered expression in exosomes in response to carnosine treatment and mRNAs with altered expression in target cells in response to exosome treatment to identify related miRNAs and their target genes. The combination of miR-6769-5p and its target gene ATXN1 was found to be involved in the exosome-induced activation of neuronal cells.	[Sugihara, Yuka; Katakura, Yoshinori] Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Nishi Ku, Fukuoka, Fukuoka, Japan; [Onoue, Shiori; Katakura, Yoshinori] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka, Fukuoka, Japan; [Tashiro, Kosuke; Katakura, Yoshinori] Kyushu Univ, Fac Agr, Nishi Ku, Fukuoka, Fukuoka, Japan; [Sato, Mikako; Hasegawa, Takanori] NH Foods Ltd, R&D Ctr, Tsukuba, Ibaraki, Japan	Kyushu University; Kyushu University; Kyushu University; NH Foods Ltd.	Katakura, Y (corresponding author), Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Nishi Ku, Fukuoka, Fukuoka, Japan.; Katakura, Y (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka, Fukuoka, Japan.; Katakura, Y (corresponding author), Kyushu Univ, Fac Agr, Nishi Ku, Fukuoka, Fukuoka, Japan.	katakura@grt.kyushu-u.ac.jp		Katakura, Yoshinori/0000-0002-9678-9602	JSPS KAKENHI (Japan Society for the Promotion of Science) [16K14929]; NH Foods Ltd.; NH Foods Ltd	JSPS KAKENHI (Japan Society for the Promotion of Science); NH Foods Ltd.; NH Foods Ltd	YK awarded JSPS KAKENHI (Japan Society for the Promotion of Science, https://www.jsps.go.jp/, Grant Number: 16K14929). YK received the collaborative research cost from NH Foods Ltd. NH Foods Ltd provided support in the form of salaries for authors [MS, TH], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Asher M, 2016, NEUROSCIENCE, V322, P54, DOI 10.1016/j.neuroscience.2016.02.011; Bellia F, 2014, MOLECULES, V19, P2299, DOI 10.3390/molecules19022299; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Canfran-Duque A, 2014, MOL NUTR FOOD RES, V58, P687, DOI 10.1002/mnfr.201300350; Ding Q, 2018, AGING DIS, V9, P334, DOI 10.14336/AD.2017.0809; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fujii K, 2017, CYTOTECHNOLOGY, V69, P523, DOI 10.1007/s10616-017-0089-0; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Hisatsune T, 2016, J ALZHEIMERS DIS, V50, P149, DOI 10.3233/JAD-150767; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingram M, 2016, NEURON, V89, P1194, DOI 10.1016/j.neuron.2016.02.011; Kadooka K, 2015, J FUNCT FOODS, V13, P32, DOI 10.1016/j.jff.2014.12.024; Katakura Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111199; Keiser MS, 2015, BRAIN, V138, P3555, DOI 10.1093/brain/awv292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Perez-Bermudez P, 2017, EUR J PHARM SCI, V98, P40, DOI 10.1016/j.ejps.2016.09.022; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sale C, 2010, AMINO ACIDS, V39, P321, DOI 10.1007/s00726-009-0443-4; Son DO, 2008, CYTOKINE, V42, P265, DOI 10.1016/j.cyto.2008.02.011; Yamashita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101864; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013	26	15	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217394	10.1371/journal.pone.0217394	http://dx.doi.org/10.1371/journal.pone.0217394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136600	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300034
J	Tsusaka, T; Makino, B; Ohsawa, R; Ezura, H				Tsusaka, Takahiro; Makino, Bunsho; Ohsawa, Ryo; Ezura, Hiroshi			Genetic and environmental factors influencing the contents of essential oil compounds in Atractylodes lancea	PLOS ONE			English	Article							EXPERIMENTAL STOMACH ULCER; CRUDE DRUG ZHU; IDENTIFICATION; RHIZOMES; QUALITY; ORIGIN	Rhizomes of Atractylodes lancea are used in traditional Japanese medicine (Kampo) and Chinese medicine to treat numerous diseases and disorders because they contain many pharmacologically active compounds. The major active compounds in A. lancea are essential oil compounds such as beta-eudesmol, hinesol, atractylon, and atractylodin. The contents of the compounds in A. lancea exhibit high variability depending on their habitat. We cultivated clonal lines of A. lancea in different years (2016, 2017) and different locations (Hokkaido, Ibaraki) to investigate the influence of genetic and environmental factors on the contents of major compounds, namely, beta-eudesmol, hinesol, atractylon, and atractylodin. Broad sense heritability of beta-eudesmol, hinesol, atractylon, and atractylodin contents were 0.84, 0.77, 0.86, and 0.87, respectively. The effects of interannual variability on the contents of the compounds were lower than those of genotype. In addition, the cultivated environmental factors were assessed by different locations, and the correlations between Hokkaido and Ibaraki grown plants based on beta-eudesmol, hinesol, atractylon, and atractylodin contents were 0.94, 0.94, 1.00, and 0.83, respectively. The results suggest that the contents of beta-eudesmol, hinesol, atractylon, and atractylodin in A. lancea are largely influenced by genetic factors, and clonal propagation could be an effective strategy for obtaining populations with high contents of essential oil compounds. Furthermore, the contents of beta-eudesmol, hinesol, atractylon, and atractylodin in A. lancea exhibited few correlations with rhizome yields. A. lancea cultivars with not only high contents of essential oil compounds but also high rhizome yield could be developed through selective breeding.	[Tsusaka, Takahiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tsusaka, Takahiro] Tsumura & Co, Bot Raw Mat Prod Dept 2, Ami, Ibaraki, Japan; [Makino, Bunsho] Tsumura & Co, Bot Raw Mat Res Labs, Ami, Ibaraki, Japan; [Ohsawa, Ryo; Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; Tsumura & Company; Tsumura & Company; University of Tsukuba	Tsusaka, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Tsusaka, T (corresponding author), Tsumura & Co, Bot Raw Mat Prod Dept 2, Ami, Ibaraki, Japan.; Ezura, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	tsusaka_takahiro@mail.tsumura.co.jp; ezura.hiroshi.fa@u.tsukuba.ac.jp	Ezura, H/AAO-8184-2021	Tsusaka, Takahiro/0000-0002-4861-0612	Tsumura Co.	Tsumura Co.(Tsumura & Company)	This study was funded by Tsumura & Co. (https://www.tsumura.co.jp/english/).The funder provided support in the form of a salary for TT (First author) and BM (Second author). HE (Last author) and RO (Third author) are supervisors at the University of Tsukuba, to which TT belongs, and there is no funding from Tsumura & Co. The specific roles of these authors have been articulated in the "author contributions" section. Tsumura & Co. was responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2016, JAP PHARM, P1803; BURTON GW, 1953, AGRON J, V45, P478, DOI 10.2134/agronj1953.00021962004500100005x; Chen F, 2017, PLANT CELL TISS ORG, V130, P73, DOI 10.1007/s11240-017-1205-8; Chinese Pharmacopoeia Commission, 2015, CHINESE PHARMACOPOEI, P161; FERREIRA JFS, 1995, PLANTA MED, V61, P351, DOI 10.1055/s-2006-958098; Hong YB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00004; Japan Meteorological Agency, 2019, MET DAT DOWNL; Kaasboll OJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149000; KALTON RR, 1952, AGRON J, V44, P481, DOI 10.2134/agronj1952.00021962004400090007x; Koonrungsesomboon N, 2014, ASIAN PAC J TROP MED, V7, P421, DOI 10.1016/S1995-7645(14)60069-9; KUBO M, 1983, YAKUGAKU ZASSHI, V103, P442, DOI 10.1248/yakushi1947.103.4_442; MCDONALD ED, 1952, AGRON J, V44, P20, DOI 10.2134/agronj1952.00021962004400010007x; Mizukami H, 2000, BIOL PHARM BULL, V23, P589, DOI 10.1248/bpb.23.589; Nakai Y, 2003, J ETHNOPHARMACOL, V84, P51, DOI 10.1016/S0378-8741(02)00260-X; Nishikawa Y., 1975, SYOYAKUGAKU ZASSHI, V29, P139; NOGAMI M, 1986, CHEM PHARM BULL, V34, P3854; Ouyang Z, 2012, REV BRAS FARMACOGN, V22, P957, DOI 10.1590/S0102-695X2012005000051; Ren CG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-128; Shiba M, 2006, BIOL PHARM BULL, V29, P315, DOI 10.1248/bpb.29.315; Sudha G, 2002, PLANT CELL TISS ORG, V71, P181, DOI 10.1023/A:1020336626361; Takeda O, 1996, PLANTA MED, V62, P444, DOI 10.1055/s-2006-957936; Takeda O, 1997, CHEM PHARM BULL, V45, P1527; Takeda Osami, 1995, Natural Medicines, V49, P18; Ukai Y, 2002, GENETIC ANAL QUANTIT; Wang HX, 2008, PHYTOCHEMISTRY, V69, P2088, DOI 10.1016/j.phytochem.2008.04.008; Wang XM, 2015, PHYSIOL PLANTARUM, V153, P30, DOI 10.1111/ppl.12236; Yoshida M, 1998, DESIGN EXPT ANIMAL H, V8th; Yosioka I, 1958, CHEM PHARM BULL, V7, P319, DOI 10.1248/cpb.7.319; Yu F, 2008, FEBS LETT, V582, P565, DOI 10.1016/j.febslet.2008.01.020; Yuan Y, 2009, RUSS J PLANT PHYSL+, V56, P133, DOI 10.1134/S1021443709010191; Zhu SD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42417	31	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217522	10.1371/journal.pone.0217522	http://dx.doi.org/10.1371/journal.pone.0217522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136627	Green Submitted, gold, Green Published			2022-12-27	WOS:000469224300049
J	Gatti, P; Bligh, MC; Cortese, CG				Gatti, Paola; Bligh, Michelle C.; Cortese, Claudio G.			When a leader job resource can be ambivalent or even destructive: Independence at work as a double-edged sword	PLOS ONE			English	Article							LAISSEZ-FAIRE LEADERSHIP; PREDICT BURNOUT; EXCHANGE THEORY; DEMANDS; MODEL; ENGAGEMENT; DECISION; QUESTIONNAIRE; CONSTRUCTION; DESIGN	Independence at work is commonly considered a job resource which fosters motivation and employee well-being. Somewhat paradoxically, it is embedded in a relationship, and employees' independence also hinges on their leaders' willingness to grant it. Analyzing this resource as part of the leader-follower relationship can be useful in exploring its beneficial, ambivalent, or detrimental reciprocal effects. We present two Actor-Partner Interdependence Models (APIM) which analyze leaders' and followers' independence as antecedents, and work engagement and emotional exhaustion as outcomes. We test our models on 112 pairs of UK workers, finding a significant partner effect between leaders' independence and followers' exhaustion. Our findings confirm the utility of a dyadic perspective for investigating leadership and well-being at work, and suggest improvements for leadership training and measures fostering job well-being.	[Gatti, Paola; Cortese, Claudio G.] Univ Torino, Dept Psychol, Turin, Italy; [Bligh, Michelle C.] Claremont Grad Univ, Div Behav & Org Sci, Claremont, CA 91711 USA	University of Turin; Claremont Colleges; Claremont Graduate School	Bligh, MC (corresponding author), Claremont Grad Univ, Div Behav & Org Sci, Claremont, CA 91711 USA.	michelle.bligh@cgu.edu			European Union's Seventh Framework Programme for research, technological development and demonstration [PIEF-GA-2013-623836]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No. PIEF-GA-2013-623836. The data used for this paper are part of a Marie Curie IEF project entitled SatisFollowers carried out at the Durham University Business School by Dr. Paola Gatti (PG), under the supervision of Professor Birgit Schyns. The funder (https://ec.europa.eu/research/mariecurieactions/actions/individual-fellowships_en) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MH, 2015, LEADERSHIP QUART, V26, P790, DOI 10.1016/j.leaqua.2015.05.002; [Anonymous], 2017, POL PSYCHOL BULL; Arnold JA, 2000, J ORGAN BEHAV, V21, P249, DOI 10.1002/(SICI)1099-1379(200005)21:3<249::AID-JOB10>3.0.CO;2-#; Bakker A.B., 2007, J MANAGE PSYCHOL, V22, P309, DOI [DOI 10.1108/02683940710733115, 10.1108/02683940710733115]; Bakker A.B., 2008, CAREER DEV INT, V13, P209, DOI [DOI 10.1108/13620430810870476, 10.1108/13620430810870476]; Bakker AB, 2004, HUM RESOUR MANAGE-US, V43, P83, DOI 10.1002/hrm.20004; Bakker AB, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P1; Bakker AB, 2017, ORGAN DYN, V46, P67, DOI 10.1016/j.orgdyn.2017.04.002; Bakker AB, 2017, J OCCUP HEALTH PSYCH, V22, P273, DOI 10.1037/ocp0000056; Bakker AB, 2005, J OCCUP HEALTH PSYCH, V10, P170, DOI 10.1037/1076-8998.10.2.170; Bakker AB, 2010, J PERS PSYCHOL, V9, P3, DOI 10.1027/1866-5888/a000006; Bakker AB, 2009, J APPL PSYCHOL, V94, P1562, DOI 10.1037/a0017525; Bass B., 1994, IMPROVING ORG EFFECT; Bass B.M., 1999, EUROPEAN J WORK ORG, V8, P9, DOI [10.1080/135943299398410, DOI 10.1080/135943299398410]; Baxter L.A., 1996, RELATING DIALOGUES D; Bedeian AG, 2006, LEADERSHIP QUART, V17, P190, DOI 10.1016/j.leaqua.2005.12.006; Bierstedt R., 1964, EXCHANGE POWER SOCIA; BREAUGH JA, 1989, HUM RELAT, V42, P1033, DOI 10.1177/001872678904201105; BREAUGH JA, 1985, HUM RELAT, V38, P551, DOI 10.1177/001872678503800604; Burns J., 1978, LEADERSHIP; Carsten MK, 2010, LEADERSHIP QUART, V21, P543, DOI 10.1016/j.leaqua.2010.03.015; Chaleff I, 2009, COURAGEOUS FOLLOWER, V3; Chung ML, 2009, J PSYCHOSOM RES, V67, P29, DOI 10.1016/j.jpsychores.2009.01.009; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Cropanzano R, 2005, J MANAGE, V31, P874, DOI 10.1177/0149206305279602; DANSEREAU F, 1975, ORGAN BEHAV HUM PERF, V13, P46, DOI 10.1016/0030-5073(75)90005-7; Deci E. L., 1985, INTRINSIC MOTIVATION; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2010, J OCCUP HEALTH PSYCH, V15, P209, DOI 10.1037/a0019408; DeRue DS, 2010, ACAD MANAGE REV, V35, P627, DOI 10.5465/AMR.2010.53503267; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; Ferrin DL, 2008, ORGAN BEHAV HUM DEC, V107, P161, DOI 10.1016/j.obhdp.2008.02.012; Fitzpatrick J, 2016, QUANT METH PSYCHOL, V12, P74, DOI 10.20982/tqmp.12.1.p074; Gerstner CR, 1997, J APPL PSYCHOL, V82, P827, DOI 10.1037/0021-9010.82.6.827; Gooty J, 2012, LEADERSHIP QUART, V23, P1080, DOI 10.1016/j.leaqua.2012.10.002; GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623; Grant AM, 2009, ACAD MANAG ANN, V3, P317, DOI 10.1080/19416520903047327; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Halbesleben JRB, 2014, HUM RESOUR MANAGE R, V24, P177, DOI 10.1016/j.hrmr.2013.09.001; Halbesleben JRB, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P102; HEROLD DM, 1977, ACAD MANAGE J, V20, P224, DOI 10.2307/255396; Hinkin TR, 2008, J APPL PSYCHOL, V93, P1234, DOI 10.1037/a0012875; Hochwarter W, 2005, J BUS PSYCHOL, V19, P505, DOI 10.1007/s10869-005-4522-6; Huynh JY, 2014, WORK STRESS, V28, P305, DOI 10.1080/02678373.2014.936922; Karasek R., 1998, ENCY OCCUPATIONAL HL, V4th ed., p34.6; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kenny D.A., 2020, DYADIC DATA ANAL; Kenny D.A., 1998, HDB SOCIAL PSYCHOL, V4th ed., P233; LEITER MP, 1988, J ORGAN BEHAV, V9, P297, DOI 10.1002/job.4030090402; LIDEN RC, 1993, J APPL PSYCHOL, V78, P662, DOI 10.1037/0021-9010.78.4.662; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Mauno S, 2016, EUR J WORK ORGAN PSY, V25, P914, DOI 10.1080/1359432X.2016.1187135; MEINDL JR, 1985, ADMIN SCI QUART, V30, P78, DOI 10.2307/2392813; Nahrgang JD, 2009, ORGAN BEHAV HUM DEC, V108, P256, DOI 10.1016/j.obhdp.2008.09.002; Neufeld DJ, 2010, GROUP DECIS NEGOT, V19, P227, DOI 10.1007/s10726-008-9142-x; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; PERDUE CW, 1990, J PERS SOC PSYCHOL, V59, P475, DOI 10.1037/0022-3514.59.3.475; Petit W.E., 2017, MOTIV SCI, V3, P119, DOI [10.1037/mot0000054, DOI 10.1037/MOT0000054]; Schaubroeck JM, 2017, J APPL PSYCHOL, V102, P203, DOI 10.1037/apl0000165; Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43; Schaufeli WB., 2002, J HAPPINESS STUD, V3, P71, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; Schyns B, 2013, LEADERSHIP QUART, V24, P138, DOI 10.1016/j.leaqua.2012.09.001; Skogstad A, 2007, J OCCUP HEALTH PSYCH, V12, P80, DOI 10.1037/1076-8998.12.1.80; Skogstad A, 2014, WORK STRESS, V28, P323, DOI 10.1080/02678373.2014.957362; Stas L, 2018, PERS RELATIONSHIP, V25, P103, DOI 10.1111/pere.12230; Stenmark CK, 2011, LEADERSHIP QUART, V22, P942, DOI 10.1016/j.leaqua.2011.07.013; Thody, 2003, LEADERSHIP POLICY SC, V2, P141, DOI DOI 10.1076/LP0S.2.2.141.15542; Uhl-Bien M., 2007, FOLLOWER CTR PERSPEC, P187; Uhl-Bien M, 2006, LEADERSHIP QUART, V17, P654, DOI 10.1016/j.leaqua.2006.10.007; vanVeldhoven MJPM, 2015, MANUAL QEEW2 0 42 SH; WARR P, 1990, J OCCUP PSYCHOL, V63, P193, DOI 10.1111/j.2044-8325.1990.tb00521.x; Warr P., 1987, WORK UNEMPLOYMENT ME; Warr P, 2007, PSYCHOLOGIST, V20, P726; Xanthopoulou D., 2007, INT J STRESS MANAGE, V14, P121, DOI [10.1037/1072-5245.14.2.121, DOI 10.1037/10725245.14.2.121, DOI 10.1037/1072-5245.14.2.121]; 2001, B WORLD HEALTH ORGAN, V79, P373	77	1	1	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217482	10.1371/journal.pone.0217482	http://dx.doi.org/10.1371/journal.pone.0217482			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31121003	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700108
J	Ray-Kaeser, S; Thommen, E; Martini, R; Jover, M; Gurtner, B; Bertrand, AM				Ray-Kaeser, Sylvie; Thommen, Evelyne; Martini, Rose; Jover, Marianne; Gurtner, Basilie; Bertrand, Anne Martine			Psychometric assessment of the French European Developmental Coordination Disorder Questionnaire (DCDQ-FE)	PLOS ONE			English	Article							CROSS-CULTURAL-ADAPTATION; PHYSICAL-ACTIVITY; CHILDREN; VERSION; PARTICIPATION; VALIDITY; DISEASE; RISK	Background The Developmental Coordination Disorder Questionnaire'07 (DCDQ'07) is a parent-report measure to identify children at risk for Developmental Coordination Disorder (DCD). We developed a French version of the DCDQ'07 (DCDQ-FE) that has shown excellent inter-language reliability (intraclass correlation coefficient (ICC) = 0.91) and is culturally relevant for use in European countries. The aims of this study were to examine the internal consistency, test-retest reliability, construct validity of the Developmental Coordination Disorder Questionnaire-French European (DCDQ-FE), as well as establish a cut-off score. Methods The psychometric properties of the DCDQ-FE were examined with a clinical group of 30 children (mean age: 9.4 years, SD = 2.6) and a control group of 43 children (mean age: 9.1 years, SD = 2.4). Their parents (n = 73) filled out the DCDQ-FE at a first sitting and 70 of them filled it out 38 days later in average for test-retest reliability. The children were assessed using the Movement Assessment Battery for Children-2 (MABC-2) so as to measure the convergent validity of the DCDQ-FE. The cut-off score was determined with an additional sample of 42 children according to scores on the MABC-2 (>= 16th percentile) (n = 115). Results and implications Internal consistency of the DCDQ-FE was excellent (Cronbach's alpha = 0.96) and test-retest reliability was good (ICC = 0.956) with no differences between scores obtained at the two sittings (p > 0.05). Differences in scores between children in the clinical and control groups (Z = -6.58, p < 0.001) provide evidence of construct validity. The correlation obtained between DCDQ-FE and MABC-2 scores (Spearman's rho correlation coefficient = 0.802, p < 0.001) supports convergent validity. Using a cut-off of 56, overall sensitivity and specificity were 85.0% and 81.6% respectively (area under the curve = 0.896). The DCDQ-FE is a reliable and valid questionnaire for detecting children who are at risk for DCD in a European-French population of children aged 5 to 15 years old.	[Ray-Kaeser, Sylvie; Gurtner, Basilie; Bertrand, Anne Martine] HES SO Univ Appl Sci & Arts Western Switzerland, EESP, Sch Social Work & Hlth Sci, Dept Occupat Therapy, Lausanne, Switzerland; [Thommen, Evelyne] HES SO Univ Appl Sci & Arts Western Switzerland, EESP, Sch Social Work & Hlth Sci, Dept Social Work, Lausanne, Switzerland; [Martini, Rose] Univ Ottawa, Fac Hlth Sci, Occupat Therapy Program, Ottawa, ON, Canada; [Jover, Marianne] Aix Marseille Univ, PSYCLE, Aix En Provence, France	University of Applied Sciences & Arts Western Switzerland; University of Applied Sciences & Arts Western Switzerland; University of Ottawa; UDICE-French Research Universities; Aix-Marseille Universite	Ray-Kaeser, S (corresponding author), HES SO Univ Appl Sci & Arts Western Switzerland, EESP, Sch Social Work & Hlth Sci, Dept Occupat Therapy, Lausanne, Switzerland.	sylvie.ray@eesp.ch	Martini, Rose/AAB-1195-2019	Jover, Marianne/0000-0003-2987-7968; Thommen, Evelyne/0000-0002-5291-8345; RAY-KAESER, Sylvie/0000-0001-6706-6934	HES-SO University of Applied Sciences and Arts of Western Switzerland [26-015]	HES-SO University of Applied Sciences and Arts of Western Switzerland	The study was supported with funding from the HES-SO University of Applied Sciences and Arts of Western Switzerland, health domain (26-015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Barnett AL, 2014, CURR DEV DISORD REP, V1, P132, DOI [10.1007/s40474-014-0011-9, DOI 10.1007/S40474-014-0011-9]; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Blank R, 2019, DEV MED CHILD NEUROL, V61, P242, DOI 10.1111/dmcn.14132; Blank R, 2012, DEV MED CHILD NEUROL, V54, P54, DOI 10.1111/j.1469-8749.2011.04171.x; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Caravale B, 2015, RES DEV DISABIL, V36, P543, DOI 10.1016/j.ridd.2014.10.035; Carney J, 2005, J PEDIATR-US, V147, P515, DOI 10.1016/j.jpeds.2005.05.013; Civetta Lauren R, 2008, Pediatr Phys Ther, V20, P39, DOI 10.1097/PEP.0b013e31815ccaeb; Darsaklis V, 2013, PHYS OCCUP THER PEDI, V33, P186, DOI 10.3109/01942638.2012.739268; Denis I, 2012, SPINE, V37, pE439, DOI 10.1097/BRS.0b013e318233eaf9; Dubert T, 2001, Chir Main, V20, P294, DOI 10.1016/S1297-3203(01)00049-X; Duque L. M. S., 2012, REV CIENC SALUD, V10, P31; Durand Marie-Jose, 2005, J Hand Ther, V18, P34, DOI 10.1197/j.jht.2004.10.010; Faught BE, 2005, J ADOLESCENT HEALTH, V37, P376, DOI 10.1016/j.jadohealth.2004.09.021; Flapper BCT, 2013, RES DEV DISABIL, V34, P756, DOI 10.1016/j.ridd.2012.10.014; Glascoe FP, 1999, J PAEDIATR CHILD H, V35, P1, DOI 10.1046/j.1440-1754.1999.00342.x; Green D, 2011, RES DEV DISABIL, V32, P1332, DOI 10.1016/j.ridd.2011.01.040; Green Dido, 2008, Can J Occup Ther, V75, P208; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hay JA, 2004, J ADOLESCENT HEALTH, V34, P308, DOI 10.1016/j.jadohealth.2003.07.004; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Jarus T, 2011, RES DEV DISABIL, V32, P1323, DOI 10.1016/j.ridd.2011.01.033; Kennedy-Behr A, 2013, NEUROPEDIATRICS, V44, P245, DOI 10.1055/s-0033-1347936; Lingam R, 2010, PEDIATRICS, V126, pE1109, DOI 10.1542/peds.2009-2789; Marquet-Doleac J, 2016, MABC 2 BATTERIE DEVA; Martini R, 2011, CAN J OCCUP THER, V78, P318, DOI 10.2182/cjot.2011.78.5.7; Memoli Robert N, 2019, EVOL PSYCHOMOT, V27, P22; Missiuna Cheryl, 2007, Phys Occup Ther Pediatr, V27, P81, DOI 10.1300/J006v27n01_06; Nakai A, 2011, RES DEV DISABIL, V32, P1615, DOI 10.1016/j.ridd.2011.02.012; Piek JP, 2010, HUM MOVEMENT SCI, V29, P777, DOI 10.1016/j.humov.2010.03.006; Piek JP, 2006, HUM MOVEMENT SCI, V25, P65, DOI 10.1016/j.humov.2005.10.011; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Prado MSS, 2009, BRAZ J PHYS THER, V13, P236, DOI 10.1590/S1413-35552009005000024; Ray-Kaeser S, 2016, REV FRANCOPH RECH ER, V2, P7, DOI DOI 10.13096/RFRE.V2N1.36; Ray-Kaeser S, 2015, PHYS OCCUP THER PEDI, V35, P132, DOI 10.3109/01942638.2015.1009229; Rihtman T, 2011, RES DEV DISABIL, V32, P1378, DOI 10.1016/j.ridd.2010.12.040; Rivilis I, 2011, RES DEV DISABIL, V32, P894, DOI 10.1016/j.ridd.2011.01.017; Schoemaker M. M, 2015, DEV COORDINATION DIS, P169; Schoemaker MM, 2006, DEV MED CHILD NEUROL, V48, P668, DOI 10.1017/S001216220600140X; Schulz J, 2011, RES DEV DISABIL, V32, P1361, DOI 10.1016/j.ridd.2011.01.032; Summers J, 2008, HUM MOVEMENT SCI, V27, P215, DOI 10.1016/j.humov.2008.02.002; Tseng MH, 2010, RES DEV DISABIL, V31, P33, DOI 10.1016/j.ridd.2009.07.018; Wilson BN, 2000, AM J OCCUP THER, V54, P484, DOI 10.5014/ajot.54.5.484; Wilson BN, 2009, PHYS OCCUP THER PEDI, V29, P182, DOI 10.1080/01942630902784761; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Zwicker JG, 2015, PHYS OCCUP THER PEDI, V35, P163, DOI 10.3109/01942638.2014.957431; Zwicker JG, 2012, EUR J PAEDIATR NEURO, V16, P573, DOI 10.1016/j.ejpn.2012.05.005	49	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217280	10.1371/journal.pone.0217280	http://dx.doi.org/10.1371/journal.pone.0217280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120966	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700079
J	Walker, KW; Salimi-Moosavi, H; Arnold, GE; Chen, Q; Soto, M; Jacobsen, FW; Hui, J				Walker, Kenneth W.; Salimi-Moosavi, Hossein; Arnold, Gregory E.; Chen, Qing; Soto, Marcus; Jacobsen, Frederick W.; Hui, John			Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; COMPLEMENTARITY-DETERMINING REGIONS; MONOCLONAL-ANTIBODY; IN-VITRO; PRECLINICAL PHARMACOKINETICS; TISSUE DISTRIBUTION; BINDING-PROPERTIES; MODEL; HALF; IMPACT	In this study we compared the pharmacokinetic profile of four unrelated antibodies, which do not bind to mammalian antigens, in IgG1 and IgG2 frameworks in both rats and non-human primates ( NHP). This allowed for extensive cross comparison of the impact of antibody isotype, complementarity determining regions ( CDR) and model species on pharmacokinetics without the confounding influence of antigen binding in the hosts. While antibody isotype had no significant impact on the pharmacokinetics, the CDRs do alter the profile, and there is an inverse correlation between the neonatal Fc receptor ( FcRn) affinity and pharmacokinetic performance. Faster clearance rates were also associated with higher isoelectric points; however, although this panel of antibodies all possess basic isoelectric points, ranging from 8.44 to 9.18, they also have exceptional in vivo half-lives, averaging 369 hours, and low clearance rates, averaging 0.18 ml/h/kg in NHPs. This pattern of pharmacokinetic characteristics was conserved between rats and NHPs.	[Walker, Kenneth W.; Salimi-Moosavi, Hossein; Arnold, Gregory E.; Chen, Qing; Soto, Marcus; Jacobsen, Frederick W.; Hui, John] Amgen Inc, Amgen Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA	Amgen	Walker, KW (corresponding author), Amgen Inc, Amgen Res, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	kennethw@amgen.com						Amano J, 2010, DRUG METAB DISPOS, V38, P2339, DOI 10.1124/dmd.110.035709; Ammons WS, 2003, NEOPLASIA, V5, P146, DOI 10.1016/S1476-5586(03)80006-4; [Anonymous], 2005, GUID IND EST MAX SAF; Avery LB, 2016, MABS-AUSTIN, V8, P1064, DOI 10.1080/19420862.2016.1193660; Bautista AC, 2012, AAPS J, V14, P843, DOI 10.1208/s12248-012-9403-0; BazinRedureau MI, 1997, J PHARM PHARMACOL, V49, P277, DOI 10.1111/j.2042-7158.1997.tb06795.x; Boswell CA, 2012, AAPS J, V14, P612, DOI 10.1208/s12248-012-9374-1; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Cao YG, 2014, J PHARMACOKINET PHAR, V41, P571, DOI 10.1007/s10928-014-9374-0; Constantinou A, 2010, BIOTECHNOL LETT, V32, P609, DOI 10.1007/s10529-010-0214-z; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P483, DOI 10.1080/19420862.2015.1016696; Datta-Mannan A, 2012, DRUG METAB DISPOS, V40, P1545, DOI 10.1124/dmd.112.045864; Davda JP, 2014, MABS-AUSTIN, V6, P1094, DOI 10.4161/mabs.29095; Dowling TC, 2005, ANTIMICROB AGENTS CH, V49, P1808, DOI 10.1128/AAC.49.5.1808-1812.2005; Gay RD, 2010, MABS-AUSTIN, V2, P625, DOI 10.4161/mabs.2.6.13493; Grimm HP, 2009, J PHARMACOKINET PHAR, V36, P407, DOI 10.1007/s10928-009-9129-5; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Iznaga-Escobar N, 2004, METHOD FIND EXP CLIN, V26, P123, DOI 10.1358/mf.2004.26.2.800065; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Khawli LA, 2010, MABS, V2, P1, DOI [10.4161/mabs.2.1.10628, DOI 10.4161/MABS.2.1.10628]; Kloft C, 2004, INVEST NEW DRUG, V22, P39, DOI 10.1023/B:DRUG.0000006173.72210.1c; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Luu KT, 2012, J PHARMACOL EXP THER, V341, P702, DOI 10.1124/jpet.112.191999; Mahmood I, 2009, J PHARM SCI-US, V98, P3850, DOI 10.1002/jps.21682; Mannan AD, 2015, MABS, V7, P1084, DOI [10.1080/19420862.2015.1075109, DOI 10.1080/19420862.2015.1075109]; Mould DR, 2007, CURR OPIN DRUG DISC, V10, P84; Naso MF, 2010, MABS-AUSTIN, V2, P519, DOI 10.4161/mabs.2.5.13078; Oitate M, 2012, DRUG METAB PHARMACOK, V27, P354, DOI 10.2133/dmpk.DMPK-11-SH-059; Perera RM, 2007, NEOPLASIA, V9, P1099, DOI 10.1593/neo.07721; Piche-Nicholas NM, 2018, MABS-AUSTIN, V10, P81, DOI 10.1080/19420862.2017.1389355; Proetzel G, 2014, METHODS, V65, P148, DOI 10.1016/j.ymeth.2013.07.005; Putnam WS, 2010, TRENDS BIOTECHNOL, V28, P509, DOI 10.1016/j.tibtech.2010.07.001; Richter WF, 1999, DRUG METAB DISPOS, V27, P21; Rowinsky EK, 2004, J CLIN ONCOL, V22, P3003, DOI 10.1200/JCO.2004.11.061; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Schoch A, 2015, P NATL ACAD SCI USA, V112, P5997, DOI 10.1073/pnas.1408766112; Shah DK, 2012, J PHARMACOKINET PHAR, V39, P67, DOI 10.1007/s10928-011-9232-2; Skartved NJO, 2011, CLIN CANCER RES, V17, P5962, DOI 10.1158/1078-0432.CCR-11-1209; Souders CA, 2015, MABS-AUSTIN, V7, P912, DOI 10.1080/19420862.2015.1054585; STEPHENS S, 1995, IMMUNOLOGY, V85, P668; Tam SH, 2013, MABS-AUSTIN, V5, P397, DOI 10.4161/mabs.23836; Ternant D, 2005, BLOOD, V106, P1503, DOI 10.1182/blood-2005-02-0798; Thway TM, 2013, AAPS J, V15, P856, DOI 10.1208/s12248-013-9484-4; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Wang Y, 2014, J DRUG TARGET, V22, P269, DOI 10.3109/1061186X.2013.875030; Yang XD, 1999, J LEUKOCYTE BIOL, V66, P401, DOI 10.1002/jlb.66.3.401; Yeung YA, 2010, CANCER RES, V70, P3269, DOI 10.1158/0008-5472.CAN-09-4580; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zia-Amirhosseini P, 1999, J PHARMACOL EXP THER, V291, P1060	55	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217061	10.1371/journal.pone.0217061	http://dx.doi.org/10.1371/journal.pone.0217061			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120944	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700052
J	Abdelsamad, NA; MacIntosh, GC; Leandro, LFS				Abdelsamad, Noor A.; MacIntosh, Gustavo C.; Leandro, Leonor F. S.			Induction of ethylene inhibits development of soybean sudden death syndrome by inducing defense-related genes and reducing Fusarium virguliforme growth	PLOS ONE			English	Article							DISEASE RESISTANCE; MOLECULAR-CLONING; CAUSAL AGENT; EXPRESSION; TOMATO; ROOTS; RICE; CHITINASE; JASMONATE; RESPONSES	Ethylene is a gaseous hormone that regulates plant responses to biotic and abiotic stresses. To investigate the importance of ethylene in soybean resistance to Fusarium virguliforme (Fv), the causal agent of sudden death syndrome (SDS), soybean cultivars Williams 82 (SDS-susceptible) and MN1606 (SDS-resistant) were treated 24 h before and 24h after Fv inoculation with either ethephon (ethylene inducer), cobalt chloride (ethylene biosynthesis inhibitor), or 1-MCP (ethylene perception inhibitor). Inoculated plants were grown for 21 days at 24 degrees C in the greenhouse and then evaluated for SDS severity and expression of soybean defense genes. In both cultivars, plants treated with ethephon showed lower SDS foliar severity compared to the other treatments, whereas those treated with cobalt chloride or 1-MCP showed the same or higher SDS foliar severity compared to the water-treated control. Ethephon application resulted in activation of genes involved in ethylene biosynthesis, such as ethylene synthase (ACS) and ethylene oxidase (ACO), and genes involved in soybean defense response, such as pathogenesis-related protein (PR), basic peroxidase (IPER), chalcone synthase (CHS), and defense-associated transcription factors. Cobalt chloride and 1-MCP treatments had little or no effect on the expression of these genes. In addition, ethephon had a direct inhibitory effect on in-vitro growth of Fv on PDA media. Our results suggest that ethephon application inhibits SDS development directly by slowing Fv growth and/or by inducing soybean ethylene signaling and the expression of defense related genes.	[Abdelsamad, Noor A.] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA; [MacIntosh, Gustavo C.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Leandro, Leonor F. S.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Leandro, LFS (corresponding author), Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA.	lleandro@iastate.edu		MacIntosh, Gustavo/0000-0003-1350-1229	Iowa Soybean Association	Iowa Soybean Association	This project was funded by a grant from the Iowa Soybean Association to LFSL. https://www.iasoybeans.com/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; Balaji V, 2008, PLANT PHYSIOL, V146, P1797, DOI 10.1104/pp.107.115188; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Belhadj A, 2008, J AGR FOOD CHEM, V56, P5781, DOI 10.1021/jf800578c; Bent AF, 2006, CROP SCI, V46, P893, DOI 10.2135/cropsci2005.08-0235; Blake SN, 2016, MOL PLANT PATHOL, V17, P680, DOI 10.1111/mpp.12320; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; ECKER JR, 1987, P NATL ACAD SCI USA, V84, P5202, DOI 10.1073/pnas.84.15.5202; Edelman NF, 2014, HORTSCIENCE, V49, P472, DOI 10.21273/HORTSCI.49.4.472; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Foo E, 2016, PLANTA, V243, P1387, DOI 10.1007/s00425-015-2449-3; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Gaige AR, 2010, PHYSIOL MOL PLANT P, V74, P412, DOI 10.1016/j.pmpp.2010.07.001; Ganesan M., 2009, American Journal of Biochemistry and Biotechnology, V5, P63, DOI 10.3844/ajbbsp.2009.63.74; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Hartman GL, 2015, CROP PROT, V73, P60, DOI 10.1016/j.cropro.2015.01.017; Helliwell EE, 2013, PLANT BIOTECHNOL J, V11, P33, DOI 10.1111/pbi.12004; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Jaleel CA, 2009, J SCI RES, V1, P128, DOI DOI 10.3329/JSR.VLIL.1226; JAYAKUMAR K, 2009, BOT RES INT, V2, P310; Jayakumar K, 2009, GLOB J MOL SCI, V4, P10; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Leandro L. F., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127053; Leandro LFS, 2013, PLANT MANAG NETW, DOI [10.1094/PHP-2013-0529-01-RS, DOI 10.1094/PHP-2013-0529-01-RS]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckew AS, 2013, THEOR APPL GENET, V126, P2391, DOI 10.1007/s00122-013-2143-4; MAUCH F, 1992, PLANTA, V186, P367, DOI 10.1007/BF00195317; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Munkvold GP, 2002, PLANT DIS, V86, P143, DOI 10.1094/PDIS.2002.86.2.143; Nunez-Pastrana R, 2011, EUR J PLANT PATHOL, V131, P669, DOI 10.1007/s10658-011-9841-z; O'Donnell PJ, 2003, PLANT PHYSIOL, V133, P1181, DOI 10.1104/pp.103.030379; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Radwan O, 2013, MOL PLANT PATHOL, V14, P293, DOI 10.1111/mpp.12006; Radwan O, 2011, MOL PLANT MICROBE IN, V24, P958, DOI 10.1094/MPMI-11-10-0271; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Roy KW, 1997, PLANT DIS, V81, P259, DOI 10.1094/PDIS.1997.81.3.259; Scherm H, 1996, PHYTOPATHOLOGY, V86, P642, DOI 10.1094/Phyto-86-642; Shrestha CL, 2008, EUR J PLANT PATHOL, V120, P69, DOI 10.1007/s10658-007-9199-4; Singh MP, 2004, PHYTOPATHOLOGY, V94, P819, DOI 10.1094/PHYTO.2004.94.8.819; Sugano S, 2013, PLANT PATHOL, V62, P1048, DOI 10.1111/ppa.12011; TAKEUCHI Y, 1990, PLANT PHYSIOL, V93, P673, DOI 10.1104/pp.93.2.673; Thao NP, 2015, PLANT PHYSIOL, V169, P73, DOI 10.1104/pp.15.00663; Tucker ML, 2010, J EXP BOT, V61, P463, DOI 10.1093/jxb/erp317; URWILER MJ, 1986, CROP SCI, V26, P976, DOI 10.2135/cropsci1986.0011183X002600050028x; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Walters D, 2005, PHYTOPATHOLOGY, V95, P1368, DOI 10.1094/PHYTO-95-1368; Wrather JA, 2006, J NEMATOL, V38, P173; Yi SY, 1998, MOL CELLS, V8, P556; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850	56	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215653	10.1371/journal.pone.0215653	http://dx.doi.org/10.1371/journal.pone.0215653			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116746	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400007
J	Avelar, BS; Mancini, MC; Fonseca, ST; Kelty-Stephen, DG; de Miranda, BM; Romano-Silva, MA; de Araujo, PA; Silva, PL				Avelar, Bruna S.; Mancini, Marisa C.; Fonseca, Sergio T.; Kelty-Stephen, Damian G.; de Miranda, Bora M.; Romano-Silva, Marco Aurelli; de Araujo, Priscila A.; Silva, Paula L.			Fractal fluctuations in exploratory movements predict differences in dynamic touch capabilities between children with Attention-Deficit Hyperactivity Disorder and typical development	PLOS ONE			English	Article							COORDINATION DISORDER; MOTOR-SKILLS; DEFICIT/HYPERACTIVITY DISORDER; BALANCE CONTROL; OBJECT LENGTH; PERCEPTION; NOISE; HAND; ADHD; INFORMATION	Children with Attention-Deficit Hyperactivity Disorder (ADHD) struggle to perform a host of daily activities. Many of these involve forceful interaction with objects and thus implicate dynamic touch. Therefore, deficits in dynamic touch could underlie functional difficulties presented by ADHD children. We investigated whether performance on a dynamic touch task (length perception by wielding) differ between children with ADHD and age-matched controls. We further examined whether this difference could be explained by fractal temporal correlations (wielding dynamics). Forty-two children (ADHD: 21; typically developing: 21) wielded unseen wooden rods and reported their perceived length in the form of magnitude productions. The rods varied in the magnitude of the first principal moment of inertia (I-1). Three-dimensional displacements of hand and rod positions were submitted to Detrended Fluctuation Analysis to estimate trial-by-trial temporal correlations. Children with ADHD reported shorter length for rods with higher I-1 than their typically developing peers, indicative of reduced sensitivity to mechanical information supporting dynamic touch. Importantly, temporal correlations in wielding dynamics moderated children's usage of I-1. This finding points to a role of exploratory movements in perceptual deficits presented by children with ADHD and, thus, should be considered a new potential target for interventions.	[Avelar, Bruna S.; Mancini, Marisa C.; Fonseca, Sergio T.; de Araujo, Priscila A.; Silva, Paula L.] Univ Fed Minas Gerais, Sch Phys Educ Phys Therapy & Occupat Therapy, Grad Program Rehabil Sci, Belo Horizonte, MG, Brazil; [Kelty-Stephen, Damian G.] Grinnell Coll, Dept Psychol, Grinnell, IA 50112 USA; [de Miranda, Bora M.] Univ Fed Minas Gerais, Sch Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Romano-Silva, Marco Aurelli] Univ Fed Minas Gerais, Sch Med, Dept Mental Hlth, Belo Horizonte, MG, Brazil; [Silva, Paula L.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University System of Ohio; University of Cincinnati	Silva, PL (corresponding author), Univ Fed Minas Gerais, Sch Phys Educ Phys Therapy & Occupat Therapy, Grad Program Rehabil Sci, Belo Horizonte, MG, Brazil.; Silva, PL (corresponding author), Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA.	paula.silva@uc.edu	Silva, Paula L./AAB-5373-2020; Fonseca, Sergio T/C-5408-2013; Mancini, Marisa/B-3951-2013; Miranda, Debora/AAQ-1952-2020; Romano-Silva, Marco Aurelio/A-1790-2008; Fonseca, Sergio T./M-6821-2019; Romano-Silva, Marco Aurelio/T-8321-2019	Silva, Paula L./0000-0002-3749-5575; Fonseca, Sergio T/0000-0002-2979-8744; Mancini, Marisa/0000-0002-7415-5043; Miranda, Debora/0000-0002-7081-8401; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Fonseca, Sergio T./0000-0002-2979-8744; Kelty-Stephen, Damian/0000-0001-7332-8486	Brazilian government agency National Council for Scientific and Technological Development [306948/2014-1, 204909/2017-1]; Research Support Foundation from the State of Minas Gerais [CDS -PPM-00611-17]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil [001]; Brazilian government agency National Council for Scientific and Technological Development (CNPq); Brazilian government agency Coordination for the Improvement of Higher-Level Personnel (CAPES) [001]; Brazilian government agency Research Support Foundation from the State of Minas Gerais (FAPEMIG); Grinnell College	Brazilian government agency National Council for Scientific and Technological Development; Research Support Foundation from the State of Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian government agency National Council for Scientific and Technological Development (CNPq); Brazilian government agency Coordination for the Improvement of Higher-Level Personnel (CAPES); Brazilian government agency Research Support Foundation from the State of Minas Gerais (FAPEMIG); Grinnell College	Financial support for this study was granted by the Brazilian government agency National Council for Scientific and Technological Development (http://www.cnpq.br) through grants awarded to MCM (306948/2014-1) and BSA (204909/2017-1). Additional funding for research development was granted to MCM (CDS -PPM-00611-17) by the Research Support Foundation from the State of Minas Gerais (http://www.fapemig.br).This study was also financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (http://www.capes.gov.br/) -Finance Code 001. DGKS acknowledges the generous internal support from Grinnell College (www.grinnell.edu) to cover submission costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge all participants, members of the Nucleo de Investigacoes sobre a Impulsivade e Atencao (NITIDA), and Isabel Gomes and Gabriela Silvestrini for help in data collection. Financial support for this study was granted by the Brazilian government agencies National Council for Scientific and Technological Development (CNPq), Coordination for the Improvement of Higher-Level Personnel (CAPES, Finance Code 001) and by the Research Support Foundation from the State of Minas Gerais (FAPEMIG). DGKS acknowledges the generous internal support from Grinnell College.	Amazeen EL, 1999, J EXP PSYCHOL HUMAN, V25, P102, DOI 10.1037/0096-1523.25.1.102; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, P1; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P36; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bloch-Salisbury E, 2009, J APPL PHYSIOL, V107, P1017, DOI 10.1152/japplphysiol.00058.2009; BURTON G, 1991, PERCEPT PSYCHOPHYS, V50, P129, DOI 10.3758/BF03212214; Carello C, 2008, BRAZ J PHYS THER, V12, P339, DOI 10.1590/S1413-35552008000500002; Carello C, 2000, DEBATES PSYCHOL, P27; Carello C, 1999, PERCEPTION, V28, P307, DOI 10.1068/p2716; Carello C, 2006, NEUROSCI LETT, V405, P159, DOI 10.1016/j.neulet.2006.06.047; Carver NS, 2017, HUM MOVEMENT SCI, V55, P61, DOI 10.1016/j.humov.2017.07.005; Cluff T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005998; Coey CA, 2016, NEUROSCI LETT, V616, P204, DOI 10.1016/j.neulet.2016.01.066; Dixon JA, 2012, TOP COGN SCI, V4, P51, DOI 10.1111/j.1756-8765.2011.01162.x; Dunn L, 2009, PHYS OCCUP THER PEDI, V29, P258, DOI 10.1080/01942630903008350; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; FITZPATRICK P, 1994, NEUROSCIENCE, V60, P551, DOI 10.1016/0306-4522(94)90264-X; Fitzpatrick P, 2010, ECOL PSYCHOL, V22, P89, DOI 10.1080/10407411003719983; Galica AM, 2009, GAIT POSTURE, V30, P383, DOI 10.1016/j.gaitpost.2009.07.005; Ghanizadeh A, 2011, PSYCHIAT INVEST, V8, P89, DOI 10.4306/pi.2011.8.2.89; Gibson JJ, 1966, SENSES CONSIDERED PE, P1; Goodman L, 2000, J MOTOR BEHAV, V32, P3, DOI 10.1080/00222890009601354; Gottlieb G, 2002, COGNITIVE DEV, V17, P1287, DOI 10.1016/S0885-2014(02)00120-X; Goulardins JB, 2015, BEHAV BRAIN RES, V292, P484, DOI 10.1016/j.bbr.2015.07.009; Hajnal A, 2007, J MOTOR BEHAV, V39, P82, DOI 10.3200/JMBR.39.2.82-88; Hajnal A, 2018, J EXP PSYCHOL HUMAN, V44, P836, DOI 10.1037/xhp0000510; Ihlen EAF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00141; Kaiser ML, 2015, RES DEV DISABIL, V36, P338, DOI 10.1016/j.ridd.2014.09.023; Kawabata Y, 2012, J ABNORM CHILD PSYCH, V40, P177, DOI 10.1007/s10802-011-9556-9; Kelty-Stephen DG, 2015, ATTEN PERCEPT PSYCHO, V77, P1854, DOI 10.3758/s13414-015-0947-9; Kelty-Stephen DG, 2014, J EXP PSYCHOL HUMAN, V40, P2289, DOI 10.1037/a0038159; Kloos H, 2002, BRIT J DEV PSYCHOL, V20, P171, DOI 10.1348/026151002166398; Kuznetsov NA, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00062; Lavasani NM, 2011, OCCUP THER INT, V18, P106, DOI 10.1002/oti.306; Lipsitz LA, 2015, ARCH PHYS MED REHAB, V96, P432, DOI 10.1016/j.apmr.2014.10.004; Mattos Paulo, 2006, Rev. psiquiatr. Rio Gd. Sul, V28, P290, DOI 10.1590/S0101-81082006000300008; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; McLeod KR, 2014, NEUROIMAGE-CLIN, V4, P566, DOI 10.1016/j.nicl.2014.03.010; Michaels CF, 2008, J EXP PSYCHOL HUMAN, V34, P944, DOI 10.1037/0096-1523.34.4.944; Molenaar PCM, 2008, DEV PSYCHOBIOL, V50, P60, DOI 10.1002/dev.20262; Ocarino JM, 2014, HUM MOVEMENT SCI, V33, P85, DOI 10.1016/j.humov.2013.08.007; PAGANO CC, 1993, PERCEPT PSYCHOPHYS, V54, P43, DOI 10.3758/BF03206936; Palatinus Z, 2014, J EXP PSYCHOL HUMAN, V40, P1808, DOI 10.1037/a0037247; Palatinus Z, 2013, ANN BIOMED ENG, V41, P1625, DOI 10.1007/s10439-012-0706-1; Pan CY, 2009, J AUTISM DEV DISORD, V39, P1694, DOI 10.1007/s10803-009-0813-5; Pasqua L, 2002, AVALIACAO PSICOLOGIC, V1, P95; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Querne L, 2008, BRAIN RES, V1244, P89, DOI 10.1016/j.brainres.2008.07.066; Sarver DE, 2015, J ABNORM CHILD PSYCH, V43, P1219, DOI 10.1007/s10802-015-0011-1; Scharoun SM, 2013, RES DEV DISABIL, V34, P4142, DOI 10.1016/j.ridd.2013.08.011; Smith VC, 2015, PEDIATRICS, V136, pE1561, DOI 10.1542/peds.2015-1334; Stephen DG, 2012, GAIT POSTURE, V36, P537, DOI 10.1016/j.gaitpost.2012.05.014; Stephen DG, 2011, ATTEN PERCEPT PSYCHO, V73, P1302, DOI 10.3758/s13414-011-0142-6; Stephen DG, 2010, J EXP PSYCHOL HUMAN, V36, P1161, DOI 10.1037/a0019219; Stephen DG, 2008, J PROBL SOLVING, V2, P72, DOI 10.7771/1932-6246.1043; Stephen DG, 2009, ATTEN PERCEPT PSYCHO, V71, P1717, DOI 10.3758/APP.71.8.1717; Sternad D, 2018, CURR OPIN BEHAV SCI, V20, P183, DOI 10.1016/j.cobeha.2018.01.004; Tryon Warren W, 2006, Clin Child Psychol Psychiatry, V11, P607, DOI 10.1177/1359104506067881; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turvey M., 1995, PERCEPTION SPACE MOT, P401, DOI [10.1016/B978-012240530-3/50013-4, DOI 10.1016/B978-012240530-3/50013-4]; Turvey MT, 1998, J EXP PSYCHOL HUMAN, V24, P35, DOI 10.1037/0096-1523.24.1.35; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; Van Orden G, 2010, MEDICINA-LITHUANIA, V46, P581, DOI 10.3390/medicina46090083; Wade MG, 2016, J MOTOR BEHAV, V48, P13, DOI 10.1080/00222895.2015.1025902; Wells KC, 2000, J ABNORM CHILD PSYCH, V28, P483, DOI 10.1023/A:1005174913412; Withagen R, 2005, J EXP PSYCHOL HUMAN, V31, P1379, DOI 10.1037/0096-1523.31.6.1379; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; 2007, PSYCHOL REV, V114, P1047, DOI DOI 10.1037/0033-295X.114.4.1047	72	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217200	10.1371/journal.pone.0217200	http://dx.doi.org/10.1371/journal.pone.0217200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112590	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000042
J	Gershon, AS; Thiruchelvam, D; Aaron, S; Stanbrook, M; Vozoris, N; Tan, WC; Cho, E; To, T				Gershon, Andrea S.; Thiruchelvam, Deva; Aaron, Shawn; Stanbrook, Matthew; Vozoris, Nicholas; Tan, Wan C.; Cho, Eunice; To, Teresa			Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: A population-based cohort study	PLOS ONE			English	Article							RISK; REHOSPITALIZATIONS; EXACERBATIONS; ICD-9-CM	Background Patients with chronic obstructive pulmonary disease (COPD) are more likely to be readmitted than patients with other chronic medical conditions, yet knowledge regarding such readmissions is limited. We aimed to determine factors associated with readmission within 30 days of a COPD hospitalization or death with an emphasis on examining aspects of socioeconomic status and specific comorbidities. Methods A population-based cohort study was conducted using health administrative data from Ontario, Canada. All hospitalizations for COPD between 2004 and 2014 were considered. The primary exposures were socioeconomic status as measured by residential instability (an ecologic variable), and comorbidities such as cardiovascular disease and cancer. Other domains of socioeconomic status were considered as secondary exposures. Logistic regression with generalized estimating equations was used to examine the effect of exposures, adjusting for other patient factors, on 30-day readmission or death. Results There were 126,013 patients contributing to 252,756 index COPD hospitalizations from 168 Ontario hospitals. Of these hospitalizations, 19.4% resulted in a readmission and 2.8% resulted in death within 30 days. After adjusting for other factors, readmissions or death were modestly more likely among people with the highest residential instability compared to the lowest (OR 1.05, 95% CI 1.01-1.09). Comorbidities such as cardiovascular disease and cancer, as well as other aspects of low socioeconomic status also increased readmission or death risk. Interpretation Socioeconomic status, measured in various ways, and many comorbidities predict 30-day readmission or death in patients hospitalized for COPD. Strategies that address these factors may help reduce readmissions and death.	[Gershon, Andrea S.; Thiruchelvam, Deva] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Gershon, Andrea S.; Thiruchelvam, Deva; To, Teresa] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Aaron, Shawn] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Stanbrook, Matthew] Toronto Western Hosp, Asthma & Airway Ctr, Toronto, ON, Canada; [Vozoris, Nicholas] St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Tan, Wan C.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Cho, Eunice] Univ Toronto, Dept Med, Toronto, ON, Canada; [To, Teresa] Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gershon, AS (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada.; Gershon, AS (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	andrea.gershon@ices.on.ca			Health Service Research Fund Capacity Grant from the Province of Ontario; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institutes of Health Research New Investigator Award; Physicians' Services Incorporated Foundation, Toronto, Ontario	Health Service Research Fund Capacity Grant from the Province of Ontario; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated Foundation, Toronto, Ontario	Funding for this project was made available from a Health Service Research Fund Capacity Grant from the Province of Ontario. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Dr. Gershon is supported by a Canadian Institutes of Health Research New Investigator Award and was supported by a Fellowship for Translational Health Research from the Physicians' Services Incorporated Foundation, Toronto, Ontario, while working on this study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; [Anonymous], 2013, LANCET RESP MED, V1, P347, DOI 10.1016/S2213-2600(13)70153-X; [Anonymous], 2017, GLOB STRAT DIAGN MAP; Bahadori Katayoun, 2009, Can Respir J, V16, pe43; Baker CL, 2013, INT J CHRONIC OBSTR, V8, P551, DOI 10.2147/COPD.S51507; Canadian Institute for Health Information, CAN COD STAND VERS 2; Chan FWK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-186; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Echevarria C, 2017, THORAX; Eisner MD, 2010, J EPIDEMIOLOGY COMMU; Feemster LC, 2014, AM J RESP CRIT CARE, V189, P634, DOI 10.1164/rccm.201308-1541PP; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon N, 2019, COST EFFECT RESOUR A, V17, DOI 10.1186/s12962-019-0174-7; Jacobs DM, 2018, ANN AM THORAC SOC, V15, P837, DOI 10.1513/AnnalsATS.201712-913OC; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jennings JH, 2015, CHEST, V147, P1227, DOI 10.1378/chest.14-1123; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kristensen SR, 2015, HEALTH POLICY, V119, P264, DOI 10.1016/j.healthpol.2014.12.009; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Press VG, 2018, ANN AM THORAC SOC, V15, P801, DOI 10.1513/AnnalsATS.201804-246ED; Prieto-Centurion Valentin, 2014, Ann Am Thorac Soc, V11, P417, DOI 10.1513/AnnalsATS.201308-254OC; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Richardson D, 2001, CURR CONTR TRIALS C, V2, P115; Roberts MH, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0231-3; Rosenberg SR, 2015, SEMIN RESP CRIT CARE, V36, P457, DOI 10.1055/s-0035-1555607; Shah T, 2015, CHEST, V147, P1219, DOI 10.1378/chest.14-2181; Simmering JE, 2016, CHRON OBSTR PULM DIS, V3, P729, DOI 10.15326/jcopdf.3.4.2016.0136; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Yu TC, 2015, CLINICOECONOMIC OUTC, V7, P37, DOI 10.2147/CEOR.S74181	33	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216741	10.1371/journal.pone.0216741	http://dx.doi.org/10.1371/journal.pone.0216741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112573	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000021
J	Hetley, RS; Stine, WW				Hetley, Richard S.; Stine, Wm Wren			At least two distinct mechanisms control binocular luster, rivalry, and perceived rotation with contrast and average luminance disparities	PLOS ONE			English	Article							IRRADIATION; INTENSITY; VISION; DEPTH; MODEL	When one views a square-wave grating and dichoptically changes the average luminance or contrast of the monocular images, at least three perceptual phenomena might occur. These are the Venetian blind effect, or a perceived rotation of the bars around individual vertical axes; binocular luster, or a perceived shimmering; and binocular rivalry, or an alternating perception between the views of the two eyes. Perception of luster and rivalry occur when the "light bars" in the grating dichoptically straddle the background luminance (one eye's image has a higher luminance than the background and the other eye's image has a lower luminance than the background), with little impact from the "dark bars." Perception of rotation, on the other hand, is related to average luminance or contrast disparity, independent of whether or not the "light bars" straddle the background luminance. The patterns for perceived rotation versus binocular luster and binocular rivalry suggest at least two separate mechanisms in the visual system for processing luminance and contrast information over and above their differing physiological states suggested by their different appearances. While luster and rivalry depend directly on the relation between stimuli and the background, perceived rotation depends on the magnitude of the luminance or contrast disparity, as described by the generalized difference model.	[Hetley, Richard S.; Stine, Wm Wren] Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Stine, WW (corresponding author), Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA.	bill.stine@unh.edu		Stine, William/0000-0002-6880-7631				Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ajasse S, 2018, J VISION, V18, DOI 10.1167/18.11.6; Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Anstis SM, 2000, VISION RES, V40, P2551, DOI 10.1016/S0042-6989(00)00131-0; Aydin O, 2005, TURK PSIKOL DERG, V20, pVII; Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; Balasubramanian V, 2009, J PHYSL, V12, P2753; Bex PJ, 1996, PERCEPT PSYCHOPHYS, V58, P31, DOI 10.3758/BF03205472; BILLMEYER FW, 1987, COLOR RES APPL, V12, P315, DOI 10.1002/col.5080120606; Birnkrant R. S., 2004, J VISION, V4; Bixby FL, 1928, J GEN PSYCHOL, V1, P138; Blake R, 2011, VISION RES, V51, P754, DOI 10.1016/j.visres.2010.10.009; Borghuis BG, 2008, J NEUROSCI, V28, P3178, DOI 10.1523/JNEUROSCI.5259-07.2008; Brascamp JW, 2015, VISION RES, V109, P20, DOI 10.1016/j.visres.2015.02.019; Brindley G. S., 1960, PHYSL RETINA VISUAL; CIBIS PA, 1951, J OPT SOC AM, V41, P676, DOI 10.1364/JOSA.41.000676; Dobias JJ, 2012, VISION RES, V60, P79, DOI 10.1016/j.visres.2012.02.013; Dove HW., 1851, POGGENDORFFS ANN, V83, P169, DOI DOI 10.1002/ANDP.18511590513; Ferwerda JA, 2001, PROC SPIE, V4299, P291, DOI 10.1117/12.429501; Filley ET, 2011, SEEING PERCEIVING, V24, P241, DOI 10.1163/187847511X580366; Formankiewicz MA, 2009, VISION RES, V49, P1929, DOI 10.1016/j.visres.2009.05.001; Fry G. A., 1933, AM J OPHTHALMOL, V16, P687; Geisler WS, 2007, J NEUROSCI, V27, P5063, DOI 10.1523/JNEUROSCI.0835-07.2007; Georgeson MA, 2016, VISION RES, V129, P98, DOI 10.1016/j.visres.2016.08.001; HARRISON VGW, 1951, BRIT J APPL PHYS, V2, P92, DOI 10.1088/0508-3443/2/4/302; Hetley RS, 2011, SEEING PERCEIVING, V24, P315, DOI 10.1163/187847511X584461; Howard I. P., 2005, BINOCULAR RIVALRY, P169; HOWARD IP, 1995, PERCEPTION, V24, P67, DOI 10.1068/p240067; Howard IP, 1995, BINOCULAR VISION STE; Jameson D., 1920, OUTLINES THEORY LIGH; JULESZ B, 1976, BIOL CYBERN, V23, P25, DOI 10.1007/BF00344148; Kingdom FAA, 2018, J VISION, V18, DOI 10.1167/18.5.9; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Larkin ET, 2017, I-PERCEPTION, V8, P1, DOI 10.1177/2041669517715475; Levelt WJM, 1965, BINOCULAR RIVALRY; LI ZP, 1994, NETWORK-COMP NEURAL, V5, P157, DOI 10.1088/0954-898X/5/2/003; Ludwig I, 2007, PERCEPT PSYCHOPHYS, V69, P92, DOI 10.3758/BF03194456; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Malkoc G, 2012, VISION RES, V62, P75, DOI 10.1016/j.visres.2012.03.018; MATHER G, 1986, VISION RES, V26, P1007, DOI 10.1016/0042-6989(86)90157-4; Matsumiya K, 2007, PERCEPTION, V36, P990, DOI 10.1068/p5749; Mausfeld R, 2014, I-PERCEPTION, V5, P1, DOI 10.1068/i0603; McCamy CS, 1998, COLOR RES APPL, V23, P362, DOI 10.1002/(SICI)1520-6378(199812)23:6<362::AID-COL4>3.0.CO;2-5; Michelson Albert A., 1927, STUDIES OPTICS; MORGAN MJ, 1984, VISION RES, V24, P713, DOI 10.1016/0042-6989(84)90212-8; Munster C, 1941, Z SINNESPHYSIOL, V69, P245; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Oppel J. J., 1854, JAHRESBERICHT PHYS V, V1854-1855, P52; Panum PL., 1858, PHYSL UNTERSUCHUNGEN; Pieper W, 2002, PERCEPTION, V31, P185; Said CP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002991; Sakano Y, 2010, J VISION, V10, DOI 10.1167/10.9.15; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SHEEDY JE, 1984, AM J OPTOM PHYS OPT, V61, P499; TELLER DY, 1984, VISION RES, V24, P1233, DOI 10.1016/0042-6989(84)90178-0; Tyler C. W., 2004, DUANES FDN CLIN OPHT, V2; von Helmholtz H., 1911, HELMHOLTZS TREATISE, VII; von Helmholtz H., 1873, POPULAR LECT SCI SUB, P197; von Helmholtz H., 1910, HELMHOLTZS TREATISE, VIII, P493; Wade N. J., 2005, BINOCULAR RIVALRY PE, P29; Wang CA, 2014, EUR J NEUROSCI, V40, P2822, DOI 10.1111/ejn.12641; Wendt G, 2010, J VISION, V10, DOI 10.1167/10.9.7; Westheimer G, 2007, PERCEPTION, V36, P483, DOI 10.1068/p5646; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wherry RJ, 1931, ANN MATH STAT, V2, P440, DOI 10.1214/aoms/1177732951; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; WOLFE JM, 1988, PERCEPT PSYCHOPHYS, V44, P81, DOI 10.3758/BF03207480; [No title captured]; 1994, VISUAL NEUROSCIENCE, V11, P23	71	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0215716	10.1371/journal.pone.0215716	http://dx.doi.org/10.1371/journal.pone.0215716			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112553	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000009
J	Speed, JDM; Austrheim, G; Kolstad, AL; Solberg, EJ				Speed, James D. M.; Austrheim, Gunnar; Kolstad, Anders Lorentzen; Solberg, Erling J.			Long-term changes in northern large-herbivore communities reveal differential rewilding rates in space and time	PLOS ONE			English	Article							WILD LARGE HERBIVORES; RED DEER; MANAGEMENT; CHALLENGES; LIVESTOCK; CONSERVATION; PERSPECTIVE; LANDSCAPES; MEGAFAUNA; UNGULATE	Herbivores have important impacts on ecological and ecosystem dynamics. Population density and species composition are both important determinants of these impacts. Large herbivore communities are shifting in many parts of the world driven by changes in livestock management and exploitation of wild populations. In this study, we analyse changes in large herbivore community structure over 66 years in Norway, with a focus on the contribution of wildlife and livestock. We calculate metabolic biomass of all large-herbivore species across the whole region between 1949 and 2015. Temporal and spatial patterns in herbivore community change are investigated and we test hypotheses that changes in wildlife biomass are driven by competition with livestock. We find that total herbivore biomass decreased from 1949 to a minimum in 1969 due to decreases in livestock biomass. Increasing wild herbivore populations lead to an increase in total herbivore biomass by 2009. Herbivore communities have thus reverted from a livestock dominated state in 1949 (2% of large herbivore metabolic biomass comprised of wildlife species) to a state with roughly equal wildlife and livestock (48% of metabolic biomass comprised of wildlife species). Declines in livestock biomass were a modest predictor of wildlife increases, suggesting that competition with livestock has not been a major limiting factor of wild herbivore populations over the past decades. Instead there was strong geographic variation in herbivore community change, with milder lowland regions becoming more dominated by wild species, but colder mountain and northern regions remaining dominated by livestock. Our findings indicate that there has been notable rewilding of herbivore communities and herbivore-ecosystem interactions in Norway, particularly in milder lowland regions. However, Norwegian herbivores remain mostly regulated by management, and our findings call for integrated management of wild and domestic herbivores.	[Speed, James D. M.; Austrheim, Gunnar; Kolstad, Anders Lorentzen] Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway; [Solberg, Erling J.] Norwegian Inst Nat Res NINA, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research	Speed, JDM (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway.	james.speed@ntnu.no	Speed, James D. M./C-1099-2009; Kolstad, Anders/N-7538-2019	Speed, James D. M./0000-0002-0633-5595; Kolstad, Anders/0000-0002-9623-9491	Research Council of Norway [DISENTANGLE 262064, SUSTAIN 244647]	Research Council of Norway(Research Council of Norway)	This work was funded by the Research Council of Norway https://www.forskningsradet.no/ (project DISENTANGLE 262064 to JDMS, while EJS was supported by SUSTAIN 244647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon SD, 2007, J APPL ECOL, V44, P1176, DOI 10.1111/j.1365-2664.2007.01318.x; Almaas R., 2004, NORWEGIAN AGR HIST T, DOI [10.1098/rstb.2017.0446, DOI 10.1098/RSTB.2017.0446]; Andersen R, 2003, LARGE PREDATORS HUMA, P25; Apollonio M., 2010, EUROPEAN UNGULATES T; Apollonio M, 2017, MAMMAL RES, V62, P209, DOI 10.1007/s13364-017-0321-5; Austrheim G, 2011, WILDLIFE BIOL, V17, P286, DOI 10.2981/10-038; Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Barton K., 2020, MUMIN MULTIMODEL INF; Charrad M, 2014, J STAT SOFTW, V61, P1; Cromsigt JPGM, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0440; Danell K., 2006, LARGE HERBIVORE ECOL; Deinet S., 2013, WILDLIFE COMEBACK EU; Deraison H, 2015, FUNCT ECOL, V29, P650, DOI 10.1111/1365-2435.12362; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Dressel S, 2018, ENVIRON SCI POLICY, V84, P105, DOI 10.1016/j.envsci.2018.03.007; du Toit JT, 2017, SPRINGER SER ENV MAN, P395, DOI 10.1007/978-3-319-46709-2_12; Espunyes J, 2019, GLOBAL CHANGE BIOL, V25, P1808, DOI 10.1111/gcb.14587; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fjellstad WJ, 1999, LANDSCAPE URBAN PLAN, V45, P177, DOI 10.1016/S0169-2046(99)00055-9; Forbes B. C., 2006, REINDEER MANAGEMENT, P245, DOI [10.1007/3-540-31392-3, DOI 10.1007/3-540-31392-3]; Forbord M, 2017, LAND USE POLICY, V67, P546, DOI 10.1016/j.landusepol.2017.06.031; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Hempson GP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17348-4; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Herfindal I, 2017, WILDLIFE BIOL, P1; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Jarvie S, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0446; KA Ims RA, 2011, BASIC APPL ECOL, V12, P643; Kolstad AL, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2458; Lavsund Sten, 2003, Alces, V39, P109; Madhusudan MD, 2004, J APPL ECOL, V41, P858, DOI 10.1111/j.0021-8901.2004.00950.x; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mysterud A, 2010, J APPL ECOL, V47, P920, DOI 10.1111/j.1365-2664.2010.01836.x; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Norwegian Forest and Landscape Institute, 2007, AR502007 NORW FOR LA; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Oksanen J., **DATA OBJECT**; Olofsson J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0437; Pelletier F, 2012, P ROY SOC B-BIOL SCI, V279, P394, DOI 10.1098/rspb.2011.0827; Pereira H.M., 2015, REWILDING EUROPEAN L; Pettorelli N, 2018, J APPL ECOL, V55, P1114, DOI 10.1111/1365-2664.13082; Pinheiro J., 2019, NLME LINEAR NONLINEA; Prins Herbert H. T., 2008, V195, P1; Pryke JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164198; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Ripple WJ, 2014, NAT CLIM CHANGE, V4, P2, DOI 10.1038/nclimate2081; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Ross LC, 2016, AMBIO, V45, P551, DOI 10.1007/s13280-016-0771-z; Rosvold J, 2008, RAPP ZOOL SER, V1, P1; Rosvold J, 2013, HOLOCENE, V23, P1143, DOI 10.1177/0959683613483625; Schmitz OJ, 2014, ECOSYSTEMS, V17, P344, DOI 10.1007/s10021-013-9715-7; Serrouya R, 2011, J APPL ECOL, V48, P935, DOI 10.1111/j.1365-2664.2011.01998.x; Smith FA, 2018, SCIENCE, V360, P310, DOI 10.1126/science.aao5987; Speed JDM, 2013, ARCT ANTARCT ALP RES, V45, P584, DOI 10.1657/1938-4246-45.4.584; Speed James D. M., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P313, DOI 10.1080/21513732.2012.725226; Speed JDM, 2010, ECOLOGY, V91, P3414, DOI 10.1890/09-2300.1; Svenning Jens-Christian, 2016, Proc Natl Acad Sci U S A, V113, P898, DOI 10.1073/pnas.1502556112; Svenning JC, 2016, P NATL ACAD SCI USA, V113, P898, DOI 10.1073/pnas.1502556112; Tanentzap AJ, 2012, BIOL REV, V87, P72, DOI 10.1111/j.1469-185X.2011.00185.x; Tape KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152636; te Beest M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/aa5128; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824; 2011, BASIC APPL ECOL, V12, P643, DOI DOI 10.1016/J.BAAE.2011.09.009; 2004, ANNU REV ECOL EVOL S, V35, P113, DOI DOI 10.1146/ANNUREV.ECOLSYS.35.021103.105725; 2011, SCIENCE, V333, P301, DOI DOI 10.1126/SCIENCE.1205106; 2014, ECOSYSTEMS, V17, P1138, DOI DOI 10.1007/S10021-014-9784-2	71	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217166	10.1371/journal.pone.0217166	http://dx.doi.org/10.1371/journal.pone.0217166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112579	gold, Green Submitted, Green Published			2022-12-27	WOS:000468451000039
J	Moors, A; Fini, C; Everaert, T; Bardi, L; Bossuyt, E; Kuppens, P; Brass, M				Moors, Agnes; Fini, Chiara; Everaert, Tom; Bardi, Lara; Bossuyt, Evelien; Kuppens, Peter; Brass, Marcel			The role of stimulus-driven versus goal-directed processes in fight and flight tendencies measured with motor evoked potentials induced by Transcranial Magnetic Stimulation	PLOS ONE			English	Article							IMPLEMENTATION INTENTIONS; EMOTION; POWER; EXCITABILITY; AGGRESSION; APPRAISAL; METAANALYSIS; ACHIEVEMENT; ANGER; PAIN	This study examines two contrasting explanations for early tendencies to fight and flee. According to a stimulus-driven explanation, goal-incompatible stimuli that are easy/difficult to control lead to the tendency to fight/flee. According to a goal-directed explanation, on the other hand, the tendency to fight/flee occurs when the expected utility of fighting/fleeing is the highest. Participants did a computer task in which they were confronted with goal-incompatible stimuli that were (a) easy to control and fighting had the highest expected utility, (b) easy to control and fleeing had the highest expected utility, and (c) difficult to control and fleeing and fighting had zero expected utility. After participants were trained to use one hand to fight and another hand to flee, they either had to choose a response or merely observe the stimuli. During the observation trials, single-pulse Transcranial Magnetic Stimulation (TMS) was applied to the primary motor cortex 450 ms post-stimulus onset and motor evoked potentials (MEPs) were measured from the hand muscles. Results showed that participants chose to fight/flee when the expected utility of fighting/fleeing was the highest, and that they responded late when the expected utility of both responses was low. They also showed larger MEPs for the right/left hand when the expected utility of fighting/fleeing was the highest. This result can be interpreted as support for the goal-directed account, but only if it is assumed that we were unable to override the presumed natural mapping between hand (right/left) and response (fight/flight).	[Moors, Agnes; Kuppens, Peter] Katholieke Univ Leuven, Res Grp Quantitat Psychol & Individual Difference, Leuven, Belgium; [Moors, Agnes] Katholieke Univ Leuven, Ctr Social & Cultural Psychol, Leuven, Belgium; [Moors, Agnes; Everaert, Tom; Bossuyt, Evelien] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Fini, Chiara] State Univ Roma La Sapienza, Dept Dynam & Clin Psychol, Rome, Italy; [Bardi, Lara; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	KU Leuven; KU Leuven; Ghent University; Sapienza University Rome; Ghent University	Moors, A (corresponding author), Katholieke Univ Leuven, Res Grp Quantitat Psychol & Individual Difference, Leuven, Belgium.; Moors, A (corresponding author), Katholieke Univ Leuven, Ctr Social & Cultural Psychol, Leuven, Belgium.; Moors, A (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.	agnes.moors@kuleuven.be	Moors, Agnes/C-6342-2008; kuppens, peter/DHG-5268-2022; Brass, Marcel/J-7082-2012; Fini, Chiara/ABC-5055-2021	Moors, Agnes/0000-0002-5137-557X; Brass, Marcel/0000-0002-3364-4019; fini, chiara/0000-0002-9939-4745; Bardi, Lara/0000-0002-1678-647X; kuppens, peter/0000-0002-2363-2356	Research Foundation - Flanders (FWO) [G073317N, G022313N]; Research Fund of KU Leuven [C14/17/047]	Research Foundation - Flanders (FWO)(FWO); Research Fund of KU Leuven	Preparation of this article was supported by Research Program G073317N to AM and PK and G022313N to AM and MB of the Research Foundation - Flanders (FWO; http://fwo.be) and Grant C14/17/047 to AM of the Research Fund of KU Leuven (https://admin.kuleuven.be/raden/en/research-council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M.B., 1960, EMOTION PERSONALITY; Avenanti A, 2009, CORTEX, V45, P1072, DOI 10.1016/j.cortex.2008.10.004; BARON RA, 1971, J PERS SOC PSYCHOL, V18, P48, DOI 10.1037/h0030643; BINDRA D, 1969, ANN NY ACAD SCI, V159, P1071, DOI 10.1111/j.1749-6632.1969.tb12998.x; Borgomaneri S, 2015, BRAIN STRUCT FUNCT, V220, P2765, DOI 10.1007/s00429-014-0825-6; Bossuyt E, 2014, PSYCHOL REC, V64, P841, DOI 10.1007/s40732-014-0065-4; CARLSON M, 1990, J PERS SOC PSYCHOL, V58, P622, DOI 10.1037/0022-3514.58.4.622; Chen S, 2001, J PERS SOC PSYCHOL, V80, P173, DOI 10.1037//0022-3514.80.2.173; Chorpita BF, 1998, PSYCHOL BULL, V124, P3, DOI 10.1037/0033-2909.124.1.3; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dickinson A., 1993, CONSCIOUSNESS PSYCHO, P105; DONNERSTEIN E, 1976, J PERS SOC PSYCHOL, V34, P774, DOI 10.1037/0022-3514.34.5.774; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fast NJ, 2009, PSYCHOL SCI, V20, P1406, DOI 10.1111/j.1467-9280.2009.02452.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frijda N. H., 2004, FEELINGS EMOTIONS AM, P158; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Galea JM, 2013, J NEUROSCI, V33, P3981, DOI 10.1523/JNEUROSCI.1294-12.2013; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gough PM, 2013, BRAIN LANG, V125, P54, DOI 10.1016/j.bandl.2013.01.012; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Kapogiannis D, 2008, EUR J NEUROSCI, V27, P1836, DOI 10.1111/j.1460-9568.2008.06147.x; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Keltner D, 2001, PSYCHOL BULL, V127, P229, DOI 10.1037//0033-2909.127.2.229; KIPNIS D, 1972, J PERS SOC PSYCHOL, V24, P33, DOI 10.1037/h0033390; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lazarus R.S., 1991, EMOTION ADAPTATION; Mandler G, 1966, ANXIETY BEHAV, P263; Mirabella G, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01334; Mirabella G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00206; Moors A, 2007, COGNITION EMOTION, V21, P1238, DOI 10.1080/02699930701438061; Moors A, 2017, EMOT REV, V9, P310, DOI 10.1177/1754073916669595; Moors A, 2017, PSYCHOL INQ, V28, P1, DOI 10.1080/1047840X.2017.1235900; Moors A, 2016, ANNU REV PSYCHOL, V67, P263, DOI 10.1146/annurev-psych-122414-033550; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Parkinson B, 2001, BRIT J PSYCHOL, V92, P507, DOI 10.1348/000712601162310; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; Phaf RH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00378; RICHARDSON DR, 1986, J RES PERS, V20, P402, DOI 10.1016/0092-6566(86)90122-4; Ridderinkhof KR, 2017, EMOT REV, V9, P319, DOI 10.1177/1754073916661765; Roseman IJ, 1996, COGNITION EMOTION, V10, P241, DOI 10.1080/026999396380240; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KR, 2001, APPRAISAL PROCESSES, P369; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Sheeran P, 2005, PERS SOC PSYCHOL B, V31, P87, DOI 10.1177/0146167204271308; Spruyt A, 2018, EMOTION, V18, P332, DOI 10.1037/emo0000361; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Suzuki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090773; Thabit MN, 2011, CLIN NEUROPHYSIOL, V122, P1764, DOI 10.1016/j.clinph.2011.02.021; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Vicario CM, 2015, CORTEX, V65, P139, DOI 10.1016/j.cortex.2014.12.017; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Zheng X, 2012, NEUROPSYCHOLOGIA, V50, P1451, DOI 10.1016/j.neuropsychologia.2012.02.030; 2012, J NEUROSCI, V32, P8373, DOI DOI 10.1523/JNEUROSCI.0270-12.2012; 2002, DEV REV, V22, P117	63	17	17	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217266	10.1371/journal.pone.0217266	http://dx.doi.org/10.1371/journal.pone.0217266			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107906	Green Submitted, Green Published, gold			2022-12-27	WOS:000468285200042
J	Winter, V; Degasperi, B; Bockstahler, B; Dupre, G				Winter, Verena; Degasperi, Brigitte; Bockstahler, Barbara; Dupre, Gilles			Suture length to wound length ratio in 175 small animal abdominal midline closures	PLOS ONE			English	Article							CONDITION SCORE SYSTEM; INCISIONAL HERNIAS; COMPLICATIONS; VALIDATION; STITCH; BITES	Experimental and human studies have reported the advantages of a suture length to wound length (SL:WL) ratio greater than 4:1 in midline abdominal closure. This is achieved when the tissue bite (TB) is equal to or larger than the stitch interval (SI). Although TB and SI values are recommended in some textbooks, SL:WL ratios are rarely reported in veterinary textbooks. Additionally, no clinical data regarding these parameters could be found in small animals. Therefore, the aim of this study was to evaluate the SL:WL ratio of midline laparotomy closure in dogs and cats performed by surgeons with different levels of expertise and to compare the findings with current textbook recommendations. Midline laparotomy incisions of 100 dogs and 75 cats were closed in continuous pattern by diplomates and residents of both the European College of Veterinary Surgeons (ECVS) and the European College of Animal Reproduction (ECAR). The mean SL:WL ratio was 2.5 0.7:1. The surgeons' level of experience and the species and body weights of the animals did not have any significant influence on the SL:WL ratio. A moderate negative correlation was observed between the mean SI to mean TB (SI:TB) ratio and the SL:WL ratio. In this study, the mean SI matched the textbook recommendations both in feline and canine species, whereas the TB in cats was different. In this study, the SL:WL ratio was less than 4:1 without apparent complications. Because of the low prevalence of incisional hernia in dogs and cats larger studies are necessary to evaluate clinical significance of the presented data.	[Winter, Verena; Degasperi, Brigitte; Bockstahler, Barbara; Dupre, Gilles] Univ Vet Med, Dept Small Anim & Horses, Div Small Anim Surg, Vienna, Austria	University of Veterinary Medicine Vienna	Winter, V (corresponding author), Univ Vet Med, Dept Small Anim & Horses, Div Small Anim Surg, Vienna, Austria.	Verena.Winter@vetmeduni.ac.at						Alnassar S, 2012, VASCULAR, V20, P273, DOI 10.1258/vasc.2011.oa0332; BELLENGER C, 2003, TXB SMALL ANIMAL SUR, P405; Berzon J L., 1979, COMPLICATIONS ELECTI, V8, P89, DOI [10.1111/j.1532-950X.1979, DOI 10.1111/J.1532-950X.1979]; Cengiz Y, 2001, ARCH SURG-CHICAGO, V136, P272, DOI 10.1001/archsurg.136.3.272; De Rooster H, 2016, COMPLICATIONS SMALL, P355, DOI 10.1002/9781119421344.ch49; Deerenberg EB, 2015, LANCET, V386, P1254, DOI 10.1016/S0140-6736(15)60459-7; Fossum TW, 2019, SMALL ANIMAL SURG, P512; Fossum TW, 2007, CHIRURG KLEINTIERE, P280; GIBSON KT, 1989, VET SURG, V18, P360, DOI [10.1111/j.1532-950X.1989.tb01100.x, 10.1111/j.1532-950X.1989.tb01045.x]; HARVEY HJ, 1990, VET SURG, V19, P289, DOI 10.1111/j.1532-950X.1990.tb01188.x; Hassan KA, 2006, VET SURG, V35, P310, DOI 10.1111/j.1532-950X.2006.00149.x; Hoer J, 2002, Hernia, V6, P11; Hoer J., 2000, HERNIA, V4, P67, DOI [DOI 10.1007/BF02353745, 10.1007/BF02353745]; Hoer J J, 2002, Hernia, V6, P93; Hope WW, 2010, HERNIA, V14, P463, DOI 10.1007/s10029-010-0691-y; Israelsson LA, 2000, EUR J SURG, V166, P642; Israelsson LA, 1996, EUR J SURG, V162, P605; Israelsson LA, 1998, EUR J SURG, V164, P353, DOI 10.1080/110241598750004382; Israelsson LA, 1997, EUR J SURG, V163, P175; ISRAELSSON LA, 1994, BRIT J SURG, V81, P1606, DOI 10.1002/bjs.1800811114; ISRAELSSON LA, 1993, BRIT J SURG, V80, P1284, DOI 10.1002/bjs.1800801020; Israelsson LA, 1999, EUR J SURG, V165, P3, DOI 10.1080/110241599750007432; Israelsson LA., 2003, EUR J SURG, V35, P5; Israelsson LA, 2013, SURG CLIN N AM, V93, P1027, DOI 10.1016/j.suc.2013.06.009; JENKINS TPN, 1976, BRIT J SURG, V63, P873, DOI 10.1002/bjs.1800631110; Klonner M., 2015, THESIS; Kroese LF, 2018, HERNIA, V22, P229, DOI 10.1007/s10029-017-1725-5; Laflamme D, 1997, CANINE PRACT, V22, P10; Laflamme D, 1997, FELINE PRACT, V25, P13; Leaper David J, 2004, Int Wound J, V1, P247, DOI 10.1111/j.1742-4801.2004.00067.x; Lester S, 2004, J SMALL ANIM PRACT, V45, P351, DOI 10.1111/j.1748-5827.2004.tb00247.x; Millbourn D, 2011, HERNIA, V15, P261, DOI 10.1007/s10029-010-0775-8; Millbourn D, 2004, Hernia, V8, P39, DOI 10.1007/s10029-003-0159-4; Millbourn D, 2009, ARCH SURG-CHICAGO, V144, P1056, DOI 10.1001/archsurg.2009.189; Mukaka MM, 2012, MALAWI MED J, V24, P69; Muysoms FE, 2015, HERNIA, V19, P1, DOI 10.1007/s10029-014-1342-5; Naleway SE, 2015, J BIOMED MATER RES B, V103, P735, DOI 10.1002/jbm.b.33171; POLLOCK AV, 1989, BRIT J SURG, V76, P953, DOI 10.1002/bjs.1800760926; Rosin E, 2014, CURRENT TECHNIQUES IN SMALL ANIMAL SURGERY, 5TH EDITION, P361; Schachtrupp A, 2016, HERNIA, V20, P601, DOI 10.1007/s10029-015-1433-y; Schmiedt CW, 2017, VET SURG SMALL ANIMA, P210; Shales C., 2014, FELINE SOFT TISSUE G, P245; Smeak D.D., 2017, VET SURG SMALL ANIMA, V2nd edn., P1564; Tobias KM, 2010, MANUAL SMALL ANIMAL, P73; Walming S, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0207-0; Williams ZF, 2017, HERNIA, V21, P869, DOI 10.1007/s10029-017-1667-y; 2001, LANGENBECK ARCH SURG, V386, P218, DOI DOI 10.1007/S004230000196	47	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216943	10.1371/journal.pone.0216943	http://dx.doi.org/10.1371/journal.pone.0216943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107892	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200021
J	Cross, GB; Yeo, BCM; Hutchinson, PE; Tan, MC; Verma, R; Lu, QS; Paton, NI				Cross, Gail B.; Yeo, Benjamin C-M; Hutchinson, Paul Edward; Tan, Mark C.; Verma, Rupangi; Lu, Qingshu; Paton, Nicholas, I			Impact of selective immune-cell depletion on growth of Mycobacterium tuberculosis (Mtb) in a whole-blood bactericidal activity (WBA) assay	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; IN-VITRO	We investigated the contribution of host immune cells to bacterial killing in a whole-blood bactericidal activity (WBA) assay, an ex vivo model used to test efficacy of drugs against mycobacterium tuberculosis (Mtb). We performed WBA assays with immuno-magnetic depletion of specific cell types, in the presence or absence of rifampicin. Innate immune cells decreased Mtb growth in absence of drug, but appeared to diminish the cidal activity of rifampicin, possibly attributable to intracellular bacterial sequestration. Adaptive immune cells had no effect with or without drug. The WBA assay may have potential for testing adjunctive host-directed therapies acting on phagocytic cells.	[Cross, Gail B.; Yeo, Benjamin C-M; Tan, Mark C.; Verma, Rupangi; Paton, Nicholas, I] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Lu, Qingshu] Singapore Clin Res Inst, Singapore, Singapore; [Cross, Gail B.; Paton, Nicholas, I] Natl Univ Singapore Hosp, Univ Med Cluster, Div Infect Dis, Singapore, Singapore; [Hutchinson, Paul Edward] Natl Univ Singapore, Life Sci Inst, Flow Cytometry Lab, Singapore, Singapore	National University of Singapore; Singapore Clinical Research Institute; National University of Singapore; National University of Singapore	Cross, GB (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.; Cross, GB (corresponding author), Natl Univ Singapore Hosp, Univ Med Cluster, Div Infect Dis, Singapore, Singapore.	mdcgbc@nus.edu.sg		Cross, Gail/0000-0001-5116-9576	Singapore Ministry of Health's National Medical Research Council (NMRC), TCR Flagship grant [NMRC/TCR/011-NUHS/2014]; Center Grant 'MINE' Research Core [4, NMRC/CG/013/2013]; NLAM Clinician Scientist Unit "Pitch for Funds" research grant [PFFR-23]	Singapore Ministry of Health's National Medical Research Council (NMRC), TCR Flagship grant; Center Grant 'MINE' Research Core; NLAM Clinician Scientist Unit "Pitch for Funds" research grant	This research was funded by Singapore Ministry of Health's National Medical Research Council (NMRC), TCR Flagship grant, NMRC/TCR/011-NUHS/2014 to NIP; Center Grant 'MINE', Research Core #4, NMRC/CG/013/2013 to NIP; NLAM Clinician Scientist Unit "Pitch for Funds" research grant PFFR-23 September 2015 to GBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan MJ, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00142-17, 10.1128/cvi.00142-17]; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; Parra JAC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00967; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Diacon AH, 2014, EXPERT REV ANTI-INFE, V12, P223, DOI 10.1586/14787210.2014.870884; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Gurumurthy M, 2017, J ANTIMICROB CHEMOTH, V72, P2012, DOI 10.1093/jac/dkx081; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Hoft DF, 2016, EBIOMEDICINE, V7, P278, DOI 10.1016/j.ebiom.2016.04.010; Khan N, 2016, INT REV IMMUNOL, V35, P386, DOI 10.3109/08830185.2015.1015718; Khan N, 2016, J INNATE IMMUN, V8, P228, DOI 10.1159/000439591; Kolloli A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00171; Liu YC, 2016, J EXP MED, V213, P809, DOI 10.1084/jem.20151248; Lowe DM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00903; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Naftalin CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31590-4; Naftalin CM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00482-17; Norris BA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007154; Paik S, 2019, VIRULENCE, V10, P448, DOI 10.1080/21505594.2018.1536598; Spencer CT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003119; Srivastava S, 2014, IMMUNOL REV, V262, P179, DOI 10.1111/imr.12217; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Tanner R, 2016, VACCINE, V34, P4656, DOI 10.1016/j.vaccine.2016.07.058; Tena GN, 2003, J INFECT DIS, V187, P1544, DOI 10.1086/374799; Torrelles JB, 2017, TRENDS MICROBIOL, V25, P688, DOI 10.1016/j.tim.2017.03.007; Turner RD, 2017, J INFECT DIS, V216, pS636, DOI 10.1093/infdis/jix361; Vankayalapati R, 2004, J IMMUNOL, V172, P130, DOI 10.4049/jimmunol.172.1.130; Venkatasubramanian S, 2017, MUCOSAL IMMUNOL, V10, P1031, DOI 10.1038/mi.2016.105; Wallis RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030479; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; 2017, CELL HOST MICROBE, V22, P519, DOI DOI 10.1016/J.CHOM.2017.09.003; 2012, TRENDS IMMUNOL, V33, P14, DOI DOI 10.1016/J.IT.2011.10; 2017, CURRENT OPINION IMMU, V48, P44, DOI DOI 10.1016/J.COI.2017.08.001	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216616	10.1371/journal.pone.0216616	http://dx.doi.org/10.1371/journal.pone.0216616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100071	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600012
J	Mitchell, J; Balem, F; Tirupula, K; Man, D; Dhiman, HK; Yanamala, N; Ollesch, J; Planas-Iglesias, J; Jennings, BJ; Gerwert, K; Iannaccone, A; Klein-Seetharaman, J				Mitchell, James; Balem, Fernanda; Tirupula, Kalyan; Man, David; Dhiman, Harpreet Kaur; Yanamala, Naveena; Ollesch, Julian; Planas-Iglesias, Joan; Jennings, Barbara J.; Gerwert, Klaus; Iannaccone, Alessandro; Klein-Seetharaman, Judith			Comparison of the molecular properties of retinitis pigmentosa P23H and N15S amino acid replacements in rhodopsin	PLOS ONE			English	Article							POINT MUTATION; VITAMIN-A; MUTANTS; GENE; EXPRESSION; SUPPLEMENTATION; GLYCOSYLATION; IMPROVEMENT; STABILITY; BINDING	Mutations in the RHO gene encoding for the visual pigment protein, rhodopsin, are among the most common cause of autosomal dominant retinitis pigmentosa (ADRP). Previous studies of ADRP mutations in different domains of rhodopsin have indicated that changes that lead to more instability in rhodopsin structure are responsible for more severe disease in patients. Here, we further test this hypothesis by comparing side-by-side and therefore quantitatively two RHO mutations, N15S and P23H, both located in the N-terminal intradiscal domain. The in vitro biochemical properties of these two rhodopsin proteins, expressed in stably transfected tetracycline-inducible HEK293S cells, their UV-visible absorption, their Fourier transform infrared, circular dichroism and Metarhodopsin II fluorescence spectroscopy properties were characterized. As compared to the severely impaired P23H molecular function, N15S is only slightly defective in structure and stability. We propose that the molecular basis for these structural differences lies in the greater distance of the N15 residue as compared to P23 with respect to the predicted rhodopsin folding core. As described previously for WT rhodopsin, addition of the cytoplasmic allosteric modulator chlorin e6 stabilizes especially the P23H protein, suggesting that chlorin e6 may be generally beneficial in the rescue of those ADRP rhodopsin proteins whose stability is affected by amino acid replacement.	[Mitchell, James; Planas-Iglesias, Joan; Klein-Seetharaman, Judith] Univ Warwick, Med Sch, Div Biomed Sci, Coventry, W Midlands, England; [Balem, Fernanda; Tirupula, Kalyan; Man, David; Dhiman, Harpreet Kaur; Yanamala, Naveena; Klein-Seetharaman, Judith] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15213 USA; [Ollesch, Julian; Gerwert, Klaus] Ruhr Univ Bochum, Dept Biophys, Bochum, Germany; [Jennings, Barbara J.; Iannaccone, Alessandro] Univ Tennessee, Hlth Sci Ctr, Hamilton Eye Inst, Retinal Degenerat & Ophthalm Genet Serv,Dept Opht, Memphis, TN 38163 USA; [Jennings, Barbara J.; Iannaccone, Alessandro] Univ Tennessee, Hlth Sci Ctr, Hamilton Eye Inst, Lions Visual Funct Diagnost Lab,Dept Ophthalmol, Memphis, TN 38163 USA; [Planas-Iglesias, Joan] Masaryk Univ, Fac Sci, Dept Expt Biol, Loschmidt Labs, Brno, Czech Republic; [Iannaccone, Alessandro] Duke Univ, Sch Med, Ctr Retinal Degenerat & Ophthalm Genet Dis, Duke Eye Ctr,Dept Ophthalmol, Durham, NC 27708 USA	University of Warwick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ruhr University Bochum; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Masaryk University Brno; Duke University	Klein-Seetharaman, J (corresponding author), Univ Warwick, Med Sch, Div Biomed Sci, Coventry, W Midlands, England.; Klein-Seetharaman, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15213 USA.; Iannaccone, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Hamilton Eye Inst, Retinal Degenerat & Ophthalm Genet Serv,Dept Opht, Memphis, TN 38163 USA.; Iannaccone, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Hamilton Eye Inst, Lions Visual Funct Diagnost Lab,Dept Ophthalmol, Memphis, TN 38163 USA.; Iannaccone, A (corresponding author), Duke Univ, Sch Med, Ctr Retinal Degenerat & Ophthalm Genet Dis, Duke Eye Ctr,Dept Ophthalmol, Durham, NC 27708 USA.	alessandro.iannacone@duke.edu; j.klein-seetharaman@warwick.ac.uk	Yanamala, Naveena/AAA-6729-2022	Planas-Iglesias, Joan/0000-0002-6279-2483; Mitchell-White, James/0000-0003-2818-8538; Yanamala, Naveena/0000-0002-4454-4240	National Science Foundation, Information and Intelligent Systems [EAGER 1144281, 0225636, CAREER 0449117]; Research to Prevent Blindness, Inc, New York, NA	National Science Foundation, Information and Intelligent Systems; Research to Prevent Blindness, Inc, New York, NA	Funded by National Science Foundation, Information and Intelligent Systems 0225636 (JKS). National Science Foundation, Information and Intelligent Systems EAGER 1144281 (JKS). National Science Foundation, Information and Intelligent Systems CAREER 0449117 (JKS). Research to Prevent Blindness, Inc, New York, NA (Unrestricted grant to the UTHSC Hamilton Eye Institute and Physician Scientist Award to AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Balem F, 2009, PHOTOCHEM PHOTOBIOL, V85, P471, DOI 10.1111/j.1751-1097.2009.00539.x; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Chen YY, 2015, INVEST OPHTH VIS SCI, V56, P2553, DOI 10.1167/iovs.14-16298; Chen YY, 2014, J BIOL CHEM, V289, P9288, DOI 10.1074/jbc.M114.551713; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Gattegna R, COMP CLIN FIND UNPUB; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Iannaccone A, 2006, VISION RES, V46, P4556, DOI 10.1016/j.visres.2006.08.018; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Iwabe S, 2016, EXP EYE RES, V146, P341, DOI 10.1016/j.exer.2016.04.006; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; KRANICH H, 1993, HUM MOL GENET, V2, P813, DOI 10.1093/hmg/2.6.813; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Lobanova ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04117-8; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4540, DOI 10.1167/iovs.06-0215; Miller LM, 2015, FEBS LETT, V589, P3119, DOI 10.1016/j.febslet.2015.08.042; Mitchell J, PHOTOCHEM PHOTOBIOL; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Opefi CA, 2013, J BIOL CHEM, V288, P33912, DOI 10.1074/jbc.M113.483032; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Porto GD, 1993, RETIN DEGENER, P91, DOI [10.1007/978-1-4615-2974-3_9, DOI 10.1007/978-1-4615-2974-3_9]; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P3261, DOI 10.1021/bi00010a016; Saliba RS, 2002, J CELL SCI, V115, P2907; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Tam BM, 2009, J NEUROSCI, V29, P15145, DOI 10.1523/JNEUROSCI.4259-09.2009; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Woods KN, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00085; Woods KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep37290; Zhu L, 2004, J BIOL CHEM, V279, P53828, DOI 10.1074/jbc.M408472200; 1977, BIOCHIM BIOPHYS ACTA, V492, P83, DOI DOI 10.1016/0005-2795(77)90216-1; 2007, APPL SPECTROSC, V61, P1025, DOI DOI 10.1366/000370207782217680	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0214639	10.1371/journal.pone.0214639	http://dx.doi.org/10.1371/journal.pone.0214639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100078	Green Submitted, Green Published, gold			2022-12-27	WOS:000468176600003
J	Huang, SQ; Bergonzi, C; Schwab, M; Elias, M; Hicks, RE				Huang, Siqian; Bergonzi, Celine; Schwab, Michael; Elias, Mikael; Hicks, Randall E.			Evaluation of biological and enzymatic quorum quencher coating additives to reduce biocorrosion of steel	PLOS ONE			English	Article							CORROSION; BACTERIA; IRON; LACTONASE; TUBERCLES; BIOFILM; SYSTEMS	Microbial colonization can be detrimental to the integrity of metal surfaces and lead to microbiologically influenced corrosion (MIC). Biocorrosion is a serious problem for aquatic and marine industries in the world. In Minnesota (USA), where this study was conducted, biocorrosion severely affects the maritime transportation industry. The anticorrosion activity of a variety of compounds, including chemical (magnesium peroxide) and biological (surfactin, capsaicin, and gramicidin) molecules were investigated as coating additives. We also evaluated a previously engineered, extremely stable, non-biocidal enzyme known to interfere in bacterial signaling, SsoPox (a quorum quenching lactonase). Experimental steel coupons were submerged in water from the Duluth Superior Harbor (DSH) for 8 weeks in the laboratory. Biocorrosion was evaluated by counting the number and the coverage of corrosion tubercles on coupons and also by ESEM imaging of the coupon surface. Three experimental coating additives significantly reduced the formation of corrosion tubercles: surfactin, magnesium peroxide and the quorum quenching lactonase by 31%, 36% and 50%, respectively. DNA sequence analysis of the V4 region of the bacterial 16S rRNA gene revealed that these decreases in corrosion were associated with significant changes in the composition of bacterial communities on the steel surfaces. These results demonstrate the potential of highly stable quorum quenching lactonases to provide a reliable, cost-effective method to treat steel structures and prevent biocorrosion.	[Huang, Siqian; Hicks, Randall E.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Bergonzi, Celine; Schwab, Michael; Elias, Mikael] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Bergonzi, Celine; Schwab, Michael; Elias, Mikael] Univ Minnesota, Biotechnol Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Huang, SQ; Hicks, RE (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.; Elias, M (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.; Elias, M (corresponding author), Univ Minnesota, Biotechnol Inst, St Paul, MN 55108 USA.	huan1012@d.umn.edu; mhelias@umn.edu; rhicks@d.umn.edu	Elias, Mikael/AAH-9385-2021; Huang, Siqian/S-3550-2018	Elias, Mikael/0000-0003-0406-7539; Huang, Siqian/0000-0002-4658-3673	Minnesota Sea Grant Program; University of Minnesota MnDRIVE Initiative postdoctoral fellowship; Minnesota Sea Grant, National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA14OAR4170080]; Minnesota Sea Grant College Program [JR658]	Minnesota Sea Grant Program; University of Minnesota MnDRIVE Initiative postdoctoral fellowship; Minnesota Sea Grant, National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; Minnesota Sea Grant College Program	This research was supported by funding from the Minnesota Sea Grant Program to REH and SH with additional funding from University of Minnesota MnDRIVE Initiative postdoctoral fellowship grants to REH and ME. https://mndrive.umn.edu/.The work by REH and SH used federal funds under award NA14OAR4170080 from Minnesota Sea Grant, National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce. The statements, findings, conclusions, and recommendations are those of the author(s) and do not necessarily reflect the views of NOAA, the Sea Grant College Program, or the U.S. Department of Commerce. This paper is journal reprint No. JR658 of the Minnesota Sea Grant College Program. http://www.seagrant.umn.edu/.	Abdolahi A, 2014, POLYM REV, V54, P702, DOI 10.1080/15583724.2014.946188; Bergonzi C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28988-5; Bostrom JR, 2010, THESIS; Buck E, 1996, GRI960056961466; Bzdrenga J, 2017, CHEM-BIOL INTERACT, V267, P104, DOI 10.1016/j.cbi.2016.05.028; Chang YJ, 2008, J IND MICROBIOL BIOT, V35, P1481, DOI 10.1007/s10295-008-0450-6; Characklis WG, 2009, BIOTECHNOL BIOENG, V102, P310; CHEUNG CWS, 1994, INT BIODETER BIODEGR, V34, P259, DOI 10.1016/0964-8305(94)90087-6; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; Coetser SE, 2005, CRIT REV MICROBIOL, V31, P213, DOI 10.1080/10408410500304074; Cummings DE, 1999, ARCH MICROBIOL, V171, P183, DOI 10.1007/s002030050697; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; Dong YH, 2005, J MICROBIOL, V43, P101; Dowling N.J.E., 1991, MIXED CULTURES BIOTE, P341; Enning D, 2012, ENVIRON MICROBIOL, V14, P1772, DOI 10.1111/j.1462-2920.2012.02778.x; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Garrity GM, 2005, BERGEYS MANUAL SYS B, V2; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gerdt JP, 2014, ACS CHEM BIOL, V9, P2291, DOI 10.1021/cb5004288; Gipperth L, 2009, J ENVIRON MANAGE, V90, pS86, DOI 10.1016/j.jenvman.2008.08.013; Guendouze A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00227; HAMILTON WA, 1985, ANNU REV MICROBIOL, V39, P195, DOI 10.1146/annurev.mi.39.100185.001211; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Hiblot J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075272; Hiblot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047028; Hraiech S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107125; Jo SJ, 2016, J MICROBIOL BIOTECHN, V26, P1593, DOI 10.4014/jmb.1604.04070; Kim SR, 2013, ENVIRON SCI TECHNOL, V47, P836, DOI 10.1021/es303995s; Koch G. H., 2002, FHWARD01156 NACE; Kondo Ryuji, 2008, Plankton & Benthos Research, V3, P180, DOI 10.3800/pbr.3.180; Korenblum E, 2012, BMC MICROBIOL, V12, DOI [10.1155/2012/156537, 10.1186/1471-2180-12-252]; Lade H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/162584; Little BJ., 2007, MICROBIOLOGICALLY IN; Liu F, 2012, MATER CORROS, V63, P431, DOI 10.1002/maco.201005955; Marsh C.P., 2005, SPECIAL PUBLICATION; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Mutlu BR, 2015, J SOL-GEL SCI TECHN, V74, P823, DOI 10.1007/s10971-015-3690-8; Mutlu BR, 2013, J MATER CHEM A, V1, P11051, DOI 10.1039/c3ta12303k; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Oster R., 2012, THESIS; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Quaiser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102561; Rani BEA, 2012, INT J CORROS, V2012, DOI 10.1155/2012/380217; Ray R, 2009, CORROSION-US, V65, P707, DOI 10.5006/1.3319097; Ray RI, 2010, MATER CORROS, V61, P993, DOI 10.1002/maco.201005739; Remy B, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00203; Remy B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37780; Sadekuzzaman M, 2015, COMPR REV FOOD SCI F, V14, P491, DOI 10.1111/1541-4337.12144; Sand W., 2003, Reviews in Environmental Science and Bio/Technology, V2, P169, DOI 10.1023/B:RESB.0000040468.88570.4e; Scarascia G, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040039; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwab M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00611; Thomas J.N., 2016, THESIS; Usher KM, 2014, CORROS SCI, V83, P189, DOI 10.1016/j.corsci.2014.02.014; Videla HA, 2005, INT MICROBIOL, V8, P169; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Xu QW, 2005, ENVIRON TOXICOL, V20, P467, DOI 10.1002/tox.20134; Zuo RJ, 2004, APPL MICROBIOL BIOT, V65, P747, DOI 10.1007/s00253-004-1651-1; 2005, PROTEIN EXPRES PURIF, V41, P207, DOI DOI 10.1016/J.PEP.2005.01.016; 2013, NAT REV MICROBIOL, V11, P157, DOI DOI 10.1038/NRMICRO2960; 2016, CURR OPIN BIOTECH, V39, P48, DOI DOI 10.1016/J.COPBIO.2015.12.012; 2011, BIOINFORMATICS, V27, P2194, DOI DOI 10.1093/BIOINFORMATICS/BTR381; 2016, ISME J, V10, P4, DOI DOI 10.1038/ISMEJ.2015.84; 2015, J BIOTECHNOL, V201, P2, DOI DOI 10.1016/J.JBIOTEC.2014.09.001; 2017, PROCESS BIOCHEM, V61, P137, DOI DOI 10.1016/J.PROCBIO.2017.05.030	67	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217059	10.1371/journal.pone.0217059	http://dx.doi.org/10.1371/journal.pone.0217059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095643	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100073
J	Lee, HJ; Park, SJ; Cheon, JH; Kim, TI; Kim, WH; Kim, HJ				Lee, Hyun Jung; Park, Soo Jung; Cheon, Jae Hee; Kim, Tae Il; Kim, Won Ho; Kim, Hyun Jung			The relationship between diverticulosis and colorectal neoplasia: A meta-analysis	PLOS ONE			English	Article							COLONIC DIVERTICULOSIS; INCREASED RISK; NATURAL-HISTORY; DISEASE; ASSOCIATION; CANCER; POLYPS; POPULATION; PREVALENCE	Background/Aims Diverticulosis and colorectal neoplasia share epidemiological trends and risk factors which are common in Western countries and incidences increase with age. However, the data on an association between diverticulosis and colorectal neoplasia are conflicting. Thus, we performed a meta-analysis to evaluate whether diverticulosis is associated with colorectal neoplasia. Methods A systematic literature search of PubMed, EMBASE, Cochrane Library, Web of Science, and SCOPUS was conducted to identify studies that investigated the association between diverticulosis and advanced colorectal neoplasia (advanced adenoma, colorectal cancer), adenomas, or polyps. The demographic characteristics of patients, including age, gender, indication for colonoscopy, confounding factors, and outcomes of colorectal neoplasia were assessed. Results We identified 29 cross-sectional studies (N = 450,953) that investigated the association between diverticulosis and colorectal neoplasia. The meta-analysis found that diverticulosis was not associated with advanced colorectal neoplasia (odds ratio [OR] 0.98, 95% confidence interval [CI] 0.63-1.50). Although there was a positive correlation between diverticulosis and adenomas (OR 1.47, 95% CI 1.18-1.84) and diverticulosis and polyps (OR 1.95, 95% CI 1.15-3.31), diverticulosis did not increase the risk of adenomas (OR 1.34, 95% CI 0.87-2.06) in patients who underwent screening colonoscopy. Moreover, all the increased risk of colorectal neoplasia in patients with diverticulosis was observed in published studies only, and not in unpublished ones. Conclusions This meta-analysis demonstrated that diverticulosis is not associated with an increased risk of advanced colorectal neoplasia. Although diverticulosis was associated with a higher risk of polyps and adenomas, the risk was not increased in screening populations. Moreover, the increased risk of colorectal neoplasia in patients with diverticulosis was observed only in published studies and not in unpublished ones.	[Lee, Hyun Jung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Hyun Jung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Lee, Hyun Jung; Park, Soo Jung; Cheon, Jae Hee; Kim, Tae Il; Kim, Won Ho] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Hyun Jung] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Kim, HJ (corresponding author), Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	moole02@naver.com	Cheon, Jae Hee/B-4523-2015	Cheon, Jae Hee/0000-0002-2282-8904; Kim, Tae Il/0000-0003-4807-890X; Kim, Won Ho/0000-0002-5682-9972; Kim, Hyun Jung/0000-0003-2018-2385				Aldoori WH, 1998, J NUTR, V128, P714, DOI 10.1093/jn/128.4.714; Ashktorab H, 2015, DIGESTION, V92, P60, DOI 10.1159/000376574; Azzam N, 2013, GASTROENTEROLOGY, V144, pS389; Choi Chang Soo, 2007, Korean J Gastroenterol, V49, P364; Comparato G, 2007, DIGEST DIS, V25, P151, DOI 10.1159/000099480; Downes MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011458; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GLOBER GA, 1977, LANCET, V2, P110; Gohil Vishal B, 2012, J Interv Gastroenterol, V2, P70; Goldstein NS, 1997, AM J CLIN PATHOL, V107, P438; Granlund J, 2011, ALIMENT PHARM THER, V34, P675, DOI 10.1111/j.1365-2036.2011.04782.x; Green S., COCHRANE HDB SYSTEMA; Hammoud I, 2009, AM J GASTROENTEROL, V104, pS165, DOI 10.14309/00000434-200910003-00442; Hirata T, 2008, WORLD J GASTROENTERO, V14, P2411, DOI 10.3748/wjg.14.2411; Hong WD, 2018, THER CLIN RISK MANAG, V14, P531, DOI 10.2147/TCRM.S146194; HORNER JL, 1958, AM J DIG DIS, V3, P343, DOI 10.1007/BF02232401; Huang WY, 2014, CLIN GASTROENTEROL H, V12, P1288, DOI 10.1016/j.cgh.2013.11.039; Jaruvongvanich V, 2017, DIGEST ENDOSC, V29, P73, DOI 10.1111/den.12701; Kieff BJ, 2004, AM J GASTROENTEROL, V99, P2007, DOI 10.1111/j.1572-0241.2004.30332.x; Lee KM, 2010, J KOREAN MED SCI, V25, P1323, DOI 10.3346/jkms.2010.25.9.1323; Loffeld R. J. L. F, 2002, Colorectal Dis, V4, P189, DOI 10.1046/j.1463-1318.2002.00328.x; MAZUMDER MK, 2011, GASTROENTEROLOGY S1, V140, pS567; Meda S, 2014, AM J GASTROENTEROL, V109, pS619, DOI 10.14309/00000434-201410002-02114; MORINI S, 1988, DIS COLON RECTUM, V31, P793, DOI 10.1007/BF02560109; Morini S, 2002, DIGEST LIVER DIS, V34, P635, DOI 10.1016/S1590-8658(02)80206-7; Morini S, 2008, J CLIN GASTROENTEROL, V42, P763, DOI 10.1097/MCG.0b013e31816200fb; Muhammad A, 2014, INT J COLORECTAL DIS, V29, P947, DOI 10.1007/s00384-014-1908-9; Neubauer K, 2011, ADV CLIN EXP MED, V20, P623; PAINTER NS, 1975, CLIN GASTROENTEROL, V4, P1; PARAVA P, 2013, AM J GASTROENTERO S1, V108, pS181; PARKS TG, 1975, CLIN GASTROENTEROL, V4, P53; Parra-Blanco A, 2006, DIGESTION, V73, P47, DOI 10.1159/000089779; Pavao Borges V., 2018, UNITED EUR GASTROENT, V6, pA690; Peery AF, 2015, AM J GASTROENTEROL, V110, P1694, DOI 10.1038/ajg.2015.359; Rajendra S, 2005, EUR J GASTROEN HEPAT, V17, P871, DOI 10.1097/00042737-200508000-00015; Rangnekar AS, 2007, AM J GASTROENTEROL, V102, pS562, DOI 10.14309/00000434-200709002-01217; Rex DK, 2015, AM J GASTROENTEROL, V110, P72, DOI 10.1038/ajg.2014.385; Rodriguez-Castro K., 2018, UNITED EUR GASTROENT, V6, pA691; Rondagh EJA, 2011, EUR J GASTROEN HEPAT, V23, P1050, DOI 10.1097/MEG.0b013e32834b0e44; Shah R, 2017, AM J GASTROENTEROL, V112, pS152, DOI 10.14309/00000434-201710001-00282; SHEN HF, 2014, AM J GASTROENTERO S2, V109, pS209; Soran A, 2006, CLIN COLORECTAL CANC, V6, P140, DOI 10.3816/CCC.2006.n.031; STEFANSSON T, 1993, GUT, V34, P499, DOI 10.1136/gut.34.4.499; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Sweetser S, 2013, CLIN GASTROENTEROL H, V11, P760, DOI 10.1016/j.cgh.2012.12.004; Szura M., 2011, SURG ENDOSC, V25, pS103; Teixeira C, 2017, REV ESP ENFERM DIG, V109, P768, DOI 10.17235/reed.2017.5009/2017; Wang FW, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0267-5; Wang SF, 2019, DIGEST DIS, V37, P116, DOI 10.1159/000493461; West AB, 2004, J CLIN GASTROENTEROL, V38, pS11, DOI 10.1097/01.mcg.0000124005.07433.69; Wong E Ru, 2016, Asian Pac J Cancer Prev, V17, P2401; Yusuf MA, 2000, GASTROINTEST ENDOSC, V51, pAB235, DOI 10.1016/S0016-5107(00)14651-6	54	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216380	10.1371/journal.pone.0216380	http://dx.doi.org/10.1371/journal.pone.0216380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141507	gold, Green Published, Green Submitted			2022-12-27	WOS:000469323000006
J	Udayanga, L; Ranathunge, T; Iqbal, MCM; Abeyewickreme, W; Hapugoda, M				Udayanga, Lahiru; Ranathunge, Tharaka; Iqbal, M. C. M.; Abeyewickreme, W.; Hapugoda, Menaka			Predatory efficacy of five locally available copepods on Aedes larvae under laboratory settings: An approach towards bio-control of dengue in Sri Lanka	PLOS ONE			English	Article							CYCLOPOID COPEPODS; BIOLOGICAL-CONTROL; MESOCYCLOPS-LONGISETUS; MALARIA VECTOR; COMMUNITY; AEGYPTI; NANOPARTICLES; CRUSTACEA; MOSQUITOS; RESPONSES	Many countries are in search of more effective and sustainable methods for controlling dengue vectors, due to undeniable inefficiencies in chemical and mechanical vector control methods. Bio-control of vectors by copepods is an ideal method of using interactions in the natural ecosystem for vector management, with minimum consequences on the environment. Current study determined the predatory efficacy of five locally abundant copepod species on, Aedes larvae under laboratory conditions. Copepods were collected from the pre-identified locations within the districts of Gampaha and Kandy, and identified morphologically. Individual species of copepods were maintained as separate colonies with Paramecium culture and wheat grain as supplementary food. Five adult copepods of each species was introduced into separate containers with 200 larvae (1st instar) of Aedes aegypti. Number of larvae survived in containers were enumerated at 3 hour intervals within a duration of 24 hours. Each experiment was repeated five times. The same procedure was followed for Ae. albopictus. Significance in the variations among predation rates was evaluated with General Linear Modelling (GLM) followed by Tukey's pair-wise comparison in SPSS (version 23). Significant variations in predation rates of studied copepod species were reported (p<0.05), whereby M. leuckarti indicated the highest followed by M. scrassus, while C. languides indicated the lowest predatory efficacy. The effect of different Aedes larval species on the predation rates of copepods remained significant (p<0.05), even though the effect on predatory efficiency was not significant. Based on the findings, both M. leuckarti and M. scrassus, with the highest predatory efficiencies, could be recommended as potential candidates for biological controlling of Aedes vectors in Sri Lanka.	[Udayanga, Lahiru] Wayamba Univ Sri Lanka, Fac Agr & Plantat Management, Dept Biosyst Engn, Kuliyapitiya, Sri Lanka; [Udayanga, Lahiru; Ranathunge, Tharaka; Hapugoda, Menaka] Univ Kelaniya, Fac Med, Mol Med Unit, Colombo, Sri Lanka; [Iqbal, M. C. M.] Natl Inst Fundamental Studies, Kandy, Sri Lanka; [Abeyewickreme, W.] Sir John Kotelawala Def Univ, Fac Med, Dept Paraclin Sci, Ratmalana, Sri Lanka	Wayamba University of Sri Lanka; University Kelaniya; University of Colombo; National Institute of Fundamental Studies (NIFS); General Sir John Kotelawala Defence University	Hapugoda, M (corresponding author), Univ Kelaniya, Fac Med, Mol Med Unit, Colombo, Sri Lanka.	menakaha@yahoo.com	Iqbal, Mohamed Cassim/AAH-2008-2021; Udayanga, Lahiru/AAM-1831-2021; Iqbal, Mohammed/GYA-1556-2022	Iqbal, Mohamed Cassim/0000-0002-4862-5099; Udayanga, N.W.B.A. Lahiru/0000-0002-5687-989X	National Research Council, Sri Lanka [TO 14-04, <LF> NRC TO 14-04]; International Atomic Energy Agency [IAEA SRL5/047]	National Research Council, Sri Lanka; International Atomic Energy Agency(International Atomic Energy Agency)	Surveillance activities were funded by the National Research Council Funded Dengue Mega Grant (NRC TO 14-04), Sri Lanka.; We acknowledge the National Research Council, Sri Lanka (TO 14-04) for funding and the International Atomic Energy Agency (IAEA SRL5/047) for technical cooperation.	Baldacchino Frederic, 2015, Pest Manag Sci, V71, P1471, DOI 10.1002/ps.4044; Bapna Saroj, 1994, Journal of Communicable Diseases, V26, P39; Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496; Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669; BROWN MD, 1991, J MED ENTOMOL, V28, P618, DOI 10.1093/jmedent/28.5.618; Chitra Thangadurai, 2013, Asian Pacific Journal of Tropical Disease, V3, P111, DOI 10.1016/S2222-1808(13)60054-7; De Roa EZ, 2002, J AM MOSQUITO CONTR, V18, P47; Dessborn L, 2009, HYDROBIOLOGIA, V636, P319, DOI 10.1007/s10750-009-9962-y; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harrison BA, 1973, COMP MORPHOLOGY EARL; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kalimuthu K, 2017, HYDROBIOLOGIA, V785, P359, DOI 10.1007/s10750-016-2943-z; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059; Klerman G, 1994, INTERPERSONAL PSYCHO; Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z; Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LING HU, 1986, LIMNOLOGICAL SURVE 2; MAMARIL A. C., 1978, NAT APPL SCI B, V30, P109; Marten G.G., 1984, Bulletin of the Society of Vector Ecologists, V9, P1; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P681; MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491, DOI 10.1007/BF00229976; MARTEN GG, 1997, COPEPOD PRODUCTION A; Mendis A.S., 1962, GUIDE FRESH WATER FA, P42; Micieli MV, 1982, MEM I O CRUZ, V97, P835; Millon A, 2008, OIKOS, V117, P1500, DOI 10.1111/j.0030-1299.2008.16458.x; Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0; Murugan K, 2017, HYDROBIOLOGIA, V797, P335, DOI 10.1007/s10750-017-3196-1; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Paaijmans KP, 2008, INT J BIOMETEOROL, V52, P747, DOI 10.1007/s00484-008-0167-2; Peterson DL, 2013, J BIOGEOGR, V40, P1664, DOI 10.1111/jbi.12107; Ramanibai R, 1998, INDIAN J NAT PROD RE, P208; Ranathunge RMTB, 2018, J VECTOR BORNE DIS; Rey JR, 2004, J VECTOR ECOL, V29, P124; RIVIERE F, 1981, ENTOMOPHAGA, V26, P427, DOI 10.1007/BF02374717; Romano D, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.187427; Romano D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12941-z; Rueda L.M., 2004, PICTORIAL KEYS IDENT; Shad A., 2013, INT J CURR MICROBIOL, V2, P172; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Sirisena PDNN, 2014, INT J INFECT DIS, V19, P6, DOI 10.1016/j.ijid.2013.10.012; Suarez-Rubio M, 2004, J AM MOSQUITO CONTR, V20, P401; TINSON S, 1985, HYDROBIOLOGIA, V127, P257, DOI 10.1007/BF00024230; Udayanga L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2995-y; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; *WHO, 1992, 15 WHO EXP COMM VECT; Williams-Howze Judith, 1997, Oceanography and Marine Biology an Annual Review, V35, P257; Yasuoka J, 2006, T ROY SOC TROP MED H, V100, P995, DOI 10.1016/j.trstmh.2005.12.014	52	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216140	10.1371/journal.pone.0216140	http://dx.doi.org/10.1371/journal.pone.0216140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136574	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300003
J	Frydenvang, K; Verkade-Vreeker, MCA; Dohmen, F; Commandeur, JNM; Rafiq, M; Mirza, O; Jorgensen, FS; Geerke, DP				Frydenvang, Karla; Verkade-Vreeker, Marlies C. A.; Dohmen, Floor; Commandeur, Jan N. M.; Rafiq, Maria; Mirza, Osman; Jorgensen, Flemming Steen; Geerke, Daan P.			Structural analysis of Cytochrome P450 BM3 mutant M11 in complex with dithiothreitol	PLOS ONE			English	Article							BINDING; HYDROXYLATION; MECHANISM; PROTEIN; CRYSTALLOGRAPHY; DEGRADATION; VALIDATION; GENERATION; MYOGLOBIN; CYP102A1	The bacterial Cytochrome P450 (CYP) BM3 (CYP102A1) is one of the most active CYP isoforms. BM3 mutants can serve as a model for human drug-metabolizing CYPs and/or as biocatalyst for selective formation of drug metabolites. Hence, molecular and computational biologists have in the last two decades shown strong interest in the discovery and design of novel BM3 variants with optimized activity and selectivity for substrate conversion. This led e.g. to the discovery of mutant M11 that is able to metabolize a variety of drugs and drug-like compounds with relatively high activity. In order to further improve our understanding of CYP binding and reactions, we performed a co-crystallization study of mutant M11 and report here the three-dimensional structure M11 in complex with dithiothreitol (DTT) at a resolution of 2.16 A. The structure shows that DTT can coordinate to the Fe atom in the heme group. UV/Vis spectroscopy and molecular dynamics simulation studies underline this finding and as first structure of the CYP BM3 mutant M11 in complex with a ligand, it offers a basis for structure-based design of novel mutants.	[Frydenvang, Karla; Rafiq, Maria; Mirza, Osman; Jorgensen, Flemming Steen] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Verkade-Vreeker, Marlies C. A.; Dohmen, Floor; Commandeur, Jan N. M.; Geerke, Daan P.] Vrije Univ, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, Amsterdam, Netherlands	University of Copenhagen; Vrije Universiteit Amsterdam	Jorgensen, FS (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.; Geerke, DP (corresponding author), Vrije Univ, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, Amsterdam, Netherlands.	fsj@sund.ku.dk; d.p.@geerke@vu.nl		Mirza, Osman Asghar/0000-0001-9435-0690; Rafiq, Maria/0000-0001-9118-0788; Jorgensen, Flemming Steen/0000-0001-8040-2998; Geerke, Daan/0000-0002-5262-6166; Commandeur, Jan N.M./0000-0002-2105-971X	Netherlands Organization for Scientific Research (NWO, VIDI grant) [723.012.105]	Netherlands Organization for Scientific Research (NWO, VIDI grant)(Netherlands Organization for Scientific Research (NWO))	DPG acknowledges The Netherlands Organization for Scientific Research (NWO, VIDI grant 723.012.105) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2009, DESM MOL DYN SYST; Arnold FH, 2018, ANGEW CHEM INT EDIT, V57, P4143, DOI 10.1002/anie.201708408; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boerma JS, 2011, CHEM RES TOXICOL, V24, P1263, DOI 10.1021/tx2001515; Bonomo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29468; Capoferri L, 2016, PROTEINS, V84, P383, DOI 10.1002/prot.24985; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Damsten MC, 2008, CHEM-BIOL INTERACT, V171, P96, DOI 10.1016/j.cbi.2007.09.007; DOPPELT P, 1984, CROAT CHEM ACTA, V57, P507; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGLISH DR, 1984, J AM CHEM SOC, V106, P7258, DOI 10.1021/ja00335a074; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gorren ACF, 1997, BIOCHEMISTRY-US, V36, P4360, DOI 10.1021/bi962381s; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; He CM, 2013, J INORG BIOCHEM, V122, P38, DOI 10.1016/j.jinorgbio.2013.01.012; Hudson SA, 2012, BIOCHEM SOC T, V40, P573, DOI 10.1042/BST20120062; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirton SB, 2005, PROTEINS, V58, P836, DOI 10.1002/prot.20389; Luirink RA, 2018, J INORG BIOCHEM, V184, P115, DOI 10.1016/j.jinorgbio.2018.04.013; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Pavlik JW, 2010, INORG CHEM, V49, P1017, DOI 10.1021/ic901853p; Qin J, 2006, BIOCHEMISTRY-US, V45, P3170, DOI 10.1021/bi052171s; Rea V, 2012, BIOCHEMISTRY-US, V51, P750, DOI 10.1021/bi201433h; Reinen J, 2011, DRUG METAB DISPOS, V39, P1568, DOI 10.1124/dmd.111.039461; Roberts AG, 2016, BBA-GEN SUBJECTS, V1860, P669, DOI 10.1016/j.bbagen.2015.12.014; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SCHAPPACHER M, 1989, INORG CHEM, V28, P4639, DOI 10.1021/ic00325a020; SONO M, 1982, J BIOL CHEM, V257, P8308; Sono M, 2018, J BIOL INORG CHEM, V23, P1085, DOI 10.1007/s00775-018-1611-3; Swanson HI, 2010, DRUG METAB DISPOS, V38, P539, DOI 10.1124/dmd.109.031351; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; van Vugt-Lussenburg BMA, 2007, J MED CHEM, V50, P455, DOI 10.1021/jm0609061; Venkataraman H, 2012, ADV SYNTH CATAL, V354, P2172, DOI 10.1002/adsc.201200067; Vottero E, 2011, J BIOL INORG CHEM, V16, P899, DOI 10.1007/s00775-011-0789-4; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada T, 2007, BIOCHEMISTRY-US, V46, P8414, DOI 10.1021/bi700605m; Yun CH, 2007, TRENDS BIOTECHNOL, V25, P289, DOI 10.1016/j.tibtech.2007.05.003	49	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217292	10.1371/journal.pone.0217292	http://dx.doi.org/10.1371/journal.pone.0217292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125381	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700027
J	Ramos, AA; Horning, EC; Wilms, IL				Ramos, Alexander A.; Horning, Emil C.; Wilms, Inge L.			Simulated prism exposure in immersed virtual reality produces larger prismatic aftereffects than standard prism exposure in healthy subjects	PLOS ONE			English	Article							HAND POSITION; ADAPTATION; EYE; COORDINATION; COMPONENTS; ALIGNMENT; NEGLECT; REHABILITATION; ENVIRONMENTS; CALIBRATION	Previous studies have shown that the size of the leftward bias after exposure to rightward prism-deviation (the prismatic after-effect) depends on the degree of rightward prism-deviation as well as the type of visual feedback receives during exposure to prism-deviation. In this study, we tested if it was possible to obtain a leftward bias in pointing precision using two different methods of creating diverted visual input by simulating a rightward prism diversion of visual input in immersive virtual reality. We compared the results to the leftward bias in pointing precision obtained after exposure to standard prism goggles deviating visual input 10 degrees to the right. Twenty healthy participants were subjected to one session of standard prism adaptation therapy under three different conditions of deviated visual input: 1) created by imitating a 10 degree leftward rotation of the head (VRR), 2) created by imitating a 2D leftward horizontal displacement of 10 degrees (VRS) and 3) a control condition using real right-deviating prisms (PCP). The study showed that the simulated prisms in the VRR and VRS conditions produced deviations in pointing precision of a similar size. However, exposure to the VRS and VRR conditions both produced larger prismatic after-effects than the exposure to real prism goggles. This research is important for the development and use of virtual reality systems in the rehabilitation of neglect after brain injury as it emphasizes that the adjustment to deviated visual input may be affected positively by the use of immersive virtual reality technology.	[Ramos, Alexander A.; Horning, Emil C.; Wilms, Inge L.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Ramos, Alexander A.; Horning, Emil C.] IT Univ Copenhagen, Copenhagen, Denmark	University of Copenhagen; IT University Copenhagen	Wilms, IL (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	inge.wilms@psy.ku.dk		Wilms, Inge/0000-0003-0369-6659	'Synoptik-Fonden', project: 'Born og Unges syn' [109383]	'Synoptik-Fonden', project: 'Born og Unges syn'	This work was supported by the 'Synoptik-Fonden', project: 'Born og Unges syn', grant no 109383 (http://synoptik-fonden.dk/) to IW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglin JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45469; [Anonymous], 2018, VIRTUAL REALITY; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Biocca F, 1995, COMMUN AGE VIRTUAL R, V15, P10; Bodenheimer B, 2017, P IEEE VIRT REAL ANN, P141, DOI 10.1109/VR.2017.7892241; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; COHEN MM, 1967, PERCEPT MOTOR SKILL, V24, P1295, DOI 10.2466/pms.1967.24.3c.1295; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Frassinetti F, 2002, BRAIN, V125, P608, DOI 10.1093/brain/awf056; Groen J, 1998, PRESENCE-TELEOP VIRT, V7, P429, DOI 10.1162/105474698565839; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; Heilman KM, 2000, SEMIN NEUROL, V20, P463, DOI 10.1055/s-2000-13179; Herlihey TA, 2012, NEUROPSYCHOLOGIA, V50, P2789, DOI 10.1016/j.neuropsychologia.2012.08.009; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kizony R, 2003, J VISUAL COMP ANIMAT, V14, P261, DOI 10.1002/vis.323; Lo Priore C, 2003, CYBERPSYCHOL BEHAV, V6, P281, DOI 10.1089/109493103322011579; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1988, J MOTOR BEHAV, V20, P242, DOI 10.1080/00222895.1988.10735444; REDDING GM, 1993, J MOTOR BEHAV, V25, P75, DOI 10.1080/00222895.1993.9941642; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; REDDING GM, 1988, PERCEPT PSYCHOPHYS, V44, P59, DOI 10.3758/BF03207476; Redding GM, 2003, J MOTOR BEHAV, V35, P399, DOI 10.1080/00222890309603159; Redding GM, 2001, J MOTOR BEHAV, V33, P401, DOI 10.1080/00222890109601923; Redding GM, 1997, J MOTOR BEHAV, V29, P119, DOI 10.1080/00222899709600827; ROSSETTI Y, 1993, PERCEPT PSYCHOPHYS, V54, P355, DOI 10.3758/BF03205270; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Sayegh PF, 2017, J COGNITIVE NEUROSCI, V29, P1194, DOI 10.1162/jocn_a_01111; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; Serino A, 2007, NEUROPSYCHOL REHABIL, V17, P657, DOI 10.1080/09602010601052006; Simani MC, 2007, J NEUROPHYSIOL, V98, P2827, DOI 10.1152/jn.00290.2007; SINGER G, 1966, J EXP PSYCHOL, V71, P725, DOI 10.1037/h0023089; STEUER J, 1992, J COMMUN, V42, P73, DOI 10.1111/j.1460-2466.1992.tb00812.x; Stratton GM, 1896, PSYCHOL REV, V3, P611, DOI DOI 10.1037/H0072918; Sunderland A, 1987, Int Disabil Stud, V9, P55; TEMPLETON WB, 1974, PERCEPT PSYCHOPHYS, V15, P249, DOI 10.3758/BF03213941; Tunik E, 2013, IEEE T NEUR SYS REH, V21, P198, DOI 10.1109/TNSRE.2013.2238250; Vangkilde S, 2010, NEUROPSYCHOLOGIA, V48, P1994, DOI 10.1016/j.neuropsychologia.2010.03.020; Veilleux LN, 2015, Q J EXP PSYCHOL, V68, P1168, DOI 10.1080/17470218.2014.977305; Wilms I, 2010, NEUROPSYCHOL REHABIL, V20, P830, DOI 10.1080/09602011.2010.492711; Yasuda K, 2017, TOP STROKE REHABIL, V24, P533, DOI 10.1080/10749357.2017.1351069	41	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217074	10.1371/journal.pone.0217074	http://dx.doi.org/10.1371/journal.pone.0217074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125360	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700016
J	Dissanayake, AA; Wagner, CM; Nair, MG				Dissanayake, Amila A.; Wagner, C. Michael; Nair, Muraleedharan G.			Nitrogenous compounds characterized in the deterrent skin extract of migratory adult sea lamprey from the Great Lakes region	PLOS ONE			English	Article							PETROMYZON-MARINUS; ALARM CUE; OLFACTORY EPITHELIUM; RAINBOW-TROUT; AMINO-ACIDS; RESPONSES; FISH; ORGANIZATION; PHEROMONE; JUVENILE	The sea lamprey (Petromzons marinus) is a devastating invasive species that represents a significant impediment to restoration of the Laurentian Great Lakes. There is substantial interest in developing environmentally benign control strategies for sea lamprey, and many other aquatic invasive species, that employ the manipulation of semiochemical information (pheromones and chemical cues) to guide the movements of invaders into control opportunities (e.g. traps, locations for safe pesticide application, etc.). A necessary precursor to the use of semiochemicals in conservation activities is the identification of the chemical constituents that compose the odors. Here, we characterize the major nitrogenous substances from the water-soluble fraction of a skin extract that contains the sea lamprey alarm cue, a powerful repellent that has proven effective in guiding the movements of migrating sea lamprey in rivers. Nitrogenous compounds are suspected components of fish alarm cues as the olfactory sensory neurons that mediate alarm responses transduce amino acids and related compounds. A laboratory assay confirmed the behavioral activity contained in the alarm cue resides in the water-soluble fraction of the skin extract. This water-soluble fraction consisted primarily of creatine (70%), heterocyclic nitrogenous compounds (4.3%) and free amino acids (18.4%), respectively. Among the free amino acids characterized in our study, essential amino acids constituted 13% of the water-soluble fraction. Free amino acids isolated from the water-soluble fraction composed of arginine, phenylalanine, threonine, and asparagine 3.9, 2.7, 2.6 and 2.4% of the water-soluble fraction, respectively. We discuss the implications of these findings for understanding the nature and use of the sea lamprey alarm cue in conservation activities.	[Dissanayake, Amila A.; Nair, Muraleedharan G.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Wagner, C. Michael] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Nair, MG (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.	nairm@msu.edu	Nair, Muraleedharan G./AAF-9984-2019	Nair, Muraleedharan G./0000-0001-9604-0055	Great Lakes Fisheries Commission; GLFC [2016-NAI-54051]; NIH [1-S10-RR04750]; NSF [CHE-88-00770, CHE-92-13241]; Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health [DRR-00480]	Great Lakes Fisheries Commission; GLFC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health	AAD, CMW and MGN received funding for this research from Great Lakes Fisheries Commission (http://www.glfc.org/).This research is a contribution from MSU AgBioResearch and funded by the GLFC under the contract 2016-NAI-54051. The NMR data were collected on instrumentation that was purchased, in part, with the funds from NIH grant no. 1-S10-RR04750, NSF grant no. CHE-88-00770, and NSF grant no. CHE-92-13241. MS data were collected at the MSU Mass Spectrometry Facility, which is supported, in part, by a grant (DRR-00480) from the Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2018, INSECT BEHAVIOR: FROM MECHANISMS TO ECOLOGICAL AND EVOLUTIONARY CONSEQUENCES, P309, DOI 10.1093/oso/9780198797500.003.0020; Araujo MJ, 2013, J APPL ICHTHYOL, V29, P808, DOI 10.1111/jai.12192; Bals JD, 2012, BEHAVIOUR, V149, P901, DOI 10.1163/1568539X-00003009; BEAMISH F W H, 1979, Environmental Biology of Fishes, V4, P3; Braubach OR, 2012, J COMP NEUROL, V520, P2317, DOI 10.1002/cne.23075; Brown GE, 2003, J CHEM ECOL, V29, P1781, DOI 10.1023/A:1024894026641; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; Buchinger TJ, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0126-9; Byford GJ, 2016, N AM J FISH MANAGE, V36, P1090, DOI 10.1080/02755947.2016.1198286; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Christie GC, 2003, J GREAT LAKES RES, V29, P1, DOI 10.1016/S0380-1330(03)70474-2; Cochran PA, 2009, AM FISH S S, V72, P139; Conlon JM, 1996, COMP BIOCHEM PHYS B, V114, P133, DOI 10.1016/0305-0491(95)02132-9; Di Rocco RT, 2016, FISHERIES MANAG ECOL, V23, P548, DOI 10.1111/fme.12198; Dissanayake AA, 2017, J NAT PROD, V80, P2472, DOI 10.1021/acs.jnatprod.7b00322; Dissanayake AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168609; DOOLITTLE RF, 1976, BIOCHIM BIOPHYS ACTA, V453, P439, DOI 10.1016/0005-2795(76)90139-2; Doving KB, 2009, ANN NY ACAD SCI, V1170, P413, DOI 10.1111/j.1749-6632.2009.04111.x; Enjin A, 2013, MOL CELLS, V35, P177, DOI 10.1007/s10059-013-0056-3; Ferrando S, 2006, NEUROSCI LETT, V403, P280, DOI 10.1016/j.neulet.2006.04.056; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; GLFC, 2017, MIDD REV PROGR STRAT; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Great Lakes Restoration Initiative, 2014, GREAT LAK REST IN AC; Green WW, 2017, J EXP BIOL, V220, P1350, DOI 10.1242/jeb.150466; Hamdani EH, 2006, CHEM SENSES, V31, P63, DOI 10.1093/chemse/bjj006; Hansen A, 2000, BRAIN BEHAV EVOLUT, V55, P100, DOI 10.1159/000006645; HARA TJ, 1976, COMP BIOCHEM PHYS A, V54, P37, DOI 10.1016/S0300-9629(76)80068-0; Hazlett BA, 2005, J CHEM ECOL, V31, P671, DOI 10.1007/s10886-005-2054-1; Holbrook CM, 2015, T AM FISH SOC, V144, P549, DOI 10.1080/00028487.2015.1017657; Hume JB, 2018, ECOL EVOL, V8, P3751, DOI 10.1002/ece3.3930; Hume JB, 2015, CAN J FISH AQUAT SCI, V72, P1799, DOI 10.1139/cjfas-2014-0535; Imre I, 2014, J FISH BIOL, V84, P1490, DOI 10.1111/jfb.12374; Imre I, 2010, J GREAT LAKES RES, V36, P790, DOI 10.1016/j.jglr.2010.07.004; Johnson NS, 2009, P NATL ACAD SCI USA, V106, P1021, DOI 10.1073/pnas.0808530106; KIMURA S, 1981, BIOCHIM BIOPHYS ACTA, V669, P251, DOI 10.1016/0005-2795(81)90248-8; Kusumaningrum I, 2018, IOP C SER EARTH ENV, V144, DOI 10.1088/1755-1315/144/1/012036; Laframboise AJ, 2007, NEUROSCI LETT, V414, P277, DOI 10.1016/j.neulet.2006.12.037; LEBLANC PJ, 1995, CAN J ZOOL, V73, P916, DOI 10.1139/z95-107; Li W., 1994, THESIS U MINNESOTA U, P88; Li Weiming, 1992, Chemical Senses, V17, P658; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; Libants S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-180; Luhring TM, 2016, ANIM BEHAV, V121, P41, DOI 10.1016/j.anbehav.2016.08.007; LUNDBERG P, 1986, MEAT SCI, V18, P133, DOI 10.1016/0309-1740(86)90089-6; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; Mirza RS, 2003, CAN J ZOOL, V81, P88, DOI 10.1139/Z02-216; Mitchell MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047428; Muralidharan N, 2013, J FOOD SCI TECH MYS, V50, P1106, DOI 10.1007/s13197-011-0440-y; Oka Y, 2012, CHEM SENSES, V37, P219, DOI 10.1093/chemse/bjr095; PFEIFFER W, 1985, J CHEM ECOL, V11, P507, DOI 10.1007/BF00989562; REED JR, 1972, P 26 ANN C SE ASS GA, P608; Reitsma BH, 1987, THESIS; Ren X, 2009, J COMP NEUROL, V516, P105, DOI 10.1002/cne.22100; Robson P, 1997, COMP BIOCHEM PHYS B, V118, P71, DOI 10.1016/S0305-0491(97)00026-6; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; SCHUTZ F, 1956, Z VERGL PHYSIOL, V38, P84, DOI 10.1007/BF00338623; Siefkes MJ, 2005, ANIM BEHAV, V70, P1037, DOI 10.1016/j.anbehav.2005.01.024; Siefkes MJ, 2004, J COMP PHYSIOL A, V190, P193, DOI 10.1007/s00359-003-0484-1; Sorensen PW, 2016, J CHEM ECOL, V42, P698, DOI 10.1007/s10886-016-0729-4; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Teijeira M, 1997, MAGN RESON CHEM, V35, P806, DOI 10.1002/(SICI)1097-458X(199711)35:11<806::AID-OMR157>3.0.CO;2-M; THORNHILL RA, 1967, J CELL SCI, V2, P591; Tucker D., 1972, OLFACTION TASTE, VIV, P121; VANDENBOSSCHE J, 1995, BRAIN BEHAV EVOLUT, V45, P19, DOI 10.1159/000113382; Vielma A, 2008, J EXP BIOL, V211, P2417, DOI 10.1242/jeb.018796; Wagner CM, 2011, CAN J FISH AQUAT SCI, V68, P1157, DOI [10.1139/f2011-072, 10.1139/F2011-072]; Wagner CM, 2009, ANIM BEHAV, V78, P593, DOI 10.1016/j.anbehav.2009.04.027; Wagner CM, 2006, CAN J FISH AQUAT SCI, V63, P475, DOI [10.1139/f06-008, 10.1139/F06-008]; Wagner RH, 2010, OIKOS, V119, P203, DOI 10.1111/j.1600-0706.2009.17315.x; Wilkie MP, 2006, PHYSIOL BIOCHEM ZOOL, V79, P885, DOI 10.1086/505998; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; Win T, 2000, THESIS; Wisenden Brian D., 2006, P259; Wisenden BD, 2015, FISH PHEROMONES AND RELATED CUES, P131; Wisenden BD, 2015, HYDROBIOLOGIA, V748, P259, DOI 10.1007/s10750-014-1917-2; Wisenden Brian D., 2003, P236, DOI 10.1007/978-0-387-22628-6_12; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4	78	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217417	10.1371/journal.pone.0217417	http://dx.doi.org/10.1371/journal.pone.0217417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120997	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700101
J	Roessig, S; Mucke, D; Grice, M				Roessig, Simon; Muecke, Doris; Grice, Martine			The dynamics of intonation: Categorical and continuous variation in an attractor-based model	PLOS ONE			English	Article							INCOMPLETE NEUTRALIZATION; SPEECH; ARTICULATION; PERCEPTION; ENGLISH	The framework of dynamical systems offers powerful tools to understand the relation between stability and variability in human cognition in general and in speech in particular. In the current paper, we propose a dynamical systems approach to the description of German nuclear pitch accents in focus marking to account for both the categorical as well as the continuous variation found in intonational data. We report on results from 27 native speakers and employ an attractor landscape to represent pitch accent types in terms of f0 measures in a continuous dimension. We demonstrate how the same system can account for both the categorical variation ( relative stability of one prosodic category) as well as the continuous variation ( detailed modifications within one prosodic category). The model is able to capture the qualitative aspects of focus marking such as falling vs. rising pitch accent types as well as the quantitative aspects such as less rising vs. more rising accents in one system by means of scaling a single parameter. Furthermore, speaker group specific strategies are analysed and modelled as differences in the scaling of this parameter. Thus, the model contributes to the ongoing debate about the relation between phonetics and phonology and the importance of variation in language and speech.	[Roessig, Simon; Muecke, Doris; Grice, Martine] Univ Cologne, IfL Phonet, Cologne, Germany	University of Cologne	Roessig, S (corresponding author), Univ Cologne, IfL Phonet, Cologne, Germany.	mail@simonroessig.de		Roessig, Simon/0000-0001-6413-1761	Deutsche Forschungsgemeinschaft [CRC1252]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft (CRC1252 Prominence in Language, Project A04) to DM, http://www.dfg.de.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrazaitis G., 2014, P 4 INT S TONAL ASPE, P138; [Anonymous], 1995, MIND MOTION EXPLORAT; BARNES J., 2012, LAB PHONOL, V3, P337; Baumann S, 2015, Z SPRACHWISS, V34, P1, DOI 10.1515/zfs-2015-0001; Beckman M.E., 2005, PROSODIC TYPOLOGY PH; Boersma P, 2001, LINGUIST INQ, V32, P45, DOI 10.1162/002438901554586; Boersma P., 2018, PRAAT DOING PHONETIC; Bolinger D., 1961, GEN GRADIENCE ALL OR; Browman Catherine, 1986, PHONOLOGY YB, V3, P219, DOI [DOI 10.1017/S0952675700000658, 10.1017/S0952675700000658]; Brown SD, 2006, J MATH PSYCHOL, V50, P402, DOI 10.1016/j.jmp.2006.03.004; Burkner P-C., 2018, R J; Byrd D, 2003, J PHONETICS, V31, P149, DOI 10.1016/S0095-4470(02)00085-2; Cangemi F, 2015, INDIVIDUAL DIFFERENC; Cangemi F, 2016, LAB PHONOL, V7, DOI 10.5334/labphon.28; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Cho TH, 2005, J PHONETICS, V33, P121, DOI 10.1016/j.wocn.2005.01.001; Coetzee AW, 2012, OXFORD HDB LAB PHONO; Coleman J, 2003, J PHONETICS, V31, P351, DOI 10.1016/j.wocn.2003.10.001; DEJONG KJ, 1995, J ACOUST SOC AM, V97, P491, DOI 10.1121/1.412275; Ernestus M., 2006, LAB PHONOL, V8, P27, DOI DOI 10.1515/9783110197211.1.27; Fodor J. A., 1975, LANGUAGE THOUGHT; FODOR JA, 1981, COGNITION, V9, P139, DOI 10.1016/0010-0277(81)90009-3; Gafos AI, 2006, COGNITIVE SCI, V30, P905, DOI 10.1207/s15516709cog0000_80; Gafos Adamantios I., 2006, LAB PHONOLOGY, V8, P51; Grabe E, 2004, J PHON, V26, P129; Grice M., 2002, LINGUISTISCHE BERICH, V191, P267; Grice M, 2017, J PHONETICS, V64, P90, DOI 10.1016/j.wocn.2017.03.003; Gussenhoven C., 2004, PHONOLOGY TONE INTON, DOI [10.1017/CBO9780511616983, DOI 10.1017/CBO9780511616983]; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H, 2012, SYNERGETIC AGENTS MU; Haken H., 1977, SYNERGETICS; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Harrington J., 2000, PAPERS LAB PHONOLOGY, P40; Hawkins S., 1992, PAPERS LAB PHONOLOGY, P9, DOI DOI 10.1017/CBO9780511519918.002; Hock HS, 2003, PERCEPT PSYCHOPHYS, V65, P429, DOI 10.3758/BF03194574; Iskarous K, 2017, J PHONETICS, V64, P8, DOI 10.1016/j.wocn.2017.05.003; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kugler F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01254; Ladd D.R., 2014, SIMULTANEOUS STRUCTU; Ladd D. R., 2011, HDB PHONOLOGICAL THE, P348, DOI DOI 10.1002/9781444343069.CH11; Ladd DR, 2008, CAMB STUD LINGUIST, V79, P1; Ladd DR, 1997, J PHONETICS, V25, P313, DOI 10.1006/jpho.1997.0046; Lancia L, 2013, LAB PHONOL, V4, P221, DOI 10.1515/lp-2013-0009; LISKER L, 1986, LANG SPEECH, V29, P3, DOI 10.1177/002383098602900102; LOFQVIST A, 1989, J ACOUST SOC AM, V85, P1314, DOI 10.1121/1.397462; Mirman D, 2009, MEM COGNITION, V37, P1026, DOI 10.3758/MC.37.7.1026; Mucke D., 2018, DYNAMISCHE MODELLIER; Mucke D, 2017, J PHONETICS, V64, P1, DOI 10.1016/j.wocn.2017.05.005; Mucke D, 2014, J PHONETICS, V44, P47, DOI 10.1016/j.wocn.2014.02.003; Nava Emily, 2010, THESIS; Newell A., 1981, COMMUNICATIONS ASS C, V19, P113; Niebuhr O., 2011, P 17 INT C PHON SCI; OHALA JJ, 1990, J PHONETICS, V18, P153, DOI 10.1016/S0095-4470(19)30399-7; Pierrehumbert J., 2000, PHONOLOGICAL KNOWLED, P273; Pierrehumbert JB, 2016, ANNU REV LINGUIST, V2, P33, DOI 10.1146/annurev-linguistics-030514-125050; PORT R, 1989, J PHONETICS, V17, P257, DOI 10.1016/S0095-4470(19)30444-9; PORT RF, 1985, J PHONETICS, V13, P455, DOI 10.1016/S0095-4470(19)30797-1; R Core Team, 2018, R LANG ENV STAT COMP; Ritter S, 2015, LANG SPEECH, V58, P114, DOI 10.1177/0023830914565688; Roettger TB, 2014, J PHONETICS, V43, P11, DOI 10.1016/j.wocn.2014.01.002; Saltzman E., 1986, EXPT BRAIN RES SERIE, V15, P129, DOI [10.1007/978-3642-71476-4_10, 10.1007/978-3-642-71476-4_10]; Saltzman E., 2008, P SPEECH PROSODY 200, P175; Savino M, 2011, STUD NAT LANG LINGUI, V82, P187, DOI 10.1007/978-94-007-0137-3_8; Silverman K, 1992, 2 INT C SPOK LANG PR; Simko J, 2010, PSYCHOL REV, V117, P1229, DOI 10.1037/a0020490; Smith LB, 2003, TRENDS COGNITIVE SCI; Spivey M. J., 2007, CONTINUITY MIND; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Thelen E., 1994, DYNAMIC SYSTEMS APPR; TULLER B, 1994, J EXP PSYCHOL HUMAN, V20, P3, DOI 10.1037/0096-1523.20.1.3; Tuller B, 2008, NEW IDEAS PSYCHOL, V26, P208, DOI 10.1016/j.newideapsych.2007.07.002; Tuller B, 2017, J PHONETICS, V64, P21, DOI 10.1016/j.wocn.2017.02.001; vanGelder T, 1995, MIND MOTION; VanLieshout P, 2004, DYNAMICAL SYSTEMS TH, P51; Winter B, 2014, BIOESSAYS, V36, P960, DOI 10.1002/bies.201400028; Yoon T-J., 2010, P SPEECH PROSODY; Zhang ZY, 2017, J ACOUST SOC AM, V142, P2311, DOI 10.1121/1.5008497	77	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216859	10.1371/journal.pone.0216859	http://dx.doi.org/10.1371/journal.pone.0216859			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120891	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700034
J	Sivapackiam, J; Kabra, S; Speidel, S; Sharma, M; Laforest, R; Salter, A; Rettig, MP; Sharma, V				Sivapackiam, Jothilingam; Kabra, Shivesh; Speidel, Sylvia; Sharma, Monica; Laforest, Richard; Salter, Amber; Rettig, Michael P.; Sharma, Vijay			Ga-68-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity	PLOS ONE			English	Article							PEGYLATED LIPOSOMAL DOXORUBICIN; ANTITUMOR-ACTIVITY; RADICAL FORMATION; MITOCHONDRIAL; CANCER; CHEMOTHERAPY; CELLS; ANTHRACYCLINES; INHIBITION; ADRIAMYCIN	Background Cancer patients undergoing Doxorubicin (DOX) treatment are susceptible to acute and chronic cardiac anomalies, including aberrant arrhythmias, ventricular dysfunction, and heart failure. To stratify patients at high risk for DOX -related heart failure (CHF), diagnostic techniques have been sought. While echocardiography is used for monitoring LVEF and LV volumes due to its wide-availability and cost-efficiency, it may not identify early stages of the initiation of DOX-induced systolic heart failure. To address these limitations, PET tracers could also provide noninvasive assessment of early and reversible metabolic changes of the myocardium. Objective Herein, we report a preliminary investigation of Ga-68-Galmydar potential to monitor Dox-induced cardiomyopathy in vivo, ex vivo, and in cellulo employing both nuclear-and optical imaging. Methods and results To assess Ga-68-Galmydar ability for monitoring DOX-induced cardiomyopathy, microPET imaging was performed 5 d post treatment of rats either with a single dose of DOX (15 mg/ kg) or vehicle as a control (saline) and images were co-registered for anatomical reference using CT. Following tail-vein injection of the radiotracer in rats at 60 min, micro-PET/CT static scan (10 min acquisition), Ga-68-Galmydar demonstrated 1.91 -fold lower uptake in hearts of DOX-treated (standard uptake value; SUV: 0.92, n = 3) rats compared with their vehicle treated (SUV: 1.76, n = 3) control counterparts. For correlation of PET imaging data, post-imaging quantitative biodistribution studies were also performed, wherein excised organs were counted for. activity, and normalized to injected dose. The post imaging pharmacokinetic data also demonstrated heart uptake values of 2.0 fold lower for DOX treated rats(%ID/g; DOX: 0.44 +/- 0.1, n = 3) compared to their vehicle-treated controls (%ID/g; Control: 0.89 +/- 0.03, n = 3, p = 0.04). Employing the fluorescent traits of Galmydar, live cell fluorescence imaging indicated a gradual decrease in uptake and retention of Galmydar within mitochondria of H9c2 cells following DOX-treatment, while indicating dose-dependent and time-dependent uptake profiles. Following depolarization of electronegative transmembrane gradients at the mitochondrial membrane, the uptake of the probe was decreased in H9c2 cells, and the uptake profiles were found to be identical, using both fluorescence and radiotracer bioassays. Finally, the decreased uptake of the metalloprobe in H9c2 cells also correlated with caspase-3 expression resulting from DOX-induced cardiotoxicity and cell death. Conclusions Ga-68-Galmydar could provide a noninvasive assessment of DOX-related and likely reversible metabolic changes at earliest stages. Further studies with other chemotherapeutics (potentially capable of inducing cardiomyopathy) are underway.	[Sivapackiam, Jothilingam; Kabra, Shivesh; Speidel, Sylvia; Laforest, Richard; Sharma, Vijay] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Sharma, Monica] Washington Univ, Sch Med, Pediat Cardiol, St Louis, MO USA; [Salter, Amber] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA; [Rettig, Michael P.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Sharma, Vijay] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sharma, Vijay] Washington Univ, Sch Engn & Appl Sci, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sharma, V (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.; Sharma, V (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Sharma, V (corresponding author), Washington Univ, Sch Engn & Appl Sci, Dept Biomed Engn, St Louis, MO 63110 USA.	sharmav@wustl.edu		Rettig, Michael/0000-0002-1091-0564; Kabra, Shivesh/0000-0001-7563-4153	National Institutes of Health [RO1 HL111163, RO1 HL142297]; NATIONAL CANCER INSTITUTE [R50CA211466] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL142297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in parts by grants RO1 HL111163 (VS) and RO1 HL142297 (VS) from the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi M, 2008, ANTICANCER RES, V28, P2519; Atcher R, 2011, RSNA NEWS, V21, P9; Beller GA, 2004, J NUCL CARDIOL, V11, P71, DOI 10.1016/j.nuclcard.2003.12.002; Beller GA, 2010, HEART LUNG CIRC, V19, P193, DOI 10.1016/j.hlc.2009.11.003; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Calvo E, 2017, ANN ONCOL, V28, P2559, DOI 10.1093/annonc/mdx357; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; D'Amore C, 2014, WORLD J RADIOL, V6, P486, DOI 10.4329/wjr.v6.i7.486; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; DOROSHOW JH, 1983, CANCER RES, V43, P460; Ferrandina G, 2010, THER CLIN RISK MANAG, V6, P463, DOI 10.2147/TCRM.S3348; Frost BM, 2002, MED PEDIATR ONCOL, V38, P329, DOI 10.1002/mpo.10052; Ghigo A, 2016, BBA-MOL CELL RES, V1863, P1916, DOI 10.1016/j.bbamcr.2016.01.021; Giantris A, 1998, CRIT REV ONCOL HEMAT, V27, P53, DOI 10.1016/S1040-8428(97)10007-5; Gibb A, 2013, BRIT J CANCER, V109, P2560, DOI 10.1038/bjc.2013.605; Gould P, 2009, NATURE, V460, P312, DOI 10.1038/460312a; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Haas NB, 2012, MED ONCOL, V29, P761, DOI 10.1007/s12032-011-9829-8; Hopkins-Donaldson S, 2002, ONCOGENE, V21, P6132, DOI 10.1038/sj.onc.1205879; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Kauffman Megan E, 2016, React Oxyg Species (Apex), V2, P361, DOI 10.20455/ros.2016.865; KEIZER HG, 1990, PHARMACOL THERAPEUT, V47, P219, DOI 10.1016/0163-7258(90)90088-J; Khiati S, 2014, CLIN CANCER RES, V20, P4873, DOI 10.1158/1078-0432.CCR-13-3373; Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Larson Richard A, 2007, Hematology Am Soc Hematol Educ Program, P453; Lu P, 2005, SEMIN NUCL MED, V35, P197, DOI 10.1053/j.semnuclmed.2005.02.005; Matuszczyk A, 2008, HORM METAB RES, V40, P210, DOI 10.1055/s-2008-1046781; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mughal W, 2012, CURR HYPERTENS REP, V14, P540, DOI 10.1007/s11906-012-0304-5; Ning YM, 2007, ONCOLOGY-NY, V21, P1503; Ning YM, 2007, ONCOLOGY WILLISTON P, V21, P13; Ning YM, 2007, ONCOLOGY WILLISTON P, V21; Ning YM, 2007, ONCOLOGY WILLISTON P, V21, P16; PIWNICAWORMS D, 1993, CANCER CHEMOTH PHARM, V32, P385, DOI 10.1007/BF00735924; PIWNICAWORMS D, 1990, J NUCL MED, V31, P464; Polster BM, 2014, METHOD ENZYMOL, V547, P225, DOI 10.1016/B978-0-12-801415-8.00013-8; Raj Shashi, 2014, Curr Treat Options Cardiovasc Med, V16, P315, DOI 10.1007/s11936-014-0315-4; Sarvazyan N, 1996, AM J PHYSIOL-HEART C, V271, pH2079, DOI 10.1152/ajpheart.1996.271.5.H2079; Sharma V, 2004, BIOCONJUGATE CHEM, V15, P1464, DOI 10.1021/bc0498469; Sharma V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109361; Shrivastava A, 2006, J BIOL CHEM, V281, P19762, DOI 10.1074/jbc.M600746200; Sivapackiam J, 2017, MEDCHEMCOMM, V8, P158, DOI 10.1039/c6md00474a; Sivapackiam J, 2016, NUCL MED BIOL, V43, P191, DOI 10.1016/j.nucmedbio.2015.12.001; Sivapackiam J, 2010, DALTON T, V39, P5842, DOI 10.1039/c002361b; Sundaram GSM, 2016, J INORG BIOCHEM, V159, P159, DOI 10.1016/j.jinorgbio.2016.02.022; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; VILASECA J, 1978, LANCET, V1, P1367; Wagner MJ, 2016, J ONCOL PRACT, V12, P208, DOI 10.1200/JOP.2015.009944; WAKABAYASHI H, 2010, J NUCL MED S2, V51; Yang L, 2016, BRIT J PHARMACOL, V173, P357, DOI 10.1111/bph.13377; Yurekli Y, 2005, ANN NUCL MED, V19, P197, DOI 10.1007/BF02984605; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	60	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0215579	10.1371/journal.pone.0215579	http://dx.doi.org/10.1371/journal.pone.0215579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120912	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700007
J	Yang, CP; Cheng, HM; Lu, MC; Lang, HC				Yang, Chun-Pai; Cheng, Hao-Min; Lu, Mei-Chun; Lang, Hui-Chu			Association between continuity of care and long-term mortality in Taiwanese first-ever stroke survivors: An 8-year cohort study	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; POTENTIALLY INAPPROPRIATE MEDICATION; ACUTE ISCHEMIC-STROKE; PREVENTABLE HOSPITALIZATION; INTRACEREBRAL HEMORRHAGE; ELDERLY-PATIENTS; SEVERITY INDEX; RISK-FACTORS; OUTCOMES; HEALTH	Background Continuity of care is considered to be an important principle of stroke care; however, few analyses of empirically related outcomes have been reported. Objective This study examined the correlation between the continuity of care for outpatients after a stroke event and the survival of stroke patients over the year following hospital discharge. Research design Data from the Taiwan National Health Insurance Database were used in this study. We defined stroke as the ICD-9-CM codes 430 to 437, and all patients were followed up regarding their survival for at least one year. The modified modified continuity index (MMCI) was used as the indicator of continuity of care. Cox proportional hazard models with robust sandwich variance estimates were employed to analyze the correlation between continuity of care and stroke-related death. Results A total of 9,252 stroke patients were included in the analysis. Those patients who had a high and a completed COC had a higher percentage of survival (97.25% and 95.39%) compared to the other two groups. After controlling for other variables, compared with the low-level continuity of care group, the moderate-level, high-level and completed continuity of care groups still showed a significantly lower risk of death HR (95% CI) were: 0.63 (0.49-0.80), 0.56 (0.40-0.79) and 0.50 (0.39-0.63), respectively. Conclusion Continuity of care may increase the survival among stroke patients and therefore plays an important role in management of stroke after survival.	[Yang, Chun-Pai] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Chun-Pai; Lu, Mei-Chun] Kuang Tien Gen Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Chun-Pai] Hung Kuang Univ, Dept Nutr, Taichung, Taiwan; [Yang, Chun-Pai] Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Cheng, Hao-Min] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan; [Cheng, Hao-Min] Natl Yang Ming Univ, Div Cardiol, Taipei, Taiwan; [Cheng, Hao-Min] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Cheng, Hao-Min] Taipei Vet Gen Hosp, Ctr Evidence Based Med, Taipei, Taiwan; [Lu, Mei-Chun] Hung Kuang Univ, Dept Nuring, Taichung, Taiwan; [Lang, Hui-Chu] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan	Hungkuang University; Hungkuang University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Hungkuang University; National Yang Ming Chiao Tung University	Lang, HC (corresponding author), Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan.	hclang@ym.edu.tw	Lang, Hui-Chu/GXG-4373-2022		Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was funded by the Ministry of Science and Technology, Taiwan to HC Lang and HM Cheng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j84; BENSIRA Z, 1980, J HEALTH SOC BEHAV, V21, P170, DOI 10.2307/2136736; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CC, 2013, MED CARE, V51, P231, DOI 10.1097/MLR.0b013e31827da5b9; Cheng SH, 2014, MED CARE, V52, P149, DOI 10.1097/MLR.0000000000000042; Chiu HY, 2016, TAIWAN J PUBLIC HLTH, V35, P66; Cho KH, 2016, INT J QUAL HEALTH C, V28, P478, DOI 10.1093/intqhc/mzw050; Cho SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139289; Chu HY, 2012, MED CARE, V50, P1002, DOI 10.1097/MLR.0b013e31826c870f; Denti L, 2015, J STROKE CEREBROVASC, V24, P330, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.034; Falsetti L, 2016, NEUROL SCI, V37, P1443, DOI 10.1007/s10072-016-2602-1; Freeman GK, 2003, FAM PRACT, V20, P623, DOI 10.1093/fampra/cmg601; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hong JS, 2013, HEALTH POLICY, V109, P158, DOI 10.1016/j.healthpol.2012.09.009; Hsieh CY, 2017, J NEUROL SCI, V372, P21, DOI 10.1016/j.jns.2016.11.026; Hsieh FI, 2014, J STROKE, V16, P59, DOI 10.5853/jos.2014.16.2.59; Hsu CH, 2016, J EPIDEMIOL, V26, P413, DOI 10.2188/jea.JE20150045; Hung LC, 2017, J EPIDEMIOL, V27, P24, DOI 10.1016/j.je.2016.08.003; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Kao YH, 2017, J AM BOARD FAM MED, V30, P384, DOI 10.3122/jabfm.2017.03.160285; Lai YR, 2016, GERIATR GERONTOL INT, V16, P1117, DOI 10.1111/ggi.12606; Leleu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071669; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin HC, 2007, STROKE, V38, P1565, DOI 10.1161/STROKEAHA.106.474841; Lin IP, 2017, HEALTH POLICY, V121, P1001, DOI 10.1016/j.healthpol.2017.06.010; MAGILL MK, 1987, J FAM PRACTICE, V24, P165; Micieli G, 2002, STROKE, V33, P1341, DOI 10.1161/01.STR.0000013663.27776.DB; Napolitano F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154940; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; PATTEN RC, 1980, J FAM PRACTICE, V11, P67; Pilotto LS, 1996, MED J AUSTRALIA, V164, P463, DOI 10.5694/j.1326-5377.1996.tb122121.x; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Shin DW, 2014, ANN FAM MED, V12, P534, DOI 10.1370/afm.1685; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Sung SF, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1769-8; Sung SF, 2016, INT J CARDIOL, V215, P277, DOI 10.1016/j.ijcard.2016.04.069; Sung SF, 2015, J CLIN EPIDEMIOL, V68, P1292, DOI 10.1016/j.jclinepi.2015.01.009; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	44	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216495	10.1371/journal.pone.0216495	http://dx.doi.org/10.1371/journal.pone.0216495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116786	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400023
J	Zhang, C; Rahman, MS; Rahman, MM; Yawson, AE; Shibuya, K				Zhang, Cherri; Rahman, Md Shafiur; Rahman, Md Mizanur; Yawson, Alfred E.; Shibuya, Kenji			Trends and projections of universal health coverage indicators in Ghana, 1995-2030: A national and subnational study	PLOS ONE			English	Article							SERVICES; INSURANCE; EQUITY; IMPACT; CARE	Ghana has made significant stride towards universal health coverage (UHC) by implementing the National Health Insurance Scheme (NHIS) in 2003. This paper investigates the progress of UHC indicators in Ghana from 1995 to 2015 and makes future predictions up to 2030 to assess the probability of achieving UHC targets. National representative surveys of Ghana were used to assess health service coverage and financial risk protection. The analyses estimated the coverage of 13 prevention and four treatment service indicators at the national level and across wealth quintiles. In addition, we calculated catastrophic health payments and impoverishment to assess financial hardship and used a Bayesian regression model to estimate trends and future projections as well as the probabilities of achieving UHC targets by 2030. Wealth-based inequalities and regional disparities were also assessed. At the national level, 14 out of the 17 health service indicators are projected to reach the target of 80% coverage by 2030. Across wealth quintiles, inequalities were observed amongst most indicators with richer groups obtaining more coverage than their poorer counterparts. Subnational analysis revealed while all regions will achieve the 80% coverage target with high probabilities for the prevention services, the same cannot be applied to the treatment services. In 2015, the proportion of households that suffered catastrophic health payments and impoverishment at a threshold of 25% non-food expenditure were 1.9% (95% CrI: 0.9-3.5) and 0.4% (95% CrI: 0.2-0.8), respectively. These are projected to reduce to 0.4% (95% CrI: 0.1-1.3) and 0.2% (0.0-0.5) respectively by 2030. Inequality measures and subnational assessment revealed that catastrophic expenditure experienced by wealth quintiles and regions are not equal. Significant improvements were seen in both health service coverage and financial risk protection over the years. However, inequalities across wealth quintiles and regions continue to be cause of concerns. Further efforts are needed to narrow these gaps.	[Zhang, Cherri; Rahman, Md Shafiur; Rahman, Md Mizanur; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Zhang, Cherri] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Rahman, Md Shafiur; Rahman, Md Mizanur] Global Publ Hlth Res Fdn, Dhaka, Bangladesh; [Yawson, Alfred E.] Univ Ghana, Sch Publ Hlth, Dept Community Hlth, Accra, Ghana; [Shibuya, Kenji] Kings Coll London, Univ Inst Populat Hlth, London, England	University of Tokyo; University of Calgary; University of Ghana; University of London; King's College London	Zhang, C (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.; Zhang, C (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	toki.cherri.zhang28@gmail.com		Shibuya, Kenji/0000-0003-2528-7530; Zhang, Cherri/0000-0001-7059-4922	Ministry of Education, Culture, Sports, Science and Technology of Japan [175094]; University of Tokyo Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tokyo Foundation	The study was supported by The Ministry of Education, Culture, Sports, Science and Technology of Japan [grant number: 175094] and The University of Tokyo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3513-z; Akazili J, 2012, HLTH POLICY PLAN; Akazili J, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0121-7; Akazili J, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1289735; Alhassan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165151; Amporfu E, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-4; [Anonymous], 2014, COMPR MULT PLAN IMM; Apanga PA A-WJ, 2017, J HEALTH CARE POOR U, V28, P11; Apoya P, 2011, ACHIEVING SHARED GOA; Aryeetey GC, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0401-1; Asamoah BO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011663; Baatiema L, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000141; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Blanchet NJ, 2012, GHANA MED J, V46, P9; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Boerma JT, 2014, PLOS MED, V11; Bonfrer I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165623; Carapinha JL, 2011, HEALTH POLICY, V99, P193, DOI 10.1016/j.healthpol.2010.11.009; Dalinjong PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0184830; Desa U, 2016, TRANSF OUR WORLD 203; Enuameh YAK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152235; Foreit J., 2011, INCREASING ACCESS FA; Gajate-Garrido G, 2013, NATL HLTH INSURANCE; Ganle JK, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0089-z; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Ghana Statistical Services Ghana Health Services, 2015, GHAN DEM HLTH SURV 2; Johnson FA, 2009, J COMMUN HEALTH, V34, P64, DOI 10.1007/s10900-008-9120-x; Joseph G, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000898; Korra A., 2002, ATTITUDES FAMILY PLA; Kusi A, 2015, BMC HEALTH SERV RES, V15, P12; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Mills A, 2012, LANCET, V380, P8; Ministry of Health Ghana Health Services, 2011, IMM PROGR COMPR MULT; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Onarheim KH, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0218-3; Onoka CA, 2011, TROP MED INT HEALTH, V16, P8; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Ryman T, 2010, J PUBLIC HEALTH-UK, V32, P18, DOI 10.1093/pubmed/fdp048; Singh K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0762-y; Somkotra T, 2008, SOC SCI MED, V67, P2027, DOI 10.1016/j.socscimed.2008.09.047; Speizer IS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0398-7; The World Bank, DAT BANK WORLD DEV I; Wang WJ, 2017, HEALTH POLICY PLANN, V32, P366, DOI 10.1093/heapol/czw135; World Bank, 2016, UNIVERSAL HLTH COVER; World Health Organization, 2015, TRACK UN HLTH COV 1; Xu K., 2005, DISTRIBUTION HLTH PA; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849; Zaidi S., 2002, GUIDELINES CONSTRUCT	51	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0209126	10.1371/journal.pone.0209126	http://dx.doi.org/10.1371/journal.pone.0209126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116754	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400002
J	Leijendekkers, RA; Hoogeboom, TJ; Van Hinte, G; Didden, L; Anijs, T; Nijhuis-van der Sanden, MWG; Verdonschot, N				Leijendekkers, Ruud A.; Hoogeboom, Thomas J.; Van Hinte, Gerben; Didden, Lars; Anijs, Thomas; Nijhuis-van der Sanden, Maria W. G.; Verdonschot, Nico			Reproducibility and discriminant validity of two clinically feasible measurement methods to obtain coronal plane gait kinematics in participants with a lower extremity amputation	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; UNILATERAL TRANSFEMORAL AMPUTEES; TRANS-FEMORAL AMPUTEES; STEP-LENGTH ASYMMETRY; LOW-BACK-PAIN; PROSTHETIC GAIT; CONCURRENT VALIDITY; MEASUREMENT SYSTEM; MOTION-ANALYSIS; TRUNK POSTURE	Introduction Measuring coronal plane gait kinematics of the pelvis and trunk during rehabilitation of participants with a lower extremity amputation is important to detect asymmetries in gait which are hypothesised as associated with secondary complaints. The aim of this study was to test the reproducibility and discriminant validity of a three-dimensional (3-D; inertial measurement units) and a two-dimensional (2-D; video-based) system. Methods We tested the test-retest and inter-rater reproducibility of both systems and the 2-D system, respectively, in participants with a lower extremity amputation (group 1) and healthy subjects (group 2). The discriminant validity was determined with a within-group comparison for the 3-D system and with a between-group comparison for both systems. Results Both system showed to be test-retest reliable, both in group 1 (2-D system: ICC3.1(agreement) 0.52-0.83; 3-D system: ICC3.1(agreement) 0.81-0.95) and in group 2 (3-D system: ICC3.1(agreement) 0.33-0.92; 2-D system: ICC3.1(agreement) 0.54-0.95). The 2-D system was also inter-rater reliable (group 1: ICC2.1(agreement) 0.80-0.92; group 2: ICC2.1(agreement) 0.39-0.90). The within-group comparison of the 3-D system revealed a statistically significant asymmetry of 0.4 degrees-0.5 degrees in group 1 and no statistically significant asymmetry in group 2. The between-group comparison revealed that the maximum amplitude towards the residual limb (MARL) in the low back (3-D system) and the (residual) limb-trunk angle (2-D system) were significantly larger with a mean difference of 1.2 degrees and 6.4 degrees, respectively, than the maximum amplitude of healthy subjects. However, these average differences were smaller than the smallest detectable change (SDC) of group 1 for both the MARL (SDCagreement: 1.5 degrees) and the residual limb-trunk angle (SDCagreement: 6.7 degrees-7.6 degrees). Conclusion The 3-D and 2-D systems tested in this study were not sensitive enough to detect real differences within and between participants with a lower extremity amputation and healthy subjects although promising reproducibility parameters for some of the outcome measures.	[Leijendekkers, Ruud A.; Van Hinte, Gerben; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Phys Therapy, Nijmegen, Netherlands; [Hoogeboom, Thomas J.; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands; [Didden, Lars; Anijs, Thomas; Verdonschot, Nico] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Orthopaed Res Lab, Med Ctr, Nijmegen, Netherlands; [Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Dept Rehabil, Med Ctr, Nijmegen, Netherlands; [Verdonschot, Nico] Univ Twente, Lab Biomech Engn, Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Twente	Leijendekkers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Phys Therapy, Nijmegen, Netherlands.	Ruud.Leijendekkers@radboudumc.nl	Leijendekkers, R.A./L-4485-2015; Verdonschot, N.J.J./H-8104-2014; der Sanden, Maria WG Nijhuis-van/B-3463-2012; van Hinte, MSc G.J./L-4374-2015	Leijendekkers, R.A./0000-0002-6158-6901; Verdonschot, N.J.J./0000-0002-7531-6523; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; van Hinte, MSc G.J./0000-0001-9357-5388	European Research Council under the European Union [323091]	European Research Council under the European Union(European Research Council (ERC))	This project was partly supported (salary L.D.) by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013), ERC Grant Agreement no. 323091 awarded to N.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baker R, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-4; Bauer CM, 2015, J ELECTROMYOGR KINES, V25, P782, DOI 10.1016/j.jelekin.2015.06.001; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bolink SAAN, 2016, MED ENG PHYS, V38, P225, DOI 10.1016/j.medengphy.2015.11.009; Borel S, 2011, GAIT POSTURE, V33, P727, DOI 10.1016/j.gaitpost.2011.02.012; Bugane F, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-146; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Centers for Medicare and Medicaid Services. U. S. Department of Health and Human Services, 2001, HCFA COMM PROC COD S; Cuesta-Vargas AI, 2010, PHYS THER REV, V15, P462, DOI 10.1179/1743288X11Y.0000000006; Darter BJ, 2011, PHYS THER, V91, P1385, DOI 10.2522/ptj.20100360; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Vet HW, 2011, MEASUREMENT MED PRAC; Dingwell JB, 1996, PROSTHET ORTHOT INT, V20, P101; Effective Public Health Practice Project (EPHPP), 2009, QUAL ASS TOOL QUANT; Ehde DM, 2001, ARCH PHYS MED REHAB, V82, P731, DOI 10.1053/apmr.2001.21962; Esposito ER, 2014, GAIT POSTURE, V40, P640, DOI 10.1016/j.gaitpost.2014.07.019; Frossard L, 2010, J PROSTHET ORTHOT, V22, P11, DOI [10.1097/JPO.0b013-3181ccc53d, DOI 10.1097/JPO.0B013E3181CCC53D]; Goodvin C, 2006, MED BIOL ENG COMPUT, V44, P1061, DOI 10.1007/s11517-006-0132-3; Grunt S, 2010, GAIT POSTURE, V31, P489, DOI 10.1016/j.gaitpost.2010.02.006; Hak L, 2014, PHYS THER, V94, P1480, DOI 10.2522/ptj.20130431; Hendershot BD, 2014, CLIN BIOMECH, V29, P235, DOI 10.1016/j.clinbiomech.2013.12.005; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Houdijk H, 2009, GAIT POSTURE, V30, P35, DOI 10.1016/j.gaitpost.2009.02.009; HURLEY GRB, 1990, PROSTHET ORTHOT INT, V14, P33; Isakov E, 1997, SCAND J REHABIL MED, V29, P75; JAEGERS SMHJ, 1995, ARCH PHYS MED REHAB, V76, P736, DOI 10.1016/S0003-9993(95)80528-1; Kark L, 2016, WORLD J ORTHOP, V7, P383, DOI 10.5312/wjo.v7.i6.383; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Kovac I, 2010, COLLEGIUM ANTROPOL, V34, P205; Kulkarni J, 2005, CLIN REHABIL, V19, P81, DOI 10.1191/0269215505cr819oa; Leijendekkers RA, 2017, PHYSIOTHER THEOR PR, V33, P147, DOI 10.1080/09593985.2016.1265620; Lin SJ, 2014, GAIT POSTURE, V40, P140, DOI 10.1016/j.gaitpost.2014.03.012; Mattes SJ, 2000, ARCH PHYS MED REHAB, V81, P561, DOI 10.1016/S0003-9993(00)90035-2; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Meldrum D, 2014, GAIT POSTURE, V39, P265, DOI 10.1016/j.gaitpost.2013.07.130; Michaud SB, 2000, J REHABIL RES DEV, V37, P1; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Molina-Rueda F, 2014, BRAZ J PHYS THER, V18, P252, DOI 10.1590/bjpt-rbf.2014.0032; Orlowski K, 2017, BIOMED TECH; Ortiz A, 2016, OPEN ACCESS J SPORTS, V7, P65, DOI 10.2147/OAJSM.S100242; Plamondon A, 2007, APPL ERGON, V38, P697, DOI 10.1016/j.apergo.2006.12.006; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Prinsen EC, 2011, ARCH PHYS MED REHAB, V92, P1311, DOI 10.1016/j.apmr.2011.01.017; Roerdink M, 2012, GAIT POSTURE, V35, P446, DOI 10.1016/j.gaitpost.2011.11.005; Rusaw D, 2011, PROSTHET ORTHOT INT, V35, P8, DOI 10.1177/0309364610393060; Sagawa Jr Y, 2011, GAIT POSTURE, V33, P37, DOI [10.1080/03093640308726686, DOI 10.1080/03093640308726686]; Schmitz-Hubsch T, 2016, GAIT POSTURE, V48, P194, DOI 10.1016/j.gaitpost.2016.05.014; Sjodahl C, 2003, PROSTHET ORTHOT INT, V27, P227, DOI 10.1080/03093640308726686; Sjodahl C, 2001, J REHABIL MED, V33, P114; Smith DG, 1999, CLIN ORTHOP RELAT R, P29; Tao WJ, 2012, SENSORS-BASEL, V12, P2255, DOI 10.3390/s120202255; Tazawa E, 1997, PROSTHET ORTHOT INT, V21, P129; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tranberg R, 2011, GAIT POSTURE, V33, P165, DOI 10.1016/j.gaitpost.2010.11.004; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Wong WY, 2008, EUR SPINE J, V17, P743, DOI 10.1007/s00586-008-0586-0; Yang ZY, 2008, IEEE ENG MED BIO, P4740, DOI 10.1109/IEMBS.2008.4650272; Yoder AJ, 2015, GAIT POSTURE, V41, P757, DOI 10.1016/j.gaitpost.2015.01.016; Zijlstra A, 2008, GAIT POSTURE, V27, P164, DOI 10.1016/j.gaitpost.2007.02.010; 2013, GAIT POSTURE, V37, P436, DOI DOI 10.1016/J.GAITPOST.2012.08.019; 2007, IEEE T NEUR SYS REH, V15, P469, DOI DOI 10.1109/TNSRE.2007.903946; 2017, GAIT POSTURE, V58, P121, DOI DOI 10.1016/J.GAITPOST.2017.07.040; 2004, DISABIL REHABIL, V26, P794, DOI DOI 10.1080/09638280410001696683	66	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217046	10.1371/journal.pone.0217046	http://dx.doi.org/10.1371/journal.pone.0217046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112589	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000035
J	Brons, S; Meulstee, JW; Nada, RM; Kuijpers, MAR; Bronkhorst, EM; Berge, SJ; Maal, TJJ; Kuijpers-Jagtman, AM				Brons, Sander; Meulstee, Jene W.; Nada, Rania M.; Kuijpers, Mette A. R.; Bronkhorst, Ewald M.; Berge, Stefaan J.; Maal, Thomas J. J.; Kuijpers-Jagtman, Anne Marie			Uniform 3D meshes to establish normative facial averages of healthy infants during the first year of life	PLOS ONE			English	Article							UNILATERAL CLEFT-LIP; CRANIOFACIAL MORPHOLOGY; GROWTH; PALATE; CHILDREN; SHAPE; AGE	Three-dimensional (3D) surface imaging systems are replacing direct anthropometry as the preferred method for capturing facial soft-tissues. Aims of this study were: (1) to develop normative average 3D faces of healthy infants aged 3, 6, 9, and 12 months and (2) to describe normative average 3D facial growth data in infants aged 3 to 12 months. Three-dimensional images of 50 healthy children were acquired at 3, 6, 9, and 12 months of age using the 3dMDcranial system. Four average faces with uniform meshes (3, 6, 9, and 12 months) were developed and registered based on the children's reference frames. Distance maps of growth of the total facial surface and of the nose, upper lip, chin, forehead and cheeks for the intervals 3 to 6 months, 6 to 9 months, and 9 to 12 months of age were calculated. Mean growth of the total facial surface was 3.9 mm (standard deviation [SD] 1.2 mm), 3.5 mm (SD 0.9 mm), and 1.6 mm (SD 0.7 mm) at 3 to 6 months, 6 to 9 months, and 9 to 12 months, respectively. Regarding the selected regions of the face, the mean growth of the nose and upper lip were the largest (3.7 mm and 3.6 mm, respectively) between 6 and 9 months of age. The mean growth of the forehead, cheeks and chin were the largest (5.4 mm, 3.2, and 4.7 mm, respectively) between 3 and 6 months of age. For all facial regions, growth clearly diminished from 9 to 12 months of age. Normative data on the growth of the full face, nose, upper lip, chin, forehead and cheeks are presented. Such data can be used in future studies to identify the effectiveness of treatment of orofacial deformities such as orofacial clefts during the first year of life.	[Brons, Sander; Kuijpers, Mette A. R.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Sect Orthodont & Craniofacial Biol, Dept Dent, Nijmegen, Netherlands; [Meulstee, Jene W.; Berge, Stefaan J.; Maal, Thomas J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, Nijmegen, Netherlands; [Nada, Rania M.] Kuwait Univ, Fac Dent, Jabriya Kuwait City, Kuwait; [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Sect Prevent & Curat Dent, Dept Dent, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Kuwait University; Radboud University Nijmegen	Brons, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sect Orthodont & Craniofacial Biol, Dept Dent, Nijmegen, Netherlands.	sander.brons@radboudumc.nl	Kuijpers, Mette/H-3308-2015; Maal, Thomas JJ/L-4497-2015; Meulstee, Jene/AAE-1903-2019; Bronkhorst, Ewald/AAR-2250-2020; Bronkhorst, Ewald/L-4230-2015; Berge, Stefaan/AAP-3708-2020; Kuijpers-Jagtman, Anne Marie/A-9413-2008; Brons, Sander/I-2714-2018	Kuijpers, Mette/0000-0001-6462-9789; Maal, Thomas JJ/0000-0002-1702-4733; Meulstee, Jene/0000-0002-1285-6602; Bronkhorst, Ewald/0000-0003-0953-8053; Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Brons, Sander/0000-0001-5263-4804	Dutch Technology Foundation [10315]	Dutch Technology Foundation(Technologiestichting STW)	Thomas J.J. Maal received a grant from the Dutch Technology Foundation to STW (grant #10315). https://www.nwo.nl/over-nwo/organisatie/nwo-onderdelen/ttw/technologiestichting+stw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omari I, 2005, CLEFT PALATE-CRAN J, V42, P145, DOI 10.1597/02-149.1; Bishara S E, 1973, Cleft Palate J, V10, P239; Brons S, 2013, INT J ORAL MAX SURG, V42, P2, DOI 10.1016/j.ijom.2012.07.006; Brons S, 2019, CLIN ORAL INVEST, V23, P1041, DOI 10.1007/s00784-018-2520-0; Bugaighis I, 2014, EUR J ORTHODONT, V36, P365, DOI 10.1093/ejo/cjs060; Djordjevic J, 2014, EUR J ORTHODONT, V36, P497, DOI 10.1093/ejo/cjs075; Farkas Leslie G., 1994, P241; Farkas LG, 1996, CLEFT PALATE-CRAN J, V33, P10, DOI 10.1597/1545-1569(1996)033<0010:AOAMPP>2.3.CO;2; Ferrario VF, 1999, PLAST RECONSTR SURG, V103, P768, DOI 10.1097/00006534-199903000-00002; FRIEDE H, 1986, AM J ORTHOD DENTOFAC, V90, P388, DOI 10.1016/0889-5406(86)90005-3; Friede H, 1998, ACTA ODONTOL SCAND, V56, P346, DOI 10.1080/000163598428293; Gazi-Coklica V, 1997, EUR J ORTHODONT, V19, P681, DOI 10.1093/ejo/19.6.681; Heike CL, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-18; Hermann NV, 2004, CLEFT PALATE-CRAN J, V41, P424, DOI 10.1597/03-056.1; Hermann NV, 1999, J CRAN GENET DEV BIO, V19, P135; Hol MLF, ANAL 3D STEREO UNPUB; Kau CH, 2006, J ORAL MAXIL SURG, V64, P1086, DOI 10.1016/j.joms.2006.03.013; Kesterke MJ, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0076-8; Kuijpers-Jagtman AM, 2012, EUR J ORTHODONT, V34, P665, DOI 10.1093/ejo/cjs069; Matthews H, 2018, FORENSIC SCI INT, V286, P61, DOI 10.1016/j.forsciint.2018.02.024; Meulstee JW, 2017, INT J ORAL MAX SURG, V46, P819, DOI 10.1016/j.ijom.2017.03.017; Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168; NORMANDO ADC, 1992, J CRANIO MAXILL SURG, V20, P111, DOI 10.1016/S1010-5182(05)80092-7; Sang Q, 2013, PATTERN RECOGN LETT, V34, P1557, DOI 10.1016/j.patrec.2013.06.019; Sforza C, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.ed3; SMAHEL Z, 1987, CLEFT PALATE J, V24, P200; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Weinberg SM, 2016, CLEFT PALATE-CRAN J, V53, pE185, DOI 10.1597/15-199; White JE, 2004, CLEFT PALATE-CRAN J, V41, P593, DOI 10.1597/03-069.1; Zhang KP, 2016, IEEE SIGNAL PROC LET, V23, P1499, DOI 10.1109/LSP.2016.2603342; 2018, CLIN ORAL INVEST, V22, P1783, DOI DOI 10.1007/S00784-017-2274-0; 2006, ANGLE ORTHOD, V76, P773, DOI DOI 10.1043/0003-3219(2006)076[0773:MAFMIT]2.0.CO;2	32	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217267	10.1371/journal.pone.0217267	http://dx.doi.org/10.1371/journal.pone.0217267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107914	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200043
J	Meyers, MT; Cochlan, WP; Carpenter, EJ; Kimmerer, WJ				Meyers, Morgan T.; Cochlan, William P.; Carpenter, Edward J.; Kimmerer, Wim J.			Effect of ocean acidification on the nutritional quality of marine phytoplankton for copepod reproduction	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; EGG-PRODUCTION; ACARTIA-TONSA; FOOD QUALITY; PLANKTONIC COPEPODS; CO2-INDUCED ACIDIFICATION; ESTUARINE COPEPOD; CO2 CONCENTRATION; HATCHING SUCCESS; FLORIDA BAY	Phytoplankton are the oceans' principal source of polyunsaturated fatty acids that support the growth and reproduction of consumers such as copepods. Previous studies have demonstrated ocean acidification (OA) can change the availability of polyunsaturated fatty acids to consumer diets which may affect consumer reproduction. Two laboratory experiments were conducted to examine the effects of feeding high-pCO(2)-reared phytoplankton on copepod egg production, hatching success, and naupliar survival. Marine phytoplankton Rhodomonas salina, Skeletonema marinoi, Prorocentrum micans, and Isochrysis galbana were exponentially grown in semi-continuous cultures at present (control) (400 ppm CO2, pH similar to 8.1) and future (1,000 ppm CO2, pH similar to 7.8) conditions and provided to Acartia tonsa copepods over 4 consecutive days as either nitrogen-limited (Exp. I) or nitrogen-depleted (Exp. II) mixed assemblage of phytoplankton. The composition of FAs in the phytoplankton diet was affected by pCO(2) concentration and nitrogen deficiency; the ratio of essential fatty acids to total poly-unsaturated fatty acids decreased in phytoplankton grown under high pCO(2) and the mass of total fatty acids increased under nitrogen depletion. Additionally, total concentrations of essential fatty acids and polyunsaturated fatty acids in the diet mixtures were less under the high-pCO(2) compared to the control-pCO(2) treatments. Median egg production, hatching success, and naupliar survival were 48-52%, 4-87%, and 9-100% lower, respectively, in females fed high-pCO(2) than females fed low-pCO(2) phytoplankton, but this decrease in reproductive success was less severe when fed N-depleted, but fatty acid-rich cells. This study demonstrates that the effects of OA on the nutritional quality of phytoplankton (i.e., their cellular fatty acid composition and quota) were modified by the level of nitrogen deficiency and the resulting negative reproductive response of marine primary consumers.	[Meyers, Morgan T.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Cochlan, William P.; Carpenter, Edward J.; Kimmerer, Wim J.] San Francisco State Univ, Estuary & Ocean Sci Ctr, Tiburon, CA USA	University of Otago; California State University System; San Francisco State University	Meyers, MT (corresponding author), Univ Otago, Dept Bot, Dunedin, New Zealand.	morgan.meyers21@gmail.com		Meyers, Morgan/0000-0002-8725-3435	United States National Science Foundation Chemical Oceanography Division [1131657]; United States National Science Foundation - Office of Polar Programs [PLR1246373]; California State University Council on Ocean Affairs, Science & Technology Graduate Student Research Award	United States National Science Foundation Chemical Oceanography Division; United States National Science Foundation - Office of Polar Programs(National Science Foundation (NSF)); California State University Council on Ocean Affairs, Science & Technology Graduate Student Research Award	This research was partially supported by the United States National Science Foundation Chemical Oceanography Division (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11698&org=OCE&from=home) grant number 1131657 award to WPC, the United States National Science Foundation - Office of Polar Programs (https://www.nsf.gov/div/index.jsp?div=OPP) grant number PLR1246373 awarded to EJC, and the California State University Council on Ocean Affairs, Science & Technology Graduate Student Research Award (https://www2.calstate.edu/impact-of-the-csu/research/coast/funding/Pages/student-funding.aspx) awarded to MTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren G, 2005, CAN J FISH AQUAT SCI, V62, P2240, DOI 10.1139/F05-140; AHLGREN G, 1990, J PLANKTON RES, V12, P809, DOI 10.1093/plankt/12.4.809; Alvarez-Fernandez S, 2018, PROG OCEANOGR, V165, P11, DOI 10.1016/j.pocean.2018.04.006; Amin RM, 2011, MAR BIOL, V158, P1965, DOI 10.1007/s00227-011-1706-7; Andersen R.A., 2005, ALGAL CULTURING TECH; [Anonymous], 2014, R LANG ENV STAT COMP; Arendt KE, 2005, MAR BIOL, V146, P513, DOI 10.1007/s00227-004-1457-9; Armengol L, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3165-2; Bermudez R, 2016, BIOGEOSCIENCES, V13, P6625, DOI 10.5194/bg-13-6625-2016; Boersma M, 2008, INT REV HYDROBIOL, V93, P479, DOI 10.1002/iroh.200811066; Bran Luebbe Inc., 1999, G17296 BRAN LUEBB IN; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Calliari D, 2006, MAR ECOL PROG SER, V312, P177, DOI 10.3354/meps312177; Castell JD, 1982, P 2 INT C AQ NUTR BI, P124; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; CHECKLEY DM, 1980, LIMNOL OCEANOGR, V25, P430, DOI 10.4319/lo.1980.25.3.0430; Chen G, 2008, MOL ECOL, V17, P1451, DOI 10.1111/j.1365-294X.2007.03657.x; Chu WL, 1996, J APPL PHYCOL, V8, P389, DOI 10.1007/BF02178582; COCHLAN WP, 1991, LIMNOL OCEANOGR, V36, P1689, DOI 10.4319/lo.1991.36.8.1689; Cripps G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151739; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; DAM HG, 1994, HYDROBIOLOGIA, V293, P191, DOI 10.1007/BF00229941; DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x; Destaillats F, 2002, J AM OIL CHEM SOC, V79, P253, DOI 10.1007/s11746-002-0469-7; Diaz-Gil C, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0331; Douillet PA, 1991, BENEFICIAL EFFECTS B; Downing JA, 1997, BIOGEOCHEMISTRY, V37, P237, DOI 10.1023/A:1005712322036; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; FRASER AJ, 1989, MAR CHEM, V27, P1, DOI 10.1016/0304-4203(89)90024-8; Galloway AWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130053; Garzke J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155952; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Griffiths MJ, 2012, J APPL PHYCOL, V24, P989, DOI 10.1007/s10811-011-9723-y; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Gulati RD, 1997, FRESHWATER BIOL, V38, P753, DOI 10.1046/j.1365-2427.1997.00275.x; HARRISON P J, 1990, Journal of Applied Phycology, V2, P45, DOI 10.1007/BF02179768; Hazzard SE, 2003, MAR ECOL PROG SER, V252, P199, DOI 10.3354/meps252199; Hessen DO, 2008, LIMNOL OCEANOGR, V53, P1685, DOI 10.4319/lo.2008.53.4.1685; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hixson SM, 2016, GLOBAL CHANGE BIOL, V22, P2744, DOI 10.1111/gcb.13295; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Illman AM, 2000, ENZYME MICROB TECH, V27, P631, DOI 10.1016/S0141-0229(00)00266-0; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Isari S, 2016, ICES J MAR SCI, V73, P650, DOI 10.1093/icesjms/fsv078; Isari S, 2015, J PLANKTON RES, V37, P912, DOI 10.1093/plankt/fbv057; Jayalakshmi T, 2016, ANN AGRAR SCI, V14, P278, DOI DOI 10.1016/J.AASCI.2016.09.001; King AL, 2015, MAR ECOL PROG SER, V537, P59, DOI 10.3354/meps11458; Kleppel GS, 1998, LIMNOL OCEANOGR, V43, P1000, DOI 10.4319/lo.1998.43.5.1000; Kleppel GS, 2000, MAR BIOL, V137, P111, DOI 10.1007/s002270000319; Koski M, 1998, MAR ECOL PROG SER, V170, P169, DOI 10.3354/meps170169; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Kurihara H, 2004, J OCEANOGR, V60, P743, DOI 10.1007/s10872-004-5766-x; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Lacoste A, 2001, J EXP MAR BIOL ECOL, V259, P85, DOI 10.1016/S0022-0981(01)00224-6; LEE RF, 1971, MAR BIOL, V9, P99, DOI 10.1007/BF00348249; Leu E, 2012, BIOGEOSCIENCES DISCU, V9, P8173; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Malzahn AM, 2012, OIKOS, V121, P1408, DOI 10.1111/j.1600-0706.2011.20186.x; Malzahn AM, 2010, OECOLOGIA, V162, P35, DOI 10.1007/s00442-009-1458-y; Mandal S, 2009, APPL MICROBIOL BIOT, V84, P281, DOI 10.1007/s00253-009-1935-6; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13690; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; Mayor DJ, 2011, FUNCT ECOL, V25, P509, DOI 10.1111/j.1365-2435.2010.01791.x; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MIRALTO A, 1995, J PLANKTON RES, V17, P1521, DOI 10.1093/plankt/17.7.1521; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pedersen SA, 2013, BIOGEOSCIENCES, V10, P7481, DOI 10.5194/bg-10-7481-2013; PIORRECK M, 1984, PHYTOCHEMISTRY, V23, P207, DOI 10.1016/S0031-9422(00)80304-0; Pleuthner RL, 2016, DEEP-SEA RES PT II, V134, P190, DOI 10.1016/j.dsr2.2015.08.003; Pond D, 1996, MAR ECOL PROG SER, V143, P45, DOI 10.3354/meps143045; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; SARGENT JR, 1988, HYDROBIOLOGIA, V167, P101, DOI 10.1007/BF00026297; Sato N, 2003, BBA-MOL CELL BIOL L, V1633, P35, DOI 10.1016/S1388-1981(03)00070-2; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; StJohn MA, 1996, MAR ECOL PROG SER, V131, P75, DOI 10.3354/meps131075; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; Tang DH, 2011, BIORESOURCE TECHNOL, V102, P3071, DOI 10.1016/j.biortech.2010.10.047; Torstensson A, 2013, BIOGEOSCIENCES, V10, P6391, DOI 10.5194/bg-10-6391-2013; TSUZUKI M, 1990, PLANT PHYSIOL, V93, P851, DOI 10.1104/pp.93.3.851; TURNER JT, 1979, BIOSCIENCE, V29, P670, DOI 10.2307/1307591; Turner JT, 2004, ZOOL STUD, V43, P255; UYE S, 1990, MAR ECOL PROG SER, V59, P97, DOI 10.3354/meps059097; Van De Waal DB, 2010, FRONTIERS ECOLOGY EN; Veloza AJ, 2006, MAR BIOL, V148, P779, DOI 10.1007/s00227-005-0123-1; Wang MH, 2018, AQUAT TOXICOL, V196, P17, DOI 10.1016/j.aquatox.2018.01.004; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Wynn-Edwards C, 2014, WATER-SUI, V6, P1840, DOI 10.3390/w6061840; YONGMANITCHAI W, 1991, APPL ENVIRON MICROB, V57, P419, DOI 10.1128/AEM.57.2.419-425.1991; Zervoudaki S, 2017, ESTUAR COAST SHELF S, V186, P152, DOI 10.1016/j.ecss.2016.06.030; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9; 2016, BIOGEOSCIENCES, V13, P1037, DOI DOI 10.5194/BG-13-1037-2016; 2010, AQUAT TOXICOL, V99, P212, DOI DOI 10.1016/J.AQUATOX.2010.04.018; 1994, MAR BIOL, V121, P67; 2014, ENVIRON SCI TECHNOL, V48, P1227, DOI DOI 10.1021/ES501581J; 1996, MAR BIOL, V125, P743; 2003, J FOOD LIPIDS, V10, P25; 2005, MAR ECOL PROG SER, V291, P125	108	10	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217047	10.1371/journal.pone.0217047	http://dx.doi.org/10.1371/journal.pone.0217047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107897	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200027
J	Becker, L; Rohleder, N				Becker, Linda; Rohleder, Nicolas			Time course of the physiological stress response to an acute stressor and its associations with the primacy and recency effect of the serial position curve	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; PHYSICAL-ACTIVITY QUESTIONNAIRE; SPATIAL WORKING-MEMORY; LONG-TERM POTENTIATION; PSYCHOSOCIAL STRESS; DECLARATIVE MEMORY; POPULATION SPIKE; LOCUS-COERULEUS; CORTISOL-LEVELS; DENTATE GYRUS	Whether stress affects memory depends on which stress pathway becomes activated and which specific memory system is involved. The activation of the sympathetic nervous system (SNS), leads to a release of catecholamines. The activation of the hypothalamic-pituitary-adrenal (HPA) axis, leads to a release of glucocorticoids. In thus study, it was investigated whether SNS and/or HPA axis activation are associated with long-term memory (LTM) and/or working memory (WM) performance in humans. Thirty-three participants underwent the socially evaluated cold-pressor test. Salivary alpha-amylase (sAA) was used as a marker for the activation of the SNS and cortisol as marker for HPA axis activation. Memory was assessed by means of word lists with 15 words each. The primacy effect (i.e., the correctly recalled words from the beginning of the lists) of the serial position curve was considered as indicator for LTM. The recency effect (i.e., the correctly recalled words from the end of the lists) were used as estimator for WM performance. In sAA responders, the recency effect and, therefore, WM performance increased immediately after the stressor. This was not found in sAA non-responders. In cortisol responders, the primacy effect and, thus, LTM performance decreased 20 minutes after the stressor. No change in LTM performance was found in cortisol non-responders. Our study supports the assumptions that 1) SNS activation is associated with WM processes via stimulation of the prefrontal cortex, and 2) HPA axis activation is associated with LTM processes through interactions with the hippocampus.	[Becker, Linda; Rohleder, Nicolas] Friedrich Alexander Univ Erlangen Nuremberg, Chair Hlth Psychol, Dept Psychol, Erlangen, Germany	University of Erlangen Nuremberg	Becker, L (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Chair Hlth Psychol, Dept Psychol, Erlangen, Germany.	linda.becker@fau.de	Rohleder, Nicolas/N-7598-2013	Rohleder, Nicolas/0000-0003-2602-517X; Becker, Linda/0000-0002-9950-6882	Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promoting Equal Opportunities for Women in Research and Teaching; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promoting Equal Opportunities for Women in Research and Teaching; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	LB was supported by the Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promoting Equal Opportunities for Women in Research and Teaching. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R. C., 1968, PSYCHOL LEARNING MOT, V2, P89, DOI [DOI 10.1016/S0079-7421(08)60422-3, 10.1016/S0079-7421(08)60422-3]; ATKINSON RC, 1971, SCI AM, V225, P82, DOI 10.1038/scientificamerican0871-82; Briand LA, 2007, PROG NEUROBIOL, V83, P69, DOI 10.1016/j.pneurobio.2007.06.007; Buchanan TW, 2001, PSYCHONEUROENDOCRINO, V26, P307, DOI 10.1016/S0306-4530(00)00058-5; Buss C, 2004, PSYCHONEUROENDOCRINO, V29, P1093, DOI 10.1016/j.psyneuen.2003.09.006; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; DEKLOET ER, 1990, J STEROID BIOCHEM, V37, P387, DOI 10.1016/0960-0760(90)90489-8; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Domes G, 2002, PSYCHONEUROENDOCRINO, V27, P843, DOI 10.1016/S0306-4530(01)00085-3; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Elzinga BM, 2005, BEHAV NEUROSCI, V119, P98, DOI 10.1037/0735-7044.119.1.98; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Hautzinger M., 2012, ADS ALLGEMEINE DEPRE; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Henckens MJAG, 2011, P NATL ACAD SCI USA, V108, P5801, DOI 10.1073/pnas.1019128108; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Het S, 2005, PSYCHONEUROENDOCRINO, V30, P771, DOI 10.1016/j.psyneuen.2005.03.005; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Luethi M, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.005.2008; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; Maslach C, 2016, MASLACH BURNOUT INVE; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Minkley N, 2014, PSYCHONEUROENDOCRINO, V45, P119, DOI 10.1016/j.psyneuen.2014.03.022; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P758, DOI 10.1016/j.psyneuen.2007.05.006; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; NEUMAN RS, 1983, BRAIN RES, V273, P162, DOI 10.1016/0006-8993(83)91106-X; NISENBAUM LK, 1991, J NEUROSCI, V11, P1478; Otte C, 2015, NEUROPSYCHOPHARMACOL, V40, P386, DOI 10.1038/npp.2014.181; Payne JD, 2007, LEARN MEMORY, V14, P861, DOI 10.1101/lm.743507; Pellissier S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105328; Quesada AA, 2012, PSYCHONEUROENDOCRINO, V37, P125, DOI 10.1016/j.psyneuen.2011.05.013; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2009, INT J PSYCHOPHYSIOL, V72, P74, DOI 10.1016/j.ijpsycho.2008.03.010; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schulz P, 1995, TRIERER INVENTAR ERF; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; STANTON PK, 1987, BRAIN RES BULL, V18, P115, DOI 10.1016/0361-9230(87)90039-6; STANTON PK, 1985, J NEUROSCI, V5, P2169; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; VERHAGE M, 1992, J NEUROCHEM, V59, P881, DOI 10.1111/j.1471-4159.1992.tb08326.x; Vogel S, 2016, TRENDS COGN SCI, V20, P192, DOI 10.1016/j.tics.2015.12.003; Weerda R, 2010, HUM BRAIN MAPP, V31, P1418, DOI 10.1002/hbm.20945; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Yuen EY, 2009, P NATL ACAD SCI USA; 2009, NATURE REV NEUROSCIE, V10, P410, DOI DOI 10.1038/NRN2648; 2014, PSYCHONEUROENDOCRINO, V39, P249, DOI DOI 10.1016/J.PSYNEUEN.2013.09.020; 1994, NATURE, V371, P702, DOI DOI 10.1038/371702A0; 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI DOI 10.1016/J.PSYNEUEN.2010.12.019	81	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0213883	10.1371/journal.pone.0213883	http://dx.doi.org/10.1371/journal.pone.0213883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY5OE	31100063	gold, Green Published, Green Submitted			2022-12-27	WOS:000468176600001
J	Cuperus, AA; Disco, RT; Sligte, IG; van der Kuil, MNA; Evers, AWM; van der Ham, IJM				Cuperus, Anne A.; Disco, Rico T.; Sligte, Ilja G.; van der Kuil, Milan N. A.; Evers, Andrea W. M.; van der Ham, Ineke J. M.			Memory-related perceptual illusions directly affect physical activity in humans	PLOS ONE			English	Article							PERFORMANCE; REALITY; STROKE; PAIN	Perceptual illusions help us understand deficits in human perception, but they also have the potential to serve as treatment methods; e.g., to alleviate phantom limb pain. Treatment effects are usually the direct result of a mismatch between false visual feedback and somatosensory/proprioceptive feedback. We aimed to influence physical activity (walking distance) using a memory-related perceptual illusion that relies on a mismatch between a spatially manipulated virtual reality environment and a weakness of memory for a similar, previously experienced environment. Participants' main task was to reproduce a baseline distance three times, by walking on a treadmill while moving through a virtual reality environment. Depending on condition, the environment was either stretched or compressed relative to the previous session, but participants were not informed about these manipulations. Because false, suggestive information can lead to alterations in memory, especially when conveyed through 'rich' forms of media such as virtual reality, we expected each manipulation to alter memory for the previous environment(s) and we hypothesized that this would influence walking distance. The results for the first time showed that memory-related perceptual illusions can directly affect physical activity in humans. The effects we found are substantial; stretching previously experienced virtual environments led participants to almost double their initial walking distance, whereas compressing the environments resulted in about half of the initial distance. Possible clinical applications arising from these findings are discussed.	[Cuperus, Anne A.; van der Kuil, Milan N. A.; Evers, Andrea W. M.; van der Ham, Ineke J. M.] Leiden Univ, Hlth Med & Neuropsychol, Leiden, Netherlands; [Disco, Rico T.; Sligte, Ilja G.] Univ Amsterdam, Brain & Cognit, Amsterdam, Netherlands; [Evers, Andrea W. M.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cuperus, AA (corresponding author), Leiden Univ, Hlth Med & Neuropsychol, Leiden, Netherlands.	acuperus@gmail.com	Evers, Andrea/GWV-9705-2022	van der Ham, Ineke/0000-0003-2520-7422				Cuperus AA, 2018, COMPUT HUM BEHAV, V79, P211, DOI 10.1016/j.chb.2017.10.037; da Silva FC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193113; Dean CM, 1997, STROKE, V28, P722, DOI 10.1161/01.STR.28.4.722; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Dunn J, 2017, NEUROREHABILITATION, V40, P595, DOI 10.3233/NRE-171447; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P398, DOI 10.1037/0096-1523.31.3.398; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Gregory RL, 1997, PHILOS T ROY SOC B, V352, P1121, DOI 10.1098/rstb.1997.0095; Kassler L., 2010, P 7 S APPL PERCEPTIO, P161, DOI [10.1145/1836248.1836283, DOI 10.1145/1836248.1836283]; Keizer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163921; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; LEFEVRE JA, 1986, MEM COGNITION, V14, P287, DOI 10.3758/BF03202506; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Mancini F, 2011, PSYCHOL SCI, V22, P325, DOI 10.1177/0956797611398496; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub4; Moseley L, 2008, CURRENT EVIDENCE FUT, V138, P7, DOI DOI 10.HTTPS://D0I.0RG/10.1016/J.PAIN.2008.06.026; Nilsson NC, 2015, P IEEE VIRT REAL ANN, P81, DOI 10.1109/VR.2015.7223328; Powell W., 2011, THESIS; Powell W, 2011, P 3 IEEE VR WORKSH P, P4; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Segovia KY, 2009, MEDIA PSYCHOL, V12, P371, DOI 10.1080/15213260903287267; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Steinicke F, 2010, IEEE T VIS COMPUT GR, V16, P17, DOI 10.1109/TVCG.2009.62; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; 1995, NATURE, V377, P489, DOI DOI 10.1038/377489A0; 2014, GAIT POSTURE, V39, P478, DOI DOI 10.1016/J.GAITPOST.2013.08.022; 2010, IEEE T VIS COMPUT GR, V16, P17, DOI DOI 10.1109/TVCG.2009.62	29	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216988	10.1371/journal.pone.0216988	http://dx.doi.org/10.1371/journal.pone.0216988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY3MG	31095650	Green Published, gold			2022-12-27	WOS:000468030100063
J	Herklots, T; van Acht, L; Khamis, RS; Meguid, T; Franx, A; Jacod, B				Herklots, Tanneke; van Acht, Lieke; Khamis, Rashid Saleh; Meguid, Tarek; Franx, Arie; Jacod, Benoit			Validity of WHO's near-miss approach in a high maternal mortality setting	PLOS ONE			English	Article							HOSPITALS	Objective To evaluate the validity of WHO's near-miss approach in a low-resource, high maternal mortality setting. Design Prospective cohort study. Setting Mnazi Mmoja Hospital, the main referral hospital of Zanzibar, Tanzania, from 1 April 2017 until 31 December 2018. Population All women, pregnant or until 42 days after the end of pregnancy, admitted at Mnazi Mmoja Hospital, the tertiary referral hospital in Zanzibar. Methods Cases of maternal morbidity and mortality were evaluated according to WHO's near-miss approach. The approach's performance was determined by calculating its accuracy through sensitivity, specificity and positive and negative likelihood ratios. The approach's validity was assessed with Pearson's correlation coefficient between the number of organ dysfunction markers and risk of mortality. Main outcomes measures Correlation between number of organ dysfunction markers and risk of mortality, sensitivity and specificity. Results 26,842 women were included. There were 335 with a severe maternal outcome: 256 maternal near-miss cases and 79 maternal deaths. No signs of organ dysfunction were documented in only 4 of the 79 cases of maternal death. The number of organ dysfunction markers was highly correlated to the risk of mortality with Pearson's correlation coefficient of 0.89. Conclusions WHO's near-miss approach adequately identifies women at high risk of maternal mortality in Zanzibar's referral hospital. There is a strong correlation between the number of markers of organ dysfunction and mortality risk.	[Herklots, Tanneke; van Acht, Lieke; Franx, Arie] Univ Med Ctr Utrecht, Div Woman & Baby, Utrecht, Netherlands; [Khamis, Rashid Saleh; Meguid, Tarek] Mnazi Mmoja Hosp, Dept Obstet & Gynaecol, Zanzibar, Tanzania; [Meguid, Tarek] State Univ Zanzibar SUZA, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Jacod, Benoit] Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Med Ctr, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Herklots, T (corresponding author), Univ Med Ctr Utrecht, Div Woman & Baby, Utrecht, Netherlands.	tannekeherklots@gmail.com	Franx, Arie/AAA-1739-2021					Herklots T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181470; Kalisa R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1119-1; Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0811-5; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450; Oppong SA, 2019, BJOG-INT J OBSTET GY, V126, P755, DOI 10.1111/1471-0528.15578; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Rulisa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0619-8; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG; 2013, INT J GYNECOL OBSTET, V123, P58, DOI DOI 10.1016/J.IJGO.2013.06.003	15	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217135	10.1371/journal.pone.0217135	http://dx.doi.org/10.1371/journal.pone.0217135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095635	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100078
J	Choi, JA; Ju, HH; Kim, JE; Kim, SK; Jee, D; Lee, J; Park, CK; Paik, SY				Choi, Jin A.; Ju, Hyun-hee; Kim, Ju-Eun; Kim, Seon-Kyu; Jee, Donghyun; Lee, Jiyoung; Park, Chan Kee; Paik, Soon-young			Transcriptional changes after herpes simplex virus type 1 infection in human trabecular meshwork cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ENTRY MEDIATOR; PATHOGENESIS; GLAUCOMA; UVEITIS	Background Herpes simplex virus type 1 (HSV-1) is causative for hypertensive anterior uveitis. Trabecular meshwork (TM) cells, which are the key cells regulating intraocular pressure (IOP), is considered to be the site of inflammation. We explored the profiles of genes expressed in human TM primary cells upon HSV-1 infection. Methods Human TM cells were infected with HSV-1 and total RNA was isolated. The global transcriptional gene network analyses were performed in mock-infected and HSV-1 infected TM cells. Using ingenuity pathway analysis, we determined the key biological networks upon HSV-1 infection. The results of microarray analyses were validated using quantitative PCR. Results TM cells had a high susceptibility to HSV-1 infection. HSV-1 induced transcriptional suppression of many components related to fibrosis in TM cells. The top biological network related to the genes which were significantly altered upon HSV-1 infection was organismal injury and abnormalities involving TGF-beta 1 and PDGF-BB. The results of PCR analyses for selected molecules were found to be in good agreement with the microarray data. HSV-1-infected TM cells showed an 80-fold increase in the expression of PDGF-BB, which was further increased by treatment with TGF-beta 1. HSV-1 also induced a 4-fold increase in the expression of the monocyte chemoattractant protein (MCP)-1, the downstream molecules of PDGF-BB. Conclusions In human TM cells, HSV-1 induced transcriptional suppression of many components related to fibrosis and enhanced expression of both PDGF-BB and MCP-1. Our study may provide a novel mechanism for the pathogenesis of HSV-1 infection in TM cells.	[Choi, Jin A.; Ju, Hyun-hee; Jee, Donghyun; Lee, Jiyoung] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Kim, Ju-Eun; Paik, Soon-young] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Kim, Seon-Kyu] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Catholic University of Korea; Seoul St. Mary's Hospital	Paik, SY (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.; Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr; paik@catholic.ac.kr		Kim, Seon-Kyu/0000-0002-4176-5187	Bumsuk Academic Research Fund	Bumsuk Academic Research Fund	This paper was supported by Bumsuk Academic Research Fund in 2018 (Jin A Choi). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2011, J VIROL, V85, P11448, DOI 10.1128/JVI.00678-11; Choi JA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43349; Diskin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044400; GRANSTEIN RD, 1990, J IMMUNOL, V144, P3021; Hoeksema L, 2017, AM J OPHTHALMOL, V181, P55, DOI 10.1016/j.ajo.2017.06.013; HOGAN MJ, 1964, AM J OPHTHALMOL, V57, P551, DOI 10.1016/0002-9394(64)92501-2; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Janjanam J, 2015, MOL BIOL CELL, V26, P4589, DOI 10.1091/mbc.E15-08-0570; Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021; Kamakura M, 2008, MICROBES INFECT, V10, P405, DOI 10.1016/j.micinf.2007.12.019; Karaba AH, 2012, P NATL ACAD SCI USA, V109, P20649, DOI 10.1073/pnas.1216967109; Khodarev NN, 1999, P NATL ACAD SCI USA, V96, P12062, DOI 10.1073/pnas.96.21.12062; Kossmann T, 2003, J INFECT DIS, V187, P534, DOI 10.1086/373995; Li YH, 2016, MOL MED REP, V14, P1297, DOI 10.3892/mmr.2016.5366; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; MICHELSON S, 1994, J VIROL, V68, P5730, DOI 10.1128/JVI.68.9.5730-5737.1994; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nie YH, 2008, MOL VIS, V14, P1631; Ohira S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147080; Sng CCA, 2015, PROG BRAIN RES, V221, P243, DOI 10.1016/bs.pbr.2015.06.008; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Suryawanshi A, 2011, J IMMUNOL, V186, P3653, DOI 10.4049/jimmunol.1003239; Takeda S, 2011, INVEST OPHTH VIS SCI, V52, P6729, DOI 10.1167/iovs.11-7805; Terasaka Y, 2010, INVEST OPHTH VIS SCI, V51, P2441, DOI 10.1167/iovs.09-4624; Tiwari V, 2005, J VIROL, V79, P13173, DOI 10.1128/JVI.79.20.13173-13179.2005; TOWNSEND WM, 1971, AM J OPHTHALMOL, V71, P904, DOI 10.1016/0002-9394(71)90265-0; Tumpey TM, 1998, J LEUKOCYTE BIOL, V63, P486, DOI 10.1002/jlb.63.4.486	28	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217567	10.1371/journal.pone.0217567	http://dx.doi.org/10.1371/journal.pone.0217567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136615	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300052
J	Tsutsumi-Arai, C; Takakusaki, K; Arai, Y; Terada-Ito, C; Takebe, Y; Imamura, T; Ide, S; Tatehara, S; Tokuyama-Toda, R; Wakabayashi, N; Satomura, K				Tsutsumi-Arai, Chiaki; Takakusaki, Kensuke; Arai, Yuki; Terada-Ito, Chika; Takebe, Yusuke; Imamura, Takahiro; Ide, Shinji; Tatehara, Seiko; Tokuyama-Toda, Reiko; Wakabayashi, Noriyuki; Satomura, Kazuhito			Grapefruit seed extract effectively inhibits the Candida albicans biofilms development on polymethyl methacrylate denture-base resin	PLOS ONE			English	Article							ANTIBACTERIAL AGENT; ANTIFUNGAL ACTIVITY; ADHESION; POLYPHENOLS; FLAVONOIDS	This study aimed to investigate the cleansing effects of grapefruit seed extract (GSE) on biofilms of Candida albicans (C. albicans) formed on denture-base resin and the influence of GSE on the mechanical and surface characteristics of the resin. GSE solution diluted with distilled water to 0.1% (0.1% GSE) and 1% (1% GSE) and solutions with Polident (R) denture cleansing tablet dissolved in distilled water (Polident) or in 0.1% GSE solution (0.1% G+P) were prepared as cleansing solutions. Discs of acrylic resin were prepared, and the biofilm of C. albicans was formed on the discs. The discs with the biofilm were treated with each solution for 5 min at 25 degrees C. After the treatment, the biofilm on the discs was analyzed using a colony forming unit (CFU) assay, fluorescence microscopy, and scanning electron microscopy (SEM). In order to assess the persistent cleansing effect, the discs treated with each solution for 5 min were aerobically incubated in Yeast Nitrogen Base medium for another 24 h. After incubation, the persistent effect was assessed by CFU assay. Some specimens of acrylic resin were immersed in each solution for 7 days, and changes in surface roughness (Ra), Vickers hardness (VH), flexural strength (FS), and flexural modulus (FM) were evaluated. As a result, the treatment with 1% GSE for 5 min almost completely eliminated the biofilm formed on the resin; whereas, the treatment with 0.1% GSE, Polident, and 0.1% G+P for 5 min showed a statistically significant inhibitory effect on biofilms. In addition, 0.1% GSE and 0.1% G+P exerted a persistent inhibitory effect on biofilms. Fluorescence microscopy indicated that Polident mainly induced the death of yeast, while the cleansing solutions containing at least 0.1% GSE induced the death of hyphae as well as yeast. SEM also revealed that Polident caused wrinkles, shrinkage, and some deep craters predominantly on the cell surfaces of yeast, while the solutions containing at least 0.1% GSE induced wrinkles, shrinkage, and some damage on cell surfaces of not only yeasts but also hyphae. No significant changes in Ra, VH, FS, or FM were observed after immersion in any of the solutions. Taken together, GSE solution is capable of cleansing C. albicans biofilms on denture-base resin and has a persistent inhibitory effect on biofilm development, without any deteriorations of resin surface.	[Tsutsumi-Arai, Chiaki; Terada-Ito, Chika; Takebe, Yusuke; Imamura, Takahiro; Ide, Shinji; Tatehara, Seiko; Tokuyama-Toda, Reiko; Satomura, Kazuhito] Tsurumi Univ, Dept Oral Med & Stomatol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Takakusaki, Kensuke; Arai, Yuki; Wakabayashi, Noriyuki] Tokyo Med & Dent Univ, Dept Removable Partial Prosthodont, Grad Sch, Tokyo, Japan	Tsurumi University; Tokyo Medical & Dental University (TMDU)	Tsutsumi-Arai, C (corresponding author), Tsurumi Univ, Dept Oral Med & Stomatol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa, Japan.	Tsutsumi-c@tsurumi-u.ac.jp	Wakabayashi, N./ABA-2063-2020		JSPS KAKENHI [17K17156]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI, Grant numbers: 17K17156 (https://www.jsps.go.jp/j-grantsinaid/) to CT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37867; Alsteens D, 2013, LANGMUIR, V29, P13473, DOI 10.1021/la403237f; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Bahrin LG, 2014, BIOORG MED CHEM LETT, V24, P2315, DOI 10.1016/j.bmcl.2014.03.071; Belofsky G, 2013, J NAT PROD, V76, P915, DOI 10.1021/np4000763; Cao SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032943; Chen M, 2015, MED MYCOL, V53, P194, DOI 10.1093/mmy/myu073; Choi JS, 2014, J FOOD SCI, V79, pM1159, DOI 10.1111/1750-3841.12469; Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784; Kammers ACE, 2015, J CLIN DIAGN RES, V9, pZC94, DOI 10.7860/JCDR/2015/11261.5975; Felipucci DNB, 2011, J APPL ORAL SCI, V19, P483, DOI 10.1590/S1678-77572011000500008; Felton D, 2011, J PROSTHODONT, V20, pS1, DOI 10.1111/j.1532-849X.2010.00683.x; Freitas-Fernandes FS, 2014, J PROSTHET DENT, V112, P1349, DOI 10.1016/j.prosdent.2014.07.004; Gleiznys Alvydas, 2015, Stomatologija, V17, P54; Hariri BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185203; Heggers JP, 2002, J ALTERN COMPLEM MED, V8, P333, DOI 10.1089/10755530260128023; Hirasawa M, 2018, ARCH ORAL BIOL, V87, P143, DOI 10.1016/j.archoralbio.2017.12.024; Jackson S, 2014, J PROSTHET DENT, V112, P988, DOI 10.1016/j.prosdent.2014.02.003; JAGGER DC, 1995, BRIT DENT J, V178, P413, DOI 10.1038/sj.bdj.4808788; Jung S, 2018, FOOD SCI BIOTECHNOL, V27, P261, DOI 10.1007/s10068-017-0198-8; Kang ST, 2017, KOREAN J FOOD SCI AN, V37, P429, DOI 10.5851/kosfa.2017.37.3.429; Kim JH, 2018, INT J BIOL MACROMOL, V120, P1468, DOI 10.1016/j.ijbiomac.2018.09.160; Kurt A, 2018, J PROSTHODONT, V27, P577, DOI 10.1111/jopr.12539; Lee H, 2015, BBA-BIOMEMBRANES, V1848, P634, DOI 10.1016/j.bbamem.2014.11.016; Liu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108474; Manoharan RK, 2018, MICROB BIOTECHNOL, V11, P1060, DOI 10.1111/1751-7915.13268; Mayahara M, 2014, J INVESTIG CLIN DENT, V5, DOI 10.1111/jicd.12055; Moussa A. R., 2016, J MED SCI, V4, P476, DOI DOI 10.3889/0AMJMS.2016.089; Paranhos HFO, 2007, J ORAL REHABIL, V34, P606, DOI 10.1111/j.1365-2842.2007.01753.x; RADFORD DR, 1993, J DENT, V21, P87, DOI 10.1016/0300-5712(93)90151-F; Reagor L, 2002, J ALTERN COMPLEM MED, V8, P325, DOI 10.1089/10755530260128014; Saito H, 2013, MICROB PATHOGENESIS, V56, P16, DOI 10.1016/j.micpath.2013.01.002; Seleem D, 2017, ARCH ORAL BIOL, V76, P76, DOI 10.1016/j.archoralbio.2016.08.030; Serpa R, 2012, J MED MICROBIOL, V61, P1704, DOI 10.1099/jmm.0.047852-0; Shankar S, 2018, INT J BIOL MACROMOL, V120, P846, DOI 10.1016/j.ijbiomac.2018.09.004; Shankar S, 2018, CARBOHYD POLYM, V196, P92, DOI 10.1016/j.carbpol.2018.04.128; Sharma A, 2014, FUNGAL BIOL-UK, V118, P264, DOI 10.1016/j.funbio.2013.12.006; Sitheeque MAM, 2009, CHEMOTHERAPY, V55, P189, DOI 10.1159/000216836; Tripathi P, 2018, J INDIAN PROSTHODONT, V18, P291, DOI 10.4103/jips.jips_335_17; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Tsutsumi C, 2016, J DENT, V44, P37, DOI 10.1016/j.jdent.2015.11.010; Xie YX, 2015, CURR MED CHEM, V22, P132; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Zoric N, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1773-5; Zuzarte M, 2012, EUR J CLIN MICROBIOL, V31, P1359, DOI 10.1007/s10096-011-1450-4	45	9	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217496	10.1371/journal.pone.0217496	http://dx.doi.org/10.1371/journal.pone.0217496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136636	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300044
J	Wan, YJ; Fu, H				Wan, Yingjia; Fu, Hong			Temporal predictability promotes prosocial behavior in 5-year-old children	PLOS ONE			English	Article							INTERPERSONAL SYNCHRONY; GENDER-DIFFERENCES; COOPERATION; ALTRUISM; MIMICRY; ROLES; WOMEN; MEN	Although interpersonal coordinative activities have been shown to produce prosocial effects in both adults and children, the underlying mechanisms remain unclear. While most approaches focus on the effect of mimicry and synchronous behavioral matching, we hypothesize that temporal predictability might play a central role in producing prosocial effects, as it directs coordination and might therefore strengthen shared intentionality. In a percussion task with pairs of 5-year old children, we manipulated temporal predictability and movement similarity/predictability between the pair's movements. Temporal predictability was manipulated by instructing the pair to play the instruments either to beats that were evenly-spaced, and therefore predictable, or to beats that were random, and therefore unpredictable. Movement similarity/predictability was manipulated by having the pair play rhythmic patterns that were similar, predictable, or independent from each other. Children who played to predictable beats were more willing to solve problems cooperatively with their partners and to help when their partners had an accident. In contrast, there was no positive effect of rhythmic predictability or similarity. These results are the first to show that temporal predictability affects prosociality independent of movement similarity or predictability. We conclude that the predictable time frame commonly seen in coordinative activities may be key to strengthening shared intentionality and producing prosocial effects.	[Wan, Yingjia; Fu, Hong] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Fu, H (corresponding author), Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China.	njfuhong@139.com		Wan, Yingjia/0000-0001-5988-1824	Graduate Student Training Fund of Nanjing Normal University	Graduate Student Training Fund of Nanjing Normal University	This study is supported by the Graduate Student Training Fund of Nanjing Normal University awarded to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney DH, 2015, COGN PROCESS, V16, P325, DOI 10.1007/s10339-015-0648-2; ANSHEL A, 1988, J MUSIC THER, V25, P145, DOI 10.1093/jmt/25.3.145; Ashton-James C, 2007, SOC COGNITION, V25, P518, DOI 10.1521/soco.2007.25.4.518; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; Capraro V, 2018, FRONT PHYS-LAUSANNE, V6, DOI 10.3389/fphy.2018.00107; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Carpenter M, 2013, CHILD DEV, V84, P1511, DOI 10.1111/cdev.12083; Catmur C, 2013, COGNITIVE SCI, V37, P1541, DOI 10.1111/cogs.12071; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cirelli LK, 2017, MUSIC PERCEPT, V34, P319, DOI 10.1525/MP.2017.34.3.319; Cirelli LK, 2016, INFANCY, V21, P807, DOI 10.1111/infa.12140; Cirelli LK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0400; Cirelli LK, 2014, DEVELOPMENTAL SCI, V17, P1003, DOI 10.1111/desc.12193; DeSteno D, 2010, EMOTION, V10, P289, DOI 10.1037/a0017883; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Esteve M, 2015, INT PUBLIC MANAG J, V18, P171, DOI 10.1080/10967494.2015.1012573; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fusaroli R, 2012, PSYCHOL SCI, V23, P931, DOI 10.1177/0956797612436816; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gregg P, 2011, J PUBLIC ECON, V95, P758, DOI 10.1016/j.jpubeco.2011.03.002; GUNNAR MR, 1984, DEV PSYCHOL, V20, P449, DOI 10.1037/0012-1649.20.3.449; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kraft-Todd G, 2015, CURR OPIN BEHAV SCI, V3, P96, DOI 10.1016/j.cobeha.2015.02.006; Maccoby EE, 2002, CURR DIR PSYCHOL SCI, V11, P54, DOI 10.1111/1467-8721.00167; Mares J., 2017, ACTA ED GEN, V7, P7, DOI [10.1515/atd-2017-0009, DOI 10.1515/ATD-2017-0009]; Martin A, 2015, PERSPECT PSYCHOL SCI, V10, P159, DOI 10.1177/1745691615568998; Pearce E, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150221; Rabinowitch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120878; Rand DG, 2017, J EXP SOC PSYCHOL, V73, P164, DOI 10.1016/j.jesp.2017.06.013; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Schellenberg EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141449; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Tarr B, 2016, EVOL HUM BEHAV, V37, P343, DOI 10.1016/j.evolhumbehav.2016.02.004; Tidhar D., 2010, P 11 INT C MUS PERC, P605; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Tuncgenc B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00782; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Wallot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168306; Walton AE, 2018, TOP COGN SCI, V10, P95, DOI 10.1111/tops.12306; Wan YJ, 2019, PSYCHON B REV, V26, P685, DOI 10.3758/s13423-018-1549-z; Weinstein D, 2016, EVOL HUM BEHAV, V37, P152, DOI 10.1016/j.evolhumbehav.2015.10.002; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217470	10.1371/journal.pone.0217470	http://dx.doi.org/10.1371/journal.pone.0217470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136622	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300042
J	Alfonso, VH; Bratcher, A; Ashbaugh, H; Doshi, R; Gadoth, A; Hoff, N; Mukadi, P; Ghanem, A; Cheng, A; Gerber, S; Mwamba, GN; Tamfum, JJM; Wemakoy, EO; Rimoin, AW				Alfonso, Vivian H.; Bratcher, Anna; Ashbaugh, Hayley; Doshi, Reena; Gadoth, Adva; Hoff, Nicole; Mukadi, Patrick; Ghanem, Angie; Cheng, Alvan; Gerber, Sue; Mwamba, Guillaume Ngoie; Tamfum, Jean Jacques Muyembe; Wemakoy, Emile Okitolonda; Rimoin, Anne W.			Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo	PLOS ONE			English	Article							IMMUNIZATION; ERADICATION; PREDICTORS; MORTALITY	Despite increased vaccination rates, the burden, morbidity and mortality associated with vaccine preventable diseases remains high. In the Democratic Republic of the Congo (DRC), potentially unreliable data and geographically varied program provision call for a better understanding of vaccination coverage and its changes over time at the country and province level. To assess changes in the proportion of children who were fully vaccinated over time in the DRC, vaccination histories for children 12-59 months of age were obtained from both the 2007 and 2013-2014 Demographic and Health Surveys (DHS). Changes were assessed, both at the country-and province-levels, to identify potential geographic variations. Vaccination coverage improved 70% between the DHS waves: 26% compared to 44% of 12-59 month-old children met full vaccination criteria in 2007 and 2013-2014, respectively (n(2007) = 3032 and n(2013-14) = 6619). Similarly, there was an overall trend across both DHS waves where as year of birth increased, so did vaccination coverage. There was geographic variation in immunization changes with most central and eastern provinces increasing in coverage and most northern, western and southern provinces having decreased vaccination coverage at the second time point. Using nationally representative data, we identified significant changes over time in vaccination coverage which may help to inform future policy, interventions and research to improve vaccination rates among children in the DRC. This study is the first of its kind for the population of DRC and provides an important initial step towards better understanding trends in vaccination coverage over time.	[Alfonso, Vivian H.; Bratcher, Anna; Ashbaugh, Hayley; Doshi, Reena; Gadoth, Adva; Hoff, Nicole; Ghanem, Angie; Cheng, Alvan; Rimoin, Anne W.] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA; [Alfonso, Vivian H.] McKing Consulting, Atlanta, GA USA; [Mukadi, Patrick; Tamfum, Jean Jacques Muyembe] Natl Inst Biomed Res INRB, Kinshasa, DEM REP CONGO; [Gerber, Sue] Bill & Melinda Gates Fdn, Seattle, WA USA; [Mwamba, Guillaume Ngoie] Expanded Programme Immunizat, Kinshasa, DEM REP CONGO; [Wemakoy, Emile Okitolonda] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO	University of California System; University of California Los Angeles; Institute Nacional de Recherche Biomedical; Bill & Melinda Gates Foundation	Rimoin, AW (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA.	arimoin@ucla.edu	Hoff, Nicole/ABE-9171-2021	Gerber, Sue/0000-0001-7621-162X; Gadoth, Adva/0000-0002-3217-2435; Mukadi, Patrick/0000-0001-9312-9345; Cheng, Alvan/0000-0003-2281-1798; Bratcher, Anna/0000-0001-5972-1249	Bill and Melinda Gates Foundation, Seattle, WA [OPP106668]	Bill and Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation, Seattle, WA [grant number: OPP106668] awarded to AWR. The Bill and Melinda Gates Foundation employs SG. McKing Consulting Corporation employs VHA. The funder provided support in the form of salaries for author SG and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Africa World Health Organization Regional Office, DESP GAINS ACC 1 5 A; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P511; [Anonymous], REP DEM CONG ENQ DEM; Ashbaugh HR, 2018, VACCINE, V36, P587, DOI 10.1016/j.vaccine.2017.11.049; Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432; Bloom DE, VALUE VACCINATION; Bosch-Capblanch X, 2009, TROP MED INT HEALTH, V14, P2, DOI 10.1111/j.1365-3156.2008.02181.x; Causes of Death Collaborators, 2015, LANCET, V385, P11; Dabbagh A, 2000, MMWR-MORBID MORTAL W, DOI [10.1016/B978-0-444-53488-0.00027-4, DOI 10.1016/B978-0-444-53488-0.00027-4]; Devkota Bhimsen, 2010, Confl Health, V4, P20, DOI 10.1186/1752-1505-4-20; Doshi RH, 2015, VACCINE, V33, P6786, DOI 10.1016/j.vaccine.2015.10.020; Ferrinho P, 2013, ANN TROP MED PUBLIC, V6, P401, DOI 10.4103/1755-6783.127773; Gavi the Vaccine Alliance, INV GAV; Gavi the Vaccine Alliance, GAV COUNTR FACTSH DE; Gayer M, 2007, EMERG INFECT DIS, V13, P1625, DOI 10.3201/eid1311.061093; Gumede N, 2013, EMERG INFECT DIS, V19, P1583, DOI 10.3201/eid1910.130028; Hagan JE, 2015, MMWR-MORBID MORTAL W, V64, P527; ICF International, 2012, DEM HLTH SURV SAMPL; Macassa G, 2003, PUBLIC HEALTH, V117, P221, DOI 10.1016/S0033-3506(03)00077-5; Machingaidze S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001405; Medecins Sans Frontieres, DEM REP CONG MSF FOR; Medecins Sans Frontieres, RIGHT SHOT EXT REACH; Mihigo R., 2016, FULFILLING PROMISE E; Ministere de la Sante Publique (MSP), 2014, ENQ DISP CAP OP RAT; Ministere du Plan Ministere de la Sante Macro International, 2014, REP DEM CONG ENQ DEM; Obradovic Zarema, 2014, Mater Sociomed, V26, P382, DOI 10.5455/msm.2014.26.382-384; PATH, 2016, IMM DEM REP CONG LAN; Repulique Democratique Du Congo Ministere de la Sante, 2014, PLAN PLUR ANN COMPL; Senessie Charles, 2007, Confl Health, V1, P14, DOI 10.1186/1752-1505-1-14; Shea Oscar Rutstein PD, 2006, GUIDE DHS STAT DEMOG; Tangermann RH, 2000, B WORLD HEALTH ORGAN, V78, P330; United Nations International Children's Emergency Fund (UNICEF), 2 3 UN CHILDR LIV CO; Vaahtera M, 2000, ANN TROP PAEDIATR, V20, P305, DOI 10.1080/02724936.2000.11748152; Van Herp M, 2003, DISASTERS, V27, P141, DOI 10.1111/1467-7717.00225; Voorman A, 2017, VACCINE, V35, P5693, DOI 10.1016/j.vaccine.2017.08.063; WHO, 2006, GLOB IMM VIS STRAT; WHO, 2018, 2018 ASS REP GLOB VA; World Health Organization, 2014, GLOB IMM DAT; World Health Organization, IMM COUNTR PROF; World Health Organization (WHO), 2017, DEM REP CONG CVDPV2	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217426	10.1371/journal.pone.0217426	http://dx.doi.org/10.1371/journal.pone.0217426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125375	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700040
J	Alemanno, F; Houdayer, E; Emedoli, D; Locatelli, M; Mortini, P; Mandelli, C; Raggi, A; Iannaccone, S				Alemanno, Federica; Houdayer, Elise; Emedoli, Daniele; Locatelli, Matteo; Mortini, Pietro; Mandelli, Carlo; Raggi, Alberto; Iannaccone, Sandro			Efficacy of virtual reality to reduce chronic low back pain: Proof-of-concept of a non-pharmacological approach on pain, quality of life, neuropsychological and functional outcome	PLOS ONE			English	Article							HEALTH SURVEY SF-36; CORTICAL REORGANIZATION; NORMATIVE DATA; PERSONALITY; ADULTS; RELIABILITY; PERCEPTION; COLLEGE	Objectives Chronic pain, such as low-back pain, can be a highly disabling condition degrading people's quality of life ( QoL). Not every patient responds to pharmacological therapies, thus alternative treatments have to be developed. The chronicity of pain can lead to a somatic dysperception, meaning a mismatch between patients' own body perception and its actual physical state. Since clinical evaluation of pain relies on patients' subjective reports, a body image disruption can be associated with an incorrect pain rating inducing incorrect treatment and a possible risk of drug abuse. Our aim was to reduce chronic low-back pain through a multi-modal neurorehabilitative strategy using innovative technologies to help patients regain a correct body image. Methods Twenty patients with chronic low-back pain were included. Before and after treatment, patients underwent: a neurological exam; a neuro-psychological evaluation testing cognitive functions ( memory, attention, executive functions) and personality traits, QoL and mood; pain ratings; sensorimotor functional abilities' testing. Patients underwent a 6 week-neurorehabilitative treatment ( total 12 sessions) using virtual reality ( VRRS system, Khymeia, Italy). Treatment consisted on teaching patients to execute correct movements with the painful body parts to regain a correct body image, based on the augmented multisensory feedback ( auditory, visual) provided by the VRRS. Results Our data showed significant reductions in all pain rating scale scores ( p<0.05); significant improvements of QoL in the domains of physical functioning, physical role functioning, bodily pain, vitality, and social role functioning; improvements in cognitive functions ( p<0.05); improvements in functional scales ( p<0.05) and mood ( p = 0.04). Conclusion This non-pharmacological approach was able to act on the multi-dimensional aspects of pain and improved patients' QoL, pain intensity, mood and patient's functional abilities.	[Alemanno, Federica; Houdayer, Elise; Emedoli, Daniele; Locatelli, Matteo; Iannaccone, Sandro] IRCCS San Raffaele Hosp, Dept Rehabil & Funct Recovery, Milan, Italy; [Alemanno, Federica; Houdayer, Elise; Emedoli, Daniele; Locatelli, Matteo; Iannaccone, Sandro] Univ Vita Salute San Raffaele, Milan, Italy; [Mortini, Pietro; Mandelli, Carlo] IRCCS San Raffaele Hosp, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy; [Mortini, Pietro; Mandelli, Carlo] Univ Vita Salute San Raffaele, Milan, Italy; [Raggi, Alberto] GB Morgagni L Pierantoni Hosp, Neurol Unit, Forli, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Alemanno, F (corresponding author), IRCCS San Raffaele Hosp, Dept Rehabil & Funct Recovery, Milan, Italy.	alemanno.federica@hsr.it	mortini, pietro/AAB-1292-2019; Locatelli, Matteo/S-2424-2019; Iannaccone, sandro/K-4252-2018	Locatelli, Matteo/0000-0002-7266-0679; Emedoli, Daniele/0000-0002-7904-1803; Iannaccone, sandro/0000-0002-8333-3972; MORTINI, Pietro/0000-0003-2320-2281	Italian Ministry of Health (Bando Conto capitale 2015)	Italian Ministry of Health (Bando Conto capitale 2015)	This work was provided by the Italian Ministry of Health (Bando Conto capitale 2015) to SI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate KL, 2005, J PAIN, V6, P92, DOI 10.1016/j.jpain.2004.11.001; Baykara RA, 2013, J BACK MUSCULOSKELET, V26, P367, DOI 10.3233/BMR-130393; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cohen JP, 2018, CLIN THER, V40, P334, DOI 10.1016/j.clinthera.2018.01.003; Corsi P.M., 1972, DISS ABSTR INT, V34; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ekman U, 2018, ACTA NEUROL SCAND, V138, P284, DOI 10.1111/ane.12955; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forderreuther S, 2004, PAIN, V110, P756, DOI 10.1016/j.pain.2004.05.019; Goodglass H., 1983, BOSTON NAMING TEST; Harstall C, 2003, PAIN CLIN UPDATES, V11, P1, DOI DOI 10.1016/S1070-7212(03)00004-6; Hartrick Craig T, 2003, Pain Pract, V3, P310; Harvie DS, 2017, PEERJ, V5, DOI 10.7717/peerj.3023; Heaton R.K., 1993, WISCONSIN CARD SORTI; Ito M, 2011, CURR OPIN NEUROBIOL, V21, P368, DOI 10.1016/j.conb.2011.04.001; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Jones T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167523; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Kato F, 2017, BIOPSYCHOSOC MED, V11, DOI 10.1186/s13030-017-0098-4; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kizony R, 2003, J VISUAL COMP ANIMAT, V14, P261, DOI 10.1002/vis.323; Kommalapati R, 2016, IEEE ENG MED BIO, P5849, DOI 10.1109/EMBC.2016.7592058; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leadley RM, 2014, PAIN PRACT, V14, P547, DOI 10.1111/papr.12125; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Macedo LG, 2012, PHYS THER, V92, P363, DOI 10.2522/ptj.20110290; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Maughan EF, 2010, EUR SPINE J, V19, P1484, DOI 10.1007/s00586-010-1353-6; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Miceli G., 1994, BATTERIA LANALISI DE; Mongini F, 2000, HEADACHE, V40, P466, DOI 10.1046/j.1526-4610.2000.00070.x; Mongini F, 2005, NEUROL SCI, V26, P203, DOI 10.1007/s10072-005-0462-1; Mongini F, 2009, PAIN, V144, P125, DOI 10.1016/j.pain.2009.03.026; Moore RA, 2014, PAIN PRACT, V14, P79, DOI 10.1111/papr.12050; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Pamment J, 2017, EUR J PAIN, V21, P334, DOI 10.1002/ejp.927; Park J, 2012, J AM GERIATR SOC, V60, P555, DOI 10.1111/j.1532-5415.2011.03846.x; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; Rizzo A. S. K., 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI DOI 10.1162/1054746053967094; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roosink M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120251; Sato K, 2010, PAIN MED, V11, P622, DOI 10.1111/j.1526-4637.2010.00819.x; Sellbom M, 2008, J PERS DISORD, V22, P291, DOI 10.1521/pedi.2008.22.3.291; Simons LE, 2014, NEUROSCI BIOBEHAV R, V39, P61, DOI 10.1016/j.neubiorev.2013.12.006; Slesinger D, 2002, ASSESSMENT, V9, P406, DOI 10.1177/1073191102238153; Solouki S, 2016, CEREBELLUM, V15, P299, DOI 10.1007/s12311-015-0695-3; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Weiss AL, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0609-9; Willigenburg NW, 2013, GAIT POSTURE, V38, P625, DOI 10.1016/j.gaitpost.2013.02.010; YANG TT, 1994, NATURE, V368, P592, DOI 10.1038/368592b0; Yelvar GDY, 2017, EUR SPINE J, V26, P538, DOI 10.1007/s00586-016-4892-7	69	26	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216858	10.1371/journal.pone.0216858	http://dx.doi.org/10.1371/journal.pone.0216858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120892	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700033
J	Balandina, AN; Koltsova, EM; Teterina, TA; Yakovenko, AG; Simonenko, EU; Poletaev, AV; Zorina, IV; Shibeko, AM; Vuimo, TA; Yakovenko, SA; Ataullakhanov, FI				Balandina, A. N.; Koltsova, E. M.; Teterina, T. A.; Yakovenko, A. G.; Simonenko, E. U.; Poletaev, A. V.; Zorina, I. V.; Shibeko, A. M.; Vuimo, T. A.; Yakovenko, S. A.; Ataullakhanov, F. I.			An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; OVARIAN HYPERSTIMULATION; THROMBIN GENERATION; BLOOD-COAGULATION; TISSUE FACTOR; DOUBLE-BLIND; IVF; IMPLANTATION; HYPERCOAGULABILITY; PARAMETERS	Background The shift towards hypercoagulation during in vitro fertilization (IVF) can lead to the impairment of embryo implantation and placental blood circulation, which is believed to be a factor in an unsuccessful IVF cycle. Objectives To assess coagulation in women with infertility before the start of an IVF cycle and during treatment to reveal the association between coagulation imbalance and IVF outcome. Patients/Methods We conducted a prospective cohort observational study including 125 participants who underwent fresh IVF cycles. Blood samples were collected at five time points: before IVF, one week after the start of controlled ovarian stimulation (COS), on the day of follicular puncture, on the day of embryo transfer (ET) and one week after ET. Coagulation tests (clotting times: activated partial thromboplastin time (APTT) and prothrombin; fibrinogen and D-dimer concentrations; thrombodynamics) were performed. Results Women with an elevated clot growth velocity (>32.3 mu m/min, detected by thrombodynamics) before IVF demonstrated a higher risk of negative IVF outcomes (adjusted RR = 1.38; 95% CI 1.28-1.49; P<0.001). During the procedure, we observed increases in prothrombin, fibrinogen and D-dimer concentrations, a slight shortening of APTT and a hypercoagulation shift in the thrombodynamics parameters. The hemostasis assay values during COS and after ET had no associations with IVF outcomes. Conclusions Hypercoagulation in the thrombodynamics before the start of IVF treatment was associated with negative IVF outcomes. After the start of COS, all tests demonstrated a hypercoagulation trend, but the hypercoagulation did not influence IVF outcome. This research is potentially beneficial for the application of thrombodynamics assay for monitoring hemostasis in infertile women prior to an IVF procedure with the goal of selecting a group requiring hemostasis correction to increase the chances of pregnancy.	[Balandina, A. N.; Koltsova, E. M.; Poletaev, A. V.; Shibeko, A. M.; Vuimo, T. A.; Ataullakhanov, F. I.] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia; [Balandina, A. N.; Koltsova, E. M.; Shibeko, A. M.; Vuimo, T. A.; Ataullakhanov, F. I.] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Teterina, T. A.; Yakovenko, A. G.; Zorina, I. V.; Yakovenko, S. A.] AltraVita IVF Clin, Moscow, Russia; [Simonenko, E. U.; Yakovenko, S. A.; Ataullakhanov, F. I.] Lomonosov Moscow State Univ, Moscow, Russia; [Ataullakhanov, F. I.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia	Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Balandina, AN (corresponding author), Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia.; Balandina, AN (corresponding author), Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia.	a_balandina@inbox.ru	Poletaev, Alexander/AAW-9954-2020; Poletaev, Alexander/A-8091-2014; Koltsova, Ekaterina/F-8337-2017; Shibeko, Alexey/A-9447-2014	Poletaev, Alexander/0000-0001-5209-2099; Koltsova, Ekaterina/0000-0003-0167-6726; Yakovenko, Sergey/0000-0003-2587-9333; Shibeko, Alexey/0000-0003-1494-3125	Russian Science Foundation [17-74-10193]; Ministry of Science and Higher Education of the Russian Federation [AAAA-A18118012390250-0]	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Science and Higher Education of the Russian Federation	This work was supported by grant from Russian Science Foundation (17-74-10-224) to ANB; Thrombodynamics analyzing (Figures 4 and 5 E, F, G) was supported by grant from Russian Science Foundation (17-74-10193) to AMS (http://rscf.ru/).The study was supported by the Ministry of Science and Higher Education of the Russian Federation (project AAAA-A18118012390250-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Altra Vita IVF clinic provided support in the form of salaries for authors TAT, AGY, IVZ, SAY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhtar MA, 2015, FERTIL STERIL, V103, P33, DOI 10.1016/j.fertnstert.2014.09.005; Al Dieri R, 2004, J THROMB HAEMOST, V2, P1395, DOI 10.1111/j.1538-7836.2004.00798.x; Martinez-Zamora MA, 2016, REPROD BIOMED ONLINE, V33, P168, DOI 10.1016/j.rbmo.2016.05.005; Ataullakhanov FI, 2016, SEMIN THROMB HEMOST, V42, P696, DOI 10.1055/s-0036-1592303; AUNE B, 1991, HUM REPROD, V6, P925, DOI 10.1093/oxfordjournals.humrep.a137461; Balandina AN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199900; Bates SM, 2014, HEMATOL-AM SOC HEMAT, P379, DOI 10.1182/asheducation-2014.1.379; Biron C, 1997, FERTIL STERIL, V67, P104, DOI 10.1016/S0015-0282(97)81864-X; BROWNBILL P, AM J PHYSL REGUL INT, V278, pR677; Brummel-Ziedins KE, 2009, THROMB RES, V124, P505, DOI 10.1016/j.thromres.2009.02.006; Cetin O, 2017, GINEKOL POL, V88, P260, DOI 10.5603/GP.a2017.0049; Chistyakova GN, 2014, GYNECOL ENDOCRINOL, V30, P39, DOI 10.3109/09513590.2014.945787; Clark DA, 2013, REPROD BIOMED ONLINE, V26, P538, DOI 10.1016/j.rbmo.2013.03.007; Curvers J, 2001, BRIT J HAEMATOL, V115, P400, DOI 10.1046/j.1365-2141.2001.03118.x; Dashkevich NM, 2012, BIOPHYS J, V103, P2233, DOI 10.1016/j.bpj.2012.10.011; Di Nisio M, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-58; Di Nisio M, 2011, BLOOD, V118, P2670, DOI 10.1182/blood-2011-03-340216; El Masry S, 2018, ACTA HAEMATOL-BASEL, V139, P1, DOI 10.1159/000484514; Fadeeva OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P734, DOI 10.1134/S0006297910060088; Fawzy M, 2008, ARCH GYNECOL OBSTET, V278, P33, DOI 10.1007/s00404-007-0527-x; Fishel S, 2017, THROMB RES, V151, pS65, DOI 10.1016/S0049-3848(17)30071-3; FOX H, 1967, AM J OBSTET GYNECOL, V98, P245; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gerotziafas GT, 2017, THROMB J, V15, DOI 10.1186/s12959-017-0131-7; Giardina EGV, 2004, J CLIN ENDOCR METAB, V89, P6179, DOI 10.1210/jc.2004-0598; Gracheva MA, 2015, LEUKEMIA LYMPHOMA, V56, P3418, DOI 10.3109/10428194.2015.1041385; Hansen AT, 2014, HUM REPROD, V29, P611, DOI 10.1093/humrep/det458; Harnett MJP, 2002, ANESTH ANALG, V95, P1063, DOI 10.1097/00000539-200210000-00050; Ivanov P, 2012, AM J REPROD IMMUNOL, V68, P189, DOI 10.1111/j.1600-0897.2012.01156.x; Koh SCL, 2005, CLIN APPL THROMB-HEM, V11, P295, DOI 10.1177/107602960501100308; Koltsova EM, 2018, J PERINAT MED, V46, P251, DOI 10.1515/jpm-2016-0333; LABARRERE CA, 1991, J REPROD IMMUNOL, V19, P167, DOI 10.1016/0165-0378(91)90015-I; Lindahl TL, 2015, THROMB RES, V135, P544, DOI 10.1016/j.thromres.2014.12.019; Lipets E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087692; Magnusson A, 2018, HUM REPROD, V33, P58, DOI 10.1093/humrep/dex334; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mayhew TM, 2000, PLACENTA, V21, P684, DOI 10.1053/plac.2000.0551; NELSON DM, 1990, AM J PATHOL, V136, P855; Orbach-Zinger S, 2016, EUR J OBSTET GYN R B, V201, P118, DOI 10.1016/j.ejogrb.2016.04.010; Ovanesov MV, 2005, J THROMB HAEMOST, V3, P321, DOI 10.1111/j.1538-7836.2005.01128.x; Poletaev AV, 2018, THROMB RES, V170, P156, DOI 10.1016/j.thromres.2018.08.024; Rogolino A, 2003, BLOOD COAGUL FIBRIN, V14, P277, DOI 10.1097/00001721-200304000-00009; Rova K, 2012, FERTIL STERIL, V97, P95, DOI 10.1016/j.fertnstert.2011.10.038; Rubinstein M, 1999, FERTIL STERIL, V71, P825, DOI 10.1016/S0015-0282(99)00088-6; Seshadri S, 2012, REPROD BIOMED ONLINE, V25, P572, DOI 10.1016/j.rbmo.2012.08.007; Sinauridze EI, 2018, TALANTA, V180, P282, DOI 10.1016/j.talanta.2017.12.055; Soshitova NP, 2012, BLOOD COAGUL FIBRIN, V23, P498, DOI 10.1097/MBC.0b013e328352e90e; Spona J, 1997, CONTRACEPTION, V56, P67, DOI 10.1016/S0010-7824(97)00094-2; Tekkesin N, 2015, ANATOL J CARDIOL, V15, P932, DOI 10.5152/akd.2014.5723; Westerlund E, 2012, THROMB RES, V130, P649, DOI 10.1016/j.thromres.2011.11.024; Westerlund E, 2011, BLOOD COAGUL FIBRIN, V22, P127, DOI 10.1097/MBC.0b013e32834363ea; Xu GL, 2018, CLIN LAB, V64, P1037, DOI 10.7754/Clin.Lab.2018.180130; Yinon Y, 2006, REPROD BIOMED ONLINE, V12, P354, DOI 10.1016/S1472-6483(10)61009-7; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	54	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216724	10.1371/journal.pone.0216724	http://dx.doi.org/10.1371/journal.pone.0216724			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120933	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700026
J	Gabrielian, A; Engle, E; Harris, M; Wollenberg, K; Juarez-Espinosa, O; Glogowski, A; Long, A; Patti, L; Hurt, DE; Rosenthal, A; Tartakovsky, M				Gabrielian, Andrei; Engle, Eric; Harris, Michael; Wollenberg, Kurt; Juarez-Espinosa, Octavio; Glogowski, Alexander; Long, Alyssa; Patti, Lisa; Hurt, Darrell E.; Rosenthal, Alex; Tartakovsky, Mike			TB DEPOT (Data Exploration Portal): A multi-domain tuberculosis data analysis resource	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS	The NIAID TB Portals Program (TBPP) established a unique and growing database repository of socioeconomic, geographic, clinical, laboratory, radiological, and genomic data from patient cases of drug-resistant tuberculosis (DR-TB). Currently, there are 2,428 total cases from nine country sites (Azerbaijan, Belarus, Moldova, Georgia, Romania, China, India, Kazakhstan, and South Africa), 1,611 (66%) of which are multidrug-or extensively-drug resistant and 1,185 (49%), 863 (36%), and 952 (39%) of which contain X-ray, computed tomography (CT) scan, and genomic data, respectively. We introduce the Data Exploration Portal (TB DEPOT, https://depot.tbportals.niaid.nih.gov) to visualize and analyze these multi-domain data. The TB DEPOT leverages the TBPP integration of clinical, socioeconomic, genomic, and imaging data into standardized formats and enables user-driven, repeatable, and reproducible analyses. It furthers the TBPP goals to provide a web-enabled analytics platform to countries with a high burden of multidrug-resistant TB (MDR-TB) but limited IT resources and inaccessible data, and enables the reusability of data, in conformity with the NIH's Findable, Accessible, Interoperable, and Reusable (FAIR) principles. TB DEPOT provides access to "analysis-ready" data and the ability to generate and test complex clinically-oriented hypotheses instantaneously with minimal statistical background and data processing skills. TB DEPOT is also promising for enhancing medical training and furnishing well annotated, hard to find, MDR-TB patient cases. TB DEPOT, as part of TBPP, further fosters collaborative research efforts to better understand drug-resistant tuberculosis and aid in the development of novel diagnostics and personalized treatment regimens.	[Gabrielian, Andrei; Engle, Eric; Harris, Michael; Wollenberg, Kurt; Juarez-Espinosa, Octavio; Glogowski, Alexander; Long, Alyssa; Patti, Lisa; Hurt, Darrell E.; Rosenthal, Alex; Tartakovsky, Mike] NIAID, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gabrielian, A (corresponding author), NIAID, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Andrei.Gabrielian@nih.gov		Harris, Michael/0000-0001-8789-0912; Meyer, Alyssa (Long)/0000-0001-7700-549X	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services under BCBB Support Services [HHSN316201300006W/HHSN27200002]; U.S. Civilian Research and Development Foundation ("CDRF") [BOB1-31120-MK-13]; International Science and Technology Center	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services under BCBB Support Services; U.S. Civilian Research and Development Foundation ("CDRF"); International Science and Technology Center	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services under BCBB Support Services Contract HHSN316201300006W/HHSN27200002 to MSC, Inc; U.S. Civilian Research and Development Foundation ("CDRF") Agreement No. BOB1-31120-MK-13; and the International Science and Technology Center. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbinot F, 2016, LUNG, V194, P871, DOI 10.1007/s00408-016-9940-x; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Comas I, 2017, ADV EXP MED BIOL, V1019, P79, DOI 10.1007/978-3-319-64371-7_4; Hu Y, 2016, TUBERCULOSIS, V97, P18, DOI 10.1016/j.tube.2015.11.007; Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099; Jo YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164923; Juarez-Espinosa OH, 2016, P 2016 INT C HLTH IN, P165; Kim J, WHO TUBERCULOSIS CON; Kovalev V, 2015, INT J COMPUT ASSI S1, V10, P1; Lew J, DATABASE RESOURCES T; MacIntyre CR, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0223-7; Malherbe ST, 2018, SEMIN IMMUNOL; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; McBryde ES, 2017, INT J INFECT DIS, V56, P14, DOI 10.1016/j.ijid.2017.01.031; Miotto P, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01354-2017; National Institutes of Health Office of Data Science Strategy, 2018, NIH STRATEGIC PLAN D; Nebenzahl-Guimaraes H, 2014, J ANTIMICROB CHEMOTH, V69, P331, DOI 10.1093/jac/dkt358; NIH/NIAID, 2018, NIAID STRAT PLAN TUB; Obama B, WHITE HOUSE OFFICE P; Purcell S, PLINK PACKAGE PLINK; Rosenthal M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006400; Satta G, 2018, CLIN MICROBIOL INFEC, V24, P604, DOI 10.1016/j.cmi.2017.10.030; Sergeev R., IEEE T COMPUTATIONAL; Stein Catherine M, 2017, Curr Genet Med Rep, V5, P149, DOI 10.1007/s40142-017-0130-9; USAID, NAT ACT PLAN COMB MU; Velayati AA, 2013, INT J CLIN EXP MED, V6, P307; Wang X, IEEE CVPR 2017; Wang YXJ, 2018, QUANT IMAG MED SURG, V8, P161, DOI 10.21037/qims.2018.03.06; Washko GR, 2012, RESPIROLOGY, V17, P432, DOI 10.1111/j.1440-1843.2011.02117.x; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Witney AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0598-2; Wollenberg KR, 2017, J CLIN MICROBIOL, V55, P457, DOI 10.1128/JCM.02116-16; World Health Organization, ANT RES; World Health Organization, DEF REP FRAM TUB 201	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217410	10.1371/journal.pone.0217410	http://dx.doi.org/10.1371/journal.pone.0217410			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120982	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700100
J	Gonzalez, CIA; Galletta, M; Melis, P; Contu, P; Watson, J; Finco, G; Herrera, MFJ				Gonzalez, Cesar Ivan Aviles; Galletta, Maura; Melis, Paola; Contu, Paolo; Watson, Jean; Finco, Gabriele; Jimenez Herrera, Maria Francisca			Cultural adaptation and psychometric validation of the Caring Efficacy scale in a sample of Italian nurses	PLOS ONE			English	Article							WATSONS THEORY; COHERENCE; SENSE; CARE; HEALTH; RELIABILITY; FIT	Caring is the essence of nursing practice. Caring Efficacy scale was developed with the purpose of measuring nurses' perceived self-efficacy in orienting and maintaining caring relationships with patients. Since any instruments measuring caring self-efficacy have not been developed in Italy, the study aimed at culturally adapting and validating Caring Efficacy scale in a sample of Italian nurses. A total of 300 registered nurses were asked to fill a self-reported questionnaire; translation-back-translation procedure was carried out to maintain semantic, idiomatic and conceptual equivalence of the original scale. Then, factor analysis was performed in order to test appropriateness of the factor structure. Convergent and discriminant validity was also tested. A two-factor structure with 17 items was found. Results show that Cronbach's Alpha value was 0.84 for Confidence to Care, and 0.75 for Doubts and Concerns. Correlation analysis for convergent and discriminant validity showed that Confidence to Care was positively correlated with sense of coherence and no significant correlation with Doubts and Concerns was found. Caring efficacy scale can be used by nurse managers as a way of assessing nurses' self-efficacy and their caring orientation, thus improving quality of patient care.	[Gonzalez, Cesar Ivan Aviles; Finco, Gabriele] Univ Cagliari, Anesthesia & Intens Care Dept, Monserrato, CA, Italy; [Galletta, Maura; Contu, Paolo] Univ Cagliari, Dept Med Sci & Publ Hlth, Monserrato, CA, Italy; [Melis, Paola] Univ Cagliari, Pain Therapy Serv, Cagliari, Italy; [Watson, Jean] Watson Caring Sci Inst, Boulder, CO USA; [Jimenez Herrera, Maria Francisca] Univ Rovira & Virgili, Dept Infermeria, Tarragona, Spain	University of Cagliari; University of Cagliari; University of Cagliari; Universitat Rovira i Virgili	Galletta, M (corresponding author), Univ Cagliari, Dept Med Sci & Publ Hlth, Monserrato, CA, Italy.	maura.galletta@gmail.com	Finco, Gabriele/AFL-9587-2022; Finco, Gabriele/AAH-1697-2022; Aviles, Cesar/AAT-8334-2021; Melis, Paola/GPK-0650-2022	Finco, Gabriele/0000-0002-3059-9865; Finco, Gabriele/0000-0002-3059-9865; Melis, Paola/0000-0001-5665-7392; Galletta, Maura/0000-0002-0124-4248; Aviles gonzalez, cesar ivan/0000-0002-1566-1974; Contu, Paolo/0000-0002-5511-0923				Ambrosi E, 2018, EUR J PERS CENT HEAL, V6, P405; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1987, UNRAVELING MYSTERY H; Antonovsky A., 1995, UNRAVELLING MYSTERY; Bachem R, 2018, EUR J PSYCHOL ASSESS, V34, P206, DOI 10.1027/1015-5759/a000323; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1986, SOCIAL FDN THOUGHT A; Basinska MA, 2011, INT J OCCUP MED ENV, V24, P256, DOI 10.2478/S13382-011-0031-1; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brislin R.W., 1980, HDB CROSS CULTURAL P, P389; Burtson PL, 2010, J ADV NURS, V66, P1819, DOI 10.1111/j.1365-2648.2010.05336.x; Byrne B. M., 2001, STRUCTURAL EQUATION; Canzan F, 2014, SCAND J CARING SCI, V28, P732, DOI 10.1111/scs.12105; Canzan F, 2013, ASSIST INFERM RIC, V32, P205, DOI 10.1702/1381.15358; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Coates C J, 1997, Adv Pract Nurs Q, V3, P53; Coe R. M., 1991, BEHAV HLTH AGING, V2, P93; Debska G, 2017, CENT EUR J PUBL HEAL, V25, P35, DOI 10.21101/cejph.a4305; Poblete-Troncoso MD, 2012, AQUICHAN, V12, P8, DOI 10.5294/aqui.2012.12.1.1; Drenkard Karen Neil, 2008, Crit Care Nurs Clin North Am, V20, P403, DOI 10.1016/j.ccell.2008.08.008; Durgun Ozan Yeter, 2017, J Caring Sci, V6, P95, DOI 10.15171/jcs.2017.010; Gallasch CH, 2007, J OCCUP REHABIL, V17, P701, DOI 10.1007/s10926-007-9103-2; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Harri M, 1998, NURS EDUC TODAY, V18, P202, DOI 10.1016/S0260-6917(98)80080-4; Hatcher L., 1994, STEP BY STEP APPROAC; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hogan BK, 2013, ISSUES MENT HEALTH N, V34, P375, DOI 10.3109/01612840.2013.768734; Kline R. B., 2005, PRINCIPLES PRACTICE; Lamke D, 2014, J HOLIST NURS, V32, P278, DOI 10.1177/0898010114531906; Larrebee JH, 2004, RES NURS HEAL, V27, P71; Lindstrom B, 2005, J EPIDEMIOL COMMUN H, V59, P440, DOI 10.1136/jech.2005.034777; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Pajnkihar M, 2017, NURS SCI QUART, V30, P243, DOI 10.1177/0894318417708409; Patiraki E, 2014, CLIN NURS RES, V23, P132, DOI 10.1177/1054773812468447; Reid C, 2015, INT J NURS PRACT, V21, P904, DOI 10.1111/ijn.12327; Sadler Judith, 2003, Nurs Educ Perspect, V24, P295; Sardu Claudia, 2012, Clin Pract Epidemiol Ment Health, V8, P1, DOI 10.2174/1745017901208010001; Scott JG, 1999, J NURS ADMIN, V29, P9, DOI 10.1097/00005110-199901000-00003; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tektas P, 2017, ARCH PSYCHIAT NURS, V31, P440, DOI 10.1016/j.apnu.2017.07.002; Tomietto Marco, 2014, G Ital Med Lav Ergon, V36, P38; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Watson, 2012, HUMAN CARING SCI THE; Watson J., 2018, UNITARY CARING SCI P; Watson J., 2008, NURSING PHILOS SCI C; Watson J., 1979, NURSING PHILOS SCI C; Watson Jean, 2007, Texto contexto - enferm., V16, P129	49	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217106	10.1371/journal.pone.0217106	http://dx.doi.org/10.1371/journal.pone.0217106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120938	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700056
J	Zhong, S; Li, WH; Bai, Y; Wu, B; Wang, XH; Jiang, SS; Zhao, YJ; Ren, JX; Li, H; Jin, RH				Zhong, Sheng; Li, Weihang; Bai, Yang; Wu, Bo; Wang, Xinhui; Jiang, Shanshan; Zhao, Yingjing; Ren, Jiaxin; Li, Hui; Jin, Rihua			Computational study on new natural compound agonists of stimulator of interferon genes (STING)	PLOS ONE			English	Article							ACTIVATION; INTERFACE; CANCER; LIGAND; CGAS	Objective This study aimed to screen lead compounds and medication candidates from drug library ( ZINC database) which has potential agonist effect targeting STING protein. Methods and materials A series of computer-aided virtual screening techniques were utilized to identify potential agonists of STING. Structure-based screening using Libdock was carried out followed by ADME ( absorption, distribution, metabolism, excretion) and toxicity prediction. Molecular docking was performed to demonstrate the binding affinity and mechanism between ligands and STING dimers. Molecular dynamic simulation was utilized to evaluate the stability of ligand-receptor complex. Finally, animal experiment was conducted to validate the effectiveness of selected compounds. Results Three novel natural compounds 1,2,3 ( ZINC000015149223, ZINC000011616633 and ZINC000001577210, respectively) from the ZINC15 database were found binding to STING with more favorable interaction energy. Also, they were predicted with less ames mutagenicity, rodent carcinogenicity, non-developmental toxic potential and tolerant with cytochrome P450 2D6 ( CYP2D6). The ligand chemical structure analysis showed the three compounds were inborn axisymmetric, such chemical structures account for combining and activating process of STING protein dimers. The dynamic simulation analysis demonstrated that ZINC000015149223-, ZINC000011616633-and ZINC000001577210-STING dimer complex had more favorable potential energy compared with amidobenzimidazole ( ABZI) and they can exist in natural environments stably. Animal experiments also demonstrated that these three compounds could suppress tumor growth. Conclusion This study demonstrates that ZINC000015149223, ZINC000011616633 and ZINC000001577210 are potential agonists targeting STING protein. These compounds are safe drug candidates and have a great significance in STING agonists development.	[Zhong, Sheng; Bai, Yang; Jin, Rihua] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Jilin, Peoples R China; [Zhong, Sheng] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Li, Weihang; Zhao, Yingjing; Ren, Jiaxin; Li, Hui] Jilin Univ, Clin Coll, Changchun, Jilin, Peoples R China; [Wu, Bo] Jilin Univ, Hosp 1, Dept Orthoped, Changchun, Jilin, Peoples R China; [Wang, Xinhui] Jilin Univ, Hosp 1, Dept Oncol, Changchun, Jilin, Peoples R China; [Jiang, Shanshan] Jilin Univ, Coll Pharm, Changchun, Jilin, Peoples R China	Jilin University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Jilin University; Jilin University; Jilin University; Jilin University	Jin, RH (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Jilin, Peoples R China.	jinrihua_jdyy@126.com	Li, Weihang/AIF-1879-2022	Li, Weihang/0000-0001-9197-4262; Jin, Rihua/0000-0001-8211-958X	Science and Technology Research Projects of the 12th Five-Year Plan of Jilin Provincial Department of Education [450 [2016]]	Science and Technology Research Projects of the 12th Five-Year Plan of Jilin Provincial Department of Education	This study was supported by Science and Technology Research Projects of the 12th Five-Year Plan of Jilin Provincial Department of Education. No. 450 [2016]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benmerzoug S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07425-1; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Chen Ning, ROLE CGAS STING PATH, DOI [10.13309/j.cnki.pmi.2018.01.010, DOI 10.13309/J.CNKI.PMI.2018.01.010]; Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ding LY, 2018, CELL REP, V25, P2972, DOI 10.1016/j.celrep.2018.11.054; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hu Q., 2019, DEGREE STING ACTIVAT, DOI [10.1136/gutjnl-2019-318597, DOI 10.1136/GUTJNL-2019-318597]; Kalani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074761; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19049; Lu qianying, 2016, INT J BIOMED ENG, DOI [10.3760/cma.J.Issn.1673-4181.2016.6.011, DOI 10.3760/CMA.J.ISSN.1673-4181.2016.6.011]; Newman DJ, 2016, PHARMACOL THERAPEUT, V162, P1, DOI 10.1016/j.pharmthera.2015.12.002; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Sarvagalla S, 2015, J COMPUT AID MOL DES, V29, P89, DOI 10.1007/s10822-014-9807-2; Sivick KE, 2018, CELL REP, V25, P3074, DOI 10.1016/j.celrep.2018.11.047; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wilson DR, 2018, NANOMED-NANOTECHNOL, V14, P237, DOI 10.1016/j.nano.2017.10.013; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu xiaoxia, 2018, BIOCHEMISTRY-US, V4, P84; XU Zhiqiang, INTERACTION STIMULAT, DOI [10.3969/j.issn1001-5256.2018.08.042, DOI 10.3969/J.ISSN1001-5256.2018.08.042]; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	28	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216678	10.1371/journal.pone.0216678	http://dx.doi.org/10.1371/journal.pone.0216678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120925	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700023
J	Kayhan, E; Heil, L; Kwisthout, J; van Rooij, I; Hunnius, S; Bekkering, H				Kayhan, Ezgi; Heil, Lieke; Kwisthout, Johan; van Rooij, Iris; Hunnius, Sabine; Bekkering, Harold			Young children integrate current observations, priors and agent information to predict others' actions	PLOS ONE			English	Article							PUPILLOMETRY; ERRORS; INFER	From early on in life, children are able to use information from their environment to form predictions about events. For instance, they can use statistical information about a population to predict the sample drawn from that population and infer an agent's preferences from systematic violations of random sampling. We investigated whether and how young children infer an agent's sampling biases. Moreover, we examined whether pupil data of toddlers follow the predictions of a computational model based on the causal Bayesian network formalization of predictive processing. We formalized three hypotheses about how different explanatory variables (i.e., prior probabilities, current observations, and agent characteristics) are used to predict others' actions. We measured pupillary responses as a behavioral marker of 'prediction errors' (i.e., the perceived mismatch between what one's model of an agent predicts and what the agent actually does). Pupillary responses of 24-month-olds, but not 18-month-olds, showed that young children integrated information about current observations, priors and agents to make predictions about agents and their actions. These findings shed light on the mechanisms behind toddlers' inferences about agent-caused events. To our knowledge, this is the first study in which young children's pupillary responses are used as markers of prediction errors, which were qualitatively compared to the predictions by a computational model based on the causal Bayesian network formalization of predictive processing.	[Kayhan, Ezgi] Univ Potsdam, Potsdam, Germany; [Kayhan, Ezgi] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Kayhan, Ezgi; Heil, Lieke; Kwisthout, Johan; van Rooij, Iris; Hunnius, Sabine; Bekkering, Harold] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of Potsdam; Max Planck Society; Radboud University Nijmegen	Kayhan, E (corresponding author), Univ Potsdam, Potsdam, Germany.; Kayhan, E (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.; Kayhan, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	kayhan@uni-potsdam.de	van Rooij, Iris/E-5236-2012	Kayhan, Ezgi/0000-0002-1725-220X; van Rooij, Iris/0000-0001-6520-4635	European Union Seventh Framework Program Initial Training Network ACT [289404]; Netherlands Organisation for Scientific Research-TOP grant [407-11-040]	European Union Seventh Framework Program Initial Training Network ACT; Netherlands Organisation for Scientific Research-TOP grant	The European Union Seventh Framework Program Initial Training Network ACT (289404) and Netherlands Organisation for Scientific Research-TOP grant (407-11-040) to H.B. and I.v.R. supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addyman C, 2014, DEV PSYCHOL, V50, P2030, DOI 10.1037/a0037108; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gopnik A, 2012, PSYCHOL BULL, V138, P1085, DOI 10.1037/a0028044; Gopnik A, 2012, SCIENCE, V337, P1623, DOI 10.1126/science.1223416; Gredeback G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026487; Henrichs I, 2014, DEV PSYCHOL, V50, P100, DOI 10.1037/a0032664; Hepach R, 2016, J COGN DEV, V17, P359, DOI 10.1080/15248372.2015.1135801; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Kushnir T, 2010, PSYCHOL SCI, V21, P1134, DOI 10.1177/0956797610376652; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Liu S, 2017, SCIENCE, V358, P1038, DOI 10.1126/science.aag2132; Ma LL, 2011, COGNITION, V120, P403, DOI 10.1016/j.cognition.2011.02.003; Meltzoff A. N., 2013, UNDERSTANDING OTHER, P19; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Phillips HN, 2015, J NEUROSCI, V35, P9255, DOI 10.1523/JNEUROSCI.5095-14.2015; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Teglas E, 2007, P NATL ACAD SCI USA, V104, P19156, DOI 10.1073/pnas.0700271104; van Pelt S, 2016, SOC COGN AFFECT NEUR, V11, P973, DOI 10.1093/scan/nsw017; Wacongne C, 2011, P NATL ACAD SCI USA, V108, P20754, DOI 10.1073/pnas.1117807108; Wellman HM, 2016, INFANCY, V21, P668, DOI 10.1111/infa.12131; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Xu F, 2009, COGNITION, V112, P97, DOI 10.1016/j.cognition.2009.04.006	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0200976	10.1371/journal.pone.0200976	http://dx.doi.org/10.1371/journal.pone.0200976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116742	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400001
J	Landry, AP; Zador, Z; Haq, R; Cusimano, MD				Landry, Alexander P.; Zador, Zsolt; Haq, Rashida; Cusimano, Michael D.			Reclassification of breast cancer: Towards improved diagnosis and outcome	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; R PACKAGE; PATTERNS; SURVIVAL; CLASSIFICATION; SUBTYPE; TRENDS; WHITE	Background The subtyping of breast cancer based on features of tumour biology such as hormonal receptor and HER2 status has led to increasingly patient-specific treatment and thus improved outcomes. However, such subgroups may not be sufficiently informed to best predict outcome and/or treatment response. The incorporation of multi-modal data may identify unexpected and actionable subgroups to enhance disease understanding and improve outcomes. Methods This retrospective cross-sectional study used the cancer registry Surveillance, Epidemiology and End Results (SEER), which represents 28% of the U.S. population. We included adult female patients diagnosed with breast cancer in 2010. Latent class analysis (LCA), a data-driven technique, was used to identify clinically homogeneous subgroups ("endophenotypes") of breast cancer from receptor status (hormonal receptor and HER2), clinical, and demographic data and each subgroup was explored using Bayesian networks. Results Included were 44,346 patients, 1257 (3%) of whom had distant organ metastases at diagnosis. Four endophenotypes were identified with LCA: 1) "Favourable biology" had entirely local disease with favourable biology, 2) "HGHR-" had the highest incidence of HR-receptor status and highest grade but few metastases and relatively good outcomes, 3) "HR+ bone" had isolated bone metastases and uniform receptor status (HR+/HER2-), and 4) "Distant organ spread" had high metastatic burden and poor survival. Bayesian networks revealed clinically intuitive interactions between patient and disease features. Conclusions We have identified four distinct subgroups of breast cancer using LCA, including one unexpected group with good outcomes despite having the highest average histologic grade and rate of HR-tumours. Deeper understanding of subgroup characteristics can allow us to 1) identify actionable group properties relating to disease biology and patient features and 2) develop group-specific diagnostics and treatments.	[Landry, Alexander P.; Zador, Zsolt; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada; [Landry, Alexander P.; Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Haq, Rashida] St Michaels Hosp, Div Hematol Oncol, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Landry, AP (corresponding author), St Michaels Hosp, Dept Surg, Toronto, ON, Canada.; Landry, AP (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.	alex.landry@mail.utoronto.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019	Zador, Zsolt/0000-0001-9767-3372	National Institute for Health Research through an Academic Clinical Lectureship [CL-2014-06-004]	National Institute for Health Research through an Academic Clinical Lectureship	ZZ acknowledges additional support from the National Institute for Health Research through an Academic Clinical Lectureship, award number: CL-2014-06-004. No funding bodies had any role in study design, in the collection, analysis, or interpretation of data, nor in the writing of the manuscript.	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Cai ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120805; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Dai XF, 2015, AM J CANCER RES, V5, P2929; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Ezzedine K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12186; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gentil-Brevet J, 2008, BRIT J CANCER, V98, P217, DOI 10.1038/sj.bjc.6604163; Gobbini E, 2018, EUR J CANCER, V96, P17, DOI 10.1016/j.ejca.2018.03.015; Gordon NH, 2003, CANCER METAST REV, V22, P55, DOI 10.1023/A:1022212018158; Hoefnagel LDC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2645; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Lanza ST, 2013, PREV SCI, V14, P157, DOI 10.1007/s11121-011-0201-1; Lim YJ, 2017, BREAST CANCER RES TR, V163, P555, DOI 10.1007/s10549-017-4206-8; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Molnar IA, 2017, VIRCHOWS ARCH, V470, P275, DOI 10.1007/s00428-017-2065-7; Nieder C, 2011, CANCER-AM CANCER SOC, V117, P2505, DOI 10.1002/cncr.25707; NIH, 2012, SURV EP END RES, V2, P2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; R Development Core Team, 2016, R FDN STAT COMP VIEN, V95, P389, DOI [10.1038/sj.hdy.6800737, DOI 10.1038/SJ.HDY.6800737]; Ren ZY, 2016, PATHOL RES PRACT, V212, P24, DOI 10.1016/j.prp.2015.11.003; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schreiber JB, 2014, CURATOR, V57, P45, DOI 10.1111/cura.12050; Scicluna BP, 2017, LANCET RESP MED, V5, P816, DOI 10.1016/S2213-2600(17)30294-1; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Shao MM, 2011, MED MOL MORPHOL, V44, P15, DOI 10.1007/s00795-010-0495-2; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Yue G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45411; Zador Z, 2018, OPER NEUROSURG, V14, P603, DOI 10.1093/ons/opx163; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217036	10.1371/journal.pone.0217036	http://dx.doi.org/10.1371/journal.pone.0217036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116801	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400041
J	Zanella, A; Silveira, RC; Roesch, LFW; Corso, AL; Dobbler, PT; Mai, V; Procianoy, RS				Zanella, Adriana; Silveira, Rita C.; Roesch, Luiz F. W.; Corso, Andrea L.; Dobbler, Priscila T.; Mai, Volker; Procianoy, Renato S.			Influence of own mother's milk and different proportions of formula on intestinal microbiota of very preterm newborns	PLOS ONE			English	Article							DELIVERY MODE; EARLY-LIFE; GUT; INFANTS; HEALTH; IMPACT; COLONIZATION; ANTIBIOTICS; DIVERSITY	Objective To determine the differences in preterm infants' stool microbiota considering the use of exclusive own mother's milk and formula in different proportions in the first 28 days of life. Methods The study included newborns with GA < 32 weeks divided in 5 group according the feeding regimen: 7 exclusive own mother's milk, 8 exclusive preterm formula, 16 mixed feeding with >70% own mother's milk, 16 mixed feeding with >70% preterm formula, and 15 mixed 50% own mother's milk and preterm formula. Exclusion criteria: congenital infections, congenital malformations and newborns of drug addicted mothers. Stools were collected weekly during the first 28 days. Microbial DNA extraction, 16S rRNA amplification and sequencing were performed. Results All groups were similar in perinatal and neonatal data. There were significant differences in microbial community among treatments. Approximately 37% of the variation in distance between microbial communities was explained by use of exclusive own mother's milk only compared to other diets. The diet composed by exclusive own mother's milk allowed for greater microbial richness (average of 85 OTUs) while diets based on preferably formula, exclusive formula, preferably maternal milk, and mixed of formula and maternal milk presented an average of 9, 29, 23, and 25 OTUs respectively. The mean proportion of the genus Escherichia and Clostridium was always greater in those containing formula than in the those with maternal milk only. Conclusions Fecal microbiota in the neonatal period of preterm infants fed with exclusive own mother's milk presented increased richness and differences in microbial composition from those fed with different proportions of formula.	[Zanella, Adriana; Silveira, Rita C.; Corso, Andrea L.; Procianoy, Renato S.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Unidade Neonatol, Porto Alegre, RS, Brazil; [Roesch, Luiz F. W.; Dobbler, Priscila T.] Univ Fed Pampa, Ctr Interdisciplinar Pesquisas Biotecnol CIP Biot, Campus Sao Gabriel, Sao Gabriel, RS, Brazil; [Mai, Volker] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Mai, Volker] Univ Florida, Coll Med, Emerging Pathogens Inst, Gainesville, FL USA	Universidade Federal do Rio Grande do Sul; Universidade Federal do Pampa; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Procianoy, RS (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Unidade Neonatol, Porto Alegre, RS, Brazil.	rprocianoy@gmail.com	Dobbler, Priscila Caroline Thiago/E-4387-2018; Roesch, Luiz/GRS-4638-2022; Roesch, Luiz F W/D-2838-2009; Procianoy, Renato/I-5133-2014	Dobbler, Priscila Caroline Thiago/0000-0002-7681-5463; Roesch, Luiz F W/0000-0003-1450-8828; SILVEIRA, RITA DE CASSIA/0000-0002-2982-2652; Procianoy, Renato/0000-0001-8297-4164; Corso, Andrea Lucia/0000-0003-1118-1145	Bill and Melinda Gates Foundation [OPP1107597]; CNPQ; DECIT Ministerio da Saude Brasil	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DECIT Ministerio da Saude Brasil	Funding was provided by the Bill and Melinda Gates Foundation (OPP1107597) and CNPQ and DECIT Ministerio da Saude Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from Bill and Melinda Gates Foundation, CNPQ and DECIT/Ministerio da Saude do Brasil.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Boix-Amoros A, 2016, FRONT MICROBIOL, V7, DOI [10.5389/fmicb.7016.00492, 10.3389/fmicb.2016.00492]; Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1; Cabreiro F, 2013, EMBO MOL MED, V5, P1300, DOI 10.1002/emmm.201100972; Cabrera-Rubio R, 2016, J DEV ORIG HLTH DIS, V7, P54, DOI 10.1017/S2040174415001397; Cacho NT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01470; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dobbler PT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02243; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039; Gregory KE, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0214-x; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Hartz LE, 2015, ADV NEONAT CARE, V15, P324, DOI 10.1097/ANC.0000000000000220; Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lees EA, 2016, EUR J CLIN MICROBIOL, V35, P1047, DOI 10.1007/s10096-016-2639-3; Lemas DJ, 2016, SEMIN FETAL NEONAT M, V21, P406, DOI 10.1016/j.siny.2016.04.013; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu B, 2013, BREASTFEED MED, V8, P354, DOI 10.1089/bfm.2013.0016; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Murphy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40597; Musekiwa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164898; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pammi M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0248-8; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Stearns JC, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0421-5; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Team RC., 2022, LANG ENV STAT COMP; Wallace JG, 2016, J DEV ORIG HLTH DIS, V7, P15, DOI 10.1017/S2040174415001518; Roesch LFW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169916; Yasmin F, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00200; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847; 2015, CELL HOST MICROBE, V17, P690, DOI DOI 10.1016/J.CHOM.2015.04.004	45	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217296	10.1371/journal.pone.0217296	http://dx.doi.org/10.1371/journal.pone.0217296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107919	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200044
J	Gerhardt, IFS; do Amaral, AT; Pena, GF; Guimaraes, LJM; de Lima, VJ; Vivas, M; Santos, PHAD; Ferreira, FRA; Freitas, MSM; Kamphorst, SH				Gerhardt, Ismael Fernando Schegoscheski; do Amaral Junior, Antonio Teixeira; Pena, Guilherme Ferreira; Moreira Guimaraes, Lauro Jose; de Lima, Valter Jario; Vivas, Marcelo; Araujo Diniz Santos, Pedro Henrique; Alves Ferreira, Fernando Rafael; Mendonca Freitas, Marta Simone; Kamphorst, Samuel Henrique			Genetic effects on the efficiency and responsiveness to phosphorus use in popcorn as estimated by diallel analysis	PLOS ONE			English	Article							ARCHITECTURE; STRATEGIES; RESISTANCE; TEMPERATE; SYSTEM; YIELD; FOOD	Agricultural expansion and the need for sustainable cultivation are challenges faced by researchers involved in the generation of new cultivars that can adapt to abiotic stress. Knowledge of the genetic effects of characteristics related to efficiency and responsiveness to phosphorus use must be considered when implementing methods to obtain better genotypes. The aim of this study was to characterize and select popcorn hybrids based on their efficiency and responsiveness to phosphorus use, and estimate their combining abilities and genetic effects via diallel analysis to implement improvement programs for sustainable agriculture. Eight contrasting inbred lines were used to obtain simple hybrids for diallel analysis. Twenty-eight diallelic hybrids plus the popcorn parental lines were evaluated at two different sites under two contrasting environments for soil phosphorus availability (6 x 6 lattice design). Grain yield, popping expansion, and volume of expanded popcorn per hectare were measured. A combined analysis of variance and a test of means were performed. The classification and utilization of the phosphorus use efficiency index, according to the grain yield performance of the hybrids under contrasting environments, was considered. Through model 2 of the Griffing's diallel analysis method, the general and specific combining abilities were estimated, along with their environmental interactions. The best strategy to obtain genotypes that are efficient and responsive to phosphorus involves exploring popcorn hybrids using genitors that result in the accumulation of additive genes that promote popping expansion. Hybrids P7 x L80, P7 x L59, P7 x L76, and P6 x L80 presented promising results and may be evaluated as cultivation options in phosphorus-deficient soils.	[Gerhardt, Ismael Fernando Schegoscheski] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [do Amaral Junior, Antonio Teixeira; de Lima, Valter Jario; Vivas, Marcelo; Araujo Diniz Santos, Pedro Henrique; Alves Ferreira, Fernando Rafael; Mendonca Freitas, Marta Simone; Kamphorst, Samuel Henrique] Univ Estadual Norte Fluminense, Lab Melhoramento Genet Vegetal, Campos Dos Goytacazes, RJ, Brazil; [Pena, Guilherme Ferreira] Univ Estadual Mato Grosso, Campus Alta Floresta, Alta Floresta, MT, Brazil; [Moreira Guimaraes, Lauro Jose] Empresa Brasileira Pesquisa Agr, Embrapa Milho & Sorgo, Sete Lagoas, MG, Brazil	University of Guelph; Universidade Estadual do Norte Fluminense; Universidade do Estado de Mato Grosso; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Gerhardt, IFS (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON, Canada.	ismael-fernando@hotmail.com	Santos, Pedro/W-2641-2019; Kamphorst, Samuel Henrique/AAJ-3687-2020; Ferreira, Fernando Rafael Alves/S-8595-2019; do Amaral, Antônio Teixeira/AAD-6291-2021; Freitas, Marta Simone Mendonça/AAI-4352-2020; de Lima, Valter Jário/AAM-2489-2020; Vivas, Marcelo/H-5653-2013	Kamphorst, Samuel Henrique/0000-0001-9727-3539; Ferreira, Fernando Rafael Alves/0000-0002-8180-5649; do Amaral, Antônio Teixeira/0000-0003-4831-7878; de Lima, Valter Jário/0000-0002-2982-085X; Vivas, Marcelo/0000-0002-7048-4149; Santos, PedroHenrique Araujo Diniz/0000-0002-7781-215X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Graduate Program in Genetics and Plant Breeding of State University of Northern Rio de Janeiro (UENF)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Graduate Program in Genetics and Plant Breeding of State University of Northern Rio de Janeiro (UENF)	We are grateful to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the scholarships granted and financial support to the Graduate Program in Genetics and Plant Breeding of State University of Northern Rio de Janeiro (UENF) given to ATdAJ.	Cordell D, 2012, CURR OPIN BIOTECH, V23, P839, DOI 10.1016/j.copbio.2012.03.010; CRUZ CD, 2014, MODELOS BIOMETRICOS, V3rd; Cruz CD, 2012, MODELOS BIOMETRICOS; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; da Silva VQR, 2010, GENET MOL RES, V9, P1742, DOI 10.4238/vol8-3gmr900; Falconer D.S., 1987, INTRO QUANTITATIVE G; Fernandes Cristiano, 2002, Sci. agric. (Piracicaba, Braz.), V59, P781, DOI 10.1590/S0103-90162002000400024; Gerhardt IFS, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16039763; Gong X, 2016, THEOR APPL GENET, V129, P1657, DOI 10.1007/s00122-016-2729-8; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Gu RL, 2016, J GENET GENOMICS, V43, P663, DOI 10.1016/j.jgg.2016.11.002; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Helgadottir A., 2016, Breeding in a world of scarcity. 31st Eucarpia Fodder Crops and Amenity Grasses Congress, Ghent, Belgium, 13-17 September 2015, P3; Heuer S, 2017, PLANT J, V90, P868, DOI 10.1111/tpj.13423; James RA, 2016, J EXP BOT, V67, P3709, DOI 10.1093/jxb/erw035; Jones R. L., 2001, BIOCH MOL BIOL PLANT; Kizilgeci F., 2016, Gaziosmanpasa Universitesi Ziraat Fakultesi Dergisi, V33, P96; Larish LLB, 1999, MAYDICA, V44, P279; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00758; March MD, 2016, ECOL INDIC, V69, P667, DOI 10.1016/j.ecolind.2016.05.022; Mendes FF, 2014, CROP SCI, V54, P1530, DOI 10.2135/cropsci2013.11.0755; Mutimaamba C, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1877-5; Novais RF, FERTILIDADE SOLO; Parentoni SN, 2010, MAYDICA, V55, P1; Pereira M. G., 2001, Crop Breeding and Applied Biotechnology, V1, P3; RAMALHO M. A. P., 2012, APLICACOES GENETICA; Rangel RM, 2007, CROP BREED APPL BIOT, V7, P287, DOI 10.12702/1984-7033.v07n03a08; Rowe H, 2016, NUTR CYCL AGROECOSYS, V104, P393, DOI 10.1007/s10705-015-9726-1; Scholz RW, 2013, SCI TOTAL ENVIRON, V461, P799, DOI 10.1016/j.scitotenv.2013.05.043; Schwantes IA, 2017, TROP PLANT PATHOL, V42, P70, DOI 10.1007/s40858-017-0136-6; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; SPEHAR CR, 1995, THEOR APPL GENET, V90, P707, DOI 10.1007/BF00222137; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; Taiz L., 2002, PLANT PHYSIOL; Uzokwe VNE, 2017, PLANT BREEDING, V136, P139, DOI 10.1111/pbr.12453; Vencovsky R, 1992, REV BRAS GENET; Vieira RA, 2011, REV CIENC AGRON, V42, P774, DOI 10.1590/S1806-66902011000300025; 2006, PESQUI AGROPECU BRAS, V41, P1599, DOI DOI 10.1590/S0100-204X2006001100005	38	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216980	10.1371/journal.pone.0216980	http://dx.doi.org/10.1371/journal.pone.0216980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095632	gold, Green Published, Green Submitted			2022-12-27	WOS:000468030100061
J	Theelen, WSME; Kuilman, T; Schulze, K; Zou, W; Krijgsman, O; Peters, DDGC; Cornelissen, S; Monkhorst, K; Sarma, P; Sumiyoshi, T; Amler, LC; Willems, SM; Blaauwgeers, JLG; van Noesel, CJM; Peeper, DS; van den Heuvel, MM; Kowanetz, M				Theelen, Willemijn S. M. E.; Kuilman, Thomas; Schulze, Katja; Zou, Wei; Krijgsman, Oscar; Peters, Dennis D. G. C.; Cornelissen, Sten; Monkhorst, Kim; Sarma, Pranamee; Sumiyoshi, Teiko; Amler, Lukas C.; Willems, Stefan M.; Blaauwgeers, Johannes L. G.; van Noesel, Carel J. M.; Peeper, Daniel S.; van den Heuvel, Michel M.; Kowanetz, Marcin			Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFN gamma signaling in non-small cell lung cancer	PLOS ONE			English	Article							ANTIBODY	Background In non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 regulation are not fully understood. To provide better insight in these mechanisms, a multiangular analysis approach was used to combine protein and mRNA expression with several clinicopathological characteristics. Patients and methods Archival tissues from 640 early stage, resected NSCLC patients were analyzed with immunohistochemistry for expression of PD-L1 and CD8 infiltration. In addition, mutational status and expression of a selection of immune genes involved in the PD-L1/PD-1 axis and T-cell response was determined. Results Tumors with high PD-L1 expression on TC or on IC represent two subsets of NSCLC with minimal overlap. We observed that PD-L1 expression on IC irrespective of expression on TC is a good marker for inflammation within tumors. In the tumors with the highest IC expression and absent TC expression an association with reduced IFN gamma downstream signaling in tumor cells was observed. Conclusions These results show that PD-L1 expression on TC and IC are both independent hallmarks of the inflamed phenotype in NSCLC, and TC-negative/IC-high tumors can also be categorized as inflamed. The lack of correlation between PD-L1 TC and IC expression in this subgroup may be caused by impaired IFN gamma signaling in tumor cells. These findings may bring a better understanding of the tumor-immune system interaction and the clinical relevance of PD-L1 expression on IC irrespective of PD-L1 expression on TC.	[Theelen, Willemijn S. M. E.] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands; [Kuilman, Thomas; Krijgsman, Oscar; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Schulze, Katja; Sarma, Pranamee; Sumiyoshi, Teiko; Amler, Lukas C.; Kowanetz, Marcin] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Zou, Wei] Genentech Inc, Biostat, San Francisco, CA 94080 USA; [Peters, Dennis D. G. C.; Cornelissen, Sten] Netherlands Canc Inst, Dept Mol Pathol, Core Facil Mol Pathol & Biobanking, Amsterdam, Netherlands; [Monkhorst, Kim] Netherlands Canc Inst, Div Pathol, Amsterdam, Netherlands; [Willems, Stefan M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Blaauwgeers, Johannes L. G.] OLVG, Dept Pathol, Amsterdam, Netherlands; [van Noesel, Carel J. M.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [van den Heuvel, Michel M.] Radboud Univ Nijmegen, Dept Pulmonol, Med Ctr, Nijmegen, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Roche Holding; Genentech; Roche Holding; Genentech; Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Theelen, WSME (corresponding author), Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.	w.theelen@nki.nl	van den Heuvel, Michel M/D-9491-2017; Peters, Dorien/AFH-8507-2022; Peeper, Daniel/AAA-2430-2020; Theelen, Willemijn/AAL-1378-2020	van den Heuvel, Michel M/0000-0002-6372-2153; Peters, Dorien/0000-0001-6974-7143; Theelen, Willemijn/0000-0001-9772-0511; Kuilman, Thomas/0000-0001-6724-6767				[Anonymous], [No title captured]; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hegde PS, 2016, CLIN CANCER RES, V22, P1865, DOI 10.1158/1078-0432.CCR-15-1507; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirsch FR, 2016, J THORACIC ONCOLOGY; Kowanetz M, 2018, P NATL ACAD SCI USA, V115, pE10119, DOI 10.1073/pnas.1802166115; Schaake EE, 2012, J CLIN ONCOL, V30, P2731, DOI 10.1200/JCO.2011.39.4882; Schats KA, 2017, HISTOPATHOLOGY, V70, P253, DOI 10.1111/his.13056; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090761; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vennapusa B, 2019, APPL IMMUNOHISTO M M, V27, P92, DOI 10.1097/PAI.0000000000000594; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560	14	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216864	10.1371/journal.pone.0216864	http://dx.doi.org/10.1371/journal.pone.0216864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125352	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700008
J	Tura, H; Licoze, A				Tura, Halkeno; Licoze, Armando			Women's experience of intimate partner violence and uptake of Antenatal Care in Sofala, Mozambique	PLOS ONE			English	Article							HEALTH CONSEQUENCES; PREVALENCE; PREGNANCY; SYMPTOMS; HIV	Intimate partner violence (IPV) is associated with negative physical and mental health outcomes. Although maternal health services, especially antenatal care (ANC), can act as a link to IPV resources, women experiencing IPV likely have reduced uptake of ANC due to social and emotional barriers. Poor ANC uptake can also further exacerbate adverse pregnancy outcomes. However, there is limited research examining the association between IPV and ANC within the context of Mozambique. Using data from a study conducted to assess the impact of membership in savings groups on maternal health service utilization in Mozambique (N = 205), we investigated the association between IPV and uptake of ANC. Pearson chi-square and logistic regression were employed to examine the association between IPV and ANC service utilization. The mean age of the participants was 33.4 years (SD = 11.88). Overall, 47.3%, 83.4%, and 51.7% of the participants reported experiencing IPV, receiving at least one ANC, and four or more ANC, respectively. Women who reported experience of IPV had lower odds of receiving both at least one (AOR 0.31 [95% CI: 0.12-0.82]) and four or more ANC (AOR 0.50 [95% CI: 0.27-0.92]). Women who reported experience of IPV also had lower odds of receiving ANC from skilled personnel (AOR 0.32 [95% CI: 0.10-0.90]). Experience of IPV showed significant association with reduced ANC service utilization among women in the study area. Further study is needed to assess whether the negative association between IPV and ANC service utilization is also a causal relationship, the evidence which will then help guide a comprehensive intervention effort to improve maternal health services use.	[Tura, Halkeno] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA; [Licoze, Armando] Oasis Mozambique, Sofala, Mozambique	University of Iowa	Tura, H (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA.	halkeno-tura@uiowa.edu	Zweigenthal, Virginia/AAW-6425-2021; Tura, Halkeno T/AAN-4939-2021	Zweigenthal, Virginia/0000-0003-3914-2156; Tura, Robsan/0000-0003-1245-6673	Oasis Mozambique	Oasis Mozambique	This project is funded by Oasis Mozambique The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript..	Allendorf K, 2010, STUD FAMILY PLANN, V41, P263, DOI 10.1111/j.1728-4465.2010.00252.x; [Anonymous], VIOLENCE AGAINST WOM; Antai D, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-56; Betron M., 2015, RECOGNIZING GENDER B; Borwankar R., 2008, GENDER BASED VIOLENC; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Cebola B., 2013, DOMESTIC VIOLENCE BE; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Khan MN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198833; Koski AD, 2011, J HEALTH POPUL NUTR, V29, P245, DOI 10.3329/jhpn.v29i3.7872; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Mozambique demographic and health survey, 2011, MOZ DEM HLTH SURV 20; Omer K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0380-4; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Peltzer K, 2013, GEN HOSP PSYCHIAT, V35, P545, DOI 10.1016/j.genhosppsych.2013.04.001; Rees K, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.712; Rutherford A, 2007, J EPIDEMIOL COMMUN H, V61, P676, DOI 10.1136/jech.2005.043711; Sharps PW, 2007, TRAUMA VIOLENCE ABUS, V8, P105, DOI 10.1177/1524838007302594; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Stephenson R, 2016, VIOLENCE AGAINST WOM, V22, P1642, DOI 10.1177/1077801216630148; Sugg N, 2015, MED CLIN N AM, V99, P629, DOI 10.1016/j.mcna.2015.01.012; WHO Department of Reproductive Health and Research London School of Hygiene and Tropical Medicine South African Medical Research Council, 2013, GLOB REG EST VIOL WO, P51; Winter A, 2013, INT J GYNECOL OBSTET, V121, P218, DOI 10.1016/j.ijgo.2012.12.018; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization , 2002, WHO ANT CAR RAND TRA; Zacarias AE, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-35	30	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217407	10.1371/journal.pone.0217407	http://dx.doi.org/10.1371/journal.pone.0217407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125370	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700037
J	Kowitt, SD; Goldstein, AO; Sutfin, EL; Osman, A; Meernik, C; Heck, C; Ranney, LM				Kowitt, Sarah D.; Goldstein, Adam O.; Sutfin, Erin L.; Osman, Amira; Meernik, Clare; Heck, Courtney; Ranney, Leah M.			Adolescents' first tobacco products: Associations with current multiple tobacco product use	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; E-CIGARETTE USE; UNITED-STATES; SMOKELESS TOBACCO; MIDDLE; SMOKING; RISK	Understanding which tobacco products adolescents use first can lead to insights for tobacco prevention interventions and policies. We used cross-sectional data from high school students who reported ever using a tobacco product from the 2017 North Carolina Youth Tobacco Survey (n = 1,053). In multivariable regressions, we examined how demographic and psychosocial factors were associated with adolescents' first product tried and how first product tried was associated with current tobacco use (i.e., no use, use of a single product, use of multiple products) and frequency of tobacco use. Cigarettes (34.8%) and e-cigarettes (33.7%) were the most frequently reported first products tried, followed by cigars (15.6%), smokeless tobacco (10.7%), waterpipe (4.0%), and other tobacco products (i.e., pipe tobacco or some other tobacco product) (1.2%). Demographic differences in adolescents' first product tried existed, with Black adolescents having higher odds of initiating tobacco use via cigars (aOR: 6.17, 95% CI: 3.75, 10.14). Adolescents who initiated tobacco use via cigars (aOR: 2.33, 95% CI: 1.31, 4.13) or smokeless tobacco (aOR: 2.45, 95% CI: 1.18, 5.04) had higher odds of being a multiple current tobacco product user, whereas adolescents who initiated tobacco use via e-cigarettes (aOR: 0.57, 95% CI: 0.34, 0.93) had lower odds of being a multiple current tobacco product user. Additionally, adolescents who initiated tobacco use via smokeless tobacco had higher odds of currently using at least one tobacco product frequently (aOR: 1.90, 95% CI: 1.04, 3.48), while adolescents who initiated tobacco use via e-cigarettes had lower odds of currently using at least one tobacco product frequently (aOR: 0.40, 95% CI: 0.23, 0.70). These findings suggest that most adolescents reported initiating tobacco use via cigarettes or e-cigarettes and that trying certain products first (e.g., cigars, smokeless tobacco) was associated with higher odds of multiple current tobacco product use.	[Kowitt, Sarah D.; Goldstein, Adam O.; Osman, Amira; Ranney, Leah M.] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA; [Goldstein, Adam O.] Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Sutfin, Erin L.] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA; [Osman, Amira] Zefat Acad Coll, Sch Nursing, Safed, Israel; [Meernik, Clare] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Heck, Courtney] North Carolina Dept Hlth & Human Serv, Tobacco Prevent & Control Branch, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill	Kowitt, SD (corresponding author), Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA.	kowitt@email.unc.edu	Meernik, Clare/O-2995-2016	Meernik, Clare/0000-0002-8564-1266; Sutfin, Erin/0000-0003-2660-8383	National Cancer Institute [P50 CA180907]; FDA Center for Tobacco Products (CTP); Centers for Disease Control and Prevention [DP005974]; NATIONAL CANCER INSTITUTE [P50CA180907] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant number P50 CA180907 from the National Cancer Institute and the FDA Center for Tobacco Products (CTP) supported the authors' time spent writing the paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. Data collection for this article was supported by the grant or cooperative agreement no. DP005974 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the US Department of Health and Human Services.	Anic GM, 2018, MMWR-MORBID MORTAL W, V67, P1353, DOI 10.15585/mmwr.mm6749a1; Apelberg BJ, 2014, AM J PREV MED, V47, pS4, DOI 10.1016/j.amepre.2014.04.013; Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Barrington-Trimis JL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0379; Berry KM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7794; Bloomberg, 2018, BLOOMBERG; Brooks A, 2008, AM J HEALTH BEHAV, V32, P640, DOI 10.5555/ajhb.2008.32.6.640; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Cullen KA, 2018, MMWR-MORBID MORTAL W, V67, P1276, DOI 10.15585/mmwr.mm6745a5; El-Toukhy S, 2016, NICOTINE TOB RES, V18, P1596, DOI 10.1093/ntr/ntw008; Frost-Pineda K, 2010, NICOTINE TOB RES, V12, P1055, DOI 10.1093/ntr/ntq147; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; Krishnan-Sarin S, 2015, NICOTINE TOB RES, V17, P810, DOI 10.1093/ntr/ntu243; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; Meier EM, 2015, AM J PREV MED, V48, pS86, DOI 10.1016/j.amepre.2014.09.018; Nicholson L.M., 2014, SPATIAL DEMOGRAPHY, V2, P55, DOI [10.1007/BF03354904, DOI 10.1007/BF03354904]; Rath JM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/679134; Ross JC, 2018, TOB REGUL SCI, V4, P38, DOI 10.18001/TRS.4.3.4; Sharapova S, 2018, TOB CONTROL; Soneji S, 2016, TOB CONTROL, V25, P174, DOI 10.1136/tobaccocontrol-2014-051638; Stokes M.E., 2012, CATEGORICAL DATA ANA; Sutfin EL, 2015, ADDICT BEHAV, V51, P152, DOI 10.1016/j.addbeh.2015.07.022; Sutfin EL, 2012, AM J HEALTH BEHAV, V36, P218, DOI 10.5993/AJHB.36.2.7; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; U.S. Food and Drug Administration, 2018, FRESH EMP CAMP 2018; U. S. Food and Drug Administration, 2018, REAL COST CAMP 2018; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; USDHHS, 2016, E CIGARETTE USE YOUT; Walsh MM, 2010, NICOTINE TOB RES, V12, P543, DOI 10.1093/ntr/ntq022; Watkins SL, 2018, JAMA PEDIAT; Willett JG, 2018, TOB CONTROL; Wills TA, 2017, TOB CONTROL, V26, P34, DOI 10.1136/tobaccocontrol-2015-052705	32	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217244	10.1371/journal.pone.0217244	http://dx.doi.org/10.1371/journal.pone.0217244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120972	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700077
J	McCoy, J; Ullman, T				McCoy, John; Ullman, Tomer			Judgments of effort for magical violations of intuitive physics	PLOS ONE			English	Article								People spend much of their time in imaginary worlds, and have beliefs about the events that are likely in those worlds, and the laws that govern them. Such beliefs are likely affected by people's intuitive theories of the real world. In three studies, people judged the effort required to cast spells that cause physical violations. People ranked the actions of spells congruently with intuitive physics. For example, people judge that it requires more effort to conjure up a frog than to levitate it one foot off the ground. A second study manipulated the target and extent of the spells, and demonstrated with a continuous measure that people are sensitive to this manipulation even between participants. A pre-registered third study replicated the results of Study 2. These results suggest that people's intuitive theories partly account for how they think about imaginary worlds.	[McCoy, John] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Ullman, Tomer] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA	University of Pennsylvania; Harvard University	Ullman, T (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	tullman@wjh.harvard.edu		/0000-0003-1722-2382	Center for Brains, Minds, and Machines (National Science Foundation STC Award) [CCF-1231216]	Center for Brains, Minds, and Machines (National Science Foundation STC Award)	TDU was supported by the Center for Brains, Minds, and Machines (funded by National Science Foundation STC Award CCF-1231216). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillargeon R, 1998, ADVANCES IN PSYCHOLOGICAL SCIENCE, VOL 2, P503; Baillargeon R., 2002, BLACKWELL HDB CHILDH, P47, DOI DOI 10.1002/9780470996652.CH3; Battaglia PW, 2013, P NATL ACAD SCI USA, V110, P18327, DOI 10.1073/pnas.1306572110; Byrne RMJ, 2005, RATIONAL IMAGINATION: HOW PEOPLE CREATE ALTERNATIVES TO REALITY, P1; Cacciari C., 1997, CREATIVE THOUGHT INV; Carey S., 1985, CONCEPTUAL CHANGE CH; Carey S., 2009, ORIGIN CONCEPTS; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Forbus K. D., 1988, EXPLORING ARTIFICIAL, P239, DOI DOI 10.1016/B978-0-934613-67-5.50011-3; Gelman S. A., 2007, ESSENTIAL CHILD ORIG; Gelman SA, 2004, TRENDS COGN SCI, V8, P404, DOI 10.1016/j.tics.2004.07.001; Gopnik A., 1997, WORDS THOUGHTS THEOR; Griffiths TL, 2015, COGNITION, V136, P43, DOI 10.1016/j.cognition.2014.10.019; Hegarty M, 2004, TRENDS COGN SCI, V8, P280, DOI 10.1016/j.tics.2004.04.001; KELLY MH, 1985, COGNITIVE SCI, V9, P403, DOI 10.1016/S0364-0213(85)80019-7; Lombrozo T., 2012, OXFORD HDB THINKING, P260, DOI DOI 10.1093/OXFORDHB/9780199734689.013.0014; MEDIN DL, 1989, AM PSYCHOL, V44, P1469, DOI 10.1037/0003-066X.44.12.1469; Sanborn AN, 2013, PSYCHOL REV, V120, P411, DOI 10.1037/a0031912; Shtulman A, 2017, PSYCHON B REV, V24, P1573, DOI 10.3758/s13423-016-1206-3; Skolnick D., 2006, ARCHITECTURE IMAGINA, P73, DOI [DOI 10.1093/ACPROF:OSO/9780199275731.001.0001, DOI 10.1093/ACPROF:OSO/9780199275731.003.0005]; Skolnick D, 2006, COGNITION, V101, pB9, DOI 10.1016/j.cognition.2005.10.001; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; SPELKE ES, 1993, PERCEPTION, V22, P1483, DOI 10.1068/p221483; Ullman TD, 2017, TRENDS COGN SCI, V21, P649, DOI 10.1016/j.tics.2017.05.012; WARD TB, 1994, COGNITIVE PSYCHOL, V27, P1, DOI 10.1006/cogp.1994.1010; Ward TB, 1997, J CREATIVE BEHAV, V31, P245, DOI 10.1002/j.2162-6057.1997.tb00797.x; Weisberg DS, 2009, J COGN CULT, V9, P69, DOI 10.1163/156853709X414647; WELLMAN HM, 1992, ANNU REV PSYCHOL, V43, P337, DOI 10.1146/annurev.ps.43.020192.002005; Xu F, 1999, COGNITION, V70, P137, DOI 10.1016/S0010-0277(99)00007-4	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217513	10.1371/journal.pone.0217513	http://dx.doi.org/10.1371/journal.pone.0217513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120990	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700109
J	Valkenet, K; Veenhof, C				Valkenet, Karin; Veenhof, Cindy			Validity of three accelerometers to investigate lying, sitting, standing and walking	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; LOW MOBILITY; VALIDATION; HOSPITALIZATION; RELIABILITY; DISABILITY; MORTALITY; DISEASE	Background Hospital stays are associated with high levels of sedentary behavior and physical inactivity. To objectively investigate physical behavior of hospitalized patients, these is a need for valid measurement instruments. The aim of this study was to assess the criterion validity of three accelerometers to measure lying, sitting, standing and walking. Methods This cross-sectional study was performed in a university hospital. Participants carried out several mobility tasks according to a structured protocol while wearing three accelerometers (ActiGraph GT9X Link, Activ8 Professional and Dynaport MoveMonitor). The participants were guided through the protocol by a test leader and were recorded on video to serve as reference. Sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV) were determined for the categories lying, sitting, standing and walking. Results In total 12 subjects were included with a mean age of 49.5 (SD 21.5) years and a mean body mass index of 23.8 kg/m 2 (SD 2.4). The ActiGraph GT9X Link showed an excellent sensitivity (90%) and PPV (98%) for walking, but a poor sensitivity for sitting and standing (57% and 53%), and a poor PPV (43%) for sitting. The Activ8 Professional showed an excellent sensitivity for sitting and walking (95% and 93%), excellent PPV (98%) for walking, but no sensitivity (0%) and PPV (0%) for lying. The Dynaport MoveMonitor showed an excellent sensitivity for sitting (94%), excellent PPV for lying and walking (100% and 99%), but a poor sensitivity (13%) and PPV (19%) for standing. Conclusions The validity outcomes for the categories lying, sitting, standing and walking vary between the investigated accelerometers. All three accelerometers scored good to excellent in identifying walking. None of the accelerometers were able to identify all categories validly.	[Valkenet, Karin; Veenhof, Cindy] Univ Utrecht, Univ Med Ctr Utrecht, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [Veenhof, Cindy] Univ Appl Sci Utrecht, Expertise Ctr Innovat Care, Res Grp Innovat Mobil Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Valkenet, K (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands.	k.valkenet@umcutrecht.nl		Valkenet, Karin/0000-0002-4715-685X; Veenhof, Cindy/0000-0003-0970-2896				Agmon M, 2017, JAMA INTERN MED, V177, P272, DOI 10.1001/jamainternmed.2016.7266; Anderson JL, 2018, CLIN REHABIL, V32, P233, DOI 10.1177/0269215517724850; Andersson M, 2014, COPD, V11, P560, DOI 10.3109/15412555.2014.898033; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; ASHER RAJ, 1947, BRIT MED J, V2, P967, DOI 10.1136/bmj.2.4536.967; Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; Brown CJ, 2009, J AM GERIATR SOC, V57, P1660, DOI 10.1111/j.1532-5415.2009.02393.x; Bussmann JB, 2013, VALIDATION ACTIVE8 A; Cleland I, 2013, SENSORS-BASEL, V13, P9183, DOI 10.3390/s130709183; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; de Groot S, 2013, MED ENG PHYS, V35, P1499, DOI 10.1016/j.medengphy.2013.04.004; Diaz KM, 2017, ANN INTERN MED, V167, P465, DOI 10.7326/M17-0212; Fokkenrood HJP, 2014, EUR J VASC ENDOVASC, V48, P194, DOI 10.1016/j.ejvs.2014.04.003; Hoyer EH, 2016, J HOSP MED, V11, P341, DOI 10.1002/jhm.2546; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Lindemann U, 2014, SENSORS-BASEL, V14, P1267, DOI 10.3390/s140101267; McGavock JM, 2009, J GERONTOL A-BIOL, V64, P293, DOI 10.1093/gerona/gln025; Mudge AM, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0399-7; Nooijen CFJ, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0004-x; OLIVER D, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J2096; Ostir GV, 2013, J AM GERIATR SOC, V61, P551, DOI 10.1111/jgs.12170; Pedersen MM, 2013, J GERONTOL A-BIOL, V68, P331, DOI 10.1093/gerona/gls165; Peterson NE, 2015, RES NURS HEALTH, V38, P492, DOI 10.1002/nur.21694; Sourdet S, 2015, J AM MED DIR ASSOC, V16, P674, DOI 10.1016/j.jamda.2015.03.011; Topp Robert, 2002, AACN Clin Issues, V13, P263, DOI 10.1097/00044067-200205000-00011; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Villumsen M, 2015, J AGING PHYS ACTIV, V23, P542, DOI 10.1123/japa.2014-0115; Wichansawakun S, 2015, APPL PHYSIOL NUTR ME, V40, P207, DOI 10.1139/apnm-2014-0276	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217545	10.1371/journal.pone.0217545	http://dx.doi.org/10.1371/journal.pone.0217545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120994	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700111
J	Ormskirk, MM; Narciso, J; Hampton, JG; Glare, TR				Ormskirk, M. Marsha; Narciso, Josefina; Hampton, John G.; Glare, Travis R.			Endophytic ability of the insecticidal bacterium Brevibacillus laterosporus in Brassica	PLOS ONE			English	Article							PIRIFORMOSPORA-INDICA; RHIZOSPHERE; TOLERANCE; ROOT; RESISTANCE; PATHOGEN; BARLEY; LEAVES	Brevibacillus laterosporus (Bl), is an insecticidal bacterium recorded as toxic to a range of invertebrates after ingestion. Isolates of Bl, which were initially recovered from surface-sterilised cabbage (Brassica oleracea var. capitata) seeds, were able to colonise brassica plants in the laboratory and field. The bacterium was recovered from surface-sterilised leaf, stem and root sections of seedlings after inoculation with Bl vegetative cells under laboratory conditions, and from mature cabbage plants sprayed with Bl in a field trial. The identity of the recovered bacterial isolates was confirmed by PCR through amplification of 16S rDNA and two strain-specific regions. The effect on diamondback moth (DBM) insect herbivory was tested with cabbage seedlings treated with one isolate (Bl 1951) as the strains are toxic to DBM after direct ingestion. While no effect on DBM larval herbivory was observed, there was a significant reduction of DBM pupation on the Bl 1951 colonised plants. The presence of Bl 1951 wild type cells within cabbage root tissue was confirmed by confocal microscopy, establishing the endophytic nature of the bacterium. The bacterium was also endophytic in three other brassica species tested, Chinese kale (Brassica oleracea var. alboglabra), oilseed rape (Brassica napus var. oleifera) and radish (Raphanus sativus).	[Ormskirk, M. Marsha; Narciso, Josefina; Hampton, John G.; Glare, Travis R.] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand	Lincoln University - New Zealand	Ormskirk, MM (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.	m.m.ormskirk@gmail.com		Ormskirk, Marsha/0000-0003-3245-0068	Ministry for Business Innovation and Employment, Next Generation Bio-Pesticides programme [C10X1310]; grant of the Smart Seeds Programme from the Ministry for Business Innovation and Employment [LINX0702]; Biotelliga	Ministry for Business Innovation and Employment, Next Generation Bio-Pesticides programme; grant of the Smart Seeds Programme from the Ministry for Business Innovation and Employment; Biotelliga	This work was partly funded by Ministry for Business Innovation and Employment contract C10X1310, Next Generation Bio-Pesticides programme. A collaboration between the BioProtection Research Centre, AgResearch, Plant and Food Research in New Zealand (MO, JN, TG). The work was also partly funded by the grant of the Smart Seeds Programme from the Ministry for Business Innovation and Employment under contract LINX0702 (MO, TG, JH). Finally, the work was sponsored by our commercial partner Biotelliga (https://www.biotelliga.com/) (MO, TG). The funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltruschat H, 2008, NEW PHYTOL, V180, P501, DOI 10.1111/j.1469-8137.2008.02583.x; Chen SF, 2017, BIOL CONTROL, V106, P89, DOI 10.1016/j.biocontrol.2017.01.005; de Jong EV, 2016, BIOCONTROL SCI TECHN, V26, P426, DOI 10.1080/09583157.2015.1118437; Costa LED, 2012, BRAZ J MICROBIOL, V43, P1562, DOI [10.1590/S1517-83822012000400041, 10.1590/S1517-838220120004000041]; de Oliveira EJ, 2004, APPL ENVIRON MICROB, V70, P6657, DOI 10.1128/AEM.70.11.6657-6664.2004; Deng ZS, 2011, FEMS MICROBIOL ECOL, V76, P463, DOI 10.1111/j.1574-6941.2011.01063.x; FInch S, 2013, ACUTE TOXICITY CULTU; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; GAGNE S, 1987, CAN J MICROBIOL, V33, P996, DOI 10.1139/m87-175; Ge Cibin, 2015, Wei Sheng Wu Xue Bao, V55, P551; Glick B.R., 2015, BENEFICIAL PLANT BAC; Himani Chaturvedi, 2016, Journal of Plant Pathology and Microbiology, V7, P376; Hinsinger P, 2006, PLANT SOIL, V283, pVII, DOI 10.1007/s11104-006-0057-5; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hubbard M, 2014, J APPL MICROBIOL, V116, P109, DOI 10.1111/jam.12311; Jones DL, 2008, PLANT SOIL, V312, P1, DOI 10.1007/s11104-008-9774-2; Kakar KU, 2014, WORLD J MICROB BIOT, V30, P469, DOI 10.1007/s11274-013-1469-z; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Le Cocq K, 2017, MOL PLANT PATHOL, V18, P469, DOI 10.1111/mpp.12483; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Mano H, 2007, MICROBES ENVIRON, V22, P175, DOI 10.1264/jsme2.22.175; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Pierret A, 2007, VADOSE ZONE J, V6, P269, DOI 10.2136/vzj2006.0067; Porubcan RS, 2003, United States patent, Patent No. [US 200300996924A1, 200300996924]; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Rasooly R, 2007, FEMS IMMUNOL MED MIC, V49, P261, DOI 10.1111/j.1574-695X.2007.00188.x; Romero FM, 2014, FEMS MICROBIOL LETT, V351, P187, DOI 10.1111/1574-6968.12377; Ruiu Luca, 2013, Insects, V4, P476, DOI 10.3390/insects4030476; Saini R, 2015, J BASIC MICROB, V55, P74, DOI 10.1002/jobm.201300173; Scott RI, 1996, POTATO RES, V39, P333, DOI 10.1007/BF02357937; Silva HSA, 2012, BIOL CONTROL, V63, P62, DOI 10.1016/j.biocontrol.2012.06.005; Song Z, 2011, AFR J MICROBIOL RES, V5, P2675; Stajkovic O., 2009, Botanica Serbica, V33, P107; Thomas P, 2009, MICROB ECOL, V58, P952, DOI 10.1007/s00248-009-9559-z; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang HQ, 2015, APPL ENVIRON MICROB, V81, P2706, DOI 10.1128/AEM.03586-14; Weise T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063538; Yang CJ, 2011, AFR J MICROBIOL RES, V5, P131; Zeigler DR, 2001, GENUS GEOBACILLUS IN, P20; [周峻沛 ZHOU Junpei], 2006, [云南大学学报. 自然科学版, Journal of Yunnan University (Natural Science)], V28, P456	43	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216341	10.1371/journal.pone.0216341	http://dx.doi.org/10.1371/journal.pone.0216341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116753	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400018
J	Albesa-Albiol, L; Serra-Paya, N; Garnacho-Castano, MA; Cano, LG; Cobo, EP; Mate-Munoz, JL; Garnacho-Castano, MV				Albesa-Albiol, Lluis; Serra-Paya, Noemi; Ana Garnacho-Castano, Maria; Guirao Cano, Lluis; Pleguezuelos Cobo, Eulogio; Luis Mate-Munoz, Jose; Garnacho-Castano, Manuel V.			Ventilatory efficiency during constant-load test at lactate threshold intensity: Endurance versus resistance exercises	PLOS ONE			English	Article							HEART-FAILURE; SLOPE; RESPONSES; TREADMILL; CYCLE; RELIABILITY; METABOLISM; CAPACITY; PROTOCOL; FITNESS	There is a lack of evidence about the ventilatory efficiency in resistance exercises despite the key role played in endurance exercises. This study aimed to compare the cardiorespiratory, metabolic responses and ventilatory efficiency between half-squat (HS) and cycle ergometer exercises during a constant-load test at the lactate threshold (LT) intensity. Eighteen healthy male participants were randomly assigned in a crossover design to carry out HS or cycle ergometer tests. For the three HS tests, a one repetition maximum (1RM) test was performed first to determine the load (kg) corresponding to the 1RM percentages. In the second test, the incremental HS exercise was carried out to establish the load (kg) at the LT intensity. Finally, a constant-load HS test was performed at the LT intensity. The first cycle ergometer test was incremental loading to determine the intensity in watts corresponding to the LT, followed by a constant-load test at the LT intensity. A recovery time of 48 hours between each test was established. During both constant-load test, cardiorespiratory and metabolic responses were monitored. A significant exercise mode x time interaction effect was only detected in oxygen uptake (VO2), heart rate, and blood lactate (p < 0.001). No differences were found between the two types of exercise in ventilatory efficiency (p>0.05). Ventilation (VE) and carbon dioxide were highly correlated (p < 0.001) in the cycle ergometer (r = 0.892) and HS (r = 0.915) exercises. In the VO2 efficiency slope (OUES), similarly significant and high correlations (p < 0.001) were found between VO2 and log(10) VE in the cycle ergometer (r = 0.875) and in the HS (r = 0.853) exercise. Although the cardioventilatory responses were greater in the cycle ergometer test as compared to HS exercise, ventilatory efficiency was very similar between the two exercise modalities in a predominantly aerobic metabolism.	[Albesa-Albiol, Lluis; Serra-Paya, Noemi; Ana Garnacho-Castano, Maria; Guirao Cano, Lluis; Pleguezuelos Cobo, Eulogio; Garnacho-Castano, Manuel V.] TecnoCampus Pompeu Fabra Univ, Sch Hlth Sci, GRI AFIRS, Barcelona, Spain; [Guirao Cano, Lluis] Hosp Asepeyo, Dept Rehabil, Barcelona, Spain; [Pleguezuelos Cobo, Eulogio] Hosp Mataro, Dept Phys & Rehabil Med, Barcelona, Spain; [Luis Mate-Munoz, Jose] Alfonso X El Sabio Univ, Dept Phys Act & Sports Sci, Madrid, Spain	Universidad Alfonso X el Sabio (UAX)	Garnacho-Castano, MV (corresponding author), TecnoCampus Pompeu Fabra Univ, Sch Hlth Sci, GRI AFIRS, Barcelona, Spain.	mgarnacho@escs.tecnocampus.cat	Albesa-Albiol, Lluís/AAT-6039-2020; Serra, Noemi/AAB-7629-2019; Garnacho-Castaño, Manuel Vicente/AAE-4620-2020	Albesa-Albiol, Lluís/0000-0003-1871-6157; Serra, Noemi/0000-0002-1048-9546; Garnacho-Castaño, Manuel Vicente/0000-0003-3180-4629; Mate-Munoz, Jose Luis/0000-0003-3282-1455				Abrantes C, 2012, INT J SPORTS MED, V33, P26, DOI 10.1055/s-0031-1285928; Akkerman M, 2010, J CARDIOPULM REHABIL, V30, P357, DOI 10.1097/HCR.0b013e3181ebf316; Arena R, 2004, AM HEART J, V147, P354, DOI 10.1016/j.ahj.2003.07.014; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; Arena R, 2010, INT J CARDIOL, V144, P101, DOI 10.1016/j.ijcard.2008.12.143; Baba R, 1996, Nagoya J Med Sci, V59, P55; Bacon L, 1999, J SPORT MED PHYS FIT, V39, P300; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Brown JC, 2016, J CACHEXIA SARCOPENI, V7, P290, DOI 10.1002/jcsm.12073; Brown SJ, 2013, J SCI MED SPORT, V16, P266, DOI 10.1016/j.jsams.2012.06.010; Chlif M, 2017, RESP CARE, V62, P936, DOI 10.4187/respcare.04923; Chua TP, 1997, J AM COLL CARDIOL, V29, P1585, DOI 10.1016/S0735-1097(97)00078-8; Coen B, 2001, INT J SPORTS MED, V22, P8, DOI 10.1055/s-2001-11332; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; Davis JA, 2006, CLIN PHYSIOL FUNCT I, V26, P191, DOI 10.1111/j.1475-097X.2006.00674.x; Davis JA, 2006, CLIN PHYSIOL FUNCT I, V26, P72, DOI 10.1111/j.1475-097X.2006.00657.x; de Sousa NMF, 2012, INT J SPORTS MED, V33, P108, DOI 10.1055/s-0031-1286315; Dominguez R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121360; Drinkard B, 2007, MED SCI SPORT EXER, V39, P1811, DOI 10.1249/mss.0b013e31812e52b3; Form P, 1995, CELL MOL BIOL RES, V41, P207; de Sousa NMF, 2011, CLIN PHYSIOL FUNCT I, V31, P376, DOI 10.1111/j.1475-097X.2011.01027.x; Garnacho-Castano MV, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00357; Garnacho-Castano MV, 2021, J STRENGTH COND RES, V35, P1014, DOI 10.1519/JSC.0000000000002905; Garnacho-Castano MV, 2015, INT J SPORTS MED, V36, P1, DOI [10.1055/s-0034-1384545, DOI 10.1055/S-0034-1384545]; Gonzalez A, 2018, EFFECTS SINGLE DOSE, V15, P49, DOI [10.1186/s12970, DOI 10.1186/S12970]; Guerrero L, 2008, J SPORT SCI, V26, P1455, DOI 10.1080/02640410802255771; Hartmann H, 2013, SPORTS MED, V43, P993, DOI 10.1007/s40279-013-0073-6; Hoshimoto-Iwamoto M, 2008, J PHYSIOL SCI, V58, P291, DOI 10.2170/physiolsci.RP006108; Keller-Ross ML, 2016, INT J CARDIOL, V202, P159, DOI 10.1016/j.ijcard.2015.08.212; Koch B, 2009, EUR RESPIR J, V33, P389, DOI 10.1183/09031936.00074208; MacIntosh BR, 2002, CAN J APPL PHYSIOL, V27, P232, DOI 10.1139/h02-014; Mateo J, 2016, COMPUT ELECTR ENG, V53, P219, DOI 10.1016/j.compeleceng.2015.12.015; Mourot L, 2004, INT J SPORTS MED, V25, P85; Myers J, 2008, AM HEART J, V156, P1177, DOI 10.1016/j.ahj.2008.07.010; Nolte K, 2014, ESC HEART FAIL, V1, P59, DOI 10.1002/ehf2.12007; ORR GW, 1982, J APPL PHYSIOL, V52, P1349, DOI 10.1152/jappl.1982.52.5.1349; Orr JL, 2013, ANAESTHESIA, V68, P497, DOI 10.1111/anae.12195; PETROFSKY JS, 1981, J APPL PHYSIOL, V50, P493, DOI 10.1152/jappl.1981.50.3.493; Reindl I, 1996, CARDIOLOGY, V91, P37; Ribeiro L, 2003, J SPORT MED PHYS FIT, V43, P312; Saengsuwan J, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0099-0; Salazar-Martinez Eduardo, 2018, Biol Sport, V35, P393, DOI 10.5114/biolsport.2018.78060; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; THOMAS TR, 1995, RES Q EXERCISE SPORT, V66, P239, DOI 10.1080/02701367.1995.10608838; Van Laethem C, 2007, EUR J HEART FAIL, V9, P625, DOI 10.1016/j.ejheart.2007.01.007; WASSERMAN K, 1964, AM J CARDIOL, V14, P844, DOI 10.1016/0002-9149(64)90012-8; WELTMAN A, 1990, INT J SPORTS MED, V11, P26, DOI 10.1055/s-2007-1024757; 2007, J HEART LUNG TRANSPL, V26, P921, DOI DOI 10.1016/J.HEALUN.2007.06.001; 2015, J STRENGTH COND RES, V29, P2867, DOI DOI 10.1519/JSC.0000000000000956; 2009, INT J SPORTS MED, V30, P496, DOI DOI 10.1055/S-0028-1112146	52	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216824	10.1371/journal.pone.0216824	http://dx.doi.org/10.1371/journal.pone.0216824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112561	gold, Green Published, Green Submitted			2022-12-27	WOS:000468451000027
J	Huang, TL; Hsiao, FY; Chiang, CK; Shen, LJ; Huang, CF				Huang, Tzu-Lan; Hsiao, Fei-Yuan; Chiang, Chih-Kang; Shen, Li-Jiuan; Huang, Chih-Fen			Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study	PLOS ONE			English	Article							COMPLICATIONS SEVERITY INDEX; HEALTH INSURANCE RESEARCH; MYOCARDIAL-INFARCTION; CLAIMS DATA; SITAGLIPTIN; OUTCOMES; HOSPITALIZATION; STROKE; METFORMIN; DATABASE	Background Cardiovascular events associated with oral hypoglycemic agents (OHAs) have raised significant safety concerns. This study assessed the association between dipeptidyl peptidase-4 inhibitors (DPP-4i) and the risk of cardiovascular events in patients with type 2 diabetes mellitus with or without chronic kidney disease (CKD). Study design A retrospective cohort study using Taiwan's National Health Insurance Research Database. Settings and participants Our study included patients with type 2 diabetes who received OHAs between March 1, 2009, and December 31, 2012. All eligible subjects were classified into CKD and non-CKD cohorts and further categorized as the DPP-4i and non-DPP-4i users in each cohort. Methods The DPP-4i and non-DPP-4i groups were matched 1:1 by propensity score to attenuate potential selection bias. Propensity score was estimated by logistic regression, using demographics, co-medications, comorbidities. and adapted diabetic complication severity index at baseline. Outcomes Outcomes of interest included a composite endpoint of ischemic stroke, myocardial infarction, cardiovascular death (major adverse cardiac events [MACE]), and hospitalization for heart failure (hHF). COX proportional hazard models were applied to examine the association between DPP-4i and outcomes of interest. Results We identified 37,641 and 87,604 patients with type 2 diabetes with and without CKD, respectively. After propensity score matching, 8,213 pairs of CKD patients and 12,313 pairs of non-CKD patients were included for analysis. In the CKD cohort, DPP-4i were associated with a 25% increased risk of hHF (DPP-4i vs. non-DPP-4i incidence/1,000 person-years: 15.0 vs. 9.9, HR = 1.25; 95% CI 1.01-1.54, p = 0.037) but not with the risk of MACE (HR = 0.89, p = 0.144). In the non-CKD cohort, DPP-4i were associated with a lower risk of MACE (DPP-4i vs. non-DPP-4i incidence/1,000 person-years: 9.8 vs. 12.6 HR = 0.73; 95% CI 0.61-0.87, p = 0.0007), but not the risk of hHF (HR = 1.09, p = 0.631). Conclusions DPP-4i were found to be associated with decreased risk of MACE in the non-CKD cohort in our study. However, DPP-4i were associated with increased risk of hHF in the CKD cohort. DPP-4i in the CKD cohort should be used cautiously.	[Huang, Tzu-Lan; Hsiao, Fei-Yuan; Shen, Li-Jiuan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan; [Huang, Tzu-Lan; Hsiao, Fei-Yuan; Shen, Li-Jiuan; Huang, Chih-Fen] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Hsiao, Fei-Yuan; Shen, Li-Jiuan; Huang, Chih-Fen] Natl Taiwan Univ, Sch Pharm, Coll Med, Taipei, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, CF (corresponding author), Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan.; Huang, CF (corresponding author), Natl Taiwan Univ, Sch Pharm, Coll Med, Taipei, Taiwan.	cfhuang1023@ntu.edu.tw	Shen, Rita/AAB-4116-2021	Shen, Rita/0000-0002-2854-3205; HSIAO, FEI-YUAN/0000-0003-1660-9120; Huang, Tzu-Lan/0000-0002-0231-6434; CHIANG, CHIH-KANG/0000-0001-9021-4616	National Taiwan University Hospital [104-A129, 105-A129, 106-A129]; Ministry of Science and Technology, Taiwan [MOST 104-2410-H-002-225-MY3]	National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Dr. Li-Jiuan Shen received the research grants from National Taiwan University Hospital (104-A129, 105-A129, and 106-A129) and Dr. Fei-Yuan Hsiao received the research grants from the Ministry of Science and Technology, Taiwan (MOST 104-2410-H-002-225-MY3).	[Anonymous], CAROLINA CARDIOVASCU; Chan SY, 2016, INT J CARDIOL, V218, P170, DOI 10.1016/j.ijcard.2016.05.062; Chang HY, 2012, AM J MANAG CARE, V18, P721; Chang YC, 2015, DIABETIC MED, V32, P1460, DOI 10.1111/dme.12800; Chen DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001128; Chen DY, 2015, INT J CARDIOL, V181, P200, DOI 10.1016/j.ijcard.2014.12.029; Chen HL, 2014, J DIABETES COMPLICAT, V28, P612, DOI 10.1016/j.jdiacomp.2014.05.011; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hicks KA, 2015, CIRCULATION, V132, P302, DOI 10.1161/CIR.0000000000000156; Hsiao FY, 2007, J FOOD DRUG ANAL, V15, P99; Ingelheim B., CARDIOVASCULAR RENAL; Kern EFO, 2006, HEALTH SERV RES, V41, P564, DOI 10.1111/j.1475-6773.2005.00482.x; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Mulvihill EE, 2016, DIABETES, V65, P742, DOI 10.2337/db15-1224; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ou SM, 2015, ANN INTERN MED, V163, P663, DOI 10.7326/M15-0308; Parsons LS, 2001, SUGI 26 REDUCING BIA; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shannon RP, 2013, DIABETES, V62, P1029, DOI 10.2337/db12-1794; Udell JA, 2015, DIABETES CARE, V38, P696, DOI 10.2337/dc14-1850; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Wang KL, 2014, INT J CARDIOL, V177, P86, DOI 10.1016/j.ijcard.2014.09.038; Wang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131122; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wilson C, 2001, PUBLIC HEALTH REP, V116, P45, DOI 10.1093/phr/116.1.45; Winkelmayer WC, 2005, AM J KIDNEY DIS, V46, P225, DOI 10.1053/j.ajkd.2005.04.029; Yang TY, 2016, ACTA DIABETOL, V53, P461, DOI 10.1007/s00592-015-0817-x; Young BA, 2008, AM J MANAG CARE, V14, P15; Zgibor JC, 2007, DIABETES RES CLIN PR, V75, P313, DOI 10.1016/j.diabres.2006.07.007; 2015, LANCET, V385, P2067, DOI DOI 10.1016/S0140-6736(14)62225-X; 2014, DIABETES CARE, V37, P277, DOI DOI 10.2337/DC13-0781	33	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0215248	10.1371/journal.pone.0215248	http://dx.doi.org/10.1371/journal.pone.0215248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112536	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000008
J	Tedesco, S; Sica, M; Ancillao, A; Timmons, S; Barton, J; O'Flynn, B				Tedesco, Salvatore; Sica, Marco; Ancillao, Andrea; Timmons, Suzanne; Barton, John; O'Flynn, Brendan			Accuracy of consumer-level and research-grade activity trackers in ambulatory settings in older adults	PLOS ONE			English	Article							STEP-COUNT ACCURACY; PHYSICAL-ACTIVITY; ACTIVITY MONITORS; WEARABLE DEVICES; VALIDITY; RELIABILITY; EXPENDITURE; VALIDATION; SENSORS	Wrist-worn activity trackers have experienced a tremendous growth lately and studies on the accuracy of mainstream trackers used by older adults are needed. This study explores the performance of six trackers (Fitbit Charge2, Garmin VivoSmart HR+, Philips Health Watch, Withings Pulse Ox, ActiGraph GT9X-BT, Omron HJ-72OITC) for estimating: steps, travelled distance, and heart-rate measurements for a cohort of older adults. Eighteen older adults completed a structured protocol involving walking tasks, simulated household activities, and sedentary activities. Less standardized activities were also included, such as: dusting, using a walking aid, or playing cards, in order to simulate real-life scenarios. Wrist-mounted and chest/waist-mounted devices were used. Gold-standards included treadmill, ECG-based chest strap, direct observation or video recording according to the activity and parameter. Every tracker showed a decreasing accuracy with slower walking speed, which resulted in a significant step under-counting. A large mean absolute percentage error (MAPE) was found for every monitor at slower walking speeds with the lowest reported MAPE at 2 km/h being 7.78%, increasing to 20.88% at 1.5 km/h, and 44.53% at 1 km/h. During household activities, the MAPE climbing up/down-stairs ranged from 8.38-19.3% and 10.06-19.01% (dominant and non-dominant arm), respectively. Waist-worn devices showed a more uniform performance. However, unstructured activities (e.g. dusting, playing cards), and using a walking aid represent a challenge for all wrist-worn trackers as evidenced by large MAPE (> 57.66% for dusting, > 67.32% when using a walking aid). Poor performance in travelled distance estimation was also evident during walking at low speeds and climbing up/down-stairs (MAPE > 71.44% and > 48.3%, respectively). Regarding heart-rate measurement, there was no significant difference (p-values > 0.05) in accuracy between trackers placed on the dominant or non-dominant arm. Concordant with existing literature, while the mean error was limited (between -3.57 bpm and 4.21 bpm), a single heart-rate measurement could be underestimated up to 30 beats-per-minute. This study showed a number of limitations of consumer-level wrist-based activity trackers for older adults. Therefore caution is required when used, in healthcare or in research settings, to measure activity in older adults.	[Tedesco, Salvatore; Sica, Marco; Ancillao, Andrea; Barton, John; O'Flynn, Brendan] Univ Coll Cork, Tyndall Natl Inst, Cork, Ireland; [Timmons, Suzanne] Univ Coll Cork, Ctr Gerontol & Rehabil, Cork, Ireland	University College Cork; University College Cork	Tedesco, S (corresponding author), Univ Coll Cork, Tyndall Natl Inst, Cork, Ireland.	salvatore.tedesco@tyndall.ie		Barton, John/0000-0002-0671-5678; Tedesco, Salvatore/0000-0002-7752-2240; O'Flynn, Brendan/0000-0002-5522-2597	EU H2020 [689996]; Science Foundation Ireland (SFI); European Regional Development Fund [13/RC/2077]; INTERREG NPA	EU H2020; Science Foundation Ireland (SFI)(Science Foundation Ireland); European Regional Development Fund(European Commission); INTERREG NPA	This publication has emanated from research supported by EU H2020 funded project ProACT under grant agreement No. 689996. Aspects of this work have been supported in part by a research grant from Science Foundation Ireland (SFI) and is co-funded under the European Regional Development Fund under Grant Number 13/RC/2077. Aspects of this work have been supported in part by INTERREG NPA funded project SenDOC.	Al Sayed C, 2017, E HLTH TELECOMMUN SY, V6, P19, DOI [10.4236/etsn.2017.62002, DOI 10.4236/ETSN.2017.62002]; Alinia P, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6321; An HS, 2017, EUR J SPORT SCI, V17, P360, DOI 10.1080/17461391.2016.1255261; Ancillao A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082564; Benedetto S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192691; Broderick L, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015580850; Bunn JA, 2019, J SPORT SCI, V37, P244, DOI 10.1080/02640414.2018.1491941; Bunn Jennifer A, 2018, Int J Exerc Sci, V11, P503; Burton E, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0793-4; Chen MD, 2016, MED SCI SPORT EXER, V48, P1942, DOI 10.1249/MSS.0000000000000984; Chu AHY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172535; Duong HT, 2017, IEEE SENS J, V17, P2100, DOI 10.1109/JSEN.2017.2658618; Evenson KR, 2015, INT J BEHAV NUTR PHY; Feehan LM, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10527; Floegel TA, 2017, J GERONTOL A-BIOL, V72, P229, DOI 10.1093/gerona/glw098; Fokkema T, 2017, MED SCI SPORT EXER, V49, P793, DOI 10.1249/MSS.0000000000001146; Gorny AW, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8233; GUALTIERI L, 2016, JMIR MHEALTH UHEALTH, V5, DOI DOI 10.2196/RESPROT.6534; Henriksen A, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9157; Huang YJ, 2016, GAIT POSTURE, V48, P36, DOI 10.1016/j.gaitpost.2016.04.025; Imboden MT, 2018, BRIT J SPORT MED, V52, P844, DOI 10.1136/bjsports-2016-096990; Kamisalic A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061714; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Le Hello C, 2018, J Med Vasc, V43, P231, DOI 10.1016/j.jdmv.2018.04.001; Malwade S, 2018, COMPUT METH PROG BIO, V161, P233, DOI 10.1016/j.cmpb.2018.04.026; McCullagh R, 2017, ARCH PHYS MED REHAB, V98, P295, DOI 10.1016/j.apmr.2016.08.476; Mercer K, 2016, JMIR MHEALTH UHEALTH, V4, P615, DOI 10.2196/mhealth.4461; Mukhopadhyay SC., 2015, WEARABLE ELECT SENSO; Mukhopadhyay SC, 2015, IEEE SENS J, V15, P1321, DOI 10.1109/JSEN.2014.2370945; O'Flynn B, 2015, SENS TRANSDUCERS, V193, P23; Phillips LJ, 2015, RES GERONTOL NURS, V8, P213, DOI 10.3928/19404921-20150429-03; Preusse KC, 2017, J APPL GERONTOL, V36, P127, DOI 10.1177/0733464815624151; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Sartor F, 2018, BMC SPORTS SCI MED R, V10, DOI 10.1186/s13102-018-0098-0; Scheurer S, 2017, INT CONF WEARAB IMPL, P5, DOI 10.1109/BSN.2017.7935994; Sears T, 2017, INT J EXECISE SCI, V10; Stahl Sarah E, 2016, BMJ Open Sport Exerc Med, V2, pe000106; Stahl ST, 2014, J HEALTH PSYCHOL, V19, P1382, DOI 10.1177/1359105313490771; Straiton N, 2018, MATURITAS, V112, P85, DOI 10.1016/j.maturitas.2018.03.016; Tedesco S, 2018, IEEE PERCOM WORKSH A, DOI [10.1249/MSS.0000000000001090, DOI 10.1249/MSS.0000000000001090]; Tedesco S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061277; Tedesco S, 2016, PROCEDIA ENGINEER, V147, P208, DOI 10.1016/j.proeng.2016.06.215; Thiebaud RS, 2018, DIGIT HEALTH, V4, P1, DOI 10.1177/2055207618770322; Thomson EA, 2019, J SPORTS SCI, V18, P1; Tophoj KH, 2018, TELEMED E-HEALTH, V24, P669, DOI 10.1089/tmj.2017.0264; Wahl Y, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00725; Webber SC, 2016, J AGING PHYS ACTIV, V24, P451, DOI 10.1123/japa.2015-0234; Wong CK, 2018, GAIT POSTURE, V59, P177, DOI 10.1016/j.gaitpost.2017.10.010; Woodman JA, 2017, MED SCI SPORT EXER, V49, P371, DOI 10.1249/MSS.0000000000001090; Xie JQ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9754; 2016, MED SCI SPORTS EXERC, V48, P1619, DOI DOI 10.1249/MSS.0000000000000933	51	44	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216891	10.1371/journal.pone.0216891	http://dx.doi.org/10.1371/journal.pone.0216891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112585	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000031
J	Saegusa, S; Fukaya, M; Kakegawa, W; Tanaka, M; Katsumata, O; Sugawara, T; Hara, Y; Itakura, M; Okubo, T; Sato, T; Yuzaki, M; Sakagami, H				Saegusa, Shintaro; Fukaya, Masahiro; Kakegawa, Wataru; Tanaka, Manabu; Katsumata, Osamu; Sugawara, Takeyuki; Hara, Yoshinobu; Itakura, Makoto; Okubo, Tadashi; Sato, Toshiya; Yuzaki, Michisuke; Sakagami, Hiroyuki			Mice lacking EFA6C/Psd2, a guanine nucleotide exchange factor for Arf6, exhibit lower Purkinje cell synaptic density but normal cerebellar motor functions	PLOS ONE			English	Article							RIBOSYLATION FACTOR 6; SMALL G-PROTEINS; SUBCELLULAR-LOCALIZATION; MESSENGER-RNA; EFA6 FAMILY; SOMATODENDRITIC LOCALIZATION; MEMBRANE; TRANSPORT; ARNO; DOMAIN	ADP ribosylation factor 6 (Arf6) is a small GTPase that regulates various neuronal events including formation of the axon, dendrites and dendritic spines, and synaptic plasticity through actin cytoskeleton remodeling and endosomal trafficking. EFA6C, also known as Psd2, is a guanine nucleotide exchange factor for Arf6 that is preferentially expressed in the cerebellar cortex of adult mice, particularly in Purkinje cells. However, the roles of EFA6C in cerebellar development and functions remain unknown. In this study, we generated global EFA6C knockout (KO) mice using the CRISPR/Cas9 system and investigated their cerebellar phenotypes by histological and behavioral analyses. Histological analyses revealed that EFA6C KO mice exhibited normal gross anatomy of the cerebellar cortex, in terms of the thickness and cellularity of each layer, morphology of Purkinje cells, and distribution patterns of parallel fibers, climbing fibers, and inhibitory synapses. Electron microscopic observation of the cerebellar molecular layer revealed that the density of asymmetric synapses of Purkinje cells was significantly lower in EFA6C KO mice compared with wild-type control mice. However, behavioral analyses using accelerating rotarod and horizontal optokinetic response tests failed to detect any differences in motor coordination, learning or adaptation between the control and EFA6C KO mice. These results suggest that EFA6C plays ancillary roles in cerebellar development and motor functions.	[Saegusa, Shintaro; Fukaya, Masahiro; Katsumata, Osamu; Sugawara, Takeyuki; Hara, Yoshinobu; Sakagami, Hiroyuki] Kitasato Univ, Dept Anat, Sch Med, Sagamihara, Kanagawa, Japan; [Kakegawa, Wataru; Yuzaki, Michisuke] Keio Univ, Dept Physiol, Sch Med, Tokyo, Japan; [Tanaka, Manabu] Kitasato Univ, Bioimaging Ctr, Sch Med, Sagamihara, Kanagawa, Japan; [Itakura, Makoto] Kitasato Univ, Dept Biochem, Sch Med, Sagamihara, Kanagawa, Japan; [Okubo, Tadashi; Sato, Toshiya] Kitasato Univ, Dept Lab Anim Sci, Sch Med, Sagamihara, Kanagawa, Japan	Kitasato University; Keio University; Kitasato University; Kitasato University; Kitasato University	Sakagami, H (corresponding author), Kitasato Univ, Dept Anat, Sch Med, Sagamihara, Kanagawa, Japan.	sakagami@med.kitasato-u.ac.jp	Kakegawa, Wataru/G-5569-2016; Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544; Sato, Toshiya/0000-0001-7844-9930	KAKENHI Grant from the Japan Society for the Promotion of Science [15H04672, 17K07082]	KAKENHI Grant from the Japan Society for the Promotion of Science	This study was supported by KAKENHI Grant No. 15H04672 to HS and KAKENHI Grant No. 17K07082 to MF from the Japan Society for the Promotion of Science.	Akiyama M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5744; Arvanitis DN, 2013, DEVELOPMENT, V140, P2082, DOI 10.1242/dev.088203; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derrien V, 2002, J CELL SCI, V115, P2867; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eva R, 2017, J CELL SCI, V130, P3663, DOI 10.1242/jcs.207423; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Falace A, 2014, P NATL ACAD SCI USA, V111, P2337, DOI 10.1073/pnas.1316294111; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fukaya M, 2016, J COMP NEUROL, V524, P2531, DOI 10.1002/cne.24048; Fukaya M, 2014, J NEUROCHEM, V129, P21, DOI 10.1111/jnc.12524; Fukaya M, 2011, J NEUROCHEM, V116, P1122, DOI 10.1111/j.1471-4159.2010.07167.x; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hara Y, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0148-16.2016; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hernandez-Deviez D, 2007, TRAFFIC, V8, P1750, DOI 10.1111/j.1600-0854.2007.00649.x; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Ito A, 2018, J NEUROCHEM, V147, P153, DOI 10.1111/jnc.14579; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Katsumata O, 2017, HISTOCHEM CELL BIOL, V148, P577, DOI 10.1007/s00418-017-1599-8; Kono M, 2019, J PHYSIOL-LONDON, V597, P903, DOI 10.1113/JP276794; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Lisberger S.G., 2013, PRINCIPLES NEURAL SC, P960; Louis ED, 2014, BRAIN, V137, P3142, DOI 10.1093/brain/awu314; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Macia E, 2008, J BIOL CHEM, V283, P19836, DOI 10.1074/jbc.M800781200; Matsuya S, 2005, J NEUROCHEM, V93, P674, DOI 10.1111/j.1471-4159.2005.03072.x; Miyazaki H, 2005, FEBS LETT, V579, P6834, DOI 10.1016/j.febslet.2005.11.022; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Reeber SL, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00083; Sakagami H, 2004, EUR J NEUROSCI, V19, P863, DOI 10.1111/j.0953-816X.2004.03195.x; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Sakagami H, 2007, EUR J NEUROSCI, V25, P618, DOI 10.1111/j.1460-9568.2007.05345.x; Sakagami H, 2006, BRAIN RES, V1093, P1, DOI 10.1016/j.brainres.2006.02.058; Sakagami H, 2013, J COMP NEUROL, V521, P860, DOI 10.1002/cne.23206; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Sironi C, 2009, J CELL SCI, V122, P2108, DOI 10.1242/jcs.042325; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Strata P, 2011, PHYSIOL RES, V60, pS39, DOI 10.33549/physiolres.932169; Suzuki I, 2002, MOL BRAIN RES, V98, P41, DOI 10.1016/S0169-328X(01)00312-6; Tagliatti E, 2016, ELIFE, V5, DOI 10.7554/eLife.10116; Takao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009460; Tsai PT, 2016, SEMIN FETAL NEONAT M, V21, P349, DOI 10.1016/j.siny.2016.04.009; Whitney ER, 2008, J NEUROSCI METH, V168, P42, DOI 10.1016/j.jneumeth.2007.09.009; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; 2004, EMBO REP, V5, P1171, DOI DOI 10.1038/SJ.EMBOR.7400292; 2018, MOL PSYCHIATR, V23, P621, DOI DOI 10.1038/MP.2017.112; 1997, J NEUROSCI, V17, P9613; 2012, J CELL SCI, V125, P2235, DOI DOI 10.1242/JCS.098657	58	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216960	10.1371/journal.pone.0216960	http://dx.doi.org/10.1371/journal.pone.0216960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095630	gold, Green Submitted, Green Published			2022-12-27	WOS:000468030100059
J	Staatz, CB; Hardy, R				Staatz, Charis Bridger; Hardy, Rebecca			Number of children and body composition in later life among men and women: Results from a British birth cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MRC NATIONAL-SURVEY; OLD-AGE FINDINGS; PHYSICAL-ACTIVITY; MASS INDEX; RISK-FACTORS; WEIGHT-GAIN; HEALTH; OBESITY; PARITY	Background Although research has found associations between increasing number of children and higher body mass index (BMI), there has been limited research investigating the association with body composition despite abdominal fat being independently associated with cardiovascular and metabolic risk. Most existing research has focussed on women, but investigating the relationship in men can help distinguish biological effects of pregnancy from social pathways related to parenthood. Methods Using the MRC National Survey of Health and Development (NSHD) multiple regression models were applied to test associations between number of children and body composition at age 60-64 years (N = 2229) and body mass index (BMI) and waist circumference (WC) at ages 60-64 and 69 years (N = 2149). Results In adjusted models, associations were observed between increasing numbers of children and increasing fat-adjusted lean mass index in women (p = 0.06). Among men, those with children had 0.59kg (95% CI: 0.15 to 1.02) greater lean mass index than those without and fat: lean mass ratio was greater in those with 4+ children because of their slightly higher mean fat mass. Weak evidence of a higher android: gynoid mass ratio among mothers (0.03, 95% CI: 0.00,0.06, p = 0.1) was observed with no associations with fat mass index, android or gynoid fat mass. Increasing parity in women was associated with increasing BMI at 60-64 years and, more strongly, with increasing BMI at 69 years. Associations among men were also observed more clearly with BMI at 69 years. Conclusion There was little evidence of a consistent association between number of children and body composition in early old age. The strongest associations are observed for lean, rather than fat mass, and in men rather than women, suggesting little evidence of biological effects of pregnancy. The results indicate social pathways associated with parenthood are the likely underlying mechanisms, with suggestion of selection into parenthood among men.	[Staatz, Charis Bridger; Hardy, Rebecca] UCL, MRC Unit Lifelong & Hlth Ageing, Dept Populat Hlth & Expt Med, London, England	University of London; University College London	Staatz, CB (corresponding author), UCL, MRC Unit Lifelong & Hlth Ageing, Dept Populat Hlth & Expt Med, London, England.	charis.staatz.17@ucl.ac.uk	Hardy, Rebecca/AFR-1989-2022	Hardy, Rebecca/0000-0001-9949-0799; Bridger Staatz, Charis/0000-0002-2872-6968	UK Medical research Council [MR/N013867/1, MC_UU_12019/1, MC_UU_12019/2]; MRC [MC_U123092720, 1905200, MC_UU_12019/1, MC_UU_00019/1, MC_UU_12019/2] Funding Source: UKRI	UK Medical research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CBS is supported by a PhD studentship from the UK Medical research Council (MR/N013867/1). The MRC NSHD and RH are supported by the UK Medical Research Council (MC_UU_12019/1, MC_UU_12019/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2013, OBESITY, V21, P1514, DOI 10.1002/oby.20503; Baker L, 2003, J SURG RES, V115, P325, DOI 10.1016/S0022-4804(03)00215-4; Bann D, 2014, INT J OBESITY, V38, P69, DOI 10.1038/ijo.2013.115; Bellows-Riecken KH, 2008, PREV MED, V46, P99, DOI 10.1016/j.ypmed.2007.08.003; Berge JM, 2011, PEDIATRICS, V127, P881, DOI 10.1542/peds.2010-3218; Blaudeau TE, 2006, INT J OBESITY, V30, P1119, DOI 10.1038/sj.ijo.0803252; Bredella MA, 2010, OBESITY, V18, P2227, DOI 10.1038/oby.2010.5; Brown DM, 2017, SSM-POPUL HLTH, V3, P558, DOI 10.1016/j.ssmph.2017.06.004; Cooper R, 2014, J GERONTOL A-BIOL, V69, P1253, DOI 10.1093/gerona/glu039; Davis EM, 2009, AM J PUBLIC HEALTH, V99, P294, DOI 10.2105/AJPH.2007.132373; Gennaro S, 2000, FAM COMMUNITY HEALTH, V22, P16, DOI 10.1097/00003727-200001000-00004; Gunderson EP, 2008, OBESITY, V16, P1078, DOI 10.1038/oby.2008.40; Guralnik JM, 2009, AGING CLIN EXP RES, V21, P174; Hardy R, 2009, J EPIDEMIOL COMMUN H, V63, P99, DOI 10.1136/jech.2008.076943; Hardy R, 2007, BJOG-INT J OBSTET GY, V114, P721, DOI 10.1111/j.1471-0528.2007.01324.x; Hinton PS, 2001, J AM DIET ASSOC, V101, P1430, DOI 10.1016/S0002-8223(01)00345-5; Hinton PS, 2001, PREDICTORS PREGNANCY, P7; Johnson W, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001828; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Laroche HH, 2007, J AM BOARD FAM MED, V20, P9, DOI 10.3122/jabfm.2007.01.060085; Laroche HH, 2013, J ACAD NUTR DIET, V113, P1504, DOI 10.1016/j.jand.2013.05.022; Laroche HH, 2012, J ACAD NUTR DIET, V112, P832, DOI 10.1016/j.jand.2012.02.024; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Lee SK, 2005, OBES RES, V13, P1263, DOI 10.1038/oby.2005.150; Li WD, 2016, NUTR METAB, P13; Lim U, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.2; Mailey EL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-657; Ngo AD, 2016, BJOG-INT J OBSTET GY, V123, P1311, DOI 10.1111/1471-0528.13729; Nishiwaki Y, 2011, J GERONTOL A-BIOL, V66, P326, DOI 10.1093/gerona/glq227; Okosun IS, 2015, NUTR DIABETES, P5; Ornelas IJ, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-3; Parikh NI, 2012, HUM REPROD, V27, P568, DOI 10.1093/humrep/der400; Pereira MA, 2007, AM J PREV MED, V32, P312, DOI 10.1016/j.amepre.2006.12.017; Reis-Santos B, 2018, BMC PUBLIC HEALTH, P18; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Saito A, 2018, J NUTR SCI, P7; Shen LJ, 2015, SCI REP, P5; Sim JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127860; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Umberson D, 2011, SOC SCI MED, V73, P1323, DOI 10.1016/j.socscimed.2011.08.014; Vasan SK, 2018, INT J OBESITY, V42, P850, DOI 10.1038/ijo.2017.289; Warin M, 2008, SOCIOL HEALTH ILL, V30, P97, DOI 10.1111/j.1467-9566.2007.01029.x; Weng HLH, 2004, J WOMENS HEALTH, V13, P85, DOI 10.1089/154099904322836492	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0209529	10.1371/journal.pone.0209529	http://dx.doi.org/10.1371/journal.pone.0209529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141503	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000001
J	Calluso, C; Tosoni, A; Cannito, L; Committed, G				Calluso, Cinzia; Tosoni, Annalisa; Cannito, Loreta; Committed, Giorgia			Concreteness and emotional valence of episodic future thinking (EFT) independently affect the dynamics of intertemporal decisions	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBES; PREFRONTAL CORTEX; TIME PERSPECTIVE; SUBJECTIVE VALUE; IMPULSIVITY; DELAY; CHOICE; PREFERENCES; ADDICTION; IMMEDIATE	During intertemporal decisions, the value of future rewards decreases as a function of the delay of its receipt (temporal discounting, TD). Since high discount rates have been associated with a series of problematic behaviours and clinical conditions, current research has focused on possible modulators of TD. Specifically, a reduction of individual discount rates has been shown during episodic future thinking (EFT), wherein time intervals are anchored to personal future events. However, it is not entirely clear whether this effect is mediated by a change in the representation of future events (i.e., from abstract to concrete) or by a positive-emotion modulation. Here, we investigated this issue by manipulating the valence of the EFT (i.e., using negative, neutral and positive episodic tags), and by collecting explicit and implicit measures of behaviour. The results showed a significant reduction of TD in all the three emotional conditions compared to the baseline, with differences among them, thus suggesting the existence of a cumulative effect of the concreteness and affective components of the EFT. The analyses of implicit measures additionally revealed that this effect was mediated by a simultaneous increase/ decrease of attraction toward the delayed/immediate alternative. Finally, these effects appeared to be modulated by participants' baseline discounting preferences. These findings provide important insights on clinical applications in reward-related disorders.	[Calluso, Cinzia; Tosoni, Annalisa; Cannito, Loreta; Committed, Giorgia] Gabriele dAnnunzio Univ, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Calluso, Cinzia; Tosoni, Annalisa; Cannito, Loreta; Committed, Giorgia] Inst Adv Biomed Technol ITAB, Chieti, Italy; [Calluso, Cinzia] LUISS Guido Carli Univ, Dept Business & Management, Rome, Italy	G d'Annunzio University of Chieti-Pescara; Luiss Guido Carli University	Calluso, C (corresponding author), Gabriele dAnnunzio Univ, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.; Calluso, C (corresponding author), Inst Adv Biomed Technol ITAB, Chieti, Italy.; Calluso, C (corresponding author), LUISS Guido Carli Univ, Dept Business & Management, Rome, Italy.	ccalluso@luiss.it	CANNITO, LORETA/AAB-2809-2022; Calluso, Cinzia/B-9662-2017; Tosoni, Annalisa/J-7410-2016	CANNITO, LORETA/0000-0002-1344-8790; Calluso, Cinzia/0000-0001-6693-0786; Tosoni, Annalisa/0000-0001-9004-2623	"Departments of Excellence" initiative of the Italian Ministry of Education, University and Research; University G. d'Annunzio	"Departments of Excellence" initiative of the Italian Ministry of Education, University and Research; University G. d'Annunzio	This work was supported by the "Departments of Excellence 2018-2022" initiative of the Italian Ministry of Education, University and Research for the Department of Neuroscience, Imaging and Clinical Sciences (DNISC) of the University of Chieti-Pescara, and by University G. d'Annunzio research grants (ex 60%) to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors to CC, AT, and LC.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Audrain-McGovern J, 2009, ADDICT BEHAV, V34, P1036, DOI 10.1016/j.addbeh.2009.06.012; Audrain-McGovern J, 2009, DRUG ALCOHOL DEPEN, V103, P99, DOI 10.1016/j.drugalcdep.2008.12.019; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Barca L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035932; Bates DM, 2010, LME4 MIXED EFFECTS M, DOI [10.1177/009286150103500418, DOI 10.1177/009286150103500418]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Bradford WD, 2010, MED DECIS MAKING, V30, P99, DOI 10.1177/0272989X09342276; Bretz F, 2016, PACKAGE MULTCOMP; Bulley A, 2019, Q J EXP PSYCHOL, V72, P1998, DOI 10.1177/1747021818819777; Calluso C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00939; Calluso C, 2017, BEHAV BRAIN RES, V330, P78, DOI 10.1016/j.bbr.2017.05.001; Calluso C, 2015, EXP BRAIN RES, V233, P3597, DOI 10.1007/s00221-015-4427-1; Calluso C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119710; Cheng YY, 2012, BRIT J PSYCHOL, V103, P129, DOI 10.1111/j.2044-8295.2011.02067.x; Daniel TO, 2013, APPETITE, V71, P120, DOI 10.1016/j.appet.2013.07.010; Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Freeman JB, 2008, J EXP PSYCHOL GEN, V137, P673, DOI 10.1037/a0013875; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hehman E, 2015, GROUP PROCESS INTERG, V18, P384, DOI 10.1177/1368430214538325; Iodice P, 2017, PSYCHOL SPORT EXERC, V33, P150, DOI 10.1016/j.psychsport.2017.08.013; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Kwan D, 2015, HIPPOCAMPUS, V25, P432, DOI 10.1002/hipo.22431; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lempert KM, 2017, SOC COGN AFFECT NEUR, V12, P1584, DOI 10.1093/scan/nsx086; Lempert KM, 2016, TRENDS COGN SCI, V20, P64, DOI 10.1016/j.tics.2015.09.005; Li N, 2013, J NEUROSCI, V33, P4886, DOI 10.1523/JNEUROSCI.1342-12.2013; Lin H, 2014, BEHAV NEUROSCI, V128, P12, DOI 10.1037/a0035705; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081717; MacKillop J, 2006, J GAMBL STUD, V22, P339, DOI 10.1007/s10899-006-9021-9; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Hora D. O., 2013, P 35 ANN M COGN SCI, P97; O'Hora D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20740; O'Hora D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02210; O'Hora D, 2013, LEARN BEHAV, V41, P256, DOI 10.3758/s13420-013-0102-1; O'Neill J, 2016, EAT BEHAV, V20, P9, DOI 10.1016/j.eatbeh.2015.10.002; Palombo DJ, 2016, NEUROPSYCHOLOGIA, V89, P437, DOI 10.1016/j.neuropsychologia.2016.07.002; Palombo DJ, 2015, HIPPOCAMPUS, V25, P345, DOI 10.1002/hipo.22376; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Quetard B, 2016, J VISION, V16, DOI 10.1167/16.11.28; Quinton JC, 2013, IEEE T CYBERNETICS, V44, P539, DOI [10.1109/TCYB.2013.2259230, DOI 10.1109/TCYB.2013.2259230]; R Development Core Team, 2009, R LANG ENV STAT COMP; Sasse LK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00058; Sasse LK, 2015, HUM BRAIN MAPP, V36, P4210, DOI 10.1002/hbm.22912; Schacter DL, 2015, NEUROBIOL LEARN MEM, V117, P14, DOI 10.1016/j.nlm.2013.12.008; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Spivey M. J., 2007, CONTINUITY MIND; Sripada CS, 2011, HUM BRAIN MAPP, V32, P1637, DOI 10.1002/hbm.21136; Story GW, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00076; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Tabatabaeian M, 2015, COGN PROCESS, V16, P291, DOI 10.1007/s10339-015-0660-6; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2000, J PERS SOC PSYCHOL, V79, P876, DOI 10.1037//0022-3514.79.6.876; van den Bos W, 2013, J EXP ANAL BEHAV, V99, P58, DOI 10.1002/jeab.6; Vuchinich RE, 1999, NBER CONF R, P103; Zhang SM, 2018, BRIT J PSYCHOL, V109, P487, DOI 10.1111/bjop.12284	77	22	22	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217224	10.1371/journal.pone.0217224	http://dx.doi.org/10.1371/journal.pone.0217224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136620	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300023
J	Skrivan, M; Englmaierova, M; Vit, T; Skrivanova, E				Skrivan, Milos; Englmaierova, Michaela; Vit, Tomas; Skrivanova, Eva			Hempseed increases gamma-tocopherol in egg yolks and the breaking strength of tibias in laying hens	PLOS ONE			English	Article							PERFORMANCE; CHEMISTRY; PLASMA; BONE	The effect of hempseed in the diet of laying hens was evaluated at 0, 30, 60 and 90 g/kg concentrations. The aim of the study was to determine the effect of dietary treatment on the performance of hens, the physical characteristics of egg quality, the concentrations of alpha- and gamma-tocopherol and the carotenoid and cholesterol contents of egg yolks, together with the breaking strength of tibial measurements. In light of the obtained results, our study aimed to address the optimal dietary level of hempseed in laying hen diets. Lohmann Brown hens (n = 240) were divided into 4 dietary treatment groups (6 cages per treatment) with 10 hens per cage. The experiment lasted for 12 weeks. The level of nutrients in all diets (wheat-corn) was well balanced. The dietary metabolisable energy was adjusted using rapeseed oil. The addition of 30 g/kg of hempseed to the diet significantly increased (P<0.001) egg production and egg mass. Alpha-tocopherol increased significantly (P = 0.002) only in the case of the 60 g/kg hempseed level (101 mg/kg dry matter (DM) versus 83 mg/kg DM in the control group). In contrast, the level of gamma-tocopherol increased gradually from 11 mg/kg DM in the control to 29, 39 and 43 mg/kg DM at the 30, 60 and 90 g/kg levels of dietary hempseed, respectively. The concentrations of beta carotene, zeaxanthin and lutein in egg yolks were not influenced by the dietary treatment. Hempseed at 90 g/kg (P = 0.036) decreased egg shell thickness without affecting its strength. The addition of hempseed decreased (P<0.001) the cholesterol concentration in the egg yolks in all experimental groups. The addition of 30, 60 and 90 g hempseed increased (P<0.001) the breaking strength of the tibia to 354, 352 and 350 N, respectively, compared to 297 N in the control group. The highest level of hempseed in the diet positively influenced the Ca concentration in the tibia (P = 0.021). The concentration of P in the tibia was negatively affected in the 60 to 90 g/kg hempseed treatments (P<0.001). Eggs are a significant source of alpha-tocopherol. Based on our results, there is a possibility for enrichment of egg yolks with gamma-tocopherol, with all of its associated health benefits, by the addition of hempseed to the diet of laying hens. Another significant benefit of hempseed is its effect on the breaking strength of the tibia, which can help with crucial problems in the commercial breeding of laying hens.	[Skrivan, Milos; Englmaierova, Michaela; Vit, Tomas; Skrivanova, Eva] Inst Anim Sci, Dept Nutr Physiol & Anim Prod Qual, Prague, Czech Republic	Czech Research Institute of Animal Science	Skrivan, M (corresponding author), Inst Anim Sci, Dept Nutr Physiol & Anim Prod Qual, Prague, Czech Republic.	skrivan.milos@vuzv.cz	Skrivanova, Eva/V-6389-2019; Vít, Tomáš/A-9389-2010	Skrivanova, Eva/0000-0001-9336-5436; Englmaierova, Michaela/0000-0003-2752-3170	Ministry of Agriculture of the Czech Republic [MZERO0719]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Ministry of Agriculture of the Czech Republic (Project MZERO0719). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borhanuddin B, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/684510; Budgell KL, 2004, CAN J ANIM SCI, V84, P745, DOI 10.4141/A04-040; Chin KY, 2014, NUTRIENTS, V6, P1424, DOI 10.3390/nu6041424; COONEY RV, 1993, P NATL ACAD SCI USA, V90, P1771, DOI 10.1073/pnas.90.5.1771; Froescheis O, 2000, J CHROMATOGR B, V739, P291, DOI 10.1016/S0378-4347(99)00562-9; Gabet Y, 2017, OSTEOPOROSIS INT, V28, pS124; Goldberg EM, 2012, J FOOD SCI, V77, pS153, DOI 10.1111/j.1750-3841.2012.02626.x; GREGORY NG, 1989, BRIT POULTRY SCI, V30, P555, DOI 10.1080/00071668908417179; Guinazi M, 2009, QUIM NOVA, V32, P2098, DOI 10.1590/S0100-40422009000800021; Halle I, 2013, J VERBRAUCH LEBENSM, V8, P185, DOI 10.1007/s00003-013-0822-3; Hamidi MS, 2012, J BONE MINER RES, V27, P1368, DOI 10.1002/jbmr.1566; Haugh R., 1937, US EGG POULTRY MAGAZ, V43, P522; Haugh R R., 1937, US EGG POULTRY MAGAZ, V43, P572; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kasai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132059; Kriese U, 2004, EUPHYTICA, V137, P339, DOI 10.1023/B:EUPH.0000040473.23941.76; Leger CL, 2000, OCL-OL CORPS GRAS LI, V7, P258, DOI 10.1051/ocl.2000.0258; Neijat M, 2014, POULTRY SCI, V93, P2827, DOI 10.3382/ps.2014-03936; Oomah BD, 2002, FOOD CHEM, V76, P33, DOI 10.1016/S0308-8146(01)00245-X; SAS, 2003, SAS STAT US GUID REL; Sauveur B., 1988, REPROD POULTRY EGG P, P472; Sazmand M, 2018, ELECTRON J GEN MED, V15, DOI 10.29333/ejgm/86195	23	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217509	10.1371/journal.pone.0217509	http://dx.doi.org/10.1371/journal.pone.0217509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136626	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300048
J	Robertson, A; Judge, J; Wilson, GJ; Vernon, IJ; Delahay, RJ; McDonald, RA				Robertson, Andrew; Judge, Joanna; Wilson, G. J.; Vernon, Ian J.; Delahay, Richard J.; McDonald, Robbie A.			Predicting badger visits to farm yards and making predictions available to farmers	PLOS ONE			English	Article							TUBERCULOSIS MYCOBACTERIUM-BOVIS; MELES-MELES; DISEASE TRANSMISSION; EUROPEAN BADGERS; WILDLIFE; CATTLE; BUILDINGS; BEHAVIOR; ECOLOGY; SPECIALIZATION	The use of agricultural resources or environments by wildlife may result in opportunities for transmission of infections amongst wild animals, livestock and humans. Targeted use of biosecurity measures may therefore reduce disease risks, although this requires practical knowledge of where such measures would be most effective, and effective means of communicating risks so that stakeholders can make informed decisions about such investment. In parts of Europe, the European badger Meles meles may act as a wildlife reservoir for Mycobacterium bovis, the causative agent of bovine tuberculosis, and badger visits to farmyards may provide potential opportunities for transmission of M. bovis to cattle. Biosecurity measures are effective in reducing badger activity in farmyards, although it is unclear which farms should be targeted with such measures. We used cameras to monitor badger activity in 155 farmyards in south west England and Wales, and related variations in the presence and frequency of badger visits to farm characteristics. Badgers were recorded on camera in 40% of farmyards monitored. However, the frequency of visits was highly variable, with badgers recorded on >50% of nights in only 10% of farms. The presence of badgers in farmyards was positively associated with the density of badger setts, the number of feed stores and the number of cattle sheds, and negatively associated with the distance to the nearest active badger sett, the presence of a house/dwelling and the number of cattle housed on the farm. The frequency of visits was negatively associated with the distance to the nearest active badger sett and the number of cattle housed. Models predicted the presence/absence of badgers in farmyards with 73% accuracy (62% sensitivity, 81% specificity, using a cut off value of 0.265). Models could not distinguish between farms with low/high frequency of visits, although farms predicted as having badgers present typically had a higher frequency of visits than those that were not. We developed and present an interactive web based application: the Badger Farm Assessment Tool (BFAT), to allow users to enter the characteristics of a farm and generate a relative risk score describing the likelihood of badger visits.	[Robertson, Andrew; McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, England; [Robertson, Andrew; Judge, Joanna; Wilson, G. J.; Vernon, Ian J.; Delahay, Richard J.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Woodchester Pk, Nympsfield, England; [Judge, Joanna] Natl Biodivers Network, Nottingham, England; [Wilson, G. J.] Biocensus Ltd, Bath, Avon, England	University of Exeter; Animal & Plant Health Agency UK	Robertson, A (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, England.; Robertson, A (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Woodchester Pk, Nympsfield, England.	a.robertson@exeter.ac.uk	Delahay, Richard/GSI-4663-2022; McDonald, Robbie/AAK-2718-2020	McDonald, Robbie/0000-0002-6922-3195	DEFRA [SE3126]	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by DEFRA (SE3126) to RM. The funder (Biocensus Ltd) provided support in the form of salaries for author Gavin Wilson, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHMED H, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E3996; Allen AR, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00109; Barton K., 2020, MUMIN MULTIMODEL INF; Bates D, 2014, ARXIV14065823; Berentsen AR, 2014, EUR J WILDLIFE RES, V60, P161, DOI 10.1007/s10344-013-0760-5; Bolker B., 2017, DEALING QUASI MODELS, V1; Chang W, 2015, R PACKAGE VERSION 01, V1, P106; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Cuite CL, 2008, MED DECIS MAKING, V28, P377, DOI 10.1177/0272989X08315246; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dean GS, 2005, INFECT IMMUN, V73, P6467, DOI 10.1128/IAI.73.10.6467-6471.2005; Donaldson R, 2012, ANIM CONSERV, V15, P427, DOI 10.1111/j.1469-1795.2012.00548.x; Fine Amanda E, 2011, Vet Med Int, V2011, P765430, DOI 10.4061/2011/765430; Garnett BT, 2003, APPL ANIM BEHAV SCI, V80, P1, DOI 10.1016/S0168-1591(02)00204-6; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Gortazar C, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2014.00027; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Judge J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03809; Judge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028941; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; McDonald JL, 2018, J ANIM ECOL, V87, P101, DOI 10.1111/1365-2656.12743; Mullen EM, 2015, APPL ANIM BEHAV SCI, V171, P170, DOI 10.1016/j.applanim.2015.08.021; O'Mahony DT, 2015, VET J, V203, P126, DOI 10.1016/j.tvjl.2014.10.011; O'Mahony DT, 2014, VET J, V202, P628, DOI 10.1016/j.tvjl.2014.10.016; Palmer Mitchell V., 2012, Veterinary Medicine International, P236205, DOI 10.1155/2012/236205; Palmer MV, 2004, AM J VET RES, V65, P1483, DOI 10.2460/ajvr.2004.65.1483; Payne A, 2016, EUR J WILDLIFE RES, V62, P33, DOI 10.1007/s10344-015-0970-0; Poole DW, 2002, CROP PROT, V21, P409, DOI 10.1016/S0261-2194(01)00123-5; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robertson A, 2017, VET REC, V180, DOI 10.1136/vr.103819; Robertson A, 2016, PREV VET MED, V135, P95, DOI 10.1016/j.prevetmed.2016.11.007; Robertson A, 2015, OECOLOGIA, V178, P31, DOI 10.1007/s00442-014-3202-5; Robertson A, 2014, OECOLOGIA, V176, P409, DOI 10.1007/s00442-014-3019-2; Skuce RA, 2012, VET MED INT, P1, DOI [10.1155/2012/621210, DOI 10.1155/2012/621210]; Smith G. C., 2009, MANAGEMENT DIS WILD; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tolhurst BA, 2008, APPL ANIM BEHAV SCI, V113, P224, DOI 10.1016/j.applanim.2007.11.006; Tolhurst BA, 2009, APPL ANIM BEHAV SCI, V117, P103, DOI 10.1016/j.applanim.2008.10.009; Tuyttens FAM, 2001, ACTA THERIOL, V46, P79, DOI 10.1007/BF03192419; Walter W. David, 2012, Veterinary Medicine International, P616318; Ward AI, 2008, VET REC, V163, P107, DOI 10.1136/vr.163.4.107; Ward AI, 2006, ANIM SCI, V82, P767, DOI 10.1017/ASC2006102; Ward AI, 2010, PREV VET MED, V93, P2, DOI 10.1016/j.prevetmed.2009.09.014; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-016-1065-2; Zhang Z., 2016, ANN TRANSL MED, V4, DOI [10.3978/j.issn.2305-5839.2015.12.66, DOI 10.3978/J.ISSN.2305-5839.2015.12.66]	52	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216953	10.1371/journal.pone.0216953	http://dx.doi.org/10.1371/journal.pone.0216953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125349	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700010
J	Almeida, DS; Paz, LN; de Oliveira, DS; Silva, DN; Ristow, P; Hamond, C; Costa, F; Portela, RW; Estrela-Lima, A; Pinna, MH				Almeida, Daniela Santos; Paz, Lucas Nogueira; de Oliveira, Daiana Santos; Silva, Danielle Nascimento; Ristow, Paula; Hamond, Camila; Costa, Federico; Portela, Ricardo Wagner; Estrela-Lima, Alessandra; Pinna, Melissa Hanzen			Investigation of chronic infection by Leptospira spp. in asymptomatic sheep slaughtered in slaughterhouse	PLOS ONE			English	Article							RISK-FACTORS; STATE; GOATS; INTERROGANS; KIDNEY; SEROPREVALENCE; DIAGNOSIS; VIRULENCE; BIOFILMS; PCR	The study aimed to evaluate the histopathological characteristics of renal lesions in chronically infected sheep and with low titers of anti-Leptospira antibodies from a slaughterhouse. In the serological analysis, 24.74% (48/194) presented seroreactivity with a titer equal to or greater than 100. Among these seroreactive sheep, titers of 100 were predominant (58.33%, 28/48), with the highest titer being 1,600 (2.08%, 1/48). Serogroup Sejroe (sv. Hardjo) was the most frequent at 35.42% (17/48). Leptospiral DNA was verified in 4.12% (8/194) of the kidney samples tested, and no urine sample was positive. All the samples corresponded to the pathogenic species L. interrogans. The eight amplicons with 202-nucleotides were identical with two mismatches (presented 100% of identity) using the PCR targeting to secY gene. Histological sections of PCR-positive kidneys were submitted to direct detection by the anti-LipL32 immunohistochemistry (IHC) technique. The Leptospira spp. antigen was evident in 62.5% (5/8) of the kidneys. Positive staining was observed in the cytoplasm of tubular cells and in the form of brownish aggregates that adhered to tubular epithelial cells and projected into the lumen. Inflammatory lymphoplasmacytic infiltrate, ranging from mild to moderate, with multifocal distribution, was the predominant finding in seroreactive animals (33.33%, 16/48). The demonstration of the leptospiral antigen lining the renal tubules through IHC of naturally infected sheep confirmed by PCR characterizes renal colonization in a species with the presence of histological changes compatible with leptospirosis.	[Almeida, Daniela Santos; Paz, Lucas Nogueira; Silva, Danielle Nascimento; Estrela-Lima, Alessandra; Pinna, Melissa Hanzen] Univ Fed Bahia, Post Grad Program Anim Sci Trop, Salvador, BA, Brazil; [de Oliveira, Daiana Santos] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil; [Ristow, Paula] Univ Fed Bahia, Inst Biol, Lab Bacteriol & Hlth, Salvador, BA, Brazil; [Hamond, Camila] INIA La Estanzuela, Inst Nacl Invest Agr, Plataforma Salud Anim, Colonia, Uruguay; [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Portela, Ricardo Wagner] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA); Universidade Federal da Bahia; Universidade Federal da Bahia	Pinna, MH (corresponding author), Univ Fed Bahia, Post Grad Program Anim Sci Trop, Salvador, BA, Brazil.	melissahp@ufba.br	Portela, Ricardo/W-1794-2019; Ristow, Paula/AAP-6522-2020; Portela, RW/H-5638-2013; Estrela-Lima, Alessandra/AAL-2745-2021; Costa, Federico/G-1838-2015; Ristow, Paula/D-1276-2013; Pinna, Melissa/AAP-6512-2020	Portela, Ricardo/0000-0001-9095-776X; Portela, RW/0000-0001-9095-776X; Estrela-Lima, Alessandra/0000-0002-9879-7999; Costa, Federico/0000-0001-6951-2336; Ristow, Paula/0000-0001-8494-361X; Pinna, Melissa/0000-0002-2293-9532; Paz, Lucas Nogueira/0000-0002-3056-0362	Foundation for Research Support of the State of Bahia, Brazil [025/2010, PPP 0034/2011]	Foundation for Research Support of the State of Bahia, Brazil	This study was funded by the Foundation for Research Support of the State of Bahia, Brazil (http://www.fapesb.ba.gov.br/), Public Notice no. 025/2010 under Term of Grant PPP 0034/2011, coordinated by Melissa Hanzen Pinna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agudelo-Florez P, 2013, BIOMEDICA, V33, P82, DOI 10.7705/biomedica.v33i0.686; Ahmed A, 2011, J BACTERIOL PARASITO; Amorim R. M., 2016, Veterinaria e Zootecnia, V23, P297; Arent Z, 2013, VET REC, V173, DOI 10.1136/vr.101969; Azevedo S. S. de, 2004, Arquivos do Instituto Biologico (Sao Paulo), V71, P383; Azizi S, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i1.821; Barbante P, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-20; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114; Ribeiro TTBC, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160234; Brihuega B, 2012, REV ARGENT MICROBIOL, V44, P138; Calderon A, 2014, TROP ANIM HEALTH PRO, V46, P427, DOI 10.1007/s11250-013-0508-y; Cameron CE, 2015, CURR TOP MICROBIOL, V387, P21, DOI 10.1007/978-3-662-45059-8_3; Campos AP, 2017, TROP ANIM HEALTH PRO, V49, P899, DOI 10.1007/s11250-017-1255-2; Cortizo P, 2015, TROP ANIM HEALTH PRO, V47, P231, DOI 10.1007/s11250-014-0684-4; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; da Costa DF, 2016, SEMIN-CIENC AGRAR, V37, P819, DOI 10.5433/1679-0359.2016v37n2p819; da Silva RC, 2012, PESQUI VET BRASIL, V32, P194, DOI 10.1590/S0100-736X2012000300002; de Carvalho SM, 2011, PESQUI VET BRASIL, V31, P637, DOI 10.1590/S0100-736X2011000800001; De Oliveira D, 2016, EPIDEMIOL INFECT, V144, P2420, DOI 10.1017/S0950268816000637; Director A, 2014, J MED MICROBIOL, V63, P1234, DOI 10.1099/jmm.0.065466-0; Dorjee S, 2008, NEW ZEAL VET J, V56, P164, DOI 10.1080/00480169.2008.36829; Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6; Fornazari F, 2012, J MICROBIOL METH, V90, P321, DOI 10.1016/j.mimet.2012.06.005; Genovez M. E., 2011, Arquivos do Instituto Biologico (Sao Paulo), V78, P587; Hamond C, 2014, VET RES COMMUN, V38, P81, DOI 10.1007/s11259-013-9582-x; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; Lilenbaum W, 2008, THERIOGENOLOGY, V69, P837, DOI 10.1016/j.theriogenology.2007.10.027; Lucchesi Paula M.A., 2004, Rev. Soc. Bras. Med. Trop., V37, P131, DOI 10.1590/S0037-86822004000200003; Martins G, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-237; Mayer-Scholl A, 2011, CURR MICROBIOL, V62, P1104, DOI 10.1007/s00284-010-9829-5; Miraglia F, 2009, BRAZ J MICROBIOL, V40, P189, DOI [10.1590/S1517-83822009000100033, 10.1590/S1517-838220090001000033]; Monahan AM, 2009, VET PATHOL, V46, P792, DOI 10.1354/vp.08-VP-0265-N-REV; Santos AAN, 2015, BRAZ J MICROBIOL, V46, P1161, DOI 10.1590/S1517-838246420140873; OIE, 2014, MAN DIAGN TESTS VAC; Otaka DY, 2012, VET REC, V170, DOI 10.1136/vr.100490; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Prophet E. B., 1992, LAB METHODS HISTOTEC; Saglam YS, 2008, SMALL RUMINANT RES, V74, P119, DOI 10.1016/j.smallrumres.2007.04.006; Salaberry SRS, 2011, BRAZ J MICROBIOL, V42, P1427, DOI [10.1590/S1517-83822011000400026, 10.1590/S1517-838220110004000026]; Silva EF, 2007, VET MICROBIOL, V121, P144, DOI 10.1016/j.vetmic.2006.11.010; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Torres-Castro M, 2016, ASIAN PAC J TROP MED, V9, P140, DOI 10.1016/j.apjtm.2016.01.018	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217391	10.1371/journal.pone.0217391	http://dx.doi.org/10.1371/journal.pone.0217391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120961	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700097
J	Fan, B; Zhang, QR				Fan, Bonai; Zhang, Qianrong			Does the aura surrounding healthy-related imported products fade in China? ERP evidence for the country-of-origin stereotype	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RACIAL STEREOTYPES; BRAIN POTENTIALS; BRAND; ATTITUDES; N270; PERCEPTION; ACTIVATION; IMPLICIT; IMAGE	Chinese consumers' craze about imported products, especially foods and drugs, peaked after various safety incidents, such as the contamination of Chinese dairy products. Recently, this boom has gradually receded because of the constant quality problems of imported products and the stricter safety supervision of domestic products. Researchers have measured consumer's perception toward domestic and imported products in various ways. In the current research, we investigated whether the country-of-origin stereotype has weakened in Chinese young consumers at the neurological level. By using a word-pair paradigm, 21 young participants were required to classify positive or negative words while event-related potentials were recorded. The results showed that reaction time to identify negative words following presentation of imported products ( imported-negative condition) was longer than domestic products ( domestic-negative condition). The amplitudes of N270 and LPP evoked in the imported-negative condition were significantly larger than those in the domestic-negative condition, possibly reflecting the higher expectation conflict when participate identified the adjectives as negative primed by imported healthy-related products. These findings revealed that young Chinese consumers still evaluated imported products better than domestic products.	[Fan, Bonai; Zhang, Qianrong] Zhejiang Univ, Sch Publ Affairs, Hangzhou, Zhejiang, Peoples R China; [Fan, Bonai] Ningbo Univ, China Nonpubl Econ Res Base, Ningbo, Zhejiang, Peoples R China	Zhejiang University; Ningbo University	Zhang, QR (corresponding author), Zhejiang Univ, Sch Publ Affairs, Hangzhou, Zhejiang, Peoples R China.	3100103567@zju.edu.cn			NSFC (Natural Science Foundation of China) [71673239]; National Natural Science Foundation of China [71673239]	NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by NSFC (Natural Science Foundation of China: 71673239).; We are grateful to Mrs. Jia Jin for her valuable comments in writing and revision. We thank Hao Ding, Menglin Zhao and Wenhao Mao for their assistance with the experiments and thank Sifang Liu, Jie Jin and Huang Wang for their fruitful discussions. This work was supported by the National Natural Science Foundation of China [grant numbers 71673239].	AHMED SA, 1994, IND MARKET MANAG, V23, P323, DOI 10.1016/0019-8501(94)90048-5; Alpaslan  Yuce, 2014, INT J ADV RENEWABLE, V2, P38; Balabanis G, 2004, J ACAD MARKET SCI, V32, P80, DOI 10.1177/0092070303257644; Bartholow BD, 2003, J PERS SOC PSYCHOL, V85, P627, DOI 10.1037/0022-3514.85.4.627; Batra R, 2000, J CONSUM PSYCHOL, V9, P83, DOI 10.1207/S15327663JCP0902_3; Bennett MA, 2014, PSYCHOPHYSIOLOGY, V51, P456, DOI 10.1111/psyp.12192; BILKEY WJ, 1982, J INT BUS STUD, V13, P89, DOI 10.1057/palgrave.jibs.8490539; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cui LL, 2000, NEUROREPORT, V11, P2415, DOI 10.1097/00001756-200008030-00015; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; DOVIDIO JF, 1986, J EXP SOC PSYCHOL, V22, P22, DOI 10.1016/0022-1031(86)90039-9; ETTENSON R, 1988, J RETAILING, V64, P85; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Fernandez-Ferrin P, 2013, FOOD QUAL PREFER, V30, P299, DOI 10.1016/j.foodqual.2013.06.011; Fudali-Czyz A, 2016, NEUROSCI LETT, V628, P30, DOI 10.1016/j.neulet.2016.06.005; GAERTNER SL, 1983, SOC PSYCHOL QUART, V46, P23, DOI 10.2307/3033657; Ger G, 1999, ADV CONSUM RES, V26, P165; Gonzalez R, 2008, CLIN NEUROPHYSIOL, V119, pe155; Gootjes L, 2011, INT J PSYCHOPHYSIOL, V79, P356, DOI 10.1016/j.ijpsycho.2010.12.003; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; GURHANCANLI Z, J CONSUMER RES, V27, P96; Hu KQ, 1997, J TEXT I, V88, P104, DOI 10.1080/00405009708658576; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jia L, 2012, INT J PSYCHOL, V47, P58, DOI 10.1080/00207594.2011.580348; Jun J.W., 2007, J TARGETING MEASUREM, V15, P234, DOI DOI 10.1057/palgrave.jt.5750050; Kong J, 2000, NEUROREPORT, V11, P1195, DOI 10.1097/00001756-200004270-00010; Koubaa Y, 2008, ASIA PAC J MARKET LO, V20, P139, DOI 10.1108/13555850810864524; Kwok S, 2006, ASIA PAC J MARKET LO, V18, P163, DOI 10.1108/13555850610675634; Lai VT, 2009, BRAIN RES, V1284, P145, DOI 10.1016/j.brainres.2009.05.088; Lattner S, 2003, NEUROSCI LETT, V339, P191, DOI 10.1016/S0304-3940(03)00027-2; LEVIN IP, 1993, ADV CONSUM RES, V20, P625; Li W. K., 1994, J CONSUM PSYCHOL, V3, P187, DOI DOI 10.1016/S1057-7408(08)80004-6; Liefeld J.P., 2004, J CONSUM BEHAV, V4, P85, DOI [10.1002/cb.161, DOI 10.1002/CB.161]; Ma QG, 2007, NEUROREPORT, V18, P1031, DOI 10.1097/WNR.0b013e3281667d59; Ma QG, 2014, NEUROREPORT, V25, P760, DOI 10.1097/WNR.0000000000000171; Maronick T. J., 1995, INT MARKET REV, V12, P15; Min BK, 2014, NEUROREPORT, V25, P274, DOI 10.1097/WNR.0000000000000102; Morin C, 2011, SOCIETY, V48, P131, DOI 10.1007/s12115-010-9408-1; NAGASHIMA A, 1970, J MARKETING, V34, P68, DOI 10.2307/1250298; Pharr JM, 2005, J MARKET THEORY PRAC, V13, P34, DOI 10.1080/10696679.2005.11658557; Phillips WJ, 2013, INT J HOSP MANAG, V32, P49, DOI 10.1016/j.ijhm.2012.04.003; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; Post K., 2014, HONORS PROJECTS; Samiee S, 2005, J INT BUS STUD, V36, P379, DOI 10.1057/palgrave.jibs.8400145; Samiee S, 2011, INT MARKET REV, V28, P473, DOI 10.1108/02651331111167598; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Scannella S, 2016, BEHAV BRAIN RES, V297, P231, DOI 10.1016/j.bbr.2015.10.014; SCHOOLER RD, 1965, J MARKETING RES, V2, P394, DOI 10.2307/3149486; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHIMP TA, 1987, J MARKETING RES, V24, P280, DOI 10.2307/3151638; Sin L., 2000, ASIA PACIFIC J MARKE, V12, P37; Tabassi S, 2012, AFRICAN J BUSINESS M, V6; Thakor M. V., 2003, Journal of Product & Brand Management, V12, P394, DOI 10.1108/10610420310498821; Tseng TH, 2011, INT MARKET REV, V28, P581, DOI 10.1108/02651331111181420; Verlegh PWJ, 1999, J ECON PSYCHOL, V20, P521, DOI 10.1016/S0167-4870(99)00023-9; Wang HJ, 2001, NEUROSCI LETT, V298, P155, DOI 10.1016/S0304-3940(00)01757-2; Wang L, 2011, BRAIN RES, V1375, P103, DOI 10.1016/j.brainres.2010.12.021; Wang P, 2017, INT J PSYCHOPHYSIOLO; Wang YP, 2004, PSYCHOPHYSIOLOGY, V41, P21, DOI 10.1111/j.1469-8986.2003.00134.x; White KR, 2009, SOC COGN AFFECT NEUR, V4, P191, DOI 10.1093/scan/nsp004; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wittenbrink B, 1997, J PERS SOC PSYCHOL, V72, P262, DOI 10.1037/0022-3514.72.2.262; Xie Y, 2018, NEUROSCI LETT, V687, P164, DOI 10.1016/j.neulet.2018.09.045; Yeong NC, 2007, ASIAN ACAD MANAG J, V12, P1; Yoon C, 2006, J CONSUM RES, V33, P31, DOI 10.1086/504132; Zhang X, 2003, CLIN NEUROPHYSIOL, V114, P2461, DOI 10.1016/S1388-2457(03)00251-7; Zhang X, 2008, EXP BRAIN RES, V186, P335, DOI 10.1007/s00221-008-1285-0	69	2	2	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216866	10.1371/journal.pone.0216866	http://dx.doi.org/10.1371/journal.pone.0216866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120899	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700035
J	Gowen, R; Filipowicz, A; Ingram, KK				Gowen, Rebecca; Filipowicz, Allan; Ingram, Krista K.			Chronotype mediates gender differences in risk propensity and risk-taking	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; SOCIAL JETLAG; CIRCADIAN TYPOLOGY; DECISION-MAKING; SEX-DIFFERENCES; SELF-CONTROL; SLEEP; BEHAVIOR; ANXIETY; WOMEN	Risk-taking is a complex form of decision-making that involves calculated assessments of potential costs and rewards that may be immediate or delayed. Thus, making predictions about inter-individual variation in risk-taking due to personality traits, decision styles or other attributes can be difficult. The association of risk-taking with gender is well-supported; males report higher propensity for risk-taking and show higher risk-taking on tasks measuring actual risk-taking behavior. Risk-taking also appears to be associated with circadian phenotypes ( chronotypes), with evening-types reporting higher levels of risk-taking-but this association may be confounded by the fact that, in certain age groups, males are more likely to be evening-types. Here, we test for gender by chronotype effects on risk-taking in young adults ( n = 610) using a self-reported risk propensity questionnaire, the health domain of the DOSPERT, and a behavioral task measuring risk-taking, the Balloon Analog Risk Task ( BART). Our results show that males report and take significantly more risks than females in this population. In addition, evening-type individuals have significantly higher self-reported risk propensity and tend to take more risks on the BART. Interestingly, there is no significant difference in risk propensity or risk-taking behavior across male circadian phenotypes, but evening-type females significantly report and take more risk than female intermediate and morning types. In regression analyses, we found both gender and chronotype predict risk propensity and risk-taking. Path analysis confirms that chronotype has an indirect effect on gender differences in both risk propensity and risk-taking. Furthermore, we found that trait anxiety ( STAI) and sleep disturbance ( PROMIS), significantly correlate with chronotype and gender in the complete dataset, but do not independently predict differences in female risk-taking. These results suggest that chronotype mediates gender effects on risk-taking and that these effects are driven primarily by morning-type females, but are not related to gender-specific differences in trait anxiety or sleep quality.	[Gowen, Rebecca; Ingram, Krista K.] Colgate Univ, Biol Dept, Hamilton, NY 13346 USA; [Filipowicz, Allan] Cornell Univ, SC Johnson Coll Business, Ithaca, NY USA	Colgate University; Cornell University	Ingram, KK (corresponding author), Colgate Univ, Biol Dept, Hamilton, NY 13346 USA.	kingram@colgate.edu			Picker Interdisciplinary Science Institute	Picker Interdisciplinary Science Institute	This research was funded by a Picker Interdisciplinary Science Institute grant to KKI and AF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan A, 2002, CHRONOBIOL INT, V19, P709, DOI 10.1081/CBI-120005390; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Adan A, 2010, CHRONOBIOL INT, V27, P606, DOI 10.3109/07420521003663827; [Anonymous], 1988, STAT POWER ANAL BEHA; Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Butler GKL, 2004, DRUG ALCOHOL DEPEN, V76, P55, DOI 10.1016/j.drugalcdep.2004.04.003; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Caci H, 2004, EUR PSYCHIAT, V19, P79, DOI 10.1016/j.eurpsy.2003.09.007; Digdon N, 2008, CHRONOBIOL INT, V25, P1029, DOI 10.1080/07420520802553671; Farstad SM, 2015, PSYCHOL ADDICT BEHAV, V29, P805, DOI 10.1037/adb0000069; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Giorgetta C, 2012, EMOTION, V12, P1373, DOI 10.1037/a0029119; Gunia BC, 2014, PSYCHOL SCI, V25, P2272, DOI 10.1177/0956797614541989; Haraszti RA, 2014, CHRONOBIOL INT, V31, P603, DOI 10.3109/07420528.2013.879164; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hayes AF, 2013, J CHEM INFORM MODELI, V53; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hornik J, 2009, INT J RES MARK, V26, P34, DOI 10.1016/j.ijresmar.2008.04.002; Ingram KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29392; Killgore WDS, 2007, PSYCHOL REP, V100, P613, DOI 10.2466/PRO.100.3.613-626; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Maestripieri D, 2014, EVOL PSYCHOL-US, V12, P130; Maner JK, 2006, BEHAV THER, V37, P181, DOI 10.1016/j.beth.2005.11.003; Maner JK, 2007, PERS INDIV DIFFER, V42, P665, DOI 10.1016/j.paid.2006.08.016; May CP, 1999, PSYCHON B REV, V6, P142, DOI 10.3758/BF03210822; Mitte K, 2007, PERS INDIV DIFFER, V43, P243, DOI 10.1016/j.paid.2006.11.028; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Panno A, 2018, SEX ROLES, V78, P286, DOI 10.1007/s11199-017-0781-8; Ponzi D, 2014, PSYCHOL REP, V115, P932, DOI 10.2466/19.12.PR0.115c28z5; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Randler C, 2011, PERS INDIV DIFFER, V50, P148, DOI 10.1016/j.paid.2010.09.016; Randler C, 2009, J APPL SOC PSYCHOL, V39, P2787, DOI 10.1111/j.1559-1816.2009.00549.x; Reniers R., 2016, PLOS ONE, V11, P1; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Santhi N, 2016, P NATL ACAD SCI USA, V113, pE2730, DOI 10.1073/pnas.1521637113; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stolarski M, 2013, BIOL RHYTHM RES, V44, P181, DOI 10.1080/09291016.2012.656248; Tonetti L, 2010, EUR PSYCHIAT, V25, P111, DOI 10.1016/j.eurpsy.2009.09.007; Tonetti L, 2016, BIOL RHYTHM RES, V47, P573, DOI 10.1080/09291016.2016.1167312; Trenell MI, 2007, CLIN EXP PHARMACOL P, V34, P1, DOI 10.1111/j.1440-1681.2007.04541.x; Wang LL, 2015, J PSYCHOL, V149, P394, DOI 10.1080/00223980.2014.885874; Wang LX, 2007, PSYCHON B REV, V14, P51, DOI 10.3758/BF03194027; Weafer J, 2014, ADDICT BEHAV, V39, P1573, DOI 10.1016/j.addbeh.2013.10.033; Weinstein A., 2015, CURR BEHAV NEUROSCI, V2, P9, DOI [10.1007/s40473-015-0031-8, DOI 10.1007/S40473-015-0031-8]; Wieth MB, 2011, THINK REASONING, V17, P387, DOI 10.1080/13546783.2011.625663; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	55	14	14	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216619	10.1371/journal.pone.0216619	http://dx.doi.org/10.1371/journal.pone.0216619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120931	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700022
J	Dupas, MC; Halloy, J; Chatzimpiros, P				Dupas, Marie-Cecile; Halloy, Jose; Chatzimpiros, Petros			Time dynamics and invariant subnetwork structures in the world cereals trade network	PLOS ONE			English	Article								The development of industrial agriculture has enabled a sharp increase in food trade at the global scale. Worldwide trade underpins food security by distributing food surpluses to food deficient countries. The study of agricultural product flows can provide insights on the complex interactions between exporting and importing countries and the resulting network structures. Commercial partnerships between countries can be modelled using a complex network approach. Based on the detailed trade matrices from FAO covering the period from 1986 to 2013, we present an analysis of the world cereal trade in terms of weighted and directed networks. The network nodes are the countries and the links are the trades of agricultural products in mass. We reveal the changing topology and degree distribution of the world network during the studied period. We distinguish three entangled subnetwork structures when considering the temporal stability of the trades. The three subnetworks display distinct properties and a differential contribution in total trade. Trades of uninterrupted activity over the 28-year study period compose the backbone network which accounts for two thirds of all traded mass and is scale-free. Inversely, two thirds of the trades only have one or two consecutive years of activity and define the transient subnetwork which displays random growth and accounts for very little traded mass. The trades of intermediate duration display an exponential growth both in numbers and in traded mass and define the intermediate subnetwork. The topology of each subnetwork is a time invariant. The identification of invariant structures is a useful basis for developing prospective agri-food network modelling to assess their resilience to perturbations and shocks.	[Dupas, Marie-Cecile; Halloy, Jose; Chatzimpiros, Petros] Univ Paris Diderot, LIED, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Dupas, MC (corresponding author), Univ Paris Diderot, LIED, Paris, France.	marie-cecile.dupas@univ-paris-diderot.fr		Halloy, Jose/0000-0003-1555-2484; Dupas, Marie-Cecile/0000-0002-8769-2243	research program Emergence Ville de Paris Convention [2015 DDEES 165]	research program Emergence Ville de Paris Convention	The work built on funds of the research program Emergence Ville de Paris Convention 2015 DDEES 165.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi A.-L., 2016, NETWORK SCI; Barabasi A-L., 2003, LINKED NEW SCI NETWO; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Carr JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051247; Chapagain A.K., 2003, VALUE WATER RES REPO, V13; d'Amour CB, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035007; D'Odorico P, 2014, EARTHS FUTURE, V2, P458, DOI 10.1002/2014EF000250; D'Odorico P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034007; Dalin C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053871; Dalin C, 2012, P NATL ACAD SCI USA, V109, P5989, DOI 10.1073/pnas.1203176109; Dang Q, 2015, WATER RESOUR RES, V51, P973, DOI 10.1002/2014WR015919; De Benedictis L, 2014, GLOB ECON J, V14, P287, DOI 10.1515/gej-2014-0032; Deng WB, 2011, PHYSICA A, V390, P1481, DOI 10.1016/j.physa.2010.12.029; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fair KR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07202-y; Gephart JA, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125014; Hagberg A. A., 2008, P 7 PYTHON SCI C, P11, DOI DOI 10.25080/ISSN.2575-9752; HARLEY CK, 1980, EXPLOR ECON HIST, V17, P218; IPCC, 2014, CONTRIBUTION WORKING; Kastner T, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034015; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Konar M, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011959; Konar M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010307; Konar M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199498; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Lin XW, 2014, ENVIRON SCI TECHNOL, V48, P5439, DOI 10.1021/es500471d; Marchand P, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/095009; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Newman M., 2018, HEGELS INTERPRETATIO; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035101; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noldus R, 2015, J COMPLEX NETW, V3, P507, DOI 10.1093/comnet/cnv005; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Puma MJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024007; Sartori M, 2015, FOOD POLICY, V57, P114, DOI 10.1016/j.foodpol.2015.10.004; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Seaquist JW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114006; Suweis S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046837; Suweis S, 2015, P NATL ACAD SCI USA, V112, P6902, DOI 10.1073/pnas.1507366112; Tigchelaar M, 2018, P NATL ACAD SCI USA, V115, P6644, DOI 10.1073/pnas.1718031115; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Torreggiani S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabf23; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei-Bing D., 2009, CHINESE PHYS LETT, V26, DOI [10.1088/0256-307X/26/11/118901, DOI 10.1088/0256-307X/26/11/118901]; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Winders B., 2016, GRAINS; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102; Zhao K, 2011, IEEE SYST J, V5, P28, DOI 10.1109/JSYST.2010.2100192	52	15	15	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216318	10.1371/journal.pone.0216318	http://dx.doi.org/10.1371/journal.pone.0216318			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116751	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400017
J	Lakshminarayanan, K; Shah, R; Li, ZM				Lakshminarayanan, Kishor; Shah, Rakshit; Li, Zong-Ming			Sex-related differences in carpal arch morphology	PLOS ONE			English	Article							TUNNEL-SYNDROME; WRIST RATIO; ANATOMY; DIAGNOSIS	The purpose of this study was to investigate the sex-based differences in the carpal arch morphology. Carpal arch morphology was quantified using palmar bowing and area of the arch formed by the transverse carpal ligament. The carpal arch was imaged at the distal and proximal tunnel levels using ultrasonography in 20 healthy young adults (10 women and 10 men). It was found that females had a smaller carpal arch height compared to men at both distal and proximal levels (p<0.05) and smaller carpal arch width only at the proximal level (p<0.05) but not distally. Palmar bowing index, the carpal arch height to width ratio, was significantly smaller in females at the distal level (p<0.05) but not at the proximal level. Carpal arch cross-sectional area normalized to the wrist cross-sectional area was found to be significantly smaller in females at both tunnel levels compared to men (p<0.05). This study demonstrates that females have a smaller carpal arch compared to men with a reduced palmar bowing distally and a smaller arch area at both tunnel levels. The findings help explain the higher incidence of carpal tunnel syndrome in women as a smaller carpal arch makes the median nerve more vulnerable to compression neuropathy.	[Lakshminarayanan, Kishor; Shah, Rakshit; Li, Zong-Ming] Cleveland Clin, Hand Res Lab, Dept Biomed Engn, Cleveland, OH 44106 USA; [Shah, Rakshit; Li, Zong-Ming] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA; [Li, Zong-Ming] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Hand Res Lab, Dept Biomed Engn, Cleveland, OH 44106 USA.; Li, ZM (corresponding author), Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.; Li, ZM (corresponding author), Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA.; Li, ZM (corresponding author), Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA.	liz@ccf.org	Lakshminarayanan, Kishor/AAA-6236-2019	Li, Zong-Ming/0000-0002-9636-7012; SHAH, RAKSHIT/0000-0003-4297-1756	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR068278]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068278] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study described in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR068278. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bianchi S, 2007, MED RADIOL DIAGN IMA, P425, DOI 10.1007/978-3-540-28163-4_10; Bower JA, 2006, CLIN BIOMECH, V21, P816, DOI 10.1016/j.clinbiomech.2006.04.008; Brett AW, 2014, CLIN BIOMECH, V29, P601, DOI 10.1016/j.clinbiomech.2014.05.003; BUCHBERGER W, 1992, AM J ROENTGENOL, V159, P793, DOI 10.2214/ajr.159.4.1529845; COBB TK, 1993, J HAND SURG-AM, V18A, P91, DOI 10.1016/0363-5023(93)90251-W; Farmer JE, J HAND SURG; Ghasemi-rad M, 2014, WORLD J RADIOL, V6, P284, DOI 10.4329/wjr.v6.i6.284; GORDON C, 1988, AM J PHYS MED REHAB, V67, P270; Horch RE, 1997, NEUROSURGERY, V41, P76, DOI 10.1097/00006123-199707000-00016; Kim HS, 2012, J ULTRAS MED, V31, P23, DOI 10.7863/jum.2012.31.1.23; Li Zong-Ming, 2005, Journal of Musculoskeletal Research, V9, P153, DOI 10.1142/S0218957705001527; LIN R, 1983, HAND, V15, P305; Monagle K, 1999, AM J ROENTGENOL, V172, P1581, DOI 10.2214/ajr.172.6.10350293; Pacek Corey A, 2010, Hand (N Y), V5, P77, DOI 10.1007/s11552-009-9220-9; Peterson C., 2013, JWHPT, V37, P108; PHALEN GS, 1972, CLIN ORTHOP RELAT R, P29; RADECKI P, 1994, AM J PHYS MED REHAB, V73, P157, DOI 10.1097/00002060-199406000-00003; Rotman MB, 2002, HAND CLIN, V18, P219, DOI 10.1016/S0749-0712(01)00003-8; Sassi SA, 2016, J HAND SURG-EUR VOL, V41, P638, DOI 10.1177/1753193415625404; Xiu KH, 2010, CLIN BIOMECH, V25, P776, DOI 10.1016/j.clinbiomech.2010.05.011	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217425	10.1371/journal.pone.0217425	http://dx.doi.org/10.1371/journal.pone.0217425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116798	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400061
J	Zaman, A; Arif, Z; Moinuddin; Akhtar, K; Ali, WM; Alam, K				Zaman, Asif; Arif, Zarina; Moinuddin; Akhtar, Kafil; Ali, Wasif Mohammad; Alam, Khursheed			A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FATTY LIVER; OXIDANT STRESS; NADPH OXIDASE; MODIFIED DNA; RECEPTOR; DISEASE; ALBUMIN; DYSREGULATION; ACTIVATION	Over consumption of fructose may lead to obesity and dyslipidemia and cause fructosylation-induced alterations in the structure and function of proteins. The aim of this study was to investigate the role of fructosylated-HSA-AGE in the pathogenesis of fatty liver (NAFLD and NASH) by biochemical, immunological and histological studies. Immunogenicity of fructosylated-HSA-AGE was probed by inducing antibodies in rabbits. Fructosylated-HSA-AGE was found to be highly immunogenic. Furthermore, fructosylated-HSA-AGE caused mild fibrosis with steatosis and portal inflammation of hepatocytes in experimental animals. Liver function test and dyslipidemic parameters in immunized animals were also found to be raised. Ultrasonography, which should form part of the assessment of chronically raised transaminases, shows fatty infiltration. Interestingly, alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, total cholesterol (TC) and triglyceride (TG) profiles confirms USG images of overweight, obese patients. Thus, present study demonstrates that fructosylated-HSA-AGE is hepatotoxic, immunologically active and may cause dyslipidemia.	[Zaman, Asif; Arif, Zarina; Moinuddin; Alam, Khursheed] Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India; [Akhtar, Kafil] Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Pathol, Aligarh, Uttar Pradesh, India; [Ali, Wasif Mohammad] Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Surg, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University	Alam, K (corresponding author), Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India.	kalam786@rediffmail.com	Akhtar, Kafil/AAA-9467-2021; Arif, Zarina/AAI-4441-2020	Akhtar, Kafil/0000-0002-3482-1195; Arif, Zarina/0000-0002-8895-353X; Zaman, Asif/0000-0003-2518-6772; Alam, Khursheed/0000-0001-9729-9966	Indian Council of Medical Research, New Delhi [61/01/2011-BMS]; University Grants Commission, New Delhi	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); University Grants Commission, New Delhi(University Grants Commission, India)	The major part of the work was supported by Indian Council of Medical Research, New Delhi, research grant no. 61/01/2011-BMS to KA. Asif Zaman is thankful to the University Grants Commission, New Delhi, for financial assistance in the form of fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam K, 2007, CELL IMMUNOL, V247, P12, DOI 10.1016/j.cellimm.2007.06.007; Ali Rashid, 2002, Methods Mol Biol, V186, P171; Allarakha S, 2015, IUBMB LIFE, V67, P338, DOI 10.1002/iub.1375; Arif B, 2012, ARCH BIOCHEM BIOPHYS, V522, P17, DOI 10.1016/j.abb.2012.04.005; Arroyo V, 2014, J HEPATOL, V61, P396, DOI 10.1016/j.jhep.2014.04.012; Ashraf JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116804; Ashraf JM, 2014, IUBMB LIFE, V66, P686, DOI 10.1002/iub.1318; Baig MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06067-5; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Basta G, 2011, LIVER TRANSPLANT, V17, P633, DOI 10.1002/lt.22306; Bhatt HB, 2015, HEPATOL SURG NUTR, V4, P101, DOI 10.3978/j.issn.2304-3881.2015.01.03; Bidwell AJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060549; Das AK., 2014, ASIAN J MED SCI, V6, P40, DOI DOI 10.3126/AJMS.V6I1.10147; Del Turco S, 2012, BIOFACTORS, V38, P266, DOI 10.1002/biof.1018; Dixit K, 2004, LUPUS, V13, P95, DOI 10.1191/0961203304lu492oa; Engelmann G, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.14112; Gaens KHJ, 2014, ARTERIOSCL THROM VAS, V34, P1199, DOI 10.1161/ATVBAHA.113.302281; Gaens KHJ, 2012, J HEPATOL, V56, P647, DOI 10.1016/j.jhep.2011.07.028; Goodwin M, 2013, J GASTROEN HEPATOL, V28, P369, DOI 10.1111/jgh.12042; Pereira ENGD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179654; Gugliucci A, 2017, ADV NUTR, V8, P54, DOI 10.3945/an.116.013912; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Habib S, 2005, INT J BIOL MACROMOL, V35, P221, DOI 10.1016/j.ijbiomac.2005.02.005; Herman MA, 2016, TRENDS ENDOCRIN MET, V27, P719, DOI 10.1016/j.tem.2016.06.005; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x; Jegatheesan P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030230; Kelly DJ, 2001, J AM SOC NEPHROL, V12, P2098, DOI 10.1681/ASN.V12102098; Khan MA, 2009, SCAND J IMMUNOL, V69, P99, DOI 10.1111/j.1365-3083.2008.02200.x; Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364; Leung C, 2016, WORLD J GASTROENTERO, V22, P8026, DOI 10.3748/wjg.v22.i35.8026; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; Mastrocola R, 2016, FREE RADICAL BIO MED, V91, P224, DOI 10.1016/j.freeradbiomed.2015.12.022; Mastrocola R, 2013, AM J PHYSIOL-GASTR L, V305, pG398, DOI 10.1152/ajpgi.00450.2012; de Castro UGM, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-136; Neelofar, 2015, RSC ADV, V5, P63605, DOI 10.1039/c5ra07232h; Neelofar K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172074; Nomura K, 2012, J NUTR BIOCHEM, V23, P203, DOI 10.1016/j.jnutbio.2011.09.006; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Patel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035143; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; RAWAT AK, 1975, DIABETES, V24, P926, DOI 10.2337/diabetes.24.10.926; Safer AM, 2015, EXP THER MED, V9, P787, DOI 10.3892/etm.2014.2158; Santos JCD, 2013, INT J MOL SCI, V14, P19846, DOI 10.3390/ijms141019846; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Serra D, 2013, ANTIOXID REDOX SIGN, V19, P269, DOI 10.1089/ars.2012.4875; Sun SZ, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-89; Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539; Takeuchi M, 2010, LAB INVEST, V90, P1117, DOI 10.1038/labinvest.2010.62; Tsuneyama K, 2013, CLIN REV ALLERG IMMU, V45, P143, DOI 10.1007/s12016-013-8383-x; VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Yagmur E, 2006, CLIN BIOCHEM, V39, P39, DOI 10.1016/j.clinbiochem.2005.07.016; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yilmaz Y, 2012, ALIMENT PHARM THER, V35, P1135, DOI 10.1111/j.1365-2036.2012.05080.x; Zaman A, 2018, INT J BIOL MACROMOL, V109, P896, DOI 10.1016/j.ijbiomac.2017.11.069	58	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216736	10.1371/journal.pone.0216736	http://dx.doi.org/10.1371/journal.pone.0216736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116779	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400028
J	Broekel, T				Broekel, Tom			Using structural diversity to measure the complexity of technologies	PLOS ONE			English	Article							PRODUCT DEVELOPMENT; BUILDING-BLOCKS; HIGH-TECH; KNOWLEDGE; INNOVATION; CAPABILITIES; IMITATION; GROWTH; DESIGN; SYSTEM	The paper introduces structural diversity as a new approach to quantify the complexity of technologies. By modeling technologies as combinatorial networks, a measure of technological complexity is derived that represents the diversity of (sub-)network topologies in these networks. It is further argued that this measure can be empirically approximated with the Network Diversity Score (NDS). The paper also presents an application of this approach to European patent data from 1980 to 2015. On this basis, the measure of structural diversity is shown to replicate a number of stylized facts commonly associated with technological complexity: Complexity increases over time and younger technologies are more complex than older technologies. Complex technologies are also associated to larger R&D efforts and require more collaborative R&D activities. Lastly, when controlling for technologies' size, technologies scoring high on structural diversity are also shown to concentrate in space.	[Broekel, Tom] Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands	Utrecht University	Broekel, T (corresponding author), Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands.	t.broekel@uu.nl	Broekel, Tom/K-7048-2014	Broekel, Tom/0000-0003-4516-4626				Acs ZJ, 2002, RES POLICY, V31, P1069, DOI 10.1016/S0048-7333(01)00184-6; Almeida P, 1996, STRATEGIC MANAGE J, V17, P155, DOI 10.1002/smj.4250171113; Arthur B.W., 2009, NATURE TECHNOLOGY WH; Arundel A, 1998, RES POLICY, V27, P127, DOI 10.1016/S0048-7333(98)00033-X; Aunger R, 2010, TECHNOL FORECAST SOC, V77, P762, DOI 10.1016/j.techfore.2010.01.008; Balland PA, 2017, ECON GEOGR, V93, P1, DOI 10.1080/00130095.2016.1205947; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Breschi S, 2011, KITES SEMINARPAPERS, P1; Camagni R., 1991, INNOVATION NETWORKS, P121; Carbonell P, 2006, J BUS RES, V59, P225, DOI 10.1016/j.jbusres.2005.08.002; Coad A, 2008, RES POLICY, V37, P633, DOI 10.1016/j.respol.2008.01.003; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; COOKE P, 1992, GEOFORUM, V23, P365, DOI 10.1016/0016-7185(92)90048-9; Dalmazzo A, 2002, SCAND J ECON, V104, P515, DOI 10.1111/1467-9442.00299; Dehmer M, 2009, PLOS ONE, V4, P20; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Emmert-Streib F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034523; EPO JPO USPTO, 2007, TRIL STAT REP; Fai F., 2001, Structural Change and Economic Dynamics, V12, P141, DOI 10.1016/S0954-349X(00)00035-7; FELDMAN M. P., 1996, AM ECON REV, V86, P253; Fleming L, 2001, RES POLICY, V30, P1019, DOI 10.1016/S0048-7333(00)00135-9; FLORIDA R, 1995, FUTURES, V27, P527, DOI 10.1016/0016-3287(95)00021-N; Goldreich O, 1998, SIAM J COMPUT, V27, P1116, DOI 10.1137/S0097539795280524; Goldreich O, 1999, COMPUT COMPLEX, V8, P50, DOI 10.1007/s000370050019; Griffin A, 1997, J MARKETING RES, V34, P24, DOI 10.2307/3152062; GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301; Hagerstrand T., 1967, INNOVATION DIFFUSION; Hargadon A., 2003, BREAKTHROUGHS HAPPEN; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Hidalgo C., 2015, WHY INFORM GROWS EVO; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Howitt P, 1999, J POLIT ECON, V107, P715, DOI 10.1086/250076; JAFFE AB, 1989, RES POLICY, V18, P87, DOI 10.1016/0048-7333(89)90007-3; Kim BW, 2015, J GLOBAL EC, V03, DOI [10.1016/j.econlet.2006.09.009, DOI 10.1016/J.ECONLET.2006.09.009]; Kim S, 2018, STRATEGIC MANAGE J, V39, P1959, DOI 10.1002/smj.2899; KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383; Madsen JB, 2007, ECON LETT, V95, P161, DOI 10.1016/j.econlet.2006.09.009; McNerney J, 2011, P NATL ACAD SCI USA, V108, P9008, DOI 10.1073/pnas.1017298108; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; NELSON RR, 1982, AM ECON REV, V72, P114; Pavitt K., 1998, IND CORP CHANGE, V7, P433, DOI DOI 10.1093/ICC/7.3.433; Pintea M, 2007, REV ECON DYNAM, V10, P276, DOI 10.1016/j.red.2006.12.001; Prencipe A, 2000, RES POLICY, V29, P895, DOI 10.1016/S0048-7333(00)00111-6; Rivkin JW, 2000, MANAGE SCI, V46, P824, DOI 10.1287/mnsc.46.6.824.11940; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Saenz J, 2009, J INTELLECT CAP, V10, P22, DOI 10.1108/14691930910922879; Schmoch U., 2003, LINKING TECHNOLOGY A; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Singh K, 1997, ACAD MANAGE J, V40, P339, DOI 10.2307/256886; Sorenson O, 2004, RES POLICY, V33, P1615, DOI 10.1016/j.respol.2004.09.008; Sorenson O, 2006, RES POLICY, V35, P994, DOI 10.1016/j.respol.2006.05.002; Sorenson O, 2005, INT STUD ENTREP, V6, P79; STEWARD DV, 1981, IEEE T ENG MANAGE, V28, P71, DOI 10.1109/TEM.1981.6448589; TEECE DJ, 1977, ECON J, V87, P242, DOI 10.2307/2232084; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Wikipedia, 2017, SOURC LIN COD; Ye FY, SCI METRICS ANAL QUA; ZANDER U, 1995, ORGAN SCI, V6, P76, DOI 10.1287/orsc.6.1.76; 2008, RES POLICY, V37, P633, DOI DOI 10.1016/J.RESPOL.2008.01.003; 2009, RES POLICY, V38, P470, DOI DOI 10.1016/J.RESPOL.2008.10.018	61	18	18	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216856	10.1371/journal.pone.0216856	http://dx.doi.org/10.1371/journal.pone.0216856			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY9HS	31112571	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000028
J	Gwyther, K; Swann, R; Casey, K; Purcell, R; Rice, SM				Gwyther, Kate; Swann, Ray; Casey, Kate; Purcell, Rosemary; Rice, Simon M.			Developing young men's wellbeing through community and school-based programs: A systematic review	PLOS ONE			English	Review							MENTAL-HEALTH-SERVICES; HELP-SEEKING; EMOTIONAL INTELLIGENCE; PHYSICAL-ACTIVITY; AGED CHILDREN; BODY-IMAGE; ADOLESCENT; MASCULINITY; INTERVENTIONS; BOYS	Boys and young men have unique health-related needs that may be poorly met by existing programs and initiatives. The mismatch between the needs of boys and young men and current service offerings driven largely by social determinants of health such as masculinity-may stymie health status. This is evidenced through high rates of self-stigma, accidental death or suicide, and low rates of help seeking and health literacy among populations of boys and young men. With growing interest in improving wellbeing and educational outcomes for all young people (including boys and young men), this systematic review aimed to evaluate community and school-based programs with specific focus on program features and outcomes directly relevant to young males aged 12-25 years. Five data-bases were searched; Medline, EMBASE, Psyclnfo, ERIC, and ERAD. Articles were included if they evaluated an intervention or program with a general or at-risk sample of young men, and measured a psychological, psychosocial, masculinity, or educational outcome. The majority of the 40 included studies had high quality reporting (62.5%). Synthesised data included theoretical frameworks, intervention characteristics, outcomes, and key results. Of the included studies, 14 were male-focussed programs, with masculinity approaches directed towards program aims and content information. The emergent trend indicated that male-targeted interventions may be more beneficial for young men than gender-neutral programs, however, none of these studies incorporated masculine-specific theory as an overarching framework. Furthermore, only three studies measured masculine-specific variables. Studies were limited by a lack of replication and program refinement approaches. It is concluded that there is significant scope for further development of community and school-based health promotion programs that target young men through incorporation of frameworks that consider the impact of gendered social and environmental determinants of health. Evaluation of these programs will provide researchers and practitioners with the capacity for translating beneficial outcomes into best-practice policy.	[Gwyther, Kate; Purcell, Rosemary; Rice, Simon M.] Orygen, Natl Ctr Excellence Youth Mental Hlth, Melbourne, Vic, Australia; [Gwyther, Kate; Purcell, Rosemary; Rice, Simon M.] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Swann, Ray; Casey, Kate] Brighton Grammar Sch, Crowther Ctr, Melbourne, Vic, Australia; [Rice, Simon M.] Orygen Youth Hlth, Youth Mood Clin, Melbourne, Vic, Australia	Orygen, The National Centre of Excellence in Youth Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health	Rice, SM (corresponding author), Orygen, Natl Ctr Excellence Youth Mental Hlth, Melbourne, Vic, Australia.; Rice, SM (corresponding author), Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia.; Rice, SM (corresponding author), Orygen Youth Hlth, Youth Mood Clin, Melbourne, Vic, Australia.	simon.rice@orygen.irg.au	Rice, Simon/J-5656-2014; Swann, Ray/AAN-6870-2020	Rice, Simon/0000-0003-4045-8553; Gwyther, Kate/0000-0001-6353-1587				Adams LA, 2008, S AFR J PSYCHOL, V38, P551, DOI 10.1177/008124630803800309; Ashton LM, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0227-8; Ashton LM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0257-6; Australian Bureau of Statistics, 2017, CAUS OF DEATH; Bademci HO, 2015, CHILD YOUTH SERV REV, V49, P20, DOI 10.1016/j.childyouth.2014.12.019; Baker D., 2017, KEEPING IT REAL REIM; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bannink R, 2014, J MED INTERNET RES, V16, P51, DOI 10.2196/jmir.3163; Bannink R, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.2855; Barker G., 2007, ENGAGING MEN BOYS CH; Bertolote Jose Manoel, 2002, World Psychiatry, V1, P181; Biddle L, 2007, SOCIOL HEALTH ILL, V29, P983, DOI 10.1111/j.1467-9566.2007.01030.x; Bluth K, 2017, J CHILD FAM STUD, V26, P1900, DOI 10.1007/s10826-017-0696-6; Bowers H, 2013, CHILD ADOL MENT H-UK, V18, P165, DOI 10.1111/j.1475-3588.2012.00673.x; Broadbent R, 2014, J CHILD ADOLESC MENT, V26, P217, DOI 10.2989/17280583.2014.923431; Brown A, 2016, ASIA-PAC PSYCHIAT, V8, P3, DOI 10.1111/appy.12199; BURNS JM, 2010, MED J AUST S, V192, pS2, DOI DOI 10.2196/JMIR.2291; Calear AL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4845-z; Campbell-Heider N, 2009, J ADDICT NURS, V20, P6, DOI 10.1080/10884600802693165; Castillo R, 2013, J ADOLESCENCE, V36, P883, DOI 10.1016/j.adolescence.2013.07.001; Chu PS, 2010, J SOC CLIN PSYCHOL, V29, P624, DOI 10.1521/jscp.2010.29.6.624; Comstock DL, 2008, J COUNS DEV, V86, P279, DOI 10.1002/j.1556-6678.2008.tb00510.x; Courtenay W. H., 2003, International Journal of Men's Health, V2, P1, DOI 10.3149/jmh.0201.1; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Crooks CV, 2017, J PRIM PREV, V38, P87, DOI 10.1007/s10935-016-0457-0; Das JK, 2016, J ADOLESCENT HEALTH, V59, pS49, DOI 10.1016/j.jadohealth.2016.06.020; De Koker P, 2014, J ADOLESCENT HEALTH, V54, P3, DOI 10.1016/j.jadohealth.2013.08.008; Eate P, 2017, FEM MEDIA STUD, V17, P248, DOI 10.1080/14680777.2016.1187640; Eather N, 2016, PSYCHOL SPORT EXERC; Edwards P, 2017, AUST J RURAL HEALTH, V25, P241, DOI 10.1111/ajr.12332; Eriksson M, 2018, SOC THEOR HEALTH, V16, P414, DOI 10.1057/s41285-018-0065-6; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Eteokleous N., 2011, MULTICULTURAL ED TEC, V5, P221; Evans J, 2011, J MENS HEALTH, V8, P7, DOI 10.1016/j.jomh.2010.09.227; Fazel M, 2014, LANCET PSYCHIAT, V1, P377, DOI 10.1016/S2215-0366(14)70312-8; Fuller RD, 2013, RES Q EXERCISE SPORT, V84, P469, DOI 10.1080/02701367.2013.839025; Garaigordobil M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00743; Gibbs A, 2015, CULT HEALTH SEX, V17, P208, DOI 10.1080/13691058.2014.966150; Gonzalez-Carrasco M, 2017, J HAPPINESS STUD, V18, P63, DOI 10.1007/s10902-016-9717-1; Gough B, 2015, PROMOTING MENTAL HLT; Grace B, 2018, AM J MENS HEALTH, V12, P252, DOI 10.1177/1557988316634088; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Hamilton CJ, 2009, J COUNS PSYCHOL, V56, P132, DOI 10.1037/a0014440; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hickey C, 2008, SPORT EDUC SOC, V13, P147, DOI 10.1080/13573320801957061; Joanna Briggs Institute, 2017, CRIT APPR TOOLS AUST; Kerr Robert, 2011, Ir J Psychol Med, V28, P61, DOI 10.1017/S0790966700011459; Kiselica MS, 2010, PSYCHOTHERAPY, V47, P276, DOI 10.1037/a0021159; Levant RF, 2011, PSYCHOL MEN MASCULIN, V12, P26, DOI 10.1037/a0021014; Liddell TM, 2014, J SCH COUNSELING, V12, P1; Lubans D, 2015, J SCI MED SPORT, V1, pe75; Lubans DR, 2016, J ADOLESCENT HEALTH, V58, P230, DOI 10.1016/j.jadohealth.2015.10.010; Lynch L, 2018, AM J MENS HEALTH, V12, P138, DOI 10.1177/1557988315619469; Margalit D, 2014, CHILD YOUTH CARE FOR, V43, P181, DOI 10.1007/s10566-013-9234-x; MARSH HW, 1988, AUST J PSYCHOL, V40, P281, DOI 10.1080/00049538808260049; Martino W., 2005, CURRICULUM LEADERSHI, V3; McCabe MP, 2010, BODY IMAGE, V7, P117, DOI 10.1016/j.bodyim.2009.10.007; McLoughlin AB, 2015, QJM-INT J MED, V108, P765, DOI 10.1093/qjmed/hcv026; Moher D., 2010, PREFERRED REPORTING; Moksnes UK, 2013, QUAL LIFE RES, V22, P1331, DOI 10.1007/s11136-012-0249-9; Namy S, 2015, CULT HEALTH SEX, V17, P206, DOI 10.1080/13691058.2015.1070434; NAo S., 2018, ACH RUR HLTH EQ WELL; O'Dea JA, 2000, INT J EAT DISORDER, V28, P43, DOI 10.1002/(SICI)1098-108X(200007)28:1<43::AID-EAT6>3.0.CO;2-D; O'Kearney Richard, 2006, Cognitive Behaviour Therapy, V35, P43, DOI 10.1080/16506070500303456; O'Neil J.M., 2013, J MENS STUDIES, V21, P191, DOI DOI 10.3149/JMS.2102.191; Oliffe JL, 2018, PSYCHOL MEN MASC; Oliffe JL, 2010, HEALTH SOCIOL REV, V19, P465, DOI 10.5172/hesr.2010.19.4.465; Opper B, 2014, J PSYCHOL AFR, V24, P193, DOI 10.1080/14330237.2014.903076; Paxton SJ, 2006, J CLIN CHILD ADOLESC, V35, P539, DOI 10.1207/s15374424jccp3504_5; Pirkis J, 2017, INT J EPIDEMIOL, V46, P793, DOI 10.1093/ije/dyw055; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Rhodes J, 2008, J VOCAT BEHAV, V72, P183, DOI 10.1016/j.jvb.2007.09.005; Rice S, 2011, EDUC DEV PSYCHOL, V28, P133, DOI 10.1375/aedp.28.2.133; Rice SM, 2018, J ADOLESCENT HEALTH, V62, pS9, DOI 10.1016/j.jadohealth.2017.07.024; Rice SM, 2018, J MENT HEALTH, V27, P59, DOI 10.1080/09638237.2016.1276528; Rickwood DJ, 2007, MED J AUSTRALIA, V187, pS35, DOI 10.5694/j.1326-5377.2007.tb01334.x; Ritchie SD, 2014, RURAL REMOTE HEALTH, V14; Roberts-Douglass K, 2013, PSYCHOL MEN MASCULIN, V14, P7, DOI 10.1037/a0029662; Robinson KH, 2005, GENDER EDUC, V17, P19, DOI 10.1080/0954025042000301285; Rogers AA, 2017, PSYCHOL MEN MASCULIN, V18, P50, DOI 10.1037/men0000041; Rojiani R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00551; Rubinstein A., 2013, MAKING MEN; Rubinstein A., 2005, J COMPLEMENT MED, V4, P43; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sanchez AL, 2018, J AM ACAD CHILD PSY, V57, P153, DOI 10.1016/j.jaac.2017.11.022; Schlichthorst M, 2018, JMIR MENT HEALTH, V5, DOI 10.2196/mental.9120; Seaton CL, 2017, AM J MENS HEALTH, V11, P1823, DOI 10.1177/1557988317728353; Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002; Sekizaki R, 2017, EARLY INTERV PSYCHIA, V14, P14; Shandley K, 2010, HEALTH EDUC RES, V25, P563, DOI 10.1093/her/cyq002; Shoshani A, 2014, J HAPPINESS STUD, V15, P1289, DOI 10.1007/s10902-013-9476-1; Sibinga EMS, 2013, PREV MED, V57, P799, DOI 10.1016/j.ypmed.2013.08.027; Skre I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-873; Smith AP, 2012, PASTOR CARE EDUC, V30, P345, DOI 10.1080/02643944.2012.688062; Smith JJ, 2014, CONTEMP CLIN TRIALS, V37, P106, DOI 10.1016/j.cct.2013.11.008; Stanford JN, 2005, EUR EAT DISORD REV, V13, P360, DOI 10.1002/erv.654; SWITZER GE, 1995, J EARLY ADOLESCENCE, V15, P429, DOI 10.1177/0272431695015004003; Taylor M, 2009, AUST J GUID COUNS, V19, P131, DOI 10.1375/ajgc.19.2.131; Thompson EH, 2015, PSYCHOL MEN MASCULIN, V16, P115, DOI 10.1037/a0038609; Ueno K, 2010, SEX ROLES, V63, P580, DOI 10.1007/s11199-010-9839-6; Vandello JA, 2013, PSYCHOL MEN MASCULIN, V14, P101, DOI 10.1037/a0029826; Vella SA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5319-7; Wade L, 2018, MENT HEALTH PHYS ACT, V14, P39, DOI 10.1016/j.mhpa.2017.12.006; Wilkinson AL, 2018, PSYCHOL MEN MASCULIN, V19, P145, DOI 10.1037/men0000088; Wong YJ, 2017, J COUNS PSYCHOL, V64, P80, DOI 10.1037/cou0000176; Yousaf O, 2015, HEALTH PSYCHOL REV, V9, P264, DOI 10.1080/17437199.2013.840954; 2015, PHYS EDUC SPORT PEDA, V20, P1, DOI DOI 10.1080/17408989.2013.780592; 2013, AM J ORTHOPSYCHIAT 3, V83, P252, DOI DOI 10.1111/AJOP.12036	108	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216955	10.1371/journal.pone.0216955	http://dx.doi.org/10.1371/journal.pone.0216955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY7BF	31107908	Green Published, gold			2022-12-27	WOS:000468285200022
J	Cooper, AM; MacDonald, C; Roberts, TE; Bridge, TCL				Cooper, Amanda M.; MacDonald, Chancey; Roberts, T. Edward; Bridge, Tom C. L.			Variability in the functional composition of coral reef fish communities on submerged and emergent reefs in the central Great Barrier Reef, Australia	PLOS ONE			English	Article							HABITAT STRUCTURE; FEEDING FISHES; DEPTH; ASSEMBLAGES; PATTERNS; COMPLEXITY; DYNAMICS; ALGAL; DISTRIBUTIONS; POPULATIONS	On coral reefs, depth and gradients related to depth (e.g. light and wave exposure) influence the composition of fish communities. However, most studies focus only on emergent reefs that break the sea surface in shallow waters (<10 m). On the Great Barrier Reef (GBR), submerged reefs (reefs that do not break the sea surface) occupy an area equivalent to all emergent reefs. However, submerged reefs have received comparatively little research attention, and fish communities associated with submerged reefs remain poorly quantified. Here, we quantify fish assemblages at each of three depths (10, 20 and 30 m) on eight submerged reefs (four mid-shelf and four outer-shelf) and two nearby emergent reefs in the central GBR where reef habitat extends from 0-similar to 25 m depth. We examine how total fish abundance, the abundance of 13 functional groups, and the functional composition of fish communities varies among depths, reef types (submerged versus emergent reefs), and shelf position (mid-shelf versus outer-shelf). Overall fish abundance decreased sevenfold with depth, but declined less steeply (twofold) on outer-shelf submerged reefs than on both mid-shelf submerged reefs and emergent reefs. The functional composition of the fish assemblage also varied significantly among depths and reef types. Turnover in the functional composition of the fish community was also steeper on the mid-shelf, suggesting that shallow-affiliated groups extend further in deeper water on the outer-shelf. Ten of the 13 functional groups were more strongly associated with the shallowest depths (the upper reef slope of emergent reefs or the 'crests' of submerged reefs), two groups (soft coral/sponge feeders and mesopredators) were more abundant at the deepest sites. Our results confirm that submerged reefs in the central GBR support a wide range of coral reef fishes, and are an important component of the GBR ecosystem.	[Cooper, Amanda M.; MacDonald, Chancey] James Cook Univ, Coll Sci & Engn, Marine Biol & Aquaculture Sci, Townsville, Qld, Australia; [MacDonald, Chancey; Roberts, T. Edward; Bridge, Tom C. L.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Bridge, Tom C. L.] Queensland Museum Network, Townsville, Qld, Australia	James Cook University; James Cook University	Cooper, AM (corresponding author), James Cook Univ, Coll Sci & Engn, Marine Biol & Aquaculture Sci, Townsville, Qld, Australia.	amanda.cooper@my.jcu.edu.au	Roberts, Thomas Edward/X-9507-2019	macdonald, chancey/0000-0003-2557-0520; Cooper, Amanda/0000-0002-1394-5746; Roberts, Thomas Edward/0000-0002-4555-8281	Ian Potter Foundation; Australian Research Council Centre of Excellence for Coral Reef Studies	Ian Potter Foundation; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research was funded by an Ian Potter Foundation grant to T. Bridge and the Australian Research Council Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would also like to thank Professor G.P. Jones for additional funding support.	Allen G.R., 2003, REEF FISH IDENTIFICA; Alvarez LJ, 2011, ECOSPHERE, V2, DOI [10.1890/ES11-00104.1, 10.1890/ES11-00185.1]; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaman, 2010, 3DGBR HIGH RESOLUTIO, V2, P13; Bejarano S, 2015, MAR BIOL, V162, P253, DOI 10.1007/s00227-014-2595-3; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Booth DJ, 2002, MAR ECOL PROG SER, V226, P157, DOI 10.3354/meps226157; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Clarke K.R., 1994, CHANGE MARINE COMMUN, V2, P117; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Eagle JV, 2001, MAR ECOL PROG SER, V214, P253, DOI 10.3354/meps214253; Emslie MJ, 2010, CORAL REEFS, V29, P705, DOI 10.1007/s00338-010-0619-0; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Graham NAJ, 2007, MAR BIOL, V153, P119, DOI 10.1007/s00227-007-0786-x; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; IHO, 2008, STAND UND FEAT NAM G; Jankowski MW, 2015, ENVIRON BIOL FISH, V98, P1373, DOI 10.1007/s10641-014-0365-1; Jones Geoffrey P., 2002, P81, DOI 10.1016/B978-012615185-5/50006-2; Kench PS, 1998, MAR GEOL, V145, P197, DOI 10.1016/S0025-3227(97)00101-1; Komyakova V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202206; Lara EN, 1998, J FISH BIOL, V53, P209, DOI 10.1111/j.1095-8649.1998.tb01028.x; LEIS JM, 1991, MAR BIOL, V109, P157, DOI 10.1007/BF01320243; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MacDonald C, 2016, MAR ECOL PROG SER, V561, P217, DOI 10.3354/meps11953; MCGEHEE MA, 1994, MAR ECOL PROG SER, V105, P243, DOI 10.3354/meps105243; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meekan M. M., 2006, SURVEYS SHARK FIN FI; Nanami A, 2002, ENVIRON BIOL FISH, V63, P353, DOI 10.1023/A:1014952932694; Nash K, 2012, ECOSYSTEMS, P1; Noonan SHC, 2012, MAR ECOL PROG SER, V456, P127, DOI 10.3354/meps09687; R Development Core Team, 2009, R LANG ENV STAT COMP; Rickel S, 2005, ANIM BEHAV, V70, P133, DOI 10.1016/j.anbehav.2004.10.014; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; ROBERTS HH, 1975, J MAR RES, V33, P233; Roberts TE, 2015, CORAL REEFS, V34, P569, DOI 10.1007/s00338-015-1261-7; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; Srinivasan M, 2003, OECOLOGIA, V137, P76, DOI 10.1007/s00442-003-1320-6; Steneck RS, 2001, MARINE COMMUNITY ECOLOGY, P445; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Sweatman HH, 2001, 5 AUSTR I MAR SCI, P106; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Thomas CJ, 2015, DIVERS DISTRIB, V21, P1254, DOI 10.1111/ddi.12360; Wilkinson C., 1985, P 5 INT COR REEF S T, V5, P125; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Williams D.M., 1982, Coral Reefs, V1, P35, DOI 10.1007/BF00286538; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; 2006, AMBIO, V35, P30; 2017, CORAL REEFS, V36, P157, DOI DOI 10.1007/S00338-016-1509-X	64	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216785	10.1371/journal.pone.0216785	http://dx.doi.org/10.1371/journal.pone.0216785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100087	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000468176600016
J	Nagai, K; Iseki, C; Iseki, K; Kondo, M; Asahi, K; Saito, C; Tsunoda, R; Okubo, R; Yamagata, K				Nagai, Kei; Iseki, Chiho; Iseki, Kunitoshi; Kondo, Masahide; Asahi, Koichi; Saito, Chie; Tsunoda, Ryoya; Okubo, Reiko; Yamagata, Kunihiro			Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; GFR DECLINE; END-POINT; PROTEINURIA; OUTCOMES; MORTALITY	To investigate how changes in eGFR can affect medical costs, a regional cohort of national health insurance beneficiaries in Japan was developed from a nationwide database system (Kokuho database, KDB), and non-individualized data were obtained. From 105,661 people, subjects on chronic dialysis and subjects without consecutive medical checkups were excluded. Finally, medical costs in the follow-up year categorized by annual changes in eGFR between baseline and the next year were longitudinally examined in 70,627 people ranging in age from 40 to 74 years. Global mean costs for subjects with a rapid decrease in eGFR (<=-30%/year) were the highest among all Delta eGFR categories. In men, the cost was 1.42 times that for a stable eGFR. A total of 6,268 (19.4%) men and 5,381 (14.0%) women with eGFR <60 ml/min/1.73 m(2) were identified in the baseline year. The mean cost was higher with a low eGFR than without a low eGFR, and there were also higher proportions newly initiating dialysis in 2014 (low eGFR with rapid decrease in eGFR vs. with stable eGFR: 9.61% vs. 0.02% in women, P<0.001). Moreover, the costs for low eGFR subjects with a rapid decrease in eGFR were more than twice those of non-low eGFR subjects with a rapid decrease in eGFR and also compared to low eGFR subjects with a stable eGFR. Moreover, initiating chronic dialysis was considered one of the major causes of high medical costs in women with rapid eGFR decline. To the best of our knowledge, this is the first study of renal disease using a cohort developed from the KDB system recently established in Japan.	[Nagai, Kei; Saito, Chie; Tsunoda, Ryoya; Okubo, Reiko; Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Iseki, Chiho; Iseki, Kunitoshi] OHRA, Naha, Okinawa, Japan; [Kondo, Masahide; Okubo, Reiko] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Tsukuba, Ibaraki, Japan; [Asahi, Koichi] Iwate Med Univ, Div Nephrol & Hypertens, Morioka, Iwate, Japan	University of Tsukuba; University of Tsukuba; Iwate Medical University	Yamagata, K (corresponding author), Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan.	k-yamagata@md.tsukuba.ac.jp		Saito, Chie/0000-0003-3962-7962; Yamagata, Kunihiro/0000-0002-7407-0410; Nagai, Kei/0000-0001-5050-5291; Tsunoda, Ryoya/0000-0001-5206-0804	Japan Agency for Medical Research and Development (AMED) [JP17ek0310005, JP18ek0310010, 18lk1010033]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Grant-in-Aid for "Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Disease" from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP17ek0310005, JP18ek0310010, and 18lk1010033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2016, J AM SOC NEPHROL, V27, P2851, DOI 10.1681/ASN.2015070829; Health and Welfare Statistics Association, 2015, J HLTH WELFARE STAT, V61, P237; Heerspink HJL, 2014, AM J KIDNEY DIS, V64, P860, DOI 10.1053/j.ajkd.2014.08.018; Higashiyama A, 2009, HYPERTENS RES, V32, P450, DOI 10.1038/hr.2009.51; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Iseki K, 2013, CLIN EXP NEPHROL, V17, P372, DOI 10.1007/s10157-012-0718-z; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Kanda E, 2018, CLIN EXP NEPHROL, V22, P318, DOI 10.1007/s10157-017-1463-0; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2016, KIDNEY INT, V90, P1109, DOI 10.1016/j.kint.2016.08.003; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Nagai K, 2014, NEPHROLOGY, V19, P574, DOI 10.1111/nep.12286; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	24	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216432	10.1371/journal.pone.0216432	http://dx.doi.org/10.1371/journal.pone.0216432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100069	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600008
J	Seow, WJ; Ngo, CS; Pan, H; Barath, VA; Tompson, SW; Whisenhunt, KN; Vithana, E; Chong, YS; Juo, SHH; Hysi, P; Young, TL; Karnani, N; Saw, SM				Seow, Wei Jie; Ngo, Cheryl S.; Pan, Hong; Barath, Veluchamy Amutha; Tompson, Stuart W.; Whisenhunt, Kristina N.; Vithana, Eranga; Chong, Yap-Seng; Juo, Suh-Hang H.; Hysi, Pirro; Young, Terri L.; Karnani, Neerja; Saw, Seang Mei			In-utero epigenetic factors are associated with early-onset myopia in young children	PLOS ONE			English	Article							RISK-FACTORS; GENOME; SCHOOLCHILDREN; EXPRESSION; METHYLOME; DISCOVERY; MULTIPLE; ORDER; SCAN	Objectives To assess whether epigenetic mechanisms affecting gene expression may be involved in the pathogenesis of early-onset myopia, we performed genome-wide DNA methylation analyses of umbilical cord tissues, and assessed any associations between CpG site-specific methylation and the development of the disorder when the children were 3 years old. Methods Genome-wide DNA methylation profiling of umbilical cord samples from 519 Singaporean infants involved in a prospective birth cohort 'Growing Up in Singapore Towards healthy Outcomes' (GUSTO) was performed using the Illumina Infinium HumanMethylation450K chip microarray. Multivariable logistic regression models were used to assess any associations between site-specific CpG methylation of umbilical cord tissue at birth and myopia risk in 3 year old children, adjusting for potential confounders. Gene expression of genes located near CpG sites that demonstrated statistically significant associations were measured in relevant ocular tissues using human and mouse fetal and adult eye samples. Results We identified statistically significant associations between DNA methylation levels at five CpG sites and early-onset myopia risk after correcting for multiple comparisons using a false discovery rate of 5%. Two statistically significant CpG sites were identified in intergenic regions: 8p23(p = 1.70x10(-7)) and 12q23.2(p = 2.53x10(-7)). The remaining 3 statistically significant CpG sites were identified within the following genes: FGB (4q28, p = 3.60x10(-7)), PQLC1 (18q23, p = 8.9x10(-7)) and KRT12 (17q21.2, p = 1.2x10(-6)). Both PQLC1 and KRT12 were found to be significantly expressed in fetal and adult cornea and sclera tissues in both human and mouse. Conclusions We identified five CpG methylation sites that demonstrate a statistically significant association with increased risk of developing early-onset myopia. These findings suggest that variability in the neonatal cord epigenome may influence early-onset myopia risk in children. Further studies of the epigenetic influences on myopia risk in larger study populations, and the associations with adulthood myopia risk are warranted.	[Seow, Wei Jie; Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Seow, Wei Jie; Saw, Seang Mei] Natl Univ Hlth Syst, Singapore, Singapore; [Seow, Wei Jie] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Ngo, Cheryl S.] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Pan, Hong; Karnani, Neerja] ASTAR, Brenner Ctr Mol Med, SICS, Singapore, Singapore; [Barath, Veluchamy Amutha; Vithana, Eranga; Saw, Seang Mei] Singapore Eye Res Inst, Singapore, Singapore; [Barath, Veluchamy Amutha; Saw, Seang Mei] Duke NUS Grad Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore; [Barath, Veluchamy Amutha] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Tompson, Stuart W.; Whisenhunt, Kristina N.; Young, Terri L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Chong, Yap-Seng] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore, Singapore; [Juo, Suh-Hang H.] China Med Univ, Inst New Drug Dev, Ctr Myopia & Eye Dis, Taichung, Taiwan; [Juo, Suh-Hang H.] China Med Univ Hosp, Taichung, Taiwan; [Hysi, Pirro] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Hysi, Pirro] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of London; King's College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Saw, SM (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Saw, SM (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Saw, SM (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Saw, SM (corresponding author), Duke NUS Grad Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore.	ephssm@nus.edu.sg		Tompson, Stuart/0000-0001-9788-6730; Karnani, Neerja/0000-0002-5301-409X; Chong, Yap Seng/0000-0002-7232-8473; Hysi, Pirro/0000-0001-5752-2510	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; NMRC Centre [NMRC/CG/SERI/2013]; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A. STAR), Singapore; National Institutes of Health/National Eye Institute (NIH/NEI) [1R01EY018246-01]; NIH/NEI [R01 EY014685]; Research to Prevent Blindness, Inc.; University of Wisconsin Centennial Scholar Funds; National Institutes of Health/National Eye Institute [R01 EY014685]; NATIONAL EYE INSTITUTE [R01EY014685] Funding Source: NIH RePORTER	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; NMRC Centre; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A. STAR), Singapore; National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); University of Wisconsin Centennial Scholar Funds; National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore-NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014; NMRC/CNIG/1088/2012; NMRC Centre Grants NMRC/CG/SERI/2013. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A. STAR), Singapore, National Institutes of Health/National Eye Institute (NIH/NEI) 1R01EY018246-01, NIH/NEI R01 EY014685, Research to Prevent Blindness, Inc., the University of Wisconsin Centennial Scholar Funds, and the National Institutes of Health/National Eye Institute R01 EY014685.	Anastasiadi D, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0205-1; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Barathi VA, 2008, VISION RES, V48, P904, DOI 10.1016/j.visres.2008.01.004; Barathi VA, 2009, MOL VIS, V15, P1277; Barathi VA, 2013, DIS MODEL MECH, V6, P1146, DOI 10.1242/dmm.010967; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cardenas A, 2015, EPIGENETICS-US, V10, P1054, DOI 10.1080/15592294.2015.1105424; Chang L, 2013, AM J OPHTHALMOL, V155, P991, DOI 10.1016/j.ajo.2013.01.016; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chua SYL, 2016, OPHTHAL PHYSL OPT, V36, P388, DOI 10.1111/opo.12305; Chua SYL, 2015, INVEST OPHTH VIS SCI, V56, P8101, DOI 10.1167/iovs.15-16577; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Duga S, 2000, BLOOD, V95, P1336, DOI 10.1182/blood.V95.4.1336.004k16_1336_1341; Fan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep25853; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Guggenheim JA, 2013, OPHTHAL EPIDEMIOL, V20, P375, DOI 10.3109/09286586.2013.848457; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hammond CJ, 2004, AM J HUM GENET, V75, P294, DOI 10.1086/423148; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; KOOPMAN J, 1992, J CLIN INVEST, V90, P238, DOI 10.1172/JCI115841; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Luo DY, 2013, J IMMUNOL, V190, P4149, DOI 10.4049/jimmunol.1203253; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; Meng WH, 2012, INVEST OPHTH VIS SCI, V53, P7983, DOI 10.1167/iovs.12-10409; MURPHY M, 2013, INVEST OPHTH VIS SCI, V54, P58323; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Stambolian D, 2005, AM J OPHTHALMOL, V140, P469, DOI 10.1016/j.ajo.2005.04.014; Su D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166486; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sullivan LS, 2007, MOL VIS, V13, P975; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Wojciechowski R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003442; Young TL, 2013, EXP EYE RES, V116, P265, DOI 10.1016/j.exer.2013.08.009; 2014, INT J EPIDEMIOL, V43, P1401, DOI DOI 10.1093/IJE/DYT125; 2016, BIOL PSYCHIAT, V79, P87, DOI DOI 10.1016/J.BIOPSYCH.2014.11.022; 2018, MOL CANCER RES, V16, P461, DOI DOI 10.1158/1541-7786.MCR-17-0227; 2016, NEUROTOXICOLOGY, V55, P92, DOI DOI 10.1016/J.NEURO.2016.05.011; 2011, MOL VIS, V17, P680; 2014, INT REV NEUROBIOL, V115, P1, DOI DOI 10.1016/B978-0-12-801311-3.00001-9; 2005, OPHTHAL PHYSL OPT, V25, P381, DOI DOI 10.1111/J.1475-1313.2005.00298.X; 2004, INVEST OPHTHALMOL, V45, P793, DOI DOI 10.1167/IOVS.03-1051; 2002, OPHTHALMOLOGY, V109, P704; 2012, MOL VIS, V18, P1312; 2014, EYE LOND, V28, P126, DOI DOI 10.1038/EYE.2013.254; 2012, OPHTHALMOLOGY, V119, P2141, DOI DOI 10.1016/J.OPHTHA.2012.04; 2002, INVESTIGATIVE OPHTHA, V43, P3633	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0214791	10.1371/journal.pone.0214791	http://dx.doi.org/10.1371/journal.pone.0214791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100065	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600004
J	Printezis, I; Grebitus, C; Hirsch, S				Printezis, Iryna; Grebitus, Carola; Hirsch, Stefan			The price is right!? A meta-regression analysis on willingness to pay for local food	PLOS ONE			English	Article							CONSUMER PREFERENCES; CHOICE EXPERIMENTS; CONJOINT-ANALYSIS; GROWN PRODUCE; METAANALYSIS; PUBLICATION; FRESH; VALUATION; BEEF; REAL	We study the literature on willingness to pay (WTP) for local food by applying meta-regression analysis to a set of 35 eligible research papers that provide 86 estimates on consumers' WTP for the attribute "local." An analysis of the distribution of WTP measures suggests the presence of publication selection bias that favors larger and statistically significant results. The analyzed literature provides evidence for statistically significant differences among consumers' WTP for various types of product. Moreover, we find that the methodological approach (choice experiments vs. other approaches) and the analyzed country can have a significant influence on the generated WTP for local.	[Printezis, Iryna] Arizona State Univ, Dept Supply Chain Management, WP Carey Sch Business, Tempe, AZ USA; [Grebitus, Carola] Arizona State Univ, Morrison Sch Agribusiness, WP Carey Sch Business, Mesa, AZ USA; [Hirsch, Stefan] Tech Univ Munich, Sch Management, Munich, Germany; [Hirsch, Stefan] Swiss Fed Inst Technol, AECP Grp, Zurich, Switzerland	Arizona State University; Arizona State University-Tempe; Arizona State University; Technical University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hirsch, S (corresponding author), Tech Univ Munich, Sch Management, Munich, Germany.; Hirsch, S (corresponding author), Swiss Fed Inst Technol, AECP Grp, Zurich, Switzerland.	stefan.hirsch@tum.de	Hirsch, Stefan/H-3552-2018; Grebitus, Carola/B-6209-2014	Hirsch, Stefan/0000-0003-2668-6824; Grebitus, Carola/0000-0001-6511-1690	EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA [2015-67003-23508]; NSF-MPS-DMS [1419593]; AFRI-NIFA [2016-67023-24809]	EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA; NSF-MPS-DMS; AFRI-NIFA	This work was supported by EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA (Grant Number: 2015-67003-23508 to CG) and NSF-MPS-DMS (Award Number: 1419593 to CG), as well as collaborative research: "Online Retailing and Local Food: How Farmers Can Capitalize", AFRI-NIFA (Award Number: 2016-67023-24809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalja A., 2015, Agricultural and Resource Economics Review, V44, P253; Adams DC, 2010, RENEW AGR FOOD SYST, V25, P331, DOI 10.1017/S1742170510000219; Ag Marketing, 2017, VAL ADD PROD; Akaichi F, 2012, BRIT FOOD J, V114, P19, DOI 10.1108/00070701211197347; Alfnes F, 2003, AM J AGR ECON, V85, P396, DOI 10.1111/1467-8276.t01-1-00128; Alston JM, 2000, AUST J AGR RESOUR EC, V44, P185, DOI 10.1111/1467-8489.00107; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Arentze T, 2003, TRANSPORT RES E-LOG, V39, P229, DOI 10.1016/S1366-5545(02)00047-9; Arnoult M., 2007, 105 EAAE SEM INT MAR, P8; Bakucs Z, 2014, J AGR ECON, V65, P1, DOI 10.1111/1477-9552.12042; Barlagne C, 2015, FOOD POLICY, V57, P62, DOI 10.1016/j.foodpol.2015.09.003; Batte MT, 2007, FOOD POLICY, V32, P145, DOI 10.1016/j.foodpol.2006.05.003; Bazzani C, 2017, FOOD QUAL PREFER, V62, P144, DOI 10.1016/j.foodqual.2017.06.019; Bond CA, 2008, AGRIBUSINESS, V24, P231, DOI 10.1002/agr.20157; Bosworth RC, 2015, J FOOD PROD MARK, V21, P274, DOI 10.1080/10454446.2013.843488; Boys Kathryn A., 2014, Environment Development and Sustainability, V16, P595, DOI 10.1007/s10668-013-9496-3; Bruhn C.M., 1992, CALIF AGR, V46, P13; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burnett P, 2011, J AGRIC FOOD SYST CO, V2, P269, DOI 10.5304/jafscd.2011.021.013; Byrd ES, 2018, J FOOD PROD MARK, V24, P235, DOI 10.1080/10454446.2016.1266556; Carlsson F, 2001, J ENVIRON ECON MANAG, V41, P179, DOI 10.1006/jeem.2000.1138; Carpio CE, 2009, AGRIBUSINESS, V25, P412, DOI 10.1002/agr.20210; Carroll KA, 2013, J AGR RESOUR ECON, V38, P379; Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009; Caussade S, 2005, TRANSPORT RES B-METH, V39, P621, DOI 10.1016/j.trb.2004.07.006; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; Costanigro M, 2014, FOOD QUAL PREFER, V31, P94, DOI 10.1016/j.foodqual.2013.08.008; Costanigro M, 2011, AGRIBUSINESS, V27, P465, DOI 10.1002/agr.20281; Darby K, 2008, AM J AGR ECON, V90, P476, DOI 10.1111/j.1467-8276.2007.01111.x; de-Magistris T, 2016, J CLEAN PROD, V118, P97, DOI 10.1016/j.jclepro.2016.01.050; de-Magistris T, 2014, INT J CONSUM STUD, V38, P660, DOI 10.1111/ijcs.12138; Dobbs L. M., 2016, Journal of Food Distribution Research, V47, P38; Dolgopolova I, 2018, APPL ECON PERSPECT P, V40, P333, DOI 10.1093/aepp/ppx036; Doucouliagos H, 2009, BRIT J IND RELAT, V47, P406, DOI 10.1111/j.1467-8543.2009.00723.x; Erez A, 1996, PERS PSYCHOL, V49, P275, DOI 10.1111/j.1744-6570.1996.tb01801.x; Feldmann C, 2015, FOOD QUAL PREFER, V40, P152, DOI 10.1016/j.foodqual.2014.09.014; Fernau E, 2019, INT REV FINANC ANAL, V61, P255, DOI 10.1016/j.irfa.2018.11.011; German C.L., 1997, J FOOD DISTRIBUTION, V28, P98; Gracia A, 2014, EMPIR ECON, V47, P111, DOI 10.1007/s00181-013-0738-x; Gracia A, 2012, AGRIBUSINESS, V28, P361, DOI 10.1002/agr.21297; Grebitus C., 2015, Journal of Agricultural & Food Industrial Organization, V13, P73, DOI 10.1515/jafio-2015-0017; Grebitus C, 2013, J ECON PSYCHOL, V36, P11, DOI 10.1016/j.joep.2013.02.004; Grebitus C, 2013, ECOL ECON, V88, P67, DOI 10.1016/j.ecolecon.2013.01.006; Gumirakiza JD, 2017, J FOOD PROD MARK, V23, P61, DOI 10.1080/10454446.2017.1244786; Harris R. J., 1985, PRIMER MULTIVARIATE; Hasselbach JL, 2015, J FOOD PROD MARK, V21, P608, DOI 10.1080/10454446.2014.885866; Havranek T, 2011, J INT ECON, V85, P234, DOI 10.1016/j.jinteco.2011.07.004; Hedges L. V., 1985, STAT METHODS METAAAN; Hirsch S, 2018, J ECON SURV, V32, P23, DOI 10.1111/joes.12188; Howell D. C., 1987, STAT PSYCHOL; Hu W. Y., 2009, Journal of Agricultural and Applied Economics, V41, P47; Hu WY, 2012, EUR REV AGRIC ECON, V39, P489, DOI 10.1093/erae/jbr039; Hughes D. W., 2015, Choices. The Magazine of Food, Farm, and Resources Issues, V30, punpaginated; Illichmann R., 2013, AGR APPL EC ASS 2013, P25; James J. S., 2009, Agricultural and Resource Economics Review, V38, P357; King R.P., 2010, CHOICES, V25, P1; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Li XG, 2018, J AGRIC APPL ECON, V50, P1, DOI 10.1017/aae.2017.17; List J. A., 2006, ADV EC ANAL POLICY, V5; Lopez-Galan B, 2013, SPAN J AGRIC RES, V11, P305, DOI 10.5424/sjar/2013112-3953; Loureiro ML., 2002, J AGR APPL EC, V34, P477, DOI [DOI 10.1017/S1074070800009251, 10.1017/S1074070800009251]; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Martinez S., 2010, Economic Research Report - Economic Research Service, USDA; Meas T., 2014, P SO AGR EC ASS ANN, P1; Meas T, 2015, AM J AGR ECON, V97, P1044, DOI 10.1093/ajae/aau108; Merritt MG, 2018, J AGRIC APPL ECON, V50, P233, DOI 10.1017/aae.2017.35; Mintel, 2019, PRIV LAB FOOD DRINK; Mintel, 2014, LOC ATT LOC SOURC FO; Mogilner C, 2008, J CONSUM RES, V35, P202, DOI 10.1086/588698; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mugera A, 2017, J FOOD PROD MARK, V23, P452, DOI 10.1080/10454446.2015.1048019; Nelson J, 2009, ENVIRON RESOUR ECON, V42, P345, DOI 10.1007/s10640-008-9253-5; Nganje W. E., 2011, Agricultural and Resource Economics Review, V40, P20; Oczkowski E, 2015, AM J AGR ECON, V97, P103, DOI 10.1093/ajae/aau057; Onken K. A., 2011, Agricultural and Resource Economics Review, V40, P33; Onken K.A., 2010, CHOICES, V25, P1; Onozaka Y., 2010, CHOICES, V25, P1, DOI DOI 10.2307/CHOICES.25.1.03; Onozaka Y, 2011, AM J AGR ECON, V93, P689, DOI 10.1093/ajae/aar005; Printezis I., 2017, CHOICES; Printezis I, 2018, ECOL ECON, V152, P161, DOI 10.1016/j.ecolecon.2018.05.021; Rainbolt GN, 2012, J FOOD PROD MARK, V18, P385, DOI 10.1080/10454446.2012.685031; Reutskaja E, 2009, PSYCHOL MARKET, V26, P197, DOI 10.1002/mar.20268; Rusnak M, 2013, J MONEY CREDIT BANK, V45, P37, DOI 10.1111/j.1538-4616.2012.00561.x; Sackett H., 2016, International Journal of Food and Agricultural Economics, V4, P17; Saito H, 2013, AGRIBUSINESS, V29, P147, DOI 10.1002/agr.21315; Sanjuan AI, 2012, APPETITE, V58, P1118, DOI 10.1016/j.appet.2012.03.001; Scheibehenne B, 2010, J CONSUM RES, V37, P409, DOI 10.1086/651235; Stanley TD, 2008, OXFORD B ECON STAT, V70, P103, DOI 10.1111/j.1468-0084.2007.00487.x; Stanley TD, 2013, J ECON SURV, V27, P390, DOI 10.1111/joes.12008; Stanley TD, 2010, J ECON SURV, V24, P170, DOI 10.1111/j.1467-6419.2009.00593.x; Stanley T.D., 1989, J ECON SURV, V3, P161, DOI [DOI 10.1111/J.1467-6419.1989.TB00064.X, 10.1111/j.1467-6419.1989.tb00064.x]; Stanley TD, 2001, J ECON PERSPECT, V15, P131, DOI 10.1257/jep.15.3.131; Stanley TD, 2005, J ECON SURV, V19, P309, DOI 10.1111/j.0950-0804.2005.00250.x; Statista, 2019, KAUFH REG HERG NAHR; Stefani G, 2006, FOOD QUAL PREFER, V17, P53, DOI 10.1016/j.foodqual.2005.07.010; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Taylor LO, 2010, ENVIRON RESOUR ECON, V47, P197, DOI 10.1007/s10640-010-9371-8; Tempesta T, 2013, FOOD QUAL PREFER, V27, P35, DOI 10.1016/j.foodqual.2012.06.005; Thilmany D, 2008, AM J AGR ECON, V90, P1303, DOI 10.1111/j.1467-8276.2008.01221.x; Umberger W. J., 2003, J FOOD DISTRIBUTION, V34, P103; Wageli S, 2016, INT J CONSUM STUD, V40, P357, DOI 10.1111/ijcs.12262; Willis DB, 2016, J AGRIC APPL ECON, V48, P192, DOI 10.1017/aae.2016.10; Yu XiaoHua, 2016, Rivista di Economia Agraria, V71, P177; Yue CY, 2009, HORTSCIENCE, V44, P366, DOI 10.21273/HORTSCI.44.2.366; Zigraiova D, 2016, J ECON SURV, V30, P944, DOI 10.1111/joes.12131	108	25	26	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0215847	10.1371/journal.pone.0215847	http://dx.doi.org/10.1371/journal.pone.0215847			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141519	gold, Green Submitted, Green Published			2022-12-27	WOS:000469323000003
J	Honda, GS; Pearce, RG; Pham, LL; Setzer, RW; Wetmore, BA; Sipes, NS; Gilbert, J; Franz, B; Thomas, RS; Wambaugh, JF				Honda, Gregory S.; Pearce, Robert G.; Pham, Ly L.; Setzer, R. W.; Wetmore, Barbara A.; Sipes, Nisha S.; Gilbert, Jon; Franz, Briana; Thomas, Russell S.; Wambaugh, John F.			Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions	PLOS ONE			English	Article							ENVIRONMENTAL CHEMICALS; BIOMONITORING DATA; HEPATIC-CLEARANCE; RISK-ASSESSMENT; TOXICITY; MODEL; DOSIMETRY; PREDICTION; EXPOSURE; HEPATOCYTES	Linking in vitro bioactivity and in vivo toxicity on a dose basis enables the use of high-throughput in vitro assays as an alternative to traditional animal studies. In this study, we evaluated assumptions in the use of a high-throughput, physiologically based toxicokinetic (PBTK) model to relate in vitro bioactivity and rat in vivo toxicity data. The fraction unbound in plasma (f(up)) and intrinsic hepatic clearance (Cl-int) were measured for rats (for 67 and 77 chemicals, respectively), combined with f(up) and Cl-int literature data for 97 chemicals, and incorporated in the PBTK model. Of these chemicals, 84 had corresponding in vitro ToxCast bioactivity data and in vivo toxicity data. For each possible comparison of in vitro and in vivo endpoint, the concordance between the in vivo and in vitro data was evaluated by a regression analysis. For a base set of assumptions, the PBTK results were more frequently better associated than either the results from a "random" model parameterization or direct comparison of the "untransformed" values of AC(50) and dose (performed best in 51%, 28%, and 21% of cases, respectively). We also investigated several assumptions in the application of PBTK for IVIVE, including clearance and internal dose selection. One of the better assumptions sets-restrictive clearance and comparing free in vivo venous plasma concentration with free in vitro concentration-outperformed the random and untransformed results in 71% of the in vitro-in vivo endpoint comparisons. These results demonstrate that applying PBTK improves our ability to observe the association between in vitro bioactivity and in vivo toxicity data in general. This suggests that potency values from in vitro screening should be transformed using in vitro-in vivo extrapolation (IVIVE) to build potentially better machine learning and other statistical models for predicting in vivo toxicity in humans.	[Honda, Gregory S.; Pearce, Robert G.; Pham, Ly L.; Setzer, R. W.; Thomas, Russell S.; Wambaugh, John F.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Honda, Gregory S.; Pearce, Robert G.; Pham, Ly L.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Wetmore, Barbara A.] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA; [Sipes, Nisha S.] NIEHS, Div Natl Toxicol Program, POB 12233, Res Triangle Pk, NC 27709 USA; [Gilbert, Jon; Franz, Briana] Cyprotex, Watertown, MA USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wambaugh, JF (corresponding author), US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.	wambaugh.john@epa.gov	Wambaugh, John/AAM-4487-2020	Wambaugh, John/0000-0002-4024-534X; Franz-Jonas, Briana/0000-0002-9513-8234; Pham, Ly/0000-0001-8467-2645; Sipes, Nisha/0000-0003-4203-6426	United States Environmental Protection Agency through its Office of Research and Development; Cyprotex; Research Participation Program at the National Center for Computational Toxicology, U.S. Environmental Protection Agency; National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103318] Funding Source: NIH RePORTER	United States Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency); Cyprotex; Research Participation Program at the National Center for Computational Toxicology, U.S. Environmental Protection Agency; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The United States Environmental Protection Agency through its Office of Research and Development funded and managed the research described here, including funding and management of the work completed by Cyprotex (B. Franz and J. Gilbert) by external contract. Cyprotex provided no independent funding in support of this work. Funding for G. S. Honda, R. Pearce, and L. Pham was supported by the Research Participation Program at the National Center for Computational Toxicology, U.S. Environmental Protection Agency, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and EPA. The National Institute of Environmental Health Sciences provided funding for N. S. Sipes. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2007, TOXICITY TESTING 21; Armitage JM, 2014, ENVIRON SCI TECHNOL, V48, P9770, DOI 10.1021/es501955g; Arnot JA, 2014, ENVIRON SCI TECHNOL, V48, P723, DOI 10.1021/es4029414; Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003; Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940; Bucher JR, 1996, FUND APPL TOXICOL, V31, P1, DOI 10.1006/faat.1996.0070; Casey WM, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP1655; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012; EPA U, EST PROGR INT SUIT W; EPA U, INVITRODB; EPA U, EPA U SER; EPA U, TOXREFDB; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Houston JB, 1997, DRUG METAB REV, V29, P891, DOI 10.3109/03602539709002237; Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kavlock RJ, 2018, CHEM RES TOXICOL, V31, P287, DOI 10.1021/acs.chemrestox.7b00339; Kilford PJ, 2008, DRUG METABOLISM DISP; Kleinstreuer NC, 2017, CHEM RES TOXICOL, V30, P946, DOI 10.1021/acs.chemrestox.6b00347; Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h; Mansouri K, 2018, J CHEMINFORMATICS, V10, DOI 10.1186/s13321-018-0263-1; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074; Naritomi Y, 2003, DRUG METAB DISPOS, V31, P580, DOI 10.1124/dmd.31.5.580; NASEM, 2017, US 21 CENT SCI IMPR; Pearce RG, 2017, J PHARMACOKINET PHAR, V44, P549, DOI 10.1007/s10928-017-9548-7; Pearce RG, 2017, J STAT SOFTW, V79, DOI [10.18637/jss.v079.i04, 10.18637/jss.v079.104]; Pelkonen O, 2007, XENOBIOTICA, V37, P1066, DOI 10.1080/00498250701620726; Ring CL, 2017, ENVIRON INT, V106, P105, DOI 10.1016/j.envint.2017.06.004; Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220; Sipes NS, 2017, ENVIRON SCI TECHNOL, V51, P10786, DOI 10.1021/acs.est.7b00650; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Sohlenius-Sternbeck AK, 2013, XENOBIOTICA, V43, P671, DOI 10.3109/00498254.2012.755578; Sohlenius-Sternbeck AK, 2012, XENOBIOTICA, V42, P841, DOI 10.3109/00498254.2012.669080; Strope CL, 2018, SCI TOTAL ENVIRON, V615, P150, DOI 10.1016/j.scitotenv.2017.09.033; Tan YM, 2007, J EXPO SCI ENV EPID, V17, P591, DOI 10.1038/sj.jes.7500540; Tan YM, 2006, J TOXICOL ENV HEAL A, V69, P1727, DOI 10.1080/15287390600631367; Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Toutain PL, 2002, J VET PHARMACOL THER, V25, P460, DOI 10.1046/j.1365-2885.2002.00442.x; Wambaugh JF, 2015, TOXICOL SCI, V147, P55, DOI 10.1093/toxsci/kfv118; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; Wetmore BA, 2015, TOXICOL SCI, V148, P121, DOI 10.1093/toxsci/kfv171; Wetmore BA, 2015, TOXICOLOGY, V332, P94, DOI 10.1016/j.tox.2014.05.012; Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012; Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254; Williams AJ, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0247-6; Wood FL, 2017, DRUG METAB DISPOS, V45, P1178, DOI 10.1124/dmd.117.077040; Yoon M, 2014, TOXICOL IN VITRO, V28, P164, DOI 10.1016/j.tiv.2013.10.023	56	20	20	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217564	10.1371/journal.pone.0217564	http://dx.doi.org/10.1371/journal.pone.0217564			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136631	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300051
J	Williams, VL; 't Sas-Rolfes, MJ				Williams, Vivienne L.; 't Sas-Rolfes, Michael J.			Born captive: A survey of the lion breeding, keeping and hunting industries in South Africa	PLOS ONE			English	Article								Commercial captive breeding and trade in body parts of threatened wild carnivores is an issue of significant concern to conservation scientists and policy-makers. Following a 2016 decision by Parties to the Convention on International Trade in Endangered Species of Wild Fauna and Flora, South Africa must establish an annual export quota for lion skeletons from captive sources, such that threats to wild lions are mitigated. As input to the quota-setting process, South Africa's Scientific Authority initiated interdisciplinary collaborative research on the captive lion industry and its potential links to wild lion conservation. A National Captive Lion Survey was conducted as one of the inputs to this research; the survey was launched in August 2017 and completed in May 2018. The structured semi-quantitative questionnaire elicited 117 usable responses, representing a substantial proportion of the industry. The survey results clearly illustrate the impact of a USA suspension on trophy imports from captive-bred South African lions, which affected 82% of respondents and economically destabilised the industry. Respondents are adapting in various ways, with many euthanizing lions and becoming increasingly reliant on income from skeleton export sales. With rising consumer demand for lion body parts, notably skulls, the export quota presents a further challenge to the industry, regulators and conservationists alike, with 52% of respondents indicating they would adapt by seeking 'alternative markets' for lion bones if the export quota allocation restricted their business. Recognizing that trade policy toward large carnivores represents a 'wicked problem', we anticipate that these results will inform future deliberations, which must nonetheless also be informed by challenging inclusive engagements with all relevant stakeholders.	[Williams, Vivienne L.; 't Sas-Rolfes, Michael J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; ['t Sas-Rolfes, Michael J.] Univ Oxford, Oxford Martin Programme Illegal Wildlife Trade, Oxford, England	University of Witwatersrand; University of Oxford	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	vivienne.williams@wits.ac.za	Sas-Rolfes, Michael t/ABC-7132-2020; Williams, Vivienne Linda/M-1453-2019	Sas-Rolfes, Michael t/0000-0002-2220-6072; Williams, Vivienne Linda/0000-0003-0698-6512	South African National Biodiversity Institute (SANBI); National Research Foundation (NRF) [109303]; School of Animal, Plant & Environmental Sciences (University of the Witwatersrand); Oxford Martin Programme on the Illegal Wildlife Trade (Oxford University); Earthmind	South African National Biodiversity Institute (SANBI); National Research Foundation (NRF); School of Animal, Plant & Environmental Sciences (University of the Witwatersrand); Oxford Martin Programme on the Illegal Wildlife Trade (Oxford University); Earthmind	VLW and MtSR acknowledge funding from the South African National Biodiversity Institute (SANBI). In addition, VLW received support from the National Research Foundation (NRF; Grant No. 109303), and the School of Animal, Plant & Environmental Sciences (University of the Witwatersrand). MtSR acknowledges financial support from the Oxford Martin Programme on the Illegal Wildlife Trade (Oxford University) and Earthmind. With the exception of SANBI having a role in study design only, the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SANBI's only role was in providing a brief on the types of information they wanted collecting, and we designed the questionnaire accordingly.	Bauer H, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12444; Breitenmoser Urs, 2016, Cat News, P3; CITES. Committee 1, 2016, CONS TRAD AFR LION; Coals P, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9020052; Government of Netherlands, 2016, ADD TROPH ADD IMP PR; Gratwicke B, 2008, CONSERV BIOL, V22, P222, DOI 10.1111/j.1523-1739.2007.00802.x; Gregory R, 2009, RISK ANAL, V29, P518, DOI 10.1111/j.1539-6924.2008.01182.x; Hubschle A, 2017, GLOB CRIME, V18, P198, DOI 10.1080/17440572.2017.1345680; Hunter LTB, 2013, ORYX, V47, P19, DOI 10.1017/S0030605312000695; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Mkono M, 2018, J SUSTAIN TOUR, V26, P1608, DOI 10.1080/09669582.2018.1489399; Pratt A, 2017, 7903 HC LIB; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Royal S., 2015, COMMUNICATION; Schroeder RA, 2018, AFR STUD REV, V61, P8, DOI 10.1017/asr.2017.94; 't Sas-Rolfes M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa854b; t Sas-Rolfes MJ, 2010, TIGERS WORLD SCI POL, P477; Tjiane M., 2017, COMMUNICATION   1121; US Fish and Service Wildlife, 2015, FED REGISTER, V80, P79999; Van der Merwe Peet, 2017, International Journal of Biodiversity and Conservation, V9, P314; Williams J, 2017, J COMPUT NONLIN DYN, V12, DOI 10.1115/1.4034390; Williams VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185996; Williams VL, 2015, NATURE, V523, P290, DOI 10.1038/523290a; Williams VL., 2015, BONES CONTENTION ASS; Williams VL, 2017, S AFRICAN LION UNPUB; Woodford DJ, 2016, NEOBIOTA, P63, DOI 10.3897/neobiota.31.10038	26	22	22	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217409	10.1371/journal.pone.0217409	http://dx.doi.org/10.1371/journal.pone.0217409			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136596	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300036
J	Zakeri, Z; Otte, V; Sipman, H; Malicek, J; Cubas, P; Rico, VJ; Lenzova, V; Svoboda, D; Divakar, PK				Zakeri, Zakieh; Otte, Volker; Sipman, Harrie; Malicek, Jiri; Cubas, Paloma; Rico, Victor J.; Lenzova, Veronika; Svoboda, David; Divakar, Pradeep K.			Discovering cryptic species in the Aspiciliella intermutans complex (Megasporaceae, Ascomycota) - First results using gene concatenation and coalescent-based species tree approaches	PLOS ONE			English	Article							LICHEN-FORMING FUNGI; BAYESIAN-INFERENCE; DELIMITATION; DIVERSITY; DNA; PARMELIACEAE; PHYLOGENY; EXAMPLE; SIMULATIONS; SELECTION	Taxonomic identifications in some groups of lichen-forming fungi have been challenge largely due to the scarcity of taxonomically relevant features and limitations of morphological and chemical characters traditionally used to distinguish closely related taxa. Delineating species boundaries in closely related species or species complexes often requires a range of multisource data sets and comprehensive analytical methods. Here we aim to examine species boundaries in a group of saxicolous lichen forming fungi, the Aspiciliella intermutans complex (Megasporaceae), widespread mainly in the Mediterranean. We gathered DNA sequences of the nuclear ribosomal internal transcribed spacer (nuITS), the nuclear large subunit (nuLSU), the mitochondrial small subunit (mtSSU) ribosomal DNA, and the DNA replication licensing factor MCM7 from 80 samples mostly from Iran, Caucasia, Greece and eastern Europe. We used a combination of phylogenetic strategies and a variety of empirical, sequence-based species delimitation approaches to infer species boundaries in this group. The latter included: the automatic barcode gap discovery (ABGD), the multispecies coalescent approach *BEAST and Bayesian Phylogenetics and Phylogeography (BPP) program. Different species delimitation scenarios were compared using Bayes factors species delimitation analysis. Furthermore, morphological, chemical, ecological and geographical features of the sampled specimens were examined. Our study uncovered cryptic species diversity in A. intermutans and showed that morphology-based taxonomy may be unreliable, underestimating species diversity in this group of lichens. We identified a total of six species-level lineages in the A. intermutans complex using inferences from multiple empirical operational criteria. We found little corroboration between morphological and ecological features with our proposed candidate species, while secondary metabolite data do not corroborate tree topology. The present study on the A. intermutans species-complex indicates that the genus Aspiciliella, as currently circumscribed, is more diverse in Eurasia than previously expected.	[Zakeri, Zakieh; Otte, Volker] Senckenberg Museum Nat Hist, Gorlitz, Germany; [Sipman, Harrie] Bot Garten, Berlin, Germany; [Sipman, Harrie] Bot Museum Berlin Dahlem, Berlin, Germany; [Malicek, Jiri] Czech Acad Sci, Inst Bot, Prohonice, Czech Republic; [Cubas, Paloma; Rico, Victor J.; Divakar, Pradeep K.] Univ Complutense, Fac Farm, Dept Farmacol Farmacognosia & Bot UD Bot, Madrid, Spain; [Lenzova, Veronika; Svoboda, David] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Senckenberg Gesellschaft fur Naturforschung (SGN); Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Complutense University of Madrid; Charles University Prague	Zakeri, Z (corresponding author), Senckenberg Museum Nat Hist, Gorlitz, Germany.	zakieh.zakeri@senckenberg.de	Rico, Víctor J./AAA-2001-2019; Divakar, Pradeep K/E-5603-2014	Divakar, Pradeep K/0000-0002-0300-0124; Malicek, Jiri/0000-0002-3119-8967; Svoboda, David/0000-0002-5619-636X	long-term research development project [RVO 67985939]; Open Access Fund of the Leibniz Association	long-term research development project; Open Access Fund of the Leibniz Association	The work of J. Malicek was supported by the long-term research development project no. RVO 67985939. The publication of this article was funded by the Open Access Fund of the Leibniz Association to Z. Zakeri.	Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Del-Prado R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161031; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FChG Arnold, 1887, VERHANDLUNGEN ZOOLOG, V37, P81; Fletcher T, 2009, ANZSOG MONOGR, P181; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Gutierrez G, 2007, J MOL EVOL, V64, P181, DOI 10.1007/s00239-005-0313-y; Hafellner J., 1995, FRITSCHIANA, V5, P1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1554/0014-3820(2002)056[1557:MCOTGS]2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch W., 2016, SYLLABUS PLANT FAM 1; John V, 2004, HERZOGIA, V17, P157; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kraichak E, 2015, ORG DIVERS EVOL, V15, P447, DOI 10.1007/s13127-015-0219-5; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leavitt S. D, 2010, THESIS; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2013, LICHENOLOGIST, V45, P553, DOI 10.1017/S0024282913000212; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Llimona X., 2001, BOCCONEA, V14, P1; Lucking R, 2014, LICHENOLOGIST, V46, P261, DOI 10.1017/S0024282913000352; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; McCune B., 2014, MONOGRAPHS N AM LICH, V2, P1; Nimis P. L., 2008, INFORM SYSTEM ITALIA; Nordin A, 2015, PHYTOTAXA, V192, P197, DOI 10.11646/phytotaxa.192.3.6; Nordin A, 2010, MYCOLOGIA, V102, P1339, DOI 10.3852/09-266; NYLANDER W, 1872, FLORA REGENSBURG, V55, P353; Orange A., 2001, MICROCHEMICAL METHOD; Otalora MAG, 2017, FUNGAL BIOL-UK, V121, P222, DOI 10.1016/j.funbio.2016.12.001; Owe-Larsson B, 2007, LICHEN FLORA GREATER, V3, P61; Park SY, 2014, MYCOBIOLOGY, V42, P311, DOI 10.5941/MYCO.2014.42.4.311; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Paukov AG, 2014, I KANT BALTIC FEDERA, V7, P102; Pitard C. J., 1909, B SOC BOT FR, V56, P243; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rannala B, 2017, SYST BIOL, V66, P823, DOI 10.1093/sysbio/syw119; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Sipman HJM., 2002, WILLDENOWIA, V32, P351; THIII Nash, 2007, LICHEN FLORA GREATER, V3; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Werner RG, 1932, CAVANILLESIA, V5, P157; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zakeri Z, 2019, LICHENOLOGIST, V51, P97, DOI 10.1017/S0024282918000476; Zakeri Z, 2017, HERZOGIA, V30, P166, DOI 10.13158/heia.30.1.2017.166; Zakeri Z, 2016, WILLDENOWIA, V46, P245, DOI 10.3372/wi.46.46205; Zoller S, 1999, LICHENOLOGIST, V31, P511	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216675	10.1371/journal.pone.0216675	http://dx.doi.org/10.1371/journal.pone.0216675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136587	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300008
J	Ye, Y; Duah, D				Ye, Yazoume; Duah, Dwomoh			The President's Malaria Initiative contributed to reducing malaria burden in sub-Saharan Africa between 2004 and 2014: Evidence from generalized estimating equation analysis	PLOS ONE			English	Article							CAUSE CHILD-MORTALITY; CONTROL INTERVENTIONS; IMPACT; MALAWI	The President's Malaria Initiative (PMI) launched in 2005 as a key player in malaria prevention and treatment in sub-Saharan Africa (SSA). Several country-specific evaluations have demonstrated great progress in reducing under-five mortality associated with scaling up malaria interventions in PMI priority countries. Documentation of PMI's specific contributions was limited, until the publication of Jakubowski, et al., which used difference-in-difference analysis to show a higher reduction of under-five mortality in PMI-supported countries than in others. To generate more evidence, this study used rigorous statistical analyses to assess the reduction in mortality attributable to PMI support. The study used generalized estimating equations and a series of matching procedures to evaluate the impact of PMI on under-five mortality and on population coverage of insecticide-treated nets (ITNs), indoor residual spraying (IRS), and artemisinin-based combination therapy (ACT) in SSA. The analyses used country-level secondary data and controlled for several country-level characteristics assumed to influence outcome measures of interest, PMI program participation, or both. The Mahalanobis distance metric, with 1: 1 nearest neighbor matching adjusting for bias in population size in the particular country, showed a reduction in under-five mortality by approximately 12 per 1,000 live births (95% Confidence Interval [CI]: 20.6-3.1; p = 0.012). There were statistically significant increases in the population coverage of ITNs, IRS, and ACTs in PMI countries over the implementation period. ITN use in the population was 0.23% higher (95% CI average treatment effect on the treated: 0.17-0.30; p<0.001) in PMI-ecipient countries than in non-PMI countries. The findings show that PMI contributed significantly to increasing the coverage of malaria control interventions and reducing under-five mortality in SSA.	[Ye, Yazoume] ICF, Rockville, MD 20850 USA; [Duah, Dwomoh] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana	University of Ghana	Ye, Y (corresponding author), ICF, Rockville, MD 20850 USA.	Ye@icf.com		Ye, Yazoume/0000-0001-7851-6603	USAID	USAID(United States Agency for International Development (USAID))	YY is working for ICF on a project funded by USAID. However, this study was perform as an independent scientist outside the normal working hours. The study was based on secondary data publicly available. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2016, WORLD MAL REP 2015; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4; DuGoff EH, 2014, HEALTH SERV RES, V49, P284, DOI 10.1111/1475-6773.12090; Eckert E, 2017, AM J TROP MED HYG, V97, P99, DOI 10.4269/ajtmh.17-0281; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Florey LS, 2017, AM J TROP MED HYG, V97, P65, DOI 10.4269/ajtmh.15-0929; Gimnig JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145282; HARRISON DA, 1989, J APPL PSYCHOL, V74, P300, DOI 10.1037/0021-9010.74.2.300; Hershey CL, 2017, AM J TROP MED HYG, V97, P76, DOI 10.4269/ajtmh.17-0203; Hewko, 2002, E EUROPEAN CONSTITUT, V11, P71; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Iacus SM, 2009, J STAT SOFTW, V30, P1; Jakubowski A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002319; Lambsdorff JG, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P3; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Ye Y, 2017, AM J TROP MED HYG, V97, P9, DOI 10.4269/ajtmh.15-0363	20	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217103	10.1371/journal.pone.0217103	http://dx.doi.org/10.1371/journal.pone.0217103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125380	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700019
J	Afridi, IU; Bashir, T; Khattak, HA; Khan, TM; Imran, M				Afridi, Imran Uddin; Bashir, Tariq; Khattak, Hasan Ali; Khan, Tariq Mahmood; Imran, Muhammad			Degraded image enhancement by image dehazing and Directional Filter Banks using Depth Image based Rendering for future free-view 3D-TV	PLOS ONE			English	Article							QUALITY ASSESSMENT; SYSTEM; MAP; 2D	DIBR-3D technology has evolved over the past few years with the demands of consumers increasing in recent times for future free-view 3D videos on their home televisions. The main issue in 3D technology is the lack of 3D content available to watch using the traditional TV systems. Although, some sophisticated devices like stereoscopic cameras have been used to fill the gap between the 3D content demand and 3D content supply. But the content generated through these sophisticated devices can not be displayed on the traditional TV systems, so there needs to be some mechanism which is inline with the traditional TV. Furthermore, the huge collection of existing 2D content should be converted to 3D using depth image-based rendering techniques. This conversion technique can highly contribute in overcoming the shortage problem of the 3D content. This paper presents a novel approach for converting 2D degraded image for DIBR 3D-TV view. This degraded or noisy/blur image is enhanced through image dehazing and Directional Filter Bank (DFB). This enhancement is necessary because of the occlusion effect or hole filling problem that occurs due to imperfect depth map. The enhanced image is then segmented into the foreground image and the background image. After the segmentation, the depth map is generated using image profiles. Moreover, Stereoscopic images are finally produced using the DIBR procedure which is based on the 2D input image and the corresponding depth map. We have verified the results of the proposed approach by comparing the results with the existing state-of-the-art techniques.	[Afridi, Imran Uddin; Khattak, Hasan Ali; Imran, Muhammad] COMSATS Univ Islamabad, Dept Comp Sci, Islamabad, Pakistan; [Bashir, Tariq; Khan, Tariq Mahmood] COMSATS Univ Islamabad, Dept Elect Engn, Islamabad, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Khattak, HA (corresponding author), COMSATS Univ Islamabad, Dept Comp Sci, Islamabad, Pakistan.	hasan.alikhattak@gmail.com	Khattak, Hasan Ali/N-4656-2014; imran, muhammad/HDM-5119-2022; Bashir, Tariq/AAC-8823-2019	Khattak, Hasan Ali/0000-0002-8198-9265; Bashir, Tariq/0000-0002-8014-7816; Khan, Tariq Mahmood/0000-0002-7477-1591; Afridi, Imran/0000-0001-9956-9229				Anand S., 2012, AUTON NEUROSCI-BASIC, V1, P10409745, DOI [10.5120/ijais12-450162, DOI 10.5120/IJAIS12-450162]; Andrews J, 2006, IEEE MICRO, V26, P25, DOI 10.1109/MM.2006.45; BAMBERGER RH, 1992, IEEE T SIGNAL PROCES, V40, P882, DOI 10.1109/78.127960; Berman D, 2016, PROC CVPR IEEE, P1674, DOI 10.1109/CVPR.2016.185; Bolecek L, 2013, 2013 36TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P890, DOI 10.1109/TSP.2013.6614068; Bouchemel A, 2018, IEEE COMMUN LETT, V22, P934, DOI 10.1109/LCOMM.2018.2812821; Calagari K, 2018, IEEE T MULTIMEDIA, V20, P605, DOI 10.1109/TMM.2017.2748458; Cameron J., 2009, AVATAR; Fehn C., 2003, P VIS IM IM PROC VII, P482; Herrera JL, 2018, IEEE T IMAGE PROCESS, V27, P3288, DOI 10.1109/TIP.2018.2813093; Huang DF, 2017, SMART SCI, V5, P75, DOI 10.1080/23080477.2017.1306903; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Jung C, 2015, MULTIMEDIA SYST, V21, P451, DOI 10.1007/s00530-014-0375-z; Khan TM, 2014, OPTIK, V125, P4206, DOI 10.1016/j.ijleo.2014.04.048; Konrad J, 2013, IEEE T IMAGE PROCESS, V22, P3485, DOI 10.1109/TIP.2013.2270375; Kulkarni JB, 2015, 1ST INTERNATIONAL CONFERENCE ON COMPUTING COMMUNICATION CONTROL AND AUTOMATION ICCUBEA 2015, P716, DOI 10.1109/ICCUBEA.2015.146; Kuznietsov Y., 2017, IEEE CVPR 2017, P6647; Liu FY, 2016, IEEE T PATTERN ANAL, V38, P2024, DOI 10.1109/TPAMI.2015.2505283; Luo GB, 2018, IEEE ACCESS, V6, P32874, DOI 10.1109/ACCESS.2018.2847312; Luo Y, 2018, PROC CVPR IEEE, P155, DOI 10.1109/CVPR.2018.00024; Matusik W, 2004, ACM T GRAPHIC, V23, P814, DOI 10.1145/1015706.1015805; Mukherjee J, 2008, IEEE T IMAGE PROCESS, V17, P1783, DOI 10.1109/TIP.2008.2002826; Park J., 2017, P IEEE C COMP VIS PA, P1736; Phan R, 2011, IEEE IMAGE PROC, P865, DOI 10.1109/ICIP.2011.6116695; Porikli S, 2017, P BRIT C MACH VIS BM, P1; Redert A., 2002, Proceedings First International Symposium on 3D Data Processing Visualization and Transmission, P313, DOI 10.1109/TDPVT.2002.1024077; Rosiles JG, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P292, DOI 10.1109/ICIP.2000.899357; Scharstein D, 2014, LECT NOTES COMPUT SC, V8753, P31, DOI 10.1007/978-3-319-11752-2_3; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P3440, DOI 10.1109/TIP.2006.881959; Shi JP, 2014, PROC CVPR IEEE, P2965, DOI 10.1109/CVPR.2014.379; Smolic A, 2007, IEEE T CIRC SYST VID, V17, P1606, DOI 10.1109/TCSVT.2007.909972; Tsai TH, 2018, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-017-0239-5; Wang H, 2014 13 INT C CONTR, DOI [10.1109/TPAMI.2015.2505283, DOI 10.1109/TPAMI.2015.2505283]; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wang ZY, 2015, PATTERN RECOGN LETT, V65, P95, DOI 10.1016/j.patrec.2015.07.025; Williem, 2015, IEEE I CONF COMP VIS, P3460, DOI 10.1109/ICCV.2015.395; Xie JY, 2016, LECT NOTES COMPUT SC, V9908, P842, DOI 10.1007/978-3-319-46493-0_51; Xiong Y., 1993, Proceedings. 1993 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.93CH3309-2), P68, DOI 10.1109/CVPR.1993.340977; Yang N. E., 2013, INT J COMPUTER GRAPH, V3, P1; Yang YZ, 2017, 3D RES, V8, DOI 10.1007/s13319-017-0138-7; Yang Y, 2019, IEEE T IMAGE PROCESS, V28, P302, DOI 10.1109/TIP.2018.2867740; Yuan HX, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/5708746; Zhang L, 2005, IEEE T BROADCAST, V51, P191, DOI 10.1109/TBC.2005.846190; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24; Zhuo SJ, 2011, PATTERN RECOGN, V44, P1852, DOI 10.1016/j.patcog.2011.03.009	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217246	10.1371/journal.pone.0217246	http://dx.doi.org/10.1371/journal.pone.0217246			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120978	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700078
J	Ahn, J; Kim, SA; Kim, KW; Oh, JH; Kim, SJ				Ahn, Jiyong; Kim, Seon Ae; Kim, Ki Won; Oh, Joon Hyuck; Kim, Seok Jung			Optimization of TGF-beta 1-transduced chondrocytes for cartilage regeneration in a 3D printed knee joint model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IMPLANTATION; MICROFRACTURE; MATRIX; TISSUE; TRIAL; OUTCOMES; DEFECT	A cell therapy product of transforming growth factor (TGF)-beta 1-transduced chondrocytes has been commercialized to treat osteoarthritis of the knee via intra-articular injection. The need for arthroscopic application of the cells to simultaneously treat intra-articular pathologies of knee osteoarthritis is increasingly urgent. The purpose of this study was to optimize TGF-beta 1-transduced chondrocytes for arthroscopic application. The optimal composition of chondrocytes and thrombin was initially determined by measuring the consolidation time of a diverse ratio of chondrocytes and thrombin mixed with 1 ml of fibrinogen. The consolidation time of the diverse ratio of fibrinogen and atelocollagen mixed with the determined optimal ratio of chondrocytes and thrombin was evaluated. The mixture of the determined optimal ratio of TGF-beta 1-transduced chondrocytes, atelocollagen, fibrinogen, and thrombin was applied to the cartilage defect of the 3D printed knee joint model arthroscopically. The status of the mixture in the defect was then evaluated. Chondrogenic activities of TGF-beta 1-transduced chondrocytes mixed with atelocollagen were evaluated. The determined ratio of TGF-beta 1-transduced chondrocytes to thrombin was 8: 2 and that of fibrin to atelocollagen was also 8: 2. Excellent maintenance of conformation of the mixture of TGF-beta 1-transduced chondrocytes, atelocollagen, fibrinogen, and thrombin in the cartilage defect of the 3D printed knee joint model was observed arthroscopically. Increased chondrogenic activities were observed in the group of TGF-beta 1-transduced chondrocytes mixed with atelocollagen. TGF-beta 1-transduced chondrocytes can be applied arthroscopically to treat cartilage defects of the knee at an optimized mixing ratio of atelocollagen, fibrinogen, and thrombin.	[Ahn, Jiyong; Kim, Seon Ae; Kim, Ki Won; Oh, Joon Hyuck; Kim, Seok Jung] Catholic Univ Korea, Coll Med, Dept Orthopaed Surg, Uijenong Bu Si, Gyeonggi Do, South Korea	Catholic University of Korea	Kim, SJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Orthopaed Surg, Uijenong Bu Si, Gyeonggi Do, South Korea.	peter@catholic.ac.kr			Global High-tech Biomedicine Technology Development Program of the National Research Foundation (NRF); Korea Health Industry Development Institute(KHIDI) - Korean government (MSIP) [2015M3D6A1065464]; Korea Health Industry Development Institute(KHIDI) - Korean government (MOHW) [2015M3D6A1065464]	Global High-tech Biomedicine Technology Development Program of the National Research Foundation (NRF); Korea Health Industry Development Institute(KHIDI) - Korean government (MSIP); Korea Health Industry Development Institute(KHIDI) - Korean government (MOHW)	This research was co-supported by the Global High-tech Biomedicine Technology Development Program of the National Research Foundation (NRF) & Korea Health Industry Development Institute(KHIDI) funded by the Korean government (MSIP&MOHW) (No. 2015M3D6A1065464). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aae TF, 2018, KNEE SURG SPORT TR A, V26, P1044, DOI 10.1007/s00167-017-4802-5; Abbas M, 2018, TISSUE ENG REGEN MED, V15, P661, DOI 10.1007/s13770-018-0131-0; Belluzzi E, 2017, J CELL PHYSIOL, V232, P1971, DOI 10.1002/jcp.25716; Benthien JP, 2010, CARTILAGE, V1, P65, DOI 10.1177/1947603509360044; BROWER TD, 1969, CLIN ORTHOP RELAT R, P9; Buldu MT, 2016, J KNEE SURG, V29, P396, DOI 10.1055/s-0035-1564592; Cho J, 2016, CYTOTHERAPY, V18, pS10, DOI 10.1016/j.jcyt.2016.03.024; CHOI H, 2016, OSTEOARTHR CARTILAGE, V24, pS33; Cvetanovich GL, 2017, AM J SPORT MED, V45, P70, DOI 10.1177/0363546516663711; de Windt TS, 2017, STEM CELLS, V35, P256, DOI 10.1002/stem.2475; Doyle AD, 2016, CURR PROTOC CELL BIO, V72, P10, DOI DOI 10.20.1; Ebert JR, 2017, AM J SPORT MED, V45, P59, DOI 10.1177/0363546516663493; Erggelet Christoph, 2016, J Clin Orthop Trauma, V7, P145, DOI 10.1016/j.jcot.2016.06.015; Finnson Kenneth W, 2012, Front Biosci (Schol Ed), V4, P251; Frappier Julie, 2014, J Med Econ, V17, P266, DOI 10.3111/13696998.2014.897626; Gillogly SD, 1998, J ORTHOP SPORT PHYS, V28, P241, DOI 10.2519/jospt.1998.28.4.241; Gobbi A, 2011, CARTILAGE, V2, P286, DOI 10.1177/1947603510392023; Gracitelli GC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010675.pub2; Huri Pinar Yilgor, 2018, Knee Surg Relat Res, V30, P179, DOI 10.5792/ksrr.17.061; Irawan V, 2018, TISSUE ENG REGEN MED, V15, P673, DOI 10.1007/s13770-018-0135-9; Knutsen G, 2016, J BONE JOINT SURG AM, V98, P1332, DOI 10.2106/JBJS.15.01208; Lee MC, 2015, BONE JOINT J, V97B, P924, DOI 10.1302/0301-620X.97B7.35852; Meyer M, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0647-0; Nawaz SZ, 2014, J BONE JOINT SURG AM, V96A, P824, DOI 10.2106/JBJS.L.01695; Niethammer T, 2015, INT ORTHOP, V39, P1615, DOI 10.1007/s00264-015-2792-9; Ning L, 2011, INT ORTHOP, V35, P831, DOI 10.1007/s00264-010-1045-1; Ogura T, 2017, AM J SPORT MED, V45, P1066, DOI 10.1177/0363546516682492; Pareek A, 2016, ARTHROSCOPY, V32, P2118, DOI 10.1016/j.arthro.2016.05.038; Pestka JM, 2016, AM J SPORT MED, V44, P370, DOI 10.1177/0363546515614578; Schrock JB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117704634; Shen J, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.2; Shetty Asode Ananthram, 2016, J Clin Orthop Trauma, V7, P164, DOI 10.1016/j.jcot.2016.05.003; Shin Young-Soo, 2018, Knee Surg Relat Res, V30, P206, DOI 10.5792/ksrr.17.201; Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303; van der Kraan PM, 2014, BIO-MED MATER ENG, V24, pS75, DOI 10.3233/BME-140976; Wang X, 2017, J RHEUMATOL, V44, P1644, DOI 10.3899/jrheum.161596; Widuchowski W, 2011, SCAND J MED SCI SPOR, V21, P106, DOI 10.1111/j.1600-0838.2009.01062.x; Wondrasch B, 2015, AM J SPORT MED, V43, P146, DOI 10.1177/0363546514554910; Zantop T, 2009, ARTHROSCOPY, V25, P1354, DOI 10.1016/j.arthro.2009.04.077; Zhai GJ, 2015, RHEUMATOL INT, V35, P1283, DOI 10.1007/s00296-015-3251-z	40	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217601	10.1371/journal.pone.0217601	http://dx.doi.org/10.1371/journal.pone.0217601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120999	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700113
J	Bianchi, E; Boekelheide, K; Sigman, M; Braun, JM; Eliot, M; Hall, SJ; Dere, E; Hwang, K				Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Braun, Joseph M.; Eliot, Melissa; Hall, Susan J.; Dere, Edward; Hwang, Kathleen			Spermatozoal large RNA content is associated with semen characteristics, sociodemographic and lifestyle factors	PLOS ONE			English	Article								Semen analysis is one of the standard diagnostic tools currently used to assess male infertility and reproductive toxicity. However, semen analysis has a limited ability to separate fertile from infertile populations. Additional methods to detect impaired fertility are needed. The purpose of the present study was to evaluate how spermatozoal RNA content varies with sociodemographic and behavior/lifestyle factors, and to determine if spermatozoal large and small RNAs discriminate normal from abnormal spermatozoa. Semen specimens were collected from 133 men aged between 18 to 55 years undergoing semen analysis as part of couple infertility evaluation while 10 proven fertile donors were recruited as control group. Semen samples were classified as normal or abnormal according to World Health Organization ( WHO) 2010 criteria. Sperm RNAs were extracted after somatic cells were lysed, and the association of large or small RNA content with semen quality and sociodemographic and behavioral/lifestyle factors was evaluated using a generalized additive model and one-way ANOVA. Inverse relationship was observed between large RNA content and sperm parameters such as sperm count, density and motility. Large RNA content per sperm was significantly increased in semen samples showing abnormal number of round cells. Furthermore, sperm motility was inversely associated with spermatozoal small RNA contents. Grouping donors by the number of semen abnormalities, we observed significant increased spermatozoal large and small RNA content in men with more than two semen abnormalities. Alcohol consumption was strongly associated with increased large RNA per sperm concentration after adjustment for age and BMI. Our study demonstrates a strong relationship between spermatozoal large RNA content and poor semen characteristics that may lead to a role in the assessment of male fertility, and may be used as an endpoint for reproductive toxicology risk assessment.	[Bianchi, Enrica; Sigman, Mark; Dere, Edward] Rhode Isl Hosp, Div Urol, Providence, RI 02905 USA; [Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Dere, Edward] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Braun, Joseph M.; Eliot, Melissa] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Hwang, Kathleen] Univ Pittsburgh, Med Ctr, Dept Urol, Pittsburgh, PA USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bianchi, E (corresponding author), Rhode Isl Hosp, Div Urol, Providence, RI 02905 USA.; Bianchi, E (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Enrica_Bianchi@brown.edu	Hwang, Kathleen/ABE-1339-2021	Bianchi, Enrica/0000-0002-8135-9730	NIEHS Superfund Research Program [P42ES013660]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660] Funding Source: NIH RePORTER	NIEHS Superfund Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research is supported by the NIEHS Superfund Research Program P42ES013660 (KB). This manuscript is subject to the NIH Public Access Policy. Kim Boekelheide and Susan J. Hall both own stock in Semma Therapeutics (formerly CytoSolv, Inc.) a not publicly-traded small biotechnology start-up company involved in the development of a cell-based therapy for diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Melinda Golde for assistance with human sperm samples processing. This research is supported by the NIEHS Superfund Research Program P42ES013660. This manuscript is subject to the NIH Public Access Policy.	Barragan M, 2015, ANDROLOGY-US, V3, P797, DOI 10.1111/andr.12053; Bianchi E, 2018, ANDROLOGY-US, V6, P374, DOI 10.1111/andr.12471; Cappallo-Obermann H, 2011, MOL HUM REPROD, V17, P669, DOI 10.1093/molehr/gar037; Cocuzza M, 2015, INT BRAZ J UROL, V41, P181, DOI 10.1590/S1677-5538.IBJU.2015.01.26; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Environmental Protection Agency, 1996, FED REGISTER, P56274; Esteves SC, 2014, INT BRAZ J UROL, V40, P443, DOI 10.1590/S1677-5538.IBJU.2014.04.02; Fedder J, 1996, ARCH ANDROLOGY, V36, P41, DOI 10.3109/01485019608987883; Gottardo F, 2011, UROLOGE, V50, P101, DOI 10.1007/s00120-010-2466-6; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Hamatani T, 2012, FERTIL STERIL, V97, P275, DOI 10.1016/j.fertnstert.2011.12.035; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Jodar M, 2013, HUM REPROD UPDATE, V19, P604, DOI 10.1093/humupd/dmt031; Johanisson E, 2000, HUM REPROD UPDATE, V6, P404, DOI 10.1093/humupd/6.4.404; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; KOVALSKI NN, 1992, FERTIL STERIL, V58, P809; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Lalancette C, 2009, J MOL MED, V87, P735, DOI 10.1007/s00109-009-0485-9; Lu Jin-Chun, 2010, Zhonghua Nan Ke Xue, V16, P867; Mao SH, 2014, SYST BIOL REPROD MED, V60, P308, DOI 10.3109/19396368.2014.944318; Mao SH, 2013, SYST BIOL REPROD MED, V59, P287, DOI 10.3109/19396368.2013.817626; McDowell S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010461.pub2; Miller D, 1997, MOL HUM REPROD, V3, P669, DOI 10.1093/molehr/3.8.669; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; PESSOT CA, 1989, BIOCHEM BIOPH RES CO, V158, P272, DOI 10.1016/S0006-291X(89)80208-6; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reza Sadeghi, 2010, J Reprod Infertil, V11, P159; Roudebush William E.M, 2004, INT C SERIES, V1271, P193; Sakkas D, 2015, HUM REPROD UPDATE, V21, P711, DOI 10.1093/humupd/dmv042; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; SUKCHAROEN N, 1995, FERTIL STERIL, V63, P1293, DOI 10.1016/S0015-0282(16)57614-6; Wang C, 2014, FERTIL STERIL, V102, P1502, DOI 10.1016/j.fertnstert.2014.10.021; Wild MD, 2000, AM J OBSTET GYNECOL, V182, P1011, DOI 10.1067/mob.2000.105387; Yuan SQ, 2016, DEVELOPMENT, V143, P635, DOI 10.1242/dev.131755; ZALATA A, 1995, HUM REPROD, V10, P1136, DOI 10.1093/oxfordjournals.humrep.a136106	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216584	10.1371/journal.pone.0216584	http://dx.doi.org/10.1371/journal.pone.0216584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120914	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700021
J	Delpini, D; Battiston, S; Caldarelli, G; Riccaboni, M				Delpini, Danilo; Battiston, Stefano; Caldarelli, Guido; Riccaboni, Massimo			Systemic risk from investment similarities	PLOS ONE			English	Article							DIVERSIFICATION; STABILITY; NETWORK; STOCKS	Network theory proved recently to be useful in the quantification of many properties of financial systems. The analysis of the structure of investment portfolios is a major application since their eventual correlation and overlap impact the actual risk by individual investors. We investigate the bipartite network of US mutual fund portfolios and their assets. We follow its evolution during the Global Financial Crisis and study the diversification, as understood in modern portfolio theory, and the similarity of the investments of different funds. We show that, on average, portfolios have become more diversified and less similar during the crisis. However, we also find that large overlap is far more likely than expected from benchmark models of random allocation of investments. This indicates the existence of strong correlations between fund investment strategies. We exploit a deliberately simplified model of shock propagation to identify a systemic risk component stemming from the similarity of portfolios. The network is still partially vulnerable after the crisis because of this effect, despite the increase in the diversification of multi asset portfolios. Diversification and similarity should be taken into account jointly to properly assess systemic risk.	[Delpini, Danilo] Univ Sassari, Dept Econ & Business, Sassari, Italy; [Delpini, Danilo; Caldarelli, Guido; Riccaboni, Massimo] IMT Inst Adv Studies, Lucca, Italy; [Battiston, Stefano] Univ Zurich, Dept Banking & Finance, Zurich, Switzerland; [Caldarelli, Guido] ISC CNR Uos Sapienza, Rome, Italy; [Riccaboni, Massimo] Katholieke Univ Leuven, Dept Managerial Econ Strategy & Innovat, Leuven, Belgium	University of Sassari; IMT School for Advanced Studies Lucca; University of Zurich; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); KU Leuven	Caldarelli, G (corresponding author), IMT Inst Adv Studies, Lucca, Italy.; Caldarelli, G (corresponding author), ISC CNR Uos Sapienza, Rome, Italy.	guido.caldarelli@imtlucca.it	DELPINI, Danilo/AAR-7544-2020; Caldarelli, Guido/AAB-8206-2022; /M-1612-2017; Caldarelli, Guido/A-5274-2010	DELPINI, Danilo/0000-0003-3366-720X; /0000-0002-0051-973X; RICCABONI, Massimo/0000-0003-4979-8933; Caldarelli, Guido/0000-0001-9377-3616	EU [Multiplex 317532, Simpol 610704, Dolfins 640772, CoeGSS 676547, SoBigdata 654024]	EU(European Commission)	Guido Caldarelli acknowledges support from EU projects Multiplex 317532, Simpol 610704, Dolfins 640772, CoeGSS 676547 and SoBigdata 654024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdesaken G, 2019, J ASSET MANAG, V20, P54, DOI 10.1057/s41260-018-00104-2; Acemoglu D, 2015, AM ECON REV, V105, P564, DOI 10.1257/aer.20130456; Agnew J, 2003, AM ECON REV, V93, P193, DOI 10.1257/000282803321455223; [Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Augustiani C, 2015, INT REV FINANC, V15, P427, DOI 10.1111/irfi.12054; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Battiston S, 2004, PHYSICA A, V338, P107, DOI 10.1016/j.physa.2004.02.031; Battiston S, 2016, SCIENCE, V351, P818, DOI 10.1126/science.aad0299; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Braverman A, 2014, NETWORKS COMMON ASSE, DOI [10.2139/ssrn.2379669, DOI 10.2139/SSRN.2379669]; Caccioli F, 2014, J BANK FINANC, V46, P233, DOI 10.1016/j.jbankfin.2014.05.021; Caldarelli G., 2007, SCALE FREE NETWORKS; Chen Y, 2009, IEEE C EVOL COMPUTAT, P2379, DOI 10.1109/CEC.2009.4983238; Corsi F, 2016, OPER RES, V64, P1073, DOI 10.1287/opre.2015.1464; Delpini D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01626; Domian DL, 2007, FINAN REV, V42, P557, DOI 10.1111/j.1540-6288.2007.00183.x; Domian DL., 2003, STUDIES EC FINANCE, V21, P40, DOI [10.1108/eb028774, DOI 10.1108/EB028774]; Elliott M, 2014, AM ECON REV, V104, P3115, DOI 10.1257/aer.104.10.3115; Feldman T, 2010, J ECON BEHAV ORGAN, V75, P192, DOI 10.1016/j.jebo.2010.03.014; Fricke C, 2017, DISCUSSION PAPERS DT, V32; Fricke D, 2018, FINANC MANAGE, P1; Galbiati M, 2013, NAT PHYS, V9, P126, DOI 10.1038/nphys2581; Glattfelder JB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036104; Gompers PA, 2001, Q J ECON, V116, P229, DOI 10.1162/003355301556392; Greenwood R, 2015, J FINANC ECON, V115, P471, DOI 10.1016/j.jfineco.2014.11.006; Gualdi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39467; Guo W, 2015, TOPOLOGY OVERLAPPING, DOI [10.2139/ssrn.2619514, DOI 10.2139/SSRN.2619514]; Hu JL, 2014, J PROD ANAL, V41, P141, DOI 10.1007/s11123-012-0331-x; Huang XQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01219; Hurd MD, 2010, EFFECTS FINANCIAL CR, P16407; Ibragimov R, 2011, J FINANC ECON, V99, P333, DOI 10.1016/j.jfineco.2010.08.015; Lou D, 2012, REV FINANC STUD, V25, P3457, DOI 10.1093/rfs/hhs103; Schwarzkopf Y, 2010, WHAT DRIVES MUTUAL F, DOI [10.2139/ssrn.1173046, DOI 10.2139/SSRN.1173046]; Schwarzkopf Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066113; Sialm C, 2015, AM ECON REV, V105, P432, DOI 10.1257/aer.p20151006; Statman M, 2004, FINANC ANAL J, V60, P44, DOI 10.2469/faj.v60.n4.2636; STATMAN M, 1987, J FINANC QUANT ANAL, V22, P353, DOI 10.2307/2330969; Woerheide W., 1993, FINANCIAL SERVICES R, V2, P73, DOI DOI 10.1016/1057-0810(92)90003-U; Wool PS., 2013, THESIS; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	41	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217141	10.1371/journal.pone.0217141	http://dx.doi.org/10.1371/journal.pone.0217141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120950	gold, Green Accepted, Green Published			2022-12-27	WOS:000468775700060
J	Li, YK; Cui, W; Wang, R; Lin, MM; Zhong, YP; Sun, LM; Qi, XJ; Fang, JB				Li, Yukuo; Cui, Wen; Wang, Ran; Lin, Miaomiao; Zhong, Yunpeng; Sun, Leiming; Qi, Xiujuan; Fang, Jinbao			MicroRNA858-mediated regulation of anthocyanin biosynthesis in kiwifruit (Actinidia arguta) based on small RNA sequencing	PLOS ONE			English	Article							OXIDATIVE DAMAGE; GENE NETWORK; IDENTIFICATION; ARABIDOPSIS; EXPRESSION; MICRORNAS; ACCUMULATION; PIGMENTATION; COMPLEXES; REVEALS	As important regulators, miRNAs could play pivotal roles in regulation of fruit coloring. Actinidia arguta is a newly emerged fruit tree with extensively application prospects. However, miRNAs involved in A. arguta fruit coloring are unknown. In this study, A. arguta fruit were investigated at three developmental stages by small RNAs high-throughput sequencing. A total of 482 conserved miRNAs corresponding to 526 pre-miRNAs and 581 novel miRNAs corresponding to 619 pre-miRNAs were grouped into 46 miRNA families. Target gene prediction and analysis revealed that miR858, a strongly candidate miRNA, was involved in anthocyanin biosynthesis in which contributes to fruit coloring. The anthocyanin level was determined in three A. arguta cultivars by UPLC-MS/MS (ultra-performance liquid chromatography coupled with tandem mass spectrometry). In addition, qPCR (quantitative real-time PCR), cluster analysis were conducted as well as correlation analysis. All results were combined to propose a model in which describes an association of miRNA and anthocyanin biosynthesis in A. arguta. The data presented herein is the first report on miRNA profile analysis in A. arguta, which can provide valuable information for further research into the regulation of the miRNAs in anthocyanin biosynthesis and fruit coloring.	[Li, Yukuo; Cui, Wen; Wang, Ran; Lin, Miaomiao; Zhong, Yunpeng; Sun, Leiming; Qi, Xiujuan; Fang, Jinbao] Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS	Qi, XJ; Fang, JB (corresponding author), Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China.	qixiujuan@caas.cn; fangjinbao@caas.cn	Zhong, Yun/HCH-6868-2022	Li, Yukuo/0000-0003-3610-6061	National Natural Science Foundation of China [31401825]; Special Funds for Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2017-ZFRI]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds for Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (Grant No. 31401825) to Xiujuan Qi and the Special Funds for Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2017-ZFRI) to Jinbao Fang. The funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Alipour B, 2016, NUTRITION, V32, P566, DOI 10.1016/j.nut.2015.11.011; An XH, 2012, J PLANT PHYSIOL, V169, P710, DOI 10.1016/j.jplph.2012.01.015; Bo XC, 2005, BIOINFORMATICS, V21, P1401, DOI 10.1093/bioinformatics/bti211; Chen WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07852; Chen Y. A., 2013, GAP PRODUCTION TECHN; Cho K, 2016, J EXP BOT, V67, P1519, DOI 10.1093/jxb/erv549; Dheilly NM, 2014, PLOS ONE; El-Sharkawy I, 2015, J EXP BOT, V66, P7359, DOI 10.1093/jxb/erv433; Fraser LG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-28; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Guo XW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00873; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huang HW, 2007, ACTA HORTIC, P31, DOI 10.17660/ActaHortic.2007.753.1; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jia XY, 2015, PLANTA, V242, P283, DOI 10.1007/s00425-015-2305-5; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kovinich N, 2014, PLANTA, V240, P931, DOI 10.1007/s00425-014-2079-1; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li W, 2014, J INTEGR PLANT BIOL, V56, P364, DOI 10.1111/jipb.12136; Li YK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051471; Li YK, 2018, GENE, V648, P31, DOI 10.1016/j.gene.2018.01.022; Liu YF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01507; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luceri C, 2008, FOOD CHEM TOXICOL, V46, P1213, DOI 10.1016/j.fct.2007.10.007; Luo QJ, 2012, PLANT MOL BIOL, V80, P117, DOI 10.1007/s11103-011-9778-9; Luo YJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0400-6; Man YP, 2015, PHYSIOL PLANTARUM, V153, P565, DOI 10.1111/ppl.12263; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Montefiori M, 2015, J EXP BOT, V66, P1427, DOI 10.1093/jxb/eru494; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131719; Schaart JG, 2013, NEW PHYTOL, V197, P454, DOI 10.1111/nph.12017; Song YH, 2008, PLANT PHYSIOL, V146, P1862, DOI 10.1104/pp.107.113217; Takos AM, 2006, PLANT SCI, V170, P487, DOI 10.1016/j.plantsci.2005.10.001; Testolin R, 2016, COMPEND PL GENOME, P1, DOI 10.1007/978-3-319-32274-2; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YL, 2016, MOL PLANT, V9, P1395, DOI 10.1016/j.molp.2016.07.003; Wu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-953; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Xu T, 2015, PLANTA, V242, P963, DOI 10.1007/s00425-015-2318-0; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Yang FX, 2013, PLANT CELL TISS ORG, V115, P159, DOI 10.1007/s11240-013-0349-4; Yang Jun, 2010, Wuhan Zhiwuxue Yanjiu, V28, P673, DOI 10.3724/SP.J.1142.2010.60673; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159253; Zhang HY, 2014, PLANT CELL, V26, P4933, DOI 10.1105/tpc.114.127340; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x; Zhang L, 2010, EUPHYTICA, V175, P133, DOI 10.1007/s10681-010-0194-z; Zhang Q, 2015, DNA RES, V22, P367, DOI 10.1093/dnares/dsv019; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]	65	18	24	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217480	10.1371/journal.pone.0217480	http://dx.doi.org/10.1371/journal.pone.0217480			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120996	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700118
J	Llewellyn, CD; Abraham, C; Pollard, A; Jones, CI; Bremner, S; Miners, A; Smith, H				Llewellyn, Carrie Diane; Abraham, Charles; Pollard, Alex; Jones, Christopher Iain; Bremner, Stephen; Miners, Alec; Smith, Helen			A randomised controlled trial of a telephone administered brief HIV risk reduction intervention amongst men who have sex with men prescribed post-exposure prophylaxis for HIV after sexual exposure in the UK: Project PEPSE	PLOS ONE			English	Article							BEHAVIOR-CHANGE; PREVENTION	Background In western countries, men who have sex with men (MSM) are most affected by HIV and increasingly likely to engage in risky sexual behaviour. MSM who experience a potential sexual exposure to HIV (PEPSE) and receive a preventative regimen of anti-HIV treatment are at particularly high risk of acquiring HIV and could potentially benefit from targeted risk reduction behavioural interventions such as motivational interviewing (MI). Purpose The aim of this trial was to examine the impact of augmented MI (MI plus information provision and behavioural skills building), over and above routine care, on reducing risky sexual behaviour in MSM prescribed PEPSE. Secondary aims of the research were to examine whether the intervention reduced sexually transmitted infections (STI) and further requests for PEP. Methods A parallel-group pragmatic randomised controlled trial was conducted with 175 MSM recruited from five sexual health (SH) clinics in the south east of England. The intervention was two fixed-duration sessions of telephone administered augmented MI. A manual guided the selection of individualised persuasive communication strategies based on underlying change mechanisms specified by the Information, Motivation and Behavioural Skills (IMB) model. Primary outcomes were the number of receptive and active anal intercourse (AI) partners, the use of condoms every time during receptive and active AI and the use of condoms sometimes during receptive and active AI. Results There were no significant impacts on sexual risk behaviour or any of the psychological measures, and no discernible reduction in requests for repeat PEP or rates of STIs within a year. Conclusion Our behavioural intervention of augmented MI did not affect risky sexual behaviour, rates of further PEP and STIs, and psychological factors, in MSM prescribed PEPSE.	[Llewellyn, Carrie Diane; Pollard, Alex; Jones, Christopher Iain; Bremner, Stephen; Smith, Helen] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Abraham, Charles] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Miners, Alec] London Sch Hyg & Trop Med, London, England; [Smith, Helen] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	University of Brighton; University of Sussex; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Llewellyn, CD (corresponding author), Brighton & Sussex Med Sch, Brighton, E Sussex, England.	c.d.llewellyn@bsms.ac.uk	Jones, Christopher Iain/O-5128-2019; Abraham, Charles/C-7130-2012; Bremner, Stephen/C-4366-2012	Jones, Christopher Iain/0000-0001-7065-1157; Abraham, Charles/0000-0002-0901-1975; Llewellyn, Carrie/0000-0002-9107-8473; Bremner, Stephen/0000-0003-0790-7070	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme [PB-PG-0110-21005]	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0110-21005 to CDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Abraham C, 2011, WRITING HLTH COMMUNI; Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Abraham C, 2014, JAIDS-J ACQ IMM DEF, V66, pS293, DOI 10.1097/QAI.0000000000000231; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; [Anonymous], 2013, FRAM SEX HLTH IMPR E; Bartholomew Eldridge L.K., 2016, PLANNING HLTH PROMOT; Brady MRA, 2018, BHIVA BASHH GUIDELIN; British Psychological Society Health Psychology Team, 2008, IMPR HLTH CHANG BEH; Cavazos-Rehg PA, 2011, AIDS BEHAV, V15, P869, DOI 10.1007/s10461-010-9669-0; Cosio D, 2010, SEX TRANSM DIS, V37, P140, DOI 10.1097/OLQ.0b013e3181c18975; Covey J, 2016, J BEHAV MED, V39, P371, DOI 10.1007/s10865-016-9714-1; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Elford J, 2004, SEX TRANSM INFECT, V80, P451, DOI 10.1136/sti.2004.010785; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fisher JD FW., 2002, EMERGING THEORIES HL, P40; Fisher M, 2006, INT J STD AIDS, V17, P81, DOI 10.1258/095646206775455829; Fisher M, 2005, SEX TRANSM INFECT, V81, P191, DOI 10.1136/sti.2005.015222; Gillespie L, 2018, SEX TRANSM INFECT, V94, P662, DOI 10.1136/sextrans-2018-053734; Global HIV Prevention Working Group, 2008, BEH CHANG HIV PREV R; Godin G, 2008, HEALTH PSYCHOL, V27, P179, DOI 10.1037/0278-6133.27.2.179; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Herrick A, 2014, J URBAN HEALTH, V91, P969, DOI 10.1007/s11524-014-9896-1; Hewitt CE, 2006, CAN MED ASSOC J, V175, P347, DOI 10.1503/cmaj.051625; Johnson BT, 2014, JAIDS-J ACQ IMM DEF, V66, pS259, DOI 10.1097/QAI.0000000000000235; Llewellyn C, 2016, SEX HEALTH, V13, P595, DOI 10.1071/SH16115; Llewellyn C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-70; Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Misovich S. J., 1998, HDB SEXUALITY RELATE, P328; Moore G, 2014, PROCESS EVALUATION C; Moyers T, 2010, REVISED GLOBAL SCALE; Naar-King S, 2012, CURR HIV-AIDS REP, V9, P335, DOI 10.1007/s11904-012-0132-x; National Institute for Health and Clinical Excellence, 2007, ON ON INT RED TRANSM, V3; Oster A. M., 2011, MMWR-MORBID MORTAL W, V60, P694; Pitipan EV, 2015, J BEHAV MED, V38, P194, DOI [10.1007/s10865-014-9591-4, DOI 10.1007/S10865-014-9591-4]; Pollard A, 2017, CULTURE HLTH SEXUALI; Public Health England, 2014, MAK IT WORK GUID WHO; Rietmeijer CA, 2007, SEX TRANSM INFECT, V83, P2, DOI [10.1136/sti.2006.017319, 10.1136/sti.2005.017319]; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Sayer C, 2009, SEX TRANSM INFECT, V85, P206, DOI 10.1136/sti.2008.033662; StataCorp, 2016, STAT STAT SOFTW REL; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; *UK COLL GROUP HIV, 2005, MAPP ISS HIV OTH SEX; von Sadovszky V, 2014, WORLDV EVID-BASED NU, V11, P107, DOI 10.1111/wvn.12017; Waldo CR, 2000, AIDS, V14, P1035, DOI 10.1097/00002030-200005260-00016	47	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216855	10.1371/journal.pone.0216855	http://dx.doi.org/10.1371/journal.pone.0216855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120898	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000468775700032
J	Moseson, H; Mahanaimy, M; Dehlendorf, C; Gerdts, C				Moseson, Heidi; Mahanaimy, Moria; Dehlendorf, Christine; Gerdts, Caitlin			" ... Society is, at the end of the day, still going to stigmatize you no matter which way": A qualitative study of the impact of stigma on social support during unintended pregnancy in early adulthood	PLOS ONE			English	Article							TEENAGE CHILDBEARING; DEPRESSIVE SYMPTOMS; RACIAL DISPARITIES; CARE; MORTALITY; BIRTH	Unintended pregnancy in adolescence and early adulthood is stigmatized in the United States because it deviates from social norms that consider young people's sexuality as a social problem. While limited, prior research has found that this stigma prevents young people from telling people in their lives about their pregnancies, for fear of judgment or negative reactions. We hypothesized that this selective disclosure of unintended pregnancy due to stigma would reduce the social support available to young pregnant people at a particularly vulnerable time-social support that we know is important for optimal physical and mental health of the young person, and the pregnancy (should they choose to carry to term). To explore this hypothesis, we conducted a qualitative study among young people to understand if and how they experienced stigma in relation to an unintended pregnancy, how this stigma shaped patterns of pregnancy disclosure, the implications for received social support, and participant thoughts on how to alleviate the influence of this stigma on their lives. In in-depth interviews with 25 young people in the San Francisco Bay area who had experienced at least one unintended pregnancy, using a thematic analysis approach, we found that the stigma of unintended pregnancy led participants to selectively disclose the pregnancy to limited people, which in turn cut them off from needed sources of social support. Black and Hispanic women disproportionately described this experience. Participants expressed a desire for programs that would connect young people who had experienced unplanned pregnancy to each other-either via the internet, organized groups through clinical care sites, college or high school campuses, or other forums-as a way to alleviate stigma, share perspectives and lessons learned, and otherwise build emotional and informational support networks for themselves where their usual support had fallen away.	[Moseson, Heidi; Gerdts, Caitlin] Ibis Reprod Hlth, Oakland, CA 94612 USA; [Mahanaimy, Moria] Ibis Reprod Hlth, Cambridge, MA USA; [Dehlendorf, Christine] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Dehlendorf, Christine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Moseson, H (corresponding author), Ibis Reprod Hlth, Oakland, CA 94612 USA.	hmoseson@ibisreproductivehealth.org			National Institute of Child Health and Human Development [5F31HD083017-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD083017] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development (5F31HD083017-02) to HM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi WA, 1998, J SOC PERS RELAT, V15, P365, DOI 10.1177/0265407598153004; Aiken ARA, 2016, PERSPECT SEX REPRO H, V48, P147, DOI 10.1363/48e10316; Aiken ARA, 2015, SOC SCI MED, V132, P149, DOI 10.1016/j.socscimed.2015.03.038; Altshuler AL, 2017, SOC SCI MED, V191, P109, DOI 10.1016/j.socscimed.2017.09.010; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Benediktsson I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S5; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burris HH, 2017, SEMIN PERINATOL, V41, P360, DOI 10.1053/j.semperi.2017.07.002; Buzi RS, 2015, MATERN CHILD HLTH J, V19, P2187, DOI 10.1007/s10995-015-1733-y; Cacioppo JT, 2015, ANNU REV PSYCHOL, V66, P733, DOI 10.1146/annurev-psych-010814-015240; Cohen S., 2000, SOCIAL SUPPORT MEASU; Crowley JL, 2019, HEALTH COMMUN, V34, P1441, DOI 10.1080/10410236.2018.1495162; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Eastwood J, 2013, BRAIN BEHAV, V3, P14, DOI 10.1002/brb3.107; Ellison MA, 2003, MED ANTHROPOL Q, V17, P322, DOI 10.1525/maq.2003.17.3.322; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Garretto D, 2014, AM J OBSTET GYNECOL, V210, P14, DOI 10.1016/j.ajog.2013.10.002; Geronimus AT, 2004, BRIT MED BULL, V69, P155, DOI 10.1093/bmb/ldh019; Geronimus AT, 2003, SOC SCI MED, V57, P881, DOI 10.1016/S0277-9536(02)00456-2; Grant N, 2009, ANN BEHAV MED, V37, P29, DOI 10.1007/s12160-009-9081-z; Greenblatt E, SEVERE STIGMA POWERF; Grobman WA, 2018, OBSTET GYNECOL, V131, P328, DOI 10.1097/AOG.0000000000002441; Harris LH, 2014, CURR OPIN OBSTET GYN, V26, P539, DOI 10.1097/GCO.0000000000000121; Hoffman S, 1996, PAEDIATR PERINAT EP, V10, P380, DOI 10.1111/j.1365-3016.1996.tb00063.x; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Horsten M, 1999, PSYCHOSOM MED, V61, P49, DOI 10.1097/00006842-199901000-00009; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kalil A, 1998, FAM RELAT, V47, P433, DOI 10.2307/585274; Kim S., 2017, ROLE CHRONIC STRESS; Kjelsvik M, 2018, HEALTH CARE WOMEN IN, V39, P784, DOI 10.1080/07399332.2018.1465945; Kop WJ, 2005, PSYCHOSOM MED, V67, P343, DOI 10.1097/01.psy.0000161201.45643.8d; Kumar A, 2009, CULT HEALTH SEX, V11, P625, DOI 10.1080/13691050902842741; Livingood WC, 2010, MATERN CHILD HLTH J, V14, P382, DOI 10.1007/s10995-009-0471-4; Morikawa M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10520; Nguyen TT, 2018, COMPUT HUM BEHAV, V89, P308, DOI 10.1016/j.chb.2018.08.010; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; Rice WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174210; Rodriguez CJ, 2011, AM J MED, V124, P164, DOI 10.1016/j.amjmed.2010.09.011; Smith W, 2016, PERSPECT SEX REPRO H, V48, P73, DOI 10.1363/48e9016; Thielen K, 2012, J PERINAT EDUC, V21, P209, DOI 10.1891/1058-1243.21.4.209; THOMPSON MS, 1992, SOC WORK, V37, P322; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turan J, 2014, CONTRACEPTION, V90, P342, DOI 10.1016/j.contraception.2014.05.173; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; Wiemann C.M., 2005, J ADOLESCENT HEALTH, V36, p352.; Yang YC, 2013, J HEALTH SOC BEHAV, V54, P182, DOI 10.1177/0022146513485244	47	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217308	10.1371/journal.pone.0217308	http://dx.doi.org/10.1371/journal.pone.0217308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120984	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700086
J	Ueda, T; Takesue, Y; Tokimatsu, I; Miyazaki, T; Nakada-Motokawa, N; Nagao, M; Nakajima, K; Mikamo, H; Yamagishi, Y; Kasahara, K; Yoshihara, S; Ukimura, A; Yoshida, K; Yoshinaga, N; Izumi, M; Kakeya, H; Yamada, K; Kawamura, H; Endou, K; Yamanaka, K; Yoshioka, M; Amino, K; Ikeuchi, H; Uchino, M; Miyazaki, Y				Ueda, Takashi; Takesue, Yoshio; Tokimatsu, Issei; Miyazaki, Taiga; Nakada-Motokawa, Nana; Nagao, Miki; Nakajima, Kazuhiko; Mikamo, Hiroshige; Yamagishi, Yuka; Kasahara, Kei; Yoshihara, Shingo; Ukimura, Akira; Yoshida, Koichiro; Yoshinaga, Naomi; Izumi, Masaaki; Kakeya, Hiroshi; Yamada, Koichi; Kawamura, Hideki; Endou, Kazuo; Yamanaka, Kazuaki; Yoshioka, Mutsunobu; Amino, Kayoko; Ikeuchi, Hiroki; Uchino, Motoi; Miyazaki, Yoshitsugu			The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia	PLOS ONE			English	Article							MANAGEMENT; CANDIDIASIS; CANDIDAEMIA; INFECTIONS; GUIDELINE	Background The incidence of ocular candidiasis ( OC) in patients with candidemia varies across different reports, and the issue of whether routine ophthalmoscopy improves outcomes has been raised. This study investigated the incidence of OC and evaluate whether the extent of OC impacts the clinical outcomes. Methods This retrospective study included non-neutropenic patients with candidemia who underwent treatment at one of 15 medical centers between 2010 and 2016. Chorioretinitis without other possible causes for the ocular lesions and endophthalmitis was classified as a probable OC. If signs of chorioretinitis were observed in patients with a systemic disease that causes similar ocular lesions, they were classified as a possible OC. Results In total, 781 of 1089 patients with candidemia underwent an ophthalmic examination. The prevalence of OC was 19.5%. The time from the collection of a positive blood culture to the initial ophthalmic examination was 5.0 +/- 3.9 days in patients with OC. The leading isolate was Candida albicans ( 77.9%). Possible OC was associated with unsuccessful treatments ( resolution of ocular findings) ( odds ratio: 0.354, 95% confidence interval: 0.141-0.887), indicating an overdiagnosis in patients with a possible OC. If these patients were excluded, the incidence fell to 12.8%. Endophthalmitis and/or macular involvement, both of which require aggressive therapy, were detected in 43.1% of patients; a significantly higher incidence of visual symptoms was observed in these patients. Conclusion Even when early routine ophthalmic examinations were performed, a high incidence of advanced ocular lesions was observed. These results suggest that routine ophthalmic examinations are still warranted in patients with candidemia.	[Ueda, Takashi; Takesue, Yoshio; Nakajima, Kazuhiko] Hyogo Coll Med, Dept Infect Control & Prevent, Nishinomiya, Hyogo, Japan; [Tokimatsu, Issei] Showa Univ, Sch Med, Dept Med, Div Clin Infect Dis, Tokyo, Japan; [Tokimatsu, Issei] Kobe Univ Hosp, Dept Infect Prevent & Control, Kobe, Hyogo, Japan; [Miyazaki, Taiga; Nakada-Motokawa, Nana] Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan; [Nagao, Miki] Kyoto Univ Hosp, Dept Infect Control & Prevent, Kyoto, Japan; [Mikamo, Hiroshige; Yamagishi, Yuka] Aichi Med Univ, Dept Clin Infect Dis, Nagakute, Aichi, Japan; [Kasahara, Kei; Yoshihara, Shingo] Nara Med Univ, Ctr Infect Dis, Nara, Japan; [Ukimura, Akira] Osaka Med Coll Hosp, Infect Control Ctr, Osaka, Japan; [Yoshida, Koichiro; Yoshinaga, Naomi] Kindai Univ Hosp, Osaka, Japan; [Izumi, Masaaki] Kansai Rosai Hosp, Dept Internal Med, Amagasaki, Hyogo, Japan; [Kakeya, Hiroshi; Yamada, Koichi] Osaka City Univ, Grad Sch Med, Dept Infect Control Sci, Osaka, Japan; [Kawamura, Hideki] Kagoshima Univ Hosp, Dept Infect Control & Prevent, Div Med & Environm Safety, Kagoshima, Japan; [Endou, Kazuo] Hyogo Prefectural Amagasaki Gen Med Ctr, Amagasaki, Hyogo, Japan; [Yamanaka, Kazuaki] Hyogo Prefectural Nishinomiya Hosp, Dept Urol, Nishinomiya, Hyogo, Japan; [Yoshioka, Mutsunobu] Takarazuka City Hosp, Dept Pharm, Takarazuka, Hyogo, Japan; [Amino, Kayoko] Nishinomiya Cent Municipal Hosp, Dent & Oral & Maxillofacial Surg, Nishinomiya, Hyogo, Japan; [Ikeuchi, Hiroki; Uchino, Motoi] Hyogo Coll Med, Dept Inflammatory Bowel Dis, Nishinomiya, Hyogo, Japan; [Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Tokyo, Japan	Hyogo College of Medicine; Showa University; Kobe University; Nagasaki University; Kyoto University; Aichi Medical University; Nara Medical University; Osaka Medical College; Kansai Rosai Hospital; Osaka Metropolitan University; Kagoshima University; Hyogo College of Medicine; National Institute of Infectious Diseases (NIID)	Ueda, T (corresponding author), Hyogo Coll Med, Dept Infect Control & Prevent, Nishinomiya, Hyogo, Japan.	taka76@hyo-med.ac.jp	Nagao, Miki/ABG-8561-2021	Nagao, Miki/0000-0002-8886-6145; miyazaki, yoshitsugu/0000-0001-8942-0869; Takesue, Yoshio/0000-0002-8635-6416	Agency for Medical Research and Development (AMED) [JP18fk0108045]	Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This research was supported by Agency for Medical Research and Development (AMED) under Grant Number JP18fk0108045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MK, 2015, AM J OPHTHALMOL, V160, P1078, DOI 10.1016/j.ajo.2015.07.033; Blennow O, 2013, INFECTION, V41, P129, DOI 10.1007/s15010-012-0369-8; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; DONAHUE SP, 1994, OPHTHALMOLOGY, V101, P1302, DOI 10.1016/S0161-6420(94)31175-4; Felton T, 2014, CLIN MICROBIOL REV, V27, P68, DOI 10.1128/CMR.00046-13; Gluck S, 2015, ANAESTH INTENS CARE, V43, P693, DOI 10.1177/0310057X1504300605; Kato H, 2018, INFECTION, V46, P635, DOI 10.1007/s15010-018-1163-z; Khalid A., 2014, Interdisciplinary Perspectives on Infectious Diseases, V2014, P650235, DOI 10.1155/2014/650235; Krishna R, 2000, EYE, V14, P30, DOI 10.1038/eye.2000.7; Lashof AMLO, 2011, CLIN INFECT DIS, V53, P262, DOI 10.1093/cid/cir355; Lingappan A, 2012, AM J OPHTHALMOL, V153, P162, DOI 10.1016/j.ajo.2011.06.020; Nagao M, 2012, DIAGN MICR INFEC DIS, V73, P149, DOI 10.1016/j.diagmicrobio.2012.03.006; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Rodriguez-Adrian LJ, 2003, MEDICINE, V82, P187, DOI 10.1097/00005792-200305000-00005; Takesue Y, 2015, J ANTIMICROB CHEMOTH, V70, P587, DOI 10.1093/jac/dku414; Vena A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183485; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	17	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216956	10.1371/journal.pone.0216956	http://dx.doi.org/10.1371/journal.pone.0216956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120928	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700041
J	Zhang, XM; Zhang, BF; Zhang, PH; Lian, LH; Li, LL; Qiu, ZH; Qian, K; Chen, A; Liu, QQ; Jiang, YJ; Cui, JJ; Qi, B				Zhang, Xiumei; Zhang, Bingfeng; Zhang, Panhong; Lian, Lihui; Li, Lianlian; Qiu, Zhihong; Qian, Kai; Chen, An; Liu, Qiongqing; Jiang, Yinjie; Cui, Jiajun; Qi, Bing			Norcantharidin regulates ER alpha signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells	PLOS ONE			English	Article							ENDOCRINE RESISTANCE; CROSS-TALK; ESTROGEN; MECHANISMS; PHOSPHORYLATION; CANTHARIDIN; INHIBITION; MICRORNAS; CDK3	MiR-873/CDK3 has been shown to play a critical role in ER alpha signaling and tamoxifen resistance. Thus, targeting this pathway may be a potential therapeutic approach for the treatment of ER positive breast cancer especially tamoxifen resistant subtype. Here we report that Norcantharidin (NCTD), currently used clinically as an ani-cancer drug in China, regulates miR-873/CDK3 axis in breast cancer cells. NCTD decreases the transcriptional activity of ER alpha but not ER beta through the modulation of miR-873/CDK3 axis. We also found that NCTD inhibits cell proliferation and tumor growth and miR-873/CDK3 axis mediates cell proliferation suppression of NCTD. More important, we found that NCTD sensitizes resistant cells to tamoxifen. NCTD inhibits tamoxifen induced the transcriptional activity as well ER alpha downstream gene expressions in tamoxifen resistant breast cancer cells. In addition, we found that NCTD restores tamoxifen induced recruitments of ER alpha co-repressors N-CoR and SMRT. Knockdown of miR-873 and overexpression of CDK3 diminish the effect of NCTD on tamoxifen resistance. Our data shows that NCTD regulates ER alpha signaling and tamoxifen resistance by targeting miR-873/CDK3 axis in breast cancer cells. This study may provide an alternative therapy strategy for tamoxifen resistant breast cancer.	[Zhang, Xiumei; Zhang, Panhong; Li, Lianlian; Qiu, Zhihong; Qian, Kai; Chen, An; Liu, Qiongqing; Jiang, Yinjie; Cui, Jiajun] Yichun Univ, Ctr Translat Med, Yichun, Jiangxi, Peoples R China; [Zhang, Xiumei; Zhang, Bingfeng; Zhang, Panhong; Liu, Qiongqing] Yichun Univ, Coll Chem & Bioengn, Yichun, Jiangxi, Peoples R China; [Lian, Lihui; Qi, Bing] Shandong First Med Univ & Shandong Acad Med Sci, Dept Cell Biol, Coll Life Sci, Tai An, Shandong, Peoples R China	Yichun University; Yichun University; Shandong First Medical University & Shandong Academy of Medical Sciences	Cui, JJ (corresponding author), Yichun Univ, Ctr Translat Med, Yichun, Jiangxi, Peoples R China.; Qi, B (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Dept Cell Biol, Coll Life Sci, Tai An, Shandong, Peoples R China.	cui_jj@hotmail.com; qibing@tsmc.edu.cn			University Science AMP; Technology landing project of Jiangxi province [93KJLD12093]; National Natural Science Foundation of China [31660325]	University Science AMP; Technology landing project of Jiangxi province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by University Science & Technology landing project of Jiangxi province (Grant No. 93KJLD12093, CJ) (http://www.jxedu.gov.cn/) and National Natural Science Foundation of China (No. 31660325, CJ) (http://www.nsfc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamolhodaei NS, 2016, CURR PHARM DESIGN, V22, P6946, DOI 10.2174/1381612822666161102100211; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Aung TN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030656; Bonofiglio D, 2016, MINI-REV MED CHEM, V16, P596, DOI 10.2174/1389557515666150709110959; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chen MJ, 2017, BIOCHEM BIOPH RES CO, V483, P840, DOI 10.1016/j.bbrc.2017.01.012; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037006; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cui J, 2015, ONCOGENE, V34, P3895, DOI 10.1038/onc.2014.430; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Cui JJ, 2011, CELL MOL LIFE SCI, V68, P1091, DOI 10.1007/s00018-010-0511-7; Ding JJ, 2018, EXP CELL RES, V369, P129, DOI 10.1016/j.yexcr.2018.05.014; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Gong XF, 2018, EXP CELL RES, V362, P378, DOI 10.1016/j.yexcr.2017.11.039; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gu J, 2018, CANCER LETT, V434, P1, DOI 10.1016/j.canlet.2018.06.039; Hsieh CH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/838651; Hu HY, 2017, BIOCHEM BIOPH RES CO, V485, P643, DOI 10.1016/j.bbrc.2017.02.080; Jin D, 2018, ONCOL REP, V40, P609, DOI 10.3892/or.2018.6486; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kok M, 2009, JNCI-J NATL CANCER I, V101, P1725, DOI 10.1093/jnci/djp412; Li XC, 2016, TUMOR BIOL, V37, P7599, DOI 10.1007/s13277-015-4655-9; Liu J, 2018, INT J ONCOL, V53, P1601, DOI 10.3892/ijo.2018.4492; Mo LJ, 2018, CANCER SCI, V109, P2109, DOI 10.1111/cas.13639; Mulrane L, 2013, CANCER RES, V73, P6554, DOI 10.1158/0008-5472.CAN-13-1841; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Opyrchal M, 2014, INT J ONCOL, V45, P1193, DOI 10.3892/ijo.2014.2523; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Radde BN, 2016, EXP CELL RES, V347, P222, DOI 10.1016/j.yexcr.2016.08.006; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tian W, 2013, CLIN TRANSL ONCOL, V15, P335, DOI 10.1007/s12094-012-0929-5; Wang L, 2014, MOL MED REP, V9, P2582, DOI 10.3892/mmr.2014.2095; Wang WJ, 2015, INT J ONCOL, V47, P1912, DOI 10.3892/ijo.2015.3156; Wesierska-Gadek J, 2011, J CELL BIOCHEM, V112, P761, DOI 10.1002/jcb.23004; Wu HY, 2015, CANCER CHEMOTH PHARM, V76, P307, DOI 10.1007/s00280-015-2792-x; Yamaguchi N, 2017, J BIOL CHEM, V292, P8136, DOI 10.1074/jbc.M116.763276; Zhang JT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-193; Zhang Y, 2018, BIOTECHNOL LETT, V40, P623, DOI 10.1007/s10529-018-2512-9	42	13	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217181	10.1371/journal.pone.0217181	http://dx.doi.org/10.1371/journal.pone.0217181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120927	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700064
J	Shi, YC; Sun, H; Wang, XR; Jin, WH; Chen, QY; Yuan, ZD; Yu, HD				Shi, Yongchun; Sun, Hui; Wang, Xiaoran; Jin, Weihuan; Chen, Qianyi; Yuan, Zhengdong; Yu, Haidong			Physiological and transcriptomic analyses reveal the molecular networks of responses induced by exogenous trehalose in plant	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; RAPHANUS-SATIVUS L.; ABIOTIC-STRESS; ARABIDOPSIS SEEDLINGS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DEFENSE SYSTEM; SALT TOLERANCE; NADPH OXIDASE; HIGH SALINITY	It is well known that exogenous trehalose can improve resistances of plants to some abiotic and biotic stresses. Nonetheless, information respecting the molecular responses of tobacco leaves to Tre treatment is limited. Here we show that exogenous Tre can rapidly reduce stomatal aperture, up-regulate NADPH oxidase genes and increase O-2(center dot-) and H2O2 on tobacco leaves at 2 h after treatment. We further demonstrated that imidazole and DPI, inhibitors of NADPH oxidase, can promote recovery of stomatal aperture of tobacco leaves upon trehalose treatment. Exogenous trehalose increased tobacco leaf resistance to tobacco mosaic disease significantly in a concentration-dependent way. To elucidate the molecular mechanisms in response to exogenous trehalose, the transcriptomic responses of tobacco leaves with 10 (low concentration) or 50 (high concentration) mM of trehalose treatment at 2 or 24h were investigated through RNA-seq approach. In total, 1288 differentially expressed genes (DEGs) were found with different conditions of trehalose treatments relative to control. Among them, 1075 (83.5%) were triggered by low concentration of trehalose (10mM), indicating that low concentration of Tre is a better elicitor. Functional annotations with KEGG pathway analysis revealed that the DEGs are involved in metabolic pathway, biosynthesis of secondary metabolites, plant hormone signal transduction, plant-pathogen interaction, protein processing in ER, flavonoid synthesis and circadian rhythm and so on. The protein-protein interaction networks generated from the core DEGs regulated by all conditions strikingly revealed that eight proteins, including ClpB1, HSP70, DnaJB1-like protein, universal stress protein (USP) A-like protein, two FTSH6 proteins, GolS1-like protein and chloroplastics HSP, play a core role in responses to exogenous trehalose in tobacco leaves. Our data suggest that trehalose triggers a signal transduction pathway which involves calcium and ROS-mediated signalings. These core components could lead to partial resistance or tolerance to abiotic and biotic stresses. Moreover, 19 DEGs were chosen for analysis of quantitative real-time polymerase chain reaction (qRT-PCR). The qRT-PCR for the 19 candidate genes coincided with the DEGs identified via the RNA-seq analysis, sustaining the reliability of our RNA-seq data.	[Shi, Yongchun; Sun, Hui; Wang, Xiaoran; Jin, Weihuan; Chen, Qianyi; Yuan, Zhengdong; Yu, Haidong] Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Yu, HD (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China.	hdy001@126.com		Yu, Haidong/0000-0002-4330-9935	National Natural Science Foundation of China [31871368]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	HY received the National Natural Science Foundation of China (31871368), which website is http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the research costs or authors' salaries have been funded in whole or in part by a tobacco company.	Aghdasi M, 2008, INT J PLANT PROD, V2, P309; Akram NA, 2016, AGROCHIMICA, V60, P186, DOI 10.12871/00021857201633; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bae HH, 2005, PHYSIOL PLANTARUM, V125, P114, DOI 10.1111/j.1399-3054.2005.00537.x; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chang BW, 2014, PLANT PHYSIOL BIOCH, V77, P140, DOI 10.1016/j.plaphy.2014.02.001; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Cheval C, 2013, BBA-MOL CELL RES, V1833, P1766, DOI 10.1016/j.bbamcr.2013.01.031; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Delorge I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00147; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; DITTRICH P, 1978, PLANTA, V139, P167, DOI 10.1007/BF00387143; Driedonks N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00999; Elbein AD, 2003, GLYCOBIOLOGY, V13, P17; Evrard A, 2013, PEERJ, V1, DOI 10.7717/peerj.59; Fernandez O, 2010, TRENDS PLANT SCI, V15, P409, DOI 10.1016/j.tplants.2010.04.004; Gao J, 2013, BIOL PLANTARUM, V57, P380, DOI 10.1007/s10535-012-0285-x; Ge LF, 2008, PLANTA, V228, P191, DOI 10.1007/s00425-008-0729-x; Gemes K, 2016, PLANT PHYSIOL, V172, P1418, DOI 10.1104/pp.16.01118; Gilroy S, 2016, PLANT PHYSIOL, V171, P1606, DOI 10.1104/pp.16.00434; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Gonzali S, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.151, 10.1038/nplants.2015.151]; Gutierrez-Beltran E, 2017, PLANT PHYSIOL, V173, P836, DOI 10.1104/pp.16.00949; Hafren A, 2010, PLANT CELL, V22, P523, DOI 10.1105/tpc.109.072413; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Kaur G, 2014, BIOTECHNOL ADV, V32, P551, DOI 10.1016/j.biotechadv.2014.02.002; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Kolmos E, 2014, P NATL ACAD SCI USA, V111, P16172, DOI 10.1073/pnas.1418483111; Kretzschmar T, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.124, 10.1038/NPLANTS.2015.124]; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2012, MOL CELLS, V34, P109, DOI 10.1007/s10059-012-0121-3; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lin YC, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1207-z; Liu YF, 2013, PLANT PHYSIOL BIOCH, V64, P92, DOI 10.1016/j.plaphy.2012.12.013; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Luyckx J, 2011, CLIN OPHTHALMOL, V5, P577, DOI 10.2147/OPTH.S18827; Manalo DJ, 2002, BIOCHEMISTRY-US, V41, P2580, DOI 10.1021/bi0159682; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Miranda JA, 2007, PLANTA, V226, P1411, DOI 10.1007/s00425-007-0579-y; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mostofa MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11433; Mostofa MG, 2015, PROTOPLASMA, V252, P461, DOI 10.1007/s00709-014-0691-3; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; O'Hara LE, 2013, MOL PLANT, V6, P261, DOI 10.1093/mp/sss120; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Perez-Salamo I, 2014, PLANT PHYSIOL, V165, P319, DOI 10.1104/pp.114.237891; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Renard-Merlier D, 2007, PHYTOCHEMISTRY, V68, P1156, DOI 10.1016/j.phytochem.2007.02.011; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Sedaghatmehr M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12439; Seo S, 2000, PLANT CELL, V12, P917, DOI 10.1105/tpc.12.6.917; Shafiq S, 2015, SCI HORTIC-AMSTERDAM, V185, P68, DOI 10.1016/j.scienta.2015.01.010; Simon-Plas F, 2002, PLANT J, V31, P137, DOI 10.1046/j.1365-313X.2002.01342.x; Singh R, 2017, REDOX BIOL, V11, P213, DOI 10.1016/j.redox.2016.11.006; Song YW, 2014, NEW PHYTOL, V201, P1121, DOI 10.1111/nph.12565; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Tayeh C, 2014, PHYTOPATHOLOGY, V104, P293, DOI 10.1094/PHYTO-07-13-0191-R; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI 10.1199/tab.0153; Tintor N, 2013, P NATL ACAD SCI USA, V110, P6211, DOI 10.1073/pnas.1216780110; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Wiesel L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00655; Williams B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005705; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Yang L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00570; Yellisetty V, 2015, J GENET, V94, P425, DOI 10.1007/s12041-015-0540-y; Yu HD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002669; Zelman AK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00095; Zeng HQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00600; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	90	17	18	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217204	10.1371/journal.pone.0217204	http://dx.doi.org/10.1371/journal.pone.0217204			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116769	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400052
J	Hawkings, C; Calkins, TL; Pietrantonio, PV; Tamborindeguy, C				Hawkings, Chloe; Calkins, Travis L.; Pietrantonio, Patricia, V; Tamborindeguy, Cecilia			Caste-based differential transcriptional expression of hexamerins in response to a juvenile hormone analog in the red imported fire ant (Solenopsis invicta)	PLOS ONE			English	Article							DIVISION-OF-LABOR; REPRODUCTIVE GROUND-PLAN; GENE-EXPRESSION; STORAGE PROTEINS; VITELLOGENIN RECEPTOR; ENDOCRINE PHYSIOLOGY; SOCIAL EXPLOITATION; HONEY-BEE; VIRGIN; QUEENS	The reproductive ground plan hypothesis proposes that gene networks regulating foraging behavior and reproductive female physiology in social insects emerged from ancestral gene and endocrine factor networks. Expression of storage proteins such as vitellogenins and hexamerins is an example of this co-option. Hexamerins, through their role modulating juvenile hormone availability, are involved in caste determination in termites. The genome of the fire ant (Solenopsis invicta) encodes four hexamerin genes, hexamerin-like (LOC105192919, hereafter called hexamerin 1), hexamerin (LOC105204474, hereafter called hexamerin 2), arylphorin subunit alpha-like, and arylphorin subunit beta. In this study, a phylogenetic analysis of the S. invicta hexamerins determined that each predicted protein clustered with one of the orthologous Apis mellifera hexamerins. Gene expression analyses by RT-qPCR revealed differential expression of the hexamerins between queens and workers, and between specific task-allocated workers (nurses and foragers). Queens and nurses had significantly higher expression of all genes when compared to foragers. Hexamerin 1 was expressed at higher levels in queens, while hexamerin 2 and arylphorin subunit beta were expressed at significantly higher levels in nurses. Arylphorin subunit alpha-like showed no significant difference in expression between virgin queens and nurses. Additionally, we analyzed the relationship between the expression of hexamerin genes and S-hydroprene, a juvenile hormone analog. Significant changes in hexamerin expression were recorded in nurses, virgin queens, and foragers 12 h after application of the analog. Hexamerin land arylphorin subunit alpha-like expression were significantly lower after analog application in virgin queens. In foragers, hexamerin 2 and arylphorin subunit beta were significantly lower after analog application, while in nurses expression of all genes were significantly lower after analog application. Our results suggest that in S. invicta hexamerin genes could be associated with reproductive division of labor and task-allocation of workers.	[Hawkings, Chloe; Calkins, Travis L.; Pietrantonio, Patricia, V; Tamborindeguy, Cecilia] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Tamborindeguy, C (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ctamborindeguy@tamu.edu			Texas Invasive Ant Research and Management program from Texas A&M AgriLife Research; National Science Foundation Integrative Organismal Systems award (2013-2017) [1257837]; USDA National Institute of Food and Agriculture, Hatch project [1015773, 1002279]; NIFA; Office of the Vice President for Research	Texas Invasive Ant Research and Management program from Texas A&M AgriLife Research; National Science Foundation Integrative Organismal Systems award (2013-2017); USDA National Institute of Food and Agriculture, Hatch project; NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Office of the Vice President for Research	Research was supported by competitive funds to CT and PVP from the Texas Invasive Ant Research and Management program from Texas A&M AgriLife Research and the National Science Foundation Integrative Organismal Systems award number 1257837 (2013-2017) to PVP and CT. This work is/was supported by the USDA National Institute of Food and Agriculture, Hatch project Accession Numbers 1015773 (CT), and 1002279 (PVP). CT and PVP programs are supported by NIFA. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Amsalem E, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-45; Azevedo DO, 2011, J INSECT PHYSIOL, V57, P972, DOI 10.1016/j.jinsphys.2011.04.015; Bitondi MMG, 2006, ARCH INSECT BIOCHEM, V63, P57, DOI 10.1002/arch.20142; Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756; Brent CS, 2003, J INSECT PHYSIOL, V49, P967, DOI 10.1016/S0022-1910(03)00166-5; Calkins TL, 2018, ECOL EVOL, V8, P4312, DOI 10.1002/ece3.3976; Chen ME, 2004, INSECT MOL BIOL, V13, P195, DOI 10.1111/j.0962-1075.2004.00477.x; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Colgan TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-623; Corona M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003730; Cristino AS, 2010, INSECT MOL BIOL, V19, P137, DOI 10.1111/j.1365-2583.2009.00970.x; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Dolezal AG, 2009, ANIM BEHAV, V77, P1005, DOI 10.1016/j.anbehav.2009.01.010; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; FLETCHER DJC, 1981, SCIENCE, V212, P73, DOI 10.1126/science.212.4490.73; FLETCHER DJC, 1983, INSECT SOC, V30, P443, DOI 10.1007/BF02223975; FLETCHER DJC, 1983, J COMP PHYSIOL, V153, P467, DOI 10.1007/BF00612601; Graham AM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-95; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hawkings C, 2018, PEERJ, V6, DOI 10.7717/peerj.4875; Hoffman EA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-23; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Ihle KE, 2010, ANIM BEHAV, V79, P1001, DOI 10.1016/j.anbehav.2010.02.009; JAYCOX E R, 1976, Journal of the Kansas Entomological Society, V49, P165; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khila A, 2008, P NATL ACAD SCI USA, V105, P17884, DOI 10.1073/pnas.0807351105; Lengyel F, 2007, J CHEM ECOL, V33, P167, DOI 10.1007/s10886-006-9185-x; LEVENBOOK L, 1984, INSECT BIOCHEM, V14, P77, DOI 10.1016/0020-1790(84)90086-6; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Maddison WP., 2021, MESQUITE MODULAR SYS; MARTINEZ T, 1994, J INSECT PHYSIOL, V40, P723, DOI 10.1016/0022-1910(94)90100-7; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; Martins JR, 2008, J INSECT PHYSIOL, V54, P867, DOI 10.1016/j.jinsphys.2008.03.009; Martins JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151035; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Morandin C, 2015, J EVOLUTION BIOL, V28, P1705, DOI 10.1111/jeb.12691; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; Norman VC, 2016, J EXP BIOL, V219, P8, DOI 10.1242/jeb.132803; Pamminger T, 2016, J INSECT PHYSIOL, V95, P1, DOI 10.1016/j.jinsphys.2016.09.004; Penick CA, 2011, J COMP PHYSIOL A, V197, P1063, DOI 10.1007/s00359-011-0667-0; Qiu HL, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex002; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Rueppell O, 2008, J INSECT BEHAV, V21, P317, DOI 10.1007/s10905-008-9135-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith CR, 2009, COLD SPRING HARB PRO; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Tschinkel WR, 2006, FIRE ANTS; Vargo EL, 1999, PHYSIOL ENTOMOL, V24, P370, DOI 10.1046/j.1365-3032.1999.00153.x; WHEELER DE, 1995, J INSECT PHYSIOL, V41, P885, DOI 10.1016/0022-1910(95)00028-S; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103; Zhou XG, 2007, DEVELOPMENT, V134, P601, DOI 10.1242/dev.02755; 2016, J EXP BIOL, V219, P103, DOI DOI 10.1242/JEB.127712; 2008, NATURWISSENSCHAFTEN, V95, P953, DOI DOI 10.1007/S00114-008-0413-9; 2005, FEBS LETT, V579, P4961, DOI DOI 10.1016/J.FEBSLET.2005.07.085	66	6	6	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216800	10.1371/journal.pone.0216800	http://dx.doi.org/10.1371/journal.pone.0216800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107891	gold, Green Published, Green Submitted			2022-12-27	WOS:000468285200018
J	Rerimoi, AJ; Niemann, J; Lange, I; Timaeus, IM				Rerimoi, A. J.; Niemann, J.; Lange, I.; Timaeus, I. M.			Gambian cultural beliefs, attitudes and discourse on reproductive health and mortality: Implications for data collection in surveys from the interviewer's perspective	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE SYSTEM; RISK; QUESTIONS; COMMUNITY; QUALITY	Background A community's cultural beliefs, attitudes and discourse can affect their responses in surveys. Knowledge of these cultural factors and how to comply with them or adjust for them during data collection can improve data quality. Objective This study describes implications of features of Gambian culture related to women's reproductive health, and mortality, when collecting data in surveys. Methods 13 in-depth interviews of female interviewers and a focus group discussion among male interviewers were conducted in two rural health and demographic surveillance systems as well as three key informant interviews in three regions in The Gambia. Results From the fieldworker's viewpoint, questions relating to reproduction were best asked by women as culturally pregnancies should be concealed, and menstruation is considered a sensitive topic. Gambians were reluctant to speak about decedents and the Fula did not like to be counted, potentially affecting estimation of mortality. Asking about siblings proved problematic among the Fula and Serahule communities. Proposals made to overcome these challenges were that culturally-appropriate metaphors and symbols should be used to discuss sensitive matters and to enumerating births/deaths singly instead of collecting summary totals, which had threatening connotations. This was as opposed to training interviewers to ask standardised and precise verbatim questions. Contribution This paper presents indigenous Gambian solutions by fieldworkers to culturally sensitive topics when collecting pregnancy outcomes and mortality data in demographic and health surveys. For researchers collecting maternal mortality data, it highlights the potential short-comings of the sibling history methodology.	[Rerimoi, A. J.; Timaeus, I. M.] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Rerimoi, A. J.] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Banjul, Gambia; [Niemann, J.] Bielefeld Univ, Dept Publ Hlth, Bielefeld, Germany; [Lange, I.] London Sch Hyg & Trop Med, Maternal Adolescent Reprod & Child Hlth Ctr MARCH, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Bielefeld; University of London; London School of Hygiene & Tropical Medicine	Rerimoi, AJ (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.; Rerimoi, AJ (corresponding author), Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Banjul, Gambia.	anne.rerimoi@lshtm.ac.uk	Timaeus, Ian M/F-7402-2011	Timaeus, Ian M/0000-0001-8011-4806; Niemann, Jana/0000-0001-6094-5143; Lange, Isabelle/0000-0001-8045-048X; Rerimoi, Anne/0000-0002-2230-1950	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was primarily funded by a PhD studentship awarded to AJR by the Medical Research Council The Gambia (www.mrc.gm).The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AAA, 2012, 2012 AM ANTHR ASS ST; Adetunji JA, 1996, SOC SCI MED, V43, P1561, DOI 10.1016/S0277-9536(96)00052-4; Adida CL, 2016, COMP POLIT STUD, V49, P1630, DOI 10.1177/0010414016633487; Affum MA, 2009, BEADS KROBO CULTURE; Afolabi MO, 2014, TROP MED INT HEALTH, V19, P625, DOI 10.1111/tmi.12288; AXINN WG, 1991, SOCIOL METHOD RES, V20, P187, DOI 10.1177/0049124191020002001; Bachrach CA, 2014, DEMOGRAPHY, V51, P3, DOI 10.1007/s13524-013-0257-6; Becker H., 1942, PHILOS PHENOMENOLOGI, V2, P310; Berger P., 1967, SOCIAL CONSTRUCTION; Biruk C, 2012, MED ANTHROPOL, V31, P347, DOI 10.1080/01459740.2011.631960; BLEEK W, 1987, POPUL DEV REV, V13, P314, DOI 10.2307/1973196; Bolak T., 2017, TRINET MESSAGE, P246; Boyatzis R., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brunton-Smith I, 2017, J R STAT SOC A STAT, V180, P551, DOI 10.1111/rssa.12205; Castle S, 2001, SOC SCI MED, V52, P1827, DOI 10.1016/S0277-9536(00)00300-2; Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487; Cleland J, 1996, POP STUD-J DEMOG, V50, P433, DOI 10.1080/0032472031000149556; Denzin NK, 1970, SOCIOLOGICAL METHODS, P471; Department of State for Health & Social Welfare, 2002, REP NAT SURV MAT PER; Dierickx S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148627; Doyle J. K., 2004, INTRO INTERVIEWING T; Dykema J, 2012, PUBLIC OPIN QUART, V76, P311, DOI 10.1093/poq/nfs021; Erikson SL, 2012, MED ANTHROPOL, V31, P367, DOI 10.1080/01459740.2011.621908; Gambia Bureau of Statistics, 2014, GAMB 2013 POP HOUS C; Gambia Bureau of Statistics, 2014, GAMB DEM HLTH SURV 2; Gambia Bureau of Statistics, 2017, GAMB 2013 POP HOUS C; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Govindasamy P, 1997, INFORMED RESPONDENT; Grundy E, 2015, OXFORD TXB GLOBAL PU, P718; Guest G, 2005, J FAM PLAN REPROD H, V31, P285, DOI 10.1783/jfp.31.2.285; Hahn R. A., 2009, ANTHR PUBLIC HLTH BR; Hunt S, 2003, BRIT MED J, V327, P352, DOI 10.1136/bmj.327.7411.352; IUSSP, 2017, WHAT IS DEM INT UN S; Jasseh M, 2015, INT J EPIDEMIOL, V44, P837, DOI 10.1093/ije/dyv049; Lee T, 2014, POLIT BEHAV, V36, P401, DOI 10.1007/s11109-013-9229-1; Lewis I. M., 2003, ECSTATIC RELIG STUDY; Lori JR, 2009, CULTURAL CHILDBIRTH; Malinowski B., 1954, MAGIC SCI RELIG OTHE, P85; Ngongo CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118025; Niang CI, 2004, FORMATIVE RES PERI N; O'Muircheartaigh C, 1998, J ROY STAT SOC A STA, V161, P63, DOI 10.1111/1467-985X.00090; O'Neill S, 2017, WOMEN STUD INT FORUM, V60, P136, DOI 10.1016/j.wsif.2016.11.003; O'Neill S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160464; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Palys T., 2008, SAGE ENCY QUALITATIV, P697, DOI DOI 10.4135/9781412963909.N349; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Quattrochi J, 2015, TROP MED INT HEALTH, V20, P941, DOI 10.1111/tmi.12490; Rao MR, 2003, PAEDIATR PERINAT EP, V17, P125, DOI 10.1046/j.1365-3016.2003.00482.x; Roberts C, 2007, MIXING MODES DATA CO; Sangaramoorthy T, 2012, MED ANTHROPOL, V31, P287, DOI 10.1080/01459740.2011.638684; Sangaramoorthy T, 2012, MED ANTHROPOL, V31, P292, DOI 10.1080/01459740.2011.622322; Sawyer A, 2011, BRIT J HEALTH PSYCH, V16, P528, DOI 10.1348/135910710X528710; Scheper-Hughes Nancy., 1992, DEATH WEEPING VIOLEN; Tolley EE., 2016, QUALITATIVE METHODS; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tylor EdwardB., 2010, PRIMITIVE CULTURE RE; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; Vaessen M, 1987, TRANSLATION QUESTION; Watkins SC, 2011, HANDB SOCIOL SOC RES, P431, DOI 10.1007/978-1-4419-7261-3_22; World Health Organization, 2014, WHO REC POSTN CAR MO; 2014, POLITICAL BEHAV, V36, P401, DOI DOI 10.1007/S11109-013-9229-1	61	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216924	10.1371/journal.pone.0216924	http://dx.doi.org/10.1371/journal.pone.0216924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY3MG	31095621	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000468030100052
J	Karuga, RN; Mireku, M; Muturi, N; McCollum, R; Vallieres, F; Kumar, M; Taegtmeyer, M; Otiso, L				Karuga, Robinson Njoroge; Mireku, Maryline; Muturi, Nelly; McCollum, Rosalind; Vallieres, Frederique; Kumar, Meghan; Taegtmeyer, Miriam; Otiso, Lilian			Supportive supervision of close-to-community providers of health care: Findings from action research conducted in two counties in Kenya	PLOS ONE			English	Article							CHILD HEALTH; WORKERS; PROGRAMS	Background Close-to-community (CTC) providers of health care are a crucial workforce for delivery of high-quality and universal health coverage. There is limited evidence on the effect of training supervisors of this cadre in supportive supervision. Our study aimed to demonstrate the effects of a training intervention on the approach to and frequency of supervision of CTC providers of health care. Methods We conducted a context analysis in 2013 in two Kenyan counties to assess factors that influenced delivery of community health services. Supervision was identified a priority factor that needed to be addressed to improve community health services. Supervision was inadequate due to lack of supervisor capacity in supportive approaches and lack of supervision guidelines. We designed a six-day training intervention and trained 48 purposively selected CTC supervisors on the educative, administrative and supportive components of supportive supervision, problem solving and advocacy and provided them with checklists to guide supervision sessions. We administered quantitative questionnaires to supervisors to assess changes in supervision frequency before and after the training and then explored perspectives on the intervention with community health volunteers (CHVs) and their supervisors using qualitative in-depth interviews. Results Six months after the intervention, we observed that supervisors had shifted the supervision approach from being controlling and administrative to coaching, mentorship and problem solving. Changes in the frequency of supervision were found in Kitui only, whereby significant decreases in group supervision were met with increases in accompanied home visit supervision. Supervisors and CHVs reported the intervention was helpful and it responded to capacity gaps in supervision of CHVs. Conclusion Our intervention responded to capacity gaps in supervision and contributed to enhanced supervision capacity among supervisors. Supervisors found the curriculum acceptable and useful in improving supervision skills.	[Karuga, Robinson Njoroge; Mireku, Maryline; Muturi, Nelly; Otiso, Lilian] LVCT Hlth, Dept Res & Strateg Informat, Nairobi, Kenya; [McCollum, Rosalind; Kumar, Meghan; Taegtmeyer, Miriam] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England; [Vallieres, Frederique] Trinity Coll Dublin, Sch Psychol, Ctr Global Hlth, Dublin, Ireland	Liverpool School of Tropical Medicine; Trinity College Dublin	Karuga, RN (corresponding author), LVCT Hlth, Dept Res & Strateg Informat, Nairobi, Kenya.	robinson.karuga@lvcthealth.org	Vallières, Frédérique/AAS-3079-2020; Muturi, Nelly/HDS-1066-2022	Vallières, Frédérique/0000-0001-6315-3029; Taegtmeyer, Miriam/0000-0002-5377-2536; Karuga, Robinson/0000-0003-3249-5047; Otiso, Lilian/0000-0003-0164-154X; Kumar, Meghan/0000-0002-4713-8328	European Commission Seventh Framework Programme ([FP7/2007-2013] [FP7/2007-2011]) [306090]; European Commission; Community Health Services and Development Unit of the Ministry of Health	European Commission Seventh Framework Programme ([FP7/2007-2013] [FP7/2007-2011]); European Commission(European CommissionEuropean Commission Joint Research Centre); Community Health Services and Development Unit of the Ministry of Health	The study presented in this paper is part of the REACHOUT programme. This programme has received funding from the European Commission Seventh Framework Programme ([FP7/2007-2013] [FP7/2007-2011]) under grant agreement number 306090. This publication reflects only the authors' views, and the European Commission is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We conducted this study through concerted efforts of various institutional and team members. Sincere gratitude to the European Commission for the financial support to implement this study. We recognize the support we received from the Community Health Services and Development Unit of the Ministry of Health. We also thank the Nairobi and Kitui County Health Departments and the sub-County Community Health Strategy Focal Persons for the key role they played in facilitating the implementation the study. We acknowledge the technical oversight and support provided by the REACHOUT team at the Liverpool School of Tropical Medicine and KIT, particularly that of Dr. Miriam Taegtmeyer, Korrie de Koning for their insights in the conceptualization and implementation of the project. The authors also thank the LVCT Health family for the support given to us towards this project, specifically Grace Kariuki, Paul Ngone, Carol Muthamia, Praxedes Ndindi, Dorothy Njeru and Kelvin Ngugi. Much thanks to the Research Assistants who helped with translation of tools, data collection and transcription and data entry. Special mention to Jordan Karanja and Dr Maryse Kok who gave their valuable time to review this manuscript. Finally, special thanks to all the participants who provided us with valuable information that assisted in generating this evidence. This study would not have been possible without your participation.	[Anonymous], 2017, LANCET GLOB HEALTH, V5, pe467, DOI [10.1016/S2214-109X(17)30152-3, DOI 10.1016/S2214-109X(17)30152-3]; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Casey L, 2005, COMMUNITY BASED FAMI; Crigler L., 2013, SUPERVISION COMMUNIT; Dahn B, 2015, 3 INT C FIN DEV ADD; De Koning KO, 2014, R SOC TROP MED HYG; Earth Institute-Columbia University, 2011, ON MILL COMM HLTH WO; Frimpong JA, 2011, TROP MED INT HEALTH, V16, P1225, DOI 10.1111/j.1365-3156.2011.02824.x; Gopalan SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001557; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Jenkins R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-368; Kawakatsu Yoshito, 2012, Prim Health Care Res Dev, V13, P294, DOI 10.1017/S1463423612000138; Kok MC, 2013, MALAWI MED J, V25, P5; Kok MC, 2015, HEALTH POLICY PLANN, V30, P1207, DOI 10.1093/heapol/czu126; Langston A, 2014, GLOB HEALTH-SCI PRAC, V2, P342, DOI 10.9745/GHSP-D-14-00067; LOEVINSOHN BP, 1995, HEALTH POLICY PLANN, V10, P144, DOI 10.1093/heapol/10.2.144; Marquez L, 2002, MAKING SUPPERVISION; Mash B, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.585; McCollum R., 2017, PROCESS POWER POLITI; McCollum R, 2018, HEALTH POLICY PLANN, V33, P729, DOI 10.1093/heapol/czy043; McCollum R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3043-8; Mireku M., 2014, CONTEXT ANAL CLOSE C; MoH, 2014, KEN HUM RES HLTH STR; Ndima SD, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0063-x; Ojakaa D, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-33; Oliver M, 2015, WHAT DO COMMUNITY HL, V2015, P8, DOI [10.3402/gha.v8.27168, DOI 10.3402/GHA.V8.27168]; Perez F, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-28; QSR International Pty Ltd, 2018, NVIVO; RCCT, 1999, STRAT PEOPL BAS CONS; Roberton T, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0010-x; Smith S., 2013, COMMUNITY HLTH VOLUN; Theobald Sally, 2015, BMC Proc, V9, pS8, DOI 10.1186/1753-6561-9-S10-S8; Tulenko K, 2013, B WORLD HEALTH ORGAN, V91, P847, DOI 10.2471/BLT.13.118745; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216444	10.1371/journal.pone.0216444	http://dx.doi.org/10.1371/journal.pone.0216444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141509	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000469323000010
J	Nita, A; Hartel, T; Manolache, S; Ciocanea, CM; Miu, IV; Rozylowicz, L				Nita, Andreea; Hartel, Tibor; Manolache, Steluta; Ciocanea, Cristiana M.; Miu, Iulia, V; Rozylowicz, Laurentiu			Who is researching biodiversity hotspots in Eastern Europe? A case study on the grasslands in Romania	PLOS ONE			English	Article							COAUTHORSHIP NETWORKS; WOOD-PASTURES; CONSERVATION; POLICY; ABANDONMENT; PERSPECTIVE; DIVERSITY; CLUSTERS; THREAT; PLANT	European farmlands are vital arenas for socio-ecological sustainability because of their significant land coverage and potential for integrating food production with biodiversity conservation. The knowledge produced by scientific research is a critical ingredient in developing and implementing socio-economically and ecologically sustainable management strategies for farming landscapes. The grasslands of Europe have been managed for millennia. They have exceptional socio-cultural and economic value and are among the most biodiverse ecosystems in the world. The quality of scientific knowledge on them and its potential to address grasslands as complex socio-ecological systems is strongly dependent not only on the creativity and scientific ambition of the researcher, but also on the network around the researcher (including both academic and non-academic sectors). The goal of this study is to map the research network around Romania's grasslands using bibliometrics analysis, a well-developed scientific domain that utilizes network theory to analyze relationships between affiliations networks, co-authorship networks, and co-word analysis. The number of studies targeting grasslands in Romania is increasing, owing mostly to international involvement. However, management of the grasslands is still deficient and the contribution of science to the process is virtually absent. The current research is mainly related to the biological and ecological characteristics of grasslands, with topics related to their management notably absent from internationally visible research, especially in the context of EU Common Agricultural Policies. To increase scientific inquiry and better inform the EU and local policies on grasslands management, Romanian researchers should capitalize on international collaborations and local academic leaders. Our findings can be used to identify research gaps and to improve collaboration and knowledge exchange between practitioners, researchers, policy makers, and stakeholders.	[Nita, Andreea; Hartel, Tibor; Manolache, Steluta; Ciocanea, Cristiana M.; Miu, Iulia, V; Rozylowicz, Laurentiu] Univ Bucharest, Ctr Environm Res & Impact Studies, Bucharest, Romania; [Hartel, Tibor] Babes Bolyai Univ, Dept Biol & Ecol Hungarian, Cluj Napoca, Romania; [Hartel, Tibor] Babes Bolyai Univ, Ctr Syst Biol Biodivers & Bioresources, Cluj Napoca, Romania; [Rozylowicz, Laurentiu] Chelonia Romania, Bucharest, Romania	University of Bucharest; Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Nita, A (corresponding author), Univ Bucharest, Ctr Environm Res & Impact Studies, Bucharest, Romania.	andreea.nita@cc.unibuc.ro	Miu, Iulia Viorica/U-4431-2017; Tibor, Hartel/B-3440-2012; CIOCANEA, CRISTIANA M/E-4859-2017; Nita, Andreea/W-2056-2018; Rozylowicz, Laurentiu/B-4540-2009; Nita, Andreea/AAY-6874-2021	Miu, Iulia Viorica/0000-0002-5060-537X; CIOCANEA, CRISTIANA M/0000-0001-6060-2749; Nita, Andreea/0000-0002-0661-608X; Rozylowicz, Laurentiu/0000-0001-7174-032X; Nita, Andreea/0000-0002-0661-608X; Hartel, Tibor/0000-0002-0469-8923	Romanian National Authority for Scientific Research [PN-III-P4-ID-PCE-2016-0483]	Romanian National Authority for Scientific Research	This work was supported by a grant of the Romanian National Authority for Scientific Research (https://uefiscdi.gov.ro), PN-III-P4-ID-PCE-2016-0483. The work of T. H. is also a contribution to the ERA-FACCE-STACCATO-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, INFORM PROCESS MANAG, V48, P671, DOI 10.1016/j.ipm.2011.09.001; Abson DJ, 2017, AMBIO, V46, P30, DOI 10.1007/s13280-016-0800-y; [Anonymous], 2005, INTRO SOCIAL NETWORK; Azadi H, 2018, INT J DISAST RISK RE, V31, P184, DOI 10.1016/j.ijdrr.2018.05.003; Babai D, 2014, AGR ECOSYST ENVIRON, V182, P123, DOI 10.1016/j.agee.2013.08.018; Balvanera P, 2017, ECOL SOC, V22, DOI 10.5751/ES-08826-220114; Barabasi A.-L., 2016, NETWORK SCI; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; Benton T, 2011, NATURE, V480, P39, DOI 10.1038/480039d; Borgatti S. P., 2018, ANAL SOCIAL NETWORK; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Borgatti S. P., 2002, NETDRAW SOFTWARE NET; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Campos-Arceiz A, 2015, BIOL CONSERV, V186, P22, DOI 10.1016/j.biocon.2015.02.025; Chen CM, 2010, J AM SOC INF SCI TEC, V61, P1386, DOI 10.1002/asi.21309; Cobo MJ, 2011, J AM SOC INF SCI TEC, V62, P1382, DOI 10.1002/asi.21525; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; David D, 2018, NATURE, V560, P167, DOI 10.1038/d41586-018-05876-6; Ding Y., 2014, SPSS 211 UYGULAMALI; Dorresteijn Ine, 2015, Ecosystem Health and Sustainability, V1, DOI 10.1890/EHS15-0021.1; Dotsika F, 2017, TECHNOL FORECAST SOC, V119, P114, DOI 10.1016/j.techfore.2017.03.020; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Flor M., CREATING D3 CHORD DI; Gazni A, 2012, J AM SOC INF SCI TEC, V63, P323, DOI 10.1002/asi.21688; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Granieri M., 2012, INNOVATION LAW POLIC; Halada L, 2011, BIODIVERS CONSERV, V20, P2365, DOI 10.1007/s10531-011-9989-z; Hancean MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep36152; Hancean MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113271; Hanspach J, 2014, ECOL SOC, V19, DOI 10.5751/ES-06915-190432; Hartel T, 2018, RANGELAND ECOL MANAG, V71, P536, DOI 10.1016/j.rama.2018.03.006; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kozak M, 2015, SCIENTOMETRICS, V102, P1101, DOI 10.1007/s11192-014-1439-8; Lescourret F, 2015, CURR OPIN ENV SUST, V14, P68, DOI 10.1016/j.cosust.2015.04.001; Leydesdorff L, 2004, J DOC, V60, P371, DOI 10.1108/00220410410548144; Lomba A, 2014, J ENVIRON MANAGE, V143, P140, DOI 10.1016/j.jenvman.2014.04.029; Manolache S., 2017, EUR J GEOGR, V8, P24; Michielsen M, 2017, APPL VEG SCI, V20, P388, DOI 10.1111/avsc.12300; Miclauș Mihai, 2018, Nature, V558, P189, DOI 10.1038/d41586-018-05390-9; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Patru-Stupariu I, 2017, ECOL INDIC, V80, P363, DOI 10.1016/j.ecolind.2017.05.010; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Peringer A, 2017, ECOL MODEL, V359, P301, DOI 10.1016/j.ecolmodel.2017.06.012; Plieninger T, 2015, BIOL CONSERV, V190, P70, DOI 10.1016/j.biocon.2015.05.014; Plieninger T, 2013, ECOL SOC, V18, DOI 10.5751/ES-05877-180420; Popescu VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113648; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Roellig M, 2018, RANGELAND ECOL MANAG, V71, P526, DOI 10.1016/j.rama.2018.04.004; Rozylowicz L, 2017, J NAT CONSERV, V38, P21, DOI 10.1016/j.jnc.2017.05.005; Ruprecht E, 2006, RESTOR ECOL, V14, P473, DOI 10.1111/j.1526-100X.2006.00155.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutcliffe LME, 2015, DIVERS DISTRIB, V21, P722, DOI 10.1111/ddi.12288; Torralba M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2176; Veen P, 2009, GRASSLANDS EUROPE; Wang J, 2016, RES POLICY, V45, P68, DOI 10.1016/j.respol.2015.09.003; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x	57	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217638	10.1371/journal.pone.0217638	http://dx.doi.org/10.1371/journal.pone.0217638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136635	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300053
J	Zhu, M; Chen, C; Wang, N; Tang, J; Bao, WX				Zhu, Ming; Chen, Chun; Wang, Nian; Tang, Jun; Bao, Wenxia			Gradually focused fine-grained sketch-based image retrieval	PLOS ONE			English	Article								This paper focuses on fine-grained image retrieval based on sketches. Sketches capture detailed information, but their highly abstract nature makes visual comparisons with images more difficult. In spite of the fact that the existing models take into account the fine-grained details, they can not accurately highlight the distinctive local features and ignore the correlation between features. To solve this problem, we design a gradually focused bilinear attention model to extract detailed information more effectively. Specifically, the attention model is to accurately focus on representative local positions, and then use the weighted bilinear coding to find more discriminative feature representations. Finally, the global triplet loss function is used to avoid oversampling or undersampling. The experimental results show that the proposed method outperforms the state-of-the-art sketch-based image retrieval methods.	[Zhu, Ming; Chen, Chun; Wang, Nian; Tang, Jun; Bao, Wenxia] Anhui Univ, Sch Elect & Informat Engn, Hefei, Anhui, Peoples R China	Anhui University	Wang, N (corresponding author), Anhui Univ, Sch Elect & Informat Engn, Hefei, Anhui, Peoples R China.	wn_xlb@ahu.edu.cn	zhu, ming/ABI-2777-2020		National Natural Science Foundation of China [61501003, 61772032, 61401001, 61672032]; National Key RD Project [SQ2018YFC080102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD Project	This work was supported by the National Natural Science Foundation of China (No. 61501003; 61772032; 61401001; 61672032) to MZ. This work was also supported by the National Key R&D Project SQ2018YFC080102) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi R., 2015, 2015 INT C INN INF E, P1, DOI DOI 10.1109/ICIIECS.2015.7192911; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Feng Z, 2018, CERAM INT, V44, P1059, DOI 10.1016/j.ceramint.2017.10.048; Feng Zheng, 2016, IJCAI, P2399; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hong S, 2005, P ANN INT IEEE EMBS, P6336; Jang SY, 2007, 9TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY: TOWARD NETWORK INNOVATION BEYOND EVOLUTION, VOLS 1-3, P502, DOI 10.1109/ICACT.2007.358404; Jiang T, 2017, IEEE IMAGE PROC, P3690; Kumar BGV, 2016, PROC CVPR IEEE, P5385, DOI 10.1109/CVPR.2016.581; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lei JJ, 2017, IEEE IMAGE PROC, P3685; Li K, 2017, IEEE T IMAGE PROCESS, V26, P5908, DOI 10.1109/TIP.2017.2745106; Lin TY, 2015, IEEE I CONF COMP VIS, P1449, DOI 10.1109/ICCV.2015.170; Liu SL, 2018, INFORM SCIENCES, V424, P235, DOI 10.1016/j.ins.2017.10.010; Matsui Y, 2014, IEEE IMAGE PROC, P3097, DOI 10.1109/ICIP.2014.7025626; Qin Zhou, ARXIV180308580; Saavedra JM, 2014, IEEE IMAGE PROC, P2998, DOI 10.1109/ICIP.2014.7025606; Saintas E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172140; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Seng WC, 2009, INTERNATIONAL CONFERENCE ON FUTURE COMPUTER AND COMMUNICATIONS, PROCEEDINGS, P412, DOI 10.1109/ICFCC.2009.112; Song JF, 2017, IEEE I CONF COMP VIS, P5552, DOI 10.1109/ICCV.2017.592; Song J, 2017, 2017 INTERNATIONAL CONFERENCE ON CULTURE AND COMPUTING (CULTURE AND COMPUTING), P127, DOI 10.1109/Culture.and.Computing.2017.20; Sun X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156327; Yu Q, 2016, PROC CVPR IEEE, P799, DOI 10.1109/CVPR.2016.93; [于谦 Yu Qian], 2015, [高分子通报, Polymer Bulletin], P1; Zhang H., 2017, 2017 IEEE VISUAL COM, P1; Zhang YT, 2016, IEEE T MULTIMEDIA, V18, P1604, DOI 10.1109/TMM.2016.2568138; Zheng F, 2018, IEEE T IMAGE PROCESS, V27, P4302, DOI 10.1109/TIP.2018.2832462; Zhou Bing, 2010, 2010 International Conference on Computer Design and Applications (ICCDA 2010), P332, DOI 10.1109/ICCDA.2010.5540864	30	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217168	10.1371/journal.pone.0217168	http://dx.doi.org/10.1371/journal.pone.0217168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136610	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300021
J	Gomez, P; Murua, M; San Martin, J; Goncalves, E; Bustamante, RO				Gomez, Persy; Murua, Maureen; San Martin, Jose; Goncalves, Estefany; Bustamante, Ramiro O.			Maintaining close canopy cover prevents the invasion of Pinus radiata: Basic ecology to manage native forest invasibility	PLOS ONE			English	Article							SOUTHERN-HEMISPHERE; FRAGMENTATION; DETERMINANTS; REGENERATION; LANDSCAPE; RESPONSES; CONIFERS; SPREAD; CHILE; SHRUB	Pine invasion is a global threat that is occurring in native forests of diverse regions of the world. This process is arising in a scenario of rapid forest deforestation and degradation. Therefore, elucidate which forests attributes explain invasibility is a central issue in forest ecology. The Coastal Maulino forest is an endemic forest of central Chile, which has suffered a large history of disturbance, being replaced by large extensions of Pinus radiata plantations. This land transformation conveys high rates of pines invasion into native remnants. In this study we examined to what extent structural features of forest patches explains invasibility of this forest-type. Within eight forest fragments, we sampled 162 plots (10 x 10 m(2) each). We quantified seedling pine density and related these estimates with tree cover, litter depth, PAR radiation, and diversity of the resident community. Our results indicate that canopy cover was the most important variable to determine seedling pine density within forest fragments. Our investigation highlights the importance to conserve the forests cover to reduce significantly their invasibility. This action can be effective even if we cannot avoid pine plantations in the region as a source of a massive seed dispersal to forests with well conserved canopy.	[Gomez, Persy] Univ Talca, Jardin Bot, Talca, Chile; [Murua, Maureen] Univ Mayor, Ctr GEMA Genom Ecol & Medio Ambiente, Santiago, Chile; [San Martin, Jose] Univ Talca, Inst Biol Vegetal & Biotecnol, Talca, Chile; [Goncalves, Estefany; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Goncalves, Estefany; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, IEB, Santiago, Chile	Universidad de Talca; Universidad Mayor; Universidad de Talca; Universidad de Chile; Universidad de Chile	Bustamante, RO (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.; Bustamante, RO (corresponding author), Univ Chile, Fac Ciencias, IEB, Santiago, Chile.	rbustama@uchile.cl		Murua Ibarra, Maureen/0000-0002-8777-9445; BUSTAMANTE, RAMIRO/0000-0001-6441-7006	Anillo Project "The structure of mutualist networks in fragmented forests", PBCT, Chile [ACT34/2006]; DI (Direccion de Investigacion), Talca University; ICM [P05-002, PFB-23]	Anillo Project "The structure of mutualist networks in fragmented forests", PBCT, Chile; DI (Direccion de Investigacion), Talca University; ICM	This work was supported by Anillo Project "The structure of mutualist networks in fragmented forests", PBCT ACT34/2006, Chile. DI (Direccion de Investigacion), Talca University gave partial support to the senior author. RO Bustamante was supported by ICM P05-002 and PFB-23.	[Anonymous], 1990, SILVICS N AM, V1; Baker AC, 2010, WEED RES, V50, P586, DOI 10.1111/j.1365-3180.2010.00805.x; Bartuszevige AM, 2006, ECOGRAPHY, V29, P213, DOI 10.1111/j.2006.0906-7590.04359.x; Bustamante R, 2005, HIST BIODIVERSIDAD E, P555; Bustamante RO, 2003, ECOL STU AN, V162, P145; Bustamante RO, 2005, BIOL INVASIONS, V7, P243, DOI 10.1007/s10530-004-0740-5; Bustamante RO, 1998, BIODIVERS CONSERV, V7, P1607, DOI 10.1023/A:1008856912888; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; CONAF, 2015, INC FOR CHIL; DAEHLER CC, 2001, B ECOL SOC AM, V82, P101, DOI DOI 10.2307/20168521; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; di Castri F., 1989, SCOPE, V37, P1; Donoso C, 1996, ECOLOGIA BOSQUES NAT; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; Garfias R, 2012, CARACTERIZACION SOCI, P101; Gomez P, 2017, GAYANA BOT, V74, P302, DOI 10.4067/S0717-66432017000200302; Gomez P, 2012, GAYANA BOT, V69, P197, DOI 10.4067/S0717-66432012000100022; Gomez P, 2009, GAYANA BOT, V66, P256; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guerrero PC, 2009, REV CHIL HIST NAT, V82, P413, DOI 10.4067/S0716-078X2009000300008; Higgins SI, 1998, PLANT ECOL, V135, P79, DOI 10.1023/A:1009760512895; Higgins SI, PINE INVASIONS SO HE; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; HUISMAN J, 1993, J VEG SCI, V4, P37, DOI 10.2307/3235732; Jansen F, 2013, J VEG SCI, V24, P1108, DOI 10.1111/jvs.12050; KRUGER FJ, 1989, BIOL INVASIONS GLOBA, P181; Lara A., 1993, FOREST PLANTATIONS C, P118; Laurance W. F., 1997, P71; Ledgard N., 2002, New Zealand Journal of Forestry, V47, P36; Liebhold A, 2017, BIOL INVASIONS, V19, P3437, DOI 10.1007/s10530-017-1458-5; Lockwood JL., 2013, INVASION ECOLOGY; Lusk CH, 2001, REV CHIL HIST NAT, V74, DOI [10.4067/S0716-078X2001000300016, DOI 10.4067/S0716-078X2001000300016]; MINORE D, 1979, COMP AUTECOLOGICAL C; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nunez MA, 2017, BIOL INVASIONS, V19, P3099, DOI 10.1007/s10530-017-1483-4; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Park DS, 2015, MOL ECOL, V24, P3181, DOI 10.1111/mec.13227; Parker IM, 2001, BIOL INVASIONS, V3, P323, DOI 10.1023/A:1015855515361; PAUCHARD A., 2006, BIODIVERSIDAD AMBIEN, P41; Pena E, 2007, BOSQUE NATIVO, V40, P3; Philipp TE, 2001, DESIGN ANAL ECOLOGIC, P183; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; R Development Core Team, 2012, R LANG ENV STAT COMP; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Relva María A., 2014, Ecol. austral, V24, P145; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; RICHARDSON DM, 1991, AM NAT, V137, P639, DOI 10.1086/285186; RICHARDSON DM, 1986, S AFR J BOT, V52, P529, DOI 10.1016/S0254-6299(16)31486-7; RICHARDSON DM, 1994, J BIOGEOGR, V21, P511, DOI 10.2307/2845655; Rouget M, 2001, PLANT ECOL, V152, P79, DOI 10.1023/A:1011412427075; San Martin J., 1996, ECOLOGIA BOSQUES NAT, P153; Sarasola Mauro M, 2006, Ecol. austral, V16, P143; Schelhas John, 1996, pXV; Simberloff Daniel, 2002, Biological Invasions, V4, P35, DOI 10.1023/A:1020576408884; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Ubeda X, 2016, GLOBAL PLANET CHANGE, V146, P152, DOI 10.1016/j.gloplacha.2016.10.004; Ulriksen R, 1979, 25 IRENCORFO; Viana V. M., 1997, TROPICAL FOREST REMN; Vila M, 2011, LANDSCAPE ECOL, V26, P461, DOI 10.1007/s10980-011-9585-3	60	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0210849	10.1371/journal.pone.0210849	http://dx.doi.org/10.1371/journal.pone.0210849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125341	gold, Green Submitted, Green Published			2022-12-27	WOS:000468865700001
J	Karunasinghe, N; Symes, E; Gamage, A; Wang, A; Murray, P; Zhu, ST; Goudie, M; Masters, J; Ferguson, LR				Karunasinghe, Nishi; Symes, Eva; Gamage, Amy; Wang, Alice; Murray, Pam; Zhu, Shuotun; Goudie, Megan; Masters, Jonathan; Ferguson, Lynnette R.			Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBON; ANDROGEN DEPRIVATION THERAPY; BODY-COMPOSITION; PRODRUG PR-104A; RISK; TESTOSTERONE; AKR1C3; GENE; MORTALITY; EXPOSURE	Introduction Aldo-keto reductase 1C3 (AKR1C3) is known for multiple functions including its catalytic activity towards producing extra-testicular androgen. The present study is towards understanding interaction between biological, lifestyle and genetic impacts of AKR1C3 and their influence on clinical factors in a prostate cancer (PC) cohort from New Zealand (NZ). Method Characteristics of 516 PC patients were collected from the Auckland Regional Urology Facility, NZ. These men were genotyped for the AKR1C3 rs12529 single nucleotide polymorphism (SNP). The leukocyte AKR1C3 activity was measured in a sub-cohort. Variability of leukocyte AKR1C3 activity between biological, lifestyle and clinical features as well as correlation between biological and clinical features were assessed with and without genetic stratification. Results The leukocyte AKR1C3 activity was associated with age at diagnosis (0.51 vs 0.34 mu M coumberol units for >69y vs. <= 69y, P = 0.03); and with anatomic stage/prognostic grouping among the AKR1C3 rs12529 CC genotype carriers (0.50 vs 28 mu M coumberol units among low-and high-risk groups respectively, P = 0.02). Significant correlation between leukocyte AKR1C3 activity and age at PC diagnosis was also observed (correlation coefficient 0.20 and P = 0.02). Ever-smoking impacted both age and PSA at PC diagnosis among AKR1C3 rs12529 GG and CG genotype carriers respectively. Age at diagnosis significantly correlated with PSA at diagnosis in the main (correlation coefficient 0.29, and P<0.001) and subcohorts (correlation coefficient 0.24, and P = 0.01); and those carrying the AKR1C3 rs12529 CG and GG genotypes in both the main (correlation coefficient 0.30, and P<0.001 and correlation coefficient 0.35, and P<0.001 respectively) and sub-cohorts (correlation coefficient 0.43, and P<0.001 and correlation coefficient 0.39, and P = 0.06 respectively); but not with those carrying the CC genotype. Conclusions Age dependent PSA thresholds in PC screening could have been valid only in men carrying the AKR1C3 rs12529 CG and GG genotypes in this NZ cohort.	[Karunasinghe, Nishi; Symes, Eva; Gamage, Amy; Wang, Alice; Murray, Pam; Zhu, Shuotun] Univ Auckland, ACSRC, FM&HS, Auckland, New Zealand; [Goudie, Megan; Masters, Jonathan] Auckland City Hosp, Urol Dept, Auckland, New Zealand; [Ferguson, Lynnette R.] Univ Auckland, FM&HS, Auckland, New Zealand	University of Auckland; Auckland City Hospital; University of Auckland	Karunasinghe, N (corresponding author), Univ Auckland, ACSRC, FM&HS, Auckland, New Zealand.	n.karunasinghe@auckland.ac.nz		Karunasinghe, Nishi/0000-0002-6383-4163	A+ Trust, Auckland District Health Board, Auckland, NZ [5461-PG-1204-007]; GoodFellow Trust, Urology Department, Auckland Hospital, Auckland, NZ [+3192]; Cancer Society NZ [10/08]	A+ Trust, Auckland District Health Board, Auckland, NZ; GoodFellow Trust, Urology Department, Auckland Hospital, Auckland, NZ; Cancer Society NZ	Authors wish to acknowledge the following grantees from New Zealand for their support with the study since 2006 -the A+ Trust, Auckland District Health Board, Auckland, NZ (Grant No. 5461-PG-1204-007-JM), the GoodFellow Trust, Urology Department, Auckland Hospital, Auckland, NZ (Grant No. +3192-JM), the Cancer Society NZ (https://cancernz.org.nz/) (Grant No. 10/08-LRF); and the Auckland Northland Cancer Society, NZ (https://auckland-northland.cancernz.org.nz/) (NK). Funders played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bastian PJ, 2012, EUR UROL, V61, P1096, DOI 10.1016/j.eururo.2012.02.031; Byrns MC, 2012, J STEROID BIOCHEM, V130, P7, DOI 10.1016/j.jsbmb.2011.12.012; Colli-Dula RC, 2018, AQUAT TOXICOL, V201, P162, DOI 10.1016/j.aquatox.2018.06.005; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Fan L, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500019; Ferguson Lynnette R., 2012, Current Pharmacogenomics & Personalized Medicine, V10, P204; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fleshner K, 2017, NAT REV UROL, V14, P26, DOI 10.1038/nrurol.2016.251; Flowers L, 1996, BIOCHEMISTRY-US, V35, P13664, DOI 10.1021/bi961077w; Flowers L, 1997, BIOCHEMISTRY-US, V36, P8640, DOI 10.1021/bi970367p; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Haseen F, 2010, J CANCER SURVIV, V4, P128, DOI 10.1007/s11764-009-0114-1; Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Islami F, 2014, EUR UROL, V66, P1054, DOI 10.1016/j.eururo.2014.08.059; Jakobsson J, 2007, PHARMACOGENOMICS J, V7, P282, DOI 10.1038/sj.tpj.6500419; Jamieson SMF, 2014, BIOCHEM PHARMACOL, V88, P36, DOI 10.1016/j.bcp.2013.12.019; Karunasinghe N, 2015, SCI CANC HLTH DISPAR; Karunasinghe N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199122; Karunasinghe N, 2017, CURR CANCER DRUG TAR, V17, P603, DOI 10.2174/1568009617666170330115722; Karunasinghe N, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0164-4; Karunasinghe Nishi, 2013, Current Pharmacogenomics & Personalized Medicine, V11, P22; Karunasinghe N, 2012, J NUTRIGENET NUTRIGE, V5, P339, DOI 10.1159/000346279; Karunasinghe N, 2012, GENES NUTR, V7, P179, DOI 10.1007/s12263-011-0259-1; Kim DK, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010113; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Malhotra R, 2013, OBESITY, V21, P1923, DOI 10.1002/oby.20318; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Merriel SWD, 2018, ADV THER, V35, P1285, DOI 10.1007/s12325-018-0766-1; Ministry-of-Health, 2015, CANC NEW REG DEATHS; Nakamura Y, 2009, J CLIN ENDOCR METAB, V94, P2192, DOI 10.1210/jc.2008-2374; Nnabugwu II, 2016, CLIN INTERV AGING, V11, DOI 10.2147/CIA.S98232; O'Reilly MW, 2017, J CLIN ENDOCR METAB, V102, P3327, DOI 10.1210/jc.2017-00947; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palermo A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060544; Powell K, 2015, CLIN CANCER RES, V21, P2569, DOI 10.1158/1078-0432.CCR-14-2352; Ricciuti A, 2016, J CLIN ENDOCR METAB, V101, P1535, DOI 10.1210/jc.2016-1016; RUBENS R, 1974, J CLIN ENDOCR METAB, V39, P40, DOI 10.1210/jcem-39-1-40; Rybicki BA, 2008, CLIN CANCER RES, V14, P750, DOI 10.1158/1078-0432.CCR-07-0986; Sausville LN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180471; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schulze JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00151; Silventoinen K, 2017, AM J CLIN NUTR, V106, P457, DOI 10.3945/ajcn.117.153643; St Helen G, 2012, CHEM RES TOXICOL, V25, P952, DOI 10.1021/tx300043k; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Tian YT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-42; Vaidyanathan V, 2017, MOL BIOSYSTEMS, V2017; Vaidyanathan V, 2017, MOL BIOSYST; van Londen GJ, 2008, CRIT REV ONCOL HEMAT, V68, P172, DOI 10.1016/j.critrevonc.2008.06.006; Verma K, 2018, MOL CANCER THER, V17, P1833, DOI 10.1158/1535-7163.MCT-17-1023; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Wang A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1843-3; Wang JH, 2007, J STEROID BIOCHEM, V107, P100, DOI 10.1016/j.jsbmb.2007.02.009; White DB, 2004, B MAR SCI, V75, P335; Yarney J, 2013, UROL ONCOL-SEMIN ORI, V31, P325, DOI 10.1016/j.urolonc.2011.01.018; Yepuru M, 2013, CLIN CANCER RES, V19, P5613, DOI 10.1158/1078-0432.CCR-13-1151; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]	62	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217373	10.1371/journal.pone.0217373	http://dx.doi.org/10.1371/journal.pone.0217373			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125365	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700033
J	Choi, IS; Choi, EY; Leeid, IH				Choi, Im-Soon; Choi, Eun Young; Leeid, Iyn-Hyang			Challenges in informed consent decision-making in Korean clinical research: A participant perspective	PLOS ONE			English	Article							CANCER-PATIENTS AWARENESS; QUALITY; TRIALS; WILLINGNESS; PERCEPTIONS; DOCUMENTS; BENEFIT	Objectives This study investigated how the essential elements of informed consent are realised during the consent process and examined the challenges in obtaining genuine informed consent in Korea. Methods Through purposive sampling, we recruited 21 subjects from those participating in anticancer drug research since 2013. We undertook 1: 1 in-depth interviews and analysed the data by framework analysis. Results Themes raised throughout the interviews were categorised into 'disclosure' and 'understanding' of clinical information and 'decision'. Provider-centred information, both verbal and written, was delivered to each participant. There were few tools that the research staff might evaluate study participants' level of understanding of the provided information during the clinical trial. Although participants did not understand basic clinical trial concepts as much as desired, they may not seek to solve difficulties through communication with trial researchers. Doubts were raised about whether participants had sufficient capacity and free will to provide informed consent. Conclusion There is a concern that informed consent can fall short of genuine in Korea. To ensure informed consent meets the international standard, greater efforts should be made to establish an explicit standard operational protocol for obtaining informed consent.	[Choi, Im-Soon] Kyungpook Natl Univ, Dept Pharm, Med Ctr, Daegu, South Korea; [Choi, Eun Young; Leeid, Iyn-Hyang] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Choi, Eun Young] Ulsan Univ Hosp, Dept Pharm, Ulsan, South Korea	Kyungpook National University; Yeungnam University; University of Ulsan; Ulsan University Hospital	Leeid, IH (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, South Korea.	leeiynhyang@ynu.ac.kr		Lee, Iyn-Hyang/0000-0001-6644-0808				APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Brennan F, 2017, CLIN J AM SOC NEPHRO, V12, P1001, DOI 10.2215/CJN.09740916; Britten N, 2006, QUALITATIVE INTERVIE; Brooke RE, 2013, INT J AUDIOL, V52, P162, DOI 10.3109/14992027.2012.745200; Bulger RE., 2002, ETHICAL DIMENSIONS B; Choi Im-Soon, 2016, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V26, P33; del Carmen MG, 2005, ONCOLOGIST, V10, P636, DOI 10.1634/theoncologist.10-8-636; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Fan RP, 1997, BIOETHICS, V11, P309, DOI 10.1111/1467-8519.00070; Farrell EH, 2014, PATIENT EDUC COUNS, V94, P20, DOI 10.1016/j.pec.2013.08.019; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gulbrandsen P, 2010, J MED ETHICS, V36, P126, DOI 10.1136/jme.2009.033456; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Jones James W, 2005, Thorac Surg Clin, V15, P451, DOI 10.1016/j.thorsurg.2005.06.001; Kim HS., 2011, PERSNAL BIOETHICS, V1, P85; Kim JW, 2008, BRIT J CANCER, V99, P1593, DOI 10.1038/sj.bjc.6604750; Knapp P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-89; Korea National Enterprise for Clinical Trials, 2015, KONECT NEWSL GLOB TR; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; Lee M, 2011, STUDY PROTECTION CLI; Lidz CW, 2004, SOC SCI MED, V58, P1689, DOI 10.1016/S0277-9536(03)00338-1; Lim Y, 2017, CANCER RES TREAT, V49, P1033, DOI 10.4143/crt.2016.413; Lipton LR, 2011, CONTEMP CLIN TRIALS, V32, P608, DOI 10.1016/j.cct.2011.04.014; Madsen S M, 1999, Ugeskr Laeger, V161, P2661; Maxwell J.A., 2013, QUALITATIVE RES DESI, V3rd; Meneguin Silmara, 2014, Invest. educ. enferm, V32, P97, DOI 10.17533/udea.iee.v32n1a11; Ministry of Food and Drug Safety, 2014, FACTSH 2013 CLIN TRI; Ministry of Food and Drug Safety, 2015, FACTSH CLIN TRIAL AP; Moon H, 2000, KOREAN J CLIN PHARM, V8, P202; Naanyu Violet, 2014, Perspect Clin Res, V5, P20, DOI 10.4103/2229-3485.124563; National Institute of Toxicological Research, 2005, UND CLIN RES ETH; Tam NT, 2015, B WORLD HEALTH ORGAN, V93, P186, DOI 10.2471/BLT.14.141390; PARSONS T, 1975, MILBANK FUND Q, V53, P257, DOI 10.2307/3349493; Pranati, 2010, Perspect Clin Res, V1, P124, DOI 10.4103/2229-3485.71769; Raynor DK, 2011, PATIENT EDUC COUNS, V83, P404, DOI 10.1016/j.pec.2011.03.016; Resnik DB, 2010, CONTEMP CLIN TRIALS, V31, P18, DOI 10.1016/j.cct.2009.11.001; Resnik DB, 2009, CONTEMP CLIN TRIALS, V30, P114, DOI 10.1016/j.cct.2008.10.004; Ritchie J., 2002, QUALITATIVE DATA ANA; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; ShinHeeYoung, 2008, Translational and Clinical Pharmacology, V16, P13; Sook Jeong， Ihn, 2010, [Korean Journal of Medical Ethics, 한국의료윤리학회지], V13, P43; Steinberg A, 2009, J CHILD NEUROL, V24, P1568, DOI 10.1177/0883073809337033; Sugarman J, 2005, CLIN TRIALS, V2, P34, DOI 10.1191/1740774505cn066oa; Wade N., 2005, NY TIMES; 이영태, 2012, [Health and Social Science, 보건과 사회과학], V32, P145; 이성희, 2009, Translational and Clinical Pharmacology, V17, P72	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216889	10.1371/journal.pone.0216889	http://dx.doi.org/10.1371/journal.pone.0216889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120918	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700037
J	Dynes, TL; Berry, JA; Delaplane, KS; Brosi, BJ; de Roode, JC				Dynes, Travis L.; Berry, Jennifer A.; Delaplane, Keith S.; Brosi, Berry J.; de Roode, Jacobus C.			Reduced density and visually complex apiaries reduce parasite load and promote honey production and overwintering survival in honey bees	PLOS ONE			English	Article							DEFORMED WING VIRUS; VARROA-DESTRUCTOR; STOCKING DENSITY; BROOD PRODUCTION; R-PACKAGE; POPULATION; COLONIES; JACOBSONI; HYMENOPTERA; THRESHOLD	Managed honey bee (Apis mellifera) colonies are kept at much greater densities than naturally occurring feral or wild colonies, which may have detrimental effects on colony health and survival, disease spread, and drifting behavior (bee movement between natal and non-natal colonies). We assessed the effects of a straightforward apiary management intervention (altering the density and visual appearance of colonies) on colony health. Specifically, we established three "high density / high drift" ("HD") and three "low density / low drift" ("LD") apiary configurations, each consisting of eight bee colonies. Hives in the HD apiary configuration were of the same color and placed 1m apart in a single linear array, while hives in the LD apiary configuration were placed 10m apart at different heights, facing outwards in a circle, and made visually distinctive with colors and symbols to reduce accidental drift between colonies. We investigated disease transmission and dynamics between the apiary configurations by clearing all colonies of the parasitic mite Varroa destructor, and subsequently inoculating two randomly-chosen colonies per apiary with controlled mite doses. We monitored the colonies for two years and found that the LD apiary configuration had significantly greater honey production and reduced overwinter mortality. Inoculation and apiary management intervention interacted to affect brood mite levels, with the highest levels in the inoculated colonies in the HD configuration. Finally, foragers were more than three times more likely to drift in the HD apiary configurations. Our results suggest that a relatively straightforward management change-placing colonies in low-density visually complex circles rather than high-density visually similar linear arrays-can provide meaningful benefits to the health and productivity of managed honey bee colonies.	[Dynes, Travis L.; Brosi, Berry J.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Berry, Jennifer A.; Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; University System of Georgia; University of Georgia; Emory University	Dynes, TL (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.	travis.dynes@gmail.com	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X; Brosi, Berry/0000-0002-9233-1151	National Institutes of Health [R01-109501]; National Science Foundation [DGE-1444932]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	Research reported in this publication was supported by the National Institutes of Health, nih.gov (R01-109501, to JCdR, BJB, and KSD), and the National Science Foundation, nsf.gov (DGE-1444932, to TLD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by the National Institutes of Health (R01-109501, to JCdR, BJB, and KSD), and the National Science Foundation (DGE-1444932, to TLD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.	Aliano NP, 2005, J APICULT RES, V44, P54, DOI 10.1080/00218839.2005.11101148; ANDERSON R M, 1991; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bowers MA, 1997, J MAMMAL, V78, P999, DOI 10.2307/1383044; Branco MR, 2006, APIDOLOGIE, V37, P452, DOI 10.1051/apido:2006010; Brosi BJ, 2017, NAT ECOL EVOL, V1, P1250, DOI 10.1038/s41559-017-0246-z; Cao TT, 2008, BIOL LETTERS, V4, P613, DOI 10.1098/rsbl.2008.0381; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Delaplane KS, 1999, APIDOLOGIE, V30, P383, DOI 10.1051/apido:19990504; Delaplane KS, 1997, J APICULT RES, V36, P125, DOI 10.1080/00218839.1997.11100938; DYNES TL, 2017, PARASITOLOGY, V48, P93, DOI DOI 10.1007/S13592-016-0453-7; Farrar CL, 1937, J AGRIC RES, V54, P0945; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Fowler C.W., 1987, Current Mammalogy, V1, P401; FREE J. B., 1958, JOUR AGRIC SCI, V51, P294; FREE JB, 1968, ENTOMOL EXP APPL, V11, P241, DOI 10.1111/j.1570-7458.1968.tb02048.x; Frey E, 2014, J ECON ENTOMOL, V107, P1, DOI [10.1603/ec13362, DOI 10.1603/EC13362]; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Harbo JR, 1999, APIDOLOGIE, V30, P183, DOI 10.1051/apido:19990208; HARBO JR, 1993, J ECON ENTOMOL, V86, P1672, DOI 10.1093/jee/86.6.1672; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Huzzey JM, 2006, J DAIRY SCI, V89, P126, DOI 10.3168/jds.S0022-0302(06)72075-6; JAY S C, 1966, Journal of Apicultural Research, V5, P137; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Lau CW, 2010, APIDOLOGIE, V41, P87, DOI 10.1051/apido/2009052; Lively CM, 2006, ECOL LETT, V9, P1089, DOI 10.1111/j.1461-0248.2006.00969.x; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Malthus T., 1798, ESSAY PRINCIPLE POPU; Milani N, 2001, APIDOLOGIE, V32, P127, DOI 10.1051/apido:2001118; Murilhas AM, 2002, APIDOLOGIE, V33, P271, DOI 10.1051/apido:2002013; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 1999, J APICULT RES, V38, P11, DOI 10.1080/00218839.1999.11100990; Neumann P, 2000, APIDOLOGIE, V31, P67, DOI 10.1051/apido:2000107; Nolan MP, 2017, APIDOLOGIE, V48, P8, DOI 10.1007/s13592-016-0443-9; OATEN A, 1975, AM NAT, V109, P289, DOI 10.1086/282998; Potts SG, 2017, ASSESSMENT REPORT PO, P556; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; RATNIEKS FLW, 1991, CAN ENTOMOL, V123, P353, DOI 10.4039/Ent123353-2; Rondeau V, 2012, J STAT SOFTW, V47, P1; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Rossetti BJ, 2017, METHODS ECOL EVOL, P1; Rueppell O, 2009, EXP GERONTOL, V44, P447, DOI 10.1016/j.exger.2009.04.003; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2015, APIDOLOGIE, V46, P716, DOI 10.1007/s13592-015-0361-2; STILING P, 1988, J ANIM ECOL, V57, P581, DOI 10.2307/4926; Thom C, 2003, J EXP BIOL, V206, P2111, DOI 10.1242/jeb.00398; Traynor KS, 2016, APIDOLOGIE, V47, P325, DOI 10.1007/s13592-016-0431-0; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Yarahmadi P, 2016, FISH SHELLFISH IMMUN, V48, P43, DOI 10.1016/j.fsi.2015.11.007	57	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216286	10.1371/journal.pone.0216286	http://dx.doi.org/10.1371/journal.pone.0216286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120911	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700011
J	Liyasova, MS; Ma, K; Voeller, D; Ryan, PE; Chen, JQ; Klevit, RE; Lipkowitz, S				Liyasova, Mariya S.; Ma, Ke; Voeller, Donna; Ryan, Philip E.; Chen, Jinqiu; Klevit, Rachel E.; Lipkowitz, Stanley			Cbl interacts with multiple E2s in vitro and in cells	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; RECEPTOR TYROSINE KINASES; C-CBL; RING FINGER; STRUCTURAL BASIS; LIGASE ACTIVITY; MEDIATED DIMERIZATION; EGF RECEPTOR; ACTIVATION; PHOSPHORYLATION	Many receptor tyrosine kinases ( RTKs, such as EGFR, MET) are negatively regulated by ubiquitination and degradation mediated by Cbl proteins, a family of RING finger ( RF) ubiquitin ligases ( E3s). Loss of Cbl protein function is associated with malignant transformation driven by increased RTK activity. RF E3s, such as the Cbl proteins, interact with a ubiquitin-conjugating enzyme ( E2) to confer specificity to the ubiquitination process and direct the transfer of ubiquitin from the E2 to one or more lysines on the target proteins. Using in vitro E3 assays and yeast two-hybrid screens, we found that Ube2d, Ube2e families, Ube2n/2v1, and Ube2w catalyze autoubiquitination of the Cbl protein and Ube2d2, Ube2e1, and Ube 2n/2v1 catalyze Cbl-mediated substrate ubiquitination of the EGFR and SYK. Phosphorylation of the Cbl protein by by Src resulted in increased E3 activity compared to unphosphorylated cbl or Cbl containing a phosphomimetic Y371E mutation. Ubiquitin chain formation depended on the E2 tested with Cbl with Ube2d2 forming both K48 and K63 linked chains, Ube2n/2v1 forming only K63 linked chains, and Ube2w inducing monoubiquitination. In cells, the Ube2d family, Ube2e family, and Ube2n/2v1 contributed to EGFR ubiquitination. Our data suggest that multiple E2s can interact with Cbl and modulate its E3 activity in vitro and in cells.	[Liyasova, Mariya S.; Ma, Ke; Voeller, Donna; Ryan, Philip E.; Lipkowitz, Stanley] NCI, Womens Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chen, Jinqiu] NCI, Collaborat Prot Technol Resource, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ryan, Philip E.] NIH, Off Intramural Training & Educ, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA	Lipkowitz, S (corresponding author), NCI, Womens Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lipkowis@navmed.nci.nih.gov	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Lipkowitz, Stanley/0000-0002-6103-2255	Center for Cancer Research, National Cancer Institute Intramural Funding;  [ZIA BC 010977];  [R01 GM 088055]; NATIONAL CANCER INSTITUTE [ZICBC011434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088055] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute Intramural Funding; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by ZIA BC 010977 Cbl Proteins as Regulators of Tyrosine Kinase Signaling to ML, KM, DV, PER, JC, SL; R01 GM 088055 Expanding Roles of E2 and E3 Enzymes in Ubiquitin Transfer to REK; and Center for Cancer Research, National Cancer Institute Intramural Funding, https://ccr.cancer.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buetow L, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0298-6; Chen JQ, 2013, ANAL BIOCHEM, V442, P97, DOI 10.1016/j.ab.2013.07.022; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2007, EUR J CELL BIOL, V86, P505, DOI 10.1016/j.ejcb.2007.04.005; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Ettenberg S A, 1999, Mol Cell Biol Res Commun, V2, P111, DOI 10.1006/mcbr.1999.0157; Fletcher AJ, 2015, P NATL ACAD SCI USA, V112, P10014, DOI 10.1073/pnas.1507534112; Fletcher AJ, 2015, EMBO J, V34, P2078, DOI 10.15252/embj.201490361; Fortian A, 2015, TRAFFIC, V16, P1137, DOI 10.1111/tra.12314; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liyasova MS, 2015, CLIN CANCER RES, V21, P1789, DOI 10.1158/1078-0432.CCR-13-2490; Ma K, 2013, VESICLE TRAFFICKING, P219, DOI [10.1007/978-1-4614-6528-7_11, DOI 10.1007/978-1-4614-6528-7_11]; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nguyen L, 2014, BIOCHEMISTRY-US, V53, P4004, DOI 10.1021/bi500072v; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Paolini R, 2002, J BIOL CHEM, V277, P36940, DOI 10.1074/jbc.M204948200; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Vittal V, 2015, NAT CHEM BIOL, V11, P83, DOI [10.1038/NCHEMBIO.1700, 10.1038/nchembio.1700]; Wang B, 2016, J BIOL CHEM, V291, P3030, DOI 10.1074/jbc.M115.676601; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang YY, 2011, MOL CELLS, V31, P113, DOI 10.1007/s10059-011-0015-9; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216967	10.1371/journal.pone.0216967	http://dx.doi.org/10.1371/journal.pone.0216967			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120930	Green Submitted, gold, Green Published			2022-12-27	WOS:000468775700042
J	Veltsos, P; Delph, LF				Veltsos, Paris; Delph, Lynda F.			The X chromosome is necessary for ovule production in Silene latifolia	PLOS ONE			English	Article							Y-CHROMOSOME; SEX DETERMINATION; ACCUMULATION; DEGENERATION; EVOLUTION; MELANDRIUM; SEQUENCES; FITNESS	Sex chromosomes stop recombining and accumulate differences over time. In particular, genes on the chromosome restricted to the heterogametic sex degenerate and become non-functional. Here, we investigated whether or not the degeneration of a plant Y chromosome was sufficient to cause ovules containing a Y to fail to develop, thereby eliminating the possibility of YY individuals. We used two genotypic assays to determine the genotype-XX, XY, or YY-of offspring from a single fruit of an otherwise normal male XY plant of Silene latifolia. The fruit contained fewer ovules than normal pistillate flowers, produced an equal offspring sex ratio, and generated no YY offspring. The results indicate that ovaries must contain an X chromosome to develop properly. While haploid selection has slowed down Y-chromosome degeneration in S. latifolia, we find that it has progressed sufficiently to prevent the proper development of ovules, and hence prevent the presence of YY individuals.	[Veltsos, Paris; Delph, Lynda F.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Veltsos, P (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	parisveltsos@gmail.com	Veltsos, Paris/AFH-1150-2022	Veltsos, Paris/0000-0002-8872-6281	National Science Foundation [DEB 1353970]	National Science Foundation(National Science Foundation (NSF))	This work received funding from National Science Foundation, grant DEB 1353970 to LD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; Blackburn KB, 1923, NATURE, V112, P687, DOI 10.1038/112687c0; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; CHARLESWORTH D, 1980, GENET RES, V35, P205, DOI 10.1017/S0016672300014051; Chibalina MV, 2011, CURR BIOL, V21, P1475, DOI 10.1016/j.cub.2011.07.045; Filatov DA, 2018, MOL ECOL; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Harkess A, 2018, BIORXIV, DOI DOI 10.1101/494112; Hobza R, 2008, MOL ECOL RESOUR, V8, P1274, DOI 10.1111/j.1755-0998.2008.02344.x; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Janousek B, 1998, HEREDITY, V80, P576, DOI 10.1046/j.1365-2540.1998.00322.x; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Krasovec M, 2018, CURR BIOL, V28, P1832, DOI 10.1016/j.cub.2018.04.069; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Lebel-Hardenack S, 2002, GENETICS, V160, P717; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Miller PM, 2011, SEX PLANT REPROD, V24, P211, DOI 10.1007/s00497-011-0163-2; Papadopulos AST, 2015, P NATL ACAD SCI USA, V112, P13021, DOI 10.1073/pnas.1508454112; R Development Core Team, 2007, R LANG ENV STAT COMP; Rhoades MM, 1942, GENETICS, V27, P0395; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Soukupova M, 2014, CYTOGENET GENOME RES, V143, P96, DOI 10.1159/000363431; TAYLOR DR, 1994, GENETICS, V136, P641; VANNIGTEVECHT G, 1966, GENETICA, V37, P307, DOI 10.1007/BF01547141; WESTERGAARD M, 1946, HEREDITAS, V32, P419; WINGE O, 1923, COMPTES RENDUS TRAVA, V15, P1; Zluvova J, 2006, P NATL ACAD SCI USA, V103, P18854, DOI 10.1073/pnas.0606622103	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217558	10.1371/journal.pone.0217558	http://dx.doi.org/10.1371/journal.pone.0217558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31121002	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700112
J	Davidson, BI; Jones, SL; Joinson, AN; Hinds, J				Davidson, Brittany, I; Jones, Simon L.; Joinson, Adam N.; Hinds, Joanne			The evolution of online ideological communities	PLOS ONE			English	Article							SOCIAL ROLES; IDENTITY; PARTICIPATION; AUTHENTICITY; MEMBERSHIP; DESIGN; SELF	Online communities are virtual spaces for users to share interests, support others, and to exchange knowledge and information. Understanding user behavior is valuable to organizations and has applications from marketing to security, for instance, identifying leaders within a community or predicting future behavior. In the present research, we seek to understand the various roles that users adopt in online communities-for instance, who leads the conversation? Who are the supporters? We examine user role changes over time and the pathways that users follow. This allows us to explore the differences between users who progress to leadership positions and users who fail to develop influence. We also reflect on how user role proportions impact the overall health of the community. Here, we examine two online ideological communities, RevLeft and Islamic Awakening (N = 1631; N = 849), and provide a novel approach to identify various types of users. Finally, we study user role trajectories over time and identify community "leaders" from meta-data alone. Study One examined both communities using K-MEANS cluster analysis of behavioral meta-data, which revealed seven user roles. We then mapped these roles against Preece and Schneiderman's (2009) Reader-to-Leader Framework (RtLF). Both communities aligned with the RtLF, where most users were "contributors", many were "collaborators", and few were "leaders". Study Two looked at one community over a two-year period and found that, despite a high churn rate of users, roles were stable over time. We built a model of user role transitions over the two years. This can be used to predict user role changes in the future, which will have implications for community managers and security focused contexts (e.g., analyzing behavioral meta-data from forums and websites known to be associated with illicit activity).	[Davidson, Brittany, I; Joinson, Adam N.; Hinds, Joanne] Univ Bath, Sch Management, Bath, Avon, England; [Jones, Simon L.] Univ Bath, Dept Comp Sci, Bath, Avon, England	University of Bath; University of Bath	Davidson, BI (corresponding author), Univ Bath, Sch Management, Bath, Avon, England.	B.I.Davidson@bath.ac.uk	Davidson, brit/HBF-8968-2022	Davidson, Brittany/0000-0001-9886-9043; Hinds, Joanne/0000-0001-8960-5361; Jones, Simon/0000-0003-4111-0591	Centre for Research and Evidence on Security Threats (ESRC Award) [ES/N009614/1]; ESRC [ES/N009614/1] Funding Source: UKRI	Centre for Research and Evidence on Security Threats (ESRC Award); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was part-funded by the Centre for Research and Evidence on Security Threats (ESRC Award: ES/N009614/1) to ANJ, www.crestresearch.ac.uk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly A, 2017, STUD CONFL TERROR, V40, P1, DOI 10.1080/1057610X.2016.1157402; Ang CS, 2010, INFORM COMMUN SOC, V13, P592, DOI 10.1080/13691180903266952; Angeletou S, 2011, LECT NOTES COMPUT SC, V7031, P35, DOI 10.1007/978-3-642-25073-6_3; Arazy O, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P2039; Arguello J., 2006, Conference on Human Factors in Computing Systems. CHI2006, P959; Bateman PJ, 2011, INFORM SYST RES, V22, P841, DOI 10.1287/isre.1090.0265; Beauchamp Z., 2018, VOX; Benigni MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181405; Bernstein M.S., 2011, P 5 INT AAAI C WEBL, P50; Bholowalia P., 2014, INT J COMP APPL, V105, P17, DOI 10.5120/18405-9674; Campbell J, 2009, INFORM SYST J, V19, P461, DOI 10.1111/j.1365-2575.2008.00301.x; Chan J, 2010, P 4 INT C WEBL SOC M, V112, P215; Dabbish L., 2012, P ACM 2012 C COMP SU, P245, DOI DOI 10.1145/2145204.2145243; Dehghani M, 2016, J EXP PSYCHOL GEN, V145, P366, DOI 10.1037/xge0000139; Donath J., 1998, COMMUNITIES CYBERSPA, P27; Edelmann N, 2016, PSYCHOLOGY OF SOCIAL NETWORKING: PERSONAL EXPERIENCE IN ONLINE COMMUNITIES, P159; Ellinas C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180193; Ellinas C, 2016, INT J PROD ECON, V182, P50, DOI 10.1016/j.ijpe.2016.08.011; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fisher D., 2006, P 39 ANN HAW INT C S; Fiske S.T., 2010, SOCIAL BEINGS, V2nd; Fullwood C, 2019, COMPUT HUM BEHAV, V90, P131, DOI 10.1016/j.chb.2018.08.037; Gilbert S, 2017, PROCEEDINGS OF THE 50TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P2293; Gleave E., 2009, 2009 42 HAWAII INT C, P1, DOI DOI 10.1109/HICSS.2009.6; Golder S. A., 2004, INTERNET RES, V5, P19; Golder Scott A, 2004, ASS INT RES AOIR C I, P1; Hamerly G, 2004, ADV NEUR IN, V16, P281; Huffaker D, 2010, HUM COMMUN RES, V36, P593, DOI 10.1111/j.1468-2958.2010.01390.x; Internet Archive Wayback Machine, 2010, ISL AW; Internet Archive Wayback Machine, 2016, HOM REV LEFT; Jackson CB, 2016, ACM CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW 2016), P624, DOI 10.1145/2818048.2835197; Levina N, 2014, INFORM SYST RES, V25, P468, DOI 10.1287/isre.2014.0535; Ma M, 2007, INFORM SYST RES, V18, P42, DOI 10.1287/isre.1070.0113; Marcoccia M, 2004, J PRAGMATICS, V36, P115, DOI 10.1016/S0378-2166(03)00038-9; Musicant DR., 2011, P 7 INT S WIK OP COL, DOI [10.1145/2038558.2038586, DOI 10.1145/2038558.2038586]; Ng AY, 2002, ADV NEUR IN, V14, P841; Nielsen J, 2006, 90 9 1 RULE PARTICIP; Obst P, 2010, J COMMUNITY APPL SOC, V20, P525, DOI 10.1002/casp.1067; Pan W, 2013, J MACH LEARN RES, V14, P1865; Panteli N, 2016, BEHAV INFORM TECHNOL, V35, P490, DOI 10.1080/0144929X.2016.1144084; Pfeil U, 2011, INT J HUM-COMPUT INT, V27, P323, DOI 10.1080/10447318.2011.540490; Preece J, 2009, T HUMAN COMPUTER INT, V1, P1, DOI DOI 10.17705/1thci.00005; Rafaeli S, 2006, P 15 INT C WORLD WID, DOI DOI 10.1145/1135777.1135806; Ransbotham S, 2011, MIS QUART, V35, P613; Ren YQ, 2007, ORGAN STUD, V28, P377, DOI 10.1177/0170840607076007; Ren YQ, 2012, MIS QUART, V36, P841; Schmader T, 2018, PERS SOC PSYCHOL REV, V22, P228, DOI 10.1177/1088868317734080; Sheldon KM, 1997, J PERS SOC PSYCHOL, V73, P1380, DOI 10.1037/0022-3514.73.6.1380; Turner TC, 2005, J COMPUT-MEDIAT COMM, V10; vBulletin Solutions, INTR US REP; Viegas F.B., 2004, P 37 ANN HAW INT C S; Wang T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200800; Weiser H. T., 2011, P 2011 ICONFERENCE, P122, DOI DOI 10.1145/1940761.1940778; Welser Howard T, 2007, J SOCIAL STRUCTURE, V8, P1, DOI DOI 10.1016/S0048-7333(03)00050-7; Williams Z., 2018, GUARDIAN; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yedla M., 2010, INT J COMPUT SCI INF, V1, P121; Zhu H, 2014, 2014 INTERNATIONAL CONFERENCE ON ECONOMICS AND MANAGEMENT, P287	58	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216932	10.1371/journal.pone.0216932	http://dx.doi.org/10.1371/journal.pone.0216932			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116767	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400033
J	Diaz-Faes, AA; Bowman, TD; Costas, R				Diaz-Faes, Adrian A.; Bowman, Timothy D.; Costas, Rodrigo			Towards a second generation of 'social media metrics': Characterizing Twitter communities of attention around science	PLOS ONE			English	Article							SOCIETAL IMPACT; ACKNOWLEDGMENTS; ALTMETRICS	'Social media metrics' are bursting into science studies as emerging new measures of impact related to scholarly activities. However, their meaning and scope as scholarly metrics is still far from being grasped. This research seeks to shift focus from the consideration of social media metrics around science as mere indicators confined to the analysis of the use and visibility of publications on social media to their consideration as metrics of interaction and circulation of scientific knowledge across different communities of attention, and particularly as metrics that can also be used to characterize these communities. Although recent research efforts have proposed tentative typologies of social media users, no study has empirically examined the full range of Twitter user's behavior within Twitter and disclosed the latent dimensions in which activity on Twitter around science can be classified. To do so, we draw on the overall activity of social media users on Twitter interacting with research objects collected from the Altmetic.com database. Data from over 1.3 million unique users, accounting for over 14 million tweets to scientific publications, is analyzed. Based on an exploratory and confirmatory factor analysis, four latent dimensions are identified: 'Science Engagement', 'Social Media Capital', 'Social Media Activity' and Science Focus'. Evidence on the predominant type of users by each of the four dimensions is provided by means of VOSviewer term maps of Twitter profile descriptions. This research breaks new ground for the systematic analysis and characterization of social media users' activity around science.	[Diaz-Faes, Adrian A.] Univ Politecn Valencia, INGENIO CSIC UPV, Valencia, Spain; [Bowman, Timothy D.] Wayne State Univ, Sch Informat Sci, Detroit, MI USA; [Costas, Rodrigo] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [Costas, Rodrigo] Stellenbosch Univ, CREST, Stellenbosch, South Africa	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Gestion de la Innovacion y del Conocimiento (INGENIO); Wayne State University; Leiden University; Leiden University - Excl LUMC; Stellenbosch University	Diaz-Faes, AA (corresponding author), Univ Politecn Valencia, INGENIO CSIC UPV, Valencia, Spain.	diazfaes@ingenio.upv.es	Bowman, Timothy D/M-3792-2015; Diaz-Faes, Adrian A./H-9085-2019	Bowman, Timothy D/0000-0003-0247-4771; Diaz-Faes, Adrian A./0000-0003-1928-4608; Costas, Rodrigo/0000-0002-7465-6462	Juan de la Cierva-Formacion postdoctoral grant from the Spanish Ministry of Economy and Competitiveness [FJCI-2015-23699]; 'Call for visit to RISIS Facilities' - Research Infrastructure for Science and Innovation Policy Studies, in February 2018; South African DST-NRF Centre of Excellence in Scientometrics and Science, Technology and Innovation Policy (SciSTIP)	Juan de la Cierva-Formacion postdoctoral grant from the Spanish Ministry of Economy and Competitiveness; 'Call for visit to RISIS Facilities' - Research Infrastructure for Science and Innovation Policy Studies, in February 2018; South African DST-NRF Centre of Excellence in Scientometrics and Science, Technology and Innovation Policy (SciSTIP)	AADF is currently supported by a Juan de la Cierva-Formacion postdoctoral grant (FJCI-2015-23699) from the Spanish Ministry of Economy and Competitiveness and benefited from a visiting stay at the Centre for Science and Technology Studies (CWTS) funded by the 'Call for visit to RISIS Facilities' - Research Infrastructure for Science and Innovation Policy Studies, in February 2018. RC was partially funded by the South African DST-NRF Centre of Excellence in Scientometrics and Science, Technology and Innovation Policy (SciSTIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo G, 2013, J INFORMETR, V7, P528, DOI 10.1016/j.joi.2013.01.013; Adie E, 2013, LEARN PUBL, V26, P11, DOI 10.1087/20130103; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; [Anonymous], 1965, SCIENCE, P510; Borgman C.L., 2010, SCHOLARSHIP DIGITAL, V1st ed.; Bornmann L, 2019, J INFORMETR, V13, P325, DOI 10.1016/j.joi.2019.01.008; Bornmann L, 2014, EMBO REP, V15, P1228, DOI 10.15252/embr.201439608; Bornmann L, 2014, J ASSOC INF SCI TECH, V65, P647, DOI 10.1002/asi.23073; Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Bowman TD, 2015, ASLIB J INFORM MANAG, V67, P356, DOI 10.1108/AJIM-12-2014-0180; Brandtzaeg PB, 2010, COMPUT HUM BEHAV, V26, P940, DOI 10.1016/j.chb.2010.02.008; Corr P, 2009, CONFLICT INTEREST ME, P375; Costas R, 2017 ALTM WORKSH; Costas R, 2017, BIBL-AN INVESTIG, V13, P1; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; Desrochers N, 2018, SOC SCI INFORM, V57, P223, DOI 10.1177/0539018417752089; Diaz-Faes AA, 2017, ASLIB J INFORM MANAG, V69, P576, DOI 10.1108/AJIM-01-2017-0008; Frank C, 2009, CAN MED ASSOC J, V180, P528, DOI 10.1503/cmaj.090016; Gazni A, 2012, J AM SOC INF SCI TEC, V63, P323, DOI 10.1002/asi.21688; Haunschild R, 2019, J INFORMETR, V13, P695, DOI 10.1016/j.joi.2019.03.008; Haustein S., 2015, ASS INF SCI TECHN AS, P9; Haustein S., 2018, HDB QUANTITATIVE SCI; Haustein S, 2015, SOC MED SOC 2015 INT, P1; HAUSTEIN S, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0120495; Haustein S, 2016, THEORIES OF INFORMETRICS AND SCHOLARLY COMMUNICATION: A FESTSCHRIFT IN HONOR OF BLAISE CRONIN, P372; Haustein S, 2016, SCIENTOMETRICS, V108, P413, DOI 10.1007/s11192-016-1910-9; Hellsten I, 2019, J ASS INF SCI TECHNO, DOI [10.1002/asi.24082, DOI 10.1002/ASI.24082]; Hicks Diana, 2015, Nature, V520, P429, DOI 10.1038/520429a; Holmberg K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106086; Holmberg KV, 2014, MONOGR ORAL SCI, V24, P1, DOI [10.1159/000358776, 10.1007/s11192-014-1229-3]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jappe A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199031; Joly PB, 2015, RES EVALUAT, V24, P440, DOI 10.1093/reseval/rvv015; Joubert M, GETTING KNOW SCI TWE; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kwak H., 2010, WEB C 2010 P WORLD W, P591; Letierce J, 2010, WEB SCI C APR 26 27; Lin N., 1999, CONNECTIONS, V22, P28, DOI DOI 10.1108/14691930410550381; Lotka A.J., 1926, J WASH ACAD SCI, V16, P317, DOI DOI 10.1002/ASI.4630280610; MARTIN BR, 1983, RES POLICY, V12, P61, DOI 10.1016/0048-7333(83)90005-7; Priem, 2010, ALTMETRICS MANIFESTO; Ravenscroft J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173152; Robinson-Garcia N, 2018, SCI PUBL POLICY, V45, P815, DOI 10.1093/scipol/scy024; Robinson-Garcia N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183551; Smith R, 2001, BRIT MED J, V323, P528, DOI 10.1136/bmj.323.7312.528; Spaapen J, 2011, RES EVALUAT, V20, P211, DOI 10.3152/095820211X12941371876742; Sugimoto CR, 2017, J ASSOC INF SCI TECH, V68, P2037, DOI 10.1002/asi.23833; Tabachnick B. G., 2007, USING MULTIVARIATE S, V5th; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Wouters P, 2018, HDB QUANTITATIVE SCI; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X; Zahedi Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197326; Zahedi Z, 2014, SCIENTOMETRICS, V101, P1491, DOI 10.1007/s11192-014-1264-0	58	33	33	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216408	10.1371/journal.pone.0216408	http://dx.doi.org/10.1371/journal.pone.0216408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116783	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400022
J	Soyster, PD; Fisher, AJ				Soyster, Peter D.; Fisher, Aaron J.			Involving stakeholders in the design of ecological momentary assessment research: An example from smoking cessation	PLOS ONE			English	Article							EXPERIENCE SAMPLING METHODOLOGY; NEGATIVE AFFECT; ASSESSMENT EMA; DYNAMICS; MODEL; VALIDATION; SEVERITY; VALIDITY; SMOKERS; ANXIETY	Ecological momentary assessment (EMA) is a data collection method that involves repeated sampling of participants' real-time experience and behavior as they unfold in context. A primary challenge in EMA research is to design surveys that adequately assess constructs of interest while minimizing participant burden. To achieve this balance, researchers must make decisions regarding which constructs should be included and how those constructs should be assessed. To date, a dearth of direction exists for how to best design and carry out EMA studies. The lack of guidelines renders it difficult to systematically compare findings across EMA studies. Study design decisions may be improved by including input from potential research participants (stakeholders). The goal of the present paper is to introduce a general approach for including stakeholders in the development of EMA research design. Rather than suggesting rigid prescriptive guidelines (e.g., the correct number of survey items), we present a systematic and reproducible process through which extant research and stakeholder experience can be leveraged to make design decisions. To that end, we report methods and results for a series of focus group discussions with current tobacco users that were conducted to inform the design of an EMA study aimed at identifying person-specific mechanisms driving tobacco use. We conclude by providing recommendations for item-selection procedures in EMA studies.	[Soyster, Peter D.; Fisher, Aaron J.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Soyster, PD (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	petersoyster@berkeley.edu		Fisher, Aaron/0000-0001-9754-4618; Soyster, Peter/0000-0003-4571-4106				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Avis JLS, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4404; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barge-Schaapveld DQ, 1995, J AFFECT DISORDERS, V17; Bergkvist L, 2009, INT J ADVERT, V28, P607, DOI 10.2501/S0265048709200783; Bolger N, 2013, INTENSIVE LONGITUDIN; Bondy SJ, 2009, TOB CONTROL, V18, P317, DOI 10.1136/tc.2008.027276; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Burke LE, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7138; Cattell RB, 1947, PSYCHOMETRIKA, V12, P267, DOI 10.1007/BF02288941; Champion VL., 2008, HLTH BEHAV HLTH ED T, V4th ed., P45; Chen LS, 2018, NEUROSCI LETT, V669, P83, DOI 10.1016/j.neulet.2016.05.033; Costa P.T., 1985, NEO PERSONALITY INVE; Doran N, 2007, ADDICT BEHAV, V32, P90, DOI 10.1016/j.addbeh.2006.03.023; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Fisher AJ, 2018, P NATL ACAD SCI USA, V115, pE6106, DOI 10.1073/pnas.1711978115; Fisher AJ, 2017, J ABNORM PSYCHOL, V126, P1044, DOI 10.1037/abn0000311; Fisher AJ, 2015, J CONSULT CLIN PSYCH, V83, P825, DOI 10.1037/ccp0000026; Fisher CD, 2012, J ORGAN BEHAV, V33, P865, DOI 10.1002/job.1803; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Hagger MS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00052; Hamaker E.L., 2012, HDB RES METHODS STUD, P43, DOI DOI 10.5860/CHOICE.50-1159; Hamaker EL, 2017, CURR DIR PSYCHOL SCI, V26, P10, DOI 10.1177/0963721416666518; Hand RK, 2016, J NUTR EDUC BEHAV, V48, P568, DOI 10.1016/j.jneb.2016.05.004; HAYNES SN, 1990, CLIN PSYCHOL REV, V10, P649, DOI 10.1016/0272-7358(90)90074-K; Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Kashdan TB, 2006, BEHAV RES THER, V44, P1301, DOI 10.1016/j.brat.2005.10.003; KENARDY J, 1992, BRIT J PSYCHIAT, V160, P668, DOI 10.1192/bjp.160.5.668; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Koval P, 2012, EMOTION, V12, P256, DOI 10.1037/a0024756; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Myin-Germeys I, 2018, WORLD PSYCHIATRY, V17, P123, DOI 10.1002/wps.20513; Norman SB, 2006, DEPRESS ANXIETY, V23, P245, DOI 10.1002/da.20182; Postmes T, 2013, BRIT J SOC PSYCHOL, V52, P597, DOI 10.1111/bjso.12006; Powell R. B., 2010, PARK SCI, V27, P46; Prochaska JJ, 2016, JAMA INTERN MED, V176, P662, DOI 10.1001/jamainternmed.2016.0772; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Shiffman S, 2009, PSYCHOL ASSESSMENT, V21, P486, DOI 10.1037/a0017074; Soyster P, 2016, PREV MED, V92, P176, DOI 10.1016/j.ypmed.2016.01.026; Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3; U. S. Department of Health and Human Services National Institutes of Health National Institute of Mental Health, 2015, NIH PUBL; US Department of Health and Human Services, 2008, EUR J CANCER PREV, V17, P535, DOI [10.1097/CEJ.0b013e3282f75e48, DOI 10.1097/CEJ.0B013E3282F75E48]; Van Hooff MLM, 2007, J OCCUP HEALTH, V49, P224, DOI 10.1539/joh.49.224; Vinci C, 2018, ADDICT BEHAV, V83, P18, DOI 10.1016/j.addbeh.2018.01.018; Warren C. R., 2007, ERGOMETRIKA, V4, P32; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WHEELER L, 1991, J PERS, V59, P339, DOI 10.1111/j.1467-6494.1991.tb00252.x; Zheng Y, 2013, MULTIVAR BEHAV RES, V48, P241, DOI 10.1080/00273171.2013.763012	53	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217150	10.1371/journal.pone.0217150	http://dx.doi.org/10.1371/journal.pone.0217150			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116777	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400047
J	Zhao, N; Zhang, Z; Wang, YM; Wang, JY; Li, BB; Zhu, TS; Xiang, YY				Zhao, Nan; Zhang, Zhan; Wang, Yameng; Wang, Jingying; Li, Baobin; Zhu, Tingshao; Xiang, Yuanyuan			See your mental state from your walk: Recognizing anxiety and depression through Kinect-recorded gait data	PLOS ONE			English	Article							GENDER-DIFFERENCES; DISORDER; DYSFUNCTION; PATTERNS; POSTURES; DISEASE; PHQ-9	As the challenge of mental health problems such as anxiety and depression increasing today, more convenient, objective, real-time assessing techniques of mental state are in need. The Microsoft Kinect camera is a possible option for contactlessly capturing human gait, which could reflect the walkers' mental state. So we tried to propose a novel method for monitoring individual's anxiety and depression based on the Kinect-recorded gait pattern. In this study, after finishing the 7-item Generalized Anxiety Disorder Scale (GAD-7) and the 9-item Patient Health Questionnaire (PHQ-9), 179 participants were required to walked on the footpath naturally while shot by the Kinect cameras. Fast Fourier Transforms (FFT) were conducted to extract features from the Kinect-captured gait data after preprocessing, and different machine learning algorithms were used to train the regression models recognizing anxiety and depression levels, and the classification models detecting the cases with specific depressive symptoms. The predictive accuracies of the regression models achieved medium to large level: The correlation coefficient between predicted and questionnaire scores reached 0.51 on anxiety (by epsilon-Support Vector Regression, e-SVR) and 0.51 on depression (by Gaussian Processes, GP). The predictive accuracies could be even higher, 0.74 on anxiety (by GP) and 0.64 on depression (by GP), while training and testing the models on the female sample. The classification models also showed effectiveness on detecting the cases with some symptoms. These results demonstrate the possibility to recognize individual's questionnaire measured anxiety/depression levels and some depressive symptoms based on Kinect-recorded gait data through machine learning method. This approach shows the potential to develop non-intrusive, low-cost methods for monitoring individuals' mental health in real time.	[Zhao, Nan; Zhang, Zhan; Wang, Yameng; Wang, Jingying; Zhu, Tingshao; Xiang, Yuanyuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China; [Zhang, Zhan; Wang, Yameng; Li, Baobin] Univ Chinese Acad Sci, Sch Comp Sci & Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, TS (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China.	tszhu@psych.ac.cn		Wang, Yameng/0000-0002-9029-5601; Wang, Jingying/0000-0002-9766-2769; Zhu, Tingshao/0000-0003-0020-3812	National Key Research & Development Program of China [2016YFC1307200]; National Natural Science Foundation of China [31700984]	National Key Research & Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Key Research & Development Program of China (2016YFC1307200; URL of the funder: http://www.most.gov.cn/eng/) and National Natural Science Foundation of China (31700984; URL of the funder: http://www.nsfc.gov.cn/english/site_1/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; [Anonymous], 2002, MENTAL HLTH 1 AID MA; Auvinet E, 2015, GAIT POSTURE, V41, P722, DOI 10.1016/j.gaitpost.2014.08.006; Bebbington P, 2000, SOC PSYCH PSYCH EPID, V35, P191, DOI 10.1007/s001270050227; Ben-Bassat M., 1982, HDB STATISTICS, P773, DOI DOI 10.1016/S0169-7161(82)02038-0; Bonnechere B, 2014, TELEMED E-HEALTH, V20, P451, DOI 10.1089/tmj.2013.0247; Brandao AF, 2016, TELEMEDICINE E HLTH, DOI [10.1089/tmj.2015, DOI 10.1089/TMJ.2015]; Brandler TC, 2012, AM J GERIAT PSYCHIAT, V20, P425, DOI 10.1097/JGP.0b013e31821181c6; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; Coulson M, 2004, J NONVERBAL BEHAV, V28, P117, DOI 10.1023/B:JONB.0000023655.25550.be; De Silva PR, 2004, COMPUT ANIMAT VIRT W, V15, P269, DOI 10.1002/cav.29; Fern'ndez-Baena A., 2012, 2012 4th International Conference on Intelligent Networking and Collaborative Systems (INCoS 2012), P656, DOI 10.1109/iNCoS.2012.66; GAUKRODGER S, 2013, GAIT POSTURE, V37, pS31, DOI DOI 10.1016/J.GAITPOST.2012.12.062; Gross MM, 2010, J NONVERBAL BEHAV, V34, P223, DOI 10.1007/s10919-010-0094-x; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Gwosdek P., 2011, INT C SCAL SPAC VAR, P447; Harrison V, 2011, J MENT HEALTH, V20, P509, DOI 10.3109/09638237.2011.608746; HAZLETT RL, 1994, PSYCHOPHYSIOLOGY, V31, P189, DOI 10.1111/j.1469-8986.1994.tb01039.x; Home CC, 2016, OUT SHAD MAK MENT HL; Hossein MH, 2014, J MED ENG, V2014; Jahedi S, 2014, J ECON BEHAV ORGAN, V98, P97, DOI 10.1016/j.jebo.2013.12.016; Jalal Ahmad, 2012, Impact Analysis of Solutions for Chronic Disease Prevention and Management. Proceedings 10th International Conference on Smart Homes and Health Telematics (ICOST 2012), P246, DOI 10.1007/978-3-642-30779-9_36; Kleinsmith A, 2007, LECT NOTES COMPUT SC, V4738, P48, DOI 10.1007/978-3-540-74889-2_5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Li S, 2016, PEERJ, V4, DOI 10.7717/peerj.2364; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; NATALE M, 1980, Motivation and Emotion, V4, P323, DOI 10.1007/BF00993583; Pompeu JE, 2014, PHYSIOTHERAPY, V100, P162, DOI 10.1016/j.physio.2013.10.003; Postel MG, 2008, TELEMED J E-HEALTH, V14, P707, DOI 10.1089/tmj.2007.0111; Robichaud M, 2003, J ANXIETY DISORD, V17, P501, DOI 10.1016/S0887-6185(02)00237-2; Roether CL, 2009, J VISION, V9, DOI 10.1167/9.6.15; Sheikh JI, 2002, AM J PSYCHIAT, V159, P55, DOI 10.1176/appi.ajp.159.1.55; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stone E, 2015, GAIT POSTURE, V41, P57, DOI 10.1016/j.gaitpost.2014.08.019; Van Loan C., 1992, COMPUTATIONAL FRAMEW, V10; Wang QF, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2015), P380, DOI 10.1109/ICHI.2015.54; Weber I., 2012, BIOMEDICAL ENG, V57; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wilhelm K, 1997, SOCIAL PSYCHIAT PSYC, V33, P16, DOI [10.1007/, DOI 10.1007/]	44	22	23	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216591	10.1371/journal.pone.0216591	http://dx.doi.org/10.1371/journal.pone.0216591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116785	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400024
J	Cepeda, FX; Virmondes, L; Rodrigues, S; Dutra-Marques, ACB; Toschi-Dias, E; Ferreira-Camargo, FC; Hussid, MF; Rondon, MUPB; Alves, MJNN; Trombetta, IC				Cepeda, Felipe X.; Virmondes, Leslie; Rodrigues, Sara; Dutra-Marques, Akothirene C. B.; Toschi-Dias, Edgar; Ferreira-Camargo, Fernanda C.; Hussid, Maria Fernanda; Rondon, Maria Urbana P. B.; Alves, Maria Janieire N. N.; Trombetta, Ivani C.			Identifying the risk of obstructive sleep apnea in metabolic syndrome patients: Diagnostic accuracy of the Berlin Questionnaire	PLOS ONE			English	Article							SENSITIVITY; PREVALENCE; SEVERITY; SCALE	Background Obstructive sleep apnea (OSA) is a risk factor frequently present in patients with metabolic syndrome (MetS). Additionally, moderate and severe OSA are highly prevalent in patients with cardiac disease, as they increase the riskfor cardiovascular events by 80%. The gold standard diagnostic method for OSA is overnight polysomnography (PSG), which remains unaffordable for the overall population. The aim of the present study was to evaluate whether the Berlin Questionnaire (BQ) is anuseful tool for assessing the risk of OSA in patients with MetS. Methods 97 patients, previously untreated and recently diagnosed with MetS (National Cholesterol Education Program, Adult Treatment Panel III, ATP-III) underwent a PSG. OSA was characterized by the apnea-hypopnea index (AHI). BQ was administered before PSG and we evaluated sensitivity, specificity, positive and negative predictive values, and accuracy. Results Of the 97 patients with MetS, 81 patients had OSA, with 47 (48.5%) presenting moderate and severe OSA. For all MetS with OSA (AHI >= 5 events/hour), the BQ showed good sensitivity (0.65, 95% CI 0.54 to 0.76) and fair specificity (0.38, 95% CI 0.15-0.65) with a positive predictive value of 0.84, a negative predictive value of 0.18 and an 84% accuracy. Similarly, for moderate-to-severe OSA (AHI >= 15 events/hour) we found good sensitivity (0.73, 95% CI 0.58-0.85) and fair specificity (0.40, 95% CI 0.27-0.55). Interestingly, for severe OSA (AHI. 30 events/hour), there was a very good sensitivity (0.91, 95% CI 0.72-0.99) and moderate specificity (0.42, 95% CI 0.31-0.54). Conclusion The BQ is a valid tool for screening the risk of OSA in MetS patients in general, and it is particularly useful in predicting severe OSA.	[Cepeda, Felipe X.; Rodrigues, Sara; Dutra-Marques, Akothirene C. B.; Toschi-Dias, Edgar; Alves, Maria Janieire N. N.] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor, Sao Paulo, Brazil; [Cepeda, Felipe X.; Virmondes, Leslie; Ferreira-Camargo, Fernanda C.; Hussid, Maria Fernanda; Trombetta, Ivani C.] Univ Nove Julho UNINOVE, Sao Paulo, Brazil; [Toschi-Dias, Edgar] Univ Ibirapuera, Sao Paulo, Brazil; [Rondon, Maria Urbana P. B.] Univ Sao Paulo, Sch Phys Educ & Sports, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Nove de Julho; Universidade Ibirapuera; Universidade de Sao Paulo	Trombetta, IC (corresponding author), Univ Nove Julho UNINOVE, Sao Paulo, Brazil.	ivani.trombetta@gmail.com	Cepeda, Felipe Xerez/N-5100-2019; Alves, Janieire/G-4548-2010; rodrigues, sara/G-4892-2013; Trombetta, Ivani C/G-5839-2012; Toschi-Dias, Edgar/AAP-9528-2020; Rondon, Maria Urbana P B/G-5272-2012	Cepeda, Felipe Xerez/0000-0003-1544-3499; Alves, Janieire/0000-0003-3207-623X; Trombetta, Ivani C/0000-0002-0979-0091; Toschi-Dias, Edgar/0000-0002-5226-2956; Rondon, Maria Urbana P B/0000-0002-4134-6126; Rodrigues, Sara/0000-0002-4998-7534; DUTRA, AKOTHIRENE/0000-0001-5711-2554	Fundacao Zerbini; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17533-6]; FAPESP [2013/15323-0, 2013/07651-7, 2015/03274-0, 2016/16831-7]; Coordenacao de Aconselhamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq) [302809/2018-0, 309821/2014-2]	Fundacao Zerbini; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aconselhamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was performed at the Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil and supported by Fundacao Zerbini and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2011/17533-6). FXC was supported by FAPESP (#2015/03274-0 and #2016/16831-7 to FXC) and Coordenacao de Aconselhamento de Pessoal de Nivel Superior (CAPES). ICT and MUPBR were supported by Conselho Nacional de Pesquisa (CNPq #302809/2018-0 to ICT and #309821/2014-2 to MUPBR, respectively). SR and ET-D were supported by FAPESP (#2013/15323-0 to SR, and #2013/07651-7 to ET-D, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D. G., 1991, PRACTICAL STAT MED R, P121; Ambrosetti M, 2006, J CARDIOVASC MED, V7, P826, DOI 10.2459/01.JCM.0000250873.01649.41; American Academy of Sleep Medicine, 2007, AASM MAN SCOR SLEEP; Auckley D, 2008, SLEEP MED, V9, P494, DOI 10.1016/j.sleep.2007.06.010; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Cepeda FX, 2015, SLEEP, V38, P1059, DOI 10.5665/sleep.4812; Chiu HY, 2017, SLEEP MED REV, V36, P57, DOI 10.1016/j.smrv.2016.10.004; Drager Luciano F, 2009, J Cardiometab Syndr, V4, P89, DOI 10.1111/j.1559-4572.2008.00046.x; Drager LF, 2010, AM J CARDIOL, V105, P1135, DOI 10.1016/j.amjcard.2009.12.017; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HOFFSTEIN V, 1992, EUR RESPIR J, V5, P377; Hou HF, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010405; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Karakoc O, 2014, B-ENT, V10, P21; Kuniyoshi FHS, 2011, CHEST, V140, P1192, DOI 10.1378/chest.10-2625; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Lopes C, 2008, BRAZ J MED BIOL RES, V41, P908, DOI 10.1590/S0100-879X2008005000036; Maimon N, 2010, J CLIN SLEEP MED, V6, P475; Moreno CRC, 2004, CHRONOBIOL INT, V21, P871, DOI 10.1081/CBI-200036880; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Santos-Silva R, 2009, SLEEP, V32, P629, DOI 10.1093/sleep/32.5.629; Senaratna CV, 2017, SLEEP MED REV, V36, P116, DOI 10.1016/j.smrv.2017.04.001; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Stojanovic M, 2014, VOJNOSANIT PREGL, V71, P1062, DOI 10.2298/VSP1411062S; The Report of an American Academy of Sleep Medicine Task Force, 1999, SLEEP, V22; Trombetta IC, 2013, SLEEP, V36, P41, DOI 10.5665/sleep.2298; Trombetta IC, 2010, SLEEP, V33, P1193, DOI 10.1093/sleep/33.9.1193; Ulasli SS, 2014, CLIN RESPIR J, V8, P292, DOI 10.1111/crj.12070; Vaza AP, 2011, REV PORT PNEUMOL, V17, P59, DOI [10.1016/S0873-2159(11)70015-0, DOI 10.1016/S0873-2159(11)70015-0]; Vgontzas AN, 2003, J INTERN MED, V254, P32, DOI 10.1046/j.1365-2796.2003.01177.x; Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006; Wilcox I, 1998, THORAX, V53, pS25; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217058	10.1371/journal.pone.0217058	http://dx.doi.org/10.1371/journal.pone.0217058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112558	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000036
J	Gueye, SB; Diop-Ndiaye, H; Diouf, O; Sow-Ndoye, A; Toure, F; Ngom-Faye, NF; Diagne-Gueye, D; Mbow-Ndiaye, K; Diallo, PAN; Gaye-Diallo, A; Mboup, S; Ndour, CT; Boye, CSB; Toure-Kane, C				Gueye, Sokhna Bousso; Diop-Ndiaye, Halimatou; Diouf, Ousmane; Sow-Ndoye, Aissatou; Toure, Fatoumata; Ngom-Faye, Ndeye Fatou; Diagne-Gueye, Diabou; Mbow-Ndiaye, Khady; Diallo, Papa Amadou Niang; Gaye-Diallo, Aissatou; Mboup, Souleymane; Ndour, Cheikh Tidiane; Boye, Cheikh Saad-Bouh; Toure-Kane, Coumba			Effectiveness of the prevention of HIV mother-to-child transmission (PMTCT) program via early infant diagnosis (EID) data in Senegal	PLOS ONE			English	Article							DRIED BLOOD SPOTS; ANTIRETROVIRAL THERAPY; ELIMINATION; ACCESS; PERFORMANCE; INFECTION; CARE	Background To improve the care and treatment of HIV-exposed children, early infant diagnosis (EID) using dried blood spot (DBS) sampling has been performed in Senegal since 2007, making molecular diagnosis accessible for patients living in decentralized settings. This study aimed to determine the evolution of the HIV transmission rate in children from 2008 to 2015 and to analyze associated factors, particularly the mother's treatment status and/or child's prophylaxis status and the feeding mode. Methods The data were analyzed using EID reports from the reference laboratory. Information related to sociodemographic characteristics, HIV profiles, the mother's treatment status, the child's prophylaxis status, and the feeding mode was included. Descriptive statistics were calculated, and bivariate and multivariate logistic regression analyses were performed. Results During the study period, a total of 5418 samples (5020 DBS and 398 buffy coat) from 168 primary prevention of HIV mother-to-child transmission (PMTCT) intervention sites in Senegal were tested. The samples were collected from 4443 children with a median age of 8 weeks (1-140 weeks) and a sex ratio (M/F) of 1.1 (2309/2095). One-third (35.2%; N = 1564) of the children were tested before 6 weeks of age. Twenty percent (N = 885) underwent molecular diagnostic testing more than once. An increased number of mothers receiving treatment (57.4%; N = 2550) and children receiving prophylaxis (52.1%; N = 2315) for protection against HIV infection during breastfeeding was found over the study period. The transmission rate decreased from 14.8% (95% confidence interval (CI): 11.4-18.3) in 2008 to 4.1% (95% CI: 2.5-7.5) in 2015 (p < 0.001). However, multivariate logistic regression analysis revealed that independent predictors of HIV mother-to-child transmission included lack of mother's treatment (adjusted odd ratio (aOR) = 3.8, 95% CI: 1.9-7.7; p < 0.001), lack of child's prophylaxis (aOR = 7.8, 95% CI: 1.7-35.7; p = 0.009), infant age at diagnosis (aOR = 2.2, 95% CI: 1.1-4.3 for <= 6 weeks versus 12-24 weeks; p = 0.025) and protective effect of breastfeeding on ART against formula feeding (aOR = 0.4, 95% CI: 0.2, 0.7; p = 0.005). Conclusion This study demonstrates the effectiveness of PMTCT interventions in Senegal but indicates also that increased efforts should be continued to reduce the MTCT rate to less than 2%.	[Gueye, Sokhna Bousso; Diop-Ndiaye, Halimatou; Diouf, Ousmane; Sow-Ndoye, Aissatou; Toure, Fatoumata; Diagne-Gueye, Diabou; Mbow-Ndiaye, Khady; Gaye-Diallo, Aissatou; Mboup, Souleymane; Boye, Cheikh Saad-Bouh; Toure-Kane, Coumba] Univ Cheikh Anta Diop Dakar, CHU Aristide Le Dantec, Lab Bacteriol Virol, Dakar, Senegal; [Diouf, Ousmane; Mboup, Souleymane] Inst Rech Sante Surveillance Epidemiol & Format I, Diamniado, Senegal; [Ngom-Faye, Ndeye Fatou; Ndour, Cheikh Tidiane] Minist Sante & Act Sociale, Div Lutte Sida & IST DLSI, Dakar, Senegal; [Ngom-Faye, Ndeye Fatou] United Nations Childrens Fund UNICEF Senegal, Dakar, Senegal; [Diallo, Papa Amadou Niang] Conseil Natl Lutte Sida CNLS, Dakar, Senegal	University Cheikh Anta Diop Dakar	Diop-Ndiaye, H (corresponding author), Univ Cheikh Anta Diop Dakar, CHU Aristide Le Dantec, Lab Bacteriol Virol, Dakar, Senegal.	halimatoudiop@yahoo.fr		Gueye, Sokhna Bousso/0000-0001-8248-5512; DIOP-NDIAYE, Halimatou/0000-0001-5885-5448	Senegal Government through the National AIDS Control Council (Conseil National de Lutte contre le Sida-CNLS); National AIDS and STIs Control Division; USAID; UNICEF; GLOBAL FUND; WHO; UNAIDS	Senegal Government through the National AIDS Control Council (Conseil National de Lutte contre le Sida-CNLS); National AIDS and STIs Control Division; USAID(United States Agency for International Development (USAID)); UNICEF; GLOBAL FUND; WHO(World Health Organization); UNAIDS	The PMTCT Program has been funded in part by Senegal Government through the National AIDS Control Council (Conseil National de Lutte contre le Sida-CNLS) and the National AIDS and STIs Control Division; and also by the development partners such as UNAIDS, UNICEF, GLOBAL FUND, WHO and USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afe AJ, 2011, HIV AIDS REV, V10, P14, DOI 10.1016/j.hivar.2011.02.001; Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2016, WHO VAL COUNTR EL MO; [Anonymous], 2020, HIGH POSS COST COVID; Bailey H, 2013, B WORLD HEALTH ORGAN, V91, P491, DOI 10.2471/BLT.12.114405; Buchanan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088679; Collins IJ, 2010, CLIN INFECT DIS, V51, P1449, DOI 10.1086/657401; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Division de Lutte contre le Sida et les IST (DLSI), 2014, DLSI RAPP ANN 2014; Division de Lutte contre le Sida et les IST (DLSI), 2009, DLSI RAPP ANN 2009; Global Fund, 2016, TECHN BRIEF STRAT SU; Ishikawa N, 2016, B WORLD HEALTH ORGAN, V94, P787, DOI 10.2471/BLT.16.185033; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Koye DN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-398; Kurewa NE, 2012, J TROP PEDIATRICS, V58, P360, DOI 10.1093/tropej/fmr112; Li B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-591; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Lussiana C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036381; Mangwiro AZ, 2014, JAIDS-J ACQ IMM DEF, V67, pS139, DOI 10.1097/QAI.0000000000000326; Mugambi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078891; Mwapasa V, 2014, JAIDS-J ACQ IMM DEF, V67, pS120, DOI 10.1097/QAI.0000000000000327; Mwendo EM, 2014, TROP MED INT HEALTH, V19, P267, DOI 10.1111/tmi.12255; Noubiap JJN, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.65.2551; Prendergast AJ, 2015, ARCH DIS CHILD, V100, pS48, DOI 10.1136/archdischild-2013-305548; Ramkissoon A, 2014, SAMJ S AFR MED J, V104, P18, DOI [10.7196/SAMJ.7603, 10.7196/samj.7603]; Rentsch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087352; Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI [10.7196/SAMJ.7598, 10.7196/samj.7598]; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Temgoua EMS, 2015, CURR HIV RES, V13, P286, DOI 10.2174/1570162X13666150407143525; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; UNAIDS, 2016, FAST TRACK AIDS FREE; UNAIDS, 2014, UNAIDS GAP REP GLOB; UNICEF, 2013, AIDS FREE GEN CHILDR; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organisation, 2015, WHO VAL EL MOTH TO C; World Health Organization, 2009, UN ACC HIV AIDS SCAL; World Health Organization, 2008, PAED HIV ART CAR GUI; World Health Organization, 2010, REC DIAGN HIV INF IN; World Health Organization, 2021, ANT DRUGS TREAT PREG	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0215941	10.1371/journal.pone.0215941	http://dx.doi.org/10.1371/journal.pone.0215941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112547	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000010
J	Lee, L; Seager, R; Nakamura, Y; Wilkinson, KA; Henley, JM				Lee, Laura; Seager, Richard; Nakamura, Yasuko; Wilkinson, Kevin A.; Henley, Jeremy M.			Parkin-mediated ubiquitination contributes to the constitutive turnover of mitochondrial fission factor (Mff)	PLOS ONE			English	Article							DRP1; PROTEASOME; PINK1; MID51; MID49; DEGRADATION; RECRUITMENT; ACTIVATION; MITOPHAGY	The mitochondrial outer membrane protein Mitochondrial Fission Factor (Mff) plays a key role in both physiological and pathological fission. It is well established that at stressed or functionally impaired mitochondria, PINK1 recruits the ubiquitin ligase Parkin which ubiquitinates Mff and other mitochondrial outer membrane proteins to facilitate the removal of defective mitochondria and maintain the integrity of the mitochondrial network. Here we show that, in addition to this clearance pathway, Parkin also ubiquitinates Mff in a PINK1-dependent manner under non-stressed conditions to regulate constitutive Mff turnover. We further show that removing Parkin via shRNA-mediated knockdown does not completely prevent Mff ubiquitination under these conditions, indicating that at least one other ubiquitin ligase contributes to Mff proteostasis. These data suggest that that Parkin plays a role in physiological maintenance of mitochondrial membrane protein composition in unstressed cells through constitutive low-level activation.	[Lee, Laura; Seager, Richard; Nakamura, Yasuko; Wilkinson, Kevin A.; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Ctr Synapt Plast, Biomed Sci Bldg, Bristol, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Biochem, Ctr Synapt Plast, Biomed Sci Bldg, Bristol, Avon, England.	j.m.henley@bristol.ac.uk	Nakamura, Yasuko/O-5551-2016; Wilkinson, Kevin/AAM-2888-2020	Nakamura, Yasuko/0000-0002-0660-4126; Wilkinson, Kevin/0000-0002-8115-8592; Lee, Laura/0000-0002-7974-6803; Henley, Jeremy/0000-0003-3589-8335; Seager, Richard/0000-0002-8904-5795	British Heart Foundation [PG/14/60/31014]; MRC [MR/L003791]; BBSRC [BB/R00787X]; Wellcome Trust [105384/Z/14/A]; BBSRC [BB/R00787X/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to the British Heart Foundation (PG/14/60/31014; JMH), Wellcome Trust (105384/Z/14/A, studentship to RS), MRC (MR/L003791; KAW, JMH) and BBSRC (BB/R00787X; KAW, JMH) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso V, 2018, PHARMACOL RES, V138, P43, DOI 10.1016/j.phrs.2018.09.006; Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384; Caulfield TR, 2015, BIOCHEM SOC T, V43, P269, DOI 10.1042/BST20140321; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao J, 2015, ACTA BIOCH BIOPH SIN, V47, P522, DOI 10.1093/abbs/gmv044; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Osellame L. D., 2016, J CELL SCI; Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pessayre D, 2002, AM J PHYSIOL-GASTR L, V282, pG193, DOI 10.1152/ajpgi.00426.2001; Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yoshida Y, 2018, MICROSCOPY OXF; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235; Zamponi N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18351-5	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0213116	10.1371/journal.pone.0213116	http://dx.doi.org/10.1371/journal.pone.0213116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112535	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000005
J	Celandroni, F; Vecchione, A; Cara, A; Mazzantini, D; Lupetti, A; Ghelardi, E				Celandroni, Francesco; Vecchione, Alessandra; Cara, Alice; Mazzantini, Diletta; Lupetti, Antonella; Ghelardi, Emilia			Identification of Bacillus species: Implication on the quality of probiotic formulations	PLOS ONE			English	Article							MALDI-TOF-MS; MOLECULAR CHARACTERIZATION; CEREUS; PRODUCTS; STRAINS; LICHENIFORMIS; SUPPLEMENTS; MECHANISM; SUBTILIS; CLAUSII	Spores of several Bacillus species have long history of consumption and safe use as probiotics and a variety of formulations containing these organisms are available in the global market. Considering the difficulties in the identification of Bacillus species and the poor microbiological quality of many probiotic formulations, we used three up-to-date methodological approaches for analyzing the content of ten formulations marketed in Italy and labeled to contain Bacillus spores. We compared the performance of biochemical tests based on the BCL Vitek2 card and MALDI-TOF mass spectrometry, using 16S rDNA sequencing as the reference technique. The BCL card performed well in identifying all Bacillus probiotic strains as well as the Bruker's MALDI Biotyper. Nevertheless, the MALDI score values were sometimes lower than those indicated by the manufacturer for correct species identification. Contaminant bacteria (Lysinibacillus fusiformis, Acinetobacter baumannii, Bacillus cereus, Brevibacillus choshinensis, Bacillus licheniformis, Bacillus badius) were detected in some formulations. Characterization of the B. cereus contaminant showed the potential pathogenicity of this strain. Microbial enumeration performed by the plate count method revealed that the number of viable cells contained in many of the analyzed products differed from the labeled amount. Overall, our data show that only two of the ten analyzed formulations qualitatively and quantitatively respect what is on the label. Since probiotic properties are most often strain specific, molecular typing of isolates of the two most common Bacillus species, B. clausii and B. coagulans, was also performed. In conclusion, the majority of the analyzed products do not comply with quality requirements, most likely leading to reduced/absent efficacy of the preparation and representing a potential infective risk for consumers.	[Celandroni, Francesco; Vecchione, Alessandra; Cara, Alice; Mazzantini, Diletta; Lupetti, Antonella; Ghelardi, Emilia] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Ghelardi, Emilia] Univ Pisa, Res Ctr Nutraceut & Food Hlth Nutrafood, Pisa, Italy	University of Pisa; University of Pisa	Ghelardi, E (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.; Ghelardi, E (corresponding author), Univ Pisa, Res Ctr Nutraceut & Food Hlth Nutrafood, Pisa, Italy.	emilia.ghelardi@med.unipi.it	Ghelardi, Emilia/ABH-6508-2020	GHELARDI, EMILIA/0000-0001-6863-1384; Celandroni, Francesco/0000-0001-7920-7159	Sanofi S.p.A.	Sanofi S.p.A.	This work received financial support from Sanofi S.p.A. in the form of research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz LD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-332; AlMasoud N, 2014, ANAL CHIM ACTA, V840, P49, DOI 10.1016/j.aca.2014.06.032; [Anonymous], 2013, PLOS ONE; Aureli P, 2010, INT J FOOD MICROBIOL, V137, P265, DOI 10.1016/j.ijfoodmicro.2009.12.016; Baccigalupi L, 2015, PROBIOTICS AND PREBIOTICS: CURRENT RESEARCH AND FUTURE TRENDS, P93; BEVERIDGE TJ, 1990, J BACTERIOL, V172, P1609, DOI 10.1128/jb.172.3.1609-1620.1990; Brink M, 2005, SAMJ S AFR MED J, V95, P114; Celandroni F, 2000, FEMS MICROBIOL LETT, V190, P247, DOI 10.1016/S0378-1097(00)00343-8; Celandroni F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152831; CLSI, 2008, MM18A CLSI; Daffonchio D, 1999, APPL ENVIRON MICROB, V65, P1298; Drago L, 2004, J CHEMOTHERAPY, V16, P463; Drisko J, 2005, DIGEST DIS SCI, V50, P1113, DOI 10.1007/s10620-005-2714-6; Elliott E, 2004, SAMJ S AFR MED J, V94, P121; Elshaghabee FMF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01490; FAO/WHO, 2002, GUIDELINES EVALUATIO; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Fasoli S, 2003, INT J FOOD MICROBIOL, V82, P59, DOI 10.1016/S0168-1605(02)00259-3; Ghelardi E, 2002, FEMS MICROBIOL LETT, V208, P129, DOI [10.1016/S0378-1097(02)00450-0, 10.1111/j.1574-6968.2002.tb11072.x]; Hamilton-Miller JMT, 2002, INT J FOOD MICROBIOL, V72, P175, DOI 10.1016/S0168-1605(01)00703-6; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; Jessberger N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00560; Khowal S, 2017, MOL PHYLOGENET EVOL, V107, P443, DOI 10.1016/j.ympev.2016.12.010; Kolacek S, 2017, J PEDIATR GASTR NUTR, V65, P117, DOI 10.1097/MPG.0000000000001603; La Jeon Y, 2012, J MED MICROBIOL, V61, P1766, DOI 10.1099/jmm.0.042275-0; Lin WH, 2006, FOOD MICROBIOL, V23, P74, DOI 10.1016/j.fm.2005.01.013; Maughan H, 2011, INFECT GENET EVOL, V11, P789, DOI 10.1016/j.meegid.2011.02.001; Ministero della Salute, DIR GEN IG SIC AL NU, DOI [10.1371/journal.pone.0080097, DOI 10.1371/JOURNAL.PONE.0080097]; Mohammed Y, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0102-7; Padhi Tapas Ranjan, 2012, Retin Cases Brief Rep, V6, P43, DOI 10.1097/ICB.0b013e3182051df9; Park DJ, 2006, NEPHROLOGY, V11, P21, DOI 10.1111/j.1440-1797.2006.00539.x; Patrone V, 2016, INT J FOOD MICROBIOL, V237, P92, DOI 10.1016/j.ijfoodmicro.2016.08.012; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Senesi S, 2001, APPL ENVIRON MICROB, V67, P834, DOI 10.1128/AEM.67.2.834-839.2001; Senesi S, 2010, TOXINS, V2, P1690, DOI 10.3390/toxins2071690; Shu LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15808-5; Starostin KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16989; Takano H, 2016, BIOSCI BIOTECH BIOCH, V80, P1264, DOI 10.1080/09168451.2016.1156478; Tanaka K, 2014, BIOENGINEERED, V5, P331, DOI 10.4161/bioe.29897; Temmerman R, 2003, INT J FOOD MICROBIOL, V81, P1, DOI 10.1016/S0168-1605(02)00162-9; Thaenthanee S, 2005, INT J FOOD MICROBIOL, V105, P203, DOI 10.1016/j.ijfoodmicro.2005.04.003; Thom KA, 2010, AM J INFECT CONTROL, V38, P751, DOI 10.1016/j.ajic.2010.03.005; Vecchione A, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00059; Venugopalan V, 2010, EMERG INFECT DIS, V16, P1661, DOI 10.3201/eid1611.100574; Wenzler E, 2015, INT J INFECT DIS, V35, P93, DOI 10.1016/j.ijid.2015.04.016; Yadav P, 2018, INDIAN PEDIATR, V55, P344, DOI 10.1007/s13312-018-1261-0; 2011, ELECTROPHORESIS, V32, P2951, DOI DOI 10.1002/ELPS.201100217; 2013, FOOD MICROBIOL, V33, P235, DOI DOI 10.1016/J.FM.2012.09.022; 2001, J FOOD PROT, V64, P716	50	21	23	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217021	10.1371/journal.pone.0217021	http://dx.doi.org/10.1371/journal.pone.0217021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107885	Green Submitted, Green Published, gold			2022-12-27	WOS:000468285200025
J	Kim, N; Chung, W; Eum, HH; Lee, HO; Park, WY				Kim, Nayoung; Chung, Woosung; Eum, Hye Hyeon; Lee, Hae-Ock; Park, Woong-Yang			Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer	PLOS ONE			English	Article							RNA; INHIBITORS; TARGET; 3'UTRS	Alternative polyadenylation (APA) in 3' untranslated regions (3' UTR) plays an important role in regulating transcript abundance, localization, and interaction with microRNAs. Length-variation of 3' UTRs by APA contributes to efficient proliferation of cancer cells. In this study, we investigated APA in single cancer cells and tumor microenvironment cells to understand the physiological implication of APA in different cell types. We analyzed APA patterns and the expression level of genes from the 515 single-cell RNA sequencing (scRNA-seq) dataset from 11 breast cancer patients. Although the overall 3' UTR length of individual genes was distributed equally in tumor and non-tumor cells, we found a differential pattern of polyadenylation in gene sets between tumor and non-tumor cells. In addition, we found a differential pattern of APA across tumor types using scRNA-seq data from 3 glioblastoma patients and 1 renal cell carcinoma patients. In detail, 1,176 gene sets and 53 genes showed the distinct pattern of 3' UTR shortening and over-expression as signatures for five cell types including B lymphocytes, T lymphocytes, myeloid cells, stromal cells, and breast cancer cells. Functional categories of gene sets for cellular proliferation demonstrated concordant regulation of APA and gene expression specific to cell types. The expression of APA genes in breast cancer was significantly correlated with the clinical outcome of earlier stage breast cancer patients. We identified cell type-specific APA in single cells, which allows the identification of cell types based on 3' UTR length variation in combination with gene expression. Specifically, an immune-specific APA signature in breast cancer could be utilized as a prognostic marker of early stage breast cancer.	[Kim, Nayoung; Chung, Woosung; Eum, Hye Hyeon; Lee, Hae-Ock; Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Kim, Nayoung; Eum, Hye Hyeon; Lee, Hae-Ock; Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; [Lee, Hae-Ock; Park, Woong-Yang] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Park, Woong-Yang] GENINUS Inc, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, HO; Park, WY (corresponding author), Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.; Lee, HO; Park, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea.; Lee, HO; Park, WY (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.; Park, WY (corresponding author), GENINUS Inc, Seoul, South Korea.	haeock.lee@samsung.com; woongyang.park@samsung.com		Park, Woong-Yang/0000-0003-4234-0380; Lee, Hae-Ock/0000-0001-5123-0322; Eum, Hye Hyeon/0000-0002-8081-4121	National Research Foundation of Korea [NRF-2017R1A6A3A11027978, NRF-2017M3C9A6044636, NRF-2016R1A5A1011974, NRF-2017M3A9A7050803]; Ministry of Food and Drug Safety of Korea [16173MFDS004]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Food and Drug Safety of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was supported by grants from the National Research Foundation of Korea (NRF-2017R1A6A3A11027978 to N.K., NRF-2017M3C9A6044636 and NRF-2016R1A5A1011974 to H.L. and NRF-2017M3A9A7050803 to W.P.) and from the Ministry of Food and Drug Safety of Korea (16173MFDS004 to W.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. W.P. is employed by a commercial company, GENINUS Inc, who provided support in the form of salary for W.P., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agresti A, 2003, CATEGORICAL DATA ANA; Aguado E, 2006, TRANSPL IMMUNOL, V17, P23, DOI 10.1016/j.trim.2006.09.013; Akman HB, 2015, HUM MOL GENET, V24, P6910, DOI 10.1093/hmg/ddv391; Begik O, 2017, NEOPLASIA, V19, P574, DOI 10.1016/j.neo.2017.04.008; Chimen M, 2015, NAT MED, V21, P467, DOI 10.1038/nm.3842; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Debald M, 2013, J CANCER RES CLIN, V139, P2125, DOI 10.1007/s00432-013-1541-y; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gillen AE, 2017, MOL CANCER RES, V15, P1741, DOI 10.1158/1541-7786.MCR-17-0010; Grassi E, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1254-8; Hayashi K, 2011, MOL IMMUNOL, V48, P941, DOI 10.1016/j.molimm.2010.12.014; Ilatovskaya DV, 2013, CELL TISSUE RES, V354, P783, DOI 10.1007/s00441-013-1710-y; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim KT, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0945-9; Le Pera L, 2015, BIOINFORMATICS, V31, P1845, DOI 10.1093/bioinformatics/btv035; Lee JK, 2017, NAT GENET, V49, P594, DOI 10.1038/ng.3806; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2014, BIOCHEM BIOPH RES CO, V453, P7, DOI 10.1016/j.bbrc.2014.09.013; Liu YZ, 2017, RESULTS PROBL CELL D, V62, P365, DOI 10.1007/978-3-319-54090-0_15; Manresa-Arrauti A, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.01235, 10.3389/timrnu.2018.01235]; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mbofung RM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00449-z; Ner-Gaon H, 2017, J IMMUNOL, V198, P3375, DOI 10.4049/jimmunol.1700272; Okamura T, 2000, INT J ONCOL, V16, P295; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; Velten L, 2015, MOL SYST BIOL, V11; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang L, 2016, ONCOTARGET, V7, P59834, DOI 10.18632/oncotarget.10975; Wang W, 2014, BIOINFORMATICS, V30, P2162, DOI 10.1093/bioinformatics/btu189; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; 2016, SCIENCE, V352, P189, DOI DOI 10.1126/SCIENCE.AAD0501; 2014, SCIENCE, V344, P1396, DOI DOI 10.1126/SCIENCE.1254257	41	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217196	10.1371/journal.pone.0217196	http://dx.doi.org/10.1371/journal.pone.0217196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100099	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600035
J	Marsillio, LE; Manghi, T; Carroll, MS; Balmert, LC; Wainwright, MS				Marsillio, Lauren E.; Manghi, Tomas; Carroll, Michael S.; Balmert, Lauren C.; Wainwright, Mark S.			Heart rate variability as a marker of recovery from critical illness in children	PLOS ONE			English	Article							DIMINISHED PHYSIOLOGICAL RESERVE; ORGAN DYSFUNCTION SYNDROME; SEPTIC SHOCK; MORTALITY; PREDICTION; INDICATOR; SEPSIS	Objectives The purpose of this study was to Identify whether changes in heart rate variability (HRV) could be detected as critical illness resolves by comparing HRV from the time of pediatric intensive care unit (PICU) admission with HRV immediately prior to discharge. We also sought to demonstrate that HRV derived from electrocardiogram (ECG) data from bedside monitors can be calculated in critically-ill children using a real-time, streaming analytics platform. Methods This was a retrospective, observational pilot study of 17 children aged 0 to 18 years admitted to the PICU of a free-standing, academic children's hospital. Three time-domain measures of HRV were calculated in real-time from bedside monitor ECG data and stored for analysis. Measures included: root mean square of successive differences between NN intervals (RMSSD), percent of successive NN interval differences above 50 ms (pNN50), and the standard deviation of NN intervals (SDNN). Results HRV values calculated from the first and last 24 hours of PICU stay were analyzed. Mixed effects models demonstrated that all three measures of HRV were significantly lower during the first 24 hours compared to the last 24 hours of PICU admission (p<0.001 for all three measures). In models exploring the relationship between time from admission and log HRV values, the predicted average HRV remained consistently higher in the last 24 hours of PICU stay compared to the first 24 hours. Conclusion HRV was significantly lower in the first 24 hours compared to the 24 hours preceding PICU discharge, after resolution of critical illness. This demonstrates that it is feasible to detect changes in HRV using an automated, streaming analytics platform. Continuous tracking of HRV may serve as a marker of recovery in critically ill children.	[Marsillio, Lauren E.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Crit Care Med, Chicago, IL 60611 USA; [Manghi, Tomas] Yale Sch Med, Dept Pediat, New Haven, CT USA; [Carroll, Michael S.] Ann & Robert H Lurie Childrens Hosp Chicago, Data Analyt & Reporting, Chicago, IL 60611 USA; [Balmert, Lauren C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Wainwright, Mark S.] Univ Washington, Dept Neurol, Div Pediat Neurol, Seattle, WA 98195 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Yale University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Marsillio, LE (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Crit Care Med, Chicago, IL 60611 USA.	LMarsillio@luriechildrens.org		Carroll, Michael/0000-0002-0526-7543; Marsillio, Lauren/0000-0003-3166-6318	Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program	Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program	MW was supported in part through the Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program, https://www.neurology.northwestern.edu/medical-specialties/neurocritical.html. No specific grant was received for this work. The funders did not play a role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Bento Luis, 2017, Rev. bras. ter. intensiva, V29, P481, DOI [10.5935/0103-507x.20170072, 10.5935/0103-507X.20170072]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Camm AJ, 1996, EUR HEART J, V17, P354; Chen WL, 2007, ACAD EMERG MED, V14, P392, DOI 10.1197/j.aem.2006.12.015; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; Ellenby MS, 2001, SHOCK, V16, P274, DOI 10.1097/00024382-200116040-00007; FINLEY JP, 1995, J AUTONOM NERV SYST, V51, P103, DOI 10.1016/0165-1838(94)00117-3; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Griffin MP, 2003, PEDIATR RES, V53, P920, DOI 10.1203/01.PDR.0000064904.05313.D2; Hilz MJ, 2018, CLIN AUTON RES; Huston JM, 2011, J INTERN MED, V269, P45, DOI 10.1111/j.1365-2796.2010.02321.x; Karmali SN, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0146-1; Kazmi SZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157557; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Mehta SK, 2002, AM J CARDIOL, V89, P50, DOI 10.1016/S0002-9149(01)02162-2; Michels N, 2013, EUR J APPL PHYSIOL, V113, P1477, DOI 10.1007/s00421-012-2572-9; Monfredi O, 2014, HYPERTENSION, V64, P1334, DOI 10.1161/HYPERTENSIONAHA.114.03782; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Mowery NT, 2008, J TRAUMA, V65, P621, DOI 10.1097/TA.0b013e3181837980; Nemati S, 2018, CRIT CARE MED, V46, P547, DOI [10.1097/ccm.0000000000002936, 10.1097/CCM.0000000000002936]; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Peltola MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00148; Pontet J, 2003, J CRIT CARE, V18, P156, DOI 10.1016/j.jcrc.2003.08.005; Pradhapan P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00208; Sacha J, 2014, ANN NONINVAS ELECTRO, V19, P207, DOI 10.1111/anec.12148; Sacha J, 2013, INT J CARDIOL, V168, P1655, DOI 10.1016/j.ijcard.2013.03.040; Schmidt H B, 2001, Curr Opin Crit Care, V7, P314, DOI 10.1097/00075198-200110000-00002; Schmidt H, 2008, CRIT CARE CLIN, V24, P149, DOI 10.1016/j.ccc.2007.10.003; Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99; Song T, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-59; Stein PK, 2013, CRIT CARE MED, V41, P666, DOI 10.1097/CCM.0b013e318270e6f0; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Toner A, 2013, ANN UPDATE INTENSIVE, P199; Winchell RJ, 2006, J TRAUMA, V60, P1173; Yokota Y, 2012, IFMBE PROC, V37, P195; 2006, ANN SURG, V243, P804, DOI DOI 10.1097/01.SLA.0000219642.92637.FD	39	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0215930	10.1371/journal.pone.0215930	http://dx.doi.org/10.1371/journal.pone.0215930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100075	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600005
J	Blomgren, C; Samuelssonm, H; Blomstrand, C; Jern, C; Jood, K; Claesson, L				Blomgren, Charlotte; Samuelssonm, Hans; Blomstrand, Christian; Jern, Christina; Jood, Katarina; Claesson, Lisbeth			Long-term performance of instrumental activities of daily living in young and middle-aged stroke survivors-Impact of cognitive dysfunction, emotional problems and fatigue	PLOS ONE			English	Article							NEUROLOGICAL INSTITUTE SCREEN; HIGHER CEREBRAL FUNCTIONS; POSTSTROKE FATIGUE; ISCHEMIC-STROKE; DEPRESSIVE SYMPTOMS; IMPAIRMENT; EXPERIENCE; REHABILITATION; VALIDATION; OUTCOMES	Background With an upward trend in the number of people who return home to independent living after stroke, the ability to perform more complex activities is becoming an increasingly important long-term outcome after stroke. Although associations between Instrumental Activities of Daily Living (IADL) and cognitive dysfunction, emotional problems, and fatigue have been reported, less is known about the long-term impact of these stroke consequences on the performance of everyday activities in young and middle-aged stroke survivors. Objective To explore the impact of cognitive dysfunction, emotional problems, and fatigue on long-term performance of instrumental activities of daily living in young and middle-aged stroke survivors Method Data on stroke survivors, aged 18-69 at index stroke, were collected from the Sahlgrenska Academy Study on Ischaemic Stroke. IADL outcome was assessed using the Frenchay Activities Index (FAI), and the impact of chosen variables was assessed using Spearman's rank-order correlation and logistic regression. Results Seven years after index stroke, 296 stroke survivors (median age of 64) were included in this study. Cognitive dysfunction showed the strongest correlations with FAI outcome and independently explained worse outcome on FAI summary score and the domain of work/leisure activities. Fatigue was independently explanatory of worse outcome on FAI summary score and domestic chores, while depressive symptoms independently explained worse outcome on work/leisure activities. In a subgroup with only those participants who had no or minimal residual neurological deficits at follow-up (NIHSS score 0), cognitive dysfunction independently explained worse outcome on FAI summary score and work/leisure activities. Depressive symptoms independently explained worse outcome on FAI summary score and domestic chores. Conclusion Our results show that in young and middle-aged stroke survivors, cognitive dysfunction, depressive symptoms, and fatigue negatively impact performance of IADL even at seven years post stroke onset. Further, we have shown that an impact of both cognitive dysfunction and depressive symptoms can be found also among stroke survivors with mild or no remaining neurological deficits.	[Blomgren, Charlotte; Claesson, Lisbeth] Univ Gothenburg, Dept Hlth & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Blomgren, Charlotte] Sodra Alvsborg Hosp, Dept Occupat Therapy, Boras, Sweden; [Samuelssonm, Hans] Univ Gothenburg, Dept Psychol, Fac Social Sci, Gothenburg, Sweden; [Samuelssonm, Hans; Blomstrand, Christian; Jood, Katarina] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Sahlgrenska Acad, Gothenburg, Sweden; [Blomstrand, Christian] Univ Gothenburg, Stroke Ctr West, Sahlgrenska Acad, Gothenburg, Sweden; [Jern, Christina] Univ Gothenburg, Inst Biomed, Dept Lab Med, Sahlgrenska Acad, Gothenburg, Sweden; [Jood, Katarina] Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Blomgren, C (corresponding author), Univ Gothenburg, Dept Hlth & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.; Blomgren, C (corresponding author), Sodra Alvsborg Hosp, Dept Occupat Therapy, Boras, Sweden.	charlotte.blomgren@gu.se		Wassenius, Charlotte/0000-0002-2791-8407	Stroke Centre West; Research and Development Council of the County of Sodra Alvsborg; Stiftelsen Handlanden Hjalmar Svenssons research fund; Swedish government; county councils [ALFGBG-720211]; Swedish Heart and Lung Foundation (CJ) [20160316]; Swedish Research Council [201802543]	Stroke Centre West; Research and Development Council of the County of Sodra Alvsborg; Stiftelsen Handlanden Hjalmar Svenssons research fund; Swedish government; county councils; Swedish Heart and Lung Foundation (CJ); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was supported by grants from Stroke Centre West, the Research and Development Council of the County of Sodra Alvsborg and of Sodra Alvsborgs Sjukhus (CB), Stiftelsen Handlanden Hjalmar Svenssons research fund (CB), the Swedish State under the agreement between the Swedish government and the county councils, the ALF agreement (all) Grant number: ALFGBG-720211, Swedish Heart and Lung Foundation (CJ) Grant number: 20160316 and the Swedish Research Council (CJ), Grant number: 201802543. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Babulal GM, 2015, TOP STROKE REHABIL, V22, P144, DOI 10.1179/1074935714Z.0000000012; Blomgren C, 2018, SCAND J OCCUP THER, V25, P119, DOI 10.1080/11038128.2017.1329343; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cacciatore F, 2005, GERONTOLOGY, V51, P53, DOI 10.1159/000081436; Cacciatore F, 2012, DEMENT GERIATR COGN, V34, P143, DOI 10.1159/000342195; Carod-Artal FJ, 2002, BRAIN INJURY, V16, P207, DOI 10.1080/02699050110103337; Choi-Kwon S, 2011, INT J STROKE, V6, P328, DOI 10.1111/j.1747-4949.2011.00624.x; Christiansen, 2004, INTRO OCCUPATION; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Elf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161942; Eriksen S, 2016, DISABIL REHABIL, V38, P30, DOI 10.3109/09638288.2015.1009181; Erikson A, 2007, OTJR-OCCUP PART HEAL, V27, P84, DOI 10.1177/153944920702700302; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Field A., 2013, DISCOVERING STAT USI; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Gillespie DC, 2015, CLIN REHABIL, V29, P120, DOI 10.1177/0269215514538982; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; IBM Corp, 2012, SOFTW WIND REL 21 0; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kauranen T, 2013, J NEUROL NEUROSUR PS, V84, P316, DOI 10.1136/jnnp-2012-302629; Kristensen H, 2014, INT J THER REHABIL, V21, P118, DOI 10.12968/ijtr.2014.21.3.118; Liguori I, 2018, J GERIATR CARDIOL, V15, P451, DOI 10.11909/j.issn.1671-5411.2018.06.014; Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6; Maaijwee NAMM, 2016, EUR J NEUROL, V23, P1262, DOI 10.1111/ene.13009; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P315, DOI 10.1038/nrneurol.2014.72; McGeough E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub2; Muina-Lopez R, 2013, EUR J PHYSIOTHER, V15, P86, DOI 10.3109/21679169.2013.792868; Naess H, 2012, J NEUROL SCI, V312, P138, DOI 10.1016/j.jns.2011.08.002; Parker CJ, 2000, INT J EPIDEMIOL, V29, P1065, DOI 10.1093/ije/29.6.1065; Redfors P, 2012, ACTA NEUROL SCAND, V126, P329, DOI 10.1111/j.1600-0404.2012.01653.x; Redfors P, 2014, J STROKE CEREBROVASC, V23, P349, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.026; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; SULLIVAN M, 1993, INT J OBESITY, V17, P503; Sveen U, 2004, CLIN REHABIL, V18, P267, DOI 10.1191/0269215504cr719oa; Swartz RH, 2016, INT J STROKE, V11, P509, DOI 10.1177/1747493016641968; Synhaeve NE, 2016, J NEUROL, V263, P1099, DOI 10.1007/s00415-016-8042-2; Synhaeve NE, 2015, NEUROLOGY, V85, P776, DOI 10.1212/WNL.0000000000001882; van der Werf SP, 2001, EUR NEUROL, V45, P28, DOI 10.1159/000052085; Walsh ME, 2015, DISABIL REHABIL, V37, P1834, DOI 10.3109/09638288.2014.981302; White JH, 2012, DISABIL REHABIL, V34, P1376, DOI 10.3109/09638288.2011.645111; Wolf TJ, 2009, AM J OCCUP THER, V63, P621, DOI 10.5014/ajot.63.5.621; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022; 2007, DISABIL REHABIL, V29, P353, DOI DOI 10.1080/09638280600787047; 2017, DISABIL REHABIL, V39, P904, DOI DOI 10.3109/09638288.2016.09638288.2015.1009181; 2002, J REHABIL MED, V34, P153; 2007, CEREBROVASC DIS, V23, P40, DOI DOI 10.1159/000095757; 2004, DISABIL REHABIL, V26, P1373, DOI DOI 10.1080/09638280400000211; 2012, J REHABIL MED, V44, P58, DOI DOI 10.2340/16501977-0911	54	26	27	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216822	10.1371/journal.pone.0216822	http://dx.doi.org/10.1371/journal.pone.0216822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HY3MG	31095631	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100047
J	Stefanidis, KB; Askew, CD; Klein, T; Lagopoulos, J; Summers, MJ				Stefanidis, Kayla B.; Askew, Christopher D.; Klein, Timo; Lagopoulos, Jim; Summers, Mathew J.			Healthy aging affects cerebrovascular reactivity and pressure-flow responses, but not neurovascular coupling: A cross-sectional study	PLOS ONE			English	Article							CARBON-DIOXIDE; AGE	Background and purpose Aging leads to alterations in cerebrovascular function, and these are thought to contribute to cognitive decline/dementia. Disturbances to cerebral blood flow regulation have been reported, but the findings are inconsistent and to date no study has comprehensively tested the collective and independent contribution of these parameters in the same age range. Such lines of enquiry are vital since aging is a heterogeneous and complex process, with cerebrovascular parameters being differentially affected depending on the individual. A multicomponent comprehensive measure of cerebrovascular function, which accounts for such diversity, is needed to differentiate between healthy young and old adults. Methods We tested the effect of aging on cerebrovascular function by comparing healthy young adults aged 18-30 and older adults aged 60-75, without cognitive impairments. Cerebrovascular blood flow velocity was assessed using transcranial Doppler ultrasound. Parameters included resting middle cerebral artery velocity (MCAv), neurovascular coupling, cerebrovascular reactivity to CO2 (hypercapnia and hypocapnia), and the pressure-flow response during a sit-to-stand procedure. Results MANOVA revealed that collectively, the parameters discriminated the groups (p < .001). MCAv and pressure-flow responses were lower in the older group (p < .001). While there were no differences in hypercapnic responses (p = .908) and neurovascular coupling (p = .517), hypocapnic responses were elevated in the old (p = .002). Conclusions Collectively, cerebrovascular parameters can distinguish between healthy young and older adults, with aging leading to reductions in MCAv, and altering cerebrovascular reactivity and pressure-flow responses under hypotensive conditions.	[Stefanidis, Kayla B.; Askew, Christopher D.; Lagopoulos, Jim; Summers, Mathew J.] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Qld, Australia; [Askew, Christopher D.; Klein, Timo] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [Klein, Timo] German Sports Univ Cologne, Inst Movement & Neurosci, Cologne, Germany	University of the Sunshine Coast; University of the Sunshine Coast; German Sport University Cologne	Stefanidis, KB (corresponding author), Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Qld, Australia.	kayla.stefanidis@research.usc.edu.au	Summers, Mathew J/G-3168-2011	Summers, Mathew J/0000-0002-3869-4920; Askew, Christopher/0000-0001-8076-8789	University of the Sunshine Coast Postgraduate Research Scholarship; Eli Lily (Australia) Pty Ltd.; Novotech Pty Ltd.	University of the Sunshine Coast Postgraduate Research Scholarship; Eli Lily (Australia) Pty Ltd.; Novotech Pty Ltd.	KS is a recipient of a University of the Sunshine Coast Postgraduate Research Scholarship. MS reports personal fees from Eli Lily (Australia) Pty Ltd. and grants from Novotech Pty Ltd., outside of the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bakker SLM, 2004, NEUROEPIDEMIOLOGY, V23, P178, DOI 10.1159/000078503; Barnes JN, 2012, J APPL PHYSIOL, V112, P1884, DOI 10.1152/japplphysiol.01270.2011; Black WC, 1995, MULTIVARIATE DATA AN, V3; Brassard P, 2017, AM J PHYSIOL-HEART C, V312, pH701, DOI 10.1152/ajpheart.00790.2016; Bright MG, 2011, J CEREBR BLOOD F MET, V31, P426, DOI 10.1038/jcbfm.2010.187; Carey BJ, 2000, STROKE, V31, P2895, DOI 10.1161/01.STR.31.12.2895; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Fluck D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00049; Galvin SD, 2010, ANAESTH INTENS CARE, V38, P710, DOI 10.1177/0310057X1003800415; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Groschel K, 2007, EUR J NEUROL, V14, P125, DOI 10.1111/j.1468-1331.2006.01563.x; Lipsitz LA, 2000, STROKE, V31, P1897, DOI 10.1161/01.STR.31.8.1897; Madureira J, 2017, J STROKE CEREBROVASC, V26, P500, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.003; Nagata K, 2016, AGEING RES REV, V30, P49, DOI 10.1016/j.arr.2016.06.001; Oudegeest-Sander MH, 2014, EXP PHYSIOL, V99, P586, DOI 10.1113/expphysiol.2013.076455; Rosengarten B, 2003, J NEUROIMAGING, V13, P43, DOI 10.1177/1051228402239716; Schwertfeger N, 2006, J NEUROL SCI, V249, P135, DOI 10.1016/j.jns.2006.06.009; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Toth P, 2017, AM J PHYSIOL-HEART C, V312, pH1, DOI 10.1152/ajpheart.00581.2016; Uzuner N, 2017, ULTRASONOGRAPHICAL A, P2; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Yam AT, 2005, J CLIN NEUROSCI, V12, P643, DOI 10.1016/j.jocn.2004.08.017; Yang T, 2017, AGEING RES REV, V34, P15, DOI 10.1016/j.arr.2016.09.007; Zhu YS, 2013, J CEREBR BLOOD F MET, V33, P1190, DOI 10.1038/jcbfm.2013.66	25	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0217082	10.1371/journal.pone.0217082	http://dx.doi.org/10.1371/journal.pone.0217082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095646	Green Published, gold, Green Submitted			2022-12-27	WOS:000468030100074
J	Karmakar, M; Rodrigues, CHM; Holt, KE; Dunstan, SJ; Denholm, J; Ascher, DB				Karmakar, Malancha; Rodrigues, Carlos H. M.; Holt, Kathryn E.; Dunstan, Sarah J.; Denholm, Justin; Ascher, David B.			Empirical ways to identify novel Bedaquiline resistance mutations in AtpE	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PROTEIN STABILITY; IN-VITRO; ACQUIRED-RESISTANCE; GENETIC-DISEASE; DIARYLQUINOLINE; SYNTHASE; SERVER; MECHANISMS; DELAMANID	Clinical resistance against Bedaquiline, the first new anti-tuberculosis compound with a novel mechanism of action in over 40 years, has already been detected in Mycobacterium tuberculosis. As a new drug, however, there is currently insufficient clinical data to facilitate reliable and timely identification of genomic determinants of resistance. Here we investigate the structural basis for M. tuberculosis associated bedaquiline resistance in the drug target, AtpE. Together with the 9 previously identified resistance-associated variants in AtpE, 54 non-resistance-associated mutations were identified through comparisons of bedaquiline susceptibility across 23 different mycobacterial species. Computational analysis of the structural and functional consequences of these variants revealed that resistance associated variants were mainly localized at the drug binding site, disrupting key interactions with bedaquiline leading to reduced binding affinity. This was used to train a supervised predictive algorithm, which accurately identified likely resistance mutations (93.3% accuracy). Application of this model to circulating variants present in the Asia-Pacific region suggests that current circulating variants are likely to be susceptible to bedaquiline. We have made this model freely available through a user-friendly web interface called SUSPECT-BDQ, StrUctural Susceptibility PrEdiCTion for bedaquiline (http://biosig.unimelb.edu.au/suspect_bdq/). This tool could be useful for the rapid characterization of novel clinical variants, to help guide the effective use of bedaquiline, and to minimize the spread of clinical resistance.	[Karmakar, Malancha; Denholm, Justin] Melbourne Hlth, Victorian TB Program, Melbourne, Vic, Australia; [Karmakar, Malancha; Rodrigues, Carlos H. M.; Holt, Kathryn E.; Ascher, David B.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Karmakar, Malancha; Denholm, Justin] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Karmakar, Malancha; Rodrigues, Carlos H. M.; Ascher, David B.] Baker Heart & Diabet Inst, Struct Biol & Bioinformat, Melbourne, Vic, Australia; [Dunstan, Sarah J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Ascher, David B.] Univ Cambridge, Dept Biochem, Cambridge, England	University of Melbourne; University of Melbourne; University of Melbourne; University of Cambridge	Ascher, DB (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.; Ascher, DB (corresponding author), Baker Heart & Diabet Inst, Struct Biol & Bioinformat, Melbourne, Vic, Australia.; Ascher, DB (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	david.ascher@unimelb.edu.au	Dunstan, Sarah/AAO-9597-2020; Miranda Rodrigues, Carlos Henrique/GRS-2397-2022; Holt, Kathryn E/A-8108-2012; Denholm, Justin/AAD-6010-2019	Miranda Rodrigues, Carlos Henrique/0000-0002-4420-6401; Holt, Kathryn E/0000-0003-3949-2471; Denholm, Justin/0000-0002-9214-6431; Ascher, David/0000-0003-2948-2413; Karmakar, Malancha/0000-0003-0303-2895; Dunstan, Sarah/0000-0001-7873-933X	Melbourne Research Scholarship; Newton Fund RCUK-CONFAP Grant - The Medical Research Council (MRC); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [MR/M026302/1]; Jack Brockhoff Foundation [JBF 4186]; C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia [APP1072476]; NHMRC Australia [APP1056689]; Victorian Government's OIS Program; MRC [MR/M026302/1] Funding Source: UKRI	Melbourne Research Scholarship; Newton Fund RCUK-CONFAP Grant - The Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Jack Brockhoff Foundation; C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.K was funded by the Melbourne Research Scholarship. D.B.A was funded by a Newton Fund RCUK-CONFAP Grant awarded by The Medical Research Council (MRC) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (MR/M026302/1), the Jack Brockhoff Foundation (JBF 4186, 2016), and a C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (APP1072476). The Vietnam genomic dataset was funded by a NHMRC Australia grant (APP1056689) to SJD and KEH. This work was supported in part by the Victorian Government's OIS Program. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Ayala DA, 2017, J MED MICROBIOL, V66, P1140, DOI 10.1099/jmm.0.000537; Albanaz ATS, 2017, EXPERT OPIN DRUG DIS, V12, P553, DOI 10.1080/17460441.2017.1322579; Almeida D, 2016, ANTIMICROB AGENTS CH, V60, P4590, DOI 10.1128/AAC.00753-16; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Chahine EB, 2014, ANN PHARMACOTHER, V48, P107, DOI 10.1177/1060028013504087; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Denholm JT, 2018, AM J RESP CRIT CARE, V198, P541, DOI 10.1164/rccm.201712-2572LE; Field SK, 2015, THER ADV CHRONIC DIS, V6, P170, DOI 10.1177/2040622315582325; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hards K, 2015, J ANTIMICROB CHEMOTH, V70, P2028, DOI 10.1093/jac/dkv054; Hawkey J, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000165; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Hoffmann H, 2016, AM J RESP CRIT CARE, V194, P1171, DOI 10.1164/rccm.201605-1065LE; Hoffmann H, 2016, AM J RESP CRIT CARE, V193, P337, DOI 10.1164/rccm.201502-0372LE; Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Huitric E, 2007, ANTIMICROB AGENTS CH, V51, P4202, DOI 10.1128/AAC.00181-07; Ji BH, 2006, ANTIMICROB AGENTS CH, V50, P1921, DOI [10.1128/AAC.00052-06, 10.1128/AAC.50.4.1558-1560.2006]; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lu P, 2014, BBA-BIOENERGETICS, V1837, P1208, DOI 10.1016/j.bbabio.2014.01.022; Pandurangan AP, 2017, BIOCHEM SOC T, V45, P303, DOI 10.1042/BST20160422; Pang Y, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02627-16, 10.1128/aac.02627-16]; Park Y, 2017, ACS INFECT DIS, V3, P18, DOI 10.1021/acsinfecdis.6b00103; Petrella S, 2006, ANTIMICROB AGENTS CH, V50, P2853, DOI 10.1128/AAC.00244-06; Thai PVK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3033-9; Phelan J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0575-9; Pires DEV, 2016, SCI REP-UK, V6, DOI 10.1038/srep29575; Pires DEV, 2016, NUCLEIC ACIDS RES, V44, pW557, DOI 10.1093/nar/gkw390; Pires DEV, 2016, SCI REP-UK, V6, DOI 10.1038/srep19848; Pires DEV, 2015, NUCLEIC ACIDS RES, V43, pD387, DOI 10.1093/nar/gku966; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Portelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33370-6; Preiss L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500106; Provost F., 2000, P AAAI 2000 WORKSH I; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Salfinger M, 2015, EUR RESPIR J, V45, P317, DOI 10.1183/09031936.00199814; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Segala E, 2012, ANTIMICROB AGENTS CH, V56, P2326, DOI 10.1128/AAC.06154-11; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh V, 2017, ACS INFECT DIS, V3, P5, DOI 10.1021/acsinfecdis.6b00102; Nguyen TVA, 2018, CLIN INFECT DIS, V66, P1625, DOI 10.1093/cid/cix992; Trapero A, 2018, J MED CHEM, V61, P2806, DOI 10.1021/acs.jmedchem.7b01622; Vedithi SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23423-1; Wager S, 2014, J MACH LEARN RES, V15, P1625; WHO, 2018, WHOCDSTB201825; World Health Organization, 2013, USE BEDAQUILINE TREA; World Health Organization, 2018, RAP COMM KEY CHANG T; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zimenkov DV, 2017, J ANTIMICROB CHEMOTH, V72, P1901, DOI 10.1093/jac/dkx094	55	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217169	10.1371/journal.pone.0217169	http://dx.doi.org/10.1371/journal.pone.0217169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141524	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000469323000043
J	Evdoshenko, E; Stepanova, A; Shumilina, M; Davydovskaya, M; Khachanova, N; Neofidov, N; Kalinin, I; Popova, E; Dubchenko, E; Pozhidaeva, N; Volkov, A; Sivertseva, S; Prilenskaya, A; Malkova, N; Korobko, D; Vergunova, I; Shchur, S; Makshakov, G				Evdoshenko, Evgeniy; Stepanova, Alexandra; Shumilina, Maria; Davydovskaya, Maria; Khachanova, Natalia; Neofidov, Nikolay; Kalinin, Ivan; Popova, Ekaterina; Dubchenko, Ekaterina; Pozhidaeva, Natalia; Volkov, Andrey; Sivertseva, Stella; Prilenskaya, Anna; Malkova, Nadezhda; Korobko, Denis; Vergunova, Ilona; Shchur, Sergey; Makshakov, Gleb			Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia	PLOS ONE			English	Article							SAFETY	Background NTZ is approved in Russia for the treatment of highly active relapsing remitting multiple sclerosis and is reimbursed via federal budget program. However, no data about NTZ treatment in Russia and the effect of federal reimbursement have been performed so far. Objective To characterize the population of patients receiving natalizumab and assess the efficacy and risk-management plan (RMP) implementation of NTZ therapy in routine clinical practice in Russia. Methods We analyzed data for 334 patients, who received at least one infusion of NTZ. Relapse rate, MRI activity, NEDA-3 status after 2 years were assessed. Anti-JC virus antibodies status and RMP implementation were evaluated. Drop-out rate and reasons for therapy discontinuation were analyzed. Results Patients switched to natalizumab in Russia are mainly female (63%), with median EDSS score of 3.5 and high disease activity: 93% had at least 1 relapse and 58% had both T1Gd+and new T2 lesion a year before therapy initiation. Introduction of federal reimbursement allowed patients with less relapses to start therapy with natalizumab. The only predictor of 6-month progression was EDSS score at the baseline of therapy (HR = 2.1375, 95% CI 1.0026- 4.5570, p = 0.0492). 82% patients reached NEDA-3 at 24 month of therapy. 25% of patients discontinued NTZ for reasons: tolerability (14.5%), JCV antibody status (61%), and patient's decision (17%). RMP was implemented in only 36% patients. Conclusion Natalizumab appeared to have high efficacy in Russian clinical practice. Federal reimbursement allowed less active patients to start natalizumab. More efforts should be done to improve RMP implementation.	[Evdoshenko, Evgeniy; Stepanova, Alexandra; Shumilina, Maria; Neofidov, Nikolay; Kalinin, Ivan; Makshakov, Gleb] SBIH City Clin Hosp 31, SPb Ctr Multiple Sclerosis & AID, St Petersburg, Russia; [Davydovskaya, Maria] Moscow Dept Healthcare, Clin Trials & Healthcare Technol Assessment Sci R, State Budgetary Inst Moscow City, Moscow, Russia; [Davydovskaya, Maria; Khachanova, Natalia] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Popova, Ekaterina] City Clin Hosp 24, Moscow, Russia; [Dubchenko, Ekaterina; Pozhidaeva, Natalia] City Clin Hosp 81, Moscow, Russia; [Volkov, Andrey] City Clin Hosp 71, Moscow, Russia; [Sivertseva, Stella; Prilenskaya, Anna] Tyumen Multiple Sclerosis Ctr, Med Sanit Unit Neftyanik, Tyumen, Russia; [Malkova, Nadezhda; Korobko, Denis; Vergunova, Ilona] State Novosibirsk Reg Clin Hosp, Ctr MS & Other AID Nervous Syst, Novosibirsk, Russia; [Malkova, Nadezhda] State Novosibirsk Med Univ, Novosibirsk, Russia; [Shchur, Sergey] City Clin Hosp 15, Moscow, Russia	Pirogov Russian National Research Medical University	Evdoshenko, E (corresponding author), SBIH City Clin Hosp 31, SPb Ctr Multiple Sclerosis & AID, St Petersburg, Russia.	e.evdoshenko@centrems.com	Korobko, Denis/ABA-7214-2021	Korobko, Denis/0000-0002-7938-3782; Neofidov, Nikolay/0000-0001-9043-9823; Kalinin, Ivan/0000-0001-8297-1529; Vergunova, Ilona/0000-0003-1769-6879				Boyko A N, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P25, DOI 10.17116/jnevro20151158225-35; Butzkueven H, 2014, J NEUROL NEUROSUR PS, V85, P1190, DOI 10.1136/jnnp-2013-306936; Davydovskaia M V, 2011, Zh Nevrol Psikhiatr Im S S Korsakova, V111, P105; Davydovskaya M V, 2016, Zh Nevrol Psikhiatr Im S S Korsakova, V116, P79, DOI 10.17116/jnevro201611610279-97; Evdoshenko E., 2016, PHARMACOECONOMICS TH, V4, P48; Kappos L, 2018, MULT SCLER J, V24, P963, DOI 10.1177/1352458517709619; O'Connor P, 2014, NEUROLOGY, V83, P78, DOI 10.1212/WNL.0000000000000541; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rudick RA, 2007, ANN NEUROL, V62, P335, DOI 10.1002/ana.21163; Schwab N, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000195; Traboulsee A, 2016, AM J NEURORADIOL, V37, P394, DOI 10.3174/ajnr.A4539; van Pesch V, 2014, ACTA NEUROL BELG, V114, P167, DOI 10.1007/s13760-014-0308-9	12	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217303	10.1371/journal.pone.0217303	http://dx.doi.org/10.1371/journal.pone.0217303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136608	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300025
J	Miller, EJ; Temple-Smith, MJ; Bilardi, JE				Miller, Ellena J.; Temple-Smith, Meredith J.; Bilardi, Jade E.			'There was just no-one there to acknowledge that it happened to me as well': A qualitative study of male partner's experience of miscarriage	PLOS ONE			English	Article							PREGNANCY LOSS; HEALTH-CARE; WOMEN; GRIEF; SUPPORT; ANXIETY	Miscarriage occurs in up to one in four pregnancies and can be a devastating event affecting both men and women. Unfortunately, the male partner's experience of miscarriage is seldom researched, particularly within Australia. This qualitative study involved semi-structured telephone interviews with 10 Australian men, whose partners miscarried between three months and ten years ago. Participants were recruited through professional networks and support organisations. Interviews explored men's general miscarriage experience and the support received or lacking from both healthcare providers and social networks. Online health seeking behaviour and opinions on online support were also discussed. Data was transcribed verbatim and analysed thematically. Most men described feeling significant grief following miscarriage and felt that there was little acknowledgment of their loss, both from healthcare providers and within their social networks. Feelings of sadness, devastation, powerlessness, fear, shock and a loss of identity were common. All men felt their primary role at the time of miscarriage was to support their partner. Most men did not want to burden their partner with their emotions or grief, and struggled to find people within their social networks to talk to about their loss, leading to feelings of isolation. Overall participants felt there was inadequate support offered to men affected by miscarriage. Men wanted information, informed professionals to talk to and male-orientated support networks. A website was one mechanism suggested by men which could adequately contribute to information and support needs during this time. Men are often greatly affected by miscarriage and yet there is all too often little acknowledgement or support available to them at this time. Men affected by miscarriage want and need further support, including reputable, Australian based information and resources tailored their needs.	[Miller, Ellena J.; Temple-Smith, Meredith J.; Bilardi, Jade E.] Univ Melbourne, Dept Gen Practice, Carlton, Vic, Australia; [Temple-Smith, Meredith J.; Bilardi, Jade E.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Bilardi, Jade E.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	University of Melbourne; Monash University	Bilardi, JE (corresponding author), Univ Melbourne, Dept Gen Practice, Carlton, Vic, Australia.; Bilardi, JE (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia.; Bilardi, JE (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.	jade.bilardi@monash.edu	Zweigenthal, Virginia/AAW-6425-2021	Zweigenthal, Virginia/0000-0003-3914-2156; Bilardi, Jade/0000-0003-0461-2605	National Health and Medical Research Council [1035135]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JEB is in receipt of a National Health and Medical Research Council Early Career Fellowship Number 1035135 (www.nhmrc.gov.au).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JEB received a partial salary from the funding body to support her postdoctoral studies.	Abboud L, 2005, J REPROD INFANT PSYC, V23, P3, DOI 10.1080/02646830512331330974; Abboud LN, 2003, SOC WORK HEALTH CARE, V36, P37, DOI 10.1300/J010v36n03_03; Armstrong D, 2001, MCN Am J Matern Child Nurs, V26, P147, DOI 10.1097/00005721-200105000-00012; Bellhouse C, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0672-3; Bellhouse C, 2019, WOMEN BIRTH, V32, P137, DOI 10.1016/j.wombi.2018.06.006; Brier N, 2004, BIRTH-ISS PERINAT C, V31, P138, DOI 10.1111/j.0730-7659.2004.00292.x; Brier N, 2008, J WOMENS HEALTH, V17, P451, DOI 10.1089/jwh.2007.0505; Conway K, 2000, BRIT J MED PSYCHOL, V73, P531, DOI 10.1348/000711200160714; CONWAY K, 1995, BRIT J MED PSYCHOL, V68, P259, DOI 10.1111/j.2044-8341.1995.tb01833.x; Cumming GP, 2007, BJOG-INT J OBSTET GY, V114, P1138, DOI 10.1111/j.1471-0528.2007.01452.x; Due C, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1560-9; Farren J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011864; Garfield CF, 2008, AM J LIFESTYLE MED, V2, P474, DOI 10.1177/1559827608323213; Johnson MP, 1996, BRIT J MED PSYCHOL, V69, P313, DOI 10.1111/j.2044-8341.1996.tb01875.x; Khan R A, 2004, Ir Med J, V97, P217; Lok IH, 2007, BEST PRACT RES CL OB, V21, P229, DOI 10.1016/j.bpobgyn.2006.11.007; McCreight BS, 2004, SOCIOL HEALTH ILL, V26, P326, DOI 10.1111/j.1467-9566.2004.00393.x; McLean A, 2013, QUAL SOC WORK, V12, P782, DOI 10.1177/1473325012464099; Meaney S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011382; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; NEUGEBAUER R, 1992, AM J PUBLIC HEALTH, V82, P1332, DOI 10.2105/AJPH.82.10.1332; Obst KL, 2019, MIDWIFERY, V70, P1, DOI 10.1016/j.midw.2018.11.013; Rinehart MS, 2010, PSYCHOTHERAPY, V47, P288, DOI 10.1037/a0021160; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Saunders M, 2009, HEALTH PROMOT J AUST, V20, P92, DOI 10.1071/HE09092; Simmons RK, 2006, SOC SCI MED, V63, P1934, DOI 10.1016/j.socscimed.2006.04.024; Stratton K, 2008, AUST NZ J OBSTET GYN, V48, P5, DOI 10.1111/j.1479-828X.2007.00806.x; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Toedter LJ, 2001, DEATH STUD, V25, P205, DOI 10.1080/074811801750073251; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; WELLS RG, 1991, POSTGRAD MED, V89, P207; Wong MKY, 2003, BRIT J GEN PRACT, V53, P697; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	33	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217395	10.1371/journal.pone.0217395	http://dx.doi.org/10.1371/journal.pone.0217395			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136597	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300035
J	Grauman, A; Hansson, MG; Puranen, A; James, S; Veldwijk, J				Grauman, Asa; Hansson, Mats G.; Puranen, Arvid; James, Stefan; Veldwijk, Jorien			Short-term mental distress in research participants after receiving cardiovascular risk information	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; HEART-DISEASE	Background Understanding of how cardiovascular risk information influence individuals is critical for the practice of risk assessment and the management of patients with cardiovascular disease. Objectives The objective of this study was to investigate change in mental distress among research participants after undergoing a cardiovascular risk assessment and receiving individual test results. Methods In 2017, a questionnaire measuring mental distress after taking part in a risk assessment was distributed among 615 participants in the Swedish Cardiopulmonary Bio Image Study in Uppsala, Sweden, aged 50-64 years. Outcome measures were re-assessed after three months (30% were lost to follow-up). Results There were no differences in outcomes after three months for participants with normal test results or for participants who were referred to primary health care. Mental distress increased in participants who were referred to the hospital, and were further explained by the fact that these participants were diagnosed with coronary artery stenosis. Conclusions CV risk information can be provided to individuals with lower levels of risk without concerns of inducing mental distress. However, in order to prevent unnecessary worry in contexts similar to this study, one should be prepared for different risk outcomes and plan for support for individuals with higher risk. The increased utility of powerful, yet not fully mature, imaging techniques requires careful considerations extending beyond medical risks and benefits; the clinician must also take into account the risk of mental distress and secure support when necessary.	[Grauman, Asa; Hansson, Mats G.] Uppsala Univ, Ctr Res Eth & Bioeth, Uppsala, Sweden; [Puranen, Arvid] Sunderby Hosp, Lulea, Region Norrbott, Sweden; [James, Stefan] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Veldwijk, Jorien] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Veldwijk, Jorien] Erasmus Univ, Erasmus Choice Modelling Ctr, Rotterdam, Netherlands	Uppsala University; Sunderby Hospital; Uppsala University; Erasmus University Rotterdam; Erasmus University Rotterdam	Grauman, A (corresponding author), Uppsala Univ, Ctr Res Eth & Bioeth, Uppsala, Sweden.	asa.grauman@crb.uu.se	James, Stefan K/J-4554-2014	Veldwijk, Jorien/0000-0003-4822-5068; Grauman, Asa/0000-0002-7293-3411	Swedish Heart and Lung Association [20150049]	Swedish Heart and Lung Association(Swedish Heart-Lung Foundation)	Financially support for this study was provided entirely by a grant from The Swedish Heart and Lung Association grant number: 20150049 (https://www.hjart-lungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/) to MH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron J, 2000, RISK ANAL, V20, P413, DOI 10.1111/0272-4332.204041; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; CHRISTENSEN B, 1995, SCAND J PRIM HEALTH, V13, P164, DOI 10.3109/02813439508996756; Collins RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-603; Das Sajal, 2006, Curr Atheroscler Rep, V8, P111, DOI 10.1007/s11883-006-0048-2; Eich E., 2000, COGNITION EMOTION, DOI [10.1080/026999300378996, DOI 10.1080/026999300378996]; Grauman A, 2019, PATIENT EDUC COUNS, V102, P1528, DOI 10.1016/j.pec.2019.03.010; Hagglund M, 2017, STUD HEALTH TECHNOL, V245, P723, DOI 10.3233/978-1-61499-830-3-723; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Jorgensen T, 2009, PREV MED, V48, P242, DOI 10.1016/j.ypmed.2008.12.010; KASH KM, 1992, J NATL CANCER I, V84, P24, DOI 10.1093/jnci/84.1.24; Lokkegaard T, 2015, SCAND J PUBLIC HEALT, V43, P102, DOI 10.1177/1403494814557886; Martensson L, 2017, SKKHL SKALA KOMMUNIK; McNaughton CD, 2015, MED DECIS MAKING, V35, P932, DOI 10.1177/0272989X15581800; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Nielsen AD, 2012, J THORAC IMAG, V27, P202, DOI 10.1097/RTI.0b013e31824752bd; Nielsen KDB, 2005, SCAND J PRIM HEALTH, V23, P233, DOI 10.1080/02813430500336245; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Peters E, 2006, HEALTH PSYCHOL, V25, P144, DOI 10.1037/0278-6133.25.2.144; Piepoli MF, 2016, EUR J PREV CARDIOL, V23, pNP1, DOI 10.1177/2047487316653709; Powers BJ, 2011, AM HEART J, V161, P673, DOI 10.1016/j.ahj.2010.12.021; Sheridan SL, 2010, ARCH INTERN MED, V170, P230, DOI 10.1001/archinternmed.2009.516; Smith AW, 2008, PSYCHO-ONCOL, V17, P767, DOI 10.1002/pon.1291; Tominaga T, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0272-3; Wangdahl JM, 2014, SCAND J PUBLIC HEALT, V42, P25, DOI 10.1177/1403494813500592; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217247	10.1371/journal.pone.0217247	http://dx.doi.org/10.1371/journal.pone.0217247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125371	gold, Green Published, Green Submitted			2022-12-27	WOS:000468865700025
J	Henning, J; Hesterberg, UW; Zenal, F; Schoonman, L; Brum, E; McGrane, J				Henning, Joerg; Hesterberg, Uta Walburga; Zenal, Farida; Schoonman, Luuk; Brum, Eric; McGrane, James			Risk factors for H5 avian influenza virus prevalence on urban live bird markets in Jakarta, Indonesia-Evaluation of long-term environmental surveillance data	PLOS ONE			English	Article							A H7N9; DYNAMICS; CHINA	In the re-emergence of Highly Pathogenic Avian Influenza (HPAI), live bird markets have been identified to play a critical role. In this repeated cross-sectional study, we combined surveillance data collected monthly on Jakarta's live bird markets over a five-year period, with risk factors related to the structure and management of live bird markets, the trading and slaughtering of birds at these markets, and environmental and demographic conditions in the areas where the markets were located. Over the study period 36.7% (95% CI: 35.1, 38.3) of samples (N = 1315) tested HPAI H5 virus positive. Using General Estimation Equation approaches to account for repeated observations over time, we explored the association between HPAI H5 virus prevalence and potential risk factors. Markets where only live birds and carcasses were sold, but no slaughtering was conducted at or at the vicinity of the markets, had a significantly reduced chance of being positive for H5 virus (OR = 0.2, 95% CI 0.1-0.5). Also, markets, that used display tables for poultry carcasses made from wood, had reduced odds of being H5 virus positive (OR = 0.7, 95% CI 0.5-1.0), while having at least one duck sample included in the pool of samples collected at the market increased the chance of being H5 virus positive (OR = 5.7, 95% CI 3.6-9.2). Markets where parent stock was traded, were more at risk of being H5 virus positive compared to markets where broilers were traded. Finally, the human population density in the district, the average distance between markets and origins of poultry sold at markets and the total rainfall per month were all positively associated with higher H5 virus prevalence. In summary, our results highlight that a combination of factors related to trading and marketing processes and environmental pressures need to be considered to reduce H5 virus infection risk for customers at urban live bird markets. In particular, the relocation of slaughter areas to well-managed separate locations should be considered.	[Henning, Joerg] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Hesterberg, Uta Walburga; Zenal, Farida; Schoonman, Luuk; Brum, Eric; McGrane, James] Food & Agr Org United Nat FAO, ECTAD, Jakarta, Java, Indonesia; [Hesterberg, Uta Walburga; Brum, Eric] Food & Agr Org United Nat FAO, ECTAD, Dhaka, Bangladesh	University of Queensland; Food & Agriculture Organization of the United Nations (FAO); Food & Agriculture Organization of the United Nations (FAO)	Henning, J (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	j.henning@uq.edu.au	hesterberg, uta/GQI-4278-2022; Schoonman, Luuk/AAD-2467-2019; Henning, Joerg/G-8662-2017	Brum, Eric/0000-0002-0244-7178; Henning, Joerg/0000-0002-0282-1318; Schoonman, Luuk/0000-0002-2651-1947	Emerging Pandemic Threats (EPT) programme by the United States Agency for International Development (USAID)	Emerging Pandemic Threats (EPT) programme by the United States Agency for International Development (USAID)	The research was funded under the Emerging Pandemic Threats (EPT) programme by the United States Agency for International Development (USAID). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviat F, 2016, COMPR REV FOOD SCI F, V15, P491, DOI 10.1111/1541-4337.12199; Biswas PK, 2017, TRANSBOUND EMERG DIS, V64, P883, DOI 10.1111/tbed.12454; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Ding H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0698-6; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; Henning J, 2010, EMERG INFECT DIS, V16, P1244, DOI 10.3201/eid1608.091540; Horm VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034160; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Leo L, 2011, PREV VET MED, V102, P50, DOI 10.1016/j.prevetmed.2011.06.006; Li LL, 2013, STAT METHODS MED RES, V22, P14, DOI 10.1177/0962280211403597; Liu TQ, 2014, FRONT MATH CHINA, V9, P329, DOI 10.1007/s11464-014-0359-5; Mariani C, 2011, FOOD CONTROL, V22, P1357, DOI 10.1016/j.foodcont.2011.02.012; Nathan Associates Inc, 2013, IND POULTR VAL CHAIN; Onder O H, 2010, COMP WORKING CORRELA; Pepin KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056157; Pinsent A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0715; Trock SC, 2008, AVIAN DIS, V52, P160, DOI 10.1637/7980-040607-Reg; Turner JCM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.142; Wahyono ND, 2018, J PHYS CONF SER, V953, DOI 10.1088/1742-6596/953/1/012125; Waziri Ndadilnasiya Endie, 2014, Pan Afr Med J, V18 Suppl 1, P11, DOI 10.11694/pamj.supp.2014.18.1.4188; Wibawa H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-425; Xu YF, 2015, INFECT GENET EVOL, V30, P159, DOI 10.1016/j.meegid.2014.12.026; Yuan J, 2015, EMERG INFECT DIS, V21, P1784, DOI 10.3201/eid2110.150623; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014; Zhou L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw182; Zhou XY, 2015, J INFECTION, V71, P470, DOI 10.1016/j.jinf.2015.06.012	29	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216984	10.1371/journal.pone.0216984	http://dx.doi.org/10.1371/journal.pone.0216984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125350	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700011
J	Adiguzel, D; Sahin, P; Kuscu, N; Ozkavukcu, S; Bektas, NI; Celik-Ozenci, C				Adiguzel, Dileyra; Sahin, Pinar; Kuscu, Nilay; Ozkavukcu, Sinan; Bektas, Nayce Ilayda; Celik-Ozenci, Ciler			Spatiotemporal expression and regulation of FoxO1 in mouse uterus during peri-implantation period	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MOLECULAR DETERMINANTS; TRANSCRIPTION FACTORS; GROWTH-FACTOR; CELL-DEATH; IMPLANTATION; RECEPTOR; PROGESTERONE; MECHANISMS; ESTROGEN	Recent studies indicate that FoxO1 has roles in female reproductive system, especially in maternal endometrium. Although various cellular aspects and molecular pathways have been identified, the exact molecular characteristics of embryo implantation are still not completely understood. In this study, we aimed to investigate uterine expression and regulation of FoxO1 during peri-implantation period in mice. Experimental mouse models including, normal pregnancy, pseudopregnancy, artificial decidualization, and delayed implantation and activation were performed. Our results showed that FoxO1 expression was spatiotemporal in mouse endometrial tissue throughout peri-implantation period and its expression was significantly upregulated in luminal and glandular epithelium at the time of implantation. Moreover, on day 5 morning ( 09: 00 AM) of pregnancy, expression of FoxO1 was cytoplasmic in endometrial luminal epithelial cells where embryo homing takes place. With progressing time on day 5 evening ( 19: 00 PM) of pregnancy FoxO1 expression was nuclear in luminal epithelium at implantation site. Pseudopregnancy and artificial decidualization models indicated that FoxO1 expression was regulated by pregnancy hormones. Delayed implantation and activation model indicated that FoxO1 expression at the time of implantation is dependent upon activation status of blastocyst due to E2 induction and uterine sensitivity to implantation. In conclusion, our findings highlight a perspective for FoxO1 expression and regulation in mouse uterus during peri-implantation period indicating that its expression is regulated by implanting embryo and pregnancy hormones.	[Adiguzel, Dileyra; Sahin, Pinar; Kuscu, Nilay; Bektas, Nayce Ilayda; Celik-Ozenci, Ciler] Akdeniz Univ, Sch Med, Dept Histol & Embryol, Antalya, Turkey; [Ozkavukcu, Sinan] Ankara Univ, Sch Med, Dept Obstet & Gynecol, Ctr Assisted Reprod, Ankara, Turkey	Akdeniz University; Ankara University	Celik-Ozenci, C (corresponding author), Akdeniz Univ, Sch Med, Dept Histol & Embryol, Antalya, Turkey.	cilerozenci@akdeniz.edu.tr	Celik-Ozenci, Ciler/ABV-6194-2022; Ozkavukcu, Sinan/A-8802-2019	Ozkavukcu, Sinan/0000-0003-4525-9027	Scientific and Technological Research Council of Turkey (TUBITAK) [SBAG-215S868]; Akdeniz University Scientific Research Projects Unit [TYL-2015-994]; In-Training Travel Grant	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Akdeniz University Scientific Research Projects Unit(Akdeniz University); In-Training Travel Grant	This project has been supported by Scientific and Technological Research Council of Turkey (TUBITAK) with grant number SBAG-215S868 and by Akdeniz University Scientific Research Projects Unit with grant number TYL-2015-994 to CC-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has been supported by Scientific and Technological Research Council of Turkey (TUBITAK) with grant number SBAG-215S868 and by Akdeniz University Scientific Research Projects Unit with grant number TYL-2015-994 and represents Dileyra Adiguzel's MSc thesis. Our study has been presented as an oral presentation at ASRM 2017 Scientific Congress and Expo in San Antonio, TEXAS and has been awarded by In-Training Travel Grant.	Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; CHAKRABORTY I, 1995, J ENDOCRINOL, V147, P339, DOI 10.1677/joe.0.1470339; Croy A, 2014, GUIDE INVESTIGATION, P348; Daftary GS, 2001, CURR OPIN OBSTET GYN, V13, P269, DOI 10.1097/00001703-200106000-00004; DAS SK, 1994, DEVELOPMENT, V120, P1071; Deb K, 2006, METH MOLEC MED, V121, P9; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grinius L, 2006, J ENDOCRINOL, V189, P179, DOI 10.1677/joe.1.06451; Guo B, 2014, CELL CYCLE, V13, P2626, DOI 10.4161/15384101.2014.943581; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Hirabayashi H, 1999, ANAT RECORD, V254, P205, DOI 10.1002/(SICI)1097-0185(19990201)254:2<205::AID-AR6>3.0.CO;2-K; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Kuscu N, 2015, GENE EXPR PATTERNS, V18, P16, DOI 10.1016/j.gep.2015.04.003; Kyo S, 2011, CLIN CANCER RES, V17, P525, DOI 10.1158/1078-0432.CCR-10-1287; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Li YJ, 2015, CELL REP, V11, P358, DOI 10.1016/j.celrep.2015.03.035; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nakamura M, 2013, CANCER LETT, V336, P68, DOI 10.1016/j.canlet.2013.04.010; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Psychoyos A., 1973, HDB PHYSL, P187; Shaklai S, 2018, HORM METAB RES, V50, P485, DOI 10.1055/a-0603-3969; Tu ZW, 2014, INT J DEV BIOL, V58, P147, DOI 10.1387/ijdb.130345wh; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xie Q, 2012, ACTA BIOCH BIOPH SIN, V44, P897, DOI 10.1093/abbs/gms067; Xie YP, 2016, INT J CLIN EXP MED, V9, P1322; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	47	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216814	10.1371/journal.pone.0216814	http://dx.doi.org/10.1371/journal.pone.0216814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120913	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700029
J	Fergusson, DA; Avey, MT; Barron, CC; Bocock, M; Biefer, KE; Boet, S; Bourque, SL; Conic, I; Chen, K; Dong, YY; Fox, GM; George, RB; Goldenberg, NM; Gragasin, FS; Harsha, P; Hong, PJ; James, TE; Larrigan, SM; MacNeil, JL; Manuel, CA; Maximos, S; Mazer, D; Mittal, R; McGinn, R; Nguyen, LH; Patel, A; Richebe, P; Saha, TK; Steinberg, BE; Sampson, SD; Stewart, DJ; Syed, S; Vella, K; Wesch, NL; Lalu, MM; Bautista, M; Boyle, D; Bryson, G; Butler, H; Denault, A; Deschamps, A; Grocott, HP; Hall, R; Karkouti, K; Kent, BA; McDonald, H; de Medicis, E; Paul, J; Ralley, F; Sampson, SD; Tran, DTT				Fergusson, Dean A.; Avey, Marc T.; Barron, Carly C.; Bocock, Mathew; Biefer, Kristen E.; Boet, Sylvain; Bourque, Stephane L.; Conic, Isidora; Chen, Kai; Dong, Yuan Yi.; Fox, Grace M.; George, Ronald B.; Goldenberg, Neil M.; Gragasin, Ferrante S.; Harsha, Prathiba; Hong, Patrick J.; James, Tyler E.; Larrigan, Sarah M.; MacNeil, Jenna L.; Manuel, Courtney A.; Maximos, Sarah; Mazer, David; Mittal, Rohan; McGinn, Ryan; Nguyen, Long H.; Patel, Abhilasha; Richebe, Philippe; Saha, Tarit K.; Steinberg, Benjamin E.; Sampson, Sonja D.; Stewart, Duncan J.; Syed, Summer; Vella, Kimberly; Wesch, Neil L.; Lalu, Manoj M.; Bautista, Michael; Boyle, David; Bryson, Gregory; Butler, Heather; Denault, Andre; Deschamps, Alain; Grocott, Hilary P.; Hall, Richard; Karkouti, Keyvan; Kent, Blaine A.; McDonald, Heather; de Medicis, Etienne; Paul, James; Ralley, Fiona; Sampson, Sonia D.; Tran, Diem T. T.		Canadian Perioperative Anesthesia	Reporting preclinical anesthesia study (REPEAT): Evaluating the quality of reporting in the preclinical anesthesiology literature	PLOS ONE			English	Article							DESIGN AFFECTS OUTCOMES; ANIMAL RESEARCH; PAIN; TRANSPARENCY; METAANALYSIS; STATEMENT; MEDICINE; THERAPY; STROKE; IMPACT	Poor reporting quality may contribute to irreproducibility of results and failed 'bench-to-bed-side' translation. Consequently, guidelines have been developed to improve the complete and transparent reporting of in vivo preclinical studies. To examine the impact of such guidelines on core methodological and analytical reporting items in the preclinical anesthesiology literature, we sampled a cohort of studies. Preclinical in vivo studies published in Anesthesiology, Anesthesia & Analgesia, Anaesthesia, and the British Journal of Anaesthesia (2008-2009, 2014-2016) were identified. Data was extracted independently and in duplicate. Reporting completeness was assessed using the National Institutes of Health Principles and Guidelines for Reporting Preclinical Research. Risk ratios were used for comparative analyses. Of 7615 screened articles, 604 met our inclusion criteria and included experiments reporting on 52 490 animals. The most common topic of investigation was pain and analgesia (30%), rodents were most frequently used (77%), and studies were most commonly conducted in the United States (36%). Use of preclinical reporting guidelines was listed in 10% of applicable articles. A minority of studies fully reported on replicates (0.3%), randomization (10%), blinding (12%), sample-size estimation (3%), and inclusion/exclusion criteria (5%). Statistics were well reported (81%). Comparative analysis demonstrated few differences in reporting rigor between journals, including those that endorsed reporting guidelines. Principal items of study design were infrequently reported, with few differences between journals. Methods to improve implementation and adherence to community-based reporting guidelines may be necessary to increase transparent and consistent reporting in the preclinical anesthesiology literature.	[Fergusson, Dean A.; Avey, Marc T.; Boet, Sylvain; Conic, Isidora; Fox, Grace M.; Larrigan, Sarah M.; MacNeil, Jenna L.; Wesch, Neil L.; Lalu, Manoj M.] Ottawa Hosp Res Inst, Blueprint Translat Res Grp, Clin Epidemiol Program, Ottawa, ON, Canada; [Fergusson, Dean A.; Avey, Marc T.; Bocock, Mathew; Dong, Yuan Yi.; Hong, Patrick J.; Larrigan, Sarah M.; McGinn, Ryan; Nguyen, Long H.; Patel, Abhilasha; Lalu, Manoj M.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Barron, Carly C.; Harsha, Prathiba; Syed, Summer] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Barron, Carly C.; James, Tyler E.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Biefer, Kristen E.; Bourque, Stephane L.; Gragasin, Ferrante S.; Mittal, Rohan] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Boet, Sylvain; Larrigan, Sarah M.; Lalu, Manoj M.] Ottawa Hosp, Dept Anesthesiol & Pain Med, Ottawa, ON, Canada; [Boet, Sylvain] Univ Ottawa, Dept Innovat Med Educ, Ottawa, ON, Canada; [Chen, Kai; Saha, Tarit K.] Queens Univ, Dept Anesthesiol & Perioperat Med, Kingston, ON, Canada; [George, Ronald B.; Vella, Kimberly] Dalhousie Univ, Dept Anesthesia Pain Management & Perioperat Med, Halifax, NS, Canada; [Goldenberg, Neil M.; Mazer, David; Steinberg, Benjamin E.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Manuel, Courtney A.; Sampson, Sonja D.] Mem Univ, Discipline Anesthesia, St John, NF, Canada; [Maximos, Sarah; Richebe, Philippe] Univ Montreal, Dept Anesthesiol, Montreal, PQ, Canada; [Stewart, Duncan J.; Lalu, Manoj M.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Stewart, Duncan J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McMaster University; McMaster University; University of Alberta; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Queens University - Canada; Dalhousie University; University of Toronto; Memorial University Newfoundland; Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Lalu, MM (corresponding author), Ottawa Hosp Res Inst, Blueprint Translat Res Grp, Clin Epidemiol Program, Ottawa, ON, Canada.; Lalu, MM (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.; Lalu, MM (corresponding author), Ottawa Hosp, Dept Anesthesiol & Pain Med, Ottawa, ON, Canada.; Lalu, MM (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	manojlalu@gmail.com	Syed, Summer/AAJ-4134-2020; George, Ronald B/S-9312-2019; boet, sylvain/C-3983-2011	George, Ronald B/0000-0002-1848-036X; Mazer, Cyril David/0000-0003-2566-4308; Fox, Grace/0000-0002-4039-4468; Avey, Marc/0000-0002-8696-3232; boet, sylvain/0000-0002-1679-818X				Andrews NA, 2016, PAIN, V157, P901, DOI 10.1097/j.pain.0000000000000458; Avey MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166733; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Clark JD, 2016, ANESTHESIOLOGY, V125, P846, DOI 10.1097/ALN.0000000000001340; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Cressey D, 2015, NATURE, V520, P271, DOI 10.1038/520271a; Davidson A, 2011, ANESTHESIOLOGY, V115, P909, DOI 10.1097/ALN.0b013e3182337a5e; Eisenach JC, 2016, ANESTHESIOLOGY, V124, P763, DOI 10.1097/ALN.0000000000001044; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hair K, 2018, BIORXIV, DOI [10.1101/370874, DOI 10.1101/370874]; Idris AH, 1996, CIRCULATION, V94, P2324, DOI 10.1161/01.CIR.94.9.2324; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Jarvis MF, 2016, TRENDS PHARMACOL SCI, V37, P290, DOI 10.1016/j.tips.2015.12.001; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kimmelman J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001863; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lalu M, 2015, REPORTING PRECLINICA; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lee MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177499; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macleod M, 2017, FINDINGS RETROSPECTI, DOI [10.1101/187245, DOI 10.1101/187245]; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Matthews RAJ, 2008, J ROY SOC MED, V101, P95, DOI 10.1258/jrsm.2007.070164; MILLER JN, 1989, STAT MED, V8, P455, DOI 10.1002/sim.4780080409; Minnerup J, 2010, J CEREBR BLOOD F MET, V30, P1619, DOI 10.1038/jcbfm.2010.74; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; NIH. National Institutes of Health, PRINC GUID REP PRECL; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Pussegoda K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0527-2; Ramirez FD, 2017, CIRC RES, V120, P1916, DOI 10.1161/CIRCRESAHA.117.310628; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sena ES, 2014, J CEREBR BLOOD F MET, V34, P737, DOI 10.1038/jcbfm.2014.28; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Yezierski RP, 2018, J PAIN, V19, P571, DOI 10.1016/j.jpain.2017.12.261	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0215221	10.1371/journal.pone.0215221	http://dx.doi.org/10.1371/journal.pone.0215221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120888	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700006
J	Nuthmann, A; de Groot, F; Huettig, F; Olivers, CNL				Nuthmann, Antje; de Groot, Floor; Huettig, Falk; Olivers, Christian N. L.			Extrafoveal attentional capture by object semantics	PLOS ONE			English	Article							VISUAL-SEARCH; EYE-MOVEMENTS; TARGET TEMPLATE; LANGUAGE; INFORMATION; FIXATION; PERCEPTION; KNOWLEDGE; GUIDANCE; SALIENCY	There is ongoing debate on whether object meaning can be processed outside foveal vision, making semantics available for attentional guidance. Much of the debate has centred on whether objects that do not fit within an overall scene draw attention, in complex displays that are often difficult to control. Here, we revisited the question by reanalysing data from three experiments that used displays consisting of standalone objects from a carefully controlled stimulus set. Observers searched for a target object, as per auditory instruction. On the critical trials, the displays contained no target but objects that were semantically related to the target, visually related, or unrelated. Analyses using ( generalized) linear mixed-effects models showed that, although visually related objects attracted most attention, semantically related objects were also fixated earlier in time than unrelated objects. Moreover, semantic matches affected the very first saccade in the display. The amplitudes of saccades that first entered semantically related objects were larger than 5 degrees on average, confirming that object semantics is available outside foveal vision. Finally, there was no semantic capture of attention for the same objects when observers did not actively look for the target, confirming that it was not stimulus-driven. We discuss the implications for existing models of visual cognition.	[Nuthmann, Antje] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Nuthmann, Antje] Univ Kiel, Inst Psychol, Kiel, Germany; [de Groot, Floor; Olivers, Christian N. L.] Vrije Univ, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [de Groot, Floor; Olivers, Christian N. L.] Vrije Univ, Inst Brain & Behav, Amsterdam, Netherlands; [Huettig, Falk] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Huettig, Falk] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands	University of Edinburgh; University of Kiel; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Max Planck Society; Radboud University Nijmegen	Olivers, CNL (corresponding author), Vrije Univ, Dept Expt & Appl Psychol, Amsterdam, Netherlands.; Olivers, CNL (corresponding author), Vrije Univ, Inst Brain & Behav, Amsterdam, Netherlands.	c.n.l.olivers@vu.nl		Olivers, Christian/0000-0001-7470-5378; Nuthmann, Antje/0000-0003-3338-3434	NWO (Netherlands Organization for Scientific Research) [404-10-321]; NWO Vici grant [453-16-002]	NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); NWO Vici grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by NWO (Netherlands Organization for Scientific Research) grant 404-10-321 (CNLO and FH), and NWO Vici grant 453-16-002 (CNLO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTES JR, 1974, J EXP PSYCHOL, V103, P62, DOI 10.1037/h0036799; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker MW, 2007, J EXP PSYCHOL HUMAN, V33, P20, DOI 10.1037/0096-1523.33.1.20; Belke E, 2008, PERCEPT PSYCHOPHYS, V70, P1444, DOI 10.3758/PP.70.8.1444; Bonitz VS, 2008, ACTA PSYCHOL, V129, P255, DOI 10.1016/j.actpsy.2008.08.006; Borges M, 2015, EUROASIANPACIFIC JOI; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; de Groot F, 2017, VIS COGN, V25, P225, DOI 10.1080/13506285.2017.1324934; de Groot F, 2016, J EXP PSYCHOL HUMAN, V42, P180, DOI 10.1037/xhp0000102; de Groot F, 2016, J COGN PSYCHOL, V28, P1, DOI 10.1080/20445911.2015.1101119; DEGRAEF P, 1990, PSYCHOL RES-PSYCH FO, V52, P317, DOI 10.1007/BF00868064; Engbert R., 2011, OXFORD HDB EYE MOVEM, P787, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0043; Gareze Lynn, 2007, P617, DOI 10.1016/B978-008044980-7/50031-8; Gelman A., 2006, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Henderson J. M., 2004, INTERFACE LANGUAGE V, P1, DOI DOI 10.4324/9780203488430; Henderson J. M., 1998, EYE GUIDANCE READING, P269, DOI [10.1016/B978-008043361-5/50013-4, DOI 10.1016/B978-008043361-5/50013-4, 10.1016/b978-008043361-5/50013-4]; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Huettig F, 2007, J MEM LANG, V57, P460, DOI 10.1016/j.jml.2007.02.001; Huettig F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00394; Hwang AD, 2009, J VISION, V9, DOI 10.1167/9.5.25; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kliegl R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00238; Knapp WH, 2012, VISION RES, V71, P28, DOI 10.1016/j.visres.2012.08.015; Kovalenko LY, 2012, BRAIN TOPOGR, V25, P272, DOI 10.1007/s10548-011-0216-8; LaPointe MRP, 2016, VIS COGN, V24, P63, DOI 10.1080/13506285.2016.1185070; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; LOFTUS GR, 1978, J EXP PSYCHOL HUMAN, V4, P565, DOI 10.1037/0096-1523.4.4.565; MACKWORTH NH, 1967, PERCEPT PSYCHOPHYS, V2, P547, DOI 10.3758/BF03210264; Malcolm GL, 2009, J VISION, V9, DOI 10.1167/9.11.8; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Matuschek H, 2017, J MEM LANG, V94, P305, DOI 10.1016/j.jml.2017.01.001; Moores E, 2003, NAT NEUROSCI, V6, P182, DOI 10.1038/nn996; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Nuthmann A, 2017, PSYCHON B REV, V24, P370, DOI 10.3758/s13423-016-1124-4; Nuthmann A, 2016, J VISION, V16, DOI 10.1167/16.2.3; Nuthmann A, 2013, VIS COGN, V21, P803, DOI 10.1080/13506285.2013.832449; Nuthmann A, 2012, VIS COGN, V20, P457, DOI 10.1080/13506285.2012.670142; Pajak M, 2013, J VISION, V13, DOI 10.1167/13.5.2; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reichle E. D., 2011, OXFORD HDB EYE MOVEM, P767, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0042; Rommers J, 2013, NEUROPSYCHOLOGIA, V51, P437, DOI 10.1016/j.neuropsychologia.2012.12.002; Schmidt J, 2011, VISION RES, V51, P535, DOI 10.1016/j.visres.2011.01.013; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stoll J, 2015, VISION RES, V107, P36, DOI 10.1016/j.visres.2014.11.006; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Underwood G, 2008, CONSCIOUS COGN, V17, P159, DOI 10.1016/j.concog.2006.11.008; Underwood G, 2006, Q J EXP PSYCHOL, V59, P1931, DOI 10.1080/17470210500416342; Underwood G, 2009, COGN COMPUT, V1, P64, DOI 10.1007/s12559-008-9002-7; Vickery TJ, 2005, J VISION, V5, P81, DOI 10.1167/5.1.8; Vo MLH, 2011, ATTEN PERCEPT PSYCHO, V73, P1742, DOI 10.3758/s13414-011-0150-6; Vo MLH, 2009, J VISION, V9, DOI 10.1167/9.3.24; Wilschut A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00148; Wolfe J. M., 2007, INTEGRATED MODELS CO, V10, P99, DOI [DOI 10.1093/ACPROF:OSO/9780195189193.003.0008, 10.1093/acprof:oso/9780195189193.003.0008]; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; Wolfe JM, 2004, VISION RES, V44, P1411, DOI 10.1016/j.visres.2003.11.024; Wu CC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00054; Zelinsky GJ, 2008, PSYCHOL REV, V115, P787, DOI 10.1037/a0013118	66	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217051	10.1371/journal.pone.0217051	http://dx.doi.org/10.1371/journal.pone.0217051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ3VE	31120948	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700051
J	Duvvuru, MK; Han, WG; Chowdhury, PR; Vahabzadeh, S; Sciammarella, F; Elsawa, SF				Duvvuru, Murali Krishna; Han, Weiguo; Chowdhury, Prantik Roy; Vahabzadeh, Sahar; Sciammarella, Federico; Elsawa, Sherine F.			Bone marrow stromal cells interaction with titanium; Effects of composition and surface modification	PLOS ONE			English	Article							TIO2 NANOTUBE ARRAYS; CORROSION-RESISTANCE; ANODIZED TITANIUM; IN-VITRO; IMPLANTS; FLUORIDE; ALLOY	Inflammation and implant loosening are major concerns when using titanium implants for hard tissue engineering applications. Surface modification is one of the promising tools to enhance tissue-material integration in metallic implants. Here, we used anodization technique to modify the surface of commercially pure titanium (CP-Ti) and titanium alloy (Ti-6Al-4V) samples. Our results show that electrolyte composition, anodization time and voltage dictated the formation of well-organized nanotubes. Although electrolyte containing HF in water resulted in nanotube formation on Ti, the presence of NH4F and ethylene glycol was necessary for successful nanotube formation on Ti-6Al-4V. Upon examination of the interaction of bone marrow stromal cells (BMSCs) with the modified samples, we found that Ti-6Al-4V without nanotubes induced cell proliferation and cluster of differentiation 40 ligand (CD40L) expression which facilitates B-cell activation to promote early bone healing. However, the expression of glioma associated protein 2 (GLI2), which regulates CD40L, was reduced in Ti-6Al-4V and the presence of nanotubes further reduced its expression. The inflammatory cytokine interleukin-6 (IL-6) expression was reduced by nanotube presence on Ti. These results suggest that Ti-6Al-4V with nanotubes may be suitable implants because they have no effect on BMSC growth and inflammation.	[Duvvuru, Murali Krishna; Chowdhury, Prantik Roy; Vahabzadeh, Sahar; Sciammarella, Federico] Northern Illinois Univ, Dept Mech Engn, De Kalb, IL 60115 USA; [Han, Weiguo; Elsawa, Sherine F.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	Northern Illinois University; University System Of New Hampshire; University of New Hampshire	Vahabzadeh, S (corresponding author), Northern Illinois Univ, Dept Mech Engn, De Kalb, IL 60115 USA.; Elsawa, SF (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	svahabzadeh@niu.edu; sherine.elsawa@unh.edu		Han, Weiguo/0000-0003-4842-4833; Elsawa, Sherine/0000-0002-3917-3078	Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource [NSF ECCS-1542205]; State of Illinois; Materials Research Science and Engineering Center [NSF DMR-1720139]; Northwestern University	Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource; State of Illinois; Materials Research Science and Engineering Center(National Science Foundation (NSF)); Northwestern University	We acknowledge Benyamin Salehi Najafabadi, Dr. Michael HajiSheikh, and Mr. Gregg Westberg (Microelectronics Research and Development Lab) at Northern Illinois University and Nancy Cherim at the University of New Hampshire. This work utilized Northwestern University Micro/Nano Fabrication Facility (NUFAB), which is partially supported by Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-1542205), the Materials Research Science and Engineering Center (NSF DMR-1720139), the State of Illinois, and Northwestern University.	Abbuehl JP, 2017, CELL STEM CELL, V21, P241, DOI 10.1016/j.stem.2017.07.004; Bandyopadhyay A, 2017, ANN BIOMED ENG, V45, P249, DOI 10.1007/s10439-016-1673-8; Beltran-Partida E, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0247-8; Bortolan CC, 2016, MATER LETT, V177, P46, DOI 10.1016/j.matlet.2016.04.188; Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008; Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088; Deligianni DD, 2014, CELL ADHES MIGR, V8, P558, DOI 10.4161/cam.32124; El-wassefy NA, 2014, CLIN ORAL IMPLAN RES, V25, pE1, DOI 10.1111/clr.12031; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Grimes CA, 2009, TIO2 NANOTUBE ARRAYS - SYNTHESIS, PROPERTIES, AND APPLICATIONS, pXIII; Han WG, 2017, J IMMUNOL, V198, P4481, DOI 10.4049/jimmunol.1601490; Indira K, 2014, J BIOMATER APPL, V29, P113, DOI 10.1177/0885328213516821; Jackson DA, 2015, J IMMUNOL, V195, P2908, DOI 10.4049/jimmunol.1402974; Kim WG, 2009, THIN SOLID FILMS, V517, P5033, DOI 10.1016/j.tsf.2009.03.165; Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6; Lee BG, 2009, T NONFERR METAL SOC, V19, P842, DOI 10.1016/S1003-6326(08)60361-1; Li BE, 2015, RSC ADV, V5, P49552, DOI 10.1039/c5ra05821j; Li YB, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045501; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Lu R, 2018, INT J NANOMED, V13, P2037, DOI 10.2147/IJN.S155532; Luo BM, 2008, MATER LETT, V62, P4512, DOI 10.1016/j.matlet.2008.08.015; Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014; Pozio Alfonso, 2012, Dent Res J (Isfahan), V9, pS169, DOI 10.4103/1735-3327.109745; Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3; Shin DH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315704; Shivaram A, 2014, APPL SURF SCI, V317, P573, DOI 10.1016/j.apsusc.2014.08.107; Suska F, 2008, J BIOMED MATER RES A, V85A, P888, DOI 10.1002/jbm.a.31575; Wang J, 2016, INT J ELECTROCHEM SC, V11, P15; Xia L, 2012, INT J NANOMED, V7, P4873, DOI 10.2147/IJN.S29496; Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551; Yashwanth IVS, 2015, MATER LETT, V142, P328, DOI 10.1016/j.matlet.2014.12.010; Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9	36	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216087	10.1371/journal.pone.0216087	http://dx.doi.org/10.1371/journal.pone.0216087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116747	gold, Green Submitted, Green Published			2022-12-27	WOS:000468607400015
J	Hitti, E; Geha, M; Hadid, D; Bachir, R				Hitti, Eveline; Geha, Mirabelle; Hadid, Dima; Bachir, Rana			The disease spectrum of adult patients at a tertiary care center emergency department in Lebanon	PLOS ONE			English	Article							PERSPECTIVES; MEDICINE	Objective There is an increase in Emergency Department (ED) utilization globally. Understanding what patients present to EDs with is important for resource allocation, training and staffing purposes. There is paucity of data pertaining to ED visit presentations in Lebanon. This study aims at describing the spectrum of diseases among adult patients who present to a tertiary care center in Lebanon, an upper-middle income country (UMIC). Methods A retrospective chart review of adult patients (age >= 19) presenting to a tertiary care hospital ED during 2010-2011 was completed. Common diagnoses in three categories (all adult visits, treat and release, admitted visits) were assessed. Diagnoses were classified according to the Clinical Classifications Software. Descriptive statistics were presented in tables as frequencies and percentages. Results During the study period, 32787 adults presented to the ED with 18.7% resulting in hospital admission. The most common diagnoses in ED patients were injuries and conditions due to external causes, abdominal pain, non-specific chest pain and intestinal infections. In the treat and release group, intestinal infections emerged in the common list for ages 19-44. Coronary atherosclerosis was common in admitted patients aged >= 45 years. Summer was the busiest season, with abdominal pain and intestinal infection being prominent diagnoses during that season. Conclusions This study is the first to assess adult ED visits in a Lebanese setting. Our study suggests that patients in our population suffer from the double burden of both communicable and non-communicable disease, with coronary atherosclerosis common in admitted patients (>= 45 years) and intestinal infections common in treat and release adult patients (19-44years), the latter condition peaking in summer and driving seasonal surges in ED visits.	[Hitti, Eveline; Geha, Mirabelle; Hadid, Dima; Bachir, Rana] Amer Univ Beirut, Med Ctr, Dept Emergency Med, Beirut, Lebanon	American University of Beirut	Hitti, E (corresponding author), Amer Univ Beirut, Med Ctr, Dept Emergency Med, Beirut, Lebanon.	eh16@aub.edu.lb						Abdulrahim S, 2015, GERONTOLOGIST, V55, P511, DOI 10.1093/geront/gnu095; Abyad A, 2001, J AM GERIATR SOC, V49, P1366, DOI 10.1046/j.1532-5415.2001.49268.x; Almahmeed W, 2012, THER CLIN RISK MANAG, V8, P65, DOI 10.2147/TCRM.S26414; Bayram JD, 2007, J EMERG MED, V32, P217, DOI 10.1016/j.jemermed.2006.12.007; Derlet RW, 2000, J EMERG MED, V18, P327, DOI 10.1016/S0736-4679(99)00223-1; Eitel DR, 2003, ACAD EMERG MED, V10, P1070, DOI 10.1197/S1069-6563(03)00350-6; El Sayed MJ, 2014, EMERGENCY MED INT, V2014; Gindi Renee M, 2016, Natl Health Stat Report, P1; Guimaraes TR, 2016, OPEN J EMERGENCY MED, V4, P45; Health MOP, 2006, HLTH MOP STAT B 2006; Health MOP, 2016, HLTH MOP STAT B 2016; Health MOP, 2015, HLTH MOP STAT B 2015; Hitti EA, 2015, EUR J EMERG MED, V22, P253, DOI 10.1097/MEJ.0000000000000155; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Mahmood S. A. I., 2013, Journal of Public Health and Epidemiology, V5, P424; Musharrafieh U, 2011, LEBAN MED J, V103, P1; Nations U., 2017, CHANGING POPULATION; Obermeyer Z, 2015, B WORLD HEALTH ORGAN, V93, P577, DOI 10.2471/BLT.14.148338; Pines JM, 2011, ACAD EMERG MED, V18, P1358, DOI 10.1111/j.1553-2712.2011.01235.x; Razzak JA, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-8; World Health Organization, 2014, NONC DIS COUNTR PROF; Yehia F, 2014, J MENT HEALTH POLICY, V17, P131; Zeeni N, 2017, COMMUNITY MENT HLT J, V53, P117, DOI 10.1007/s10597-015-9917-x; Zeytin AT, 2014, TURK J EMERG MED, V14, P75, DOI 10.5505/1304.7361.2014.91489	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216740	10.1371/journal.pone.0216740	http://dx.doi.org/10.1371/journal.pone.0216740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ1LE	31116760	Green Submitted, Green Published, gold			2022-12-27	WOS:000468607400029
J	Zuo, JP; Xu, JH; Li, WH; Yang, DY				Zuo, Jingping; Xu, Jianhua; Li, Weihong; Yang, Dongyang			Understanding shallow soil moisture variation in the data-scarce area and its relationship with climate change by GLDAS data	PLOS ONE			English	Article							TARIM RIVER-BASIN; WATER-RESOURCES; XINJIANG; RUNOFF; IMPACT; CHINA	Quantitatively evaluating the spatiotemporal variation of soil moisture (SM) and its causes can help us to understand regional eco-hydrological processes. However, the complicated geographical environment and the scarce observation data make it difficult to evaluate SM in Northwest China. Selecting the Tarim River Basin (TRB) as a typical representative of the data-scarce area in Northwest China, we conducted an integrated approach to quantitatively assess the spatiotemporal variation of shallow soil moisture (SSM) and its responses to climate change by gathering the earth system data product. Results show that the low-value of SSM distributes in Taklamakan Desert while the high-value basically distributes in the Pamirs and the southern foothill of Tianshan Mountains, where the land types are mostly forest, grassland, and farmland. Annual average SSM of these three land types present a significant increasing trend during the study period. SM at 0-10 cm of all land types are positively correlated to precipitation in spring and autumn, and SM at 0-10 cm in the forest, grassland, and farmland are positively correlated with temperature in winter. SSM presents in-phase relation with precipitation whereas it presents anti-phase relation with temperature, with the significant resonance periods about 6-8 years and 2-3 years which mainly distribute from 1970s to early 1990s and 1960s respectively. The time lags of SSM relative to temperature change are longer than its lags relative to precipitation change, and the lags vary from different land types.	[Zuo, Jingping; Xu, Jianhua; Yang, Dongyang] East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China; [Zuo, Jingping; Xu, Jianhua; Yang, Dongyang] East China Normal Univ, Res Ctr East West Cooperat China, Shanghai, Peoples R China; [Li, Weihong] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China	East China Normal University; East China Normal University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Xu, JH (corresponding author), East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China.; Xu, JH (corresponding author), East China Normal Univ, Res Ctr East West Cooperat China, Shanghai, Peoples R China.	jhxu@geo.ecnu.edu.cn	Xu, Jianhua/B-1062-2009; zuo, jingping/GZB-1752-2022; Xu, Jianhua/I-1869-2019; Yang, Dongyang/AAP-6350-2020	Xu, Jianhua/0000-0001-6134-4833; zuo, jingping/0000-0002-5276-2547; 	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20100303]; National Natural Science Foundation of China [41871025, 41630859]; Open Foundation of State Key Laboratory, Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences [G2014-02-07]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory, Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	The following funding had important roles in study design, data collection and analysis of the manuscript: (1) The Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA20100303); (2) The National Natural Science Foundation of China (Grant No. 41871025, 41630859); (3) The Open Foundation of State Key Laboratory, Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences (Grant No. G2014-02-07).	Allen MR, 1996, MONTE CARLO SSA DETE; Beaudoing H., 2019, GLDAS NOAH LAND SURF, DOI [10.5067/9SQ1B3ZXP2C5, DOI 10.5067/9SQ1B3ZXP2C5]; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Cai JZ, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7060566; CHAHINE MT, 1992, NATURE, V359, P373, DOI 10.1038/359373a0; [柴强 Chai Qiang], 2015, [中国草地学报, Chinese Journal of Grassland], V37, P18; Chen Y, 2013, EVALUATION AMSR E RE, P4466; Chen YN, 2006, HYDROL PROCESS, V20, P2207, DOI 10.1002/hyp.6200; Chen YN, 2013, ENVIRON MANAGE, V51, P138, DOI 10.1007/s00267-012-9823-8; Chen YN, 2011, QUATERN INT, V244, P264, DOI 10.1016/j.quaint.2011.01.039; Chen YN, 2009, QUATERN INT, V208, P53, DOI 10.1016/j.quaint.2008.11.011; Chen YY, 2013, J GEOPHYS RES-ATMOS, V118, P4466, DOI 10.1002/jgrd.50301; Chen YN, 2006, J ARID ENVIRON, V66, P231, DOI 10.1016/j.jaridenv.2005.11.009; Chen YN, 2005, SCI CHINA SER D, V48, P65, DOI 10.1360/04yd0539; [陈志诚 Chen Zhicheng], 2004, [土壤, Soils], V36, P584; Dirmeyer P., 2011, TERRESTRIAL SEGMENT; Dorigo W, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052988; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Guo DL, 2017, J GEOPHYS RES-ATMOS, V122, P12269, DOI 10.1002/2017JD027477; Jimenez C, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014545; Krishnamurti TN, 2014, RELIABILITY EVALUATI, V9265, DOI [10.1117/12.2074566, DOI 10.1117/12.2074566]; [李红军 LI HongJun], 2007, [地理科学, Scientia Geographica Sinica], V27, P801; [李若麟 Li Ruolin], 2016, [冰川冻土, Journal of Glaciology and Geocryology], V38, P1470; [李时越 Li Shiyue], 2018, [冰川冻土, Journal of Glaciology and Geocryology], V40, P322; [刘纪远 Liu Jiyuan], 2018, [地理学报, Acta Geographica Sinica], V73, P789; Liu JY, 2010, J GEOGR SCI, V20, P483, DOI 10.1007/s11442-010-0483-4; Liu LJ, 2019, CHINESE J POLYM SCI, V37, P401, DOI 10.1007/s10118-019-2206-3; Long D, 2014, DROUGHT FLOOD MONITO; Long D, 2013, GRACE SATELLITE MONI, P3395; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Namias J., 1958, ATMOSPHERE SEA MOTIO, P240; PEARSON K., 1895, NOTE REGRESSION INHE, P240; [普宗朝 PU Zong-chao], 2010, [中国沙漠, Journal of Desert Research], V30, P413; Qiang Z, 2003, STUDY PHYS PARAMETER; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Shang KZ, 2007, ATMOS CHEM PHYS, V7, P5197, DOI 10.5194/acp-7-5197-2007; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Spennemann PC, 2015, J HYDROMETEOROL, V16, P158, DOI 10.1175/JHM-D-13-0190.1; Su B, 2016, INT J APPL EARTH OBS, V48, P122, DOI 10.1016/j.jag.2015.06.012; Walker J, 1977, EFFECT SOIL MOISTURE, P29; [万文亮 Wan Wenliang], 2018, [水土保持学报, Journal of Soil and Water Conservation], V32, P166; Wang C, 2017, HYBRID MODEL ASSESS; Wang HJ, 2015, CLIM RES, V62, P99, DOI 10.3354/cr01266; Wang Y, 2017, J NANOMATER, V2017, DOI 10.1155/2017/6540120; Xu JH, 2018, METHODSX, V5, P561, DOI 10.1016/j.mex.2018.05.005; Xu JH, 2016, THEOR APPL CLIMATOL, V123, P321, DOI 10.1007/s00704-014-1364-z; Xu JH, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/272715; Xu ZX, 2004, WATER RESOUR MANAG, V18, P439, DOI 10.1023/B:WARM.0000049142.95583.98; Yang K, 2019, WATER STORAGE EFFECT, P280; Yang K, 2018, IMPROVED SIMULATION; Yang P, 2015, QUATERN INT, V358, P106, DOI 10.1016/j.quaint.2014.09.077; Yang YH, 2003, CLIMATIC CHANGE, V57, P163, DOI 10.1023/A:1022102510975; Yao YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160776; Yi Chen, 2015, Acta Pedologica Sinica, V52, P220; Zaitchik BF, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007811; Zhan MJ, 2017, QUATERN INT, V440, P23, DOI 10.1016/j.quaint.2016.01.003; Zhang H, 2003, J ARID ENVIRON, V55, P545, DOI 10.1016/S0140-1963(02)00283-5; Zhang YC, 2013, ECOHYDROLOGY, V6, P1031, DOI 10.1002/eco.1416; Zhao RF, 2013, ENVIRON EARTH SCI, V68, P591, DOI 10.1007/s12665-012-1763-3	60	3	3	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217020	10.1371/journal.pone.0217020	http://dx.doi.org/10.1371/journal.pone.0217020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116787	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400036
J	Kurozumi, S; Yamaguchi, Y; Matsumoto, H; Kurosumi, M; Hayashi, S; Fujii, T; Horiguchi, J; Shirabe, K; Inoue, K				Kurozumi, Sasagu; Yamaguchi, Yuri; Matsumoto, Hiroshi; Kurosumi, Masafumi; Hayashi, Shin-ichi; Fujii, Takaaki; Horiguchi, Jun; Shirabe, Ken; Inoue, Kenichi			Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; FULVESTRANT 500 MG; DOUBLE-BLIND; RECEPTOR; CHEMOTHERAPY; PALBOCICLIB; CYCLOPHOSPHAMIDE; LETROZOLE; ONCOLOGY; LESSONS	In this study, we investigated the relationships of pathological response after neoadjuvant chemo-endocrine therapy with alterations in the Ki67 labeling index (LI), expression of cyclin D1 (CCND1) and progesterone receptor (PgR), and estrogen receptor (ER) activity in breast cancer. A total of 43 Japanese post-menopausal ER-positive and human epidermal growth factor receptor 2-negative invasive breast cancer patients with tumors >2 cm or positive lymph nodes were enrolled. Exemestane alone was administered for 2 months. Neoadjuvant chemo-endocrine therapy included four cycles of doxorubicin plus paclitaxel followed by weekly paclitaxel. The immunohistochemical expression of Ki67 LI, CCND1, and PgR, and ER activity were evaluated using core needle biopsy samples at the pretreatment and post-exemestane alone stages. ER activity was evaluated through transfection of an adenovirus vector carrying an estrogen-response element-green fluorescent protein gene. In current study, marked pathological responses (including 4.7% with pathological complete response) were obtained in 34.9% of patients. Ki67 LI and PgR expression were significantly decreased after treatment. High Ki67 LI at pretreatment was a significant predictive factor of marked pathological response. At the stage of post-exemestane alone, Ki67 LI was not significantly associated with pathological response; however, high CCND1 expression was significantly correlated with high Ki67 LI. Moreover, low-level ER activity at the post-exemestane alone stage was significantly associated with marked pathological response. In conclusions, pretreatment Ki67 LI was a predictor of response to neoadjuvant chemo-endocrine therapy. CCND1 expression and ER activity at the post-endocrine therapy alone stage may be useful in determining further treatments.	[Kurozumi, Sasagu; Fujii, Takaaki; Shirabe, Ken] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Gunma, Japan; [Kurozumi, Sasagu; Matsumoto, Hiroshi] Saitama Canc Ctr, Div Breast Surg, Saitama, Japan; [Yamaguchi, Yuri] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan; [Kurosumi, Masafumi] Saitama Canc Ctr, Dept Pathol, Saitama, Japan; [Hayashi, Shin-ichi] Tohoku Univ, Dept Mol & Funct Dynam, Sendai, Miyagi, Japan; [Horiguchi, Jun] Int Univ Hlth & Welf, Dept Breast Surg, Chiba, Japan; [Inoue, Kenichi] Saitama Canc Ctr, Div Breast Oncol, Saitama, Japan	Gunma University; Tohoku University; International University of Health & Welfare	Kurozumi, S (corresponding author), Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Gunma, Japan.; Kurozumi, S (corresponding author), Saitama Canc Ctr, Div Breast Surg, Saitama, Japan.	chachagot-a-mail@hotmail.co.jp						Acs B, 2017, DIAGN PATHOL, V12, P1, DOI 10.1186/s13000-017-0608-5; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Chow LWC, 2018, ENDOCR-RELAT CANCER, V25, P123, DOI 10.1530/ERC-17-0396; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Curigliano G, 2017, ANN ONCOL, V28, P1700, DOI 10.1093/annonc/mdx308; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2017, BREAST, V34, pS104, DOI 10.1016/j.breast.2017.06.039; Ellis MJ, 2017, J CLIN ONCOL, V35, P1061, DOI 10.1200/JCO.2016.69.4406; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; GERDES J, 1984, J IMMUNOL, V133, P1710; Gohno T, 2012, CANCER MED-US, V1, P328, DOI 10.1002/cam4.41; Hayashi S, 2008, BREAST CANCER-TOKYO, V15, P256, DOI 10.1007/s12282-008-0070-z; Honma N, 2015, BREAST CANCER-TOKYO, V22, P71, DOI 10.1007/s12282-013-0455-5; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Johnston S, 2019, J CLIN ONCOL, V37, P178, DOI 10.1200/JCO.18.01624; Kurozumi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38272-1; Kurozumi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201846; Kurozumi S, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3331-4; Kurozumi S, 2016, CANCER MED-US, V5, P1873, DOI 10.1002/cam4.780; Kurozumi S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1641-y; Lanari C, 2002, BREAST CANCER RES, V4, P240, DOI 10.1186/bcr539; Mohammadizadeh F, 2013, J RES MED SCI, V18, P1021; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; Robertson JFR, 2016, LANCET, V388, P2997, DOI 10.1016/S0140-6736(16)32389-3; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Tokuda E, 2012, BREAST CANCER RES TR, V133, P427, DOI 10.1007/s10549-011-1758-x; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Yamamoto S, 2013, BREAST CANCER-TOKYO, V20, P262, DOI 10.1007/s12282-012-0332-7; Yu KD, 2019, CANCER; 2017, CONTEMP CLIN TRIALS, V62, P168, DOI DOI 10.1016/J.CCT.2017.09.002	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217279	10.1371/journal.pone.0217279	http://dx.doi.org/10.1371/journal.pone.0217279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112577	Green Submitted, gold, Green Published			2022-12-27	WOS:000468451000046
J	Duvallet, C; Larson, K; Snapper, S; Iosim, S; Lee, A; Freer, K; May, K; Alm, E; Rosen, R				Duvallet, Claire; Larson, Kara; Snapper, Scott; Iosim, Sonia; Lee, Ann; Freer, Katherine; May, Kara; Alm, Eric; Rosen, Rachel			Aerodigestive sampling reveals altered microbial exchange between lung, oropharyngeal, and gastric microbiomes in children with impaired swallow function	PLOS ONE			English	Article							ANTIREFLUX PROCEDURES; ORAL DECONTAMINATION; ASPIRATION; FUNDOPLICATION; COLONIZATION; PNEUMONIA	Background Children with oropharyngeal dysphagia have impaired airway protection mechanisms and are at higher risk for pneumonia and other pulmonary complications. Aspiration of gastric contents is often implicated as a cause for these pulmonary complications, despite being supported by little evidence. The goal of this study is to determine the relative contribution of oropharyngeal and gastric microbial communities to perturbations in the lung microbiome of children with and without oropharyngeal dysphagia and aspiration. Methods We conducted a prospective cohort study of 220 patients consecutively recruited from a tertiary aerodigestive center undergoing simultaneous esophagogastroduodenoscopy and flexible bronchoscopy. Bronchoalveolar lavage, gastric and oropharyngeal samples were collected from all recruited patients and 16S sequencing was performed. A subset of 104 patients also underwent video fluoroscopic swallow studies to assess swallow function and were categorized as aspiration/no aspiration. To ensure the validity of the results, we compared the microbiome of these aerodigestive patients to the microbiome of pediatric patients recruited to a longitudinal cohort study of children with suspected GERD; patients recruited to this study had oropharyngeal, gastric and/or stool samples available. The relationships between microbial communities across the aerodigestive tract were described by analyzing within- and between-patient beta diversities and identifying taxa which are exchanged between aerodigestive sites within patients. These relationships were then compared in patients with and without aspiration to evaluate the effect of aspiration on the aerodigestive microbiome. Results Within all patients, lung, oropharyngeal and gastric microbiomes overlap. The degree of similarity is the lowest between the oropharynx and lungs (median Jensen-Shannon distance (JSD) = 0.90), and as high between the stomach and lungs as between the oropharynx and stomach (median JSD = 0.56 for both; p = 0.6). Unlike the oropharyngeal microbiome, lung and gastric communities are highly variable across people and driven primarily by person rather than body site. In patients with aspiration, the lung microbiome more closely resembles oropharyngeal rather than gastric communities and there is greater prevalence of microbial exchange between the lung and oropharynx than between gastric and lung sites (p = 0.04 and 4x10(-5), respectively). Conclusions The gastric and lung microbiomes display significant overlap in patients with intact airway protective mechanisms while the lung and oropharynx remain distinct. In patients with impaired swallow function and aspiration, the lung microbiome shifts towards oropharyngeal rather than gastric communities. This finding may explain why antireflux surgeries fail to show benefit in pediatric pulmonary outcomes.	[Duvallet, Claire; Alm, Eric] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Duvallet, Claire; Alm, Eric] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Larson, Kara; Iosim, Sonia; Rosen, Rachel] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Aerodigest Ctr, Boston, MA 02115 USA; [Snapper, Scott; Lee, Ann; Freer, Katherine] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [May, Kara] Boston Childrens Hosp, Div Pulm Med, Boston, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Rosen, R (corresponding author), Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Aerodigest Ctr, Boston, MA 02115 USA.	Rachel.Rosen@childrens.harvard.edu		Rosen, Rachel/0000-0003-3949-3060	NIH [R01 DK097112]; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Grant for Diseases of the Upper Gastrointestinal Tract; Center for Microbiome Informatics and Therapeutics; National Defense Science & Engineering Graduate Fellowship (NDSEG); Boston Children's Hospital Translational Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK097112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Grant for Diseases of the Upper Gastrointestinal Tract; Center for Microbiome Informatics and Therapeutics; National Defense Science & Engineering Graduate Fellowship (NDSEG); Boston Children's Hospital Translational Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded through the NIH R01 DK097112, Translational Research Program (R.R.), and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Grant for Diseases of the Upper Gastrointestinal Tract (R.R.). Computational resources for this work were supported by the Center for Microbiome Informatics and Therapeutics (E.A.). C.D. acknowledges support through the National Defense Science & Engineering Graduate Fellowship (NDSEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH R01 DK097112 (R.R.), the Boston Children's Hospital Translational Research Program (R.R.), and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Grant for Diseases of the Upper Gastrointestinal Tract (R.R.). Computational resources for this work were supported by the Center for Microbiome Informatics and Therapeutics (E.A.). C.D. acknowledges support through the National Defense Science & Engineering Graduate Fellowship (NDSEG).	Akata K, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0235-z; Barnhart DC, 2013, JAMA PEDIATR, V167, P911, DOI 10.1001/jamapediatrics.2013.334; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Goldin AB, 2006, PEDIATRICS, V118, P2326, DOI 10.1542/peds.2006-2212; Goldin AB, 2009, ARCH PEDIAT ADOL MED, V163, P658, DOI 10.1001/archpediatrics.2009.103; Hatch LD, 2018, J PERINATOL, V38, P1270, DOI 10.1038/s41372-018-0145-4; Heintz-Buschart A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.180; HOLAS MA, 1994, ARCH NEUROL-CHICAGO, V51, P1051, DOI 10.1001/archneur.1994.00540220099020; Hu HB, 2010, AM J INFECT CONTROL, V38, P746, DOI 10.1016/j.ajic.2010.02.012; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jancelewicz T, 2017, J PEDIATR SURG, V52, P1228, DOI 10.1016/j.jpedsurg.2016.09.072; Jones E., 2001, SCIPY OPEN SOURCE SC; Kageyama S, 2017, J GERONTOLOGY A; Koeman M, 2006, AM J RESP CRIT CARE, V173, P1348, DOI 10.1164/rccm.200505-820OC; Lasser MS, 2006, PEDIATRICS, V118, P1828, DOI 10.1542/peds.2006-1185; Lee SL, 2008, J PEDIATR SURG, V43, P59, DOI 10.1016/j.jpedsurg.2007.09.020; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Ortega O, 2015, NEUROGASTROENT MOTIL, V27, P1804, DOI 10.1111/nmo.12690; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Preheim SP, 2013, METHOD ENZYMOL, V531, P353, DOI 10.1016/B978-0-12-407863-5.00018-6; Rosen R, 2004, AM J GASTROENTEROL, V99, P2452, DOI 10.1111/j.1572-0241.2004.40268.x; Rosen R, 2015, J PEDIATR-US, V166, P917, DOI 10.1016/j.jpeds.2014.12.067; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Srivastava R, 2009, PEDIATRICS, V123, P338, DOI 10.1542/peds.2007-1740; Tantipong H, 2008, INFECT CONT HOSP EP, V29, P131, DOI 10.1086/526438; Thomson J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1612; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weir K, 2007, PEDIATR PULM, V42, P1024, DOI 10.1002/ppul.20687; Yeh J, 2016, PEDIATR PULM, V51, P1206, DOI 10.1002/ppul.23442	38	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0216453	10.1371/journal.pone.0216453	http://dx.doi.org/10.1371/journal.pone.0216453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107879	Green Submitted, Green Published, gold			2022-12-27	WOS:000468285200010
J	Roussel, E; Touleimat, S; Ollivier, L; Verspyck, E				Roussel, Estelle; Touleimat, Salma; Ollivier, Laurence; Verspyck, Eric			Birthweight and pregnancy outcomes in obese class II women with low weight gain: A retrospective study	PLOS ONE			English	Article								Introduction To determine if weight gain below the institute of medicine (IOM) guidelines improves pregnancy outcomes and influences birthweight for women with class II obesity. Materials and methods We retrospectively included 996 women with class II obesity with singleton gestations and delivered at term in two hospitals providing level III maternal care between January 2006 and December 2015. Women were classified into three groups: weight gain within IOM recommendations (>= 5-<= 9kg), low weight gain (>= 0-<5kg), and weight loss (<0kg). Maternal complications and birth weight were reported in all groups. The group presenting weight gain within IOM recommendations was considered as the reference group. Results 424 women (42.5%) constituted the reference group and presented weight gain within IOM recommendations; whereas 370 (37.1%) presented low weight gain and 202 (20.3%) presented weight loss. The rate of birthweight above 4000 g was reduced in women with low weight gain (odds ratio (OR) = 0.62 [0.42-0.93]; p = 0.02) and in women with weight loss (OR = 0.58 [0.35-0.96]; p = 0.02). However, the rates of small for gestational age fetuses (SGA) < 10th percentile was increased in women with weight loss (OR = 1.63 [1.03-2.58]; p = 0.02). Maternal and neonatal complications were not significantly different between groups. Conclusion While low weight gain in women with class II obesity may reduce macrosomia without excessive risk of SGA, it has no effect on maternal and neonatal complication rates.	[Roussel, Estelle; Ollivier, Laurence] Belvedere Matern Hosp, Dept Obstet & Gynecol, Mont St Aignan, France; [Touleimat, Salma; Verspyck, Eric] Rouen Univ Hosp, Dept Obstet & Gynecol, Rouen, France; [Verspyck, Eric] Normandie Univ, UNIROUEN, EA NeoVasc, Lab Microvasc Endothelium & Neonate Brain Les, Rouen, France	CHU de Rouen	Verspyck, E (corresponding author), Rouen Univ Hosp, Dept Obstet & Gynecol, Rouen, France.; Verspyck, E (corresponding author), Normandie Univ, UNIROUEN, EA NeoVasc, Lab Microvasc Endothelium & Neonate Brain Les, Rouen, France.	eric.verspyck@chu-rouen.fr						[Anonymous], 2010, ANN FR ANESTH REANIM, V29; [Anonymous], 2013, OBSTET GYNECOL, V121, P213, DOI 10.1097/01.AOG; Artal R, 2010, OBSTET GYNECOL, V115, P152, DOI 10.1097/AOG.0b013e3181c51908; Carroll MD, PREVALENCE OVERWEIGH; Ego A, 2006, AM J OBSTET GYNECOL, V194, P1042, DOI 10.1016/j.ajog.2005.10.816; Gestational diabetes, 2010, J GYNECOL OBSTET S2, V39, pS139; Gunatilake RP, 2011, AM J OBSTET GYNECOL, V204, P106, DOI 10.1016/j.ajog.2010.10.002; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Restrepo E, 2015, INT J WOMEN HEAL REP, V3, P78, DOI 10.15296/ijwhr.2015.15; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Swank ML, 2014, OBSTET GYNECOL, V124, P1105, DOI 10.1097/AOG.0000000000000553; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; 2004, AM J OBSTET GYNECOL, V190, P1091, DOI DOI 10.1016/J.AJOG.2003.09.058	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0215833	10.1371/journal.pone.0215833	http://dx.doi.org/10.1371/journal.pone.0215833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107890	gold, Green Published, Green Submitted			2022-12-27	WOS:000468285200004
J	Arefian, H; Hagel, S; Fischer, D; Scherag, A; Brunkhorst, FM; Maschmann, J; Hartmann, M				Arefian, Habibollah; Hagel, Stefan; Fischer, Dagmar; Scherag, Andre; Brunkhorst, Frank Martin; Maschmann, Jens; Hartmann, Michael			Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program	PLOS ONE			English	Article							HAND HYGIENE COMPLIANCE; TIME-DEPENDENT BIAS; GUIDELINES; COST	Introduction Healthcare-associated infections (HAIs) are a major health concern and have substantial effects on morbidity and mortality and increase healthcare costs. We investigated the effect of a hospital-wide program for the prevention of HAIs on additional length of stay (LOS). Methods We analyzed data from a prospective, single-center, quasi-experimental study with two surveillance periods before and after implementation of an infection prevention intervention program. HAI diagnosis was made according to surveillance definition criteria established by the US Centers for Disease Control and Prevention. A multistate model was used to estimate additional LOS for patients with HAI in both surveillance periods. Results During the first and second periods, 1,568 and 2,336 HAIs were identified among 26,943 and 35,211 patients, respectively. For HAI patients exclusively treated in a general ward, additional LOS was 8.4 (95% confidence interval, CI: 6.8-10.0) days in the first period and 9.6 (95% CI: 8.3-11.0) days in the second period (p = 0.26). For HAI patients treated in both an intensive care unit (ICU) and a general ward, additional LOS was 8.1 (95% CI: 6.3-9.9) days in the first period to 7.3 (95% CI: 6.1-8.5) days in the second period (p = 0.47). Conclusions Healthcare-associated infections prolong LOS. A hospital-wide infection control program did not alter the prolongation of LOS.	[Arefian, Habibollah; Hagel, Stefan; Scherag, Andre; Brunkhorst, Frank Martin; Hartmann, Michael] Jena Univ Hosp, CSCC, Jena, Germany; [Arefian, Habibollah; Fischer, Dagmar] Friedrich Schiller Univ Jena, Dept Pharmaceut Technol & Biopharm, Jena, Germany; [Arefian, Habibollah; Hartmann, Michael] Jena Univ Hosp, Hosp Pharm, Jena, Germany; [Hagel, Stefan] Jena Univ Hosp, Inst Infect Dis & Infect Control, Jena, Germany; [Scherag, Andre] Jena Univ Hosp, Inst Med Stat Comp & Data Sci, Jena, Germany; [Brunkhorst, Frank Martin] Jena Univ Hosp, Ctr Clin Studies, Jena, Germany; [Brunkhorst, Frank Martin] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Paul Martini Clin Sepsis Res Unit, Jena, Germany; [Maschmann, Jens] Jena Univ Hosp, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Arefian, H (corresponding author), Jena Univ Hosp, CSCC, Jena, Germany.; Arefian, H (corresponding author), Friedrich Schiller Univ Jena, Dept Pharmaceut Technol & Biopharm, Jena, Germany.; Arefian, H (corresponding author), Jena Univ Hosp, Hosp Pharm, Jena, Germany.	Habibollah.Arefian@med.uni-jena.de	Hartmann, Michael/Y-2331-2019; Arefian, Habib/AAK-3701-2020; Hagel, Stefan/AAE-1174-2022	Arefian, Habib/0000-0002-8838-084X; Hagel, Stefan/0000-0003-2999-6131; Hartmann, Michael/0000-0002-6777-4540	German Ministry of Education and Research (BMBF) [FKZ 01EO1002, 01EO1502]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The CSCC and this research were supported by the German Ministry of Education and Research (BMBF) under grants FKZ 01EO1002 and 01EO1502.	AALEN OO, 1978, SCAND J STAT, V5, P141; Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Allignol A, 2011, COMPUTATION STAT, V26, P181, DOI 10.1007/s00180-010-0200-x; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Arefian H, 2016, AM J INFECT CONTROL, V44, P160, DOI 10.1016/j.ajic.2015.09.005; Barnett AG, 2011, VALUE HEALTH, V14, P381, DOI 10.1016/j.jval.2010.09.008; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Beyersmann J, 2011, COMPETING RISKS MULT; Beyersmann J, 2011, BIOMETRICAL J, V53, P332, DOI 10.1002/bimj.201000146; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Graves N, 2010, CLIN INFECT DIS, V50, P1017, DOI 10.1086/651110; Hagel S, CLIN MICROBIOLOGY IN; Hagel S, 2015, INFECT CONT HOSP EP, V36, P957, DOI 10.1017/ice.2015.93; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Macedo-Vinas M, 2013, J HOSP INFECT, V84, P132, DOI 10.1016/j.jhin.2013.02.015; McGuckin M, 2009, AM J MED QUAL, V24, P205, DOI 10.1177/1062860609332369; Nelson RE, 2015, INFECT CONT HOSP EP, V36, P1089, DOI 10.1017/ice.2015.129; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2009, INFECT CONT HOSP EP, V30, P611, DOI 10.1086/600379; Schulgen G, 1996, Lifetime Data Anal, V2, P219, DOI 10.1007/BF00128975; Sickbert-Bennett EE, 2016, EMERG INFECT DIS, V22, P1628, DOI 10.3201/eid2209.151440; Stewardson AJ, 2016, EURO SURVEILL, V21; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217159	10.1371/journal.pone.0217159	http://dx.doi.org/10.1371/journal.pone.0217159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100094	Green Published, Green Submitted, gold			2022-12-27	WOS:000468176600032
J	Lu, ZG; Lin, V; May, A; Che, B; Xiao, X; Shaw, DH; Su, F; Wang, ZH; Do, HJ; Shaw, PX				Lu, Zhigang; Lin, Victor; May, Adam; Che, Briana; Xiao, Xu; Shaw, Daniel H.; Su, Fei; Wang, Zhihao; Do, Hongjun; Shaw, Peter X.			HTRA1 synergizes with oxidized phospholipids in promoting inflammation and macrophage infiltration essential for ocular VEGF expression	PLOS ONE			English	Article							MACULAR DEGENERATION; SERINE-PROTEASE; BETA-CATENIN; FAMILY; NEOVASCULARIZATION; ASSOCIATION; MECHANISMS; MEMBER; RISK	Understanding oxidative stress and HTRA1 locus in abnormal angiogenesis resulting in wet AMD pathology is an important step in developing a novel therapeutic approach. Using sub-retinal injection of oxLDL into C57BL/6 mice, we observed a lesion resembling the features of choroidal neovascularization (CNV), including macrophage infiltration, increased VEGF expression, and neovascularization. However, incubating ARPE-19 cells with oxLDL-a carrier of oxidized phospholipids-resulted in increased expression of inflammatory cytokines and chemoattractant proteins that recruited monocytes, but no substantial increase in expression of VEGF. Furthermore, incubation of ARPE-19 with oxLDL induced higher expression of HTRA1, which we showed to synergize with oxLDL in elevating the expression of inflammatory cytokines and chemoattractant factors. To investigate the role of macrophage infiltration on these expression changes, we treated cultured J774 macrophages with oxLDL and applied the conditioned medium onto ARPE-19 cells. This treatment was found to greatly enhance the expression of VEGF in ARPE-19, indicating the necessity of macrophage secretory products to induce increased expression of VEGF in retinal pigment epithelium. Gene expression analysis revealed that oxLDL induced the expression of Wnt3A in macrophages, a key activator of canonical Wnt signaling pathways. In addition, western blot analysis showed that the macrophage conditioned media further enhanced the reduction of phosphorylated beta-catenin induced by oxLDL. Lastly, we investigated HTRA1 as a potential target for AMD therapeutics. We demonstrated the ability of anti-HTRA1 antibody in vitro to neutralize the protease activity of HTRA1 and reduce the inflammatory and angiogenic response to oxidative stress. Finally, we validated the neutralizing effect of anti-HTRA1 antibody in vivo by evaluating lesion size and protein expression in a laser-photocoagulation murine model of CNV. We found that the combination of oxLDL and HTRA1 enhanced CNV size, which was reversed by the addition of anti-HTRA1 antibody. This study not only provides preliminary evidence that HTRA1 may be a viable target for AMD therapeutics but also elucidates the biochemical mechanisms by which this therapeutic effect may be mediated.	[Lu, Zhigang; Lin, Victor; May, Adam; Che, Briana; Shaw, Daniel H.; Su, Fei; Wang, Zhihao; Shaw, Peter X.] Univ Calif San Diego, Altman Clin & Translat Res Inst, Dept Ophthalmol, La Jolla, CA 92093 USA; [Xiao, Xu] Sichuan Prov Peoples Hosp, Dept Emergency Med, Chengdu, Sichuan, Peoples R China; [Shaw, Daniel H.] Westview High Sch, San Diego, CA USA; [Do, Hongjun] Xijing Hosp, Dept Ophthalmol, Xian, Shaanxi, Peoples R China	University of California System; University of California San Diego; Sichuan Provincial People's Hospital; Air Force Military Medical University	Shaw, PX (corresponding author), Univ Calif San Diego, Altman Clin & Translat Res Inst, Dept Ophthalmol, La Jolla, CA 92093 USA.	pshaw@ucsd.edu		Shaw, Peter/0000-0001-7392-6224; Lin, Victor/0000-0003-4948-1979; Shaw, Daniel/0000-0003-3365-6834; May, Adam/0000-0003-0713-8371	National Institutes of Health [R01EY025693, P30EY022589]; NATIONAL EYE INSTITUTE [R01EY025693, P30EY022589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01EY025693 (to P.X. S.) and P30EY022589.	Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; DeAngelis MM, 2017, HUM MOL GENET, V26, pR45, DOI 10.1093/hmg/ddx228; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Easwaran V, 2003, CANCER RES, V63, P3145; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kim SR, 2008, EXP EYE RES, V86, P975, DOI 10.1016/j.exer.2008.03.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Ramsey SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004828; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Schick T, 2016, RETINA-J RET VIT DIS, V36, P787, DOI 10.1097/IAE.0000000000000756; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; WIEGAND RD, 1991, J NEUROCHEM, V57, P1690, DOI 10.1111/j.1471-4159.1991.tb06369.x; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002; 2010, INVEST OPHTH VIS SCI, V51, P4371, DOI DOI 10.1167/IOVS.09-4278; 2012, PPAR RES, DOI DOI 10.1155/2012/641087; 1990, EXP EYE RES, V51, P159; J CLIN INVEST, V105, P1731, DOI DOI 10.1172/JCI8472; 1990, ARTERIOSCLEROSIS, V10, P325; 2006, J BIOL CHEM, V281, P6124, DOI DOI 10.1074/JBC.M500361200; 1955, J CLIN INVEST, V34, P1345, DOI DOI 10.1172/JCI103182; 2006, SCIENCE, V314, P989, DOI DOI 10.1126/SCIENCE.1133807; 2009, EXP EYE RES, V88, P479, DOI DOI 10.1016/J.EXER.2008.10.019; 2017, ASIA PACIFIC JOURNAL, V6, P527, DOI DOI 10.22608/APO.2017260; 2001, CURRENT BIOL, V11, P951; 2002, ANGEWANDTE CHEMIE IN, V41, P814; 1999, J BIOL CHEM, V274, P1946	46	18	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216808	10.1371/journal.pone.0216808	http://dx.doi.org/10.1371/journal.pone.0216808			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100080	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600017
J	Englbrecht, M; Alten, R; Aringer, M; Baerwald, CG; Burkharde, H; Eby, N; Flacke, JP; Fliedner, G; Henkemeier, U; Hofmann, MW; Kleinert, S; Kneitz, C; Kruger, K; Pohl, C; Schett, G; Schmalzing, M; Tausche, AK; Tony, HP; Wendler, J				Englbrecht, Matthias; Alten, Rieke; Aringer, Martin; Baerwald, Christoph G.; Burkharde, Harald; Eby, Nancy; Flacke, Jan-Paul; Fliedner, Gerhard; Henkemeier, Ulf; Hofmann, Michael W.; Kleinert, Stefan; Kneitz, Christian; Krueger, Klaus; Pohl, Christoph; Schett, Georg; Schmalzing, Marc; Tausche, Anne-Kathrin; Tony, Hans-Peter; Wendler, Joerg			New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study	PLOS ONE			English	Article							PAIN; ABSENTEEISM; FATIGUE; IMPACT; PRODUCTIVITY; VALIDATION; ANXIETY; COSTS; PHQ-9; WORK	Objectives To investigate the prevalence of depressive symptoms in rheumatoid arthritis (RA) patients using two previously validated questionnaires in a large patient sample, and to evaluate depressive symptoms in the context of clinical characteristics (e.g. remission of disease) and patient-reported impact of disease. Methods In this cross-sectional study, the previously validated Patient Health Questionnaire (PHQ-9) and Beck-Depression Inventory II (BDI-II) were used to assess the extent of depressive symptoms in RA patients. Demographic background, RA disease activity score (DAS28), RA impact of disease (RAID) score, comorbidities, anti-rheumatic therapy and antidepressive treatment, were recorded. Cut-off values for depressive symptomatology were PHQ-9 >= 5 or BDI-II >= 14 for mild depressive symptoms or worse and PHQ-9 >= 10 or BDI-II >= 20 for moderate depressive symptoms or worse. Prevalence of depressive symptomatology was derived by frequency analysis while factors independently associated with depressive symptomatology were investigated by using multiple logistic regression analyses. Ethics committee approval was obtained, and all patients provided written informed consent before participation. Results In 1004 RA-patients (75.1% female, mean +/- SD age: 61.0 +/- 12.9 years, mean disease duration: 12.2 +/- 9.9 years, DAS28 (ESR): 2.5 +/- 1.2), the prevalence of depressive symptoms was 55.4% (mild or worse) and 22.8% (moderate or worse). Characteristics independently associated with depressive symptomatology were: age <60 years (OR = 1.78), RAID score >2 (OR = 10.54) and presence of chronic pain (OR = 3.25). Of patients classified as having depressive symptoms, only 11.7% were receiving anti-depressive therapy. Conclusions Mild and moderate depressive symptoms were common in RA patients according to validated tools. In routine clinical practice, screening for depression with corresponding follow-up procedures is as relevant as incorporating these results with patient-reported outcomes (e.g. symptom state), because the mere assessment of clinical disease activity does not sufficiently reflect the prevalence of depressive symptoms.	[Englbrecht, Matthias; Schett, Georg] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany; [Alten, Rieke; Pohl, Christoph] Charite Univ Med Berlin, Schlosspk Klin, Internal Med, Rheumatol, Berlin, Germany; [Aringer, Martin; Tausche, Anne-Kathrin] Tech Univ Dresden, Univ Med Ctr Carl Gustav Carus, Med 3, Dresden, Germany; [Baerwald, Christoph G.] Univ Hosp Leipzig, Dept Med Neurol & Dermatol, Rheumatol Unit, Leipzig, Germany; [Burkharde, Harald; Henkemeier, Ulf] Univ Hosp Frankfurt Main Goethe Univ, Div Rheumatol, Frankfurt, Germany; [Eby, Nancy] Ams Adv Med Serv GmbH, Biostat, Mannheim, Germany; [Flacke, Jan-Paul] Roche Pharma AG, Med Dept Rheumatol, Grenzach Wyhlen, Germany; [Fliedner, Gerhard] Rheumatol Schwerpunktpraxis, Rheumatol, Osnabruck, Germany; [Hofmann, Michael W.] Chugai Pharma Europe Ltd, Med Dept Rheumatol, Frankfurt, Germany; [Kleinert, Stefan; Wendler, Joerg] Rheumatol Schwerpunktpraxis, Rheumatol, Erlangen, Germany; [Kleinert, Stefan; Schmalzing, Marc; Tony, Hans-Peter] Univ Hosp Wuerzburg, Rheumatol Clin Immunol Dept, Internal Med 2, Wurzburg, Germany; [Kneitz, Christian] Rheumatol Schwerpunktpraxis, Schwerin, Germany; [Kneitz, Christian] Klinikum Sudstadt Rostock, Med Rheumatol Immunol, Rostock, Germany; [Krueger, Klaus] Praxiszentrum St Bonifatius, Rheumatol, Munich, Germany	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Leipzig University; Roche Holding; Chugai Pharmaceutical Co., Ltd.; University of Wurzburg	Englbrecht, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany.	m.englbrecht@statscoach.de	Aringer, Martin/AAJ-7641-2020; Baerwald, Christoph/AAD-9013-2020; Baerwald, Christoph/T-7107-2019	Aringer, Martin/0000-0003-4471-8375; Baerwald, Christoph/0000-0002-1406-3024; Kleinert, Stefan/0000-0002-2588-7547; Hofmann, Michael Werner/0000-0002-2729-6062	Roche Pharma AG; Chugai Pharma Europe Ltd.	Roche Pharma AG(Roche Holding); Chugai Pharma Europe Ltd.	This work was supported by Roche Pharma AG and Chugai Pharma Europe Ltd. Drs. Englbrecht, Alten, Aringer, Baerwald, Burkhardt, Fliedner, Kleinert, Kneitz, Krueger, Schett, Schmalzing, Tausche, Tony, and Wendler received funding. Data analysis was done by AMS Advanced Medical Services GmbH (Mannheim, Germany) and was funded by Roche Pharma AG and Chugai Pharma Europe Ltd.	[Anonymous], WHO INF PACK MAST DE; Baillet A, 2016, ANN RHEUM DIS, V75, P965, DOI 10.1136/annrheumdis-2016-209233; Beck A.T., 1996, MANUAL BECK DEPRESSI; BROWN GK, 1990, J ABNORM PSYCHOL, V99, P127, DOI 10.1037/0021-843X.99.2.127; Conner TS, 2006, PAIN, V126, P198, DOI 10.1016/j.pain.2006.06.033; Covic T, 2003, RHEUMATOLOGY, V42, P1287, DOI 10.1093/rheumatology/keg369; Covic T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-6; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dougados M, 2013, ANN RHEUM DIS, V72, P1270, DOI 10.1136/annrheumdis-2012-201469corr1; Dougados M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3859; Englbrecht M, 2017, ARTHRIT CARE RES, V69, P58, DOI 10.1002/acr.23002; Englbrecht M, 2012, SEMIN ARTHRITIS RHEU, V41, P545, DOI 10.1016/j.semarthrit.2011.07.009; Evans-Lacko S, 2016, SOC PSYCH PSYCH EPID, V51, P1525, DOI 10.1007/s00127-016-1278-4; Gossec L, 2011, ANN RHEUM DIS, V70, P935, DOI 10.1136/ard.2010.142901; Gossec L, 2009, ANN RHEUM DIS, V68, P1680, DOI 10.1136/ard.2008.100271; Gunnarsson C, 2015, J OCCUP ENVIRON MED, V57, P635, DOI 10.1097/JOM.0000000000000461; Husted JA, 2012, ARTHRIT CARE RES, V64, P758, DOI 10.1002/acr.21602; Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742; Isik A, 2007, CLIN RHEUMATOL, V26, P872, DOI 10.1007/s10067-006-0407-y; Kohlmann T, 1996, Rehabilitation (Stuttg), V35, pI; Krishnadas R, 2016, BRAIN BEHAV IMMUN, V51, P29, DOI 10.1016/j.bbi.2015.08.005; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Matcham F, 2013, RHEUMATOLOGY, V52, P2136, DOI 10.1093/rheumatology/ket169; Mattila K, 2015, RHEUMATOL INT, V35, P1791, DOI 10.1007/s00296-015-3275-4; Moll Line Thorndal, 2011, Ugeskr Laeger, V173, P2564; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Pollard LC, 2006, RHEUMATOLOGY, V45, P885, DOI 10.1093/rheumatology/kel021; Rathbun AM, 2013, RHEUMATOLOGY, V52, P1785, DOI 10.1093/rheumatology/kes356; Sergeeva M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0783-2; Sharpe L, 2001, J PSYCHOSOM RES, V51, P713, DOI 10.1016/S0022-3999(01)00266-5; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Sruamsiri R, 2018, MOD RHEUMATOL, V28, P482, DOI 10.1080/14397595.2017.1361893; Sturgeon JA, 2016, NAT REV RHEUMATOL, V12, P532, DOI 10.1038/nrrheum.2016.112; Verstappen SMM, 2015, BEST PRACT RES CL RH, V29, P495, DOI 10.1016/j.berh.2015.06.001; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; Wolfe F, 2009, ARTHRIT RHEUM-ARTHR, V61, P667, DOI 10.1002/art.24428; Ziarko M, 2014, SCI WORLD J, DOI 10.1155/2014/585063	41	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217412	10.1371/journal.pone.0217412	http://dx.doi.org/10.1371/journal.pone.0217412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136632	Green Published, gold, Green Submitted			2022-12-27	WOS:000469224300037
J	Siika, A; Liljeqvist, ML; Zommorodi, S; Nilsson, O; Andersson, P; Gasser, TC; Roy, J; Hultgren, R				Siika, Antti; Liljeqvist, Moritz Lindquist; Zommorodi, Sayid; Nilsson, Olga; Andersson, Patricia; Gasser, T. Christian; Roy, Joy; Hultgren, Rebecka			A large proportion of patients with small ruptured abdominal aortic aneurysms are women and have chronic obstructive pulmonary disease	PLOS ONE			English	Article							WALL STRESS; BODY-SIZE; SURVEILLANCE; GROWTH; REPAIR; METAANALYSIS; GENDER; RISK; PREVALENCE; MORPHOLOGY	Objective In a population-based cohort of ruptured abdominal aortic aneurysms (rAAAs), our aim was to investigate clinical, morphological and biomechanical features in patients with small rAAAs. Methods All patients admitted to an emergency department in Stockholm and Gotland, a region with a population of 2.1 million, between 2009-2013 with a CT-verified rupture (n = 192) were included, and morphological measurements were performed. Patients with small rAAAs, maximal diameter (Dmax) <= 60 mm were selected (n = 27), and matched 2: 1 by Dmax, sex and age to intact AAA (iAAAs). For these patients, morphology including volume and finite element analysis-derived biomechanics were assessed. Results The mean Dmax for all rAAAs was 80.8 mm (SD = 18.9 mm), women had smaller Dmax at rupture (73.4 +/- 18.4 mm vs 83.1 +/- 18.5 mm, p = 0.003), and smaller neck and iliac diameters compared to men. Aortic size index (ASI) was similar between men and women (4.1 +/- 3.1 cm/m(2) vs 3.8 +/- 1.0 cm/m(2)). Fourteen percent of all patients ruptured at Dmax <= 60 mm, and a higher proportion of women compared to men ruptured at Dmax <= 60 mm: 27% (12/45) vs. 10% (15/147), p = 0.005. Also, a higher proportion of patients with a chronic obstructive pulmonary disease ruptured at Dmax <= 60 mm (34.6% vs 14.6%, p = 0.026). Supra-renal aortic size index (14.0, IQR 13.3-15.3 vs 12.8, IQR = 11.4-14.0) and peak wall rupture index (PWRI, 0.35 +/- 0.08 vs 0.43 +/- 0.11, p = 0.016) were higher for small rAAAs compared to matched iAAAs. Aortic size index, peak wall stress and aneurysm volume did not differ. Conclusion More than one tenth of ruptures occur at smaller diameters, women continuously suffer an even higher risk of presenting with smaller diameters, and this must be considered in surveillance programs. The increased supra-renal aortic size index and PWRI are potential markers for rupture risk, and patients under surveillance with these markers may benefit from increased attention, and potentially from timely repair.	[Siika, Antti; Liljeqvist, Moritz Lindquist; Zommorodi, Sayid; Nilsson, Olga; Andersson, Patricia; Roy, Joy; Hultgren, Rebecka] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Zommorodi, Sayid] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden; [Roy, Joy; Hultgren, Rebecka] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden; [Gasser, T. Christian] KTH Royal Inst Technol, Dept Solid Mech, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Siika, A (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	antti.siika@ki.se	Hultgren, Rebecka/K-8738-2012	Hultgren, Rebecka/0000-0002-8869-0493; Nilsson, Olga/0000-0002-7670-1677; Saratzis, Athanasios/0000-0002-3399-094X	Swedish Heart-Lung Foundation [20140722, 20130657, 20160266, 20180596]; Swedish Society of Medicine [SLS-174151]; regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council [20150537, 20180072, 20150916, 20180867]; Health, Medicine and Technology (Stockholm County Council) [20150916, 20180867]; Senior Clinical Research Appointment (Stockholm County Council) [20150906]; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council; Health, Medicine and Technology (Stockholm County Council)(Stockholm County Council); Senior Clinical Research Appointment (Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This research was supported by the Swedish Heart-Lung Foundation (20140722, 20130657, 20160266, 20180596), the Swedish Society of Medicine (SLS-174151), and through the regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council (20150537, 20180072, 20150916, 20180867), The Health, Medicine and Technology (Stockholm County Council 20150916, 20180867), Senior Clinical Research Appointment (Stockholm County Council: 20150906), and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Deery SE, 2018, VASC ENDOVASC SURG, V52, P543, DOI 10.1177/1538574418773247; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Dunsmore Sarah E, 2008, Int J Chron Obstruct Pulmon Dis, V3, P113; Erhart P, 2016, J ENDOVASC THER, V23, P115, DOI 10.1177/1526602815612196; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Forbes TL, 2006, ANN VASC SURG, V20, P564, DOI 10.1007/s10016-006-9079-y; Gasser TC, 2010, EUR J VASC ENDOVASC, V40, P176, DOI 10.1016/j.ejvs.2010.04.003; Ghatwary T, 2012, J ENDOVASC THER, V19, P400, DOI 10.1583/11-3731MR.1; GLOVICZKI P, 1992, J VASC SURG, V15, P851, DOI 10.1016/0741-5214(92)90720-S; Hardman DTA, 1996, J VASC SURG, V23, P123, DOI 10.1016/S0741-5214(05)80042-4; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [DOI 10.18637/JSS.V042.I08, 10.18637/jss.v042.i08]; Hultgren R, 2019, BRIT J SURG, V106, P206, DOI 10.1002/bjs.11047; Hultgren R, 2016, WORLD J SURG, V40, P3080, DOI 10.1007/s00268-016-3705-9; Indrakusuma R, 2016, EUR J VASC ENDOVASC, V52, P475, DOI 10.1016/j.ejvs.2016.07.003; Jones GT, 2019, EUR J VASC ENDOVASC, V57, P221, DOI 10.1016/j.ejvs.2018.08.048; Khosla S, 2014, BRIT J SURG, V101, P1350, DOI 10.1002/bjs.9578; Kristmundsson T, 2016, ANN VASC SURG, V31, P18, DOI 10.1016/j.avsg.2015.09.016; Laine MT, 2016, EUR J VASC ENDOVASC, V51, P511, DOI 10.1016/j.ejvs.2015.12.011; Larsson E, 2011, J VASC SURG, V54, P295, DOI 10.1016/j.jvs.2010.12.053; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 2016, JAMA INTERN MED, V176, P1767, DOI 10.1001/jamainternmed.2016.6663; Liljeqvist ML, 2017, J VASC SURG, V65, P1014, DOI 10.1016/j.jvs.2016.10.074; Liljeqvist ML, 2016, J VASC SURG, V63, P1434, DOI 10.1016/j.jvs.2015.11.051; Lo RC, 2014, J VASC SURG, V59, P1209, DOI 10.1016/j.jvs.2013.10.104; Manning BJ, 2009, J VASC SURG, V50, P263, DOI 10.1016/j.jvs.2009.02.243; McCready R A, 1993, Ann Vasc Surg, V7, P225, DOI 10.1007/BF02000246; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Oliver-Williams C, 2018, BRIT J SURG, V105, P68, DOI 10.1002/bjs.10715; Oliver-Williams C, 2019, CIRCULATION, V139, P1371, DOI 10.1161/CIRCULATIONAHA.118.036966; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; Parkinson F, 2015, J VASC SURG, V61, P1606, DOI 10.1016/j.jvs.2014.10.023; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; R Development Core Team, 2009, R LANG ENV STAT COMP; Shang EK, 2013, J VASC SURG, V57, P84, DOI 10.1016/j.jvs.2012.07.002; Takagi H, 2017, INT ANGIOL, V36, P322, DOI 10.23736/S0392-9590.16.03762-7; Thompson SG, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17410; Truijers M, 2007, EUR J VASC ENDOVASC, V33, P401, DOI 10.1016/j.ejvs.2006.10.009; Ulug P, 2016, BRIT J SURG, V103, P1097, DOI 10.1002/bjs.10225; Ulug P, 2017, LANCET, V389, P2482, DOI 10.1016/S0140-6736(17)30639-6; Villard C, 2017, J VASC SURG, V66, P579, DOI 10.1016/j.jvs.2016.02.056; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wanhainen A, 2016, CIRCULATION, V134, P1141, DOI 10.1161/CIRCULATIONAHA.116.022305; Zommorodi S, 2016, J VASC SURG, V64, P949, DOI 10.1016/j.jvs.2016.04.007	45	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216558	10.1371/journal.pone.0216558	http://dx.doi.org/10.1371/journal.pone.0216558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136570	gold, Green Submitted, Green Published			2022-12-27	WOS:000469224300007
J	Chang, PY; Chung, CH; Chang, WC; Lin, CS; Lin, HH; Dai, MS; Ho, CL; Chien, WC				Chang, Ping-Ying; Chung, Chi-Hsiang; Chang, Wei-Chou; Lin, Chun-Shu; Lin, Hsuan-Hwai; Dai, Ming-Shen; Ho, Ching-Liang; Chien, Wu-Chien			The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study	PLOS ONE			English	Article							BETA-BLOCKER USAGE; CANCER SURVIVAL; INTRAHEPATIC RECURRENCE; SORAFENIB RESISTANCE; MALIGNANT-MELANOMA; RISK-FACTORS; ANGIOGENESIS; METAANALYSIS; MORTALITY; INVASION	Background Beta-blockers can reduce recurrence, metastasis, and mortality in various cancers. In this study, we investigated the effect of propranolol, a non-selective beta-blocker on overall survival (OS) in unresectable/metastatic hepatocellular carcinoma (HCC) and on recurrencefree survival (RFS) in resectable, curable HCC. Methods Data were retrieved from the Taiwan National Health Insurance Research Database between January 2000 and December 2013. Propranolol users (for >1 year) and non-propranolol users were matched using a 1: 2 propensity score in both cohorts. Results The unresectable/metastatic HCC cohort comprised 1,560 propranolol users and 3,120 non-propranolol users (control group). On multivariate Cox regression analysis of HCC mortality, propranolol significantly reduced the mortality risk by 22% (hazard ratio [HR] = 0.78, 95% confidence interval [CI] 0.72-0.84, P < 0.001). On stratified Cox regression analysis, propranolol also reduced the mortality risk in HCC patients with hepatitis B (HR = 0.92, 95% CI 0.85-0.99, P = 0.045), hepatitis C (HR = 0.85, 95% CI = 0.78-0.92, P = 0.001), liver cirrhosis (HR = 0.78, 95% CI = 0.72-0.85, P < 0.001), and diabetes mellitus (HR = 0.87, 95% CI = 0.81-0.94, P = 0.008). The resectable, curable HCC cohort comprised 289 propranolol users and 578 non-propranolol users (control group), but there was no significant difference in RFS (P = 0.762) between propranolol and non-propranolol users. Conclusion This study revealed that propranolol could improve OS in unresectable/metastatic HCC.	[Chang, Ping-Ying; Dai, Ming-Shen; Ho, Ching-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Hematol Oncol, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chang, Wei-Chou] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Chun-Shu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Lin, Hsuan-Hwai] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.	chienwu@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; DAI, M/GPS-8291-2022		Tri-Service General Hospital Research Foundation [TSGH-C108-003]	Tri-Service General Hospital Research Foundation	This study was supported by grants from Tri-Service General Hospital Research Foundation (TSGH-C108-003 to W-CC), and the sponsor has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Bonovas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045259; BRAILLON A, 1992, HEPATOLOGY, V15, P58, DOI 10.1002/hep.1840150112; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Cardwell CR, 2014, CANCER EPIDEMIOL, V38, P279, DOI 10.1016/j.canep.2014.03.011; Cardwell CR, 2013, INT J EPIDEMIOL, V42, P1852, DOI 10.1093/ije/dyt196; Chang PY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001097; Chen DT, 2012, ANN SURG ONCOL, V19, P3556, DOI 10.1245/s10434-012-2396-1; Chen HY, 2014, ENDOCR-RELAT CANCER, V21, P783, DOI 10.1530/ERC-14-0236; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Grytli HH, 2014, EUR UROL, V65, P635, DOI 10.1016/j.eururo.2013.01.007; Guo K, 2009, ONCOL REP, V22, P825, DOI 10.3892/or_00000505; Hicks BM, 2013, ANN ONCOL, V24, P3100, DOI 10.1093/annonc/mdt381; Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kassahun WT, 2012, PHARMACOLOGY, V89, P313, DOI 10.1159/000337381; Lemeshow S, 2011, CANCER EPIDEM BIOMAR, V20, P2273, DOI 10.1158/1055-9965.EPI-11-0249; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu LC, 2014, SEMIN LIVER DIS, V34, P427, DOI 10.1055/s-0034-1394141; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; McCourt C, 2014, BRIT J DERMATOL, V170, P930, DOI 10.1111/bjd.12894; Monami M, 2013, CURR MED RES OPIN, V29, P369, DOI 10.1185/03007995.2013.772505; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nkontchou G, 2012, CANCER PREV RES, V5, P1007, DOI 10.1158/1940-6207.CAPR-11-0450; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Shah SM, 2011, BRIT J CLIN PHARMACO, V72, P157, DOI 10.1111/j.1365-2125.2011.03980.x; Shen J, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316656679; Singh S, 2014, NAT REV GASTRO HEPAT, V11, P45, DOI 10.1038/nrgastro.2013.143; Smith C, 1999, CARDIOVASC DRUG THER, V13, P123, DOI 10.1023/A:1007784109255; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thiele M, 2015, LIVER INT, V35, P2009, DOI 10.1111/liv.12782; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616; Watkins JL, 2015, CANCER-AM CANCER SOC, V121, P3444, DOI 10.1002/cncr.29392; Wu FQ, 2016, J HEPATOL, V65, P314, DOI 10.1016/j.jhep.2016.04.019; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Zhang ZF, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0474-8; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216828	10.1371/journal.pone.0216828	http://dx.doi.org/10.1371/journal.pone.0216828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125347	Green Submitted, Green Published, gold			2022-12-27	WOS:000468865700007
J	Domingues, RMSM; Figueiredo, VC; Leal, MD				Soares Madeira Domingues, Rosa Maria; Figueiredo, Valeska Carvalho; Leal, Maria do Carmo			Prevalence of pre-gestational and gestational smoking and factors associated with smoking cessation during pregnancy, Brazil, 2011-2012	PLOS ONE			English	Article							BIRTH-WEIGHT; RISK-FACTORS; ALCOHOL-USE; TOBACCO USE; WOMEN; ARGENTINA; EXPOSURE	Gestational smoking is associated with various adverse maternal and fetal outcomes. Over the last three decades, despite considerable advances in tobacco control policy in Brazil, gestational smoking has caused a considerable number of fetal deaths and disabilities. The aim of this study is to estimate the prevalence of pre-gestational and gestational smoking and to identify the factors associated with smoking cessation up to the 20 th gestational week. Methods: "Birth in Brazil" was a nationwide hospital-based study conducted from February 2011 to October 2012. Smoking prevalence and smoking cessation during pregnancy was estimated through face-to-face interviews with postpartum women during hospitalization for birth care. We performed multivariate logistic regression to verify the factors associated with smoking cessation up to the 5th month of pregnancy. Results: prevalence of pre-gestational smoking of 16.1% (CI 95% 15.3%-16.9%); prevalence of smoking any time during pregnancy of 9.6% (CI 95% 9.0%-10.3%); and prevalence of smoking cessation up to the 5th month of pregnancy of 56.7% (CI 95% 54.0%-59.4%). The factors associated with smoking cessation were residence in the North, Northeast, and Central-West of Brazil, having received at least one prenatal consultation (OR 3.51 CI 95% 1.85-6.67), more years of schooling (15 or more vs less than 7 years of schooling OR 5.54 CI 95% 2.97-10.34), living with a partner (OR 1.35 CI 95% 1.01-1.79), no children prior to the index pregnancy (OR 2.77 CI 95% 2.13-3.61), and absence of alcohol use (1.74 CI 95% 1.39-2.18) or of suspected alcohol abuse (OR 1.62 CI 95% 1.07-2.45). Conclusion: The estimated smoking rate during pregnancy in Brazil is still high and is associated with factors of increased maternal social vulnerability, which may contribute to the increased occurrence of unfavorable perinatal outcomes.	[Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST Aids, Rio De Janeiro, Brazil; [Figueiredo, Valeska Carvalho; Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Dept Epidemiol & Metodos Quantitat Saude, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Domingues, RMSM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST Aids, Rio De Janeiro, Brazil.	rosa.domingues@ini.fiocruz.br	Domingues, Rosa/AAS-3606-2020; Figueiredo, Valeska Carvalho/D-4268-2018; Carvalho Figueiredo, Valeska/D-4268-2018	Domingues, Rosa/0000-0001-5722-8127; Figueiredo, Valeska Carvalho/0000-0002-3379-0024; Carvalho Figueiredo, Valeska/0000-0001-8617-5386	National Council of Technological and Scientific Development (CNPq); National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the funding from the National Council of Technological and Scientific Development (CNPq); the National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althabe F, 2008, MEDICINA-BUENOS AIRE, V68, P48; Alves E, 2013, NICOTINE TOB RES, V15, P1598, DOI 10.1093/ntr/ntt026; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Berrueta M, 2016, NICOTINE TOB RES, V18, P1116, DOI 10.1093/ntr/ntv145; Bloch M, 2008, AM J PUBLIC HEALTH, V98, P1833, DOI 10.2105/AJPH.2007.117887; Bloch M, 2014, LANCET GLOB HEALTH, V2, pE489, DOI 10.1016/S2214-109X(14)70294-3; Brasil. Ministerio do Planejamento Orcamento e Instituto Brasileiro de Geografia e Estatistica-IBGE. Diretoria de Pesquisas Coordenac de Trabalho e Rendimento. Pesquisa Nacional de Saude do estado de saude, 2014, DIR PESQ COORD TRAB; Castles A, 1999, AM J PREV MED, V16, P208, DOI 10.1016/S0749-3797(98)00089-0; Lopes NMC, 2015, MUNDO SAUDE, V39, P102; Pereira PPD, 2017, NICOTINE TOB RES, V19, P497, DOI 10.1093/ntr/ntw228; David A, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P199; Delpisheh A, 2006, WOMENS HEALTH, V2, P389, DOI 10.2217/17455057.2.3.389; Department of Health, 2003, IMPL GUID MAINSTR GE; Dias-Dame JL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/345430; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; Drake P, 2018, CIGARETTE SMOKING PR; EURO-PERISTAT Project with SCPE and EUROCAT, 2013, HLTH CAR PREGN WOM B; Gilbert NL, 2015, J OBSTET GYNAECOL CA, V37, P32, DOI 10.1016/S1701-2163(15)30360-1; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; IBM Corp, 2010, IBM SPSS STAT WINDOW; Kale PL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1737-y; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lange S, 2018, LANCET GLOB HEALTH, V6, pE769, DOI 10.1016/S2214-109X(18)30223-7; Lange S, 2015, ADDICT BEHAV, V50, P102, DOI 10.1016/j.addbeh.2015.06.018; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013; Lucchese R, 2016, ACTA PAUL ENFERM, V29, P325, DOI 10.1590/1982-0194201600045; Marufu TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1552-5; Ministerio da Saude, 2002, PROGR HUM PRE NAT NA; Moraes CL, 2007, REV SAUDE PUBL, V41, P695, DOI 10.1590/S0034-89102007000500002; Nielsen SS, 2014, ANN EPIDEMIOL, V24, P236, DOI 10.1016/j.annepidem.2013.12.008; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Perez-Franco J, 2015, REV CHIL SALUD PUBLI, V19, P37; Pineles BL, 2014, AM J EPIDEMIOL, V179, P807, DOI 10.1093/aje/kwt334; Portes LH, 2018, CIENC SAUDE COLETIVA, V23, P1837, DOI 10.1590/1413-81232018236.05202018; Portes LH, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00017317; Reis Liane G., 2008, Rev. Bras. Saude Mater. Infant., V8, P217, DOI 10.1590/S1519-38292008000200009; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Riaz M, 2018, ADDICTION, V113, P610, DOI 10.1111/add.14135; Santos IS, 2008, CAD SAUDE PUBLICA, V24, pS381, DOI 10.1590/S0102-311X2008001500003; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Smedberg J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-213; Stringhini S, 2017, LANCET GLOB HEALTH, V5, pE230, DOI 10.1016/S2214-109X(17)30054-2; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Szklo AS, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00207416, 10.1590/0102-311x00207416]; Szklo AS, 2016, TOB CONTROL, V25, P564, DOI 10.1136/tobaccocontrol-2015-052324; Tong VT, 2013, PUBLIC HEALTH REP, V128, P179, DOI 10.1177/003335491312800308; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; World Health Organization, 2013, WHO REC PREV MAN TOB; Yan J, 2015, MATERN CHILD HLTH J, V19, P447, DOI 10.1007/s10995-014-1516-x	51	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217397	10.1371/journal.pone.0217397	http://dx.doi.org/10.1371/journal.pone.0217397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125373	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700035
J	Truijens, D; van Exel, J				Truijens, Daphne; van Exel, Job			Views on deceased organ donation in the Netherlands: A q-methodology study	PLOS ONE			English	Article							NEXT-OF-KIN; PRESUMED CONSENT; ATTITUDES; BEHAVIOR; HEALTH; DONOR; REGISTRATION; KNOWLEDGE; RISK; COMMUNICATION	In many countries, such as the US, Germany, France, and the Netherlands, governments are dealing with a great shortage of organ donors. Even though people generally show positive attitudes towards organ donation, they often do not actually register as organ donors themselves. This study's objective was to explore prevailing viewpoints among the Dutch population on deceased organ donation and the relation between aspects of the viewpoints potentially influencing the decision to register as an organ donor. Although substantive research about attitudes on organ donation has been conducted, this is the first study investigating people's viewpoints focusing on the relation between beliefs, tastes, preferences, motives, goals and other constituents underlying people's viewpoints on organ donation, such as the role of the media and public policies. This Q-methodology study revealed four viewpoints: "not donating your organs is a waste", "it does not go with my religion", "my family should decide"; and "it's a good deed, but I'm doubtful". These viewpoints convey information on potential reasons for the gap between people's favourable attitudes towards organ donation and the low number of actual registrations, and opportunities for policy makers to address certain target groups more adequately.	[Truijens, Daphne] Erasmus Univ, Inst Philosophy & Econ, Rotterdam, Netherlands; [Truijens, Daphne; van Exel, Job] Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands; [van Exel, Job] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam	Truijens, D (corresponding author), Erasmus Univ, Inst Philosophy & Econ, Rotterdam, Netherlands.; Truijens, D (corresponding author), Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands.	truijens@ese.eur.nl	van Exel, Job/E-6191-2013	van Exel, Job/0000-0002-4178-1777; Truijens, Daphne/0000-0003-2844-2364				Abadie A, 2006, J HEALTH ECON, V25, P599, DOI 10.1016/j.jhealeco.2006.01.003; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akhtar-Danesh Noori, 2007, Nurs Leadersh (Tor Ont), V20, P67; Baker R.M., 2010, OPERANT SUBJECTIVITY, V34, P38; Baker Rachel, 2006, J Health Serv Res Policy, V11, P38, DOI 10.1258/135581906775094217; Bernhardt AM, 2014, CURR OPIN ORGAN TRAN, V19, P494, DOI 10.1097/MOT.0000000000000118; Brown S.R., 1995, OPERANT SUBJECTIVITY, V18, P1; Brown S.R., 1980, POLITICAL SUBJECTIVI; Bryant LD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015973; Cross RM, 2005, HEALTH EDUC RES, V20, P206, DOI 10.1093/her/cyg121; Davison SN, 2014, AM J KIDNEY DIS, V64, P781, DOI 10.1053/j.ajkd.2014.06.029; Dinner I, 2011, J EXP PSYCHOL-APPL, V17, P332, DOI 10.1037/a0024354; Falomir-Pichastor JM, 2013, HEALTH PSYCHOL REV, V7, P202, DOI 10.1080/17437199.2011.570516; Feeley TH, 2007, J APPL SOC PSYCHOL, V37, P243, DOI 10.1111/j.0021-9029.2007.00159.x; Feeley TH, 2009, COMMUN REP, V22, P63, DOI 10.1080/08934210903258852; Guden E, 2013, J RELIG HEALTH, V52, P439, DOI 10.1007/s10943-011-9490-8; Hubner G, 2014, OPEN J MED PSYCHOL, V3, P355; Hyde MK, 2013, HEALTH EDUC RES, V28, P1092, DOI 10.1093/her/cyt078; Jachimowicz JM, 2016, DEFAULT SWITCHING HI; Johnson EJ, 2004, TRANSPLANTATION, V78, P1713, DOI 10.1097/01.TP.0000149788.10382.B2; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Kennedy I, 1998, LANCET, V351, P1650, DOI 10.1016/S0140-6736(97)08212-3; Kitzinger C., 1987, SOCIAL CONSTRUCTION; Levitt M, 2011, ORGAN SHORTAGE ETHIC, V10, P52; MANNINEN DL, 1985, JAMA-J AM MED ASSOC, V253, P3111, DOI 10.1001/jama.253.21.3111; Marck CH, 2014, ORGANS TISSUES CELLS, V17, P175; Marlais M, 2017, TRANSPLANTATION, V101, P1177, DOI 10.1097/TP.0000000000001264; McKeown B., 2013, Q METHODOLOGY, V66; Mohamed E, 2013, TRANSPL P, V45, P3469, DOI 10.1016/j.transproceed.2013.08.095; Morgan M, 2013, ETHNIC HEALTH, V18, P367, DOI 10.1080/13557858.2012.752073; Morgan SE, 2002, J APPL COMMUN RES, V30, P163, DOI 10.1080/00909880216580; Morgan SE, 2009, COMMUN THEOR, V19, P29, DOI 10.1111/j.1468-2885.2008.01331.x; Murray L, 2013, TRANSPL P, V45, P10, DOI 10.1016/j.transproceed.2012.10.021; Orentlicher D, 2009, RUTGERS LAW REV, V61, P295; Patty NJS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4879-2; Quick BL, 2016, HEALTH COMMUN, V31, P265, DOI 10.1080/10410236.2014.947468; Radecki CMM, 1997, HEALTH PSYCHOL, V16, P183, DOI 10.1037/0278-6133.16.2.183; Rady MY, 2014, PHILOS ETHICS HUM ME, V9, DOI 10.1186/1747-5341-9-11; Risdon A, 2003, SOC SCI MED, V56, P375, DOI 10.1016/S0277-9536(02)00043-6; Rodrigue JR, 2006, TRANSPLANTATION, V81, P1249, DOI 10.1097/01.tp.0000203165.49905.4a; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Schmolck P, PQ METHOD SOFTWARE M; Shemmings D., 2006, QUALITATIVE RES PSYC, V3, P147, DOI [DOI 10.1191/1478088706qp060oa, https://doi.org/10.1191/1478088706qp060oa, DOI 10.1191/1478088706QP060OA]; Shepherd L, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0131-4; Shepherd L, 2014, J HEALTH PSYCHOL, V19, P1329, DOI 10.1177/1359105313488984; Siegel JT, 2014, HEALTH PSYCHOL, V33, P1084, DOI 10.1037/hea0000062; Smith NC, 2013, J PUBLIC POLICY MARK, V32, P159, DOI 10.1509/jppm.10.114; Stevens C., APPL SINGLE CATEGORY; Thaler RH, 2008, WEALTH HAPPINESS, V6; Tielen M, 2008, TRANSPLANTATION, V85, P700, DOI 10.1097/TP.0b013e318166163e; van Exel J, 2015, SOC SCI MED, V126, P128, DOI 10.1016/j.socscimed.2014.12.023; van Exel NJA, 2006, SOC SCI MED, V63, P2628, DOI 10.1016/j.socscimed.2006.06.028; Vermaire JH, 2010, COMMUNITY DENT ORAL, V38, P507, DOI 10.1111/j.1600-0528.2010.00558.x; Wall SP, 2015, JAMA-J AM MED ASSOC, V313, P2321, DOI 10.1001/jama.2015.5328; Watts S., 2012, DOING Q METHODOLOGIC; Zimmerman D, 2006, NEPHROL DIAL TRANSPL, V21, P2569, DOI 10.1093/ndt/gfl218	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216479	10.1371/journal.pone.0216479	http://dx.doi.org/10.1371/journal.pone.0216479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125339	Green Published, Green Submitted, gold			2022-12-27	WOS:000468865700005
J	van Leersum, CM; Moser, A; van Steenkiste, B; Wolf, JRLM; van der Weijden, T				van Leersum, Catharina M.; Moser, Albine; van Steenkiste, Ben; Wolf, Judith R. L. M.; van der Weijden, Trudy			Getting to grips with the process of decision-making in long-term care. Descriptive cases illustrate the chaotic reality of the construction of preferences	PLOS ONE			English	Article							MENTAL-CAPACITY; LIFE	Background Clients facing decision-making for long-term care are in need of support and accessible information. Construction of preferences, including context and calculations, for clients in long-term care is challenging because of the variability in supply and demand. This study considers clients in four different sectors of long-term care: the nursing and care of the elderly, mental health care, care of people with disabilities, and social care. The aim is to understand the construction of preferences in real-life situations. Method Client choices were investigated by qualitative descriptive research. Data were collected from 16 in-depth interviews and 79 client records. Interviews were conducted with clients and relatives or informal caregivers from different care sectors. The original client records were explored, containing texts, letters, and comments of clients and caregivers. All data were analyzed using thematic analysis. Results Four cases showed how preferences were constructed during the decision-making process. Clients discussed a wide range of challenging aspects that have an impact on the construction of preferences, e.g. previous experiences, current treatment or family situation. This study describes two main characteristics of the construction of preferences: context and calculation. Conclusion Clients face diverse challenges during the decision-making process on long-term care and their construction of preferences is variable. A well-designed tool to support the elicitation of preferences seems beneficial.	[van Leersum, Catharina M.; Moser, Albine; van Steenkiste, Ben; van der Weijden, Trudy] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Med Ctr, Maastricht, Netherlands; [Moser, Albine] Zuyd Univ Appl Sci, Res Ctr Auton & Participat Persons Chron Illness, Heerlen, Netherlands; [Wolf, Judith R. L. M.] Radboud Univ Nijmegen, Impuls Netherlands Ctr Social Care Res, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands	Maastricht University; Radboud University Nijmegen	van Leersum, CM (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Med Ctr, Maastricht, Netherlands.	karin.vanleersum@maastrichtuniversity.nl	Wolf, Judith/H-8122-2014	Wolf, Judith/0000-0001-7106-9142; van Leersum, Catharina/0000-0002-1003-0794; van der weijden, trudy/0000-0002-7469-3781	ZonMw, The Hague, The Netherlands [516012502]	ZonMw, The Hague, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	TvdW received a fund by ZonMw, The Hague, The Netherlands (516012502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boot AWA, 2017, WETEN IS NOG GEEN DO; Bosselaar H., 2013, BOUWPLAATS LOKALE VE; Carter G, 2017, DEMENTIA-LONDON, V16, P79, DOI 10.1177/1471301215581227; Chatfield DA, 2018, NURS CRIT CARE, V23, P82, DOI 10.1111/nicc.12290; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Friesen-Storms JHHM, 2015, INT J NURS STUD, V52, P393, DOI 10.1016/j.ijnurstu.2014.06.012; Guo L, 2016, MANAGE SCI, V62, P2977, DOI 10.1287/mnsc.2015.2290; Habermas Jurgen, THEORY COMMUNICATIVE, P368; Hendrinks M, 2017, VERSLAG TWEEDAAGSE B; Iederin NPCF, 2017, ALS ZORG ONDERSTEUNI; Kahneman D, 2011, ONS FEILBARE DENKEN; Kane RA, 2001, GERONTOLOGIST, V41, P293, DOI 10.1093/geront/41.3.293; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Lindquist LA, 2017, PATIENT EDUC COUNS, V100, P1996, DOI 10.1016/j.pec.2017.06.028; McCall N, 2001, WHO WILL PAY LONG TE, P3; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Nicholson TRJ, 2008, BRIT MED J, V336, P322, DOI 10.1136/bmj.39457.485347.80; Oosterkamp E, 2016, SOCIAALBESTEK, V78, P3, DOI DOI 10.1007/S41196-016-0064-X; SLOVIC P, 1995, AM PSYCHOL, V50, P364, DOI 10.1037/0003-066X.50.5.364; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Tinetti ME, 2016, CLIN GERIATR MED, V32, P261, DOI 10.1016/j.cger.2016.01.012; Turnpenny A, 2015, HEALTH SOC CARE COMM, V23, P349, DOI 10.1111/hsc.12133; Warren C, 2011, WIRES COGN SCI, V2, P193, DOI 10.1002/wcs.98	24	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217338	10.1371/journal.pone.0217338	http://dx.doi.org/10.1371/journal.pone.0217338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125374	Green Published, gold, Green Submitted			2022-12-27	WOS:000468865700029
J	Adeniyi, OF; Odeghe, EA; Lawal, MA; Olowu, AO; Ademuyiwa, A				Adeniyi, Oluwafunmilayo Funke; Odeghe, Emuobor Aghoghor; Lawal, Mary Adetola; Olowu, Adebambo Olatunde; Ademuyiwa, Adesoji			Recurrent abdominal pain and upper gastrointestinal endoscopy findings in children and adolescents presenting at the Lagos University Teaching Hospital	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GASTRITIS; CLASSIFICATION; DIAGNOSIS	Introduction Recurrent abdominal pain (RAP) is a common reason for referral to the paediatric gastroenterology unit and the attending physician needs to be able to rule out an organic cause when evaluating any child with this condition. The aim of this study was to describe the endoscopic findings in children who presented to the paediatric gastroenterology unit of the Lagos University Teaching Hospital (LUTH) with RAP. Methods This was a prospective descriptive study which was conducted from January 2015 to July 2018 at the Paediatric Gastroenterology unit of the department of Paediatrics and the endoscopy unit of the LUTH, Lagos, Nigeria. All children and adolescents. 19 years old with recurrent abdominal pain who were referred for upper GI endoscopy during the study period, were recruited. Baseline sociodemographic data, dyspepsia and alarm symptoms if present were documented. Results of other investigations namely stool examination for ova, parasites, occult blood and faecal antigen for Helicobacter pylori and abdominal scan were also documented. Results A total of 113 children with recurrent abdominal pain was referred during the study period and 87 (76.7%) of them had upper GI endoscopy done. Out of the participants, 38(43.7%) were boys and 49(56.3) girls. Alarm features were present in 15(17.6%) and dyspepsia was seen in 22(25.3%) of the subjects. The main endoscopic findings were: gastritis in 39 (44.8%), gastric erosions in 14(16.2%), hiatus hernia in 7(8.1%), duodenitis in 6 (6.9%), gastric polyp in 4 (4.6%). Conclusion Upper GI endoscopy remains an invaluable tool in the tool in evaluating RAP in children as it enables accurate diagnosis of GI causes of RAP. There is a need to advocate for easier access to this procedure in the developing countries.	[Adeniyi, Oluwafunmilayo Funke] Univ Lagos, Coll Med, Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Odeghe, Emuobor Aghoghor] Univ Lagos, Coll Med, Lagos Univ Teaching Hosp, Dept Med, Lagos, Nigeria; [Lawal, Mary Adetola] Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Olowu, Adebambo Olatunde] Lagos Univ Teaching Hosp, Dept Anaesthesia, Lagos, Nigeria; [Ademuyiwa, Adesoji] Lagos Univ Teaching Hosp, Dept Surg, Paediat Surg Unit, Lagos, Nigeria	University of Lagos; University of Lagos	Adeniyi, OF (corresponding author), Univ Lagos, Coll Med, Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria.	layo_funke@yahoo.co.uk	Adeniyi, Oluwafunmilayo/CAF-6583-2022; Adeniyi, Oluwafunmilayo/ABA-2009-2020	Adeniyi, Oluwafunmilayo/0000-0003-2564-6118; Odeghe, Emuobor/0000-0003-1108-9293; Ademuyiwa, Adesoji/0000-0003-2415-3098				Aanpreung Prapun, 1997, Journal of the Medical Association of Thailand, V80, P22; Agreus Lars, 1993, Scandinavian Journal of Primary Health Care, V11, P252, DOI 10.3109/02813439308994840; APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; ASHORN M, 1993, J PEDIATR GASTR NUTR, V16, P273, DOI 10.1097/00005176-199304000-00009; Bangoura AD, 2016, OPEN J GASTROENTEROL, V6, P397, DOI [10.4236/ojgas.2016.612042, DOI 10.4236/OJGAS.2016.612042]; Brett T, 2012, BRIT J GEN PRACT, V62, P386, DOI 10.3399/bjgp12X652562; Calvet X, 2010, CLIN INFECT DIS, V50, P323, DOI 10.1086/649860; Di Lorenzo C, 2005, PEDIATRICS, V115, P812, DOI 10.1542/peds.2004-2497; Dominguez J, 2006, ALIMENT PHARM THER, V23, P1735, DOI 10.1111/j.1365-2036.2006.02936.x; Edwards T, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0769-z; Elwyn G, 2007, BRIT J GEN PRACT, V57, P401; Hyams JS, 2016, GASTROENTEROLOGY, V150, P1456, DOI 10.1053/j.gastro.2016.02.015; Joshi M R, 2005, Kathmandu Univ Med J (KUMJ), V3, P111; Kayacetin S, 2014, TURK J GASTROENTEROL, V25, P233, DOI 10.5152/tjg.2014.7906; Motamed F, 2012, IRAN J PEDIATR, V22, P309; Okello Tom Richard, 2006, Afr Health Sci, V6, P39; Plunkett A, 2005, J ROY SOC MED, V98, P101, DOI 10.1258/jrsm.98.3.101; Quak SH, 2015, SINGAP MED J, V56, P125, DOI 10.11622/smedj.2015038; Reust CE, 2018, AM FAM PHYSICIAN, V97, P785; Shahraki T, 2007, IRAN J PEDIATR, V17, P235; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Stordal K, 2001, ACTA PAEDIATR, V90, P638, DOI 10.1080/080352501750258694; Takeda K, 1997, CLIN NEPHROL, V48, P266; Ukarapol N, 2004, Singapore Med J, V45, P121; Upadhyay S, 2017, NEPAL MED COLL J, V19, P21; Walker LS, 2004, J PEDIATR GASTR NUTR, V38, P187, DOI 10.1097/00005176-200402000-00016	26	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216394	10.1371/journal.pone.0216394	http://dx.doi.org/10.1371/journal.pone.0216394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120915	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700015
J	Greer, JB; Mager, EM; Fieber, LA				Greer, Justin B.; Mager, Edward M.; Fieber, Lynne A.			Altered expression of ionotropic L-Glutamate receptors in aged sensory neurons of Aplysia californica	PLOS ONE			English	Article							D-ASPARTATE; CALORIC RESTRICTION; SYNAPTIC PLASTICITY; BEHAVIORAL-CHANGES; RAT HIPPOCAMPUS; DENTATE GYRUS; SPINE DENSITY; LIFE-SPAN; NMDA; SYNAPSES	The simplified nervous system of Aplysia californica (Aplysia) allows for detailed studies of physiological and molecular changes in small sets of neurons. Sensory neurons of the biting and tail withdrawal reflexes are glutamatergic and show reduced L-Glutamate current density in aged animals, making them a good candidate to study age-related changes in glutamatergic responses. To examine if changes in ionotropic L-Glu receptor (iGluR) transcription underlie reduced physiology, mRNA expression of iGluR was quantified in two sensory neuron clusters of two cohorts of Aplysia at both sexual maturity (similar to 8 months) and advanced age (similar to 12 months). Sensory neuron aging resulted in a significant overall decrease in expression of iGluR subunits in both sensory neuron clusters and cohorts. Although the individual subunits differentially expressed varied between sensory neuron clusters and different cohorts of animals, all differentially expressed subunits were downregulated, with no subunits showing significantly increased expression with age. Overall declines in transcript expression suggest that age-related declines in L-Glu responsiveness in Aplysia sensory neurons could be linked to overall declines in iGluR expression, rather than dysregulation of specific subunits. In both sensory neuron clusters tested the N-methyl-D-aspartate receptor subtype was expressed at significantly greater levels than other iGluR subtypes, suggesting an in vivo role for NMDAR-like receptors in Aplysia sensory neurons.	[Greer, Justin B.; Fieber, Lynne A.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Mager, Edward M.] Univ North Texas, Dept Biol Sci, Denton, TX USA	University of Miami; University of North Texas System; University of North Texas Denton	Greer, JB (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	jgreer@rsmas.miami.edu		Fieber, Lynne/0000-0002-7717-2260; Greer, Justin/0000-0001-6660-9976	National Institutes of Health [P40 OD010952]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health Grant (P40 OD010952; LAF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Akhmedov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084793; BAILEY CH, 1983, BEHAV NEURAL BIOL, V38, P70, DOI 10.1016/S0163-1047(83)90399-0; Carlson SL, 2012, BRAIN BEHAV, V2, P391, DOI 10.1002/brb3.60; Carlson SL, 2012, COMP BIOCHEM PHYS C, V155, P151, DOI 10.1016/j.cbpc.2011.04.001; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Fieber LA, 2013, JOVE-J VIS EXP, DOI 10.3791/50543; Fieber LA, 2010, BRAIN RES, V1343, P28, DOI 10.1016/j.brainres.2010.05.001; Flinn Jane M., 1997, Invertebrate Neuroscience, V2, P253, DOI 10.1007/BF02211938; Gazzaley AH, 1996, P NATL ACAD SCI USA, V93, P3121, DOI 10.1073/pnas.93.7.3121; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; Goebel DJ, 1999, MOL BRAIN RES, V69, P164; Greer JB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4909-1; Greer JB, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-016-0871-1; Ha TJ, 2006, BIOL BULL-US, V210, P255, DOI 10.2307/4134562; Hof PR, 2002, BRAIN RES, V928, P175, DOI 10.1016/S0006-8993(01)03345-5; Jouvenceau A, 1998, HIPPOCAMPUS, V8, P627, DOI 10.1002/(SICI)1098-1063(1998)8:6<627::AID-HIPO5>3.0.CO;2-X; Kadakkuzha BM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-880; Kempsell AT, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00173; Kempsell AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127056; Kempsell AT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00084; MAGNUSSON KR, 1993, NEUROBIOL AGING, V14, P197, DOI 10.1016/0197-4580(93)90001-R; Magnusson KR, 2002, MOL BRAIN RES, V99, P40, DOI 10.1016/S0169-328X(01)00344-8; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Mitchell JJ, 1998, NEUROBIOL AGING, V19, P259, DOI 10.1016/S0197-4580(98)00058-X; Moroz LL, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.006.2010; Newton IG, 2008, NEUROBIOL AGING, V29, P1308, DOI 10.1016/j.neurobiolaging.2007.03.009; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Nicolle MM, 1996, NEUROSCIENCE, V74, P741, DOI 10.1016/0306-4522(96)00147-9; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; PERETZ B, 1984, P NATL ACAD SCI-BIOL, V81, P4232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potier B, 2000, EXP GERONTOL, V35, P1185, DOI 10.1016/S0531-5565(00)00122-4; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shi L, 2007, EXP NEUROL, V206, P70, DOI 10.1016/j.expneurol.2007.03.026; Southall MD, 1997, COMP BIOCHEM PHYS C, V118, P137, DOI 10.1016/S0742-8413(97)00109-6; Stommes D, 2005, CONTEMP TOP LAB ANIM, V44, P31; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TRUDEAU LE, 1993, J NEUROPHYSIOL, V70, P1221, DOI 10.1152/jn.1993.70.3.1221; Wallace M, 2007, ANN NY ACAD SCI, V1097, P54, DOI 10.1196/annals.1379.026; Wang WT, 2013, BIOORG MED CHEM LETT, V23, P1949, DOI 10.1016/j.bmcl.2013.02.046; Wardas J, 1996, POL J PHARMACOL, V49, P401; Wenk GL, 2000, BRAIN RES, V885, P1, DOI 10.1016/S0006-8993(00)02792-X; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	48	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217300	10.1371/journal.pone.0217300	http://dx.doi.org/10.1371/journal.pone.0217300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120976	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700084
J	Reynolds, RT; Lambert, JS; Kay, SL; Sanderlin, JS; Bird, BJ				Reynolds, Richard T.; Lambert, Jeffrey S.; Kay, Shannon L.; Sanderlin, Jamie S.; Bird, Benjamin J.			Factors affecting lifetime reproduction, long-term territory-specific reproduction, and estimation of habitat quality in northern goshawks	PLOS ONE			English	Article							INTRASPECIFIC NEST INTRUSIONS; DENSITY-DEPENDENT FECUNDITY; SPANISH IMPERIAL EAGLE; SEXUAL SIZE DIMORPHISM; EXTRA-PAIR COPULATION; BREEDING PERFORMANCE; INDIVIDUAL QUALITY; ACCIPITER-GENTILIS; PUBLIC INFORMATION; TEMPORAL VARIATION	One measure of habitat quality is a species' demographic performance in a habitat and the gold standard metric of performance is reproduction. Such a measure, however, may be misleading if individual quality is a fitness determinant. We report on factors affecting lifetime reproduction (LR), the total number of lifetime fledglings produced by an individual, and long-term territory-specific reproduction in a multi-generational study of northern goshawks (Accipiter gentilis). LR increased with longer lifespans and more breeding attempts and was strongly correlated with the number of recruits in two filial generations indicating that LR was a good fitness predictor. Extensive differences in LR attested to heterogeneity in individual quality, a requisite for the ideal pre-emptive distribution model (IPD) of habitat settling wherein high quality individuals get the best habitats forcing lower quality individuals into poorer habitats with lower reproduction. In response to 7-9-year prey abundance cycles, annual frequency of territory occupancy by breeders was highly variable and low overall with monotonic increases in vacancies through low prey years. Occupancy of territories by breeders differed from random; some appeared preferred while others were avoided, producing a right-skewed distribution of total territory-specific fledgling production. However, mean fledglings per nest attempt was only slightly lower in less versus more productive territories, and, contrary to IPD predictions of increases in annual territory-specific coefficients of variation (CV) in reproduction as breeder densities increase, the CV of production decreased as density increased. Rather than habitat quality per se, conspecific attraction elicited territory selection by prospecting goshawks as 70% of settlers comprised turnovers on territories, resulting in occupancy continuity and increased territory-specific reproduction. Top-producing territories had as few as 2 long-lived (high LR) and up to 6 short-lived (low LR) sequential breeders. While individual quality appeared to effect territory-specific heterogeneity in reproductive performance, our data suggests that differences in individual quality may be washed-out by a random settling of prospectors in response to conspecific attraction.	[Reynolds, Richard T.; Lambert, Jeffrey S.; Kay, Shannon L.; Bird, Benjamin J.] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO 80526 USA; [Sanderlin, Jamie S.] US Forest Serv, Rocky Mt Res Stn, Flagstaff, AZ 86001 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Reynolds, RT (corresponding author), US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO 80526 USA.	rreynolds@fs.fed.us	Reynolds, Richard/ABF-6026-2020	Reynolds, Richard/0000-0002-5193-786X	USDA Forest Service Southwestern Region; Rocky Mountain Research Station; Arizona Game and Fish Department; Joint Fire Science Program	USDA Forest Service Southwestern Region; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); Arizona Game and Fish Department; Joint Fire Science Program	This study was funded by the USDA Forest Service Southwestern Region and Rocky Mountain Research Station, Arizona Game and Fish Department, and Joint Fire Science Program. Housing and logistical support was provided by the North Kaibab Ranger District. Other than the Arizona Game and Fish Department, the funders provided support in the form of salaries, logistics, and field equipment, but did not have any role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. In addition to support in the form of salaries and field equipment, Arizona Game and Fish Department provided 4 employees to help in data collection in 1992. These employees did not have any role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Abt K., 2007, CORAX, V20, P245; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; [Anonymous], 2021, LANG ENV STAT COMP; Arizaga J, 2017, ORNIS FENNICA, V94, P13; Aubry LM, 2009, ECOLOGY, V90, P2491, DOI 10.1890/08-1475.1; Auguie B, 2017, GRIDEXTRA MISCELLANE; BARROWCLOUGH GF, 1993, AM NAT, V141, P281, DOI 10.1086/285473; Barton K., MUMIN MULTIMODEL INF; BEDNARZ JC, 1987, AUK, V104, P393, DOI 10.2307/4087535; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Bezzel E, 1997, J ORNITHOL, V138, P413, DOI 10.1007/BF01651378; Blas J, 2009, ECOGRAPHY, V32, P647, DOI 10.1111/j.1600-0587.2008.05700.x; Block William M., 1993, Current Ornithology, V11, P35; Boal CW, 2001, CONDOR, V103, P381, DOI 10.1650/0010-5422(2001)103[0381:NMAPOA]2.0.CO;2; Bookstein FL, 1985, SPECIAL PUBLICATION; BORTOLOTTI GR, 1992, ANIM BEHAV, V44, P811, DOI 10.1016/S0003-3472(05)80577-9; BOWMAN R, 1987, WILSON BULL, V99, P465; Briggs CW, 2011, CONDOR, V113, P547, DOI 10.1525/cond.2011.100174; Brommer JE, 1998, J ANIM ECOL, V67, P359, DOI 10.1046/j.1365-2656.1998.00201.x; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Cezilly F, 1997, IBIS, V139, P331, DOI 10.1111/j.1474-919X.1997.tb04632.x; Chalfoun AD, 2012, AUK, V129, P589, DOI 10.1525/auk.2012.129.4.589; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; CluttonBrock TH, 1997, PHILOS T R SOC B, V352, P839, DOI 10.1098/rstb.1997.0064; Costello CM, 1994, BEARS THEIR BIOL MAN, V9, P375; Detrich Phillip J., 1994, Studies in Avian Biology, V16, P130; Doyle Frank I., 1994, Studies in Avian Biology, V16, P122; Drugger KM, 2005, CONDOR, V107, P863; Ekman J, 2001, J ANIM ECOL, V70, P317, DOI 10.1046/j.1365-2656.2001.00490.x; Farrell SL, 2012, J ANIM ECOL, V81, P1056, DOI 10.1111/j.1365-2656.2012.01995.x; Fasola M, 2001, WATERBIRDS, V24, P272, DOI 10.2307/1522041; Ferrer M, 2006, J ANIM ECOL, V75, P111, DOI 10.1111/j.1365-2656.2005.01026.x; Ferrer M, 2004, ECOL APPL, V14, P616, DOI 10.1890/02-5361; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Ferrer M, 2003, BIOL CONSERV, V114, P463, DOI 10.1016/S0006-3207(03)00085-5; Ferrer M, 2003, ANIM BEHAV, V66, P137, DOI 10.1006/anbe.2003.2158; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Ferrer M, 2009, CONSERV BIOL, V23, P1017, DOI 10.1111/j.1523-1739.2009.01215.x; Forero MG, 1999, ECOLOGY, V80, P1298, DOI 10.1890/0012-9658(1999)080[1298:CACOTC]2.0.CO;2; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Gavin TA, 1998, CONDOR, V100, P556, DOI 10.2307/1369724; Germain RR, 2014, ECOLOGY, V95, P436, DOI 10.1890/13-0467.1; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; Hakkarainen H, 1997, ECOSCIENCE, V4, P35, DOI 10.1080/11956860.1997.11682374; HAMANN J, 1987, IBIS, V129, P527, DOI 10.1111/j.1474-919X.1987.tb08240.x; Herfindal I, 2015, J ANIM ECOL, V84, P702, DOI 10.1111/1365-2656.12318; HILDEN OLAVL, 1965, ANN ZOOL FEN NICI, V2, P53; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Hunt PD, 1996, AUK, V113, P875; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Johnson MD, 2007, CONDOR, V109, P14; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Joy S. M, 2002, THESIS; Kenward R, 2006, GOSHAWK; Kenward RE, 1999, J ANIM ECOL, V68, P1020, DOI 10.1046/j.1365-2656.1999.00347.x; Keppel G., 2004, DESIGN ANAL RES HDB, P111; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kleiber C, 2008, USE R, P1, DOI 10.1007/978-0-387-77318-6_1; KORPIMAKI E, 1988, J ANIM ECOL, V57, P97, DOI 10.2307/4766; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; KORPIMAKI E, 1990, ORNIS SCAND, V21, P169, DOI 10.2307/3676776; Kostrzewa A, 1996, ETHOL ECOL EVOL, V8, P1, DOI 10.1080/08927014.1996.9522931; KOSTRZEWA R, 1991, AUK, V108, P342; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kruger O, 2005, J ANIM ECOL, V74, P266, DOI 10.1111/j.1365-2656.2005.00920.x; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Kruger O, 2001, J ANIM ECOL, V70, P173, DOI 10.1046/j.1365-2656.2001.00481.x; Laaksonen T, 2004, P ROY SOC B-BIOL SCI, V271, pS461, DOI 10.1098/rsbl.2004.0221; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; LINDEN H, 1983, J ANIM ECOL, V52, P953, DOI 10.2307/4466; Linkhart BD, 2007, AUK, V124, P264, DOI 10.1642/0004-8038(2007)124[264:RRFADI]2.0.CO;2; Linkhart BD, 2006, J RAPTOR RES, V40, P29, DOI 10.3356/0892-1016(2006)40[29:LROFOI]2.0.CO;2; Ludwig SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1601, DOI 10.1007/s00265-008-0589-1; MACARTHUR R, 1962, AM NAT, V96, P167, DOI 10.1086/282219; Machin P, 2017, IBIS, V159, P657, DOI 10.1111/ibi.12479; MARTI CD, 1990, AUK, V107, P246, DOI 10.2307/4087606; Marti CD, 1997, AUK, V114, P581, DOI 10.2307/4089277; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; McClaren EL, 2002, CONDOR, V104, P343, DOI 10.1650/0010-5422(2002)104[0343:DSNGNA]2.0.CO;2; McDonald PG, 2005, BEHAV ECOL, V16, P48, DOI 10.1093/beheco/arh118; McGowan JD, 1975, W173 AL DEP FISH GAM; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; MICHOD RE, 1979, AM NAT, V113, P531, DOI 10.1086/283411; Milenkaya O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136582; Mills J.A., 1989, P387; Millsap BA, 2018, CONDOR, V120, P63, DOI 10.1650/CONDOR-17-124.1; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Murphy MT, 2007, AUK, V124, P1010, DOI 10.1642/0004-8038(2007)124[1010:LRSOFE]2.0.CO;2; NEWTON I, 1981, J ANIM ECOL, V50, P839, DOI 10.2307/4141; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; Newton I., 1989, P441; NEWTON I, 1983, AUK, V100, P344, DOI 10.1093/auk/100.2.344; NEWTON I, 1985, J ANIM ECOL, V54, P241, DOI 10.2307/4634; Newton I., 1976, Raptor Research, V10, P65; NEWTON I, 1982, J ANIM ECOL, V51, P327, DOI 10.2307/4327; Newton I, 1998, ARDEA, V86, P21; Newton I, 1989, LIFETIME REPROD BIRD; Newton I., 1986, SPARROWHAWK; Newton I., 1979, POPULATION ECOLOGY R; Nielsen JT, 2003, IBIS, V145, P1; North M, 2000, J WILDLIFE MANAGE, V64, P797, DOI 10.2307/3802750; Oli MK, 2002, EVOL ECOL RES, V4, P563; Olsen P, 1998, J AVIAN BIOL, V29, P197, DOI 10.2307/3677199; Part T, 2003, P ROY SOC B-BIOL SCI, V270, P1809, DOI 10.1098/rspb.2003.2419; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Penteriani V, 2003, IBIS, V145, pE77, DOI 10.1046/j.1474-919X.2003.00159.x; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Penteriani V, 2013, NATURWISSENSCHAFTEN, V100, P935, DOI 10.1007/s00114-013-1093-7; PERDECK AC, 1992, J ANIM ECOL, V61, P13, DOI 10.2307/5504; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; Piper WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1329, DOI 10.1007/s00265-011-1195-1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; RASMUSSEN D. I., 1941, ECOL MONOGR, V11, P229, DOI 10.2307/1943204; Reich RM, 2004, ECOL MODEL, V176, P109, DOI 10.1016/j.ecolmodel.2003.09.039; REID WV, 1988, AUK, V105, P278, DOI 10.2307/4087491; Reynolds RT, 2017, WILDLIFE MONOGR, V197, P1, DOI 10.1002/wmon.1023; Reynolds Richard T., 1994, Studies in Avian Biology, V16, P106; Reynolds Richard T., 2006, Studies in Avian Biology, P299; Reynolds Richard T., 2006, Studies in Avian Biology, P63; REYNOLDS RT, 1972, CONDOR, V74, P191, DOI 10.2307/1366283; Reynolds RT, 2005, J RAPTOR RES, V39, P274; REYNOLDS RT, 1990, ORNIS SCAND, V21, P74, DOI 10.2307/3676382; REYNOLDS RT, 1982, J WILDLIFE MANAGE, V46, P124, DOI 10.2307/3808415; Risch M., 2004, Corax, V19, P323; RISING JD, 1989, AUK, V106, P666; Rodenhouse NL, 2003, P ROY SOC B-BIOL SCI, V270, P2105, DOI 10.1098/rspb.2003.2438; Rose KE, 1998, J ANIM ECOL, V67, P979, DOI 10.1046/j.1365-2656.1998.6760979.x; Rosenfield RN, 1999, AUK, V116, P830, DOI 10.2307/4089346; Rosenfield RN, 2017, IBIS, V159, P703, DOI 10.1111/ibi.12470; Rosenfield RN, 2015, J FIELD ORNITHOL, V86, P144, DOI 10.1111/jofo.12097; Rosenfield RN, 2009, WILSON J ORNITHOL, V121, P610, DOI 10.1676/08-149.1; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Rutz C, 2005, IBIS, V147, P831, DOI 10.1111/j.1474-919x.2005.00453.x; Rutz C, 2012, BIOL J LINN SOC, V105, P937, DOI 10.1111/j.1095-8312.2011.01818.x; Saether B.-E., 1990, Current Ornithology, V7, P251; Salafsky S. R., 2015, THESIS; Salafsky SR, 2005, J RAPTOR RES, V39, P237; Salafsky SR, 2007, J WILDLIFE MANAGE, V71, P2274, DOI 10.2193/2006-357; Saurola P., 1989, P327; Sergio F, 2003, BIOL CONSERV, V112, P351, DOI 10.1016/S0006-3207(02)00332-4; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; SODHI NS, 1991, CONDOR, V93, P433, DOI 10.2307/1368960; SONERUD GA, 1985, ORNIS SCAND, V16, P261, DOI 10.2307/3676689; SONERUD GA, 1985, J ANIM ECOL, V54, P179, DOI 10.2307/4629; SPEISER R, 1991, Journal of Raptor Research, V25, P132; SQUIRES J. R., 1997, BIRDS N AM; Squires John R., 2006, Studies in Avian Biology, P8; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; STEENHOF K, 1983, AUK, V100, P743; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Sternberg H., 1989, P55; Tolvanen J, 2017, BIRD STUDY, V64, P168, DOI 10.1080/00063657.2017.1309351; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Valkama J, 1999, BIRD STUDY, V46, P81, DOI 10.1080/00063659909461117; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Viallefont A, 1995, AUK, V112, P67, DOI 10.2307/4088767; WARKENTIN IG, 1992, CONDOR, V94, P418, DOI 10.2307/1369214; Weatherhead PJ, 2000, AUK, V117, P627, DOI 10.1642/0004-8038(2000)117[0627:FSAAIO]2.0.CO;2; WHITE MA, 1993, VEGETATIO, V109, P161, DOI 10.1007/BF00044748; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; Wiens J. D, 2006, THESIS; Wiens JD, 2005, J RAPTOR RES, V39, P210; WIKLUND CG, 1995, ECOLOGY, V76, P1994, DOI 10.2307/1940731; Williams G. C., 1966, P307; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Younk James V., 1994, Studies in Avian Biology, V16, P119; YOUNK JV, 1994, EFFECT GOLD MINING A; Zabala J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090254	177	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0215841	10.1371/journal.pone.0215841	http://dx.doi.org/10.1371/journal.pone.0215841			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116756	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400009
J	Sehgal, S; Patel, ND; Malik, A; Roop, PS; Trew, ML				Sehgal, Sucheta; Patel, Nitish D.; Malik, Avinash; Roop, Partha S.; Trew, Mark L.			Resonant model-A new paradigm for modeling an action potential of biological cells	PLOS ONE			English	Article							CARDIAC ELECTROPHYSIOLOGY; SYNCHRONIZATION; MECHANISMS; SIMULATION; CLAMP	Organ level simulation of bioelectric behavior in the body benefits from flexible and efficient models of cellular membrane potential. These computational organ and cell models can be used to study the impact of pharmaceutical drugs, test hypotheses, assess risk and for closed-loop validation of medical devices. To move closer to the real-time requirements of this modeling a new flexible Fourier based general membrane potential model, called as a Resonant model, is developed that is computationally inexpensive. The new model accurately reproduces non-linear potential morphologies for a variety of cell types. Specifically, the method is used to model human and rabbit sinoatrial node, human ventricular myocyte and squid giant axon electrophysiology. The Resonant models are validated with experimental data and with other published models. Dynamic changes in biological conditions are modeled with changing model coefficients and this approach enables ionic channel alterations to be captured. The Resonant model is used to simulate entrainment between competing sinoatrial node cells. These models can be easily implemented in low-cost digital hardware and an alternative, resource-efficient implementations of sine and cosine functions are presented and it is shown that a Fourier term is produced with two additions and a binary shift.	[Sehgal, Sucheta; Patel, Nitish D.; Malik, Avinash; Roop, Partha S.] Univ Auckland, Dept Elect & Comp Engn, Auckland 1010, New Zealand; [Trew, Mark L.] Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand	University of Auckland; University of Auckland	Patel, ND (corresponding author), Univ Auckland, Dept Elect & Comp Engn, Auckland 1010, New Zealand.	nd.patel@auckland.ac.nz	Roop, Partha/AAL-2839-2020	Patel, Nitish/0000-0002-3459-5407	Leducq foundation (RHYTHM)	Leducq foundation (RHYTHM)	Mark L. Trew was supported by a grant from the Leducq foundation (RHYTHM) (www.foundationleducq.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WW, 2018, IEEE T BIO-MED ENG, V65, P123, DOI 10.1109/TBME.2017.2695537; Alemzadeh H, 2013, IEEE SECUR PRIV, V11, P14, DOI 10.1109/MSP.2013.49; ATTINGER EO, 1966, BIOPHYS J, V6, P291, DOI 10.1016/S0006-3495(66)86657-2; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; Bordas R, 2009, PHILOS T R SOC A, V367, P1951, DOI 10.1098/rsta.2008.0298; Bouman L, 1995, PACEMAKER ACTIVITY I, P37; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Cherry EM, 2007, AM J PHYSIOL-HEART C, V292, pH43, DOI 10.1152/ajpheart.00955.2006; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; DELMAR M, 1986, J PHYSIOL-LONDON, V370, P127, DOI 10.1113/jphysiol.1986.sp015926; Ewilhelms M, 2013, FRONTIERS PHYSL, V3; Fabbri A, 2017, J PHYSIOL-LONDON, V595, P2365, DOI 10.1113/JP273259; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fink M, 2011, PROG BIOPHYS MOL BIO, V104, P2, DOI 10.1016/j.pbiomolbio.2010.03.002; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Grandi E, 2009, NOVEL COMPUTATIONAL; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Gray RA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005087; Groenendaal W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004242; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; JALIFE J, 1984, J PHYSIOL-LONDON, V356, P221, DOI 10.1113/jphysiol.1984.sp015461; KELLY GE, 1992, J ROY STAT SOC D-STA, V41, P303; KODAMA I, 1985, PFLUG ARCH EUR J PHY, V404, P214, DOI 10.1007/BF00581242; Kurata Y, 2002, AM J PHYSIOL-HEART C, V283, pH2074, DOI 10.1152/ajpheart.00900.2001; Lombardo DM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005060; Mohammed M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087503; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Niederer SA, 2009, EXP PHYSIOL, V94, P486, DOI 10.1113/expphysiol.2008.044610; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; Richter Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190448; Sukhov V, 2011, J THEOR BIOL, V291, P47, DOI 10.1016/j.jtbi.2011.09.019; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Verheijck EE, 1998, J GEN PHYSIOL, V111, P95, DOI 10.1085/jgp.111.1.95; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Verkerk AO, 2009, INT J CARDIOL, V132, P318, DOI 10.1016/j.ijcard.2008.12.196; WEST GA, 1985, PFLUG ARCH EUR J PHY, V403, P66, DOI 10.1007/BF00583284; Wilders R, 1996, AM J PHYSIOL-HEART C, V271, pH2168, DOI 10.1152/ajpheart.1996.271.5.H2168	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216999	10.1371/journal.pone.0216999	http://dx.doi.org/10.1371/journal.pone.0216999			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116780	Green Published, Green Submitted, gold			2022-12-27	WOS:000468607400034
J	Bartonid, J; Barton, C; Bertoli, L				Bartonid, James; Barton, Clayborn; Bertoli, Luigi			Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency	PLOS ONE			English	Article							PRIMARY ANTIBODY DEFICIENCY; IMMUNOGLOBULIN; IMMUNODEFICIENCY	Many adults with IgG subclass deficiency (IgGSD) experience long intervals of frequent/severe respiratory tract infection before IgGSD diagnosis, but reasons for delays in IgGSD diagnoses are incompletely understood. We performed a retrospective study of 300 white adults (ages >= 18 y) with IgGSD including frequency analyses of age at IgGSD diagnosis, duration of frequent/severe respiratory tract infection before IgGSD diagnosis, and age at onset of frequent/severe infection (calculated). We performed multivariable regressions on age at diagnosis, infection duration, and age at infection onset using these variables, as appropriate: sex; age at diagnosis; diabetes; autoimmune condition(s); atopy; allergy; corticosteroid use; body mass index; serum immunoglobulin isotype levels; blood lymphocyte subsets; three IgGSD-associated human leukocyte antigen-A and -B haplotypes; and referring physician specialties. Mean age at diagnosis was 50 +/- 12 (standard deviation) y (median 50 y (range 19-79)). There were 247 women (82.3%). Mean infection duration at IgGSD diagnosis was 12 +/- 13 y (median 7 y (range 1-66)). Mean age at infection onset was 38 +/- 16 y (median 38 y (range 4, 76)). Age at infection onset was >= 18 y in 95.7% of subjects. Regressions on age at diagnosis and infection duration revealed no significant associations. Regression on age at infection onset revealed one positive association: age at diagnosis (p <0.0001). We conclude that the median duration of frequent/severe respiratory tract infection in adults before IgGSD diagnosis was 7 y. Older adults may be diagnosed to have IgGSD after longer intervals of infection than younger adults. Duration of frequent/severe respiratory tract infection before IgGSD diagnosis was not significantly associated with routine clinical and laboratory variables, including referring physician specialties.	[Bartonid, James; Barton, Clayborn; Bertoli, Luigi] Southern Iron Disorders Ctr, Birmingham, AL 35209 USA; [Bartonid, James] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bartonid, James; Bertoli, Luigi] Brookwood Med Ctr, Dept Med, Birmingham, AL 35209 USA	University of Alabama System; University of Alabama Birmingham	Bartonid, J (corresponding author), Southern Iron Disorders Ctr, Birmingham, AL 35209 USA.; Bartonid, J (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Bartonid, J (corresponding author), Brookwood Med Ctr, Dept Med, Birmingham, AL 35209 USA.	ironmd@isp.com		Barton, James/0000-0003-2876-8276; Barton, Jackson/0000-0002-2646-4466	Southern Iron Disorders Center	Southern Iron Disorders Center	Southern Iron Disorders Center provided financial support for publication costs alone. The sole funder (Southern Iron Disorders Center) provided support for publication costs for all authors, but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamian F, 2010, CLIN EXP IMMUNOL, V159, P344, DOI 10.1111/j.1365-2249.2009.04062.x; Albin S, 2014, IMMUNOTHERAPY-UK, V6, P1113, DOI [10.2217/imt.14.67, 10.2217/IMT.14.67]; Alho OP, 2004, CLIN EXP IMMUNOL, V137, P366, DOI 10.1111/j.1365-2249.2004.02530.x; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Arkwright PD, 2002, BLOOD, V99, P2694, DOI 10.1182/blood.V99.8.2694; Barton James C, 2003, BMC Med Genet, V4, P3, DOI 10.1186/1471-2350-4-3; Barton JC, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1405950; Barton JC, 2016, CELL IMMUNOL, V299, P50, DOI 10.1016/j.cellimm.2015.09.004; Barton JC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/542706; Barton James C, 2002, BMC Med Genet, V3, P9, DOI 10.1186/1471-2350-3-9; Berger Melvin, 2017, Respir Med, V132, P181, DOI 10.1016/j.rmed.2017.10.016; BLORE J, 1989, BRIT MED J, V298, P516, DOI 10.1136/bmj.298.6672.516; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; Centers for Disease Control and Prevention, 2018, DIAB 2017 REP CARD; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Duraisingham SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100324; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Iikura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123584; Kim JH, 2016, J KOREAN MED SCI, V31, P1560, DOI 10.3346/jkms.2016.31.10.1560; Mao W, 2015, GENET MOL RES, V14, P16146, DOI 10.4238/2015.December.8.3; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Mazer NA, 2011, J ALLERGY CLIN IMMUN, V127, pAB12, DOI 10.1016/j.jaci.2010.12.061; Odat H, 2016, EUR ARCH OTO-RHINO-L, V273, P3189, DOI 10.1007/s00405-016-3981-x; OKEEFFE S, 1991, EUR RESPIR J, V4, P932; Parker AR, 2017, LAB MED, V48, P314, DOI 10.1093/labmed/lmx058; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; POPA V, 1994, CHEST, V105, P1066, DOI 10.1378/chest.105.4.1066; Schauer U, 2003, CLIN CHEM, V49, P1924, DOI 10.1373/clinchem.2003.022350; Seymour B, 2005, J CLIN PATHOL, V58, P546, DOI 10.1136/jcp.2004.016204; Srinivasa BT, 2012, AM J MED, V125, P779, DOI 10.1016/j.amjmed.2012.02.015; Van Kessel DA, 1999, CLIN EXP IMMUNOL, V118, P102; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; 2015, J ALLERGY CLIN IMMUN, V136, P1523, DOI DOI 10.1016/J.JACI.2015.07.016	33	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216940	10.1371/journal.pone.0216940	http://dx.doi.org/10.1371/journal.pone.0216940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112572	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000032
J	Campbell, ARM; Titus, BR; Kuenzi, MR; Rodriguez-Perez, F; Brunsch, ADL; Schroll, MM; Owen, MC; Cronk, JD; Anders, KR; Shepherd, JN				Campbell, Amanda R. M.; Titus, Benjamin R.; Kuenzi, Madeline R.; Rodriguez-Perez, Fernando; Brunsch, Alysha D. L.; Schroll, Monica M.; Owen, Matthew C.; Cronk, Jeff D.; Anders, Kirk R.; Shepherd, Jennifer N.			Investigation of candidate genes involved in the rhodoquinone biosynthetic pathway in Rhodospirillum rubrum	PLOS ONE			English	Article							FUMARATE REDUCTASE; ELECTRON-TRANSFER; UBIQUINONE; BACTERIUM; EXPRESSION; YEAST	The lipophilic electron-transport cofactor rhodoquinone (RQ) facilitates anaerobic metabolism in a variety of bacteria and selected eukaryotic organisms in hypoxic environments. We have shown that an intact rquA gene in Rhodospirillum rubrum is required for RQ production and efficient growth of the bacterium under anoxic conditions. While the explicit details of RQ biosynthesis have yet to be fully delineated, ubiquinone (Q) is a required precursor to RQ in R. rubrum, and the RquA gene product is homologous to a class I methyltransferase. In order to identify any additional requirements for RQ biosynthesis or factors influencing RQ production in R. rubrum, we performed transcriptome analysis to identify differentially expressed genes in anoxic, illuminated R. rubrum cultures, compared with those aerobically grown in the dark. To further select target genes, we employed a bioinformatics approach to assess the likelihood that a given differentially expressed gene under anoxic conditions may also have a direct role in RQ production or regulation of its levels in vivo. Having thus compiled a list of candidate genes, nine were chosen for further study by generation of knockout strains. RQ and Q levels were quantified using liquid chromatography-mass spectrometry, and rquA gene expression was measured using the real-time quantitative polymerase chain reaction. In one case, Q and RQ levels were decreased relative to wild type; in another case, the opposite effect was observed. These results comport with the crucial roles of rquA and Q in RQ biosynthesis, and reveal the existence of potential modulators of RQ levels in R. rubrum.	[Campbell, Amanda R. M.; Titus, Benjamin R.; Kuenzi, Madeline R.; Rodriguez-Perez, Fernando; Brunsch, Alysha D. L.; Schroll, Monica M.; Owen, Matthew C.; Cronk, Jeff D.; Shepherd, Jennifer N.] Gonzaga Univ, Dept Chem & Biochem, Spokane, WA 99258 USA; [Anders, Kirk R.] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Campbell, Amanda R. M.] Univ Washington, Sch Pharm, Seattle, WA 98195 USA; [Titus, Benjamin R.] Univ Washington, Sch Med, Spokane, WA USA; [Kuenzi, Madeline R.] Graham Contracting LTD, Bellevue, WA USA; [Rodriguez-Perez, Fernando] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Brunsch, Alysha D. L.] Inland Northwest Blood Ctr, Spokane, WA USA; [Schroll, Monica M.] Hlth Advances, San Francisco, CA USA; [Owen, Matthew C.] La Salle Catholic Coll Preparatory, Milwaukie, OR USA	Gonzaga University; Gonzaga University; University of Washington; University of Washington Seattle; University of Washington; Washington State University; University of California System; University of California Berkeley	Shepherd, JN (corresponding author), Gonzaga Univ, Dept Chem & Biochem, Spokane, WA 99258 USA.	shepherd@gonzaga.edu		Campbell, Amanda/0000-0002-3534-2778; Shepherd, Jennifer/0000-0002-6926-6777; Rodriguez-Perez, Fernando/0000-0002-4922-5011	National Institutes of Health [1R15GM096398-01]; Howard Hughes Medical Institute through the Undergraduate Science Education Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute through the Undergraduate Science Education Program(Howard Hughes Medical Institute)	This research was supported in part by grants from the National Institutes of Health Award No. 1R15GM096398-01 (JNS), https://area.nih.gov/; and Howard Hughes Medical Institute through the Undergraduate Science Education Program (award to Gonzaga University), https://hhmi.umd.edu/. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; Applied Biosystems, 2008, GUID PERF REL QUANT; Baba SW, 2004, J BIOL CHEM, V279, P10052, DOI 10.1074/jbc.M313712200; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, DOI [10.1128/JB.00423-08, DOI 10.1128/JB.00423-08]; Brajcich BC, 2010, J BACTERIOL, V192, P436, DOI 10.1128/JB.01040-09; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Ghosh R, 2018, MICROBIOL-SGM, V164, P1416, DOI 10.1099/mic.0.000718; GLOVER J, 1962, BIOCHEM J, V85, pP14; Graige MS, 1999, BIOCHEMISTRY-US, V38, P11465, DOI 10.1021/bi990708u; Grammel H, 2003, APPL ENVIRON MICROB, V69, P6577, DOI 10.1128/AEM.69.11.6577-6586.2003; Grammel H, 2008, J BACTERIOL, V190, P4912, DOI 10.1128/JB.00423-08; HIRAISHI A, 1995, J GEN APPL MICROBIOL, V41, P99, DOI 10.2323/jgam.41.99; Hoffmeister M, 2004, J BIOL CHEM, V279, P22422, DOI 10.1074/jbc.M400913200; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; IMHOFF JF, 1984, FEMS MICROBIOL LETT, V25, P85; Iwata F, 2008, PARASITOL INT, V57, P54, DOI 10.1016/j.parint.2007.08.002; Jansson A, 2005, J BIOL CHEM, V280, P3636, DOI 10.1074/jbc.M412095200; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2013, BBA-BIOENERGETICS, V1827, P668, DOI 10.1016/j.bbabio.2013.01.010; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Ohashi M, 2017, NATURE, V549, P502, DOI 10.1038/nature23882; RAMIREZPONCE MP, 1980, FEBS LETT, V114, P319, DOI 10.1016/0014-5793(80)81142-2; Stairs CW, 2018, ELIFE, V7, DOI 10.7554/eLife.34292; Stairs CW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0326; 2012, J BACTERIOL, V194, P965, DOI DOI 10.1128/JB.06319-11	28	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217281	10.1371/journal.pone.0217281	http://dx.doi.org/10.1371/journal.pone.0217281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112563	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000047
J	Zadeh, NS; Mohammadi, F; Rarani, MA; Javadi, M; Mohammadzade, M; Yazdi-Feyzabadi, V				Zadeh, Nasrin Shaarbafchi; Mohammadi, Farzaneh; Rarani, Mostafa Amini; Javadi, Marzieh; Mohammadzade, Mohammadjavad; Yazdi-Feyzabadi, Vahid			How the service delivery works in the Iranian specialised burns hospitals? A qualitative approach	PLOS ONE			English	Article							CARE; EPIDEMIOLOGY; PREVENTION	As burn injuries are a major cause of death and infirmity, successful service delivery is vital in health systems. In Iran, a few specialised burns hospitals (SBHs) located in big provinces provide burn services in which burn patients with more severe conditions are referred to. However, SBHs are faced with several challenges for delivering due treatment for burn patients. So, for the first time in Iran, the main aim of the study was to identify the challenges of delivering burn services in SBHs. For this purpose, we conducted a qualitative study during February 2017 to April 2018. Key informants were purposefully selected and interviewed at national and provincial levels from the Ministry of Health, medical universities, and informants working in eight SBHs. The saturation point was reached at 21 face-to-face semi-structured interviews. A thematic analysis approach was employed to analyse transcribed documents assisted by MAXQDA Plus version 12. Our results reveal four themes and twelve subthemes on the challenges of delivering services in SBHs. Themes and (subthemes) including burn care continuum (preventive care, pre-hospital care, hospital care, follow-up, and home care), regionalisation of burning services (access to other specialties and medical services, access to specialized care in provinces without a SBH, standardised regionalisation system for burn related services (BRSs), costs of providing BRSs (expensive services and supplies and long hospitalisation), and non-compliance with standardised care (guidelines to provide burn care and physical space to provide BRSs). Results suggest that improving BRSs delivery in Iran may be reached by strengthening burn care continuum, regionalising burn care, allocating sufficient budgets to burn services and formulating burn care guidelines. These policy actions can be better addressed via intra-sectoral collaborations.	[Zadeh, Nasrin Shaarbafchi; Mohammadzade, Mohammadjavad] Isfahan Univ Med Sci, Social Determinants Hlth Res Ctr, Esfahan, Iran; [Mohammadi, Farzaneh; Rarani, Mostafa Amini; Javadi, Marzieh] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Yazdi-Feyzabadi, Vahid] Kerman Univ Med Sci, Hlth Serv Management Res Ctr, Inst Futures Studies Hlth, Kerman, Iran	Isfahan University Medical Science; Isfahan University Medical Science; Kerman University of Medical Sciences	Rarani, MA (corresponding author), Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran.	m.amini@mng.mui.ac.ir	Yazdi-Feyzabadi, Vahid/H-9647-2017; zadeh, Nasrin Shaarbafchi/ABF-1943-2020; Amini-Rarani, Mostafa/O-3651-2018	Yazdi-Feyzabadi, Vahid/0000-0002-8009-470X; Amini-Rarani, Mostafa/0000-0002-4809-2237	Isfahan University of Medical Sciences, Isfahan, Iran [295292]	Isfahan University of Medical Sciences, Isfahan, Iran	This study was funded by Isfahan University of Medical Sciences, Isfahan, Iran with research code No. 295292. MAR is author who received study fund.	Adams O., 2003, HLTH SYSTEMS PERFORM, P235; Atiyeh B, 2010, Ann Burns Fire Disasters, V23, P13; Atiyeh BS, 2009, BURNS, V35, P181, DOI 10.1016/j.burns.2008.06.002; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Dowling Maura, 2006, Nurse Res, V13, P7; Gallaher JR, 2015, INT J SURG, V19, P116, DOI 10.1016/j.ijsu.2015.05.015; Hewitt-Taylor Jaquelina, 2002, Nurs Stand, V16, P33; Hodgins P, 2011, BURNS, V37, P1354, DOI 10.1016/j.burns.2011.07.001; Holmes JH, 2011, J AM COLL SURGEONS, V212, P487, DOI 10.1016/j.jamcollsurg.2010.12.044; Jagnoor J, 2018, BMC Res Notes, V11, P224, DOI 10.1186/s13104-018-3314-9; Jagnoor J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020045; Karimi H, 2012, Ann Burns Fire Disasters, V25, P115; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Mock C, 2008, WHO PLAN BURN PREVEN, P3; Outwater AH, 2013, INT J BURNS TRAUMA, V3, P18; Peck MD, 2011, BURNS, V37, P1087, DOI 10.1016/j.burns.2011.06.005; Rode H, 2015, SAMJ, S. Afr. med. j., V105, P853, DOI [10.7196/SAMJnew.8187, 10.7196/SAMJNEW.8187]; Smolle C, 2017, BURNS, V43, P249, DOI 10.1016/j.burns.2016.08.013; Wang Y, 2018, ADV DRUG DELIVER REV, V123, P3, DOI 10.1016/j.addr.2017.09.018; Warden GD, 2003, REGIONALIZATION BURN; World Bank, 2013, ENH SERV DEL IMPR EF; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2000, WORLD HLTH REP 2000; Yurt RW, 2009, SURG INFECT, V10, P441, DOI 10.1089/sur.2009.050; Zia N, 2018, J BURN CARE RES, V39, pS208, DOI [10.1093/jbcr/iry006.393, DOI 10.1093/JBCR/IRY006.393]	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216489	10.1371/journal.pone.0216489	http://dx.doi.org/10.1371/journal.pone.0216489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112548	Green Submitted, Green Published, gold			2022-12-27	WOS:000468451000015
J	Hoshino, C; Koga, D; Koyano, G; Yamauchi, Y; Sakai, T; Okawa, A; Jinno, T				Hoshino, Chisato; Koga, Daisuke; Koyano, Gaku; Yamauchi, Yuki; Sakai, Tomoko; Okawa, Atsushi; Jinno, Tetsuya			Femoral nerve palsy following primary total hip arthroplasty with the direct anterior approach	PLOS ONE			English	Article							MEDICAL MALPRACTICE; COST-EFFECTIVENESS; REPLACEMENT; INJURY; LITIGATION; THA	Nerve palsy following total hip arthroplasty (THA) can have a serious effect on a patient's functional prognosis and on cost-effectiveness, and it is the leading cause of THA-associated medical litigation. However, only a few studies focus on femoral nerve palsy (FNP) following THA with the direct anterior approach (DAA). Moreover, several studies have reported that THA with DAA may result in higher complication rates, particularly during the so-called learning-curve period' for the surgeon. This study aimed to identify the incidence of FNP following primary THA with DAA, to determine presumed etiologies through a retrospective investigation of FNP clinical courses following primary THA with DAA and to identify any relationship between the occurrence of FNP following primary THA with DAA and the surgeon's experience of DAA. Since August 2007, DAA for primary THA was introduced in our institution. All 273 consecutive primary THAs with DAA (42 bilateral and 189 unilateral cases) between August 2007 and February 2014 were included in this study. All patients' charts and radiographs were reviewed to identify cases with palsy and to retrieve related factors. In this study, FNP was defined as weakness of the quadriceps femoris (manual muscle test <3) with or without sensory disturbance over the anteromedial aspect of the thigh. The incidence of FNP following primary THA with DAA was 1.1% (3/273 joints). In all 3 cases, the motor deficit recovered completely within a year. Suspected causes of the palsy in the 3 cases were believed to be improper positioning of the anterior acetabular retractor, excessive leg lengthening, or unknown etiology. There was no significant relationship between palsy and surgeon's experience of DAA. In THA with DAA for patients requiring major leg lengthening, the likelihood of FNP must be considered. To prevent FNP, the anterior acetabular retractor must be placed properly.	[Hoshino, Chisato; Sakai, Tomoko; Okawa, Atsushi; Jinno, Tetsuya] Tokyo Med & Dent Univ, Dept Rehabil Med, Bunkyo Ku, Tokyo, Japan; [Koga, Daisuke; Koyano, Gaku; Yamauchi, Yuki; Okawa, Atsushi; Jinno, Tetsuya] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan; [Koga, Daisuke] Saitama Red Cross Hosp, Dept Orthopaed Surg, Saitama, Saitama, Japan; [Koyano, Gaku] Tsuchiura Kyodo Gen Hosp, Dept Orthopaed Surg, Tsuchiura, Ibaraki, Japan; [Yamauchi, Yuki] Doujin Hosp, Dept Orthopaed Surg, Naha, Okinawa, Japan; [Jinno, Tetsuya] Dokkyo Med Univ, Dept Orthopaed Surg 2, Saitama Med Ctr, Koshigaya, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tsuchiura Kyodo Hospital; Dokkyo Medical University	Jinno, T (corresponding author), Tokyo Med & Dent Univ, Dept Rehabil Med, Bunkyo Ku, Tokyo, Japan.; Jinno, T (corresponding author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan.; Jinno, T (corresponding author), Dokkyo Med Univ, Dept Orthopaed Surg 2, Saitama Med Ctr, Koshigaya, Saitama, Japan.	jinno.orth@tmd.ac.jp		Koga, Daisuke/0000-0001-8426-5425; Jinno, Tetsuya/0000-0001-8629-2283				Bhargava Tarun, 2010, Orthopedics, V33, P472, DOI 10.3928/01477447-20100526-05; Bokshan SL, 2017, J ARTHROPLASTY, V32, P3573, DOI 10.1016/j.arth.2017.07.001; Brown Gabriel D, 2008, Am J Orthop (Belle Mead NJ), V37, P191; D'Arrigo C, 2009, J ORTHOP TRAUMATOL, V10, P47, DOI 10.1007/s10195-008-0043-1; den Hartog YM, 2013, ACTA ORTHOP, V84, P116, DOI 10.3109/17453674.2013.773412; EDWARDS BN, 1987, CLIN ORTHOP RELAT R, P136; Eggli S, 1999, J BONE JOINT SURG BR, V81B, P843, DOI 10.1302/0301-620X.81B5.9610; Elmallah RK, 2017, J ARTHROPLASTY, V32, P351, DOI 10.1016/j.arth.2016.08.006; Farrell CM, 2005, J BONE JOINT SURG AM, V87A, P2619, DOI 10.2106/JBJS.C.01564; Fleischman AN, 2018, J ARTHROPLASTY, V33, P1194, DOI 10.1016/j.arth.2017.10.050; Fox AJS, 2012, ACTA ORTHOP BELG, V78, P145; Goulding K, 2010, CLIN ORTHOP RELAT R, V468, P2397, DOI 10.1007/s11999-010-1406-5; Hallert O, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-17; Heller KD, 1998, ARCH ORTHOP TRAUM SU, V117, P153, DOI 10.1007/s004020050216; Hofmann AA, 2000, ORTHOPEDICS, V23, P943; Ishimatsu T, 2018, J BONE JOINT SURG AM, V100, P572, DOI 10.2106/JBJS.17.00679; Jingushi S, 2010, J ORTHOP SCI, V15, P626, DOI 10.1007/s00776-010-1507-8; JOHANSON NA, 1983, CLIN ORTHOP RELAT R, P214; Kennon RE, 2003, J BONE JOINT SURG AM, V85A, P39, DOI 10.2106/00004623-200300004-00005; Koenig L, 2016, CLIN ORTHOP RELAT R, V474, P2645, DOI 10.1007/s11999-016-5084-9; Lovell TP, 2008, J ARTHROPLASTY, V23, P64, DOI 10.1016/j.arth.2008.06.027; Macheras GA, 2016, HIP INT, V26, P338, DOI 10.5301/hipint.5000352; Matta JM, 2005, CLIN ORTHOP RELAT R, P115, DOI 10.1097/01.blo.0000194309.70518.cb; McConaghie FA, 2014, BONE JOINT RES, V3, P212, DOI 10.1302/2046-3758.36.2000255; McGrory BJ, 2009, CLIN ORTHOP RELAT R, V467, P358, DOI 10.1007/s11999-008-0581-0; McWilliams AB, 2013, BONE JOINT J, V95B, P122, DOI 10.1302/0301-620X.95B1.30908; Navarro R A, 1995, J Arthroplasty, V10, P1; Restrepo C, 2010, J ARTHROPLASTY, V25, P671, DOI 10.1016/j.arth.2010.02.002; Rue JPH, 2004, ORTHOPEDICS, V27, P73; Schmalzried TP, 1997, CLIN ORTHOP RELAT R, P188; SCHMALZRIED TP, 1991, J BONE JOINT SURG AM, V73A, P1074, DOI 10.2106/00004623-199173070-00018; Shearer DW, 2015, CLIN ORTHOP RELAT R, V473, P1702, DOI 10.1007/s11999-014-4110-z; Shubert D, 2015, J ARTHROPLASTY, V30, P145, DOI 10.1016/j.arth.2014.08.024; Siguier T, 2004, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000136651.21191.9f; Simmons C Jr, 1991, J Arthroplasty, V6 Suppl, pS57; Slater N, 2000, J ROY COLL SURG EDIN, V45, P231; Takada R, 2018, J ORTHOP SCI; Unger Anthony S, 2014, Instr Course Lect, V63, P227; Upadhyay A, 2007, J ARTHROPLASTY, V22, P2, DOI 10.1016/j.arth.2007.05.003; Weale AE, 1996, J BONE JOINT SURG BR, V78B, P899, DOI 10.1302/0301-620X78B6.6603; WEBER ER, 1976, J BONE JOINT SURG AM, V58, P66, DOI 10.2106/00004623-197658010-00011	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217068	10.1371/journal.pone.0217068	http://dx.doi.org/10.1371/journal.pone.0217068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107921	Green Submitted, Green Published, gold			2022-12-27	WOS:000468285200030
J	Andersen, M; Bjorkman-Burtscher, IM; Marsman, A; Petersen, ET; Boer, VO				Andersen, Mads; Bjorkman-Burtscher, Isabella M.; Marsman, Anouk; Petersen, Esben Thade; Boer, Vincent Oltman			Improvement in diagnostic quality of structural and angiographic MRI of the brain using motion correction with interleaved, volumetric navigators	PLOS ONE			English	Article							UTILITY; PROMO	Introduction Subject movements lead to severe artifacts in magnetic resonance (MR) brain imaging. In this study we evaluate the diagnostic image quality in T1-weighted, T2-weighted, and time-of-flight angiographic MR sequences when using a flexible, navigator-based prospective motion correction system (iMOCO). Methods Five healthy volunteers were scanned during different movement scenarios with and without (+/-) iMOCO activated. An experienced neuroradiologist graded images for image quality criteria (grey-white-matter discrimination, basal ganglia, and small structure and vessel delineation), and general image quality on a four-grade scale. Results In scans with deliberate motion, there was a significant improvement in the image quality with iMOCO compared to the scans without iMOCO in both general image impression (T1 p<0.01, T2 p<0.01, TOF p = 0.03) and in anatomical grading (T1 p<0.01, T2 p<0.01, TOF p = 0.01). Subjective image quality was considered non-diagnostic in 91% of the scans with motion -iMOCO, but only in 4% of the scans with motion +iMOCO. iMOCO performed best in the T1-weighted sequence and least well in the angiography sequence. iMOCO was not shown to have any negative effect on diagnostic image quality, as no significant difference in diagnostic quality was seen between scans -iMOCO and +iMOCO with no deliberate movement. Conclusion The evaluation showed that iMOCO enables substantial improvements in image quality in scans affected by subject movement, recovering important diagnostic information in an otherwise unusable scan.	[Andersen, Mads; Marsman, Anouk; Petersen, Esben Thade; Boer, Vincent Oltman] Copenhagen Univ Hosp Hvidovre, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Andersen, Mads] Philips Healthcare, Copenhagen, Denmark; [Bjorkman-Burtscher, Isabella M.] Lund Univ, Dept Radiol, Clin Sci Lund, Lund, Sweden; [Bjorkman-Burtscher, Isabella M.] Skane Univ Hosp, Dept Med Imaging & Physiol, Lund, Sweden; [Bjorkman-Burtscher, Isabella M.] Lund Univ, Bioimaging Ctr LBIC, Lund, Sweden; [Petersen, Esben Thade] Tech Univ Denmark, Dept Hlth Technol, Ctr Magnet Resonance, Lyngby, Denmark	University of Copenhagen; Philips; Philips Healthcare; Lund University; Lund University; Skane University Hospital; Lund University; Technical University of Denmark	Andersen, M (corresponding author), Copenhagen Univ Hosp Hvidovre, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark.; Andersen, M (corresponding author), Philips Healthcare, Copenhagen, Denmark.	mads.andersen@philips.com	Marsman, Anouk/C-9145-2018; Boer, Vincent/AAR-8536-2020; Petersen, Esben Thade/Q-8266-2019; Björkman-Burtscher, Isabella/AAC-8480-2020	Marsman, Anouk/0000-0003-4768-7762; Boer, Vincent/0000-0001-6026-3134; Petersen, Esben Thade/0000-0001-7529-3432; Andersen, Mads/0000-0002-2702-1640; Bjorkman-Burtscher, Isabella/0000-0002-9023-3363	Danish Council for Independent Research [6111-00349A]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	VOB was supported by the Danish Council for Independent Research (https://ufm.dk/en/research-and-innovation/councils-and-commissions/independent-research-fund-Denmark) grant no. 6111-00349A. MA is an employee of Philips Danmark A/S (https://www.philips.dk).The funders provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afacan O, 2016, PEDIATR RADIOL, V46, P1728, DOI 10.1007/s00247-016-3677-9; Andersen M, 2017, P INT SOC MAG RESON, P3934; Andersen M, 2016, P ISMRM ANN M, P4254; Andre JB, 2015, J AM COLL RADIOL, V12, P689, DOI 10.1016/j.jacr.2015.03.007; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Gallichan D, 2016, MAGN RESON MED, V75, P1030, DOI 10.1002/mrm.25670; Gretsch F., 2017, P INT SOC MAG RESON, P780; Haeberlin M, 2015, MAGN RESON MED, V74, P647, DOI 10.1002/mrm.25432; Henningsson M, 2015, MAGN RESON MED, V73, P692, DOI 10.1002/mrm.25149; Hess AT, 2011, MAGN RESON MED, V66, P314, DOI 10.1002/mrm.22805; Kuperman JM, 2011, PEDIATR RADIOL, V41, P1578, DOI 10.1007/s00247-011-2205-1; Maclaren J, 2013, MAGN RESON MED, V69, P621, DOI 10.1002/mrm.24314; Maclaren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048088; Marsman A, 2017, P INT SOC MAG RESON, P5493; Sarlls JE, 2018, PLOS ONE, P1; Tisdall MD, 2016, NEUROIMAGE, V127, P11, DOI 10.1016/j.neuroimage.2015.11.054; Tisdall MD, 2012, MAGN RESON MED, V68, P389, DOI 10.1002/mrm.23228; Tisdall M. Dylan, 2014, ISMRM; Tornqvist E, 2006, ACTA RADIOL, V47, P474, DOI 10.1080/02841850600690355; van der Kouwe AJW, 2006, MAGN RESON MED, V56, P1019, DOI 10.1002/mrm.21038; Ward HA, 2000, MAGNET RESON MED, V43, P459, DOI 10.1002/(SICI)1522-2594(200003)43:3<459::AID-MRM19>3.0.CO;2-1; Watanabe K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38366; Welch EB, 2002, MAGN RESON MED, V47, P32, DOI 10.1002/mrm.10012; White N, 2010, MAGN RESON MED, V63, P91, DOI 10.1002/mrm.22176; 2015, MAGN RESON IMAGING, V33, P984, DOI DOI 10.1016/J.MRI.2015.06.014	25	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217145	10.1371/journal.pone.0217145	http://dx.doi.org/10.1371/journal.pone.0217145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100092	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600031
J	Yu, WY; Wardrop, NA; Bain, RES; Alegana, V; Graham, LJ; Wright, JA				Yu, Weiyu; Wardrop, Nicola A.; Bain, Robert E. S.; Alegana, Victor; Graham, Laura J.; Wright, Jim A.			Mapping access to domestic water supplies from incomplete data in developing countries: An illustrative assessment for Kenya	PLOS ONE			English	Article							ECOLOGICAL NICHE MODELS; CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; CHAGAS-DISEASE; RANDOM FOREST; POPULATION; PREDICT; BIODIVERSITY; REGRESSION; PATTERNS	Water point mapping databases, generated through surveys of water sources such as wells and boreholes, are now available in many low and middle income countries, but often suffer from incomplete coverage. To address the partial coverage in such databases and gain insights into spatial patterns of water resource use, this study investigated the use of a maximum entropy (MaxEnt) approach to predict the geospatial distribution of drinking-water sources, using two types of unimproved sources in Kenya as illustration. Geographic locations of unprotected dug wells and surface water sources derived from the Water Point Data Exchange (WPDx) database were used as inputs to the MaxEnt model alongside geological/hydrogeological and socio-economic covariates. Predictive performance of the MaxEnt models was high (all > 0.9) based on Area Under the Receiver Operator Curve (AUC), and the predicted spatial distribution of water point was broadly consistent with household use of these unimproved drinking-water sources reported in household survey and census data. In developing countries where geospatial datasets concerning drinking-water sources often have necessarily limited resolution or incomplete spatial coverage, the modelled surface can provide an initial indication of the geography of unimproved drinking-water sources to target unserved populations and assess water source vulnerability to contamination and hazards.	[Yu, Weiyu; Wardrop, Nicola A.; Alegana, Victor; Graham, Laura J.; Wright, Jim A.] Univ Southampton, Southampton, Hants, England; [Bain, Robert E. S.] United Nat Children S Fund UNICEF, Div Data Res & Policy, New York, NY USA; [Alegana, Victor] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Populat Hlth Unit, Nairobi, Kenya	University of Southampton; Kenya Medical Research Institute	Yu, WY (corresponding author), Univ Southampton, Southampton, Hants, England.	W.Yu@soton.ac.uk	Graham, Laura/H-4549-2019; Wright, Jim/C-7881-2013; Yu, Weiyu/AAV-4385-2020; Alegana, Victor/P-6579-2019	Graham, Laura/0000-0002-3611-7281; Wright, Jim/0000-0002-8842-2181; Alegana, Victor/0000-0001-5177-9227; Yu, Weiyu/0000-0003-4624-2139				Alkire S., 2015, MULTIDIMENSIONAL POV, DOI [10.1093/acprof:oso/9780199689491.001.0001, DOI 10.1093/ACPROF:OSO/9780199689491.001.0001]; Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Aneesh R., 2015, INT ADV RES J SCI EN, V2, P129, DOI DOI 10.17148/IARJSET.2015.2628; [Anonymous], 2008, PROGR DRINK WAT SAN; Arnold JD, 2014, FIRE ECOL, V10, P64, DOI 10.4996/fireecology.1002064; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Beard CB, 2003, EMERG INFECT DIS, V9, P103, DOI 10.3201/eid0901.020217; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Burgert CR, 2013, 7 DHS; Busby J. R., 1991, NATURE CONSERVATION; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Carter R, 2014, SITING DRILLED WATER; CLARK JD, 1993, J WILDLIFE MANAGE, V57, P519, DOI 10.2307/3809276; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516; DeBarros RP, 2009, MEASURING INEQUALITY OF OPPORTUNITIES IN LATIN AMERICA AND THE CARIBBEAN, P1, DOI 10.1596/978-0-8213-7745-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devisscher T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161323; Drasgow F., 1986, ENCY STAT SCI, VVol. 7, P68, DOI DOI 10.1002/0471667196.ESS2014.PUB2.ACCESSED; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith Jane, 2002, P39; Falah F, 2017, GEOCARTO INT, V32, P1069, DOI 10.1080/10106049.2016.1188166; Fantom N, 2016, WORLD BANKS CLASSIFI, DOI [10.1596/1813-9450-7528, DOI 10.1596/1813-9450-7528]; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Fox J., 2016, POLYCOR; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gething P, 2015, 11 DHS, V11; Golding N, 2018, METHODS ECOL EVOL, V9, P260, DOI 10.1111/2041-210X.12858; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Hastie TJ., 2017, GEN ADDITIVE MODELS; Hefley T.J., 2016, CURR LANDSC ECOL REP, V1, P87, DOI [10.1007/s40823-016-0008-7, DOI 10.1007/S40823-016-0008-7]; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; ICF International Funded by the United States Agency for International Development (USAID), SPAT DAT REP DEM HLT; International Livestock Research Institute, WAT POINTS NO KEN GE; International Livestock Research Institute, DISTR WAT POINTS ALM; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute National Council for Population and Development The DHS Program ICF International, 2015, DHS PROGR ICF INT; Kimani-Murage EW, 2007, J URBAN HEALTH, V84, P829, DOI 10.1007/s11524-007-9199-x; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; MacDonald AM, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024009; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Masuoka P, 2010, GEOSPATIAL HEALTH, V5, P45, DOI 10.4081/gh.2010.186; Mccullagh P., 1989, GEN LINEAR MODELS, P532, DOI DOI 10.1007/978-1-4899-3242-6; Mekonnen MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500323; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Miraki S, 2019, WATER RESOUR MANAG, V33, P281, DOI 10.1007/s11269-018-2102-6; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Mohamed KI, 2006, AMBIO, V35, P281, DOI 10.1579/05-R-051R.1; Naghibi SA, 2017, WATER RESOUR MANAG, V31, P2761, DOI 10.1007/s11269-017-1660-3; Naghibi SA, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5049-6; Nejad SG, 2017, GEOCARTO INT, V32, P167, DOI 10.1080/10106049.2015.1132481; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Odiere MR, 2011, PARASITOLOGY, V138, P1569, DOI 10.1017/S003118201100059X; Ortega-Huerta MA, 2004, DIVERS DISTRIB, V10, P39, DOI 10.1111/j.1472-4642.2004.00051.x; Ouedraogo I, 2016, SCI TOTAL ENVIRON, V544, P939, DOI 10.1016/j.scitotenv.2015.11.135; Park NW, 2015, ENVIRON EARTH SCI, V73, P937, DOI 10.1007/s12665-014-3442-z; Pearce A, 2016, ASA CSSA SSSA INT AN; Pesaresi M., 2016, GHS SETTLEMENT GRID; Peterson AT, 2006, ECOL MODEL, V195, P229, DOI 10.1016/j.ecolmodel.2005.11.020; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2003, CONSERV BIOL, V17, P1161, DOI 10.1046/j.1523-1739.2003.02206.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pullan RL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001626; Rahmati O, 2018, J HYDROL, V565, P248, DOI 10.1016/j.jhydrol.2018.08.027; Rahmati O, 2018, ENVIRON MODELL SOFTW, V102, P1, DOI 10.1016/j.envsoft.2018.01.004; Rahmati O, 2016, CATENA, V137, P360, DOI 10.1016/j.catena.2015.10.010; Rahmati O, 2015, ARAB J GEOSCI, V8, P7059, DOI 10.1007/s12517-014-1668-4; Ramu B., 2014, INT J GEOMAT GEOSCI, V5, P393; Renard Q, 2012, INT J WILDLAND FIRE, V21, P368, DOI 10.1071/WF10109; Rhoden CM, 2017, PEERJ, V5, DOI 10.7717/peerj.3632; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Schumacher JV, 2000, ENVIRON MONIT ASSESS, V64, P127, DOI 10.1023/A:1006496023729; Simon R., 2007, FUNDAMENTALS DATA MI, P173, DOI [10.1007/978-0-387-47509-7, DOI 10.1007/978-0-387-47509-7]; Snedecor GW., 1968, STAT METHODS; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stumpf A, 2011, REMOTE SENS ENVIRON, V115, P2564, DOI 10.1016/j.rse.2011.05.013; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; UNICEF, 1999, WAT HDB; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; University of Notre Dame, 2010, SPACES SPAT PORT AN; van Wijk-Sijbesma C, 1985, TECHNICAL PAPER SERI, V22; van Wijk-Sijbesma C., 1998, GENDER WATER RESOURC; Verplanke J, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6080244; Vorpahl P, 2012, ECOL MODEL, V239, P27, DOI 10.1016/j.ecolmodel.2011.12.007; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; WHO UNICEF, 2017, REP TASK FORC MON IN; WHO UNICEF, 2015, PROGR WAT SAN 2015 U; World Health Organization United Nations Children's Fund., 2017, PROGR DRINKING WATER; WPDx, 2015, WAT POINT DAT EXCH W; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yu WY, 2017, INT J HYG ENVIR HEAL, V220, P888, DOI 10.1016/j.ijheh.2017.04.006; 2007, TRENDS ECOL EVOL, V22, P42, DOI DOI 10.1016/J.TREE.2006.09.010	104	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216923	10.1371/journal.pone.0216923	http://dx.doi.org/10.1371/journal.pone.0216923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100084	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000468176600021
J	Kwizera, R; Musaazi, J; Meya, DB; Worodria, W; Bwanga, F; Kajumbula, H; Fowler, SJ; Kirenga, BJ; Gore, R; Denning, DW				Kwizera, Richard; Musaazi, Joseph; Meya, David B.; Worodria, William; Bwanga, Freddie; Kajumbula, Henry; Fowler, Stephen J.; Kirenga, Bruce J.; Gore, Robin; Denning, David W.			Burden of fungal asthma in Africa: A systematic review and meta-analysis	PLOS ONE			English	Review							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; RESPIRATORY SYMPTOMS; INDOOR ALLERGENS; GLOBAL BURDEN; 1ST YEAR; SENSITIZATION; PREVALENCE; INFECTIONS; MANAGEMENT; RISK	Background Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of fungal asthma among adults and children in Africa using a systematic review. Methods We first engaged the Institute for Health Metrics and Evaluation (IHME) to highlight the trend in morbidity and mortality attributed to asthma in Africa. We then searched PubMed, HINARI and Google Scholar for all studies of any design focusing on fungal asthma in any African country. Languages were restricted to English and French, but not year of publication. We estimated the weighted prevalence of allergic fungal infections among asthmatics with a 95% CI and pooled the results using a random effects model. This study is registered with PROSPERO, number CRD42019117319. Results The IHME data showed that there has been a gradual increase in morbidity and mortality due to asthma in African adults with a prevalence of 4%. Our search retrieved 5233 citations. We retained 20 studies that met our selection criteria. These were from 13 African countries published between 1967 and 2018. There were eight cross-sectional studies and twelve review articles. The average asthma prevalence in Africa was 6% from these studies. The prevalence of fungal sensitisation was relatively high (3-52%) in the asthmatic population with an average of 28% and a pooled estimate of 23.3%, mostly due to Aspergillus species. Prevalence of Allergic bronchopulmonary apsergillosis was estimated at 1.6-21.2%. Diagnosis of fungal allergy was mostly made by skin prick tests. There was no data on the use of medication to manage fungal asthma. None of the studies evaluated the association between fungal allergy and asthma severity. Data were lacking in children. Conclusion There is a high prevalence of fungal sensitization among Africans with asthma. Fungal asthma is a significant problem in Africa but there remains a paucity of data on the epidemiology and associated complications. There is urgent need for national epidemiological studies to estimate the actual burden of fungal asthma in Africa.	[Kwizera, Richard; Musaazi, Joseph; Meya, David B.] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Kwizera, Richard; Kirenga, Bruce J.] Makerere Univ, Lung Inst, Coll Hlth Sci, Kampala, Uganda; [Meya, David B.; Worodria, William; Kirenga, Bruce J.] Makerere Univ, Sch Med, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Worodria, William; Kirenga, Bruce J.] Mulago Natl Referral Hosp, Kampala, Uganda; [Bwanga, Freddie; Kajumbula, Henry] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Fowler, Stephen J.] Univ Manchester, Div Infect Immun & Resp Med, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Fowler, Stephen J.] Manchester Univ Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester, Lancs, England; [Gore, Robin] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Denning, David W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Natl Aspergillosis Ctr, Wythenshawe Hosp, Manchester, Lancs, England	Makerere University; Makerere University; Makerere University; Mulago National Referral Hospital; Makerere University; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Cambridge; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Kwizera, R (corresponding author), Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.; Kwizera, R (corresponding author), Makerere Univ, Lung Inst, Coll Hlth Sci, Kampala, Uganda.	kwizerarichard@ymail.com	Meya, David/AAO-2796-2020; Kwizera, Richard/I-5247-2019; Denning, David/AAC-6931-2019	Kwizera, Richard/0000-0002-5270-3539; Denning, David/0000-0001-5626-2251; Fowler, Stephen/0000-0002-4524-1663; Kajumbula, Henry/0000-0002-2075-0007; , David/0000-0002-8854-0321	DELTAS Africa Initiative grant [DEL-15-011]; Wellcome Trust [107742/Z/15/Z]; UK government	DELTAS Africa Initiative grant; Wellcome Trust(Wellcome TrustEuropean Commission); UK government	The authors received no specific funding for this work. However, we thank institutional support from the IDI research office and Makerere University Lung Institute. Dr David Meya and Richard Kwizera are currently supported through the DELTAS Africa Initiative grant #DEL-15-011 to THRiVE-2, from Wellcome Trust grant #107742/Z/15/Z and the UK government.	Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; Agarwal R, 2011, MED MYCOL, V49, pS150, DOI 10.3109/13693786.2010.504752; ALSHISHTAWY MM, 1991, INT ARCH ALLER A IMM, V96, P348, DOI 10.1159/000235520; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Baatjies R, 2009, EUR RESPIR J, V34, P825, DOI 10.1183/09031936.00164408; Badiane AS, 2015, MYCOSES, V58, P63, DOI 10.1111/myc.12381; Bamba S, 2018, J FUNGI, V4, DOI 10.3390/jof4010035; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Baxi SN, 2016, J ALLER CL IMM-PRACT, V4, P396, DOI 10.1016/j.jaip.2016.01.008; Belanger K, 2003, AM J EPIDEMIOL, V158, P195, DOI 10.1093/aje/kwg148; BENATAR SR, 1980, CLIN ALLERGY, V10, P285, DOI 10.1111/j.1365-2222.1980.tb02109.x; BENATAR SR, 1977, S AFR MED J, V51, P297; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3020026; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Bush RK, 2004, J ALLERGY CLIN IMMUN, V113, P227, DOI 10.1016/j.jaci.2003.11.023; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Chekiri-Talbi M, 2017, J MYCOL MED, V27, P139, DOI 10.1016/j.mycmed.2017.02.005; Chotirmall SH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/723129; D'Amato G, 2005, CLIN EXP ALLERGY, V35, P1113, DOI 10.1111/j.1365-2222.2005.02328.x; Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 2009, AM J RESP CRIT CARE, V179, P11, DOI 10.1164/rccm.200805-737OC; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; EL-HEFNY A, 1967, Journal of the Egyptian Medical Association, V50, P354; Esamai F, 2002, East Afr Med J, V79, P514; Faini D, 2015, MYCOSES, V58, P70, DOI 10.1111/myc.12390; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Fraczek MG, 2018, J ALLERGY CLIN IMMUN, V142, P407, DOI 10.1016/j.jaci.2017.09.039; Fukutomi Y, 2015, ALLERGOL INT, V64, P321, DOI 10.1016/j.alit.2015.05.007; Gent JF, 2002, ENVIRON HEALTH PERSP, V110, pA781, DOI 10.1289/ehp.021100781; Georgy V, 2006, EUR RESPIR J, V28, P756, DOI 10.1183/09031936.06.00089005; Guto JA, 2016, J INFECT DEV COUNTR, V10, P777, DOI 10.3855/jidc.7614; Hasnain SM, 2012, WORLD ALLERGY ORGAN, V5, P59, DOI 10.1097/WOX.0b013e31825a73cd; HEARN VM, 1985, J IMMUNOASSAY, V6, P165, DOI 10.1080/01971528508063028; Hekking PPW, 2015, J ALLERGY CLIN IMMUN, V135, P896, DOI 10.1016/j.jaci.2014.08.042; Institute for Health Metrics and Evaluation (IHME), 2017, GBD COMP DAT VIS; Kalua K, 2018, J FUNGI, V4, DOI 10.3390/jof4020061; Kauffman HF, 2003, FRONT BIOSCI-LANDMRK, V8, pE190, DOI 10.2741/990; Kneale M, 2016, J ANTIMICROB CHEMOTH, V71, P3599, DOI 10.1093/jac/dkw325; Lalloo U, 2007, S AFR FAM PRACT, V49, P19, DOI 10.1080/20786204.2007.10873553; Li E, 2018, IMMUN INFLAMM DIS, V6, P264, DOI 10.1002/iid3.215; Lopata AL, 2005, ALLERGY, V60, P200, DOI 10.1111/j.1398-9995.2005.00661.x; Mandengue CE, 2018, J FUNGI, V4, DOI 10.3390/jof4020044; Masjedi M, 2018, TURK THORAC J, V19, P56, DOI 10.5152/TurkThoracJ.2018.17051; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Menzies D, 2011, ALLERGY, V66, P679, DOI 10.1111/j.1398-9995.2010.02542.x; Motala C, 2009, SAMJ S AFR MED J, V99, P898; Neukirch C, 1999, J ALLERGY CLIN IMMUN, V103, P709, DOI 10.1016/S0091-6749(99)70247-2; Nnko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142194; Nriagu J, 1999, EUR J EPIDEMIOL, V15, P747, DOI 10.1023/A:1007653709188; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; O'Driscoll BR, 2009, CLIN EXP ALLERGY, V39, P1677, DOI 10.1111/j.1365-2222.2009.03339.x; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; Obel KB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176875; Oladele R O, 2014, West Afr J Med, V33, P107; Parkes-Ratanshi R, 2015, MYCOSES, V58, P85, DOI 10.1111/myc.12387; Quansah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047526; Sabry Mohammed K, 2016, Egypt J Immunol, V23, P31; Sacarlal J, 2018, J FUNGI, V4, DOI 10.3390/jof4030075; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; Weinberg EG, 2000, J ALLERGY CLIN IMMUN, V105, P224, DOI 10.1016/S0091-6749(00)90069-1; WHO, 2017, CHANG 2017 WHO MOD L; WHO, 2011, GUID ASTHM MAN KEN; WHO, 2003, WHOMNCCRA022; Yakubovich A, 2016, LINK ASTHMA STRESS D; Yakubovich A R, 2016, SAMJ, S. Afr. med. j., V106, P407, DOI [10.7196/samj.2016.v106i4.10168, 10.7196/SAMJ.2016.v106i4.10168]; Zaki SM, 2017, EUR J CLIN MICROBIOL, V36, P971, DOI 10.1007/s10096-017-2929-4; 2007, THORAX, V62, P758, DOI DOI 10.1136/THX.2006.070169; 2013, AFR HEALTH SCI, V13, P144, DOI DOI 10.4314/AHS.V13I1.20	75	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2019	14	5							e0216568	10.1371/journal.pone.0216568	http://dx.doi.org/10.1371/journal.pone.0216568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY3MG	31095641	Green Published, Green Submitted, gold			2022-12-27	WOS:000468030100031
J	Abd Gani, S; Muhammad, SA; Kura, AU; Barahuie, F; Hussein, MZ; Fakurazi, S				Abd Gani, Shafinaz; Muhammad, Suleiman Alhaji; Kura, Aminu Umar; Barahuie, Farahnaz; Hussein, Mohd Zobir; Fakurazi, Sharida			Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice	PLOS ONE			English	Article							FOCAL LESION GROWTH; ZINC-DEFICIENCY; TRACE-METALS; LIVER; CANCER; TUMOR; EXTRACT; BREAST; CELLS; CHEMOPREVENTION	Researchers investigating cancer chemotherapy and management continue to search for agents that selectively kill malignant cells and leave healthy neighboring cells intact. Natural products provide relevant resources for anti-cancer drug discovery. However, the physicochemical properties of these compounds limit their efficient uptake and bioavailability. We introduced a nanocarrier system, namely, zinc-aluminum-layered double hydroxide (ZnAl-LDH) intercalated with protocatechuic acid. In this study, the efficacy and toxicity of protocatechuic acid intercalated in zinc aluminum-layered double hydroxide nanoparticles (PCA-ZnAl) against diethylnitrosamine/phenobarbital (DEN/PB)-induced hepatocellular carcinoma (HCC) in BALB/c mice was evaluated. HCC in male mice was induced by a single-dose intraperitoneal administration of DEN and was promoted by the introduction of PB via drinking water for 12 weeks. HCC induction was confirmed after the DEN/PB introduction period by measurement of the elevated level of serum a-feto protein (AFP). The results showed that the level of alpha-fetoprotein was significantly reduced in PCA-ZnAl (350 +/- 43.90 ng/mL), doxorubicin (DOX) (290 +/- 20.52 ng/mL) and ZnAl-LDH (390 +/- 19.65 ng/mL) treated animals compared to HCC mice treated with normal saline (580.4 +/- 52.04 ng/mL). Superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) levels were significantly increased, whereas the level of lipid peroxidation was significantly decreased in HCC mice treated with DOX, PCA-ZnAl and ZnAl-LDH compared with those in HCC mice treated with saline. Restoration of hepatocyte morphology was observed following treatment that was comparable to that in the normal control group. Deterioration of hepatic cells and a significant increase of aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) were observed in the cancer-induced untreated group compared with that in the groups treated with nanoparticles. The histopathological features of the liver obtained from PCA-ZnAl-treated mice showed a uniform size with a similar distribution of the nuclear-cytoplasmic ratio and nucleus centrally located in the cytoplasm, similar to the normal liver cells. The results underscored the potential of PCA-ZnAl for the treatment of hepatocellular carcinoma.	[Abd Gani, Shafinaz; Muhammad, Suleiman Alhaji; Fakurazi, Sharida] Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Immunotherapeut, Serdang, Selangor, Malaysia; [Abd Gani, Shafinaz] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor, Malaysia; [Kura, Aminu Umar] Bauchi State Univ, Dept Pharmacol, Fac Med, Gadau, Nigeria; [Barahuie, Farahnaz] Univ Sistan & Baluchestan, Fac Ind & Min, Zahedan, Iran; [Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol ITMA, Mat Synth & Characterizat Lab, Serdang, Selangor, Malaysia; [Fakurazi, Sharida] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; University of Sistan & Baluchestan; Universiti Putra Malaysia; Universiti Putra Malaysia	Fakurazi, S (corresponding author), Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Immunotherapeut, Serdang, Selangor, Malaysia.; Fakurazi, S (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia.	sharida@upm.edu.my	Muhammad, Suleiman/ABA-3384-2020; Barahuie, Farahnaz/AAG-8428-2019	Barahuie, Farahnaz/0000-0003-4745-6454; FAKURAZI, SHARIDA/0000-0001-8986-876X; Muhammad, Suleiman A./0000-0003-2421-3556	Fundamental research grant scheme from the Ministry of Education, Malaysia [5524841]	Fundamental research grant scheme from the Ministry of Education, Malaysia	This work was funded by Fundamental research grant scheme with grant number 5524841 from the Ministry of Education, Malaysia. The funder has no role in study design, collection and analysis of the data, preparing the manuscripts, and decisions to publish. The researchers have no conflict of interest in designing, obtaining, analyzing and publishing the data. No salary was obtained from the funders of the project.	Afonne, 2002, INDIAN J PHARM, V34, P26; Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Al-Ebraheem A, 2009, APPL RADIAT ISOTOPES, V67, P470, DOI 10.1016/j.apradiso.2008.06.018; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Atefipour Narges, 2016, Electron Physician, V8, P2410, DOI 10.19082/2410; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Barahuie F, 2015, J SOLID STATE CHEM, V221, P21, DOI 10.1016/j.jssc.2014.09.001; Beytur A, 2012, ANDROLOGIA, V44, P454, DOI 10.1111/j.1439-0272.2011.01204.x; Bianchi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177995; Bianchi GP, 2000, NUTR RES, V20, P1079, DOI 10.1016/S0271-5317(00)00194-9; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; BISHAYEE A, 1995, BRIT J CANCER, V71, P1214, DOI 10.1038/bjc.1995.236; Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039; Cho SK, 2011, DIAGN INTERV RADIOL, V17, P374, DOI 10.4261/1305-3825.DIR.4016-10.1; Choi G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04430; Choi SJ, 2010, J MATER CHEM, V20, P9463, DOI 10.1039/b925831k; COMPORTI M, 1989, CHEM-BIOL INTERACT, V72, P1, DOI 10.1016/0009-2797(89)90016-1; FARBER E, 1990, BIOCHEM PHARMACOL, V39, P1837, DOI 10.1016/0006-2952(90)90599-G; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Giovannini C, 2008, J NUTR BIOCHEM, V19, P118, DOI 10.1016/j.jnutbio.2007.01.010; Gutierrez L, 2009, BBA-MOL BASIS DIS, V1792, P541, DOI 10.1016/j.bbadis.2009.03.007; Hefaiedh Rania, 2013, Tunis Med, V91, P505; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; Jagan S, 2008, MOL CELL BIOCHEM, V319, P51, DOI 10.1007/s11010-008-9876-4; JAMES RC, 1982, BIOCHEM PHARMACOL, V31, P1829, DOI 10.1016/0006-2952(82)90484-1; Jarapala SR, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/201506; Jayaprakash R, 2015, J PHARM BIOALLIED SC, V7, pS40, DOI 10.4103/0975-7406.155791; Kawata T, 2006, BIOL PHARM BULL, V29, P403, DOI 10.1248/bpb.29.403; Klaunig JE, 1999, TOXICOL SCI, V52, P101, DOI 10.1093/toxsci/52.2.101; KLAUNIG JE, 1988, TOXICOL PATHOL, V16, P381, DOI 10.1177/019262338801600310; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kolaja KL, 1997, TOXICOL APPL PHARM, V143, P380, DOI 10.1006/taap.1996.8089; Kushida M, 2011, TOXICOL PATHOL, V39, P776, DOI 10.1177/0192623311409596; Kuthati Y, 2015, APPL CLAY SCI, V112, P100, DOI 10.1016/j.clay.2015.04.018; Lee JS, 2005, INFECT IMMUN, V73, P4399, DOI 10.1128/IAI.73.7.4399-4403.2005; Liccioni A, 2014, DIGEST DIS, V32, P554, DOI 10.1159/000360501; Lin HH, 2011, BRIT J PHARMACOL, V162, P237, DOI 10.1111/j.1476-5381.2010.01022.x; Lin SB, 2012, LIVER CANCER, V1, P144, DOI 10.1159/000343828; Liu CL, 2002, FOOD CHEM TOXICOL, V40, P635, DOI 10.1016/S0278-6915(02)00002-9; Liu ZQ, 2019, J HEPATOL, V70, P674, DOI 10.1016/j.jhep.2018.12.001; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mangray S, 2015, DIGEST DIS SCI, V60, P2868, DOI 10.1007/s10620-015-3854-y; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Masella R, 2004, J NUTR, V134, P785, DOI 10.1093/jn/134.4.785; Masella R, 2012, CURR MED CHEM, V19, P2901; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; OLSSON M, 1977, J EXP MED, V145, P819, DOI 10.1084/jem.145.4.819; Paradis Valerie, 2013, Recent Results Cancer Res, V190, P21, DOI 10.1007/978-3-642-16037-0_2; Patrick Lyn, 2003, Altern Med Rev, V8, P106; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063; Semaming Y, 2015, EVID-BASED COMPL ALT, V2015, DOI [10.1155/2015/593902, DOI 10.1155/2015/593902]; Sengupta S, 2015, DIGEST DIS SCI, V60, P3130, DOI 10.1007/s10620-015-3613-0; Shaheen N., 2014, OXIDATIVE STRESS DIE; Singh RP, 2000, MOL CELL BIOCHEM, V213, P99, DOI 10.1023/A:1007182913931; Sukowati CHC, 2010, WORLD J HEPATOL, V2, P114, DOI 10.4254/wjh.v2.i3.114; Sun H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/584728; Sun XD, 2015, J COLLOID INTERF SCI, V459, P264, DOI 10.1016/j.jcis.2015.07.073; TANAKA T, 1993, CANCER RES, V53, P2775; Tashiro-Itoh T, 1997, LIVER, V17, P300; Vargas-Olvera CY, 2012, MOL CELL BIOCHEM, V369, P105, DOI 10.1007/s11010-012-1373-0; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wadei HM, 2006, CLIN J AM SOC NEPHRO, V1, P1066, DOI 10.2215/CJN.01340406; Wong MCS, 2019, NAT REV GASTRO HEPAT, V16, P57, DOI 10.1038/s41575-018-0055-0; Xiao B, 2014, ONCOL LETT, V7, P23, DOI 10.3892/ol.2013.1651; Yin MC, 2009, J AGR FOOD CHEM, V57, P6468, DOI 10.1021/jf9004466	69	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217009	10.1371/journal.pone.0217009	http://dx.doi.org/10.1371/journal.pone.0217009			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141523	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000469323000035
J	Ayllon, S; Alsina, A; Colomer, J				Ayllon, Sara; Alsina, Angel; Colomer, Jordi			Teachers' involvement and students' self-efficacy: Keys to achievement in higher education	PLOS ONE			English	Article							AUTONOMY SUPPORT; NEED; ENGAGEMENT; MOTIVATION; CONFIGURATIONS; PREDICTOR; QUALITY	We study the relative importance of the three dimensions of need-supportive teaching (NST) and students' self-efficacy to gain new knowledge about students' achievement in higher education. NST assumes that teachers are key to the motivation of students, providing autonomy support, structure (support of competence), and involvement (support of relatedness). In turn, self-efficacy raises students' confidence in their ability to succeed in academic tasks. Drawing on 86,000 records of teaching evaluations by students at the University of Girona (Spain), we present evidence that teachers' involvement and students' self-efficacy are the two elements most strongly and positively related to achievement. Students obtain higher marks when they believe that their teachers are dependable and available to offer resources, and when they feel capable of organizing and implementing the courses of action necessary to acquire knowledge. We also find that students' experience of autonomy support and structure are negatively (or not) correlated with achievement. Subgroup analyses also indicate that students have different needs in different knowledge areas.	[Ayllon, Sara] Univ Girona, Dept Econ, Girona, Spain; [Ayllon, Sara; Alsina, Angel; Colomer, Jordi] Univ Girona, Inst Educ Sci Josep Pallach, Teaching Innovat Network Reflect Learning, Girona, Spain; [Alsina, Angel] Univ Girona, Dept Specif Didact, Girona, Spain; [Colomer, Jordi] Univ Girona, Dept Phys, Girona, Spain	Universitat de Girona; Universitat de Girona; Universitat de Girona; Universitat de Girona	Ayllon, S (corresponding author), Univ Girona, Dept Econ, Girona, Spain.; Ayllon, S (corresponding author), Univ Girona, Inst Educ Sci Josep Pallach, Teaching Innovat Network Reflect Learning, Girona, Spain.	sara.ayllon@udg.edu	Ayllón, Sara/N-5350-2015; Colomer, Jordi/Y-5386-2018	Ayllón, Sara/0000-0002-3338-1183; Colomer, Jordi/0000-0002-9330-0269	Teaching Innovation Network on Reflective Learning; Institut de Ciencies de l'Educacio Josep Pallach at the University of Girona	Teaching Innovation Network on Reflective Learning; Institut de Ciencies de l'Educacio Josep Pallach at the University of Girona	The Teaching Innovation Network on Reflective Learning and Institut de Ciencies de l'Educacio Josep Pallach at the University of Girona both provided support to pay for the publication fees. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelterman N, 2013, TEACH TEACH EDUC, V29, P64, DOI 10.1016/j.tate.2012.09.001; Allan J., 2007, INT J TEACH LEARN HI, V21, P362; Amado D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085275; Andrew S, 1998, J ADV NURS, V27, P596, DOI 10.1046/j.1365-2648.1998.00550.x; [Anonymous], 1977, SELF EFFICACY EXERCI; Assor A., 2001, TRENDS PROSPECTS MOT, P101; Bandura A, 2003, J APPL PSYCHOL, V88, P87, DOI 10.1037/0021-9010.88.1.87; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Carnell E, 2007, TEACH HIGH EDUC, V12, P25, DOI 10.1080/13562510601102081; Choi N, 2005, PSYCHOL SCHOOLS, V42, P197, DOI 10.1002/pits.20048; Commission European, 2013, SUPP TEACH COMP DEV; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Dietrich J, 2015, LEARN INSTR, V39, P45, DOI 10.1016/j.learninstruc.2015.05.007; Friedkin NE, 2016, SCIENCE, V354, P321, DOI 10.1126/science.aag2624; Furrer C, 2003, J EDUC PSYCHOL, V95, P148, DOI 10.1037/0022-0663.95.1.148; Gonzalez A, 2018, HIGH EDUC, V75, P625, DOI 10.1007/s10734-017-0160-y; GROLNICK WS, 1987, J PERS SOC PSYCHOL, V52, P890, DOI 10.1037/0022-3514.52.5.890; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; Jang H, 2010, J EDUC PSYCHOL, V102, P588, DOI 10.1037/a0019682; Kunter M, 2013, J EDUC PSYCHOL, V105, P805, DOI 10.1037/a0032583; Lamote C, 2010, EUR J TEACH EDUC, V33, P3, DOI 10.1080/02619760903457735; Lane J, 2004, SOC BEHAV PERSONAL, V32, P247, DOI 10.2224/sbp.2004.32.3.247; Leenknecht MJM, 2017, TEACH TEACH EDUC, V68, P134, DOI 10.1016/j.tate.2017.08.020; Lent R. W., 2002, CAREER CHOICE DEV, P255, DOI DOI 10.4135/9781412952675.N261; Los R. E., 2014, THESIS, P1; Martin DP, 2015, J SCHOOL PSYCHOL, V53, P359, DOI 10.1016/j.jsp.2015.07.001; Panadero E, 2017, EDUC RES REV-NETH, V22, P74, DOI 10.1016/j.edurev.2017.08.004; Ratelle CF, 2014, CONTEMP EDUC PSYCHOL, V39, P388, DOI 10.1016/j.cedpsych.2014.09.003; Reeve J, 2004, MOTIV EMOTION, V28, P147, DOI 10.1023/B:MOEM.0000032312.95499.6f; Reeve J, 2013, J EDUC PSYCHOL, V105, P579, DOI 10.1037/a0032690; Reeve J, 2011, CONTEMP EDUC PSYCHOL, V36, P257, DOI 10.1016/j.cedpsych.2011.05.002; Reeve J, 2006, HANDBOOK OF CLASSROOM MANAGEMENT: RESEARCH, PRACTICE, AND CONTEMPORARY ISSUES, P645; Reeve J, 2009, EDUC PSYCHOL-US, V44, P159, DOI 10.1080/00461520903028990; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SCHUNK DH, 1991, EDUC PSYCHOL, V26, P207, DOI 10.1207/s15326985ep2603&4_2; Sierens E, 2009, BRIT J EDUC PSYCHOL, V79, P57, DOI 10.1348/000709908X304398; SKINNER EA, 1993, J EDUC PSYCHOL, V85, P571, DOI 10.1037/0022-0663.85.4.571; Soenens B, 2012, J EDUC PSYCHOL, V104, P108, DOI 10.1037/a0025742; Stroet K, 2015, SOC PSYCHOL EDUC, V18, P585, DOI 10.1007/s11218-015-9290-1; Stroet K, 2013, EDUC RES REV-NETH, V9, P65, DOI 10.1016/j.edurev.2012.11.003; Su YL, 2011, EDUC PSYCHOL REV, V23, P159, DOI 10.1007/s10648-010-9142-7; Sutherland L, 2012, HIGH EDUC, V64, P747, DOI 10.1007/s10734-012-9522-7; van Dinther M, 2011, EDUC RES REV-NETH, V6, P95, DOI 10.1016/j.edurev.2010.10.003; Vansteenkiste M, 2012, LEARN INSTR, V22, P431, DOI 10.1016/j.learninstruc.2012.04.002; Yeager DS, 2016, P NATL ACAD SCI USA, V113, pE3341, DOI 10.1073/pnas.1524360113; Young V., 2003, MUSIC EDUC RES, V5, P139, DOI [10.1080/1461380032000085522, DOI 10.1080/1461380032000085522]; Zimmerman B.J., 2006, SELF EFFICACY BELIEF, V5, P45	47	32	32	9	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0216865	10.1371/journal.pone.0216865	http://dx.doi.org/10.1371/journal.pone.0216865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125346	Green Published, gold			2022-12-27	WOS:000468865700009
J	Amirav, I; Masumbuko, CK; Hawkes, MT; Solomon, I; Aldar, Y; Margalit, G; Zvirin, A; Honen, Y; Sivasivugha, ES; Kimmel, R				Amirav, Israel; Masumbuko, Claude Kasereka; Hawkes, Michael T.; Solomon, Ian; Aldar, Yossi; Margalit, Gil; Zvirin, Alon; Honen, Yaron; Sivasivugha, Eugenie Sahika; Kimmel, Ron			3D analysis of child facial dimensions for design of medical devices in low-middle income countries (LMIC)	PLOS ONE			English	Article							REGISTRATION	Background Facial anthropometric data are scarce in African children. However, such data may be useful for the design of medical devices for high disease burden settings. The aim of this study was to obtain 3D facial anthropometric data of Congolese children aged 0-5 years. Methods & findings The faces of 287 Congolese children were successfully scanned using a portable structured-light based 3D video camera, suitable for field work in low-income settings. The images were analyzed using facial analysis algorithms. Normal growth curves were generated for the following facial dimensions: distance between nares and distance from subnasion to upper lip. At birth, 1 year, and 5 years of age the median dimensions were: 13.92, 14.66, and 17.60 mm, respectively for distance between nares, and 10.16, 10.88, and 13.79 mm, respectively for distance from subnasion to upper lip. Modeled facial contours conveniently clustered into three average sizes which could be used as templates for the design of medical instruments. Conclusion Capturing of 3D images of infants and young children in LMICs is feasible using portable cameras and computerized analysis. This method and these specific data on Congolese pediatric facial dimensions may assist in the design of appropriately sized medical devices (thermometers, face masks, pulse oximeters, etc.) for this population.	[Amirav, Israel; Hawkes, Michael T.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Masumbuko, Claude Kasereka; Sivasivugha, Eugenie Sahika] Assoc Hlth Innovat Africa, Butembo, DEM REP CONGO; [Masumbuko, Claude Kasereka] Univ Catholique Graben, Butembo, DEM REP CONGO; [Solomon, Ian; Aldar, Yossi] RespiDx Ltd, Tel Aviv, Israel; [Margalit, Gil] Tel Aviv Univ, Tel Aviv, Israel; [Zvirin, Alon; Honen, Yaron; Kimmel, Ron] Technion Univ, Dept Comp Sci, Haifa, Israel; [Amirav, Israel] Tel Aviv Med Ctr & Sch Med, Dana Dwek Childrens Hosp, Pediat Pulmonol Unit, Tel Aviv, Israel	University of Alberta; Tel Aviv University; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Masumbuko, CK (corresponding author), Assoc Hlth Innovat Africa, Butembo, DEM REP CONGO.; Masumbuko, CK (corresponding author), Univ Catholique Graben, Butembo, DEM REP CONGO.	claudemasumbuko@gmail.com	, Michael/AAP-3049-2020	Kasereka, Masumbuko/0000-0003-1367-3426; Amirav, Israel/0000-0002-6917-5285	Association for Health Innovation in Africa (AFHIA) [047/2018]; Grand Challenges Canada Grant Stars in Global Health [R-STPOC-1707-06344]; Gene & Anja Rosenberg Research Fund for Scanning & analysis of Geometry in Children	Association for Health Innovation in Africa (AFHIA); Grand Challenges Canada Grant Stars in Global Health; Gene & Anja Rosenberg Research Fund for Scanning & analysis of Geometry in Children	The study was supported by Association for Health Innovation in Africa (AFHIA), grant number 047/2018 (CKM). It was also supported by Gene & Anja Rosenberg Research Fund for Scanning & analysis of Geometry in Children (RK) and by Grand Challenges Canada (https://www.grandchallenges.ca/) Grant Number R-STPOC-1707-06344, Stars in Global Health (IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ian Solomon and Yossi Aldar shareholders in RespiDx Ltd., the manufacturer of the Multimometer product.	Ajayi EO, 2005, AM J ORTHOD DENTOFAC, V128, P653, DOI 10.1016/j.ajodo.2005.07.002; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bronstein Bronstein, 2003, CIS200306 TECHN; Carroll A, 2014, AM J RESP CRIT CARE, V190, P950, DOI 10.1164/rccm.201407-1357IM; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Chui HL, 2000, PROC CVPR IEEE, P44, DOI 10.1109/CVPR.2000.854733; Fadeju AD, 2012, W AFR J ORTHOD, V1, P20; Fourie Zacharias, 2012, Shanghai Kou Qiang Yi Xue, V21, P220; Kimoto K, 2007, J ORAL REHABIL, V34, P201, DOI 10.1111/j.1365-2842.2006.01663.x; Larson JR, 2018, AM J PHYS ANTHROPOL, V165, P327, DOI 10.1002/ajpa.23356; Luder Amirav, 2013, J AEROSOL MED PULMON; MacQueen, 1967, P 5 BERK S MATH STAT; McAllister DA, 2019, LANCET GLOB HEALTH, V7, pE47, DOI 10.1016/S2214-109X(18)30408-X; Muteweye W, 2015, ANN MED SURG, V4, P287, DOI 10.1016/j.amsu.2015.08.003; Rubinstein Honen, 2009, ICCV WORKSH; Schaaf H, 2010, J CRANIOFAC SURG, V21, P1677, DOI 10.1097/SCS.0b013e3181f3c630; Sforza C, 2014, J CRANIO MAXILL SURG, V42, pE318, DOI 10.1016/j.jcms.2013.10.013; Turnbull H., 2018, BMJ INNOV, V4, P185, DOI [DOI 10.1136/BMJINNOV-2017-000267, 10.1136/bmjinnov-2017-000267]; Zhuang ZQ, 2010, ANN OCCUP HYG, V54, P391, DOI 10.1093/annhyg/meq007	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216548	10.1371/journal.pone.0216548	http://dx.doi.org/10.1371/journal.pone.0216548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120916	Green Published, Green Submitted, gold			2022-12-27	WOS:000468775700020
J	Pinneh, EC; Stoppel, R; Knight, H; Knight, MR; Steel, PG; Denny, PW				Pinneh, Elizabeth C.; Stoppel, Rhea; Knight, Heather; Knight, Marc R.; Steel, Patrick G.; Denny, Paul W.			Expression levels of inositol phosphorylceramide synthase modulate plant responses to biotic and abiotic stress in Arabidopsis thaliana	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INOSITOLPHOSPHORYLCERAMIDE SYNTHASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SPHINGOLIPIDS; ACTIVATION; DEFENSE; PROTEIN; PATHWAYS; ROLES	This research was undertaken to investigate the global role of the plant inositol phosphorylceramide synthase ( IPCS), a non-mammalian enzyme previously shown to be associated with the pathogen response. RNA-Seq analyses demonstrated that over-expression of inositol phosphorylceramide synthase isoforms AtIPCS1, 2 or 3 in Arabidopsis thaliana resulted in the down-regulation of genes involved in plant response to pathogens. In addition, genes associated with the abiotic stress response to salinity, cold and drought were found to be similarly down-regulated. Detailed analyses of transgenic lines over-expressing AtIPCS1-3 at various levels revealed that the degree of down-regulation is specifically correlated with the level of IPCS expression. Singular enrichment analysis of these down-regulated genes showed that AtIPCS1-3 expression affects biological signaling pathways involved in plant response to biotic and abiotic stress. The up-regulation of genes involved in photosynthesis and lipid localization was also observed in the over-expressing lines.	[Pinneh, Elizabeth C.; Knight, Heather; Knight, Marc R.; Denny, Paul W.] Univ Durham, Dept Biosci, Durham, England; [Pinneh, Elizabeth C.; Steel, Patrick G.] Univ Durham, Dept Chem, Durham, England; [Stoppel, Rhea] Bayer AG, Crop Sci Div, Ind Pk Hochst, Frankfurt, Germany	Durham University; Durham University; Bayer AG	Denny, PW (corresponding author), Univ Durham, Dept Biosci, Durham, England.	p.w.denny@durham.ac.uk	Denny, Paul/B-8431-2013	Denny, Paul/0000-0002-5051-1613; Knight, Marc/0000-0002-4830-8608	British Biotechnology Research Council [BB/K012703/1]; Bayer Crop Sciences	British Biotechnology Research Council; Bayer Crop Sciences	Funding was provided by the British Biotechnology Research Council (BB/K012703/1). The funder provided support in the form of salaries for authors [ECP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bayer Crop Sciences provided support in the form of salaries for authors [RS] and was involved in the study design and data collection, but did not have any additional role in the decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agricultural Development Economics Division FaAo United Nations, 2009, FEED WORLD 2050 HIGH; Ali HZ, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/691363; Alqaisi AQI, 2018, PARASITOLOGY, V145, P148, DOI 10.1017/S0031182017000506; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Berkey R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00068; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Breitenbach HH, 2014, PLANT PHYSIOL; Bromley PE, 2003, ARCH BIOCHEM BIOPHYS, V417, P219, DOI 10.1016/S0003-9861(03)00339-4; Brusslan JA, 2015, PLANT PHYSIOL, V168, P1246, DOI 10.1104/pp.114.252999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coupe SA, 2004, J EXP BOT, V55, P59, DOI 10.1093/jxb/erh018; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Dhondt S, 2000, PLANT J, V23, P431, DOI 10.1046/j.1365-313x.2000.00802.x; Dietrich CR, 2008, PLANT J, V54, P284, DOI 10.1111/j.1365-313X.2008.03420.x; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Dobin A, 2015, CURRENT PROTOCOLS BI; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Dutilleul C, 2012, NEW PHYTOL, V194, P181, DOI 10.1111/j.1469-8137.2011.04017.x; Egan JF, 2011, P NATL ACAD SCI USA, V108, pE37, DOI 10.1073/pnas.1017414108; Howard BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074183; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Knoth C, 2008, PLANT J, V55, P53, DOI 10.1111/j.1365-313X.2008.03486.x; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Levy YY, 1998, CURR OPIN PLANT BIOL, V1, P49, DOI 10.1016/S1369-5266(98)80127-1; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liao PF, 2017, GENES GENOM, V39, P485, DOI 10.1007/s13258-016-0489-0; Lin YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064980; Liu S, 2015, ELIFE, V4, DOI 10.7554/eLife.07320; Liu WX, 2013, MOL PLANT, V6, P1487, DOI 10.1093/mp/sst031; Lotkowska ME, 2015, PLANT PHYSIOL; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Maekawa T, 2012, P NATL ACAD SCI USA, V109, P20119, DOI 10.1073/pnas.1218059109; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Mina JG, 2010, PLANT MOL BIOL, V73, P399, DOI 10.1007/s11103-010-9626-3; Mizoguchi M, 2010, PLANT CELL PHYSIOL, V51, P842, DOI 10.1093/pcp/pcq041; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; PANG PP, 1988, PLANT MOL BIOL, V11, P805, DOI 10.1007/BF00019521; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Poxleitner M, 2006, PLANT J, V47, P917, DOI 10.1111/j.1365-313X.2006.02845.x; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Shimada TL, 2008, PLANT J, V55, P798, DOI 10.1111/j.1365-313X.2008.03553.x; Stacy RAP, 1999, PLANT J, V19, P1, DOI 10.1046/j.1365-313X.1999.00488.x; Tartaglio V, 2017, PLANT J, V89, P278, DOI 10.1111/tpj.13382; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; United Nations DoEaSA Population Division, 2017, ESAPWP248 UN DOEASA; Vrancken K, 2013, MICROBIOL-SGM, V159, P823, DOI 10.1099/mic.0.064881-0; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Xu EJ, 2015, MOL PLANT, V8, P1776, DOI 10.1016/j.molp.2015.08.008; Xu EJ, 2015, PLANT CELL ENVIRON, V38, P1418, DOI 10.1111/pce.12499; Yang HP, 1996, PHYSIOL PLANTARUM, V98, P661, DOI 10.1111/j.1399-3054.1996.tb05724.x; Yang YA, 2012, PLANT PHYSIOL, V159, P1857, DOI 10.1104/pp.112.197152; Young SA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/248135	66	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217087	10.1371/journal.pone.0217087	http://dx.doi.org/10.1371/journal.pone.0217087			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120963	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000468775700054
J	Qi, XY; Gui, X; Zhuang, K				Qi, Xiaoying; Gui, Xien; Zhuang, Ke			Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; MARGINAL ZONE LYMPHOMA; HEPATITIS-B; VIRUS INFECTION; HIGH PREVALENCE; CELL-LINE; EPIDEMIOLOGY; MECHANISMS; LEUKEMIA; COHORT	Emerging evidences indicate that hepatitis B virus (HBV) infection is associated with non-Hodgkin lymphoma (NHL), but the mechanisms of HBV-induction lymphomagenesis remain unclear. In this report, retrospective analysis of the prevalence of hepatitis B surface antigen (HBsAg) among NHL cases demonstrated significantly higher HBsAg carrier rate among B-cell NHL cases than controls (other cancers except primary liver cancer) (adjusted odds ratio, 1.56; 95% confidence interval, 1.13-2.16). Furthermore, cells with an immortalization potential existed in the peripheral blood of 4 patients with chronic HBV infection. Characterization of these cells showed their immunophenotypes similar to that of the majority of HBsAg-positive B-cell NHL patients. Immunoglobulin (Ig) gene rearrangements confirmed the clonal Ig gene rearrangements. Cytogenetic analysis revealed abnormal karyotypes of these cells with an immortalization potential. Compared with cells with an immortalization potential that we previously found in B-cell NHL patients by the same way, these cells showed many similar features. In conclusion, cells with an immortalization potential existed in the part of patients with chronic HBV infection before lymphoma development and showed some malignant features. They may be the cellular basis of HBV-associated lymphomagenesis.	[Qi, Xiaoying; Gui, Xien] Wuhan Univ, Zhongnan Hosp, Dept Infect Dis, Wuhan, Hubei, Peoples R China; [Zhuang, Ke] Wuhan Univ, State Key Lab Virol, ABSL III Lab, Ctr Anim Expt, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Gui, X (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Infect Dis, Wuhan, Hubei, Peoples R China.	znact@126.com		Gui, Xien/0000-0002-3229-8628	ZeShan Foundation [250000160]	ZeShan Foundation	This study was funded by the ZeShan Foundation (Grant Numbers: 250000160 to XG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathangelidis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130195; Bo J, 2017, ONCOL LETT, V14, P433, DOI 10.3892/ol.2017.6114; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Dalia S, 2015, CANCER CONTROL, V22, P360, DOI 10.1177/107327481502200315; Deng LJ, 2015, ONCOTARGET, V6, P25061, DOI 10.18632/oncotarget.4677; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; Ghorbian S, 2014, CLIN TRANSL ONCOL, V16, P1006, DOI 10.1007/s12094-014-1188-4; Ghorbian S, 2017, ANN DIAGN PATHOL, V29, P28, DOI 10.1016/j.anndiagpath.2017.04.008; Goy A, 2004, LEUKEMIA LYMPHOMA, V45, P1255, DOI 10.1080/10428190310001642729; Gu LH, 2015, CLIN LAB, V61, P731, DOI 10.7754/Clin.Lab.2014.140602; Gualco G, 2010, APPL IMMUNOHISTO M M, V18, P301, DOI 10.1097/PAI.0b013e3181cf1126; Hartmann S, 2013, PATHOL RES PRACT, V209, P495, DOI 10.1016/j.prp.2013.05.004; Huang CE, 2017, J VIRAL HEPATITIS, V24, P885, DOI 10.1111/jvh.12713; Huang CX, 2015, SCI CHINA LIFE SCI, V58, P1226, DOI 10.1007/s11427-015-4919-z; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; Koot AWA, 2015, ACTA CLIN BELG, V70, P301, DOI 10.1179/2295333715Y.0000000005; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Li XY, 2017, ACTA HAEMATOL-BASEL, V137, P209, DOI 10.1159/000468973; Liang XF, 2013, VACCINE, V31, pJ21, DOI 10.1016/j.vaccine.2013.08.012; LOKEN MR, 1987, BLOOD, V70, P1316; MacLeod RAF, 2008, CURR MED CHEM, V15, P339, DOI 10.2174/092986708783497319; Mansoor MS, 2015, J CLIN GASTROENTEROL, V49, P885, DOI 10.1097/MCG.0000000000000313; Marcucci F, 2006, HAEMATOLOGICA, V91, P554; Marcucci F, 2011, BLOOD, V117, P1792, DOI 10.1182/blood-2010-06-275818; Matsuo Y, 1998, LEUKEMIA RES, V22, P567, DOI 10.1016/S0145-2126(98)00050-2; OFFIT K, 1995, BLOOD, V86, P2365, DOI 10.1182/blood.V86.6.2365.bloodjournal8662365; Park SC, 2008, J MED VIROL, V80, P960, DOI 10.1002/jmv.21168; Pham LV, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0218-1; Robledo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024939; SOLE F, 1993, CANCER GENET CYTOGEN, V65, P170, DOI 10.1016/0165-4608(93)90229-F; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuboi K, 2000, LEUKEMIA, V14, P449, DOI 10.1038/sj.leu.2401696; Wang CY, 2018, ANN HEMATOL, V97, P453, DOI 10.1007/s00277-017-3188-2; Wang F, 2007, CANCER-AM CANCER SOC, V109, P1360, DOI 10.1002/cncr.22549; Watkins AJ, 2010, J PATHOL, V220, P461, DOI 10.1002/path.2665; WHO, 2017, GLOB HEP REP 2017, P83; Yi HZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0084-7; Yood MU, 2007, HEPATOLOGY, V46, P107, DOI 10.1002/hep.21642	39	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217161	10.1371/journal.pone.0217161	http://dx.doi.org/10.1371/journal.pone.0217161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120924	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700063
J	Pellizzaro, M; Martins, CM; Yamakawa, AC; Ferraz, DD; Morikawa, VM; Ferreira, F; dos Santos, AP; Biondo, AW; Langoni, H				Pellizzaro, Maysa; Martins, Camila Marinelli; Yamakawa, Ana Carolina; Ferraz, Diogo da Cunha; Morikawa, Vivien Midori; Ferreira, Fernando; dos Santos, Andrea Pires; Biondo, Alexander Welker; Langoni, Helio			Molecular detection of Leptospira spp. in rats as early spatial predictor for human disease in an endemic urban area	PLOS ONE			English	Article							RATTUS-NORVEGICUS; NORWAY RATS; INTERROGANS	Background Leptospirosis is considered a neglected zoonosis associated with infrastructure problems and low socioeconomic status, particularly slums. Since the disease is mainly transmitted in urban settings by rat urine, this risk factor may be important predictor tool for prompt control and effective prevention at the local level in urban endemic areas. Accordingly, the present study aimed to propose an early spatial predictor tool for human leptospirosis in urban settings, to test the methodology of molecular methods for assessing Leptospira spp. in trapped rats, and report associated environmental data. Methodology/Principal findings Official city records and previous study were used to select risk factors for human leptospirosis in an endemic neighborhood of Curitiba, Brazil. Neighborhood census sectors were divided in high- and low-risk areas using 12 selected factors: flood area, water supply, water course, green coverage, afforestation, sewage network, open sewage, open garbage, garbage collection, dumpster, pavement, and rodent complaints. In addition, rats were captured in pre-determined sites from January through March 2017, euthanized, and individual kidneys samples sent for molecular diagnosis. Human cases were obtained from official city records. In total, 95/112 (84.8%) census sectors were classified as low-risk to human leptospirosis. No significant statistical differences were found in human case frequencies between high and low-risk areas. Kidney samples from 17/25 (68.0%) trapped rats were positive for Leptospira spp. The main risk factors associated with rodent presence included inadequate water supply (p = 0.04), sanitary sewage (p = 0.04), unpaved streets (p = 0.04), and complaint of rodents (p = 0.04). Conclusions/Significance This study offers a new approach to score leptospirosis transmission risk, and to compare small areas and their heterogeneity in the same census sector of endemic areas. Environmental risk factors for Leptospira spp. transmission within the neighborhood were mainly due to differences in infrastructure and basic services. To the author's knowledge, this is the first study using Leptospira spp. in rats as predictor for human disease in an urban setting of a major city. Although the number of rats trapped was low, this methodology may be used as basis for early and effective interventions, focused on high risk areas for leptospirosis prior to human cases, and potentially reducing morbidity and mortality in low-income areas of urban settings.	[Pellizzaro, Maysa; Langoni, Helio] Sao Paulo State Univ, Sch Vet Med, Dept Vet Hyg & Publ Hlth, Sao Paulo, Brazil; [Martins, Camila Marinelli] Univ Estadual Ponta Grossa, Dept Nursing & Publ Hlth, Ponta Grossa, Parana, Brazil; [Martins, Camila Marinelli; Ferreira, Fernando] Univ Sao Paulo, Sch Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil; [Yamakawa, Ana Carolina; Biondo, Alexander Welker] Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil; [Ferraz, Diogo da Cunha; Morikawa, Vivien Midori] Zoonoses Surveillance Unit, Curitiba, Parana, Brazil; [Morikawa, Vivien Midori] Univ Fed Parana, Dept Community Hlth, Curitiba, Parana, Brazil; [dos Santos, Andrea Pires] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Universidade Estadual Paulista; Universidade Estadual de Ponta Grossa; Universidade de Sao Paulo; Universidade Federal do Parana; Universidade Federal do Parana; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pellizzaro, M; Langoni, H (corresponding author), Sao Paulo State Univ, Sch Vet Med, Dept Vet Hyg & Publ Hlth, Sao Paulo, Brazil.	maysa.pellizzaro@gmail.com; hlangoni@fmvz.unesp.br	dos Santos, Andrea Pires/O-5371-2019; Yamakawa, Ana Carolina/AAD-3668-2020; BIONDO, ALEXANDER WELKER/AAU-8955-2021; Langoni, Helio/D-2376-2010; BIONDO, ALEXANDER WELKER W/E-8823-2018; Langoni, Helio/AAQ-5249-2020	dos Santos, Andrea Pires/0000-0002-1037-970X; BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; Langoni, Helio/0000-0001-5127-0762; Yamakawa, Ana Carolina/0000-0002-4557-2083				Ahmed A., 2012, J BACTERIOL PARASITO, V3, DOI DOI 10.4172/2155-9597.1000133; [Anonymous], 2002, MAN CONTR ROED; [Anonymous], 2014, GUIA VIG SAUD, P1; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819; Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338; Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Gracie R, 2014, INT J ENV RES PUB HE, V11, P10366, DOI 10.3390/ijerph111010366; Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275; Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270; Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Oliveira DSC, 2009, ANN TROP MED PARASIT, V103, P149, DOI 10.1179/136485909X398221; Pellizzaro M, 2017, REV SOC BRAS MED TRO, V50, P857, DOI 10.1590/0037-8682-0138-2017; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Santos SM, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-34; Sarkar U, 2002, AM J TROP MED HYG, V66, P605; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Uria IT, 2013, ECOHEALTH, V10, P137, DOI 10.1007/s10393-013-0829-3; Tassinari WS, 2008, TROP MED INT HEALTH, V13, P503, DOI 10.1111/j.1365-3156.2008.02028.x; Waggoner JJ, 2016, CURR OPIN INFECT DIS, V29, P440, DOI 10.1097/QCO.0000000000000295	29	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216830	10.1371/journal.pone.0216830	http://dx.doi.org/10.1371/journal.pone.0216830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116784	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400031
J	Pucker, B; Holtgrawe, D; Stadermann, KB; Frey, K; Huettel, B; Reinhardt, R; Weisshaar, B				Pucker, Boas; Holtgraewe, Daniela; Stadermann, Kai Bernd; Frey, Katharina; Huettel, Bruno; Reinhardt, Richard; Weisshaar, Bernd			A chromosome-level sequence assembly reveals the structure of the Arabidopsis thaliana Nd-1 genome and its gene set	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; ORGANIZATION; DNA; EVOLUTION; PSEUDOGENES; DIVERSITY; TELOMERES; INSERTION; SOFTWARE; SIZE	In addition to the BAC-based reference sequence of the accession Columbia-0 from the year 2000, several short read assemblies of THE plant model organism Arabidopsis thaliana were published during the last years. Also, a SMRT-based assembly of Landsberg erecta has been generated that identified translocation and inversion polymorphisms between two genotypes of the species. Here we provide a chromosome-arm level assembly of the A. thaliana accession Niederzenz-1 (AthNd-1_v2c) based on SMRT sequencing data. The best assembly comprises 69 nucleome sequences and displays a contig length of up to 16 Mbp. Compared to an earlier Illumina short read-based NGS assembly (AthNd-1_v1), a 75 fold increase in contiguity was observed for AthNd-1_v2c. To assign contig locations independent from the Col-0 gold standard reference sequence, we used genetic anchoring to generate a de novo assembly. In addition, we assembled the chondrome and plastome sequences. Detailed analyses of AthNd-1_v2c allowed reliable identification of large genomic rearrangements between A. thaliana accessions contributing to differences in the gene sets that distinguish the genotypes. One of the differences detected identified a gene that is lacking from the Col-0 gold standard sequence. This de novo assembly extends the known proportion of the A. thaliana pan-genome.	[Pucker, Boas; Holtgraewe, Daniela; Stadermann, Kai Bernd; Frey, Katharina; Weisshaar, Bernd] Bielefeld Univ, Fac Biol, Bielefeld, Germany; [Pucker, Boas; Holtgraewe, Daniela; Stadermann, Kai Bernd; Frey, Katharina; Weisshaar, Bernd] Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Genome Ctr Cologne, Max Planck Inst Plant Breeding Res, Cologne, Germany	University of Bielefeld; University of Bielefeld; Max Planck Society	Weisshaar, B (corresponding author), Bielefeld Univ, Fac Biol, Bielefeld, Germany.; Weisshaar, B (corresponding author), Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany.	bernd.weisshaar@uni-bielefeld.de	Pucker, Boas/B-6549-2019; Sielemann, Katharina/AAE-1722-2020; Weisshaar, Bernd/B-3859-2014	Pucker, Boas/0000-0002-3321-7471; Sielemann, Katharina/0000-0002-4022-8531; Weisshaar, Bernd/0000-0002-7635-3473; Stadermann, Dr. Kai Bernd/0000-0002-8036-1492	German Research Foundation (DFG) [WE1576/16-2]; DFG; Open Access Publication Fund of Bielefeld University	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	We acknowledge the financial support of the German Research Foundation (DFG, http://www.dfg.de) to BW (WE1576/16-2). We also acknowledge support for the Article Processing Charge by the DFG and the Open Access Publication Fund of Bielefeld University. The funding bodies did not influence the design of the study, the data collection, the analysis, the interpretation of data, or the writing of the manuscript.; We thank Willy Keller for isolating high molecular weight DNA, Katharina Kemmet for extensive genotyping of plants for the genetic map, Helene Schellenberg, Ann-Christin Polikeit and Prisca Vieho ver for Sanger sequencing, and Melanie Kuhlmann as well as Andrea Voigt for taking excellent care of the plants. We are very grateful for support from the Bioinformatics Resource Facility of the CeBiTec and Stefan Albaum for help with installation of appropriate software tools.	Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arend D, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw033; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Belser C, 2018, NAT PLANTS, V4, P879, DOI 10.1038/s41477-018-0289-4; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chandrasekhara C, 2016, GENE DEV, V30, P177, DOI 10.1101/gad.273755.115; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Cho YS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13637; Christensen AC, 2013, GENOME BIOL EVOL, V5, P1079, DOI 10.1093/gbe/evt069; Copenhaver GP, 1996, PLANT J, V9, P259, DOI 10.1046/j.1365-313X.1996.09020259.x; Denton JF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003998; Fiddes IT, 2018, GENOME RES, V28, P1029, DOI 10.1101/gr.233460.117; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Golicz AA, 2016, PLANT BIOTECHNOL J, V14, P1099, DOI 10.1111/pbi.12499; Healey A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-21; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; Istace B, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw018; Kalvari I, 2018, NUCLEIC ACIDS RES, V46, pD335, DOI 10.1093/nar/gkx1038; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Khelik K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1748-z; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Kolmogorov M, 2018, ASSEMBLY LOING ERROR; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; KOWALSKI SP, 1994, GENETICS, V138, P499; Kumekawa N, 2000, DNA RES, V7, P315, DOI 10.1093/dnares/7.6.315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam KK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S4; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Li H, 2013, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON VITICULTURE AND ENOLOGY (2013), P1; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marroni F, 2014, CURR OPIN PLANT BIOL, V18, P31, DOI 10.1016/j.pbi.2014.01.003; Michael TP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03016-2; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Payne A, 2018, BIOINFORMATICS; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; Pucker B, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5360-z; Pucker Boas, 2017, BMC Res Notes, V10, P667, DOI 10.1186/s13104-017-2985-y; Pucker B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164321; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Shoromony I, 2015, IEEE INT S INF THEOR, P919; Siena LA, 2016, J EXP BOT, V67, P1965, DOI 10.1093/jxb/erw018; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Simpson JT, 2015, ANNU REV GENOM HUM G, V16, P153, DOI 10.1146/annurev-genom-090314-050032; Smit A, REPEATMASKER OPEN 4; Stadermann KB, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00975-16; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Tan SJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-86; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Villasante A, 2007, P NATL ACAD SCI USA, V104, P10542, DOI 10.1073/pnas.0703808104; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; Woloszynska M, 2012, ACTA BIOCHIM POL, V59, P703; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Zapata L, 2016, P NATL ACAD SCI US; Zmienko A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3221-1; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632; 2016, NATURE, V538, P243, DOI DOI 10.1038/NATURE20098; 2015, BIOINFORMATICS, V31, P3210, DOI [10.1093/bioinformatics/btv351, DOI 10.1093/BIOINFORMATICS/BTV351]; 1992, PLANT CELL, V4, P889, DOI DOI 10.1105/TPC.4.8.889; 1993, PLANT J, V4, P1051	85	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216233	10.1371/journal.pone.0216233	http://dx.doi.org/10.1371/journal.pone.0216233			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112551	Green Published, Green Submitted, gold			2022-12-27	WOS:000468451000012
J	Thee, S; Kruger, R; von Bernuth, H; Meisel, C; Kolsch, U; Kirchberger, V; Feiterna-Sperling, C				Thee, Stephanie; Krueger, Renate; von Bernuth, Horst; Meisel, Christian; Koelsch, Uwe; Kirchberger, Valerie; Feiterna-Sperling, Cornelia			Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany	PLOS ONE			English	Article							LATENT TUBERCULOSIS; PREVENTIVE THERAPY; ISONIAZID HEPATOTOXICITY; CHRONIC HEPATITIS; SEEKING ASYLUM; LIVER-INJURY; INFECTION; RIFAMPIN; CHEMOPROPHYLAXIS; CHILDHOOD	Introduction In 2015, 4062 unaccompanied minor refugees were registered in Berlin, Germany. According to national policies, basic clinical examination and tuberculosis (TB) screening is a prerequisite to admission to permanent accommodation and schooling for every refugee. This article evaluates the use of an interferon-gamma-release-assay (IGRA) during the initial examination and TB screening of 970 unaccompanied minor refugees. Results IGRA test were obtained during TB screening for 301 (31.0%) of 970 adolescents not previously screened for TB. Positive IGRA results were obtained in 13.9% (42/301). Most of the 42 IGRA-positive refugees originated from Afghanistan or Syria (n?20 and 10 respectively). Two IGRA-positive adolescents were lost to follow-up, 2 were diagnosed with TB and the remaining 38 diagnosed with latent TB infection (LTBI). Demographic features of the 40 patients with positive IGRA result were as follows: 39 male, median age 16.8 years (IQR 16.0-17.2y), none meeting underweight criteria (median BMI 21.3kg/m(2)). On initial chest X-ray 2/40 participants had signs of active TB, while in 38 active disease was excluded and the diagnosis of latent TB infection (LTBI) made. Active hepatitis B-co-infection was diagnosed in 3/38 patients. All patients with LTBI received Isoniazid and Rifampicin for 3 months without occurrence of severe adverse events. The most frequently observed side effect was transient upper abdominal pain (n = 5). Asymptomatic elevation of liver transaminases was seen in 2 patients. 29 patients completed treatment with no signs of TB disease at the end of chemoprevention and 9 were lost to follow up. Conclusion Screening for TB infection in minor refugees was feasible in our setting with a relatively high rate of TB infection detected. Chemopreventive treatment was tolerated well regardless of underlying hepatitis-B-status. Minor refugees migrating to Germany should be screened for TB infection, instead of TB disease only, regardless of the background TB incidence.	[Thee, Stephanie; Krueger, Renate; von Bernuth, Horst; Kirchberger, Valerie; Feiterna-Sperling, Cornelia] Charite, Dept Pediat, Div Pneumonol & Immunol Intens Med, Berlin, Germany; [von Bernuth, Horst; Meisel, Christian; Koelsch, Uwe] Charite Vivantes GmbH, Dept Immunol, Lab Berlin, Berlin, Germany; [von Bernuth, Horst] Charite, Berlin Ctr Regenerat Therapies, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Labor Berlin - Charite Vivantes GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thee, S (corresponding author), Charite, Dept Pediat, Div Pneumonol & Immunol Intens Med, Berlin, Germany.	Stephanie.thee@charite.de	von Bernuth, Horst/AAQ-9797-2021; von Bernuth, Horst/ABD-7779-2020	von Bernuth, Horst/0000-0002-5812-7675; Feiterna-Sperling, Cornelia/0000-0003-4171-1098; Thee, Stephanie/0000-0001-9090-7869; Meisel, Christian/0000-0003-0222-991X	Department of Immunology, Labor Berlin, Charite Vivantes GmbH, Germany	Department of Immunology, Labor Berlin, Charite Vivantes GmbH, Germany	The funder (Department of Immunology, Labor Berlin, Charite Vivantes GmbH, Germany) provided support in the form of salaries for authors [HvB, CM, UK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2008, ARCH DIS CHILD, V93, P1017, DOI 10.1136/adc.2008.139543; [Anonymous], 2017, FUBALL TALENTE DEUTS; BEAUDRY PH, 1974, AM REV RESPIR DIS, V110, P581; Bennet R, 2017, INFECT DIS-NOR, V49, P501, DOI 10.1080/23744235.2017.1292540; Bliven EE, 2009, INT J TUBERC LUNG D, V13, P1054; Borrell S, 2010, CLIN MICROBIOL INFEC, V16, P568, DOI 10.1111/j.1469-0691.2009.02886.x; Cookson ST, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0044-7; DASH LA, 1980, AM REV RESPIR DIS, V121, P1039; Donald PR, 2011, PEDIATRIC REP, V3, P51, DOI 10.4081/pr.2011.e16; Ena J, 2005, CLIN INFECT DIS, V40, P670, DOI 10.1086/427802; Feiterna-Sperling C, 2017, PNEUMOLOGIE, V71, P629, DOI 10.1055/s-0043-116545; Gray EL, 2016, INTERN MED J, V46, P281, DOI 10.1111/imj.12979; Greenaway C, 2018, EUROSURVEILLANCE, V23, P24, DOI 10.2807/1560-7917.ES.2018.23.14.17-00543; Kunst H, 2017, INT J TUBERC LUNG D, V21, P840, DOI 10.5588/ijtld.17.0036; LITT IF, 1976, J PEDIATR-US, V89, P133, DOI 10.1016/S0022-3476(76)80949-3; Menzies D, 2018, NEW ENGL J MED, V379, P440, DOI 10.1056/NEJMoa1714283; Miyazawa S, 2015, INTERNAL MED, V54, P591, DOI 10.2169/internalmedicine.54.3669; Mueller-Hermelink M, 2018, EUROSURVEILLANCE, V23, P4, DOI 10.2807/1560-7917.ES.2018.23.12.17-00536; RAPP RS, 1978, AM REV RESPIR DIS, V118, P794, DOI 10.1164/arrd.1978.118.4.794; Rendon A, 2018, PULMONOLOGY, V24, P99, DOI 10.1016/j.rppnen.2017.11.007; Ritz N, 2015, LANCET, V386, P2475, DOI 10.1016/S0140-6736(15)01241-6; Ritz N, 2015, MONATSSCHR KINDERH, V163, P1287, DOI 10.1007/s00112-015-0007-5; SPYRIDIS P, 1979, ARCH DIS CHILD, V54, P65, DOI 10.1136/adc.54.1.65; Thee S., 2015, 33 ANN M EUR SOC PAE; Theuring S, 2016, EUR J EPIDEMIOL, V31, P707, DOI 10.1007/s10654-016-0187-x; Usemann J, 2018, 40 JAHR GES PAD PNEU; Villarino ME, 1997, AM J RESP CRIT CARE, V155, P1735, DOI 10.1164/ajrccm.155.5.9154885; Wang NT, 2016, J CHIN MED ASSOC, V79, P368, DOI 10.1016/j.jcma.2015.12.006; World Health Organization, 2011, ANNEX C WHO REG GROU; World Health Organization, GROWTH REF 5 19 YEAR; World Health Organization, TUB COUNTR PROF 2018; World Health Organization, 2018, LAT TB INF UPD CONS; Zenner D, 2017, INT J TUBERC LUNG D, V21, P965, DOI 10.5588/ijtld.16.0935; Zenner D, 2017, ANN INTERN MED, V167, P248, DOI 10.7326/M17-0609; Zenner D, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02505-2016; Zenner D, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0031-2016	36	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0216234	10.1371/journal.pone.0216234	http://dx.doi.org/10.1371/journal.pone.0216234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112542	Green Published, gold, Green Submitted			2022-12-27	WOS:000468451000013
J	Fernandez-Cooke, E; Tascon, AB; Sanchez-Manubens, J; Anton, J; Lozano, CDG; Santos, JA; Pinto, EV; Garulo, DC; Rodriguez, BM; Alonso, MB; Cuadros, EN; Gomez, MLN; Dominguez-Rodriguez, S; Calvo, C; Perez, DM; Cantero, MM; Gallego, BC; Campos, LIM; Garcia, FS; Lovillo, MC; Marques, R; Neth, O; Silveira, LF; Forte, MS; Montes, AO; Mancheno, BB; Camacho, M; Claros, AFM; Salido, C; Cruz, RC; Rico, MT; Hernandez, MAT; Guzman, EG; Marin, MJA; Aguirre, JR; Cruz, MJL; Carrasco, KM; Gonzalez, MR; Jover, EB; Lopez, AR; Fernandez, JU; Alcalde, MMI; Collado, P; Laleona, CG; Montanes, LJ; Casas, AA; Zapico, BM; Mendez, CP; Aracama, JF; Rodriguez, L; Fernandez, MAI; Campo, SN; Bori, SE; Perello, MCM; Sanchez, MAD; Garcia, PA; Briales, C; Crespi, JC; Gil, MEC; Cabrera, ND; Naranjo, AB; Paez, JP; Yanez, MG; Garcia, MG; Bezanilla, EP; Montero, BJ; Garcia, OD; Pinedo, BL; Martin, GI; Gomez, LME; Cepillo, A; Lillo, M; Buedo, MI; del Rey, L; Rodriguez, EU; Rodriguez, SR; Cantero, T; Izquierdo, BP; Alvarez, LGC; Erroz, IO; Santaolalla, EP; Martin, CA; Malfaz, FC; Gutierrez, EP; Casso, MJ; Prada, F; Bou, R; Iglesias, E; Calzada, J; Garsaball, OC; Rue, MT; Garcia, GG; Ruiz, SY; Lobato, Z; Gordillo, NR; Torres, MP; Hernandez, MM; Garcia, L; Villar, SF; Domingo, LM; Ballester, A; Miralles, A; Soler, BP; Vidal, AF; Castellvi, PS; Aguiar, AS; Rodriguez, JMS; Iranzo, AS; Perez, RA; Cajas, PR; Jornet, PGI; Tejada, AG; Zarallo, C; Martinon-Torres, F; Calle, IR; Grande, AJ; Saez, BR; Sousa, ML; Vilas, AS; Abe, BL; Esteban, ED; Mendez, BR; Blazquez, D; Conejo, PR; Tome, MG; Lozano, CG; Toral, B; De la Torre, LA; de Inocencio, J; Santos, M; de la Pena, RDD; Ramos, PC; Tagarro, A; Raga, T; Latorre, L; Guillen, S; Caballero, IC; Tato, LMP; Monagas, MFG; Lopez, IJ; Villagra, S; Arreo, V; Perez, RP; de la Parte, M; Tamariz-Martes, A; Romano, ML; Ruperez, BH; Martin, SR; Sombrero, HR; Cerro, EG; Cano, IM; Alonso, MV; Marco, MPO; Veron, JJ; Mesa, MDR; Esteban, SR; Amador, JTR; Menchen, CG; Jimenez, AB; Galan, P; Campos, DP; Bueno, MM; Marcos, DC; Barasoain, EOD; Giraldo, WAS; Gamir, ML; Ortega, MJC; Lopez, A; Vaquerizo, CS; Carrasco, AIU; Gomez, EM; Colom, JC; del Castillo, OC; Menendez, BD; Navarro, KB; Baquero, F; Bronte, LD; Fraga, PF; Dominguez, N; Garcia, FC; Romero, EV; Chamorro, AH; Rodriguez, PA; Garcia, MS; Nicolas, MCR; Nicolas, AL; Oloron, PM; Cilveti, BR; Berridi, A; Vazquez, LSD; Fernandez, O; Tamarit, AP; Calvo, I; Lopez, B; Fernandez, MIG; Otero, MC; Oltra, M; Archiles, MD; Sanchez, P; Gavilan, C; Fos, II; Robles, MIS; Sanchez, YH				Fernandez-Cooke, Elisa; Barrios Tascon, Ana; Sanchez-Manubens, Judith; Anton, Jordi; Grasa Lozano, Carlos Daniel; Aracil Santos, Javier; Villalobos Pinto, Enrique; Clemente Garulo, Daniel; Mercader Rodriguez, Beatriz; Bustillo Alonso, Matilde; Nunez Cuadros, Esmeralda; Navarro Gomez, Maria Luisa; Dominguez-Rodriguez, Sara; Calvo, Cristina; Moreno Perez, David; Martin Cantero, Maria; Carazo Gallego, Begona; Martinez Campos, Leticia Isabel; Sanchez Garcia, Fernando; Camacho Lovillo, Marisol; Marques, Renata; Neth, Olaf; Fernandez Silveira, Laura; Sanchez Forte, Miguel; Ortega Montes, Angeles; Bravo Mancheno, Beatriz; Camacho, Margarita; Medina Claros, Antonio F.; Salido, Carlos; Chulian Cruz, Rafael; Torres Rico, Maria; Tejero Hernandez, Ma Angeles; Gomez Guzman, Elena; Arroyo Marin, Ma Jose; Rumbao Aguirre, Jose; Lirola Cruz, Ma Jose; Maya Carrasco, Kety; Rodriguez Gonzalez, Moises; Blanca Jover, Enrique; Ruiz Lopez, Aida; Uberos Fernandez, Jose; Ibanez Alcalde, Maria Mercedes; Collado, Pilar; Guerrero Laleona, Carmelo; Jimenez Montanes, Lorenzo; Ayerza Casas, Ariadna; Montes Zapico, Barbara; Perez Mendez, Carlos; Fernandez Aracama, Javier; Rodriguez, Lucia; Ibanez Fernandez, Maria Aleida; Navarro Campo, Sandra; Escriba Bori, Silvia; Mir Perello, Maria Concepcion; de la Fuente Sanchez, Ma Angeles; Aparicio Garcia, Patricia; Briales, Carlos; Castilla Crespi, Joaquin; Colino Gil, Maria Elena; Delgado Cabrera, Nerea; Bello Naranjo, Ana; Poch Paez, Jesus; Garcia Yanez, Moneyba; Gonzalez Garcia, Montse; Pereira Bezanilla, Elena; Jimenez Montero, Beatriz; Dominguez Garcia, Olga; Losada Pinedo, Begona; Inigo Martin, Gema; Escribano Gomez, Lucia Maria; Cepillo, Antonio; Lillo Lillo, Miguel; Isabel Buedo, Maria; del Rey, Laura; Urbaneja Rodriguez, Elena; Rellan Rodriguez, Sara; Cantero, Teresa; Plata Izquierdo, Beatriz; Garcia-Cuenllas Alvarez, Luisa; Oulego Erroz, Ignacio; Perez Santaolalla, Elena; Alcalde Martin, Carlos; Centeno Malfaz, Fernando; Perez Gutierrez, Elena; Jimenez Casso, Marisol; Prada, Fredy; Bou, Rosa; Iglesias, Estibaliz; Calzada, Joan; Calavia Garsaball, Olga; Tobena Rue, Marc; Giralt Garcia, Gemma; Yevenes Ruiz, Silvia; Lobato, Zulema; Rius Gordillo, Neus; Pascual Torres, Montserrat; Mendez Hernandez, Maria; Garcia, Lourdes; Flores Villar, Sergio; Minguell Domingo, Laura; Ballester, Anna; Miralles, Ana; Pujol Soler, Berta; Foguet Vidal, Anton; Sala Castellvi, Pere; Serrano Aguiar, Angelita; Siurana Rodriguez, Jose Manuel; Sangorrin Iranzo, Anna; Alvarez Perez, Roser; Ribes Cajas, Paula; Genaro i Jornet, Pere; Grande Tejada, Ana; Zarallo, Cristina; Martinon-Torres, Federico; Rivero Calle, Irene; Justicia Grande, Antonio; Ruiz Saez, Beatriz; Lopez Sousa, Maria; Souto Vilas, Alejandro; Lopez Abe, Bernardo; de Miguel Esteban, Elisa; Riano Mendez, Bibiana; Blazquez, Daniel; Rojo Conejo, Pablo; Gonzalez Tome, Maribel; Grasa Lozano, Carlos; Toral, Belen; Albert De la Torre, Leticia; de Inocencio, Jaime; Santos, Mar; Diaz-Delgado de la Pena, Rafael; Collado Ramos, Paz; Tagarro, Alfredo; Raga, Teresa; Latorre, Libertad; Guillen, Sara; Callejas Caballero, Ignacio; Prieto Tato, Luis Manuel; Guzman Monagas, Maria Fernanda; Jimenez Lopez, Isabel; Villagra, Sandra; Arreo, Viviana; Pineiro Perez, Roi; de la Parte, Maria; Tamariz-Martes, Amalia; Llorente Romano, Marta; Hernandez Ruperez, Belen; Rodriguez Martin, Sonia; Rojo Sombrero, Henar; Garcia Cerro, Estefania; Mate Cano, Irene; Villares Alonso, Marta; Osuna Marco, Marta Pilar; Jensen Veron, Julia; Rodriguez Mesa, Maria Dolores; Rueda Esteban, Santiago; Ramos Amador, Jose Tomas; Gonzalez Menchen, Cristina; Jimenez Jimenez, Ana Belen; Galan, Pilar; Perez Campos, Dolores; Mercedes Bueno, Ma; Crespo Marcos, David; de Tejada Barasoain, Enrique Otheo; Sifuentes Giraldo, Walter Alberto; Gamir Gamir, Maria Luz; Cilleruelo Ortega, Maria Jose; Lopez Lopez, Agustin; Sanchez Vaquerizo, Cristina; Usano Carrasco, Ana Isabel; Moreno Gomez, Ester; Carrasco Colom, Jaime; Carvajal del Castillo, Olga; Del Pozo Menendez, Beatriz; Badillo Navarro, Katie; Baquero, Fernando; Deiros Bronte, Lucia; Fernandez Fraga, Pablo; Dominguez, Nieves; Castro Garcia, Francisco; Vera Romero, Elena; Herrera Chamorro, Agueda; Alcaniz Rodriguez, Paula; Sorli Garcia, Moises; Rex Nicolas, Maria Concepcion; Lorente Nicolas, Ana; Martinez Oloron, Patricia; Rocandio Cilveti, Beatriz; Berridi, Amaia; Santos-Diez Vazquez, Laura; Fernandez, Olaia; Perez Tamarit, Amparo; Calvo, Inmaculada; Lopez, Berta; Gonzalez Fernandez, Ma Isabel; Carmen Otero, Ma; Oltra, Manuel; Dapena Archiles, Marta; Sanchez, Paco; Gavilan, Cesar; Izquierdo Fos, Ignacio; Serrano Robles, Maria Isabel; Herranz Sanchez, Yolanda		KAWA-RACE Study Grp	Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group	PLOS ONE			English	Article							CORONARY-ARTERY ABNORMALITIES; INTRAVENOUS GAMMA-GLOBULIN; LONG-TERM MANAGEMENT; HEALTH-PROFESSIONALS; SUSCEPTIBILITY; PREDICTION; SURVEILLANCE; ASSOCIATION; RESISTANCE; STATEMENT	Background Kawasaki disease (KD) is an acute self-limited systemic vasculitis of unknown etiology affecting mainly children less than 5 years of age. Risk factors for cardiac involvement and resistance to treatment are insufficiently studied in non-Japanese children. Objective This study aimed to investigate the epidemiology, clinical features and risk factors for resistance to treatment and coronary artery lesions (CAL) in KD in Spain. Methods Retrospective study (May 2011-June 2016) of all patients less than 16 years of age diagnosed with KD included in KAWA-RACE network (84 Spanish hospitals). Results A total of 625 cases were analyzed, 63% were males, 79% under 5 year-olds and 16.8% younger than 12 months. On echocardiographic examination CAL were the most frequent findings (23%) being ectasia the most common (12%). Coronary aneurysms were diagnosed in 9.6%, reaching 20% in infants under 12 months (p<0.001). A total of 97% of the patients received intravenous immunoglobulin (IVIG) with a median number of days from fever onset to IVIG administration of 7.2. A second dose was given to 15.7% and steroids to 14.5% patients. Only 1.4% patients received infliximab. No deaths were reported. A multivariate analysis identified anemia, hypoalbuminemia, hyponatremia, higher creatinine and procalcitonin as independent risk factors for treatment failure and length under 103 cm, hemoglobin < 10.2 mg/dL, platelets > 900,000 cells/mm(3), maximum temperature < 39.5 degrees C, total duration of fever > 10 days and fever before treatment >= 8 days as independent risk factors for developing coronary aneurysms. Conclusions In our population, children under 12 months develop coronary aneurysms more frequently and children with KD with anemia and leukocytosis have high risk of cardiac involvement. Adding steroids early should be considered in those patients, especially if the treatment is not started before 8 days of fever. A score applicable to non-Japanese children able to predict the risk of aneurysm development and IVIG resistance is necessary.	[Fernandez-Cooke, Elisa; Grasa Lozano, Carlos Daniel] Hosp Univ Doce Octubre, Dept Pediat, Madrid, Spain; [Barrios Tascon, Ana] Hosp Univ Infanta Sofia, Dept Pediat, Madrid, Spain; [Sanchez-Manubens, Judith; Anton, Jordi] Hosp St Joan de Deu, Dept Pediat Rheumatol, Barcelona, Spain; [Sanchez-Manubens, Judith] Hosp Parc Tauli, Dept Pediat Rheumatol, Sabadell, Spain; [Aracil Santos, Javier; Calvo, Cristina] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Villalobos Pinto, Enrique; Clemente Garulo, Daniel] Hosp Infantil Univ Nino Jesus, Dept Pediat, Madrid, Spain; [Mercader Rodriguez, Beatriz] Hosp Clin Univ Virgen de la Arrixaca, Dept Pediat, Murcia, Spain; [Bustillo Alonso, Matilde] Hosp Univ Miguel Servet, Dept Pediat, Zaragoza, Spain; [Nunez Cuadros, Esmeralda] Hosp Reg Univ Malaga, Dept Pediat, Andalucia, Spain; [Navarro Gomez, Maria Luisa] Hosp Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Dominguez-Rodriguez, Sara] Fdn Invest Hosp 12 Octubre, Madrid, Spain; [Dominguez-Rodriguez, Sara] Fdn PENTA ONLUS, Padua, Italy; [Fernandez-Cooke, Elisa] Hosp Doce Octubre, Madrid, Spain; [Aracil Santos, Javier; Calvo, Cristina; Baquero, Fernando; Deiros Bronte, Lucia; Fernandez Fraga, Pablo] Hosp Univ La Paz, Madrid, Spain; [Barrios Tascon, Ana; Tagarro, Alfredo; Raga, Teresa; Latorre, Libertad] Hosp Univ Infanta Sofia, Madrid, Spain; [Sanchez-Manubens, Judith; Anton, Jordi; Prada, Fredy; Bou, Rosa; Iglesias, Estibaliz; Calzada, Joan] Hosp St Joan de Deu, Barcelona, Spain; [Nunez Cuadros, Esmeralda; Moreno Perez, David; Martin Cantero, Maria; Carazo Gallego, Begona] Hosp Reg Univ Malaga, Malaga, Spain; [Navarro Gomez, Maria Luisa; Santos, Mar] Hosp Univ Gregorio Maranon, Madrid, Spain; [Martinez Campos, Leticia Isabel; Sanchez Garcia, Fernando] Hosp La Inmaculada, Almeria, Spain; [Camacho Lovillo, Marisol; Marques, Renata; Neth, Olaf; Fernandez Silveira, Laura] Hosp Virgen del Rocio, Seville, Spain; [Sanchez Forte, Miguel; Ortega Montes, Angeles] Hosp Torrecardenas, Almeria, Spain; [Bravo Mancheno, Beatriz; Camacho, Margarita] Hosp Univ Virgen de las Nieves, Granada, Spain; [Medina Claros, Antonio F.] Hosp Axarquia, Murcia, Spain; [Salido, Carlos; Chulian Cruz, Rafael] Hosp Jerez, Frontera, Spain; [Torres Rico, Maria] Hosp Juan Ramon Jimenez Huelva, Huelva, Spain; [Tejero Hernandez, Ma Angeles; Gomez Guzman, Elena; Arroyo Marin, Ma Jose; Rumbao Aguirre, Jose] Hosp Reina Sofia Cordoba, Cordoba, Spain; [Lirola Cruz, Ma Jose; Maya Carrasco, Kety] Inst Hispalense Pediat, Seville, Spain; [Rodriguez Gonzalez, Moises] Hosp Univ Puerta del Mar Cadiz, Cadiz, Spain; [Blanca Jover, Enrique; Ruiz Lopez, Aida; Uberos Fernandez, Jose] Complejo Hosp Granada, Granada, Spain; [Ibanez Alcalde, Maria Mercedes] Hosp Poniente, Almeria, Spain; [Collado, Pilar; Guerrero Laleona, Carmelo; Jimenez Montanes, Lorenzo] Hosp Univ Miguel Servet, Zaragoza, Spain; [Ayerza Casas, Ariadna] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain; [Montes Zapico, Barbara; Perez Mendez, Carlos] Hosp San Agustin, Aviles, Spain; [Fernandez Aracama, Javier; Fernandez, Olaia] Hosp Univ Basurto, Bilbao, Spain; [Rodriguez, Lucia; Ibanez Fernandez, Maria Aleida; Navarro Campo, Sandra] Hosp Cent Asturias, Oviedo, Spain; [Escriba Bori, Silvia; Mir Perello, Maria Concepcion; de la Fuente Sanchez, Ma Angeles] Hosp Univ Son Espases, Palma De Mallorca, Spain; [Aparicio Garcia, Patricia; Briales, Carlos; Castilla Crespi, Joaquin] Hosp Son Llatzer, Palma De Mallorca, Spain; [Colino Gil, Maria Elena; Delgado Cabrera, Nerea; Bello Naranjo, Ana; Poch Paez, Jesus; Garcia Yanez, Moneyba] Hosp Materno Infantil Las Palmas de Gran Canaria, Las Palmas Gran Canaria, Spain; [Gonzalez Garcia, Montse] Hosp Univ Nuestra Senora Candelaria Santa Cruz Te, Santa Cruz de La Palma, Spain; [Pereira Bezanilla, Elena; Jimenez Montero, Beatriz] Hosp Univ Marques Valdecilla, Santander, Spain; [Dominguez Garcia, Olga; Losada Pinedo, Begona; Inigo Martin, Gema] Hosp Virgen de la Salud Toledo, Toledo, Spain; [Escribano Gomez, Lucia Maria; Cepillo, Antonio; Lillo Lillo, Miguel; Isabel Buedo, Maria; del Rey, Laura] Hosp Gen Albacete, Albacete, Spain; [Urbaneja Rodriguez, Elena; Rellan Rodriguez, Sara] Hosp Clin Univ Valladolid, Valladolid, Spain; [Cantero, Teresa] Hosp Palencia, Palencia, Spain; [Plata Izquierdo, Beatriz; Garcia-Cuenllas Alvarez, Luisa] Complejo Asistencial Univ Salamanca, Salamanca, Spain; [Oulego Erroz, Ignacio] Hosp Leon, Leon, Spain; [Perez Santaolalla, Elena] Hosp Univ Burgos, Burgos, Spain; [Alcalde Martin, Carlos; Centeno Malfaz, Fernando; Perez Gutierrez, Elena] Hosp Univ Rio Hortega Valladolid, Valladolid, Spain; [Jimenez Casso, Marisol] Hosp Gen Segovia, Segovia, Spain; [Calavia Garsaball, Olga] Hosp Joan XXIII Tarragona, Tarragona, Spain; [Tobena Rue, Marc; Giralt Garcia, Gemma; Yevenes Ruiz, Silvia] Hosp Valle De Hebron, Barcelona, Spain; [Lobato, Zulema] Xarxa Assistencial & Univ Manresa, Barcelona, Spain; [Rius Gordillo, Neus; Pascual Torres, Montserrat] Hosp St Joan de Reus, Tarragona, Spain; [Mendez Hernandez, Maria] Hosp Germans Trias & Pujol Badalona, Badalona, Spain; [Garcia, Lourdes] Hosp Mataro, Mataro, Spain; [Flores Villar, Sergio] Hosp Univ MUtua Terrassa, Terrassa, Spain; [Minguell Domingo, Laura] Hosp Arnau Vilanova, Lleida, Spain; [Ballester, Anna] Hosp Calella, Calella, Spain; [Miralles, Ana] Hosp Palamos, Palamos, Spain; [Pujol Soler, Berta] Hosp Gen Granollers, Granollers, Spain; [Foguet Vidal, Anton] Hosp Gen Olot, Olot, Spain; [Sala Castellvi, Pere] Hosp Barcelona, Barcelona, Spain; [Serrano Aguiar, Angelita] Hosp Comarcal Mora dEbre, Mora Debre, Spain; [Siurana Rodriguez, Jose Manuel; Sangorrin Iranzo, Anna] Fdn Hosp Nens Barcelona, Barcelona, Spain; [Alvarez Perez, Roser] Hosp Santa Creu & St Pau Barcelona, Barcelona, Spain; [Ribes Cajas, Paula] Hosp Gen Cataluna, Barcelona, Spain; [Genaro i Jornet, Pere] Hosp Verge Cinta, Tortosa, Spain; [Grande Tejada, Ana; Zarallo, Cristina] Complejo Hosp Univ Infanta Cristina, Badajoz, Spain; [Martinon-Torres, Federico; Rivero Calle, Irene; Justicia Grande, Antonio; Ruiz Saez, Beatriz; Lopez Sousa, Maria; Souto Vilas, Alejandro; Lopez Abe, Bernardo] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela, Spain; [de Miguel Esteban, Elisa; Riano Mendez, Bibiana] Hosp San Pedro, Logrono, Spain; [Blazquez, Daniel; Rojo Conejo, Pablo; Gonzalez Tome, Maribel; Grasa Lozano, Carlos; Toral, Belen; Albert De la Torre, Leticia; de Inocencio, Jaime] Hosp Univ Doce Octubre, Madrid, Spain; [Diaz-Delgado de la Pena, Rafael; Collado Ramos, Paz] Hosp Severo Ochoa, Leganes, Spain; [Guillen, Sara; Callejas Caballero, Ignacio] Hosp Getafe, Getafe, Spain; [Prieto Tato, Luis Manuel] Hosp 12 Octubre, Madrid, Spain; [Guzman Monagas, Maria Fernanda; Jimenez Lopez, Isabel; Villagra, Sandra; Arreo, Viviana] HM Hosp Madrid, Madrid, Spain; [Pineiro Perez, Roi; de la Parte, Maria] Hosp Gen Vilalba, Madrid, Spain; [Villalobos Pinto, Enrique; Clemente Garulo, Daniel; Tamariz-Martes, Amalia] Hosp Infantil Univ Nino Jesus, Madrid, Spain; [Llorente Romano, Marta; Hernandez Ruperez, Belen] Hosp Sureste, Madrid, Spain; [Rodriguez Martin, Sonia; Rojo Sombrero, Henar; Garcia Cerro, Estefania] Hosp Univ Principe Asturias, Alcala De Henares, Spain; [Mate Cano, Irene] Hosp Henares, Coslada, Spain; [Villares Alonso, Marta; Osuna Marco, Marta Pilar] Hosp Mostoles, Madrid, Spain; [Zarallo, Cristina; Jensen Veron, Julia; Rodriguez Mesa, Maria Dolores] Hosp Infanta Cristina, Madrid, Spain; [Rueda Esteban, Santiago; Ramos Amador, Jose Tomas; Gonzalez Menchen, Cristina] Hosp Clin San Carlos, Madrid, Spain; [Jimenez Jimenez, Ana Belen] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain; [Galan, Pilar; Perez Campos, Dolores] Hosp Univ Fuenlabrada, Fuenlabrada, Spain; [Mercedes Bueno, Ma; Crespo Marcos, David] Fdn Hosp Alcorcon, Alcorcon, Spain; [de Tejada Barasoain, Enrique Otheo; Sifuentes Giraldo, Walter Alberto; Gamir Gamir, Maria Luz] Hosp Ramon & Cajal, Madrid, Spain; [Cilleruelo Ortega, Maria Jose; Lopez Lopez, Agustin; Sanchez Vaquerizo, Cristina; Usano Carrasco, Ana Isabel] Hosp Puerta Hierro, Majadahonda, Spain; [Moreno Gomez, Ester] Hosp San Rafael, Madrid, Spain; [Carrasco Colom, Jaime] Hosp Sanitas La Moraleja, Madrid, Spain; [Carvajal del Castillo, Olga] Hosp Rey Juan Carlos, Mostoles, Spain; [Del Pozo Menendez, Beatriz; Badillo Navarro, Katie] Hosp Torrejon, Madrid, Spain; [Dominguez, Nieves] Hosp Univ Infanta Elena, Madrid, Spain; [Castro Garcia, Francisco; Vera Romero, Elena; Herrera Chamorro, Agueda; Alcaniz Rodriguez, Paula] Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain; [Sorli Garcia, Moises; Rex Nicolas, Maria Concepcion; Lorente Nicolas, Ana] Hosp Univ Santa Lucia, Cartagena, Spain; [Martinez Oloron, Patricia] Complejo Hosp Navarra, Pamplona, Spain; [Rocandio Cilveti, Beatriz; Berridi, Amaia] Hosp Donostia, Donostia San Sebastian, Spain; [Santos-Diez Vazquez, Laura] Hosp Cruces, Bilbao, Spain; [Perez Tamarit, Amparo; Calvo, Inmaculada; Lopez, Berta; Gonzalez Fernandez, Ma Isabel; Carmen Otero, Ma; Oltra, Manuel] Hosp Univ & Politecn La Fe, Valencia, Spain; [Dapena Archiles, Marta] Hosp Gen Castellon, Castellon de La Plana, Spain; [Sanchez, Paco; Gavilan, Cesar] Hosp Univ San Juan Alicante, Alicante, Spain; [Izquierdo Fos, Ignacio; Serrano Robles, Maria Isabel] Hosp Univ Elche, Elche, Spain; [Herranz Sanchez, Yolanda] Hosp Marina Baixa Alicante, Alicante, Spain	Hospital Universitario 12 de Octubre; Hospital Universitario Infanta Sofia; University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario La Paz; Hospital Clinico Universitario Virgen de la Arrixaca; Miguel Servet University Hospital; General University Gregorio Maranon Hospital; Hospital Universitario 12 de Octubre; Hospital Universitario La Paz; Hospital Universitario Infanta Sofia; University of Barcelona; General University Gregorio Maranon Hospital; Virgen del Rocio University Hospital; Hospital Torrecardenas; Hospital Universitario Virgen de las Nieves; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Hospital San Agustin; Basurto Hospital; Central University Hospital Asturias; Hospital Universitari Son Espases; Hospital Universitari Son Llatzer; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Valladolid; Universidad de Leon; Hospital de Leon; Hospital del Rio Hortega; Hospital Universitari Vall d'Hebron; Hospital Germans Trias i Pujol; Hospital Universitario Mutua Terrassa; University Hospital Arnau de Vilanova; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario 12 de Octubre; Severo Ochoa University Hospital; Hospital Universitario de Getafe; Hospital Universitario 12 de Octubre; Prince of Asturias University Hospital; Hospital Infanta Cristina; Hospital Clinico San Carlos; Hospital Universitario Fuenlabrada; Alcorcon Foundation University Hospital; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Hospital Clinico Universitario Virgen de la Arrixaca; Servicio Navarro de Salud - Osasunbidea; University Hospital Donostia; Hospital Universitario Cruces; Hospital Universitari i Politecnic La Fe	Fernandez-Cooke, E (corresponding author), Hosp Univ Doce Octubre, Dept Pediat, Madrid, Spain.; Fernandez-Cooke, E (corresponding author), Hosp Doce Octubre, Madrid, Spain.	elisafcooke@gmail.com	Campos, Letícia/HIK-2898-2022; Silveira, Luis/V-6161-2019; Rodriguez-Gonzalez, Moises/J-9699-2019; Casas, Ariadna Ayerza/AAI-3187-2020; Anton, Jordi/A-9848-2017; Domínguez Rodríguez, Sara/AFO-1443-2022; García, Lourdes/GZK-6681-2022; De Inocencio, Jaime/AAI-8881-2020; Osuna-Marco, Marta P/F-5654-2015; Centeno, Fernando/R-5056-2017; Tagarro, Alfredo/N-6930-2019; Martinon-Torres, Federico/E-4982-2016	Silveira, Luis/0000-0003-2576-7657; Rodriguez-Gonzalez, Moises/0000-0002-5587-435X; Casas, Ariadna Ayerza/0000-0002-0023-8137; Anton, Jordi/0000-0002-8792-4219; Domínguez Rodríguez, Sara/0000-0003-3747-9265; Osuna-Marco, Marta P/0000-0002-2169-9266; Centeno, Fernando/0000-0002-4816-7649; Martinon-Torres, Federico/0000-0002-9023-581X; Clemente, Daniel/0000-0002-1605-7488; Sanchez-Manubens, Judith/0000-0002-7615-4765; BUSTILLO ALONSO, MATILDE/0000-0002-2946-2167; Nunez Cuadros, Esmeralda/0000-0003-1938-1678; Giralt-Garcia, Gemma/0000-0002-8186-7073; Grasa, Carlos/0000-0002-9323-2024; Fernandez-Cooke, Elisa/0000-0002-5921-8261; GARCIA CUENLLAS ALVAREZ, LUISA/0000-0001-8614-7406	Spanish Society of Paediatric Rheumatology (SERPE)	Spanish Society of Paediatric Rheumatology (SERPE)	CC received a grant from Spanish Society of Paediatric Rheumatology (SERPE), 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belay ED, 2006, PEDIATR INFECT DIS J, V25, P245, DOI 10.1097/01.inf.0000202068.30956.16; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Chang A, 2018, PEDIAT INFECT DIS J; Chen JJ, 2016, PEDIATR INFECT DIS J, V35, P7, DOI 10.1097/INF.0000000000000914; Cimaz R, 2017, EUR J PEDIATR, V176, P1061, DOI 10.1007/s00431-017-2947-3; Davies S, 2015, ARCH DIS CHILD, V100, P366, DOI 10.1136/archdischild-2014-307397; Dietz SM, 2017, EUR J PEDIATR, V176, P995, DOI 10.1007/s00431-017-2937-5; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; Eleftheriou D, 2014, ARCH DIS CHILD, V99, P74, DOI 10.1136/archdischild-2012-302841; Fischer TK, 2007, PEDIATR INFECT DIS J, V26, P411, DOI 10.1097/01.inf.0000259964.47941.00; FURUSHO K, 1984, LANCET, V2, P1055; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huang Y.C., 2017, INT J MOL SCI, V18; Jakob A, 2016, PEDIATR INFECT DIS J, V35, P129, DOI 10.1097/INF.0000000000000953; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Kim Gi Beom, 2017, Pediatr Infect Dis J, V36, P482, DOI [10.1097/INF.0000000000001474, 10.1097/inf.0000000000001474]; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Kwon H, 2016, EUR J PEDIATR, V175, P1997, DOI 10.1007/s00431-016-2798-3; Phuong LK, 2017, JAMA PEDIATR, V171, P397, DOI 10.1001/jamapediatrics.2016.5140; Makino N, 2018, PEDIATR INT, V60, P581, DOI 10.1111/ped.13544; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Pinto FF, 2016, PEDIATR INFECT DIS J, V36, P1; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Riancho-Zarrabeitia L, 2018, RHEUMATOL INT, V38, P1259, DOI 10.1007/s00296-018-4066-5; Sanchez-Manubens J, 2016, CLIN EXP RHEUMATOL, V34, pS139; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; Son MBF, 2018, PEDIATR REV, V39, P78, DOI 10.1542/pir.2016-0182; Tacke CE, 2014, PEDIATR INFECT DIS J, V33, P793, DOI 10.1097/INF.0000000000000271; Tulloh RMR, 2018, ARCH DIS CHILD; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Wardle AJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011188.pub2; Wright VJ, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2293	38	32	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0215665	10.1371/journal.pone.0215665	http://dx.doi.org/10.1371/journal.pone.0215665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107862	Green Published, gold, Green Submitted			2022-12-27	WOS:000468285200002
J	Guiet, J; Galbraith, E; Kroodsma, D; Worm, B				Guiet, Jerome; Galbraith, Eric; Kroodsma, David; Worm, Boris			Seasonal variability in global industrial fishing effort	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; FLEET DYNAMICS; MARINE; MANAGEMENT; FISHERY; TRACKING; BEHAVIOR; ECOLOGY; CATCH	Human beings are the dominant top predator in the marine ecosystem. Throughout most of the global ocean this predation is carried out by industrial fishing vessels, that can now be observed in unprecedented detail via satellite monitoring of Automatic Identification System (AIS) messages. The spatial and temporal distribution of this fishing effort emerges from the coupled interaction of ecological and socio-economic drivers and can therefore yield insights on the dynamics of both the ecosystem and fishers. Here we analyze temporal variability of industrial fishing effort from 2015-2017 as recorded by global AIS coverage, and differentiated by fishing gear type. The strongest seasonal signal is a reduction of total deployed effort during the annual fishing moratorium on the numerically-dominant Chinese fleet, which occurs during boreal summer. An additional societally-controlled reduction of effort occurs during boreal winter holidays. After accounting for these societal controls, the total deployed effort is relatively invariant throughout the year for all gear types except squid jiggers and coastal purse seiners. Despite constant deployment levels, strong seasonal variability occurs in the spatial pattern of fishing effort for gears targeting motile pelagic species, including purse seiners, squid jiggers and longliners. Trawlers and fixed gears target bottom-associated coastal prey and show very little overall seasonality, although they exhibit more seasonal variation at locations that are further from port. Our results suggest that societal controls dominate the total deployment of fishing effort, while the behavior of pelagic fish, including seasonal migration and aggregation, is likely the most prominent driver of the spatial seasonal variations in global fishing effort.	[Guiet, Jerome; Galbraith, Eric] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals ICTA UAB, Barcelona, Spain; [Guiet, Jerome] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Galbraith, Eric] ICREA, Barcelona, Spain; [Kroodsma, David] Global Fishing Watch, Washington, DC USA; [Worm, Boris] Dalhousie Univ, Biol Dept, Halifax, NS, Canada	Autonomous University of Barcelona; University of California System; University of California Los Angeles; ICREA; Dalhousie University	Guiet, J (corresponding author), Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals ICTA UAB, Barcelona, Spain.; Guiet, J (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	jguiet@atmos.ucla.edu		Worm, Boris/0000-0002-5742-8716	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [682602]; Spanish Ministry of Economy and Competitiveness, through the Maria de Maeztu Programme for Centres/Units of Excellence in RD [MDM-2015-0552]; Ocean Frontier Institute	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness, through the Maria de Maeztu Programme for Centres/Units of Excellence in RD; Ocean Frontier Institute	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 682602), support from the Spanish Ministry of Economy and Competitiveness, through the Maria de Maeztu Programme for Centres/Units of Excellence in RD (MDM-2015-0552), and support from the Ocean Frontier Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Arkhipkin AI, 2015, REV FISH SCI AQUAC, V23, P92, DOI 10.1080/23308249.2015.1026226; Asche F, 2015, AQUACULT ECON MANAG, V19, P316, DOI 10.1080/13657305.2015.1057879; Bell JD, 2017, FISH FISH, V18, P489, DOI 10.1111/faf.12187; Bertrand S, 2004, ICES J MAR SCI, V61, P1127, DOI 10.1016/j.icesjms.2004.07.016; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Datta S, 2016, CAN J FISH AQUAT SCI, V73, P598, DOI 10.1139/cjfas-2015-0468; de Souza EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158248; Dhurmeea Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168605; Druon JN, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00315; EKLUND AM, 1991, FISH RES, V12, P1, DOI 10.1016/0165-7836(91)90045-H; Galbraith ED, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14884; Gelchu A., 2007, GROWTH DISTRIBUTION; He X, 1997, FISH RES, V31, P147, DOI 10.1016/S0165-7836(96)00564-4; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Kroodsma DA, 2018, SCIENCE, V359, P904, DOI 10.1126/science.aao5646; Lam VWY, 2011, ICES J MAR SCI, V68, P1996, DOI 10.1093/icesjms/fsr121; Lan KW, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050444; Larkin SL, 1999, AM J AGR ECON, V81, P29, DOI 10.2307/1244448; Lehodey P, 2015, DEEP-SEA RES PT II, V113, P246, DOI 10.1016/j.dsr2.2014.10.028; Maury O, 2007, PROG OCEANOGR, V74, P500, DOI 10.1016/j.pocean.2007.05.001; Maury O, 2017, PROG OCEANOGR, V156, P91, DOI 10.1016/j.pocean.2017.06.003; McCauley DJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2161; McCauley DJ, 2016, SCIENCE, V351, P1148, DOI 10.1126/science.aad5686; Mello LGS, 2005, ICES J MAR SCI, V62, P1006, DOI 10.1016/j.icesjms.2005.03.008; O'Toole MD, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00021; Pelletier D, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-1-51; Pellowe KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182200; Quetglas A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148770; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Salthaug A, 2003, CAN J FISH AQUAT SCI, V60, P259, DOI 10.1139/F03-018; Sharples J, 2013, PROG OCEANOGR, V117, P130, DOI 10.1016/j.pocean.2013.06.014; Smith M. D, 2016, DUKE ENV ENERGY EC W; Soykan CU, 2014, ECOL APPL, V24, P71, DOI 10.1890/12-0826.1; Stephenson F, 2018, MAR POLICY, V88, P189, DOI 10.1016/j.marpol.2017.11.029; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; Tommasi D, 2017, PROG OCEANOGR, V152, P15, DOI 10.1016/j.pocean.2016.12.011; Torres-Irineo E, 2011, AQUAT LIVING RESOUR, V24, P337, DOI 10.1051/alr/2011143; Valcu A, 2013, MAR RESOUR ECON, V28, P111, DOI 10.5950/0738-1360-28.2.111; van Denderen PD, 2015, ICES J MAR SCI, V72, P952, DOI 10.1093/icesjms/fsu183; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Walsh R. P. D., 1981, Weather, V36, P201, DOI 10.1002/j.1477-8696.1981.tb05400.x; Watson R, 2006, FISH RES, V79, P97, DOI 10.1016/j.fishres.2006.01.010; Watson RA, 2013, FISH FISH, V14, P493, DOI 10.1111/j.1467-2979.2012.00483.x	49	23	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0216819	10.1371/journal.pone.0216819	http://dx.doi.org/10.1371/journal.pone.0216819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100079	Green Submitted, Green Published, gold			2022-12-27	WOS:000468176600019
J	Yuen, CM; Millones, AK; Contreras, CC; Lecca, L; Becerra, MC; Keshavjee, S				Yuen, Courtney M.; Millones, Ana K.; Contreras, Carmen C.; Lecca, Leonid; Becerra, Mercedes C.; Keshavjee, Salmaan			Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; CHILDHOOD TUBERCULOSIS; CHALLENGES; BARRIERS; POLICIES; CHILDREN	Background Appropriate management of people exposed in the home to tuberculosis is essential to prevent morbidity. These household contacts, particularly children, should receive preventive therapy to prevent them from falling ill. However, few people receive preventive therapy worldwide. We sought to determine whether a community-based accompaniment intervention could improve tuberculosis contact management. Methods We conducted a prospective cohort study of household contacts of tuberculosis patients who initiated treatment during September 2015-June 2016 in Lima, Peru. Enrolled households received an intervention comprising home visits, transport vouchers, assistance coordinating evaluation procedures, and adherence support during preventive therapy. To evaluate the impact of the intervention, we conducted retrospective chart reviews of all patients initiating treatment during 6-month baseline and intervention periods. Results We enrolled 314 household contacts of 109 index patients. Of these, 283 (90%) completed evaluation, and 4 (1%) were diagnosed with tuberculosis. Preventive therapy was prescribed for 35/38 (92%) contacts 0-19 years old who were eligible under Peruvian guidelines. Preventive therapy was also prescribed for 6/26 (23%) contacts with unknown eligibility due to lack of a tuberculin skin test (TST), and 20/69 (29%) who were ineligible either because of a negative TST result or exposure to a drug-resistant or extrapulmonary case. Of the 61 contacts who were prescribed preventive therapy, 57 (93%) initiated treatment, and 51 (91%) completed treatment. The proportion of contacts who completed evaluation increased from 42% during the baseline period to 71% during the evaluation period (risk ratio [RR] = 1.73, 95% confidence interval [95% CI]: 1.41-2.13). The proportion of contacts who initiated preventive therapy increased from 15% to 40% (RR = 2.45, 95% CI: 1.42-4.22). Conclusion Accompaniment of TB patient households greatly improved the evaluation of household contacts for TB and increased the use of preventive therapy.	[Yuen, Courtney M.; Keshavjee, Salmaan] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Yuen, Courtney M.; Becerra, Mercedes C.; Keshavjee, Salmaan] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Millones, Ana K.; Contreras, Carmen C.; Lecca, Leonid] Socios Salud Sucursal Peru, Lima, Peru; [Becerra, Mercedes C.; Keshavjee, Salmaan] Partners In Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Yuen, CM (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Yuen, CM (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	courtney_yuen@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305; Yuen, Courtney/0000-0002-5219-2599; Lecca, Leonid/0000-0003-1363-3985	Charles H. Hood Foundation (Child Health Research Award); Janssen Global Public Health; Cassell Family Fund	Charles H. Hood Foundation (Child Health Research Award); Janssen Global Public Health; Cassell Family Fund	This work was funded by the Charles H. Hood Foundation (Child Health Research Award to CMY), Janssen Global Public Health, and the Cassell Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2017, NAT STRAT PLAN TUB E; Arscott-Mills T, 2017, INT J TUBERC LUNG D, V21, P586, DOI 10.5588/ijtld.16.0668; Chiang SS, 2017, INT J TUBERC LUNG D, V21, P154, DOI 10.5588/ijtld.16.0624; Chiang SS, 2015, INT J TUBERC LUNG D, V19, P1144, DOI 10.5588/ijtld.15.0178; Contreras CC, 2017, TROP MED INT HEALTH, V22, P505, DOI 10.1111/tmi.12844; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Hall C, 2015, TROP MED INT HEALTH, V20, P730, DOI 10.1111/tmi.12479; Hill RC, 2014, INT J TUBERC LUNG D, V18, P899, DOI 10.5588/ijtld.14.0007; Hwang TJ, 2011, INT J TUBERC LUNG D, V15, P1620, DOI 10.5588/ijtld.11.0222; Lecca L, 2017, AIDS, V31, P1207, DOI 10.1097/QAD.0000000000001471; Ministry of Health, 2013, NORM TECN SAL AT INT; Molfenter T, 2013, SUBST USE MISUSE, V48, P743, DOI 10.3109/10826084.2013.787098; Pease C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2377-x; Rodriguez CA, 2017, INT J TUBERC LUNG D, V21, P935, DOI 10.5588/ijtld.17.0061; Rutherford Merrin E, 2012, BMC Res Notes, V5, P7, DOI 10.1186/1756-0500-5-7; Singh AR, 2017, J TROP PEDIATRICS, V63, P274, DOI 10.1093/tropej/fmw086; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Smith SR, 2004, J PEDIATR-US, V145, P772, DOI 10.1016/j.jpeds.2004.08.029; Stop TB Partnership, ZER TB IN SPARKS NEW; Szkwarko D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182185; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Wingfield T, 2017, B WORLD HEALTH ORGAN, V95, P270, DOI [10.2471/BLT.16.170167, 10.2471/blt.16.170167]; Wingfield T, 2016, EUR RESPIR J, V48, P1396, DOI 10.1183/13993003.00066-2016; Wingfield T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2128-0; World Health Organization, 2018, WHOCDSTB20184; World Health Organization (WHO), 2017, GLOB TUB REP 2018; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033; Zero TB Initiative, 2017, BEST PRACT FRAM PROG	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217104	10.1371/journal.pone.0217104	http://dx.doi.org/10.1371/journal.pone.0217104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100097	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600029
J	Kanankege, KST; Abdrakhmanov, SK; Alvarez, J; Glaser, L; Bender, JB; Mukhanbetkaliyev, YY; Korennoy, FI; Kadyrov, AS; Abdrakhmanova, AS; Perez, AM				Kanankege, Kaushi S. T.; Abdrakhmanov, Sarsenbay K.; Alvarez, Julio; Glaser, Linda; Bender, Jeffrey B.; Mukhanbetkaliyev, Yersyn Y.; Korennoy, Fedor, I; Kadyrov, Ablaikhan S.; Abdrakhmanova, Aruzhan S.; Perez, Andres M.			Comparison of spatiotemporal patterns of historic natural Anthrax outbreaks in Minnesota and Kazakhstan	PLOS ONE			English	Article							UNITED-STATES; MANAGEMENT	Disease spread in populations is a consequence of the interaction between host, pathogen, and environment, i.e. the epidemiological triad. Yet the influences of each triad component may vary dramatically for different settings. Comparison of environmental, demographic, socio-economic, and historical backgrounds may support tailoring site-specific control measures. Because of the long-term survival of Bacillus anthracis, Anthrax is a suitable example for studying the influence of triad components in different endemic settings. We compared the spatiotemporal patterns of historic animal Anthrax records in two endemic areas, located at northern latitudes in the western and eastern hemispheres. Our goal was to compare the spatiotemporal patterns in Anthrax progression, intensity, direction, and recurrence (disease hot spots), in relation to epidemiological factors and potential trigger events. Reported animal cases in Minnesota, USA (n = 289 cases between 1912 and 2014) and Kazakhstan (n = 3,997 cases between 1933 and 2014) were analyzed using the spatiotemporal directionality test and the spatial scan statistic. Over the last century Anthrax occurrence in Minnesota was sporadic whereas Kazakhstan experienced a long-term epidemic. Nevertheless, the seasonality was comparable between sites, with a peak in August. Declining number of cases at both sites was attributed to vaccination and control measures. The spatiotemporal directionality test detected a relative northeastern directionality in disease spread for long-term trends in Minnesota, whereas a southwestern directionality was observed in Kazakhstan. In terms of recurrence, the maximum timespans between cases at the same location were 55 and 60 years for Minnesota and Kazakhstan, respectively. Disease hotspots were recognized in both settings, with spatially overlapping clusters years apart. Distribution of the spatiotemporal cluster radii between study sites supported suggestion of site-specific control zones. Spatiotemporal patterns of Anthrax occurrence in both endemic regions were attributed to multiple potential trigger events including major river floods, changes in land use, agriculture, and susceptible livestock populations. Results here help to understand the long-term epidemiological dynamics of Anthrax while providing suggestions to the design and implementation of prevention and control programs, in endemic settings.	[Kanankege, Kaushi S. T.; Perez, Andres M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Abdrakhmanov, Sarsenbay K.; Mukhanbetkaliyev, Yersyn Y.; Kadyrov, Ablaikhan S.; Abdrakhmanova, Aruzhan S.] S Seifullin Kazakh Agrotech Univ, Astana, Kazakhstan; [Alvarez, Julio] Univ Complutense, Fac Vet, Dept Sanidad Anim, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain; [Glaser, Linda] Minnesota Board Anim Hlth, St Paul, MN USA; [Bender, Jeffrey B.] Univ Minnesota, Sch Publ Hlth, Environm Hlth Sci, Minneapolis, MN USA; [Korennoy, Fedor, I] FGBI Fed Ctr Anim Hlth, Vladimir, Russia	University of Minnesota System; University of Minnesota Twin Cities; Saken Seifullin Kazakh Agrotechnical University; Complutense University of Madrid; University of Minnesota System; University of Minnesota Twin Cities; Federal Centre for Animal Health	Kanankege, KST (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	kanan009@umn.edu	Perez, Andres/HGD-8377-2022; Kadyrov, Ablaikhan/GRS-6971-2022; Korennoy, Fedor/I-9428-2016; Mukhanbetkaliyev, Yersyn/S-8811-2016; Abdrakhmanov, Sarsenbay/O-5800-2017; Alvarez, Julio/H-8292-2013	Korennoy, Fedor/0000-0002-7378-3531; Bender, Jeffrey/0000-0003-4645-9936; Mukhanbetkaliyev, Yersyn/0000-0003-3320-7182; Abdrakhmanov, Sarsenbay/0000-0003-3707-3767; Kanankege, Kaushi/0000-0002-5931-1634; Alvarez, Julio/0000-0002-8999-9417	Minnesota Discovery, Research, and Innovation Economy (MnDRIVE) program of the Office of the Vice President for Research (OVPR) of the University of Minnesota; Scientific Thematic "Zonification of Kazakhstan according to biosecurity categories with regard to dangerous infectious animal diseases" under the scientific researches in agro-industry and environmental management by the Ministry of Agriculture of Kazakhs [249]	Minnesota Discovery, Research, and Innovation Economy (MnDRIVE) program of the Office of the Vice President for Research (OVPR) of the University of Minnesota; Scientific Thematic "Zonification of Kazakhstan according to biosecurity categories with regard to dangerous infectious animal diseases" under the scientific researches in agro-industry and environmental management by the Ministry of Agriculture of Kazakhs	This study was funded in part by: 1) AMP: the Minnesota Discovery, Research, and Innovation Economy (MnDRIVE) program of the Office of the Vice President for Research (OVPR) of the University of Minnesota and 2) SKA: Scientific Thematic "Zonification of Kazakhstan according to biosecurity categories with regard to dangerous infectious animal diseases" under the Program #249 of funding scientific researches in agro-industry and environmental management by the Ministry of Agriculture of Kazakhstan.	Abdrakhmanov SK, 2017, PREV VET MED, V144, P149, DOI 10.1016/j.prevetmed.2017.06.003; Abdrakhmanov SK, 2017, GEOSPATIAL HEALTH, V12, P316, DOI 10.4081/gh.2017.589; Adamovich VL, 1970, J MICROBIOL, V8, P113; Aikembayev AM, 2010, EMERG INFECT DIS, V16, P789, DOI 10.3201/eid1605.091427; [Anonymous], 1980, MASTER PLAN PUBLIC U; [Anonymous], 2019, LIVE DRY ANIMAL ANTH; Arkhipkin OP, 2010, GEOSCIENCE AND REMOTE SENSING, NEW ACHIEVEMENTS, P419; Bellan SE, 2013, METHODS ECOL EVOL, V4, P361, DOI 10.1111/2041-210x.12021; Bender J, 2006, INT C EM INF DIS ATL, P156; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Bourn D., 2013, DRAFT GUIDELINES ENU; Chen Xinguang, 2017, Prev Med Rep, V5, P301, DOI 10.1016/j.pmedr.2017.01.009; Crickman CW, 1934, MINNESOTA B; Department of the Interior Bison Leadership Team and Working Group and Biological Resource Management Division National Park Service, 2014, NPSNRSSBRMDNRR201482; Driks A, 2009, MOL ASPECTS MED, V30, P368, DOI 10.1016/j.mam.2009.08.001; Elvander M, 2017, TRANSBOUND EMERG DIS, V64, P892, DOI 10.1111/tbed.12456; Halvorson Harlyn O., 1997, Microbiologia (Madrid), V13, P131; Hearne RR, 2010, WATER POLICY, V12, P898, DOI 10.2166/wp.2010.145; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Hughes-Jones M, 1999, J APPL MICROBIOL, V87, P189, DOI 10.1046/j.1365-2672.1999.00867.x; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kunkel KE, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018052; Lukhnova L. Yu., 2004, B AGR SCI KAZAKHSTAN, V7, P44; McCauley M., 1976, KHRUSHCHEV DEV SOVIE, DOI [10.1007/978-1-349-03059-0, DOI 10.1007/978-1-349-03059-0]; Morgan ER, 2006, VET PARASITOL, V139, P180, DOI 10.1016/j.vetpar.2006.02.016; Morris LR, 2016, J WILDLIFE MANAGE, V80, P235, DOI 10.1002/jwmg.1016; Mullins JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072451; Ottorino C, 2008, ANTHRAX HUMANS ANIMA; Popov YA, 2002, PROBLEMS ESPECIALLY, P21; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Rowe WC, 2011, TURNING SOVIET UNION; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Sorge US, 2015, J DAIRY SCI, V98, P3143, DOI 10.3168/jds.2014-9031; Sternbach G, 2003, J EMERG MED, V24, P463, DOI 10.1016/S0736-4679(03)00079-9; Stoltenow CL, 2010, UNIFIED ANTHRAX RECO; Turnbull PCB, 1998, J APPL MICROBIOL, V84, P667, DOI 10.1046/j.1365-2672.1998.00394.x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Ward SH, 1914, 11 ANN REPORT, P31	40	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217144	10.1371/journal.pone.0217144	http://dx.doi.org/10.1371/journal.pone.0217144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100100	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600030
J	Recharla, N; Kim, D; Ramani, S; Song, M; Park, J; Balasubramanian, B; Puligundla, P; Park, S				Recharla, Neeraja; Kim, Duwan; Ramani, Sivasubramanian; Song, Minho; Park, Juncheol; Balasubramanian, Balamuralikrishnan; Puligundla, Pradeep; Park, Sungkwon			Dietary multi-enzyme complex improves In Vitro nutrient digestibility and hind gut microbial fermentation of pigs	PLOS ONE			English	Article							WHEAT-BASED DIETS; GROWTH-PERFORMANCE; SOYBEAN-MEAL; NONSTARCH POLYSACCHARIDES; ENZYME SUPPLEMENTATION; BETA-GLUCANASE; GASTROINTESTINAL-TRACT; BLOOD CHARACTERISTICS; BROILER-CHICKENS; HULLESS BARLEY	This study was conducted in two stages to investigate the potential of multi-enzyme supplementation on the nutrient digestibility, growth performance, and gut microbial composition of pigs. In stage 1, effects of multi-enzyme complex (xylanase, alpha-amylase, beta-glucanase, and protease) supplementation on the ileal and total tract dry matter (DM) digestibility of feedstuffs were investigated with in vitro two-stage and three-stage enzyme incubation methods. A wide range of feed ingredients, namely, corn meal, wheat meal, soybean meal, fish meal, Oriental herbal extract, Italian rye-grass (IRG) and peanut hull were used as substrates. Supplementation of the multi-enzyme complex increased (P < 0.05) the digestibility of the Oriental herbal extract and corn meal. In stage 2, in vivo animal studies were performed to further investigate the effects of the dietary multi-enzyme complex on the nutrient utilization, growth performance, and fecal microbial composition of pigs. A total of 36 weaned pigs were fed corn- and soybean meal-based diets without (control) and with the multi-enzyme complex (treatment) for 6 weeks. Fecal samples were collected from 12 pigs to analyze the microbial communities by using DNA sequencing and bioinformatics tools. Multi-enzyme supplementation had no effect on apparent digestibility of nutrients and growth performance of pigs compared to control. Taxonomic analysis of the fecal samples indicated that the bacteria in both control and treatment samples predominantly belonged to Firmicutes and Bacteroidetes. In addition, the proportion of the phylum Firmicutes was slightly higher in the treatment group. At the genus level, the abundance of Treponema and Barnesiella increased in the treatment group; whereas the numbers of the genera including Prevotella, Butyricicoccus, Ruminococcus and Succinivibrio decreased in the treatment group. These results suggest that multi-enzyme supplementation with basal diets have the potential to improve nutrient digestibility and modify microbial communities in the hind-gut of pigs.	[Recharla, Neeraja; Ramani, Sivasubramanian; Balasubramanian, Balamuralikrishnan; Park, Sungkwon] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea; [Kim, Duwan; Park, Juncheol] RDA, Natl Inst Anim Sci, Swine Div, Sunghwan, South Korea; [Song, Minho] Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea; [Puligundla, Pradeep] Gachon Univ, Dept Food Sci & Biotechnol, Seongnam, South Korea	Sejong University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Chungnam National University; Gachon University	Park, S (corresponding author), Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea.	sungkwonpark@sejong.ac.kr	Balasubramanian, Balamuralikrishnan/K-6132-2019; Puligundla, Pradeep/C-3895-2012; Recharla, Neeraja/P-2776-2019; RAMANI, SIVASUBRAMANIAN/P-6080-2017; Balasubramanian, Balamuralikrishnan/AAB-1199-2020	Balasubramanian, Balamuralikrishnan/0000-0001-6938-1495; Puligundla, Pradeep/0000-0002-2457-0273; Recharla, Neeraja/0000-0001-9343-7436; RAMANI, SIVASUBRAMANIAN/0000-0001-9370-6552; Balasubramanian, Balamuralikrishnan/0000-0001-6938-1495; park, sungkwon/0000-0002-7684-9719	"Cooperative Research Program for Agriculture science Technology Development Rural Development" Administration and Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future planning, South [PJ012615, 2015R1C1A1A01051767]	"Cooperative Research Program for Agriculture science Technology Development Rural Development" Administration and Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future planning, South	This work was carried out with the support of "Cooperative Research Program for Agriculture science & Technology Development (Project No. PJ012615)" Rural Development Administration and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future planning 2015R1C1A1A01051767), South Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeola O, 2004, BRIT J NUTR, V92, P87, DOI 10.1079/BJN20041180; Adeola O., 2001, SWINE NUTR, VLewis, P903, DOI DOI 10.1201/9781420041842.CH40; ANDERSON DC, 1973, J ANIM SCI, V37, P148, DOI 10.2527/jas1973.371148x; AOAC, 2000, OFFICIAL METHODS ANA; Bakker GCM, 1998, VET QUART, V20, pS59; BEDFORD MR, 1992, CAN J ANIM SCI, V72, P97, DOI 10.4141/cjas92-011; Boisen S, 1997, ANIM FEED SCI TECH, V68, P277, DOI 10.1016/S0377-8401(97)00058-8; BOISEN S, 1995, ANIM FEED SCI TECH, V51, P29, DOI 10.1016/0377-8401(94)00686-4; Choct M, 2010, ASIAN AUSTRAL J ANIM, V23, P1386, DOI 10.5713/ajas.2010.90222; Choct M., 1997, FEED MILLING INT, V191, P13; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Hogberg A, 2004, ANIM FEED SCI TECH, V116, P113, DOI 10.1016/j.anifeedsci.2004.03.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jha R, 2015, ANIMAL, V9, P1441, DOI 10.1017/S1751731115000919; Jha R., 2016, P NZ POULTR IND C, V13, P84; Jo JK, 2012, J ANIM SCI, V90, P3041, DOI 10.2527/jas.2010-3430; KERR TJ, 1986, J SCI FOOD AGR, V37, P632, DOI 10.1002/jsfa.2740370706; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Kim S. W, 2014, 6 C LAT AM NUTR AN S; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Kong C, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1060-1; KORNEGAY ET, 1995, J ANIM SCI, V73, P1381; l'Anson KA, 2013, ANIM PROD SCI, V53, P531, DOI 10.1071/AN12256; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li S, 1996, J ANIM SCI, V74, P1649; LINDEMANN MD, 1986, J ANIM SCI, V62, P412, DOI 10.2527/jas1986.622412x; Liu HY, 2012, APPL ENVIRON MICROB, V78, P4102, DOI 10.1128/AEM.07702-11; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Meng X, 2005, POULTRY SCI, V84, P1242, DOI 10.1093/ps/84.8.1242; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Nortey TN, 2007, J ANIM SCI, V85, P1432, DOI 10.2527/jas.2006-613; O'Neill HVM, 2014, ASIAN AUSTRAL J ANIM, V27, P290, DOI 10.5713/ajas.2013.13261; Omogbenigun FO, 2004, J ANIM SCI, V82, P1053; Owusu-Asiedu A, 2010, LIVEST SCI, V134, P76, DOI 10.1016/j.livsci.2010.06.102; Park KR, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2194-5; Pryde SE, 1999, APPL ENVIRON MICROB, V65, P5372; Prykhodko O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116947; Ramayo-Caldas Y, 2016, ISME J, V10, P2973, DOI 10.1038/ismej.2016.77; Ravindran V, 2013, J APPL POULTRY RES, V22, P628, DOI 10.3382/japr.2013-00739; Regmi PR, 2009, J ANIM SCI, V87, P3620, DOI 10.2527/jas.2008-1739; ROBINSON IM, 1984, APPL ENVIRON MICROB, V48, P964, DOI 10.1128/AEM.48.5.964-969.1984; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Shim YH, 2003, ASIAN AUSTRAL J ANIM, V16, P1339, DOI 10.5713/ajas.2003.1339; Sieo CC, 2005, POULTRY SCI, V84, P734, DOI 10.1093/ps/84.5.734; Slominski BA, 2011, POULTRY SCI, V90, P2013, DOI 10.3382/ps.2011-01372; Tactacan GB, 2016, ASIAN AUSTRAL J ANIM, V29, P998, DOI 10.5713/ajas.15.0886; Toscano M, 2017, DIGEST LIVER DIS, V49, P261, DOI 10.1016/j.dld.2016.11.011; Upadhaya SD, 2016, ANIM FEED SCI TECH, V216, P281, DOI 10.1016/j.anifeedsci.2016.04.003; Vahjen W, 2007, ARCH ANIM NUTR, V61, P90, DOI 10.1080/17450390701203881; Wang H, 2008, ANIM FEED SCI TECH, V140, P376, DOI 10.1016/j.anifeedsci.2007.04.003; Ward NE, 2008, POULTRY SCI, V87, P91; Willamil J, 2012, J ANIM SCI, V90, P824, DOI 10.2527/jas.2010-3766; WILLIAMS CH, 1962, J AGR SCI, V59, P381, DOI 10.1017/S002185960001546X; Yang Y, 2010, J ANIM SCI, V88, P3304, DOI 10.2527/jas.2009-2318; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin YL, 2001, LIVEST PROD SCI, V71, P97, DOI 10.1016/S0301-6226(01)00214-7; Yuan L, 2017, P 50 HAW INT C SYST, P12, DOI DOI 10.24251/HICSS.2017; Zhang YJ, 2018, LIVEST SCI, V207, P105, DOI 10.1016/j.livsci.2017.11.017	63	10	10	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217459	10.1371/journal.pone.0217459	http://dx.doi.org/10.1371/journal.pone.0217459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136616	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300041
J	Ebot-Ojong, F; Jurado, E; Davis, AK				Ebot-Ojong, Felicia; Jurado, Elizabeth; Davis, Andrew K.			Direct measurement of fight or flight behavior in a beetle reveals individual variation and the influence of parasitism	PLOS ONE			English	Article							CHONDRONEMA-PASSALI LEIDY; OCTOPAMINE LEVELS; STRESS RESPONSES; HORNED PASSALUS; BODY-SIZE; COLEOPTERA; NEMATODE; CRICKET; POPULATIONS; PERFORMANCE	How and to what degree an animal deals with potential threats is a fascinating topic that has been well-researched, particularly in insects, though usually not with the impact of parasites in mind. A growing body of work is showing how even benign parasites can affect, positively or negatively, their hosts' physiological or behavioral reaction to threats. With this in mind we conducted an experiment using horned passalus beetles, Odontotaenius disjunctus that were naturally parasitized with a nematode Chondronema passali; we subjected beetles to simulated attacks (resembling rival fighting or predator attacks) and from videos of the encounters we quantified a suite of behaviors (antennae movement, aggressive posturing, threat displays, etc.), plus rates of alarm calls (stridulations) which all correspond to the "fight or flight" reaction. We obtained behavioral and parasite data from 140 beetles from two field collections, of which half had been housed in our lab for three weeks in conditions that would be stressful (little cover for burrowing). We observed a wide range of behaviors during the simulated attack procedure, from beetles offering little resistance to those which were extremely aggressive, though most beetles showed a moderate reaction. Alarm calling rates also varied, but surprisingly, these were not correlated with the magnitude of behavioral reactions. Also surprising was that stressful housing did not heighten the physical resistance during attacks, but did elevate alarm calling rate. Importantly, parasitized beetles had significantly reduced physical reactions to attack than those without nematodes (meaning their resistance to the attack was muted). The results concerning parasitism, coupled with prior work in our lab, indicate that the C. passali nematode depresses the hosts' acute stress, or fight or flight, reaction (likely from its energetic cost), which may make hosts more susceptible to the very dangers that they are coping with during the stress events.	[Ebot-Ojong, Felicia; Jurado, Elizabeth; Davis, Andrew K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Davis, AK (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	akdavis@uga.edu			National Science Foundation [DBI-1156707]	National Science Foundation(National Science Foundation (NSF))	This work was conducted as a part of the Population Biology of Infectious Diseases REU Site, a program funded by the National Science Foundation (Grant #DBI-1156707).	ADAMO SA, 1995, J EXP BIOL, V198, P1691; Adamo SA, 2017, J EXP BIOL, V220, P868, DOI 10.1242/jeb.153320; Adamo SA, 2013, J EXP BIOL, V216, P4608, DOI 10.1242/jeb.094482; Benelli G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09347; Benowitz KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042738; BUCHLER ER, 1981, ANIM BEHAV, V29, P483, DOI 10.1016/S0003-3472(81)80108-X; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Christie J. R., 1931, Journal of the Washington Academy of Sciences, V21, P356; Cox D, 2013, COLEOPTS BULL, V67, P179, DOI 10.1649/0010-065X-67.2.179; DAVENPORT AP, 1984, INSECT BIOCHEM, V14, P135, DOI 10.1016/0020-1790(84)90021-0; Davis AK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0018; Davis AK, 2017, INSECTS, V8, DOI 10.3390/insects8040110; Davis AK, 2017, PHYSIOL BIOCHEM ZOOL, V90, P273, DOI 10.1086/689301; Dhabhar FS, 2002, INTEGR COMP BIOL, V42, P556, DOI 10.1093/icb/42.3.556; DUNLAP KD, 1995, PHYSIOL ZOOL, V68, P608, DOI 10.1086/physzool.68.4.30166347; DuRant SE, 2015, J EXP BIOL, V218, P2297, DOI 10.1242/jeb.118703; Graham SP, 2012, HORM BEHAV, V62, P146, DOI 10.1016/j.yhbeh.2012.06.001; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Hall MD, 2010, FUNCT ECOL, V24, P159, DOI 10.1111/j.1365-2435.2009.01611.x; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; HIRASHIMA A, 1992, PESTIC BIOCHEM PHYS, V44, P217, DOI 10.1016/0048-3575(92)90092-E; Inoue A, 2013, J ETHOL, V31, P55, DOI 10.1007/s10164-012-0350-0; Lailvaux SP, 2005, FUNCT ECOL, V19, P632, DOI 10.1111/j.1365-2435.2005.01024.x; LeFeuvre J, 2015, COLEOPTS BULL, V69, P744, DOI 10.1649/0010-065X-69.4.744; Lindstrom KM, 2005, GEN COMP ENDOCR, V143, P231, DOI 10.1016/j.ygcen.2005.04.005; MULLEN V T, 1973, Journal of the Georgia Entomological Society, V8, P115; Murray DL, 1997, J ANIM ECOL, V66, P250, DOI 10.2307/6026; OTRONEN M, 1988, ANN ZOOL FENN, V25, P191; Pearse A. S., 1936, Ecological Monographs, V6, P455; REINERT J A, 1973, Florida Entomologist, V56, P273, DOI 10.2307/3493803; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; Ruane NM, 1999, FISH PHYSIOL BIOCHEM, V20, P43, DOI 10.1023/A:1007744617518; SCHUSTER JC, 1983, FLA ENTOMOL, V66, P486, DOI 10.2307/3494020; Schuster JC, 1975, THESIS; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Stevenson PA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00118; Valenzuela-Gonzalez J., 1986, FOLIA ENTOMOL MEX, V70, P53; Vasquez D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121614; Wicknick JA, 2009, COLEOPTS BULL, V63, P108, DOI 10.1649/0010-065X-63.1.108; WOODRING JP, 1988, J INSECT PHYSIOL, V34, P759, DOI 10.1016/0022-1910(88)90149-7	42	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0216387	10.1371/journal.pone.0216387	http://dx.doi.org/10.1371/journal.pone.0216387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116775	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400021
J	Olson, RM; Anderson, DM				Olson, Rachel M.; Anderson, Deborah M.			Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model	PLOS ONE			English	Article							UNITED-STATES; RESISTANCE; PIGMENTATION; VIRULENCE; SYSTEM; MICE	Yersinia pestis is the causative agent of pneumonic plague, a disease involving uncontrolled bacterial growth and host immunopathology. Secondary septicemic plague commonly occurs as a consequence of the host inflammatory response that causes vasodilation and vascular leakage, which facilitates systemic spread of the bacteria and the colonization of secondary tissues. The mortality rates of pneumonic and septicemic plague are high even when antibiotics are administered. In this work, we show that primary pneumonic or secondary septicemic plague can be preferentially modeled in mice by varying the volume used for intranasal delivery of Y. pestis. Low volume intranasal challenge (10 mu L) of wild type Y. pestis resulted in a high frequency of lethal secondary septicemic plague, with a low degree of primary lung infection and rapid development of sepsis. In contrast, high volume intranasal challenge (30 mu L) yielded uniform early lung infection and primary disease and a significant increase in lethality. In a commonly used BSL2 model, high volume challenge with Y. pestis lacking the pigmentation locus (pgm-) gave 10(5)-fold greater deposition compared to low volume challenge, yet moribund mice did not develop severe lung disease and there was no detectable difference in lethality. These data indicate the primary cause of death of mice in the BSL2 model is sepsis regardless of intranasal dosing method. Overall, these findings allow for the preferential modeling of pneumonic or septicemic plague by intranasal dosing of mice with Y. pestis.	[Olson, Rachel M.; Anderson, Deborah M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Olson, Rachel M.; Anderson, Deborah M.] Univ Missouri, Lab Infect Dis Res, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Olson, RM (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Olson, RM (corresponding author), Univ Missouri, Lab Infect Dis Res, Columbia, MO 65211 USA.	olsonra@missouri.edu		Olson, Rachel/0000-0002-6973-4331	National Institutes of Health/National Institute of Allergy and Infectious Disease, public health service award [R01A129996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129996] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease, public health service award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this work came from the National Institutes of Health/National Institute of Allergy and Infectious Disease, public health service award #R01A129996 (DA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Cabanel N, 2017, INT J ANTIMICROB AG, DOI 10.1016/j.ijantimicag.2017.09.015; Cantwell AM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-29; DeBord KL, 2006, INFECT IMMUN, V74, P4910, DOI 10.1128/IAI.01860-05; Dhariwala MO, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00570-17; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; FDA, 2004, FDA CTR BIOL EV PUBL; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Galvan EM, 2010, INFECT IMMUN, V78, P3443, DOI 10.1128/IAI.00382-10; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; House R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205077; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kwit N, 2015, MMWR-MORBID MORTAL W, V64, P918, DOI 10.15585/mmwr.mm6433a6; Lee-Lewis H, 2010, INFECT IMMUN, V78, P220, DOI 10.1128/IAI.00559-09; LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; McGill MR, 2016, EXCLI J, V15, P817, DOI 10.17179/excli2016-800; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; Olson RM, 2019, INFECT IMMUN, V87, DOI [10.1128/IAI.00757-18, 10.1128/iai.00757-18]; Pechous RD, 2016, TRENDS MICROBIOL, V24, P190, DOI 10.1016/j.tim.2015.11.008; Pollitzer R., 1954, PLAGUE; Shiuan Lin SP Jr, 2011, VACCINE, V29, P357; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217440	10.1371/journal.pone.0217440	http://dx.doi.org/10.1371/journal.pone.0217440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31121001	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700105
J	Hettiarachchi, IT; Hanoun, S; Nahavandi, D; Nahavandi, S				Hettiarachchi, Imali T.; Hanoun, Samer; Nahavandi, Darius; Nahavandi, Saeid			Validation of Polar OH1 optical heart rate sensor for moderate and high intensity physical activities	PLOS ONE			English	Article							MONITORS	Background Optical measurement techniques and recent advances in wearable technology have made heart rate (HR) sensing simpler and more affordable. Objectives The Polar OH1 is an arm worn optical heart rate monitor. The objectives of this study are two-fold; 1) to validate the OH1 optical HR sensor with the gold standard of HR measurement, electrocardiography (ECG), over a range of moderate to high intensity physical activities, 2) to validate wearing the OH1 at the temple as an alternative location to its recommended wearing location around the forearm and upper arm. Methods Twenty-four individuals participated in a physical exercise protocol, by walking on a treadmill and riding a stationary spin bike at different speeds while the criterion measure, ECG and Polar OH1 HR were recorded simultaneously at three different body locations; forearm, upper arm and the temple. Time synchronised HR data points were compared using Bland-Altman analyses and intraclass correlation. Results The intraclass correlation between the ECG and Polar OH1, for the aggregated data, was 0.99 and the estimated mean bias ranged 0.27-0.33 bpm for the sensor locations. The three sensors exhibited a 95% limit of agreement (LoA: forearm 5.22, -4.68 bpm; upper arm 5.15, -4.49; temple 5.22, -4.66). The mean of the ECG HR for the aggregated data was 112.15 +/- 24.52 bpm. The intraclass correlation of HR values below and above this mean were 0.98 and 0.99 respectively. The reported mean bias ranged 0.38-0.47 bpm (95% LoA: forearm 6.14, -5.38 bpm; upper arm 6.07, -5.13 bpm; temple 6.09, -5.31 bpm), and 0.15-0.16 bpm (95% LoA: forearm 3.99, -3.69 bpm; upper arm 3.90, -3.58 bpm; temple 4.06, -3.76 bpm) respectively. During different exercise intensities, the intraclass correlation ranged 0.95-0.99 for the three sensor locations. During the entire protocol, the estimated mean bias was in the range -0.15-0.55 bpm, 0.01-0.53 bpm and -0.37-0.48 bpm, for the forearm, upper arm and temple locations respectively. The corresponding upper limits of 95% LoA were 3.22-7.03 bpm, 3.25-6.82 bpm and 3.18-7.04 bpm while the lower limits of 95% LoA were -6.36-(-2.35) bpm, -6.46-(-2.30) bpm and -7.42-(-2.41) bpm. Conclusion Polar OH1 demonstrates high level of agreement with the criterion measure ECG HR, thus can be used as a valid measure of HR in lab and field settings during moderate and high intensity physical activities.	[Hettiarachchi, Imali T.; Hanoun, Samer; Nahavandi, Darius; Nahavandi, Saeid] Deakin Univ, Inst Intelligent Syst Res & Innovat, Waurn Ponds, Vic 3216, Australia	Deakin University	Hettiarachchi, IT (corresponding author), Deakin Univ, Inst Intelligent Syst Res & Innovat, Waurn Ponds, Vic 3216, Australia.	imali.hettiarachchi@deakin.edu.au	Nahavandi, Saeid/AAE-5536-2022		Institute for Intelligent Systems Research and Innovation (IISRI), Deakin University, Australia	Institute for Intelligent Systems Research and Innovation (IISRI), Deakin University, Australia	This research is fully funded by the Institute for Intelligent Systems Research and Innovation (IISRI), Deakin University, Australia.	Bartels R, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0401-4; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Butler MJ, 2016, PHYSIOL MEAS, V37, pN27, DOI 10.1088/0967-3334/37/5/N27; Dolezal BA, 2014, J OCCUP ENVIRON HYG, V11, P833, DOI 10.1080/15459624.2014.925114; Engstrom E, 2012, EUR J PHYSIOTHER, V14, P115, DOI 10.3109/14038196.2012.694118; Gillinov S, 2017, MED SCI SPORT EXER, V49, P1697, DOI 10.1249/MSS.0000000000001284; Hettiarachchi I, 2018, P IEEE SMC, P1; Jo E, 2016, J SPORT SCI MED, V15, P540; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Parak J, 2014, IEEE ENG MED BIO, P3670, DOI 10.1109/EMBC.2014.6944419; Piskorski J, 2005, COMPUT METH SCI TECH, V11, P39, DOI [DOI 10.12921/CMST.2005.11.01.39-48, 10.12921/cmst.2005.11.01.39-48]; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Schubert Matthew M, 2018, Sports Med Int Open, V2, pE67, DOI 10.1055/a-0631-0920; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536; Stahl S. E., 2016, BMJ OPEN SPORT EXERC, V2, pe106, DOI 10.1136/bmjsem-2015-000106; Temko A, 2017, IEEE T BIO-MED ENG, V64, P2016, DOI 10.1109/TBME.2017.2676243; Terbizan D., 2002, MEAS PHYS EDUC EXERC, V6, P243, DOI DOI 10.1207/S15327841MPEE0604_3; Wright SP, 2017, AM J PHYSIOL-REG I, V312, pR358, DOI 10.1152/ajpregu.00349.2016	21	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217288	10.1371/journal.pone.0217288	http://dx.doi.org/10.1371/journal.pone.0217288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120968	Green Published, gold, Green Submitted			2022-12-27	WOS:000468775700080
J	Jenvey, CJ; Shircliff, AL; Bannantine, JP; Stabel, JR				Jenvey, Caitlin J.; Shircliff, Adrienne L.; Bannantine, John P.; Stabel, Judith R.			Phenotypes of macrophages present in the intestine are impacted by stage of disease in cattle naturally infected with Mycobacterium avium subsp. paratuberculosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BOVINE MACROPHAGES; GAMMA-INTERFERON; EXPRESSION; INTERLEUKIN-10; MONOCYTES; RESPONSES; SURVIVAL; CD163; IL-23	Macrophages play an important role in the host immune response to Mycobacterium avium subsp. paratuberculosis (MAP) infection, however, MAP is able to disrupt normal macrophage functions to avoid destruction. It is unclear whether the phenotypes of macrophages present in the target tissue play a role in the inability to clear MAP infection. The aim of this study was to identify macrophage phenotypes (host defense or resolution and repair) present within the bovine ileum of naturally infected cattle, as well as to ascertain abundance of each macrophage phenotype present during different stages of MAP infection. Immunofluorescent (IF) labeling was performed on frozen bovine mid-ileal tissue sections collected from 28 Holstein dairy cows. Comprehensive IF staining for cytokines, such as IFN-gamma, IL-1R alpha, IL-1 beta, IL-10, TGF-beta, TNF-alpha, and uNOS, along with markers such as CD163, CD206, and TLR4, served to define the macrophage phenotypes. Overall, cows in the clinical stage of disease demonstrated significantly higher numbers of resolution and repair macrophages and lower numbers of host defense macrophages in the ileal tissue. Interestingly, subclinically affected cows with asymptomatic disease had a nearly equal ratio of host defense and resolution and repair macrophage phenotypes, whereas macrophage phenotype was skewed to a host defense macrophage in the tissues of the control noninfected cows. The preponderance of M2-like resolution and repair phenotype for macrophages in the tissues of cows with clinical disease would explain why the host fails to control and/or clear the infection, leading to a higher MAP burden. The results of the current study offer insight into the disparate macrophage phenotypes present in the bovine ileum during different stages of infection.	[Jenvey, Caitlin J.; Shircliff, Adrienne L.; Bannantine, John P.; Stabel, Judith R.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA; [Jenvey, Caitlin J.] La Trobe Univ, Dept Anim Plant & Soil Sci, Agribio Ctr Agribiosci, Bundoora, Vic, Australia	United States Department of Agriculture (USDA); La Trobe University	Stabel, JR (corresponding author), USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA.	judy.stabel@ars.usda.gov		Bannantine, John/0000-0002-5692-7898; Jenvey, Caitlin/0000-0002-4052-4330				Alzuherri HM, 1997, RES VET SCI, V63, P139, DOI 10.1016/S0034-5288(97)90007-2; Alzuherri HM, 1996, VET IMMUNOL IMMUNOP, V49, P331, DOI 10.1016/0165-2427(95)05477-4; Arsenault RJ, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-54; Arsenault RJ, 2012, INFECT IMMUN, V80, P3039, DOI 10.1128/IAI.00406-12; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Cheville NF, 2001, DEUT TIERARZTL WOCH, V108, P236; Coussens PM, 2004, INFECT IMMUN, V72, P3089, DOI 10.1128/IAI.72.6.3089-3096.2004; Fernandez M, 2017, VET PATHOL, V54, P82, DOI 10.1177/0300985816653794; Gossner AG, 2012, VET IMMUNOL IMMUNOP, V150, P118, DOI 10.1016/j.vetimm.2012.08.004; Hostetter J, 2003, COMP IMMUNOL MICROB, V26, P269, DOI 10.1016/S0147-9571(02)00070-X; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jenvey CJ, 2018, VET IMMUNOL IMMUNOP, V202, P93, DOI 10.1016/j.vetimm.2018.06.012; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Khalifeh MS, 2004, VET IMMUNOL IMMUNOP, V99, P39, DOI 10.1016/j.vetimm.2004.01.009; Khalifeh MS, 2004, INFECT IMMUN, V72, P1974, DOI 10.1128/IAI.72.4.1974-1982.2004; Koets AP, 2015, VET RES, V46, DOI 10.1186/s13567-015-0185-0; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kowal K, 2011, FOLIA HISTOCHEM CYTO, V49, P365, DOI 10.5603/FHC.2011.0052; Lamont EA, 2012, INFECT IMMUN, V80, P3225, DOI 10.1128/IAI.06322-11; Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326; Lee H, 2001, VET IMMUNOL IMMUNOP, V82, P73, DOI 10.1016/S0165-2427(01)00340-3; Li MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127356; Malvisi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164461; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; McClean CM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw068; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Robinson MW, 2011, INFECT IMMUN, V79, P2089, DOI 10.1128/IAI.00779-10; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Sommer S, 2009, VET IMMUNOL IMMUNOP, V128, P44, DOI 10.1016/j.vetimm.2008.10.294; Souza C, 2013, PLOS ONE, V8, pe75; Stabel JR, 2019, J DAIRY SCI, V102, P1594, DOI 10.3168/jds.2018-15241; Stabel JR, 2014, J DAIRY SCI, V97, P6296, DOI 10.3168/jds.2014-8204; Stabel JR, 2001, VET IMMUNOL IMMUNOP, V79, P69, DOI 10.1016/S0165-2427(01)00253-7; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sun L, 2015, CYTOKINE, V75, P249, DOI 10.1016/j.cyto.2015.01.030; Suzuki Y, 2017, ANN AM THORAC SOC, V14, P57, DOI [10.1513/annalsats.201607-528oc, 10.1513/AnnalsATS.201607-528OC]; Sweet L, 2010, INFECT IMMUN, V78, P518, DOI 10.1128/IAI.00257-09; Thirunavukkarasu S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176400; Thirunavukkarasu S, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv085; Weiss DJ, 2005, AM J VET RES, V66, P1114, DOI 10.2460/ajvr.2005.66.1114; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Weiss DJ, 2001, INFECT IMMUN, V69, P1002, DOI 10.1128/IAI.69.2.1002-1008.2001; Zhao BY, 1999, CAN J VET RES, V63, P56	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217649	10.1371/journal.pone.0217649	http://dx.doi.org/10.1371/journal.pone.0217649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31121006	gold, Green Published, Green Submitted			2022-12-27	WOS:000468775700115
J	Zhi, XY; Han, YC; Xing, FF; Lei, YP; Wang, GP; Feng, L; Yang, BF; Wang, ZB; Li, XF; Xiong, SW; Fan, ZY; Li, YB				Zhi, Xiaoyu; Han, Yingchun; Xing, Fangfang; Lei, Yaping; Wang, Guoping; Feng, Lu; Yang, Beifang; Wang, Zhanbiao; Li, Xiaofei; Xiong, Shiwu; Fan, Zhengyi; Li, Yabing			How do cotton light interception and carbohydrate partitioning respond to cropping systems including monoculture, intercropping with wheat, and direct-seeding after wheat?	PLOS ONE			English	Article							ECONOMIC-BENEFITS; YIELD; GROWTH	Different cotton (Gossypium hirsutum L.)-wheat (Triticum aestivum) planting patterns are widely applied in the Yellow River Valley of China, and crop yield mainly depends on light interception. However, little information is available on how cotton canopy light capturing and yield distribution are affected by planting patterns. Hence, field experiments were conducted in 2016 and 2017 to study the response of cotton canopy light interception, square and boll distribution, the leaf area index (LAI) and biomass accumulation to three planting patterns: a cotton monoculture (CM, planted on 15 May) system, a cotton/wheat relay intercropping (CWI, planted on 15 May) system, in which three rows of wheat rows were intercropped with one row of cotton, and a system in which cotton was directly seeded after wheat (CWD, planted on 15 June). The following results were obtained: 1) greater light capture capacity was observed for cotton plants in the CM and CWI compared with the CWD, and the light interception of the CM was 22.4% and 51.4% greater than that of the CWI and CWD, respectively, at 30 days after sowing (DAS) in 2016; 2) more bolls occurred at the first sympodial position (SP) than at other SPs for plants in the CM; 3) based on the LAI and biomass accumulation, the cotton growth rate was the greatest in CWD, followed by CM and CWI; and 4) the CM produced significantly greater yields than did the other two treatments because it yielded more bolls and greater boll weight. Information on the characteristics of cotton growth and development in response to different planting patterns would be helpful for understanding the response of cotton yields to planting patterns and would facilitate the improvement of cotton productivity.	[Zhi, Xiaoyu; Han, Yingchun; Xing, Fangfang; Lei, Yaping; Wang, Guoping; Feng, Lu; Yang, Beifang; Wang, Zhanbiao; Li, Xiaofei; Xiong, Shiwu; Fan, Zhengyi; Li, Yabing] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	criliyabing@163.com	Li, xiaofei/GXF-7187-2022; Li, Xiaofei/ABB-4458-2022; Yabing, Li/GLU-9964-2022	Zhi, Xiaoyu/0000-0003-2028-7267	Public Welfare Industry (agriculture) scientific research project: Fertilization and rational farming system in double cropping areas of dry-land [201503121]; Public welfare industry (agriculture) scientific research project: Fertilization and rational farming system in double cropping areas of dry land [201503121]	Public Welfare Industry (agriculture) scientific research project: Fertilization and rational farming system in double cropping areas of dry-land; Public welfare industry (agriculture) scientific research project: Fertilization and rational farming system in double cropping areas of dry land	This study was funded by the Public Welfare Industry (agriculture) scientific research project: Fertilization and rational farming system in double cropping areas of dry-land (201503121).; We greatly appreciate the work of the technicians from the experimental station at the Institute of Cotton Research of the Chinese Academy of Agricultural Sciences. This study was funded by the Public welfare industry (agriculture) scientific research project: Fertilization and rational farming system in double cropping areas of dry land (201503121).	Bange MP, 2004, FIELD CROP RES, V87, P73, DOI 10.1016/j.fcr.2003.09.007; Chen ZK, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00173; Cirilo AG, 2009, FIELD CROP RES, V113, P116, DOI 10.1016/j.fcr.2009.04.011; Constable GA, 2015, FIELD CROP RES, V182, P98, DOI 10.1016/j.fcr.2015.07.017; Dai JL, 2014, FIELD CROP RES, V155, P99, DOI 10.1016/j.fcr.2013.09.017; Du X, 2016, INT J PLANT PROD, V10, P29; Du XB, 2015, FIELD CROP RES, V170, P21, DOI 10.1016/j.fcr.2014.09.013; Feng L, 2017, FIELD CROP RES, V213, P100, DOI 10.1016/j.fcr.2017.07.003; Gangwar B, 2005, INDIAN J AGR SCI, V75, P65; Huang CD, 2017, FIELD CROP RES, V201, P41, DOI 10.1016/j.fcr.2016.10.021; Liu TD, 2012, PHOTOSYNTHETICA, V50, P215, DOI 10.1007/s11099-012-0011-0; Lu HQ, 2017, FIELD CROP RES, V200, P80, DOI 10.1016/j.fcr.2016.10.006; Mao LL, 2016, FIELD CROP RES, V187, P1, DOI 10.1016/j.fcr.2015.12.005; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Siebert JD, 2006, AGRON J, V98, P562, DOI 10.2134/agronj2005.0181; Szumigalski AR, 2008, AGRON J, V100, P1145, DOI 10.2134/agronj2006.0343; Tanveer M, 2017, ENVIRON SCI POLLUT R, V24, P6973, DOI 10.1007/s11356-017-8371-4; Wang ZK, 2017, FIELD CROP RES, V214, P1, DOI 10.1016/j.fcr.2017.08.017; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang L, 2008, FIELD CROP RES, V106, P258, DOI 10.1016/j.fcr.2007.12.010; Zhang L, 2007, FIELD CROP RES, V103, P178, DOI 10.1016/j.fcr.2007.06.002; Zhi XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113409	22	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2019	14	5							e0217243	10.1371/journal.pone.0217243	http://dx.doi.org/10.1371/journal.pone.0217243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY7BF	31107925	Green Published, Green Submitted, gold			2022-12-27	WOS:000468285200040
J	Feng, RF; Zhao, G; Yang, YG; Xu, MY; Huang, SB; Sun, GP; Guo, J; Li, JJ				Feng, Rongfang; Zhao, Gang; Yang, Yonggang; Xu, Meiying; Huang, Shaobin; Sun, Guoping; Guo, Jun; Li, Jianjun			Enhanced biological removal of intermittent VOCs and deciphering the roles of sodium alginate and polyvinyl alcohol in biofilm formation	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; BIOTRICKLING FILTER; PHYSICOCHEMICAL PROPERTIES; PERFORMANCE; MIXTURE; IMMOBILIZATION; BIODEGRADATION; EPS; PH	Developing a robust biofilm is a prerequisite for a biotrickling filter to obtain the good performance in removing volatile organic compounds (VOCs). But the biofilm formation can be seriously disturbed under intermittent loading condition due to carbon starvation stress in idle time. In this study, a biotrickling filter, with its packing materials being modified by 3% sodium alginate and 5% polyvinyl alcohol (v/v = 1:3), was employed to treat intermittent VOCs. Results showed that the removal efficiencies of toluene, ethylbenzene, p-xylene, m-xylene, and o-xylene was significantly enhanced in the BTF compared to the control one. Under relatively lower inlet loading, nearly complete removal of the five pollutants was achieved. A quantitative analysis showed that the concentration of total organic compound (TOC) in the leachate maintained at a high level, and had a strongly positive correlation with the divergence of microbial communities. The capacity of biofilm formation in the BTF was approximately four-fold higher than the control BTF, while the quantity of EPS secreted was more than ten-fold. EPS comprised largely of protein, and to less extent, polysaccharide. The biofilm formed on the modified packing materials maintained higher levels of microbial diversity and stability, even when modifiers were complete depleted or the VOCs inlet loading was increased. This study highlights the importance of packing materials for reducing the gap in performance between laboratory and industrial applications of BTFs.	[Feng, Rongfang; Sun, Guoping; Guo, Jun] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Feng, Rongfang; Zhao, Gang; Yang, Yonggang; Xu, Meiying; Sun, Guoping; Guo, Jun; Li, Jianjun] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Feng, Rongfang; Zhao, Gang; Yang, Yonggang; Xu, Meiying; Sun, Guoping; Guo, Jun; Li, Jianjun] State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China; [Feng, Rongfang; Zhao, Gang; Yang, Yonggang; Xu, Meiying; Sun, Guoping; Guo, Jun; Li, Jianjun] Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China; [Huang, Shaobin] South China Univ Technol, Sch Environm & Energy, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; South China University of Technology	Li, JJ (corresponding author), Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China.; Li, JJ (corresponding author), State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.; Li, JJ (corresponding author), Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China.	lijianjun1672@163.com	Xu, Meiying/AAM-1646-2020		National Natural Science Foundation of China [U1701243, 41501244]; Science and Technology Project of Guangdong Province, China [2016A030310314, 2017B090901049]; Science and Technology Project of Guangzhou [201504010014, 201610010090, 201704020204, 201707010377]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangdong Province, China; Science and Technology Project of Guangzhou	This work was supported as follows: Shaobin Huang: National Natural Science Foundation of China (U1701243); Gang Zhao: National Natural Science Foundation of China (41501244); Gang Zhao: Science and Technology Project of Guangdong Province, China (2016A030310314); Jianjun Li: Science and Technology Project of Guangdong Province, China (2017B090901049); Guoping Sun: Science and Technology Project of Guangzhou (201504010014); Yonggang Yang: Science and Technology Project of Guangzhou (201610010090); Jianjun Li: Science and Technology Project of Guangzhou (201704020204); Gang Zhao: Science and Technology Project of Guangzhou (201707010377).	Alinejad A, 2017, APPL MICROBIOL BIOT, V101, P3451, DOI 10.1007/s00253-016-8075-6; Alvarez-Hornos FJ, 2007, ENVIRON PROG, V26, P327, DOI 10.1002/ep.10226; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Darracq G, 2012, WATER AIR SOIL POLL, V223, P4969, DOI 10.1007/s11270-012-1251-0; Dedysh SN., 2018, ACIDOBACTERIA; Dogruoz N, 2009, J BASIC MICROB, V49, pS5, DOI 10.1002/jobm.200800250; Dong YW, 2017, BRAZ J MICROBIOL, V48, P515, DOI 10.1016/j.bjm.2017.02.001; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dumont E, 2010, CHEM ENG J, V162, P927, DOI 10.1016/j.cej.2010.06.045; Lopez ME, 2013, BIORESOURCE TECHNOL, V138, P245, DOI 10.1016/j.biortech.2013.03.136; Feng RF, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-018-0726-9; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flemming HC, 2001, WATER SCI TECHNOL, V43, P9, DOI 10.2166/wst.2001.0328; Goldford JE, 2018, SCIENCE, V361, P469, DOI 10.1126/science.aat1168; Groeber M, PB92180058XAB; He Z, 2009, J HAZARD MATER, V167, P275, DOI 10.1016/j.jhazmat.2008.12.116; Jia FX, 2017, ENVIRON SCI TECHNOL, V51, P3260, DOI 10.1021/acs.est.6b05761; Lebrero R, 2013, APPL MICROBIOL BIOT, V97, P4627, DOI 10.1007/s00253-012-4247-1; Li CN, 2005, ENVIRON SCI TECHNOL, V39, P2349, DOI 10.1021/es049152a; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Moe WM, 2004, WATER RES, V38, P2259, DOI 10.1016/j.watres.2004.02.017; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Pang CM, 2005, ENVIRON SCI TECHNOL, V39, P7541, DOI 10.1021/es050170h; Qi B, 2006, J HAZARD MATER, V135, P303, DOI 10.1016/j.jhazmat.2005.11.065; Qian J, 2017, BIORESOURCE TECHNOL, V241, P276, DOI 10.1016/j.biortech.2017.05.121; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; San-Valero P, 2013, BIOPROC BIOSYST ENG, V36, P975, DOI 10.1007/s00449-012-0833-y; Sempere F, 2008, CHEMOSPHERE, V73, P1533, DOI 10.1016/j.chemosphere.2008.08.037; Shemesh M, 2014, J FOOD PROTECT, V77, P1418, DOI 10.4315/0362-028X.JFP-13-425; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Solak Ayten O., 2014, Ecologia Balkanica, V6, P25; Song SH, 2005, ENZYME MICROB TECH, V37, P567, DOI 10.1016/j.enzmictec.2005.07.012; Sponza DT, 2003, ENZYME MICROB TECH, V32, P375, DOI 10.1016/S0141-0229(02)00309-5; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Veerachamy S, 2014, P I MECH ENG H, V228, P1083, DOI 10.1177/0954411914556137; Webster TS, 1999, ENVIRON PROG, V18, P162, DOI 10.1002/ep.670180312; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wu C, 2018, ENVIRON TECHNOL, V39, P109, DOI 10.1080/09593330.2017.1296892; Youssef NH, 2014, PHYLUM PLANCTOMYCETE; Zhang XQ, 2003, CHEMOSPHERE, V50, P63, DOI 10.1016/S0045-6535(02)00319-3	42	3	3	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217401	10.1371/journal.pone.0217401	http://dx.doi.org/10.1371/journal.pone.0217401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116790	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400060
J	Lopez-Mancilla, D; Lopez-Cahuich, G; Posadas-Castillo, C; Castaneda, CE; Garcia-Lopez, JH; Vazquez-Gutierrez, JL; Tlelo-Cuautle, E				Lopez-Mancilla, D.; Lopez-Cahuich, G.; Posadas-Castillo, C.; Castaneda, C. E.; Garcia-Lopez, J. H.; Vazquez-Gutierrez, J. L.; Tlelo-Cuautle, E.			Synchronization of complex networks of identical and nonidentical chaotic systems via model-matching control	PLOS ONE			English	Article							OUTPUT SYNCHRONIZATION	In this work, a synchronization scheme for networks of complex systems is presented. The proposed synchronization scheme uses a control law obtained with some definitions from graph theory and solving the Model-Matching Problem for complex networks. In particular, Rossler, Chen, Lorenz and Lu chaotic systems are used as complex chaotic systems into complex networks. Particular cases with regular and irregular networks of six identical chaotic systems are implemented, with some well-known topologies as star and ring small-world, and tree topologies. Highlighting, the obtained control law is applied to synchronize an irregular network of six different chaotic systems in a tree topology. The usefulness and advantages of the proposed synchronization scheme are highlighted performing numerical simulations of the chaotic complex networks.	[Lopez-Mancilla, D.; Lopez-Cahuich, G.; Castaneda, C. E.; Garcia-Lopez, J. H.; Vazquez-Gutierrez, J. L.] Univ Guadalajara UDG, Ctr Univ Lagos, Guadalajara, Jalisco, Mexico; [Posadas-Castillo, C.] UANL, Nuevo Leon, Mexico; [Tlelo-Cuautle, E.] INAOE, Puebla, Mexico	Universidad Autonoma de Nuevo Leon; Instituto Nacional de Astrofisica, Optica y Electronica	Lopez-Mancilla, D (corresponding author), Univ Guadalajara UDG, Ctr Univ Lagos, Guadalajara, Jalisco, Mexico.	didier.lopez@academicos.udg.mx	Lopez-Mancilla, Didier/AAG-5100-2019; García-López, J.H./AAU-5614-2021; Tlelo-Cuautle, Esteban/H-3141-2014; Posadas-Castillo, Cornelio/AAC-6047-2020; Garcia-Lopez, Juan Hugo/P-9338-2019	Lopez-Mancilla, Didier/0000-0002-0971-3176; Tlelo-Cuautle, Esteban/0000-0001-7187-4686; Posadas-Castillo, Cornelio/0000-0002-7821-467X; Garcia-Lopez, Juan Hugo/0000-0002-3739-0781; Castaneda, Carlos Eduardo/0000-0002-0781-0490	Universidad de Guadalajara, under UDG, Mexico [RC/075/2018, RG/006/2018]	Universidad de Guadalajara, under UDG, Mexico	This research was funded by Universidad de Guadalajara, under the project RC/075/2018 (RG/006/2018 to DL-M, UDG, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the financial support from the University of Guadalajara under the project RC/075/2018, Agreement RG/006/2018, UDG, Mexico.	Angulo-Guzman S, 2016, INT J CONTROL AUTOM, V14, P1114, DOI 10.1007/s12555-015-0168-y; [Anonymous], 2017, SCI REP-UK; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bustos A, 2008, NONLINEAR DYNAMICS S, V8, P221; Chiu R, 2019, CHAOS SOLITON FRACT, V119, P255, DOI 10.1016/j.chaos.2018.12.029; Cruz-Hernandez C, 2009, SERIES STABILITY OSC, V4; DIBENEDETTO MD, 1994, IEEE T AUTOMAT CONTR, V39, P1539, DOI 10.1109/9.310028; Estrada E, 2015, LECT NOTES MATH, V2126, P93, DOI 10.1007/978-3-319-11322-7_3; Isidori A, 1995, NONLINEAR CONTROL SYSTEMS DESIGN 1995, VOLS 1 AND 2, P87; Lopez-Mancilla D., 2005, NONLINEAR DYN, V5, P141; Lopez-Mancillla D, 2008, CHAOS SOLITON FRACT, V37, P1172, DOI 10.1016/j.chaos.2006.10.020; Pisarchik AN, 2008, INT J BIFURCAT CHAOS, V18, P1801, DOI 10.1142/S0218127408021385; Pisarchik AN, 2013, SENSORS-BASEL, V13, P17322, DOI 10.3390/s131217322; Posadas-Castillo C, 2008, THESIS, P19; Serrano-Guerrero H, 2010, INT J NONLIN SCI NUM, V11, P571, DOI 10.1515/IJNSNS.2010.11.8.571; Seyboth G. S., 2014, 19 WORLD C INT FED A, V47, P1985; Soriano-Sanchez AGS, 2018, CHAOS SOLITON FRACT, V114, P415, DOI 10.1016/j.chaos.2018.07.038; Soriano-Sanchez AG, 2015, J ENG SCI TECHNOL RE, V8, P185, DOI DOI 10.25103/JESTR.082.23; Su H, 2010, IET CONTROL THEORY A, V4, P2719, DOI 10.1049/iet-cta.2009.0404; Wang XF, 2002, INT J BIFURCAT CHAOS, V12, P187, DOI 10.1142/S0218127402004292; Wang XF, 2002, INT J BIFURCAT CHAOS, V12, P885, DOI 10.1142/S0218127402004802; Wang X, 2017, NONLINEAR ANAL-HYBRI, V26, P307, DOI 10.1016/j.nahs.2017.06.005; Yang HL, 2018, APPL MATH COMPUT, V320, P75, DOI 10.1016/j.amc.2017.09.019; Zheng ZG, 2018, CHINESE PHYS B, V27, DOI 10.1088/1674-1056/27/1/018901; Zhu LJ, 2016, SYST CONTROL LETT, V94, P37, DOI 10.1016/j.sysconle.2016.04.003	25	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0216349	10.1371/journal.pone.0216349	http://dx.doi.org/10.1371/journal.pone.0216349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120901	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700013
J	Muguruma, T; Toida, C; Gakumazawa, M; Yogo, N; Shinohara, M; Takeuchi, I				Muguruma, Takashi; Toida, Chiaki; Gakumazawa, Masayasu; Yogo, Naoki; Shinohara, Mafumi; Takeuchi, Ichiro			Effects of establishing a trauma center on the mortality rate among injured pediatric patients in Japan	PLOS ONE			English	Article							CARE; SURVIVAL	Introduction It remains unclear whether trauma centers are effective for the treatment of injured pediatric patients. The aim of this study was to evaluate children's mortality before and after the establishment a trauma center by using standard mortality ratios (SMR) and a modified observed-expected chart. Methods This was a single center, retrospective chart review study that included injured pediatric patients (age <16 years) who were transported to our trauma center by the emergency medical services from 2012 to 2016 in Japan. Results Our study included 143 subjects: 45 (31%) were preschoolers aged <6 years, and 43 (30%) had an injury severity score (ISS). >= 16. After the trauma centers established, the number of patients increased (70% increase per month), as did the number of the patients with an ISS of 41-75. The percentage of indirect transportations was significantly higher in the trauma center than in the non-trauma center (49% vs. 28%; p < 0.05). The SMR was significantly lower in the trauma-center than in the non-trauma center (0.461 vs. 0.589; p < 0.05). The mean value of the modified observed-expected chart was significantly higher in the trauma-center than in the non-trauma center (4.6 vs. 2.3; p < 0.05). For the patients who were directly transferred to our center, the transfer distance was greater in the trauma-center than in the non-trauma center (6.8 vs. 6.2 km; p < 0.05). The time interval from hospital admission to initiation of computed tomography (15.5 vs. 33 minutes; p < 0.05) and to definitive care (44 vs. 64.5 minutes; p < 0.05) decreased in the after group compared to the non-trauma center. Conclusions The results of our study revealed that the centralization of pediatric injured pediatric patients in trauma centers improved the mortality rate in this population in Japan.	[Muguruma, Takashi; Toida, Chiaki; Gakumazawa, Masayasu; Yogo, Naoki; Shinohara, Mafumi; Takeuchi, Ichiro] Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Yokohama, Kanagawa, Japan	Yokohama City University	Toida, C (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Yokohama, Kanagawa, Japan.	toida-ygc@umin.ac.jp		Yogo, Naoki/0000-0002-6360-3541				Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brown JB, 2016, J TRAUMA ACUTE CARE, V80, P702, DOI 10.1097/TA.0000000000000971; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Dieppe C, 2009, INTENS CARE MED, V35, P334, DOI 10.1007/s00134-008-1323-1; Fire and Disaster Management Agency Japan, PRES SIT EM RESC 201; Gregory CJ, 2008, PEDIATRICS, V121, pE906, DOI 10.1542/peds.2007-2089; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hondo K, 2013, J AM COLL SURGEONS, V217, P850, DOI 10.1016/j.jamcollsurg.2013.05.026; Japan Trauma Care and Research, JAP TRAUM DAT BANK R; Kaku N, 2014, JJSEM, V17, P414; Kunihiro M., 2005, J NIPPON MED SCH, V72, P194, DOI [10.1272/jnms.72.194, DOI 10.1272/JNMS.72.194]; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mashiko Kunihiro, 2005, Journal of Nippon Medical School, V72, P194, DOI 10.1272/jnms.72.194; Ministry of Health Labour and Welfare, JAP VIT STAT JAP 201; Morimura N., 2017, J JPN ASS SURG TRAUM, V31, P79; Nakamura T, 2014, OPEN ACCESS EMERG M, V6, P27, DOI 10.2147/OAEM.S61114; Osler TM, 2001, J TRAUMA, V50, P96, DOI 10.1097/00005373-200101000-00017; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; The Royal College of Surgeons of England, 2009, RCSENG PROF STAND RE; Toida C, 2014, ACUTE MED SURG, V1, P170, DOI 10.1002/ams2.30	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217140	10.1371/journal.pone.0217140	http://dx.doi.org/10.1371/journal.pone.0217140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31121009	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700059
J	Han, HJ; Song, X; Yadav, D; Hwang, MS; Lee, JH; Lee, CH; Kim, TH; Lee, JJ; Kwon, J				Han, Hye-Ju; Song, Xinjie; Yadav, Dhananjay; Hwang, Mi Sun; Lee, Joo Hee; Lee, Chang Hoon; Kim, Tae Hee; Lee, Jeong Jun; Kwon, Jungkee			Ulmus macrocarpa Hance modulates lipid metabolism in hyperlipidemia via activation of AMPK pathway	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; EXTRACT	Ulmus macrocarpa Hance as an oriental medicinal plant has shown enormous potential for the treatment of several metabolic disorders in Korea. Hyperlipidemia, which is characterized by the excess accumulation of lipid contents in the bloodstream, may lead to several cardiovascular diseases. Therefore, in this study, anti-hyperlipidemic potential of U. macrocarpa water extract (UME) was examined in vitro and in vivo using HepG2 cells and experimental rats, respectively. The hyperlipidemia in experimental rats was induced by the high-cholesterol diet (HCD) followed by oral administration of various concentrations (25, 50 and 100 mg/kg) of UME for 6 weeks. As a result, the UME significantly improved the biochemical parameters such as increased the level of triglyceride, total cholesterol, and low-density lipoprotein cholesterol as well as reduced the high-density lipoprotein cholesterol in the HCD-fed rats. In addition, UME also prevented lipid accumulation through regulating AMPK activity and lipid metabolism proteins (ACC, SREBP1 and HMGCR) in the HCD-fed rats as compared to the controls. Moreover, similar pattern of gene expression levels was confirmed in oleic acid (OA)-treated HepG2 cells. Taken together, our results indicate that UME prevents hyperlipidemia via activating the AMPK pathway and regulates lipid metabolism. Thus, based on the above findings, it is estimated that UME could be a potential therapeutic agent for preventing the hyperlipidemia.	[Han, Hye-Ju; Kwon, Jungkee] Chonbuk Natl Univ, Dept Lab Anim Med, Coll Vet Med, Iksan, South Korea; [Song, Xinjie] Yeungnam Univ, Dept Food Sci & Technol, Gyongsan, Gyeongsangbuk D, South Korea; [Yadav, Dhananjay] Yeungnam Univ, Dept Med Biotechnol, Gyongsan, Gyeongsangbuk D, South Korea; [Hwang, Mi Sun; Lee, Joo Hee; Lee, Chang Hoon] Pusan Natl Univ, Korea Nanotechnol Ctr, Busan, South Korea; [Hwang, Mi Sun; Lee, Joo Hee; Lee, Chang Hoon] Pusan Natl Univ, Ctr Antiaging Ind, Busan, South Korea; [Kim, Tae Hee; Lee, Jeong Jun] Naturetech Co Ltd, Jincheon Gun, Chungbuk, South Korea	Jeonbuk National University; Yeungnam University; Yeungnam University; Pusan National University; Pusan National University	Kwon, J (corresponding author), Chonbuk Natl Univ, Dept Lab Anim Med, Coll Vet Med, Iksan, South Korea.	jkwon@jbnu.ac.kr	Yadav, Dhananjay/AAZ-9435-2021	Yadav, Dhananjay/0000-0003-4047-7236; Kwon, Jungkee/0000-0001-6008-3918	Ministry of Trade, industry, and Energy (MOTIE) Korea, under the "Regional Specialized Industry Development Program (RD) [P0002747]	Ministry of Trade, industry, and Energy (MOTIE) Korea, under the "Regional Specialized Industry Development Program (RD)	This research was financially supported by the Ministry of Trade, industry, and Energy (MOTIE) Korea, under the "Regional Specialized Industry Development Program (R&D, P0002747)" supervised by the Korea Institute for Advancement of Technology (KIAT). Naturetech Co. Ltd. provided support in the form of research materials and salaries for authors THK and JJL. The specific roles of these authors are articulated in the 'author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandhi R, 2013, J PHYSIOL BIOCHEM, V69, P313, DOI 10.1007/s13105-012-0215-6; Atkinson LL, 2003, AM J PHYSIOL-ENDOC M, V284, pE923, DOI 10.1152/ajpendo.00360.2002; Bauters C, 2018, ARCH CARDIOVASC DIS, V111, P634, DOI 10.1016/j.acvd.2017.07.007; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Choudhary MI, 2005, J ETHNOPHARMACOL, V98, P217, DOI 10.1016/j.jep.2005.01.013; Das PP, 2010, WORLD J BIOL PSYCHIA, V11, P321, DOI [10.3109/15622970902960889, 10.1080/15622970902960889]; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Guo P, 2010, J PHARMACOL SCI, V113, P395, DOI 10.1254/jphs.10041FP; Le NA, 2008, CURR OPIN LIPIDOL, V19, P545, DOI 10.1097/MOL.0b013e32830f4a57; Le Ngoc-Anh, 2007, Curr Atheroscler Rep, V9, P110, DOI 10.1007/s11883-007-0006-7; Lee I, 2014, J LIFE SCI, V24, P151; Lee MS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1031-2; Leslie MA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0049-7; Okerson T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004909; 김경범, 2012, 한국식품저장유통학회지, V19, P909; Rho J, 2019, J ETHNOPHARMACOL, V233, P115, DOI 10.1016/j.jep.2018.11.042; Rosenson RS, 2006, AM HEART J, V151, P556, DOI 10.1016/j.ahj.2005.03.049; Shimano H, 2000, TRENDS CARDIOVAS MED, V10, P275, DOI 10.1016/S1050-1738(00)00079-7; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Uddin MJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/652473; Watts GF, 2011, HEART, V97, P350, DOI 10.1136/hrt.2010.204990; Xiao CT, 2016, DIABETES, V65, P1767, DOI 10.2337/db16-0046; Yanai Hidekatsu, 2018, J Clin Med Res, V10, P281, DOI 10.14740/jocmr3362w	25	5	6	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217112	10.1371/journal.pone.0217112	http://dx.doi.org/10.1371/journal.pone.0217112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120956	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700057
J	Degioanni, A; Bonenfant, C; Cabut, S; Condemi, S				Degioanni, Anna; Bonenfant, Christophe; Cabut, Sandrine; Condemi, Silvana			Living on the edge: Was demographic weakness the cause of Neanderthal demise?	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; GENOME SEQUENCE; MODERN HUMANS; MORTALITY PATTERNS; LATE PLEISTOCENE; LIFE-HISTORY; POPULATIONS; ORIGIN; MIDDLE; SURVIVAL	The causes of disappearance of the Neanderthals, the only human population living in Europe before the arrival of Homo sapiens, have been debated for decades by the scientific community. Different hypotheses have been advanced to explain this demise, such as cognitive, adaptive and cultural inferiority of Neanderthals. Here, we investigate the disappearance of Neanderthals by examining the extent of demographic changes needed over a period of 10,000 years (yrs) to lead to their extinction. In regard to such fossil populations, we inferred demographic parameters from present day and past hunter-gatherer populations, and from bio-anthropological rules. We used demographic modeling and simulations to identify the set of plausible demographic parameters of the Neanderthal population compatible with the observed dynamics, and to explore the circumstances under which they might have led to the disappearance of Neanderthals. A slight (< 4%) but continuous decrease in the fertility rate of younger Neanderthal women could have had a significant impact on these dynamics, and could have precipitated their demise. Our results open the way to non-catastrophic events as plausible explanations for Neanderthal extinction.	[Degioanni, Anna; Cabut, Sandrine] Aix Marseille Univ, CNRS, Minist Culture, LAMPEA, Aix En Provence, France; [Bonenfant, Christophe] Univ Claude Bernard Lyon Villeurbanne, CNRS, UMR, Lab Biometrie Biol Evolut, Villeurbanne, France; [Condemi, Silvana] Aix Marseille Univ, CNRS, EFS, ADES, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Degioanni, A (corresponding author), Aix Marseille Univ, CNRS, Minist Culture, LAMPEA, Aix En Provence, France.	anna.degioanni@univ-amu.fr	Condemi, Silvana/ABE-2701-2021; Bonenfant, Christophe/I-8645-2019	Condemi, Silvana/0000-0002-6516-0879; Bonenfant, Christophe/0000-0002-9924-419X				Agusti J, 2017, QUATERN INT, V431, P232, DOI 10.1016/j.quaint.2016.02.017; Aitken MJ, 2014, ORIGIN MODERN HUMANS; Alberts Susan C., 2003, P66; ARMENIAN HK, 1993, INT J EPIDEMIOL, V22, P457, DOI 10.1093/ije/22.3.457; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Barton CM, 2011, HUM ECOL, V39, P705, DOI 10.1007/s10745-011-9433-8; Bennett P. M., 2002, OX ECOL EV; Bischof R, 2018, NAT ECOL EVOL, V2, P116, DOI 10.1038/s41559-017-0400-7; Bocquet-Appel JP, 2013, CURR ANTHROPOL, V54, pS202, DOI 10.1086/673725; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Bosch MD, 2015, P NATL ACAD SCI USA, V112, P7683, DOI 10.1073/pnas.1501529112; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown M S, 1984, Nurse Pract, V9, P42; Brown MS, 1984, NURSE PRACT, V9, P46; Brown MS, 1984, NURSE PRACT, V9, P42; Caswell H, 2008, MATRIX POPULATION MO; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Churchill SE, 2014, THIN ON THE GROUND: NEANDERTAL BIOLOGY, ARCHEOLOGY, AND ECOLOGY, P1, DOI 10.1002/9781118590836; Conard NJ, 2011, VERTEBR PALEOBIOL PA, P223, DOI 10.1007/978-94-007-0415-2_19; Condemi S, 2001, NEANDERTALIENS CHAIS; Cucart-Mora C, 2018, J ARCHAEOL SCI, V89, P14, DOI 10.1016/j.jas.2017.11.001; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; Garralda MD, 2014, J HUM EVOL, V75, P1, DOI 10.1016/j.jhevol.2014.02.019; Fabre V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005151; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Finlayson C, 2008, QUATERNARY SCI REV, V27, P2246, DOI 10.1016/j.quascirev.2008.08.033; Fowler C.W., 1987, Current Mammalogy, V1, P401; FRISCH RE, 1990, BAILLIERE CLIN OB GY, V4, P419, DOI 10.1016/S0950-3552(05)80302-5; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Galvan B, 2014, J HUM EVOL, V75, P16, DOI 10.1016/j.jhevol.2014.06.002; Gilpin W, 2016, P NATL ACAD SCI USA, V113, P2134, DOI 10.1073/pnas.1524861113; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunz P, 2010, CURR BIOL, V20, pR921, DOI 10.1016/j.cub.2010.10.018; Hanski I, 1998, OIKOS, V83, P390, DOI 10.2307/3546854; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; HEWLETT BS, 1991, J ANTHROPOL RES, V47, P1; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hodgkins J, 2016, J HUM EVOL, V96, P1, DOI 10.1016/j.jhevol.2016.03.009; Hoffmann DL, 2018, SCIENCE, V359, P912, DOI 10.1126/science.aap7778; Houldcroft CJ, 2016, AM J PHYS ANTHROPOL, V160, P379, DOI 10.1002/ajpa.22985; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Jarry M, 2013, INTRO CULTURES ENV P, P13; Klein RG, 2003, SCIENCE, V299, P1525, DOI 10.1126/science.1082025; Kochiyama T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24331-0; Kotsakis T., 2006, EVOLUTION MAMMALIAN, V2006, P30; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Kuhn SL, 2006, CURR ANTHROPOL, V47, P953, DOI 10.1086/507197; KYRIACOU A, 2011, PALEOANTHROPOLOGY, P130; LACAVA J, 1984, WILDLIFE SOC B, V12, P370; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R., 1968, SOME MATH PROBLEMS B; Lutz W, 2006, POPUL ENVIRON, V28, P69, DOI 10.1007/s11111-007-0037-6; Mace R, 2000, ANIM BEHAV, V59, P1, DOI 10.1006/anbe.1999.1287; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Mellars P, 2011, NATURE, V479, P483, DOI 10.1038/479483a; Mendez FL, 2016, AM J HUM GENET, V98, P728, DOI 10.1016/j.ajhg.2016.02.023; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Nannan N, 2007, J BIOSOC SCI, V39, P613, DOI 10.1017/S0021932006001702; Neves AGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047076; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Otto S.P., 2011, BIOLOGISTS GUIDE MAT; Pearce E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0168; Pearson OM, 2007, VERTEBR PALEOBIOL PA, P135; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; Polgar S., 1975, POPULATION ECOLOGY S; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; R Core Team, 2017, LANG ENV STAT COMP; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Robert-Lamblin J., 1978, REV ETUDES INUIT STU, V2, P23; Roberts MF, 2018, J ARCHAEOL SCI, V100, P16, DOI 10.1016/j.jas.2018.09.012; Roebroeks W, 2016, P NATL ACAD SCI USA, V113, P6372, DOI 10.1073/pnas.1521269113; Rogers AR, 2017, P NATL ACAD SCI USA, V114, P9859, DOI 10.1073/pnas.1706426114; Rougier H, 2012, LIFE DEATH PESTERA C, P257; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Serva M, 2015, B MATH BIOL, V77, P2354, DOI 10.1007/s11538-015-0127-z; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Sikora M, 2017, SCIENCE, V358, P659, DOI 10.1126/science.aao1807; Sorensen B, 2011, J ANTHROPOL ARCHAEOL, V30, P17, DOI 10.1016/j.jaa.2010.12.003; Stapert D, 2007, PALARCHS J ARCHAEOLO, V1, P16; Sullivan AP, 2017, J HUM EVOL, V108, P62, DOI 10.1016/j.jhevol.2017.03.004; TRINKAUS E, 1995, J ARCHAEOL SCI, V22, P121, DOI 10.1016/S0305-4403(95)80170-7; Trinkaus E., 2014, PEOPLE SUNGHIR BURIA; Trinkaus E, 2012, LIFE DEATH PESTERA C, P389; Trinkaus E, 2012, LIFE DEATH PESTERA C, P234; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; Underdown S, 2008, MED HYPOTHESES, V71, P4, DOI 10.1016/j.mehy.2007.12.014; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; von Koenigswald W, 2011, VERTEBR PALEOBIOL PA, P101, DOI 10.1007/978-94-007-0492-3_9; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; WEGMAN ME, 1994, PEDIATRICS, V94, P792; Wolff H, 2010, MED HYPOTHESES, V75, P99, DOI 10.1016/j.mehy.2010.01.048; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899; [No title captured], DOI DOI 10.7557/2.11.4.989	108	17	17	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216742	10.1371/journal.pone.0216742	http://dx.doi.org/10.1371/journal.pone.0216742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141515	Green Published, gold, Green Submitted			2022-12-27	WOS:000469323000020
J	Rada, A; Kuvacic, G; De Giorgio, A; Sellami, M; Ardigo, LP; Bragazzi, NL; Padulo, J				Rada, Ante; Kuvacic, Goran; De Giorgio, Andrea; Sellami, Maha; Ardigo, Luca Paolo; Bragazzi, Nicola Luigi; Padulo, Johnny			The ball kicking speed: A new, efficient performance indicator in youth soccer	PLOS ONE			English	Article							TALENT IDENTIFICATION; INSTEP KICKING; BIOMECHANICS; PLAYERS; ELITE; STRENGTH; MATURITY; VELOCITY; POWER; LEG	Success in different soccer skills like kicking depends on motor abilities achieved. Kicking is a soccer fundamental, which depends on many different and complex factors (technique, foot-ball interaction, ball flight, etc.). Therefore, it is important to identify players that are able to perform faster kicks using both dominant and non-dominant leg. The current study investigated some basic variables of different soccer kicking speed and their relevance to success in youth soccer academy. 119 players from the first and the second division participated to this study. They were randomly divided into age groups (U-15, U-17, and U19) and team status (first team, reserves). The diagnostic ability of the different ball kicking speed tests in capturing differences between first team players and reserves among different age categories were computed using the receiver operating characteristics analysis. Results demonstrated that first team players achieved better results when comparing to reserves in each category. In addition, differences were greater in the U-15 and the U-17 than in the U-19 age group. In conclusion, ball kicking speed could be one of the possible identification tools to evaluate players' success in youth soccer.	[Rada, Ante; Kuvacic, Goran] Univ Split, Fac Kinesiol, Split, Croatia; [Kuvacic, Goran; De Giorgio, Andrea; Padulo, Johnny] Univ Split, Sport Performance Lab, Split, Croatia; [De Giorgio, Andrea; Padulo, Johnny] Univ eCampus, Dept Psychol, Novedrate, Italy; [Sellami, Maha] Qatar Univ, CAS, SSP, Doha, Qatar; [Ardigo, Luca Paolo] Univ Verona, Sch Exercise & Sport Sci, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Bragazzi, Nicola Luigi] Univ Genoa, Sch Publ Hlth, Dept Hlth Sci DISSAL, Genoa, Italy; [Padulo, Johnny] Natl Ctr Med & Sci Sport, Tunisian Res Lab Sports Performance Optimizat, Tunis, Tunisia	University of Split; University of Split; Universita Ecampus; Qatar University; University of Verona; University of Genoa; Centre National de la Medecine Sciences des Sports	Ardigo, LP (corresponding author), Univ Verona, Sch Exercise & Sport Sci, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	luca.ardigo@univr.it	Bragazzi, Nicola Luigi/G-1672-2011; Padulo, Johnny/AAK-2207-2020; Ardigò, Luca Paolo/H-8955-2019; Kuvačić, Goran/D-4903-2017; Rada, Ante/D-6382-2017	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Padulo, Johnny/0000-0002-4254-3105; Ardigò, Luca Paolo/0000-0001-7677-5070; Kuvačić, Goran/0000-0001-5302-7192; Rada, Ante/0000-0003-4216-6917; Sellami, Maha/0000-0003-1832-409X				Amiri-Khorasani M, 2011, J STRENGTH COND RES, V25, P1177, DOI 10.1519/JSC.0b013e3181d6508c; Arpinar-Avsar P, 2010, J SPORT SCI MED, V9, P382; Asai T., 2002, SPORTS ENG, V5, P183, DOI DOI 10.1046/J.1460-2687.2002.00108.X; Bacvarevic BB, 2012, J STRENGTH COND RES, V26, P1945, DOI 10.1519/JSC.0b013e318237e79d; Barfield WR, 1998, CLIN SPORT MED, V17, P711, DOI 10.1016/S0278-5919(05)70113-7; Bjelica D, 2013, MONTENEGRIN J SPORT, V2, P5; Bull-Andersen T., 1999, SPORTS ENG, V2, P121, DOI [10.1046/j.1460-2687.1999.00015.x, DOI 10.1046/J.1460-2687.1999.00015.X]; Chibane S, 2008, SCI FOOTBALL, P125; Chuman K, 2009, AGE, V7, P8; Cometti G, 2001, INT J SPORTS MED, V22, P45, DOI 10.1055/s-2001-11331; De Giorgio A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200689; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEWEY KG, 1995, PEDIATRICS, V96, P495; Figueiredo AJ, 2009, J SPORT SCI, V27, P883, DOI 10.1080/02640410902946469; Kellis E, 2007, J SPORT SCI MED, V6, P154; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; le Gall F, 2010, J SCI MED SPORT, V13, P90, DOI 10.1016/j.jsams.2008.07.004; Lees A, 1998, J SPORT SCI, V16, P211, DOI 10.1080/026404198366740; Lees A, 2010, J SPORT SCI, V28, P805, DOI 10.1080/02640414.2010.481305; Levanon J, 1998, MED SCI SPORT EXER, V30, P917, DOI 10.1097/00005768-199806000-00022; Malina RM, 2000, J SPORT SCI, V18, P685, DOI 10.1080/02640410050120069; Malina Robert, 2004, GROWTH MATURATION PH, DOI DOI 10.1016/j.jsams.2011.04.003; Malina RM, 2010, CLIN J SPORT MED, V20, P469, DOI [10.1097/JSM.0b013e3181f827ea, 10.1097/01.jsm.0000369404.77182.60]; Markovic G, 2006, J SPORT MED PHYS FIT, V46, P215; Marques MC, 2013, J HUM KINET, V39, P157, DOI 10.2478/hukin-2013-0078; McKinnon NB, 2017, AGEING RES REV, V35, P147, DOI 10.1016/j.arr.2016.09.003; MCLEAN BD, 1993, BRIT J SPORT MED, V27, P260, DOI 10.1136/bjsm.27.4.260; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Njororai S., 2013, J PHYS ED SPORT, V13, P6, DOI [DOI 10.7752/JPES.2013.01002, 10.7752/jpes.2013.01002]; Nunome H, 2006, J SPORT SCI, V24, P529, DOI 10.1080/02640410500298024; Nunome H, 2002, MED SCI SPORT EXER, V34, P2028, DOI 10.1097/00005768-200212000-00025; Rada A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201795; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Rodriguez-Lorenzo L, 2018, KINESIOL INT J FUNDA, V50, P80; Rodriguez-Lorenzo L, 2015, STRENGTH COND J, V37, P26, DOI 10.1519/SSC.0000000000000172; Severino V, 2011, ANN RES SPORT PHYS A, V1, P36; Shan GB, 2009, EUR J SPORT SCI, V9, P107, DOI 10.1080/17461390802594250; Sinclair J, 2014, J SPORT SCI, V32, P1914, DOI 10.1080/02640414.2014.965188; van den Tillaar R, 2014, J MOTOR BEHAV, V46, P287, DOI 10.1080/00222895.2014.898609; Wong DP, 2009, J STRENGTH COND RES, V23, P1383, DOI 10.1519/JSC.0b013e3181a4f074; 2014, J HUM KINET, V40, P149, DOI DOI 10.2478/HUKIN-2014-0017; 2002, J SPORTS SCI, V20, P293, DOI DOI 10.1080/026404102753576062; 2011, J SPORTS SCI MED, V10, P465; 2016, J SPORTS SCI, V34, P1466, DOI DOI 10.1080/02640414.2015.1119298; 2011, EUR J SPORT SCI, V11, P191, DOI DOI 10.1080/17461391.2010.500335; 2014, J STRENGTH COND RES, V28, P2452, DOI DOI 10.1519/JSC.0000000000000452	47	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217101	10.1371/journal.pone.0217101	http://dx.doi.org/10.1371/journal.pone.0217101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100091	Green Published, gold, Green Submitted			2022-12-27	WOS:000468176600028
J	Smirnov, I				Smirnov, Ivan			Schools are segregated by educational outcomes in the digital space	PLOS ONE			English	Article							SOCIAL NETWORKS; PEER INFLUENCE; FRIENDS	The Internet provides students with a unique opportunity to connect and maintain social ties with peers from other schools, irrespective of how far they are from each other. However, little is known about the real structure of such online relationships. In this paper, we investigate the structure of interschool friendship on a popular social networking site. We use data from 36, 951 students from 590 schools of a large European city. We find that the probability of a friendship tie between students from neighboring schools is high and that it decreases with the distance between schools following the power law. We also find that students are more likely to be connected if the educational outcomes of their schools are similar. We show that this fact is not a consequence of residential segregation. While high- and low-performing schools are evenly distributed across the city, this is not the case for the digital space, where schools turn out to be segregated by educational outcomes. There is no significant correlation between the educational outcomes of a school and its geographical neighbors; however, there is a strong correlation between the educational outcomes of a school and its digital neighbors. These results challenge the common assumption that the Internet is a borderless space, and may have important implications for the understanding of educational inequality in the digital age.	[Smirnov, Ivan] Natl Res Univ, Higher Sch Econ, Inst Educ, Moscow, Russia	HSE University (National Research University Higher School of Economics)	Smirnov, I (corresponding author), Natl Res Univ, Higher Sch Econ, Inst Educ, Moscow, Russia.	ibsmirnov@hse.ru	Smirnov, Ivan/K-5068-2015	Smirnov, Ivan/0000-0002-8347-6703	Basic Research Program of the National Research University Higher School of Economics	Basic Research Program of the National Research University Higher School of Economics	Support from the Basic Research Program of the National Research University Higher School of Economics is gratefully acknowledged.; Support from the Basic Research Program of the National Research University Higher School of Economics is gratefully acknowledged.	Allen R, 2007, OXFORD REV EDUC, V33, P643, DOI 10.1080/03054980701366306; Buchi M, 2016, NEW MEDIA SOC, V18, P2703, DOI 10.1177/1461444815604154; COHEN J, 1983, AM SOCIOL REV, V48, P728, DOI 10.2307/2094931; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DiMaggio P., 2004, SOCIAL INEQUALITY, P355; Flores CA, 2008, RESIDENTIAL SEGREGAT; Gordon I, 2003, URBAN SIZE SPATIAL S; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; Hobbs WR, 2016, P NATL ACAD SCI USA, V113, P12980, DOI 10.1073/pnas.1605554113; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Junco R, 2012, COMPUT HUM BEHAV, V28, P187, DOI 10.1016/j.chb.2011.08.026; Kasamara Valeria, 2017, RUSSIAN STUDENTS VAL; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Koroleva D, 2016, VOPR OBRAZOVANIYA-ED, P205, DOI 10.17323/1814-9545-2016-1-205-224; Lengyel B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137248; Lomi A, 2011, SOC SCI RES, V40, P1506, DOI 10.1016/j.ssresearch.2011.06.010; Manago AM, 2012, DEV PSYCHOL, V48, P369, DOI 10.1037/a0026338; Maxwell KA, 2002, J YOUTH ADOLESCENCE, V31, P267, DOI 10.1023/A:1015493316865; Ng TWH, 2005, PERS PSYCHOL, V58, P367, DOI 10.1111/j.1744-6570.2005.00515.x; Owens A, 2018, SOCIOL EDUC, V91, P1, DOI 10.1177/0038040717741180; Pearce KE, 2017, SOC MEDIA SOC, V3, DOI 10.1177/2056305117716272; Podolny JM, 1997, AM SOCIOL REV, V62, P673, DOI 10.2307/2657354; Public Opinion Foundation, 2016, ONL PRACT RUSS SOC N; Reardon SF, 2017, 1610 CEPA; Shin WY, 2015, J INF SCI, V41, P751, DOI 10.1177/0165551515600136; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Smirnov I, 2016, VOPR OBRAZOVANIYA-ED, P106, DOI 10.17323/1814-9545-2016-4-106-122; Smirnov I., 2018, P 12 INT AAAI C WEB, P360; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; van Deursen AJAM, 2014, NEW MEDIA SOC, V16, P507, DOI 10.1177/1461444813487959; Yasterbov G, 2014, CONTEXTUALIZING ACAD	31	1	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217142	10.1371/journal.pone.0217142	http://dx.doi.org/10.1371/journal.pone.0217142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136591	gold, Green Published, Green Submitted			2022-12-27	WOS:000469224300020
J	Gupte, AN; Paradkar, M; Selvaraju, S; Thiruvengadam, K; Shivakumar, VBY; Sekar, K; Marinaik, S; Momin, A; Gaikwad, A; Natrajan, P; Prithivi, M; Shivaramakrishnan, G; Pradhan, N; Kohli, R; Raskar, S; Jain, D; Velu, R; Karthavarayan, B; Lokhande, R; Suryavanshi, N; Gupte, N; Murali, L; Salvi, S; Checkley, W; Golub, J; Bollinger, R; Mave, V; Padmapriyadarasini, C; Gupta, A				Gupte, Akshay N.; Paradkar, Mandar; Selvaraju, Sriram; Thiruvengadam, Kannan; Shivakumar, Vijay Bala Yogendra; Sekar, Krithikaa; Marinaik, Srinivasa; Momin, Ayesha; Gaikwad, Archana; Natrajan, Premkumar; Prithivi, Munivardhan; Shivaramakrishnan, Gomathy; Pradhan, Neeta; Kohli, Rewa; Raskar, Swapnil; Jain, Divyashri; Velu, Rani; Karthavarayan, Bharath; Lokhande, Rahul; Suryavanshi, Nishi; Gupte, Nikhil; Murali, Lakshmi; Salvi, Sundeep; Checkley, William; Golub, Jonathan; Bollinger, Robert; Mave, Vidya; Padmapriyadarasini, Chandrasekaran; Gupta, Amita			Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; FUNCTION IMPAIRMENT; DIABETES-MELLITUS; REFERENCE VALUES; GLOBAL BURDEN; HEALTH-STATUS; PREVALENCE; SPIROMETRY; MORTALITY	Background Burden, phenotype and risk-factors of lung function defects in successfully treated tuberculosis cases are unclear. Methods We performed spirometry with bronchodilators in new drug-sensitive adult (>= 18 years) pulmonary tuberculosis cases during the 12 months following successful treatment in India. Airflow obstruction was defined as pre-bronchodilator FEV1/FVC<5th percentile of Global Lung Initiative mixed-ethnicity reference (lower limit of normal [LLN]). Chronic obstructive pulmonary disease (COPD) was defined as post-bronchodilator FEV1/FVC<LLN among participants with obstruction. Restrictive spirometry pattern was defined as FVC<LLN among participants without obstruction. Multivariable logistic and linear regression was used to identify risk-factors for obstruction, restriction and low lung function despite successful treatment. Results Of the 172 participants included in the analysis, 82 (48%) were female, 22 (13%) had diabetes and 34 (20%) ever-smoked with a median (IQR) exposure of 3.5 (0.2-9.9) pack-years. Median (IQR) age and body-mass index (BMI) at enrollment was 32 (23-39) years and 18.1 (16.0-20.5) kg/m(2) respectively. Airflow obstruction was detected in 42 (24%) participants; of whom 9 (21%) responded to short-acting bronchodilators and 25 (56%) had COPD; and was associated with duration of illness prior to treatment (aOR = 1.32 per 30-days, 95% CI 1.04-1.68, p = 0.02). A restrictive spirometry pattern was detected in 89 (52%) participants and was associated with female sex (aOR = 3.73, 95% CI 1.51-9.17, p = 0.004) and diabetes (aOR = 4.06, 95% CI 1.14-14.42, p = 0.03). Higher HbA1c at treatment initiation was associated with greater odds of a restrictive spirometry pattern (aOR = 1.29 per unit higher HbA1c, 95% CI 1.04 to 1.60, p = 0.02). Conclusion We found a high burden of lung function defects and COPD in tuberculosis cases who successfully completed treatment. Screening for chronic lung diseases following treatment and linkage to respiratory health clinics should be included in the routine management plan of all tuberculosis cases in India, regardless of conventional COPD risk-factors such as older age and smoking.	[Gupte, Akshay N.; Suryavanshi, Nishi; Gupte, Nikhil; Checkley, William; Golub, Jonathan; Bollinger, Robert; Mave, Vidya; Gupta, Amita] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Paradkar, Mandar; Momin, Ayesha; Gaikwad, Archana; Pradhan, Neeta; Kohli, Rewa; Raskar, Swapnil; Jain, Divyashri] Byramjee Jeejeebhoy Govt Med Coll Johns Hopkins U, Pune, Maharashtra, India; [Selvaraju, Sriram; Thiruvengadam, Kannan; Sekar, Krithikaa; Marinaik, Srinivasa; Natrajan, Premkumar; Prithivi, Munivardhan; Shivaramakrishnan, Gomathy; Velu, Rani; Karthavarayan, Bharath; Murali, Lakshmi; Padmapriyadarasini, Chandrasekaran] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Shivakumar, Vijay Bala Yogendra] Johns Hopkins Univ India Off, Pune, Maharashtra, India; [Lokhande, Rahul] Byramjee Jeejeebhoy Govt Med Coll & Sassoon Gen H, Pune, Maharashtra, India; [Salvi, Sundeep] Chest Res Fdn, Pune, Maharashtra, India	Johns Hopkins University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); B.J. Govt. Medical College & Sassoon General Hospitals, Pune	Gupte, AN (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	agupte1@jhmi.edu	Thiruvengadam, Kannan/AAQ-8532-2021; Pradhan, Neeta/ABE-5539-2021; Kohli, Rewa/AAD-6052-2021; Paradkar, Mandar/ABF-6776-2020	Thiruvengadam, Kannan/0000-0002-3758-1094; Paradkar, Mandar/0000-0001-9843-4656; Checkley, William/0000-0003-1106-8812; Bollinger, Robert/0000-0002-6798-6834; , Rewa/0000-0001-7208-1282; Gupta, Amita/0000-0001-7036-2718	Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); United States National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR); CRDF Global; NIAID of the NIH [R01AI097494, UM1AI069465]; Wyncote Foundation; Gilead Foundation; Ujala Foundation; Newton Square PA, USA; NIH Research Training Grant - NIH Fogarty International Center, NINDS [D43 TW009340]; NIMH; NHBLI; NIEHS; Fogarty International Center, NIH [D43TW009574]; FOGARTY INTERNATIONAL CENTER [D43TW009340, D43TW009574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069465, R01AI097494] Funding Source: NIH RePORTER	Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR); CRDF Global; NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wyncote Foundation; Gilead Foundation(Gilead Sciences); Ujala Foundation; Newton Square PA, USA; NIH Research Training Grant - NIH Fogarty International Center, NINDS; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHBLI; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript were collected as part of the Regional Prospective Observational Research for Tuberculosis (RePORT) India Consortium. This project has been funded in whole or in part with Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the United States National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR), and distributed in part by CRDF Global. Research reported in this publication was also supported by NIAID of the NIH under award number R01AI097494 and UM1AI069465, the Wyncote Foundation, the Gilead Foundation and the Ujala Foundation, Newton Square PA, USA. ANG was supported by NIH Research Training Grant # D43 TW009340 funded by the NIH Fogarty International Center, NINDS, NIMH, NHBLI and NIEHS. RL was supported by the BJGMC JHU HIV TB Program funded by the Fogarty International Center, NIH (D43TW009574). The funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the DBT, the ICMR, the NIH, or CRDF Global. Any mention of trade names, commercial projects, or organizations does not imply endorsement by any of the sponsoring organizations. The authors also acknowledge support from Persistent Systems in kind.	Akkara SA, 2013, INT J TUBERC LUNG D, V17, P810, DOI 10.5588/ijtld.12.0317; Allwood BW, 2017, SAMJ S AFR MED J, V107, P440, DOI [10.7196/samj.2017.v107i5.12118, 10.7196/SAMJ.2017.v107i5.12118]; Amaral AFS, 2015, EUR RESPIR J, V46, P1104, DOI 10.1183/13993003.02325-2014; Banu Rekha V V, 2009, Indian J Tuberc, V56, P132; Bua J, 2005, INT J OBESITY, V29, P1055, DOI 10.1038/sj.ijo.0802998; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chin AT, 2019, INT J TUBERC LUNG D, V23, P203, DOI 10.5588/ijtld.18.0313; Christensen ASH, 2014, CLIN EPIDEMIOL, V6, P405, DOI 10.2147/CLEP.S65331; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Collaborators IS-LDBIC, 2018, LANCET GLOB HLTH; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Fiogbe AA, 2019, INT J TUBERC LUNG D, V23, P195, DOI 10.5588/ijtld.18.0234; Godfrey MS, 2016, CHEST, V149, P238, DOI 10.1378/chest.15-1045; Hanania NA, 2011, CHEST, V140, P1055, DOI 10.1378/chest.10-2974; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Hickson DA, 2011, LUNG, V189, P311, DOI 10.1007/s00408-011-9296-1; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Hooper R, 2012, EUR RESPIR J, V39, P1343, DOI 10.1183/09031936.00002711; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jindal S K, 2006, Indian J Chest Dis Allied Sci, V48, P23; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Jung JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141230; Kadam D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010542; Kinney GL, 2014, DIABETES CARE, V37, P389, DOI 10.2337/dc13-1435; Klein OL, 2011, RESP MED, V105, P1095, DOI 10.1016/j.rmed.2011.03.010; Ko Y, 2015, INT J TUBERC LUNG D, V19, P589, DOI 10.5588/ijtld.14.0454; Kodgule RR, 2014, J POSTGRAD MED, V60, P123, DOI 10.4103/0022-3859.132311; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miller TL, 2015, AM J PUBLIC HEALTH, V105, P930, DOI 10.2105/AJPH.2014.302431; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; Ngahane BHM, 2016, RESP MED, V114, P67, DOI 10.1016/j.rmed.2016.03.007; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2012, EUR RESPIR J, V40, P190, DOI 10.1183/09031936.00161011; Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sehgal M, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25326; Shuldiner J, 2016, INT J TUBERC LUNG D, V20, P43, DOI 10.5588/ijtld.14.0427; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thyagarajan B, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-31; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2019, WORLD HLTH STAT MON	63	21	23	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217289	10.1371/journal.pone.0217289	http://dx.doi.org/10.1371/journal.pone.0217289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120971	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000468775700081
J	Vilander, LM; Vaara, ST; Donner, KM; Lakkisto, P; Kaunisto, MA; Pettila, V; Laru-Sompa, R; Pulkkinen, A; Saarelainen, M; Reilama, M; Tolmunen, S; Rantalainen, U; Miettinen, M; Suvela, M; Pesola, K; Saastamoinen, P; Kauppinen, S; Kaukonen, KM; Korhonen, AM; Nisula, S; Vaara, S; Suojaranta-Ylinen, R; Mildh, L; Haapio, M; Nurminen, L; Sutinen, S; Pettila, L; Laitinen, H; Syrja, H; Henttonen, K; Lappi, E; Boman, H; Varpula, T; Porkka, P; Sivula, M; Rahkonen, M; Tsurkka, A; Nieminen, T; Prittinen, N; Alaspaa, A; Salanto, V; Juntunen, H; Sanisalo, T; Parviainen, I; Uusaro, A; Ruokonen, E; Bendel, S; Rissanen, N; Lang, M; Rahikainen, S; Rissanen, S; Ahonen, M; Halonen, E; Vaskelainen, E; Poukkanen, M; Lintula, E; Suominen, S; Heikkinen, J; Lavander, T; Heinonen, K; Juopperi, AM; Kaminski, T; Gaddnas, F; Kuusela, T; Roiko, J; Karlsson, S; Reinikainen, M; Surakka, T; Jyrkonen, H; Eiserbeck, T; Kallinen, J; Lund, V; Tuominen, P; Perkola, P; Tuominen, R; Hietaranta, M; Johansson, S; Hovilehto, S; Kirsi, A; Tiainen, P; Myllarinen, T; Leino, P; Toropainen, A; Kuitunen, A; Leppanen, I; Levoranta, M; Hoppu, S; Sauranen, J; Tenhunen, J; Kukkurainen, A; Kortelainen, S; Varila, S; Inkinen, O; Koivuviita, N; Kotamaki, J; Laine, A; Ala-Kokko, T; Laurila, J; Salkio, S; Koivisto, SP; Hautamaki, R; Skinnar, M				Vilander, Laura M.; Vaara, Suvi T.; Donner, Kati M.; Lakkisto, Paivi; Kaunisto, Mari A.; Pettila, Ville; Laru-Sompa, Raili; Pulkkinen, Anni; Saarelainen, Minna; Reilama, Mikko; Tolmunen, Sinikka; Rantalainen, Ulla; Miettinen, Marja; Suvela, Markku; Pesola, Katrine; Saastamoinen, Pekka; Kauppinen, Sirpa; Kaukonen, Kirsi-Maija; Korhonen, Anna-Maija; Nisula, Sara; Vaara, Suvi; Suojaranta-Ylinen, Raili; Mildh, Leena; Haapio, Mikko; Nurminen, Laura; Sutinen, Sari; Pettila, Leena; Laitinen, Helina; Syrja, Heidi; Henttonen, Kirsi; Lappi, Elina; Boman, Hillevi; Varpula, Tero; Porkka, Paivi; Sivula, Mirka; Rahkonen, Mira; Tsurkka, Anne; Nieminen, Taina; Prittinen, Niina; Alaspaa, Ari; Salanto, Ville; Juntunen, Hanna; Sanisalo, Teija; Parviainen, Ilkka; Uusaro, Ari; Ruokonen, Esko; Bendel, Stepani; Rissanen, Niina; Lang, Maarit; Rahikainen, Sari; Rissanen, Saija; Ahonen, Merja; Halonen, Elina; Vaskelainen, Eija; Poukkanen, Meri; Lintula, Esa; Suominen, Sirpa; Heikkinen, Jorma; Lavander, Timo; Heinonen, Kirsi; Juopperi, Anne-Mari; Kaminski, Tadeusz; Gaddnas, Fiia; Kuusela, Tuija; Roiko, Jane; Karlsson, Sari; Reinikainen, Matti; Surakka, Tero; Jyrkonen, Helena; Eiserbeck, Tanja; Kallinen, Jaana; Lund, Vesa; Tuominen, Paivi; Perkola, Pauliina; Tuominen, Riikka; Hietaranta, Marika; Johansson, Satu; Hovilehto, Seppo; Kirsi, Anne; Tiainen, Pekka; Myllarinen, Tuija; Leino, Pirjo; Toropainen, Anne; Kuitunen, Anne; Leppanen, Ilona; Levoranta, Markus; Hoppu, Sanna; Sauranen, Jukka; Tenhunen, Jyrki; Kukkurainen, Atte; Kortelainen, Samuli; Varila, Simo; Inkinen, Outi; Koivuviita, Niina; Kotamaki, Jutta; Laine, Anu; Ala-Kokko, Tero; Laurila, Jouko; Salkio, Sinikka; Koivisto, Simo-Pekka; Hautamaki, Raku; Skinnar, Maria		FINNAKI Study Grp	Heme oxygenase-1 repeat polymorphism in septic acute kidney injury	PLOS ONE			English	Article							GENE PROMOTER; MICROSATELLITE POLYMORPHISM; PLASMA; RISK; HEME-OXYGENASE-1; SUSCEPTIBILITY; INFLAMMATION; ASSOCIATION; FERRITIN; LINKAGE	Acute kidney injury (AKI) is a syndrome that frequently affects the critically ill. Recently, an increased number of dinucleotide repeats in the HMOX1 gene were reported to associate with development of AKI in cardiac surgery. We aimed to test the replicability of this finding in a Finnish cohort of critically ill septic patients. This multicenter study was part of the national FINNAKI study. We genotyped 300 patients with severe AKI (KDIGO 2 or 3) and 353 controls without AKI (KDIGO 0) for the guanine-thymine (GTn) repeat in the promoter region of the HMOX1 gene. The allele calling was based on the number of repeats, the cut off being 27 repeats in the S-L (short to long) classification, and 27 and 34 repeats for the S-M-L2 (short to medium to very long) classification. The plasma concentrations of heme oxygenase-1 (HO-1) enzyme were measured on admission. The allele distribution in our patients was similar to that published previously, with peaks at 23 and 30 repeats. The S-allele increases AKI risk. An adjusted OR was 1.30 for each S-allele in an additive genetic model (95% CI 1.01-1.66; p = 0.041). Alleles with a repeat number greater than 34 were significantly associated with lower HO-1 concentration (p<0.001). In septic patients, we report an association between a short repeat in HMOX1 and AKI risk.	[Vilander, Laura M.; Vaara, Suvi T.; Pettila, Ville] Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland; [Vilander, Laura M.; Vaara, Suvi T.; Lakkisto, Paivi; Pettila, Ville] Helsinki Univ Hosp, Helsinki, Finland; [Donner, Kati M.; Kaunisto, Mari A.] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Lakkisto, Paivi] Univ Helsinki, Dept Clin Chem, Helsinki, Finland; [Lakkisto, Paivi] Minerva Fdn, Helsinki, Finland; [Laru-Sompa, Raili; Pulkkinen, Anni; Saarelainen, Minna; Reilama, Mikko; Tolmunen, Sinikka; Rantalainen, Ulla; Miettinen, Marja] Cent Finland Cent Hosp, Jyvaskyla, Finland; [Suvela, Markku; Pesola, Katrine; Saastamoinen, Pekka; Kauppinen, Sirpa] East Savo Cent Hosp, Savonlinna, Finland; [Pettila, Ville; Kaukonen, Kirsi-Maija; Korhonen, Anna-Maija; Nisula, Sara; Vaara, Suvi; Suojaranta-Ylinen, Raili; Mildh, Leena; Haapio, Mikko; Nurminen, Laura; Sutinen, Sari; Pettila, Leena; Laitinen, Helina; Syrja, Heidi; Henttonen, Kirsi; Lappi, Elina; Boman, Hillevi] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Varpula, Tero; Porkka, Paivi; Sivula, Mirka; Rahkonen, Mira; Tsurkka, Anne; Nieminen, Taina; Prittinen, Niina] Jorvi Cent Hosp, Espoo, Finland; [Alaspaa, Ari; Salanto, Ville; Juntunen, Hanna; Sanisalo, Teija] KantaHame Cent Hosp, Hameenlinna, Finland; [Parviainen, Ilkka; Uusaro, Ari; Ruokonen, Esko; Bendel, Stepani; Rissanen, Niina; Lang, Maarit; Rahikainen, Sari; Rissanen, Saija; Ahonen, Merja; Halonen, Elina; Vaskelainen, Eija] Kuopio Univ Hosp, Kuopio, Finland; [Poukkanen, Meri; Lintula, Esa; Suominen, Sirpa] Lapland Cent Hosp, Rovaniemi, Finland; [Heikkinen, Jorma; Lavander, Timo; Heinonen, Kirsi; Juopperi, Anne-Mari] Lansi Pohja Cent Hosp, Kemi, Finland; [Kaminski, Tadeusz; Gaddnas, Fiia; Kuusela, Tuija; Roiko, Jane] Middle Ostrobothnia Cent Hosp, Soite, Finland; [Karlsson, Sari; Reinikainen, Matti; Surakka, Tero; Jyrkonen, Helena; Eiserbeck, Tanja; Kallinen, Jaana] North Karelia Cent Hosp, Joensuu, Finland; [Lund, Vesa; Tuominen, Paivi; Perkola, Pauliina; Tuominen, Riikka; Hietaranta, Marika; Johansson, Satu] Satakunta Hosp Dist, Pori, Finland; [Hovilehto, Seppo; Kirsi, Anne; Tiainen, Pekka; Myllarinen, Tuija; Leino, Pirjo; Toropainen, Anne] South Karelia Cent Hosp, Lappeenranta, Finland; [Kuitunen, Anne; Leppanen, Ilona; Levoranta, Markus; Hoppu, Sanna; Sauranen, Jukka; Tenhunen, Jyrki; Kukkurainen, Atte; Kortelainen, Samuli; Varila, Simo] Tampere Univ Hosp, Tampere, Finland; [Inkinen, Outi; Koivuviita, Niina; Kotamaki, Jutta; Laine, Anu] Turku Univ Hosp, Turku, Finland; [Ala-Kokko, Tero; Laurila, Jouko; Salkio, Sinikka] Oulu Univ Hosp, Oulu, Finland; [Koivisto, Simo-Pekka; Hautamaki, Raku; Skinnar, Maria] Vaasa Cent Hosp, Vaasa, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Central Finland Central Hospital; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital; University of Turku; University of Oulu; Vaasa Central Hospital	Vilander, LM (corresponding author), Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland.; Vilander, LM (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	laura.vilander@helsinki.fi; ville.pettila@hus.fi		Kaunisto, Mari/0000-0002-6946-9195; Lakkisto, Paivi/0000-0001-9935-6573	Munuaissaatio fund; Finnish Society of Anaesthesiologists [TYH 2013343, 2016243, 2017241, Y102011091]; Helsinki University Hospital; Sigrid Juselius Foundation	Munuaissaatio fund; Finnish Society of Anaesthesiologists; Helsinki University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study received grants from Munuaissaatio fund (https://www.muma.fi/liitto/munuaissaatio)(LV), and The Finnish Society of Anaesthesiologists (https://www.say.fi/fi/)(LV).In addition, funding by grants TYH 2013343, 2016243, 2017241, and Y102011091 from the Helsinki University Hospital research funding (http://www.hus.fi/en/researchers/Pages/default.aspx)(VP), and a grant from the Sigrid Juselius Foundation (https://sigridjuselius.fi/en/)(VP) were received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews M, 2016, J TRACE ELEM MED BIO, V37, P25, DOI 10.1016/j.jtemb.2016.06.001; Bolisetty S, 2017, AM J KIDNEY DIS, V69, P531, DOI 10.1053/j.ajkd.2016.10.037; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Chen YH, 2014, J AM SOC NEPHROL, V25, P2669, DOI 10.1681/ASN.2013111205; Costa DL, 2016, MBIO, V7, DOI 10.1128/mBio.01675-16; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fujioka K, 2018, PEDIATR RES, V84, P139, DOI 10.1038/s41390-018-0028-6; Kellum JA, 2017, AM J RESP CRIT CARE, V195, P784, DOI 10.1164/rccm.201604-0799OC; Leaf DE, 2015, KIDNEY INT, V87, P1046, DOI 10.1038/ki.2014.374; Leaf DE, 2016, J AM SOC NEPHROL; Lever JM, 2016, ANTIOXID REDOX SIGN, V25, P165, DOI 10.1089/ars.2016.6659; Melley DD, 2007, CRIT CARE MED, V35, P1882, DOI 10.1097/01.CCM.0000275268.94404.43; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2001, KIDNEY INT, V59, P106, DOI 10.1046/j.1523-1755.2001.00471.x; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2014, CURR OPIN NEPHROL HY, V23, P17, DOI 10.1097/01.mnh.0000437613.88158.d3; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Siren J, 2016, SHOCK, V45, P320, DOI 10.1097/SHK.0000000000000521; Sponholz C, 2012, SHOCK, V38, P459, DOI 10.1097/SHK.0b013e31826ae951; Turpeinen H, 2007, INT J IMMUNOGENET, V34, P253, DOI 10.1111/j.1744-313X.2007.00688.x; Vazquez-Armenta G, 2013, TOHOKU J EXP MED, V231, P201, DOI 10.1620/tjem.231.201; Waza AA, 2018, INFLAMM RES, V67, P579, DOI 10.1007/s00011-018-1151-x; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zarjou A, 2013, J CLIN INVEST, V123, P4423, DOI 10.1172/JCI67867	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217291	10.1371/journal.pone.0217291	http://dx.doi.org/10.1371/journal.pone.0217291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120979	Green Submitted, Green Published, gold			2022-12-27	WOS:000468775700082
J	Garapaty, A; Champion, JA				Garapaty, Anusha; Champion, Julie A.			Shape of ligand immobilized particles dominates and amplifies the macrophage cytokine response to ligands	PLOS ONE			English	Article							SILICA NANOPARTICLES; GOLD NANOPARTICLES; PROTEIN ADSORPTION; CELLULAR UPTAKE; SIZE; PHAGOCYTOSIS; ACTIVATION; RECEPTOR; TOPOGRAPHY; STABILITY	Macrophages aid in clearing synthetic particulates introduced into the body and bridge innate and adaptive immunity through orchestrated secretion of cytokines and chemokines. While the field has made tremendous progress in understanding the effect of particle physicochemical properties on particle-macrophage interactions, it is not known how macrophage functions like cytokine production are affected while presenting active ligands on particles with altered physical properties. Moreover, it is unknown if ligand presentation through an altered particle shape can elicit differential macrophage cytokine responses and if responses are ligand dependent. Therefore, we investigated the influence of geometric particle presentation of diverse ligands, bovine serum albumin, immunoglobulin-G and ovalbumin, on macrophage inflammatory cytokine response. Our results indicate that for similar ligand densities, ligand presentation on rods enhanced production of inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) compared to spheres regardless of the nature of the ligand and its cellular receptor. Surprisingly, TNF-alpha responses were affected by ligand density in a shape-dependent manner and did not correlate to total particle-macrophage association. This study demonstrates the ability of geometric manipulation of particle ligands to alter macrophage cytokine response irrespective of the nature of the ligand.	[Garapaty, Anusha; Champion, Julie A.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Champion, JA (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	julie.champion@chbe.gatech.edu						Alexander JF, 2015, ADV HEALTHC MATER, V4, P2657, DOI 10.1002/adhm.201500537; [Anonymous], 2018, F190318 ASTM INT; Autenrieth SE, 2009, IMMUNOLOGY, V127, P523, DOI 10.1111/j.1365-2567.2008.02960.x; Chakraborty S, 2011, LANGMUIR, V27, P7722, DOI 10.1021/la200787t; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2009, PHARM RES, V26; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104; Chang TZ, 2017, BIOMATER SCI-UK, V5, P223, DOI 10.1039/c6bm00500d; Chen X, 2016, BIOMACROMOLECULES, V17, P1205, DOI 10.1021/acs.biomac.6b00027; Chittasupho C, 2011, ACS NANO, V5, P1693, DOI 10.1021/nn102159g; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Doshi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010051; Fleischer CC, 2014, J PHYS CHEM B, V118, P14017, DOI 10.1021/jp502624n; Garapaty A, 2016, BIOENG TRANSL MED; Garapaty A, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922798; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A; Huang Z, 2012, J BIOL CHEM, V287, P4492, DOI 10.1074/jbc.M111.315598; Hutter E, 2010, ACS NANO, V4, P2595, DOI 10.1021/nn901869f; Janeway C.J., 2001, PRINCIPLES INNATE AD; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; Kumar S, 2015, J CONTROL RELEASE, V220, P141, DOI 10.1016/j.jconrel.2015.09.069; Li Z, 2016, ACS MACRO LETT, V5, P1059, DOI 10.1021/acsmacrolett.6b00419; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Mortimer GM, 2014, ACS NANO, P8; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Niikura K, 2013, ACS NANO, V7, P3926, DOI 10.1021/nn3057005; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Pacheco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060989; Pacheco PM, 2014, FC COATED MICRO NANO; Qie Y, 2016, SCI REP, V6; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Ramezani F, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2512-1; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roberts RA, 2015, BIOMATERIALS, V72, P1, DOI 10.1016/j.biomaterials.2015.08.040; Shang W, 2009, SMALL, V5, P470, DOI 10.1002/smll.200800995; Sobota A, 2015, J IMMUNOL, V175; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Stepanenko OV, 2013, INT REV CEL MOL BIO, V302, P221, DOI 10.1016/B978-0-12-407699-0.00004-2; Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050; Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200; Wurster EC, 2015, ACS APPL MATER INTER, V7, P7891, DOI 10.1021/am508435j; Yan Y, 2013, ACS NANO, V7, P10960, DOI 10.1021/nn404481f; Yoo JW, 2010, MACROMOL RAPID COMM, V31, P142, DOI 10.1002/marc.200900592; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P19332, DOI 10.1073/pnas.1008248107; 2005, J IMMUNOL, V175, P469; 2004, LETT APPL MICROBIOL, V38, P135, DOI DOI 10.1111/J.1472-765X.2003.01460.X; 2009, ANNU REV IMMUNOL, V27, P693, DOI DOI 10.1146/ANNUREV.IMMUNOL.021908.132641	51	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2019	14	5							e0217022	10.1371/journal.pone.0217022	http://dx.doi.org/10.1371/journal.pone.0217022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY5OE	31100081	Green Submitted, Green Published, gold			2022-12-27	WOS:000468176600025
J	Vigneshwari, A; Rakk, D; Nemeth, A; Kocsube, S; Kiss, N; Csupor, D; Papp, T; Skrbic, B; Vagvolgyi, C; Szekeres, A				Vigneshwari, Aruna; Rakk, David; Nemeth, Aniko; Kocsube, Sandor; Kiss, Noemi; Csupor, Dezso; Papp, Tamas; Skrbic, Biljana; Vagvolgyi, Csaba; Szekeres, Andras			Host metabolite producing endophytic fungi isolated from Hypericum perforatum	PLOS ONE			English	Article							ST-JOHNS-WORT; SECONDARY METABOLITES; ALTERNARIA-ALTERNATA; TAXOL PRODUCTION; IDENTIFICATION; EMODIN; PSEUDOHYPERICIN; PLANTS	In the present study, endophytic fungi have been isolated from various parts of the medicinal herb Hypericum perforatum (St. John's Wort), which is known as a source of medically important metabolites. The isolated strains were cultured in liquid media and their ability to synthesize hypericin, the secondary metabolite of the host and its suspected precursor, emodin was tested analyzing the extracts of the fermentation broth and the mycelia. The HPLC-UV analysis of the chloroform/methanol extracts of the mycelia revealed that three isolates were able to produce emodin (SZMC 23771, 19.9 ng/mg; SZMC 23772, 20.8 ng/mg; SZMC 23769, 427.9 ng/mg) and one of them also could synthesize hypericin (SZMC 23769, 320.4 ng/mg). These results were also confirmed via UHPLC-HRMS technique both in full scan and MS/MS mode. The strains producing only emodin belong to the section Alternata of the genus Alternaria, while the isolate producing both metabolites was identified as Epicoccum nigrum. The mycelial extracts of E. nigrum and the Alternaria sp. SZMC 23772 showed higher inhibitory activities in the antimicrobial tests against the six selected bacteria compared to the hypericin and emodin standards in the applied concentration (100 mu g/mL), while in case of the Alternaria sp. SZMC 23771 lower inhibition activities were observed on Staphylococcus aureus and Streptomyces albus than the pure compounds.	[Vigneshwari, Aruna; Rakk, David; Kocsube, Sandor; Kiss, Noemi; Papp, Tamas; Vagvolgyi, Csaba; Szekeres, Andras] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary; [Vigneshwari, Aruna] Univ Szeged, Doctoral Sch Biol, Fac Sci & Informat, Szeged, Hungary; [Nemeth, Aniko] Univ Szeged, Bot Garden, Szeged, Hungary; [Csupor, Dezso] Univ Szeged, Dept Pharmacognosy, Fac Pharm, Szeged, Hungary; [Papp, Tamas] Univ Szeged, Hungarian Acad Sci, MTA SZTE Fungal Pathogen Mech Res Grp, Szeged, Hungary; [Skrbic, Biljana] Univ Novi Sad, Fac Technol, Novi Sad, Serbia; [Vagvolgyi, Csaba; Szekeres, Andras] Univ Szeged, Interdisciplinary Ctr Nat Prod, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University; Hungarian Academy of Sciences; Szeged University; University of Novi Sad; Szeged University	Szekeres, A (corresponding author), Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary.; Szekeres, A (corresponding author), Univ Szeged, Interdisciplinary Ctr Nat Prod, Szeged, Hungary.	andras.j.szekeres@gmail.com	Csupor, Dezső/ABE-1830-2021; Vagvolgyi, Csaba/L-8497-2018; Skrbic, Biljana/ABE-9412-2020; Skrbic, Biljana/T-1660-2019; Szekeres, Andras/I-8956-2012	Csupor, Dezső/0000-0002-4088-3333; Vagvolgyi, Csaba/0000-0003-0009-7773; Skrbic, Biljana/0000-0002-8615-8989; RAMASAMY, ARUNA VIGNESHWARI/0000-0002-8131-1518; Szekeres, Andras/0000-0003-1651-4623; Papp, Tamas/0000-0001-8211-5431; Kocsube, Sandor/0000-0001-7839-0510	Hungarian Government; European Union [GINOP-2.3.2-15-2016-00012]; Szechenyi 2020 Programme [GINOP-2.3.3-15-2016-00006]; National Research, Development and Innovation Fund of Hungary [TET_16-1-2016-0148]; Hungarian Academy of Sciences [LP2016-8/2016];  [PD 116609]	Hungarian Government; European Union(European Commission); Szechenyi 2020 Programme; National Research, Development and Innovation Fund of Hungary; Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This work was supported by the Hungarian Government and the European Union within the frames of the Szechenyi 2020 Programme through grant GINOP-2.3.2-15-2016-00012. The infrastructural background was established with the support of GINOP-2.3.3-15-2016-00006 grant (Szechenyi 2020 Programme). The research was carried out with the contribution of the project TET_16-1-2016-0148 (National Research, Development and Innovation Fund of Hungary). TP was supported by the LP2016-8/2016 project of the Hungarian Academy of Sciences and SK was supported by the PD 116609 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapouda A, 2019, J PHARM PHARMACOL, V71, P15, DOI 10.1111/jphp.12711; AGOSTI G, 1962, BIOCHEM J, V85, P528, DOI 10.1042/bj0850528; Agostinis P, 2002, INT J BIOCHEM CELL B, V34, P221, DOI 10.1016/S1357-2725(01)00126-1; Andrew M, 2009, MYCOLOGIA, V101, P95, DOI 10.3852/08-135; Armitage AD, 2015, FUNGAL BIOL-UK, V119, P994, DOI 10.1016/j.funbio.2015.06.012; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Ayan AK, 2008, PHARM BIOL, V46, P288, DOI 10.1080/13880200701741211; BAMFORD PHILIP C., 1961, TRANS BRIT MYCOL SOC, V44, P354; BAUTE MA, 1978, J ANTIBIOT, V31, P1099, DOI 10.7164/antibiotics.31.1099; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Butterweck V, 2003, CNS DRUGS, V17, P539, DOI 10.2165/00023210-200317080-00001; Chen Q, 2017, STUD MYCOL, P105, DOI 10.1016/j.simyco.2017.06.002; Crockett Sara L, 2011, Med Aromat Plant Sci Biotechnol, V5, P1; Cui YN, 2012, FITOTERAPIA, V83, P913, DOI 10.1016/j.fitote.2012.04.009; Devari S, 2014, PHYTOCHEMISTRY, V98, P183, DOI 10.1016/j.phytochem.2013.12.001; Dewick P.M., 2009, MED NATURAL PRODUCTS; Dong XX, 2016, PHYTOTHER RES, V30, P1207, DOI 10.1002/ptr.5631; Fatima N, 2016, ACTA POL PHARM, V73, P13; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garnica S, 2003, MYCOL RES, V107, P1143, DOI 10.1017/S0953756203008414; Garyali S, 2013, J MICROBIOL BIOTECHN, V23, P1372, DOI 10.4014/jmb.1305.05070; Holscher D, 2009, PLANT J, V60, P907, DOI 10.1111/j.1365-313X.2009.04012.x; Huang LF, 2014, CHIN J NAT MEDICINES, V12, P81, DOI 10.1016/S1875-5364(14)60014-5; IKAWA M, 1978, J ANTIBIOT, V31, P159, DOI 10.7164/antibiotics.31.159; Karioti A, 2010, INT J MOL SCI, V11, P562, DOI 10.3390/ijms11020562; Kaul S, 2008, ANN MICROBIOL, V58, P443, DOI 10.1007/BF03175541; Kaul S, 2013, 3 BIOTECH, V3, P335, DOI 10.1007/s13205-012-0106-0; Kaul S, 2012, PHYTOCHEM REV, V11, P487, DOI 10.1007/s11101-012-9260-6; Kharwar RN, 2011, NAT PROD REP, V28, P1208, DOI 10.1039/c1np00008j; Kitanov GM, 2001, BIOCHEM SYST ECOL, V29, P171, DOI 10.1016/S0305-1978(00)00032-6; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kusari P, 2015, APPL MICROBIOL BIOT, V99, P5383, DOI 10.1007/s00253-015-6660-8; Kusari S, 2009, J APPL MICROBIOL, V107, P1019, DOI 10.1111/j.1365-2672.2009.04285.x; Kusari S, 2008, J NAT PROD, V71, P159, DOI 10.1021/np070669k; Kusari S, 2015, ANAL BIOANAL CHEM, V407, P4779, DOI 10.1007/s00216-015-8682-6; Lawrence DP, 2016, MYCOL PROG, V15, DOI 10.1007/s11557-015-1144-x; Lawrence DP, 2013, MYCOLOGIA, V105, P530, DOI 10.3852/12-249; Li MJ, 2014, MYCOBIOLOGY, V42, P412, DOI 10.5941/MYCO.2014.42.4.412; Li WK, 2001, J CHROMATOGR B, V765, P99, DOI 10.1016/S0378-4347(01)00404-2; Lu P, 2010, AFR J BIOTECHNOL, V9, P512; Martonfi P, 2006, BIOLOGIA, V61, P473, DOI 10.2478/s11756-006-0079-8; Mims CW, 2005, CAN J BOT, V83, P1354, DOI 10.1139/b05-137; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; Silva BA, 2005, FOOD CHEM, V90, P157, DOI 10.1016/j.foodchem.2004.03.049; Singh U. P., 1992, Fitopatologia Brasileira, V17, P420; Somjaipeng S, 2015, FUNGAL BIOL-UK, V119, P1022, DOI 10.1016/j.funbio.2015.07.007; Sotak M, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2010.01039, 10.3389/fpls.2016.01039]; Southwell IA, 2001, PHYTOCHEMISTRY, V56, P437, DOI 10.1016/S0031-9422(00)00411-8; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thunig J, 2011, ANAL CHEM, V83, P3256, DOI 10.1021/ac2004967; Wayne P.A., 2015, METHODS DILUTION ANT, DOI 10.1109/bsn.2015.7299391; WELLS JM, 1975, APPL MICROBIOL, V30, P26, DOI 10.1106/0U8J-DK8P-MUER-FCKG; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Woudenberg JHC, 2013, STUD MYCOL, P171, DOI 10.3114/sim0015; Yin H, 2011, PHYTOMEDICINE, V18, P802, DOI 10.1016/j.phymed.2011.01.005; Zhang YG, 2007, J NAT PROD, V70, P1522, DOI 10.1021/np070239u; Zhao J, 2010, CURRENT RES TECHNOLO, P567, DOI DOI 10.1016/J.PHYTOCHEM.2012.07.021; 2015, PLANT CELL TISS ORG, V122, P45, DOI DOI 10.1007/S11240-015-0748-9; 2009, J NAT PRODUCTS, V72, P1825, DOI DOI 10.1021/NP9002977; 2007, ORG BIOMOL CHEM, V5, P1702, DOI DOI 10.1039/B702378B; 1925, LIEBIGS ANN CHEM, V444, P1, DOI DOI 10.1002/JLAC.19254440102; 2005, FUNGAL GENET BIOL, V42, P813, DOI DOI 10.1016/J.FGB.2005.06.007; 2017, APPL MICROBIOL BIOT, V101, P5831, DOI DOI 10.1007/S00253-017-8354-X	67	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2019	14	5							e0217060	10.1371/journal.pone.0217060	http://dx.doi.org/10.1371/journal.pone.0217060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY9HS	31112560	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000468451000037
J	Carbonell, G; Berna-Serna, JD; Oltra, L; Martinez, CM; Garcia-Carrillo, N; Guzman-Aroca, F; Salazar, FJ; Tudela, J; Berna-Mestre, JD				Carbonell, Guillermo; de Dios Berna-Serna, Juan; Oltra, Lidia; Martinez, Carlos M.; Garcia-Carrillo, Nuria; Guzman-Aroca, Florentina; Javier Salazar, Francisco; Tudela, Jose; de Dios Berna-Mestre, Juan			Evaluation of rat liver with ARFI elastography: In vivo and ex vivo study	PLOS ONE			English	Article							IMPULSE IMAGING ELASTOGRAPHY; NONALCOHOLIC STEATOHEPATITIS; TISSUE QUANTIFICATION; RADIATION; FIBROSIS; REPRODUCIBILITY; REPEATABILITY; STIFFNESS	Objective The aim of this study was to compare in vivo vs ex vivo liver stiffness in rats with acoustic radiation force impulse (ARFI) elastography using the histological findings as the gold standard. Methods Eighteen male Wistar rats aged 16-18 months were divided into a control group (n = 6) and obese group (n = 12). Liver stiffness was measured with shear wave velocity (SWV) using the ARFI technique both in vivo and ex vivo. The degree of fibrosis, steatosis and liver inflammation was evaluated in the histological findings. Pearson's correlation coefficient was applied to relate the SWV values to the histological parameters. Results The SWV values acquired in the ex vivo study were significantly lower than those obtained in vivo (P < 0.004). A significantly higher correlation value between the degree of liver fibrosis and the ARFI elastography assessment was observed in the ex vivo study (r = 0.706, P < 0.002), than the in vivo study (r = 0.623, P < 0.05). Conclusion Assessment of liver stiffness using ARFI elastography yielded a significant correlation between SWV and liver fibrosis in both the in vivo and ex vivo experiments. We consider that by minimising the influence of possible sources of artefact we could improve the accuracy of the measurements acquired with ARFI.	[Carbonell, Guillermo; de Dios Berna-Serna, Juan; Guzman-Aroca, Florentina; de Dios Berna-Mestre, Juan] Univ Murcia, Virgen de la Arrixaca Univ Clin Hosp, Dept Radiol, Murcia, Spain; [Carbonell, Guillermo; de Dios Berna-Serna, Juan; Oltra, Lidia; Martinez, Carlos M.; Garcia-Carrillo, Nuria; Guzman-Aroca, Florentina; Javier Salazar, Francisco; de Dios Berna-Mestre, Juan] Univ Murcia, Virgen de la Arrixaca Univ Clin Hosp, Inst Biomed Res IMIB, Murcia, Spain; [Oltra, Lidia; Javier Salazar, Francisco] Univ Murcia, Sch Med, Dept Physiol, Murcia, Spain; [Garcia-Carrillo, Nuria] Univ Murcia, Lab Anim Serv, Preclin Imaging Unit, Murcia, Spain; [Tudela, Jose] Univ Murcia, Dept Biochem & Mol Biol A, GENZ Grp Res Enzymol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Murcia; University of Murcia; University of Murcia	Carbonell, G (corresponding author), Univ Murcia, Virgen de la Arrixaca Univ Clin Hosp, Dept Radiol, Murcia, Spain.; Carbonell, G (corresponding author), Univ Murcia, Virgen de la Arrixaca Univ Clin Hosp, Inst Biomed Res IMIB, Murcia, Spain.	guillermo.carbonell@um.es	Salazar, F. Javier/K-1865-2013; Tudela, Jose/M-1278-2014; Martinez, Carlos M./E-4986-2016; Guzman Aroca, Florentina/G-9970-2015	Tudela, Jose/0000-0002-5528-4296; Martinez, Carlos M./0000-0003-3307-1326; Guzman Aroca, Florentina/0000-0002-4475-9022; Carbonell, Guillermo/0000-0001-6780-6883	"Subdireccion General de Proyectos de Investigacion" of "Ministerio de Economia y Competitividad" (Spain) [PI16/01556]	"Subdireccion General de Proyectos de Investigacion" of "Ministerio de Economia y Competitividad" (Spain)	This work was supported by the "Subdireccion General de Proyectos de Investigacion" of "Ministerio de Economia y Competitividad" (Spain) (PI16/01556).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Bruno C, 2016, INSIGHTS IMAGING, V7, P735, DOI 10.1007/s13244-016-0514-5; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chang S, 2013, ULTRASCHALL MED, V34, P260, DOI 10.1055/s-0032-1313008; D'Onofrio M, 2010, AM J ROENTGENOL, V195, P132, DOI 10.2214/AJR.09.3923; Dillman JR, 2015, PEDIATR RADIOL, V45, P376, DOI 10.1007/s00247-014-3150-6; Fierbinteanu-Braticevici C, 2009, WORLD J GASTROENTERO, V15, P5525, DOI 10.3748/wjg.15.5525; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Guo YR, 2018, MED ENG PHYS, V59, P30, DOI 10.1016/j.medengphy.2018.06.003; Guo YR, 2017, IEEE ENG MED BIO, P2988, DOI 10.1109/EMBC.2017.8037485; Guo YR, 2017, ULTRASOUND MED BIOL, V43, P2619, DOI 10.1016/j.ultrasmedbio.2017.06.026; Guo YR, 2017, ULTRASONICS, V74, P161, DOI 10.1016/j.ultras.2016.10.009; Guzman-Aroca F, 2012, EUR RADIOL, V22, P2525, DOI 10.1007/s00330-012-2505-3; Guzman-Aroca F, 2011, J ULTRAS MED, V30, P975, DOI 10.7863/jum.2011.30.7.975; Hashimoto E, 2013, J GASTROEN HEPATOL, V28, P64, DOI 10.1111/jgh.12271; Kaminuma C, 2011, J ULTRAS MED, V30, P745, DOI 10.7863/jum.2011.30.6.745; Kang BK, 2015, ULTRASOUND MED BIOL, V41, P3205, DOI 10.1016/j.ultrasmedbio.2015.07.025; Kazemirad S, 2017, RADIOLOGY, V282, P726, DOI 10.1148/radiol.2016160308; Lee KY, 2008, KOREAN J RADIOL, V9, P312, DOI 10.3348/kjr.2008.9.4.312; Liu HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127782; Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x; Nierhoff J, 2013, EUR RADIOL, V23, P3040, DOI 10.1007/s00330-013-2927-6; Nishikawa T, 2014, WORLD J GASTROENTERO, V20, P1289, DOI 10.3748/wjg.v20.i5.1289; Petta S, 2015, HEPATOLOGY, V62, P1101, DOI 10.1002/hep.27844; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Shin HJ, 2018, MED ULTRASON, V20, P14, DOI 10.11152/mu-1138; Sporea I, 2012, ULTRASOUND MED BIOL, V38, DOI 10.1016/j.ultrasmedbio.2012.03.011; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662	33	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2019	14	5							e0217297	10.1371/journal.pone.0217297	http://dx.doi.org/10.1371/journal.pone.0217297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ3VE	31120974	gold, Green Submitted, Green Published			2022-12-27	WOS:000468775700083
J	Gesto-Borroto, R; Cardoso-Taketa, A; Yactayo-Chang, JP; Medina-Jimenez, K; Hornung-Leoni, C; Lorence, A; Villarreal, ML				Gesto-Borroto, Reinier; Cardoso-Taketa, Alexandre; Yactayo-Chang, Jessica P.; Medina-Jimenez, Karina; Hornung-Leoni, Claudia; Lorence, Argelia; Luisa Villarreal, Maria			DNA barcoding and TLC as tools to properly identify natural populations of the Mexican medicinal species Galphimia glauca Cav	PLOS ONE			English	Article							HERBAL PRODUCT; LAND PLANTS; AUTHENTICATION; IDENTIFICATION; MALPIGHIACEAE; PHYLOGENY; EVOLUTION	Galphimia glauca is a plant that is endemic to Mexico and has been commonly used since pre-Hispanic times to treat various illnesses, including central nervous system disorders and inflammation. The first studies investigating a natural population of G. glauca in Mexico showed that the plant has anxiolytic and sedative activities in mice and humans. The plant's bioactive compounds were isolated and identified, and they belong to a family of nor-secofriedelanes called galphimines. The integration of DNA barcoding and thin-layer chromatography analysis was performed to clarify whether the botanical classification of the populations in the study, which were collected in different regions of Mexico, as G. glauca was correct or if the populations consist of more than one species of the genus Galphimia. We employed six DNA barcodes (matK, rbcL, rpoC1, psbA-trnH, ITS1 and ITS2) that were analyzed individually and in combination and then compared each other, to indicate differences among the studied populations. In the phylogenetic analysis, ITS1 and ITS2 markers as well as the combination of all DNA regions were the most efficient for discriminating the population studied. The thin-layer chromatography analysis exhibited four principal chemical profiles, one of which corresponded to the populations that produced galphimines. DNA barcoding was consistent and enabled us to differentiate the populations that produce galphimines from those that do not. The results of this investigation suggest that the studied populations belong to at least four different species of the genus Galphimia. The phylogenetic analysis and the thin-layer chromatography chemical profiles were convenient tools for establishing a strong relationship between the genotype and phenotype of the studied populations and could be used for quality control purposes to prepare herbal medicines from plants of the genus Galphimia.	[Gesto-Borroto, Reinier] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Dinam Celular, Ciencias, Cuernavaca, Morelos, Mexico; [Gesto-Borroto, Reinier; Cardoso-Taketa, Alexandre; Luisa Villarreal, Maria] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Invest Plantas Med, Cuernavaca, Morelos, Mexico; [Yactayo-Chang, Jessica P.; Medina-Jimenez, Karina; Lorence, Argelia] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA; [Hornung-Leoni, Claudia] Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Pachuca, Hidalgo, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Arkansas State University; Universidad Autonoma del Estado de Hidalgo	Villarreal, ML (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Invest Plantas Med, Cuernavaca, Morelos, Mexico.; Lorence, A (corresponding author), Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA.	alorence@astate.edu; luisav@uaem.mx	Gesto-Borroto, Reinier/AAM-6038-2021; Taketa, Alexandre Cardoso/AAG-8912-2020	Medina-Jimenez, Karina/0000-0002-4305-7854	CONACYT Ciencia Basica [222714]; CONACYT, Mexico [293307]; Arkansas Bioscience Institute (ABI); Arkansas Research Alliance (ARA)	CONACYT Ciencia Basica; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Arkansas Bioscience Institute (ABI); Arkansas Research Alliance (ARA)	Grant from CONACYT Ciencia Basica (222714) to MLV supported this research and the stay of RG-B at the Arkansas Biosciences Institute, Arkansas State University, Arkansas, USA. RG-B was awarded by CONACYT (293307), Mexico. Research done in AL's Laboratory was supported by funds from the Arkansas Bioscience Institute (ABI) and the Arkansas Research Alliance (ARA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Christiane, 2007, Contributions from the University of Michigan Herbarium, V25, P1; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bolson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143049; Cameron KM, 2001, AM J BOT, V88, P1847, DOI 10.2307/3558361; Cardoso-Taketa AT, 2008, PLANTA MED, V74, P1295, DOI 10.1055/s-2008-1074583; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cordell GA, 2014, PHYTOCHEM LETT, V10, pXXVIII, DOI 10.1016/j.phytol.2014.06.002; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Davis CC, 2004, AM J BOT, V91, P262, DOI 10.3732/ajb.91.2.262; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; Estrada E., 1985, JARDIN BOT PLANTAS M; Ferri G, 2015, FORENSIC SCI INT-GEN, V15, P131, DOI 10.1016/j.fsigen.2014.10.005; Ferri G, 2008, FORENS SCI INT-GEN S, V1, P593, DOI 10.1016/j.fsigss.2007.10.023; Ganie Showkat Hussain, 2015, Plant Gene, V4, P83, DOI 10.1016/j.plgene.2015.10.002; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gere J, 2013, ZOOKEYS, P127, DOI 10.3897/zookeys.365.5728; Ghorbani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175722; Gonzalez-Cortazar M, 2014, PLANTA MED, V80, P90, DOI 10.1055/s-0033-1360150; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Herrera-Arellano A, 2007, PLANTA MED, V73, P713, DOI 10.1055/s-2007-981539; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knibbe C, 2007, MOL BIOL EVOL, V24, P2344, DOI 10.1093/molbev/msm165; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Kshirsagar Parthraj, 2017, Proceedings of the Indian National Science Academy Part B Biological Sciences, V87, P101, DOI 10.1007/s40011-015-0556-3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lu QP, 2014, BIOCHEM SYST ECOL, V52, P20, DOI 10.1016/j.bse.2013.11.002; Michel CI, 2016, J APPL RES MED AROMA, V3, P94, DOI 10.1016/j.jarmap.2016.02.002; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Purushothaman N, 2014, GENET MOL RES, V13, P2959, DOI 10.4238/2014.April.16.4; Raclariu AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01389-w; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sarwat M, 2016, CRIT REV BIOTECHNOL, V36, P191, DOI 10.3109/07388551.2014.947563; Selvaraj Dhivya, 2012, Genomics Proteomics & Bioinformatics, V10, P364, DOI 10.1016/j.gpb.2012.03.002; Sharma A, 2012, J ETHNOPHARMACOL, V144, P371, DOI 10.1016/j.jep.2012.09.022; Sharma A, 2012, J ETHNOPHARMACOL, V141, P964, DOI 10.1016/j.jep.2012.03.033; Taketa ATC, 2004, J NAT PROD, V67, P644, DOI 10.1021/np0304666; Tate JA, 2003, SYST BOT, V28, P723; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tnah LH, 2019, FOOD CONTROL, V95, P318, DOI 10.1016/j.foodcont.2018.08.022; Tokuoka T, 2006, J PLANT RES, V119, P599, DOI 10.1007/s10265-006-0025-4; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vassou SL, 2015, GENE, V559, P86, DOI 10.1016/j.gene.2015.01.025; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125574; Zhen Y, 2012, METHODS MOL BIOL, V856, P141, DOI 10.1007/978-1-61779-585-5_6	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217313	10.1371/journal.pone.0217313	http://dx.doi.org/10.1371/journal.pone.0217313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136619	Green Submitted, Green Published, gold			2022-12-27	WOS:000469224300026
J	McHugh, LC; Snyder, K; Yager, TD				McHugh, Leo C.; Snyder, Kevin; Yager, Thomas D.			The effect of uncertainty in patient classification on diagnostic performance estimations	PLOS ONE			English	Article							IMPERFECT GOLD STANDARDS; TESTS; SENSITIVITY; SPECIFICITY; MANAGEMENT; ACCURACY; ERRORS; BIAS	Background The performance of a new diagnostic test is typically evaluated against a comparator which is assumed to correspond closely to some true state of interest. Judgments about the new test's performance are based on the differences between the outputs of the test and comparator. It is commonly assumed that a small amount of uncertainty in the comparator's classifications will negligibly affect the measured performance of a diagnostic test. Methods Simulated datasets were generated to represent typical diagnostic scenarios. Comparator noise was introduced in the form of random misclassifications, and the effect on the apparent performance of the diagnostic test was determined. An actual dataset from a clinical trial on a new diagnostic test for sepsis was also analyzed. Results We demonstrate that as little as 5% misclassification of patients by the comparator can be enough to statistically invalidate performance estimates such as sensitivity, specificity and area under the receiver operating characteristic curve, if this uncertainty is not measured and taken into account. This distortion effect is found to increase non-linearly with comparator uncertainty, under some common diagnostic scenarios. For clinical populations exhibiting high degrees of classification uncertainty, failure to measure and account for this effect will introduce significant risks of drawing false conclusions. The effect of classification uncertainty is magnified further for high performing tests that would otherwise reach near-perfection in diagnostic evaluation trials. A requirement of very high diagnostic performance for clinical adoption, such as a 99% sensitivity, can be rendered nearly unachievable even for a perfect test, if the comparator diagnosis contains even small amounts of uncertainty. This paper and an accompanying online simulation tool demonstrate the effect of classification uncertainty on the apparent performance of tests across a range of typical diagnostic scenarios. Both simulated and real datasets are used to show the degradation of apparent test performance as comparator uncertainty increases. Conclusions Overall, a 5% or greater misclassification rate by the comparator can lead to significant underestimation of true test performance. An online simulation tool allows researchers to explore this effect using their own trial parameters (https://imperfect-gold-standard.shinyapps.io/classification-noise/) and the source code is freely available (https://github.com/ksny/Imperfect-Gold-Standard).	[McHugh, Leo C.; Yager, Thomas D.] Immunexpress Inc, Seattle, WA 98109 USA; [Snyder, Kevin] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	McHugh, LC (corresponding author), Immunexpress Inc, Seattle, WA 98109 USA.	leo@leomchugh.com		Snyder, Kevin/0000-0003-3029-4815				Apgar BS, 2004, AM FAM PHYSICIAN, V70, P1905; Bachmann LM, 2005, INT J EPIDEMIOL, V34, P953, DOI 10.1093/ije/dyi105; Bailey DC, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160600; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Betebenner DW, 2008, J EDUC MEAS, V45, P119, DOI 10.1111/j.1745-3984.2007.00056.x; Boardman LA, 2008, OBSTET GYN CLIN N AM, V35, P599, DOI 10.1016/j.ogc.2008.09.001; Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191; Bond RR, 2018, J ELECTROCARDIOL, V51, pS6, DOI 10.1016/j.jelectrocard.2018.08.007; Bossuyt PM, 2015, CLIN CHEM, V61, P1446, DOI 10.1373/clinchem.2015.246280; BOYKO EJ, 1988, J GEN INTERN MED, V3, P476, DOI 10.1007/BF02595925; Brody JP, 2002, P NATL ACAD SCI USA, V99, P12975, DOI 10.1073/pnas.162468199; BROSS I, 1954, BIOMETRICS, V10, P478, DOI 10.2307/3001619; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; DAVIAUD J, 1993, CLIN CHEM, V39, P53; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; Green TA, 1998, J CLIN MICROBIOL, V36, P375, DOI 10.1128/JCM.36.2.375-381.1998; Hawkins DM, 2001, STAT MED, V20, P1987, DOI 10.1002/sim.819; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; McHugh LC, 2017, INTENSIVE CARE ME S1, V5, pP34, DOI [10.1186/s40635-017-0149-y, DOI 10.1186/S40635-017-0149-Y]; McLaughlin JK, 2013, CANCER EPIDEM BIOMAR, V22, P11, DOI 10.1158/1055-9965.EPI-12-0995; Miller RR, 2018, AM J RESP CRIT CARE, V198, P903, DOI [10.1164/rccm.201712-2472OC, 10.1164/rccm.201712-2472oc]; Omurtag A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052221; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; VALENSTEIN PN, 1990, AM J CLIN PATHOL, V93, P252, DOI 10.1093/ajcp/93.2.252; Waikar SS, 2013, CLIN TRIALS, V10, P696, DOI 10.1177/1740774513497540; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Yadav YK, 2013, J POSTGRAD MED, V59, P153, DOI 10.4103/0022-3859.113838	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217146	10.1371/journal.pone.0217146	http://dx.doi.org/10.1371/journal.pone.0217146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116772	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400045
J	Hamilton, DT; Rosenberg, ES; Jenness, SM; Sullivan, PS; Wang, L; Dunville, RL; Barrios, LC; Aslam, M; Goodreau, SM				Hamilton, Deven T.; Rosenberg, Eli S.; Jenness, Samuel M.; Sullivan, Patrick S.; Wang, Li Yan; Dunville, Richard L.; Barrios, Lisa C.; Aslam, Maria; Goodreau, Steven M.			Modeling the joint effects of adolescent and adult PrEP for sexual minority males in the United States	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV-INFECTION; YOUNG MEN; RACIAL DISPARITIES; RISK-FACTORS; TRANSMISSION; PREVALENCE; PARTNERS; ATLANTA; HEALTH	Background Pre-exposure prophylaxis (PrEP) is an effective and safe intervention approved for use to prevent HIV transmission. PrEP scale-up strategies and clinical practice are currently being informed by modeling studies, which have estimated the impact of PrEP in adult and adolescent MSM populations separately. This partitioning may miss important effects or yield biased estimates by excluding dependencies between populations. Methods We combined two published models of HIV transmission among adults and adolescent MSM. We simulated an HIV epidemic among MSM aged 13-39 without PrEP, with PrEP for adult MSM ages (19-39) and with the addition of PrEP for adolescents ages (16-18), comparing percent of incident infections averted (impact), the number of person-years on PrEP per infection averted (efficiency), and changes in prevalence. Results PrEP use among eligible 19-39 year old MSM averted 29.0% of infections and reduced HIV prevalence from 23.2% to 17.0% over ten years in the population as a whole. Despite being ineligible for PrEP in this scenario, prevalence among sexually active 18 year-olds declined from 6.0% to 4.3% due to reduced transmissions across age cohorts. The addition of PrEP for adolescents ages 16-18 had a small impact on the overall epidemic, further reducing overall prevalence from 17.0% to 16.8%; however prevalence among the sexually active 18 year-olds further declined from 4.3% to 3.8%. Conclusions PrEP use among adults may significantly reduce HIV prevalence among MSM and may also have significant downstream effects on HIV incidence among adolescents; PrEP targeting adolescents remains an important intervention for HIV prevention.	[Hamilton, Deven T.; Goodreau, Steven M.] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Rosenberg, Eli S.] State Univ New York, Albany Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY USA; [Jenness, Samuel M.; Sullivan, Patrick S.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Sullivan, Patrick S.] Emory Univ, Dept Global Hlth, Atlanta, GA 30322 USA; [Wang, Li Yan; Dunville, Richard L.; Barrios, Lisa C.] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Atlanta, GA USA; [Aslam, Maria] Ctr Dis Control & Prevent, Program & Performance Improvement Off, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA; [Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; State University of New York (SUNY) System; SUNY Delhi; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle	Hamilton, DT (corresponding author), Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA.	dth2@uw.edu		Sullivan, Patrick Sean/0000-0002-7728-0587; Goodreau, Steven/0000-0003-1009-5763; Aslam, Maria Vyshnya/0000-0002-0036-3851; Jenness, Samuel/0000-0001-8840-105X; Hamilton, Deven/0000-0003-4334-958X	US Centers for Disease Control and Prevention National Center for HIV, Viral Hepatitis, STD, and TB Prevention [6NU38PS004646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI138783] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention National Center for HIV, Viral Hepatitis, STD, and TB Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by US Centers for Disease Control and Prevention National Center for HIV, Viral Hepatitis, STD, and TB Prevention (Epidemiologic and Economic Modeling Agreement number 6NU38PS004646). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. https://www.cdc.gov/.	Anema A, 2013, CURR HIV-AIDS REP, V10, P398, DOI 10.1007/s11904-013-0187-3; Benaglia T, 2009, J STAT SOFTW, V32, P1; Berry M, 2007, AIDS, V21, P2349, DOI 10.1097/QAD.0b013e3282f12f41; Brookmeyer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112668; Bruce D, 2012, ARCH SEX BEHAV, V41, P441, DOI 10.1007/s10508-011-9730-8; CAMERON DW, 1989, LANCET, V2, P403; CDC, 2018, SERV CFDCAPUPH; Cenetrs for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI, V6; Centers for Disease Control and Prevention (CDC), 2017, HIV SURV REP, V28; Coburn BJ, 2010, JAIDS-J ACQ IMM DEF, V54, P113, DOI 10.1097/QAI.0b013e3181d43999; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Folayan MO, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-83; Garofalo R, 2016, JAIDS-J ACQ IMM DEF, V72, P79, DOI 10.1097/QAI.0000000000000933; Goodreau SM, 2017, TARGETING HIV PREEXP; Goodreau SM, 2017, LANCET HIV, V4, pE311, DOI 10.1016/S2352-3018(17)30067-X; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grey JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129877; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Halkitis P, 2015, JAIDS-J ACQ IMM DEF, V69, P466, DOI 10.1097/QAI.0000000000000616; Hamilton DT, 2018, AJPH, V108; Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; Hurt CB, 2010, JAIDS-J ACQ IMM DEF, V54, P185, DOI 10.1097/QAI.0b013e3181c99114; Jenness SM, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i08; Jenness SM, 2017, CLIN INFECT DIS, V65, P712, DOI 10.1093/cid/cix439; Jenness SM, 2016, J INFECT DIS; Krivitsky PN, 2014, J R STAT SOC B, V76, P29, DOI 10.1111/rssb.12014; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; MacFadden DR, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20791; Maughan-Brown B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159162; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; National Research Council (US) and Institute of Medicine (US) Committee on Adolescent Health Care Services and Models of Care for Treatment P and Healthy Development, 2009, AD HLTH SERV MISS OP; PIOT P, 1989, BRIT MED J, V298, P623, DOI 10.1136/bmj.298.6674.623; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Sharma A, 2016, J ADOLESCENT HEALTH, V58, pS80, DOI 10.1016/j.jadohealth.2015.10.173; Sullivan P, 2018, 22 INT AIDS C AMST N; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; WEBER JN, 1986, GENITOURIN MED, V62, P177; Wejnert C, 2016, J INFECT DIS, V213, P776, DOI 10.1093/infdis/jiv500; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878; Whiteside YO, 2015, AIDS, V29, P2517, DOI 10.1097/QAD.0000000000000852; Wolf E, 2017, AIDS RES HUM RETROV, V33, P318, DOI [10.1089/aid.2016.0061, 10.1089/AID.2016.0061]	46	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217315	10.1371/journal.pone.0217315	http://dx.doi.org/10.1371/journal.pone.0217315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116802	gold, Green Published, Green Submitted			2022-12-27	WOS:000468607400057
J	Banierink, H; ten Duis, K; de Vries, R; Wendt, K; Heineman, E; Reininga, I; IJpma, F				Banierink, Hester; ten Duis, Kaj; de Vries, Rob; Wendt, Klaus; Heineman, Erik; Reininga, Inge; IJpma, Frank			Pelvic ring injury in the elderly: Fragile patients with substantial mortality rates and long-term physical impairment	PLOS ONE			English	Article							FUNCTION ASSESSMENT QUESTIONNAIRE; FRACTURES; EPIDEMIOLOGY; VALIDITY	Background Pelvic ring injuries in the elderly often occur after low-energy accidents. They may result in prolonged immobilization, complications and an intense rehabilitation process. The aim of this study was to assess mortality, physical functioning and quality of life (QoL) in elderly patients with pelvic ring injuries. Methods A cross-sectional study was performed including all elderly patients (. 65 years) admitted for a pelvic ring injury between 2007-2016. Mortality and survival were evaluated and patient reported outcome measures (PROMs) were used to assess physical functioning (SMFA) and QoL (EQ-5D). These were compared to age-matched normative data from the general Dutch population. Results A total of 153 patients, with a mean age of 79 years (SD 8) at the time of injury, were included in this study. The mortality rate was 20% at 30 days, 27% at 1 year and 41% at 3 years of follow-up. All six patients with a type C fracture died within 30 days. Analyses of the 153 patients showed that increasing age, fracture type C and Injury Severity Score (ISS) were all independent risk factors for mortality. Eventually, after excluding patients that died (N = 78) or were unable to contact (N = 2), 73 patients were eligible for follow-up, of which 53 patients (73%) responded. Mean Short Musculoskeletal Function Assessment (SMFA) scores were respectively 67.4 (function index), 65.2 (bother index), 66.5 (lower extremity), 60.4 (activities of daily living) and 68.2 (emotion). Mean EuroQuol-5D (EQ-5D) score was 0.72. Overall, physical functioning and quality of life were significantly decreased in comparison with normative data from the general population. Conclusion Elderly people who sustain a pelvic ring injury should be considered as a fragile population with substantial mortality rates. The patients who survived demonstrated a substantially lower level of physical functioning and quality of life in comparison with their age-matched peers from the general population.	[Banierink, Hester; ten Duis, Kaj; de Vries, Rob; Wendt, Klaus; Reininga, Inge; IJpma, Frank] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands; [Wendt, Klaus; Reininga, Inge] Northern Netherlands Trauma Registry, Emergency Care Network Northern Netherlands AZNN, Groningen, Netherlands; [Heineman, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands	University of Groningen; University of Groningen	Banierink, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands.	h.banierink@umcg.nl	Heineman, Erik/ABG-9592-2021; IJpma, Frank/AAH-6350-2019; Reininga, Inge H.F./H-4250-2013	Reininga, Inge H.F./0000-0003-1341-845X				AO/OTA, 2018, J ORTHOP TRAUMA, V32; Balogh Z, 2007, J TRAUMA, V63, P1066, DOI 10.1097/TA.0b013e3181589fa4; Bible JE, 2013, ORTHOPEDICS, V36, P760, DOI 10.3928/01477447-20130523-21; Butler M, 2011, J BONE JOINT SURG AM, V93A, P1104, DOI [10.2106/JBJSJ.00296, 10.2106/JBJS.J.00296]; Centraal Bureau voor de Statistiek, 2018, LEV GESL LEEFT JAAR; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clement Nicholas D, 2014, Eur J Orthop Surg Traumatol, V24, P1431, DOI 10.1007/s00590-014-1439-7; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; de Graaf MW, 2015, QUAL LIFE RES, V24, P2015, DOI 10.1007/s11136-015-0929-3; de Vries R., 2018, AV TECHN INT OP C 20, P1; Dechert TA, 2009, AM SURGEON, V75, P291; Forni C, 2018, INT ORTHOP, P15; Giesbers H, 2013, WAT ZIJN BELANGRIJKS; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; MELTON LJ, 1981, CLIN ORTHOP RELAT R, P43; Morris RO, 2000, POSTGRAD MED J, V76, P646, DOI 10.1136/pmj.76.900.646; Mundi S, 2014, ACTA ORTHOP, V85, P54, DOI 10.3109/17453674.2013.878831; Osterhoff G, 1994, PRAXIS, V40, P1195; Reininga IHF, 2012, INJURY, V43, P726, DOI 10.1016/j.injury.2011.07.013; Schmitz P, 2018, INT ORTHOP; Soles GLS, 2012, CURR REV MUSCULOSKE, V5, P222, DOI 10.1007/s12178-012-9128-9; Studer P, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13859; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Tile M., 2015, THIEME; van Dijk WA, 2010, INJURY, V41, P411, DOI 10.1016/j.injury.2009.12.014; Verbeek Diederik O, 2018, Eur J Orthop Surg Traumatol, V28, P197, DOI 10.1007/s00590-017-2044-3; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003	27	17	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216809	10.1371/journal.pone.0216809	http://dx.doi.org/10.1371/journal.pone.0216809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136589	Green Published, Green Submitted, gold			2022-12-27	WOS:000469224300010
J	Lin, WW; Lin, MH; Zhou, HY; Wu, HM; Li, ZW; Lin, WX				Lin, Weiwei; Lin, Manhong; Zhou, Hongyan; Wu, Hongmiao; Li, Zhaowei; Lin, Wenxiong			The effects of chemical and organic fertilizer usage on rhizosphere soil in tea orchards	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BACTERIAL COMMUNITIES; ACIDIFICATION; ACID; AGRICULTURE; ADSORPTION; MANAGEMENT; IMPACTS; GROWTH; MANURE	Sustainable agriculture is an important global issue. The use of organic fertilizers can enhance crop yield and soil properties while restraining pests and diseases. The objective of this study was to assess the effects of long-term use of chemical and organic fertilizers on tea and rhizosphere soil properties in tea orchards. Inductively coupled plasma mass spectrometry (ICP-MS) and high-throughput sequencing technology analyses were used to investigate heavy metals content and bacterial composition in rhizosphere soils. Our results indicated that organic fertilizer treatment significantly decreased Cu, Pb and Cd contents in rhizosphere soil sample. The results also showed that treatment with organic fertilizer significantly decreased the contents of Cd, Pb and As in tea leaves. Furthermore, organic fertilizer significantly increased the amino acids content of tea and the pH of the soil. The use of organic fertilizer significantly increased in the relative abundance of Burkholderiales, Myxococcales, Streptomycetales, Nitrospirales, Ktedonobacterales, Acidobacteriales, Gemmatimonadales, and Solibacterales, and decreased the abundance of Pseudonocardiales, Frankiales, Rhizobiales, and Xanthomonadales. In conclusion, organic fertilizer can help to shape the microbial composition and recruit beneficial bacteria into the rhizosphere of tea, leading to improved tea quality and reduced heavy metals content in rhizosphere soil and tea leaves.	[Lin, Weiwei; Wu, Hongmiao; Li, Zhaowei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China; [Lin, Weiwei; Lin, Manhong; Wu, Hongmiao; Li, Zhaowei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Key Lab Crop Ecol & Mol Physiol, Fuzhou, Fujian, Peoples R China; [Lin, Manhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China; [Zhou, Hongyan] Fujian Vocat Coll Agr, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Li, ZW; Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China.; Li, ZW; Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Key Lab Crop Ecol & Mol Physiol, Fuzhou, Fujian, Peoples R China.; Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China.	zhaoweili@fafu.edu.cn; lwx@fafu.edu.cn	Wu, Hongmiao/J-5958-2014	Wu, Hongmiao/0000-0002-9664-0824	National Natural Science Foundation of China [31701329, 81573530]; Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program), China [2015-75]; Natural Science Foundation of Fujian Province [2016J01100]; China Postdoral Science Foundation [2015M580560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program), China; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); China Postdoral Science Foundation	This work was supported by: National Natural Science Foundation of China (No. 31701329, 81573530); Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program, No. 2015-75, China); the Natural Science Foundation of Fujian Province (No. 2016J01100); and the Project Funded by China Postdoral Science Foundation (No. 2015M580560).; This work was supported by by the National Natural Science Foundation of China (No. 31701329, 81573530), Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program, No. 2015-75, China), the Natural Science Foundation of Fujian Province (No. 2016J01100), and the Project Funded by China Postdoral Science Foundation (No. 2015M580560).	Ahmad R, 2007, ANN MICROBIOL, V57, P471, DOI 10.1007/BF03175343; Arafat Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081727; Bao SD, 2000, SOIL AGR CHEM ANAL, P263; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Blake L, 2002, PLANT SOIL, V240, P235, DOI 10.1023/A:1015731530498; BOLAN NS, 1991, PLANT SOIL, V134, P53, DOI 10.1007/BF00010717; Carpio IEM, 2014, CARBON, V77, P289, DOI 10.1016/j.carbon.2014.05.032; Chang KH, 2010, SCI HORTIC-AMSTERDAM, V125, P434, DOI 10.1016/j.scienta.2010.04.011; Cheng Y, 2015, PLANT SOIL, V389, P45, DOI 10.1007/s11104-014-2343-y; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DORMAAR JF, 1988, CAN J SOIL SCI, V68, P669, DOI 10.4141/cjss88-064; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gao G., 2001, CHIN J FOOD HYG, V13, P12; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; Gremion F, 2004, FEMS MICROBIOL ECOL, V48, P273, DOI 10.1016/j.femsec.2004.02.004; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hacquard S, 2016, NEW PHYTOL, V209, P454, DOI 10.1111/nph.13760; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Horrigan L, 2002, ENVIRON HEALTH PERSP, V110, P445, DOI 10.1289/ehp.02110445; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Kinkel LL, 2012, RES MICROBIOL, V163, P490, DOI 10.1016/j.resmic.2012.07.005; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; [兰海霞 LAN Haixia], 2008, [农业环境科学学报, Journal of Agro-Environment Science], V27, P1077; Li YC, 2016, J APPL MICROBIOL, V121, P787, DOI 10.1111/jam.13225; Li Yan-chun, 2018, Yingyong Shengtai Xuebao, V29, P1273, DOI 10.13287/j.1001-9332.201804.036; Li YC, 2017, EUR J SOIL BIOL, V81, P48, DOI 10.1016/j.ejsobi.2017.06.008; Lin B., 2010, FUJIAN J AGR SCI, V25, P90, DOI [DOI 10.19303/J.ISSN.1008-0384.2010.01.018, 10.19303/j.issn.1008-0384.2010.01.018]; LIU L, 1995, PHYTOPATHOLOGY, V85, P1064, DOI 10.1094/Phyto-85-1064; Liu ZA, 2012, NUTR CYCL AGROECOSYS, V93, P297, DOI 10.1007/s10705-012-9517-x; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Nkoa R, 2014, AGRON SUSTAIN DEV, V34, P473, DOI 10.1007/s13593-013-0196-z; Owuor P. O., 2011, International Journal of Tea Science (IJTS), V8, P15; Pansu Marc, 2006, P3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; Savci S., 2012, International Journal of Environmental Science and Development, V3, P77; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sun Q., 2017, J CHIN AGR SCI B, V33, P52; Sun RB, 2015, SOIL BIOL BIOCHEM, V88, P9, DOI 10.1016/j.soilbio.2015.05.007; Van VT, 2000, PLANT SOIL, V218, P273, DOI 10.1023/A:1014986916913; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang WW, 2011, POL J ECOL, V59, P37; Wu HM, 2019, AGR ECOSYST ENVIRON, V270, P19, DOI 10.1016/j.agee.2018.10.014; Wu HM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00335; Wu LK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01788; Wu LK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15871; Xu H., 2010, CHIN J SOIL SCI, V41, P1355; Yan XY, 2010, PLANT SOIL, V331, P471, DOI 10.1007/s11104-009-0268-7; Yang SX, 2010, CHEMOSPHERE, V80, P852, DOI 10.1016/j.chemosphere.2010.05.055; Zhang QC, 2012, APPL SOIL ECOL, V57, P1, DOI 10.1016/j.apsoil.2012.02.012; Zhang Qin, 2012, Guizhou Agricultural Sciences, P65; Zhao J, 2012, WORLD J MICROB BIOT, V28, P1967, DOI 10.1007/s11274-011-0999-5; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	54	108	115	47	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217018	10.1371/journal.pone.0217018	http://dx.doi.org/10.1371/journal.pone.0217018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136614	gold, Green Submitted, Green Published			2022-12-27	WOS:000469224300013
J	Zhuang, JG; Zhao, L; Gao, XP; Xu, FD				Zhuang, Jianguo; Zhao, Lei; Gao, Xiuping; Xu, Fadi			An advanced recording and analysis system for the differentiation of guinea pig cough responses to citric acid and prostaglandin E-2 in real time	PLOS ONE			English	Article							AIRWAY INFLAMMATION; REFLEX SENSITIVITY; RESPIRATORY-TRACT; VAGAL AFFERENTS; SOUND ANALYSIS; SUBSTANCE-P; C-FIBERS; CAPSAICIN; DIAGNOSIS; STIMULATION	Cough number and/or sound have been used to assess cough sensitivity/intensity and to discriminate cough patterns in clinical settings. However, to date, only manual counting of cough number in an offline manner is applied in animal cough studies, which diminishes the efficiency of cough identification and hinders the diagnostic discrimination of cough patterns, especially in animals with pulmonary diseases. This study aims to validate a novel recording/analysis system by which cough numbers are automatically counted and cough patterns are comprehensively differentiated in real time. The experiment was carried out in conscious guinea pigs exposed to aerosolized citric acid (CA, 150 mM) and prostaglandin E-2 (PGE(2), 0.43 mM). Animal body posture (video), respiratory flow, and cough acoustics (audio) were simultaneously monitored and recorded. Cough number was counted automatically, and cough sound parameters including waveform, duration, power spectral density, spectrogram, and intensity, were analyzed in real time. Our results showed that CA- and PGE(2)-evoked coughs had the same cough numbers but completely different patterns [individual coughs vs. bout(s) of coughs]. Compared to CA-evoked coughs, PGE(2)-evoked coughs possess a longer latency, higher cough rate (coughs/min), shorter cough sound duration, lower cough sound intensity, and distinct cough waveforms and spectrograms. A few mucus- and wheeze-like coughs were noted in response to CA but not to PGE(2). In conclusion, our recording/analysis system is capable of automatically counting the cough number and successfully differentiating the cough pattern by using valuable cough sound indexes in real time. Our system enhances the objectivity, accuracy, and efficiency of cough identification and count, improves the intensity evaluation, and offers ability for pattern discrimination compared to traditional types of cough identification. Importantly, this approach is beneficial for assessing the efficacy of putative antitussive drugs in animals without or with pulmonary diseases, particularly in cases without significant change in cough number.	[Zhuang, Jianguo; Zhao, Lei; Gao, Xiuping; Xu, Fadi] Lovelace Resp Res Inst, Pathophysiol Program, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Xu, FD (corresponding author), Lovelace Resp Res Inst, Pathophysiol Program, Albuquerque, NM 87108 USA.	fxu@lrri.org			Lovelace Respiratory Research Institute	Lovelace Respiratory Research Institute	This study is internally funded by Lovelace Respiratory Research Institute.	BANNER AS, 1986, LUNG, V164, P79, DOI 10.1007/BF02713631; Belvisi MG, 2008, BRIT J PHARMACOL, V155, P547, DOI 10.1038/bjp.2008.298; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Brozmanova M, 2007, J PHYSIOL PHARMACOL, V58, P67; Brozmanova M, 2008, J PHYSIOL PHARMACOL, V59, P153; Chen YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055000, 10.1371/journal.pone.0059263]; Chen ZY, 2017, EXP THER MED, V14, P3485, DOI 10.3892/etm.2017.4937; Chou YL, 2018, AM J PHYSIOL-REG I, V314, pR489, DOI 10.1152/ajpregu.00313.2017; Chung K. F., 2009, V187, P1, DOI 10.1007/978-3-540-79842-2_1; COLERIDGE HM, 1977, RESP PHYSIOL, V29, P125, DOI 10.1016/0034-5687(77)90086-X; COLERIDGE HM, 1994, ANNU REV PHYSIOL, V56, P69, DOI 10.1146/annurev.ph.56.030194.000441; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; COSTELLO JF, 1985, BRIT J CLIN PHARMACO, V20, P355, DOI 10.1111/j.1365-2125.1985.tb05077.x; DAWSON KP, 1991, J PAEDIATR CHILD H, V27, P4, DOI 10.1111/j.1440-1754.1991.tb00336.x; Decalmer SC, 2007, THORAX, V62, P329, DOI 10.1136/thx.2006.067413; Dutta A, 2010, ACTA PHYSIOL, V200, P87, DOI 10.1111/j.1748-1716.2010.02105.x; Ferrari S, 2008, T ASABE, V51, P1051, DOI 10.13031/2013.24524; Ferrari S, 2010, PREV VET MED, V96, P276, DOI 10.1016/j.prevetmed.2010.06.013; Ferrari S, 2008, COMPUT ELECTRON AGR, V64, P318, DOI 10.1016/j.compag.2008.07.003; Fischer P, 2018, INT J CHRONIC OBSTR, V13, P1071, DOI 10.2147/COPD.S154539; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; FORSBERG K, 1986, ACTA PHYSIOL SCAND, V128, P319, DOI 10.1111/j.1748-1716.1986.tb07981.x; Forsberg K, 1988, Pulm Pharmacol, V1, P33, DOI 10.1016/0952-0600(88)90008-7; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; GIRARD V, 1995, EUR RESPIR J, V8, P1110, DOI 10.1183/09031936.95.08071110; GREEN JF, 1984, J APPL PHYSIOL, V57, P562, DOI 10.1152/jappl.1984.57.2.562; Hashimoto Y, 2003, RESPIROLOGY, V8, P45, DOI 10.1046/j.1440-1843.2003.00432.x; HUTCHISON AA, 1987, PEDIATR PULM, V3, P45, DOI 10.1002/ppul.1950030112; IMAMURA T, 1992, AGENTS ACTIONS, V37, P245, DOI 10.1007/BF02028116; Iwata T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141823; KARLSSON JA, 1991, RESP MED, V85, P47, DOI 10.1016/S0954-6111(06)80254-4; KARLSSON JA, 1993, J APPL PHYSIOL, V74, P2380, DOI 10.1152/jappl.1993.74.5.2380; KAWAKAMI Y, 1973, EUR J CLIN PHARMACOL, V6, P127, DOI 10.1007/BF00562439; Korpas J., 2003, Acta Physiologica Hungarica, V90, P27, DOI 10.1556/APhysiol.90.2003.1.4; KORPAS J, 1993, RESP MED, V87, P49, DOI 10.1016/S0954-6111(05)80313-0; Korpas J, 1996, PULM PHARMACOL THER, V9, P261, DOI 10.1006/pulp.1996.0034; KORPAS J, 1993, RESP MED, V87, P55, DOI 10.1016/S0954-6111(05)80314-2; KORPAS J, 1979, COUGH OTHER RESP REF, P15; Kovacova-Hanuskova E, 2015, RESP PHYSIOL NEUROBI, V216, P9, DOI 10.1016/j.resp.2015.05.007; Larsell O, 1924, AM J PHYSIOL, V70, P311, DOI 10.1152/ajplegacy.1924.70.2.311; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Leith DE, 1986, HDB PHYSL RESP SYS 1, P316; LUNDBERG JM, 1984, CELL TISSUE RES, V235, P251; LUNDBERG JM, 1983, NATURE, V302, P251, DOI 10.1038/302251a0; Maher SA, 2010, LUNG, V188, pS9, DOI 10.1007/s00408-009-9190-2; Maher SA, 2009, AM J RESP CRIT CARE, V180, P923, DOI 10.1164/rccm.200903-0388OC; Makwana R, 2015, J PHARMACOL EXP THER, V353, P169, DOI 10.1124/jpet.114.221283; Masini E, 2008, J PHARMACOL EXP THER, V324, P548, DOI 10.1124/jpet.107.131565; McGarvey LPA, 1998, INT J CLIN PRACT, V52, P158; Moreira TS, 2007, J NEUROPHYSIOL, V98, P3627, DOI 10.1152/jn.00675.2007; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; Murata A, 1998, INTERNAL MED, V37, P732, DOI 10.2169/internalmedicine.37.732; Olia P M, 2000, Respirology, V5, P271, DOI 10.1046/j.1440-1843.2000.00259.x; PIIRILA P, 1989, CHEST, V96, P46, DOI 10.1378/chest.96.1.46; REECE CA, 1966, AM J DIS CHILD, V112, P124, DOI 10.1001/archpedi.1966.02090110068005; SATOH H, 1993, EUR J PHARMACOL, V236, P367, DOI 10.1016/0014-2999(93)90473-U; Schappert Susan M, 2006, Vital Health Stat 13, P1; SCHERTEL ER, 1986, J APPL PHYSIOL, V61, P1237, DOI 10.1152/jappl.1986.61.3.1237; Shin SH, 2009, IEEE T INF TECHNOL B, V13, P486, DOI 10.1109/TITB.2008.923771; Smith Jaclyn A, 2006, Cough, V2, P1, DOI 10.1186/1745-9974-2-1; Subburaj S, 1996, PULM PHARMACOL THER, V9, P269, DOI 10.1006/pulp.1996.0035; Tanaka M, 2005, J PHARMACOL SCI, V99, P77, DOI 10.1254/jphs.FPJ05014X; Tanaka M, 2003, J PHARMACOL SCI, V93, P465, DOI 10.1254/jphs.93.465; THORPE CW, 1992, EUR RESPIR J, V5, P685; TOOP LJ, 1989, FAM PRACT, V6, P83, DOI 10.1093/fampra/6.2.83; Vrabec M, 1997, Bratisl Lek Listy, V98, P141; WALLOIS F, 1994, RESP PHYSIOL, V97, P47, DOI 10.1016/0034-5687(94)90011-6; Widdicombe J., 1986, HDB PHYSL SECT 3 RES, VII, P363; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; Widdicombe JG, 1988, RESP FUNCTION UPPER, P193; Xiang AB, 1998, J APPL PHYSIOL, V85, P1847, DOI 10.1152/jappl.1998.85.5.1847	72	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2019	14	5							e0217366	10.1371/journal.pone.0217366	http://dx.doi.org/10.1371/journal.pone.0217366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1LE	31116792	Green Published, gold, Green Submitted			2022-12-27	WOS:000468607400059
